PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Khor, CC; Davila, S; Breunis, WB; Lee, YC; Shimizu, C; Wright, VJ; Yeung, RSM; Tan, DEK; Sim, KS; Wang, JJ; Wong, TY; Pang, JX; Mitchell, P; Cimaz, R; Dahdah, N; Cheung, YF; Huang, GY; Yang, WL; Park, IS; Lee, JK; Wu, JY; Levin, M; Burns, JC; Burgner, D; Kuijpers, TW; Hibberd, ML; Lau, YL; Zhang, J; Ma, XJ; Liu, F; Wu, L; Yoo, JJ; Hong, SJ; Kim, KJ; Kim, JJ; Park, YM; Hong, YM; Sohn, S; Jang, GY; Ha, KS; Nam, HK; Byeon, JH; Yun, SW; Han, MK; Lee, KY; Hwang, JY; Rhim, JW; Song, MS; Lee, HD; Kim, DS; Lee, JM; Chang, JS; Tsai, FJ; Liang, CD; Chen, MR; Chi, H; Chiu, NC; Huang, FY; Chang, LY; Huang, LM; Kuo, HC; Huang, KP; Lee, ML; Hwang, B; Huang, YC; Lee, PC; Odam, M; Christiansen, FT; Witt, C; Goldwater, P; Curtis, N; Palasanthiran, P; Ziegler, J; Nissen, M; Nourse, C; Kuipers, IM; Ottenkamp, JJ; Geissler, J; Biezeveld, M; Tacke, C; Filippini, L; Brogan, P; Klein, N; Shah, V; Dillon, M; Booy, R; Shingadia, D; Bose, A; Mukasa, T; Tulloh, R; Michie, C; Newburger, JW; Baker, AL; Rowley, AH; Shulman, ST; Mason, W; Takahashi, M; Melish, ME; Tremoulet, AH; Viswanathan, A; Rochtchina, E; Attia, J; Scott, R; Holliday, E; Harrap, S				Khor, Chiea Chuen; Davila, Sonia; Breunis, Willemijn B.; Lee, Yi-Ching; Shimizu, Chisato; Wright, Victoria J.; Yeung, Rae S. M.; Tan, Dennis E. K.; Sim, Kar Seng; Wang, Jie Jin; Wong, Tien Yin; Pang, Junxiong; Mitchell, Paul; Cimaz, Rolando; Dahdah, Nagib; Cheung, Yiu-Fai; Huang, Guo-Ying; Yang, Wanling; Park, In-Sook; Lee, Jong-Keuk; Wu, Jer-Yuarn; Levin, Michael; Burns, Jane C.; Burgner, David; Kuijpers, Taco W.; Hibberd, Martin L.; Lau, Yu-Lung; Zhang, Jing; Ma, Xiao-Jing; Liu, Fang; Wu, Lin; Yoo, Jeong-Jin; Hong, Soo-Jong; Kim, Kwi-Joo; Kim, Jae-Jung; Park, Young-Mi; Hong, Young Mi; Sohn, Sejung; Jang, Gi Young; Ha, Kee-Soo; Nam, Hyo-Kyoung; Byeon, Jung-Hye; Yun, Sin Weon; Han, Myung Ki; Lee, Kyung-Yil; Hwang, Ja-Young; Rhim, Jung-Woo; Song, Min Seob; Lee, Hyoung-Doo; Kim, Dong Soo; Lee, Jae-Moo; Chang, Jeng-Sheng; Tsai, Fuu-Jen; Liang, Chi-Di; Chen, Ming-Ren; Chi, Hsin; Chiu, Nan-Chang; Huang, Fu-Yuan; Chang, Luan-Yin; Huang, Li-Min; Kuo, Ho-Chang; Huang, Kao-Pin; Lee, Meng-Luen; Hwang, Betau; Huang, Yhu-Chering; Lee, Pi-Chang; Odam, Miranda; Christiansen, Frank T.; Witt, Campbell; Goldwater, Paul; Curtis, Nigel; Palasanthiran, Pamela; Ziegler, John; Nissen, Michael; Nourse, Clare; Kuipers, Irene M.; Ottenkamp, Jaap J.; Geissler, Judy; Biezeveld, Maarten; Tacke, Carline; Filippini, Luc; Brogan, Paul; Klein, Nigel; Shah, Vanita; Dillon, Michael; Booy, Robert; Shingadia, Delane; Bose, Anu; Mukasa, Thomas; Tulloh, Robert; Michie, Colin; Newburger, Jane W.; Baker, Annette L.; Rowley, Anne H.; Shulman, Stanford T.; Mason, Wilbert; Takahashi, Masato; Melish, Marian E.; Tremoulet, Adriana H.; Viswanathan, Ananth; Rochtchina, Elena; Attia, John; Scott, Rodney; Holliday, Elizabeth; Harrap, Stephen		Hong Kong-Shanghai Kawasaki Dis Ge; Korean Kawasaki Dis Genetics Conso; Taiwan Kawasaki Dis Genetics Conso; Int Kawasaki Dis Genetics Consor; US Kawasaki Dis Genetics Consortiu; Blue Mt Eye Study	Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease	NATURE GENETICS			English	Article							COPY NUMBER VARIATION; INTRAVENOUS IMMUNOGLOBULIN; ULCERATIVE-COLITIS; VARIANTS; LINKAGE; POLYMORPHISM; RECEPTORS; GENETICS; DESIGN; POWER	Kawasaki disease is a systemic vasculitis of unknown etiology, with clinical observations suggesting a substantial genetic contribution to disease susceptibility. We conducted a genome-wide association study and replication analysis in 2,173 individuals with Kawasaki disease and 9,383 controls from five independent sample collections. Two loci exceeded the formal threshold for genome-wide significance. The first locus is a functional polymorphism in the IgG receptor gene FCGR2A (encoding an H131R substitution) (rs1801274; P = 7.35 x 10(-11), odds ratio (OR) = 1.32), with the A allele (coding for histadine) conferring elevated disease risk. The second locus is at 19q13, (P = 2.51 x 10(-9), OR = 1.42 for the rs2233152 SNP near MIA and RAB4B; P = 1.68 x 10(-12), OR = 1.52 for rs28493229 in ITPKC), which confirms previous findings(1). The involvement of the FCGR2A locus may have implications for understanding immune activation in Kawasaki disease pathogenesis and the mechanism of response to intravenous immunoglobulin, the only proven therapy for this disease.	[Wright, Victoria J.; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Pediat, London, England; [Khor, Chiea Chuen; Davila, Sonia] Natl Univ Singapore, Genome Inst Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Khor, Chiea Chuen; Hibberd, Martin L.] Natl Univ Singapore, Dept Paediat, Fac Med, Singapore 117548, Singapore; [Breunis, Willemijn B.; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Breunis, Willemijn B.; Kuijpers, Taco W.] Univ Amsterdam, Dept Blood Cell Res, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Burns, Jane C.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Burns, Jane C.] Rady Childrens Hosp, Dept Pediat, San Diego, CA USA; [Yeung, Rae S. M.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Yeung, Rae S. M.] Univ Toronto, Hosp Sick Children, Dept Immunol, Toronto, ON M5G 1X8, Canada; [Yeung, Rae S. M.] Univ Toronto, Hosp Sick Children, Dept Med Sci, Toronto, ON M5G 1X8, Canada; [Wang, Jie Jin; Wong, Tien Yin; Mitchell, Paul] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Sydney, NSW, Australia; [Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Pang, Junxiong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Fac Med, Singapore 117548, Singapore; [Cimaz, Rolando] Anna Meyer Childrens Hosp, Rheumatol Unit, Florence, Italy; [Cimaz, Rolando] Univ Florence, Dept Pediat, Florence, Italy; [Dahdah, Nagib] Univ Montreal, Div Pediat Cardiol, St Justine Univ Hosp Ctr, Montreal, PQ, Canada; [Cheung, Yiu-Fai; Yang, Wanling; Lau, Yu-Lung; Zhang, Jing] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Guo-Ying; Ma, Xiao-Jing; Liu, Fang; Wu, Lin] Fudan Univ, Pediat Cardiovasc Ctr, Childrens Hosp, Shanghai 200433, Peoples R China; [Park, In-Sook; Curtis, Nigel] Univ Ulsan, Dept Pediat, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lee, Jong-Keuk; Kim, Jae-Jung; Park, Young-Mi; Odam, Miranda] Univ Ulsan, Asan Inst Life Sci, Coll Med, Seoul, South Korea; [Burgner, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Burgner, David] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Yoo, Jeong-Jin; Hong, Soo-Jong; Kim, Kwi-Joo] Asan Med Ctr, Dept Pediat, Seoul, South Korea; [Hong, Young Mi; Sohn, Sejung] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea; [Jang, Gi Young; Ha, Kee-Soo; Nam, Hyo-Kyoung; Byeon, Jung-Hye] Univ Korea Hosp, Dept Pediat, Seoul, South Korea; [Yun, Sin Weon] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea; [Han, Myung Ki] Univ Ulsan, Dept Pediat, Gangneung Asan Hosp, Kangnung, South Korea; [Lee, Kyung-Yil; Hwang, Ja-Young; Rhim, Jung-Woo] Catholic Univ Korea, Dept Pediat, Daejeon St Marys Hosp, Taejon, South Korea; [Song, Min Seob] Inje Univ, Dept Pediat, Paik Hosp, Pusan, South Korea; [Lee, Hyoung-Doo] Pusan Natl Univ Hosp, Dept Pediat, Pusan, South Korea; [Kim, Dong Soo] Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp, Seoul, South Korea; [Lee, Jae-Moo] Seoul Clin Labs, Seoul, South Korea; [Chang, Jeng-Sheng; Tsai, Fuu-Jen] China Med Univ & Hosp, Dept Pediat, Taichung, Taiwan; [Liang, Chi-Di; Kuo, Ho-Chang; Huang, Kao-Pin] Chang Gung Mem Hosp, Dept Pediat, Kaohsiung Med Ctr, Kaohsiung, Taiwan; [Chen, Ming-Ren; Chi, Hsin; Chiu, Nan-Chang; Huang, Fu-Yuan] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Kuo, Ho-Chang; Huang, Kao-Pin] Chang Gung Mem Hosp, Dept Allergy & Immunol, Kaohsiung Med Ctr, Kaohsiung, Taiwan; [Lee, Meng-Luen] Changhua Christian Hosp, Div Pediat Cardiol, Changhua, Taiwan; [Lee, Meng-Luen] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Hwang, Betau] Taipei City Hosp, Dept Pediat, Zhongxiao Branch, Taipei, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Linkou, Taiwan; [Lee, Pi-Chang] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Odam, Miranda; Christiansen, Frank T.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Witt, Campbell] PathWest Royal Perth Hosp, Dept Clin Immunol & Immunogenet, Perth, WA, Australia; [Goldwater, Paul] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia; [Goldwater, Paul] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Curtis, Nigel] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Palasanthiran, Pamela; Ziegler, John] Sydney Childrens Hosp, Paediat HIV Serv, Randwick, NSW, Australia; [Nissen, Michael] Univ Queensland, Australian Infect Dis Ctr, Sch Med, Fac Hlth Sci, Brisbane, Qld, Australia; [Nourse, Clare] Univ Queensland, Mater Childrens Hosp, Fac Paediat, Brisbane, Qld 4101, Australia; [Filippini, Luc] Juliana Childrens Hosp, Dept Paediat, The Hague, Netherlands; [Brogan, Paul; Klein, Nigel; Shah, Vanita; Dillon, Michael] Inst Child Hlth, London, England; [Booy, Robert; Shingadia, Delane; Bose, Anu; Mukasa, Thomas] Royal London Hosp, Acad Unit Paediat, Barts & London Sch Med & Dent, London E1 1BB, England; [Tulloh, Robert] Univ Hosp Bristol Natl Hlth Serv Fdn Trust, Bristol Congenital Heart Ctr, Bristol, Avon, England; [Newburger, Jane W.; Baker, Annette L.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Michie, Colin] Ealing Gen Hosp, Dept Paediat, London, England; [Rowley, Anne H.; Shulman, Stanford T.] Northwestern Univ, Childrens Mem Hosp, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA; [Mason, Wilbert] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA USA; [Takahashi, Masato] Childrens Hosp Los Angeles, Dept Cardiol, Los Angeles, CA 90027 USA; [Melish, Marian E.] Kapliolani Childrens Hosp, Dept Pediat, Honolulu, HI USA; [Viswanathan, Ananth] UCL, Inst Ophthalmol, London, England; [Viswanathan, Ananth] Moorfields Eye Hosp, Natl Inst Hlth Res Biomed Res Ctr Ophthalmol, Natl Hlth Serv Fdn Trust, London, England; [Rochtchina, Elena] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Rochtchina, Elena] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Attia, John; Scott, Rodney; Holliday, Elizabeth] Hunter Med Res Inst, Newcastle, NSW, Australia; [Harrap, Stephen] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia	Imperial College London; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academia Sinica - Taiwan; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Centre for Eye Research Australia; University of Melbourne; University of Sydney; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Universite de Montreal; University of Hong Kong; Fudan University; University of Ulsan; University of Ulsan; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Western Australia; University of Ulsan; Asan Medical Center; Ewha Womans University; Korea University; Korea University Medicine (KU Medicine); Chung Ang University; Chung Ang University Hospital; University of Ulsan; Catholic University of Korea; Inje University; Pusan National University; Pusan National University Hospital; Yonsei University; Yonsei University Health System; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Mackay Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Taipei City Hospital; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; University of Western Australia; Royal Perth Hospital; SA Pathology; Womens & Childrens Hospital Australia; University of Adelaide; Royal Children's Hospital Melbourne; University of Queensland; University of Queensland; University of London; University College London; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Harvard University; Boston Children's Hospital; Imperial College London; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Hunter Medical Research Institute; University of Newcastle; University of Melbourne	Levin, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Pediat, London, England.	m.levin@imperial.ac.uk; jcburns@ucsd.edu; david.burgner@mcri.edu.au; t.w.kuijpers@amc.uva.nl; hibberdml@gis.a-star.edu.sg	Nissen, Michael D/M-6823-2013; Burns, Jane C/J-6167-2015; MA, XIAO/HHN-5611-2022; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Wang, Jie Jin/P-1499-2014; Nourse, Clare/F-5285-2016; Attia, John R/F-5376-2013; Hong, Soo-Jong/AAR-1788-2020; Palasanthiran, Pamela/AAK-6907-2021; Song, Min Seob/R-3075-2019; Tsai, Fuu-Jen/J-4140-2015; Kuo, Ho-Chang/AAQ-6644-2020; Shimizu, Chisato/J-6516-2015; Hibberd, Martin L/D-5050-2009; Mitchell, Paul/P-1498-2014; Pang, Junxiong/AAI-5115-2021; Lee, Yi-Ching/AAE-6900-2022; CIMAZ, Rolando/AAA-9058-2019; Wu, Jer-Yuarn/S-7010-2018; Scott, Rodney/B-2827-2013; Lau, Yu Lung/C-4322-2009; Curtis, Nigel/B-3491-2012; Cheung, Yiu Fai/C-4240-2009	Nissen, Michael D/0000-0003-1686-3313; Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Nourse, Clare/0000-0001-7246-8540; Attia, John R/0000-0001-9800-1308; Hong, Soo-Jong/0000-0003-1409-2113; Palasanthiran, Pamela/0000-0002-1625-4051; Kuo, Ho-Chang/0000-0002-3295-2984; Lee, Yi-Ching/0000-0002-7734-5619; CIMAZ, Rolando/0000-0002-3260-4226; Scott, Rodney/0000-0001-7724-3404; Rowley, Anne/0000-0003-4695-6676; Wright, Victoria/0000-0001-7826-1516; Hibberd, Martin/0000-0001-8587-1849; Shimizu, Chisato/0000-0002-3149-2699; Levin, Michael/0000-0003-2767-6919; Yeung, Rae/0000-0003-2361-725X; BYEON, JUNGHYE/0000-0001-5479-2451; CHANG, LUAN-YIN/0000-0003-2632-1956; Khor, Chiea Chuen/0000-0002-1128-4729; Brogan, Paul/0000-0001-6178-6893; Burgner, David/0000-0002-8304-4302; Tulloh, Robert/0000-0002-3180-6993; Lee, Kyung-Yil/0000-0001-6510-1580; Lau, Yu Lung/0000-0002-4780-0289; Sim, Kar Seng/0000-0002-3822-7759; Harrap, Stephen/0000-0003-2907-6714; Curtis, Nigel/0000-0003-3446-4594; Tan, Dennis/0000-0001-6149-5084; Klein, Nigel/0000-0003-3925-9258; Cheung, Yiu Fai/0000-0002-7279-4992; HUANG, LI-MIN/0000-0002-9291-260X; Pang, Junxiong, Vincent/0000-0002-9788-701X	Sainte-Justine Hospital research center; US National Institutes of Health, National Heart, Lung, Blood Institute [HL69413]; National Heart Foundation of Australia; Agency for Science, Technology, and Research, Singapore; Ministry of Health & Welfare of the Republic of Korea [A010384]; Shun Tak District Min Yuen Tong; Victorian Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069413] Funding Source: NIH RePORTER	Sainte-Justine Hospital research center; US National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart Foundation of Australia(National Heart Foundation of Australia); Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health & Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Shun Tak District Min Yuen Tong; Victorian Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank all the individuals with Kawasaki disease and their families for participating in this study. We are grateful to W.-Y. Meah, H.-B. Toh, X. Chen, K.-K. Heng, C.-H. Wong, P.-L. Ng, S.H.Y. Chen and J.-W. Tay for technical assistance, to J. Pancheri, N. Innocentini, D. Donati and S. Fernandez for subject data collection and to D. Scherrer for laboratory assistance. The authors acknowledge the contributions of The Kawasaki Syndrome Support Group (UK) for their assistance in recruitment of the UK collection. This study makes use of data generated by the Wellcome Trust Case Control Consortium 2. A full list of the investigators who contributed to the generation of this data is available from the WTCCC2 website (see URLs). This work was funded in part by internal funding from the Sainte-Justine Hospital research center (awarded to N.D.), by grants from the US National Institutes of Health, National Heart, Lung, Blood Institute (HL69413, awarded to J.C.B.), from the National Heart Foundation of Australia (to D.B.) and by the Agency for Science, Technology, and Research, Singapore. The Korean Kawasaki Disease Genetics Consortium was supported by a grant from the Ministry of Health & Welfare of the Republic of Korea (A010384). The Hong Kong Kawasaki Disease Genetics Consortium was supported by the Shun Tak District Min Yuen Tong. The Australian research activity was partly supported by the Victorian Government's Operational Infrastructure Support Program.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; [Anonymous], 2005, NAT GENET, V37, P1153, DOI 10.1038/ng1105-1153; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2008, J PEDIATR-US, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Falcini F, 1997, CLIN EXP RHEUMATOL, V15, P685; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ikram MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001184; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kim S, 2005, CURR OPIN PEDIATR, V17, P695, DOI 10.1097/01.mop.0000187190.97166.83; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; LEVIN M, 1991, ARCH DIS CHILD, V66, P1369, DOI 10.1136/adc.66.12.1369; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Onouchi Y, 2009, PEDIATR RES, V65, p46R, DOI 10.1203/PDR.0b013e31819dba60; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rowley AH, 2008, NAT REV MICROBIOL, V6, P394, DOI 10.1038/nrmicro1853; Shimizu C, 2010, J HUM GENET, V55, P779, DOI 10.1038/jhg.2010.109; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Tsai MH, 2006, J PEDIATR-US, V148, P38, DOI 10.1016/j.jpeds.2005.08.024	46	228	244	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1241	1246		10.1038/ng.981	http://dx.doi.org/10.1038/ng.981			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22081228				2022-12-25	WOS:000297931400020
J	Accili, D				Accili, Domenico			Domenico Accili	NATURE MEDICINE			English	Editorial Material									[Accili, Domenico] Columbia Univ Coll Phys & Surg, Berrie Diabet Ctr, New York, NY 10032 USA; [Accili, Domenico] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Accili, D (corresponding author), Columbia Univ Coll Phys & Surg, Berrie Diabet Ctr, 630 W 168th St, New York, NY 10032 USA.		de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; Sinclair, David/0000-0002-9936-436X; de Cabo, Rafael/0000-0002-3354-2442	NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG019719, R01AG028730] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG028730, R01 AG019719, R01 AG028730] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))			0	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1350	1351		10.1038/nm1111-1350	http://dx.doi.org/10.1038/nm1111-1350			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064411				2022-12-25	WOS:000296779300022
J	Anastassiadis, T; Deacon, SW; Devarajan, K; Ma, HC; Peterson, JR				Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.			Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity	NATURE BIOTECHNOLOGY			English	Article							INTERACTION MAP; DRUG DISCOVERY; CANCER KINOME; UPDATE; EGFR	Small-molecule protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents. Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases. Interpretation of experiments that use these compounds is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors. Here we used functional assays to profile the activity of 178 commercially available kinase inhibitors against a panel of 300 recombinant protein kinases. Quantitative analysis revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity. Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases. The results have implications for drug development and provide a resource for selecting compounds to elucidate kinase function and for interpreting the results of experiments involving kinase inhibitors.	[Anastassiadis, Theonie; Devarajan, Karthik; Peterson, Jeffrey R.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Deacon, Sean W.; Ma, Haiching] React Biol Corp, Malvern, PA USA	Fox Chase Cancer Center	Peterson, JR (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	jeffrey.peterson@fccc.edu		Peterson, Jeffrey/0000-0002-0604-718X	W.W. Smith Foundation; Fox Chase Cancer Center; US National Institutes of Health [RO1 GM083025, P30 CA006927, RO1 HG003818, R44 CA114995]; NATIONAL CANCER INSTITUTE [P30CA006927, R44CA114995] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083025] Funding Source: NIH RePORTER	W.W. Smith Foundation; Fox Chase Cancer Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge B. Turk, A. Andrews and members of the Peterson laboratory for comments on the manuscript and R. Hartman of Reaction Biology Corp. for developing the Kinase Inhibitor Resource (KIR) web application tool. This work was supported by a W.W. Smith Foundation Award, funding from the Keystone Program in Head and Neck Cancer of Fox Chase Cancer Center and by US National Institutes of Health awards RO1 GM083025 to J.R.P. and P30 CA006927 to Fox Chase Cancer Center. HotSpot technology development was partially supported by the US National Institutes of Health (RO1 HG003818 and R44 CA114995 to H.M.).	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cockerill S, 2001, BIOORG MED CHEM LETT, V11, P1401, DOI 10.1016/S0960-894X(01)00219-0; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Miduturu CV, 2011, CHEM BIOL, V18, P868, DOI 10.1016/j.chembiol.2011.05.010; Morphy R, 2004, DRUG DISCOV TODAY, V9, P641, DOI 10.1016/S1359-6446(04)03163-0; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; van der Loo M.P.J, 2010, 10003 STAT NETH; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Yee TW, 2003, STAT MODEL, V3, P15, DOI 10.1191/1471082X03st045oa; Zhang Q, 2006, J AM CHEM SOC, V128, P2182, DOI 10.1021/ja0567485	36	617	653	3	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1039	U117		10.1038/nbt.2017	http://dx.doi.org/10.1038/nbt.2017			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22037377	Green Accepted			2022-12-25	WOS:000296801300027
J	Carlsson, J; Coleman, RG; Setola, V; Irwin, JJ; Fan, H; Schlessinger, A; Sali, A; Roth, BL; Shoichet, BK				Carlsson, Jens; Coleman, Ryan G.; Setola, Vincent; Irwin, John J.; Fan, Hao; Schlessinger, Avner; Sali, Andrej; Roth, Bryan L.; Shoichet, Brian K.			Ligand discovery from a dopamine D-3 receptor homology model and crystal structure	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED-RECEPTOR; 2ND EXTRACELLULAR LOOP; DRUG DISCOVERY; BINDING-SITE; D3 RECEPTOR; DATABASE; AGONISTS; DOCKING; DESIGN; ANTAGONISTS	G protein-coupled receptors (GPCRs) are intensely studied as drug targets and for their role in signaling. With the determination of the first crystal structures, interest in structure-based ligand discovery increased. Unfortunately, for most GPCRs no experimental structures are available. The determination of the D-3 receptor structure and the challenge to the community to predict it enabled a fully prospective comparison of ligand discovery from a modeled structure versus that of the subsequently released crystal structure. Over 3.3 million molecules were docked against a homology model, and 26 of the highest ranking were tested for binding. Six had affinities ranging from 0.2 to 3.1 mu M. Subsequently, the crystal structure was released and the docking screen repeated. Of the 25 compounds selected, five had affinities ranging from 0.3 to 3.0 mu M. One of the new ligands from the homology model screen was optimized for affinity to 81 nM. The feasibility of docking screens against modeled GPCRs more generally is considered.	[Carlsson, Jens; Coleman, Ryan G.; Irwin, John J.; Fan, Hao; Schlessinger, Avner; Sali, Andrej; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Setola, Vincent; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Fan, Hao; Schlessinger, Avner; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Fan, Hao; Schlessinger, Avner; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bryan_roth@med.unc.edu; shoichet@cgl.ucsf.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Setola, Vincent/0000-0002-9791-2270; Coleman, Ryan/0000-0003-4093-4281; Irwin, John/0000-0002-1195-6417; Carlsson, Jens/0000-0003-4623-2977	US National Institutes of Health [GM59957, GM71630, U54GM093342, GM71790, R01GM54762]; National Institutes of Mental Health; Knut and Alice Wallenberg Foundation; National Research Service [F32GM096544, F32GM088991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096544, R01GM054762, F32GM088991, U54GM093342, P01GM071790, R01GM071630, R01GM059957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R01DA027170] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Q. Yang and K. Sharp for help with 3K-ENM, M. Burlingame with help with compound LC/MS and G. Barnea (Brown University) for supplying beginning Tango constructs and a plasmid encoding the human V<INF>2</INF> Tango receptor. We thank OpenEye Scientific Software for the use of OEChem and Omega. Supported by US National Institutes of Health grants GM59957 and GM71630 (to B.K.S.), U54GM093342 (to A. Sali and B.K.S.), GM71790 and R01GM54762 (to A. Sali), the National Institutes of Mental Health Psychoactive Drug Screening Program (to B.L.R.), postdoctoral fellowships from the Knut and Alice Wallenberg Foundation (to J.C.) and National Research Service Award-Kirschstein fellowships F32GM096544 (to R.G.C.) and F32GM088991 (to A. Schlessinger).	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Bissantz C, 2005, PROTEINS, V61, P938, DOI 10.1002/prot.20651; Bucci M, 2010, NAT CHEM BIOL, V6, P847, DOI 10.1038/nchembio.489; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; de Graaf C, 2008, PROTEINS, V71, P599, DOI 10.1002/prot.21724; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; DONNELLY D, 1994, CURR OPIN STRUC BIOL, V4, P582, DOI 10.1016/S0959-440X(94)90221-6; Engel S, 2008, J AM CHEM SOC, V130, P5115, DOI 10.1021/ja077620l; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Evers A, 2005, J MED CHEM, V48, P1088, DOI 10.1021/jm0491804; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Evers A, 2003, J MOL BIOL, V334, P327, DOI 10.1016/j.jmb.2003.09.032; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jensen NH, 2008, NEUROPSYCHOPHARMACOL, V33, P2303, DOI 10.1038/sj.npp.1301646; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Kellenberger E, 2007, J MED CHEM, V50, P1294, DOI 10.1021/jm061389p; Kiss R, 2008, J MED CHEM, V51, P3145, DOI 10.1021/jm7014777; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kratochwil NA, 2005, J CHEM INF MODEL, V45, P1324, DOI 10.1021/ci050221u; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Newman AH, 2009, J MED CHEM, V52, P2559, DOI 10.1021/jm900095y; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Salo OMH, 2005, J MED CHEM, V48, P7166, DOI 10.1021/jm050565b; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Varady J, 2003, J MED CHEM, V46, P4377, DOI 10.1021/jm030085p; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yang QY, 2009, PROTEINS, V74, P682, DOI 10.1002/prot.22184	50	232	236	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					769	778		10.1038/nchembio.662	http://dx.doi.org/10.1038/nchembio.662			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21926995	Green Submitted, Green Accepted			2022-12-25	WOS:000296381600006
J	Duggan, KC; Hermanson, DJ; Musee, J; Prusakiewicz, JJ; Scheib, JL; Carter, BD; Banerjee, S; Oates, JA; Marnett, LJ				Duggan, Kelsey C.; Hermanson, Daniel J.; Musee, Joel; Prusakiewicz, Jeffery J.; Scheib, Jami L.; Carter, Bruce D.; Banerjee, Surajit; Oates, J. A.; Marnett, Lawrence J.			(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2	NATURE CHEMICAL BIOLOGY			English	Article							CYCLOOXYGENASE ACTIVE-SITE; ANTIINFLAMMATORY AGENTS; SYNAPTIC-TRANSMISSION; OXIDATIVE METABOLITE; ARACHIDONIC-ACID; GLYCEROL ESTER; 2-ARACHIDONOYLGLYCEROL; BINDING; RECEPTOR; SYSTEM	Cyclooxygenase-2 (COX-2) catalyzes the oxygenation of arachidonic acid and the endocannabinoids 2-arachidonoylglycerol and arachidonoylethanolamide. Evaluation of a series of COX-2 inhibitors revealed that many weak competitive inhibitors of arachidonic acid oxygenation are potent inhibitors of endocannabinoid oxygenation. (R) enantiomers of ibuprofen, naproxen and flurbiprofen, which are considered to be inactive as COX-2 inhibitors, are potent 'substrate-selective inhibitors' of endocannabinoid oxygenation. Crystal structures of the COX-2-(R)-naproxen and COX-2-(R)-flurbiprofen complexes verified this unexpected binding and defined the orientation of the (R) enantiomers relative to (S) enantiomers. (R)-Profens selectively inhibited endocannabinoid oxygenation by lipopolysaccharide-stimulated dorsal root ganglion (DRG) cells. Substrate-selective inhibition provides new tools for investigating the role of COX-2 in endocannabinoid oxygenation and a possible explanation for the ability of (R)-profens to maintain endocannabinoid tone in models of neuropathic pain.	[Duggan, Kelsey C.; Musee, Joel; Prusakiewicz, Jeffery J.; Scheib, Jami L.; Carter, Bruce D.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Marnett, Lawrence J.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Banerjee, Surajit] Cornell Univ, NE Collaborat Access Team, Ithaca, NY USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Banerjee, Surajit] Argonne Natl Lab, Argonne, IL 60439 USA; [Oates, J. A.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37212 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Oates, J. A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Cornell University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	larry.marnett@vanderbilt.edu		Banerjee, Surajit/0000-0002-9414-7163	A.B. Hancock Jr. Memorial Laboratory for Cancer Research and by research [CA89450, GM15431, NS064278]; US National Institutes of Health [DA022873, DA031572]; National Center for Research Resources at the US National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873, F31DA031572] Funding Source: NIH RePORTER	A.B. Hancock Jr. Memorial Laboratory for Cancer Research and by research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the A.B. Hancock Jr. Memorial Laboratory for Cancer Research and by research (CA89450, GM15431, NS064278) and training grants (DA022873, DA031572) from the US National Institutes of Health. It is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the US National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. We are grateful to J. Harp for assistance with crystallography; K. Masuda, M. Brown, R. Stevens and B. Cravatt for a sample of FAAH; A. Brash for a sample of 15-lipoxygenase and J. Uddin for a sample of fluorocoxib A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; BRUNE K, 1992, J CLIN PHARMACOL, V32, P944, DOI 10.1002/j.1552-4604.1992.tb04643.x; Chen JK, 2008, J BIOL CHEM, V283, P24514, DOI 10.1074/jbc.M709873200; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; Di Marzo V, 2005, HANDB EXP PHARMACOL, V168, P147; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Guay J, 2004, J BIOL CHEM, V279, P24866, DOI 10.1074/jbc.M403106200; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; JAMALI F, 1988, J PHARM SCI, V77, P666, DOI 10.1002/jps.2600770805; Kalgutkar AS, 1998, J MED CHEM, V41, P4800, DOI 10.1021/jm980303s; Kingsley PJ, 2007, METHOD ENZYMOL, V433, P91, DOI 10.1016/s0076-6879(07)33005-X; Kogan N M, 2006, J Endocrinol Invest, V29, P3; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Liang Y, 2008, BRIT J PHARMACOL, V154, P1079, DOI 10.1038/bjp.2008.142; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; LOTSCH J, 1995, BRIT J CLIN PHARMACO, V40, P339, DOI 10.1111/j.1365-2125.1995.tb04556.x; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Richie-Jannetta R, 2010, PROSTAG OTH LIPID M, V92, P19, DOI 10.1016/j.prostaglandins.2010.01.003; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Rouzer CA, 2005, J BIOL CHEM, V280, P26690, DOI 10.1074/jbc.M501021200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664; UEDA N, 1995, BBA-LIPID LIPID MET, V1254, P127, DOI 10.1016/0005-2760(94)00170-4; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xie SQ, 2010, CHEM RES TOXICOL, V23, P1890, DOI 10.1021/tx1002194; Yang HW, 2008, CURR PHARM DESIGN, V14, P1443, DOI 10.2174/138161208784480144; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	48	129	134	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					803	809		10.1038/nchembio.663	http://dx.doi.org/10.1038/nchembio.663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	22053353	Green Accepted			2022-12-25	WOS:000296381600010
J	Harris, AF; Nimmo, D; McKemey, AR; Kelly, N; Scaife, S; Donnelly, CA; Beech, C; Petrie, WD; Alphey, L				Harris, Angela F.; Nimmo, Derric; McKemey, Andrew R.; Kelly, Nick; Scaife, Sarah; Donnelly, Christl A.; Beech, Camilla; Petrie, William D.; Alphey, Luke			Field performance of engineered male mosquitoes	NATURE BIOTECHNOLOGY			English	Article							AEDES-AEGYPTI; DOMINANT; FITNESS; DIPTERA; TEPHRITIDAE; SYSTEMS	Dengue is the most medically important arthropod-borne viral disease, with 50-100 million cases reported annually worldwide(1). As no licensed vaccine or dedicated therapy exists for dengue, the most promising strategies to control the disease involve targeting the predominant mosquito vector, Aedes aegypti. However, the current methods to do this are inadequate. Various approaches involving genetically engineered mosquitoes have been proposed(2-4), including the release of transgenic sterile males(5-10). However, the ability of laboratory-reared, engineered male mosquitoes to effectively compete with wild males in terms of finding and mating with wild females, which is critical to the success of these strategies, has remained untested. We report data from the first open-field trial involving a strain of engineered mosquito. We demonstrated that genetically modified male mosquitoes, released across 10 hectares for a 4-week period, mated successfully with wild females and fertilized their eggs. These findings suggest the feasibility of this technology to control dengue by suppressing field populations of A. aegypti.	[Nimmo, Derric; McKemey, Andrew R.; Scaife, Sarah; Beech, Camilla; Alphey, Luke] Oxitec Ltd, Oxford, England; [Harris, Angela F.; Kelly, Nick; Petrie, William D.] Mosquito Res & Control Unit MRCU, Grand Cayman, KY USA; [Harris, Angela F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London; University of Oxford	Alphey, L (corresponding author), Oxitec Ltd, Oxford, England.	luke.alphey@oxitec.com		Donnelly, Christl/0000-0002-0195-2463; Alphey, Luke/0000-0002-2916-3802	Adapco; Bayer; Central Life Sciences; UK Medical Research Council; Medical Research Council [G0600719B] Funding Source: researchfish	Adapco; Bayer(Bayer AG); Central Life Sciences; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Z. Ebanks, I. Black, Z. Curtis, C. Phillips, A. Miles and T. Matthews for technical and logistical assistance, G. Labbe and P. Gray for strain development, and G. Labbe and N. Morrison for manuscript review. We are grateful to the Lands & Survey Department of the Cayman Islands Government for permission to use imagery and data. A. F. H. thanks Adapco, Bayer and Central Life Sciences for supporting her PhD studentship. C. A. D. thanks the UK Medical Research Council for Centre funding.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey Luke, 2009, Journal of Biology (London), V8, P40, DOI 10.1186/jbiol143; [Anonymous], 2009, RISK ANAL OX513A AED; ANSARI MA, 1977, INDIAN J MED RES, V65, P91; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Dyck V.A., 2006, STERILE INSECT TECHN; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Lee H. L., 2009, Dengue Bulletin, V33, P103; Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mayer DG, 1998, PREV VET MED, V36, P1, DOI 10.1016/S0167-5877(98)00078-6; McKemey A., 2008, P 2 INT WORKSH WILD; Nazni W. A., 2009, Dengue Bulletin, V33, P124; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Polson K. A., 2002, Dengue Bulletin, V26, P178; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Shelly TE, 2007, J ECON ENTOMOL, V100, P273, DOI 10.1603/0022-0493(2007)100[273:SITAMF]2.0.CO;2; Simmons GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024110; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Vasan S, 2008, SCI REPORT INNOVATIV; Vreysen MJB, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P325, DOI 10.1007/1-4020-4051-2_12; WHO-TDR, 2006, SCI WORK GROUP REP D, P162; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	38	259	276	1	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1034	U109		10.1038/nbt.2019	http://dx.doi.org/10.1038/nbt.2019			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22037376				2022-12-25	WOS:000296801300026
J	Studer, A; Zhao, Q; Ross-Ibarra, J; Doebley, J				Studer, Anthony; Zhao, Qiong; Ross-Ibarra, Jeffrey; Doebley, John			Identification of a functional transposon insertion in the maize domestication gene tb1	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; ELEMENT INSERTIONS; EVOLUTION; RETROTRANSPOSON; POLYMORPHISM; EXPRESSION; PLANT; COALESCENT; DIVERSITY; HAPLOTYPE	Genetic diversity created by transposable elements is an important source of functional variation upon which selection acts during evolution(1-6). Transposable elements are associated with adaptation to temperate climates in Drosophila(7), a SINE element is associated with the domestication of small dog breeds from the gray wolf(8) and there is evidence that transposable elements were targets of selection during human evolution(9). Although the list of examples of transposable elements associated with host gene function continues to grow, proof that transposable elements are causative and not just correlated with functional variation is limited. Here we show that a transposable element (Hopscotch) inserted in a regulatory region of the maize domestication gene, teosinte branched1 (tb1), acts as an enhancer of gene expression and partially explains the increased apical dominance in maize compared to its progenitor, teosinte. Molecular dating indicates that the Hopscotch insertion predates maize domestication by at least 10,000 years, indicating that selection acted on standing variation rather than new mutation.	[Studer, Anthony; Zhao, Qiong; Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Doebley, J (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jdoebley@wisc.edu	Ross-Ibarra, Jeffrey/D-7782-2011; Studer, Anthony/V-2570-2019	Ross-Ibarra, Jeffrey/0000-0003-1656-4954; 	US Department of Agriculture [MSN101593]; US National Science Foundation [DBI0820619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	US Department of Agriculture(United States Department of Agriculture (USDA)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Doebley laboratory for technical assistance, especially H. Wang. We also thank A.J. Eckert, K. Thornton, G. Coop and R.A. Cartwright for helpful discussion and J. Holland for statistical advice. This work is supported by US Department of Agriculture Hatch grant MSN101593 and US National Science Foundation grant DBI0820619.	Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Clark RM, 2005, MOL BIOL EVOL, V22, P2304, DOI 10.1093/molbev/msi228; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Gonzalez J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000905; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; HUDSON RR, 1987, GENETICS, V116, P153; MACKAY TFC, 1992, GENETICS, V130, P315; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Pi WH, 2010, P NATL ACAD SCI USA, V107, P12992, DOI 10.1073/pnas.1004139107; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; TORKAMANZEHI A, 1992, GENETICS, V131, P73; WHITE SE, 1994, P NATL ACAD SCI USA, V91, P11792, DOI 10.1073/pnas.91.25.11792; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; ZHAO Q, 2006, THESIS U WISCONSIN M; Zhao Q, 2011, GENET RES, V93, P65, DOI 10.1017/S0016672310000509	33	439	457	3	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1160	U164		10.1038/ng.942	http://dx.doi.org/10.1038/ng.942			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21946354	Green Accepted			2022-12-25	WOS:000296584000024
J	Benedetti, F; Amanzio, M; Rosato, R; Blanchard, C				Benedetti, Fabrizio; Amanzio, Martina; Rosato, Rosalba; Blanchard, Catherine			Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors	NATURE MEDICINE			English	Article							EXPECTATION; DISSECTION; RESPONSES; SYSTEMS; DISEASE; PAIN	Placebo analgesia is mediated by both opioid and nonopioid mechanisms, but so far nothing is known about the nonopioid component. Here we show that the specific CB1 cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-1-pyrazole-3-carboxamide (rimonabant or SR141716) blocks nonopioid placebo analgesic responses but has no effect on opioid placebo responses. These findings suggest that the endocannabinoid system has a pivotal role in placebo analgesia in some circumstances when the opioid system is not involved.	[Benedetti, Fabrizio] Univ Turin, Dept Neurosci, Sch Med, Turin, Italy; [Benedetti, Fabrizio] Natl Inst Neurosci, Turin, Italy; [Amanzio, Martina; Rosato, Rosalba] Univ Turin, Dept Psychol, Turin, Italy; [Rosato, Rosalba] San Giovanni Battista Hosp, Unit Canc Epidemiol, Prevent Oncol Ctr CPO Piemonte, Turin, Italy; [Blanchard, Catherine] Ctr Endocrine & Metab Disorders, Aoste, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Benedetti, F (corresponding author), Univ Turin, Dept Neurosci, Sch Med, Turin, Italy.	fabrizio.benedetti@unito.it	Amanzio, Martina/A-9085-2010	Amanzio, Martina/0000-0002-2504-032X; ROSATO, Rosalba/0000-0002-4921-374X	Istituto San Paolo di Torino and Regione Piemonte (Turin, Italy); Volkswagen Foundation (Hannover, Germany)	Istituto San Paolo di Torino and Regione Piemonte (Turin, Italy); Volkswagen Foundation (Hannover, Germany)(Volkswagen)	This work was supported by grants from Istituto San Paolo di Torino and Regione Piemonte (Turin, Italy) and from the Volkswagen Foundation (Hannover, Germany).	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; BENEDETTI F, 1995, LANCET, V346, P1231, DOI 10.1016/S0140-6736(95)92938-X; Benedetti F, 2007, J NEUROSCI, V27, P11934, DOI 10.1523/JNEUROSCI.3330-07.2007; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fowler CJ, 2007, BRIT J PHARMACOL, V152, P594, DOI 10.1038/sj.bjp.0707379; Guo JY, 2010, J PSYCHOPHARMACOL, V24, P1561, DOI 10.1177/0269881109104848; Hamza May, 2009, Curr Mol Pharmacol, V2, P1; Horti AG, 2006, J NUCL MED, V47, P1689; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wong DF, 2010, NEUROIMAGE, V52, P1505, DOI 10.1016/j.neuroimage.2010.04.034; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	20	186	191	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1228	1230		10.1038/nm.2435	http://dx.doi.org/10.1038/nm.2435			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21963514	Green Submitted			2022-12-25	WOS:000296022100039
J	Wang, H; Claveau, D; Vaillancourt, JP; Roemer, T; Meredith, TC				Wang, Hao; Claveau, David; Vaillancourt, John P.; Roemer, Terry; Meredith, Timothy C.			High-frequency transposition for determining antibacterial mode of action	NATURE CHEMICAL BIOLOGY			English	Article							STAPHYLOCOCCUS-AUREUS; DRUG DISCOVERY; QUINOLONE RESISTANCE; BACILLUS-SUBTILIS; ACID BIOSYNTHESIS; ESCHERICHIA-COLI; GENE-EXPRESSION; IN-VITRO; BAD BUGS; IDENTIFICATION	Connecting bacterial growth inhibitors to molecular targets at the whole-cell level is a major impediment to antibacterial development. Herein we report the design of a highly efficient and versatile bacteriophage-based mariner transposon delivery system in Staphylococcus aureus for determining inhibitor mode of action. Using bacteriophage-mediated delivery of concatameric minitransposon cassettes, we generated nonclonal transposant libraries with genome-wide insertion-site coverage in either laboratory or methicillin-resistant strain backgrounds and screened for drug resistance in situ on a single agar plate in one step. A gradient of gene-target expression levels, along with a correspondingly diverse assortment of drug-resistant phenotypes, was achieved by fitting the transposon cassette with a suite of outward-facing promoters. Using a panel of antibiotics, we demonstrate the ability to unveil not only an inhibitor's molecular target but also its route of cellular entry, efflux susceptibility and other off-target resistance mechanisms.	[Wang, Hao; Claveau, David; Vaillancourt, John P.; Roemer, Terry; Meredith, Timothy C.] Merck Frosst Ctr Therapeut Res, Div Infect Dis, Kirkland, PQ, Canada	Merck & Company	Meredith, TC (corresponding author), Novartis Inst Biomed Res, Infect Dis, Cambridge, MA USA.	terry_roemer@merck.com; tcmered@gmail.com	Meredith, Timothy/X-2713-2019	Meredith, Timothy/0000-0002-1901-6841				Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Anthony RM, 2005, J MICROBIOL METH, V60, P47, DOI 10.1016/j.mimet.2004.08.009; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bockstael K, 2009, CENT EUR J MED, V4, P141, DOI 10.2478/s11536-008-0088-9; Bordi C, 2008, APPL ENVIRON MICROB, V74, P3419, DOI 10.1128/AEM.00476-08; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; Breithaupt H, 1999, NAT BIOTECHNOL, V17, P1165, DOI 10.1038/70705; Brotz-Oesterhelt H, 2010, FUTURE MICROBIOL, V5, P1553, DOI 10.2217/FMB.10.119; CARLETON S, 1984, EMBO J, V3, P2407, DOI 10.1002/j.1460-2075.1984.tb02147.x; CASSELS R, 1995, J BACTERIOL, V177, P5161, DOI 10.1128/jb.177.17.5161-5165.1995; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; de Crecy-Lagard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-245; Donald RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/j.chembiol.2009.07.004; Freiberg C, 2006, MOL CELL PROTEOMICS, V5, P2326, DOI 10.1074/mcp.M600127-MCP200; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hurdle JG, 2004, J ANTIMICROB CHEMOTH, V54, P549, DOI 10.1093/jac/dkh352; Ince D, 2003, J BACTERIOL, V185, P6883, DOI 10.1128/JB.185.23.6883-6892.2003; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lange RP, 2007, CURR PHARM DESIGN, V13, P3140, DOI 10.2174/138161207782110408; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luong TT, 2002, J BACTERIOL, V184, P3623, DOI 10.1128/JB.184.13.3623-3629.2002; Meredith TC, 2008, J BACTERIOL, V190, P3046, DOI 10.1128/JB.01880-07; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; Mills SD, 2006, BIOCHEM PHARMACOL, V71, P1096, DOI 10.1016/j.bcp.2005.11.025; Ng EY, 1996, ANTIMICROB AGENTS CH, V40, P1881, DOI 10.1128/AAC.40.8.1881; NG EYW, 1994, ANTIMICROB AGENTS CH, V38, P1345, DOI 10.1128/AAC.38.6.1345; NOVICK RP, 1986, J MOL BIOL, V192, P209, DOI 10.1016/0022-2836(86)90360-8; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Payne David J, 2004, Methods Mol Biol, V266, P231; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Salipante SJ, 2003, ANTIMICROB AGENTS CH, V47, P3840, DOI 10.1128/AAC.47.12.3840-3845.2003; SAMMES PG, 1990, COMPREHENSIVE MED CH, P255; Saxild HH, 2001, J BACTERIOL, V183, P6175, DOI 10.1128/JB.183.21.6175-6183.2001; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; SWEDBERG G, 1979, J BACTERIOL, V137, P129, DOI 10.1128/JB.137.1.129-136.1979; Theuretzbacher U, 2009, INT J ANTIMICROB AG, V34, P15, DOI 10.1016/j.ijantimicag.2009.02.005; WERNER RG, 1976, EUR J BIOCHEM, V68, P1, DOI 10.1111/j.1432-1033.1976.tb10758.x; Wolz C, 2010, INT J MED MICROBIOL, V300, P142, DOI 10.1016/j.ijmm.2009.08.017; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Xia MM, 1999, PLASMID, V42, P144, DOI 10.1006/plas.1999.1422; YANSURA DG, 1984, P NATL ACAD SCI-BIOL, V81, P439, DOI 10.1073/pnas.81.2.439	50	39	43	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					720	729		10.1038/NCHEMBIO.643	http://dx.doi.org/10.1038/NCHEMBIO.643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21892185				2022-12-25	WOS:000295027100016
J	Wiesner, T; Obenauf, AC; Murali, R; Fried, I; Griewank, KG; Ulz, P; Windpassinger, C; Wackernagel, W; Loy, S; Wolf, I; Viale, A; Lash, AE; Pirun, M; Socci, ND; Rutten, A; Palmedo, G; Abramson, D; Offit, K; Ott, A; Becker, JC; Cerroni, L; Kutzner, H; Bastian, BC; Speicher, MR				Wiesner, Thomas; Obenauf, Anna C.; Murali, Rajmohan; Fried, Isabella; Griewank, Klaus G.; Ulz, Peter; Windpassinger, Christian; Wackernagel, Werner; Loy, Shea; Wolf, Ingrid; Viale, Agnes; Lash, Alex E.; Pirun, Mono; Socci, Nicholas D.; Ruetten, Arno; Palmedo, Gabriele; Abramson, David; Offit, Kenneth; Ott, Arthur; Becker, Juergen C.; Cerroni, Lorenzo; Kutzner, Heinz; Bastian, Boris C.; Speicher, Michael R.			Germline mutations in BAP1 predispose to melanocytic tumors	NATURE GENETICS			English	Article							PROTEIN FUNCTION; UVEAL MELANOMA; CANCER; BREAST; NEVI	Common acquired melanocytic nevi are benign neoplasms that are composed of small, uniform melanocytes and are typically present as flat or slightly elevated pigmented lesions on the skin. We describe two families with a new autosomal dominant syndrome characterized by multiple, skin-colored, elevated melanocytic tumors. In contrast to common acquired nevi, the melanocytic neoplasms in affected family members ranged histopathologically from epithelioid nevi to atypical melanocytic proliferations that showed overlapping features with melanoma. Some affected individuals developed uveal or cutaneous melanomas. Segregating with this phenotype, we found inactivating germline mutations of BAP1, which encodes a ubiquitin carboxy-terminal hydrolase. The majority of melanocytic neoplasms lost the remaining wild-type allele of BAP1 by various somatic alterations. In addition, we found BAP1 mutations in a subset of sporadic melanocytic neoplasms showing histological similarities to the familial tumors. These findings suggest that loss of BAP1 is associated with a clinically and morphologically distinct type of melanocytic neoplasm.	[Wiesner, Thomas; Fried, Isabella; Wolf, Ingrid; Becker, Juergen C.; Cerroni, Lorenzo] Med Univ Graz, Dept Dermatol, Graz, Austria; [Wiesner, Thomas; Murali, Rajmohan; Griewank, Klaus G.; Loy, Shea; Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Obenauf, Anna C.; Ulz, Peter; Windpassinger, Christian; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Obenauf, Anna C.; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Wackernagel, Werner] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Lash, Alex E.; Pirun, Mono; Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Abramson, David] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, New York, NY 10021 USA; [Ott, Arthur] Med Univ Graz, Inst Pathol, Graz, Austria; [Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Medical University of Graz; Memorial Sloan Kettering Cancer Center; Medical University of Graz; Memorial Sloan Kettering Cancer Center; Medical University of Graz; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Medical University of Graz; Memorial Sloan Kettering Cancer Center	Wiesner, T (corresponding author), Med Univ Graz, Dept Dermatol, Graz, Austria.	wiesnert@mskcc.org; bastianb@mskcc.org; michael.speicher@medunigraz.at	Speicher, Michael R/B-5362-2013; Griewank, Klaus/A-9097-2017; Murali, Rajmohan/A-7960-2008; Ulz, Peter/B-7528-2014	Speicher, Michael R/0000-0003-0105-955X; Bastian, Boris/0000-0003-1836-6062; Griewank, Klaus/0000-0003-3899-9449; Murali, Rajmohan/0000-0001-6988-4295; Lash, Alex/0000-0003-3787-1590; Wiesner, Thomas/0000-0001-5877-2992; Obenauf, Anna/0000-0002-9556-5914; Wackernagel, Werner/0000-0002-4524-4012; Ulz, Peter/0000-0001-5941-1160	Max-Kade Fellowship; Austrian Science Fund [J3013]; Deutsche Forschungsgemeinschaft [GR 3671/1-1a]; US National Institutes of Health [R01 CA131524]; Geoffrey Beene Cancer Research Center [CC 66270]; American Skin Association; Andrew Sabin Family Foundation; European Commission (GENINCA) [HEALTH-F2-2008-202230]; Jubilaeumsfonds of the Oesterreichische Nationalbank [13837]; Austrian Science Fund (FWF) [J 3013] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA131524] Funding Source: NIH RePORTER	Max-Kade Fellowship; Austrian Science Fund(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Research Center; American Skin Association; Andrew Sabin Family Foundation; European Commission (GENINCA)(European CommissionEuropean Commission Joint Research Centre); Jubilaeumsfonds of the Oesterreichische Nationalbank; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to all participating subjects for their enthusiastic participation in the study. We thank W. Stieber for clinical photography, U. Schmidbauer for providing histotechnical services, M. Leversha for performing FISH, A. Heguy for supporting sequencing, M. Asher for immunohistochemistry, H. Al-Ahmadie for assistance with the histological images and P. Dillinger for helping to collect the tissue samples. T. W. was supported by a Max-Kade Fellowship and expresses special thanks to H. Kerl for supporting, encouraging and inspiring his academic interests. A.C.O. is supported by the Austrian Science Fund (J3013) and K. G. G. by the Deutsche Forschungsgemeinschaft (GR 3671/1-1a). This work was funded by grants from the US National Institutes of Health (R01 CA131524), Geoffrey Beene Cancer Research Center (CC 66270), the American Skin Association (all to B. C. B.), the Andrew Sabin Family Foundation (to K.O.), the European Commission (GENINCA, contract no. HEALTH-F2-2008-202230) and the Jubilaeumsfonds of the Oesterreichische Nationalbank (13837).	BUCHHAGEN DL, 1994, INT J CANCER, V57, P473, DOI 10.1002/ijc.2910570406; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Palmedo G, 2004, J CUTAN PATHOL, V31, P266, DOI 10.1111/j.0303-6987.2003.00179.x; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	17	479	483	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					1018	U163		10.1038/ng.910	http://dx.doi.org/10.1038/ng.910			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21874003	Green Accepted			2022-12-25	WOS:000295316200019
J	Zhang, M; Lin, SX; Song, XW; Liu, J; Fu, Y; Ge, X; Fu, XM; Chang, ZY; Chen, PR				Zhang, Meng; Lin, Shixian; Song, Xinwen; Liu, Jun; Fu, Ye; Ge, Xi; Fu, Xinmiao; Chang, Zengyi; Chen, Peng R.			A genetically incorporated crosslinker reveals chaperone cooperation in acid resistance	NATURE CHEMICAL BIOLOGY			English	Article							SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; TRANSFER-RNA; PERIPLASMIC PROTEIN; ENTERIC BACTERIA; CODE; HDEA; BINDING	Acid chaperones are essential factors in preserving the protein homeostasis for enteric pathogens to survive in the extremely acidic mammalian stomach (pH 1-3). The client proteins of these chaperones remain largely unknown, primarily because of the exceeding difficulty of determining protein-protein interactions under low-pH conditions. We developed a genetically encoded, highly efficient protein photocrosslinking probe, which enabled us to profile the in vivo substrates of a major acid-protection chaperone, HdeA, in Escherichia coli periplasm. Among the identified HdeA client proteins, the periplasmic chaperones DegP and SurA were initially found to be protected by HdeA at a low pH, but they subsequently facilitated the HdeA-mediated acid recovery of other client proteins. This unique, ATP-independent chaperone cooperation in the ATP-deprived E. coli periplasm may support the acid resistance of enteric bacteria. The crosslinker would be valuable in unveiling the physiological interaction partners of any given protein and thus their functions under normal and stress conditions.	[Zhang, Meng; Lin, Shixian; Liu, Jun; Chen, Peng R.] Peking Univ, Beijing Natl Lab Mol Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhang, Meng; Song, Xinwen; Ge, Xi; Fu, Xinmiao; Chang, Zengyi] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing 100871, Peoples R China; [Fu, Ye] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Fu, Xinmiao; Chang, Zengyi; Chen, Peng R.] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Chen, Peng R.] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University; University of Chicago; Peking University	Chen, PR (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	changzy@pku.edu.cn; pengchen@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904; Fu, Ye/0000-0003-4434-6014; Lin, Shixian/0000-0001-9718-9986; Fu, Ye/0000-0002-3807-9717	National Natural Science Foundation of China [91013005, 21001010, 30570355, 30670022]; National Key Basic Research Foundation of China [2010CB912300, 2006CB806508, 2006CB910300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China)	We thank the Nara Institute of Science and Technology (Ikoma, Nara, Japan) for E. coli strains BW25113 and JWK3478 and P. Schultz for the aminoacyl-tRNA synthetase and tRNA expression vectors. We are grateful to W. Hong, Y. Liu and C. Liu for valuable discussions. We would also like to thank T. Kellie of the Graduate University of the Chinese Academy of Sciences for his editorial assistance. This work was supported by research grants from the National Natural Science Foundation of China (91013005 and 21001010 to P. R. C., 30570355 and 30670022 to Z.C.) and the National Key Basic Research Foundation of China (2010CB912300 to P. R. C., 2006CB806508 and 2006CB910300 to Z.C.).	Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Fekner T, 2010, EUR J ORG CHEM, V2010, P4171, DOI 10.1002/ejoc.201000204; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Huang Y, 2010, BIOORG MED CHEM LETT, V20, P878, DOI 10.1016/j.bmcl.2009.12.077; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Majmudar CY, 2009, J AM CHEM SOC, V131, P14240, DOI 10.1021/ja904378z; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Tanaka Y, 2008, J AM CHEM SOC, V130, P3278, DOI 10.1021/ja7109772; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tippmann EM, 2007, CHEMBIOCHEM, V8, P2210, DOI 10.1002/cbic.200700460; Vila-Perello M, 2007, J AM CHEM SOC, V129, P8068, DOI 10.1021/ja072013j; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI [10.1139/O09-182, 10.1139/o09-182]	30	181	193	8	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					671	677		10.1038/NCHEMBIO.644	http://dx.doi.org/10.1038/NCHEMBIO.644			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21892184				2022-12-25	WOS:000295027100010
J	Korpal, M; Ell, BJ; Buffa, FM; Ibrahim, T; Blanco, MA; Celia-Terrassa, T; Mercatali, L; Khan, Z; Goodarzi, H; Hua, YL; Wei, Y; Hu, GH; Garcia, BA; Ragoussis, J; Amadori, D; Harris, AL; Kang, YB				Korpal, Manav; Ell, Brian J.; Buffa, Francesca M.; Ibrahim, Toni; Blanco, Mario A.; Celia-Terrassa, Toni; Mercatali, Laura; Khan, Zia; Goodarzi, Hani; Hua, Yuling; Wei, Yong; Hu, Guohong; Garcia, Benjamin A.; Ragoussis, Jiannis; Amadori, Dino; Harris, Adrian L.; Kang, Yibin			Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; E-CADHERIN; MICRORNA-21 TARGETS; REPRESSORS ZEB1; TUMOR INVASION; FEEDBACK LOOP; FAMILY; EMT; EXPRESSION	Although the role of miR-200s in regulating E-cadherin expression and epithelial-to-mesenchymal transition is well established, their influence on metastatic colonization remains controversial. Here we have used clinical and experimental models of breast cancer metastasis to discover a pro-metastatic role of miR-200s that goes beyond their regulation of E-cadherin and epithelial phenotype. Overexpression of miR-200s is associated with increased risk of metastasis in breast cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be recapitulated by E-cadherin expression alone. Genomic and proteomic analyses revealed global shifts in gene expression upon miR-200 overexpression toward that of highly metastatic cells. miR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis-suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies. Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.	[Korpal, Manav; Ell, Brian J.; Blanco, Mario A.; Celia-Terrassa, Toni; Goodarzi, Hani; Hua, Yuling; Wei, Yong; Hu, Guohong; Garcia, Benjamin A.; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Buffa, Francesca M.; Harris, Adrian L.] Univ Oxford, John Radcliffe Hosp, Mol Oncol Labs, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Ibrahim, Toni; Mercatali, Laura; Amadori, Dino] Ist Sci Romagnolo Studio & Cura Tumori, Osteoncol Ctr, Meldola, Italy; [Celia-Terrassa, Toni] CSIC, Dept Cell Biol, Inst Biol Mol Barcelona, Barcelona, Spain; [Khan, Zia] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Khan, Zia; Goodarzi, Hani] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kang, Yibin] Canc Inst New Jersey, Genom Instabil & Tumor Progress Program, New Brunswick, NJ USA	Princeton University; University of Oxford; IRCCS Meldola (IRST); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Princeton University; Princeton University; University of Oxford; Wellcome Centre for Human Genetics; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ykang@princeton.edu	Harris, Adrian L/ABA-3343-2020; Buffa, Francesca/D-2574-2013; Mercatali, Laura/J-9154-2016; Xie, Huangming/B-2260-2012; Ragoussis, Ioannis/AAD-9790-2022; Celia-Terrassa, Toni/M-4808-2014	Harris, Adrian L/0000-0003-1376-8409; Buffa, Francesca/0000-0003-0409-406X; Mercatali, Laura/0000-0003-2162-8238; Kang, Yibin/0000-0002-1626-6730; Ragoussis, Ioannis/0000-0002-8515-0934; Celia-Terrassa, Toni/0000-0002-0615-8744; Goodarzi, Hani/0000-0002-9648-8949; Ibrahim, Toni/0000-0003-0259-4167; Blanco, M. Andres/0000-0003-4404-2301; Khan, Zia/0000-0002-7859-3489; Hu, Guohong/0000-0002-2980-5166	Department of Defense; US National Institutes of Health [1R01-CA141062]; Brewster Foundation; Cancer Research UK; Oxford NHS Biomedical Research Centre; Friends of Kennington Cancer Fund; US Department of Defense; NATIONAL CANCER INSTITUTE [R01CA141062, P30CA072720, R01CA134519] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brewster Foundation; Cancer Research UK(Cancer Research UK); Oxford NHS Biomedical Research Centre; Friends of Kennington Cancer Fund; US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Kyne at the mass spectrometry core facility, D. Storton and J. Buckles at the microarray core facility, and E. Williams at the electron microscopy facility of Princeton University for expert technical advice and support, N. Sethi for insightful discussions and blinded verification of tumor counts, S.J. Parkinson for technical advice, and K. Socha for colony counting. We also thank E. Williams (Monash Institute of Medical Research) and F. Miller (Barbara Ann Karmanos Cancer Institute) for the TSU-PR1 and 4T1 cell line series, respectively. Y.K. is a Champalimaud Investigator and a Department of Defense Era of Hope Scholar Award recipient. This research was supported by grants from the US National Institutes of Health (1R01-CA141062) and the Brewster Foundation to Y.K. and from Cancer Research UK, Oxford NHS Biomedical Research Centre and Friends of Kennington Cancer Fund to A.L.H.M.K. and Y.H. are recipients of US Department of Defense predoctoral fellowships.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Jeschke U, 2007, ANTICANCER RES, V27, P1969; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Park D, 2007, APMIS, V115, P52, DOI 10.1111/j.1600-0463.2007.apm_524.x; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	51	479	498	4	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1101	U108		10.1038/nm.2401	http://dx.doi.org/10.1038/nm.2401			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21822286	Green Accepted, Green Submitted			2022-12-25	WOS:000294605100030
J	Lu, ZJ; Elliott, MR; Chen, YB; Walsh, JT; Klibanov, AL; Ravichandran, KS; Kipnis, J				Lu, Zhenjie; Elliott, Michael R.; Chen, Yubo; Walsh, James T.; Klibanov, Alexander L.; Ravichandran, Kodi S.; Kipnis, Jonathan			Phagocytic activity of neuronal progenitors regulates adult neurogenesis	NATURE CELL BIOLOGY			English	Article							NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; ENGULFMENT RECEPTOR; MICROGLIAL PHAGOCYTOSIS; ENRICHED ENVIRONMENT; SUBVENTRICULAR ZONE; PRIMATE NEOCORTEX; OLFACTORY-BULB; CLEARANCE; PROLIFERATION	Whereas thousands of new neurons are generated daily during adult life, only a fraction of them survive and become part of neural circuits; the rest die, and their corpses are presumably cleared by resident phagocytes. How the dying neurons are removed and how such clearance influences neurogenesis are not well understood. Here, we identify an unexpected phagocytic role for the doublecortin (DCX)-positive neuronal progenitor cells during adult neurogenesis. Our in vivo and ex vivo studies demonstrate that DCX+ cells comprise a significant phagocytic population within the neurogenic zones. Intracellular engulfment protein ELMO1, which promotes Rac activation downstream of phagocytic receptors, was required for phagocytosis by DCX+ cells. Disruption of engulfment in vivo genetically (in Elmo1-null mice) or pharmacologically (in wild-type mice) led to reduced uptake by DCX+ cells, accumulation of apoptotic nuclei in the neurogenic niches and impaired neurogenesis. Collectively, these findings indicate a paradigm wherein DCX+ neuronal precursors also serve as phagocytes, and that their phagocytic activity critically contributes to neurogenesis in the adult brain.	[Elliott, Michael R.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22901 USA; [Lu, Zhenjie; Chen, Yubo; Walsh, James T.; Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA 22901 USA; [Klibanov, Alexander L.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22901 USA; [Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22901 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22901 USA.	Ravi@virginia.edu; Kipnis@virginia.edu	Kipnis, Jonathan/AGG-9735-2022; Walsh, James/AAV-4781-2021	Kipnis, Jonathan/0000-0002-3714-517X; Elliott, Michael/0000-0002-0642-482X; Ravichandran, Kodi/0000-0001-9049-1410	National Institute of General Medical Sciences [GM55761]; National Institute on Aging [R01AG034113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055761, T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034113] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Smith for editing the original version of the manuscript and S. Zeitlin for comments. We also thank the members of the Kipnis and Ravichandran laboratories for discussions at many stages of conducting the work and the preparation of the manuscript. This work was supported in part by an award from the National Institute of General Medical Sciences (GM55761) to K.S.R. and in part by an award from the National Institute on Aging (R01AG034113) to J.K. K.S.R. is a Bill Benter Senior Fellow of the American Asthma Foundation.	Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; D'Arceuil H, 2000, STROKE, V31, P2692, DOI 10.1161/01.STR.31.11.2692; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Maeda Y, 2002, CELL DEATH DIFFER, V9, P742, DOI 10.1038/sj.cdd.4401046; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; McFarland KN, 2006, J NEUROSCI, V26, P7885, DOI 10.1523/JNEUROSCI.3524-05.2006; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Zhang X, 2009, TOXICOL SCI, V111, P355, DOI 10.1093/toxsci/kfp167; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	40	114	118	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1076	U99		10.1038/ncb2299	http://dx.doi.org/10.1038/ncb2299			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21804544	Green Accepted			2022-12-25	WOS:000294487000012
J	Savidge, TC; Urvil, P; Oezguen, N; Ali, K; Choudhury, A; Acharya, V; Pinchuk, I; Torres, AG; English, RD; Wiktorowicz, JE; Loeffelholz, M; Kumar, R; Shi, LF; Nie, WJ; Braun, W; Herman, B; Hausladen, A; Feng, HP; Stamler, JS; Pothoulakis, C				Savidge, Tor C.; Urvil, Petri; Oezguen, Numan; Ali, Kausar; Choudhury, Aproteem; Acharya, Vinay; Pinchuk, Irina; Torres, Alfredo G.; English, Robert D.; Wiktorowicz, John E.; Loeffelholz, Michael; Kumar, Raj; Shi, Lianfa; Nie, Weijia; Braun, Werner; Herman, Bo; Hausladen, Alfred; Feng, Hanping; Stamler, Jonathan S.; Pothoulakis, Charalabos			Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins	NATURE MEDICINE			English	Article							CYSTEINE PROTEASE DOMAIN; DIFFICILE TOXIN; NITRIC-OXIDE; RTX TOXIN; CLEAVAGE; DENITROSYLATION; INFLAMMATION; ENTEROTOXIN; VIRULENCE; RELEASE	The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins(1-4). Virulence is dependent on the autoactivation of a toxin cysteine protease(5-9), which is promoted by the allosteric cofactor inositol hexakisphosphate (InsP(6))(10-17). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins(18,19). Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, InsP(6)- and inositol pyrophosphate (InsP(7))-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous InsP(6) enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.	[Savidge, Tor C.; Urvil, Petri; Ali, Kausar; Choudhury, Aproteem; Acharya, Vinay; Pinchuk, Irina] Univ Texas Med Branch, Dept Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Oezguen, Numan; Wiktorowicz, John E.; Braun, Werner] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [English, Robert D.; Wiktorowicz, John E.] Univ Texas Med Branch, Natl Heart Lung & Blood Inst Prote Ctr, Galveston, TX USA; [Loeffelholz, Michael] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Shi, Lianfa; Nie, Weijia; Feng, Hanping] Tufts Univ Cummings Sch Vet Med, Div Infect Dis, Dept Biomed Sci, North Grafton, MA USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Inste Transformat Mol Med, Cleveland, OH 44106 USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Univ Hosp, Cleveland, OH USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Pothoulakis, Charalabos] Univ Calif Los Angeles, Div Digest Dis, Los Angeles, CA USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Geisinger Commonwealth School of Medicine; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University of California System; University of California Los Angeles	Savidge, TC (corresponding author), Univ Texas Med Branch, Dept Gastroenterol & Hepatol, Galveston, TX 77555 USA.	tcsavidg@utmb.edu	Braun, Werner/A-6642-2012; Pinchuk, Irina V/A-7227-2008; Oezguen, Numan/C-9267-2009	Pinchuk, Irina V/0000-0003-1505-5779; Oezguen, Numan/0000-0002-3175-2382; Torres, Alfredo/0000-0001-6450-0643; Stamler, Jonathan/0000-0002-6866-1572	Eli & Edith Broad Foundation; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Howard Hughes Medical Institute; US National Institutes of Health National Institute of Allergy and Infectious Diseases [R01AI088748, N01AI30050]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK084509, K01DK076549, R21-DK078032-01]; National Heart, Lung, and Blood Institute [R01-HL059130, R01-HL091876, R01-HL095463, P01-HL075443-06A, NO1-HV-00245];  [1UL1RR029876-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095463, R01HL091876, P01HL075443, R01HL059130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050, R01AI088748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078032, R01DK084509, K01DK076549] Funding Source: NIH RePORTER	Eli & Edith Broad Foundation; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Eli & Edith Broad Foundation, the John S. Dunn Gulf Coast Consortium for Chemical Genomics Robert A. Welch Collaborative Grant Program, the Howard Hughes Medical Institute and grants from the US National Institutes of Health National Institute of Allergy and Infectious Diseases (R01AI088748, N01AI30050), National Institute of Diabetes and Digestive and Kidney Diseases (R01DK084509, K01DK076549; R21-DK078032-01), National Heart, Lung, and Blood Institute (R01-HL059130, R01-HL091876, R01-HL095463, P01-HL075443-06A, NO1-HV-00245) and 1UL1RR029876-01. We thank D. Powell, S. Weinman, C.S. Schein and G. Prestwich for their critiques.	Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Guttenberg G, 2011, J BIOL CHEM, V286, P14779, DOI 10.1074/jbc.M110.200691; Hausladen A, 2007, P NATL ACAD SCI USA, V104, P2157, DOI 10.1073/pnas.0611191104; He XY, 2009, J MICROBIOL METH, V78, P97, DOI 10.1016/j.mimet.2009.04.007; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kreimeyer I, 2011, N-S ARCH PHARMACOL, V383, P253, DOI 10.1007/s00210-010-0574-x; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; McMahon TJ, 2000, J BIOL CHEM, V275, P16738, DOI 10.1074/jbc.M000532200; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Pei JM, 2009, PROTEIN SCI, V18, P856, DOI 10.1002/pro.78; Popoff M.R., 2009, BIOCHIM BIOPHYS ACTA, V88, P797; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Puri AW, 2010, CHEM BIOL, V17, P1201, DOI 10.1016/j.chembiol.2010.09.011; Qiu BS, 1996, GASTROENTEROLOGY, V111, P409, DOI 10.1053/gast.1996.v111.pm8690206; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Saura M, 1999, IMMUNITY, V10, P21, DOI 10.1016/S1074-7613(00)80003-5; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Tang HY, 2004, ANAL BIOCHEM, V334, P48, DOI 10.1016/j.ab.2004.08.008; Wiktorowicz JE, 2011, BIOCHEMISTRY-US, V50, P5601, DOI 10.1021/bi200008b	40	71	72	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1136	U147		10.1038/nm.2405	http://dx.doi.org/10.1038/nm.2405			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857653	Green Accepted			2022-12-25	WOS:000294605100036
J	Zhang, X; Yalcin, S; Lee, DF; Yeh, TYJ; Lee, SM; Su, J; Mungamuri, SK; Rimmele, P; Kennedy, M; Sellers, R; Landthaler, M; Tuschl, T; Chi, NW; Lemischka, I; Keller, G; Ghaffari, S				Zhang, Xin; Yalcin, Safak; Lee, Dung-Fang; Yeh, Tsung-Yin J.; Lee, Seung-Min; Su, Jie; Mungamuri, Sathish Kumar; Rimmele, Pauline; Kennedy, Marion; Sellers, Rani; Landthaler, Markus; Tuschl, Thomas; Chi, Nai-Wen; Lemischka, Ihor; Keller, Gordon; Ghaffari, Saghi			FOXO1 is an essential regulator of pluripotency in human embryonic stem cells	NATURE CELL BIOLOGY			English	Article							SELF-RENEWAL; TRANSCRIPTION FACTORS; OXIDATIVE STRESS; TUMOR SUPPRESSORS; ACTIVATION; MOUSE; DIFFERENTIATION; EXPRESSION; CIRCUITRY; PHOSPHORYLATION	Pluripotency of embryonic stem cells (ESCs) is defined by their ability to differentiate into three germ layers and derivative cell types' and is established by an interactive network of proteins including OCT4 (also known as POU5F1; ref. 4), NANOG (refs 5,6), SOX2 (ref. 7) and their binding partners. The forkhead box 0 (FoxO) transcription factors are evolutionarily conserved regulators of longevity and stress response whose function is inhibited by AKT protein kinase. Fox() proteins are required for the maintenance of somatic and cancer stem cells(8-13); however, their function in ESCs is unknown. We show that FOXO1 is essential for the maintenance of human ESC pluripotency, and that an orthologue of FOXO1 (Foxo1) exerts a similar function in mouse ESCs. This function is probably mediated through direct control by FOXO1 of OCT4 and SOX2 gene expression through occupation and activation of their respective promoters. Finally, AKT is not the predominant regulator of FOXO1 in human ESCs. Together these results indicate that FOXO1 is a component of the circuitry of human ESC pluripotency. These findings have critical implications for stem cell biology, development, longevity and reprogramming, with potentially important ramifications for therapy.	[Zhang, Xin; Yalcin, Safak; Lee, Dung-Fang; Lee, Seung-Min; Su, Jie; Mungamuri, Sathish Kumar; Rimmele, Pauline; Lemischka, Ihor; Ghaffari, Saghi] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Yeh, Tsung-Yin J.; Chi, Nai-Wen] Univ Calif San Diego, Sch Med, VA San Diego Healthcare Syst, Res Serv, La Jolla, CA 92093 USA; [Kennedy, Marion; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Sellers, Rani] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Landthaler, Markus; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Lemischka, Ihor; Ghaffari, Saghi] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Ghaffari, Saghi] Mt Sinai Sch Med, Div Hematol, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Rockefeller University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ghaffari, S (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	Saghi.Ghaffari@mssm.edu	Landthaler, Markus/A-1427-2010	Landthaler, Markus/0000-0002-1075-8734; Mungamuri, Sathish Kumar/0000-0002-0012-5298; Keller, Gordon/0000-0001-9309-9297; Lee, Dung-Fang/0000-0003-2387-597X; Zhang, Xin/0000-0001-5113-1420; Su, Jie/0000-0002-3071-7139	National Institutes of Health [RO1 DK077174]; American Cancer Society [RSG LIB-110480]; Black Family Stem Cell Institute; New York State Stem Cell Science (NYSTEM) award [CO24408]; Irma Hirschl/Weill-Caulier Trust; Roche Foundation for Anemia Research (RoFAR); NIH [P20 GM75019];  [K18 HL76510-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K18HL076510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Black Family Stem Cell Institute; New York State Stem Cell Science (NYSTEM) award; Irma Hirschl/Weill-Caulier Trust; Roche Foundation for Anemia Research (RoFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Lohmann for advice on the ChIP assay, J. Bicker (Mount Sinai School of Medicine) and G. Blobel (University of Pennsylvania) for critical reading of the manuscript, I. George and M. Grisotto for cell sorting, and the Flow Cytometry Shared Research Facility of Mount Sinai School of Medicine. This work was supported in part by a National Institutes of Health grant RO1 DK077174, an American Cancer Society Research Scholarship (RSG LIB-110480), a Career Enhancement Award (K18 HL76510-01), a Black Family Stem Cell Institute Exploratory Research Award, a New York State Stem Cell Science (NYSTEM) award (CO24408), an Irma Hirschl/Weill-Caulier Trust Research Award and a Roche Foundation for Anemia Research (RoFAR) Award to S.G., and an NIH P20 GM75019 (S.G. CoPI).	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Im Hogune, 2004, Methods Mol Biol, V284, P129; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lohmann F, 2008, DEVELOPMENT, V135, P2071, DOI 10.1242/dev.018200; Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van den Berg MCW, 2011, ANTIOXID REDOX SIGN, V14, P607, DOI 10.1089/ars.2010.3415; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang WS, 2008, NAT CELL BIOL, V10, P125, DOI 10.1038/ncb0208-125; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2011, CURR DRUG TARGETS, V12, P1267, DOI 10.2174/138945011796150325	53	169	174	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1092	U118		10.1038/ncb2293	http://dx.doi.org/10.1038/ncb2293			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21804543	Green Accepted			2022-12-25	WOS:000294487000014
J	Harterink, M; Port, F; Lorenowicz, MJ; McGough, IJ; Silhankova, M; Betist, MC; van Weering, JRT; van Heesbeen, RGHP; Middelkoop, TC; Basler, K; Cullen, PJ; Korswagen, HC				Harterink, Martin; Port, Fillip; Lorenowicz, Magdalena J.; McGough, Ian J.; Silhankova, Marie; Betist, Marco C.; van Weering, Jan R. T.; van Heesbeen, Roy G. H. P.; Middelkoop, Teije C.; Basler, Konrad; Cullen, Peter J.; Korswagen, Hendrik C.			A SNX3-dependent retromer pathway mediates retrograde transport of the Wnt sorting receptor Wntless and is required for Wnt secretion	NATURE CELL BIOLOGY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; HOX GENE-EXPRESSION; GRADIENT FORMATION; MEMBRANE-PROTEINS; SACCHAROMYCES-CEREVISIAE; ENDOSOME; COMPLEX; RETRIEVAL; POLARITY; MIGRATION	Wnt proteins are lipid-modified glycoproteins that play a central role in development, adult tissue homeostasis and disease. Secretion of Wnt proteins is mediated by the Wnt-binding protein Wntless (Wls), which transports Wnt from the Golgi network to the cell surface for release. It has recently been shown that recycling of Wls through a retromer-dependent endosome-to-Golgi trafficking pathway is required for efficient Wnt secretion, but the mechanism of this retrograde transport pathway is poorly understood. Here, we report that Wls recycling is mediated through a retromer pathway that is independent of the retromer sorting nexins SNX1-SNX2 and SNX5-SNX6. We have found that the unrelated sorting nexin, SNX3, has an evolutionarily conserved function in Wls recycling and Wnt secretion and show that SNX3 interacts directly with the cargo-selective subcomplex of the retromer to sort Wls into a morphologically distinct retrieval pathway. These results demonstrate that SNX3 is part of an alternative retromer pathway that functionally separates the retrograde transport of Wls from other retromer cargo.	[McGough, Ian J.; van Weering, Jan R. T.; Cullen, Peter J.] Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrated Signaling Labs, Bristol BS8 1TD, Avon, England; [Harterink, Martin; Lorenowicz, Magdalena J.; Silhankova, Marie; Betist, Marco C.; van Heesbeen, Roy G. H. P.; Middelkoop, Teije C.; Korswagen, Hendrik C.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Harterink, Martin; Lorenowicz, Magdalena J.; Silhankova, Marie; Betist, Marco C.; van Heesbeen, Roy G. H. P.; Middelkoop, Teije C.; Korswagen, Hendrik C.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Port, Fillip; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Bristol; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Zurich	Cullen, PJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrated Signaling Labs, Bristol BS8 1TD, Avon, England.	pete.cullen@bristol.ac.uk; r.korswagen@hubrecht.eu	Harterink, Martin/M-2244-2019; Korswagen, Hendrik/I-8782-2012; Macurkova, Marie/B-4424-2014; McGough, Ian John/AAW-6299-2020	McGough, Ian John/0000-0002-4622-5358; Basler, Konrad/0000-0003-3534-1529; Harterink, Martin/0000-0002-8256-6651; Middelkoop, Teije/0000-0002-0346-6143; van Weering, Jan/0000-0001-5259-4945; Port, Fillip/0000-0002-5157-4835; Cullen, Peter/0000-0002-9070-8349; Macurkova, Marie/0000-0002-7082-0093	Dutch Cancer Society [HUBR 2008-4114]; EU; NWO [016.076.317]; Boehringer Ingelheim Foundation; Swiss National Science Foundation; Forschungskredit of the University of Zurich; Wellcome Trust [089928/Z/09/Z, 085743, 086777/Z/08/Z]	Dutch Cancer Society(KWF Kankerbestrijding); EU(European Commission); NWO(Netherlands Organization for Scientific Research (NWO)); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of the University of Zurich; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C. Rabouille for critically reading the manuscript, M. Seaman for advice, D. Xue (University of Colorado, Boulder) for smIs34, M. Tabuchi (Kawasaki Medical School, Okayama, Japan) for the bacterial construct expressing 3 x Flag-tagged retromer complex, S. Mitani (National Bioresource Project for the Nematode, Tokyo, Japan) for deletion mutants, A. Fire for expression vectors and the Caenorhabditis Genetic Center (University of Minnesota, Minneapolis) for strains. This work was funded by the Dutch Cancer Society (HUBR 2008-4114), the EU FP6 Programme Cells into Organs and NWO VIDI (016.076.317) (H. C. K.), an NWO VENI fellowship (M.J.L.), a Boehringer Ingelheim Foundation fellowship (M. H.), the Swiss National Science Foundation and the Forschungskredit of the University of Zurich (F. P. and K. B.) and the Wellcome Trust (089928/Z/09/Z and 085743) (P.J.C.). I.J.M. is a Wellcome Trust-funded PhD student (086777/Z/08/Z).	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Attar N, 2010, ADV ENZYME REGUL, V50, P216, DOI 10.1016/j.advenzreg.2009.10.002; Baeg GH, 2001, DEVELOPMENT, V128, P87; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, J CELL SCI, V118, P4527, DOI 10.1242/jcs.02568; Ch'ng' Q, 2003, GENETICS, V164, P1355; Chen DD, 2010, SCIENCE, V327, P1261, DOI 10.1126/science.1184840; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; HIDALGO A, 1990, DEVELOPMENT, V110, P291; JIN M, 1989, J BIOL CHEM, V264, P7675; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawakami A, 2008, J INVEST DERMATOL, V128, P143, DOI 10.1038/sj.jid.5700964; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; Maloof JN, 1999, DEVELOPMENT, V126, P37; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Nothwehr SF, 1997, J CELL SCI, V110, P1063; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Popoff V, 2009, TRAFFIC, V10, P1868, DOI 10.1111/j.1600-0854.2009.00993.x; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Skanland SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005935; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Whangbo J, 2000, DEVELOPMENT, V127, P4587; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	56	232	250	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					914	U358		10.1038/ncb2281	http://dx.doi.org/10.1038/ncb2281			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21725319	Green Accepted			2022-12-25	WOS:000293373700009
J	Sasaki, M; Kawahara, K; Nishio, M; Mimori, K; Kogo, R; Hamada, K; Itoh, B; Wang, J; Komatsu, Y; Yang, YR; Hikasa, H; Horie, Y; Yamashita, T; Kamijo, T; Zhang, YP; Zhu, Y; Prives, C; Nakano, T; Mak, TW; Sasaki, T; Maehama, T; Mori, M; Suzuki, A				Sasaki, Masato; Kawahara, Kohichi; Nishio, Miki; Mimori, Koshi; Kogo, Ryunosuke; Hamada, Koichi; Itoh, Bunsho; Wang, Jia; Komatsu, Yukako; Yang, Yong Ryoul; Hikasa, Hiroki; Horie, Yasuo; Yamashita, Takayuki; Kamijo, Takehiko; Zhang, Yanping; Zhu, Yan; Prives, Carol; Nakano, Toru; Mak, Tak Wah; Sasaki, Takehiko; Maehama, Tomohiko; Mori, Masaki; Suzuki, Akira			Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11	NATURE MEDICINE			English	Article							RIBOSOMAL-PROTEIN L11; SUPPRESSOR CANDIDATE; P53 STABILITY; GENE-PRODUCT; DNA-DAMAGE; INHIBITION; EXPRESSION; SURVIVAL; HDM2; DIFFERENTIATION	PICT1 (also known as GLTSCR2) is considered a tumor suppressor because it stabilizes phosphatase and tensin homolog (PTEN), but individuals with oligodendrogliomas lacking chromosome 19q13, where PICT1 is located, have better prognoses than other oligodendroglioma patients. To clarify the function of PICT1, we generated Pict1-deficient mice and embryonic stem (ES) cells. Pict1 is a nucleolar protein essential for embryogenesis and ES cell survival. Even without DNA damage, Pict1 loss led to p53-dependent arrest of cell cycle phase G(1) and apoptosis. Pict1-deficient cells accumulated p53, owing to impaired Mdm2 function. Pict1 binds Rpl11, and Rpl11 is released from nucleoli in the absence of Pict1. In Pict1-deficient cells, increased binding of Rpl11 to Mdm2 blocks Mdm2-mediated ubiquitination of p53. In human cancer, individuals whose tumors express less PICT1 have better prognoses. When PICT1 is depleted in tumor cells with intact P53 signaling, the cells grow more slowly and accumulate P53. Thus, PICT1 is a potent regulator of the MDM2-P53 pathway and promotes tumor progression by retaining RPL11 in the nucleolus.	[Sasaki, Masato; Sasaki, Takehiko; Suzuki, Akira] Akita Univ, Sch Med, Global Ctr Excellence Program, Akita 010, Japan; [Kawahara, Kohichi; Nishio, Miki; Hamada, Koichi; Itoh, Bunsho; Wang, Jia; Komatsu, Yukako; Yang, Yong Ryoul; Hikasa, Hiroki; Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 812, Japan; [Mimori, Koshi; Kogo, Ryunosuke; Mori, Masaki] Kyushu Univ, Med Inst Bioregulat, Div Mol & Surg Oncol, Fukuoka 812, Japan; [Horie, Yasuo] Akita Univ, Grad Sch Med, Dept Gastroenterol, Akita 010, Japan; [Yamashita, Takayuki] Gunma Univ, Inst Mol & Cellular Regulat, Mol Genet Lab, Maebashi, Gunma 371, Japan; [Kamijo, Takehiko] Chiba Canc Ctr, Res Inst, Div Biochem & Mol Carcinogenesis, Chiba 2608717, Japan; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhu, Yan; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Nakano, Toru] Osaka Univ, Dept Pathol, Suita, Osaka, Japan; [Mak, Tak Wah] Univ Hlth Network, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 010, Japan; [Maehama, Tomohiko] Dept Biochem & Cell Biol, Tokyo, Japan; Natl Inst Infect Dis, Tokyo, Japan; [Mori, Masaki] Osaka Univ, Sch Med, Dept Surg Gastroenterol, Suita, Osaka 565, Japan; [Mori, Masaki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 565, Japan	Akita University; Kyushu University; Kyushu University; Akita University; Gunma University; Chiba Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Osaka University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Akita University; National Institute of Infectious Diseases (NIID); Osaka University; Osaka University	Suzuki, A (corresponding author), Akita Univ, Sch Med, Global Ctr Excellence Program, Akita 010, Japan.	mmori@gesurg.med.osaka-u.ac.jp; suzuki@bioreg.kyushu-u.ac.jp	Kawahara, Kohichi/AAQ-5381-2021; Kogo, Ryunosuke/GOJ-9354-2022; Suzuki, Akira/GYD-6697-2022; Maehama, Tomohiko/HGB-4896-2022; Maehama, Tomohiko/AAX-8926-2020; 高, 雨莉/HGU-8187-2022	Kogo, Ryunosuke/0000-0002-7030-7302; Suzuki, Akira/0000-0002-5950-8808; Maehama, Tomohiko/0000-0002-9685-2317; Mimori, Koshi/0000-0003-3897-9974; Sasaki, Takehiko/0000-0003-1837-3748	Ministry of Education, Culture, Sports and Technology of Japan (MEXT); Takeda Medical Foundation; Naito Foundation; Ono Medical Research Foundation; Yasuda Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Japanese Science and Technology Agency; NATIONAL CANCER INSTITUTE [K01CA087580, R01CA127770, R01CA100302] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23592132] Funding Source: KAKEN	Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Medical Foundation; Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Yasuda Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. Noda, S. Kuroda, H. Kishimoto, M. Natsui, H. Takahashi, H. Tashiro, N. Yasui, M. Suzuki, S. Suzuki, T. Shono and T. Sasaki for expert technical support and helpful discussions. We also thank H. Miyoshi (RIKEN BioResource Center, Tsukuba, Japan) for providing lentivirus vector plasmid DNA. This work was supported by grants from the Ministry of Education, Culture, Sports and Technology of Japan (MEXT), Takeda Medical Foundation, Naito Foundation, Ono Medical Research Foundation, Yasuda Medical Foundation, and Astellas Foundation for Research on Metabolic Disorders. K. M. and M. M. are supported by the Core Research for Evolutionary Science and Technology program of the Japanese Science and Technology Agency. T.Y., T. S., M. M. and A. S. are supported by the Global Centers of Excellence Program of MEXT.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Egashira A, 2007, CANCER SCI, V98, P1152, DOI 10.1111/j.1349-7006.2007.00524.x; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Inoue-Narita T, 2008, CANCER RES, V68, P5760, DOI 10.1158/0008-5472.CAN-08-0889; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kim JY, 2010, PATHOL RES PRACT, V206, P295, DOI 10.1016/j.prp.2009.12.012; Kim YJ, 2008, J PATHOL, V216, P218, DOI 10.1002/path.2401; Kitajima K, 2002, EMBO J, V21, P3060, DOI 10.1093/emboj/cdf301; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mariani L, 2006, J CLIN ONCOL, V24, P4758, DOI 10.1200/JCO.2006.05.9238; Merritt MA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-378; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Nakagawa Y, 2006, ONCOL REP, V15, P297; Okahara F, 2005, ANAL BIOCHEM, V336, P138, DOI 10.1016/j.ab.2004.09.018; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Smith JS, 2000, GENOMICS, V64, P44, DOI 10.1006/geno.1999.6101; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; VONDEIMLING A, 1994, CANCER RES, V54, P1397; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yim JH, 2007, CELL DEATH DIFFER, V14, P1872, DOI 10.1038/sj.cdd.4402204; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	53	133	135	0	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					944	U153		10.1038/nm.2392	http://dx.doi.org/10.1038/nm.2392			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21804542	Green Accepted, Green Submitted			2022-12-25	WOS:000293507400027
J	Adibekian, A; Martin, BR; Wang, C; Hsu, KL; Bachovchin, DA; Niessen, S; Hoover, H; Cravatt, BF				Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Niessen, Sherry; Hoover, Heather; Cravatt, Benjamin F.			Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							ENZYME-ACTIVITY PROFILES; ACYLPEPTIDE HYDROLASE; FUNCTIONAL PROTEOMICS; CARCINOMA; BLOCKADE; POTENT; FAAH; TRANSPORT; PROTEINS; COVALENT	Serine hydrolases are a diverse enzyme class representing -1% of all human proteins. The biological functions of most serine hydrolases remain poorly characterized owing to a lack of selective inhibitors to probe their activity in living systems. Here we show that a substantial number of serine hydrolases can be irreversibly inactivated by 1,2,3-triazoleureas, which show negligible cross-reactivity with other protein classes. Rapid lead optimization by click chemistry-enabled synthesis and competitive activity-based profiling identified 1,2,3-triazole ureas that selectively inhibit enzymes from diverse branches of the serine hydrolase class, including peptidases (acyl-peptide hydrolase, or APEH), lipases (platelet-activating factor acetylhydrolase-2, or PAFAH2) and uncharacterized hydrolases (alpha,beta-hydrolase-11, or ABHD11), with exceptional potency in cells (sub-nanomolar) and mice (< 1 mg kg(-1)). We show that APEH inhibition leads to accumulation of N-acetylated proteins and promotes proliferation in T cells. These data indicate 1,2,3-triazole ureas are a pharmacologically privileged chemotype for serine hydrolase inhibition, combining broad activity across the serine hydrolase class with tunable selectivity for individual enzymes.	[Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Niessen, Sherry; Hoover, Heather; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niessen, Sherry; Hoover, Heather] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Adibekian, A (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	wang, chu/GYJ-2191-2022; Hsu, Ku-Lung/J-2885-2014; Wang, Chu/C-4442-2015; Hsu, Ku-Lung/L-6256-2019; Wang, Chu/AAE-8759-2021; Martin, Brent/B-4370-2012; cisar, justin/C-4002-2012	Hsu, Ku-Lung/0000-0001-5620-3972; Wang, Chu/0000-0002-6925-1268; Hsu, Ku-Lung/0000-0001-5620-3972; Wang, Chu/0000-0002-6925-1268; Martin, Brent/0000-0002-7136-2397; 	US National Institutes of Health [DA028845, CA151460]; Deutscher Akademischer Austausch Dienst; US National Science Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [K99CA151460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025285, RC2DA028845] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); US National Science Foundation(National Science Foundation (NSF)); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Savas and D. McClatchy (The Scripps Research Institute) for generously providing <SUP>15</SUP>N-labeled mice and T. Ji for technical assistance. This work was supported by the US National Institutes of Health (DA028845, CA151460 (K99 award to B. R. M.)), the Deutscher Akademischer Austausch Dienst (postdoctoral fellowship to A. A.), the US National Science Foundation (predoctoral fellowship to D. A. B.) and the Skaggs Institute for Chemical Biology.	Alexander JP, 2006, J AM CHEM SOC, V128, P9699, DOI 10.1021/ja062999h; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Barglow KT, 2004, CHEM BIOL, V11, P1523, DOI 10.1016/j.chembiol.2004.08.023; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blais DR, 2010, J BIOL CHEM, V285, P25602, DOI 10.1074/jbc.M110.135483; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Ebdrup S, 2004, J MED CHEM, V47, P400, DOI 10.1021/jm031004s; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; Everley PA, 2007, MOL CELL PROTEOMICS, V6, P1771, DOI 10.1074/mcp.M700057-MCP200; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Henness S, 2006, DRUGS, V66, P1625, DOI 10.2165/00003495-200666120-00012; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Johnson DS, 2010, FUTURE MED CHEM, V2, P949, DOI 10.4155/FMC.10.21; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kaschani F, 2009, MOL CELL PROTEOMICS, V8, P1082, DOI 10.1074/mcp.M800494-MCP200; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kluge AF, 2010, CURR OPIN CHEM BIOL, V14, P421, DOI 10.1016/j.cbpa.2010.03.035; Kodadek T, 2010, NAT CHEM BIOL, V6, P162, DOI 10.1038/nchembio.303; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mazzucchelli L, 2002, AM J PATHOL, V160, P7, DOI 10.1016/S0002-9440(10)64342-8; Moore SA, 2005, P NATL ACAD SCI USA, V102, P17852, DOI 10.1073/pnas.0507470102; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Okerberg ES, 2005, P NATL ACAD SCI USA, V102, P4996, DOI 10.1073/pnas.0501205102; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Orre LM, 2007, MOL CELL PROTEOMICS, V6, P2122, DOI 10.1074/mcp.M700202-MCP200; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Thornberry NA, 2007, CURR TOP MED CHEM, V7, P557, DOI 10.2174/156802607780091028; Timmer JC, 2007, BIOCHEM J, V407, P41, DOI 10.1042/BJ20070775; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j	50	164	169	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					469	478		10.1038/NCHEMBIO.579	http://dx.doi.org/10.1038/NCHEMBIO.579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21572424	Green Accepted			2022-12-25	WOS:000292252100015
J	Huang, Q; Li, F; Liu, XJ; Li, WR; Shi, W; Liu, FF; O'Sullivan, B; He, ZM; Peng, YL; Tan, AC; Zhou, L; Shen, JP; Han, GW; Wang, XJ; Thorburn, J; Thorburn, A; Jimeno, A; Raben, D; Bedford, JS; Li, CY				Huang, Qian; Li, Fang; Liu, Xinjian; Li, Wenrong; Shi, Wei; Liu, Fei-Fei; O'Sullivan, Brian; He, Zhimin; Peng, Yuanlin; Tan, Aik-Choon; Zhou, Ling; Shen, Jingping; Han, Gangwen; Wang, Xiao-Jing; Thorburn, Jackie; Thorburn, Andrew; Jimeno, Antonio; Raben, David; Bedford, Joel S.; Li, Chuan-Yuan			Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy	NATURE MEDICINE			English	Article							APOPTOTIC CELLS; PHOSPHOLIPASE A(2); PROLIFERATION; DIFFERENTIATION; REGENERATION; ACTIVATION; MIGRATION; RELEASE	In cancer treatment, apoptosis is a well-recognized cell death mechanism through which cytotoxic agents kill tumor cells. Here we report that dying tumor cells use the apoptotic process to generate potent growth-stimulating signals to stimulate the repopulation of tumors undergoing radiotherapy. Furthermore, activated caspase 3, a key executioner in apoptosis, is involved in the growth stimulation. One downstream effector that caspase 3 regulates is prostaglandin E2 (PGE2), which can potently stimulate growth of surviving tumor cells. Deficiency of caspase 3 either in tumor cells or in tumor stroma caused substantial tumor sensitivity to radiotherapy in xenograft or mouse tumors. In human subjects with cancer, higher amounts of activated caspase 3 in tumor tissues are correlated with markedly increased rate of recurrence and death. We propose the existence of a cell death-induced tumor repopulation pathway in which caspase 3 has a major role.	[Huang, Qian; Li, Fang; Liu, Xinjian; Li, Wenrong; He, Zhimin; Shen, Jingping; Raben, David; Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA; [Huang, Qian] Shanghai Jiao Tong Univ, Peoples Hosp 1, Expt Res Ctr, Shanghai 200030, Peoples R China; [Huang, Qian] Shanghai Jiao Tong Univ, Inst Canc, Natl Lab Oncogenes & Related Genes Res, Shanghai 200030, Peoples R China; [Shi, Wei; Liu, Fei-Fei; O'Sullivan, Brian] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON, Canada; [Shi, Wei; Liu, Fei-Fei; O'Sullivan, Brian] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON, Canada; [Peng, Yuanlin; Bedford, Joel S.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Tan, Aik-Choon; Jimeno, Antonio] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Zhou, Ling] Shanghai First Peoples Branch Hosp, Dept Surg, Shanghai, Peoples R China; [Han, Gangwen; Wang, Xiao-Jing] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Wang, Xiao-Jing; Jimeno, Antonio; Raben, David] Univ Colorado, Ctr Canc, Head & Neck Canc Res Program, Aurora, CO USA; [Wang, Xiao-Jing; Jimeno, Antonio; Li, Chuan-Yuan] Univ Colorado, Sch Med, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA; [Thorburn, Jackie; Thorburn, Andrew; Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, CY (corresponding author), Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA.	chuan.li@ucdenver.edu	Li, Chuan-Yuan/H-4148-2013; Tan, Aik Choon/A-3135-2011; Han, Gangwen/A-1773-2014	Tan, Aik Choon/0000-0003-2955-8369; Spence, Tara/0000-0001-7098-4103; O'Sullivan, Brian/0000-0001-8887-843X; Liu, Fei-Fei/0000-0003-4344-6486	US National Cancer Institute [CA131408, CA136748]; US National Aeronautics and Space Administration Ground [NNX09AH19G]; US Department of Energy [DEFG0207ER64350]; National Basic Research Project of China [2010CB529900]; China National Natural Science Foundation [30325043, 30428015]; NATIONAL CANCER INSTITUTE [R01CA136748, P30CA046934, R01CA131408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015953] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Aeronautics and Space Administration Ground; US Department of Energy(United States Department of Energy (DOE)); National Basic Research Project of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank R. Flavell of Yale University for providing us with MEF cells with caspase 3 or 7 deficiencies. We thank B. Liu of University of Colorado School of Medicine for providing us with the MCF-7 and MCF-7CASP3 cells. We also thank P. Kabos for insightful discussions. This study was supported in part by grants CA131408 and CA136748 from the US National Cancer Institute (to C.-Y.L.), and grant NNX09AH19G (to C.-Y.L.) from US National Aeronautics and Space Administration Ground-based Space Radiation Biology Research Program. It was also supported by a subcontract (to C.-Y.L.) of grant DEFG0207ER64350 (to J.S.B.) from the US Department of Energy Low Dose Radiation Research Program. Q.H. was supported by grant 2010CB529900 from the National Basic Research Project of China and Outstanding Young Scientist grants 30325043 & 30428015 from China National Natural Science Foundation.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Hall E J, 2006, RADIOBIOLOGY RADIOLO, P378; HERMENS AF, 1969, EUR J CANCER, V5, P173, DOI 10.1016/0014-2964(69)90065-6; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; STEEL GG, 2002, BASIC CLIN RADIOBIOL, P52; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; STEPHENS TC, 1978, BRIT J CANCER, V38, P573, DOI 10.1038/bjc.1978.252; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200; [No title captured]	29	573	609	3	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					860	U231		10.1038/nm.2385	http://dx.doi.org/10.1038/nm.2385			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21725296	Green Accepted			2022-12-25	WOS:000292500800041
J	Johnson, N; Li, YC; Walton, ZE; Cheng, KA; Li, DA; Rodig, SJ; Moreau, LA; Unitt, C; Bronson, RT; Thomas, HD; Newell, DR; D'Andrea, AD; Curtin, NJ; Wong, KK; Shapiro, GI				Johnson, Neil; Li, Yu-Chen; Walton, Zandra E.; Cheng, Katherine A.; Li, Danan; Rodig, Scott J.; Moreau, Lisa A.; Unitt, Christine; Bronson, Roderick T.; Thomas, Huw D.; Newell, David R.; D'Andrea, Alan D.; Curtin, Nicola J.; Wong, Kwok-Kin; Shapiro, Geoffrey I.			Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition	NATURE MEDICINE			English	Article							DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; LUNG-CANCER; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; REPAIR; PHOSPHORYLATION; TUMORS; CISPLATIN; LINES	Cells that are deficient in homologous recombination, such as those that lack functional breast cancer-associated 1 (BRCA1) or BRCA2, are hypersensitive to inhibition of poly(ADP-ribose) polymerase (PARP). However, BRCA-deficient tumors represent only a small fraction of adult cancers, which might restrict the therapeutic utility of PARP inhibitor monotherapy. Cyclindependent kinase 1 (Cdk1) phosphorylates BRCA1, and this is essential for efficient formation of BRCA1 foci. Here we show that depletion or inhibition of Cdk1 compromises the ability of cells to repair DNA by homologous recombination. Combined inhibition of Cdk1 and PARP in BRCA-wild-type cancer cells resulted in reduced colony formation, delayed growth of human tumor xenografts and tumor regression with prolonged survival in a mouse model of lung adenocarcinoma. Inhibition of Cdk1 did not sensitize nontransformed cells or tissues to inhibition of PARP. Because reduced Cdk1 activity impaired BRCA1 function and consequently, repair by homologous recombination, inhibition of Cdk1 represents a plausible strategy for expanding the utility of PARP inhibitors to BRCA-proficient cancers.	[Johnson, Neil; Li, Yu-Chen; Walton, Zandra E.; Cheng, Katherine A.; Li, Danan; Wong, Kwok-Kin; Shapiro, Geoffrey I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Rodig, Scott J.; Unitt, Christine; Bronson, Roderick T.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Johnson, Neil; Wong, Kwok-Kin; Shapiro, Geoffrey I.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rodig, Scott J.; Unitt, Christine] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Moreau, Lisa A.; D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Moreau, Lisa A.; D'Andrea, Alan D.] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Thomas, Huw D.; Newell, David R.; Curtin, Nicola J.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Newcastle University - UK; Harvard University; Dana-Farber Cancer Institute	Shapiro, GI (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	geoffrey_shapiro@dfci.harvard.edu	Rodig, Scott/Y-3889-2019	Walton, Zandra/0000-0002-0465-0153; wong, kwok kin/0000-0001-6323-235X; Curtin, Nicola/0000-0003-1369-1843	US National Institutes of Health (NIH) [R01 CA090687, P50 CA089393]; Career Development Award; Susan G. Komen Post-Doctoral Fellowship [KG080773]; NIH [P50 CA090578, U01 CA141576, R01 AG2400401, R01 CA122794, R01 CA140594, 1RC2 CA147940-01]; Cancer Research U.K.; Uniting Against Lung Cancer grant; NATIONAL CANCER INSTITUTE [P50CA090578, UM1CA186709, R01CA090687, P50CA089393, RC2CA147940, U01CA141576, R01CA140594, R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG024004] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award; Susan G. Komen Post-Doctoral Fellowship(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research U.K.(Cancer Research UK); Uniting Against Lung Cancer grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Institutes of Health (NIH) Grants R01 CA090687 (G.I.S.), P50 CA089393 (Dana-Farber/Harvard Cancer Center (DF/HCC) Specialized Program of Research Excellence (SPORE) in Breast Cancer), including Developmental Project Funding (G.I.S.) and a Career Development Award (N.J.), as well as Susan G. Komen Post-Doctoral Fellowship Award KG080773 (N.J., G.I.S. and N.J. C.) and NIH Grant P50 CA090578 (DF/HCC SPORE in Lung Cancer) (G.I.S. and K.-K.W.). H.D.T., N.J.C. and D.R.N. were supported by a Programme Grant from Cancer Research U.K. K.-K. W. was also supported by a Uniting Against Lung Cancer grant and NIH grants U01 CA141576, R01 AG2400401, R01 CA122794, R01 CA140594 and 1RC2 CA147940-01. We thank M. Arora and J.D. Parvin for assistance with preliminary experiments; D. Skinner for technical assistance with tissue block and slide preparation; members of the Confocal and Light Microscopy Core Facility at the Dana-Farber Cancer Institute for technical assistance with acquisition of confocal microscopy images; M. Jasin (Memorial Sloan-Kettering Cancer Center) for U2OS pDR-GFP cells; and K. Hook, D. Madren and Z. Hostomsky of Pfizer for AG14361, AG014699 (PF-01367338) and AG024322 (PF-00176275).	Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Brown AP, 2008, CANCER CHEMOTH PHARM, V62, P1091, DOI 10.1007/s00280-008-0771-1; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103	36	206	210	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					875	U257		10.1038/nm.2377	http://dx.doi.org/10.1038/nm.2377			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21706030	Green Accepted			2022-12-25	WOS:000292500800043
J	Yim, H; Haselbeck, R; Niu, W; Pujol-Baxley, C; Burgard, A; Boldt, J; Khandurina, J; Trawick, JD; Osterhout, RE; Stephen, R; Estadilla, J; Teisan, S; Schreyer, HB; Andrae, S; Yang, TH; Lee, SY; Burk, MJ; Van Dien, S				Yim, Harry; Haselbeck, Robert; Niu, Wei; Pujol-Baxley, Catherine; Burgard, Anthony; Boldt, Jeff; Khandurina, Julia; Trawick, John D.; Osterhout, Robin E.; Stephen, Rosary; Estadilla, Jazell; Teisan, Sy; Schreyer, H. Brett; Andrae, Stefan; Yang, Tae Hoon; Lee, Sang Yup; Burk, Mark J.; Van Dien, Stephen			Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol	NATURE CHEMICAL BIOLOGY			English	Article							PYRUVATE-DEHYDROGENASE; SUCCINIC ACID; CITRATE SYNTHASE; PATHWAY; GENE; K-12; NADH; 4-HYDROXYBUTYRATE; BIOSYNTHESIS; FERMENTATION	1,4-Butanediol (BDO) is an important commodity chemical used to manufacture over 2.5 million tons annually of valuable polymers, and it is currently produced exclusively through feedstocks derived from oil and natural gas. Herein we report what are to our knowledge the first direct biocatalytic routes to BDO from renewable carbohydrate feedstocks, leading to a strain of Escherichia coli capable of producing 18 gl-1 of this highly reduced, non-natural chemical. A pathway-identification algorithm elucidated multiple pathways for the biosynthesis of BDO from common metabolic intermediates. Guided by a genome-scale metabolic model, we engineered the E. coli host to enhance anaerobic operation of the oxidative tricarboxylic acid cycle, thereby generating reducing power to drive the BDO pathway. The organism produced BDO from glucose, xylose, sucrose and biomass-derived mixed sugar streams. This work demonstrates a systems-based metabolic engineering approach to strain design and development that can enable new bioprocesses for commodity chemicals that are not naturally produced by living cells.	[Yim, Harry; Haselbeck, Robert; Niu, Wei; Pujol-Baxley, Catherine; Burgard, Anthony; Boldt, Jeff; Khandurina, Julia; Trawick, John D.; Osterhout, Robin E.; Stephen, Rosary; Estadilla, Jazell; Teisan, Sy; Schreyer, H. Brett; Andrae, Stefan; Yang, Tae Hoon; Burk, Mark J.; Van Dien, Stephen] Genomat Inc, San Diego, CA USA; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, Inst BioCentury, Ctr Syst & Synthet Biotechnol, Dept Chem & Biomol Engn,Program BK21, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Yim, H (corresponding author), Genomat Inc, San Diego, CA USA.	svandien@genomatica.com	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; Niu, Wei/0000-0003-3826-1276				Altaras NE, 1999, APPL ENVIRON MICROB, V65, P1180; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burk M. J., 2010, World patent, Patent No. [2010030711, WO 2010030711 A3]; CAROLE TM, 2004, Appl BIOCH Biotechno, V113, P113; Cho A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-35; Donnelly MI, 1998, APPL BIOCHEM BIOTECH, V70-2, P187, DOI 10.1007/BF02920135; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Henry CS, 2010, BIOTECHNOL BIOENG, V106, P462, DOI 10.1002/bit.22673; Hong SH, 2001, BIOTECHNOL BIOENG, V74, P89, DOI 10.1002/bit.1098; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; JEWELL JB, 1986, CURR MICROBIOL, V13, P215, DOI 10.1007/BF01568949; Kim Y, 2008, J BACTERIOL, V190, P3851, DOI 10.1128/JB.00104-08; Kim Y, 2007, APPL ENVIRON MICROB, V73, P1766, DOI 10.1128/AEM.02456-06; KROSCHWITZ J, 1993, ENCY CHEM TECHNOLOGY; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mahadevan R, 2005, BIOTECHNOL BIOPROC E, V10, P408; MAVROVOUNIOTIS ML, 1990, BIOTECHNOL BIOENG, V36, P1070, DOI 10.1002/bit.260361013; Menzel K, 1997, J BIOTECHNOL, V56, P135, DOI 10.1016/S0168-1656(97)00110-7; Moon TS, 2009, APPL ENVIRON MICROB, V75, P589, DOI 10.1128/AEM.00973-08; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Orencio-Trejo M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-8; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; PEREIRA DS, 1994, J BIOL CHEM, V269, P412; Qian ZG, 2009, BIOTECHNOL BIOENG, V104, P651, DOI 10.1002/bit.22502; Rathnasingh C, 2009, BIOTECHNOL BIOENG, V104, P729, DOI 10.1002/bit.22429; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHERF U, 1991, APPL ENVIRON MICROB, V57, P2699, DOI 10.1128/AEM.57.9.2699-2702.1991; Sivaraman K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1181; SNOEP JL, 1993, FEMS MICROBIOL LETT, V114, P279, DOI 10.1016/0378-1097(93)90284-9; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; Sohling B, 1996, J BACTERIOL, V178, P871; SPRENGER GA, 1988, J GEN MICROBIOL, V134, P1635; Stokell DJ, 2003, J BIOL CHEM, V278, P35435, DOI 10.1074/jbc.M302786200; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Toth J, 1999, APPL ENVIRON MICROB, V65, P4973; VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x; Webb E. C., 1992, ENZYME NOMENCLATURE	45	736	803	18	445	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					445	452		10.1038/NCHEMBIO.580	http://dx.doi.org/10.1038/NCHEMBIO.580			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21602812				2022-12-25	WOS:000292252100012
J	Portugal, S; Carret, C; Recker, M; Armitage, AE; Goncalves, LA; Epiphanio, S; Sullivan, D; Roy, C; Newbold, CI; Drakesmith, H; Mota, MM				Portugal, Silvia; Carret, Celine; Recker, Mario; Armitage, Andrew E.; Goncalves, Ligia A.; Epiphanio, Sabrina; Sullivan, David; Roy, Cindy; Newbold, Chris I.; Drakesmith, Hal; Mota, Maria M.			Host-mediated regulation of superinfection in malaria	NATURE MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; LIVER STAGE; HEPATIC DEVELOPMENT; IRON; HEPCIDIN; TRANSMISSION; INFECTION; AREA; EPIDEMIOLOGY; FERROPORTIN	In regions of high rates of malaria transmission, mosquitoes repeatedly transmit liver-tropic Plasmodium sporozoites to individuals who already have blood-stage parasitemia(1). This manifests itself in semi-immune children (who have been exposed since birth to Plasmodium infection and as such show low levels of peripheral parasitemia but can still be infected) older than 5 years of age by concurrent carriage of different parasite genotypes at low asymptomatic parasitemias(2). Superinfection presents an increased risk of hyperparasitemia and death in less immune individuals but counterintuitively is not frequently observed in the young(3,4). Here we show in a mouse model that ongoing blood-stage infections, above a minimum threshold, impair the growth of subsequently inoculated sporozoites such that they become growth arrested in liver hepatocytes and fail to develop into blood-stage parasites. Inhibition of the liver-stage infection is mediated by the host iron regulatory hormone hepcidin(5), whose synthesis we found to be stimulated by blood-stage parasites in a density-dependent manner. We mathematically modeled this phenomenon and show how density-dependent protection against liver-stage malaria can shape the epidemiological patterns of age-related risk and the complexity of malaria infections seen in young children. The interaction between these two Plasmodium stages and host iron metabolism has relevance for the global efforts to reduce malaria transmission and for evaluation of iron supplementation programs in malaria-endemic regions.	[Portugal, Silvia; Carret, Celine; Epiphanio, Sabrina; Mota, Maria M.] Univ Lisbon, Fac Med, IMM, P-1699 Lisbon, Portugal; [Recker, Mario] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Armitage, Andrew E.; Newbold, Chris I.; Drakesmith, Hal] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Goncalves, Ligia A.; Mota, Maria M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Sullivan, David] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD USA; [Roy, Cindy] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD USA	Universidade de Lisboa; University of Oxford; University of Oxford; Instituto Gulbenkian de Ciencia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Mota, MM (corresponding author), Univ Lisbon, Fac Med, IMM, P-1699 Lisbon, Portugal.	mmota@fm.ul.pt	Mota, Maria/AAF-2048-2019; Epiphanio, Sabrina/C-7572-2012; Gonçalves, Lígia Antunes/F-6242-2014; Epiphanio, Sabrina/S-2564-2019	Epiphanio, Sabrina/0000-0001-6094-9750; Gonçalves, Lígia Antunes/0000-0001-9804-6899; Epiphanio, Sabrina/0000-0001-6094-9750; Armitage, Andrew/0000-0001-5977-6602; Drakesmith, Alexander/0000-0002-8503-6103; Mota, Maria Manuel/0000-0002-2858-1041; Recker, Mario/0000-0001-9489-1315; Portugal, Silvia/0000-0003-4567-9101; Newbold, Chris/0000-0002-9274-3789	European Community [242095]; Fundacao para a Ciencia e Tecnologia; European Science Foundation; Howard Hughes Medical Institute; Medical Research Council UK [92044]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/31523/2006, SFRH/BPD/40965/2007]; Royal Society; MRC [G0901149] Funding Source: UKRI; Medical Research Council [G0901149] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD061241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082722] Funding Source: NIH RePORTER	European Community(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank L. Renia (Agency for Science, Technology and Research, Singapore) for helpful comments and S-methylthiourea and N-acetylcysteine, as well as R. Appelberg (Instituto de Biologia Molecular e Celular (IBMC), Portugal), J. Di Santo (Institut Pasteur) and J. Rivera (US National Institutes of Arthritis and Musculoskeletal and Skin Diseases) for IFN-gamma-, RAG2 gamma<INF>c</INF>- and Mcpt4-deficient mice, respectively, S. Rivella (Weill Cornell Medical College) for GFP- and HAMP.GFP-expressing adenoviruses, and P. Arosio (Faculty of Medicine, University of Brescia) for antibodies against mouse heavy and light ferritin chains. P. berghei ANKA, P. berghei NK65, P. yoelii 17X NL and P. chabaudi chabaudi AS were obtained from C. Jansen (Leiden University), A. Rodriguez (New York University), D. Walliker (Edinburgh University) and W. Jarra (UK National Institute for Medical Research), respectively. This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095 (M.M.M.), Fundacao para a Ciencia e Tecnologia, European Science Foundation (European Young Investigator Award to M.M.M.), Howard Hughes Medical Institute (to M.M.M.) and the Medical Research Council UK (grant ID 92044). H.D. is a Beit Memorial Fellow for Medical Research and a Medical Research Council New Investigator. S.P. and C.C. were supported by Fundacao para a Ciencia e a Tecnologia fellowships (SFRH/BD/31523/2006 and SFRH/BPD/40965/2007, respectively). M.R. is supported by a Royal Society University Research Fellowship.	Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Armitage AE, 2009, BRIT J HAEMATOL, V147, P769, DOI 10.1111/j.1365-2141.2009.07880.x; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; Drakesmith H, 2005, BLOOD, V106, P1092, DOI 10.1182/blood-2005-02-0561; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; GOMA J, 1995, PARASITE, V2, P351; Goma J, 1996, PARASITOLOGY, V112, P165, DOI 10.1017/S0031182000084729; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; HEPPNER DG, 1988, BLOOD, V72, P358; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; Mmbando BP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-165; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Sama W, 2006, PARASITOLOGY, V132, P13, DOI 10.1017/S0031182005008607; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; STAHEL E, 1988, AM J TROP MED HYG, V39, P236, DOI 10.4269/ajtmh.1988.39.236; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	36	176	179	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					732	U126		10.1038/nm.2368	http://dx.doi.org/10.1038/nm.2368			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21572427	Green Accepted			2022-12-25	WOS:000291308800035
J	Toya, M; Terasawa, M; Nagata, K; Tida, Y; Sugimoto, A				Toya, Mika; Terasawa, Masahiro; Nagata, Kayo; Tida, Yumi; Sugimoto, Asako			A kinase-independent role for Aurora A in the assembly of mitotic spindle microtubules in Caenorhabditis elegans embryos	NATURE CELL BIOLOGY			English	Article							GAMMA-TUBULIN; A KINASE; CENTROSOME MATURATION; IDENTIFICATION; PROTEIN; TPX2; CELLS; RAN	The assembly of a functional mitotic spindle is crucial for achieving successful mitosis. Aurora A kinase is one of the key regulators of mitotic events, including mitotic entry, centrosome maturation and spindle bipolarity(1,2). Caenorhabditis elegans Aurora A (AIR-1) is responsible for the assembly of gamma-tubulin-independent microtubules in early embryos(3); however, the mechanism by which AIR-1 contributes to microtubule assembly during mitosis has been unclear. Here we show by live-cell imaging and RNA-mediated interference (RNAi)-based modulation of gene activity that AIR-1 has a crucial role in the assembly of chromatin-stimulated microtubules that is independent of the gamma-tubulin complex. Surprisingly, the kinase activity of AIR-1 is dispensable for this process. Although the kinase-inactive form of AIR-1 was detected along the microtubules as well as on centrosomes, the kinase-active form of AIR-1 was restricted to centrosomes. Thus, we propose that AIR-1 has a kinase-dependent role at centrosomes and a kinase-independent role for stabilizing spindle microtubules and that coordination of these two roles is crucial for the assembly of mitotic spindles.	[Toya, Mika; Terasawa, Masahiro; Nagata, Kayo; Tida, Yumi; Sugimoto, Asako] RIKEN, Ctr Dev Biol, Lab Dev Genom, Kobe, Hyogo 6500047, Japan; [Sugimoto, Asako] Tohoku Univ, Grad Sch Life Sci, Lab Dev Dynam, Aoba Ku, Sendai, Miyagi 9808577, Japan	RIKEN; Tohoku University	Sugimoto, A (corresponding author), RIKEN, Ctr Dev Biol, Lab Dev Genom, Kobe, Hyogo 6500047, Japan.	asugimoto@m.tohoku.ac.jp	Sugimoto, Asako/I-7239-2015; Sugimoto, Asako/U-3707-2019	Sugimoto, Asako/0000-0001-6001-4293; Sugimoto, Asako/0000-0001-6001-4293; Toya, Mika/0000-0003-0999-3021	MEXT [17017038]; JSPS [19671003, 21570209]; National Institutes of Health National Center for Research Resources	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank F. Motegi, M. Sato and R. E. Carazo-Salas for discussion and critically reading the manuscript. We also thank Y. Kohara, A. A. Hyman, A. Audya and K. Oegema for reagents and T. Toda and M. Mishima for helpful comments. We are grateful to the Sugimoto Laboratory members for their support. This work was supported by MEXT KAKENHI 17017038 and JSPS KAKENHI 19671003 to A.S. and by JSPS KAKENHI 21570209 to M. Toya. M. Toya is a RIKEN Special Postdoctoral Researcher. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources.	Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bobinnec Y, 2000, J CELL SCI, V113, P3747; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Green RA, 2008, METHOD CELL BIOL, V85, P179, DOI 10.1016/S0091-679X(08)85009-1; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Haydon CE, 2003, MOL CELL PROTEOMICS, V2, P1055, DOI 10.1074/mcp.M300054-MCP200; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; KARSENTI E, 1984, J CELL BIOL, V99, pS47, DOI 10.1083/jcb.99.1.47s; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Praitis V, 2001, GENETICS, V157, P1217; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Toya M, 2010, METHOD CELL BIOL, V97, P359, DOI 10.1016/S0091-679X(10)97019-2; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054	29	60	64	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					708	U187		10.1038/ncb2242	http://dx.doi.org/10.1038/ncb2242			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21572421				2022-12-25	WOS:000291147400012
J	Yoo, H; Kim, JW; Shishkov, M; Namati, E; Morse, T; Shubochkin, R; McCarthy, JR; Ntziachristos, V; Bouma, BE; Jaffer, FA; Tearney, GJ				Yoo, Hongki; Kim, Jin Won; Shishkov, Milen; Namati, Eman; Morse, Theodore; Shubochkin, Roman; McCarthy, Jason R.; Ntziachristos, Vasilis; Bouma, Brett E.; Jaffer, Farouc A.; Tearney, Guillermo J.			Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo	NATURE MEDICINE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; DRUG-ELUTING STENTS; REPRODUCIBILITY; MICROSCOPY; ADVANTAGE; SYSTEM	Advancing understanding of human coronary artery disease requires new methods that can be used in patients for studying atherosclerotic plaque microstructure in relation to the molecular mechanisms that underlie its initiation, progression and clinical complications, including myocardial infarction and sudden cardiac death. Here we report a dual-modality intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo using a combination of optical frequency domain imaging (OFDI) and near-infrared fluorescence (NIRF) imaging. By providing simultaneous molecular information in the context of the surrounding tissue microstructure, this new catheter could provide new opportunities for investigating coronary atherosclerosis and stent healing and for identifying high-risk biological and structural coronary arterial plaques in vivo.	[Kim, Jin Won; Jaffer, Farouc A.] Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Yoo, Hongki; Shishkov, Milen; Namati, Eman; Bouma, Brett E.] Harvard Univ, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Yoo, Hongki; Kim, Jin Won; Shishkov, Milen; Namati, Eman; McCarthy, Jason R.; Bouma, Brett E.; Tearney, Guillermo J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kim, Jin Won; Jaffer, Farouc A.] Harvard Univ, Sch Med, Div Cardiol, Boston, MA USA; [Kim, Jin Won] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul, South Korea; [Morse, Theodore; Shubochkin, Roman] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [McCarthy, Jason R.] Harvard Univ, Sch Med, Ctr Syst Biol, Boston, MA USA; [Ntziachristos, Vasilis] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Munich, Germany; [Ntziachristos, Vasilis] Tech Univ Munich, Munich, Germany; [Bouma, Brett E.; Tearney, Guillermo J.] Harvard Massachusetts Inst Technol Hlth Sci & Tec, Cambridge, MA USA; [Tearney, Guillermo J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Korea University; Korea University Medicine (KU Medicine); Boston University; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Harvard University; Harvard University; Harvard Medical School	Jaffer, FA (corresponding author), Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA.	fjaffer@mgh.harvard.edu; gtearney@partners.org	Jaffer, Farouc/AAK-8803-2020; Yoo, Hongki/B-6421-2013	Jaffer, Farouc/0000-0001-7980-384X; Yoo, Hongki/0000-0001-9819-3135	US National Institutes of Health [R01HL076398, R01HL093717, R01HL108229-01A1]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; American Heart Association [0830352N]; Howard Hughes Medical Institute; Cardio Vascular Research Foundation (CVRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076398, R01HL108229, R01HL093717] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology; American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cardio Vascular Research Foundation (CVRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Gardecki for preparation of the cadaver coronary artery and CVPath for pathology of the stented artery. We also thank A. Rosenthal and G. Mallas for their technical support and A. Mauskapf for preparing and assisting in animal procedures. We thank Y. Iwamoto, Y. Yagi and E. Salomatina for assistance in histopathology. This research was supported in part by the US National Institutes of Health (R01HL076398 and R01HL093717 to G.J.T. and R01HL108229-01A1 to F.A.J.), the Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006 to G.J.T. and F.A.J.), an American Heart Association Scientist Development grant (#0830352N to F.A.J.), a Howard Hughes Medical Institute Early Career Award (F.A.J.) and the Cardio Vascular Research Foundation (CVRF, J.W.K.).	Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; de Boer OJ, 1999, CARDIOVASC RES, V41, P443, DOI 10.1016/S0008-6363(98)00255-7; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Gonzalo N, 2009, EUROINTERVENTION, V5, P224, DOI 10.4244/EIJV5I2A35; Guagliumi G, 2008, CATHETER CARDIO INTE, V72, P237, DOI 10.1002/ccd.21606; Hausler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899; Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881; Jaffer FA, 2009, ARTERIOSCL THROM VAS, V29, P1017, DOI 10.1161/ATVBAHA.108.165530; Kume T, 2006, AM J CARDIOL, V97, P1713, DOI 10.1016/j.amjcard.2006.01.031; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Ryu SY, 2008, OPT LETT, V33, P2347, DOI 10.1364/OL.33.002347; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Takano M, 2007, AM J CARDIOL, V99, P1033, DOI 10.1016/j.amjcard.2006.11.068; Takarada S, 2010, CATHETER CARDIO INTE, V75, P202, DOI 10.1002/ccd.22273; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Terashima M, 2009, J INVASIVE CARDIOL, V21, P602; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	26	223	230	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1680	U202		10.1038/nm.2555	http://dx.doi.org/10.1038/nm.2555			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057345	Green Accepted			2022-12-25	WOS:000297978000043
J	Hartl, FU				Hartl, F. Ulrich			Chaperone-assisted protein folding: the path to discovery from a personal perspective	NATURE MEDICINE			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; HEAT-SHOCK; CENTRAL CAVITY; YEAST MITOCHONDRIA; CRYSTAL-STRUCTURE; POLYPEPTIDE FLUX; ATPASE ACTIVITY; REACTION CYCLE		Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; COPPO A, 1973, J MOL BIOL, V76, P61, DOI 10.1016/0022-2836(73)90081-8; CREIGHTON TE, 1991, NATURE, V352, P17, DOI 10.1038/352017a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; ELLIS RJ, 1994, CURR BIOL, V4, P633; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LORIMER GH, 1994, STRUCTURE, V2, P1125, DOI 10.1016/S0969-2126(94)00114-6; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MARTIN J, 1993, STRUCTURE, V1, P161, DOI 10.1016/0969-2126(93)90017-B; Mayhew M, 1996, SCIENCE, V271, P161, DOI 10.1126/science.271.5246.161; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; POLLOCK RA, 1988, EMBO J, V7, P3493, DOI 10.1002/j.1460-2075.1988.tb03225.x; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; STERNBERG N, 1973, J MOL BIOL, V76, P25, DOI 10.1016/0022-2836(73)90079-X; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	58	33	34	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1206	1210		10.1038/nm.2467	http://dx.doi.org/10.1038/nm.2467			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989011				2022-12-25	WOS:000296022100034
J	Peuscher, MH; Jacobs, JJL				Peuscher, Marieke H.; Jacobs, Jacqueline J. L.			DNA-damage response and repair activities at uncapped telomeres depend on RNF8	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; CHROMATIN-STRUCTURE; HISTONE H2B; ATM; UBIQUITYLATION; PROTECTION; ROLES; SITES	Loss of telomere protection causes natural chromosome ends to become recognized by DNA-damage response and repair proteins. These events result in ligation of chromosome ends with dysfunctional telomeres, thereby causing chromosomal aberrations on cell division. The control of these potentially dangerous events at deprotected chromosome ends with their unique telomeric chromatin configuration is poorly understood. In particular, it is unknown to what extent bulky modification of telomeric chromatin is involved. Here we show that uncapped telomeres accumulate ubiquitylated histone H2A in a manner dependent on the E3 ligase RNF8. The ability of RNF8 to ubiquitylate telomeric chromatin is associated with its capacity to facilitate accumulation of both 53BP1 and phospho-ATM at uncapped telomeres and to promote non-homologous end-joining of deprotected chromosome ends. In line with the detrimental effect of RNF8 on uncapped telomeres, depletion of RNF8, as well as of the E3 ligase RNF168, reduces telomere-induced genome instability. This indicates that, besides suppressing tumorigenesis by mediating repair of DNA double-strand breaks, RNF8 and RNF168 might enhance cancer development by aggravating telomere-induced genome instability.	[Peuscher, Marieke H.; Jacobs, Jacqueline J. L.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Jacobs, JJL (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.jacobs@nki.nl	Jacobs, Jacqueline/ABA-5652-2020	Jacobs, Jacqueline/0000-0002-7704-4795; Peuscher, Marieke/0000-0001-9410-4350	Dutch Cancer Society [NKI 2005-3458, NKI 2007-3907]	Dutch Cancer Society(KWF Kankerbestrijding)	We thank A. Konishi, G. Celli and T. de Lange for the Trf2ts allele, Trf2<SUP>flox/-</SUP>; p53<SUP>-/-</SUP> MEFs and Trf2<SUP>flox/-</SUP>; p53<SUP>-/-</SUP>; Lig4<SUP>-/-</SUP> MEFs, J. van der Torre and K. Beekhuis for help with generating and testing Trf2<SUP>-/-</SUP>; p53<SUP>-/-</SUP>;TRF2ts clones, J. van Noord for technical assistance at the beginning of this project, S. Burkhard for help with RNF168 qRT-PCR, D. Silver and D. Livingston for the HR-Cre plasmid, F. Mattiroli for pCDNA-HA-RNF8, S. Kabir (de Lange laboratory) for technical advice on IF-FISH and FISH and L. Oomen and L. Brocks of the NKI digital microscope facility for help with confocal microscope imaging. We also thank J. van der Torre and S. Burkhard for sharing unpublished results on the identification of RNF8 shRNAs in a genome-wide shRNA library screen in TRF2ts cells and E. Citterio and A. Berns for critically reading this manuscript. This work was supported by grants NKI 2005-3458 and NKI 2007-3907 from the Dutch Cancer Society to J.J.L.J.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Giraud-Panis MJ, 2010, FEBS LETT, V584, P3785, DOI 10.1016/j.febslet.2010.08.004; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wu P, 2008, MOL CELL BIOL, V28, P5724, DOI 10.1128/MCB.01764-07; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360	39	62	65	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1139	U175		10.1038/ncb2326	http://dx.doi.org/10.1038/ncb2326			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21857671				2022-12-25	WOS:000294487000020
J	Brittain, JM; Duarte, DB; Wilson, SM; Zhu, WG; Ballard, C; Johnson, PL; Liu, NK; Xiong, WH; Ripsch, MS; Wang, YY; Fehrenbacher, JC; Fitz, SD; Khanna, M; Park, CK; Schmutzler, BS; Cheon, BM; Due, MR; Brustovetsky, T; Ashpole, NM; Hudmon, A; Meroueh, SO; Hingtgen, CM; Brustovetsky, N; Ji, RR; Hurley, JH; Jin, XM; Shekhar, A; Xu, XM; Oxford, GS; Vasko, MR; White, FA; Khanna, R				Brittain, Joel M.; Duarte, Djane B.; Wilson, Sarah M.; Zhu, Weiguo; Ballard, Carrie; Johnson, Philip L.; Liu, Naikui; Xiong, Wenhui; Ripsch, Matthew S.; Wang, Yuying; Fehrenbacher, Jill C.; Fitz, Stephanie D.; Khanna, May; Park, Chul-Kyu; Schmutzler, Brian S.; Cheon, Bo Myung; Due, Michael R.; Brustovetsky, Tatiana; Ashpole, Nicole M.; Hudmon, Andy; Meroueh, Samy O.; Hingtgen, Cynthia M.; Brustovetsky, Nickolay; Ji, Ru-Rong; Hurley, Joyce H.; Jin, Xiaoming; Shekhar, Anantha; Xu, Xiao-Ming; Oxford, Gerry S.; Vasko, Michael R.; White, Fletcher A.; Khanna, Rajesh			Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex	NATURE MEDICINE			English	Article							VIVO PROTEIN TRANSDUCTION; GATED CALCIUM-CHANNELS; N-TYPE; INTRATHECAL ZICONOTIDE; FORMALIN TEST; MODEL; AIDS; 2',3'-DIDEOXYCYTIDINE; LOCALIZATION; ANTAGONISTS	The use of N-type voltage-gated calcium channel (CaV2.2) blockers to treat pain is limited by many physiological side effects. Here we report that inflammatory and neuropathic hypersensitivity can be suppressed by inhibiting the binding of collapsin response mediator protein 2 (CRMP-2) to CaV2.2 and thereby reducing channel function. A peptide of CRMP-2 fused to the HIV transactivator of transcription (TAT) protein (TAT-CBD3) decreased neuropeptide release from sensory neurons and excitatory synaptic transmission in dorsal horn neurons, reduced meningeal blood flow, reduced nocifensive behavior induced by formalin injection or corneal capsaicin application and reversed neuropathic hypersensitivity produced by an antiretroviral drug. TAT-CBD3 was mildly anxiolytic without affecting memory retrieval, sensorimotor function or depression. At doses tenfold higher than that required to reduce hypersensitivity in vivo, TAT-CBD3 caused a transient episode of tail kinking and body contortion. By preventing CRMP-2-mediated enhancement of CaV2.2 function, TAT-CBD3 alleviated inflammatory and neuropathic hypersensitivity, an approach that may prove useful in managing chronic pain.	[Brittain, Joel M.; Duarte, Djane B.; Wilson, Sarah M.; Zhu, Weiguo; Ballard, Carrie; Liu, Naikui; Xiong, Wenhui; Ripsch, Matthew S.; Wang, Yuying; Fehrenbacher, Jill C.; Schmutzler, Brian S.; Cheon, Bo Myung; Due, Michael R.; Ashpole, Nicole M.; Hudmon, Andy; Meroueh, Samy O.; Hingtgen, Cynthia M.; Brustovetsky, Nickolay; Hurley, Joyce H.; Jin, Xiaoming; Xu, Xiao-Ming; Oxford, Gerry S.; Vasko, Michael R.; White, Fletcher A.; Khanna, Rajesh] Indiana Univ Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46204 USA; [Zhu, Weiguo; Wang, Yuying; Fehrenbacher, Jill C.; Schmutzler, Brian S.; Brustovetsky, Tatiana; Hudmon, Andy; Hingtgen, Cynthia M.; Brustovetsky, Nickolay; Oxford, Gerry S.; Vasko, Michael R.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN USA; [Ballard, Carrie; Khanna, May; Ashpole, Nicole M.; Hudmon, Andy; Meroueh, Samy O.; Hurley, Joyce H.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Johnson, Philip L.; Fitz, Stephanie D.; Shekhar, Anantha] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA; [Liu, Naikui] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN USA; [Xiong, Wenhui; Jin, Xiaoming; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Ripsch, Matthew S.; Fehrenbacher, Jill C.; Cheon, Bo Myung; Due, Michael R.; Vasko, Michael R.; White, Fletcher A.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN USA; [Park, Chul-Kyu; Ji, Ru-Rong] Brigham & Womens Hosp, Sensory Plast Lab, Pain Res Ctr, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Park, Chul-Kyu; Ji, Ru-Rong] Harvard Univ, Sch Med, Boston, MA USA; [Hingtgen, Cynthia M.; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN USA; [Shekhar, Anantha] Indiana Univ Sch Med, Dept Indiana Clin, Indianapolis, IN USA; [Shekhar, Anantha] Indiana Univ Sch Med, Translat Sci Inst, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), Indiana Univ Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46204 USA.	khanna5@iupui.edu	Johnson, Philip/K-8574-2019; White, Fletcher/F-3203-2015; Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016; Ji, Ru-Rong/L-7070-2017; White, Fletcher A/F-2895-2012	Johnson, Philip/0000-0002-5398-8214; White, Fletcher/0000-0002-8408-9262; Jin, Xiaoming/0000-0002-8671-8640; Ji, Ru-Rong/0000-0002-9355-3688; Khanna, Rajesh/0000-0002-9066-2969; Xu, Xiao-ming/0000-0002-7229-0081; Khanna, May/0000-0002-9989-6374; Due, Michael/0000-0001-6771-7100	US National Institutes of Health: Dental and Craniofacial Research [DE14318-06, DE017794]; Drug Abuse [DA026040]; Neurological Disorders and Stroke [NS051668, NS050131]; Environmental Health Sciences [ES017430]; Indiana State Department of Health [A70-0-079212, A70-9-079138]; Indiana University Biomedical Committee [2286501]; American Heart Association [SDG5280023]; Elwert Award in Medicine; Larry Kays Medical Neuroscience fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017794, T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049136, R01NS051668, R01NS050131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	US National Institutes of Health: Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Drug Abuse; Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Environmental Health Sciences; Indiana State Department of Health; Indiana University Biomedical Committee; American Heart Association(American Heart Association); Elwert Award in Medicine; Larry Kays Medical Neuroscience fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by grants from the US National Institutes of Health: Dental and Craniofacial Research (DE14318-06 to J.C.F. and DE017794 to R.-R.J.), Drug Abuse (DA026040 to F.A.W.), Neurological Disorders and Stroke (NS051668 to C.M.H. and NS050131 to N.B.) and Environmental Health Sciences (ES017430 to G.S.O. and J.H.H.); the Indiana State Department of Health-Spinal Cord and Brain Injury Fund (A70-0-079212 to N.B. and A70-9-079138 to R.K.) and the Indiana University Biomedical Committee-Research Support Funds (2286501 to R.K.); a National Scientist Development Grant from the American Heart Association (SDG5280023 to R.K.); and the Elwert Award in Medicine to R.K. J.M.B. is the recipient of a Larry Kays Medical Neuroscience fellowship. S.M.W. is a Stark Scholar. We thank A. Molosh and members of the Pain and Sensory Group for discussions, S.K. Ahuja for assistance with behavioral experiments and C. Kohn for comments on the manuscript.	Altier C, 2007, J NEUROSCI, V27, P6363, DOI 10.1523/JNEUROSCI.0307-07.2007; Andrade A, 2010, NAT NEUROSCI, V13, P1249, DOI 10.1038/nn.2643; Arimura N, 2009, J NEUROCHEM, V111, P380, DOI 10.1111/j.1471-4159.2009.06317.x; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bhangoo SK, 2007, BRAIN BEHAV IMMUN, V21, P581, DOI 10.1016/j.bbi.2006.12.003; Bhangoo SK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-48; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DICKENSON AH, 1987, PAIN, V30, P349, DOI 10.1016/0304-3959(87)90023-6; Doak GJ, 1997, NEUROSCIENCE, V80, P939, DOI 10.1016/S0306-4522(97)00066-3; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUBINSKY RM, 1989, MUSCLE NERVE, V12, P856, DOI 10.1002/mus.880121012; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Farazifard R, 2005, BRAIN RES PROTOC, V16, P44, DOI 10.1016/j.brainresprot.2005.10.003; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GAGE FH, 1988, NEUROBIOL AGING, V9, P645, DOI 10.1016/S0197-4580(88)80129-5; Goadsby PJ, 2008, NEUROLOGY, V70, P1300, DOI 10.1212/01.wnl.0000309214.25038.fd; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Joseph EK, 2004, PAIN, V107, P147, DOI 10.1016/j.pain.2003.10.010; Kunkler PE, 2011, PAIN, V152, P38, DOI 10.1016/j.pain.2010.08.021; Lalonde R, 2008, J NEUROSCI METH, V171, P48, DOI 10.1016/j.jneumeth.2008.02.003; Le Bars D, 2001, PHARMACOL REV, V53, P597; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; MALMBERG AB, 1994, J NEUROSCI, V14, P4882; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Nakamura A, 2007, J CHEM NEUROANAT, V34, P95, DOI 10.1016/j.jchemneu.2007.05.005; Nakanishi O, 1999, CELL MOL NEUROBIOL, V19, P191, DOI 10.1023/A:1006937209676; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Rauck RL, 2009, PAIN PRACT, V9, P327, DOI 10.1111/j.1533-2500.2009.00303.x; Rauck RL, 2006, J PAIN SYMPTOM MANAG, V31, P393, DOI 10.1016/j.jpainsymman.2005.10.003; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; SEWARD E, 1991, P ROY SOC B-BIOL SCI, V244, P129, DOI 10.1098/rspb.1991.0061; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Varty GB, 2003, BEHAV PHARMACOL, V14, P87, DOI 10.1097/00008877-200302000-00009; Wallace MS, 2008, ANESTH ANALG, V106, P628, DOI 10.1213/ane.0b013e3181606fad; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; Whiteside GT, 2005, J PHARMACOL EXP THER, V314, P1234, DOI 10.1124/jpet.105.088351; Winquist RJ, 2005, BIOCHEM PHARMACOL, V70, P489, DOI 10.1016/j.bcp.2005.04.035; Yamamoto T, 2009, CURR TOP MED CHEM, V9, P377, DOI 10.2174/156802609788317838; YARCHOAN R, 1988, LANCET, V1, P76; Yoon JS, 2004, J MICROBIOL, V42, P328; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021	59	162	166	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					822	U260		10.1038/nm.2345	http://dx.doi.org/10.1038/nm.2345			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21642979	Green Accepted			2022-12-25	WOS:000292500800036
J	Palazzoli, F; Bire, S; Bigot, Y; Bonnin-Rouleux, F				Palazzoli, Fabien; Bire, Solenne; Bigot, Yves; Bonnin-Rouleux, Florence			Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction	NATURE BIOTECHNOLOGY			English	Editorial Material							TRANSGENE EXPRESSION; ALLOWS		[Palazzoli, Fabien; Bire, Solenne; Bigot, Yves; Bonnin-Rouleux, Florence] Univ Tours, GICC, Tours, France	Universite de Tours	Palazzoli, F (corresponding author), Univ Tours, GICC, Tours, France.	yves.bigot@univ-tours.fr						Benton T, 2002, CYTOTECHNOLOGY, V38, P43, DOI 10.1023/A:1021141712344; Buceta M, 2011, GENE THER, V18, P7, DOI 10.1038/gt.2010.115; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; Girod PA, 2007, NAT METHODS, V4, P747, DOI 10.1038/NMETH1076; Harraghy N, 2008, CURR GENE THER, V8, P353, DOI 10.2174/156652308786071032; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; LEDERGERBER W, 2003, WORLD PATENT INFORM, V25, P57; van Blokland HJM, 2007, J BIOTECHNOL, V128, P237, DOI 10.1016/j.jbiotec.2006.09.023; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; WILLIAMS S, 2008, INNOV PHARM TECHNOL, V26, P52	11	11	12	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					593	598		10.1038/nbt.1907	http://dx.doi.org/10.1038/nbt.1907			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21747382				2022-12-25	WOS:000292595200015
J	Dominguez-Villar, M; Baecher-Allan, CM; Hafler, DA				Dominguez-Villar, Margarita; Baecher-Allan, Clare M.; Hafler, David A.			Identification of T helper type 1-like, Foxp3(+) regulatory T cells in human autoimmune disease	NATURE MEDICINE			English	Article							MULTIPLE-SCLEROSIS; INTERLEUKIN-12; LYMPHOCYTES; VIVO	CD4(+) CD25(high)CD127(low)/-forkhead box p3 (Foxp3)(+) regulatory T cells (T-reg cells) possess functional plasticity. Here we describe a higher frequency of T helper type 1 (T(H)1)-like, interferon-gamma (IFN-gamma)-secreting Foxp3(+) T cells in untreated subjects with relapsing remitting multiple sclerosis (RRMS) as compared to healthy control individuals. In subjects treated with IFN-beta, the frequency of IFN-gamma(+) Foxp3(+) T cells is similar to that in healthy control subjects. In vitro, human T-reg cells from healthy subjects acquire a T(H)1-like phenotype when cultured in the presence of interleukin-12 (IL-12). T(H)1-like T-reg cells show reduced suppressive activity in vitro, which can partially be reversed by IFN-gamma-specific antibodies or by removal of IL-12.	[Dominguez-Villar, Margarita; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Dominguez-Villar, Margarita; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Dominguez-Villar, Margarita; Baecher-Allan, Clare M.; Hafler, David A.] Harvard Univ, Sch Med, Boston, MA USA	Yale University; Yale University; Harvard University; Harvard Medical School	Hafler, DA (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	david.hafler@yale.edu		Dominguez-Villar, Margarita/0000-0002-9719-0028; Baecher-Allan, Clare/0000-0003-2405-8525	US National Institutes of Health [U19AI070352, R01NS024247, P01AI03971, P01NS038037]; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, U19AI070352, R01AI091568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037, R01NS024247] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank K.C. O'Connor and members of the Hafler lab for valuable discussions and comments and D. Kozoriz for technical assistance. This work was supported by the US National Institutes of Health grants U19AI070352, R01NS024247, P01AI03971 and P01NS038037 (D.A.H.). D.A.H. is a Jacob Javits Scholar of the National Institute of Neurological Disorders and Stroke. C.M.B.-A. is supported by a Dana Scholars Grant from the Dana Foundation.	Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; HAFLER DA, 1985, NEW ENGL J MED, V312, P1405, DOI 10.1056/NEJM198505303122201; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kumar M, 2006, J NEUROIMMUNOL, V180, P178, DOI 10.1016/j.jneuroim.2006.08.003; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Rabinovitch A, 1996, J AUTOIMMUN, V9, P645, DOI 10.1006/jaut.1996.0084; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	15	325	333	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					673	675		10.1038/nm.2389	http://dx.doi.org/10.1038/nm.2389			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21540856	Green Accepted			2022-12-25	WOS:000291308800026
J	Ejim, L; Farha, MA; Falconer, SB; Wildenhain, J; Coombes, BK; Tyers, M; Brown, ED; Wright, GD				Ejim, Linda; Farha, Maya A.; Falconer, Shannon B.; Wildenhain, Jan; Coombes, Brian K.; Tyers, Mike; Brown, Eric D.; Wright, Gerard D.			Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; RESISTANCE; DISEASES; MICE	Combinations of antibiotics are commonly used in medicine to broaden antimicrobial spectrum and generate synergistic effects. Alternatively, combination of nonantibiotic drugs with antibiotics offers an opportunity to sample a previously untapped expanse of bioactive chemical space. We screened a collection of drugs to identify compounds that augment the activity of the antibiotic minocycline. Unexpected synergistic drug combinations exhibited in vitro and in vivo activity against bacterial pathogens, including multidrug-resistant isolates.	[Ejim, Linda; Farha, Maya A.; Falconer, Shannon B.; Coombes, Brian K.; Brown, Eric D.; Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Ejim, Linda; Farha, Maya A.; Falconer, Shannon B.; Coombes, Brian K.; Brown, Eric D.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Wildenhain, Jan; Tyers, Mike] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	McMaster University; McMaster University; University of Edinburgh	Ejim, L (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	ebrown@mcmaster.ca; wrightge@mcmaster.ca	Wildenhain, Jan/Q-6596-2019; Wright, G/ABB-7666-2021; Coombes, Brian K/A-1727-2009; Wildenhain, Jan/E-5597-2011; Tyers, Michael/ABE-3194-2021	Wildenhain, Jan/0000-0002-5461-3828; Wildenhain, Jan/0000-0002-5461-3828; Wright, Gerard/0000-0002-9129-7131; Coombes, Brian/0000-0001-9883-1010	Canada Research Chairs; Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research [MOP-81330, XNE-8705, FRN-79488]; European Research Council	Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Research Council(European Research Council (ERC)European Commission)	The authors thank the staff of the McMaster High Throughput Screening Laboratory for technical assistance. The work was supported by Canada Research Chairs to E.D.B., M.T., G.D.W., the Canadian Cystic Fibrosis Foundation, Canadian Institutes of Health Research operating grants to E.D.B. (MOP-81330), G.D.W. (XNE-8705, FRN-79488) and the European Research Council to M.T.	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; CHOPRA I, 1989, FEMS MICROBIOL LETT, V60, P21, DOI 10.1016/0378-1097(89)90070-0; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; HURWITZ A, 1994, LIFE SCI, V54, P1687, DOI 10.1016/0024-3205(94)00609-1; Kristiansen JE, 2007, J ANTIMICROB CHEMOTH, V59, P1271, DOI 10.1093/jac/dkm071; Kruszewska Hanna, 2004, Acta Pol Pharm, V61 Suppl, P18; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lehtinen J, 2007, INT J ANTIMICROB AG, V30, P44, DOI 10.1016/j.ijantimicag.2007.02.019; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Mazumdar K, 2009, EUR J CLIN MICROBIOL, V28, P881, DOI 10.1007/s10096-009-0739-z; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Sharom JR, 2004, CURR OPIN CHEM BIOL, V8, P81, DOI 10.1016/j.cbpa.2003.12.007; Stolk P, 2006, B WORLD HEALTH ORGAN, V84, P745, DOI 10.2471/BLT.06.031518; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; YAMAGUCHI A, 1991, ANTIMICROB AGENTS CH, V35, P53, DOI 10.1128/AAC.35.1.53	24	342	355	6	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					348	350		10.1038/NCHEMBIO.559	http://dx.doi.org/10.1038/NCHEMBIO.559			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21516114				2022-12-25	WOS:000290677900009
J	Freedman, ML; Monteiro, ANA; Gayther, SA; Coetzee, GA; Risch, A; Plass, C; Casey, G; De Biasi, M; Carlson, C; Duggan, D; James, M; Liu, PY; Tichelaar, JW; Vikis, HG; You, M; Mills, IG				Freedman, Matthew L.; Monteiro, Alvaro N. A.; Gayther, Simon A.; Coetzee, Gerhard A.; Risch, Angela; Plass, Christoph; Casey, Graham; De Biasi, Mariella; Carlson, Chris; Duggan, David; James, Michael; Liu, Pengyuan; Tichelaar, Jay W.; Vikis, Haris G.; You, Ming; Mills, Ian G.			Principles for the post-GWAS functional characterization of cancer risk loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LONG-RANGE INTERACTION; HUMAN GENE-EXPRESSION; GERMLINE EPIMUTATION; VARIANTS; BREAST; IDENTIFICATION; EPIGENOMICS; ELEMENTS; UNDERLIE		[Mills, Ian G.] Univ Oslo, Nord European Mol Biol Lab EMBL Partnership, Norwegian Ctr Mol Med, Oslo, Norway; [Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Freedman, Matthew L.] Eli & Edythe L Broad Inst MIT & Harvard, Cambridge, MA USA; [Monteiro, Alvaro N. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Gayther, Simon A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gayther, Simon A.] UCL, Elizabeth Garrett Anderson Inst Womens Hlth EGA, Translat Res Lab, London, England; [Coetzee, Gerhard A.] Univ So Calif, Dept Urol, Norris Canc Ctr, Los Angeles, CA USA; [Risch, Angela; Plass, Christoph] German Canc Res Ctr, Div Epigenom & Canc Risk Factors, D-6900 Heidelberg, Germany; [Casey, Graham] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [De Biasi, Mariella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Carlson, Chris] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Duggan, David] Translat Genom Res Inst TGen, Phoenix, AZ USA; [James, Michael; Liu, Pengyuan; Tichelaar, Jay W.; Vikis, Haris G.; You, Ming] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Mills, Ian G.] Canc Res UK Cambridge Res Inst, Urooncol Res Grp, Cambridge, England	University of Oslo; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Southern California; University of London; University College London; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California; Baylor College of Medicine; Fred Hutchinson Cancer Center; Translational Genomics Research Institute; Medical College of Wisconsin; Cancer Research UK; CRUK Cambridge Institute	Mills, IG (corresponding author), Univ Oslo, Nord European Mol Biol Lab EMBL Partnership, Norwegian Ctr Mol Med, Oslo, Norway.	ian.mills@ncmm.uio.no	coetzee, Gerhard/AAT-6203-2020; Plass, Christoph/H-7192-2014; Risch, Angela/H-2669-2013; James, Michael/L-7772-2019; Coetzee, Gerhard/AAG-8439-2019; Mills, Ian/AAK-9292-2020; Pillay, Nischalan/F-9536-2012; Monteiro, Alvaro N. A./A-7566-2009; De Biasi, Mariella/M-7646-2017	Risch, Angela/0000-0002-8026-5505; Mills, Ian/0000-0001-5347-5083; Monteiro, Alvaro N. A./0000-0002-8448-4801; De Biasi, Mariella/0000-0002-0687-8872; Coetzee, Gerhard/0000-0001-8820-8364; James, Michael/0000-0002-8112-1108	NIH Post-Genome Wide Association Initiative [1U19CA148537-01, 1U19CA148065-01, 1U19CA148112-01, 1U19CA148107-01, 1U19CA148127-01]; MRC [G0801875] Funding Source: UKRI; Medical Research Council [G0801875] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U19CA148065, U19CA148127, U19CA148537, U19CA148112, U19CA148107] Funding Source: NIH RePORTER	NIH Post-Genome Wide Association Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank F. Bunz and all the members of the NIH Post-Genome Wide Association Initiative for helpful discussions and, in particular, I. Tomlinson (Wellcome Trust Centre for Human Genetics, Oxford). The contributing groups are supported by funding made available through the NIH Post-Genome Wide Association Initiative in response to Call (http://grants.nih.gov./grants/oer.htm). This Call sustains research across five cancer organ sites (prostate: 1U19CA148537-01; breast: 1U19CA148065-01; ovarian: 1U19CA148112-01; colorectal: 1U19CA148107-01; and lung: 1U19CA148127-01). For further information on this Initiative, please refer to the website: (http://epi.grants.cancer.gov/). In addition, this article is the product of the first attempt to engage the entire scientific community in the drafting of a scientific paper through open-access websites. We would like to thank R. Hoffmann at WikiGenes for hosting the pre-submission version of this submission (http://www.wikigenes.org/e/pub/e/84.html) and his unstinting energy and enthusiasm for this project and also Nature Precedings for hosting the same version (http://precedings.nature.com/documents/5162/version/1).	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; [Anonymous], 2010, NAT GENET, V42, P551, DOI 10.1038/ng0710-551; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bumgarner Roger E., 2009, V541, P225, DOI 10.1007/978-1-59745-243-4_11; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; COETZEE GA, 2010, CELL CYCLE, V9, P47; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Saccone NL, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-58; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	57	315	328	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					513	518		10.1038/ng.840	http://dx.doi.org/10.1038/ng.840			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21614091	Green Accepted			2022-12-25	WOS:000291017000006
J	Erez, A; Nagamani, SCS; Shchelochkov, OA; Premkumar, MH; Campeau, PM; Chen, YQ; Garg, HK; Li, L; Mian, A; Bertin, TK; Black, JO; Zeng, H; Tang, YP; Reddy, AK; Summar, M; O'Brien, WE; Harrison, DG; Mitch, WE; Marini, JC; Aschner, JL; Bryan, NS; Lee, B				Erez, Ayelet; Nagamani, Sandesh C. S.; Shchelochkov, Oleg A.; Premkumar, Muralidhar H.; Campeau, Philippe M.; Chen, Yuqing; Garg, Harsha K.; Li, Li; Mian, Asad; Bertin, Terry K.; Black, Jennifer O.; Zeng, Heng; Tang, Yaoping; Reddy, Anilkumar K.; Summar, Marshall; O'Brien, William E.; Harrison, David G.; Mitch, William E.; Marini, Juan C.; Aschner, Judy L.; Bryan, Nathan S.; Lee, Brendan			Requirement of argininosuccinate lyase for systemic nitric oxide production	NATURE MEDICINE			English	Article							L-ARGININE; LIVER FIBROSIS; SYNTHASE; RELAXATION; DEFICIENCY; CRYSTALLIN; ENZYMES; MUSCLE	Nitric oxide (NO) is crucial in diverse physiological and pathological processes. We show that a hypomorphic mouse model of argininosuccinate lyase (encoded by Asl) deficiency has a distinct phenotype of multiorgan dysfunction and NO deficiency. Loss of Asl in both humans and mice leads to reduced NO synthesis, owing to both decreased endogenous arginine synthesis and an impaired ability to use extracellular arginine for NO production. Administration of nitrite, which can be converted into NO in vivo, rescued the manifestations of NO deficiency in hypomorphic Asl mice, and a nitric oxide synthase (NOS)-independent NO donor restored NO-dependent vascular reactivity in humans with ASL deficiency. Mechanistic studies showed that ASL has a structural function in addition to its catalytic activity, by which it contributes to the formation of a multiprotein complex required for NO production. Our data demonstrate a previously unappreciated role for ASL in NOS function and NO homeostasis. Hence, ASL may serve as a target for manipulating NO production in experimental models, as well as for the treatment of NO-related diseases.	[Erez, Ayelet; Nagamani, Sandesh C. S.; Shchelochkov, Oleg A.; Premkumar, Muralidhar H.; Campeau, Philippe M.; Chen, Yuqing; Mian, Asad; Bertin, Terry K.; O'Brien, William E.; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Chen, Yuqing; Bertin, Terry K.; Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA; [Garg, Harsha K.; Tang, Yaoping; Bryan, Nathan S.] Univ Texas Houston Hlth Sci Ctr, Brown Fdn Inst Mol Med, Houston, TX USA; [Li, Li; Harrison, David G.] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA; [Black, Jennifer O.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Zeng, Heng; Summar, Marshall; Aschner, Judy L.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Zeng, Heng; Summar, Marshall; Aschner, Judy L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Reddy, Anilkumar K.; Mitch, William E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Reddy, Anilkumar K.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Mitch, William E.] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [Marini, Juan C.] USDA ARS, Dept Pediat Nutr, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX USA	Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Health Science Center Houston; Emory University; Baylor College of Medicine; Vanderbilt University; Vanderbilt University; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.tmc.edu	Premkumar, Muralidhar/AAX-6868-2020; Reddy, Anilkumar/GLS-1391-2022; Black, Jennifer/A-3612-2012; Campeau, Philippe/J-8614-2015	Campeau, Philippe/0000-0001-9713-7107; Nagamani, Sandesh/0000-0001-6818-7367; Summar, Marshall/0000-0001-8920-0110	US National Institutes of Health [DK54450, RR19453, RR00188, GM90310, GM07526, DK081735, HL75511, RR024173, DK37175]; National Urea Cycle Disorder Foundation; Urea Cycle Disorders Rare Disease Clinical Research Network; American Heart Association [National 0735042N]; Canadian Institute of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR024173, U54RR019453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075511, R01HL022512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081735, R01DK054450, R01DK037175, R37DK037175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090310, T32GM007526] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Urea Cycle Disorder Foundation; Urea Cycle Disorders Rare Disease Clinical Research Network; American Heart Association(American Heart Association); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (DK54450, RR19453, RR00188, GM90310 to B.L., GM07526 and DK081735 to A.E., HL75511 to J.L.A., RR024173 to J.C.M. and DK37175 to W.E.M.). We acknowledge and thank the clinical efforts of M. Mullins, S. Carter, A. Tran, J. Stuff, W. Martinek and the Texas Children's Hospital General Clinical Research Center nursing staff. The mutated human ASL-encoding plasmids were kindly provided by L. Salviati from the Department of Pediatrics, University of Padova, Padova, Italy. We thank the families of the subjects for their kind participation. We greatly appreciate the technical contributions of M. Jiang, E. Munivez, B. Dawson, G. Sule and J. Zhang. We thank L. Castillo for helpful discussions. Figures were produced using Servier Medical Art. A.E., S.C.S.N. and O.A.S. are awardees of the National Urea Cycle Disorder Foundation Research Fellowship. O.A.S. is an awardee of the O'Malley Fellowship of the Urea Cycle Disorders Rare Disease Clinical Research Network. N.S.B. is supported by the American Heart Association-National 0735042N. P.M.C. is an awardee of the Canadian Institute of Health Research clinician-scientist training award.	Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Brunetti-Pierri N, 2009, MOL GENET METAB, V98, P195, DOI 10.1016/j.ymgme.2009.06.006; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Cals-Grierson MM, 2004, NITRIC OXIDE-BIOL CH, V10, P179, DOI 10.1016/j.niox.2004.04.005; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dal Pra I, 2005, J CELL BIOCHEM, V96, P428, DOI 10.1002/jcb.20511; de Jonge WJ, 2002, AM J CLIN NUTR, V76, P128, DOI 10.1093/ajcn/76.1.128; Erez A, 2011, AM J MED GENET C, V157C, P45, DOI 10.1002/ajmg.c.30289; FAKLER CR, 1995, ACTA PAEDIATR, V84, P460, DOI 10.1111/j.1651-2227.1995.tb13673.x; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; GOLD ME, 1990, AM J PHYSIOL, V259, pH1813, DOI 10.1152/ajpheart.1990.259.6.H1813; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; Krivitzky L, 2009, PEDIATR RES, V66, P96, DOI 10.1203/PDR.0b013e3181a27a16; Kurotobi S, 2004, PEDIATR NEPHROL, V19, P138, DOI 10.1007/s00467-003-1335-6; LEE HJ, 1992, BIOCHEM J, V283, P597, DOI 10.1042/bj2830597; Li CY, 2005, BIOCHEM J, V386, P567, DOI 10.1042/BJ20041005; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Marley R, 2000, FREE RADICAL RES, V32, P1, DOI 10.1080/10715760000300011; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Mori T, 2002, PEDIATR DEVEL PATHOL, V5, P597, DOI 10.1007/s10024-002-0109-7; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Nagasaka H, 2009, METABOLISM, V58, P278, DOI 10.1016/j.metabol.2008.09.025; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Oyadomari S, 2001, NITRIC OXIDE-BIOL CH, V5, P252, DOI 10.1006/niox.2001.0344; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; Scaglia F, 2004, J NUTR, V134, p2775S, DOI 10.1093/jn/134.10.2775S; Shimizu Yoshinori, 1997, Journal of Dermatology (Tokyo), V24, P80; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Summar ML, 2004, HYPERTENSION, V43, P186, DOI 10.1161/01.HYP.0000112424.06921.52; Sutton VR, 2003, MOL GENET METAB, V78, P11, DOI 10.1016/S1096-7192(02)00206-8; THOMAS G, 1989, BIOCHEM BIOPH RES CO, V158, P177, DOI 10.1016/S0006-291X(89)80194-9; Tojo A, 2006, MED MOL MORPHOL, V39, P2, DOI 10.1007/s00795-006-0310-2; Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498; Trevisson E, 2009, J BIOL CHEM, V284, P28926, DOI 10.1074/jbc.M109.050195; Vallee F, 1999, BIOCHEMISTRY-US, V38, P2425, DOI 10.1021/bi982149h; Wang RJ, 1996, J INVEST DERMATOL, V106, P419, DOI 10.1111/1523-1747.ep12343428; Wang XD, 2006, J BIOL CHEM, V281, P26994, DOI 10.1074/jbc.M603953200; ZIMMERMANN A, 1986, ARCH PATHOL LAB MED, V110, P136; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	43	146	152	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1619	U134		10.1038/nm.2544	http://dx.doi.org/10.1038/nm.2544			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081021	Green Submitted, Green Accepted			2022-12-25	WOS:000297978000033
J	Reimer, D; Pos, KM; Thines, M; Grun, P; Bode, HB				Reimer, Daniela; Pos, Klaas M.; Thines, Marco; Gruen, Peter; Bode, Helge B.			A natural prodrug activation mechanism in nonribosomal peptide synthesis	NATURE CHEMICAL BIOLOGY			English	Article							XENORHABDUS-NEMATOPHILA; GENE-CLUSTER; ESCHERICHIA-COLI; CYCLIC-PEPTIDES; BIOSYNTHESIS; ALIGNMENT; TOOL	We have identified a new mechanism for the cleavage and activation of nonribosomally made peptides and peptidepolyketide hybrids that are apparently operational in several different bacteria. This process includes the cleavage of a precursor molecule by a membrane-bound and d-asparagine-specific peptidase, as shown here in the biosynthesis of the antibiotic xenocoumacin from Xenorhabdus nematophila.	[Reimer, Daniela; Gruen, Peter; Bode, Helge B.] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Pos, Klaas M.] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Pos, Klaas M.] Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes, Frankfurt, Germany; [Thines, Marco] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Inst Ecol, Dept Biol Sci, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Bode, HB (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Thines, Marco/H-1685-2011; Bode, Helge B/F-7022-2014; Reimer, Daniela/P-9070-2014	Bode, Helge B/0000-0001-6048-5909; 	Deutsche Forschungsgemeinschaft (DFG); Frankfurt Initiative for Microbial Sciences (FIMS); European Community [223328 (GameXP)]; Hessen's Ministry of Higher Education, Research, and the Arts	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Frankfurt Initiative for Microbial Sciences (FIMS); European Community(European Commission); Hessen's Ministry of Higher Education, Research, and the Arts	The authors thank A. Venneri for technical assistance. D. R., P. G. and H. B. B. are grateful to the Deutsche Forschungsgemeinschaft (DFG) for financial support. Work in H. B. B.'s lab is additionally supported by the Frankfurt Initiative for Microbial Sciences (FIMS), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 223328 (GameXP), and by the research funding program "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-"konomischer Exzellenz" of Hessen's Ministry of Higher Education, Research, and the Arts. Support by the DFG-EXC115 (Cluster of Excellence Macromolecular Complexes at the Goethe-University Frankfurt), DFG-SFB807 (Transport and Communication across Biological Membranes) and FIMS is gratefully acknowledged by K. M. P. M. T. is financially supported by the LOEWE program of Hessen's Ministry of Higher Education, Research, and the Arts.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Dubois D, 2011, J BIOL CHEM, V286, P35562, DOI 10.1074/jbc.M111.221960; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fujii K, 1997, ANAL CHEM, V69, P3346, DOI 10.1021/ac9701795; Goodrich-Blair H, 2007, CURR OPIN MICROBIOL, V10, P225, DOI 10.1016/j.mib.2007.05.006; Green David, 2006, Hemodial Int, V10 Suppl 2, pS2, DOI 10.1111/j.1542-4758.2006.00119.x; Hashimoto M, 2007, J ANTIBIOT, V60, P752, DOI 10.1038/ja.2007.99; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Koketsu K, 2010, NAT CHEM BIOL, V6, P408, DOI 10.1038/nchembio.365; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang G, 2008, J NAT PROD, V71, P1074, DOI 10.1021/np800053n; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Reimer D, 2009, CHEMBIOCHEM, V10, P1997, DOI 10.1002/cbic.200900187; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	22	100	104	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					888	890		10.1038/NCHEMBIO.688	http://dx.doi.org/10.1038/NCHEMBIO.688			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	21926994				2022-12-25	WOS:000297166200010
J	Wakatsuki, S; Saitoh, F; Araki, T				Wakatsuki, Shuji; Saitoh, Fuminori; Araki, Toshiyuki			ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; AXON DEGENERATION; SELF-DESTRUCTION; DEGRADATION; MECHANISMS; REGENERATION; GSK-3-BETA; MODULATION; ACTIVATION; PROTEIN	Wallerian degeneration is observed in many neurological disorders, and it is therefore important to elucidate the axonal degeneration mechanism to prevent, and further develop treatment for, such diseases. The ubiquitin proteasome system (UPS) has been implicated in Wallerian degeneration, but the underlying molecular mechanism remains unclear. Here we show that ZNRF1, an E3 ligase, promotes Wallerian degeneration by targeting AKT to degrade through the UPS. AKT phosphorylates glycogen synthase kinase-3 beta (GSK3B), and thereby inactivates it in axons. AKT overexpression significantly delays axonal degeneration. Overexpression of the active (non-phosphorylated) form of GSK3B induces CRMP2 phosphorylation, which is required for the microtubule reorganization observed in the degenerating axon. The inhibition of GSK3B and the overexpression of non-phosphorylated CRMP2 both protected axons from Wallerian degeneration. These findings indicate that the ZNRF1 AKT GSK3B CRMP2 pathway plays an important role in controlling Wallerian degeneration.	[Wakatsuki, Shuji; Saitoh, Fuminori; Araki, Toshiyuki] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Peripheral Nervous Syst Res, Tokyo 1878502, Japan	National Center for Neurology & Psychiatry - Japan	Araki, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Peripheral Nervous Syst Res, 4-1-1 Ogawa Higashi, Tokyo 1878502, Japan.	taraki@ncnp.go.jp	Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042	Ministry of Health, Labour, and Welfare; NIBIO (Program for Promotion of Fundamental Studies in Health Sciences); Japan Foundation for Neuroscience and Mental Health; Japan Health Sciences Foundation; NICHD; Grants-in-Aid for Scientific Research [23700462] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); NIBIO (Program for Promotion of Fundamental Studies in Health Sciences); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Japan Health Sciences Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to thank N. Matsuda and H. Yashiroda for technical advice and all members of our laboratory for many helpful discussions. This study is supported by grants from the Ministry of Health, Labour, and Welfare (T.A.), NIBIO (Program for Promotion of Fundamental Studies in Health Sciences; T.A.), Japan Foundation for Neuroscience and Mental Health (T.A. and S.W.) and Japan Health Sciences Foundation (T.A. and S.W.). The E7, 2H3 and 9E10 antibody clones developed by M. Klymkowsky, T. Jessel and J. Dodd, and J. Bishop, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology, The University of Iowa, USA.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Araki T, 2003, J NEUROSCI, V23, P9385; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; CORMACK B, 2001, CURR PROTOC MOL BIOL; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Ding M, 2008, BIOESSAYS, V30, P1075, DOI 10.1002/bies.20843; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Saitoh F, 2010, J NEUROSCI, V30, P1204, DOI 10.1523/JNEUROSCI.3591-09.2010; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Waller Augustus, 1851, Edinb Med Surg J, V76, P369; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	30	108	117	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1415	U259		10.1038/ncb2373	http://dx.doi.org/10.1038/ncb2373			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	22057101				2022-12-25	WOS:000298157500008
J	Chitsaz, H; Yee-Greenbaum, JL; Tesler, G; Lombardo, MJ; Dupont, CL; Badger, JH; Novotny, M; Rusch, DB; Fraser, LJ; Gormley, NA; Schulz-Trieglaff, O; Smith, GP; Evers, DJ; Pevzner, PA; Lasken, RS				Chitsaz, Hamidreza; Yee-Greenbaum, Joyclyn L.; Tesler, Glenn; Lombardo, Mary-Jane; Dupont, Christopher L.; Badger, Jonathan H.; Novotny, Mark; Rusch, Douglas B.; Fraser, Louise J.; Gormley, Niall A.; Schulz-Trieglaff, Ole; Smith, Geoffrey P.; Evers, Dirk J.; Pevzner, Pavel A.; Lasken, Roger S.			Efficient de novo assembly of single-cell bacterial genomes from short-read data sets	NATURE BIOTECHNOLOGY			English	Article							AMPLIFICATION; POLYMERASE; SEQUENCE	Whole genome amplification by the multiple displacement amplification (MDA) method allows sequencing of DNA from single cells of bacteria that cannot be cultured. Assembling a genome is challenging, however, because MDA generates highly nonuniform coverage of the genome. Here we describe an algorithm tailored for short-read data from single cells that improves assembly through the use of a progressively increasing coverage cutoff. Assembly of reads from single Escherichia coli and Staphylococcus aureus cells captures >91% of genes within contigs, approaching the 95% captured from an assembly based on many E. coli cells. We apply this method to assemble a genome from a single cell of an uncultivated SAR324 clade of Deltaproteobacteria, a cosmopolitan bacterial lineage in the global ocean. Metabolic reconstruction suggests that SAR324 is aerobic, motile and chemotaxic. Our approach enables acquisition of genome assemblies for individual uncultivated bacteria using only short reads, providing cell-specific genetic information absent from metagenomic studies.	[Yee-Greenbaum, Joyclyn L.; Lombardo, Mary-Jane; Dupont, Christopher L.; Badger, Jonathan H.; Novotny, Mark; Lasken, Roger S.] J Craig Venter Inst, San Diego, CA USA; [Chitsaz, Hamidreza; Pevzner, Pavel A.] Univ Calif San Diego, Dept Comp Sci, La Jolla, CA 92093 USA; [Tesler, Glenn] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Rusch, Douglas B.] J Craig Venter Inst, Rockville, MD USA; [Fraser, Louise J.; Gormley, Niall A.; Schulz-Trieglaff, Ole; Smith, Geoffrey P.; Evers, Dirk J.] Illumina Cambridge Ltd, Saffron Walden, Essex, England	J. Craig Venter Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; J. Craig Venter Institute; Illumina	Lasken, RS (corresponding author), J Craig Venter Inst, San Diego, CA USA.	rlasken@jcvi.org			National Human Genome Research Institute [NIH-2 R01 HG003647]; Alfred P. Sloan Foundation [Sloan Foundation-2007-10-19]; US National Institutes of Health (NIH) [3P41RR024851-02S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR024851] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003647] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was partially supported by grants to R. S. L. from the National Human Genome Research Institute (NIH-2 R01 HG003647) and the Alfred P. Sloan Foundation (Sloan Foundation-2007-10-19), and by a grant to P. A. P. and G. T. from the US National Institutes of Health (NIH grant 3P41RR024851-02S1). We thank M. Kim (J. Craig Venter Institute) for bioinformatics support.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Iizuka T, 2003, INT J SYST EVOL MICR, V53, P189, DOI 10.1099/ijs.0.02418-0; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; King GM, 2007, FEMS MICROBIOL ECOL, V59, P2, DOI 10.1111/j.1574-6941.2006.00215.x; Kvist T, 2007, APPL MICROBIOL BIOT, V74, P926, DOI 10.1007/s00253-006-0725-7; Lasken R., 2005, WHOLE GENOME AMPLIFI, P119; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MITREVA M, 2008, BACTERIAL CORE GENE; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Ramirez-Flandes S, 2008, BIOINFORMATICS, V24, P2539, DOI 10.1093/bioinformatics/btn466; Rich VI, 2011, ENVIRON MICROBIOL, V13, P116, DOI 10.1111/j.1462-2920.2010.02314.x; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; WILGENBUSCH JC, 2003, CURR PROT BIOINFORMA; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wright TD, 1997, APPL ENVIRON MICROB, V63, P1441, DOI 10.1128/AEM.63.4.1441-1448.1997; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	47	161	166	3	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					915	U214		10.1038/nbt.1966	http://dx.doi.org/10.1038/nbt.1966			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21926975	Green Accepted			2022-12-25	WOS:000296273000018
J	Hahn, CN; Chong, CE; Carmichael, CL; Wilkins, EJ; Brautigan, PJ; Li, XC; Babic, M; Lin, M; Carmagnac, A; Lee, YK; Kok, CH; Gagliardi, L; Friend, KL; Ekert, PG; Butcher, CM; Brown, AL; Lewis, ID; To, LB; Timms, AE; Storek, J; Moore, S; Altree, M; Escher, R; Bardy, PG; Suthers, GK; D'Andrea, RJ; Horwitz, MS; Scott, HS				Hahn, Christopher N.; Chong, Chan-Eng; Carmichael, Catherine L.; Wilkins, Ella J.; Brautigan, Peter J.; Li, Xiao-Chun; Babic, Milena; Lin, Ming; Carmagnac, Amandine; Lee, Young K.; Kok, Chung H.; Gagliardi, Lucia; Friend, Kathryn L.; Ekert, Paul G.; Butcher, Carolyn M.; Brown, Anna L.; Lewis, Ian D.; To, L. Bik; Timms, Andrew E.; Storek, Jan; Moore, Sarah; Altree, Meryl; Escher, Robert; Bardy, Peter G.; Suthers, Graeme K.; D'Andrea, Richard J.; Horwitz, Marshall S.; Scott, Hamish S.			Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; RUNX1; APOPTOSIS; HEALTH	We report the discovery of GATA2 as a new myelodysplastic syndrome (MDS)-acute myeloid leukemia (AML) predisposition gene. We found the same, previously unidentified heterozygous c. 1061C>T (p.Thr354Met) missense mutation in the GATA2 transcription factor gene segregating with the multigenerational transmission of MDS-AML in three families and a GATA2 c. 1063_1065delACA (p.Thr355del) mutation at an adjacent codon in a fourth MDS family. The resulting alterations reside within the second zinc finger of GATA2, which mediates DNA-binding and protein-protein interactions. We show differential effects of the mutations on the transactivation of target genes, cellular differentiation, apoptosis and global gene expression. Identification of such predisposing genes to familial forms of MDS and AML is critical for more effective diagnosis and prognosis, counseling, selection of related bone marrow transplant donors and development of therapies.	[Hahn, Christopher N.; Chong, Chan-Eng; Brautigan, Peter J.; Li, Xiao-Chun; Babic, Milena; Lin, Ming; Lee, Young K.; Gagliardi, Lucia; Moore, Sarah; Scott, Hamish S.] SA Pathol, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA, Australia; [Hahn, Christopher N.; Chong, Chan-Eng; Lewis, Ian D.; To, L. Bik; D'Andrea, Richard J.; Scott, Hamish S.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [Carmichael, Catherine L.; Wilkins, Ella J.; Carmagnac, Amandine; Escher, Robert; Scott, Hamish S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Med Div, Parkville, Vic 3050, Australia; [Kok, Chung H.; Butcher, Carolyn M.; D'Andrea, Richard J.] Queen Elizabeth Hosp, Dept Haematol & Oncol, Woodville, SA 5011, Australia; [Kok, Chung H.; Butcher, Carolyn M.; Brown, Anna L.; Lewis, Ian D.; To, L. Bik; Bardy, Peter G.; D'Andrea, Richard J.] SA Pathol, Ctr Canc Biol, Dept Haematol, Adelaide, SA, Australia; [Friend, Kathryn L.] SA Pathol, Dept Paediat & Reprod Genet, Adelaide, SA, Australia; [Ekert, Paul G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Cell Signalling & Cell Death Div, Parkville, Vic 3050, Australia; [Timms, Andrew E.; Horwitz, Marshall S.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Storek, Jan] Univ Calgary, Dept Med, Calgary, AB, Canada; [Altree, Meryl; Suthers, Graeme K.] SA Pathol, SA Clin Genet Serv, Adelaide, SA, Australia; [Suthers, Graeme K.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Scott, Hamish S.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Centre for Cancer Biology; SA Pathology; SA Pathology; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Washington; University of Washington Seattle; University of Calgary; SA Pathology; University of Adelaide; University of Adelaide	Scott, HS (corresponding author), SA Pathol, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA, Australia.	hamish.scott@health.sa.gov.au	Ekert, Paul G/C-7247-2013; Hahn, Christopher/C-1369-2009; HAHN, CHRISTOPHER/D-8427-2018; wittert, gary/AAE-2398-2019; Scott, Hamish/B-2122-2009; Ekert, Paul/Q-1842-2015; CHONG, CHAN ENG/M-5109-2017	Ekert, Paul G/0000-0002-2976-8617; Hahn, Christopher/0000-0001-5105-2554; Scott, Hamish/0000-0002-5813-631X; Ekert, Paul/0000-0002-2976-8617; CHONG, CHAN ENG/0000-0001-8922-2416; D'Andrea, Richard/0000-0002-4915-4612; Horwitz, Marshall/0000-0002-1683-1680; Brown, Anna/0000-0002-9023-0138; Brautigan, Peter/0000-0001-9570-5879; Carmichael, Catherine/0000-0002-6751-153X	Major National Research Facilities program; National Health and Medical Research Council of Australia [257501, 219176, 1002317, 171601, 461204]; Dora Lush Postgraduate Award; Leukaemia Foundation of Australia; Cancer Council of South Australia; MedVet Pty Ltd; Adelaide Scholarships International; US National Institutes of Health [R01DK058161]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058161] Funding Source: NIH RePORTER	Major National Research Facilities program; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush Postgraduate Award; Leukaemia Foundation of Australia; Cancer Council of South Australia(Cancer Council South Australia); MedVet Pty Ltd; Adelaide Scholarships International; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank the families for their participation in our studies. Thanks also to J. Melo for provision of CML cell lines and R. Sharma for help with EMSA. Large-scale Sanger sequencing was performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities program. This work was supported by grants from the National Health and Medical Research Council of Australia (program grants 257501 (H. S. S.) and 219176 (H. S. S.), project grant 1002317 (C.N.H., R.J.D. and H. S. S.), fellowships 171601 (H. S. S.) and 461204 (H. S. S.), and a Dora Lush Postgraduate Award (C. L. C.)), Leukaemia Foundation of Australia (grant in aid to H. S. S. and a postdoctoral fellowship to C. L. C.), the Cancer Council of South Australia (H. S. S.) and MedVet Pty Ltd (H. S. S. and R.J.D.), Adelaide Scholarships International (scholarship to C.-E. C.) and US National Institutes of Health grant R01DK058161 (M.S.H.).	Barzi A, 2010, CLEV CLIN J MED, V77, P37, DOI 10.3949/ccjm.77a.09069; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Carmichael CL, 2010, BRIT J HAEMATOL, V150, P382, DOI 10.1111/j.1365-2141.2010.08204.x; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; DICKINSON RE, 2011, BLOOD           0715, DOI DOI 10.1182/BLOOD-2011-06-360313; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Ernst T, 2010, HAEMATOL-HEMATOL J, V95, P1473, DOI 10.3324/haematol.2010.021808; Fadilah SAW, 2002, LEUKEMIA, V16, P1563, DOI 10.1038/sj.leu.2402517; Horwitz M, 1996, AM J HEMATOL, V52, P295, DOI 10.1002/(SICI)1096-8652(199608)52:4<295::AID-AJH9>3.0.CO;2-N; HSU AP, 2011, BLOOD           0613, DOI DOI 10.1182/BLOOD-2011-05-356352; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Koldej R, 2005, J GENE MED, V7, P1390, DOI 10.1002/jgm.803; Kumar R, 2008, J BIOL CHEM, V283, P19026, DOI 10.1074/jbc.M709136200; Lahortiga I, 2004, GENE CHROMOSOME CANC, V40, P179, DOI 10.1002/gcc.20033; Mansour S, 2010, AM J MED GENET A, V152A, P2287, DOI 10.1002/ajmg.a.33445; Matheny CJ, 2007, EMBO J, V26, P1163, DOI 10.1038/sj.emboj.7601568; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; Minelli A, 2001, CANCER GENET CYTOGEN, V124, P147, DOI 10.1016/S0165-4608(00)00344-7; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Owen CJ, 2008, BLOOD, V112, P4639, DOI 10.1182/blood-2008-05-156745; ROBINSON CW, 1983, AUST NZ J MED, V13, P141, DOI 10.1111/j.1445-5994.1983.tb02669.x; Slape C, 2007, CANCER RES, V67, P5148, DOI 10.1158/0008-5472.CAN-07-0075; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsuzuki S, 2000, MOL CELL BIOL, V20, P6276, DOI 10.1128/MCB.20.17.6276-6286.2000; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Veitia RA, 2009, J PATHOL, V218, P409, DOI 10.1002/path.2583; Wieser R, 2000, BIOCHEM BIOPH RES CO, V273, P239, DOI 10.1006/bbrc.2000.2947; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105; Zhang SJ, 2009, LEUKEMIA RES, V33, P1141, DOI 10.1016/j.leukres.2009.02.025; Zhang SJ, 2008, BLOOD, V112, P536	36	399	408	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					1012	U130		10.1038/ng.913	http://dx.doi.org/10.1038/ng.913			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892162	Green Accepted			2022-12-25	WOS:000295316200018
J	Inoshima, I; Inoshima, N; Wilke, GA; Powers, ME; Frank, KM; Wang, Y; Wardenburg, JB				Inoshima, Ichiro; Inoshima, Naoko; Wilke, Georgia A.; Powers, Michael E.; Frank, Karen M.; Wang, Yang; Wardenburg, Juliane Bubeck			A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice	NATURE MEDICINE			English	Article							ALPHA-HEMOLYSIN; E-CADHERIN; DISINTEGRIN; PATHOGENESIS; METALLOPROTEINASES; CYTOLYSINS; EXPRESSION; PROTECTION; PROTEINS; NOTCH	Staphylococcus aureus is a major cause of human disease, responsible for half a million infections and approximately 20,000 deaths per year in the United States alone(1,2). This pathogen secretes a-hemolysin, a pore-forming cytotoxin that contributes to the pathogenesis of pneumonia(3-5). alpha-hemolysin injures epithelial cells in vitro by interacting with its receptor, the zinc-dependent metalloprotease ADAM10 ( ref. 6). We show here that mice harboring a conditional disruption of the Adam10 gene in lung epithelium are resistant to lethal pneumonia. Investigation of the molecular mechanism of toxin-receptor function revealed that alpha-hemolysin upregulates ADAM10 metalloprotease activity in alveolar epithelial cells, resulting in cleavage of the adherens junction protein E-cadherin. Cleavage is associated with disruption of epithelial barrier function, contributing to the pathogenesis of lethal acute lung injury. A metalloprotease inhibitor of ADAM10 prevents E-cadherin cleavage in response to Hla; similarly, toxin-dependent E-cadherin proteolysis and barrier disruption is attenuated in ADAM10-knockout mice. Together, these data attest to the function of ADAM10 as the cellular receptor for alpha-hemolysin. The observation that alpha-hemolysin can usurp the metalloprotease activity of its receptor reveals a previously unknown mechanism of pore-forming cytotoxin action in which pathologic insults are not solely the result of irreversible membrane injury and defines ADAM10 inhibition as a strategy to attenuate alpha-hemolysin-induced disease.	[Inoshima, Ichiro; Inoshima, Naoko; Wilke, Georgia A.; Wang, Yang; Wardenburg, Juliane Bubeck] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Powers, Michael E.; Wardenburg, Juliane Bubeck] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Frank, Karen M.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Wardenburg, JB (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	jbubeckw@peds.bsd.uchicago.edu			Departments of Pediatrics and Microbiology at the University of Chicago; US National Institutes of Health [T32 GM007183]; Region V 'Great Lakes' Regional Center for Excellence (US National Institutes of Health [2-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	Departments of Pediatrics and Microbiology at the University of Chicago(University of Chicago); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region V 'Great Lakes' Regional Center for Excellence (US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Golovkina for assistance with mouse breeding strategies, A. Crofts for pilot studies of E-cadherin cleavage in vitro, D. Gruenert (University of California San Francisco) for 16HBE14o-cells, R. Tweten (The University of Oklahoma Health Sciences Center) for the provision of recombinant PLY, J. Whitsett (Cincinnati Children's Medical Center) for SP-C-rtTA-(tetO)<INF>7</INF>CMV-Cre mice, O. Schneewind for discussions and comments on the manuscript, C. Labno for microscopy support, T. Li for immunohistochemistry support, and the Integrated Microscopy and Immunohistochemistry Facilities at the University of Chicago. This work was supported by the Departments of Pediatrics and Microbiology at the University of Chicago. M. E. P. was partially supported by US National Institutes of Health grant T32 GM007183. The authors acknowledge membership in and support from the Region V 'Great Lakes' Regional Center for Excellence (US National Institutes of Health award 2-U54-AI-057153).	Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hoettecke N, 2010, NEURODEGENER DIS, V7, P232, DOI 10.1159/000267865; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; Martin FJ, 2011, INFECT IMMUN, V79, P1898, DOI 10.1128/IAI.01299-10; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Tomita T, 1997, BIOSCI BIOTECH BIOCH, V61, P565, DOI 10.1271/bbb.61.565; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	32	288	297	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1310	U196		10.1038/nm.2451	http://dx.doi.org/10.1038/nm.2451			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21926978	Green Accepted			2022-12-25	WOS:000296022100051
J	Ojika, M; Molli, SD; Kanazawa, H; Yajima, A; Toda, K; Nukada, T; Mao, HM; Murata, R; Asano, T; Qi, JH; Sakagami, Y				Ojika, Makoto; Molli, Shylaja D.; Kanazawa, Harumi; Yajima, Arata; Toda, Kou; Nukada, Tomoo; Mao, Haimeng; Murata, Ryo; Asano, Tomoyo; Qi, Jianhua; Sakagami, Youji			The second Phytophthora mating hormone defines interspecies biosynthetic crosstalk	NATURE CHEMICAL BIOLOGY			English	Article							SEXUAL REPRODUCTION; ALPHA-HORMONES; PARASITICA; INFESTANS; HETEROTHALLISM; HOMOTHALLISM; DESTROYER; CACTORUM; PLANT	The heterothallic species of the agricultural pest Phytophthora use mating hormones alpha 1 and alpha 2 to regulate their sexual reproduction. Here we describe the absolute stereostructure of the second mating hormone alpha 2 as defined by spectroscopic analysis and total synthesis. We have uncovered not only the interspecies universality of alpha hormones but also the pathway by which alpha 2 is biosynthesized from phytol by A2-mating type strains and metabolized to alpha 1 by A1 strains.	[Ojika, Makoto; Molli, Shylaja D.; Kanazawa, Harumi; Mao, Haimeng; Murata, Ryo; Asano, Tomoyo; Qi, Jianhua; Sakagami, Youji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Yajima, Arata; Toda, Kou; Nukada, Tomoo] Tokyo Univ Agr, Fac Appl Biosci, Dept Fermentat Sci, Tokyo, Japan; [Qi, Jianhua] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China	Nagoya University; Tokyo University of Agriculture; Zhejiang University	Ojika, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	ojika@agr.nagoya-u.ac.jp	Yajima, Arata/G-7677-2011	Yajima, Arata/0000-0003-1167-6041	Japan Society for the Promotion of Science [22248012, 21710239, 18380073]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [080028]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Kawakita for P infestans strains and W.H. Ko for valuable suggestions. This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (22248012, 21710239 and 18380073). S.D.M. is a recipient of a Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) scholarship (080028).	ASHBY S. F., 1929, Trains. Brit. Mycol. Soc., V14, P18; Bajpai R, 2007, TETRAHEDRON LETT, V48, P7965, DOI 10.1016/j.tetlet.2007.09.054; Chern LL, 1996, CAN J MICROBIOL, V42, P172, DOI 10.1139/m96-025; Chern LL, 1999, BOT BULL ACAD SINICA, V40, P79; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harutyunyan SR, 2008, P NATL ACAD SCI USA, V105, P8507, DOI 10.1073/pnas.0709289105; Jee HJ, 2002, BOT BULL ACAD SINICA, V43, P203; Jee HJ, 1997, MYCOL RES, V101, P1140, DOI 10.1017/S0953756297004127; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Ko WH, 2007, BOT STUD, V48, P365; KO WH, 1978, J GEN MICROBIOL, V107, P15, DOI 10.1099/00221287-107-1-15; KO WH, 1983, J GEN MICROBIOL, V129, P1397; KO WH, 1988, ANNU REV PHYTOPATHOL, V26, P57, DOI 10.1146/annurev.py.26.090188.000421; PEISKER C, 1989, J PLANT PHYSIOL, V135, P428, DOI 10.1016/S0176-1617(89)80099-9; Qi JH, 2005, SCIENCE, V309, P1828, DOI 10.1126/science.1114756; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; SAVAGE EJ, 1968, PHYTOPATHOLOGY, V58, P1004; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Wang SY, 2010, ORG LETT, V12, P5166, DOI 10.1021/ol102177j; Yajima A, 2008, NAT CHEM BIOL, V4, P235, DOI 10.1038/nchembio.74; Yajima A, 2007, TETRAHEDRON LETT, V48, P4601, DOI 10.1016/j.tetlet.2007.04.109	25	28	28	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					591	593		10.1038/NCHEMBIO.617	http://dx.doi.org/10.1038/NCHEMBIO.617			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21785427				2022-12-25	WOS:000294381400008
J	Cellitti, SE; Ou, WJ; Chiu, HP; Grunewald, J; Jones, DH; Hao, XS; Fan, Q; Quinn, LL; Ng, K; Anfora, AT; Lesley, SA; Uno, T; Brock, A; Geierstanger, BH				Cellitti, Susan E.; Ou, Weijia; Chiu, Hsien-Po; Gruenewald, Jan; Jones, David H.; Hao, Xueshi; Fan, Qian; Quinn, Lisa L.; Ng, Kenneth; Anfora, Andrew T.; Lesley, Scott A.; Uno, Tetsuo; Brock, Ansgar; Geierstanger, Bernhard H.			D-Ornithine coopts pyrrolysine biosynthesis to make and insert pyrroline-carboxy-lysine	NATURE CHEMICAL BIOLOGY			English	Article							TRANSFER-RNA SYNTHETASE; ENCODED AMINO-ACID; GENETIC-CODE; IN-VIVO; UAG; METHYLTRANSFERASES; EXPANSION; RESIDUE; PROTEIN	D-Ornithine has previously been suggested to enhance the expression of pyrrolysine-containing proteins. We unexpectedly discovered that uptake of D-ornithine results in the insertion of a new amino acid, pyrroline-carboxy-lysine (Pcl) instead of the anticipated pyrrolysine (Pyl). Our feeding and biochemical studies point to specific roles of the poorly understood Pyl biosynthetic enzymes PylC and PylD in converting L-lysine and D-ornithine to Pcl and confirm intermediates in the biosynthesis of Pyl.	[Cellitti, Susan E.; Ou, Weijia; Chiu, Hsien-Po; Gruenewald, Jan; Jones, David H.; Hao, Xueshi; Fan, Qian; Quinn, Lisa L.; Ng, Kenneth; Anfora, Andrew T.; Lesley, Scott A.; Uno, Tetsuo; Brock, Ansgar; Geierstanger, Bernhard H.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis	Cellitti, SE (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA USA.	bgeierst@gnf.org		Anfora, Andrew/0000-0003-3849-1784				Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Cellitti SE, 2008, J AM CHEM SOC, V130, P9268, DOI 10.1021/ja801602q; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gaston MA, 2011, NATURE, V471, P647, DOI 10.1038/nature09918; Geierstanger B., 2010, Bio-synthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues, Patent No. [WO2010048582A1, 2010048582]; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Longstaff DG, 2007, P NATL ACAD SCI USA, V104, P1021, DOI 10.1073/pnas.0610294104; Longstaff DG, 2007, MOL MICROBIOL, V63, P229, DOI 10.1111/j.1365-2958.2006.05500.x; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Namy O, 2007, FEBS LETT, V581, P5282, DOI 10.1016/j.febslet.2007.10.022; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; Yuan J, 2010, FEBS LETT, V584, P342, DOI 10.1016/j.febslet.2009.11.005; Zhang Y, 2005, J BIOL CHEM, V280, P20740, DOI 10.1074/jbc.M501458200	23	24	26	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					528	530		10.1038/NCHEMBIO.586	http://dx.doi.org/10.1038/NCHEMBIO.586			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21525873				2022-12-25	WOS:000292825400013
J	Li, YR; Zheng, HC; Luo, RB; Wu, HL; Zhu, HM; Li, RQ; Cao, HZ; Wu, BX; Huang, SJ; Shao, HJ; Ma, HZ; Zhang, F; Feng, SJ; Zhang, W; Du, HL; Tian, G; Li, JX; Zhang, XQ; Li, SG; Bolund, L; Kristiansen, K; De Smith, AJ; Blakemore, AIF; Coin, LJM; Yang, HM; Wang, J; Wang, J				Li, Yingrui; Zheng, Hancheng; Luo, Ruibang; Wu, Honglong; Zhu, Hongmei; Li, Ruiqiang; Cao, Hongzhi; Wu, Boxin; Huang, Shujia; Shao, Haojing; Ma, Hanzhou; Zhang, Fan; Feng, Shuijian; Zhang, Wei; Du, Hongli; Tian, Geng; Li, Jingxiang; Zhang, Xiuqing; Li, Songgang; Bolund, Lars; Kristiansen, Karsten; De Smith, Adam J.; Blakemore, Alexandra I. F.; Coin, Lachlan J. M.; Yang, Huanming; Wang, Jian; Wang, Jun			Structural variation in two human genomes mapped at single-nucleotide resolution by whole genome de novo assembly	NATURE BIOTECHNOLOGY			English	Article							SHORT READ ALIGNMENT; COMPLEX TRAITS; COPY-NUMBER; SEQUENCE; INSERTIONS; ALGORITHMS; DELETIONS; GENES; TOOL; DNA	Here we use whole-genome de novo assembly of second-generation sequencing reads to map structural variation (SV) in an Asian genome and an African genome. Our approach identifies small-and intermediate-size homozygous variants (1-50 kb) including insertions, deletions, inversions and their precise breakpoints, and in contrast to other methods, can resolve complex rearrangements. In total, we identified 277,243 SVs ranging in length from 1-23 kb. Validation using computational and experimental methods suggests that we achieve overall <6% false-positive rate and <10% false-negative rate in genomic regions that can be assembled, which outperforms other methods. Analysis of the SVs in the genomes of 106 individuals sequenced as part of the 1000 Genomes Project suggests that SVs account for a greater fraction of the diversity between individuals than do single-nucleotide polymorphisms (SNPs). These findings demonstrate that whole-genome de novo assembly is a feasible approach to deriving more comprehensive maps of genetic variation.	[Li, Yingrui; Zheng, Hancheng; Luo, Ruibang; Wu, Honglong; Zhu, Hongmei; Li, Ruiqiang; Cao, Hongzhi; Wu, Boxin; Huang, Shujia; Shao, Haojing; Ma, Hanzhou; Zhang, Fan; Feng, Shuijian; Zhang, Wei; Tian, Geng; Li, Jingxiang; Zhang, Xiuqing; Li, Songgang; Bolund, Lars; Kristiansen, Karsten; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Luo, Ruibang; Huang, Shujia; Shao, Haojing; Ma, Hanzhou; Zhang, Fan; Du, Hongli] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Peoples R China; [Luo, Ruibang] Univ Hong Kong, Dept Comp Sci, Hong Kong, Peoples R China; [Wu, Honglong; Cao, Hongzhi] Shenzhen Univ Med Sch, Genome Res Inst, Shenzhen, Peoples R China; [Bolund, Lars] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [De Smith, Adam J.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, London, England; [Coin, Lachlan J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Beijing Genomics Institute (BGI); South China University of Technology; University of Hong Kong; Shenzhen University; Aarhus University; University of Copenhagen; Imperial College London; Imperial College London; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.org.cn	Wang, Jun/A-7261-2013; Shao, Haojing/C-5429-2017; Coin, Lachlan JM/A-9001-2014; Li, Yingrui/K-1064-2015; Huang, Shujia/GXG-8583-2022; Coin, Lachlan/O-4976-2019; Blakemore, Alexandra I F/D-2253-2009; Kristiansen, Karsten/J-5148-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Shao, Haojing/0000-0002-8806-197X; Coin, Lachlan JM/0000-0002-4300-455X; Huang, Shujia/0000-0003-2100-2534; Coin, Lachlan/0000-0002-4300-455X; Blakemore, Alexandra I F/0000-0003-0661-564X; Kristiansen, Karsten/0000-0002-6024-0917; Zhang, Wei/0000-0002-6968-6974; de Smith, Adam/0000-0003-4880-7543; Luo, Ruibang/0000-0001-9711-6533; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Chinese 863 program [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240 076A, ZYC200903240080A]; Danish Natural Science Research Council; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK; Wellcome Trust; Medical Research Council; Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Chinese 863 program [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240 076A, ZYC200903240080A]; Danish Natural Science Research Council; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK; Wellcome Trust; Medical Research Council; Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; Diabetes UK [08/0003775] Funding Source: researchfish	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; Diabetes UK(Diabetes UK)	This work was supported by a National Basic Research Program of China (973 program no. 2011CB809200), the National Natural Science Foundation of China (30725008; 30890032; 30811130531; 30221004), the Chinese 863 program (2006AA02Z177; 2006AA02Z334; 2006AA02A302; 2009AA022707), the Shenzhen Municipal Government of China (grants JC200903190767A; JC200903190772A; ZYC200903240076A; CXB200903110066A; ZYC200903240077A; ZYC200903240 076A and ZYC200903240080A) and the Ole Romer grant from the Danish Natural Science Research Council. This project is also funded by the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen. The 1000 Genomes Project Consortium provided the data for population analysis. AIFB is supported by Diabetes UK, the Wellcome Trust, the Medical Research Council and the Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust. Thanks to X. Wang from School of Biosciences & Bioengineering, SCUT, for his excellent coordination. Thanks to J. El-Sayed Moustafa for her help analyzing the experimental validation data. L. Goodman, S. Edmunds and A. Basford edited the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chanock S, 2009, NAT GENET, V41, P765, DOI 10.1038/ng0709-765; Chen FC, 2007, GENOME RES, V17, P16, DOI 10.1101/gr.5429606; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Harris R.S., 2007, THESIS PENN STATE U; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wong K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r128; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yi L., 2010, NAT GENET, V42, P969; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	95	96	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					723	+		10.1038/nbt.1904	http://dx.doi.org/10.1038/nbt.1904			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21785424	Bronze			2022-12-25	WOS:000293696500024
J	Smallwood, SA; Tomizawa, S; Krueger, F; Ruf, N; Carli, N; Segonds-Pichon, A; Sato, S; Hata, K; Andrews, SR; Kelsey, G				Smallwood, Sebastien A.; Tomizawa, Shin-ichi; Krueger, Felix; Ruf, Nico; Carli, Natasha; Segonds-Pichon, Anne; Sato, Shun; Hata, Kenichiro; Andrews, Simon R.; Kelsey, Gavin			Dynamic CpG island methylation landscape in oocytes and preimplantation embryos	NATURE GENETICS			English	Article							MATERNAL GENOMIC IMPRINTS; DNA METHYLATION; GERM-CELLS; HISTONE H3; DNMT3L; DOMAIN; ESTABLISHMENT; TRANSCRIPTION; GENES	Elucidating how and to what extent CpG islands (CGIs) are methylated in germ cells is essential to understand genomic imprinting and epigenetic reprogramming(1-3). Here we present, to our knowledge, the first integrated epigenomic analysis of mammalian oocytes, identifying over a thousand CGIs methylated in mature oocytes. We show that these CGIs depend on DNMT3A and DNMT3L(4,5) but are not distinct at the sequence level, including in CpG periodicity(6). They are preferentially located within active transcription units and are relatively depleted in H3K4me3, supporting a general transcription-dependent mechanism of methylation. Very few methylated CGIs are fully protected from post-fertilization reprogramming but, notably, the majority show incomplete demethylation in embryonic day (E) 3.5 blastocysts. Our study shows that CGI methylation in gametes is not entirely related to genomic imprinting but is a strong factor in determining methylation status in preimplantation embryos, suggesting a need to reassess mechanisms of post-fertilization demethylation.	[Smallwood, Sebastien A.; Tomizawa, Shin-ichi; Ruf, Nico; Carli, Natasha; Kelsey, Gavin] Babraham Inst, Epigenet Programme, Cambridge, England; [Krueger, Felix; Segonds-Pichon, Anne; Andrews, Simon R.] Babraham Inst, Bioinformat Grp, Cambridge, England; [Sato, Shun; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan; [Kelsey, Gavin] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; National Center for Child Health & Development - Japan; University of Cambridge	Kelsey, G (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	gavin.kelsey@babraham.ac.uk	Smallwood, Sebastien/M-9783-2014; Krueger, Felix/J-3340-2019; Tomizawa, Shinichi/AAT-7149-2020	Tomizawa, Shinichi/0000-0002-8291-6623; Krueger, Felix/0000-0002-5513-3324; Kelsey, Gavin/0000-0002-9762-5634	Medical Research Council [G0800013, G0801156]; Biotechnology and Biological Sciences Research Council; Babraham Institute; Centre for Trophoblast Research; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000L747, BBS/E/B/0000S222, BBS/E/B/0000M233] Funding Source: researchfish; Medical Research Council [G9723500] Funding Source: researchfish; BBSRC [BBS/E/B/0000L747, BBS/E/B/0000M233, BBS/E/B/0000S222] Funding Source: UKRI; MRC [G9723500, G0800013, G0801156] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre for Trophoblast Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Tabbada for technical assistance with Illumina sequencing, H. Mertani, P. Mollard, W. Dean and W. Reik for input and discussions and M. Branco and W. Reik for making available the DNMT3A conditional knockout line. This work was supported by grants G0800013 and G0801156 from the Medical Research Council to G. K. and by the Biotechnology and Biological Sciences Research Council. S. A. S. was supported by the Babraham Institute and the Centre for Trophoblast Research.	Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Bock C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r14; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Hata K, 2002, DEVELOPMENT, V129, P1983; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reinhart B, 2006, MOL CELL BIOL, V26, P8347, DOI 10.1128/MCB.00981-06; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Tartakover-Matalon S, 2007, HUM REPROD, V22, P1161, DOI 10.1093/humrep/del464; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	31	472	484	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					811	U126		10.1038/ng.864	http://dx.doi.org/10.1038/ng.864			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21706000	Green Accepted			2022-12-25	WOS:000293178300020
J	Vassar, R				Vassar, Robert			Alzheimer's therapy: a BACE in the hand?	NATURE MEDICINE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; CLEAVAGE; DISEASE		Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.							Alzheimer Research Forum, 2011, UPPS IS TAU IMMU TAK; Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Kim SH, 2010, J NEUROSCI, V30, P3870, DOI 10.1523/JNEUROSCI.4717-09.2010; Lilly E., 2010, LILLY HALTS DEV SEMA; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yamakawa H, 2010, J BIOL CHEM, V285, P1634, DOI 10.1074/jbc.M109.066753; Yoshimizu T, 2004, BIOCHEM BIOPH RES CO, V315, P493, DOI 10.1016/j.bbrc.2004.01.073; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	11	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					932	933		10.1038/nm0811-932	http://dx.doi.org/10.1038/nm0811-932			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21818090				2022-12-25	WOS:000293507400023
J	Fugier, C; Klein, AF; Hammer, C; Vassilopoulos, S; Ivarsson, Y; Toussaint, A; Tosch, V; Vignaud, A; Ferry, A; Messaddeq, N; Kokunai, Y; Tsuburaya, R; de la Grange, P; Dembele, D; Francois, V; Precigout, G; Boulade-Ladame, C; Hummel, MC; de Munain, AL; Sergeant, N; Laquerriere, A; Thibault, C; Deryckere, F; Auboeuf, D; Garcia, L; Zimmermann, P; Udd, B; Schoser, B; Takahashi, MP; Nishino, I; Bassez, G; Laporte, J; Furling, D; Charlet-Berguerand, N				Fugier, Charlotte; Klein, Arnaud F.; Hammer, Caroline; Vassilopoulos, Stephane; Ivarsson, Ylva; Toussaint, Anne; Tosch, Valerie; Vignaud, Alban; Ferry, Arnaud; Messaddeq, Nadia; Kokunai, Yosuke; Tsuburaya, Rie; de la Grange, Pierre; Dembele, Doulaye; Francois, Virginie; Precigout, Guillaume; Boulade-Ladame, Charlotte; Hummel, Marie-Christine; Lopez de Munain, Adolfo; Sergeant, Nicolas; Laquerriere, Annie; Thibault, Christelle; Deryckere, Francois; Auboeuf, Didier; Garcia, Luis; Zimmermann, Pascale; Udd, Bjarne; Schoser, Benedikt; Takahashi, Masanori P.; Nishino, Ichizo; Bassez, Guillaume; Laporte, Jocelyn; Furling, Denis; Charlet-Berguerand, Nicolas			Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy	NATURE MEDICINE			English	Article							SKELETAL-MUSCLE; CHLORIDE CHANNEL; AMPHIPHYSIN-2 BIN1; PROTEIN-KINASE; MESSENGER-RNA; CTG REPEAT; MUTATIONS; RECEPTOR; GENE; DISORGANIZATION	Myotonic dystrophy is the most common muscular dystrophy in adults and the first recognized example of an RNA-mediated disease. Congenital myotonic dystrophy (CDM1) and myotonic dystrophy of type 1 (DM1) or of type 2 (DM2) are caused by the expression of mutant RNAs containing expanded CUG or CCUG repeats, respectively. These mutant RNAs sequester the splicing regulator Muscleblind-like-1 (MBNL1), resulting in specific misregulation of the alternative splicing of other pre-mRNAs. We found that alternative splicing of the bridging integrator-1 (BIN1) pre-mRNA is altered in skeletal muscle samples of people with CDM1, DM1 and DM2. BIN1 is involved in tubular invaginations of membranes and is required for the biogenesis of muscle T tubules, which are specialized skeletal muscle membrane structures essential for excitation-contraction coupling. Mutations in the BIN1 gene cause centronuclear myopathy, which shares some histopathological features with myotonic dystrophy. We found that MBNL1 binds the BIN1 pre-mRNA and regulates its alternative splicing. BIN1 missplicing results in expression of an inactive form of BIN1 lacking phosphatidylinositol 5-phosphate-binding and membrane-tubulating activities. Consistent with a defect of BIN1, muscle T tubules are altered in people with myotonic dystrophy, and membrane structures are restored upon expression of the normal splicing form of BIN1 in muscle cells of such individuals. Finally, reproducing BIN1 splicing alteration in mice is sufficient to promote T tubule alterations and muscle weakness, a predominant feature of myotonic dystrophy.	[Fugier, Charlotte; Hammer, Caroline; Toussaint, Anne; Tosch, Valerie; Messaddeq, Nadia; Dembele, Doulaye; Hummel, Marie-Christine; Thibault, Christelle; Laporte, Jocelyn; Charlet-Berguerand, Nicolas] Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR7104, Illkirch Graffenstaden, France; [Klein, Arnaud F.; Vassilopoulos, Stephane; Vignaud, Alban; Ferry, Arnaud; Francois, Virginie; Precigout, Guillaume; Garcia, Luis; Furling, Denis] Univ Paris 06, INSERM, Inst Myol, UM76,U974, Paris, France; [Klein, Arnaud F.; Vassilopoulos, Stephane; Vignaud, Alban; Ferry, Arnaud; Francois, Virginie; Precigout, Guillaume; Garcia, Luis; Furling, Denis] CNRS, UMR7215, Paris, France; [Ivarsson, Ylva; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Kokunai, Yosuke] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Tsuburaya, Rie; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [de la Grange, Pierre] Hop St Louis, Paris, France; [Boulade-Ladame, Charlotte] Univ Strasbourg 1, Ecole Super Biotechnol Strasbourg, CNRS, UMR7175, Illkirch Graffenstaden, France; [Lopez de Munain, Adolfo] Hosp Donostia, Biodonostia Inst, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Carlos III, San Sebastian, Spain; [Sergeant, Nicolas] Jean Pierre Aubert Res Ctr, INSERM, U837 1, Lille, France; [Laquerriere, Annie] Univ Hosp Rouen, Pathol Lab, Rouen, France; [Auboeuf, Didier] Ctr Leon Berard, INSERM, U590, F-69373 Lyon, France; [Udd, Bjarne] Tampere Univ, Neuromuscular Res Ctr, FIN-33101 Tampere, Finland; [Udd, Bjarne] Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, Helsinki, Finland; [Udd, Bjarne] Vasa Cent Hosp, Dept Neurol, Vaasa, Finland; [Schoser, Benedikt] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Bassez, Guillaume] Inst Mondor Rech Biomed, INSERM, U955, Creteil, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); KU Leuven; Osaka University; National Center for Neurology & Psychiatry - Japan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CIBERNED; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Tampere University; University of Helsinki; Vaasa Central Hospital; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Charlet-Berguerand, N (corresponding author), Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR7104, Illkirch Graffenstaden, France.	ncharlet@igbmc.fr	Bassez, Guillaume/AAD-3033-2022; Sergeant, Nicolas/O-5467-2017; laporte, jocelyn/O-4888-2019; Nishino, Ichizo/G-2676-2010; Charlet-Berguerand, Nicolas/I-6727-2016; Furling, Denis/M-2346-2017; Ivarsson, Ylva/HGE-0283-2022; Schoser, Benedikt/AAH-6286-2020; ferry, arnaud/D-2816-2019; Charlet-Berguerand, Nicolas/GZM-6636-2022; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; KLEIN, Arnaud/AAD-3333-2022; Laporte, Jocelyn/H-6801-2016; Zimmermann, Pascale/P-4190-2017; laporte, jocelyn/J-7008-2012; Auboeuf, Didier/M-4610-2014; Dembélé, Doulaye/O-6513-2017; Takahashi, Masanori/O-8946-2019; vassilopoulos, stephane/AAF-3865-2021; vassilopoulos, stéphane/F-6041-2014	Sergeant, Nicolas/0000-0003-1448-124X; Nishino, Ichizo/0000-0001-9452-112X; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Furling, Denis/0000-0001-7912-4409; Ivarsson, Ylva/0000-0002-7081-3846; ferry, arnaud/0000-0002-6050-4556; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; KLEIN, Arnaud/0000-0002-3860-7049; Dembélé, Doulaye/0000-0003-3879-6940; Takahashi, Masanori/0000-0002-5513-5012; vassilopoulos, stephane/0000-0003-0172-330X; Auboeuf, Didier/0000-0002-3757-0002; Bassez, Guillaume/0000-0002-2044-1052; /0000-0002-9509-4032; Schoser, Benedikt/0000-0002-2757-8131; Thibault-Carpentier, Christelle/0000-0003-1562-1451	INSERM AVENIR; Agence nationale de la recherche [07-942, 08-005, 07-065]; Association Francaise contre les Myopathies [MNM1 12982, 12570, 14269, 12576, 14058]; Fondation pour la Recherche Medicale [20071210538]; Japan Society for the Promotion of Science [20590998]; European Molecular Biology Organization	INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence nationale de la recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank T. Cooper (Baylor College of Medicine) for the gift of the beta-globin 4.11.12, DMPKS, DT960 and tgCUGBP1 plasmids, L. Ranum (University of Minnesota) for the gift of the CCTG300 expression plasmid, C. Branlant (CNRS) for the gift of the pGEX-MBNL1 Delta 101 vector, M. Swanson (University of Florida) for the gift of the pGEX-6P-MBNL1-His vector, P. Hawkins (Babraham Research Campus) for the gift of the GFP-PH domain of PLCg and GFP-PX domain of P40 constructs, O. Gozani (Stanford University) for the gift of the GFP-PHD domain of ING2 vector, Z. Xue (Universite Paris 7) for the gift of the synemin-specific antibody, I. Marty (INSERM) for the gift of the RYR1-specific antibody, M. Swanson (University of Florida), G. Gourdon (INSERM) and C. Thornton (University of Rochester) for the gift of RNA from skeletal muscles of MBNL1<SUP>Delta E3</SUP>, DM300 and HSA<SUP>LR</SUP> mice, respectively, the IGBMC facilities for assistance, J. Laine, G. Butler-Browne and all members of the French DM Network for fruitful discussion. This work was supported by INSERM AVENIR (N.C.-B.), Agence nationale de la recherche GENOPAT 07-942 (N.C.-B.), 08-005 (J.L.) and BLANC 07-065 (J.L.), Association Francaise contre les Myopathies MNM1 12982 (N.C.-B.), 12570 and 14269 (D.F.), 12576 and 14058 (J.L.), Fondation pour la Recherche Medicale 20071210538 (J.L.), Japan Society for the Promotion of Science KAKENHI 20590998 (M.P.T.) and a European Molecular Biology Organization long-term fellowship (Y.I.).	Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mouisel E, 2006, NEUROSCI RES, V55, P389, DOI 10.1016/j.neures.2006.05.002; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Ueda H, 1999, J NEUROL SCI, V162, P38, DOI 10.1016/S0022-510X(98)00290-1; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; YUAN S, 1990, J CELL BIOL, V110, P1187, DOI 10.1083/jcb.110.4.1187; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	40	220	224	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					720	U112		10.1038/nm.2374	http://dx.doi.org/10.1038/nm.2374			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21623381				2022-12-25	WOS:000291308800033
J	Ohi, Y; Qin, H; Hong, CB; Blouin, L; Polo, JM; Guo, TX; Qi, ZX; Downey, SL; Manos, PD; Rossi, DJ; Yu, JW; Hebrok, M; Hochedlinger, K; Costello, JF; Song, JS; Ramalho-Santos, M				Ohi, Yuki; Qin, Han; Hong, Chibo; Blouin, Laure; Polo, Jose M.; Guo, Tingxia; Qi, Zhongxia; Downey, Sara L.; Manos, Philip D.; Rossi, Derrick J.; Yu, Jingwei; Hebrok, Matthias; Hochedlinger, Konrad; Costello, Joseph F.; Song, Jun S.; Ramalho-Santos, Miguel			Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells	NATURE CELL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; ABERRANT PROMOTER METHYLATION; GENE-EXPRESSION; DIFFERENTIATION; IDENTIFICATION; GENERATION; REVEALS; TARGETS; SYSTEM	Human induced pluripotent stem (iPS) cells are remarkably similar to embryonic stem (ES) cells, but recent reports indicate that there may be important differences between them. We carried out a systematic comparison of human iPS cells generated from hepatocytes (representative of endoderm), skin fibroblasts (mesoderm) and melanocytes (ectoderm). All low-passage iPS cells analysed retain a transcriptional memory of the original cells. The persistent expression of somatic genes can be partially explained by incomplete promoter DNA methylation. This epigenetic mechanism underlies a robust form of memory that can be found in iPS cells generated by multiple laboratories using different methods, including RNA transfection. Incompletely silenced genes tend to be isolated from other genes that are repressed during reprogramming, indicating that recruitment of the silencing machinery may be inefficient at isolated genes. Knockdown of the incompletely reprogrammed gene C9orf64 (chromosome 9 open reading frame 64) reduces the efficiency of human iPS cell generation, indicating that somatic memory genes may be functionally relevant during reprogramming.	[Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ohi, Yuki; Qin, Han; Blouin, Laure; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Ob Gyn, San Francisco, CA 94143 USA; [Ohi, Yuki; Qin, Han; Blouin, Laure; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Ohi, Yuki; Qin, Han; Blouin, Laure; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Ohi, Yuki; Qin, Han; Blouin, Laure; Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ohi, Yuki; Qin, Han; Blouin, Laure; Guo, Tingxia; Hebrok, Matthias; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Hong, Chibo; Downey, Sara L.; Costello, Joseph F.] Univ Calif San Francisco, Dept Neurosurg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Howard Hughes Med Inst,Canc Ctr, Boston, MA 02114 USA; [Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose M.; Manos, Philip D.; Rossi, Derrick J.; Hochedlinger, Konrad] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Guo, Tingxia; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Qi, Zhongxia; Yu, Jingwei] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA; [Manos, Philip D.; Rossi, Derrick J.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst,Program Cellular & Mol Med,Dept P, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Song, JS (corresponding author), Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol & Biostat, 513 Parnassus Ave, San Francisco, CA 94143 USA.	SongJ@humgen.ucsf.edu; mrsantos@diabetes.ucsf.edu	Song, Jun S/E-2526-2016; Ramalho-Santos, Miguel/L-9092-2018; Mills, Sara/AAN-1351-2021; Guo, Tingxia/K-8713-2012	Song, Jun S/0000-0002-0422-2175; Ramalho-Santos, Miguel/0000-0003-0177-5556; Guo, Tingxia/0000-0001-6463-4908; Polo, Jose M/0000-0002-2531-778X	CIRM; JDRF; NIH; Leona M. and Harry B. Helmsley Charitable Trust; UCSF Diabetes Center; NICHD; PhRMA Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; UCSF Diabetes Center; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PhRMA Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors wish to thank S. Fisher, O. Genbachev, A. Leavitt and B. Conklin for expert advice on culturing human ES cells, D. Subramanyam and R. Blelloch for the Adult Fibroblast-iPS 1 cell line, L. Ta, A. Williams and A. Holloway at the Gladstone Institutes, J. Bolen at the Mouse Pathology Core Facility for expert assistance, J. Utikal for technical advice, and J. Yang and A. Campain for sharing their meta-DEDS code. We thank members of the Santos laboratory, R. Blelloch, H. Willenbring, S. Fisher and M. Grskovic for helpful discussions and critical reading of the manuscript. Work in the Santos laboratory is supported by CIRM, JDRF, an NIH Director's New Innovator Award and the Leona M. and Harry B. Helmsley Charitable Trust. Y.O. was partially supported by the UCSF Diabetes Center and a T32 grant from the NICHD to the UCSF Center for Reproductive Sciences. Work in M.H.'s laboratory was supported by grants from the JDRF and the Leona M. and Harry B. Helmsley Charitable Trust. T.G. was supported by the JDRF and the Leona M. and Harry B. Helmsley Charitable Trust. S.L.D. was partially supported by CIRM. J.S.S. was partially supported by the PhRMA Foundation.	Avery K, 2008, STEM CELLS DEV, V17, P1195, DOI 10.1089/scd.2008.0063; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Cai LY, 2007, LIFE SCI, V80, P1458, DOI 10.1016/j.lfs.2007.01.015; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Chapman EJ, 2008, MOL CANCER RES, V6, P1154, DOI 10.1158/1541-7786.MCR-07-2168; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hirasawa Y, 2006, ONCOLOGY-BASEL, V71, P77, DOI 10.1159/000100475; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jung Y, 2008, LAB INVEST, V88, P153, DOI 10.1038/labinvest.3700706; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Li SSL, 2009, J CELL BIOCHEM, V106, P1020, DOI 10.1002/jcb.22084; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sweetser DA, 2005, GENE CHROMOSOME CANC, V44, P279, DOI 10.1002/gcc.20236; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang YH, 2005, BIOINFORMATICS, V21, P1084, DOI 10.1093/bioinformatics/bti108; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	39	428	439	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					541	U328		10.1038/ncb2239	http://dx.doi.org/10.1038/ncb2239			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21499256	Green Accepted			2022-12-25	WOS:000290148700013
J	Ismail, SA; Chen, YX; Rusinova, A; Chandra, A; Bierbaum, M; Gremer, L; Triola, G; Waldmann, H; Bastiaens, PIH; Wittinghofer, A				Ismail, Shehab A.; Chen, Yong-Xiang; Rusinova, Alexandra; Chandra, Anchal; Bierbaum, Martin; Gremer, Lothar; Triola, Gemma; Waldmann, Herbert; Bastiaens, Philippe I. H.; Wittinghofer, Alfred			Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo	NATURE CHEMICAL BIOLOGY			English	Article							GTPASE-ACTIVATING PROTEIN; PRENYL-BINDING PROTEIN; DELTA-SUBUNIT; PDE-DELTA; DISSOCIATION INHIBITOR; STRUCTURAL BASIS; CELL-GROWTH; RAB GTPASES; RHEB; MEMBRANE	Lipidated Rho and Rab GTP-binding proteins are transported between membranes in complex with solubilizing factors called 'guanine nucleotide dissociation inhibitors' (GDIs). Unloading from GDIs using GDI displacement factors (GDFs) has been proposed but remains mechanistically elusive. PDE delta is a putative solubilizing factor for several prenylated Ras-subfamily proteins. Here we report the structure of fully modified farnesylated Rheb-GDP in complex with PDE delta. The structure explains the nucleotide-independent binding of Rheb to PDE delta and the relaxed specificity of PDE delta. We demonstrate that the G proteins Arl2 and Arl3 act in a GTP-dependent manner as allosteric release factors for farnesylated cargo. We thus describe a new transport system for farnesylated G proteins involving a GDI-like molecule and an unequivocal GDF. Considering the importance of PDE delta for proper Ras and Rheb signaling, this study is instrumental in developing a new target for anticancer therapy.	[Ismail, Shehab A.; Rusinova, Alexandra; Chandra, Anchal; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Struct Biol Grp, D-44139 Dortmund, Germany; [Chen, Yong-Xiang; Triola, Gemma; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Chem Biol, D-44139 Dortmund, Germany; [Chandra, Anchal; Bierbaum, Martin; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44139 Dortmund, Germany; [Waldmann, Herbert] Tech Univ Dortmund, Fac Chem, Dept Chem Biol, Dortmund, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Dortmund University of Technology	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Struct Biol Grp, Rheinlanddamm 201, D-44139 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Chandra, Anchal/AAT-5644-2021; Gremer, Lothar/H-9128-2013; Waldmann, Herbert/B-7406-2017; CHEN, YONG-XIANG/D-4792-2017; Triola, Gemma/E-2235-2017	Chandra, Anchal/0000-0003-4096-4771; Gremer, Lothar/0000-0001-7065-5027; Waldmann, Herbert/0000-0002-9606-7247; CHEN, YONG-XIANG/0000-0003-3518-0139; Triola, Gemma/0000-0003-4177-8989; Ismail, Shehab/0000-0002-4150-1077	German Research Foundation (DFG) [SFB 642]; European Research Council (ERC) [268782, 268309]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC))	A.W., H. W. and P. I. H. B. thank the German Research Foundation (DFG) for financial support (SFB 642). A. W. and H. W. thank the European Research Council for financial support (ERC Grants 268782 and 268309). We thank A. Itzen and R. S. Goody for help with the stopped flow and discussion, D. Kuhlmann and C. Koerner for expert technical assistance. We thank I. Vetter. and R. Gaspar for scientific discussion and I. Schlichting for X-ray data collection.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; BOS JL, 1989, CANCER RES, V49, P4682; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Chen YX, 2010, ANGEW CHEM INT EDIT, V49, P6090, DOI 10.1002/anie.201001884; Cox AD, 2002, CURR OPIN PHARMACOL, V2, P388, DOI 10.1016/S1471-4892(02)00181-9; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Florio SK, 1996, J BIOL CHEM, V271, P24036, DOI 10.1074/jbc.271.39.24036; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Nikolova S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-146; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Vartak N, 2010, EMBO J, V29, P2689, DOI 10.1038/emboj.2010.184; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Walther KA, 2011, MOL BIOSYST, V7, P322, DOI 10.1039/c0mb00132e; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang TL, 2009, STRUCTURE, V17, P602, DOI 10.1016/j.str.2009.01.014	47	184	189	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					942	949		10.1038/NCHEMBIO.686	http://dx.doi.org/10.1038/NCHEMBIO.686			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22002721				2022-12-25	WOS:000297166200018
J	Badeanlou, L; Furlan-Freguia, C; Yang, G; Ruf, W; Samad, F				Badeanlou, Leylla; Furlan-Freguia, Christian; Yang, Guang; Ruf, Wolfram; Samad, Fahumiya			Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation	NATURE MEDICINE			English	Article							INDUCED INSULIN-RESISTANCE; FACTOR GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; FACTOR CYTOPLASMIC DOMAIN; METABOLIC SYNDROME; IN-VIVO; DIABETES-MELLITUS; SKELETAL-MUSCLE; KUPFFER CELLS; BODY-WEIGHT	Tissue factor, the initiator of the coagulation cascade, mediates coagulation factor VIIa-dependent activation of protease-activated receptor 2 (PAR2). Here we delineate a role for this signaling pathway in obesity and its complications. Mice lacking PAR2 (F2rl1) or the cytoplasmic domain of tissue factor were protected from weight gain and insulin resistance induced by a high-fat diet. In hematopoietic cells, genetic ablation of tissue factor-PAR2 signaling reduced adipose tissue macrophage inflammation, and specific pharmacological inhibition of macrophage tissue factor signaling rapidly ameliorated insulin resistance. In contrast, nonhematopoietic cell tissue factor-VIIa-PAR2 signaling specifically promoted obesity. Mechanistically, adipocyte tissue factor cytoplasmic domain-dependent VIIa signaling suppressed Akt phosphorylation with concordant adverse transcriptional changes of key regulators of obesity and metabolism. Pharmacological blockade of adipocyte tissue factor in vivo reversed these effects of tissue factor-VIIa signaling and rapidly increased energy expenditure. Thus, inhibition of tissue factor signaling is a potential therapeutic avenue for improving impaired metabolism and insulin resistance in obesity.	[Furlan-Freguia, Christian; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Badeanlou, Leylla; Yang, Guang; Samad, Fahumiya] Torrey Pines Inst Mol Studies, Dept Cell Biol, San Diego, CA USA	Scripps Research Institute; Torrey Pines Institute for Molecular Studies, California	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ruf@scripps.edu; fsamad@tpims.org			US National Institutes of Health [HL71146, HL104232, HL77753]; Diabetes National Research Group; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071146, R01HL077753, R01HL104232] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes National Research Group; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by US National Institutes of Health grants HL71146, HL104232 (F. S.) and HL77753 (W. R.), a grant from the Diabetes National Research Group (F. S.) and a postdoctoral fellowship from the American Heart Association (C.F.-F.). We thank M. Anderson (Johnson & Johnson Pharmaceutical Research and Development, Radnor, Pennsylvania, USA) for TFKI mice, C. Biazak, J. Royce, N. Vu and R. Zubairi for technical assistance, A. J. Roberts for assistance with metabolic studies and C. Johnson for preparation of figures.	Ahamed J, 2007, BLOOD, V109, P5251, DOI 10.1182/blood-2006-10-051334; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Bradshaw G, 2005, P NATL ACAD SCI USA, V102, P11029, DOI 10.1073/pnas.0502677102; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007; Diamant M, 2002, CIRCULATION, V106, P2442, DOI 10.1161/01.CIR.0000036596.59665.C6; Dorfleutner A, 2004, MOL BIOL CELL, V15, P4416, DOI 10.1091/mbc.E03-09-0640; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gerrits AJ, 2011, J THROMB HAEMOST, V9, P873, DOI 10.1111/j.1538-7836.2011.04201.x; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Kopp CW, 2003, OBES RES, V11, P950, DOI 10.1038/oby.2003.131; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MACKMAN N, 1993, AM J PATHOL, V143, P76; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Melis E, 2001, BIOCHEM BIOPH RES CO, V286, P580, DOI 10.1006/bbrc.2001.5425; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Randolph GJ, 1998, BLOOD, V92, P4167, DOI 10.1182/blood.V92.11.4167.423k35_4167_4177; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Samad F, 2001, BLOOD, V98, P3353, DOI 10.1182/blood.V98.12.3353; Schaffner F, 2010, BLOOD, V116, P6106, DOI 10.1182/blood-2010-06-289314; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Snyder LA, 2008, J THROMB HAEMOST, V6, P306, DOI 10.1111/j.1538-7836.2007.02833.x; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Venugopal J, 2004, P NATL ACAD SCI USA, V101, P17120, DOI 10.1073/pnas.0405278101; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang P, 2007, BIOCHEM J, V408, P221, DOI 10.1042/BJ20070483; Wang P, 2006, BIOCHEMISTRY-US, V45, P9374, DOI 10.1021/bi0602617; Wang P, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-36; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	60	121	127	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1490	U200		10.1038/nm.2461	http://dx.doi.org/10.1038/nm.2461			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22019885	Green Accepted			2022-12-25	WOS:000296779300041
J	Inui, M; Manfrin, A; Mamidi, A; Martello, G; Morsut, L; Soligo, S; Enzo, E; Moro, S; Polo, S; Dupont, S; Cordenonsi, M; Piccolo, S				Inui, Masafumi; Manfrin, Andrea; Mamidi, Anant; Martello, Graziano; Morsut, Leonardo; Soligo, Sandra; Enzo, Elena; Moro, Stefano; Polo, Simona; Dupont, Sirio; Cordenonsi, Michelangelo; Piccolo, Stefano			USP15 is a deubiquitylating enzyme for receptor-activated SMADs	NATURE CELL BIOLOGY			English	Article							TGF-BETA SUPERFAMILY; NUCLEAR EXPORT; CELL-GROWTH; COMPLEX; SIGNAL; BMP; LOCALIZATION; TARGETS; P53	The TGF beta pathway is critical for embryonic development and adult tissue homeostasis. On ligand stimulation, TGF beta and BMP receptors phosphorylate receptor-activated SMADs (R-SMADs), which then associate with SMAD4 to form a transcriptional complex that regulates gene expression through specific DNA recognition(1,2). Several ubiquitin ligases serve as inhibitors of R-SMADs(3,4), yet no deubiquitylating enzyme (DUB) for these molecules has so far been identified. This has left unexplored the possibility that ubiquitylation of R-SMADs is reversible and engaged in regulating SMAD function, in addition to degradation(5). Here we identify USP15 as a DUB for R-SMADs. USP15 is required for TGF beta and BMP responses in mammalian cells and Xenopus embryos. At the biochemical level, USP15 primarily opposes R-SMAD monoubiquitylation, which targets the DNA-binding domains of R-SMADs and prevents promoter recognition. As such, USP15 is critical for the occupancy of endogenous target promoters by the SMAD complex. These data identify an additional layer of control by which the ubiquitin system regulates TGF beta biology.	[Inui, Masafumi; Manfrin, Andrea; Mamidi, Anant; Martello, Graziano; Morsut, Leonardo; Soligo, Sandra; Enzo, Elena; Dupont, Sirio; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Dept Med Biotechnol, Sect Histol & Embryol, I-35100 Padua, Italy; [Moro, Stefano] Univ Padua, Dept Pharmaceut Sci, Mol Modelling Sect, I-35100 Padua, Italy; [Polo, Simona] Ist Europeo Oncol, Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy	University of Padua; University of Padua; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Piccolo, S (corresponding author), Univ Padua, Dept Med Biotechnol, Sect Histol & Embryol, Viale G Colombo 3, I-35100 Padua, Italy.	piccolo@civ.bio.unipd.it	Cordenonsi, Michelangelo/K-7692-2016; Martello, Graziano/AAM-3325-2021; Moro, Stefano/A-2979-2012; Dupont, Sirio/AAP-8133-2021; Manfrin, Andrea/AAC-1066-2020; Inui, Masafumi/GWZ-2521-2022; Polo, Simona/P-3509-2014	Cordenonsi, Michelangelo/0000-0002-8253-5724; Moro, Stefano/0000-0002-7514-3802; Manfrin, Andrea/0000-0002-1519-6582; Inui, Masafumi/0000-0003-4720-007X; Dupont, Sirio/0000-0002-6869-1966; Mamidi, Anant/0000-0001-7953-7991; Martello, Graziano/0000-0001-5520-085X; Enzo, Elena/0000-0001-9768-6368; Polo, Simona/0000-0001-5536-9399; PICCOLO, STEFANO/0000-0002-2037-0004	AIRC (Italian Association for Cancer Research); PI; University of Padua; IIT; Comitato Promotore Telethon; MIUR; Toyobo Memorial Foundation; Uehara Memorial Foundation	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); PI; University of Padua; IIT(Istituto Italiano di Tecnologia - IIT); Comitato Promotore Telethon(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR)); Toyobo Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank W. Dubiel, P. ten Dijke, C. Hill, A. Moustakas and E. De Robertis for gifts of reagents, and E. Maspero and G. Fontemaggi for help with enzyme purification and ChIP. We are grateful to M. Aragona, F. Zanconato and O. Wessely for comments on the manuscript. This work is supported by grants from the following agencies: AIRC (Italian Association for Cancer Research) PI and AIRC Special Program Molecular Clinical Oncology '5 per mille', University of Padua strategic grant, excellence grant IIT and Comitato Promotore Telethon grant to S.P., and AIRC and MIUR grants to S.D. and M.C. M.I. was a recipient of a Toyobo and Uehara Memorial Foundations grant and is a Marie Curie FP-7 IIF fellow.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Baker RT, 1999, GENOMICS, V59, P264, DOI 10.1006/geno.1999.5879; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2001, BIOESSAYS, V23, P223, DOI 10.1002/1521-1878(200103)23:3<223::AID-BIES1032>3.3.CO;2-L; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Wrana J. L., 2008, SIGNALING RECEPTORS; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	35	144	153	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1368	U187		10.1038/ncb2346	http://dx.doi.org/10.1038/ncb2346			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	21947082				2022-12-25	WOS:000296737900014
J	Lynch, VJ; Leclerc, RD; May, G; Wagner, GP				Lynch, Vincent J.; Leclerc, Robert D.; May, Gemma; Wagner, Guenter P.			Transposon-mediated rewiring of gene regulatory networks contributed to the evolution of pregnancy in mammals	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; HUMAN ENDOMETRIUM; HUMAN GENOME; CYCLIC-AMP; ELEMENTS; INSULATOR; BINDING; CELLS; DECIDUALIZATION; METHYLATIONS	A fundamental challenge in biology is explaining the origin of novel phenotypic characters such as new cell types(1-4); the molecular mechanisms that give rise to novelties are unclear(5-7). We explored the gene regulatory landscape of mammalian endometrial cells using comparative RNA-Seq and found that 1,532 genes were recruited into endometrial expression in placental mammals, indicating that the evolution of pregnancy was associated with a large-scale rewiring of the gene regulatory network. About 13% of recruited genes are within 200 kb of a Eutherian-specific transposable element (MER20). These transposons have the epigenetic signatures of enhancers, insulators and repressors, directly bind transcription factors essential for pregnancy and coordinately regulate gene expression in response to progesterone and cAMP. We conclude that the transposable element, MER20, contributed to the origin of a novel gene regulatory network dedicated to pregnancy in placental mammals, particularly by recruiting the cAMP signaling pathway into endometrial stromal cells.	[Lynch, Vincent J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Yale Syst Biol Inst, New Haven, CT USA	Yale University; Yale University	Lynch, VJ (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	vincent.j.lynch@yale.edu		Wagner, Gunter/0000-0002-3097-002X; Lynch, Vincent/0000-0001-5311-3824	John Templeton Foundation [12793]	John Templeton Foundation	The authors would like to thank A. Pyle and the three anonymous reviewers for comments on an earlier version of this manuscript. We would also like to thank R.W. Truman (National Hansen's Disease Program/US National Institutes of Allergy and Infectious Diseases IAA-2646) and K. Smith for the generous gifts of pregnant armadillo and opossum uterus and R. Bjornson and N. Carriero for assistance with RNA-Seq read mapping. This work was funded by a grant from the John Templeton Foundation, no. 12793, Genetics and the Origin of Organismal Complexity; results presented here do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish or manuscript preparation.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; DARWIN CD, 1883, ORIGIN SPECIES; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gerlo S, 2006, BIOESSAYS, V28, P1051, DOI 10.1002/bies.20468; HARTI D, 2010, ESSENTIAL GENETICS G; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mayr E., 1960, EVOLUTION DARWIN, P349; MCCLINTOCK B, 1965, COMPONENTS ACTION RE, V64, P527; Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079; Mivart St. George, 1871, GENESIS SPECIES; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; Oliver KR, 2009, BIOESSAYS, V31, P703, DOI 10.1002/bies.200800219; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Wagner GP, 2005, J EXP ZOOL PART B, V304B, P580, DOI 10.1002/jez.b.21074; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei W, 2001, MOL CELL BIOL, V21, P7714, DOI 10.1128/MCB.21.22.7714-7720.2001; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103	38	264	269	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1154	U158		10.1038/ng.917	http://dx.doi.org/10.1038/ng.917			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21946353				2022-12-25	WOS:000296584000023
J	Hockemeyer, D; Wang, HY; Kiani, S; Lai, CS; Gao, Q; Cassady, JP; Cost, GJ; Zhang, L; Santiago, Y; Miller, JC; Zeitler, B; Cherone, JM; Meng, XD; Hinkley, SJ; Rebar, EJ; Gregory, PD; Urnov, FD; Jaenisch, R				Hockemeyer, Dirk; Wang, Haoyi; Kiani, Samira; Lai, Christine S.; Gao, Qing; Cassady, John P.; Cost, Gregory J.; Zhang, Lei; Santiago, Yolanda; Miller, Jeffrey C.; Zeitler, Bryan; Cherone, Jennifer M.; Meng, Xiangdong; Hinkley, Sarah J.; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Jaenisch, Rudolf			Genetic engineering of human pluripotent cells using TALE nucleases	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; III EFFECTORS	Targeted genetic engineering of human pluripotent cells is a prerequisite for exploiting their full potential. Such genetic manipulations can be achieved using site-specific nucleases. Here we engineered transcription activator-like effector nucleases (TALENs) for five distinct genomic loci. At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location. Our data suggest that TALENs employing the specific architectures described here mediate site-specific genome modification in human pluripotent cells with similar efficiency and precision as do zinc-finger nucleases (ZFNs).	[Hockemeyer, Dirk; Wang, Haoyi; Kiani, Samira; Lai, Christine S.; Gao, Qing; Cassady, John P.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA USA; [Lai, Christine S.; Cassady, John P.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA; [Cost, Gregory J.; Zhang, Lei; Santiago, Yolanda; Miller, Jeffrey C.; Zeitler, Bryan; Cherone, Jennifer M.; Meng, Xiangdong; Hinkley, Sarah J.; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Sangamo Therapeutics, Inc.	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA USA.	jaenisch@wi.mit.edu		Hockemeyer, Dirk/0000-0002-5598-5092; Gregory, Philip/0000-0001-9249-2468; Cost, Gregory/0000-0002-8509-4653	US National Institutes of Health [R37-CA084198, RO1-CA087869, RO1-HD045022]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087869, R01CA084198, R37CA084198] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Alagappan, P. Xu, S. Cristea, S. Lam and A. Vincent for expert technical assistance. We thank F. Soldner for helpful discussions on the manuscript. D. H. is a Merck Fellow of the Life Sciences Research Foundation. R.J. was supported by US National Institutes of Health grants R37-CA084198, RO1-CA087869 and RO1-HD045022 and by a grant from the Howard Hughes Medical Institute.	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Hockemeyer D, 2010, COLD SH Q B, V75, P201, DOI 10.1101/sqb.2010.75.021; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; SOLDNER F, CELL IN PRESS; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	14	851	1044	7	333	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					731	734		10.1038/nbt.1927	http://dx.doi.org/10.1038/nbt.1927			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21738127	Green Accepted, Green Submitted			2022-12-25	WOS:000293696500025
J	Wei, CL; El Hindi, S; Li, J; Fornoni, A; Goes, N; Sageshima, J; Maiguel, D; Karumanchi, SA; Yap, HK; Saleem, M; Zhang, QY; Nikolic, B; Chaudhuri, A; Daftarian, P; Salido, E; Torres, A; Salifu, M; Sarwal, MM; Schaefer, F; Morath, C; Schwenger, V; Zeier, M; Gupta, V; Roth, D; Rastaldi, MP; Burke, G; Ruiz, P; Reiser, J				Wei, Changli; El Hindi, Shafic; Li, Jing; Fornoni, Alessia; Goes, Nelson; Sageshima, Junichiro; Maiguel, Dony; Karumanchi, S. Ananth; Yap, Hui-Kim; Saleem, Moin; Zhang, Qingyin; Nikolic, Boris; Chaudhuri, Abanti; Daftarian, Pirouz; Salido, Eduardo; Torres, Armando; Salifu, Moro; Sarwal, Minnie M.; Schaefer, Franz; Morath, Christian; Schwenger, Vedat; Zeier, Martin; Gupta, Vineet; Roth, David; Rastaldi, Maria Pia; Burke, George; Ruiz, Phillip; Reiser, Jochen			Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis	NATURE MEDICINE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; IDIOPATHIC NEPHROTIC SYNDROME; GLOMERULAR-PERMEABILITY; RENAL-TRANSPLANTATION; PL(A2) POLYMORPHISM; RECURRENCE; PROTEINURIA; SERUM; FSGS; PLASMAPHERESIS	Focal segmental glomerulosclerosis (FSGS) is a cause of proteinuric kidney disease, compromising both native and transplanted kidneys. Treatment is limited because of a complex pathogenesis, including unknown serum factors. Here we report that serum soluble urokinase receptor (suPAR) is elevated in two-thirds of subjects with primary FSGS, but not in people with other glomerular diseases. We further find that a higher concentration of suPAR before transplantation underlies an increased risk for recurrence of FSGS after transplantation. Using three mouse models, we explore the effects of suPAR on kidney function and morphology. We show that circulating suPAR activates podocyte beta(3) integrin in both native and grafted kidneys, causing foot process effacement, proteinuria and FSGS-like glomerulopathy. Our findings suggest that the renal disease only develops when suPAR sufficiently activates podocyte beta(3) integrin. Thus, the disease can be abrogated by lowering serum suPAR concentrations through plasmapheresis, or by interfering with the suPAR-beta(3) integrin interaction through antibodies and small molecules targeting either uPAR or beta(3) integrin. Our study identifies serum suPAR as a circulating factor that may cause FSGS.	[Wei, Changli; El Hindi, Shafic; Li, Jing; Fornoni, Alessia; Maiguel, Dony; Gupta, Vineet; Roth, David; Reiser, Jochen] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Fornoni, Alessia] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Goes, Nelson] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Goes, Nelson; Karumanchi, S. Ananth; Nikolic, Boris] Harvard Univ, Sch Med, Boston, MA USA; [Sageshima, Junichiro; Burke, George; Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Yap, Hui-Kim] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore; [Saleem, Moin] Univ Bristol, Childrens Renal Unit, Bristol Royal Hosp Children, Bristol, Avon, England; [Zhang, Qingyin] Columbia Univ, Dept Surg, New York, NY USA; [Chaudhuri, Abanti; Sarwal, Minnie M.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Daftarian, Pirouz] Univ Miami, Miller Sch Med, Wallace H Coulter Ctr Translat Res, Miami, FL 33136 USA; [Daftarian, Pirouz] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Salido, Eduardo; Torres, Armando] Hosp Univ Canarias, Serv Nefrol, Canary Isl, Spain; [Salido, Eduardo; Torres, Armando] Hosp Univ Canarias, Ctr Biomed Res Rare Dis CIBERER, Canary Isl, Spain; [Salifu, Moro] Suny Downstate Med Ctr, Div Nephrol, Brooklyn, NY 11203 USA; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Morath, Christian; Schwenger, Vedat; Zeier, Martin] Heidelberg Univ, Dept Nephrol & Endocrinol, Heidelberg, Germany; [Rastaldi, Maria Pia] Fdn IRCCS Osped Maggiore Policlin, Renal Res Lab, Milan, Italy; [Rastaldi, Maria Pia] Fdn Amico Ric Malattie Renali, Milan, Italy; [Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	University of Miami; University of Miami; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Miami; Harvard University; Beth Israel Deaconess Medical Center; National University of Singapore; Bristol Royal Hospital For Children; University of Bristol; Columbia University; Stanford University; University of Miami; University of Miami; Universidad de la Laguna; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de la Laguna; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Miami	Reiser, J (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	jreiser@med.miami.edu	Fornoni, Alessia/F-8350-2013; Yap, Hui Kim/S-2934-2016; Salido, Eduardo C/I-2232-2015; Morath, Christian/ABC-5091-2021; Karumanchi, Subbian Ananth/AAI-1694-2021; Schaefer, Franz/G-4365-2010	Salido, Eduardo C/0000-0001-9599-9854; Saleem, Moin/0000-0002-9808-4518; Gupta, Vineet/0000-0001-6987-2550; fornoni, Alessia/0000-0002-1313-7773; Torres, Armando/0000-0003-1121-5173; Yap, Hui Kim/0000-0001-6008-382X	US National Institutes of Health [DK073495, DK089394, DK-82636, DK070011]; Halpin Foundation-American Society of Nephrology; American Diabetes Association [7-09-JF-23]; Diabetes Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101350, R01DK070011, K08DK082636, Z01DK070011, R01DK073495, R01DK089394] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Halpin Foundation-American Society of Nephrology; American Diabetes Association(American Diabetes Association); Diabetes Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Sidenius (Foundation FIRC Institute of Molecular Oncology, Italy) for help with the suPAR assay in mouse samples. We are grateful to L. H. Beck, Jr. and D. Salant (Boston University Medical Center) for providing the membranous nephropathy patient cohort. We thank S. Hsiesh for help with sample collection. We thank G. Hoyer-Hansen (the Finsen Laboratory, Denmark) for additional suPAR assays and discussions. The authors are grateful to P.J. Goldschmidt for helpful scientific discussions regarding the manuscript and to M.J. Tracy for critical reading of the manuscript. This work was supported in part by the US National Institutes of Health (grants DK073495 and DK089394 to J.R., DK-82636 to A. F., DK070011 to G. B.), the Halpin Foundation-American Society of Nephrology Research Grant (to C. W.), a grant from the American Diabetes Association (7-09-JF-23 to A. F.), and a grant from the Diabetes Research Institute Foundation (to A. F.). The authors also wish to acknowledge the generous support of the Katz Family Fund.	ARTERO ML, 1994, AM J KIDNEY DIS, V23, P574, DOI 10.1016/S0272-6386(12)80381-7; Baum MA, 2004, PEDIATR TRANSPLANT, V8, P329, DOI 10.1111/j.1399-3046.2004.00181.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bruneau S, 2009, AM J KIDNEY DIS, V54, P522, DOI 10.1053/j.ajkd.2009.03.021; Chiras T, 2009, IN VIVO, V23, P177; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Dekkers PEP, 2000, INFECT IMMUN, V68, P2156, DOI 10.1128/IAI.68.4.2156-2160.2000; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Ghiggeri GM, 2004, NEPHROL DIAL TRANSPL, V19, P1036, DOI 10.1093/ndt/gfh173; Glassock RJ, 2003, J AM SOC NEPHROL, V14, P541, DOI 10.1097/01.ASN.0000051640.04273.75; Gohh RY, 2005, AM J TRANSPLANT, V5, P2907, DOI 10.1111/j.1600-6143.2005.01112.x; Haas M, 1998, NEPHROL DIAL TRANSPL, V13, P2013, DOI 10.1093/ndt/13.8.2013; Hada Y, 2007, BIOCHEM BIOPH RES CO, V356, P487, DOI 10.1016/j.bbrc.2007.03.004; Hickson LJ, 2009, TRANSPLANTATION, V87, P1232, DOI 10.1097/TP.0b013e31819f12be; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Hoyer JR, 2001, J AM SOC NEPHROL, V12, P1994; HOYER JR, 1972, LANCET, V2, P343; Kemper MJ, 2001, NEW ENGL J MED, V344, P386, DOI 10.1056/NEJM200102013440517; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; KRISTENSEN P, 1991, J CELL BIOL, V115, P1763, DOI 10.1083/jcb.115.6.1763; Marszal J, 2006, NEPHRON EXP NEPHROL, V104, pE1, DOI 10.1159/000093259; Mathieson PW, 2008, NEW ENGL J MED, V359, P2492, DOI 10.1056/NEJMcibr0806881; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Ponticelli C, 2010, CLIN J AM SOC NEPHRO, V5, P2363, DOI 10.2215/CJN.06720810; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Salido E, 1999, J AM SOC NEPHROL, V10, P2599; Savin VJ, 2008, TRANSL RES, V151, P288, DOI 10.1016/j.trsl.2008.04.001; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Selleri C, 2006, CANCER RES, V66, P10885, DOI 10.1158/0008-5472.CAN-06-1311; SENGGUTUVAN P, 1990, PEDIATR NEPHROL, V4, P21, DOI 10.1007/BF00858431; Sharma M, 1999, J AM SOC NEPHROL, V10, P552; Sidenius N, 2000, BLOOD, V96, P4091; Sier CFM, 1998, CANCER RES, V58, P1843; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tjwa M, 2009, J CLIN INVEST, V119, P1008, DOI 10.1172/JCI36010; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang SY, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000678	47	589	625	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					952	U70		10.1038/nm.2411	http://dx.doi.org/10.1038/nm.2411			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21804539	Green Accepted			2022-12-25	WOS:000293507400028
J	Atwal, RS; Desmond, CR; Caron, N; Maiuri, T; Xia, JR; Sipione, S; Truant, R				Atwal, Randy Singh; Desmond, Carly R.; Caron, Nicholas; Maiuri, Tamara; Xia, Jianrun; Sipione, Simonetta; Truant, Ray			Kinase inhibitors modulate huntingtin cell localization and toxicity	NATURE CHEMICAL BIOLOGY			English	Article							KAPPA-B KINASE; MUTANT HUNTINGTIN; SELECTIVE INHIBITOR; PHOSPHORYLATION; PROTEIN; AGGREGATION; DISEASE; GENE; DEPHOSPHORYLATION; TRANSCRIPTION	Two serine residues within the first 17 amino acid residues of huntingtin (N17) are crucial for modulation of mutant huntingtin toxicity in cell and mouse genetic models of Huntington's disease. Here we show that the stress-dependent phosphorylation of huntingtin at Ser13 and Ser16 affects N17 conformation and targets full-length huntingtin to chromatin-dependent sub-regions of the nucleus, the mitotic spindle and cleavage furrow during cell division. Polyglutamine-expanded mutant huntingtin is hypophosphorylated in N17 in both homozygous and heterozygous cell contexts. By high-content screening in live cells, we identified kinase inhibitors that modulated N17 phosphorylation and hence huntingtin subcellular localization. N17 phosphorylation was reduced by casein kinase-2 inhibitors. Paradoxically, IKK beta kinase inhibition increased N17 phosphorylation, affecting huntingtin nuclear and subnuclear localization. These data indicate that huntingtin phosphorylation at Ser13 and Ser16 can be modulated by small-molecule drugs, which may have therapeutic potential in Huntington's disease.	[Atwal, Randy Singh; Desmond, Carly R.; Caron, Nicholas; Maiuri, Tamara; Xia, Jianrun; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Sipione, Simonetta] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada	McMaster University; University of Alberta	Atwal, RS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA.	truantr@mcmaster.ca		Caron, Nicholas/0000-0002-3877-455X; Maiuri, Tamara/0000-0002-6103-5835	Canadian Institutes of Health Research [MOP 165174]; Krembil Foundation; CHDI Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; CHDI Foundation	This work was supported by operating grants from the Canadian Institutes of Health Research (MOP 165174), the Krembil Foundation and the CHDI Foundation (to R. T.). We thank M. Prakesch (Ontario Institute for Cancer Research) for supplying multiple CK2 and IKK beta inhibitors, I. Bezprozvanny (University of Texas Southwestern) and G. Hajnocsky (Thomas Jefferson University) for the gift of huntingtin-null MEF cell lines, M. E. MacDonald (Massachusetts General Hospital) for the gift of mouse striatal STHdh cell lines, and Raquel and Richard Epand for assistance and advice with CD spectroscopy.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bamborough P, 2009, CURR TOP MED CHEM, V9, P623, DOI 10.2174/156802609789007336; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Cozza G, 2009, BIOCHEM J, V421, P387, DOI 10.1042/BJ20090069; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Di Maira G, 2009, CELL MOL LIFE SCI, V66, P3363, DOI 10.1007/s00018-009-0108-1; Fan MMY, 2008, J NEUROCHEM, V104, P790, DOI 10.1111/j.1471-4159.2007.05016.x; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hoffner G, 2002, J CELL SCI, V115, P941; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kageura T, 2001, BIOORGAN MED CHEM, V9, P1887, DOI 10.1016/S0968-0896(01)00093-1; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin-Aparicio E, 2002, EUR J NEUROSCI, V16, P355, DOI 10.1046/j.1460-9568.2002.02075.x; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; Metzler M, 2010, J NEUROSCI, V30, P14318, DOI 10.1523/JNEUROSCI.1589-10.2010; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Snyder-Keller A, 2010, J NEUROPATH EXP NEUR, V69, P1078, DOI 10.1097/NEN.0b013e3181f530ec; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021; Wetzel R, 2006, NAT CHEM BIOL, V2, P297, DOI 10.1038/nchembio0606-297; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Zhang H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-38	48	125	130	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					453	460		10.1038/NCHEMBIO.582	http://dx.doi.org/10.1038/NCHEMBIO.582			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21623356				2022-12-25	WOS:000292252100013
J	Joffre, C; Barrow, R; Menard, L; Calleja, V; Hart, IR; Kermorgant, S				Joffre, Carine; Barrow, Rachel; Menard, Ludovic; Calleja, Veronique; Hart, Ian R.; Kermorgant, Stephanie			A direct role for Met endocytosis in tumorigenesis	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASE; C-MET; SIGNAL-TRANSDUCTION; CELL-MIGRATION; EGF RECEPTOR; ENDOPLASMIC-RETICULUM; MEDIATED ENDOCYTOSIS; SPATIAL RESTRICTION; SOMATIC MUTATIONS; HUMAN CANCER	Compartmentalization of signals generated by receptor tyrosine kinase (RTK) endocytosis has emerged as a major determinant of various cell functions. Here, using tumour-associated Met-activating mutations, we demonstrate a direct link between endocytosis and tumorigenicity. Met mutants exhibit increased endocytosis/recycling activity and decreased levels of degradation, leading to accumulation on endosomes, activation oft he GTPase Rac1, loss of actin stress fibres and increased levels of cell migration. Blocking endocytosis inhibited mutants' anchorage-independent growth, in vivo tumorigenesis and metastasis while maintaining their activation. One mutant resistant to inhibition by a Met-specific tyrosine kinase inhibitor was sensitive to endocytosis inhibition. Thus, oncogenicity of Met mutants results not only from activation but also from their altered endocytic trafficking, indicating that endosomal signalling may be a crucial mechanism regulating RTK-dependent tumorigenesis.	[Joffre, Carine; Barrow, Rachel; Menard, Ludovic; Kermorgant, Stephanie] Queen Mary Univ London, Barts Canc Inst, Tumor Biol Ctr, Spatial Signalling Team,John Vane Sci Ctr, London EC1M 6BQ, England; [Calleja, Veronique] London Res Inst, Canc Res UK, Cell Biophys Lab, London WC2A 3PX, England	University of London; Queen Mary University London; Cancer Research UK	Kermorgant, S (corresponding author), Queen Mary Univ London, Barts Canc Inst, Tumor Biol Ctr, Spatial Signalling Team,John Vane Sci Ctr, London EC1M 6BQ, England.	s.kermorgant@qmul.ac.uk	JOFFRE, Carine/P-1551-2014; Kermorgant, Stephanie/AAB-4931-2020	JOFFRE, Carine/0000-0002-7551-356X; Kermorgant, Stephanie/0000-0001-5921-479X	Medical Research Council [G0501003] Funding Source: Medline; British Lung Foundation [CAN09-4] Funding Source: researchfish; MRC [G0501003] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Assaker G, 2010, P NATL ACAD SCI USA, V107, P22558, DOI 10.1073/pnas.1010795108; Bardelli A, 1998, P NATL ACAD SCI USA, V95, P14379, DOI 10.1073/pnas.95.24.14379; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Comoglio PM, 2001, NAT CELL BIOL, V3, pE161, DOI 10.1038/35083116; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Grandal MV, 2007, CARCINOGENESIS, V28, P1408, DOI 10.1093/carcin/bgm058; Graveel CR, 2005, CELL CYCLE, V4, P518, DOI 10.4161/cc.4.4.1590; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nakaigawa N, 2000, ONCOGENE, V19, P2996, DOI 10.1038/sj.onc.1203628; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; Rao DS, 2003, CANCER CELL, V3, P471, DOI 10.1016/S1535-6108(03)00107-7; Runeberg-Roos P, 2007, ONCOGENE, V26, P7909, DOI 10.1038/sj.onc.1210591; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; SCITA G, NATURE, V463, P464; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06	57	176	181	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					827	U227		10.1038/ncb2257	http://dx.doi.org/10.1038/ncb2257			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21642981				2022-12-25	WOS:000292305700013
J	Purkayastha, S; Zhang, G; Cai, DS				Purkayastha, Sudarshana; Zhang, Guo; Cai, Dongsheng			Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappa B	NATURE MEDICINE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; BLOOD-PRESSURE; INSULIN-RESISTANCE; LEPTIN RESISTANCE; IMMUNE-SYSTEM; INFLAMMATION; MICE; DYSFUNCTION; MODULATION; BRAIN	Obesity-related hypertension has become an epidemic health problem and a major risk factor for the development of cardiovascular disease (CVD). Recent research on the pathophysiology of obesity has implicated a role for the hypothalamus in the pathogenesis of this condition(1-3). However, it remains unknown whether the often-seen coupling of hypertension with obesity can also be explained by hypothalamic dysfunction, despite the emerging appreciation that many forms of hypertension are neurogenic in origin4-13. Our studies here revealed that acute activation of the proinflammatory protein nuclear factor kB (NF-kappa B) and its upstream activator I kappa B kinase-beta (IKK-beta, encoded by Ikbkb) in the mediobasal hypothalamus rapidly elevated blood pressure in mice independently of obesity. This form of hypothalamic inflammation-induced hypertension involved the sympathetic upregulation of hemodynamics and was reversed by sympathetic suppression. Loss-of-function studies further showed that NF-kappa B inhibition in the mediobasal hypothalamus counteracted obesity-related hypertension in a manner that was dissociable from changes in body weight. In addition, we found that pro-opiomelanocortin (POMC) neurons were crucial for the hypertensive effects of the activation of hypothalamic IKK-beta and NF-kappa B, which underlie obesity-related hypertension. In conclusion, obesity-associated activation of IKK-beta and NF-kappa B in the mediobasal hypothalamus-particularly in the hypothalamic POMC neurons-is a primary pathogenic link between obesity and hypertension. Breaking this pathogenic link may represent an avenue for controlling obesity-related hypertension and CVD without requiring obesity control.	[Purkayastha, Sudarshana; Zhang, Guo; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY USA; [Purkayastha, Sudarshana; Zhang, Guo; Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, New York, NY USA	Yeshiva University; Yeshiva University	Cai, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY USA.	dongsheng.cai@einstein.yu.edu	Zhang, Guo/Q-8513-2016	Zhang, Guo/0000-0003-0841-4710; Zhang, Guo/0000-0002-3880-6996	US National Institutes of Health [RO1 DK078750, RO1 AG 031774]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Barsh and A. Xu for Pomc-Cre and Agrp-Cre mice. This study was supported by US National Institutes of Health grants (RO1 DK078750 and RO1 AG 031774) (D.C.) and by an American Diabetes Association Junior Faculty Award (1-07-JF-09) (D.C.).	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cai DS, 2009, CELL CYCLE, V8, P2542, DOI 10.4161/cc.8.16.9386; Campese VM, 2004, AM J PHYSIOL-HEART C, V287, pH695, DOI 10.1152/ajpheart.00619.2003; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Farah VMA, 2004, PHYSIOL BEHAV, V83, P135, DOI 10.1016/j.physbeh.2004.08.004; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Goncalves ACD, 2009, HYPERTENSION, V53, P387, DOI 10.1161/HYPERTENSIONAHA.108.124776; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Harrison David G, 2008, Curr Cardiol Rep, V10, P464; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Haynes WG, 2005, EXP PHYSIOL, V90, P683, DOI 10.1113/expphysiol.2005.031237; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Osborn JW, 2007, CURR HYPERTENS REP, V9, P228, DOI 10.1007/s11906-007-0041-3; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Veerasingham SJ, 2004, PROG BIOPHYS MOL BIO, V84, P107, DOI 10.1016/j.pbiomolbio.2003.11.007; Veerasingham SJ, 2003, BRIT J PHARMACOL, V139, P191, DOI 10.1038/sj.bjp.0705262; Wofford MR, 2004, CURR PHARM DESIGN, V10, P3621, DOI 10.2174/1381612043382855; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	39	180	184	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					883	U255		10.1038/nm.2372	http://dx.doi.org/10.1038/nm.2372			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21642978	Green Accepted			2022-12-25	WOS:000292500800044
J	Al-Dous, EK; George, B; Al-Mahmoud, ME; Al-Jaber, MY; Wang, H; Salameh, YM; Al-Azwani, EK; Chaluvadi, S; Pontaroli, AC; DeBarry, J; Arondel, V; Ohlrogge, J; Saie, IJ; Suliman-Elmeer, KM; Bennetzen, JL; Kruegger, RR; Malek, JA				Al-Dous, Eman K.; George, Binu; Al-Mahmoud, Maryam E.; Al-Jaber, Moneera Y.; Wang, Hao; Salameh, Yasmeen M.; Al-Azwani, Eman K.; Chaluvadi, Srinivasa; Pontaroli, Ana C.; DeBarry, Jeremy; Arondel, Vincent; Ohlrogge, John; Saie, Imad J.; Suliman-Elmeer, Khaled M.; Bennetzen, Jeffrey L.; Kruegger, Robert R.; Malek, Joel A.			De novo genome sequencing and comparative genomics of date palm (Phoenix dactylifera)	NATURE BIOTECHNOLOGY			English	Article							SEX DETERMINATION; SHORT-READ; DIVERGENCE; EVOLUTION; ALIGNMENT; GENES; TREE	Date palm is one of the most economically important woody crops cultivated in the Middle East and North Africa and is a good candidate for improving agricultural yields in arid environments. Nonetheless, long generation times (5-8 years) and dioecy (separate male and female trees) have complicated its cultivation and genetic analysis. To address these issues, we assembled a draft genome for a Khalas variety female date palm, the first publicly available resource of its type for a member of the order Arecales. The similar to 380 Mb sequence, spanning mainly gene-rich regions, includes >25,000 gene models and is predicted to cover similar to 90% of genes and similar to 60% of the genome. Sequencing of eight other cultivars, including females of the Deglet Noor and Medjool varieties and their backcrossed males, identified >3.5 million polymorphic sites, including >10,000 genic copy number variations. A small subset of these polymorphisms can distinguish multiple varieties. We identified a region of the genome linked to gender and found evidence that date palm employs an XY system of gender inheritance.	Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar; [Wang, Hao; Chaluvadi, Srinivasa; Pontaroli, Ana C.; DeBarry, Jeremy; Bennetzen, Jeffrey L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Arondel, Vincent] Univ V Segalen Bordeaux, CNRS UMR, Lab Biogenese Membranaire, Bordeaux, France; [Ohlrogge, John] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Suliman-Elmeer, Khaled M.] Minist Environm, Ctr Biotechnol, Doha, Qatar; [Kruegger, Robert R.] Univ Calif Riverside, USDA ARS Natl Clonal Germplasm Repository Citrus, Riverside, CA 92521 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Michigan State University; United States Department of Agriculture (USDA); University of California System; University of California Riverside	Malek, JA (corresponding author), Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar.	jom2042@qatar-med.cornell.edu	Chaluvadi, Srinivasa Rao/C-7163-2011; MALEK, JALALUDDIN ABDUL/ABU-1982-2022; chaluvadi, srinivasa/AAC-5258-2020; Wang, Hao/C-7651-2009	DeBarry, Jeremy/0000-0001-5718-2675; Chaluvadi, Srinivasa/0000-0003-2865-4156; Wang, Hao/0000-0002-9634-8778; Elmeer, Khaled/0000-0002-7855-5319	Qatar Foundation	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was supported by Qatar Foundation Biomedical Research Program Grant funding. We thank G. Parra for running the CEGMA pipeline on our initial assembly. We thank the Cornell Center for Academic Computing for providing hardware systems support during the assembly stage. We thank K. Machaca and R. Crystal for critical review of the manuscript.	Adam H, 2006, J MOL EVOL, V62, P15, DOI 10.1007/s00239-005-0333-7; Ainsworth C, 1998, CURR TOP DEV BIOL, V38, P167; Al-Farsi MA, 2008, CRIT REV FOOD SCI, V48, P877, DOI 10.1080/10408390701724264; BARRETT H C, 1973, Fruit Varieties Journal, V27, P50; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Caballero B., 2003, ENCY FOOD SCI NUTR; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Daher A, 2010, ANN BOT-LONDON, V106, P255, DOI 10.1093/aob/mcq103; Ding J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-154; Haas M, 2004, BIOCHEMISTRY-US, V43, P8152, DOI 10.1021/bi035857y; HAN Y, 2010, NUCL ACIDS RES; HODEL DR, 2007, DATES IMPORTED AM VA; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Okazaki N, 1998, MOL CELL BIOL, V18, P887, DOI 10.1128/MCB.18.2.887; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pontaroli AC, 2009, PLANT GENOME-US, V2, P93, DOI 10.3835/plantgenome2008.09.0007; Pop M, 2004, GENOME RES, V14, P149; Qacif N, 2007, SCI HORTIC-AMSTERDAM, V114, P298, DOI 10.1016/j.scienta.2007.07.015; SiljakYakovlev S, 1996, SEX PLANT REPROD, V9, P127, DOI 10.1007/BF02221391; Singh R, 2010, COMPR REV FOOD SCI F, V9, P398, DOI 10.1111/j.1541-4337.2010.00116.x; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yalovsky S, 2000, PLANT CELL, V12, P1257, DOI 10.1105/tpc.12.8.1257; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	45	260	274	0	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2011	29	6					521	U84		10.1038/nbt.1860	http://dx.doi.org/10.1038/nbt.1860			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	773WL	21623354	hybrid			2022-12-25	WOS:000291342100018
J	Lancaster, MA; Schroth, J; Gleeson, JG				Lancaster, Madeline A.; Schroth, Jana; Gleeson, Joseph G.			Subcellular spatial regulation of canonical Wnt signalling at the primary cilium	NATURE CELL BIOLOGY			English	Article							JOUBERT-SYNDROME; CEREBELLAR DEVELOPMENT; CATENIN; MUTATIONS; MOUSE; GENE; EXPRESSION; CILIARY; TUMORIGENESIS; MECHANISMS	Mechanisms of signal transduction regulation remain a fundamental question in a variety of biological processes and diseases. Previous evidence indicates that the primary cilium can act as a signalling hub(1), but its exact role in many of the described pathways has remained elusive. Here, we investigate the mechanism of cilia-mediated regulation of the canonical Wnt pathway. We found that primary cilia dampen canonical Wnt signalling through a spatial mechanism involving compartmentalization of signalling components. The cilium, through regulated intraflagellar transport, diverts Jouberin (Jbn), a ciliopathy protein and context-specific Wnt pathway regulator(2), away from the nucleus and limits beta-catenin nuclear entry. This repressive regulation does not silence the pathway, but instead maintains a discrete range of Wnt responsiveness; cells without cilia have potentiated Wnt responses, whereas cells with multiple cilia have inhibited responses. Furthermore, we show that this regulation occurs during embryonic development and is disrupted in cancer cell proliferation. Together these data explain a spatial mechanism of Wnt signalling regulation that may provide insight into ciliary regulation of other signalling pathways.	[Lancaster, Madeline A.; Schroth, Jana; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Lab Neurogenet,Biomed Sci Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Lab Neurogenet,Biomed Sci Program, LBR 3A16,9500 Gilman Dr, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu		Lancaster, Madeline/0000-0003-2324-8853	Bear Necessities Pediatric Cancer Foundation; US National Institutes of Health; Burroughs Wellcome Fund in Translational Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455, P30NS047101] Funding Source: NIH RePORTER	Bear Necessities Pediatric Cancer Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund in Translational Research(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to members of the Gleeson laboratory for technical expertise and feedback and the UCSD Neuroscience Microscopy Core. We would like to thank C. Kintner for helpful feedback on the manuscript. We also thank K. Willert (School of Medicine, University of California, San Diego) for reagents and technical expertise. We are grateful to S. Piccolo (Departments of Histology, Microbiology and Medical Biotechnologies, University of Padua, Italy) for the BATgal mice and to A. S. Peterson (Ernest Gallo Clinic and Research Center, Emeryville, California) for the Duchc2 mutant mice and MEFs as well as L. S. B. Goldstein (School of Medicine, University of California, San Diego) for Kif3a mutant mice. We also thank M. G. Rosenfeld (School of Medicine, University of California, San Diego) for the beta-cat Delta N construct and R. T. Moon (Department of Pharmacology, University of Washington) for the Super Topflash construct, as well as T. Caspary (Department of Human Genetics, Emory University School of Medicine) for the Arl13b antibody, C. Janke (Curie Institut, Paris, France) for GT335 antibody and R. B. Vallee (Department of Pathology and Cell Biology, Columbia University) for Dnchc1 and Dnchc2 antibodies. We also thank P. Mellon (School of Medicine, University of California, San Diego) for the beta-galactosidase expression construct for luciferase assays. M.A.L. received support from the Bear Necessities Pediatric Cancer Foundation. This work was supported by the US National Institutes of Health, and the Burroughs Wellcome Fund in Translational Research (J.G.G.). J.G.G. is an investigator with Howard Hughes Medical Institute.	Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kennah E, 2009, BLOOD, V113, P4646, DOI 10.1182/blood-2008-08-174037; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Miyoshi K, 2009, BIOCHEM BIOPH RES CO, V388, P757, DOI 10.1016/j.bbrc.2009.08.099; Nelson SB, 2000, MOL ENDOCRINOL, V14, P1509, DOI 10.1210/me.14.9.1509; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; PAZOUR GJ, 1999, MOL BIOL CELL S, V10, pA396; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277	38	179	183	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					700	U173		10.1038/ncb2259	http://dx.doi.org/10.1038/ncb2259			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21602792	Green Accepted			2022-12-25	WOS:000291147400011
J	Frontini, MJ; Nong, ZX; Gros, R; Drangova, M; O'Neil, C; Rahman, MN; Akawi, O; Yin, H; Ellis, CG; Pickering, JG				Frontini, Matthew J.; Nong, Zengxuan; Gros, Robert; Drangova, Maria; O'Neil, Caroline; Rahman, Mona N.; Akawi, Oula; Yin, Hao; Ellis, Christopher G.; Pickering, J. Geoffrey			Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells	NATURE BIOTECHNOLOGY			English	Article							ENDOTHELIAL-CELLS; THERAPEUTIC ANGIOGENESIS; HINDLIMB ISCHEMIA; GENE-THERAPY; IN-VIVO; PDGF-BB; MOUSE; NEOVASCULARIZATION; DIFFERENTIATION; DISEASE	The therapeutic potential of angiogenic growth factors has not been realized. This may be because formation of endothelial sprouts is not followed by their muscularization into vasoreactive arteries. Using microarray expression analysis, we discovered that fibroblast growth factor 9 (FGF9) was highly upregulated as human vascular smooth muscle cells (SMCs) assemble into layered cords. FGF9 was not angiogenic when mixed with tissue implants or delivered to the ischemic mouse hind limb, but instead orchestrated wrapping of SMCs around neovessels. SMC wrapping in implants was driven by sonic hedgehog-mediated upregulation of PDGFRb. Computed tomography microangiography and intravital microscopy revealed that microvessels formed in the presence of FGF9 had enhanced capacity to receive flow and were vasoreactive. Moreover, the vessels persisted beyond 1 year, remodeling into multilayered arteries paired with peripheral nerves. This mature physiological competency was attained by targeting mesenchymal cells rather than endothelial cells, a finding that could inform strategies for therapeutic angiogenesis and tissue engineering.	[Frontini, Matthew J.; Nong, Zengxuan; Gros, Robert; Drangova, Maria; O'Neil, Caroline; Rahman, Mona N.; Akawi, Oula; Yin, Hao; Pickering, J. Geoffrey] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [Frontini, Matthew J.; Nong, Zengxuan; Gros, Robert; Drangova, Maria; O'Neil, Caroline; Rahman, Mona N.; Akawi, Oula; Yin, Hao; Pickering, J. Geoffrey] London Hlth Sci Ctr, London, ON, Canada; [Pickering, J. Geoffrey] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Cardiol, London, ON, Canada; [Frontini, Matthew J.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Drangova, Maria; Ellis, Christopher G.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Med Biophys, Schulich Sch Med & Dent, London, ON, Canada; [Gros, Robert] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Pickering, JG (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada.	gpickering@robarts.ca	Pickering, J. Geoffrey/G-3341-2011; Rahman, Mona/GRF-6475-2022; Ellis, Christopher G/AAV-2325-2020; Ellis, Christopher G/G-8649-2013; Gros, Robert/A-3010-2009; Gros, Robert/AAV-2237-2020; Drangova, Maria/J-3123-2012	Pickering, J. Geoffrey/0000-0001-6474-3274; Ellis, Christopher G/0000-0002-7760-1846; Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011; Rahman, Mona Naeema/0000-0002-9782-0173; Drangova, Maria/0000-0003-1856-9038	Canadian Institutes of Health Research [FRN-11715]; Heart and Stroke Foundation of Ontario [T7081]; Lawson Health Research Institute; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Lawson Health Research Institute; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research (FRN-11715), Heart and Stroke Foundation of Ontario (T7081) and Lawson Health Research Institute. J.G.P. holds the Heart and Stroke Foundation of Ontario/Barnett-Ivey Chair, M. D. holds a Career Investigator Award from the Heart and Stroke Foundation of Ontario and R. G. is supported by a New Investigator Award from the Heart and Stroke Foundation of Canada.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frontini MJ, 2009, CIRC RES, V104, P832, DOI 10.1161/CIRCRESAHA.108.187302; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; KOYAMA N, 1994, CIRC RES, V75, P682, DOI 10.1161/01.RES.75.4.682; Kuzuya M, 1999, EXP CELL RES, V248, P498, DOI 10.1006/excr.1999.4422; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lekas M, 2006, CURR OPIN CARDIOL, V21, P376, DOI 10.1097/01.hco.0000231409.69307.d2; Li SH, 1999, CIRC RES, V85, P338, DOI 10.1161/01.RES.85.4.338; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Masocha W, 2009, LIFE SCI, V85, P462, DOI 10.1016/j.lfs.2009.07.015; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Miller DL, 2000, MOL CELL BIOL, V20, P2260, DOI 10.1128/MCB.20.6.2260-2268.2000; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Murakami M, 2009, J MOL MED, V87, P571, DOI 10.1007/s00109-009-0463-2; NARUO K, 1993, J BIOL CHEM, V268, P2857; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Small TW, 2006, CIRC RES, V99, P1338, DOI 10.1161/01.RES.0000252289.79841.d3; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655; Yi L, 2009, DEV DYNAM, V238, P123, DOI 10.1002/dvdy.21831; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	47	83	87	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					421	U232		10.1038/nbt.1845	http://dx.doi.org/10.1038/nbt.1845			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21499246				2022-12-25	WOS:000290301700022
J	Logan, CV; Lucke, B; Pottinger, C; Abdelhamed, ZA; Parry, DA; Szymanska, K; Diggle, CP; van Riesen, A; Morgan, JE; Markham, G; Ellis, I; Manzur, AY; Markham, AF; Shires, M; Helliwell, T; Scoto, M; Hubner, C; Bonthron, DT; Taylor, GR; Sheridan, E; Muntoni, F; Carr, IM; Schuelke, M; Johnson, CA				Logan, Clare V.; Lucke, Barbara; Pottinger, Caroline; Abdelhamed, Zakia A.; Parry, David A.; Szymanska, Katarzyna; Diggle, Christine P.; van Riesen, Anne; Morgan, Joanne E.; Markham, Grace; Ellis, Ian; Manzur, Adnan Y.; Markham, Alexander F.; Shires, Mike; Helliwell, Tim; Scoto, Mariacristina; Huebner, Christoph; Bonthron, David T.; Taylor, Graham R.; Sheridan, Eamonn; Muntoni, Francesco; Carr, Ian M.; Schuelke, Markus; Johnson, Colin A.			Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; DIAPHRAGMATIC WEAKNESS; SMARD1; ORTHOLOG; IGHMBP2; TYPE-1; CED-1	Infantile myopathies with diaphragmatic paralysis are genetically heterogeneous, and clinical symptoms do not assist in differentiating between them. We used phased haplotype analysis with subsequent targeted exome sequencing to identify MEGF10 mutations in a previously unidentified type of infantile myopathy with diaphragmatic weakness, areflexia, respiratory distress and dysphagia. MEGF10 is highly expressed in activated satellite cells and regulates their proliferation as well as their differentiation and fusion into multinucleated myofibers, which are greatly reduced in muscle from individuals with early onset myopathy, areflexia, respiratory distress and dysphagia.	[Logan, Clare V.; Abdelhamed, Zakia A.; Parry, David A.; Szymanska, Katarzyna; Diggle, Christine P.; Morgan, Joanne E.; Markham, Grace; Markham, Alexander F.; Shires, Mike; Bonthron, David T.; Taylor, Graham R.; Sheridan, Eamonn; Carr, Ian M.; Johnson, Colin A.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Lucke, Barbara; van Riesen, Anne; Huebner, Christoph; Schuelke, Markus] Charite, Dept Neuropediat, D-13353 Berlin, Germany; [Lucke, Barbara; van Riesen, Anne; Huebner, Christoph; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Pottinger, Caroline] Birmingham Womens Hosp, Clin Genet Unit, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Abdelhamed, Zakia A.] Al Azhar Univ, Dept Anat & Embryol, Fac Med, Girls Sect, Cairo, Egypt; [Ellis, Ian] Alder Hey Childrens Hosp, Dept Clin Genet, Liverpool L12 2AP, Merseyside, England; [Manzur, Adnan Y.; Scoto, Mariacristina; Muntoni, Francesco] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Manzur, Adnan Y.; Scoto, Mariacristina; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Helliwell, Tim] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England	University of Leeds; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Birmingham Women's Hospital; Egyptian Knowledge Bank (EKB); Al Azhar University; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Johnson, CA (corresponding author), Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	markus.schuelke@charite.de; c.johnson@leeds.ac.uk		Parry, David/0000-0003-0376-7736; Schuelke, Markus/0000-0003-2824-3891; Bonthron, David/0000-0001-8132-8179; Helliwell, Timothy/0000-0003-2112-4128; Logan, Clare/0000-0003-4323-1602; Johnson, Colin/0000-0002-2979-8234	Great Ormond Street Hospital Children's Charity; Egyptian Government Scholarship; Newlife Foundation for Disabled Children; Sir Jules Thorn Award for Biomedical Research; Deutsche Forschungsgemeinschaft [SFB 665 TP C4, KFO 192]; NeuroCure Cluster of Excellence [Exc 257]; 'Helft dem muskelkranken Kind' Hamburg, Germany; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Great Ormond Street Hospital Children's Charity; Egyptian Government Scholarship; Newlife Foundation for Disabled Children; Sir Jules Thorn Award for Biomedical Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Cluster of Excellence; 'Helft dem muskelkranken Kind' Hamburg, Germany; The Sir Jules Thorn Charitable Trust	The authors thank the families who participated in this study. F.M. is supported by the Great Ormond Street Hospital Children's Charity. Z.A.A. receives an Egyptian Government Scholarship. This work was supported by grants from Newlife Foundation for Disabled Children (to I.M.C. and C.A.J.) and the Sir Jules Thorn Award for Biomedical Research (to C.A.J., E.S., G.R.T. and D.T.B.), the Deutsche Forschungsgemeinschaft (SFB 665 TP C4 and KFO 192) and the NeuroCure Cluster of Excellence, Exc 257 (to M. Schuelke) and the parents' support group 'Helft dem muskelkranken Kind' Hamburg, Germany (to C.H.). We acknowledge the contribution of clinical data by U. Schara and T. Polster.	Carr IM, 2009, HUM MUTAT, V30, P960, DOI 10.1002/humu.20974; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Grohmann K, 2004, HUM MOL GENET, V13, P2031, DOI 10.1093/hmg/ddh222; Guenther UP, 2007, HUM MUTAT, V28, P808, DOI 10.1002/humu.20525; Guenther UP, 2009, J MOL MED, V87, P31, DOI 10.1007/s00109-008-0402-7; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hartley L, 2007, NEUROMUSCULAR DISORD, V17, P174, DOI 10.1016/j.nmd.2006.11.002; Holterman CE, 2007, J CELL BIOL, V179, P911, DOI 10.1083/jcb.200709083; Maddatu TP, 2004, HUM MOL GENET, V13, P1105, DOI 10.1093/hmg/ddh129; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; Pitt M, 2003, BRAIN, V126, P2682, DOI 10.1093/brain/awg278; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Suzuki E, 2007, EXP CELL RES, V313, P2451, DOI 10.1016/j.yexcr.2007.03.041; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446	15	68	73	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1189	1192		10.1038/ng.995	http://dx.doi.org/10.1038/ng.995			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22101682				2022-12-25	WOS:000297931400010
J	Milias-Argeitis, A; Summers, S; Stewart-Ornstein, J; Zuleta, I; Pincus, D; El-Samad, H; Khammash, M; Lygeros, J				Milias-Argeitis, Andreas; Summers, Sean; Stewart-Ornstein, Jacob; Zuleta, Ignacio; Pincus, David; El-Samad, Hana; Khammash, Mustafa; Lygeros, John			In silico feedback for in vivo regulation of a gene expression circuit	NATURE BIOTECHNOLOGY			English	Article							SYNTHETIC BIOLOGY; LIGHT	We show that difficulties in regulating cellular behavior with synthetic biological circuits may be circumvented using in silico feedback control. By tracking a circuit's output in Saccharomyces cerevisiae in real time, we precisely control its behavior using an in silico feedback algorithm to compute regulatory inputs implemented through a genetically encoded light-responsive module. Moving control functions outside the cell should enable more sophisticated manipulation of cellular processes whenever real-time measurements of cellular variables are possible.	[Stewart-Ornstein, Jacob; Zuleta, Ignacio; Pincus, David; El-Samad, Hana] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Milias-Argeitis, Andreas; Summers, Sean; Lygeros, John] Swiss Fed Inst Technol, Automat Control Lab, Dept Elect Engn, Zurich, Switzerland; [Khammash, Mustafa] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	El-Samad, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hana.el-samad@ucsf.edu; mustafa.khammash@bsse.ethz.ch; lygeros@control.ee.ethz.ch	Milias-Argeitis, Andreas/O-9434-2017	Milias-Argeitis, Andreas/0000-0002-4291-4228; Zuleta, Ignacio/0000-0002-1113-7083	National Science Foundation [CCF-0943385, ECCS-0835847]; MoVeS [FP7-ICT-2009-257005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); MoVeS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank P. Quail (UC, Berkeley) for the generous gift of the PIF3 construct and W. Lim (UCSF) and J. Stelling (ETH, Zurich) for providing PCB. The work was supported by National Science Foundation grant CCF-0943385 (H.E.-S.), ECCS-0835847 (M. K.), and MoVeS FP7-ICT-2009-257005 (J.L.).	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Leung DW, 2008, P NATL ACAD SCI USA, V105, P12797, DOI 10.1073/pnas.0801232105; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Morari M, 1999, COMPUT CHEM ENG, V23, P667, DOI 10.1016/S0098-1354(98)00301-9; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Sorokina Oxana, 2009, J Biol Eng, V3, P15, DOI 10.1186/1754-1611-3-15; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]	13	186	189	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1114	1116		10.1038/nbt.2018	http://dx.doi.org/10.1038/nbt.2018			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22057053	Green Accepted			2022-12-25	WOS:000298038700021
J	Lamande, SR; Yuan, Y; Gresshoff, IL; Rowley, L; Belluoccio, D; Kaluarachchi, K; Little, CB; Botzenhart, E; Zerres, K; Amor, DJ; Cole, WG; Savarirayan, R; McIntyre, P; Bateman, JF				Lamande, Shireen R.; Yuan, Yuan; Gresshoff, Irma L.; Rowley, Lynn; Belluoccio, Daniele; Kaluarachchi, Kumara; Little, Christopher B.; Botzenhart, Elke; Zerres, Klaus; Amor, David J.; Cole, William G.; Savarirayan, Ravi; McIntyre, Peter; Bateman, John F.			Mutations in TRPV4 cause an inherited arthropathy of hands and feet	NATURE GENETICS			English	Article							SENSITIVE ION-CHANNEL; CATION CHANNEL; ACTIVATION; OSTEOARTHRITIS; DYSPLASIA; SPECTRUM	Familial digital arthropathy-brachydactyly (FDAB) is a dominantly inherited condition that is characterized by aggressive osteoarthropathy of the fingers and toes and consequent shortening of the middle and distal phalanges(1). Here we show in three unrelated families that FDAB is caused by mutations encoding p. Gly270Val, p. Arg271Pro and p. Phe273Leu substitutions in the intracellular ankyrin-repeat domain of the cation channel TRPV4. Functional testing of mutant TRPV4 in HEK-293 cells showed that the mutant proteins have poor cell-surface localization. Calcium influx in response to the synthetic TRPV4 agonists GSK1016790A and 4 alpha PDD was significantly reduced, and mutant channels did not respond to hypotonic stress. Others have shown that gain-of-function TRPV4 mutations cause skeletal dysplasias and peripheral neuropathies2-11. Our data indicate that TRPV4 mutations that reduce channel activity cause a third phenotype, inherited osteoarthropathy, and show the importance of TRPV4 activity in articular cartilage homeostasis. Our data raise the possibility that TRPV4 may also have a role in age- or injury-related osteoarthritis.	[Lamande, Shireen R.; Gresshoff, Irma L.; Rowley, Lynn; Belluoccio, Daniele; Kaluarachchi, Kumara; Amor, David J.; Savarirayan, Ravi; Bateman, John F.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Lamande, Shireen R.; Gresshoff, Irma L.; Amor, David J.; Savarirayan, Ravi] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Yuan, Yuan; McIntyre, Peter] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia; [Little, Christopher B.] Univ Sydney, Kolling Inst, Raymond Purves Bone & Joint Res Labs, Sydney, NSW 2006, Australia; [Botzenhart, Elke; Zerres, Klaus] Rhein Westfal TH Aachen, Inst Human Genet, Fac Med, Aachen, Germany; [Amor, David J.; Savarirayan, Ravi] Royal Childrens Hosp, Genet Hlth Serv Victoria, Melbourne, Vic, Australia; [Cole, William G.] Univ Alberta, Div Pediat Surg, Edmonton, AB, Canada; [Bateman, John F.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Sydney; Kolling Institute of Medical Research; RWTH Aachen University; Royal Children's Hospital Melbourne; University of Alberta; University of Melbourne	Lamande, SR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	shireen.lamande@mcri.edu.au	Amor, David J/A-6478-2018; Mcintyre, Peter/N-4109-2013; Little, Christopher B/A-9280-2015	Amor, David J/0000-0001-7191-8511; Little, Christopher B/0000-0002-0353-7634; Kaluarachchi, Kumara/0000-0002-5777-2912; McIntyre, Peter/0000-0001-9506-5998; Lamande, Shireen/0000-0003-2938-2711; Bateman, John/0000-0001-8542-0730	National Health and Medical Research Council of Australia [350347, 384414, 436903, 490037, 566834]; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	We thank U. Maus for referring one subject to the Institute of Human Genetics in Aachen. This work was supported in part by grants from the National Health and Medical Research Council of Australia (350347, 384414, 436903, 490037, 566834) and by the Victorian Government's Operational Infrastructure Support Program.	Amor DJ, 2002, AM J MED GENET, V108, P235, DOI 10.1002/ajmg.10269; Andreucci E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-37; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Camacho N, 2010, AM J MED GENET A, V152A, P1169, DOI 10.1002/ajmg.a.33392; Cameron T. L., 2009, BMC DEV BIOL, p[2009, 9]; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Chen DH, 2010, NEUROLOGY, V75, P1968, DOI 10.1212/WNL.0b013e3181ffe4bb; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; Dai J, 2010, J MED GENET, V47, P704, DOI 10.1136/jmg.2009.075358; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Fecto F, 2011, J BIOL CHEM, V286, P17281, DOI 10.1074/jbc.M111.237685; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Klein CJ, 2011, NEUROLOGY, V76, P887, DOI 10.1212/WNL.0b013e31820f2de3; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Little CB, 2007, J CLIN INVEST, V117, P1627, DOI 10.1172/JCI30765; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Nishimura G, 2010, AM J MED GENET A, V152A, P1443, DOI 10.1002/ajmg.a.33414; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Zimon M, 2010, BRAIN, V133, P1798, DOI 10.1093/brain/awq109; Zreiqat H, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2917	33	101	103	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1142	U141		10.1038/ng.945	http://dx.doi.org/10.1038/ng.945			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21964574				2022-12-25	WOS:000296584000021
J	Lehwess-Litzmann, A; Neumann, P; Parthier, C; Ludtke, S; Golbik, R; Ficner, R; Tittmann, K				Lehwess-Litzmann, Anja; Neumann, Piotr; Parthier, Christoph; Luedtke, Stefan; Golbik, Ralph; Ficner, Ralf; Tittmann, Kai			Twisted Schiff base intermediates and substrate locale revise transaldolase mechanism	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-SITE; FRUCTOSE-6-PHOSPHATE ALDOLASE; INDUCED FIT; CATALYSIS; COMPLEX; TRANSKETOLASE; 6-PHOSPHATE; ERYTHROSE	We examined the catalytic cycle of transaldolase (TAL) from Thermoplasma acidophilum by cryocrystallography and were able to structurally characterize-for the first time, to our knowledge-different genuine TAL reaction intermediates. These include the Schiff base adducts formed between the catalytic lysine and the donor ketose substrates fructose-6-phosphate and sedoheptulose-7-phosphate as well as the Michaelis complex with acceptor aldose erythrose-4-phosphate. These structural snapshots necessitate a revision of the accepted reaction mechanism with respect to functional roles of active site residues, and they further reveal fundamental insights into the general structural features of enzymatic Schiff base intermediates and the role of conformational dynamics in enzyme catalysis, substrate binding and discrimination. A nonplanar arrangement of the substituents around the Schiff base double bond was observed, suggesting that a structurally encoded reactant-state destabilization is a driving force of catalysis. Protein dynamics and the intrinsic hydrogen-bonding pattern appear to be crucial for selective recognition and binding of ketose as first substrate.	[Lehwess-Litzmann, Anja; Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Albrecht von Haller Inst, Gottingen, Germany; [Lehwess-Litzmann, Anja; Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Gottingen Ctr Mol Biosci, Gottingen, Germany; [Neumann, Piotr] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany; [Parthier, Christoph; Golbik, Ralph] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Martin Luther University Halle Wittenberg	Tittmann, K (corresponding author), Univ Gottingen, Albrecht von Haller Inst, Gottingen, Germany.	ktittma@gwdg.de			Friedrich-Naumann-Stiftung; Fonds der Chemischen Industrie; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Deutsche Forschungsgemeinschaft	Friedrich-Naumann-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Gottingen Graduate School for Neurosciences and Molecular Biosciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge access to synchrotron radiation beamtime at the Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung (BESSY). This work was supported by the Friedrich-Naumann-Stiftung (stipend to A. L.-L.), the Fonds der Chemischen Industrie (stipend to S. L.), and the Gottingen Graduate School for Neurosciences and Molecular Biosciences funded by the Deutsche Forschungsgemeinschaft (to K.T.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALBERY WJ, 1977, ANGEW CHEM INT EDIT, V16, P285, DOI 10.1002/anie.197702851; ANGYAL SJ, 1972, CARBOHYD RES, V23, P121, DOI 10.1016/S0008-6215(00)81583-9; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BLACKMORE PF, 1976, FEBS LETT, V64, P222, DOI 10.1016/0014-5793(76)80288-8; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charmantray F, 2009, J MOL CATAL B-ENZYM, V57, P6, DOI 10.1016/j.molcatb.2008.06.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Horecker BL, 2002, J BIOL CHEM, V277, P47965, DOI 10.1074/jbc.X200007200; Jia J, 1996, STRUCTURE, V4, P715, DOI 10.1016/S0969-2126(96)00077-9; Jia J, 1997, PROTEIN SCI, V6, P119; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Lehwess-Litzmann A, 2011, ACTA CRYSTALLOGR F, V67, P584, DOI 10.1107/S1744309111009274; LowKam C, 2010, J BIOL CHEM, V285, P21143, DOI 10.1074/jbc.M109.080358; Mitschke L, 2010, J BIOL CHEM, V285, P31559, DOI 10.1074/jbc.M110.149955; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Samland AK, 2009, INT J BIOCHEM CELL B, V41, P1482, DOI 10.1016/j.biocel.2009.02.001; Schneider S, 2008, J BIOL CHEM, V283, P30064, DOI 10.1074/jbc.M803184200; Schneider S, 2010, CHEMBIOCHEM, V11, P681, DOI 10.1002/cbic.200900720; Schorken U, 2001, EUR J BIOCHEM, V268, P2408, DOI 10.1046/j.1432-1327.2001.02128.x; SERIANNI AS, 1979, CARBOHYD RES, V72, P79, DOI 10.1016/S0008-6215(00)83925-7; SPECK JC, 1963, J AM CHEM SOC, V85, P1012, DOI 10.1021/ja00890a048; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; Thorell S, 2000, FEBS LETT, V475, P205, DOI 10.1016/S0014-5793(00)01658-6; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684	31	50	50	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					678	684		10.1038/NCHEMBIO.633	http://dx.doi.org/10.1038/NCHEMBIO.633			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21857661				2022-12-25	WOS:000295027100011
J	Mata, MA; Satterly, N; Versteeg, GA; Frantz, D; Wei, SG; Williams, N; Schmolke, M; Pena-Llopis, S; Brugarolas, J; Forst, CV; White, MA; Garcia-Sastre, A; Roth, MG; Fontoura, BMA				Mata, Miguel A.; Satterly, Neal; Versteeg, Gijs A.; Frantz, Doug; Wei, Shuguang; Williams, Noelle; Schmolke, Mirco; Pena-Llopis, Samuel; Brugarolas, James; Forst, Christian V.; White, Michael A.; Garcia-Sastre, Adolfo; Roth, Michael G.; Fontoura, Beatriz M. A.			Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor	NATURE CHEMICAL BIOLOGY			English	Article							INFLUENZA-A-VIRUS; NS1 PROTEIN BINDS; NUCLEAR EXPORT; INFECTED-CELLS; UP-REGULATION; RIG-I; MTOR; INTERFERON; INDUCTION; INTERACTS	A chemical genetics approach was taken to identify inhibitors of NS1, a major influenza A virus virulence factor that inhibits host gene expression. A high-throughput screen of 200,000 synthetic compounds identified small molecules that reversed NS1-mediated inhibition of host gene expression. A counterscreen for suppression of influenza virus cytotoxicity identified naphthalimides that inhibited replication of influenza virus and vesicular stomatitis virus (VSV). The mechanism of action occurs through activation of REDD1 expression and concomitant inhibition of mammalian target of rapamycin complex 1 (mTORC1) via TSC1-TSC2 complex. The antiviral activity of naphthalimides was abolished in REDD1(-/-) cells. Inhibition of REDD1 expression by viruses resulted in activation of the mTORC1 pathway. REDD1(-/-) cells prematurely upregulated viral proteins via mTORC1 activation and were permissive to virus replication. In contrast, cells conditionally expressing high concentrations of REDD1 downregulated the amount of viral protein. Thus, REDD1 is a new host defense factor, and chemical activation of REDD1 expression represents a potent antiviral intervention strategy. (C) 2011 Nature America, Inc. All rights reserved.	[Mata, Miguel A.; Satterly, Neal; White, Michael A.; Fontoura, Beatriz M. A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Versteeg, Gijs A.; Schmolke, Mirco; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Frantz, Doug; Wei, Shuguang; Williams, Noelle; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pena-Llopis, Samuel; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pena-Llopis, Samuel; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Pena-Llopis, Samuel; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Forst, Christian V.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fontoura, BMA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	beatriz.fontoura@utsouthwestern.edu	Schmolke, Mirco/AAI-9081-2020; Peña-Llopis, Samuel/ABH-2358-2020	Schmolke, Mirco/0000-0002-2491-3029; Brugarolas, James/0000-0002-8575-499X; Versteeg, Gijs/0000-0002-6150-2165; Pena-Llopis, Samuel/0000-0003-3847-1353; Forst, Christian/0000-0003-0229-9459; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Roth, Michael/0000-0002-9056-332X	US National Institutes of Health (NIH) [R01GM07159, R01AI079110, R01AI089539]; Diane and Hal Brierley Distinguished Chair in Biomedical Research; National Center for Research Resources [C06-RR15437]; NIH [R01AI046954, P01AI058113, U54AI057158, U01AI074539, R01CA129387, R01GM06715908S1]; Center for Research on Influenza Pathogenesis; National Institute of Allergy and Infectious Diseases; Center of Excellence for Influenza Research and Surveillance [HHSN266200700010C]; NATIONAL CANCER INSTITUTE [R01CA129387, R01CA071443] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089539, U54AI057158, R01AI079110, U01AI074539, P01AI058113, R01AI046954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067159] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diane and Hal Brierley Distinguished Chair in Biomedical Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research on Influenza Pathogenesis; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center of Excellence for Influenza Research and Surveillance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Sakthivel (University of Texas Southwestern) for technical assistance with plaque assays and L. Melito and J. Naidoo (University of Texas Southwestern) for technical assistance with compound synthesis. We thank S. Rubin de Celis (University of Texas Southwestern) for providing REDD1 cells, D. Levy (New York University) for providing Stat1<SUP>-/-</SUP>cells and B. Levine (University of Texas Southwestern) for providing ATG5<SUP>-/-</SUP> cells and LC3 antibodies. This work was supported by US National Institutes of Health (NIH) grants R01GM07159 to B. M. A. F.; R01AI079110 and R01AI089539 to B. M. A. F. and M. G. R.; the Diane and Hal Brierley Distinguished Chair in Biomedical Research to M. G. R; National Center for Research Resources grant C06-RR15437; NIH grants R01AI046954, P01AI058113, U54AI057158 and U01AI074539; the Center for Research on Influenza Pathogenesis, the National Institute of Allergy and Infectious Diseases-funded Center of Excellence for Influenza Research and Surveillance (HHSN266200700010C to A.G.-S.); NIH grant R01CA129387 to J. B.; and support to M. A. M. from the NIH Diversity Supplement (R01GM06715908S1).	Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas J, 2010, CANCER DRUG DISCOV D, P75, DOI 10.1007/978-1-60327-271-1_4; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Farny NG, 2008, GENE DEV, V22, P66, DOI 10.1101/gad.1616008; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Krishnamoorthy J, 2008, CELL CYCLE, V7, P2346, DOI 10.4161/cc.6323; KRUG RM, 1973, VIROLOGY, V56, P334, DOI 10.1016/0042-6822(73)90310-3; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; McNaney CA, 2008, ASSAY DRUG DEV TECHN, V6, P121, DOI 10.1089/adt.2007.103; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; QIAN XY, 1994, J VIROL, V68, P2433, DOI 10.1128/JVI.68.4.2433-2441.1994; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; QIU Y, 1995, RNA, V1, P304; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Vega-Rubin-de-Celis S, 2010, BIOCHEMISTRY-US, V49, P2491, DOI 10.1021/bi902135e; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	47	60	65	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					712	719		10.1038/NCHEMBIO.645	http://dx.doi.org/10.1038/NCHEMBIO.645			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21909097	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000295027100015
J	Pikovskaya, O; Polonskaia, A; Patel, DJ; Serganov, A				Pikovskaya, Olga; Polonskaia, Anna; Patel, Dinshaw J.; Serganov, Alexander			Structural principles of nucleoside selectivity in a 2 '-deoxyguanosine riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							GUANINE-SENSING RIBOSWITCH; APTAMER DOMAIN; PURINE RIBOSWITCH; S-ADENOSYLMETHIONINE; LIGAND-BINDING; ADENINE RIBOSWITCH; GENE-EXPRESSION; INDUCED FIT; RNA; RECOGNITION	Purine riboswitches have an essential role in genetic regulation of bacterial metabolism. This family includes the 2'-deoxyguanosine (dG) riboswitch, which is involved in feedback control of deoxyguanosine biosynthesis. To understand the principles that define dG selectivity, we determined crystal structures of the natural Mesoplasma florum riboswitch bound to cognate dG as well as to noncognate guanosine, deoxyguanosine monophosphate and guanosine monophosphate. Comparison with related purine riboswitch structures reveals that the dG riboswitch achieves its specificity through modification of key interactions involving the nucleobase and rearrangement of the ligand-binding pocket to accommodate the additional sugar moiety. In addition, we observe new conformational changes beyond the junctional binding pocket extending as far as peripheral loop-loop interactions. It appears that re-engineering riboswitch scaffolds will require consideration of selectivity features dispersed throughout the riboswitch tertiary fold, and structure-guided drug design efforts targeted to junctional RNA scaffolds need to be addressed within such an expanded framework.	[Pikovskaya, Olga; Polonskaia, Anna; Patel, Dinshaw J.; Serganov, Alexander] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	pateld@mskcc.org; alexander.serganov@nyumc.org		Serganov, Alexander/0000-0001-8328-9310	US Department of Energy; US National Institutes of Health [GM66354]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354, R01GM073618, R01GM034504] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of beamline X29 at the Brookhaven National Laboratory, funded by the US Department of Energy, for assistance in data collection. We thank O. Ouerfelli (Memorial Sloan-Kettering Cancer Center, New York) for the synthesis of iridium hexamine and E. Ennifar (Institut de Biologie Moleculaire et Cellulaire, Strasbourg) for the discussion of the refinement strategy. D.J.P. was supported by funds from the US National Institutes of Health grant GM66354.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Buck J, 2010, NUCLEIC ACIDS RES, V38, P4143, DOI 10.1093/nar/gkq138; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Edwards AL, 2009, J MOL BIOL, V385, P938, DOI 10.1016/j.jmb.2008.10.074; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, J AM CHEM SOC, V128, P14214, DOI 10.1021/ja063645t; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gilbert SD, 2009, STRUCTURE, V17, P857, DOI 10.1016/j.str.2009.04.009; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Jain N, 2010, BIOCHEMISTRY-US, V49, P3703, DOI 10.1021/bi1000036; Kim JN, 2007, P NATL ACAD SCI USA, V104, P16092, DOI 10.1073/pnas.0705884104; Kim JN, 2009, ACS CHEM BIOL, V4, P915, DOI 10.1021/cb900146k; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lu C, 2008, NAT STRUCT MOL BIOL, V15, P1076, DOI 10.1038/nsmb.1494; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P5262, DOI 10.1093/nar/gkm565; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2010, RNA BIOL, V7, P98, DOI 10.4161/rna.7.1.10756; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Wacker A, 2011, NUCLEIC ACIDS RES, V39, P6802, DOI 10.1093/nar/gkr238	50	47	48	3	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					748	755		10.1038/NCHEMBIO.631	http://dx.doi.org/10.1038/NCHEMBIO.631			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21841796	Green Accepted			2022-12-25	WOS:000295027100019
J	Qin, K; Dong, CM; Wu, GY; Lambert, NA				Qin, Kou; Dong, Chunmin; Wu, Guangyu; Lambert, Nevin A.			Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; PLASMA-MEMBRANE LOCALIZATION; RESONANCE ENERGY-TRANSFER; BETA-ADRENERGIC-RECEPTOR; 4TH CYTOPLASMIC LOOP; LIVING CELLS; STRUCTURAL BASIS; MUSCARINIC RECEPTOR; ADENYLATE-CYCLASE; ACTIVATION	G protein-coupled receptors (GPCRs) transmit signals by forming active-state complexes with heterotrimeric G proteins. It has been suggested that some GPCRs also assemble with G proteins before ligand-induced activation and that inactive-state preassembly facilitates rapid and specific G protein activation. However, no mechanism of preassembly has been described, and no functional consequences of preassembly have been demonstrated. Here we show that M-3 muscarinic acetylcholine receptors (M3R) form inactive-state complexes with G(q) heterotrimers in intact cells. The M3R C terminus is sufficient, and a six-amino-acid polybasic sequence distal to helix 8 ((KKKRRK570)-K-565) is necessary for preassembly with G(q). Replacing this sequence with six alanine residues prevents preassembly, slows the rate of G(q) activation and decreases steady-state agonist sensitivity. That other G(q)-coupled receptors possess similar polybasic regions and also preassemble with G(q) suggests that these GPCRs may use a common preassembly mechanism to facilitate activation of G(q) heterotrimers.	[Qin, Kou; Dong, Chunmin; Wu, Guangyu; Lambert, Nevin A.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	University System of Georgia; Augusta University	Lambert, NA (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	nlambert@georgiahealth.edu			US National Institutes of Health [GM076167, GM096762, GM078319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096762, R01GM076167, R01GM078319] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Digby and S. Kuravi for invaluable assistance. This work was supported by US National Institutes of Health grants GM076167 (G. W.), GM096762 and GM078319 (N.A.L.).	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Lohse MJ, 2007, ADV PROTEIN CHEM, V74, P167, DOI 10.1016/S0065-3233(07)74005-6; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Pedone KH, 2007, J BIOL CHEM, V282, P25199, DOI 10.1074/jbc.M610297200; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Rasmussen S.G., 2011, NATURE; Rebois RV, 2003, RECEPTOR CHANNEL, V9, P169, DOI 10.1080/10606820308243; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Wess J, 1997, LIFE SCI, V60, P1007, DOI 10.1016/S0024-3205(97)00041-6; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	38	103	105	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					740	747		10.1038/NCHEMBIO.642	http://dx.doi.org/10.1038/NCHEMBIO.642			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21873996	Green Accepted			2022-12-25	WOS:000295027100018
J	Woods, LA; Platt, GW; Hellewell, AL; Hewitt, EW; Homans, SW; Ashcroft, AE; Radford, SE				Woods, Lucy A.; Platt, Geoffrey W.; Hellewell, Andrew L.; Hewitt, Eric W.; Homans, Steve W.; Ashcroft, Alison E.; Radford, Sheena E.			Ligand binding to distinct states diverts aggregation of an amyloid-forming protein	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-SYNUCLEIN; FIBRIL FORMATION; A-BETA; COMMON MECHANISM; BETA(2)-MICROGLOBULIN; RIFAMPICIN; INHIBITORS; OLIGOMERS; FIBRILLIZATION; POLYPHENOLS	Although small molecules that modulate amyloid formation in vitro have been identified, significant challenges remain in determining precisely how these species act. Here we describe the identification of rifamycin SV as a potent inhibitor of beta(2) microglobulin (beta(2)m) fibrillogenesis when added during the lag time of assembly or early during fibril elongation. Biochemical experiments demonstrate that the small molecule does not act by a colloidal mechanism. Exploiting the ability of electrospray ionization-ion mobility spectrometry-mass spectrometry (ESI-IMS-MS) to resolve intermediates of amyloid assembly, we show instead that rifamycin SV inhibits beta(2)m fibrillation by binding distinct monomeric conformers, disfavoring oligomer formation and diverting the course of assembly to the formation of spherical aggregates. The results demonstrate the power of ESI-IMS-MS to identify specific protein conformers as targets for intervention in fibrillogenesis using small molecules and reveal a mechanism of action in which ligand binding diverts unfolded protein monomers toward alternative assembly pathways.	[Woods, Lucy A.; Platt, Geoffrey W.; Hellewell, Andrew L.; Hewitt, Eric W.; Homans, Steve W.; Ashcroft, Alison E.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Woods, Lucy A.; Platt, Geoffrey W.; Hellewell, Andrew L.; Hewitt, Eric W.; Homans, Steve W.; Ashcroft, Alison E.; Radford, Sheena E.] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	a.e.ashcroft@leeds.ac.uk; s.e.radford@leeds.ac.uk	Platt, Geoffrey/D-2416-2013	Hewitt, Eric/0000-0002-6238-6303; Platt, Geoffrey/0000-0003-1754-0110; Radford, Sheena/0000-0002-3079-8039; Hellewell, Andrew/0000-0002-7803-2884	Wellcome Trust [075675, 062164]; BBSRC [BB/526502/1]; Biotechnology and Biological Sciences Research Council (Research Equipment Initiative) [BB/E012558/1]; BBSRC [BB/E012558/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012558/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (Research Equipment Initiative)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Kalverda for advice on NMR spectroscopy, D. P. Smith for advice about alpha-synuclein, K. Ainley for technical assistance, C. Glabe for the gift of OC and A11 antibodies and A beta<INF>1-40</INF> oligomers, J. Rushworth for creating fibrillar oligomers of A beta<INF>1-42</INF>, R. Wetzel for the gift of WO1 antibodies and the Radford and Ashcroft groups for helpful discussions and advice. We acknowledge the Wellcome Trust (grant numbers 075675 and 062164) and BBSRC (Grant Number BB/526502/1) for funding. The Synapt HDMS mass spectrometer was purchased with funding from the Biotechnology and Biological Sciences Research Council (Research Equipment Initiative grant BB/E012558/1).	Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; Armstrong DW, 1999, J PHYS CHEM B, V103, P4338, DOI 10.1021/jp990279+; Ashcroft AE, 2010, J AM SOC MASS SPECTR, V21, P1087, DOI 10.1016/j.jasms.2010.02.026; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Borysik AJH, 2004, J BIOL CHEM, V279, P27069, DOI 10.1074/jbc.M401472200; Carazzone C, 2008, ELECTROPHORESIS, V29, P1502, DOI 10.1002/elps.200700677; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HG, 2004, ANN NY ACAD SCI, V1019, P1, DOI 10.1196/annals.1297.001; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Li J, 2004, CHEM BIOL, V11, P1513, DOI 10.1016/j.chembiol.2004.08.025; Lieu VH, 2007, BIOTECHNOL PROGR, V23, P698, DOI 10.1021/bp060353n; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Regazzoni L, 2010, CHEMMEDCHEM, V5, P1015, DOI 10.1002/cmdc.201000082; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; Smith DP, 2007, J AM SOC MASS SPECTR, V18, P2180, DOI 10.1016/j.jasms.2007.09.017; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tomiyama T, 1997, BIOCHEM J, V322, P859, DOI 10.1042/bj3220859; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	50	81	82	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					730	739		10.1038/NCHEMBIO.635	http://dx.doi.org/10.1038/NCHEMBIO.635			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21873994	Green Accepted			2022-12-25	WOS:000295027100017
J	Blanchet, E; Annicotte, JS; Lagarrigue, S; Aguilar, V; Clape, C; Chavey, C; Fritz, V; Casas, F; Apparailly, F; Auwerx, J; Fajas, L				Blanchet, Emilie; Annicotte, Jean-Sebastien; Lagarrigue, Sylviane; Aguilar, Victor; Clape, Cyrielle; Chavey, Carine; Fritz, Vanessa; Casas, Francois; Apparailly, Florence; Auwerx, Johan; Fajas, Lluis			E2F transcription factor-1 regulates oxidative metabolism	NATURE CELL BIOLOGY			English	Article							ACTIVATED-RECEPTOR-GAMMA; SKELETAL-MUSCLE; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ENZYME-ACTIVITY; PGC-1-ALPHA; GROWTH; COACTIVATOR; REPRESSION; PROTECTS	Cells respond to stress by coordinating proliferative and metabolic pathways. Starvation restricts cell proliferative (glycolytic) and activates energy productive (oxidative) pathways. Conversely, cell growth and proliferation require increased glycolytic and decreased oxidative metabolism levels(1). E2F transcription factors regulate both proliferative and metabolic genes(2,3). E2Fs have been implicated in the G1/S cell-cycle transition, DNA repair, apoptosis, development and differentiation(2-4). In pancreatic beta-cells, E2F1 gene regulation facilitated glucose-stimulated insulin secretion(5,6). Moreover, mice lacking E2F1 (E2f1(-/-)) were resistant to diet-induced obesity(4). Here, we show that E2F1 coordinates cellular responses by acting as a regulatory switch between cell proliferation and metabolism. In basal conditions, E2F1 repressed key genes that regulate energy homeostasis and mitochondrial functions in muscle and brown adipose tissue. Consequently, E2f1(-/-) mice had a marked oxidative phenotype. An association between E2F1 and pRB was required for repression of genes implicated in oxidative metabolism. This repression was alleviated in a constitutively active CDK4 (CDK4(R24C)) mouse model or when adaptation to energy demand was required. Thus, E2F1 represents a metabolic switch from oxidative to glycolytic metabolism that responds to stressful conditions.	[Blanchet, Emilie; Annicotte, Jean-Sebastien; Lagarrigue, Sylviane; Aguilar, Victor; Clape, Cyrielle; Chavey, Carine; Fritz, Vanessa; Fajas, Lluis] Inst Rech Cancerol Montpellier, IRCM, F-34298 Montpellier, France; [Blanchet, Emilie; Annicotte, Jean-Sebastien; Lagarrigue, Sylviane; Aguilar, Victor; Clape, Cyrielle; Chavey, Carine; Fritz, Vanessa; Fajas, Lluis] INSERM, U896, F-34298 Montpellier, France; [Blanchet, Emilie; Annicotte, Jean-Sebastien; Lagarrigue, Sylviane; Aguilar, Victor; Clape, Cyrielle; Chavey, Carine; Fritz, Vanessa; Fajas, Lluis] Univ Montpellier 1, F-34298 Montpellier, France; [Blanchet, Emilie; Annicotte, Jean-Sebastien; Lagarrigue, Sylviane; Aguilar, Victor; Clape, Cyrielle; Chavey, Carine; Fritz, Vanessa; Fajas, Lluis] CRLC Val dAurelle Paul Lamarque, F-34298 Montpellier, France; [Blanchet, Emilie; Annicotte, Jean-Sebastien; Lagarrigue, Sylviane; Chavey, Carine; Fritz, Vanessa; Fajas, Lluis] Inst Genet Mol Montpellier, IGMM, F-34293 Montpellier, France; [Blanchet, Emilie; Annicotte, Jean-Sebastien; Lagarrigue, Sylviane; Chavey, Carine; Fritz, Vanessa; Fajas, Lluis] CNRS, UMR5535, F-34293 Montpellier, France; [Casas, Francois] INRA, UMR0866, F-34060 Montpellier, France; [Apparailly, Florence] INSERM, U844, F-34295 Montpellier, France; [Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1115 Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Fajas, L (corresponding author), Inst Rech Cancerol Montpellier, IRCM, F-34298 Montpellier, France.	lluis.fajas@inserm.fr	APPARAILLY, Florence/D-8635-2016; APPARAILLY, Florence/AAU-5489-2020; Coll, Lluis Fajas/C-8567-2014; Auwerx, Johan/ABE-9307-2021; Annicotte, Jean-Sébastien/H-4641-2018	APPARAILLY, Florence/0000-0003-1762-084X; Annicotte, Jean-Sébastien/0000-0002-2109-4849; Francois, Casas/0000-0002-5535-8195; Fajas, Lluis/0000-0002-1283-9503; Auwerx, Johan/0000-0002-5065-5393; Chavey, Carine/0000-0002-5267-5638	Agence Nationale pour la Recherche (ANR genopath); INSERM-Association pour la Recherche sur le Diabete (PNR Diabete); Association Francaise des Diabetiques; Societe Francophone du Diabete; Association pour la Recherche contre le Cancer; Fondation pour la Recherche Medicale; Ligue Contre le Cancer; European Research Council; National Institutes of Health; Swiss National Science Foundation; EPFL; Ministere de l'Enseignement Superieur et de la Recherche; Agence Nationale pour la Recherche	Agence Nationale pour la Recherche (ANR genopath)(French National Research Agency (ANR)); INSERM-Association pour la Recherche sur le Diabete (PNR Diabete); Association Francaise des Diabetiques; Societe Francophone du Diabete; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Contre le Cancer(Ligue nationale contre le cancer); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	We thank M. Barbacid, B.M. Spiegelman, C. Sardet and L. Le Cam for the gift of materials and D. Greuet, C. Henriquet, S. Hure and J. Teyssier for their technical help. The authors are grateful to C. Cazevieille from Centre de Ressources en Imagerie Cellulaire de Montpellier for her technical assistance, data interpretation and ultrastructural evaluations. We are indebted to the RHEM network (Reseau d'Histologie Experimentale de Montpellier, IFR122, France) for histology and, in particular, for tissue and slide preparations. Members of the Fajas laboratory are acknowledged for support and discussions. This work was supported by grants from Agence Nationale pour la Recherche (ANR genopath), INSERM-Association pour la Recherche sur le Diabete (PNR Diabete), Association Francaise des Diabetiques, Societe Francophone du Diabete, Association pour la Recherche contre le Cancer, Fondation pour la Recherche Medicale, Ligue Contre le Cancer, European Research Council, National Institutes of Health, Swiss National Science Foundation and EPFL. E.B. was supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche; C.C. was supported by a grant from the Agence Nationale pour la Recherche.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Annicotte JS, 2006, MOL CELL BIOL, V26, P7561, DOI 10.1128/MCB.00605-06; Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Annicotte JS, 2003, MOL CELL BIOL, V23, P6713, DOI 10.1128/MCB.23.19.6713-6724.2003; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; SARDET C, 1997, PROGR GENE EXPRESSIO, V2, P1; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Warburg O, 1930, UEBER STOFFWECHSEL T	30	187	191	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1146	U184		10.1038/ncb2309	http://dx.doi.org/10.1038/ncb2309			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21841792	Green Accepted			2022-12-25	WOS:000294487000021
J	Cooper, GM; Coe, BP; Girirajan, S; Rosenfeld, JA; Vu, TH; Baker, C; Williams, C; Stalker, H; Hamid, R; Hannig, V; Abdel-Hamid, H; Bader, P; McCracken, E; Niyazov, D; Leppig, K; Thiese, H; Hummel, M; Alexander, N; Gorski, J; Kussmann, J; Shashi, V; Johnson, K; Rehder, C; Ballif, BC; Shaffer, LG; Eichler, EE				Cooper, Gregory M.; Coe, Bradley P.; Girirajan, Santhosh; Rosenfeld, Jill A.; Vu, Tiffany H.; Baker, Carl; Williams, Charles; Stalker, Heather; Hamid, Rizwan; Hannig, Vickie; Abdel-Hamid, Hoda; Bader, Patricia; McCracken, Elizabeth; Niyazov, Dmitriy; Leppig, Kathleen; Thiese, Heidi; Hummel, Marybeth; Alexander, Nora; Gorski, Jerome; Kussmann, Jennifer; Shashi, Vandana; Johnson, Krys; Rehder, Catherine; Ballif, Blake C.; Shaffer, Lisa G.; Eichler, Evan E.			A copy number variation morbidity map of developmental delay	NATURE GENETICS			English	Article							RARE CHROMOSOMAL DELETIONS; HOLT-ORAM SYNDROME; HUMAN GENOME; STRUCTURAL VARIATION; INCREASE RISK; ARRAY CGH; SCHIZOPHRENIA; COMMON; MICRODELETION; GENES	To understand the genetic heterogeneity underlying developmental delay, we compared copy number variants (CNVs) in 15,767 children with intellectual disability and various congenital defects (cases) to CNVs in 8,329 unaffected adult controls. We estimate that similar to 14.2% of disease in these children is caused by CNVs >400 kb. We observed a greater enrichment of CNVs in individuals with craniofacial anomalies and cardiovascular defects compared to those with epilepsy or autism. We identified 59 pathogenic CNVs, including 14 new or previously weakly supported candidates, refined the critical interval for several genomic disorders, such as the 17q21.31 microdeletion syndrome, and identified 940 candidate dosage-sensitive genes. We also developed methods to opportunistically discover small, disruptive CNVs within the large and growing diagnostic array datasets. This evolving CNV morbidity map, combined with exome and genome sequencing, will be critical for deciphering the genetic basis of developmental delay, intellectual disability and autism spectrum disorders.	[Cooper, Gregory M.; Coe, Bradley P.; Girirajan, Santhosh; Vu, Tiffany H.; Baker, Carl; Ballif, Blake C.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] Signature Genom Labs LLC, Spokane, WA USA; [Williams, Charles; Stalker, Heather] Univ Florida, Dept Pediat, Div Genet, Gainesville, FL USA; [Hamid, Rizwan; Hannig, Vickie] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Abdel-Hamid, Hoda] Univ Pittsburgh, Dept Pediat, Div Child Neurol, Pittsburgh, PA 15260 USA; [Bader, Patricia] NE Indiana Genet Counseling Ctr, Ft Wayne, IN USA; [McCracken, Elizabeth] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Niyazov, Dmitriy] Ochsner Clin & Alton Ochsner Med Fdn, New Orleans, LA USA; [Leppig, Kathleen; Thiese, Heidi] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Hummel, Marybeth; Alexander, Nora] W Virginia Univ, Morgantown, WV 26506 USA; [Gorski, Jerome; Kussmann, Jennifer] Univ Missouri, Columbia, MO USA; [Shashi, Vandana] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Johnson, Krys] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Rehder, Catherine] Duke Univ Hlth Syst, Clin Mol Diagnost Lab, Durham, NC USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ochsner Health System; Group Health Cooperative; West Virginia University; University of Missouri System; University of Missouri Columbia; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Coe, Bradley/A-2878-2009	Coe, Bradley/0000-0001-8471-4016	Canadian Institutes of Health Research; Wellcome Trust [076113, 085475]; US National Institutes of Health [HD065285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102020] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Krumm, M. Malig, L. Vives and J. Luu for assistance in validation experiments. We also thank M. Dennis, C. Alkan, E. Karakoc and T. Brown for useful discussions and for editing the manuscript. B. P. C. is supported by a fellowship from the Canadian Institutes of Health Research. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475. We also thank A. Aragaki, C. Kooperberg and R. Jackson for access to SNP data (Fred Hutchinson Cancer Research Center (FHCRC) control dataset) generated as part of the ongoing genome-wide association study to identify genetic components of hip fracture in the Women's Health Initiative. This work was supported by US National Institutes of Health HD065285 to E.E.E. E.E.E. is an investigator of the Howard Hughes Medical Institute.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Baroni T, 2010, J CELL PHYSIOL, V222, P748, DOI 10.1002/jcp.22006; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Bowden NA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-199; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; BRONS JTJ, 1988, PRENATAL DIAG, V8, P175, DOI 10.1002/pd.1970080303; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaabouni M, 2007, AM J MED GENET A, V143A, P1100, DOI 10.1002/ajmg.a.31704; Chen L, 2010, J NEUROSCI, V30, P14824, DOI 10.1523/JNEUROSCI.3742-10.2010; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Li F, 2010, AM J MED GENET A, V152A, P1318, DOI 10.1002/ajmg.a.33355; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCullumsmith RE, 2002, NEUROPSYCHOPHARMACOL, V26, P368, DOI 10.1016/S0893-133X(01)00370-0; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Park JW, 2006, J MED GENET, V43, P598, DOI 10.1136/jmg.2005.040162; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; SHPRINTZEN RJ, 1994, J MED GENET, V31, P423, DOI 10.1136/jmg.31.5.423-b; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Stalker DJ, 2000, J MED GENET, V37, P974, DOI 10.1136/jmg.37.12.974; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Suls A, 2006, HUM MUTAT, V27, P914, DOI 10.1002/humu.20350; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	60	889	923	0	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					838	U44		10.1038/ng.909	http://dx.doi.org/10.1038/ng.909			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21841781	Green Accepted			2022-12-25	WOS:000294325800008
J	Hirota, T; Takahashi, A; Kubo, M; Tsunoda, T; Tomita, K; Doi, S; Fujita, K; Miyatake, A; Enomoto, T; Miyagawa, T; Adachi, M; Tanaka, H; Niimi, A; Matsumoto, H; Ito, I; Masuko, H; Sakamoto, T; Hizawa, N; Taniguchi, M; Lima, JJ; Irvin, CG; Peters, SP; Himes, BE; Litonjua, AA; Tantisira, KG; Weiss, ST; Kamatani, N; Nakamura, Y; Tamari, M				Hirota, Tomomitsu; Takahashi, Atsushi; Kubo, Michiaki; Tsunoda, Tatsuhiko; Tomita, Kaori; Doi, Satoru; Fujita, Kimie; Miyatake, Akihiko; Enomoto, Tadao; Miyagawa, Takehiko; Adachi, Mitsuru; Tanaka, Hiroshi; Niimi, Akio; Matsumoto, Hisako; Ito, Isao; Masuko, Hironori; Sakamoto, Tohru; Hizawa, Nobuyuki; Taniguchi, Masami; Lima, John J.; Irvin, Charles G.; Peters, Stephen P.; Himes, Blanca E.; Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.; Kamatani, Naoyuki; Nakamura, Yusuke; Tamari, Mayumi			Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population	NATURE GENETICS			English	Article							PROSTATE-CANCER; VARIANTS; EXPRESSION; IMMUNITY; LINKAGE; TRAITS; GENES; CELLS; RISK; LUNG	Bronchial asthma is a common inflammatory disease caused by the interaction of genetic and environmental factors(1,2). Through a genome-wide association study and a replication study consisting of a total of 7,171 individuals with adult asthma (cases) and 27,912 controls in the Japanese population, we identified five loci associated with susceptibility to adult asthma. In addition to the major histocompatibility complex and TSLP-WDR36 loci previously reported, we identified three additional loci: a USP38-GAB1 locus on chromosome 4q31 (combined P = 1.87 x 10(-12)), a locus on chromosome 10p14 (P = 1.79 x 10(-15)) and a gene-rich region on chromosome 12q13 (P = 2.33 x 10(-13)). We observed the most significant association with adult asthma at rs404860 in the major histocompatiblity complex region (P = 4.07 x 10(-23)), which is close to rs2070600, a SNP previously reported for association with FEV(1)/FVC in genome-wide association studies for lung function. Our findings offer a better understanding of the genetic contribution to asthma susceptibility.	[Hirota, Tomomitsu; Tomita, Kaori; Tamari, Mayumi] RIKEN, Lab Resp Dis, Ctr Genom Med, Kanagawa, Japan; [Takahashi, Atsushi] RIKEN, Lab Stat Anal, Ctr Genom Med, Tokyo, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Genom Med, Kanagawa, Japan; [Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Ctr Genom Med, Kanagawa, Japan; [Doi, Satoru] Osaka Prefectural Med Ctr Resp & Allerg Dis, Osaka, Japan; [Fujita, Kimie; Miyatake, Akihiko] Miyatake Asthma Clin, Osaka, Japan; [Enomoto, Tadao] Nonprofit Org NPO Japan Hlth Promot Supporting Ne, Wakayama, Japan; [Miyagawa, Takehiko] Miyagawa Clin, Gifu, Japan; [Adachi, Mitsuru] Showa Univ, Sch Med, Dept Internal Med 1, Shinagawa Ku, Tokyo 142, Japan; [Tanaka, Hiroshi] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido, Japan; [Niimi, Akio; Matsumoto, Hisako; Ito, Isao] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Masuko, Hironori; Sakamoto, Tohru; Hizawa, Nobuyuki] Univ Tsukuba, Inst Clin Med, Div Resp Med, Tsukuba, Ibaraki 305, Japan; [Taniguchi, Masami] Sagamihara Natl Hosp, Natl Clin Res Ctr, Natl Hosp Org, Kanagawa, Japan; [Lima, John J.] Nemours Childrens Clin, Ctr Clin Pediat Pharmacol, Jacksonville, FL USA; [Lima, John J.] Nemours Childrens Clin, Ctr Pharmacogenet, Jacksonville, FL USA; [Irvin, Charles G.] Univ Vermont, Dept Physiol & Med, Vermont Lung Ctr, Burlington, VT USA; [Peters, Stephen P.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Sect Pulm Crit Care Allergy & Immunol Dis, Winston Salem, NC USA; [Himes, Blanca E.; Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Himes, Blanca E.; Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA; [Kamatani, Naoyuki] RIKEN, Lab Int Alliance, Ctr Genom Med, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; Showa University; Sapporo Medical University; Kyoto University; University of Tsukuba; University of Vermont; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; RIKEN; University of Tokyo	Tamari, M (corresponding author), RIKEN, Lab Resp Dis, Ctr Genom Med, Kanagawa, Japan.	tamari@src.riken.jp	Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014; Tamari, Mayumi/N-5378-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ito, Isao/0000-0003-3109-898X; Sakamoto, Tohru/0000-0002-8876-1466; Litonjua, Augusto/0000-0003-0422-5875	Ministry of Health, Labour and Welfare, Japan; American Lung Association (ALA); National Heart, Lung, and Blood Institute [HL071394, HL074755]; Nemours Children's Clinic; GlaxoSmithKline; Sepracor, Inc.; US National Institutes of Health [NCRR RR022675, RR015557]; ALA; Asthma Clinical Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015557, U13RR022675] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071394, K99HL105663, R01HL074755] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23791204, 22590834] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); American Lung Association (ALA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Nemours Children's Clinic; GlaxoSmithKline(GlaxoSmithKline); Sepracor, Inc.; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALA; Asthma Clinical Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the subjects for participating in the study and also thank the collaborating physicians for helping with sample collection. We are grateful to the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. We thank M. T. Shimizu, H. Sekiguchi, A. I. Jodo, N. Kawaraichi and the technical staff of the Center for Genomic Medicine for providing technical assistance. This work was conducted as a part of the BioBank Japan Project supported by of Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also partly supported by grants from the Ministry of Health, Labour and Welfare, Japan. We acknowledge the American Lung Association (ALA) and the ALA's Asthma Clinical Research Centers investigators and research teams for use of Leukotriene Modifier or Corticosteroid Salmeterol (LOCCS) and Effectiveness of Low Dose Theophylline as an Add-on Treatment in Asthma (LODO) data, with additional funding from HL071394 and HL074755 from the National Heart, Lung, and Blood Institute and the Nemours Children's Clinic. GlaxoSmithKline supported the conduct of the LOCCS Trial by an unrestricted grant to the ALA. We acknowledge Sepracor, Inc. for use of the Asthma Trial data. C. G. I. was supported by grants from the US National Institutes of Health NCRR RR022675 and RR015557 as well as the ALA, Asthma Clinical Research Center award. S. P. P. serves as an advisor to the data coordinating center of the ALA Asthma Clinical Research Centers and served as the principal investigator of the LOCCS trial.	Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Harada M, 2009, AM J RESP CRIT CARE, V180, P1048, DOI 10.1164/rccm.200905-0652OC; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Kabesch M, 2010, CHEST, V137, P909, DOI 10.1378/chest.09-1554; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Moffatt MF, 2001, EUR J HUM GENET, V9, P341, DOI 10.1038/sj.ejhg.5200636; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Weiss ST, 2010, NAT GENET, V42, P14, DOI 10.1038/ng0110-14; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	32	237	242	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					893	U108		10.1038/ng.887	http://dx.doi.org/10.1038/ng.887			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21804548	Green Accepted, Green Submitted			2022-12-25	WOS:000294325800018
J	Sullivan, NJ; Hensley, L; Asiedu, C; Geisbert, TW; Stanley, D; Johnson, J; Honko, A; Olinger, G; Bailey, M; Geisbert, JB; Reimann, KA; Bao, S; Rao, S; Roederer, M; Jahrling, PB; Koup, RA; Nabel, GJ				Sullivan, Nancy J.; Hensley, Lisa; Asiedu, Clement; Geisbert, Thomas W.; Stanley, Daphne; Johnson, Joshua; Honko, Anna; Olinger, Gene; Bailey, Michael; Geisbert, Joan B.; Reimann, Keith A.; Bao, Saran; Rao, Srinivas; Roederer, Mario; Jahrling, Peter B.; Koup, Richard A.; Nabel, Gary J.			CD8(+) cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates	NATURE MEDICINE			English	Article							HEMORRHAGIC-FEVER; MARBURG VIRUS; INDUCTION; ANTIBODY	Vaccine-induced immunity to Ebola virus infection in nonhuman primates (NHPs) is marked by potent antigen-specific cellular and humoral immune responses(1,2); however, the immune mechanism of protection remains unknown. Here we define the immune basis of protection conferred by a highly protective recombinant adenovirus virus serotype 5 (rAd5) encoding Ebola virus glycoprotein (GP)(1,3) in NHPs. Passive transfer of high-titer polyclonal antibodies from vaccinated Ebola virus-immune cynomolgus macaques to naive macaques failed to confer protection against disease, suggesting a limited role of humoral immunity. In contrast, depletion of CD3(+) T cells in vivo after vaccination and immediately before challenge eliminated immunity in two vaccinated macaques, indicating a crucial requirement for T cells in this setting. The protective effect was mediated largely by CD8(+) cells, as depletion of CD8(+) cells in vivo using the cM-T807 monoclonal antibody (mAb), which does not affect CD4(+) T cell or humoral immune responses, abrogated protection in four out of five subjects. These findings indicate that CD8(+) cells have a major role in rAd5-GP-induced immune protection against Ebola virus infection in NHPs. Understanding the immunologic mechanism of Ebola virus protection will facilitate the development of vaccines for Ebola and related hemorrhagic fever viruses in humans.	[Sullivan, Nancy J.; Asiedu, Clement; Stanley, Daphne; Bailey, Michael; Bao, Saran; Rao, Srinivas; Roederer, Mario; Koup, Richard A.; Nabel, Gary J.] US Natl Inst Allergy & Infect Dis, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD USA; [Hensley, Lisa; Geisbert, Thomas W.; Johnson, Joshua; Honko, Anna; Olinger, Gene; Geisbert, Joan B.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Reimann, Keith A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Jahrling, Peter B.] US Natl Inst Allergy & Infect Dis, Integrated Res Facil, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sullivan, NJ (corresponding author), US Natl Inst Allergy & Infect Dis, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD USA.	nsullivan@nih.gov	Honko, Anna/H-9539-2019; Roederer, Mario/G-1887-2011	Honko, Anna/0000-0001-9165-148X; Johnson, Joshua/0000-0002-5677-3841; Hensley, Lisa/0000-0003-1188-4342; Olinger, Gene/0000-0001-7338-0292	National Center for Research Resource, US National Institutes of Health [R24RR016001]; US National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005001, ZIAAI005019, ZIAAI005079, ZIAAI005082, ZIAAI001025] Funding Source: NIH RePORTER	National Center for Research Resource, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Jeffers, T. Suhana, A. Tislerics and B. Hartman for help with manuscript preparation; M. Cichanowski for graphics; D. Braun, K. Daddario and C. Rice for technical and animal care assistance; S. Norris and M. Nason for assistance with statistical considerations; and K. Kenyon for editorial support. We thank D. Neville (US National Institute of Mental Health) for the generous gift of FN18-CRM9 immunotoxin. Reagent support was provided by the Nonhuman Primate Reagent Resource (grant number R24RR016001 from the National Center for Research Resource, US National Institutes of Health). Support for this work was provided by the Intramural Research Program of the US National Institutes of Health. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the US Army or the Department of Defense.	Chattopadhyay Pratip K, 2007, Methods Mol Biol, V374, P175; Geisbert TW, 2010, J VIROL, V84, P10386, DOI 10.1128/JVI.00594-10; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Gupta M, 2004, J VIROL, V78, P958, DOI 10.1128/JVI.78.2.958-967.2004; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Jahrling PB, 1996, ARCH VIROL, P135; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Neville DM, 1996, J IMMUNOTHER, V19, P85, DOI 10.1097/00002371-199603000-00001; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037	20	162	167	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1128	U135		10.1038/nm.2447	http://dx.doi.org/10.1038/nm.2447			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857654				2022-12-25	WOS:000294605100034
J	Yoon, WH; Meinhardt, H; Montell, DJ				Yoon, Wan Hee; Meinhardt, Hans; Montell, Denise J.			miRNA-mediated feedback inhibition of JAK/STAT morphogen signalling establishes a cell fate threshold	NATURE CELL BIOLOGY			English	Article							DROSOPHILA-MELANOGASTER; EXPRESSION; MIGRATION; GRADIENT; PROTEIN; GENES; DIFFERENTIATION; EMBRYO	Patterns of cell fates generated by morphogens are critically important for normal development; however, the mechanisms by which graded morphogen signals are converted into all-or-none cell fate responses are incompletely understood. In the Drosophila ovary, high and sustained levels of the secreted morphogen Unpaired (Upd) specify the migratory border-cell population by activating the signal transducer and activator of transcription(1,2) (STAT). A lower or transient level of STAT activity specifies a non-migratory population of follicle cells(3,4). Here we identify miR-279 as a component of a feedback pathway that further dampens the response in cells with low levels of JAK/STAT activity. miR-279 directly repressed STAT, and loss of miR-279 mimicked STAT gain-of-function or loss of Apontic (Apt), a known feedback inhibitor of STAT. Apt was essential for miR-279 expression in non-migratory follicle cells, whereas another STAT target, Ken and Barbie (Ken), downregulated miR-279 in border cells. Mathematical modelling and simulations of this regulatory circuit including miR-279, Apt and Ken supported key roles for miR-279 and Apt in generating threshold responses to the Upd gradient.	[Yoon, Wan Hee; Montell, Denise J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Meinhardt, Hans] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Johns Hopkins University; Max Planck Society	Montell, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Cell Dynam, 855 N Wolfe St,Suite 450, Baltimore, MD 21205 USA.	dmontell@jhmi.edu		Yoon, Wan Hee/0000-0002-9459-3139	NIH [GM46425]; Korea Science and Engineering Foundation (KOSEF); H.A. and Mary K. Chapman Young Investigator Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046425, R29GM046425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); H.A. and Mary K. Chapman Young Investigator Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM46425 to D.J.M. W.H.Y. was supported by a fellowship from the Korea Science and Engineering Foundation (KOSEF) and the H.A. and Mary K. Chapman Young Investigator Fellowship. We acknowledge A. H. McDonald and B. Steiner for technical assistance. We thank J. S. Kang for data illustration. We thank M. Issigonis for helpful discussion. We thank present and past members of the D.J.M. and C. Montell laboratories for helpful discussion and comments. Flybase and the Bloomington Drosophila Stock Center provided critical information and reagents for this study.	Arbouzova NI, 2006, CURR BIOL, V16, P80, DOI 10.1016/j.cub.2005.11.033; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Baksa K, 2002, DEV BIOL, V243, P166, DOI 10.1006/dbio.2001.0539; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CASTRILLON DH, 1993, GENETICS, V135, P489; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Enright AJ, 2004, GENOME BIOL, V5; Eulenberg KG, 1997, EMBO J, V16, P7156, DOI 10.1093/emboj/16.23.7156; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Flaherty MS, 2009, DEV DYNAM, V238, P2235, DOI 10.1002/dvdy.21989; Gellon G, 1997, DEVELOPMENT, V124, P3321; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Ghiglione C, 2008, EMBO REP, V9, P676, DOI 10.1038/embor.2008.79; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Lukacsovich T, 1999, GENOMICS, V57, P43, DOI 10.1006/geno.1999.5746; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Pek JW, 2009, DEV CELL, V17, P417, DOI 10.1016/j.devcel.2009.07.017; Rorth P, 1998, DEVELOPMENT, V125, P1049; Saka Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-47; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Starz-Gaiano M, 2008, DEV CELL, V14, P726, DOI 10.1016/j.devcel.2008.03.005; Starz-Gaiano M, 2009, CELL CYCLE, V8, P2917; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Xi RW, 2003, DEV CELL, V4, P167, DOI 10.1016/S1534-5807(02)00412-4	36	45	47	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1062	U82		10.1038/ncb2316	http://dx.doi.org/10.1038/ncb2316			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21857668	Green Accepted			2022-12-25	WOS:000294487000010
J	Yu, J; Wei, W; Danner, E; Ashley, RK; Israelachvili, JN; Waite, JH				Yu, Jing; Wei, Wei; Danner, Eric; Ashley, Rebekah K.; Israelachvili, Jacob N.; Waite, J. Herbert			Mussel protein adhesion depends on interprotein thiol-mediated redox modulation	NATURE CHEMICAL BIOLOGY			English	Article							MYTILUS-CALIFORNIANUS; ATTACHMENT PLAQUE; FOOT PROTEINS; BYSSUS; FILMS; DOPA	Mussel adhesion is mediated by foot proteins (mfps) rich in a catecholic amino acid, 3,4-dihydroxyphenylalanine (dopa), capable of forming strong bidentate interactions with a variety of surfaces. A tendency toward facile auto-oxidation, however, often renders dopa unreliable for adhesion. We demonstrate that mussels limit dopa oxidation during adhesive plaque formation by imposing an acidic, reducing regime based on the thiol-rich mfp-6, which restores dopa by coupling the oxidation of thiols to dopaquinone reduction.	[Yu, Jing; Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Wei, Wei] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Danner, Eric; Ashley, Rebekah K.; Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Yu, J (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	jacob@engineering.ucsb.edu; waite@lifesci.ucsb.edu	Yu, Jing/C-4138-2017; Yu, Jing/D-3625-2013	Yu, Jing/0000-0002-4288-951X; , Eric/0000-0003-3277-5727; Danner, Eric/0000-0003-4630-1100	US National Institutes of Health [R01 DE018468]; National Science Foundation Materials Science & Engineering Research Center [DM R05-20415]; Human Frontiers of Science Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Materials Science & Engineering Research Center; Human Frontiers of Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the US National Institutes of Health (R01 DE018468), the National Science Foundation Materials Science & Engineering Research Center Program (DM R05-20415) and the Human Frontiers of Science Program for supporting this research. C. Thorpe provided helpful insights about thiol chemistry. S. Nicklisch and P. Schmitt introduced us to the DPPH assay.	Anderson TH, 2010, ADV FUNCT MATER, V20, P4196, DOI 10.1002/adfm.201000932; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; FREUND J, 1995, J BIOMOL NMR, V5, P321, DOI 10.1007/BF00211760; HUNSAKER DB, 1983, TALANTA, V30, P475, DOI 10.1016/0039-9140(83)80113-1; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; Inaba K, 2010, GENES CELLS, V15, P935, DOI 10.1111/j.1365-2443.2010.01434.x; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Jensen KS, 2009, ANTIOXID REDOX SIGN, V11, P1047, DOI 10.1089/ARS.2008.2297; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Liu B, 2007, J AM CHEM SOC, V129, P12348, DOI 10.1021/ja072904r; McDowell LM, 1999, J BIOL CHEM, V274, P20293, DOI 10.1074/jbc.274.29.20293; Ohkawa K, 2009, J ADHESION, V85, P770, DOI 10.1080/00218460903291353; PROUDFOOT GM, 1983, AUST J CHEM, V36, P885, DOI 10.1071/CH9830885; RZEPECKI LM, 1991, ARCH BIOCHEM BIOPHYS, V285, P17, DOI 10.1016/0003-9861(91)90323-B; Sagert J, 2009, J EXP BIOL, V212, P2224, DOI 10.1242/jeb.029686; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Stewart RJ, 2011, APPL MICROBIOL BIOT, V89, P27, DOI 10.1007/s00253-010-2913-8; TAMARIN A, 1976, J MORPHOL, V149, P199, DOI 10.1002/jmor.1051490205; WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0; Yu J, 2011, ADV MATER, V23, P2362, DOI 10.1002/adma.201003580; Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107; Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200	24	317	327	7	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					588	590		10.1038/NCHEMBIO.630	http://dx.doi.org/10.1038/NCHEMBIO.630			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21804534	Green Submitted, Green Accepted			2022-12-25	WOS:000294381400007
J	Hauser, AT; Jung, M				Hauser, Alexander-Thomas; Jung, Manfred			CHEMICAL PROBES Sharpen your epigenetic tools	NATURE CHEMICAL BIOLOGY			English	News Item							G9A HISTONE METHYLTRANSFERASE; METHYLATION		[Hauser, Alexander-Thomas; Jung, Manfred] Univ Freiburg, Inst Pharmaceut Sci, D-7800 Freiburg, Germany	University of Freiburg	Hauser, AT (corresponding author), Univ Freiburg, Inst Pharmaceut Sci, D-7800 Freiburg, Germany.	manfred.jung@pharmazie.uni-freiburg.de	Jung, Manfred/Q-8029-2016	Jung, Manfred/0000-0002-6361-7716				Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Huang J, 2010, J BIOL CHEM, V285, P18122, DOI 10.1074/jbc.A109.062588; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]	11	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					499	500		10.1038/nchembio.615	http://dx.doi.org/10.1038/nchembio.615			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769094				2022-12-25	WOS:000292825400007
J	Schockel, L; Mockel, M; Mayer, B; Boos, D; Stemmann, O				Schoeckel, Laura; Moeckel, Martin; Mayer, Bernd; Boos, Dominik; Stemmann, Olaf			Cleavage of cohesin rings coordinates the separation of centrioles and chromatids	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; HUMAN-CELLS; CENTROSOME INTEGRITY; SISTER; INHIBITION; SHUGOSHIN; MITOSIS; KINASE; REDUPLICATION; DISJUNCTION	Cohesin pairs sister chromatids by forming a tripartite Scc1-Smc1-Smc3 ring around them(1,2). In mitosis, cohesin is removed from chromosome arms by the phosphorylation-dependent prophase pathway(3). Centromeric cohesin is protected by shugoshin 1 and protein phosphatase 2A (Sgo1-PP2A) and opened only in anaphase by separase-dependent cleavage of Scc1 (refs 4-6). Following chromosome segregation, centrioles loosen their tight orthogonal arrangement, which licenses later centrosome duplication in S phase(7). Although a role of separase in centriole disengagement has been reported, the molecular details of this process remain enigmatic(8,9). Here, we identify cohesin as a centriole-engagement factor. Both premature sister-chromatid separation and centriole disengagement are induced by ectopic activation of separase or depletion of Sgo1. These unscheduled events are suppressed by expression of non-cleavable Scc1 or inhibition of the prophase pathway. When endogenous Scc1 is replaced by artificially cleavable Scc1, the corresponding site-specific protease triggers centriole disengagement. Separation of centrioles can alternatively be induced by ectopic cleavage of an engineered Smc3. Thus, the chromosome and centrosome cycles exhibit extensive parallels and are coordinated with each other by dual use of the cohesin ring complex.	[Schoeckel, Laura; Moeckel, Martin; Mayer, Bernd; Stemmann, Olaf] Univ Bayreuth, D-95440 Bayreuth, Germany; [Boos, Dominik] Canc Res UK, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	University of Bayreuth; Cancer Research UK	Stemmann, O (corresponding author), Univ Bayreuth, POB 101251, D-95440 Bayreuth, Germany.	olaf.stemmann@uni-bayreuth.de	Mockel, Martin/AAC-2600-2019	Mockel, Martin/0000-0002-7691-3709; Boos, Dominik/0000-0003-0018-4375; Mockel, Martin/0000-0003-1237-2410; Stemmann, Olaf/0000-0003-3044-2515; Schockel, Laura/0000-0002-8887-9958	Deutsche Forschungsgemeinschaft [SPP1384]; Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank M. Hermann, L. Mohr, A. Rehn and B. Sunkel for technical assistance, H. Bujard for pRTS1, D. van Essen, S. Saccani and S. Heidmann for anti-GFP, E. A. Nigg for anti-C-NAP1 and J. L. Salisbury for anti-centrin, K. Mayer for introducing us to the centrosome isolation procedure and S. Geimer, S. Heidmann and members of the Stemmann lab for discussions. This work was supported by grants of the Deutsche Forschungsgemeinschaft (grant SPP1384) and Deutsche Krebshilfe to O.S.	Beauchene NA, 2010, CELL CYCLE, V9, P1774, DOI 10.4161/cc.9.9.11524; Boos D, 2008, J BIOL CHEM, V283, P816, DOI 10.1074/jbc.M706748200; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gregson HC, 2001, J BIOL CHEM, V276, P47575, DOI 10.1074/jbc.M103364200; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guan J, 2008, BIOCHEM BIOPH RES CO, V372, P761, DOI 10.1016/j.bbrc.2008.05.120; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kong XD, 2009, MOL BIOL CELL, V20, P1289, DOI 10.1091/mbc.E08-04-0419; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Wong RW, 2008, P NATL ACAD SCI USA, V105, P15441, DOI 10.1073/pnas.0807660105; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	40	111	114	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					966	U211		10.1038/ncb2280	http://dx.doi.org/10.1038/ncb2280			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21743463				2022-12-25	WOS:000293373700015
J	Zhou, Q; Xiao, JM; Jiang, DW; Wang, RW; Vembaiyan, K; Wang, AX; Smith, CD; Xie, CH; Chen, WQ; Zhang, JQ; Tian, XX; Jones, PP; Zhong, XW; Guo, A; Chen, HY; Zhang, L; Zhu, WZ; Yang, DM; Li, XD; Chen, J; Gillis, AM; Duff, HJ; Cheng, HP; Feldman, AM; Song, LS; Fill, M; Back, TG; Chen, SRW				Zhou, Qiang; Xiao, Jianmin; Jiang, Dawei; Wang, Ruiwu; Vembaiyan, Kannan; Wang, Aixia; Smith, Chris D.; Xie, Cuihong; Chen, Wenqian; Zhang, Jingqun; Tian, Xixi; Jones, Peter P.; Zhong, Xiaowei; Guo, Ang; Chen, Haiyan; Zhang, Lin; Zhu, Weizhong; Yang, Dongmei; Li, Xiaodong; Chen, Ju; Gillis, Anne M.; Duff, Henry J.; Cheng, Heping; Feldman, Arthur M.; Song, Long-Sheng; Fill, Michael; Back, Thomas G.; Chen, S. R. Wayne			Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release	NATURE MEDICINE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; CARDIAC RYANODINE RECEPTOR; CONGESTIVE-HEART-FAILURE; BETA-BLOCKER THERAPY; IN MOUSE MODEL; MYOCARDIAL-INFARCTION; INTRACELLULAR CALCIUM; PURKINJE-FIBERS; SUDDEN-DEATH; MUSCLE	Carvedilol is one of the most effective beta blockers for preventing ventricular tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic benefits remain unclear. Spontaneous Ca2+ waves, also called store overload-induced Ca2+ release (SOICR), evoke ventricular tachyarrhythmias in individuals with heart failure. Here we show that carvedilol is the only beta blocker tested that effectively suppresses SOICR by directly reducing the open duration of the cardiac ryanodine receptor (RyR2). This unique anti-SOICR activity of carvedilol, combined with its beta-blocking activity, probably contributes to its favorable antiarrhythmic effect. To enable optimal titration of carvedilol's actions as a beta blocker and as a suppressor of SOICR separately, we developed a new SOICR-inhibiting, minimally beta-blocking carvedilol analog, VK-II-86. VK-II-86 prevented stress-induced ventricular tachyarrhythmias in RyR2-mutant mice and did so more effectively when combined with either of the selective beta blockers metoprolol or bisoprolol. Combining SOICR inhibition with optimal beta blockade has the potential to provide antiarrhythmic therapy that can be tailored to individual patients.	[Zhou, Qiang; Xiao, Jianmin; Jiang, Dawei; Wang, Ruiwu; Xie, Cuihong; Chen, Wenqian; Tian, Xixi; Jones, Peter P.; Zhong, Xiaowei; Zhang, Lin; Gillis, Anne M.; Duff, Henry J.; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Zhou, Qiang; Xie, Cuihong; Zhang, Jingqun; Chen, Haiyan; Fill, Michael; Chen, S. R. Wayne] Rush Univ, Med Ctr, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA; [Vembaiyan, Kannan; Wang, Aixia; Smith, Chris D.; Back, Thomas G.] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; [Guo, Ang; Song, Long-Sheng] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Zhu, Weizhong; Feldman, Arthur M.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA; [Yang, Dongmei; Cheng, Heping] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Li, Xiaodong; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Rush University; University of Calgary; University of Iowa; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.	swchen@ucalgary.ca	cheng, heping/A-7299-2011; Chen, Ju/E-5579-2011; Guo, Ang/M-3549-2013; Chen, Haiyan/HGB-6216-2022; Jones, Peter P/G-2618-2013; Heping, Cheng/AAE-2680-2019; Song, Long-Sheng/D-5899-2012	Guo, Ang/0000-0002-5551-2279; Heping, Cheng/0000-0002-9604-6702; Jones, Pete/0000-0001-7977-1737; Song, Long-Sheng/0000-0002-6035-8106; Duff, Henry/0000-0001-9292-5411	Canadian Institutes of Health Research; US National Institutes of Health (NIH); Heart and Stroke Foundation of Alberta; US National Institute on Aging; Alberta Innovates-Health Solutions (AIHS); Heart and Stroke Foundation; King family; Libin Cardiovascular Institute of Alberta; Alberta Innovates [201001238] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075210, R01HL090905, R01HL057832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111397] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Alberta; US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alberta Innovates-Health Solutions (AIHS); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); King family; Libin Cardiovascular Institute of Alberta; Alberta Innovates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Canadian Institutes of Health Research (S. R. W. C.), the US National Institutes of Health (NIH; S. R. W. C., L.-S.S., M. F. and A. M. F.), the Heart and Stroke Foundation of Alberta (A. M. G. and H.J.D.) and the Intramural Research Program of the US National Institute on Aging (D.Y. and H. Cheng). D.J., W. C. and X. T. were supported by Alberta Innovates-Health Solutions (AIHS) studentship awards, C. D. S. by an AIHS fellowship award, P.P.J. by an AIHS and Heart and Stroke Foundation fellowship award and H.J.D. and S. R. W. C. by AIHS scientist awards. We thank the King family and the Libin Cardiovascular Institute of Alberta for their donations and S. Pogwizd and S. Priori for critical reading of the manuscript.	Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Caron G, 1999, HELV CHIM ACTA, V82, P1211, DOI 10.1002/(SICI)1522-2675(19990804)82:8<1211::AID-HLCA1211>3.0.CO;2-K; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; Cerrone M, 2007, CIRC RES, V101, P1039, DOI 10.1161/CIRCRESAHA.107.148064; Chen BY, 2009, J MOL CELL CARDIOL, V47, P706, DOI 10.1016/j.yjmcc.2009.07.007; Doze P, 2002, NEUROCHEM INT, V40, P145, DOI 10.1016/S0197-0186(01)00081-X; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Foody JM, 2002, JAMA-J AM MED ASSOC, V287, P883, DOI 10.1001/jama.287.7.883; FUJIMAKI M, 1992, CHIRALITY, V4, P148, DOI 10.1002/chir.530040304; Greenberg Barry, 2004, Rev Cardiovasc Med, V5 Suppl 1, pS10; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; Hjalmarson A, 2000, BASIC RES CARDIOL, V95, P41; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Hwang HS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P128, DOI 10.1161/CIRCEP.110.959916; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kamath GS, 2008, PROG CARDIOVASC DIS, V50, P439, DOI 10.1016/j.pcad.2007.12.001; Kannankeril PJ, 2006, P NATL ACAD SCI USA, V103, P12179, DOI 10.1073/pnas.0600268103; KASS RS, 1982, BIOPHYS J, V38, P259, DOI 10.1016/S0006-3495(82)84557-8; Ko DT, 2004, ARCH INTERN MED, V164, P1389, DOI 10.1001/archinte.164.13.1389; Kukin ML, 1996, AM J CARDIOL, V77, P486, DOI 10.1016/S0002-9149(97)89342-3; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; McMurray J, 2005, J AM COLL CARDIOL, V45, P525, DOI 10.1016/j.jacc.2004.09.076; Miller Leslie W, 2003, Rev Cardiovasc Med, V4 Suppl 2, pS21; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; NEUGEBAUER G, 1987, J CARDIOVASC PHA S11, V10, P85; OHLSTEIN EH, 1993, P NATL ACAD SCI USA, V90, P6189, DOI 10.1073/pnas.90.13.6189; Okafor Chukwuka C, 2003, BMC Physiol, V3, P6, DOI 10.1186/1472-6793-3-6; ORCHARD CH, 1983, NATURE, V304, P735, DOI 10.1038/304735a0; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Remme WJ, 2010, CARDIOVASC DRUG THER, V24, P351, DOI 10.1007/s10557-010-6247-7; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; STAHL E, 1993, ARCH PHARM, V326, P529, DOI 10.1002/ardp.19933260907; STERN MD, 1983, J GEN PHYSIOL, V82, P119, DOI 10.1085/jgp.82.1.119; Stroe Alice F, 2004, Rev Cardiovasc Med, V5 Suppl 1, pS18; Tenero D, 2000, J CLIN PHARMACOL, V40, P844, DOI 10.1177/00912700022009576; Thomson MJ, 2007, CARDIOVASC DRUG THER, V21, P195, DOI 10.1007/s10557-007-6027-1; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; VERMEULEN JT, 1994, CARDIOVASC RES, V28, P1547, DOI 10.1093/cvr/28.10.1547; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; WIER WG, 1983, P NATL ACAD SCI-BIOL, V80, P7367, DOI 10.1073/pnas.80.23.7367; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; YAO A, 2003, NATURE, V67, P83; YUE TL, 1992, J PHARMACOL EXP THER, V263, P92	53	163	169	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					1003	U126		10.1038/nm.2406	http://dx.doi.org/10.1038/nm.2406			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21743453	Green Accepted			2022-12-25	WOS:000293507400035
J	Bott, M; Brevet, M; Taylor, BS; Shimizu, S; Ito, T; Wang, L; Creaney, J; Lake, RA; Zakowski, MF; Reva, B; Sander, C; Delsite, R; Powell, S; Zhou, Q; Shen, RL; Olshen, A; Rusch, V; Ladanyi, M				Bott, Matthew; Brevet, Marie; Taylor, Barry S.; Shimizu, Shigeki; Ito, Tatsuo; Wang, Lu; Creaney, Jenette; Lake, Richard A.; Zakowski, Maureen F.; Reva, Boris; Sander, Chris; Delsite, Robert; Powell, Simon; Zhou, Qin; Shen, Ronglai; Olshen, Adam; Rusch, Valerie; Ladanyi, Marc			The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma	NATURE GENETICS			English	Article							BRCA1-ASSOCIATED PROTEIN-1; UBIQUITIN HYDROLASE; DELETION; GENOME; CANCER; CELLS; GENE; ADENOCARCINOMA; ASSOCIATION; ACTIVATION	Malignant pleural mesotheliomas (MPMs) often show CDKN2A and NF2 inactivation, but other highly recurrent mutations have not been described. To identify additional driver genes, we used an integrated genomic analysis of 53 MPM tumor samples to guide a focused sequencing effort that uncovered somatic inactivating mutations in BAP1 in 23% of MPMs. The BAP1 nuclear deubiquitinase is known to target histones (together with ASXL1 as a Polycomb repressor subunit) and the HCF1 transcriptional co-factor, and we show that BAP1 knockdown in MPM cell lines affects E2F and Polycomb target genes. These findings implicate transcriptional deregulation in the pathogenesis of MPM.	[Bott, Matthew; Brevet, Marie; Shimizu, Shigeki; Ito, Tatsuo; Wang, Lu; Zakowski, Maureen F.; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Bott, Matthew; Rusch, Valerie] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Taylor, Barry S.; Reva, Boris; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Creaney, Jenette; Lake, Richard A.] Univ Western Australia, Sir Charles Gairdner Hosp, Sch Med & Pharmacol, Natl Ctr Asbestos Dis Res, Nedlands, WA 6009, Australia; [Delsite, Robert; Powell, Simon] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Western Australia; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ladanyi, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	ladanyim@mskcc.org	Sander, Chris/H-1452-2011; Wang, Lu/N-8128-2018; Ladanyi, Marc/AAG-8585-2019; Reva, Boris/AAB-8932-2022; Reva, Boris A./B-6436-2014	Sander, Chris/0000-0001-6059-6270; Wang, Lu/0000-0002-0073-0666; Reva, Boris A./0000-0002-8805-389X; Rusch, Valerie/0000-0003-2345-6900; BREVET, Marie/0000-0003-2275-691X	La Fondation de France; National Health and Medical Research Council (NHMRC) of Australia; NATIONAL CANCER INSTITUTE [R01CA169306] Funding Source: NIH RePORTER	La Fondation de France(Fondation de France); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Holloway for help in combining MPM cell line microarray datasets, R. Levine and O. Abdel-Wahab for helpful discussions and Merck for providing PARP inhibitor MK4827. We thank A. Heguy and the personnel of the Beene Translational Oncology Core Facility (MSKCC), A. Lash and Y. Liang of the Bioinfomatics Core Facility (MSKCC), A. Viale and the personnel of the Genomics Core Facility (MSKCC) and M. Asher in the Pathology Core Facility (MSKCC). The project was supported by a generous donation from an anonymous private donor. M. Brevet was supported in part by La Fondation de France. B.S.T. is the David H. Koch Fellow in Cancer Genomics (MSKCC). R.A.L. is supported by the National Health and Medical Research Council (NHMRC) of Australia.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chou WC, 2010, BLOOD, V116, P4086, DOI 10.1182/blood-2010-05-283291; Crisanti MC, 2009, MOL CANCER THER, V8, P2221, DOI 10.1158/1535-7163.MCT-09-0138; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hassan KA, 2009, CLIN CANCER RES, V15, P6386, DOI 10.1158/1078-0432.CCR-09-1105; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Krug LM, 2006, CLIN LUNG CANCER, V7, P257, DOI 10.3816/CLC.2006.n.003; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; LU YY, 1994, GENE CHROMOSOME CANC, V9, P76, DOI 10.1002/gcc.2870090114; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Thurneysen C, 2009, LUNG CANCER, V64, P140, DOI 10.1016/j.lungcan.2008.08.014; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365	35	484	496	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2011	43	7					668	U81		10.1038/ng.855	http://dx.doi.org/10.1038/ng.855			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21642991	Green Accepted			2022-12-25	WOS:000292184600011
J	Ferreira, HC; Luke, B; Schober, H; Kalck, V; Lingner, J; Gasser, SM				Ferreira, Helder C.; Luke, Brian; Schober, Heiko; Kalck, Veronique; Lingner, Joachim; Gasser, Susan M.			The PIAS homologue Siz2 regulates perinuclear telomere position and telomerase activity in budding yeast	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN SUMOYLATION; SUMO MODIFICATION; DNA-DAMAGE; LENGTH; COMPLEX; LOCALIZATION; CONJUGATION; SEPARATION; DYNAMICS	Budding yeast telomeres are reversibly bound at the nuclear envelope through two partially redundant pathways that involve the Sir2/3/4 silencing complex and the Yku70/80 heterodimer(1,2). To better understand how this is regulated, we studied the role of SUMOylation in telomere anchoring. We find that the PIAS-like SUMO E3 ligase Siz2 sumoylates both Yku70/80 and Sir4 in vivo and promotes telomere anchoring to the nuclear envelope. Remarkably, loss of Siz2 also provokes telomere extension in a telomerase-dependent manner that is epistatic with loss of the helicase Pif1. Consistent with our previously documented role for telomerase in anchorage(3), normal telomere anchoring in siz2 Delta is restored by PIF1 deletion. By live-cell imaging of a critically short telomere, we show that telomeres shift a way from the nuclear envelope when elongating. We propose that SUMO-dependent association with the nuclear periphery restrains bound telomerase, whereas active elongation correlates with telomere release.	[Ferreira, Helder C.; Schober, Heiko; Kalck, Veronique; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Luke, Brian; Lingner, Joachim] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	Susan.Gasser@fmi.ch	Ferreira, Helder/K-9440-2013	Ferreira, Helder/0000-0001-9143-504X; Lingner, Joachim/0000-0002-2853-5803; Gasser, Susan/0000-0003-3610-9123; Luke, Brian/0000-0002-1648-5511	Marie Curie fellowship; EMBO; Novartis Research Foundation; Swiss National Science Foundation; European Community [200950]; European Research Council [232812]; SNF, Genetics National Center of Competence in Research	Marie Curie fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); SNF, Genetics National Center of Competence in Research	We thank V. Zakian and E. Johnson for yeast strains, and N. Iglesias and M. Arneric for advice on the single-telomere extension system. H.C.F. was financially supported by Marie Curie and EMBO long-term fellowships, and the Gasser Laboratory by the Novartis Research Foundation. J.L. was supported by the Swiss National Science Foundation, the European Community's Seventh Framework Programme (grant 200950) and a European Research Council advanced investigator grant (grant 232812). Both laboratories are part of the SNF-funded Frontiers in Genetics National Center of Competence in Research.	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Ansari A, 1997, MOL CELL BIOL, V17, P7061, DOI 10.1128/MCB.17.12.7061; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen XL, 2007, GENETICS, V177, P17, DOI 10.1534/genetics.107.074708; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hediger F, 2006, EMBO J, V25, P857, DOI 10.1038/sj.emboj.7600976; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Hiraga S, 2008, J CELL BIOL, V183, P641, DOI 10.1083/jcb.200806065; Hirano Y, 2009, MOL CELL, V33, P312, DOI 10.1016/j.molcel.2008.12.027; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maillet L, 2001, EMBO REP, V2, P203, DOI 10.1093/embo-reports/kve044; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marvin ME, 2009, GENETICS, V183, P453, DOI 10.1534/genetics.109.106682; Mondoux MA, 2007, GENETICS, V177, P2019, DOI 10.1534/genetics.107.079848; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; PARKER RE, 1997, INTRO STAT BIOL; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Ungar L, 2009, NUCLEIC ACIDS RES, V37, P3840, DOI 10.1093/nar/gkp259; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zhu SS, 2006, EXP CELL RES, V312, P1042, DOI 10.1016/j.yexcr.2005.12.031	49	72	74	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					867	U313		10.1038/ncb2263	http://dx.doi.org/10.1038/ncb2263			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21666682				2022-12-25	WOS:000292305700018
J	Krastev, DB; Slabicki, M; Paszkowski-Rogacz, M; Hubner, NC; Junqueira, M; Shevchenko, A; Mann, M; Neugebauer, KM; Buchholz, F				Krastev, Dragomir B.; Slabicki, Mikolaj; Paszkowski-Rogacz, Maciej; Hubner, Nina C.; Junqueira, Magno; Shevchenko, Andrej; Mann, Matthias; Neugebauer, Karla M.; Buchholz, Frank			A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly	NATURE CELL BIOLOGY			English	Article							NUCLEOLAR RIBONUCLEOPROTEIN-PARTICLES; RIBOSOMAL-RNA; BAC TRANSGENEOMICS; SMN COMPLEXES; U SNRNPS; PROTEIN; NOPP140; IDENTIFICATION; COMPONENT; PATHWAY	TP53 (tumour protein 53) is one of the most frequently mutated genes in human cancer and its role during cellular transformation has been studied extensively. However, the homeostatic functions of p53 are less well understood. Here, we explore the molecular dependency network of TP53 through an RNAi-mediated synthetic interaction screen employing two HCT116 isogenic cell lines and a genome-scale endoribonuclease-prepared short interfering RNA library. We identify a variety of TP53 synthetic interactions unmasking the complex connections of p53 to cellular physiology and growth control. Molecular dissection of the TP53 synthetic interaction with UNRIP indicates an enhanced dependency of TP53-negative cells on small nucleolar ribonucleoprotein (snoRNP) assembly. This dependency is mediated by the snoRNP chaperone gene NOLC1(also known as NOPP140), which we identify as a physiological p53 target gene. This unanticipated function of TP53 in snoRNP assembly highlights the potential of RNAi-mediated synthetic interaction screens to dissect molecular pathways of tumour suppressor genes.	[Krastev, Dragomir B.; Paszkowski-Rogacz, Maciej; Buchholz, Frank] Tech Univ Dresden, Univ Hosp, D-01307 Dresden, Germany; [Krastev, Dragomir B.; Paszkowski-Rogacz, Maciej; Buchholz, Frank] Med Fac Carl Gustav Carus, Dept Med Syst Biol, D-01307 Dresden, Germany; [Krastev, Dragomir B.; Slabicki, Mikolaj; Paszkowski-Rogacz, Maciej; Junqueira, Magno; Shevchenko, Andrej; Neugebauer, Karla M.; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Hubner, Nina C.; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Max Planck Society	Buchholz, F (corresponding author), Tech Univ Dresden, Univ Hosp, Fetscherstr 74, D-01307 Dresden, Germany.	buchholz@mpi-cbg.de	Mann, Matthias/A-3454-2013; Buchholz, Frank/B-4700-2017; Hubner, Nina C/C-4298-2008; Junqueira, Magno/A-7495-2012	Mann, Matthias/0000-0003-1292-4799; Buchholz, Frank/0000-0002-4577-3344; Hubner, Nina C/0000-0002-7864-2877; Junqueira, Magno/0000-0002-7036-0728; Krastev, Dragomir/0000-0003-4298-7272	MaxPlanckSociety; German Federal Ministry of Education and Research [Go-Bio (0315105), DiGtoP (01GS0859)]; DFG [SFB655]	MaxPlanckSociety(Max Planck SocietyFoundation CELLEX); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	We would like to thank all members of the Buchholz laboratory for discussions and sharing reagents. We thank A. K. Heninger for help with carrying out the screen, V. Surendranath for esiRNA design, M. Theis, S. Rose and A. Weise for esiRNA production and I. Poser for assistance with BAC cell line generation. This work was supported by the MaxPlanckSociety, the German Federal Ministry of Education and Research grants Go-Bio (0315105), DiGtoP (01GS0859) and the DFG grant SFB655.	Almeida F, 1998, J CELL BIOL, V142, P899, DOI 10.1083/jcb.142.4.899; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Cui ZF, 2007, MOL BIOL CELL, V18, P2179, DOI 10.1091/mbc.E07-01-0074; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; FISCHER U, 1993, EMBO J, V12, P573, DOI 10.1002/j.1460-2075.1993.tb05689.x; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; HAMM J, 1990, CELL, V62, P569, DOI 10.1016/0092-8674(90)90021-6; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Isaac C, 2000, MOL BIOL CELL, V11, P3061, DOI 10.1091/mbc.11.9.3061; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Junqueira M, 2008, J PROTEOME RES, V7, P3382, DOI 10.1021/pr800140v; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Listerman I, 2007, PLOS GENET, V3, P2268, DOI 10.1371/journal.pgen.0030212; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mattia M, 2007, MOL CELL BIOL, V27, P1309, DOI 10.1128/MCB.01520-06; MEIER UT, 1992, CELL, V70, P127; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; PAI CY, 1995, J CELL SCI, V108, P1911; Pellizzoni L, 2001, CURR BIOL, V11, P1079, DOI 10.1016/S0960-9822(01)00316-5; PETTERSSON I, 1984, J BIOL CHEM, V259, P5907; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Renvoise B, 2009, HUM MOL GENET, V18, P1181, DOI 10.1093/hmg/ddp009; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; SMEENK L, 2008, NUCL ACIDS RES, V17; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verheggen C, 2001, EMBO J, V20, P5480, DOI 10.1093/emboj/20.19.5480; Wang C, 2002, MOL CELL BIOL, V22, P8457, DOI 10.1128/MCB.22.24.8457-8466.2002; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yang YF, 2003, J BIOL CHEM, V278, P23553, DOI 10.1074/jbc.M300695200; Yang YF, 2000, MOL BIOL CELL, V11, P567, DOI 10.1091/mbc.11.2.567; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299	70	59	66	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					809	U186		10.1038/ncb2264	http://dx.doi.org/10.1038/ncb2264			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21642980	Green Submitted			2022-12-25	WOS:000292305700011
J	Lecoq, J; Parpaleix, A; Roussakis, E; Ducros, M; Houssen, YG; Vinogradov, SA; Charpak, S				Lecoq, Jerome; Parpaleix, Alexandre; Roussakis, Emmanuel; Ducros, Mathieu; Houssen, Yannick Goulam; Vinogradov, Sergei A.; Charpak, Serge			Simultaneous two-photon imaging of oxygen and blood flow in deep cerebral vessels	NATURE MEDICINE			English	Article							ERYTHROCYTE-ASSOCIATED TRANSIENTS; BRAIN-TISSUE; CAPILLARIES; MICROSCOPY; PO-2; PHOSPHORESCENCE; CONSUMPTION; ARTERIOLES; MODEL; PO2	Uncovering principles that regulate energy metabolism in the brain requires mapping of partial pressure of oxygen (PO2) and blood flow with high spatial and temporal resolution. Using two-photon phosphorescence lifetime microscopy (2PLM) and the oxygen probe PtP-C343, we show that PO2 can be accurately measured in the brain at depths up to 300 mm with micron-scale resolution. In addition, 2PLM allowed simultaneous measurements of blood flow and of PO2 in capillaries with less than one-second temporal resolution. Using this approach, we detected erythrocyte-associated transients (EATs) in oxygen in the rat olfactory bulb and showed the existence of diffusion-based arterio-venous shunts. Sensory stimulation evoked functional hyperemia, accompanied by an increase in PO2 in capillaries and by a biphasic PO2 response in the neuropil, consisting of an 'initial dip' and a rebound. 2PLM of PO2 opens new avenues for studies of brain metabolism and blood flow regulation.	[Lecoq, Jerome; Parpaleix, Alexandre; Ducros, Mathieu; Houssen, Yannick Goulam; Charpak, Serge] INSERM, U603, Paris, France; [Lecoq, Jerome; Parpaleix, Alexandre; Ducros, Mathieu; Houssen, Yannick Goulam; Charpak, Serge] CNRS, UMR 8154, Paris, France; [Lecoq, Jerome; Parpaleix, Alexandre; Ducros, Mathieu; Houssen, Yannick Goulam; Charpak, Serge] Univ Paris 05, Lab Neurophysiol & New Microscopies, Paris, France; [Roussakis, Emmanuel; Vinogradov, Sergei A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Charpak, S (corresponding author), INSERM, U603, Paris, France.	vinograd@mail.med.upenn.edu; serge.charpak@parisdescartes.fr	Ducros, Mathieu/Q-6663-2017; Charpak, Serge/M-9412-2017	Ducros, Mathieu/0000-0002-7625-036X; , Emmanouil/0000-0002-2824-2840; PARPALEIX, Alexandre/0000-0001-9007-3155	INSERM; CNRS; Region Ile de France (Sesame program); Fondation Bettancourt Schueller the Leducq Foundation; Human Frontier Science Program Organization; European Commission [LSHM-CT-2007-037765]; Fondation pour la Recherche Medicale; US National Institutes of Health [EB007279]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007279] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile de France (Sesame program)(Region Ile-de-France); Fondation Bettancourt Schueller the Leducq Foundation; Human Frontier Science Program Organization(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank V. De Sars and N. Chaari for technical assistance in the design of electronic circuits, G. Bouchery for her help in rat surgery, C. Pouzat for help with statistical analysis and L.E. Sinks for discussion of the phosphorescence microscopy data. Support was provided by INSERM, CNRS, the Region Ile de France (Sesame program), the Fondation Bettancourt Schueller the Leducq Foundation, the Human Frontier Science Program Organization, the European Commission FP6 (LSHM-CT-2007-037765), the Fondation pour la Recherche Medicale and the US National Institutes of Health (grant EB007279). Photophysical characterization of the probe was performed in the Ultrafast Optical Processes Laboratory at the University of Pennsylvania (US National Institutes of Health grant P41-RR001348).	Barker MC, 2007, AM J PHYSIOL-HEART C, V292, pH2540, DOI 10.1152/ajpheart.00915.2006; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; ELLSWORTH ML, 1990, AM J PHYSIOL, V258, pH1240, DOI 10.1152/ajpheart.1990.258.4.H1240; Estrada AD, 2008, OPT LETT, V33, P1038, DOI 10.1364/OL.33.001038; Finikova OS, 2008, CHEMPHYSCHEM, V9, P1673, DOI 10.1002/cphc.200800296; Finikova OS, 2007, J PHYS CHEM A, V111, P6977, DOI 10.1021/jp071586f; Golub AS, 2008, AM J PHYSIOL-HEART C, V294, pH2905, DOI 10.1152/ajpheart.01347.2007; Golub AS, 2005, AM J PHYSIOL-HEART C, V288, pH2735, DOI 10.1152/ajpheart.00711.2004; HELLUMS JD, 1977, MICROVASC RES, V13, P131, DOI 10.1016/0026-2862(77)90122-4; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Lebedev AY, 2009, ACS APPL MATER INTER, V1, P1292, DOI 10.1021/am9001698; Lecoq J, 2009, J NEUROSCI, V29, P3067, DOI 10.1523/JNEUROSCI.6187-08.2009; Lecoq J, 2009, J NEUROSCI, V29, P1424, DOI 10.1523/JNEUROSCI.4817-08.2009; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; Ndubuizu O, 2007, ANTIOXID REDOX SIGN, V9, P1207, DOI 10.1089/ars.2007.1634; Nwaigwe CI, 2003, ADV EXP MED BIOL, V530, P101; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; RUMSEY WL, 1988, SCIENCE, V241, P1649, DOI 10.1126/science.3420417; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Shepherd GM, 2008, NEURON, V58, P827, DOI 10.1016/j.neuron.2008.06.005; Sinks LE, 2010, J PHYS CHEM B, V114, P14373, DOI 10.1021/jp100353v; STEIN JC, 1993, AM J PHYSIOL, V265, pH537, DOI 10.1152/ajpheart.1993.265.2.H537; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tsai AG, 2005, AM J PHYSIOL-HEART C, V289, pH1777, DOI 10.1152/ajpheart.00503.2005; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Tsoukias NM, 2007, J THEOR BIOL, V248, P657, DOI 10.1016/j.jtbi.2007.06.012; Vovenko E, 1999, PFLUG ARCH EUR J PHY, V437, P617, DOI 10.1007/s004240050825	29	174	178	5	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					893	U262		10.1038/nm.2394	http://dx.doi.org/10.1038/nm.2394			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21642977	Green Accepted			2022-12-25	WOS:000292500800046
J	Lundin, P				Lundin, Per			Is silence still golden? Mapping the RNAi patent landscape	NATURE BIOTECHNOLOGY			English	Editorial Material							INTERFERENCE; NANOPARTICLES; NUMBERS		[Lundin, Per] Albihns Zacco, Stockholm, Sweden; [Lundin, Per] Karolinska Inst, Dept Lab Med, Huddinge, Sweden	Karolinska Institutet	Lundin, P (corresponding author), Albihns Zacco, Stockholm, Sweden.	per.lundin@albihnszacco.com						*ALN PHARM, 2009, ALN CUB ANN COMPL DA; Burgess P, 2010, NAT BIOTECHNOL, V28, P1267, DOI 10.1038/nbt.1725; Couzin-Frankel J, 2010, SCIENCE, V330, P1163, DOI 10.1126/science.330.6008.1163; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; *EUR PAT OFF, 2010, OFFICIAL J EPO, V5, P296; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Huggett B, 2009, NAT BIOTECHNOL, V27, P710, DOI 10.1038/nbt0809-710; Jones D, 2009, NAT REV DRUG DISCOV, V8, P525, DOI 10.1038/nrd2940; Lahteenmaki R, 2007, NAT BIOTECHNOL, V25, P729, DOI 10.1038/nbt0707-729; Ledford H, 2010, NATURE, V468, P487, DOI 10.1038/468487a; MACRON D, 2011, GENE SILENCING  0203; McLeod BW, 2011, NAT BIOTECHNOL, V29, P129, DOI 10.1038/nbt.1765; *OPK HLTH, 2009, OPK HLTH ANN UPD PHA; POLLACK A, 2011, NY TIMES        0207; Yang W, 2010, NAT BIOTECHNOL, V28, P116, DOI 10.1038/nbt0210-116	16	19	19	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2011	29	6					493	498		10.1038/nbt.1885	http://dx.doi.org/10.1038/nbt.1885			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	773WL	21654666				2022-12-25	WOS:000291342100012
J	Li, G; Siddiqui, H; Teng, YB; Lin, RC; Wan, XY; Li, JG; Lau, OS; Ouyang, XH; Dai, MQ; Wan, JM; Devlin, PF; Deng, XW; Wang, HY				Li, Gang; Siddiqui, Hamad; Teng, Yibo; Lin, Rongcheng; Wan, Xiang-yuan; Li, Jigang; Lau, On-Sun; Ouyang, Xinhao; Dai, Mingqiu; Wan, Jianmin; Devlin, Paul F.; Deng, Xing Wang; Wang, Haiyang			Coordinated transcriptional regulation underlying the circadian clock in Arabidopsis	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; PROTEIN INTERACTIONS; HIGHER-PLANTS; PHYTOCHROME; CCA1; TIME; OSCILLATOR; COMPONENT; LOOP; ELF4	The circadian clock controls many metabolic, developmental and physiological processes in a time-of-day-specific manner in both plants and animals(1,2). The photoreceptors involved in the perception of light and entrainment of the circadian clock have been well characterized in plants(3). However, how light signals are transduced from the photoreceptors to the central circadian oscillator, and how the rhythmic expression pattern of a clock gene is generated and maintained by diurnal light signals remain unclear. Here, we show that in Arabidopsis thaliana, FHY3, FAR1 and HY5, three positive regulators of the phytochrome A signalling pathway, directly bind to the promoter of ELF4, a proposed component of the central oscillator, and activate its expression during the day, whereas the circadian-controlled CCA1 and LHY proteins directly suppress ELF4 expression periodically at dawn through physical interactions with these transcription-promoting factors. Our findings provide evidence that a set of light- and circadian-regulated transcription factors act directly and coordinately at the ELF4 promoter to regulate its cyclic expression, and establish a potential molecular link connecting the environmental light dark cycle to the central oscillator.	[Li, Gang; Li, Jigang; Lau, On-Sun; Ouyang, Xinhao; Dai, Mingqiu; Deng, Xing Wang; Wang, Haiyang] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Siddiqui, Hamad; Devlin, Paul F.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Teng, Yibo] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Lin, Rongcheng] Chinese Acad Sci, Key Lab Photobiol, Inst Bot, Beijing 100093, Peoples R China; [Wan, Xiang-yuan; Deng, Xing Wang; Wang, Haiyang] Natl Engn Res Ctr Crop Mol Design, Beijing 100085, Peoples R China; [Wan, Jianmin; Wang, Haiyang] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Wang, Haiyang] Hunan Hybrid Rice Res Ctr, Changsha 410125, Hunan, Peoples R China	Yale University; University of London; Royal Holloway University London; Hangzhou Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hunan Academy of Agricultural Sciences	Wang, HY (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	haiyang.wang@yale.edu	Li, Jigang/G-9446-2012; Li, Jigang/ABD-6301-2021; Deng, Xing Wang/ABF-4107-2020; Lin, Rongcheng/I-8105-2014; Wan, Xiangyuan/GRJ-1567-2022; Lau, On Sun/D-2521-2016	Li, Jigang/0000-0002-4395-2656; Li, Jigang/0000-0002-4395-2656; Lin, Rongcheng/0000-0001-8346-3390; Lau, On Sun/0000-0002-8121-235X; Dai, Mingqiu/0000-0001-6737-8209; Devlin, Paul/0000-0002-0168-3793	National Science Foundation [IOS-1026630, MCB-1004808]; Biotechnology and Biological Sciences Research Council [BBF02116X1]; National Institutes of Health [GM47850]; National High Technology Research and Development Program of China [2009AA101101]; BBSRC [BB/F02116X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F02116X/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047850, R29GM047850, R37GM047850] Funding Source: NIH RePORTER; Direct For Biological Sciences [0954313] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank S. Kay for providing the CAB2::LUC, TOC1::LUC and CCA1::GFP-CCA1 reporter lines; R. McClung for CAT3::LUC reporter lines; R. Ulm for the HY5::HY5-YFP seeds; K. Halliday for the cca1-11 lhy-21 double-mutant seeds; T. Mockler for discussion; T. Xu for technical help with IVIS Spectrum; and C. Lin and J-M. Zhou for providing the transient expression system (Dual-LUG) and LCI system. This work was supported by grants from National Science Foundation (IOS-1026630 and MCB-1004808) to H.W., the Biotechnology and Biological Sciences Research Council (BBF02116X1) to P.F.D., National Institutes of Health (GM47850) to X.W.D. and National High Technology Research and Development Program of China (2009AA101101) to J.W.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Allen T, 2006, PLANT CELL, V18, P2506, DOI 10.1105/tpc.105.037358; Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Khanna R, 2003, PLANT PHYSIOL, V133, P1530, DOI 10.1104/pp.103.030007; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Kim JY, 2003, EMBO J, V22, P935, DOI 10.1093/emboj/cdg075; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kwok SF, 1999, J MOL BIOL, V285, P85, DOI 10.1006/jmbi.1998.2315; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lin RC, 2008, PLANT PHYSIOL, V148, P981, DOI 10.1104/pp.108.120436; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lu SX, 2009, PLANT PHYSIOL, V150, P834, DOI 10.1104/pp.108.133272; Mas P, 2009, CURR OPIN PLANT BIOL, V12, P574, DOI 10.1016/j.pbi.2009.07.010; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Saijo Y, 2008, MOL CELL, V31, P607, DOI 10.1016/j.molcel.2008.08.003; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yakir E, 2009, PLANT PHYSIOL, V150, P844, DOI 10.1104/pp.109.137414; Yamamoto YY, 1998, PLANT CELL, V10, P1083, DOI 10.1105/tpc.10.7.1083; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205	47	170	188	8	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					616	U275		10.1038/ncb2219	http://dx.doi.org/10.1038/ncb2219			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21499259				2022-12-25	WOS:000290148700021
J	Kempf, T; Zarbock, A; Widera, C; Butz, S; Stadtmann, A; Rossaint, J; Bolomini-Vittori, M; Korf-Klingebiel, M; Napp, LC; Hansen, B; Kanwischer, A; Bavendiek, U; Beutel, G; Hapke, M; Sauer, MG; Laudanna, C; Hogg, N; Vestweber, D; Wollert, KC				Kempf, Tibor; Zarbock, Alexander; Widera, Christian; Butz, Stefan; Stadtmann, Anika; Rossaint, Jan; Bolomini-Vittori, Matteo; Korf-Klingebiel, Mortimer; Napp, L. Christian; Hansen, Birte; Kanwischer, Anna; Bavendiek, Udo; Beutel, Gernot; Hapke, Martin; Sauer, Martin G.; Laudanna, Carlo; Hogg, Nancy; Vestweber, Dietmar; Wollert, Kai C.			GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice	NATURE MEDICINE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; ACUTE CORONARY SYNDROME; INTERCELLULAR-ADHESION MOLECULE-1; ISCHEMIA-REPERFUSION INJURY; PREVENTS CARDIAC RUPTURE; TGF-BETA SUPERFAMILY; TARGETED DELETION; NEUTROPHIL ARREST; P-SELECTIN; LFA-1	Inflammatory cell recruitment after myocardial infarction needs to be tightly controlled to permit infarct healing while avoiding fatal complications such as cardiac rupture. Growth differentiation factor-15 (GDF-15), a transforming growth factor-beta (TGF-beta)-related cytokine, is induced in the infarcted heart of mice and humans. We show that coronary artery ligation in Gdf15-deficient mice led to enhanced recruitment of polymorphonuclear leukocytes (PMNs) into the infarcted myocardium and an increased incidence of cardiac rupture. Conversely, infusion of recombinant GDF-15 repressed PMN recruitment after myocardial infarction. In vitro, GDF-15 inhibited PMN adhesion, arrest under flow and transendothelial migration. Mechanistically, GDF-15 counteracted chemokine-triggered conformational activation and clustering of beta(2) integrins on PMNs by activating the small GTPase Cdc42 and inhibiting activation of the small GTPase Rap1. Intravital microscopy in vivo in Gdf15-deficient mice showed that Gdf-15 is required to prevent excessive chemokine-activated leukocyte arrest on the endothelium. Genetic ablation of beta(2) integrins in myeloid cells rescued the mortality of Gdf15-deficient mice after myocardial infarction. To our knowledge, GDF-15 is the first cytokine identified as an inhibitor of PMN recruitment by direct interference with chemokine signaling and integrin activation. Loss of this anti-inflammatory mechanism leads to fatal cardiac rupture after myocardial infarction.	[Kempf, Tibor; Widera, Christian; Korf-Klingebiel, Mortimer; Napp, L. Christian; Kanwischer, Anna; Wollert, Kai C.] Hannover Med Sch, Hans Borst Ctr Heart & Stem Cell Res, D-3000 Hannover, Germany; [Kempf, Tibor; Widera, Christian; Korf-Klingebiel, Mortimer; Napp, L. Christian; Hansen, Birte; Kanwischer, Anna; Bavendiek, Udo; Wollert, Kai C.] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Zarbock, Alexander; Butz, Stefan; Stadtmann, Anika; Rossaint, Jan; Vestweber, Dietmar] Univ Munster, Max Planck Inst Mol Biomed, Munster, Germany; [Zarbock, Alexander; Stadtmann, Anika; Rossaint, Jan] Univ Munster, Dept Anesthesiol & Crit Care Med, Munster, Germany; [Bolomini-Vittori, Matteo] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Beutel, Gernot] Hannover Med Sch, Dept Hematol & Oncol, D-3000 Hannover, Germany; [Hapke, Martin; Sauer, Martin G.] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-3000 Hannover, Germany; [Hogg, Nancy] London Res Inst, London, England	Hannover Medical School; Hannover Medical School; Max Planck Society; University of Munster; University of Munster; University of Verona; Hannover Medical School; Hannover Medical School	Wollert, KC (corresponding author), Hannover Med Sch, Hans Borst Ctr Heart & Stem Cell Res, D-3000 Hannover, Germany.	wollert.kai@mh-hannover.de	Bolomini-Vittori, Matteo/Q-5659-2016; Napp, L. Christian/AAD-2498-2020; Kempf, Tibor/ABA-3167-2021	Bolomini-Vittori, Matteo/0000-0002-5762-0791; Kempf, Tibor/0000-0001-6901-8442; Vestweber, Dietmar/0000-0002-3517-732X; Napp, L. Christian/0000-0001-9945-0842	German Research Foundation [SFB 566, AZ 428/3-1, SFB 738]; Else Kroner Fresenius Foundation [2010_EKES.01]; Max Planck Society	German Research Foundation(German Research Foundation (DFG)); Else Kroner Fresenius Foundation; Max Planck Society(Max Planck Society)	K.C.W. was supported by the German Research Foundation (SFB 566), A.Z. by the German Research Foundation (AZ 428/3-1) and the Else Kroner Fresenius Foundation (2010_EKES.01), M. G. S. by the German Research Foundation (SFB 738) and D. V. by the Max Planck Society. We acknowledge A. Quint for expert technical assistance. We thank S.J. Lee (Johns Hopkins University) for providing the Gdf15-knockout mouse.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Baran KW, 2001, CIRCULATION, V104, P2778, DOI 10.1161/hc4801.100236; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Bonaca MP, 2011, ARTERIOSCL THROM VAS, V31, P203, DOI 10.1161/ATVBAHA.110.213512; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Dirksen MT, 2007, CARDIOVASC RES, V74, P343, DOI 10.1016/j.cardiores.2007.01.014; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Giugliano RP, 2003, CIRCULATION, V108, P2828, DOI 10.1161/01.CIR.0000106684.71725.98; HAVERSTICK DM, 1991, J IMMUNOL, V146, P3306; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Ichihara S, 2002, CIRCULATION, V106, P2244, DOI 10.1161/01.CIR.0000033826.52681.37; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kinashi T, 2005, IMMUNOLOGY, V116, P164, DOI 10.1111/j.1365-2567.2005.02214.x; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lum AFH, 2002, J BIOL CHEM, V277, P20660, DOI 10.1074/jbc.M202223200; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Palazzo AJ, 1998, AM J PHYSIOL-HEART C, V275, pH1865, DOI 10.1152/ajpheart.1998.275.5.H1865; Palazzo AJ, 1998, AM J PHYSIOL-HEART C, V275, pH2300, DOI 10.1152/ajpheart.1998.275.6.H2300; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; van den Bome SWM, 2009, CARDIOVASC PATHOL, V18, P37, DOI 10.1016/j.carpath.2007.12.012; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wehrens XHT, 2004, INT J CARDIOL, V95, P285, DOI 10.1016/j.ijcard.2003.06.006; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; Wollert KC, 2007, CIRCULATION, V116, P1540, DOI 10.1161/CIRCULATIONAHA.107.697714; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	52	335	353	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					581	U101		10.1038/nm.2354	http://dx.doi.org/10.1038/nm.2354			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21516086				2022-12-25	WOS:000290250400034
J	Wei, XM; Walia, V; Lin, JC; Teer, JK; Prickett, TD; Gartner, J; Davis, S; Stemke-Hale, K; Davies, MA; Gershenwald, JE; Robinson, W; Robinson, S; Rosenberg, SA; Samuels, Y				Wei, Xiaomu; Walia, Vijay; Lin, Jimmy C.; Teer, Jamie K.; Prickett, Todd D.; Gartner, Jared; Davis, Sean; Stemke-Hale, Katherine; Davies, Michael A.; Gershenwald, Jeffrey E.; Robinson, William; Robinson, Steven; Rosenberg, Steven A.; Samuels, Yardena		NISC Comparative Sequencing Progra	Exome sequencing identifies GRIN2A as frequently mutated in melanoma	NATURE GENETICS			English	Article							MUTATIONS; GENE; EXPRESSION; RECEPTORS; REVEALS; TRRAP	The incidence of melanoma is increasing more than any other cancer, and knowledge of its genetic alterations is limited. To systematically analyze such alterations, we performed whole-exome sequencing of 14 matched normal and metastatic tumor DNAs. Using stringent criteria, we identified 68 genes that appeared to be somatically mutated at elevated frequency, many of which are not known to be genetically altered in tumors. Most importantly, we discovered that TRRAP harbored a recurrent mutation that clustered in one position (p. Ser722Phe) in 6 out of 167 affected individuals (similar to 4%), as well as a previously unidentified gene, GRIN2A, which was mutated in 33% of melanoma samples. The nature, pattern and functional evaluation of the TRRAP recurrent mutation suggest that TRRAP functions as an oncogene. Our study provides, to our knowledge, the most comprehensive map of genetic alterations in melanoma to date and suggests that the glutamate signaling pathway is involved in this disease.	[Wei, Xiaomu; Walia, Vijay; Prickett, Todd D.; Gartner, Jared; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA; [Teer, Jamie K.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Davis, Sean] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Stemke-Hale, Katherine; Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Robinson, William; Robinson, Steven] Univ Colorado, Denver Sch Med, Div Med Oncol, Aurora, CO USA; [Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Samuels, Y (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	samuelsy@mail.nih.gov	Davis, Sean/AAD-1801-2021; Gershenwald, Jeff/AAX-4367-2020; Davies, Michael/GWV-2527-2022; Stemke-Hale, Katherine/K-9113-2013; Walia, Vijay/F-1647-2013	Davis, Sean/0000-0002-8991-6458; Gershenwald, Jeff/0000-0003-4519-5369; Stemke-Hale, Katherine/0000-0002-1231-4192; Samuels, Yardena/0000-0002-3349-7266; Robinson, William/0000-0003-1875-9691	National Human Genome Research Institute; National Cancer Institute, National Institutes of Health, USA; University of Texas MD Anderson Cancer Center [P50 CA93459]; NATIONAL CANCER INSTITUTE [P30CA016672, ZIABC010984, P50CA093459] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196, ZIAHG200337] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank V. Maduro, H. Abaan, P. Cruz and J. Mullikin for generating the sequence data analyzed here. We thank V.G. Prieto for pathologic review of the biospecimens from MelCore at MD Anderson. We thank T. Wolfsberg for bioinformatics help and J. Fekecs and D. Leja for graphical assistance. This work was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Cancer Institute, National Institutes of Health, USA and The University of Texas MD Anderson Cancer Center Melanoma SPORE (P50 CA93459).	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Morente MM, 2006, EUR J CANCER, V42, P2684, DOI 10.1016/j.ejca.2006.04.029; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; PIN JP, 1995, BIOCHEM SOC T, V23, P91, DOI 10.1042/bst0230091; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087	30	356	382	0	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					442	+		10.1038/ng.810	http://dx.doi.org/10.1038/ng.810			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21499247	Green Accepted			2022-12-25	WOS:000289972600013
J	Neul, JL				Neul, Jeffrey L.			BEDSIDE TO BENCH The mystery of developing connections	NATURE MEDICINE			English	Editorial Material							FUNCTIONAL CONNECTIVITY; DEFAULT NETWORK; BRAIN; CIRCUIT; FMRI		[Neul, Jeffrey L.] Texas Childrens Hosp, Duncan Neurol Res Inst, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Pediat, Program Dev Biol, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Neurosci, Program Dev Biol, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Mol & Human Genet, Program Dev Biol, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Neul, JL (corresponding author), Texas Childrens Hosp, Duncan Neurol Res Inst, Houston, TX 77030 USA.	jneul@bcm.edu	Neul, Jeffrey/AAF-5324-2020	Neul, Jeffrey/0000-0002-5628-5872	NICHD NIH HHS [R01 HD062553] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062553] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	15	9	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1353	1355		10.1038/nm.2552	http://dx.doi.org/10.1038/nm.2552			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064413	Green Accepted			2022-12-25	WOS:000296779300026
J	Tayyari, F; Marchant, D; Moraes, TJ; Duan, WM; Mastrangelo, P; Hegele, RG				Tayyari, Farnoosh; Marchant, David; Moraes, Theo J.; Duan, Wenming; Mastrangelo, Peter; Hegele, Richard G.			Identification of nucleolin as a cellular receptor for human respiratory syncytial virus	NATURE MEDICINE			English	Article							SURFACE-EXPRESSED NUCLEOLIN; EPITHELIAL-CELLS; FUSION GLYCOPROTEIN; INFECTION; BINDING; ATTACHMENT; GLYCOSAMINOGLYCANS; NEUTRALIZATION; PALIVIZUMAB; PROTEIN	Human respiratory syncytial virus (RSV) causes a large burden of disease worldwide(1). There is no effective vaccine or therapy, and the use of passive immunoprophylaxis with RSV-specific antibodies is limited to high-risk patients(2-5). The cellular receptor (or receptors) required for viral entry and replication has yet to be described; its identification will improve understanding of the pathogenesis of infection and provide a target for the development of novel antiviral interventions. Here we show that RSV interacts with host-cell nucleolin via the viral fusion envelope glycoprotein and binds specifically to nucleolin at the apical cell surface in vitro. We observed decreased RSV infection in vitro in neutralization experiments using nucleolin-specific antibodies before viral inoculation, in competition experiments in which virus was incubated with soluble nucleolin before inoculation of cells, and upon RNA interference (RNAi) to silence cellular nucleolin expression. Transfection of nonpermissive Spodoptera frugiperda Sf9 insect cells with human nucleolin conferred susceptibility to RSV infection. RNAi-mediated knockdown of lung nucleolin was associated with a significant reduction in RSV infection in mice (P = 0.0004), confirming that nucleolin is a functional RSV receptor in vivo.	[Moraes, Theo J.; Mastrangelo, Peter; Hegele, Richard G.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Tayyari, Farnoosh; Marchant, David] Univ British Columbia, James Hogg Res Ctr, Providence Heart & Lung Inst, St Pauls Hosp,Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Moraes, Theo J.; Duan, Wenming] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Hegele, Richard G.] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada	University of Toronto; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Hegele, RG (corresponding author), Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada.	richard.hegele@utoronto.ca	Moraes, Theo/CAJ-3254-2022	Moraes, Theo/0000-0001-9968-6601; Hegele, Richard/0000-0003-1073-8044	Canadian Institutes of Health Research (CIHR) Institute of Genetics; CIHR IMPACT and Heart and Stroke Foundation of British Columbia	Canadian Institutes of Health Research (CIHR) Institute of Genetics(Canadian Institutes of Health Research (CIHR)); CIHR IMPACT and Heart and Stroke Foundation of British Columbia(Canadian Institutes of Health Research (CIHR))	The authors thank R.A. Weiss, B. McManus and F. Jean for helpful comments, and L. Morikawa and Q. Xu for help with immunohistochemical staining of mouse lung. F.T. is the recipient of a Canadian Institutes of Health Research (CIHR) Institute of Genetics Grant for Short-term Visits, and D.M. is the recipient of CIHR IMPACT and Heart and Stroke Foundation of British Columbia Post-doctoral Fellowship awards.	Adams O, 2010, CLIN INFECT DIS, V51, P185, DOI 10.1086/653534; Behera AK, 2001, BIOCHEM BIOPH RES CO, V280, P188, DOI 10.1006/bbrc.2000.4093; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; COLLINS PL, 1991, J GEN VIROL, V72, P3095, DOI 10.1099/0022-1317-72-12-3095; Crim RL, 2007, J VIROL, V81, P261, DOI 10.1128/JVI.01226-06; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Dimmock NJ., 2007, INTRO MODERN VIROLOG, V6th ed.; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Hallak Louay K, 2007, Methods Mol Biol, V379, P15; HIBBS AR, 2006, HDB BIOL CONFOCAL MI; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Losfeld ME, 2009, EXP CELL RES, V315, P357, DOI 10.1016/j.yexcr.2008.10.039; LOWRY F, 2010, MEDSCAPE NEWS   0603; Magro M, 2010, J VIROL, V84, P7970, DOI 10.1128/JVI.00447-10; Malhotra R, 2003, MICROBES INFECT, V5, P123, DOI 10.1016/S1286-4579(02)00079-5; Martinez I, 2000, J GEN VIROL, V81, P2715, DOI 10.1099/0022-1317-81-11-2715; Mikhaylova LM, 2006, P NATL ACAD SCI USA, V103, P11975, DOI 10.1073/pnas.0605087103; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; Olszewska W, 2011, EUR RESPIR J, V38, P401, DOI 10.1183/09031936.00005610; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; OSIOWY C, 1995, J VIROL, V69, P1271, DOI 10.1128/JVI.69.2.1271-1274.1995; Perlman SL, 1999, VIROLOGY, V265, P57, DOI 10.1006/viro.1999.0024; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; TAYLOR G, 1984, INFECT IMMUN, V43, P649, DOI 10.1128/IAI.43.2.649-655.1984; Techaarpornkul S, 2002, VIROLOGY, V294, P296, DOI 10.1006/viro.2001.1340; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tufaro F, 1997, TRENDS MICROBIOL, V5, P257, DOI 10.1016/S0966-842X(97)01057-3; Welliver RC, 2010, CURR OPIN PHARMACOL, V10, P289, DOI 10.1016/j.coph.2010.04.013; Wu H, 2008, CURR TOP MICROBIOL, V317, P103; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	38	258	268	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1132	U140		10.1038/nm.2444	http://dx.doi.org/10.1038/nm.2444			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21841784				2022-12-25	WOS:000294605100035
J	Chung, Y; Tanaka, S; Chu, FL; Nurieva, RI; Martinez, GJ; Rawal, S; Wang, YH; Lim, H; Reynolds, JM; Zhou, XH; Fan, HM; Liu, ZM; Neelapu, SS; Dong, C				Chung, Yeonseok; Tanaka, Shinya; Chu, Fuliang; Nurieva, Roza I.; Martinez, Gustavo J.; Rawal, Seema; Wang, Yi-Hong; Lim, Hoyong; Reynolds, Joseph M.; Zhou, Xiao-hui; Fan, Hui-min; Liu, Zhong-ming; Neelapu, Sattva S.; Dong, Chen			Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions	NATURE MEDICINE			English	Article							CXC CHEMOKINE RECEPTOR-5; TRANSCRIPTION FACTOR; HELPER-CELLS; GENERATION; DIFFERENTIATION; INTERLEUKIN-21; FOLLICLES; BLIMP-1; IRF4; ACTS	Foxp3(+) regulatory T (T-reg) cells suppress different types of immune responses to help maintain homeostasis in the body. How T-reg cells regulate humoral immunity, including germinal center reactions, is unclear. Here we identify a subset of Treg cells expressing CXCR5 and Bcl-6 that localize to the germinal centers in mice and humans. The expression of CXCR5 on T-reg cells depends on Bcl-6. These CXCR5(+) Bcl-6(+) T-reg cells are absent in the thymus but can be generated de novo from CXCR5-Foxp3(+) natural T-reg precursors. A lack of CXCR5+ T-reg cells leads to greater germinal center reactions including germinal center B cells, affinity maturation of antibodies and the differentiation of plasma cells. These results unveil a Bcl-6-CXCR5 axis in T-reg cells that drives the development of follicular regulatory T (T-FR) cells that function to inhibit the germinal center reactions.	[Chung, Yeonseok; Tanaka, Shinya; Nurieva, Roza I.; Martinez, Gustavo J.; Wang, Yi-Hong; Reynolds, Joseph M.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Chung, Yeonseok; Lim, Hoyong] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Ctr Immunol & Autoimmune Dis, Houston, TX USA; [Chu, Fuliang; Rawal, Seema; Neelapu, Sattva S.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Zhou, Xiao-hui; Fan, Hui-min; Liu, Zhong-ming] Shanghai Dong Fang Hosp, Shanghai, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Ctr Canc Immunol Res, Houston, TX 77030 USA.	yeonseok.chung@uth.tmc.edu; cdong@mdanderson.org	Tanaka, Shinya/AAO-8771-2021; dong, chen/B-3181-2009; Chu, Fuliang/F-6925-2011	Tanaka, Shinya/0000-0001-6470-3301; dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841; Reynolds, Joseph/0000-0003-3490-0544; Martinez, Gustavo/0000-0003-0178-3329	US National Institutes of Health; Leukemia and Lymphoma Society; MD Anderson Cancer Center; American Heart Association; Doris Duke Charitable Foundation; China Ministry of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR059010, R01AR050772] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MD Anderson Cancer Center; American Heart Association(American Heart Association); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); China Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Dalla-Favera (Columbia University) for the Bcl-6-deficient mice, A. Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3<SUP>GFP</SUP> reporter mice, D. Tran (University of Texas at Houston) for the antibody to Helios, Z. He, K. Ramirez and K. Dwyer for help with cell sorting and the entire Dong lab for their help. This work was supported by research grants from the US National Institutes of Health (C. D., to R.I.N. and to S.S.N.), the Leukemia and Lymphoma Society (C. D.), the MD Anderson Cancer Center (C. D.), the American Heart Association (Y.C.), Doris Duke Charitable Foundation Clinical Scientist Development Award (S.S.N.) and China Ministry of Science and Technology Protein Science Key Research Project (X. Z., H. F. and C. D.).	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	36	750	783	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					983	U102		10.1038/nm.2426	http://dx.doi.org/10.1038/nm.2426			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785430	Green Accepted			2022-12-25	WOS:000293507400032
J	Kahr, WHA; Hinckley, J; Li, L; Schwertz, H; Christensen, H; Rowley, JW; Pluthero, FG; Urban, D; Fabbro, S; Nixon, B; Gadzinski, R; Storck, M; Wang, K; Ryu, GY; Jobe, SM; Schutte, BC; Moseley, J; Loughran, NB; Parkinson, J; Weyrich, AS; Di Paola, J				Kahr, Walter H. A.; Hinckley, Jesse; Li, Ling; Schwertz, Hansjorg; Christensen, Hilary; Rowley, Jesse W.; Pluthero, Fred G.; Urban, Denisa; Fabbro, Shay; Nixon, Brie; Gadzinski, Rick; Storck, Mike; Wang, Kai; Ryu, Gi-Yung; Jobe, Shawn M.; Schutte, Brian C.; Moseley, Jack; Loughran, Noeleen B.; Parkinson, John; Weyrich, Andrew S.; Di Paola, Jorge			Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome	NATURE GENETICS			English	Article							CHEDIAK-HIGASHI-SYNDROME; IDENTIFICATION; DOMAINS	Next-generation RNA sequence analysis of platelets from an individual with autosomal recessive gray platelet syndrome (GPS, MIM139090) detected abnormal transcript reads, including intron retention, mapping to NBEAL2 (encoding neurobeachin-like 2). Genomic DNA sequencing confirmed mutations in NBEAL2 as the genetic cause of GPS. NBEAL2 encodes a protein containing a BEACH domain that is predicted to be involved in vesicular trafficking and may be critical for the development of platelet alpha-granules.	[Kahr, Walter H. A.] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Kahr, Walter H. A.; Li, Ling; Christensen, Hilary; Pluthero, Fred G.; Urban, Denisa] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Kahr, Walter H. A.; Urban, Denisa] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Hinckley, Jesse; Fabbro, Shay; Nixon, Brie; Di Paola, Jorge] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Hinckley, Jesse; Fabbro, Shay; Nixon, Brie; Di Paola, Jorge] Univ Colorado Denver, Human Med Genet Program, Aurora, CO USA; [Schwertz, Hansjorg] Univ Utah, Dept Surg, Div Vasc Surg, Salt Lake City, UT USA; [Rowley, Jesse W.; Weyrich, Andrew S.] Univ Utah, Program Mol Med, Eccles Inst Human Genet, Salt Lake City, UT USA; [Rowley, Jesse W.; Weyrich, Andrew S.] Univ Utah, Dept Internal Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Gadzinski, Rick; Storck, Mike] Funct Biosci, Madison, WI USA; [Wang, Kai] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Ryu, Gi-Yung] Univ Iowa, Inst Clin & Translat Sci, Iowa City, IA USA; [Jobe, Shawn M.] Childrens Healthcare Atlanta, Aflac Canc Ctr, Atlanta, GA USA; [Jobe, Shawn M.] Childrens Healthcare Atlanta, Blood Disorders Serv, Atlanta, GA USA; [Jobe, Shawn M.] Emory Univ, Atlanta, GA 30322 USA; [Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Moseley, Jack] No Oklahoma Resource Ctr, Enid, OK USA; [Loughran, Noeleen B.; Parkinson, John] Univ Toronto, Hosp Sick Children, Dept Biochem & Mol & Med Genet, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Iowa; University of Iowa; Children's Healthcare of Atlanta (CHOA); Children's Healthcare of Atlanta (CHOA); Emory University; Michigan State University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kahr, WHA (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada.	walter.kahr@sickkids.ca; jorge.dipaola@ucdenver.edu	Pluthero, Fred/T-8593-2019; Schwertz, Hansjorg/Q-3305-2019; Parkinson, John/A-4424-2008; Kahr, Walter/K-9040-2019	Parkinson, John/0000-0001-9815-1189; Pluthero, Fred/0000-0002-0451-5840; Weyrich, Andrew/0000-0001-9622-4647	US National Institutes of Health (NIH) [NIH HL084086-01, NIH HL066277, HL091283, NIH T32 HL105321, NIH UL1RR024979, NIH P30DK57516]; Canadian Institutes of Health Research [MOP-81208, MOP-84556]; American Heart Association [AHA 09BG1A2250381]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091283, R01HL084086, R01HL066277, T32HL105321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the families that participated in this study. This work was supported by grants from the US National Institutes of Health (NIH) to J.D.P. (NIH HL084086-01), A.S.W. (NIH HL066277 and HL091283), J.W.R. (NIH T32 HL105321), B.C.S. and G.-Y.R. (NIH UL1RR024979), the Canadian Institutes of Health Research to W.H.A.K. (MOP-81208), J.P. and N.B.L. (MOP-84556), and the American Heart Association to H. S. (AHA 09BG1A2250381). We thank R. Wong from the Diabetes and Endocrinology Research Center Molecular Biology Core at the University of Colorado-Denver for sequencing assistance (grant NIH P30DK57516), the Bioinformatics and Molecular Evolution Group, Dublin City University for the use of their computational facilities and D. Lim for preparing figures.	Burgess A, 2009, BIOINFORMATICS, V25, P1219, DOI 10.1093/bioinformatics/btp151; Certain S, 2000, BLOOD, V95, P979; Fabbro S, 2011, BLOOD, V117, P3430, DOI 10.1182/blood-2010-12-322990; Gunay-Aygun M, 2010, BLOOD, V116, P4990, DOI 10.1182/blood-2010-05-286534; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Khodosh R, 2006, DEVELOPMENT, V133, P4655, DOI 10.1242/dev.02650; Kypri E, 2007, TRAFFIC, V8, P774, DOI 10.1111/j.1600-0854.2007.00567.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; Nurden AT, 2007, BLOOD REV, V21, P21, DOI 10.1016/j.blre.2005.12.003; ROWLEY JW, 2011, BLOOD           0519, DOI DOI 10.1182/BLOOD-2011-03-339705; Shiflett SL, 2004, TRAFFIC, V5, P700, DOI 10.1111/j.1600-0854.2004.00213.x; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Ward DM, 2003, TRAFFIC, V4, P403, DOI 10.1034/j.1600-0854.2003.00093.x	15	162	167	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					738	740		10.1038/ng.884	http://dx.doi.org/10.1038/ng.884			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21765413	Green Accepted			2022-12-25	WOS:000293178300008
J	Kelly, OG; Chan, MY; Martinson, LA; Kadoya, K; Ostertag, TM; Ross, KG; Richardson, M; Carpenter, MK; D'Amour, KA; Kroon, E; Moorman, M; Baetge, EE; Bang, AG				Kelly, Olivia G.; Chan, Man Yin; Martinson, Laura A.; Kadoya, Kuniko; Ostertag, Traci M.; Ross, Kelly G.; Richardson, Mike; Carpenter, Melissa K.; D'Amour, Kevin A.; Kroon, Evert; Moorman, Mark; Baetge, Emmanuel E.; Bang, Anne G.			Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							PROGENITOR CELLS; TISSUE FACTOR; BETA-CELLS; ISLET TRANSPLANTATION; ENDOCRINE-CELLS; ROCK INHIBITOR; ALPHA-CELLS; EXPRESSION; INSULIN; NEOGENESIS	Using a flow cytometry-based screen of commercial antibodies, we have identified cell-surface markers for the separation of pancreatic cell types derived from human embryonic stem (hES) cells. We show enrichment of pancreatic endoderm cells using CD142 and of endocrine cells using CD200 and CD318. After transplantation into mice, enriched pancreatic endoderm cells give rise to all the pancreatic lineages, including functional insulin-producing cells, demonstrating that they are pancreatic progenitors. In contrast, implanted, enriched polyhormonal endocrine cells principally give rise to glucagon cells. These antibodies will aid investigations that use pancreatic cells generated from pluripotent stem cells to study diabetes and pancreas biology.	[Kelly, Olivia G.; Chan, Man Yin; Martinson, Laura A.; Kadoya, Kuniko; Ostertag, Traci M.; Ross, Kelly G.; Richardson, Mike; Carpenter, Melissa K.; D'Amour, Kevin A.; Kroon, Evert; Moorman, Mark; Baetge, Emmanuel E.; Bang, Anne G.] ViaCyte Inc, San Diego, CA USA		Kelly, OG (corresponding author), ViaCyte Inc, San Diego, CA USA.	okelly@viacyte.com		KROON, EVERT/0000-0002-4069-3644	Juvenile Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	We thank O. Madsen (Hagedorn Research Institute), C. Wright (Vanderbilt University), J. Johnson (UT Southwestern Medical Center) and BD Biosciences for providing antibodies and A. Elefanty and E. Stanley (Monash University) for providing the MEL1 hES cell line. The CyT203 and CyT49 hES cell lines were derived with partial funding from the Juvenile Diabetes Research Foundation.	Beuneu C, 2004, DIABETES, V53, P1407, DOI 10.2337/diabetes.53.6.1407; Braam SR, 2010, ANN NY ACAD SCI, V1188, P52, DOI 10.1111/j.1749-6632.2009.05083.x; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Hald J, 2008, J HISTOCHEM CYTOCHEM, V56, P587, DOI 10.1369/jhc.2008.950675; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hori Y, 2008, STEM CELLS, V26, P2912, DOI 10.1634/stemcells.2008-0192; Jiang W, 2011, STEM CELLS, V29, P609, DOI 10.1002/stem.608; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Luther T, 1996, AM J PATHOL, V149, P101; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Murray HE, 2005, MOL CELL ENDOCRINOL, V238, P39, DOI 10.1016/j.mce.2005.03.014; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Sugiyama T, 2008, DIABETES OBES METAB, V10, P179, DOI 10.1111/j.1463-1326.2008.00954.x; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilson ME, 2002, MECH DEVELOP, V115, P171, DOI 10.1016/S0925-4773(02)00118-1; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N	34	236	284	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					750	U114		10.1038/nbt.1931	http://dx.doi.org/10.1038/nbt.1931			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804561				2022-12-25	WOS:000293696500028
J	Wray, J; Kalkan, T; Gomez-Lopez, S; Eckardt, D; Cook, A; Kemler, R; Smith, A				Wray, Jason; Kalkan, Tuezer; Gomez-Lopez, Sandra; Eckardt, Dominik; Cook, Andrew; Kemler, Rolf; Smith, Austin			Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; SELF-RENEWAL; AXIS FORMATION; GROUND-STATE; TRANSCRIPTION; GENE; ACTIVATION; WNT; REQUIREMENT; EXPRESSION	Self-renewal of rodent embryonic stem cells is enhanced by partial inhibition of glycogen synthase kinase-3 (Gsk3; refs 1,2). This effect has variously been attributed to stimulation of Wnt signalling by beta-catenin(1), stabilization of Myc protein(3) and global de-inhibition of anabolic processes(4). Here we demonstrate that beta-catenin is not necessary for embryonic stem cell identity or expansion, but its absence eliminates the self-renewal response to Gsk3 inhibition. Responsiveness is fully restored by truncated beta-catenin lacking the carboxy-terminal transactivation domain(5). However, requirement for Gsk3 inhibition is dictated by expression of T-cell factor3 (Tcf3) and mediated by direct interaction with beta-catenin. Tcf3 localizes to many pluripotency genes(6) in embryonic stem cells. Our findings confirm that Tcf3 acts as a transcriptional repressor and reveal that beta-catenin directly abrogates Tcf3 function. We conclude that Gsk3 inhibition stabilizes the embryonic stem cell state primarily by reducing repressive influence on the core pluripotency network.	[Wray, Jason; Kalkan, Tuezer; Gomez-Lopez, Sandra; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Wray, Jason; Kalkan, Tuezer; Gomez-Lopez, Sandra; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Eckardt, Dominik; Kemler, Rolf] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Cook, Andrew] Pfizer Ltd, World Wide Med Chem, Sandwich CT13 9NJ, Kent, England	University of Cambridge; University of Cambridge; Max Planck Society; Pfizer	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	ags39@cam.ac.uk		Gomez Lopez, Sandra/0000-0001-5163-6066; Smith, Austin/0000-0002-3029-4682	Biotechnology and Biological Sciences Research Council; Medical Research Council of the United Kingdom; Wellcome Trust; European Commission; CONACYT; Biotechnology and Biological Sciences Research Council [BB/G015678/1] Funding Source: researchfish; Medical Research Council [G1100526] Funding Source: researchfish; BBSRC [BB/G015678/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank N. Lyashenko and C. Hartmann for discussion and exchange of unpublished data. We also thank A. Martinez-Arias for comments on the manuscript. We are grateful to B. Merrill (University of Illinois at Chicago, USA) for generously providing Tcf3 mutant embryonic stem cells and to B. Doble (Stem Cell and Cancer Research Institute, McMaster University, Canada) and J. Woodgett (Samuel Lunenfeld Research Institute, Mount Sinai Hospital and University of Toronto, Canada) for Gsk3 mutant embryonic stem cells. We thank R. Grosschedl for the beta-catenin Delta C construct. Gsk3 inhibitors, compounds A-G, were provided by Pfizer. R. Walker and P. Humphreys supported flow cytometry and imaging, respectively. The study was financially supported by the Biotechnology and Biological Sciences Research Council and the Medical Research Council of the United Kingdom, the Wellcome Trust and the European Commission FP7 project EuroSyStem. S.G-L. was supported by a CONACYT Studentship. A.S. is a Medical Research Council Professor.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brault V, 2001, DEVELOPMENT, V128, P1253; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; GUO G, 2011, PLOS ONE, V18; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Robson P, 2001, DEV BIOL, V234, P317, DOI 10.1006/dbio.2001.0274; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	41	374	383	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					838	U246		10.1038/ncb2267	http://dx.doi.org/10.1038/ncb2267			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21685889	Green Accepted			2022-12-25	WOS:000292305700014
J	Andrabi, SA; Kang, HC; Haince, JF; Lee, YI; Zhang, J; Chi, ZK; West, AB; Koehler, RC; Poirier, GG; Dawson, TM; Dawson, VL				Andrabi, Shaida A.; Kang, Ho Chul; Haince, Jean-Francois; Lee, Yun-Il; Zhang, Jian; Chi, Zhikai; West, Andrew B.; Koehler, Raymond C.; Poirier, Guy G.; Dawson, Ted M.; Dawson, Valina L.			Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death	NATURE MEDICINE			English	Article							ELEMENT-BINDING PROTEIN; IN-VITRO; PAR POLYMER; IDENTIFICATION; ACTIVATION; VIVO; PARTHANATOS; PLASTICITY; CHROMATIN; NUCLEAR	Glutamate acting on N-methyl-D-aspartate (NMDA) receptors induces neuronal injury following stroke, through activation of poly(ADPribose) polymerase-1 (PARP-1) and generation of the death molecule poly(ADP-ribose) (PAR) polymer. Here we identify Iduna, a previously undescribed NMDA receptor-induced survival protein that is neuroprotective against glutamate NMDA receptor-mediated excitotoxicity both in vitro and in vivo and against stroke through interfering with PAR polymer-induced cell death (parthanatos). Iduna's protective effects are independent and downstream of PARP-1 activity. Iduna is a PAR polymer-binding protein, and mutation at the PAR polymer binding site abolishes the PAR binding activity of Iduna and attenuates its protective actions. Iduna is protective in vivo against NMDA-induced excitotoxicity and middle cerebral artery occlusion-induced stroke in mice. To our knowledge, these results define Iduna as the first known endogenous inhibitor of parthanatos. Interfering with PAR polymer signaling could be a new therapeutic strategy for the treatment of neurologic disorders.	[Andrabi, Shaida A.; Kang, Ho Chul; Lee, Yun-Il; Chi, Zhikai; West, Andrew B.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA; [Andrabi, Shaida A.; Kang, Ho Chul; Lee, Yun-Il; Chi, Zhikai; West, Andrew B.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Haince, Jean-Francois; Poirier, Guy G.] Univ Laval, Med Res Ctr, Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada; [Zhang, Jian; Koehler, Raymond C.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Laval University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Andrabi, Shaida/I-6167-2012	Andrabi, Shaida/0000-0002-3305-2638; Dawson, Valina/0000-0002-2915-3970; West, Andrew/0000-0002-3034-4061; Poirier, Guy/0000-0002-4869-1424	US National Institutes of Health National Institute of Neurological Disorders and Stroke [NS039148, NS067525, NS051764]; National Institute on Drug Abuse [DA000266]; McKnight Endowment for the Neurosciences; Canadian Institutes Health Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067525, R01NS051764, R37NS067525, P01NS039148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); McKnight Endowment for the Neurosciences; Canadian Institutes Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	pROSA26PA was provided by P. Soriano (University of Washington). This work was supported by grants from the US National Institutes of Health National Institute of Neurological Disorders and Stroke (NS039148, NS067525 and NS051764) and National Institute on Drug Abuse (DA000266) and the McKnight Endowment for the Neurosciences. S.A.A. is an American Heart Research Postdoctoral Fellow. G.G.P. was supported from a Canadian Institutes Health Research grant and holds a Research Chair in Proteomics. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Affar EB, 1999, BBA-GEN SUBJECTS, V1428, P137, DOI 10.1016/S0304-4165(99)00054-9; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; BROCHU G, 1994, ANAL BIOCHEM, V218, P265, DOI 10.1006/abio.1994.1177; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Faraco G, 2010, STROKE, V41, P181, DOI 10.1161/STROKEAHA.109.567826; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Gnegy ME, 2000, CRIT REV NEUROBIOL, V14, P91; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Hara T, 2003, J NEUROCHEM, V86, P805, DOI 10.1046/j.1471-4159.2003.01847.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; KIEHLBAUCH CC, 1993, ANAL BIOCHEM, V208, P26, DOI 10.1006/abio.1993.1004; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lee HT, 2004, ANN NEUROL, V56, P611, DOI 10.1002/ana.20259; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zheng S, 2010, J CLIN INVEST, V120, P2446, DOI 10.1172/JCI33144	44	155	169	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					692	U82		10.1038/nm.2387	http://dx.doi.org/10.1038/nm.2387			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602803	Green Accepted			2022-12-25	WOS:000291308800029
J	Haller, A; Rieder, U; Aigner, M; Blanchard, SC; Micura, R				Haller, Andrea; Rieder, Ulrike; Aigner, Michaela; Blanchard, Scott C.; Micura, Ronald			Conformational capture of the SAM-II riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							INDUCED FIT; S-ADENOSYLMETHIONINE; RNA DYNAMICS; MOLECULAR RECOGNITION; SENSING RIBOSWITCH; APTAMER DOMAIN; BINDING; ENSEMBLES; GUANINE; MECHANISM	Riboswitches are gene regulation elements in mRNA that function by specifically responding to metabolites. Although the metabolite-bound states of riboswitches have proven amenable to structure determination efforts, knowledge of the structural features of riboswitches in their ligand-free forms and their ligand-response mechanisms giving rise to regulatory control is lacking. Here we explore the ligand-induced folding process of the S-adenosylmethionine type II (SAM-II) riboswitch using chemical and biophysical methods, including NMR and fluorescence spectroscopy, and single-molecule fluorescence imaging. The data reveal that the unliganded SAM-II riboswitch is dynamic in nature, in that its stem-loop element becomes engaged in a pseudoknot fold through base-pairing with nucleosides in the 3' overhang containing the Shine-Dalgarno sequence. Although the pseudoknot structure is highly transient in the absence of its ligand, S-adenosylmethionine (SAM), it becomes conformationally restrained upon ligand recognition, through a conformational capture mechanism. These insights provide a molecular understanding of riboswitch dynamics that shed new light on the mechanism of riboswitch-mediated translational regulation.	[Haller, Andrea; Rieder, Ulrike; Aigner, Michaela; Micura, Ronald] Univ Innsbruck, Ctr Mol Biosci, Inst Organ Chem, A-6020 Innsbruck, Austria; [Blanchard, Scott C.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA	University of Innsbruck; Cornell University	Haller, A (corresponding author), Univ Innsbruck, Ctr Mol Biosci, Inst Organ Chem, A-6020 Innsbruck, Austria.	scb2005@med.cornell.edu; ronald.micura@uibk.ac.at	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365	Austrian Science Foundation FWF [I317, P21641]; Austrian Ministry of Science and Research [P0726-012-012]; Irma T. Hirschl/Monique Weill-Caulier Trust; Austrian Science Fund (FWF) [I 317] Funding Source: researchfish	Austrian Science Foundation FWF(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Irma T. Hirschl/Monique Weill-Caulier Trust; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank D. Lafontaine for discussions on labeling of riboswitches for smFRET experiments; K. Lang (University of Innsbruck; presently at Medical Research Council, Cambridge) for a previous synthesis of <SUP>15</SUP>N-labeled cytidine phosphoramidite; C. Kreutz and M. Tollinger for NMR assistance; D. S. Terry for contributions to the development and implementation of the single-molecule imaging platform and data analysis software used; and M. Souliere for critical reading of the manuscript. This work was funded by the Austrian Science Foundation FWF (I317 and P21641 to R. M.) and the Austrian Ministry of Science and Research (GenAU project consortium 'non-coding RNAs' P0726-012-012 to R. M.). S. C. B. was supported by the Irma T. Hirschl/Monique Weill-Caulier Trust.	Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Aleman EA, 2008, CURR OPIN CHEM BIOL, V12, P647, DOI 10.1016/j.cbpa.2008.09.010; Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Blouin S, 2009, CHEMBIOCHEM, V10, P400, DOI 10.1002/cbic.200800593; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Duchardt-Ferner E, 2010, ANGEW CHEM INT EDIT, V49, P6216, DOI 10.1002/anie.201001339; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Frank AT, 2009, NUCLEIC ACIDS RES, V37, P3670, DOI 10.1093/nar/gkp156; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Kelley JM, 2010, NUCLEIC ACIDS RES, V38, P1392, DOI 10.1093/nar/gkp1106; Lang K, 2007, NUCLEIC ACIDS RES, V35, P5370, DOI 10.1093/nar/gkm580; Lang K, 2008, NAT PROTOC, V3, P1457, DOI 10.1038/nprot.2008.135; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Lu CR, 2010, J MOL BIOL, V404, P803, DOI 10.1016/j.jmb.2010.09.059; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P5262, DOI 10.1093/nar/gkm565; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Puffer B, 2009, NUCLEIC ACIDS RES, V37, P7728, DOI 10.1093/nar/gkp862; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rieder U, 2010, P NATL ACAD SCI USA, V107, P10804, DOI 10.1073/pnas.0914925107; Rieder U, 2009, CHEMBIOCHEM, V10, P1141, DOI 10.1002/cbic.200900155; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Serganov A, 2002, J MOL BIOL, V320, P963, DOI 10.1016/S0022-2836(02)00553-3; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2010, RNA BIOL, V7, P98, DOI 10.4161/rna.7.1.10756; Staple DW, 2005, PLOS BIOL, V3, P956, DOI 10.1371/journal.pbio.0030213; Stelzer AC, 2010, ANGEW CHEM INT EDIT, V49, P5731, DOI 10.1002/anie.201000814; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Wang JX, 2008, BIOCHEM CELL BIOL, V86, P157, DOI 10.1139/O08-008; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wilson RC, 2011, J MOL BIOL, V405, P926, DOI 10.1016/j.jmb.2010.10.056	50	125	130	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					393	400		10.1038/NCHEMBIO.562	http://dx.doi.org/10.1038/NCHEMBIO.562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21532598				2022-12-25	WOS:000290677900015
J	Heppell, B; Blouin, S; Dussault, AM; Mulhbacher, J; Ennifar, E; Penedo, JC; Lafontaine, DA				Heppell, Benoit; Blouin, Simon; Dussault, Anne-Marie; Mulhbacher, Jerome; Ennifar, Eric; Penedo, J. Carlos; Lafontaine, Daniel A.			Molecular insights into the ligand-controlled organization of the SAM-I riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA ELEMENT; S-ADENOSYLMETHIONINE; APTAMER DOMAIN; GENE-EXPRESSION; TRANSCRIPTION TERMINATION; PURINE RIBOSWITCH; BINDING; FLUORESCENCE; ELECTROPHORESIS; CONFORMATION	S-adenosylmethionine (SAM) riboswitches are widespread in bacteria, and up to five different SAM riboswitch families have been reported, highlighting the relevance of SAM regulation. On the basis of crystallographic and biochemical data, it has been postulated, but never demonstrated, that ligand recognition by SAM riboswitches involves key conformational changes in the RNA architecture. We show here that the aptamer follows a two-step hierarchical folding selectively induced by metal ions and ligand binding, each of them leading to the formation of one of the two helical stacks observed in the crystal structure. Moreover, we find that the anti-antiterminator P1 stem is rotated along its helical axis upon ligand binding, a mechanistic feature that could be common to other riboswitches. We also show that the nonconserved P4 helical domain is used as an auxiliary element to enhance the ligand-binding affinity. This work provides the first comprehensive characterization, to our knowledge, of a ligand-controlled riboswitch folding pathway.	[Heppell, Benoit; Blouin, Simon; Dussault, Anne-Marie; Mulhbacher, Jerome; Lafontaine, Daniel A.] Univ Sherbrooke, Fac Sci, Dept Biol, Grp ARN,RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Ennifar, Eric] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & Reactiv ARN, F-67084 Strasbourg, France; [Penedo, J. Carlos] Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland	University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of St Andrews	Heppell, B (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Grp ARN,RNA Grp, Sherbrooke, PQ J1K 2R1, Canada.	jcp10@st-andrews.ac.uk; Daniel.Lafontaine@USherbrooke.ca	Penedo, Carlos/B-5568-2009	Penedo, Carlos/0000-0002-5807-5385; Blouin, Simon/0000-0001-8433-4654	Canadian Institutes of Health Research (CIHR); National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank A. Lavigueur for critical reading of the manuscript. We also thank D. Norman and P. St.-Pierre for discussion. This work was supported by the Canadian Institutes of Health Research (CIHR). S. B. is supported by a studentship from the National Sciences and Engineering Research Council of Canada. D. A. L. is a CIHR New Investigator scholar as well as a Chercheur-boursier Junior 2 from the Fonds de la recherche en Sante du Quebec. J.C.P. thanks the UK Biological and Biotechnological Science Research Council. We are also grateful to T. Ha and S. McKinney (University of Illinois at Urbana-Champaign) for providing the source code software for hidden Markov analysis.	Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Edwards TE, 2007, CURR OPIN STRUC BIOL, V17, P273, DOI 10.1016/j.sbi.2007.05.004; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; Hennelly SP, 2011, NUCLEIC ACIDS RES, V39, P2416, DOI 10.1093/nar/gkq1096; Heppell B, 2008, BIOCHEMISTRY-US, V47, P1490, DOI 10.1021/bi701164y; Huang W, 2009, NUCLEIC ACIDS RES, V37, P6528, DOI 10.1093/nar/gkp664; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JN, 2009, ACS CHEM BIOL, V4, P915, DOI 10.1021/cb900146k; Lang K, 2007, NUCLEIC ACIDS RES, V35, P5370, DOI 10.1093/nar/gkm580; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lilley DMJ, 2000, METHOD ENZYMOL, V317, P368; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; LUMPKIN OJ, 1982, BIOPOLYMERS, V21, P2315, DOI 10.1002/bip.360211116; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; McDaniel BA, 2005, MOL MICROBIOL, V57, P1008, DOI 10.1111/j.1365-2958.2005.04740.x; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Mulhbacher J, 2010, CURR OPIN PHARMACOL, V10, P551, DOI 10.1016/j.coph.2010.07.002; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Tomsic J, 2008, J BACTERIOL, V190, P823, DOI 10.1128/JB.01034-07; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Whitford PC, 2009, BIOPHYS J, V96, pL7, DOI 10.1016/j.bpj.2008.10.033; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967	49	85	85	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					384	392		10.1038/NCHEMBIO.563	http://dx.doi.org/10.1038/NCHEMBIO.563			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21532599				2022-12-25	WOS:000290677900014
J	Liu, YC; Li, YS; Lyu, SY; Hsu, LJ; Chen, YH; Huang, YT; Chan, HC; Huang, CJ; Chen, GH; Chou, CC; Tsai, MD; Li, TL				Liu, Yu-Chen; Li, Yi-Shan; Lyu, Syue-Yi; Hsu, Li-Jen; Chen, Yu-Hou; Huang, Yu-Ting; Chan, Hsiu-Chien; Huang, Chuen-Jiuan; Chen, Gan-Hong; Chou, Chia-Cheng; Tsai, Ming-Daw; Li, Tsung-Lin			Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; GENE-CLUSTER; LIPOGLYCOPEPTIDE; OXIDASE; BIOSYNTHESIS; DALBAVANCIN; ANTIBACTERIALS; GLYCOPEPTIDES; DEHYDROGENASE; INFECTIONS	In the search for new efficacious antibiotics, biosynthetic engineering offers attractive opportunities to introduce minor alterations to antibiotic structures that may overcome resistance. Dbv29, a flavin-containing oxidase, catalyzes the four-electron oxidation of a vancomycin-like glycopeptide to yield A40926. Structural and biochemical examination of Dbv29 now provides insights into residues that govern flavinylation and activity, protein conformation and reaction mechanism. In particular, the serendipitous discovery of a reaction intermediate in the crystal structure led us to identify an unexpected opportunity to intercept the normal enzyme mechanism at two different points to create new teicoplanin analogs. Using this method, we synthesized families of antibiotic analogs with amidated and aminated lipid chains, some of which showed marked potency and efficacy against multidrug resistant pathogens. This method offers a new strategy for the development of chemical diversity to combat antibacterial resistance.	[Liu, Yu-Chen; Li, Yi-Shan; Lyu, Syue-Yi; Hsu, Li-Jen; Chen, Yu-Hou; Huang, Yu-Ting; Chan, Hsiu-Chien; Huang, Chuen-Jiuan; Chen, Gan-Hong; Tsai, Ming-Daw; Li, Tsung-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Liu, Yu-Chen] Acad Sinica, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 115, Taiwan; [Liu, Yu-Chen; Tsai, Ming-Daw] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Lyu, Syue-Yi] Natl Yang Ming Univ, Dept Microbiol & Immunol, Taipei 112, Taiwan; [Chen, Yu-Hou; Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Chou, Chia-Cheng] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan; [Li, Tsung-Lin] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Synchrotron Radiation Research Center; National Chung Hsing University	Li, TL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	tlli@gate.sinica.edu.tw	Liu, Yu-Chen/B-5013-2009; HUANG, CHUEN-JIUAN/O-5472-2017; Tsai, Ming-Daw/G-4689-2019	Liu, Yu-Chen/0000-0002-7232-144X; HUANG, CHUEN-JIUAN/0000-0002-4818-0894; Tsai, Ming-Daw/0000-0003-1374-0414	National Science Council of Taiwan [96-2628B-001-026-MY3, 98-2311-B-001-014-MY3]; Academia Sinica intramural; National Research Program for Genomic Medicine; National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica intramural; National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The research was supported by the National Science Council of Taiwan (grants 96-2628B-001-026-MY3 and 98-2311-B-001-014-MY3 to T.-L. L.) and Academia Sinica intramural funding. X-ray diffraction was carried out at the Protein Crystallography Facility at the National Synchrotron Radiation Research Center, supported by the National Research Program for Genomic Medicine and the National Science Council of Taiwan. We thank C.-Y. Wu (Academia Sinica) for providing 5-azide pentylamine.	Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Bailey J, 2008, AM J HEALTH-SYST PH, V65, P599, DOI 10.2146/ajhp070255; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chan HC, 2011, MOL BIOSYST, V7, P1224, DOI 10.1039/c0mb00320d; Donadio S, 2008, CURR TOP MED CHEM, V8, P654, DOI 10.2174/156802608784221541; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Ho JY, 2006, J AM CHEM SOC, V128, P13694, DOI 10.1021/ja0644834; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim A, 2007, EXPERT OPIN INV DRUG, V16, P717, DOI 10.1517/13543784.16.5.717; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Leskovac V, 2005, INT J BIOCHEM CELL B, V37, P731, DOI 10.1016/j.biocel.2004.10.014; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Li YS, 2007, J AM CHEM SOC, V129, P13384, DOI 10.1021/ja075748x; Linden PK, 2008, EXPERT REV ANTI-INFE, V6, P917, DOI 10.1586/14787210.6.6.917; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rice LB, 2006, AM J INFECT CONTROL, V34, pS11, DOI 10.1016/j.ajic.2006.05.220; Roecker AM, 2008, EXPERT OPIN PHARMACO, V9, P1745, DOI [10.1517/14656566.9.10.1745, 10.1517/14656566.9.10.1745 ]; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Snook CF, 2003, BIOCHEMISTRY-US, V42, P4658, DOI 10.1021/bi027328k; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123	32	51	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					304	309		10.1038/nchembio.556	http://dx.doi.org/10.1038/nchembio.556			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21478878	Green Submitted			2022-12-25	WOS:000289617800014
J	Al-Mayouf, SM; Sunker, A; Abdwani, R; Al Abrawi, S; Almurshedi, F; Alhashmi, N; Al Sonbul, A; Sewairi, W; Qari, A; Abdallah, E; Al-Owain, M; Al Motywee, S; Al-Rayes, H; Hashem, M; Khalak, H; Al-Jebali, L; Alkuraya, FS				Al-Mayouf, Sulaiman M.; Sunker, Asma; Abdwani, Reem; Al Abrawi, Safiya; Almurshedi, Fathiya; Alhashmi, Nadia; Al Sonbul, Abdullah; Sewairi, Wafaa; Qari, Aliya; Abdallah, Eiman; Al-Owain, Mohammed; Al Motywee, Saleh; Al-Rayes, Hanan; Hashem, Mais; Khalak, Hanif; Al-Jebali, Latifa; Alkuraya, Fowzan S.			Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus	NATURE GENETICS			English	Article							SUSCEPTIBILITY VARIANTS; DEOXYRIBONUCLEASE I; PXK	Systemic lupus erythematosus (SLE) is a complex autoimmune disease that causes substantial morbidity. As is typical for many other multifactorial disorders, much of the heritability of SLE remains unknown. We identified a rare autosomal recessive form of SLE, in which autozygome analysis revealed a null mutation in the DNASE1L3 gene. The DNASE1L3-related SLE we describe was always pediatric in onset and correlated with a high frequency of lupus nephritis. Our findings confirm the critical role of impaired clearance of degraded DNA in SLE pathogenesis.	[Sunker, Asma; Hashem, Mais; Khalak, Hanif; Al-Jebali, Latifa; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Al-Mayouf, Sulaiman M.; Al Sonbul, Abdullah] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Rheumatol Sect, Riyadh 11211, Saudi Arabia; [Abdwani, Reem; Abdallah, Eiman] Sultan Qaboos Univ Hosp, Dept Child Hlth, Muscat, Oman; [Al Abrawi, Safiya; Alhashmi, Nadia] Royal Hosp, Dept Child Hlth, Muscat, Oman; [Almurshedi, Fathiya] Sultan Qaboos Univ Hosp, Dept Genet, Muscat, Oman; [Sewairi, Wafaa; Al Motywee, Saleh] King Fahad Natl Guard Hosp, Div Rheumatol, Dept Med, Riyadh, Saudi Arabia; [Sewairi, Wafaa; Al Motywee, Saleh] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Qari, Aliya; Al-Owain, Mohammed] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh, Saudi Arabia; [Al-Owain, Mohammed; Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia; [Al-Rayes, Hanan] Riyadh Mil Hosp, Dept Med, Riyadh, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11472, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Sultan Qaboos University; The Royal Hospital, Sultanate of Oman; Sultan Qaboos University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Faisal Specialist Hospital & Research Center; Alfaisal University; Prince Sultan Military Medical City; King Saud University; King Saud University; King Khalid University Hospital	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Alkuraya, Fowzan S./A-1542-2009	Alkuraya, Fowzan S./0000-0003-4158-341X; Al-Mayouf, Sulaiman/0000-0003-0142-6698; Abdwani, Reem/0000-0002-1189-1959	Dubai Harvard Foundation for Medical Research	Dubai Harvard Foundation for Medical Research	We would like to thank the families for their participation and the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center for their technical help. This work is supported by a Dubai Harvard Foundation for Medical Research collaborative grant (FSA).	Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; ALMAYOUF S, RHEUMATOL I IN PRESS; Chen WJ, 2004, PROTEIN SCI, V13, P875, DOI 10.1110/ps.03438204; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; KIM EM, RHEUMATOL I IN PRESS; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Rodriguez AM, 1997, GENOMICS, V42, P507, DOI 10.1006/geno.1997.4748; RUMORE PM, 1990, J CLIN INVEST, V86, P69, DOI 10.1172/JCI114716; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Ueki M, 2009, CLIN CHIM ACTA, V407, P20, DOI 10.1016/j.cca.2009.06.022; Yang W, 2009, GENES IMMUN, V10, P219, DOI 10.1038/gene.2009.1; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V231, P499, DOI 10.1006/bbrc.1996.5923	13	262	273	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1186	1188		10.1038/ng.975	http://dx.doi.org/10.1038/ng.975			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019780				2022-12-25	WOS:000297931400009
J	Shi, YY; Li, ZQ; Xu, Q; Wang, T; Li, T; Shen, JW; Zhang, FY; Chen, JH; Zhou, GQ; Ji, WD; Li, BJ; Xu, YF; Liu, DT; Wang, P; Yang, P; Liu, BX; Sun, WS; Wan, CL; Qin, SY; He, G; Steinberg, S; Cichon, S; Werge, T; Sigurdsson, E; Tosato, S; Palotie, A; Nothen, MM; Rietschel, M; Ophoff, RA; Collier, DA; Rujescu, D; St Clair, D; Stefansson, H; Stefansson, K; Ji, J; Wang, QZ; Li, WJ; Zheng, LQ; Zhang, HR; Feng, GY; He, L				Shi, Yongyong; Li, Zhiqiang; Xu, Qi; Wang, Ti; Li, Tao; Shen, Jiawei; Zhang, Fengyu; Chen, Jianhua; Zhou, Guoquan; Ji, Weidong; Li, Baojie; Xu, Yifeng; Liu, Dengtang; Wang, Peng; Yang, Ping; Liu, Benxiu; Sun, Wensheng; Wan, Chunling; Qin, Shengying; He, Guang; Steinberg, Stacy; Cichon, Sven; Werge, Thomas; Sigurdsson, Engilbert; Tosato, Sarah; Palotie, Aarno; Noethen, Markus M.; Rietschel, Marcella; Ophoff, Roel A.; Collier, David A.; Rujescu, Dan; St Clair, David; Stefansson, Hreinn; Stefansson, Kari; Ji, Jue; Wang, Qingzhong; Li, Wenjin; Zheng, Linqing; Zhang, Hairong; Feng, Guoyin; He, Lin			Common variants on 8p12 and 1q24.2 confer risk of schizophrenia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; GENETIC ASSOCIATION; HAN CHINESE; LOCI; EXPRESSION; NUCLEOTIDE; MUTATIONS; DNA	Schizophrenia is a severe mental disorder affecting similar to 1% of the world population, with heritability of up to 80%. To identify new common genetic risk factors, we performed a genome-wide association study (GWAS) in the Han Chinese population. The discovery sample set consisted of 3,750 individuals with schizophrenia and 6,468 healthy controls (1,578 cases and 1,592 controls from northern Han Chinese, 1,238 cases and 2,856 controls from central Han Chinese, and 934 cases and 2,020 controls from the southern Han Chinese). We further analyzed the strongest association signals in an additional independent cohort of 4,383 cases and 4,539 controls from the Han Chinese population. Meta-analysis identified common SNPs that associated with schizophrenia with genome-wide significance on 8p12 (rs16887244, P = 1.27 x 10(-10)) and 1q24.2 (rs10489202, P = 9.50 x 10(-9)). Our findings provide new insights into the pathogenesis of schizophrenia.	[Shi, Yongyong; Li, Zhiqiang; Wang, Ti; Li, Tao; Shen, Jiawei; Li, Baojie; Wan, Chunling; Qin, Shengying; He, Guang; Ji, Jue; Wang, Qingzhong; Li, Wenjin; Zheng, Linqing; Zhang, Hairong; He, Lin] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Shi, Yongyong; Li, Zhiqiang; Qin, Shengying; He, Guang; He, Lin] Shanghai GenomePilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [Shi, Yongyong; Zhou, Guoquan; Ji, Weidong] Changning Mental Hlth Ctr, Shanghai, Peoples R China; [Xu, Qi] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Xu, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Fengyu; Feng, Guoyin] NIMH, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Chen, Jianhua; Xu, Yifeng; Liu, Dengtang] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [Wang, Peng; Yang, Ping] Fourth Peoples Hosp, Wuhu, Peoples R China; [Liu, Benxiu; Sun, Wensheng] Longquan Mt Hosp Guangxi Prov, Liuzhou, Peoples R China; [Steinberg, Stacy] deCODE Genet, Reykjavik, Iceland; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Res Ctr Juelich, Inst Neurosci & Med INM 1, Struct & Funct Org Brain Genom Imaging, Julich, Germany; [Werge, Thomas] Copenhagen Univ Hosp, Inst Biol Psychiat, Mental Hlth Ctr St Hans, Roskilde, Denmark; [Sigurdsson, Engilbert] Natl Univ Hosp Reykjavik, Dept Psychiat, Reykjavik, Iceland; [Tosato, Sarah] Univ Verona, Sect Psychiat & Clin Psychol, I-37100 Verona, Italy; [Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Univ Helsinki, FIMM, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA USA; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland; German Ctr Neurodegenerat Disorders, Bonn, Germany; [Rietschel, Marcella] Heidelberg Univ, Dept Genet Epidemiol Psychiat, Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Rietschel, Marcella] Univ Bonn, Dept Psychiat, Bonn, Germany; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Collier, David A.] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Rujescu, Dan] Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-8000 Munich, Germany; [St Clair, David] Univ Aberdeen, Dept Mental Hlth, Royal Cornhill Hosp, Aberdeen, Scotland; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [He, Lin] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Bonn; University of Bonn; Helmholtz Association; Research Center Julich; University of Copenhagen; Landspitali National University Hospital; University of Verona; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of London; King's College London; University of Munich; University of Aberdeen; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	shiyongyong@gmail.com; helinhelin@gmail.com	Rujescu, Dan/GRS-3875-2022; Sigurdsson, Engilbert/D-2486-2014; Tosato, Sarah/E-6045-2010; St Clair, David/AAN-2412-2021; Stefansson, Kari/AAE-7187-2019; Shi, Yongyong/GSO-1627-2022; Li, Zhiqiang/AAI-4003-2021; Xu, Yifeng/AAA-2064-2021; Zhang, Fengyu/M-1396-2019; Werge, Thomas/G-7263-2012; Cichon, Sven/H-8803-2013; Collier, David A/D-1649-2011; Chen, Jianhua/AAS-8417-2020; He, Guang/ABF-7381-2021; Cichon, Sven/B-9618-2014	Sigurdsson, Engilbert/0000-0001-9404-7982; Tosato, Sarah/0000-0002-9665-7538; Shi, Yongyong/0000-0003-1710-1505; Li, Zhiqiang/0000-0002-0174-9254; Xu, Yifeng/0000-0002-0403-1141; Zhang, Fengyu/0000-0001-8504-0770; Cichon, Sven/0000-0002-9475-086X; Collier, David A/0000-0003-4087-1559; He, Guang/0000-0002-4911-088X; Cichon, Sven/0000-0002-9475-086X; Stefansson, Hreinn/0000-0002-9331-6666; Palotie, Aarno/0000-0002-2527-5874; Nothen, Markus/0000-0002-8770-2464	973 Program [2010CB529600, 2009AA022701, 2006AA02A407]; Natural Science Foundation of China [81130022, 81121001, 31000553]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201026]; Program for New Century Excellent Talents in University [NCET-09-0550]; Shanghai Municipal Health Bureau [2008095]; Shanghai Changning Health Bureau [2008406002]; Shanghai Municipal Commission [09DJ1400601]; National Key Technology RD Program [2006BAI05A09]; Shanghai Leading Academic Discipline Project [B205]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022701] Funding Source: NIH RePORTER; Medical Research Council [G9817803B] Funding Source: researchfish	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Municipal Health Bureau; Shanghai Changning Health Bureau; Shanghai Municipal Commission; National Key Technology RD Program(National Key Technology R&D Program); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are deeply grateful to all the participants as well as to the doctors working on this project. The authors also thank the editors and anonymous reviewers for their valuable comments on the manuscript. This work was supported by grants from the 973 Program (2010CB529600, 2009AA022701, 2006AA02A407), the Natural Science Foundation of China (81130022, 81121001, 31000553), the Foundation for the Author of National Excellent Doctoral Dissertation of China (201026), the Program for New Century Excellent Talents in University (NCET-09-0550), the Shanghai Municipal Health Bureau program (2008095), the Shanghai Changning Health Bureau program (2008406002), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the National Key Technology R&D Program (2006BAI05A09) and the Shanghai Leading Academic Discipline Project (B205).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; He G, 2006, MOL PSYCHIATR, V11, P748, DOI 10.1038/sj.mp.4001841; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Klejbor I, 2006, J NEUROCHEM, V97, P1243, DOI 10.1111/j.1471-4159.2006.03754.x; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li T, 2010, BIOL PSYCHIAT, V68, P671, DOI 10.1016/j.biopsych.2010.06.014; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; O'Donovan MC, 2009, MOL PSYCHIATR, V14, P30, DOI 10.1038/mp.2008.108; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; van Scheltinga AFT, 2010, SCHIZOPHRENIA BULL, V36, P1157, DOI 10.1093/schbul/sbp033; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yi P, 2009, PRENATAL DIAG, V29, P217, DOI 10.1002/pd.2072	32	186	202	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1224	U79		10.1038/ng.980	http://dx.doi.org/10.1038/ng.980			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22037555	Green Accepted			2022-12-25	WOS:000297931400016
J	Khor, CC; Tran, NBC; Pang, JX; Davila, S; Long, HT; Ong, RTH; Dunstan, SJ; Wills, B; Farrar, J; Van Tram, T; Gan, TT; Nguyen, TNB; Tri, LT; Lien, LB; Tuan, NM; Nguyen, THT; Lanh, MN; Nguyet, NM; Hieu, NT; Nguyen, VC; Thuy, TT; Tan, DEK; Sakuntabhai, A; Teo, YY; Hibberd, ML; Simmons, CP				Khor, Chiea Chuen; Tran Nguyen Bich Chau; Pang, Junxiong; Davila, Sonia; Hoang Truong Long; Ong, Rick T. H.; Dunstan, Sarah J.; Wills, Bridget; Farrar, Jeremy; Ta Van Tram; Tran Thi Gan; Nguyen Thi Nguyet Binh; Le Trung Tri; Le Bich Lien; Nguyen Minh Tuan; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Nguyen Minh Nguyet; Nguyen Trong Hieu; Nguyen VanVinh Chau; Tran Thi Thuy; Tan, Dennis E. K.; Sakuntabhai, Anavaj; Teo, Yik-Ying; Hibberd, Martin L.; Simmons, Cameron P.			Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1	NATURE GENETICS			English	Article							PRIMARY-SCHOOL CHILDREN; HEMORRHAGIC-FEVER; DISEASE SEVERITY; ULCERATIVE-COLITIS; VIRUS-INFECTIONS; KAMPHAENG PHET; ETHNIC THAIS; POPULATION; VIETNAM; NKG2D	Hypovolemic shock (dengue shock syndrome (DSS)) is the most common life-threatening complication of dengue. We conducted a genome-wide association study of 2,008 pediatric cases treated for DSS and 2,018 controls from Vietnam. Replication of the most significantly associated markers was carried out in an independent Vietnamese sample of 1,737 cases and 2,934 controls. SNPs at two loci showed genome-wide significant association with DSS. We identified a susceptibility locus at MICB (major histocompatibility complex (MHC) class I polypeptide-related sequence B), which was within the broad MHC region on chromosome 6 but outside the class I and class II HLA loci (rs3132468, Pmeta = 4.41 x 10(-11), per-allele odds ratio (OR) = 1.34 (95% confidence interval: 1.23-1.46)). We identified associated variants within PLCE1 (phospholipase C, epsilon 1) on chromosome 10 (rs3765524, Pmeta = 3.08 x 10(-10), per-allele OR = 0.80 (95% confidence interval: 0.75-0.86)). We identify two loci associated with susceptibility to DSS in people with dengue, suggesting possible mechanisms for this severe complication of dengue.	[Khor, Chiea Chuen; Davila, Sonia; Ong, Rick T. H.; Hibberd, Martin L.] Natl Univ Singapore, Genome Inst Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Tran Nguyen Bich Chau; Hoang Truong Long; Dunstan, Sarah J.; Wills, Bridget; Farrar, Jeremy; Nguyen Minh Nguyet; Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Pang, Junxiong; Teo, Yik-Ying] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Dunstan, Sarah J.; Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Ta Van Tram; Tran Thi Gan] Tien Giang Hosp, My Tho City, Tien Giang Prov, Vietnam; [Nguyen Thi Nguyet Binh; Le Trung Tri] Sa Dec Hosp, Sa Dec Town, Dong Thap Provi, Vietnam; [Le Bich Lien; Nguyen Minh Tuan] Childrens Hosp 1, Dept Dengue Hemorrhag Fever, Ho Chi Minh City, Vietnam; [Nguyen Thi Hong Tham; Mai Ngoc Lanh] Dong Thap Hosp, Cao Lanh City, Dong Thap Provi, Vietnam; [Nguyen Trong Hieu] Hung Vuong Hosp, Ho Chi Minh City, Vietnam; [Nguyen VanVinh Chau] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tran Thi Thuy] Childrens Hosp 2, Dept Infect Dis, Ho Chi Minh City, Vietnam; [Sakuntabhai, Anavaj] Inst Pasteur, Lab Genet Reponse Infect Chez Homme, Paris, France; [Sakuntabhai, Anavaj] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Teo, Yik-Ying] Natl Univ Singapore, Fac Sci, Dept Stat & Appl Probabil, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; University of Oxford; National University of Singapore; University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; National University of Singapore	Hibberd, ML (corresponding author), Natl Univ Singapore, Genome Inst Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore.	hibberdml@gis.a-star.edu.sg; csimmons@oucru.org	Hibberd, Martin L/D-5050-2009; Dunstan, Sarah/AAO-9597-2020; Farrar, Jeremy J./HGA-7610-2022; Simmons, Cameron P/ABA-3896-2021; Pang, Junxiong/AAI-5115-2021	Simmons, Cameron P/0000-0002-9039-7392; Nguyen, Nguyet/0000-0002-5960-7849; Khor, Chiea Chuen/0000-0002-1128-4729; Tan, Dennis/0000-0001-6149-5084; Wills, Bridget/0000-0001-9086-8804; Hibberd, Martin/0000-0001-8587-1849; Dunstan, Sarah/0000-0001-7873-933X; Pang, Junxiong, Vincent/0000-0002-9788-701X; Farrar, Jeremy/0000-0002-2700-623X; Nguyen, Tuan/0000-0001-8058-7750	Wellcome Trust, United Kingdom [088791/A/09/Z, 084368/Z/07/Z]; Agency for Science, Technology and Research, Singapore	Wellcome Trust, United Kingdom(Wellcome Trust); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Wellcome Trust, United Kingdom (grant 088791/A/09/Z and 084368/Z/07/Z), and the Agency for Science, Technology and Research, Singapore.	Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Long TH, 2010, J VIROL, V84, P12982, DOI 10.1128/JVI.01224-10; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003; Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vejbaesya S, 2009, J INFECT DIS, V199, P1442, DOI 10.1086/597422	32	152	155	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1139	U134		10.1038/ng.960	http://dx.doi.org/10.1038/ng.960			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	22001756	Green Submitted, Green Accepted			2022-12-25	WOS:000296584000020
J	Negishi-Koga, T; Shinohara, M; Komatsu, N; Bito, H; Kodama, T; Friedel, RH; Takayanagi, H				Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Bito, Haruhiko; Kodama, Tatsuhiko; Friedel, Roland H.; Takayanagi, Hiroshi			Suppression of bone formation by osteoclastic expression of semaphorin 4D	NATURE MEDICINE			English	Article							NERVOUS-SYSTEM; OSTEOBLAST DIFFERENTIATION; BIOLOGICAL-ACTIVITY; SOLUBLE CD100; GROWTH CONE; PDZ-RHOGEF; B-CELL; RECEPTORS; MECHANISMS; PLEXIN-B1	Most of the currently available drugs for osteoporosis inhibit osteoclastic bone resorption; only a few drugs promote osteoblastic bone formation. It is thus becoming increasingly necessary to identify the factors that regulate bone formation. We found that osteoclasts express semaphorin 4D (Sema4D), previously shown to be an axon guidance molecule, which potently inhibits bone formation. The binding of Sema4D to its receptor Plexin-B1 on osteoblasts resulted in the activation of the small GTPase RhoA, which inhibits bone formation by suppressing insulin-like growth factor-1 (IGF-1) signaling and by modulating osteoblast motility. Sema4d(-/-) mice, Plxnb1(-/-) mice and mice expressing a dominant-negative RhoA specifically in osteoblasts showed an osteosclerotic phenotype due to augmented bone formation. Notably, Sema4D-specific antibody treatment markedly prevented bone loss in a model of postmenopausal osteoporosis. Thus, Sema4D has emerged as a new therapeutic target for the discovery and development of bone-increasing drugs.	[Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan; [Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, Takayanagi Osteonetwork Project, Tokyo, Japan; [Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Tokyo, Japan; [Bito, Haruhiko] Univ Tokyo, Dept Neurochem, Grad Sch Med, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Tokyo, Japan; [Friedel, Roland H.] Mt Sinai Sch Med, Dept Neurosurg, New York, NY USA; [Takayanagi, Hiroshi] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Perth, WA 6009, Australia	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Icahn School of Medicine at Mount Sinai; University of Western Australia	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan.	taka.csi@tmd.ac.jp	Bito, Haruhiko/A-8635-2008	Shinohara, Masahiro/0000-0002-5532-1042; Friedel, Roland/0000-0002-7513-3604; Bito, Haruhiko/0000-0001-6315-9594	Japan Science and Technology Agency; JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ichiro Kanehara Foundation; Uehara Memorial Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [20670002, 23659149] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ichiro Kanehara Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to G. Karsenty (Columbia University), K. Kobayashi (Fukushima Medical University School of Medicine), A. Kumanogoh (Osaka University) and T. Kitamura (The University of Tokyo) for kindly providing alpha(1)I-Cre mice, CAT-RhoA DN mice, recombinant Fc-sema4D protein, and the retrovirus vectors and Plat-E cells, respectively. We also thank E. Sumiya, A. Suematsu, Y. Kunisawa, T. Ando, K. Okamoto, T. Nakashima, M. Oh-hora, M. Hayashi, A. Terashima, Y. Nagai and H. Negishi for discussion and assistance. This work was supported in part by a grant for the Exploratory Research for Advanced Technology, Takayanagi Osteonetwork Project from the Japan Science and Technology Agency, Grant-in-Aid for Young Scientist A, Grant-in-Aid for Challenging Exploratory Research and Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science, a grant for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Ichiro Kanehara Foundation, the Uehara Memorial Foundation and the Naito Foundation.	Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Delorme G, 2005, BIOL CELL, V97, P589; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; HAYDEN JM, 1995, BONE, V17, P93; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koh JM, 2006, J HUM GENET, V51, P112, DOI 10.1007/s10038-005-0331-z; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Parfitt AM, 1996, J BONE MINER RES, V11, P150; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Regev A, 2005, FERTIL STERIL, V84, P1210, DOI 10.1016/j.fertnstert.2005.05.011; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Sutton ALM, 2008, MOL ENDOCRINOL, V22, P1370, DOI 10.1210/me.2007-0363; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; TAKAHASHI H, 1964, Surg Forum, V15, P437; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	55	314	354	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1473	U181		10.1038/nm.2489	http://dx.doi.org/10.1038/nm.2489			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22019888				2022-12-25	WOS:000296779300039
J	Stacey, SN; Sulem, P; Jonasdottir, A; Masson, G; Gudmundsson, J; Gudbjartsson, DF; Magnusson, OT; Gudjonsson, SA; Sigurgeirsson, B; Thorisdottir, K; Ragnarsson, R; Benediktsdottir, KR; Nexo, BA; Tjonneland, A; Overvad, K; Rudnai, P; Gurzau, E; Koppova, K; Hemminki, K; Corredera, C; Fuentelsaz, V; Grasa, P; Navarrete, S; Fuertes, F; Garcia-Prats, MD; Sanambrosio, E; Panadero, A; De Juan, A; Garcia, A; Rivera, F; Planelles, D; Soriano, V; Requena, C; Aben, KK; van Rossum, MM; Cremers, RGHM; van Oort, IM; van Spronsen, DJ; Schalken, JA; Peters, WHM; Helfand, BT; Donovan, JL; Hamdy, FC; Badescu, D; Codreanu, O; Jinga, M; Csiki, IE; Constantinescu, V; Badea, P; Mates, IN; Dinu, DE; Constantin, A; Mates, D; Kristjansdottir, S; Agnarsson, BA; Jonsson, E; Barkardottir, RB; Einarsson, GV; Sigurdsson, F; Moller, PH; Stefansson, T; Valdimarsson, T; Johannsson, OT; Sigurdsson, H; Jonsson, T; Jonasson, JG; Tryggvadottir, L; Rice, T; Hansen, HM; Xiao, YY; Lachance, DH; Neill, BPO; Kosel, ML; Decker, PA; Thorleifsson, G; Johannsdottir, H; Helgadottir, HT; Sigurdsson, A; Steinthorsdottir, V; Lindblom, A; Sandler, RS; Keku, TO; Banasik, K; Jorgensen, T; Witte, DR; Hansen, T; Pedersen, O; Jinga, V; Neal, DE; Catalona, WJ; Wrensch, M; Wiencke, J; Jenkins, RB; Nagore, E; Vogel, U; Kiemeney, LA; Kumar, R; Mayordomo, JI; Olafsson, JH; Kong, A; Thorsteinsdottir, U; Rafnar, T; Stefansson, K				Stacey, Simon N.; Sulem, Patrick; Jonasdottir, Aslaug; Masson, Gisli; Gudmundsson, Julius; Gudbjartsson, Daniel F.; Magnusson, Olafur T.; Gudjonsson, Sigurjon A.; Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Nexo, Bjorn A.; Tjonneland, Anne; Overvad, Kim; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Hemminki, Kari; Corredera, Cristina; Fuentelsaz, Victoria; Grasa, Pilar; Navarrete, Sebastian; Fuertes, Fernando; Garcia-Prats, Maria D.; Sanambrosio, Enrique; Panadero, Angeles; De Juan, Ana; Garcia, Almudena; Rivera, Fernando; Planelles, Dolores; Soriano, Virtudes; Requena, Celia; Aben, Katja K.; van Rossum, Michelle M.; Cremers, Ruben G. H. M.; van Oort, Inge M.; van Spronsen, Dick-Johan; Schalken, Jack A.; Peters, Wilbert H. M.; Helfand, Brian T.; Donovan, Jenny L.; Hamdy, Freddie C.; Badescu, Daniel; Codreanu, Ovidiu; Jinga, Mariana; Csiki, Irma E.; Constantinescu, Vali; Badea, Paula; Mates, Ioan N.; Dinu, Daniela E.; Constantin, Adrian; Mates, Dana; Kristjansdottir, Sjofn; Agnarsson, Bjarni A.; Jonsson, Eirikur; Barkardottir, Rosa B.; Einarsson, Gudmundur V.; Sigurdsson, Fridbjorn; Moller, Pall H.; Stefansson, Tryggvi; Valdimarsson, Trausti; Johannsson, Oskar T.; Sigurdsson, Helgi; Jonsson, Thorvaldur; Jonasson, Jon G.; Tryggvadottir, Laufey; Rice, Terri; Hansen, Helen M.; Xiao, Yuanyuan; Lachance, Daniel H.; Neill, Brian Patrick O'; Kosel, Matthew L.; Decker, Paul A.; Thorleifsson, Gudmar; Johannsdottir, Hrefna; Helgadottir, Hafdis T.; Sigurdsson, Asgeir; Steinthorsdottir, Valgerdur; Lindblom, Annika; Sandler, Robert S.; Keku, Temitope O.; Banasik, Karina; Jorgensen, Torben; Witte, Daniel R.; Hansen, Torben; Pedersen, Oluf; Jinga, Viorel; Neal, David E.; Catalona, William J.; Wrensch, Margaret; Wiencke, John; Jenkins, Robert B.; Nagore, Eduardo; Vogel, Ulla; Kiemeney, Lambertus A.; Kumar, Rajiv; Mayordomo, Jose I.; Olafsson, Jon H.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari		Swedish Low-Risk Colorectal Canc	A germline variant in the TP53 polyadenylation signal confers cancer susceptibility	NATURE GENETICS			English	Article							GENETIC-DETERMINANTS; SEQUENCE VARIANTS; COMMON VARIANTS; BASAL; PIGMENTATION; P53; MUTATIONS; ASSOCIATE; MELANOMA	To identify new risk variants for cutaneous basal cell carcinoma, we performed a genome-wide association study of 16 million SNPs identified through whole-genome sequencing of 457 Icelanders. We imputed genotypes for 41,675 Illumina SNP chip-typed Icelanders and their relatives. In the discovery phase, the strongest signal came from rs78378222[C] (odds ratio (OR) = 2.36, P = 5.2 x 10(-17)), which has a frequency of 0.0192 in the Icelandic population. We then confirmed this association in non-Icelandic samples (OR = 1.75, P = 0.0060; overall OR = 2.16, P = 2.2 x 10(-20)). rs78378222 is in the 3' untranslated region of TP53 and changes the AATAAA polyadenylation signal to AATACA, resulting in impaired 3'-end processing of TP53 mRNA. Investigation of other tumor types identified associations of this SNP with prostate cancer (OR = 1.44, P = 2.4 x 10(-6)), glioma (OR = 2.35, P = 1.0 x 10(-5)) and colorectal adenoma (OR = 1.39, P = 1.6 x 10(-4)). However, we observed no effect for breast cancer, a common Li-Fraumeni syndrome tumor (OR = 1.06, P = 0.57, 95% confidence interval 0.88-1.27).	[Stacey, Simon N.; Sulem, Patrick; Jonasdottir, Aslaug; Masson, Gisli; Gudmundsson, Julius; Gudbjartsson, Daniel F.; Magnusson, Olafur T.; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Johannsdottir, Hrefna; Helgadottir, Hafdis T.; Sigurdsson, Asgeir; Steinthorsdottir, Valgerdur; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Agnarsson, Bjarni A.; Jonsson, Eirikur; Barkardottir, Rosa B.; Einarsson, Gudmundur V.; Sigurdsson, Fridbjorn; Moller, Pall H.; Stefansson, Tryggvi; Johannsson, Oskar T.; Sigurdsson, Helgi; Jonsson, Thorvaldur; Jonasson, Jon G.; Olafsson, Jon H.] Landspitali Univ Hosp, Reykjavik, Iceland; [Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Agnarsson, Bjarni A.; Jonsson, Eirikur; Barkardottir, Rosa B.; Jonasson, Jon G.; Olafsson, Jon H.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Nexo, Bjorn A.] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Overvad, Kim] Univ Aarhus, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, Banska Bystrica, Slovakia; [Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Corredera, Cristina; Grasa, Pilar] Univ Zaragoza, Div Dermatol, Zaragoza, Spain; [Fuentelsaz, Victoria] Gregorio Maranon Univ Hosp, Div Dermatol, Madrid, Spain; [Navarrete, Sebastian; Fuertes, Fernando] Univ Zaragoza, Div Radiat Oncol, Zaragoza, Spain; [Garcia-Prats, Maria D.] San Jorge Gen Hosp, Div Pathol, Huesca, Spain; [Sanambrosio, Enrique] Gen Hosp, Div Surg, Soria, Spain; [Panadero, Angeles] Ciudad Coria Hosp, Div Med Oncol, Coria, Spain; [De Juan, Ana; Garcia, Almudena; Rivera, Fernando] Marques de Valdecilla Univ Hosp, Div Med Oncol, Santander, Spain; [Planelles, Dolores] Ctr Transfus Comunidad Valenciana, Lab Histocompatibil Mol Biol, Valencia, Spain; [Soriano, Virtudes] Inst Valenciano Oncol, Dept Oncol, Valencia, Spain; [Requena, Celia; Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain; [Aben, Katja K.; Cremers, Ruben G. H. M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K.] Comprehens Canc Ctr Netherlands, Nijmegen, Netherlands; [van Rossum, Michelle M.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Cremers, Ruben G. H. M.; van Oort, Inge M.; Schalken, Jack A.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [van Spronsen, Dick-Johan] Canisius Wilhelmina Ziekenhuis, Dept Internal Med, Nijmegen, Netherlands; [Peters, Wilbert H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands; [Helfand, Brian T.; Catalona, William J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Donovan, Jenny L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hamdy, Freddie C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England; [Mates, Ioan N.; Dinu, Daniela E.; Constantin, Adrian] Univ Med & Pharm Carol Davila, St Mary Surg Clin, Bucharest, Romania; [Csiki, Irma E.; Constantinescu, Vali; Badea, Paula; Mates, Dana] Natl Inst Publ Hlth, Bucharest, Romania; [Kristjansdottir, Sjofn] Speglun Ehf, Reykjavik, Iceland; [Valdimarsson, Trausti] Domus Med, Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [Rice, Terri; Hansen, Helen M.; Wrensch, Margaret; Wiencke, John] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Xiao, Yuanyuan; Wrensch, Margaret; Wiencke, John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lachance, Daniel H.; Neill, Brian Patrick O'] Mayo Clin, Dept Neurol, Rochester, MN USA; [Kosel, Matthew L.; Decker, Paul A.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Sandler, Robert S.; Keku, Temitope O.] Univ N Carolina, Univ Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Banasik, Karina; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben; Pedersen, Oluf] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England; [Jenkins, Robert B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza, Spain	Landspitali National University Hospital; University of Iceland; Aarhus University; Danish Cancer Society; Aarhus University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zaragoza; General University Gregorio Maranon Hospital; University of Zaragoza; Hospital Universidad San Jorge; Hospital Universitario Marques de Valdecilla (HUMV); Instituto Valenciano De Oncologia; Instituto Valenciano De Oncologia; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; Northwestern University; Feinberg School of Medicine; University of Bristol; University of Oxford; Carol Davila University of Medicine & Pharmacy; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Southern Denmark; Novo Nordisk; Hagedorn Research Institute; Aarhus University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Mayo Clinic; National Research Centre for the Working Environment; Miguel Servet University Hospital	Stacey, SN (corresponding author), deCODE Genet, Reykjavik, Iceland.	simon.stacey@decode.is; kari.stefansson@decode.is	van Oort, Inge/AAD-1197-2020; Rossum, M.M./L-4614-2015; Witte, Daniel/AAF-9535-2019; Vogel, Ulla B/I-5048-2012; Sigurgeirsson, Bárður/B-6130-2011; Soriano, Vicente/O-5730-2018; Schalken, Jack A/B-1277-2014; Pedersen, Oluf/Z-1731-2019; Sigurgeirsson, Bardur/AAP-7755-2020; PLANELLES, DOLORES/F-2689-2015; Aben, Katja KH/G-9686-2016; PLANELLES, DOLORES/AAS-5437-2020; Peters, W.H.M./L-4572-2015; Jinga, Mariana/AAA-7101-2022; Kumar, Rajiv/H-6431-2019; Kiemeney, Lambertus A./D-3357-2009; Mayordomo, Jose/K-3453-2013; Vogel, Ulla/ABC-2212-2020; Mates, Ioan Nicolae/E-9255-2017; Stefansson, Tryggvi/U-1023-2019; Banasik, Karina/G-1728-2013; Nagore, Eduardo/Z-2126-2019; Witte, Daniel R/C-1722-2008; Banasik, Karina/S-3475-2019; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/AAG-8015-2020; Rice, Terri/J-6071-2014; Stefansson, Kari/AAE-7187-2019; Requena, Celia/Z-2344-2019; van Oort, Inge/L-4554-2015	van Oort, Inge/0000-0002-8002-1869; Witte, Daniel/0000-0002-0769-2922; Vogel, Ulla B/0000-0001-6807-1524; Soriano, Vicente/0000-0002-4624-5199; Schalken, Jack A/0000-0001-8274-7797; Pedersen, Oluf/0000-0002-3321-3972; PLANELLES, DOLORES/0000-0001-6433-4825; Aben, Katja KH/0000-0002-0214-2147; PLANELLES, DOLORES/0000-0001-6433-4825; Jinga, Mariana/0000-0001-5826-0815; Kumar, Rajiv/0000-0002-6093-0395; Kiemeney, Lambertus A./0000-0002-2368-1326; Vogel, Ulla/0000-0001-6807-1524; Nagore, Eduardo/0000-0003-3433-8707; Witte, Daniel R/0000-0002-0769-2922; Banasik, Karina/0000-0003-2489-2499; van Oort, Inge/0000-0002-8002-1869; mates, dana/0000-0002-6219-9807; Tryggvadottir, Laufey/0000-0001-8067-9030; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Overvad, Kim/0000-0001-6429-7921; Gudbjartsson, Daniel/0000-0002-5222-9857; Gurzau, Eugen/0000-0002-8688-6118; Smedh, Kenneth/0000-0002-7056-670X; Neal, David/0000-0002-6033-5086; Jonasson, Jon G./0000-0002-2635-5032; Hansen, Torben/0000-0001-8748-3831; Hamdy, Freddie/0000-0003-2627-2154; Sigurgeirsson, Bardur/0000-0002-9733-9742; Tjonneland, Anne/0000-0003-4385-2097; Jorgensen, Torben/0000-0001-9453-2830; Kong, Augustine/0000-0001-8193-5438; Helgadottir, Hafdis/0000-0003-4352-152X; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Ioan Nicoale, Mates/0000-0001-7210-0615	European Union [202059]; Danish Cancer Society; Danish Research Council; Danish Centre for Health Technology Assessment; Novo Nordisk Inc.; Research Foundation of Copenhagen County; Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; US National Institutes of Health (NIH) [R01CA52689]; UCSF Brain Tumor SPORE [P50CA097257]; National Brain Tumor Foundation; UCSF Lewis Chair in Brain Tumor Research; Mayo Clinic Brain Tumor SPORE [NIH P50 CA108961]; Mayo Clinic Comprehensive Cancer Center [NIH P30 CA15083]; American Recovery and Reinvestment Act (ARRA) [NIH NS068222]; Urological Research Foundation [P50 CA90386-05S2]; Robert H. Lurie Comprehensive Cancer Center [P30 CA60553]; National Institute for Health Research (NIHR) [96/20/06, 96/20/99]; Romanian National Council For Scientific Research (CNCSIS-UEFISCSU) [PNII-IDEI 1184/2008]; Red Tematica de Investigacion Cooperative en Cancer [RD06/0020/1054]; MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA015083, P30CA060553, P50CA097257, P50CA090386, R01CA052689, P50CA108961] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068222] Funding Source: NIH RePORTER	European Union(European Commission); Danish Cancer Society(Danish Cancer Society); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Centre for Health Technology Assessment; Novo Nordisk Inc.(Novo Nordisk); Research Foundation of Copenhagen County; Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Brain Tumor SPORE; National Brain Tumor Foundation; UCSF Lewis Chair in Brain Tumor Research; Mayo Clinic Brain Tumor SPORE; Mayo Clinic Comprehensive Cancer Center; American Recovery and Reinvestment Act (ARRA); Urological Research Foundation; Robert H. Lurie Comprehensive Cancer Center; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Romanian National Council For Scientific Research (CNCSIS-UEFISCSU)(Consiliul National al Cercetarii Stiintifice (CNCS)); Red Tematica de Investigacion Cooperative en Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work at deCODE genetics was funded in part by contract number 202059 (PROMARK) from the 7th Framework Program of the European Union. The Danish study 'Diet, Cancer and Health' was supported by grants from the Danish Cancer Society and 'Europe against cancer': European Prospective Investigation into Cancer and Nutrition (EPIC). The Inter99 study 'A population-based primary prevention study on cardiovascular disease and type 2 diabetes' was initiated by T. Jorgensen (principal investigator), K. Borch-Johnsen (co-principal investigator), H. Ibsen and T.F. Thomsen. The steering committee comprises the former two individuals and C. Pisinger. The establishment of the cohort was financially supported by research grants from the Danish Research Council, The Danish Centre for Health Technology Assessment, Novo Nordisk Inc., Research Foundation of Copenhagen County, the Ministry of Internal Affairs and Health, The Danish Heart Foundation, The Danish Pharmaceutical Association, The Augustinus Foundation, The Ib Henriksen Foundation and the Becket Foundation. The University of California, San Francisco (UCSF) Adult Glioma Study also acknowledges the people who have made substantial contributions to subject recruitment, specimen processing, pathology review and data analysis, including L.S. McCoy, I. Smirnov, J.S. Patoka, M.D. Prados, S.M. Chang and M.S. Berger (Department of Neurological Surgery, UCSF), J.L. Wiemels (Department of Epidemiology and Biostatistics, UCSF) and T. Tihan (Department of Pathology, UCSF). Work at the University of California, San Francisco has been supported by US National Institutes of Health (NIH) grants R01CA52689 and UCSF Brain Tumor SPORE, P50CA097257, as well as by grants from the National Brain Tumor Foundation, the UCSF Lewis Chair in Brain Tumor Research and by donations from families and friends of J. Berardi, H. Glaser, E. Olsen, R. E. Cooper and W. Martinusen. Work at the Mayo Clinic has been supported by the Mayo Clinic Brain Tumor SPORE (NIH P50 CA108961), the Mayo Clinic Comprehensive Cancer Center (NIH P30 CA15083) and an American Recovery and Reinvestment Act (ARRA) Recovery grant (NIH NS068222). Members of the Swedish Low-risk Colorectal Cancer Study Group are: D. Edler, Karolinska Universitetssjukhuset, Solna, Stockholm, Sweden; C. Lenander, Mag-tarm-centrum, Ersta sjukhus, Stockholm, Sweden; J. Dalen, St Grans sjukhus, Stockholm, Sweden; F. Hjern, Danderyds sjukhus, Danderyd, Sweden; N. Lundqvist, Norrt lje sjukhus, Norrt lje, Sweden; U. Lindforss, Sdert lje sjukhus, Sdert lje, Sweden; L. Pahlman, Akademiska sjukhuset, Uppsala, Sweden; K. Smedh, Centrallasarettet, V steres, Sweden; A. Trnqvist, Centralsjukhuset, Karlstad, Sweden; J. Holm, L nssjukhuset G vle-Sandviken, G vle. Sweden; M. Janson, Karolinska Universitetssjukhuset, Huddinge, Huddinge, Sweden; M. Andersson, Universitetssjukhuset, rebro, Sweden; S. Ekelund, Sdersjukhuset, Stockholm, Sweden; and E. Olsson, M larsjukhuset, Eskilstuna, Sweden. Work on the US Prostate Cancer sample set was supported in part by the Urological Research Foundation, Prostate SPORE grant (P50 CA90386-05S2) and the Robert H. Lurie Comprehensive Cancer Center grant (P30 CA60553). For the UK Prostate Cancer sample set, the UK Department of Health funded the ProtecT study through the National Institute for Health Research (NIHR) Health Technology Assessment programme (projects 96/20/06, 96/20/99). We acknowledge the contribution of all members of the ProtecT study research group.; We acknowledge the support of the NIHR Cambridge Biomedical Research Centre and the Natinal Cancer Research Institute (ProMPT) Prostate Cancer Collaborative. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the UK Department of Health. Sample collection in Romania was supported in part by the Romanian National Council For Scientific Research (CNCSIS-UEFISCSU), grant PNII-IDEI 1184/2008. In Spain, J.I.M. is funded by Red Tematica de Investigacion Cooperative en Cancer RD06/0020/1054.	BIRCH JM, 1994, CANCER RES, V54, P1298; Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; de Zwaan SE, 2010, AUSTRALAS J DERMATOL, V51, P81, DOI 10.1111/j.1440-0960.2009.00579.x; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; HIGGS DR, 1983, NATURE, V306, P398, DOI 10.1038/306398a0; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lalloo F, 2003, LANCET, V361, P1101, DOI 10.1016/S0140-6736(03)12856-5; LI FP, 1988, CANCER RES, V48, P5358; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Miller AJ, 2010, BRIT J DERMATOL, V162, P22, DOI 10.1111/j.1365-2133.2009.09565.x; Palmero EI, 2010, CURR OPIN ONCOL, V22, P64, DOI 10.1097/CCO.0b013e328333bf00; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584	25	199	204	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1098	U85		10.1038/ng.926	http://dx.doi.org/10.1038/ng.926			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21946351	Green Accepted, Green Published			2022-12-25	WOS:000296584000013
J	Arakawa, S; Takahashi, A; Ashikawa, K; Hosono, N; Aoi, T; Yasuda, M; Oshima, Y; Yoshida, S; Enaida, H; Tsuchihashi, T; Mori, K; Honda, S; Negi, A; Arakawa, A; Kadonosono, K; Kiyohara, Y; Kamatani, N; Nakamura, Y; Ishibashi, T; Kubo, M				Arakawa, Satoshi; Takahashi, Atsushi; Ashikawa, Kyota; Hosono, Naoya; Aoi, Tomomi; Yasuda, Miho; Oshima, Yuji; Yoshida, Shigeo; Enaida, Hiroshi; Tsuchihashi, Takashi; Mori, Keisuke; Honda, Shigeru; Negi, Akira; Arakawa, Akira; Kadonosono, Kazuaki; Kiyohara, Yutaka; Kamatani, Naoyuki; Nakamura, Yusuke; Ishibashi, Tatsuro; Kubo, Michiaki			Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population	NATURE GENETICS			English	Article							RETINAL ANGIOMATOUS PROLIFERATION; POLYPOIDAL CHOROIDAL VASCULOPATHY; TOMOGRAPHIC FEATURES; GENETIC-VARIANTS; FACTOR-B; POLYMORPHISM; APOPTOSIS; RISK; PATHWAY; LINKAGE	Age-related macular degeneration (AMD), the leading cause of irreversible blindness in the world, is a complex disease caused by multiple environmental and genetic risk factors. To identify genetic factors that modify the risk of exudative AMD in the Japanese population, we conducted a genome-wide association study and a replication study using a total of 1,536 individuals with exudative AMD and 18,894 controls. In addition to CFH (rs800292, P = 4.23 x 10(-15)) and ARMS2 (rs3750847, P = 8.67 x 10(-29)) loci, we identified two new susceptibility loci for exudative AMD: TNFRSF10A-LOC389641 on chromosome 8p21 (rs13278062, combined P = 1.03 x 10(-12), odds ratio = 0.73) and REST-C4orf14-POLR2B-IGFBP7 on chromosome 4q12 (rs1713985, combined P = 2.34 x 10(-8), odds ratio = 1.30). Fine mapping revealed that rs13278062, which is known to alter TNFRSF10A transcriptional activity, had the most significant association in 8p21 region. Our results provide new insights into the pathophysiology of exudative AMD.	[Arakawa, Satoshi; Ashikawa, Kyota; Hosono, Naoya; Aoi, Tomomi; Kubo, Michiaki] RIKEN Yokohama Inst, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Arakawa, Satoshi; Yasuda, Miho; Oshima, Yuji; Yoshida, Shigeo; Enaida, Hiroshi; Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN Yokohama Inst, Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Tsuchihashi, Takashi; Mori, Keisuke] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan; [Honda, Shigeru; Negi, Akira] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 657, Japan; [Arakawa, Akira; Kadonosono, Kazuaki] Yokohama City Univ, Dept Ophthalmol, Med Ctr, Yokohama, Kanagawa 232, Japan; [Kiyohara, Yutaka] Kyushu Univ, Dept Environm Med, Grad Sch Med Sci, Fukuoka 812, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan	RIKEN; Kyushu University; RIKEN; Saitama Medical University; Kobe University; Yokohama City University; Kyushu University; University of Tokyo	Kubo, M (corresponding author), RIKEN Yokohama Inst, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan.	mkubo@src.riken.jp	Honda, Shigeru/W-4761-2019; Kubo, Michiaki/N-7947-2015	Yoshida, Shigeo/0000-0003-1049-8909	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all of the subjects who participated in this study. We are grateful to A. Yoshida, K. Kano, S. Kawahara, R. Arita, K. Ishikawa, E. Hasegawa, R. Asato, S. Notomi, T. Asakuma and A. Kuni of the Kyushu University, K. Horie-Inoue, S. Inoue and T. Awata of the Saitama Medical University, H. Bessho, N. Kondo and W. Matsumiya of the Kobe university and M. Inoue of the Yokohama City University Medical Center for collecting samples. We thank the staff of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, the staffs of the BioBank Japan project and the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan. We want to express special thanks to F. Miya for the support of gene expression data. This work was conducted as a part of the BioBank Japan Project and supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Matsumoto H, 2010, RETINA-J RET VIT DIS, V30, P425, DOI 10.1097/IAE.0b013e3181bd2d95; Montes T, 2009, P NATL ACAD SCI USA, V106, P4366, DOI 10.1073/pnas.0812584106; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Parapuram SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013885; Parihar A, 2008, LIFE SCI, V82, P1077, DOI 10.1016/j.lfs.2008.03.019; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sato T, 2007, RETINA-J RET VIT DIS, V27, P589, DOI 10.1097/01.iae.0000249386.63482.05; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Wang ML, 2009, MUTAT RES-FUND MOL M, V661, P85, DOI 10.1016/j.mrfmmm.2008.11.009; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017; Yuzawa M, 1997, INT OPHTHALMOL, V21, P1, DOI 10.1023/A:1005845521424	35	107	112	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					1001	U114		10.1038/ng.938	http://dx.doi.org/10.1038/ng.938			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21909106	Green Published			2022-12-25	WOS:000295316200016
J	Kwon, C; Cheng, P; King, IN; Andersen, P; Shenje, L; Nigam, V; Srivastava, D				Kwon, Chulan; Cheng, Paul; King, Isabelle N.; Andersen, Peter; Shenje, Lincoln; Nigam, Vishal; Srivastava, Deepak			Notch post-translationally regulates beta-catenin protein in stem and progenitor cells	NATURE CELL BIOLOGY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GAMMA-SECRETASE; EXPRESSION; CANCER; DIFFERENTIATION; ACTIVATION; INHIBITORS; INDUCTION; RELEASE; RENEWAL	Cellular decisions of self-renewal or differentiation arise from integration and reciprocal titration of numerous regulatory networks. Notch and Wnt/beta-catenin signalling often intersect in stem and progenitor cells and regulate each other transcriptionally. The biological outcome of signalling through each pathway often depends on the context and timing as cells progress through stages of differentiation. Here, we show that membrane-bound Notch physically associates with unphosphorylated (active) beta-catenin in stem and colon cancer cells and negatively regulates post-translational accumulation of active beta-catenin protein. Notch-dependent regulation of beta-catenin protein did not require ligand-dependent membrane cleavage of Notch or the glycogen synthase kinase-3 beta-dependent activity of the beta-catenin destruction complex. It did, however, require the endocytic adaptor protein Numb and lysosomal activity. This study reveals a previously unrecognized function of Notch in negatively titrating active beta-catenin protein levels in stem and progenitor cells.	[Kwon, Chulan; Cheng, Paul; King, Isabelle N.; Nigam, Vishal; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Kwon, Chulan; Cheng, Paul; King, Isabelle N.; Nigam, Vishal; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Kwon, Chulan; Cheng, Paul; King, Isabelle N.; Nigam, Vishal; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kwon, Chulan; Andersen, Peter; Shenje, Lincoln] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University	Kwon, C (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	ckwon13@jhmi.edu; dsrivastava@gladstone.ucsf.edu		Nigam, Vishal/0000-0002-9652-8146; Cheng, Paul/0000-0003-3429-2702; Andersen, Peter/0000-0003-3971-0467	American Heart Association; National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH) [1K99HL092234, 4R00HL09223, P01 HL089707, U01 HL100406]; March of Dimes Basil O'Connor Award; California Institute for Regenerative Medicine; Younger Family Foundation; NIH/National Center for Research Resources [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, R00HL092234, K08HL079260, U01HL100406, K99HL092234] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); March of Dimes Basil O'Connor Award(March of Dimes); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Younger Family Foundation; NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Kopan (Washington University), M. Nakafuku (Cincinnati Children's Hospital), T. Honjo (Kyoto University) and P. Stanley (Albert Einstein College of Medicine) for providing tethered Notch constructs, Notch deletion constructs, RBP-J<SUP>flox</SUP> mice and Notch1<SUP>lbd/lbd</SUP> ES cells, respectively. The authors thank G. Howard and S. Ordway for editorial assistance, Srivastava and Kwon laboratory members for discussions, B. Taylor for assistance with manuscript and figure preparation and B. Bruneau for critical reading of the manuscript. We also thank J. Fish and C. Miller in the Gladstone Histology core. C.K. was supported by grants from the American Heart Association Beginning Grant-in-Aid and National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH; 1K99HL092234, 4R00HL09223); I.N.K. was supported by a March of Dimes Basil O'Connor Award; D.S. was supported by grants from NHLBI/NIH (P01 HL089707, U01 HL100406), the California Institute for Regenerative Medicine and the Younger Family Foundation. This work was supported by NIH/National Center for Research Resources grant C06 RR018928 to the Gladstone Institute.	Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ge CH, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-36; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Sanders PGT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000169; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; TAPPER H, 1995, J CELL PHYSIOL, V163, P137, DOI 10.1002/jcp.1041630116; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong WM, 1997, DEVELOPMENT, V124, P1887	40	195	205	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1244	U169		10.1038/ncb2313	http://dx.doi.org/10.1038/ncb2313			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21841793	Green Accepted, Green Submitted			2022-12-25	WOS:000295617900014
J	Sim, FJ; McClain, CR; Schanz, SJ; Protack, TL; Windrem, MS; Goldman, SA				Sim, Fraser J.; McClain, Crystal R.; Schanz, Steven J.; Protack, Tricia L.; Windrem, Martha S.; Goldman, Steven A.			CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells	NATURE BIOTECHNOLOGY			English	Article							SUBCORTICAL WHITE-MATTER; ADULT HUMAN BRAIN; GROWTH-FACTOR RECEPTOR; PDGF ALPHA-RECEPTOR; MONOCLONAL-ANTIBODY; MULTIPLE-SCLEROSIS; NG2 PROTEOGLYCAN; PRECURSOR CELLS; STEM-CELLS; RAT-BRAIN	Experimental animals with myelin disorders can be treated by transplanting oligodendrocyte progenitor cells (OPCs) into the affected brain or spinal cord. OPCs have been isolated by their expression of gangliosides recognized by mAb A2B5, but this marker also identifies lineage-restricted astrocytes and immature neurons. To establish a more efficient means of isolating myelinogenic OPCs, we sorted fetal human forebrain cells for CD140a, an epitope of platelet derived growth factor receptor (PDGFR) a, which is differentially expressed by OPCs. CD140a(+) cells were isolated as mitotic bipotential progenitors that initially expressed neither mature neuronal nor astrocytic phenotypic markers, yet could be instructed to either oligodendrocyte or astrocyte fate in vitro. Transplanted CD140a(+) cells were highly migratory and robustly myelinated the hypomyelinated shiverer mouse brain more rapidly and efficiently than did A2B5(+) cells. Microarray analysis of CD140a(+) cells revealed overexpression of the oligodendroglial marker CD9, suggesting that CD9(+)/CD140a(+) cells may constitute an even more highly enriched population of myelinogenic progenitor cells.	[Sim, Fraser J.; McClain, Crystal R.; Schanz, Steven J.; Protack, Tricia L.; Windrem, Martha S.; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Sim, Fraser J.; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Sim, Fraser J.] SUNY Buffalo, Dept Pharmacol, Buffalo, NY 14260 USA	University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sim, FJ (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	fjsim@buffalo.edu; Steven_Goldman@urmc.rochester.edu	Sim, Fraser/G-3060-2010	Sim, Fraser/0000-0002-3942-6637; Goldman, Steven/0000-0002-5498-4303	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS039559, R01NS75345, P01NS050315]; National Multiple Sclerosis Society; New York State Stem Cell Research Board (NYSTEM); Adelson Medical Research Foundation; Mathers Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS050315, R01NS075345, R01NS039559] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); New York State Stem Cell Research Board (NYSTEM); Adelson Medical Research Foundation; Mathers Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) grants R01NS039559, R01NS75345 and P01NS050315, the National Multiple Sclerosis Society, the New York State Stem Cell Research Board (NYSTEM), the Adelson Medical Research Foundation, and the Mathers Charitable Foundation. We would like to thank X.-J. Li for technical support, and M. Zanche, A. Cardillo and the University of Rochester Medical Center Functional Genomics core for Affymetrix and Taqman array support. O4 supernatant was a gift of R. Bansal and the late S. Pfeiffer (University of Connecticut).	ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; Back SA, 2001, J NEUROSCI, V21, P1302; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Furge K., 2006, R PACKAGE VERSION, P1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOGATE N, 1994, J NEUROSCI, V14, P4571; Goldman SA, 2011, ARCH NEUROL-CHICAGO, V68, P848, DOI 10.1001/archneurol.2011.46; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keyoung HM, 2007, NEUROSURG CLIN N AM, V18, P93, DOI 10.1016/j.nec.2006.10.009; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; LAROCHELLE WJ, 1993, CELL GROWTH DIFFER, V4, P547; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; Mabie PC, 1997, J NEUROSCI, V17, P4112; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Scolding N, 1998, NEUROSCIENTIST, V4, P264, DOI 10.1177/107385849800400415; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Terada N, 2002, GLIA, V40, P350, DOI 10.1002/glia.10134; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Zhang SC, 2000, J NEUROSCI RES, V59, P421, DOI 10.1002/(SICI)1097-4547(20000201)59:3<421::AID-JNR17>3.3.CO;2-3	43	140	150	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					934	U123		10.1038/nbt.1972	http://dx.doi.org/10.1038/nbt.1972			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21947029	Green Accepted			2022-12-25	WOS:000296273000021
J	Yi, K; Unruh, JR; Deng, MQ; Slaughter, BD; Rubinstein, B; Li, R				Yi, Kexi; Unruh, Jay R.; Deng, Manqi; Slaughter, Brian D.; Rubinstein, Boris; Li, Rong			Dynamic maintenance of asymmetric meiotic spindle position through Arp2/3-complex-driven cytoplasmic streaming in mouse oocytes	NATURE CELL BIOLOGY			English	Article							POLAR BODY EXTRUSION; ARP2/3 COMPLEX; F-ACTIN; CORTICAL POLARITY; EGGS; ICSI; PARTHENOGENESIS; POLYMERIZATION; CYTOSKELETON; NUCLEATOR	Mature mammalian oocytes are poised for completing meiosis II (MII) on fertilization by positioning the spindle close to an actomyosin-rich cortical cap(1-3). Here, we show that the Arp2/3 complex localizes to the cortical cap in a Ran-GTPase-dependent manner and nucleates actin filaments in the cortical cap and a cytoplasmic actin network. Inhibition of Arp2/3 activity leads to rapid dissociation of the spindle from the cortex. Live-cell imaging and spatiotemporal image correlation spectroscopy analysis reveal that actin filaments flow continuously away from the Arp2/3-rich cortex, driving a cytoplasmic streaming expected to exert a net pushing force on the spindle towards the cortex. Arp2/3 inhibition not only diminishes this actin flow and cytoplasmic streaming but also enables a reverse streaming driven by myosin-II-based cortical contraction, moving the spindle away from the cortex. Thus, the asymmetric MII spindle position is dynamically maintained as a result of balanced forces governed by the Arp2/3 complex.	[Yi, Kexi; Unruh, Jay R.; Slaughter, Brian D.; Rubinstein, Boris; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Deng, Manqi] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol & Reprod Biol, Boston, MA 02115 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org		Unruh, Jay/0000-0003-3077-4990	NIH [P01 GM 066311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066311] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. M. Bement (University of Wisconsin, USA) for providing pCS2+-UtrCH-GFP plasmid; J. Bamburg (Colorado State University, USA) for providing anti-cofilin and phos-cofilin antibodies; H. Cartwright (Stowers Institute, USA) for microfabricated wells for oocyte imaging; and M. Durnin and K. Westfahl (both Stowers Institute, USA) for technical assistance and mice maintenance. This work was supported in part by NIH grant P01 GM 066311.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Cohen Y, 2004, HUM REPROD, V19, P649, DOI 10.1093/humrep/deh113; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007171; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kim NH, 1996, MOL REPROD DEV, V43, P513, DOI 10.1002/(SICI)1098-2795(199604)43:4&lt;513::AID-MRD14&gt;3.0.CO;2-#; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li HB, 2008, NAT CELL BIOL, V10, P1301, DOI 10.1038/ncb1788; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Lueptow R.M., 1998, EXP FLUIDS, P183; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Pudasaini SP, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2007487; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rossow M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088203; Rossow MJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3365946; Sathananthan A H, 1997, Hum Cell, V10, P21; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; WEBB M, 1986, J EMBRYOL EXP MORPH, V95, P131; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Zamir EA, 2005, ANN BIOMED ENG, V33, P854, DOI 10.1007/s10439-005-3037-7; Zhu ZY, 2003, BIOL REPROD, V68, P943, DOI 10.1095/biolreprod.102.009910	42	188	189	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1252	U186		10.1038/ncb2320	http://dx.doi.org/10.1038/ncb2320			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21874009	Green Accepted			2022-12-25	WOS:000295617900015
J	Pless, SA; Galpin, JD; Niciforovic, AP; Ahern, CA				Pless, Stephan A.; Galpin, Jason D.; Niciforovic, Ana P.; Ahern, Christopher A.			Contributions of counter-charge in a potassium channel voltage-sensor domain	NATURE CHEMICAL BIOLOGY			English	Article							SHAKER K+ CHANNEL; FOCUSED ELECTRIC-FIELD; CATION-PI INTERACTIONS; ELECTROSTATIC INTERACTIONS; SENSING DOMAINS; GATING CURRENTS; SODIUM-CHANNELS; BINDING-SITE; TRANSMEMBRANE SEGMENTS; MEMBRANE ENVIRONMENT	Voltage-sensor domains couple membrane potential to conformational changes in voltage-gated ion channels and phosphatases. Highly coevolved acidic and aromatic side chains assist the transfer of cationic side chains across the transmembrane electric field during voltage sensing. We investigated the functional contribution of negative electrostatic potentials from these residues to channel gating and voltage sensing with unnatural amino acid mutagenesis, electrophysiology, voltage-clamp fluorometry and ab initio calculations. The data show that neutralization of two conserved acidic side chains in transmembrane segments S2 and 53, namely Glu293 and Asp316 in Shaker potassium channels, has little functional effect on conductance-voltage relationships, although Glu293 appears to catalyze S4 movement. Our results suggest that neither Glu293 nor Asp316 engages in electrostatic state-dependent charge-charge interactions with S4, likely because they occupy, and possibly help create, a water-filled vestibule.	[Pless, Stephan A.; Galpin, Jason D.; Niciforovic, Ana P.; Ahern, Christopher A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Pless, Stephan A.; Galpin, Jason D.; Niciforovic, Ana P.; Ahern, Christopher A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Pless, SA (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	cahern@interchange.ubc.ca		Pless, Stephan/0000-0001-6654-114X; Galpin, Jason/0000-0003-1923-5312; Ahern, Christopher/0000-0002-7975-2744	Canadian Institutes of Health Research [56858]; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	We thank R. Horn, H. Kurata and S. Goodchild for helpful discussions. This work was supported by the Canadian Institutes of Health Research (56858), the Heart and Stroke Foundation of Canada, the Michael Smith Foundation for Health Research (to C.A.A.) and a postdoctoral fellowship from the Heart and Stroke Foundation of Canada (to SAP.).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Chanda B, 2008, NEURON, V57, P345, DOI 10.1016/j.neuron.2008.01.015; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; KELLY TR, 1994, J AM CHEM SOC, V116, P7072, DOI 10.1021/ja00095a009; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lacroix JJ, 2011, BIOPHYS J, V100, pL28, DOI 10.1016/j.bpj.2011.01.043; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	50	80	80	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					617	623		10.1038/NCHEMBIO.622	http://dx.doi.org/10.1038/NCHEMBIO.622			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21785425	Green Accepted			2022-12-25	WOS:000294381400012
J	Elahi, S; Dinges, WL; Lejarcegui, N; Laing, KJ; Collier, AC; Koelle, DM; McElrath, MJ; Horton, H				Elahi, Shokrollah; Dinges, Warren L.; Lejarcegui, Nicholas; Laing, Kerry J.; Collier, Ann C.; Koelle, David M.; McElrath, M. Juliana; Horton, Helen			Protective HIV-specific CD8(+) T cells evade T-reg cell suppression	NATURE MEDICINE			English	Article							DISEASE PROGRESSION; INFECTED PATIENTS; IMMUNE CONTROL; CUTTING EDGE; EXPRESSION; TIM-3; PROLIFERATION; AUTOIMMUNITY; TOLERANCE; RESPONSES	Specific human leukocyte antigens (HLAs), notably HLA-B* 27 and HLA-B* 57 allele groups, have long been associated with control of HIV-1. Although the majority of HIV-specific CD8(+) T cells lose proliferative capacity during chronic infection, T cells restricted by HLA-B* 27 or HLA-B* 57 allele groups do not. Here we show that CD8(+) T cells restricted by 'protective' HLA allele groups are not suppressed by T-reg cells, whereas, within the same individual, T cells restricted by 'nonprotective' alleles are highly suppressed ex vivo. This differential sensitivity of HIV-specific CD8(+) T cells to T-reg cell-mediated suppression correlates with their expression of the inhibitory receptor T cell immunoglobulin domain and mucin domain 3 (Tim-3) after stimulation with their cognate epitopes. Furthermore, we show that HLA-B* 27- and HLA-B* 57-restricted effectors also evade T-reg cell-mediated suppression by directly killing T-reg cells they encounter in a granzyme B (GzmB)-dependent manner. This study uncovers a previously unknown explanation for why HLA-B* 27 and HLA-B* 57 allele groups are associated with delayed HIV-1 disease progression.	[Elahi, Shokrollah; Dinges, Warren L.; Lejarcegui, Nicholas; Horton, Helen] Seattle Biomed Res Inst Seattle Biomed, Viral Vaccine Program, Seattle, WA USA; [Dinges, Warren L.] Polyclin Infect Dis, Seattle, WA USA; [Laing, Kerry J.; Koelle, David M.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Collier, Ann C.; Koelle, David M.; McElrath, M. Juliana; Horton, Helen] Univ Washington, Dept Med, Seattle, WA USA; [Koelle, David M.; McElrath, M. Juliana; Horton, Helen] Univ Washington, Dept Global Hlth Med, Seattle, WA 98195 USA; [Koelle, David M.; McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Koelle, David M.] Benaroya Res Inst, Seattle, WA USA	Center for Infectious Disease Research; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute	Horton, H (corresponding author), Seattle Biomed Res Inst Seattle Biomed, Viral Vaccine Program, Seattle, WA USA.	helen.horton@seattlebiomed.org	Koelle, David/Q-6529-2016; Laing, Kerry J./C-2211-2008	Koelle, David/0000-0003-1255-9023; Laing, Kerry J./0000-0001-9245-5325; Elahi, Shokrollah/0000-0002-7215-2009	US National Institutes of Health (NIH) [R01 AI65328, R21 AI089373, U01 AI4674, U01 AI 46725, P01 AI57005, P30 AI27757]; University of Washington/Fred Hutchinson Cancer Research Center Center for AIDS Research (CFAR) (the University of Washington General Clinical Research Center) [AI30731, AI 081060, R37 AI042528, M01-RR-00037]; University of Washington Center for AIDS Research (CFAR); NIH [P30 AI027757]; James. B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014, M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042528, R01AI065328, P30AI027757, P01AI057005, U01AI046725, R21AI089373, R21AI081060, R01AI042528, U01AI046747, P01AI030731] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington/Fred Hutchinson Cancer Research Center Center for AIDS Research (CFAR) (the University of Washington General Clinical Research Center)(University of Washington); University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James. B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our study volunteers for providing samples and supporting this work, as well as the clinical staff for their dedication to this research. This work was supported by US National Institutes of Health (NIH) grants R01 AI65328, R21 AI089373, U01 AI4674, U01 AI 46725, P01 AI57005, P30 AI27757, a New Investigator Award (for S. E.) from the University of Washington/Fred Hutchinson Cancer Research Center Center for AIDS Research (CFAR), AI30731, AI 081060, R37 AI042528 and M01-RR-00037 (the University of Washington General Clinical Research Center). This research was supported by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the NIH National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute and National Center for Complementary and Alternative Medicine). We also acknowledge the support of the James. B. Pendleton Charitable Trust.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Antoniou AN, 2004, J BIOL CHEM, V279, P8895, DOI 10.1074/jbc.M311757200; Ashley CW, 2009, J IMMUNOL, V183, P4843, DOI 10.4049/jimmunol.0900845; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Galgani M, 2009, CURR MED CHEM, V16, P4626, DOI 10.2174/092986709789878201; Henseler T, 1998, ARCH DERMATOL RES, V290, P463, DOI 10.1007/s004030050338; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Horton H, 2006, J VIROL, V80, P9779, DOI 10.1128/JVI.00794-06; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Migueles SA, 2001, IMMUNOL LETT, V79, P141, DOI 10.1016/S0165-2478(01)00276-0; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sabbagh L, 2004, J IMMUNOL, V173, P5425, DOI 10.4049/jimmunol.173.9.5425; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Vila J, 2009, CURR OPIN HEMATOL, V16, P274, DOI 10.1097/MOH.0b013e32832a9a01; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wehler TC, 2008, J IMMUNOL METHODS, V339, P23, DOI 10.1016/j.jim.2008.07.017; Weiss L, 2010, P NATL ACAD SCI USA, V107, P10632, DOI 10.1073/pnas.1000027107; Xing SJ, 2010, JAIDS-J ACQ IMM DEF, V54, P455, DOI 10.1097/QAI.0b013e3181e453b9; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	41	160	164	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					989	U110		10.1038/nm.2422	http://dx.doi.org/10.1038/nm.2422			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21765403	Green Accepted			2022-12-25	WOS:000293507400033
J	Payne, BAI; Wilson, IJ; Hateley, CA; Horvath, R; Santibanez-Koref, M; Samuels, DC; Price, DA; Chinnery, PF				Payne, Brendan A. I.; Wilson, Ian J.; Hateley, Charlotte A.; Horvath, Rita; Santibanez-Koref, Mauro; Samuels, David C.; Price, D. Ashley; Chinnery, Patrick F.			Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations	NATURE GENETICS			English	Article							HIV-INFECTED PATIENTS; DNA MUTATIONS; POLYMERASE-GAMMA; POINT MUTATIONS; DELETIONS; CELLS; AGE; DISEASE; MUSCLE; ACCUMULATION	There is emerging evidence that people with successfully treated HIV infection age prematurely, leading to progressive multi-organ disease(1), but the reasons for this are not known. Here we show that patients treated with commonly used nucleoside analog anti-retroviral drugs progressively accumulate somatic mitochondrial DNA (mtDNA) mutations, mirroring those seen much later in life caused by normal aging(2,3). Ultra-deep re-sequencing by synthesis, combined with single-cell analyses, suggests that the increase in somatic mutation is not caused by increased mutagenesis but might instead be caused by accelerated mtDNA turnover. This leads to the clonal expansion of preexisting age-related somatic mtDNA mutations and a biochemical defect that can affect up to 10% of cells. These observations add weight to the role of somatic mtDNA mutations in the aging process and raise the specter of progressive iatrogenic mitochondrial genetic disease emerging over the next decade.	[Payne, Brendan A. I.; Wilson, Ian J.; Hateley, Charlotte A.; Horvath, Rita; Santibanez-Koref, Mauro; Chinnery, Patrick F.] Newcastle Univ, Mitochondrial Res Grp, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Payne, Brendan A. I.; Price, D. Ashley] Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Samuels, David C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	Newcastle University - UK; Newcastle University - UK; Vanderbilt University	Chinnery, PF (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk	Payne, Brendan/I-1233-2016; Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Horvath, Rita/AAY-7042-2020	Payne, Brendan/0000-0002-3101-3512; Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Price, David/0000-0002-0562-7326; Horvath, Rita/0000-0002-9841-170X; Wilson, Ian/0000-0001-6893-2873; Chinnery, Patrick/0000-0002-7065-6617	Medical Research Council; British Infection Society; Newcastle Healthcare Charity; UK National Institute for Health Research (NIHR) Biomedical Research Centre for Aging and Age-related disease; Wellcome Trust; MRC [G1000848, G0800470] Funding Source: UKRI; Medical Research Council [G1000848, G0800470] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Infection Society; Newcastle Healthcare Charity; UK National Institute for Health Research (NIHR) Biomedical Research Centre for Aging and Age-related disease(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was support by grants from the Medical Research Council (B. A. I. P.), British Infection Society (B. A. I. P.), the Newcastle Healthcare Charity (D. A. P.), the UK National Institute for Health Research (NIHR) Biomedical Research Centre for Aging and Age-related disease award to the Newcastle upon Tyne Foundation Hospitals National Health Service (NHS) Trust (P. F. C.) and the Wellcome Trust (P. F. C.). The authors thank G. L. Toms for the use of his containment level 3 facility, E. L. C. Ong, M. L. Schmid, U. Schwab and R. Pattman for access to their clinic cohorts, J. Coxhead (NewGene, Newcastle upon Tyne, UK) for assistance with Roche 454 FLX and D. Deehan for assistance with obtaining control muscle samples.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cherry CL, 2006, JAIDS-J ACQ IMM DEF, V42, P435, DOI 10.1097/01.qai.0000224974.67962.ce; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012; Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x; Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Maagaard A, 2006, ANTIVIR THER, V11, P601; McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002; Oursler KK, 2006, AIDS RES HUM RETROV, V22, P1113, DOI 10.1089/aid.2006.22.1113; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Shieh DB, 2007, CHEM-BIOL INTERACT, V165, P211, DOI 10.1016/j.cbi.2006.12.008; Smyth K, 2007, HIV MED, V8, P367, DOI 10.1111/j.1468-1293.2007.00478.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; World Health Organization, 2006, ANT THER HIV INF AD	35	161	166	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					806	U121		10.1038/ng.863	http://dx.doi.org/10.1038/ng.863			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21706004	Green Accepted			2022-12-25	WOS:000293178300019
J	Puklowski, A; Homsi, Y; Keller, D; May, M; Chauhan, S; Kossatz, U; Grunwald, V; Kubicka, S; Pich, A; Manns, MP; Hoffmann, I; Gonczy, P; Malek, NP				Puklowski, Anja; Homsi, Yahya; Keller, Debora; May, Martin; Chauhan, Sangeeta; Kossatz, Uta; Gruenwald, Viktor; Kubicka, Stefan; Pich, Andreas; Manns, Michael P.; Hoffmann, Ingrid; Goenczy, Pierre; Malek, Nisar P.			The SCF-FBXW5 E3-ubiquitin ligase is regulated by PLK4 and targets HsSAS-6 to control centrosome duplication	NATURE CELL BIOLOGY			English	Article							CENTRIOLE; PROTEIN; SUPPRESSOR; FAMILY; BOX	Deregulated centrosome duplication can result in genetic instability and contribute to tumorigenesis(1,2). Here, we show that centrosome duplication is regulated by the activity of an E3-ubiquitin ligase that employs the F-box protein FBXW5 (ref. 3) as its targeting subunit. Depletion of endogenous FBXW5 or over expression of an F-box-deleted mutant version results in centrosome overduplication and formation of multipolar spindles. We identify the centriolar protein HsSAS-6 (refs 4,5) as a critical substrate of the SCF-FBXW5 complex. FBXW5 binds HsSAS-6 and promotes its ubiquitylation in vivo. The activity of SCF-FBXW5 is in turn negatively regulated by Polo-like kinase 4 (PLK4), which phosphorylates FBXW5 at Ser 151 to suppress its ability to ubiquitylate HsSAS-6. FBXW5 is a cell-cycle-regulated protein with expression levels peaking at the G1/S transition. We show that FBXW5 levels are controlled by the anaphase-promoting (APC/C) complex, which targets FBXW5 for degradation during mitosis and G1, thereby helping to reset the centrosome duplication machinery. In summary, we show that a cell-cycle-regulated SCF complex is regulated by the kinase PLK4, and that this in turn restricts centrosome re-duplication through degradation of the centriolar protein HsSAS-6.	[Puklowski, Anja; Homsi, Yahya; Chauhan, Sangeeta; Kossatz, Uta; Malek, Nisar P.] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Keller, Debora; Goenczy, Pierre] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [May, Martin; Pich, Andreas] Hannover Med Sch, Inst Pharmacol & Toxicol, D-30625 Hannover, Germany; [Gruenwald, Viktor] Hannover Med Sch, Dept Hematol, D-30625 Hannover, Germany; [Kubicka, Stefan; Manns, Michael P.; Malek, Nisar P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Hoffmann, Ingrid] DKFZ, German Canc Res Ctr, Heidelberg, Germany	Hannover Medical School; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Hannover Medical School; Hannover Medical School; Hannover Medical School; Helmholtz Association; German Cancer Research Center (DKFZ)	Malek, NP (corresponding author), Hannover Med Sch, Inst Mol Biol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Malek.Nisar@MH-Hannover.de	Grünwald, Viktor/D-9601-2012	May, Martin/0000-0002-8335-6699; Kossatz, Uta/0000-0002-9092-7154; Gonczy, Pierre/0000-0002-6305-6883; Keller, Debora/0000-0002-5284-3195	Deutsche Forschungsgemeinschaft [Transregio 77]; Deutsche Krebshilfe; Swiss Cancer League [OCS KLS 02024-02-2007]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Swiss Cancer League	We thank H. S. Malek, J. Roberts and A. Besson for critical reading of the manuscript. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Transregio 77) to N.P.M., and by a grant from the Deutsche Krebshilfe to V.G. and S.K., as well as by the Swiss Cancer League to P.G. (OCS KLS 02024-02-2007).	Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Korzeniewski N, 2009, CANCER RES, V69, P6668, DOI 10.1158/0008-5472.CAN-09-1284; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; MOUDJOU M, 1994, CELL BIOL LAB HDB; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670	28	110	117	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					1004	U291		10.1038/ncb2282	http://dx.doi.org/10.1038/ncb2282			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21725316				2022-12-25	WOS:000293373700020
J	Lee, JH; Giannikopoulos, P; Duncan, SA; Wang, J; Johansen, CT; Brown, JD; Plutzky, J; Hegele, RA; Glimcher, LH; Lee, AH				Lee, Jung Hoon; Giannikopoulos, Petros; Duncan, Stephen A.; Wang, Jian; Johansen, Christopher T.; Brown, Jonathan D.; Plutzky, Jorge; Hegele, Robert A.; Glimcher, Laurie H.; Lee, Ann-Hwee			The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism	NATURE MEDICINE			English	Article							LIPOPROTEIN-LIPASE; RARE VARIANTS; PPAR-ALPHA; CREB-H; LIVER; ASSOCIATION; EXPRESSION; GENETICS; DISEASES	Here we report that the transcription factor cyclic AMP-responsive element-binding protein H (CREB-H, encoded by CREB3L3) is required for the maintenance of normal plasma triglyceride concentrations. CREB-H-deficient mice showed hypertriglyceridemia secondary to inefficient triglyceride clearance catalyzed by lipoprotein lipase (Lpl), partly due to defective expression of the Lpl coactivators Apoc2, Apoa4 and Apoa5 (encoding apolipoproteins C2, A4 and A5, respectively) and concurrent augmentation of the Lpl inhibitor Apoc3. We identified multiple nonsynonymous mutations in CREB3L3 that produced hypomorphic or nonfunctional CREB-H protein in humans with extreme hypertriglyceridemia, implying a crucial role for CREB-H in human triglyceride metabolism.	[Lee, Jung Hoon; Giannikopoulos, Petros; Glimcher, Laurie H.; Lee, Ann-Hwee] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Wang, Jian; Johansen, Christopher T.; Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Wang, Jian; Johansen, Christopher T.; Hegele, Robert A.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Brown, Jonathan D.; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA; [Glimcher, Laurie H.] Ragon Inst MGH MIT & Harvard, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Medical College of Wisconsin; Western University (University of Western Ontario); Western University (University of Western Ontario); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu; ahlee@hsph.harvard.edu	Hegele, Robert/AAF-6482-2020; Hegele, Robert/G-3301-2011; Plutzky, Jorge/V-3410-2019	Hegele, Robert/0000-0003-2861-5325; Duncan, Stephen/0000-0002-2507-7827	Harvard University; Howard Hughes Medical Institute (HHMI); Harvard Digestive Disease Center; US National Institutes of Health [P30 DK34845, DK082448]; American Heart Association; Canadian Institutes for Health Research and Genome Canada through the Ontario Genomics Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK082448] Funding Source: NIH RePORTER	Harvard University; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Harvard Digestive Disease Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Canadian Institutes for Health Research and Genome Canada through the Ontario Genomics Institute(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank. B. Zhai and S. Gygi for mass spectrometry analysis, K. Sigrist for assistance with the development of transgenic mice, R. Hassell for assistance with genomic DNA sequencing, B. Monia (Isis Innovation) for Apoc3-specific antibody and D. Cohen for invaluable suggestions and comments on the manuscript. The research was supported by the Harvard University Accelerator Fund (L.H.G.), a Howard Hughes Medical Institute (HHMI) fellowship (P.G.), the Harvard Digestive Disease Center, US National Institutes of Health grant P30 DK34845 (A.-H.L.), US National Institutes of Health grant DK082448 (L.H.G.) and grants from the American Heart Association (A.-H.L. and J.H.L.), Canadian Institutes for Health Research and Genome Canada through the Ontario Genomics Institute.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bailey D, 2007, TRAFFIC, V8, P1796, DOI 10.1111/j.1600-0854.2007.00654.x; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	20	145	149	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					812	815		10.1038/nm.2347	http://dx.doi.org/10.1038/nm.2347			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21666694	Green Accepted			2022-12-25	WOS:000292500800034
J	Russell, RC; Sufan, RI; Zhou, B; Heir, P; Bunda, S; Sybingco, SS; Greer, SN; Roche, O; Heathcote, SA; Chow, VWK; Boba, LM; Richmond, TD; Hickey, MM; Barber, DL; Cheresh, DA; Simon, MC; Irwin, MS; Kim, WY; Ohh, M				Russell, Ryan C.; Sufan, Roxana I.; Zhou, Bing; Heir, Pardeep; Bunda, Severa; Sybingco, Stephanie S.; Greer, Samantha N.; Roche, Olga; Heathcote, Samuel A.; Chow, Vinca W. K.; Boba, Lukasz M.; Richmond, Terri D.; Hickey, Michele M.; Barber, Dwayne L.; Cheresh, David A.; Simon, M. Celeste; Irwin, Meredith S.; Kim, William Y.; Ohh, Michael			Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia	NATURE MEDICINE			English	Article							VON-HIPPEL-LINDAU; TUMOR-SUPPRESSOR PROTEIN; TYROSINE KINASE JAK2; OF-FUNCTION MUTATION; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; CONGENITAL POLYCYTHEMIA; DEPENDENT PROTEOLYSIS; HEMATOPOIETIC-CELLS; OXYGEN HOMEOSTASIS	Chuvash polycythemia is a rare congenital form of polycythemia caused by homozygous R200W and H191D mutations in the VHL (von Hippel-Lindau) gene, whose gene product is the principal negative regulator of hypoxia-inducible factor. However, the molecular mechanisms underlying some of the hallmark abnormalities of Chuvash polycythemia, such as hypersensitivity to erythropoietin, are unclear. Here we show that VHL directly binds suppressor of cytokine signaling 1 (SOCS1) to form a heterodimeric E3 ligase that targets phosphorylated JAK2 (pJAK2) for ubiquitin-mediated destruction. In contrast, Chuvash polycythemia-associated VHL mutants have altered affinity for SOCS1 and do not engage with and degrade pJAK2. Systemic administration of a highly selective JAK2 inhibitor, TG101209, reversed the disease phenotype in Vhl(R200W/R200W) knock-in mice, an experimental model that recapitulates human Chuvash polycythemia. These results show that VHL is a SOCS1-cooperative negative regulator of JAK2 and provide biochemical and preclinical support for JAK2-targeted therapy in individuals with Chuvash polycythemia.	[Russell, Ryan C.; Sufan, Roxana I.; Heir, Pardeep; Bunda, Severa; Sybingco, Stephanie S.; Greer, Samantha N.; Roche, Olga; Chow, Vinca W. K.; Boba, Lukasz M.; Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhou, Bing; Heathcote, Samuel A.; Kim, William Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Hematol Oncol, Chapel Hill, NC 27599 USA; [Richmond, Terri D.; Barber, Dwayne L.] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON, Canada; [Hickey, Michele M.; Simon, M. Celeste] Univ Penn, Sch Med, Dept Cell & Dev Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Cheresh, David A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Simon, M. Celeste] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Irwin, Meredith S.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ohh, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	michael.ohh@utoronto.ca	Simon, Celeste/AAG-3941-2021; Roche, Olga/K-9342-2014; zhou, bing/C-2150-2011; Roche, UCLM/F-5697-2019	Roche, UCLM/0000-0003-1884-8256; Barber, Dwayne/0000-0001-5528-8150; Russell, Ryan/0000-0003-3364-8869	Canadian Cancer Society [020110, 018054]; US National Institutes of Health [R01 CA142794, U54 CA151652]; US Department of Defense [PC094631, W81XWH-08-1-0064]; NATIONAL CANCER INSTITUTE [U54CA151652, R01CA142794] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from the Canadian Cancer Society (020110 to M.O. and 018054 to M.S.I.), US National Institutes of Health R01 CA142794 (W.Y.K.), U54 CA151652 (W.Y.K.) and US Department of Defense grants PC094631 and W81XWH-08-1-0064 (W.Y.K). Plasmid encoding HA-SOCS1 was provided by R. Rottapel (Ontario Cancer Institute). Lentiviral reagents pMDG1. vsvg and psPAX2 were provided by L. Penn (Ontario Cancer Institute). JAK2 inhibitor TG101209 was provided by TargeGen. We thank the University North Carolina Animal Studies Core Facility and Mouse Phase 1 Unit for their assistance in the animal study. W.Y.K. is a Damon Runyon Merck clinical investigator. M.O. is a Canada Research Chair in molecular oncology.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellucci S, 2006, SEMIN THROMB HEMOST, V32, P381, DOI 10.1055/s-2006-942759; Bento JC, 2005, HAEMATOLOGICA, V90, P128; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Cario H, 2005, HAEMATOLOGICA, V90, P19; Chung J, 2006, ONCOGENE, V25, P3079, DOI 10.1038/sj.onc.1209328; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Constantinescu SN, 2008, TRENDS BIOCHEM SCI, V33, P122, DOI 10.1016/j.tibs.2007.12.002; Dixon C, 2003, EUKARYOT CELL, V2, P123, DOI 10.1128/EC.2.1.123-133.2003; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Le Y, 2009, AM J HEMATOL, V84, P273, DOI 10.1002/ajh.21381; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Messinezy M, 1999, CLIN LAB HAEMATOL, V21, P309, DOI 10.1046/j.1365-2257.1999.00246.x; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pastore Y, 2003, AM J HUM GENET, V73, P412, DOI 10.1086/377108; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Perrotta S, 2006, BLOOD, V107, P514, DOI 10.1182/blood-2005-06-2422; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Roberts AM, 2008, CURR OPIN ONCOL, V20, P83, DOI 10.1097/CCO.0b013e3282f310de; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Shibata J, 2003, BLOOD, V101, P4416, DOI 10.1182/blood-2002-09-2814; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	59	56	56	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					845	U261		10.1038/nm.2370	http://dx.doi.org/10.1038/nm.2370			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21685897	Green Accepted			2022-12-25	WOS:000292500800039
J	Putoux, A; Thomas, S; Coene, KLM; Davis, EE; Alanay, Y; Ogur, G; Uz, E; Buzas, D; Gomes, C; Patrier, S; Bennett, CL; Elkhartoufi, N; Saint Frison, MH; Rigonnot, L; Joye, N; Pruvost, S; Utine, GE; Boduroglu, K; Nitschke, P; Fertitta, L; Thauvin-Robinet, C; Munnich, A; Cormier-Daire, V; Hennekam, R; Colin, E; Akarsu, NA; Bole-Feysot, C; Cagnard, N; Schmitt, A; Goudin, N; Lyonnet, S; Encha-Razavi, F; Siffroi, JP; Winey, M; Katsanis, N; Gonzales, M; Vekemans, M; Beales, PL; Attie-Bitach, T				Putoux, Audrey; Thomas, Sophie; Coene, Karlien L. M.; Davis, Erica E.; Alanay, Yasemin; Ogur, Gonul; Uz, Elif; Buzas, Daniela; Gomes, Celine; Patrier, Sophie; Bennett, Christopher L.; Elkhartoufi, Nadia; Saint Frison, Marie-Helene; Rigonnot, Luc; Joye, Nicole; Pruvost, Solenn; Utine, Gulen Eda; Boduroglu, Koray; Nitschke, Patrick; Fertitta, Laura; Thauvin-Robinet, Christel; Munnich, Arnold; Cormier-Daire, Valerie; Hennekam, Raoul; Colin, Estelle; Akarsu, Nurten Ayse; Bole-Feysot, Christine; Cagnard, Nicolas; Schmitt, Alain; Goudin, Nicolas; Lyonnet, Stanislas; Encha-Razavi, Ferechte; Siffroi, Jean-Pierre; Winey, Mark; Katsanis, Nicholas; Gonzales, Marie; Vekemans, Michel; Beales, Philip L.; Attie-Bitach, Tania			KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes	NATURE GENETICS			English	Article							SIGNAL-TRANSDUCTION; PROTEIN; CILIA; CILIOGENESIS; RPGRIP1L; JOUBERT; ALLELES; MECKEL	KIF7, the human ortholog of Drosophila Costal2, is a key component of the Hedgehog signaling pathway. Here we report mutations in KIF7 in individuals with hydrolethalus and acrocallosal syndromes, two multiple malformation disorders with overlapping features that include polydactyly, brain abnormalities and cleft palate. Consistent with a role of KIF7 in Hedgehog signaling, we show deregulation of most GLI transcription factor targets and impaired GLI3 processing in tissues from individuals with KIF7 mutations. KIF7 is also a likely contributor of alleles across the ciliopathy spectrum, as sequencing of a diverse cohort identified several missense mutations detrimental to protein function. In addition, in vivo genetic interaction studies indicated that knockdown of KIF7 could exacerbate the phenotype induced by knockdown of other ciliopathy transcripts. Our data show the role of KIF7 in human primary cilia, especially in the Hedgehog pathway through the regulation of GLI targets, and expand the clinical spectrum of ciliopathies.	[Putoux, Audrey; Thomas, Sophie; Gomes, Celine; Fertitta, Laura; Munnich, Arnold; Cormier-Daire, Valerie; Lyonnet, Stanislas; Encha-Razavi, Ferechte; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, INSERM, U 781, Paris, France; [Putoux, Audrey; Thomas, Sophie; Munnich, Arnold; Cormier-Daire, Valerie; Lyonnet, Stanislas; Encha-Razavi, Ferechte; Vekemans, Michel; Attie-Bitach, Tania] Univ Paris 05, Paris, France; [Coene, Karlien L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Coene, Karlien L. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Davis, Erica E.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Alanay, Yasemin; Utine, Gulen Eda; Boduroglu, Koray] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Genet Unit, TR-06100 Ankara, Turkey; [Ogur, Gonul; Bennett, Christopher L.] Ondokuz Mayis Univ, Dept Med Pediat Genet, Samsun, Turkey; [Uz, Elif; Akarsu, Nurten Ayse] Hacettepe Univ, Fac Med, Dept Med Genet, Gene Mapping Lab, TR-06100 Ankara, Turkey; [Buzas, Daniela; Rigonnot, Luc] Ctr Hosp CH Sud Francilien, Gynecol Serv, Evry, France; [Patrier, Sophie; Joye, Nicole; Siffroi, Jean-Pierre; Gonzales, Marie] Hop Armand Trousseau, Serv Genet & Embryol Med, AP HP, Paris, France; [Elkhartoufi, Nadia; Munnich, Arnold; Cormier-Daire, Valerie; Lyonnet, Stanislas; Encha-Razavi, Ferechte; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, Dept Genet, AP HP, Paris, France; [Saint Frison, Marie-Helene] CH Victor Dupouy, Serv Anat & Cytol Pathol, Argenteuil, France; [Joye, Nicole; Siffroi, Jean-Pierre; Gonzales, Marie] Univ Paris 06, Paris, France; [Pruvost, Solenn; Bole-Feysot, Christine] Hop Necker Enfants Malad, Genom Core Facil, Imagine Fdn, Paris, France; [Nitschke, Patrick; Cagnard, Nicolas] Univ Paris 05, Serv Bioinformat, Paris, France; [Thauvin-Robinet, Christel] CHU Dijon, Serv Genet, Dijon, France; [Hennekam, Raoul] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Colin, Estelle] Hop Angers, Serv Genet, Angers, France; [Schmitt, Alain] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Goudin, Nicolas] Fac Med Necker Enfants Malad, IFR 94, Paris, France; [Winey, Mark] Univ Colorado, Boulder, CO 80309 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Radboud University Nijmegen; Duke University; Duke University; Hacettepe University; Ondokuz Mayis University; Hacettepe University; Centre Hospitalier Sud Francilien; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; University of Amsterdam; Academic Medical Center Amsterdam; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Colorado System; University of Colorado Boulder; Duke University; University of London; University College London	Attie-Bitach, T (corresponding author), Hop Necker Enfants Malad, INSERM, U 781, Paris, France.	tania.attie@inserm.fr	colin, estelle/K-6398-2015; Coene, Karlien/K-7583-2016; BODUROGLU, KORAY O/I-9094-2013; Putoux, Audrey/D-7265-2015; Alanay, Yasemin/A-1516-2016; Lyonnet, Stanislas/H-5483-2017; Akarsu, Nurten/E-9758-2013; Uz, Elif/A-4666-2012; Beales, Philip L/C-7367-2009; THOMAS, Sophie/F-4492-2017; colin, estelle/AAI-2447-2019; Katsanis, Nicholas/E-1837-2012; thomas, sophie/GVS-1279-2022; ATTIE-BITACH, Tania/K-1453-2017; cormier-daire, valerie/H-6520-2017; Cagnard, Nicolas/K-2754-2014	Coene, Karlien/0000-0001-9873-1458; Alanay, Yasemin/0000-0003-0683-9731; Lyonnet, Stanislas/0000-0001-5426-9417; Akarsu, Nurten/0000-0001-5432-0032; THOMAS, Sophie/0000-0002-8569-3277; ATTIE-BITACH, Tania/0000-0002-1155-3626; cormier-daire, valerie/0000-0002-2839-9856; Fertitta, Laura/0000-0003-3528-9804; Cagnard, Nicolas/0000-0002-9051-1896; PUTOUX, Audrey/0000-0001-5496-4604; Katsanis, Nicholas/0000-0002-2480-0171; Bennett, Christopher/0000-0002-8467-6192; Boduroglu, Koray/0000-0001-6260-1942; Davis, Erica/0000-0002-2412-8397	ANR [07-MRAR-010-02, BLAN-1122-01]; E-RARE [07-ERare-001-01]; Scientific and Technological Research Council of Turkey (TUBITAK) [108S420]; US National Institutes of Health from the National Institute of Child Health and Development [R01HD04260]; National Institute of Diabetes, Digestive and Kidney Disorders [R01DK072301]; Academie de Medecine; NIH [NS039818-07]; Huygens Scholarship Programme; Netherlands Organization for Scientific Research [NWO Toptalent-021.001.014]; March of Dimes Foundation [1-FY07-422]; MRC [G0801843] Funding Source: UKRI; Medical Research Council [G0801843] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039818] Funding Source: NIH RePORTER	ANR(French National Research Agency (ANR)); E-RARE; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); US National Institutes of Health from the National Institute of Child Health and Development; National Institute of Diabetes, Digestive and Kidney Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Academie de Medecine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huygens Scholarship Programme; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); March of Dimes Foundation(March of Dimes); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to families and to the French Society of Fetal Pathology (SOFFOET) for participating in the study, to C. Dubourg, P. Wieacker, B. Leroy, N. Laurent, V. Fermeaux, S. Odent for fetuses' referral and to A. Schinzel and A. David for ACLS samples. We thank M. Zarhrate, A. Aguilar, N. Spasky and L. Besse for technical help. We thank N. Boddaert for helpful discussion. This work was supported by grants from ANR (FETALCILIOPATHIES number 07-MRAR-010-02 and FOETOCILPATH number BLAN-1122-01), E-RARE (Cranirare number 07-ERare-001-01) the Scientific and Technological Research Council of Turkey (TUBITAK, grant number 108S420 to N. A. A.), the US National Institutes of Health grant R01HD04260 from the National Institute of Child Health and Development (N. K.), R01DK072301 from the National Institute of Diabetes, Digestive and Kidney Disorders (N. K.) and the European Union (EU-SYSCILIA; E. E. D., N. K. and P. L. B.). A. P. was granted a fellowship from the Academie de Medecine. S. T. is supported by NIH 'Hereditary Basis of Neural Tube Defects' N<SUP>o</SUP> NS039818-07 to M. Speer. K. L. M. C. is supported by the Huygens Scholarship Programme and the Netherlands Organization for Scientific Research (NWO Toptalent-021.001.014). M. W. was a fellow of the Guggenheim Foundation and was supported by the March of Dimes Foundation (1-FY07-422). P. L. B. is a Wellcome Trust Senior Research Fellow. N. K. is a Distinguished George W. Brumley Professor.	Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Dammermann A, 2009, GENE DEV, V23, P2046, DOI 10.1101/gad.1810409; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Kalderon D, 2004, CURR BIOL, V14, pR67, DOI 10.1016/j.cub.2003.12.047; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; Mee L, 2005, HUM MOL GENET, V14, P1475, DOI 10.1093/hmg/ddi157; Monnier Veronique, 2002, BMC Dev Biol, V2, P4, DOI 10.1186/1471-213X-2-4; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; SALONEN R, 1981, CLIN GENET, V19, P321; SCHINZEL A, 1980, AM J MED GENET, V6, P241, DOI 10.1002/ajmg.1320060308; SCHINZEL A, 1986, CLIN GENET, V30, P399; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107	27	157	160	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					601	U147		10.1038/ng.826	http://dx.doi.org/10.1038/ng.826			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21552264	Green Accepted			2022-12-25	WOS:000291017000021
J	Subramanyam, D; Lamouille, S; Judson, RL; Liu, JY; Bucay, N; Derynck, R; Blelloch, R				Subramanyam, Deepa; Lamouille, Samy; Judson, Robert L.; Liu, Jason Y.; Bucay, Nathan; Derynck, Rik; Blelloch, Robert			Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							MICRORNAS; PATHWAY; TRANSITION; EXPRESSION; GENERATION; DISCOVERY; STATE	The embryonic stem cell-specific cell cycle-regulating (ESCC) family of microRNAs (miRNAs) enhances reprogramming of mouse embryonic fibroblasts to induced pluripotent stem cells(1). Here we show that the human ESCC miRNA orthologs hsa-miR-302b and hsa-miR-372 promote human somatic cell reprogramming. Furthermore, these miRNAs repress multiple target genes, with downregulation of individual targets only partially recapitulating the total miRNA effects. These targets regulate various cellular processes, including cell cycle, epithelial-mesenchymal transition (EMT), epigenetic regulation and vesicular transport. ESCC miRNAs have a known role in regulating the unique embryonic stem cell cycle(2,3). We show that they also increase the kinetics of mesenchymal-epithelial transition during reprogramming and block TGF beta-induced EMT of human epithelial cells. These results demonstrate that the ESCC miRNAs promote dedifferentiation by acting on multiple downstream pathways. We propose that individual miRNAs generally act through numerous pathways that synergize to regulate and enforce cell fate decisions.	[Subramanyam, Deepa; Lamouille, Samy; Judson, Robert L.; Liu, Jason Y.; Bucay, Nathan; Derynck, Rik; Blelloch, Robert] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Subramanyam, Deepa; Judson, Robert L.; Liu, Jason Y.; Bucay, Nathan; Blelloch, Robert] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Subramanyam, Deepa; Judson, Robert L.; Liu, Jason Y.; Bucay, Nathan; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Lamouille, Samy; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA; [Lamouille, Samy; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, Program Dev Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blelloch, R (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu		Subramanyam, Deepa/0000-0002-1650-5690	NATIONAL CANCER INSTITUTE [R01CA136690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118, R01NS057221] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA136690, R01 CA136690] Funding Source: Medline; NINDS NIH HHS [R01 NS057221-03, R01 NS057221, K08 NS48118, K08 NS048118-01A1, R01 NS057221-01A1, K08 NS048118-02, K08 NS048118, R01 NS057221-04, R01 NS057221-04S1, K08 NS048118-03, K08 NS048118-06, K08 NS048118-04, K08 NS048118-05, R01 NS057221-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	36	433	462	2	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					443	+		10.1038/nbt.1862	http://dx.doi.org/10.1038/nbt.1862			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21490602	Green Accepted			2022-12-25	WOS:000290301700025
J	Santos, AM; Schechtman, D; Cardoso, AC; Clemente, CFMZ; Silva, JC; Fioramonte, M; Pereira, MBM; Marin, TM; Oliveira, PSL; Figueira, ACM; Oliveira, SHP; Torriani, IL; Gozzo, FC; Neto, JX; Franchini, KG				Santos, Aline M.; Schechtman, Deborah; Cardoso, Alisson C.; Clemente, Carolina F. M. Z.; Silva, Julio C.; Fioramonte, Mariana; Pereira, Michelle B. M.; Marin, Talita M.; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Oliveira, Saulo H. P.; Torriani, Iris L.; Gozzo, Fabio C.; Neto, Jose Xavier; Franchini, Kleber G.			FERM domain interaction with myosin negatively regulates FAK in cardiomyocyte hypertrophy	NATURE CHEMICAL BIOLOGY			English	Article							FOCAL ADHESION KINASE; SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; PROTEIN; PHOSPHORYLATION; INHIBITOR; PEPTIDES; GROWTH; SRC	Focal adhesion kinase (FAK) regulates cellular processes that affect several aspects of development and disease. The FAK N-terminal FERM (4.1 protein-ezrin-radixin-moesin homology) domain, a compact clover-leaf structure, binds partner proteins and mediates intramolecular regulatory interactions. Combined chemical cross-linking coupled to MS, small-angle X-ray scattering, computational docking and mutational analyses showed that the FAK FERM domain has a molecular cleft (similar to 998 angstrom(2)) that interacts with sarcomeric myosin, resulting in FAK inhibition. Accordingly, mutations in a unique short amino acid sequence of the FERM myosin cleft, FP-1, impaired the interaction with myosin and enhanced FAK activity in cardiomyocytes. An FP-1 decoy peptide selectively inhibited myosin interaction and increased FAK activity, promoting cardiomyocyte hypertrophy through activation of the AKT-mammalian target of rapamycin pathway. Our findings uncover an inhibitory interaction between the FAK FERM domain and sarcomeric myosin that presents potential opportunities to modulate the cardiac hypertrophic response through changes in FAK activity.	[Santos, Aline M.; Cardoso, Alisson C.; Pereira, Michelle B. M.; Marin, Talita M.; Franchini, Kleber G.] Univ Estadual Campinas, Sch Med, Dept Internal Med, Campinas, SP, Brazil; [Santos, Aline M.; Cardoso, Alisson C.; Clemente, Carolina F. M. Z.; Silva, Julio C.; Pereira, Michelle B. M.; Marin, Talita M.; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Oliveira, Saulo H. P.; Torriani, Iris L.; Neto, Jose Xavier; Franchini, Kleber G.] Brazilian Assoc Synchrotron Light Technol, Brazilian Natl Lab Biosci, Campinas, SP, Brazil; [Schechtman, Deborah] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Fioramonte, Mariana; Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil; [Torriani, Iris L.] Univ Estadual Campinas, Gleb Wataghin Phys Inst, Campinas, SP, Brazil	Universidade Estadual de Campinas; Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Santos, AM (corresponding author), Univ Estadual Campinas, Sch Med, Dept Internal Med, Campinas, SP, Brazil.	kleber.franchini@lnbio.org.br	Torriani, Iris L/E-5686-2010; Oliveira, Paulo S/K-5588-2013; da Silva, Julio Cesar/A-5240-2011; Gozzo, Fabio/F-8123-2010; schechtman, deborah/B-7572-2012; Marin, Talita Miguel/K-1964-2019; Fioramonte, Mariana/U-2890-2019; Fioramonte, Mariana/D-7484-2014; Oliveira, Paulo/D-5463-2011; Marin, Talita M/P-1181-2016; Figueira, Ana Carolina/X-1649-2019	da Silva, Julio Cesar/0000-0001-8035-0550; Marin, Talita Miguel/0000-0002-2605-7166; Fioramonte, Mariana/0000-0002-1022-0811; Oliveira, Paulo/0000-0002-1287-8019; Marin, Talita M/0000-0002-2605-7166; Figueira, Ana Carolina/0000-0002-7023-8490; Cardoso, Alisson/0000-0002-3051-9976; Franchini, Kleber/0000-0002-0190-6635; Schechtman, Deborah/0000-0002-8874-7023	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/54878-3, 2007/55930-1, 2007/59442-1, 2008/53519-5, 2008/57805-2, 2010/02628-9]; Conselho Nacional de Pesquisa (CNPq) [304366/2009-9, 475158/2010-5, 573672/2008-3, 559698/2009-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Grants 2006/54878-3, 2007/55930-1, 2007/59442-1, 2008/53519-5, 2008/57805-2, 2010/02628-9) and Conselho Nacional de Pesquisa (CNPq: Grants 304366/2009-9, 475158/2010-5, 573672/2008-3, 559698/2009-7).	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; DiMichele LA, 2006, CIRC RES, V99, P636, DOI 10.1161/01.RES.0000240498.44752.d6; Dunty JM, 2002, J BIOL CHEM, V277, P45644, DOI 10.1074/jbc.M201779200; Eble DM, 2000, AM J PHYSIOL-HEART C, V278, pH1695, DOI 10.1152/ajpheart.2000.278.5.H1695; Fonseca PM, 2005, CIRC RES, V96, P73, DOI 10.1161/01.RES.0000152390.99806.A5; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Golubovskaya VM, 2009, HISTOL HISTOPATHOL, V24, P503, DOI 10.14670/HH-24.503; Iglesias AH, 2010, ANAL CHEM, V82, P909, DOI 10.1021/ac902051q; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Marin TM, 2008, CIRC RES, V103, P813, DOI 10.1161/CIRCRESAHA.108.179754; Medley QG, 2003, J BIOL CHEM, V278, P13265, DOI 10.1074/jbc.M300277200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413	39	15	15	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					102	110		10.1038/nchembio.717	http://dx.doi.org/10.1038/nchembio.717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101605				2022-12-25	WOS:000298414100018
J	Ting, JT; Feng, GP				Ting, Jonathan T.; Feng, Guoping			Found in translation	NATURE MEDICINE			English	Editorial Material							X MENTAL-RETARDATION; MESSENGER-RNAS; MOUSE MODEL; PROTEIN; FMRP; ASSOCIATION		[Ting, Jonathan T.; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Stanley Ctr Psychiat Res,Broad Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ting, JT (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Stanley Ctr Psychiat Res,Broad Inst, E25-618, Cambridge, MA 02139 USA.	fengg@mit.edu	Feng, Guoping/Y-2827-2019	Ting, Jonathan/0000-0001-8266-0392				Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Feng Y, 1997, J NEUROSCI, V17, P1539; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Sherman S. L., 2002, FRAGILE X SYNDROME D, P136; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758	15	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1352	1353		10.1038/nm.2553	http://dx.doi.org/10.1038/nm.2553			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064412				2022-12-25	WOS:000296779300025
J	Alavian, KN; Li, HM; Collis, L; Bonanni, L; Zeng, L; Sacchetti, S; Lazrove, E; Nabili, P; Flaherty, B; Graham, M; Chen, YB; Messerli, SM; Mariggio, MA; Rahner, C; McNay, E; Shore, GC; Smith, PJS; Hardwick, JM; Jonas, EA				Alavian, Kambiz N.; Li, Hongmei; Collis, Leon; Bonanni, Laura; Zeng, Lu; Sacchetti, Silvio; Lazrove, Emma; Nabili, Panah; Flaherty, Benjamin; Graham, Morven; Chen, Yingbei; Messerli, Shanta M.; Mariggio, Maria A.; Rahner, Christoph; McNay, Ewan; Shore, Gordon C.; Smith, Peter J. S.; Hardwick, J. Marie; Jonas, Elizabeth A.			Bcl-x(L) regulates metabolic efficiency of neurons through interaction with the mitochondrial F1F0 ATP synthase	NATURE CELL BIOLOGY			English	Article							BCL-X; UNCOUPLING PROTEIN-2; SUPEROXIDE-DISMUTASE; INNER MITOCHONDRIAL; P-I; MEMBRANE; BAX; LOCALIZATION; INHIBITOR; APOPTOSIS	Anti-apoptotic Bcl2 family proteins such as Bcl-x(L) protect cells from death by sequestering apoptotic molecules, but also contribute to normal neuronal function. We find in hippocampal neurons that Bcl-x(L) enhances the efficiency of energy metabolism. Our evidence indicates that Bcl-x(L)interacts directly with the beta-subunit of the F1F0 ATP synthase, decreasing an ion leak within the F1F0 ATPase complex and thereby increasing net transport of H+ by F1F0 during F1F0 ATPase activity. By patch clamping submitochondrial vesicles enriched in F1F0 ATP synthase complexes, we find that, in the presence of ATP, pharmacological or genetic inhibition of Bcl-x(L) activity increases the membrane leak conductance. In addition, recombinant Bcl-x(L) protein directly increases the level of ATPase activity of purified synthase complexes, and inhibition of endogenous Bcl-x(L) decreases the level of F1F0 enzymatic activity. Our findings indicate that increased mitochondrial efficiency contributes to the enhanced synaptic efficacy found in Bcl-x(L)-expressing neurons.	[Alavian, Kambiz N.; Li, Hongmei; Zeng, Lu; Sacchetti, Silvio; Lazrove, Emma; Nabili, Panah; Flaherty, Benjamin; Jonas, Elizabeth A.] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA; [Collis, Leon; Messerli, Shanta M.; Smith, Peter J. S.] Marine Biol Lab, Biocurrents Res Ctr, Woods Hole, MA 02543 USA; [Bonanni, Laura] Univ G dAnnunzio, Dept Oncol & Neurosci, I-66013 Chieti, Italy; [Bonanni, Laura] Univ G dAnnunzio, Aging Res Ctr, I-66013 Chieti, Italy; [Sacchetti, Silvio; Mariggio, Maria A.] Univ G dAnnunzio, Dept Biochem Physiol & Pathol Muscle, I-66013 Chieti, Italy; [Graham, Morven; Rahner, Christoph] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Chen, Yingbei; Hardwick, J. Marie] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [McNay, Ewan] SUNY Albany, Neurosci Res Ctr, Albany, NY 12222 USA; [Shore, Gordon C.] Gemin X Pharmaceut, Montreal, PQ H2X 2H7, Canada; [Smith, Peter J. S.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Hardwick, J. Marie] Johns Hopkins, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Yale University; Marine Biological Laboratory - Woods Hole; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Yale University; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Southampton; Johns Hopkins University	Jonas, EA (corresponding author), Yale Univ, Dept Internal Med, New Haven, CT 06520 USA.	elizabeth.jonas@yale.edu	Mariggiò, Maria Addolorata/T-9047-2017; chen, ying/HHS-8254-2022; Alavian, Kambiz N/D-7720-2012; Alavian, Kambiz/O-2831-2017; Bonanni, Laura/K-3868-2016	Mariggiò, Maria Addolorata/0000-0001-5306-7143; Alavian, Kambiz/0000-0002-0653-3057; Bonanni, Laura/0000-0001-7443-9233; Mariggio, Maria Addolorata/0000-0002-3508-8706; Smith, Peter/0000-0003-4400-6853	NIH [NS064967, NS37402]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS064967, R01NS045876, R01NS037402, R01NS064967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. K. Kaczmarek for scientific discussion and review of the manuscript. We thank C. Kinnally and N. Danial for the gift of Bax, Bak (DKO) MEFs and Institut de Recherches Servier, Croissy sur Seine, France for ABT-737. This work was supported by NIH NS064967 (E.A.J.) and NS37402 (J.M.H.).	AKAI F, 1990, NEUROSCI LETT, V115, P19, DOI 10.1016/0304-3940(90)90510-G; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Banasiak KJ, 2000, PROG NEUROBIOL, V62, P215, DOI 10.1016/S0301-0082(00)00011-3; Belzacq AS, 2003, CANCER RES, V63, P541; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Bouvier D, 2010, J NEUROCHEM, V113, P153, DOI 10.1111/j.1471-4159.2010.06582.x; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; CHAN TL, 1970, J CELL BIOL, V45, P291, DOI 10.1083/jcb.45.2.291; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Costa ADT, 2009, J BIOENERG BIOMEMBR, V41, P123, DOI 10.1007/s10863-009-9213-y; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; GolshaniHebroni SG, 1997, J BIOENERG BIOMEMBR, V29, P331, DOI 10.1023/A:1022442629543; Gotow T, 2000, CELL DEATH DIFFER, V7, P666, DOI 10.1038/sj.cdd.4400694; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; HACKENBROCK CR, 1971, J CELL BIOL, V51, P123, DOI 10.1083/jcb.51.1.123; Hardwick JM, 2009, CELL, V138, DOI 10.1016/j.cell.2009.07.003; Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hickman JA, 2008, J NEUROPHYSIOL, V99, P1515, DOI 10.1152/jn.00598.2007; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Horvath TL, 2003, BIOCHEM PHARMACOL, V65, P1917, DOI 10.1016/S0006-2952(03)00143-6; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jonas EA, 1999, SCIENCE, V286, P1347, DOI 10.1126/science.286.5443.1347; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; KOBAYASHI T, 1993, ACTA DERM-VENEREOL, V73, P41; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Kunjilwar KK, 2009, J NEUROPHYSIOL, V101, P1351, DOI 10.1152/jn.91012.2008; Land SC, 1999, J EXP BIOL, V202, P211; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4134, DOI 10.1021/bi00313a019; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; NIEUWENHUIS FJ, 1973, BIOCHIM BIOPHYS ACTA, V325, P62, DOI 10.1016/0005-2728(73)90151-5; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Porter RK, 2008, J BIOENERG BIOMEMBR, V40, P457, DOI 10.1007/s10863-008-9172-8; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; SUZUKI K, 1993, AM J PHYSIOL, V265, pH1173, DOI 10.1152/ajpheart.1993.265.4.H1173; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; WARBURG O, 1956, SCIENCE, V124, P269; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	71	199	207	1	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1224	U130		10.1038/ncb2330	http://dx.doi.org/10.1038/ncb2330			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21926988	Green Submitted, Green Accepted			2022-12-25	WOS:000295617900012
J	Buckingham, SC; Campbell, SL; Haas, BR; Montana, V; Robel, S; Ogunrinu, T; Sontheimer, H				Buckingham, Susan C.; Campbell, Susan L.; Haas, Brian R.; Montana, Vedrana; Robel, Stefanie; Ogunrinu, Toyin; Sontheimer, Harald			Glutamate release by primary brain tumors induces epileptic activity	NATURE MEDICINE			English	Article							MALIGNANT GLIOMAS; EXTRACELLULAR MAGNESIUM; EPILEPTOGENESIS; TRANSPORTER; INVASION; SEIZURE; GROWTH; CELLS; MICRODIALYSIS; SULFASALAZINE	Epileptic seizures are a common and poorly understood comorbidity for individuals with primary brain tumors. To investigate peritumoral seizure etiology, we implanted human-derived glioma cells into severe combined immunodeficient mice. Within 14-18 d, glioma-bearing mice developed spontaneous and recurring abnormal electroencephalogram events consistent with progressive epileptic activity. Acute brain slices from these mice showed marked glutamate release from the tumor mediated by the system x(c)(-) cystine-glutamate transporter (encoded by Slc7a11). Biophysical and optical recordings showed glutamatergic epileptiform hyperexcitability that spread into adjacent brain tissue. We inhibited glutamate release from the tumor and the ensuing hyperexcitability by sulfasalazine (SAS), a US Food and Drug Administration-approved drug that blocks system x(c)(-). We found that acute administration of SAS at concentrations equivalent to those used to treat Crohn's disease in humans reduced epileptic event frequency in tumor-bearing mice compared with untreated controls. SAS should be considered as an adjuvant treatment to ameliorate peritumoral seizures associated with glioma in humans.	[Buckingham, Susan C.; Campbell, Susan L.; Haas, Brian R.; Montana, Vedrana; Robel, Stefanie; Ogunrinu, Toyin; Sontheimer, Harald] Univ Alabama, Dept Neurobiol, Ctr Glial Biol Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), Univ Alabama, Dept Neurobiol, Ctr Glial Biol Med, Birmingham, AL 35294 USA.	sontheimer@uab.edu	Robel, Stefanie/G-2924-2011; Robel, Stefanie/AAA-7166-2019	Robel, Stefanie/0000-0001-6716-3670; Sontheimer, Harald/0000-0002-5843-9871	National Center for Research Resources [S10 RR19231]; US National Institutes of Health [U54 CA 100949, P50 AT00477, P30 DK079337, P30 AR50948, 2R01-NS052634, 5R01-NS036692, 5T32NS048039-03]; Neuroscience Blueprint Core Grant [NS57098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA097247, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039, P30NS057098, R01NS052634, R01NS036692] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint Core Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank J. Hablitz and A. Albertson for technical assistance with diode array recordings; A. Margolies for help with histology; C. Langford for orthotopic xenografts; V. Cuddapah for editorial advice; M. McFerrin for technical support, and E. Dudek and K. Wilson at the University of Utah for training in EEG acquisition. We conducted glutamate measurements at the University of Alabama at Birmingham Targeted Metabolomics and Proteomics Facility (funded by the National Center for Research Resources grant S10 RR19231 and US National Institutes of Health grants U54 CA 100949, P50 AT00477, P30 DK079337 and P30 AR50948). We obtained bioluminescence imaging and some field electrode recordings in the Neuroscience Blueprint Core facility (Neuroscience Blueprint Core Grant NS57098). We obtained U251-MG cells from Y. Gillespie (University of Alabama at Birmingham) and U251-MGffluc cells from M. Jensen (City of Hope National Medical Center); GBM12 and GBM22 tumors were obtained from J. Sarkaria (Mayo Clinic) and provided by the University of Alabama at Birmingham Brain Tumor Animal Models Core (UAB SPORE P50-CA097247). This work was supported by US National Institutes of Health grants 2R01-NS052634, 5R01-NS036692 and 5T32NS048039-03.	Behrens PF, 2000, J NEURO-ONCOL, V47, P11, DOI 10.1023/A:1006426917654; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Vries NA, 2009, CANCER TREAT REV, V35, P714, DOI 10.1016/j.ctrv.2009.08.011; DeFazio RA, 2005, DEV BRAIN RES, V157, P83, DOI 10.1016/j.devbrainres.2005.03.008; DURING MJ, 1993, LANCET, V341, P1607; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; JONES RSG, 1989, EXP NEUROL, V104, P155, DOI 10.1016/S0014-4886(89)80009-3; Kim JY, 2001, BBA-BIOMEMBRANES, V1512, P335, DOI 10.1016/S0005-2736(01)00338-8; Kohling R, 2006, NEUROBIOL DIS, V22, P64, DOI 10.1016/j.nbd.2005.10.001; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; MELDRUM BS, 1994, NEUROLOGY, V44, P14; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; MOOTS PL, 1995, ARCH NEUROL-CHICAGO, V52, P717, DOI 10.1001/archneur.1995.00540310091021; Patt S, 2000, NEUROBIOL DIS, V7, P260, DOI 10.1006/nbdi.2000.0288; Robe PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-372; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Senner V, 2004, ACTA NEUROPATHOL, V107, P1, DOI 10.1007/s00401-003-0771-5; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; van Breemen MSM, 2009, J NEUROL, V256, P1519, DOI 10.1007/s00415-009-5156-9; Ye ZC, 1999, CANCER RES, V59, P4383; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; ZHENG W, 1993, DRUG METAB DISPOS, V21, P1091	34	303	310	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1269	U299		10.1038/nm.2453	http://dx.doi.org/10.1038/nm.2453			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21909104	Green Accepted			2022-12-25	WOS:000296022100045
J	Richter, C; Oktaba, K; Steinmann, J; Muller, J; Knoblich, JA				Richter, Constance; Oktaba, Katarzyna; Steinmann, Jonas; Mueller, Juerg; Knoblich, Juergen A.			The tumour suppressor L(3)mbt inhibits neuroepithelial proliferation and acts on insulator elements	NATURE CELL BIOLOGY			English	Article							DROSOPHILA OPTIC LOBE; ORGAN SIZE CONTROL; HISTONE LYSINE METHYLATION; NEUROBLAST SELF-RENEWAL; NEURAL STEM-CELLS; HIPPO PATHWAY; CHROMATIN INSULATORS; TRANSCRIPTION FACTOR; ASYMMETRIC DIVISION; SIGNALING PATHWAYS	In Drosophila, defects in asymmetric cell division often result in the formation of stem-cell-derived tumours. Here, we show that very similar terminal brain tumour phenotypes arise through a fundamentally different mechanism. We demonstrate that brain tumours in l(3)mbt mutants originate from overproliferation of neuroepithelial cells in the optic lobes caused by derepression of target genes in the Salvador Warts Hippo (SWH) pathway. We use ChIP-sequencing to identify L(3)mbt binding sites and show that L(3)mbt binds to chromatin insulator elements. Mutating l(3)mbt or inhibiting expression of the insulator protein gene mod(mdg4) results in upregulation of SWH pathway reporters. As l(3)mbt tumours are rescued by mutations in bantam or yorkie or by overexpression of Expanded, the deregulation of SWH pathway target genes is an essential step in brain tumour formation. Therefore, very different primary defects result in the formation of brain tumours, which behave quite similarly in their advanced stages.	[Richter, Constance; Steinmann, Jonas; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Oktaba, Katarzyna; Mueller, Juerg] European Mol Biol Lab, D-69117 Heidelberg, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); European Molecular Biology Laboratory (EMBL)	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Oktaba, Katarzyna/A-7737-2018; Richter, Constance/P-8714-2019; Müller, Jürg/ABB-3007-2020; Knoblich, Juergen A/C-2974-2015	Oktaba, Katarzyna/0000-0002-3950-5626; Müller, Jürg/0000-0003-2391-4641; Knoblich, Juergen A/0000-0002-6751-3404; Richter, Constance/0000-0003-3312-0941	Austrian Academy of Sciences; Austrian Science Fund (FWF); EU [FP7]; Austrian Science Fund (FWF) [I 552, Z 153] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We wish to thank I. Reichardt, N. Corsini, A. Fischer and C. Jueschke for comments on the manuscript; R. Neumueller and all former and present members of the Knoblich laboratory, as well as W. Wei, C. Girardot and J. Gagneur for discussions; R. Lehmann, D. Pan, L. Zhang, N. Tapon, B. Thompson, G. Haider, G. H. Baeg, M. Labrador, the Flytrap Yale, the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center and the Developmental Studies Hybridoma Bank for fly stocks, antibodies and constructs; P. Serrano Drozdowskyj and M. Novatchkova for bio-informatic support; M. Madalinski for affinity purification; E. Kleiner for technical assistance; K. Aumayr, P. Pasierbek and G. Schmauss for bio-optics support; and S. F. Lopez, S. Wculek and C. Valenta for fly work support. Work in J.A.K.'s laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF) and the EU FP7 network EuroSystem.	Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; GATEFF E, 1990, CONTRIB ONCOL, V39, P135; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hipfner DR, 2002, GENETICS, V161, P1527; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; PROKOP A, 1991, DEVELOPMENT, V111, P79; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Reddy BVVG, 2010, DEVELOPMENT, V137, P2397, DOI 10.1242/dev.050013; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Toriya M, 2006, DEV NEUROSCI-BASEL, V28, P142, DOI 10.1159/000090760; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Wallace HA, 2010, CHROMOSOMA, V119, P177, DOI 10.1007/s00412-009-0246-0; Wang W, 2011, DEV BIOL, V350, P414, DOI 10.1016/j.ydbio.2010.12.002; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117; Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058; Yohn CB, 2003, GENETICS, V165, P1889; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	79	48	48	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1029	U46		10.1038/ncb2306	http://dx.doi.org/10.1038/ncb2306			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21857667	Green Accepted			2022-12-25	WOS:000294487000007
J	Gunay-Aygun, M; Falik-Zaccai, TC; Vilboux, T; Zivony-Elboum, Y; Gumruk, F; Cetin, M; Khayat, M; Boerkoel, CF; Kfir, N; Huang, Y; Maynard, D; Dorward, H; Berger, K; Kleta, R; Anikster, Y; Arat, M; Freiberg, AS; Kehrel, BE; Jurk, K; Cruz, P; Mullikin, JC; White, JG; Huizing, M; Gahl, WA				Gunay-Aygun, Meral; Falik-Zaccai, Tzipora C.; Vilboux, Thierry; Zivony-Elboum, Yifat; Gumruk, Fatma; Cetin, Mualla; Khayat, Morad; Boerkoel, Cornelius F.; Kfir, Nehama; Huang, Yan; Maynard, Dawn; Dorward, Heidi; Berger, Katherine; Kleta, Robert; Anikster, Yair; Arat, Mutlu; Freiberg, Andrew S.; Kehrel, Beate E.; Jurk, Kerstin; Cruz, Pedro; Mullikin, Jim C.; White, James G.; Huizing, Marjan; Gahl, William A.			NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet alpha-granules	NATURE GENETICS			English	Article							PROTEINS	Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder that is characterized by large platelets that lack alpha-granules. Here we show that mutations in NBEAL2 (neurobeachin-like 2), which encodes a BEACH/ARM/WD40 domain protein, cause GPS and that megakaryocytes and platelets from individuals with GPS express a unique combination of NBEAL2 transcripts. Proteomic analysis of sucrose-gradient subcellular fractions of platelets indicated that NBEAL2 localizes to the dense tubular system (endoplasmic reticulum) in platelets.	[Gunay-Aygun, Meral; Vilboux, Thierry; Boerkoel, Cornelius F.; Huang, Yan; Maynard, Dawn; Dorward, Heidi; Berger, Katherine; Kleta, Robert; Huizing, Marjan; Gahl, William A.] NHGRI, Sect Human Biochem Genet, Med Genet Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Gunay-Aygun, Meral; Gahl, William A.] US Natl Inst Hlth, Off Rare Dis Res, Bethesda, MD USA; [Falik-Zaccai, Tzipora C.; Zivony-Elboum, Yifat; Khayat, Morad; Kfir, Nehama] Western Galilee Hosp, Inst Human Genet, Nahariyya, Israel; [Falik-Zaccai, Tzipora C.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Gumruk, Fatma; Cetin, Mualla] Hacettepe Univ Childrens Hosp, Pediat Hematol Unit, Ankara, Turkey; [Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Metab Dis Unit, Tel Aviv, Israel; [Anikster, Yair] Sackler Sch Med, Tel Aviv, Israel; [Arat, Mutlu] Ankara Univ, Fac Med, Dept Hematol, TR-06100 Ankara, Turkey; [Freiberg, Andrew S.] Penn State Hershey Childrens Hosp, Div Pediat Hematol Oncol, Hershey, PA USA; [Kehrel, Beate E.; Jurk, Kerstin] Univ Hosp Munster, Dept Anaesthesiol & Intens Care Expt & Clin Haemo, Munster, Germany; [Cruz, Pedro; Mullikin, Jim C.] US Natl Inst Hlth NIH, Intramural Sequencing Ctr, NIH, Bethesda, MD USA; [White, James G.] Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Western Galilee Hospital; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Ankara University; Hacettepe University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Ankara University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Munster; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Minnesota System; University of Minnesota Twin Cities	Gunay-Aygun, M (corresponding author), NHGRI, Sect Human Biochem Genet, Med Genet Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA.	mgaygun@mail.nih.gov	Boerkoel, Cornelius Franciscus/AFW-4948-2022; Huizing, Marjan/AAR-8860-2020; Jurk, Kerstin/AAT-7768-2020; Arat, Mutlu/AAI-1481-2019	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Arat, Mutlu/0000-0003-2039-8557	National Human Genome Research Institute; NIH Clinical Center; Israeli Ministry of Justice [84/2004, 85/2004, 9090-25/2007]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322, ZIBHG000196, ZIAHG200330, ZIAHG000215] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); Israeli Ministry of Justice; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all of our subjects with GPS and their families for their cooperation; the NIH Intramural Sequencing Center for performing the whole-exome sequencing and analysis; A. Nurden for the French patient; I. Bernardini and R. Fisher for technical assistance; H. Edwards, L. Riley, K. Patzel, P. Tanpaiboon, J. Chezar and J. Manaster for DNA sequencing assistance; T. Markello for the SNP array; and I. Maric, S. Gucer and I. Kuzu for assistance with bone marrow slides. This study was supported by the Intramural Research Programs of the National Human Genome Research Institute and the NIH Clinical Center and by the Israeli Ministry of Justice; Izvonot Fund, grants 84/2004, 85/2004 and 9090-25/2007 to T.C.F.-Z.	BRETONGORIUS J, 1981, AM J PATHOL, V102, P10; Gunay-Aygun M, 2004, SEMIN THROMB HEMOST, V30, P537, DOI 10.1055/s-2004-835674; Gunay-Aygun M, 2010, BLOOD, V116, P4990, DOI 10.1182/blood-2010-05-286534; Hyman T, 2003, BRIT J HAEMATOL, V122, P142, DOI 10.1046/j.1365-2141.2003.04410.x; Jiang F, 2002, BLOOD, V99, P3579, DOI 10.1182/blood.V99.10.3579; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; Maynard DM, 2010, J THROMB HAEMOST, V8, P1786, DOI 10.1111/j.1538-7836.2010.03932.x; Nurden AT, 2007, BLOOD REV, V21, P21, DOI 10.1016/j.blre.2005.12.003; RACCUGLIA G, 1971, AM J MED, V51, P818, DOI 10.1016/0002-9343(71)90311-1; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Wang N, 2002, J CELL BIOCHEM, V86, P561, DOI 10.1002/jcb.10254; WEISS HJ, 1979, BLOOD, V54, P1296; WHITE JG, 1979, AM J PATHOL, V95, P445	15	157	160	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2011	43	8					732	734		10.1038/ng.883	http://dx.doi.org/10.1038/ng.883			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21765412	Green Accepted			2022-12-25	WOS:000293178300006
J	Kilpelainen, TO; Zillikens, MC; Stancakova, A; Finucane, FM; Ried, JS; Langenberg, C; Zhang, WH; Beckmann, JS; Luan, JA; Vandenput, L; Styrkarsdottir, U; Zhou, YH; Smith, AV; Zhao, JH; Amin, N; Vedantam, S; Shin, SY; Haritunians, T; Fu, M; Feitosa, MF; Kumari, M; Halldorsson, BV; Tikkanen, E; Mangino, M; Hayward, C; Song, C; Arnold, AM; Aulchenko, YS; Oostra, BA; Campbell, H; Cupples, LA; Davis, KE; Doring, A; Eiriksdottir, G; Estrada, K; Fernandez-Real, JM; Garcia, M; Gieger, C; Glazer, NL; Guiducci, C; Hofman, A; Humphries, SE; Isomaa, B; Jacobs, LC; Jula, A; Karasik, D; Karlsson, MK; Khaw, KT; Kim, LJ; Kivimaki, M; Klopp, N; Kuhnel, B; Kuusisto, J; Liu, YM; Ljunggren, O; Lorentzon, M; Luben, RN; McKnight, B; Mellstrom, D; Mitchell, BD; Mooser, V; Moreno, JM; Mannisto, S; O'Connell, JR; Pascoe, L; Peltonen, L; Peral, B; Perola, M; Psaty, BM; Salomaa, V; Savage, DB; Semple, RK; Skaric-Juric, T; Sigurdsson, G; Song, KS; Spector, TD; Syvanen, AC; Talmud, PJ; Thorleifsson, G; Thorsteinsdottir, U; Uitterlinden, AG; van Duijn, CM; Vidal-Puig, A; Wild, SH; Wright, AF; Clegg, DJ; Schadt, E; Wilson, JF; Rudan, I; Ripatti, S; Borecki, IB; Shuldiner, AR; Ingelsson, E; Jansson, JO; Kaplan, RC; Gudnason, V; Harris, TB; Groop, L; Kiel, DP; Rivadeneira, F; Walker, M; Barroso, I; Vollenweider, P; Waeber, G; Chambers, JC; Kooner, JS; Soranzo, N; Hirschhorn, JN; Stefansson, K; Wichmann, HE; Ohlsson, C; O'Rahilly, S; Wareham, NJ; Speliotes, EK; Fox, CS; Laakso, M; Loos, RJF				Kilpelainen, Tuomas O.; Zillikens, M. Carola; Stancakova, Alena; Finucane, Francis M.; Ried, Janina S.; Langenberg, Claudia; Zhang, Weihua; Beckmann, Jacques S.; Luan, Jian'an; Vandenput, Liesbeth; Styrkarsdottir, Unnur; Zhou, Yanhua; Smith, Albert Vernon; Zhao, Jing-Hua; Amin, Najaf; Vedantam, Sailaja; Shin, So-Youn; Haritunians, Talin; Fu, Mao; Feitosa, Mary F.; Kumari, Meena; Halldorsson, Bjarni V.; Tikkanen, Emmi; Mangino, Massimo; Hayward, Caroline; Song, Ci; Arnold, Alice M.; Aulchenko, Yurii S.; Oostra, Ben A.; Campbell, Harry; Cupples, L. Adrienne; Davis, Kathryn E.; Doering, Angela; Eiriksdottir, Gudny; Estrada, Karol; Manuel Fernandez-Real, Jose; Garcia, Melissa; Gieger, Christian; Glazer, Nicole L.; Guiducci, Candace; Hofman, Albert; Humphries, Steve E.; Isomaa, Bo; Jacobs, Leonie C.; Jula, Antti; Karasik, David; Karlsson, Magnus K.; Khaw, Kay-Tee; Kim, Lauren J.; Kivimaeki, Mika; Klopp, Norman; Kuehnel, Brigitte; Kuusisto, Johanna; Liu, Yongmei; Ljunggren, Osten; Lorentzon, Mattias; Luben, Robert N.; McKnight, Barbara; Mellstrom, Dan; Mitchell, Braxton D.; Mooser, Vincent; Maria Moreno, Jose; Mannisto, Satu; O'Connell, Jeffery R.; Pascoe, Laura; Peltonen, Leena; Peral, Belen; Perola, Markus; Psaty, Bruce M.; Salomaa, Veikko; Savage, David B.; Semple, Robert K.; Skaric-Juric, Tatjana; Sigurdsson, Gunnar; Song, Kijoung S.; Spector, Timothy D.; Syvanen, Ann-Christine; Talmud, Philippa J.; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Vidal-Puig, Antonio; Wild, Sarah H.; Wright, Alan F.; Clegg, Deborah J.; Schadt, Eric; Wilson, James F.; Rudan, Igor; Ripatti, Samuli; Borecki, Ingrid B.; Shuldiner, Alan R.; Ingelsson, Erik; Jansson, John-Olov; Kaplan, Robert C.; Gudnason, Vilmundur; Harris, Tamara B.; Groop, Leif; Kiel, Douglas P.; Rivadeneira, Fernando; Walker, Mark; Barroso, Ines; Vollenweider, Peter; Waeber, Gerard; Chambers, John C.; Kooner, Jaspal S.; Soranzo, Nicole; Hirschhorn, Joel N.; Stefansson, Kari; Wichmann, H-Erich; Ohlsson, Claes; O'Rahilly, Stephen; Wareham, Nicholas J.; Speliotes, Elizabeth K.; Fox, Caroline S.; Laakso, Markku; Loos, Ruth J. F.			Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RECEPTOR SUBSTRATE-1; FTO GENE; LOCI; RESISTANCE; ADIPOCYTE; MIGRATION; VARIANTS; RISK; MASS	Genome-wide association studies have identified 32 loci influencing body mass index, but this measure does not distinguish lean from fat mass. To identify adiposity loci, we meta-analyzed associations between similar to 2.5 million SNPs and body fat percentage from 36,626 individuals and followed up the 14 most significant (P < 10(-6)) independent loci in 39,576 individuals. We confirmed a previously established adiposity locus in FTO (P = 3 x 10(-26)) and identified two new loci associated with body fat percentage, one near IRS1 (P = 4 x 10(-11)) and one near SPRY2 (P = 3 x 10(-8)). Both loci contain genes with potential links to adipocyte physiology. Notably, the body-fat-decreasing allele near IRS1 is associated with decreased IRS1 expression and with an impaired metabolic profile, including an increased visceral to subcutaneous fat ratio, insulin resistance, dyslipidemia, risk of diabetes and coronary artery disease and decreased adiponectin levels. Our findings provide new insights into adiposity and insulin resistance.	[Kilpelainen, Tuomas O.; Finucane, Francis M.; Langenberg, Claudia; Luan, Jian'an; Zhao, Jing-Hua; Wareham, Nicholas J.; Loos, Ruth J. F.] MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Zillikens, M. Carola; Estrada, Karol; Jacobs, Leonie C.; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Zillikens, M. Carola; Estrada, Karol; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Rivadeneira, Fernando] NGI, NCHA, Leiden, Netherlands; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Ried, Janina S.; Doering, Angela; Gieger, Christian; Klopp, Norman; Kuehnel, Brigitte; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Zhang, Weihua; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Beckmann, Jacques S.] Univ Lausanne Hosp, Dept Med Genet, Lausanne, Switzerland; [Vandenput, Liesbeth; Lorentzon, Mattias; Mellstrom, Dan; Ohlsson, Claes] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden; [Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Zhou, Yanhua; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Smith, Albert Vernon; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Heart Prevent Clin, Kopavogur, Iceland; [Smith, Albert Vernon; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Res Inst, Kopavogur, Iceland; [Amin, Najaf; Aulchenko, Yurii S.; Oostra, Ben A.; Estrada, Karol; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Vedantam, Sailaja; Guiducci, Candace; Hirschhorn, Joel N.; Speliotes, Elizabeth K.] Broad Inst, Metab Initiat, Cambridge, MA USA; [Vedantam, Sailaja; Guiducci, Candace; Hirschhorn, Joel N.; Speliotes, Elizabeth K.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Shin, So-Youn; Peltonen, Leena; Barroso, Ines; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Haritunians, Talin] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Fu, Mao; Mitchell, Braxton D.; O'Connell, Jeffery R.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Feitosa, Mary F.; Borecki, Ingrid B.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Kumari, Meena] UCL, Dept Epidemiol, Genet Epidemiol Grp, London, England; [Halldorsson, Bjarni V.] Reykjavik Univ, Reykjavik, Iceland; [Tikkanen, Emmi; Peltonen, Leena; Perola, Markus; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Mangino, Massimo; Spector, Timothy D.] Kings Coll London, London WC2R 2LS, England; [Hayward, Caroline; Wright, Alan F.] MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Song, Ci; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Arnold, Alice M.; McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Campbell, Harry; Wild, Sarah H.; Wilson, James F.; Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Davis, Kathryn E.; Clegg, Deborah J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Manuel Fernandez-Real, Jose; Maria Moreno, Jose] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Inst Invest Biomed Girona, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Garcia, Melissa; Kim, Lauren J.; Harris, Tamara B.] NIA, Intramural Res Program, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Glazer, Nicole L.; McKnight, Barbara; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Glazer, Nicole L.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Humphries, Steve E.; Talmud, Philippa J.] UCL, Dept Med, Ctr Cardiovasc Genet, London, England; [Isomaa, Bo] Folkhalsan Res Ctr, Helsinki, Finland; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Jula, Antti] Natl Inst Hlth & Welf, Populat Studies Unit, Helsinki, Finland; [Karasik, David; Kiel, Douglas P.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Karlsson, Magnus K.] Malmo Univ Hosp, Dept Orthopaed, Malmo, Sweden; [Khaw, Kay-Tee; Luben, Robert N.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Liu, Yongmei] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Ljunggren, Osten] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Mooser, Vincent; Song, Kijoung S.] GlaxoSmithKline, Genet Res & Dev, King Of Prussia, PA USA; [Mannisto, Satu; Salomaa, Veikko] Natl Inst Hlth & Welf, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Pascoe, Laura; Walker, Mark] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Peral, Belen] CSIC, Inst Invest Biomed, Madrid, Spain; [Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Savage, David B.; Semple, Robert K.; Vidal-Puig, Antonio; Barroso, Ines; O'Rahilly, Stephen] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Skaric-Juric, Tatjana] Inst Anthropol Res, Zagreb, Croatia; [Sigurdsson, Gunnar] Univ Hosp, Dept Endocrinol & Metab, Reykjavik, Iceland; [Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden; [van Duijn, Cornelia M.] CMSB, NGI, Leiden, Netherlands; [Schadt, Eric] Pacific Biosci, Menlo Pk, CA USA; [Schadt, Eric] Sage Bionetworks, Seattle, WA USA; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Gen Info Ltd, Zagreb, Croatia; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21218 USA; [Ingelsson, Erik] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Jansson, John-Olov] Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Groop, Leif] Lund Univ, Dept Clin Sci, Ctr Diabet, Malmo, Sweden; [Vollenweider, Peter; Waeber, Gerard] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Speliotes, Elizabeth K.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Fox, Caroline S.] NHLBI, Boston, MA USA	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Gothenburg; Boston University; Icelandic Heart Association; Icelandic Heart Association; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Wellcome Trust Sanger Institute; Cedars Sinai Medical Center; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); University of London; University College London; Reykjavik University; University of Helsinki; University of London; King's College London; University of Edinburgh; Karolinska Institutet; University of Washington; University of Washington Seattle; University of Edinburgh; Framingham Heart Study; University of Texas System; University of Texas Southwestern Medical Center Dallas; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; University College London; Folkhalsan Research Center; Finland National Institute for Health & Welfare; Harvard University; Hebrew SeniorLife; Lund University; Skane University Hospital; University of Cambridge; University of London; University College London; Wake Forest University; Wake Forest Baptist Medical Center; Uppsala University; GlaxoSmithKline; Finland National Institute for Health & Welfare; Newcastle University - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Institute for Anthropological Research Zagreb; Landspitali National University Hospital; University of Iceland; Uppsala University; University of Split; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Uppsala University; University of Gothenburg; Yeshiva University; University of Iceland; Lund University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London; Harvard University; Harvard Medical School; University of Munich; University of Munich; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Loos, RJF (corresponding author), MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England.	ruth.loos@mrc-epid.cam.ac.uk	zhang, weihua/GXV-1334-2022; Rudan, Igor/I-1467-2012; Loos, Ruth J F/Q-2862-2016; Amin, Najaf N/D-1859-2012; Hayward, Caroline/M-8818-2016; Loos, Ruth/GON-5877-2022; Ohlsson, Claes/AGP-3544-2022; Luben, Robert N/H-5519-2015; Feitosa, Mary F/K-8044-2012; Skaric-Juric, Tatjana/H-5997-2011; Ripatti, Samuli/H-9446-2014; Vandenput, Liesbeth/AAP-3655-2020; Langenberg, Claudia/ABG-9067-2021; Moreno-Navarrete, José María/H-9772-2015; Wichmann, Heinz Erich/AAA-5695-2022; Fernández-Real, Jose Manuel/AGH-3599-2022; Smith, Albert Vernon/K-5150-2015; Semple, Robert/AAB-2948-2019; Mangino, Massimo/F-5134-2011; Vandenput, Liesbeth/AAI-4100-2021; Gudnason, Vilmundur/AAE-7126-2019; Campbell, Harry/E-2959-2010; Stefansson, Kari/AAE-7187-2019; Lorentzon, Mattias/W-7878-2019; Kivimaki, Mika/B-3607-2012; O'Rahilly, Stephen/ABF-6509-2020; Wilson, James F/A-5704-2009; Gudnason, Vilmundur/K-6885-2015; Colaus, PsyColaus/K-6607-2013; Mitchell, Braxton/CAF-0876-2022; Finucane, Francis/G-6031-2012; Kilpeläinen, Tuomas/F-8569-2012; Rivadeneira, Fernando/O-5385-2015; Stancakova, Alena/AAN-6723-2020; Aulchenko, Yurii/M-8270-2013; Moreno-Navarrete, José María/ABG-5548-2021; Khaw, Kay-Tee/AAZ-3209-2021; Beckmann, Jacques S/A-9772-2008; PERAL, BELEN/F-4562-2015	Rudan, Igor/0000-0001-6993-6884; Loos, Ruth J F/0000-0002-8532-5087; Hayward, Caroline/0000-0002-9405-9550; Ohlsson, Claes/0000-0002-9633-2805; Luben, Robert N/0000-0002-5088-6343; Feitosa, Mary F/0000-0002-0933-2410; Ripatti, Samuli/0000-0002-0504-1202; Vandenput, Liesbeth/0000-0002-1712-6131; Langenberg, Claudia/0000-0002-5017-7344; Moreno-Navarrete, José María/0000-0002-2883-511X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Smith, Albert Vernon/0000-0003-1942-5845; Mangino, Massimo/0000-0002-2167-7470; Vandenput, Liesbeth/0000-0002-1712-6131; Gudnason, Vilmundur/0000-0001-5696-0084; Campbell, Harry/0000-0002-6169-6262; Lorentzon, Mattias/0000-0003-0749-1431; Kivimaki, Mika/0000-0002-4699-5627; O'Rahilly, Stephen/0000-0003-2199-4449; Wilson, James F/0000-0001-5751-9178; Gudnason, Vilmundur/0000-0001-5696-0084; Finucane, Francis/0000-0002-5374-7090; Kilpeläinen, Tuomas/0000-0002-8349-3028; Rivadeneira, Fernando/0000-0001-9435-9441; Stancakova, Alena/0000-0002-1375-0252; Aulchenko, Yurii/0000-0002-7899-1575; Moreno-Navarrete, José María/0000-0002-2883-511X; Beckmann, Jacques S/0000-0002-9741-1900; PERAL, BELEN/0000-0003-4984-4020; Mitchell, Braxton/0000-0003-4920-4744; Styrkarsdottir, Unnur/0000-0001-8146-8278; Soranzo, Nicole/0000-0003-1095-3852; Karasik, David/0000-0002-8826-0530; Savage, David Bousfield/0000-0002-7857-7032; Waeber, Gerard/0000-0003-4193-788X; Skaric-Juric, Tatjana/0000-0003-3708-6170; Mannisto, Satu/0000-0002-8668-3046; Halldorsson, Bjarni/0000-0003-0756-0767; Cupples, L. Adrienne/0000-0003-0273-7965; Kiel, Douglas/0000-0001-8474-0310; Vidal-Puig, Antonio/0000-0003-4220-9577; Barroso, Ines/0000-0001-5800-4520; Amin, Najaf/0000-0002-8944-1771; Gieger, Christian/0000-0001-6986-9554; Humphries, Stephen E/0000-0002-8221-6547; Shuldiner, Alan/0000-0001-9921-4305; Song, Ci/0000-0002-0947-9068; Van Duijn, Cornelia/0000-0002-2374-9204; Talmud, Philippa/0000-0002-5560-1933; Semple, Robert Kenneth/0000-0001-6539-3069; Glazer, Nicole/0000-0002-6397-609X	Academy of Finland [10404, 124243, 129680, 129494, 141005, 213506]; Agency for Health Care Policy Research [HS06516]; Althingi (the Icelandic Parliament); American Heart Association [10SDG269004]; AstraZeneca; Baltimore Geriatric Research Education and Clinical Centers; Biocentrum Helsinki Foundation; Biotechnology and Biological Sciences Research Council [G20234]; British Heart Foundation [PG/07/133/24260, RG/08/008, SP/04/002, SP/07/007/23671]; CamStrad; Cancer Research UK; Cedars-Sinai Board of Governors' Chair in Medical Genetics; Centre for Medical Systems Biology (The Netherlands); Centre Hospitalier Universitaire Vaudois (Lausanne); Croatian Ministry of Science, Education and Sport [196-1962766-2747, 216-1080315-0302, 309-0061194-2023]; Department of Health (UK); Department of Veterans Affairs (USA); Emil and Vera Cornell Foundation; Erasmus Medical Center (Rotterdam); Erasmus University (Rotterdam); European Commission [FP7/2007-2013, FP7-KBBE-2010-4-266408, HEALTH-F2-2007-201681, HEALTH-F2-2008-201865-GEFOS, HEALTH-F4-2007-201413, HEALTH-F4-2007-201550, LSHG-CT-2006-018947, LSHG-CT-2006-01947, LSHM-CT-2003-503041, LSHM-CT-2004-512013, QLG1-CT-2001-01252, QLG2-CT-2002-01254]; Finnish Diabetes Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Heart Foundation; Finnish Medical Society; Folkhalsan Research Foundation; Food Standards Agency (UK); Foundation for Life and Health in Finland; German Bundesministerium fur Forschung und Technology [01AK803A-H, 01IG07015G]; German Federal Ministry of Education and Research; German National Genome Research Network [NGFN-2, NGFNPlus: 01GS0823]; Giorgi-Cavaglieri Foundation; GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Health and Safety Executive (UK); Health Care Center in Vasa; Health Care Center in Narpes; Health Care Center in Korsholm; Hjartavernd (the Icelandic Heart Association); John D. and Catherine T. MacArthur Foundation; Knut and Alice Wallenberg Foundation; Leenaards Foundation; Ludwig-Maximilians Universitat Munchen; Lundberg Foundation; Medical Research Council (UK); Men's Associates of Hebrew SeniorLife; Ministerio de Ciencia e Innovacion (Spain) [SAF-2009, SAF-2008-02073]; Ministry for Health, Welfare and Sports (The Netherlands); Ministry of Education (Finland); Ministry of Education, Culture and Science (The Netherlands); Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Institute for Health Research (UK); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging [050-060-810]; Netherlands Organisation for Scientific Research [175.010.2005.011, 911-03-012]; Netherlands Organization for the Health Research and Development; Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation; Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Robert Dawson Evans Endowment; Royal Society (UK); Sahlgrenska Center for Cardiovascular and Metabolic Research [A305:188]; Sahlgrenska University Hospital Foundation (ALF/LUA); Science Funding programme (UK); Scottish Executive Health Department; Sigrid Juselius Foundation; State of Bavaria; Stroke Association (UK); Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research; Swedish Research Council [K2010-54X-09894-19-3, K2010-52X-20229-05-3, 2006-3832]; Swedish Strategic Foundation; Swiss Institute of Bioinformatics; Swiss National Science Foundation [3100AO-116323/1, 310000-112552, 33CSCO-122661]; TEKES [1510/31/06]; Torsten and Ragnar Soderberg's Foundation; United Kingdom NIHR Cambridge Biomedical Research Centre; University of Lausanne; University of Maryland General Clinical Research Center [M01 RR 16500]; Uppsala University; British Heart Foundation [RG/08/008/25291, RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_U106188470, MC_U127561128, G1000143, MC_U106179471, G0700931, G0802051, G8802774, G0701863, G0100222, G19/35, G0401527, G0600717B, G0902037, G0601966] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; MRC [G0902037, MC_U106188470, G0701863, G0802051, G0700931, MC_U127561128, G0601966] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC085086, N01HC075150, N01HC015103, N01HC045133, N01HC055222, N01HC025195, N01HC085079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500, M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084756, U01HL080295, U01HL072515, R01HL064278, R01HL036310, R01HL087700, R01HL087652, R01HL117078, R01HL088119, ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838, R01AR041398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, R01DK075681, K23DK080145, R01DK075787, R01DK068336, R01DK089256, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, R01AG013196, N01AG062103, N01AG012100, R01AG018728, R01AG032098, N01AG062106, R01AG031890, R37AG013196] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Althingi (the Icelandic Parliament); American Heart Association(American Heart Association); AstraZeneca(AstraZeneca); Baltimore Geriatric Research Education and Clinical Centers; Biocentrum Helsinki Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); CamStrad; Cancer Research UK(Cancer Research UK); Cedars-Sinai Board of Governors' Chair in Medical Genetics; Centre for Medical Systems Biology (The Netherlands)(Netherlands Government); Centre Hospitalier Universitaire Vaudois (Lausanne); Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Department of Health (UK); Department of Veterans Affairs (USA)(US Department of Veterans Affairs); Emil and Vera Cornell Foundation; Erasmus Medical Center (Rotterdam); Erasmus University (Rotterdam); European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Diabetes Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Heart Foundation; Finnish Medical Society; Folkhalsan Research Foundation; Food Standards Agency (UK); Foundation for Life and Health in Finland; German Bundesministerium fur Forschung und Technology; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Giorgi-Cavaglieri Foundation; GlaxoSmithKline(GlaxoSmithKline); Goteborg Medical Society; Gyllenberg Foundation; Health and Safety Executive (UK); Health Care Center in Vasa; Health Care Center in Narpes; Health Care Center in Korsholm; Hjartavernd (the Icelandic Heart Association); John D. and Catherine T. MacArthur Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leenaards Foundation; Ludwig-Maximilians Universitat Munchen; Lundberg Foundation(European Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Men's Associates of Hebrew SeniorLife; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry for Health, Welfare and Sports (The Netherlands)(Netherlands Government); Ministry of Education (Finland); Ministry of Education, Culture and Science (The Netherlands)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Netherlands Government); Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for the Health Research and Development(Netherlands Organization for Health Research and Development); Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly; Robert Dawson Evans Endowment; Royal Society (UK)(Royal Society of London); Sahlgrenska Center for Cardiovascular and Metabolic Research; Sahlgrenska University Hospital Foundation (ALF/LUA); Science Funding programme (UK); Scottish Executive Health Department; Sigrid Juselius Foundation(Sigrid Juselius Foundation); State of Bavaria; Stroke Association (UK); Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Foundation; Swiss Institute of Bioinformatics; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Torsten and Ragnar Soderberg's Foundation; United Kingdom NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); University of Lausanne; University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Uppsala University; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A full list of Acknowledgments appears in the Supplementary Note. Funding was provided by Academy of Finland (10404, 124243, 129680, 129494, 141005 and 213506); Agency for Health Care Policy Research (HS06516); Althingi (the Icelandic Parliament); American Heart Association (10SDG269004); AstraZeneca; Baltimore Geriatric Research Education and Clinical Centers; Biocentrum Helsinki Foundation; Biotechnology and Biological Sciences Research Council (G20234); British Heart Foundation (PG/07/133/24260, RG/08/008, SP/04/002, SP/07/007/23671); CamStrad; Cancer Research UK; Cedars-Sinai Board of Governors' Chair in Medical Genetics; Centre for Medical Systems Biology (The Netherlands); Centre Hospitalier Universitaire Vaudois (Lausanne); Croatian Ministry of Science, Education and Sport (196-1962766-2747, 216-1080315-0302 and 309-0061194-2023); Department of Health (UK); Department of Veterans Affairs (USA); Emil and Vera Cornell Foundation; Erasmus Medical Center (Rotterdam); Erasmus University (Rotterdam); European Commission (DG XII, FP7/2007-2013, FP7-KBBE-2010-4-266408, HEALTH-F2-2007-201681, HEALTH-F2-2008-201865-GEFOS, HEALTH-F4-2007-201413, HEALTH-F4-2007-201550, LSHG-CT-2006-018947, LSHG-CT-2006-01947, LSHM-CT-2003-503041, LSHM-CT-2004-512013, QLG1-CT-2001-01252 and QLG2-CT-2002-01254); Finnish Diabetes Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Heart Foundation; Finnish Medical Society; Folkhalsan Research Foundation; Food Standards Agency (UK); Foundation for Life and Health in Finland; German Bundesministerium fur Forschung und Technology (01AK803A-H and 01IG07015G); German Federal Ministry of Education and Research; German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823); Giorgi-Cavaglieri Foundation; GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Health and Safety Executive (UK); Health Care Centers in Vasa, Narpes and Korsholm; Hjartavernd (the Icelandic Heart Association); John D. and Catherine T. MacArthur Foundation; Knut and Alice Wallenberg Foundation; Leenaards Foundation; Ludwig-Maximilians Universitat Munchen; Lundberg Foundation; Medical Research Council (UK); Men's Associates of Hebrew SeniorLife; Ministerio de Ciencia e Innovacion (Spain) (SAF-2009 and SAF-2008-02073); Ministry for Health, Welfare and Sports (The Netherlands); Ministry of Education (Finland); Ministry of Education, Culture and Science (The Netherlands); Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Institute for Health Research (UK); US National Institutes of Health (USA) (AG13196, DK063491, K23-DK080145, M01-RR00425, N01-AG12100, N01-AG62101, N01-AG62103, N01-AG62106, N01-HC15103, N01-HC25195, N01-HC35129, N01-HC45133, N01-HC55222, N01-HC75150, N01-HC85079 through N01-HC85086, P30-DK072488, R01-AG031890-01, R01-AG18728, R01-AG032098-01A1, R01-AR/AG41398, R01-AR046838, R01-DK06833603, R01-DK075787, R01-DK07568102, R01-HL036310-20A2, R01-HL087652, R01-HL08770003, R01-HL088119, U01-HL080295, U01-HL72515 and U01-HL84756); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging (050-060-810); Netherlands Organisation for Scientific Research (175.010.2005.; 011 and 911-03-012); Netherlands Organization for the Health Research and Development; Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation; Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly (01-93-015; RIDE2); Robert Dawson Evans Endowment; Royal Society (UK); Sahlgrenska Center for Cardiovascular and Metabolic Research (A305:188); Sahlgrenska University Hospital Foundation (ALF/LUA); Science Funding programme (UK); Scottish Executive Health Department; Sigrid Juselius Foundation; State of Bavaria; Stroke Association (UK); Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research; Swedish Research Council (K2010-54X-09894-19-3, K2010-52X-20229-05-3 and 2006-3832); Swedish Strategic Foundation; Swiss Institute of Bioinformatics; Swiss National Science Foundation (3100AO-116323/1, 310000-112552 and 33CSCO-122661); TEKES (1510/31/06); Torsten and Ragnar Soderberg's Foundation; United Kingdom NIHR Cambridge Biomedical Research Centre; University of Lausanne; University of Maryland General Clinical Research Center (M01 RR 16500); Uppsala University; Vastra Gotaland Foundation; and Wellcome Trust (077016/Z/05/Z, 084723/Z/08/Z and 091746/Z/10/Z).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Barnett AH, 2006, DIABETOLOGIA, V49, P2234, DOI 10.1007/s00125-006-0325-1; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grarup N, 2010, CURR DIABETES REP, V10, P485, DOI 10.1007/s11892-010-0154-y; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; SmithHall J, 1997, BIOCHEMISTRY-US, V36, P8304, DOI 10.1021/bi9630974; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stumvoll M, 1999, EXP CLIN ENDOCR DIAB, V107, P107, DOI 10.1055/s-0029-1212083; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Urs S, 2010, FASEB J, V24, P3264, DOI 10.1096/fj.10-155127; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020; Zhou LX, 1997, J BIOL CHEM, V272, P29829, DOI 10.1074/jbc.272.47.29829	51	212	219	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2011	43	8					753	U58		10.1038/ng.866	http://dx.doi.org/10.1038/ng.866			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21706003	Green Accepted, Green Submitted			2022-12-25	WOS:000293178300011
J	Kovacs, EM; Verma, S; Ali, RG; Ratheesh, A; Hamilton, NA; Akhmanova, A; Yap, AS				Kovacs, Eva M.; Verma, Suzie; Ali, Radiya G.; Ratheesh, Aparna; Hamilton, Nicholas A.; Akhmanova, Anna; Yap, Alpha S.			N-WASP regulates the epithelial junctional actin cytoskeleton through a non-canonical post-nucleation pathway	NATURE CELL BIOLOGY			English	Article							CELL-CELL JUNCTIONS; E-CADHERIN; ARP2/3 COMPLEX; PROTEIN; WIP; POLYMERIZATION; MOTILITY; SYSTEM; MECHANISMS; FAMILY	N-WASP is a major cytoskeletal regulator that stimulates Arp2/3-mediated actin nucleation. Here, we identify a nucleation-independent pathway by which N-WASP regulates the cytoskeleton and junctional integrity at the epithelial zonula adherens. N-WASP is a junctional protein whose depletion decreased junctional F-actin content and organization. However, N-WASP (also known as WASL) RNAi did not affect junctional actin nucleation, dominantly mediated by Arp2/3. Furthermore, the junctional effect of N-WASP RNAi was rescued by an N-WASP mutant that cannot directly activate Arp2/3. Instead, N-WASP stabilized newly formed actin-laments and facilitated their incorporation into apical rings at the zonula adherens. A major physiological effect of N-WASP at the zonula adherens thus occurs through a non-canonical pathway that is distinct from its capacity to activate Arp2/3. Indeed, the junctional impact of N-WASP was mediated by the WIP-family protein, WIRE, which binds to the N-WASP WH1 domain. We conclude that N-WASP-WIRE serves as an integrator that couples actin nucleation with the subsequent steps of filament stabilization and organization necessary for zonula adherens integrity.	[Kovacs, Eva M.; Verma, Suzie; Ali, Radiya G.; Ratheesh, Aparna; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia; [Ali, Radiya G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Hamilton, Nicholas A.] Univ Queensland, Inst Mol Biosci, Div Genom & Computat Biol, Brisbane, Qld 4072, Australia; [Akhmanova, Anna] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands	University of Queensland; University of Queensland; University of Queensland; Utrecht University	Yap, AS (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia.	a.yap@uq.edu.au	Kovacs, Eva/U-3526-2019; Yap, Alpha S./J-1554-2014; Hamilton, Nicholas A/A-6033-2010; Akhmanova, Anna S/B-8896-2011	Kovacs, Eva/0000-0002-7228-4028; Yap, Alpha S./0000-0002-1038-8956; Hamilton, Nicholas A/0000-0003-0331-3427; Akhmanova, Anna S/0000-0002-9048-8614; Ratheesh, Aparna/0000-0001-7190-0776	National Health and Medical Council of Australia; Human Frontiers Science Program	National Health and Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program(Human Frontier Science Program)	We thank our laboratory colleagues for their advice and support and other colleagues for the gifts of reagents, notably S. Thomas (Birmingham University, UK) for an early gift of N-WASP antibodies and J. Demmers (Erasmus MC, Rotterdam, The Netherlands) for proteomics analysis. This work was financially supported by the National Health and Medical Council of Australia and the Human Frontiers Science Program. A.S.Y. is a Research Fellow of the NHMRC. Confocal imaging was carried out at the IMB/ACRF Cancer Biology Imaging Facility, established with the generous support of the Australian Cancer Research Foundation.	Anton IM, 2007, TRENDS CELL BIOL, V17, P555, DOI 10.1016/j.tcb.2007.08.005; Aspenstrom P, 2004, EXP CELL RES, V298, P485, DOI 10.1016/j.yexcr.2004.04.050; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Chan AY, 1998, J CELL SCI, V111, P199; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HIROKAWA N, 1983, J CELL BIOL, V96, P1325, DOI 10.1083/jcb.96.5.1325; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Kato M, 2005, BIOCHEM BIOPH RES CO, V328, P1058, DOI 10.1016/j.bbrc.2005.01.058; Kato M, 2002, BIOCHEM BIOPH RES CO, V291, P41, DOI 10.1006/bbrc.2002.6406; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Peterson FC, 2007, J BIOL CHEM, V282, P8446, DOI 10.1074/jbc.M609902200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Schindelhauer D, 1996, HUM GENET, V98, P68, DOI 10.1007/s004390050162; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	44	99	102	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					934	U400		10.1038/ncb2290	http://dx.doi.org/10.1038/ncb2290			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21785420				2022-12-25	WOS:000293373700011
J	Yang, JS; Valente, C; Polishchuk, RS; Turacchio, G; Layre, E; Moody, DB; Leslie, CC; Gelb, MH; Brown, WJ; Corda, D; Luini, A; Hsu, VW				Yang, Jia-Shu; Valente, Carmen; Polishchuk, Roman S.; Turacchio, Gabriele; Layre, Emilie; Moody, D. Branch; Leslie, Christina C.; Gelb, Michael H.; Brown, William J.; Corda, Daniela; Luini, Alberto; Hsu, Victor W.			COPI acts in both vesicular and tubular transport	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR; VESICLE FORMATION; GOLGI MEMBRANES; LYSOPHOSPHATIDIC ACID; FISSION; COMPLEX; COATOMER; PROTEIN; IDENTIFICATION; CTBP/BARS	Intracellular transport occurs through two general types of carrier, either vesicles(1,2) or tubules(3,4). Coat proteins act as the core machinery that initiates vesicle formation(1,2), but the counter part that initiates tubule formation has been unclear. Here, we find that the coat protein I (COPI) complex initially drives the formation of Golgi buds. Subsequently, a set of opposing lipid enzymatic activities determines whether these buds become vesicles or tubules. Lysophosphatidic acid acyltransferase-gamma (LPAAT gamma) promotes COPI vesicle fission for retrograde vesicular transport. In contrast, cytosolic phospholipase A2-alpha (cPLA2 alpha) inhibits this fission event to induce COPI tubules, which act in anterograde intra-Golgi transport and Golgi ribbon formation. These findings not only advance a molecular understanding of how COPI vesicle fission is achieved, but also provide insight into how COPI acts in intra-Golgi transport and reveal an unexpected mechanistic relationship between vesicular and tubular transport.	[Valente, Carmen; Polishchuk, Roman S.; Luini, Alberto] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Yang, Jia-Shu; Layre, Emilie; Moody, D. Branch; Hsu, Victor W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Yang, Jia-Shu; Layre, Emilie; Moody, D. Branch; Hsu, Victor W.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Valente, Carmen; Turacchio, Gabriele; Corda, Daniela; Luini, Alberto] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Leslie, Christina C.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA; [Leslie, Christina C.] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA; [Leslie, Christina C.] Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA; [Gelb, Michael H.] Univ Washington, Dept Chem & Biochem, Seattle, WA 98195 USA; [Brown, William J.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Washington; University of Washington Seattle; Cornell University	Luini, A (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	luini@tigem.it; vhsu@rics.bwh.harvard.edu	Corda, Daniela/K-6385-2016; Brown, William/GXN-2777-2022; Valente, Carmen/AAH-5261-2019	Corda, Daniela/0000-0002-3614-751X; Valente, Carmen/0000-0002-6244-9108; gelb, michael/0000-0001-7000-5219; Layre, Emilie/0000-0001-8024-8513; Polishchuk, Roman/0000-0002-7698-1955; Layre, Emilie/0000-0003-3044-1299	National Institutes of Health [GM058615, AI071155, AR048632, HL061378, HL050040, GM051596]; Telethon [GGPO823, GTF08001]; AIRC [IG4700, IG4664, IG10233]; European Grant Eucilia [HEALT-2-2007-201804]; Italian Foundation for Cancer Research; Burroughs Wellcome Fund Program in Translational Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061378, R01HL050040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051596, R56DK051596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058615, R01GM058615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); European Grant Eucilia; Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Burroughs Wellcome Fund Program in Translational Medicine(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Li and M. Bai for advice and discussions, G. Di Tullio and M. Santoro for generating the anti-LPAAT gamma antibody, and R. Loper for technical assistance. This work is financially supported by grants from the National Institutes of Health to V.W.H. (GM058615), D.B.M. (AI071155 and AR048632), C.C.L. (HL061378), M.H.G. (HL050040) and W.J.B. (GM051596), and also by grants from Telethon to A.L. (GGPO823) and R.S.P. (GTF08001), from AIRC to A.L. (IG4700), D.C. (IG4664) and R.P. (IG10233), and from European Grant Eucilia to A.L. (HEALT-2-2007-201804). C.V. is a recipient of an Italian Foundation for Cancer Research Fellowship. D.B.M. is supported by the Burroughs Wellcome Fund Program in Translational Medicine.	Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bollinger JG, 2010, J LIPID RES, V51, P440, DOI 10.1194/jlr.D000885; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chambers K, 2005, J CELL SCI, V118, P3061, DOI 10.1242/jcs.02435; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Kweon HS, 2004, MOL BIOL CELL, V15, P4710, DOI 10.1091/mbc.E03-12-0881; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schmidt JA, 2009, J CELL BIOL, V186, P211, DOI 10.1083/jcb.200904147; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200	36	83	84	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					996	U275		10.1038/ncb2273	http://dx.doi.org/10.1038/ncb2273			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21725317	Green Accepted			2022-12-25	WOS:000293373700019
J	O'Roak, BJ; Deriziotis, P; Lee, C; Vives, L; Schwartz, JJ; Girirajan, S; Karakoc, E; MacKenzie, AP; Ng, SB; Baker, C; Rieder, MJ; Nickerson, DA; Bernier, R; Fisher, SE; Shendure, J; Eichler, EE				O'Roak, Brian J.; Deriziotis, Pelagia; Lee, Choli; Vives, Laura; Schwartz, Jerrod J.; Girirajan, Santhosh; Karakoc, Emre; MacKenzie, Alexandra P.; Ng, Sarah B.; Baker, Carl; Rieder, Mark J.; Nickerson, Deborah A.; Bernier, Raphael; Fisher, Simon E.; Shendure, Jay; Eichler, Evan E.			Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations	NATURE GENETICS			English	Article							HUMAN-GENOME; RECURRENT MICRODELETIONS; SEGMENTAL DUPLICATIONS; MENTAL-RETARDATION; LANGUAGE DISORDER; GENE; SPEECH; SCN1A; FOXP1; RISK	Evidence for the etiology of autism spectrum disorders (ASDs) has consistently pointed to a strong genetic component complicated by substantial locus heterogeneity(1,2). We sequenced the exomes of 20 individuals with sporadic ASD (cases) and their parents, reasoning that these families would be enriched for de novo mutations of major effect. We identified 21 de novo mutations, 11 of which were protein altering. Protein-altering mutations were significantly enriched for changes at highly conserved residues. We identified potentially causative de novo events in 4 out of 20 probands, particularly among more severely affected individuals, in FOXP1, GRIN2B, SCN1A and LAMC3. In the FOXP1 mutation carrier, we also observed a rare inherited CNTNAP2 missense variant, and we provide functional support for a multi-hit model for disease risk(3). Our results show that trio-based exome sequencing is a powerful approach for identifying new candidate genes for ASDs and suggest that de novo mutations may contribute substantially to the genetic etiology of ASDs.	[O'Roak, Brian J.; Lee, Choli; Vives, Laura; Schwartz, Jerrod J.; Girirajan, Santhosh; Karakoc, Emre; MacKenzie, Alexandra P.; Ng, Sarah B.; Baker, Carl; Rieder, Mark J.; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Deriziotis, Pelagia; Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Eichler, Evan E.] Howard Hughes Med Inst, Washington, DC USA	University of Washington; University of Washington Seattle; University of Oxford; Wellcome Centre for Human Genetics; University of Washington; University of Washington Seattle; Max Planck Society; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; eee@gs.washington.edu	Fisher, Simon E./E-9130-2012; Shendure, Jay/AAU-3684-2021; Derizioti, Pelagia/C-3857-2015	Fisher, Simon E./0000-0002-3132-1996; Derizioti, Pelagia/0000-0001-5544-8345; Derizioti, Pelagia/0000-0001-5004-6865; O'Roak, Brian/0000-0002-4141-0095; Shendure, Jay/0000-0002-1516-1865	US National Institutes of Health [HD065285]; Wellcome Trust [075491/Z/04]; Max Planck Society; Simons Foundation Autism Research Initiative (SFARI) [191889, 137578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976, RC2HL102926, UC2HL102926, UC2HL102924, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Simons Foundation Autism Research Initiative (SFARI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank and recognize the following ongoing studies that produced and provided exome variant calls for comparison: National Heart, Lung, and Blood Institute (NHBLI) Lung Cohort Sequencing Project (HL 1029230), NHLBI Women's Health Initiative (WHI) Sequencing Project (HL 102924), National Institute of Environmental Health Sciences (NIEHS) SNPs (HHSN273200800010C), NHLBI/National Human Genome Research Institute (NHGRI) SeattleSeq (HL 094976), NHGRI Next Generation Mendelian Genetics (HG 005608) and the Northwest Genomics Center (HL 102926). We also thank M.-C. King and S. Stray for processing and managing DNA samples, B. H. King and E. Bliss for their work in subject recruitment and phenotype collection, E. Turner, C. Igartua, I. Stanaway, M. Dennis and B. Coe for thoughtful discussions, M. State for providing SNP genotyping data and especially the families that volunteered their time to participate in this research. This work was supported by US National Institutes of Health grant HD065285 (E. E. E. and J.S.), Wellcome Trust core award 075491/Z/04 (S. E. F. and P. D.), the Max Planck Society (S. E. F.) and grants from the Simons Foundation Autism Research Initiative (SFARI) (191889 and 137578) (E. E. E., R. B., S. E. F. and P. D.). E. E. E. is an Investigator of the Howard Hughes Medical Institute.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Hurley RSE, 2007, J AUTISM DEV DISORD, V37, P1679, DOI 10.1007/s10803-006-0299-3; Igartua C, 2010, CURR PROTOC HUM GENE, V18; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241	52	819	839	0	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					585	U125		10.1038/ng.835	http://dx.doi.org/10.1038/ng.835			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21572417	Green Accepted			2022-12-25	WOS:000291017000018
J	Mayor, S				Mayor, Satyajit			Squishy matter and active chemistry: understanding membrane organization	NATURE CELL BIOLOGY			English	Editorial Material									Natl Ctr Biol Sci, Bangalore 560005, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mayor, S (corresponding author), Natl Ctr Biol Sci, Bellary Rd, Bangalore 560005, Karnataka, India.	mayor@ncbs.res.in							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					519	519		10.1038/ncb0511-519	http://dx.doi.org/10.1038/ncb0511-519			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21540848	Bronze			2022-12-25	WOS:000290148700007
J	Bieschke, J; Herbst, M; Wiglenda, T; Friedrich, RP; Boeddrich, A; Schiele, F; Kleckers, D; del Amo, JML; Gruning, BA; Wang, QW; Schmidt, MR; Lurz, R; Anwyl, R; Schnoegl, S; Fandrich, M; Frank, RF; Reif, B; Gunther, S; Walsh, DM; Wanker, EE				Bieschke, Jan; Herbst, Martin; Wiglenda, Thomas; Friedrich, Ralf P.; Boeddrich, Annett; Schiele, Franziska; Kleckers, Daniela; del Amo, Juan Miguel Lopez; Gruening, Bjoern A.; Wang, Qinwen; Schmidt, Michael R.; Lurz, Rudi; Anwyl, Roger; Schnoegl, Sigrid; Faendrich, Marcus; Frank, Ronald F.; Reif, Bernd; Guenther, Stefan; Walsh, Dominic M.; Wanker, Erich E.			Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils	NATURE CHEMICAL BIOLOGY			English	Article							LONG-TERM POTENTIATION; A-BETA; HUNTINGTONS-DISEASE; MISFOLDING DISEASES; COMMON MECHANISM; ALPHA-SYNUCLEIN; IN-VITRO; AGGREGATION; PEPTIDE; INHIBITORS	Several lines of evidence indicate that prefibrillar assemblies of amyloid-beta (A beta) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of A beta fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in A beta peptides and stabilizes the self-assembly of seeding-competent, beta-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic A beta oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by A beta oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.	[Bieschke, Jan; Herbst, Martin; Wiglenda, Thomas; Friedrich, Ralf P.; Boeddrich, Annett; Schiele, Franziska; Kleckers, Daniela; Schmidt, Michael R.; Schnoegl, Sigrid; Wanker, Erich E.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Herbst, Martin] Charite, Dept Neurol, D-13353 Berlin, Germany; [del Amo, Juan Miguel Lopez; Reif, Bernd] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Gruening, Bjoern A.; Guenther, Stefan] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Wang, Qinwen; Anwyl, Roger] Trinity Coll Dublin, Sch Med, Dept Physiol, Dublin, Ireland; [Lurz, Rudi] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Faendrich, Marcus] Max Planck Res Unit Enzymol Prot Folding, Halle, Saale, Germany; [Frank, Ronald F.] Helmholtz Ctr Infect Res, Dept Chem, Braunschweig, Germany; [Reif, Bernd] Tech Univ Munich, Munich, Germany; [Walsh, Dominic M.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Lab Neurodegenerat Res, Dublin, Ireland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center for Infection Research; University of Freiburg; Trinity College Dublin; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center for Infection Research; Technical University of Munich; University College Dublin	Bieschke, J (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	ewanker@mdc-berlin.de	Günther, Stefan/AAY-8944-2020; del Amo, Juan Miguel Lopez/I-9392-2012; Friedrich, Ralf P/R-2580-2016; Bieschke, Jan/AAG-2705-2019	del Amo, Juan Miguel Lopez/0000-0002-2315-5414; Friedrich, Ralf P/0000-0001-6370-3545; Reif, Bernd/0000-0001-7368-7198; Boddrich, Annett/0000-0001-9118-050X; Bieschke, Jan/0000-0002-3485-9767; Gruning, Bjorn/0000-0002-3079-6586; Wiglenda, Thomas/0000-0002-8460-9459; Wanker, Erich/0000-0001-8072-1630	European Commission [241498, 242167]; European Integrated Project APOPIS [503330]; European Integrated Project EUROSCA [503304]; Helmholtz Association; Helmholtz Alliance for Mental Health in an Ageing Society; Deutsche Forschungsgemeinschaft (DFG) [WA 1151/5]; Bundesministerium fur Bildung und Forschung (BMBF) [NGFN1, 01KW0015, NGFN2, 01GR0471, 0311853, 0313881, 01GS08132]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Integrated Project APOPIS; European Integrated Project EUROSCA; Helmholtz Association(Helmholtz Association); Helmholtz Alliance for Mental Health in an Ageing Society; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank S. Kostka, G. Grelle and S. Rautenberg for technical assistance; A. Otto for analysis of compound mixtures by MS; and M. Peters for expert discussions. The research leading to these results has received funding from the European Commission FP7 grants EUROSPIN (241498) and SYNSYS (242167) and from the European Integrated Projects APOPIS (503330) and EUROSCA (503304) as well as from the Initiative and Networking Fund of the Helmholtz Association (MSBN, TP3, TP5) and the Helmholtz Alliance for Mental Health in an Ageing Society to E. E. W. Furthermore, this work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) (WA 1151/5), Bundesministerium fur Bildung und Forschung (BMBF) (NGFN1, 01KW0015; NGFN2, 01GR0471; BioFuture, 0311853; GO-Bio, 0313881) to E. E. W., BMBF (NGFN-Plus, 01GS08132) to J.B. and E. E. W. and DFG (BI 1409/2-1) to J.B.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Beecken H, 2003, BIOTECH HISTOCHEM, V78, P289, DOI 10.1080/10520290410001671362; Beutling U, 2008, ADV BIOCHEM ENG BIOT, V110, P115, DOI 10.1007/10_2008_096; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; CAPUTO CB, 1992, ARCH BIOCHEM BIOPHYS, V292, P199, DOI 10.1016/0003-9861(92)90068-8; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Herbst M, 2006, CURR PHARM DESIGN, V12, P2543, DOI 10.2174/138161206777698828; Howlett DR, 1999, BIOCHEM J, V340, P283, DOI 10.1042/0264-6021:3400283; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LeVine H, 2002, CURR MED CHEM, V9, P1121, DOI 10.2174/0929867023370167; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; PAZ MA, 1991, J BIOL CHEM, V266, P689; Reixach N, 2000, J STRUCT BIOL, V130, P247, DOI 10.1006/jsbi.2000.4245; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Williams AD, 2005, P NATL ACAD SCI USA, V102, P7115, DOI 10.1073/pnas.0408582102; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905	49	345	347	4	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					93	101		10.1038/nchembio.719	http://dx.doi.org/10.1038/nchembio.719			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101602	Green Accepted			2022-12-25	WOS:000298414100017
J	Chen, WJ; Lin, Y; Xiong, ZQ; Wei, W; Ni, W; Tan, GH; Guo, SL; He, J; Chen, YF; Zhang, QJ; Li, HF; Lin, Y; Murong, SX; Xu, JF; Wang, N; Wu, ZY				Chen, Wan-Jin; Lin, Yu; Xiong, Zhi-Qi; Wei, Wei; Ni, Wang; Tan, Guo-He; Guo, Shun-Ling; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Li, Hong-Fu; Lin, Yi; Murong, Shen-Xing; Xu, Jianfeng; Wang, Ning; Wu, Zhi-Ying			Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia	NATURE GENETICS			English	Article							HUMAN-CHROMOSOME 16; CHOREOATHETOSIS; DISORDERS; LINKAGE; LOCUS; CHANNELOPATHIES; GENES; MAPS	Paroxysmal kinesigenic dyskinesia is the most common type of paroxysmal movement disorder and is often misdiagnosed clinically as epilepsy. Using whole-exome sequencing followed by Sanger sequencing, we identified three truncating mutations within PRRT2 (NM_145239.2) in eight Han Chinese families with histories of paroxysmal kinesigenic dyskinesia: c.514_517delTCTG (p.Ser172Argfs*3) in one family, c.649dupC (p.Arg217Profs*8) in six families and c.972delA (p.Val325Serfs*12) in one family. These truncating mutations co-segregated exactly with the disease in these families and were not observed in 1,000 control subjects of matched ancestry. PRRT2 is a newly discovered gene consisting of four exons encoding the proline-rich transmembrane protein 2, which encompasses 340 amino acids and contains two predicted transmembrane domains. PRRT2 is highly expressed in the developing nervous system, and a truncating mutation alters the subcellular localization of the PRRT2 protein. The function of PRRT2 and its role in paroxysmal kinesigenic dyskinesia should be further investigated.	[Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, Inst Brain Sci, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, Inst Brain Sci, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Lin, Yu; Wei, Wei; Ni, Wang; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Lin, Yi; Murong, Shen-Xing; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China; [Chen, Wan-Jin; Lin, Yu; Wei, Wei; Ni, Wang; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Lin, Yi; Murong, Shen-Xing; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Peoples R China; [Xiong, Zhi-Qi; Tan, Guo-He; Guo, Shun-Ling] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Xu, Jianfeng] Fudan Univ, Fudan Inst Urol, Shanghai Med Coll, Huashan Hosp, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Fudan Van Andel Res Inst VARI, Ctr Genet Epidemiol, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fujian Medical University; Fujian Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University	Wu, ZY (corresponding author), Fudan Univ, Inst Brain Sci, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	ningwang63@yahoo.com; zhiyingwu@fudan.edu.cn	Chen, yafang/GVS-0304-2022		National Natural Science Foundation (China) [81125009]; Huashan Hospital; Fudan University; Fujian Medical University [2009D064]	National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); Huashan Hospital; Fudan University; Fujian Medical University	The authors sincerely thank the participants for their help and willingness to take part in this study. The authors also thank the Beijing Genomics Institute (BGI)-Shenzhen for assistance in the analysis of exome sequence data. This work was supported by a grant from the National Natural Science Foundation (China; 81125009 to Z.-Y.W.) and a grant from Huashan Hospital for the special professorship of Fudan University (to Z.-Y.W.) and by a key program of scientific research of Fujian Medical University (2009D064 to N.W.).	Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Bhatia KP, 2000, MOVEMENT DISORD, V15, P429, DOI 10.1002/1531-8257(200005)15:3<429::AID-MDS1001>3.0.CO;2-R; Bruno MK, 2004, NEUROLOGY, V63, P2280, DOI 10.1212/01.WNL.0000147298.05983.50; Celesia GG, 2001, CLIN NEUROPHYSIOL, V112, P2, DOI 10.1016/S1388-2457(00)00496-X; GOODENOUGH DJ, 1978, ARCH NEUROL-CHICAGO, V35, P827, DOI 10.1001/archneur.1978.00500360051010; Hu XL, 2011, CEREB CORTEX, V21, P2158, DOI 10.1093/cercor/bhq284; KERTESZ AZ, 1967, NEUROLOGY, V17, P680, DOI 10.1212/WNL.17.7.680; Kikuchi T, 2007, J HUM GENET, V52, P334, DOI 10.1007/s10038-007-0116-7; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ono S, 2011, MOVEMENT DISORD, V26, P761, DOI 10.1002/mds.23475; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swoboda KJ, 2000, NEUROLOGY, V55, P224, DOI 10.1212/WNL.55.2.224; Tomita H, 1999, AM J HUM GENET, V65, P1688, DOI 10.1086/302682; Valente EM, 2000, BRAIN, V123, P2040, DOI 10.1093/brain/123.10.2040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	20	321	373	3	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1252	U116		10.1038/ng.1008	http://dx.doi.org/10.1038/ng.1008			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22101681				2022-12-25	WOS:000297931400022
J	Haiman, CA; Chen, GK; Vachon, CM; Canzian, F; Dunning, A; Millikan, RC; Wang, XS; Ademuyiwa, F; Ahmed, S; Ambrosone, CB; Baglietto, L; Balleine, R; Bandera, EV; Beckmann, MW; Berg, CD; Bernstein, L; Blomqvist, C; Blot, WJ; Brauch, H; Buring, JE; Carey, LA; Carpenter, JE; Chang-Claude, J; Chanock, SJ; Chasman, DI; Clarke, CL; Cox, A; Cross, SS; Deming, SL; Diasio, RB; Dimopoulos, AM; Driver, WR; Dunnebier, T; Durcan, L; Eccles, D; Edlund, CK; Ekici, AB; Fasching, PA; Feigelson, HS; Flesch-Janys, D; Fostira, F; Forsti, A; Fountzilas, G; Gerty, SM; Giles, GG; Godwin, AK; Goodfellow, P; Graham, N; Greco, D; Hamann, U; Hankinson, SE; Hartmann, A; Hein, R; Heinz, J; Holbrook, A; Hoover, RN; Hu, JJ; Hunter, DJ; Ingles, SA; Irwanto, A; Ivanovich, J; John, EM; Johnson, N; Jukkola-Vuorinen, A; Kaaks, R; Ko, YD; Kolonel, LN; Konstantopoulou, I; Kosma, VM; Kulkarni, S; Lambrechts, D; Lee, AM; Le Marchand, L; Lesnick, T; Liu, JJ; Lindstrom, S; Mannermaa, A; Margolin, S; Martin, NG; Miron, P; Montgomery, GW; Nevanlinna, H; Nickels, S; Nyante, S; Olswold, C; Palmer, J; Pathak, H; Pectasides, D; Perou, CM; Peto, J; Pharoah, PDP; Pooler, LC; Press, MF; Pylkas, K; Rebbeck, TR; Rodriguez-Gil, JL; Rosenberg, L; Ross, E; Rudiger, T; Silva, ID; Sawyer, E; Schmidt, MK; Schulz-Wendtland, R; Schumacher, F; Severi, G; Sheng, X; Signorello, LB; Sinn, HP; Stevens, KN; Southey, MC; Tapper, WJ; Tomlinson, I; Hogervorst, FBL; Wauters, E; Weaver, J; Wildiers, H; Winqvist, R; Van Den Berg, D; Wan, P; Xia, LY; Yannoukakos, D; Zheng, W; Ziegler, RG; Siddiq, A; Slager, SL; Stram, DO; Easton, D; Kraft, P; Henderson, BE; Couch, FJ				Haiman, Christopher A.; Chen, Gary K.; Vachon, Celine M.; Canzian, Federico; Dunning, Alison; Millikan, Robert C.; Wang, Xianshu; Ademuyiwa, Foluso; Ahmed, Shahana; Ambrosone, Christine B.; Baglietto, Laura; Balleine, Rosemary; Bandera, Elisa V.; Beckmann, Matthias W.; Berg, Christine D.; Bernstein, Leslie; Blomqvist, Carl; Blot, William J.; Brauch, Hiltrud; Buring, Julie E.; Carey, Lisa A.; Carpenter, Jane E.; Chang-Claude, Jenny; Chanock, Stephen J.; Chasman, Daniel I.; Clarke, Christine L.; Cox, Angela; Cross, Simon S.; Deming, Sandra L.; Diasio, Robert B.; Dimopoulos, Athanasios M.; Driver, W. Ryan; Duennebier, Thomas; Durcan, Lorraine; Eccles, Diana; Edlund, Christopher K.; Ekici, Arif B.; Fasching, Peter A.; Feigelson, Heather S.; Flesch-Janys, Dieter; Fostira, Florentia; Foersti, Asta; Fountzilas, George; Gerty, Susan M.; Giles, Graham G.; Godwin, Andrew K.; Goodfellow, Paul; Graham, Nikki; Greco, Dario; Hamann, Ute; Hankinson, Susan E.; Hartmann, Arndt; Hein, Rebecca; Heinz, Judith; Holbrook, Andrea; Hoover, Robert N.; Hu, Jennifer J.; Hunter, David J.; Ingles, Sue A.; Irwanto, Astrid; Ivanovich, Jennifer; John, Esther M.; Johnson, Nicola; Jukkola-Vuorinen, Arja; Kaaks, Rudolf; Ko, Yon-Dschun; Kolonel, Laurence N.; Konstantopoulou, Irene; Kosma, Veli-Matti; Kulkarni, Swati; Lambrechts, Diether; Lee, Adam M.; Le Marchand, Loic; Lesnick, Timothy; Liu, Jianjun; Lindstrom, Sara; Mannermaa, Arto; Margolin, Sara; Martin, Nicholas G.; Miron, Penelope; Montgomery, Grant W.; Nevanlinna, Heli; Nickels, Stephan; Nyante, Sarah; Olswold, Curtis; Palmer, Julie; Pathak, Harsh; Pectasides, Dimitrios; Perou, Charles M.; Peto, Julian; Pharoah, Paul D. P.; Pooler, Loreall C.; Press, Michael F.; Pylkas, Katri; Rebbeck, Timothy R.; Rodriguez-Gil, Jorge L.; Rosenberg, Lynn; Ross, Eric; Ruediger, Thomas; Silva, Isabel dos Santos; Sawyer, Elinor; Schmidt, Marjanka K.; Schulz-Wendtland, Ruediger; Schumacher, Fredrick; Severi, Gianluca; Sheng, Xin; Signorello, Lisa B.; Sinn, Hans-Peter; Stevens, Kristen N.; Southey, Melissa C.; Tapper, William J.; Tomlinson, Ian; Hogervorst, Frans B. L.; Wauters, Els; Weaver, JoEllen; Wildiers, Hans; Winqvist, Robert; Van Den Berg, David; Wan, Peggy; Xia, Lucy Y.; Yannoukakos, Drakoulis; Zheng, Wei; Ziegler, Regina G.; Siddiq, Afshan; Slager, Susan L.; Stram, Daniel O.; Easton, Douglas; Kraft, Peter; Henderson, Brian E.; Couch, Fergus J.		Gene Environm Interaction Breast C	A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; PROSTATE-CANCER; IDENTIFIES 5; RISK	Estrogen receptor (ER)-negative breast cancer shows a higher incidence in women of African ancestry compared to women of European ancestry. In search of common risk alleles for ER-negative breast cancer, we combined genome-wide association study (GWAS) data from women of African ancestry (1,004 ER-negative cases and 2,745 controls) and European ancestry (1,718 ER-negative cases and 3,670 controls), with replication testing conducted in an additional 2,292 ER-negative cases and 16,901 controls of European ancestry. We identified a common risk variant for ER-negative breast cancer at the TERT-CLPTM1L locus on chromosome 5p15 (rs10069690: per-allele odds ratio (OR) = 1.18 per allele, P = 1.0 x 10(-10)). The variant was also significantly associated with triple-negative (ER-negative, progesterone receptor (PR)-negative and human epidermal growth factor-2 (HER2)-negative) breast cancer (OR = 1.25, P = 1.1 x 10(-9)), particularly in younger women (<50 years of age) (OR = 1.48, P = 1.9 x 10(-9)). Our results identify a genetic locus associated with estrogen receptor negative breast cancer subtypes in multiple populations.	[Haiman, Christopher A.; Chen, Gary K.; Edlund, Christopher K.; Holbrook, Andrea; Ingles, Sue A.; Pooler, Loreall C.; Schumacher, Fredrick; Sheng, Xin; Van Den Berg, David; Wan, Peggy; Xia, Lucy Y.; Stram, Daniel O.; Henderson, Brian E.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Vachon, Celine M.; Lesnick, Timothy; Olswold, Curtis; Stevens, Kristen N.; Slager, Susan L.; Couch, Fergus J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Canzian, Federico] DKFZ, Genom Epidemiol Grp, Heidelberg, Germany; [Dunning, Alison; Ahmed, Shahana; Pharoah, Paul D. P.; Easton, Douglas] Strangeways Lab, Ctr Canc Genet Epidemiol, Cambridge, England; [Wang, Xianshu; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Ademuyiwa, Foluso] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Baglietto, Laura; Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Canc Epidemiol Ctr, Canc Council Victoria, Melbourne, Vic 3010, Australia; [Baglietto, Laura; Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Balleine, Rosemary] Western Sydney Local Hlth Network, Westmead Hosp, Dept Translat Oncol, Westmead, NSW, Australia; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [Beckmann, Matthias W.; Fasching, Peter A.] Univ Erlangen Nurnberg, Dept Gynecol & Obstet, Univ Hosp Erlangen, D-91054 Erlangen, Germany; [Berg, Christine D.] NCI, Canc Prevent Div, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Bernstein, Leslie] Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, City Of Hope, CA USA; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Blot, William J.; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Blot, William J.; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD USA; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Buring, Julie E.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Carey, Lisa A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; [Carpenter, Jane E.; Clarke, Christine L.] Univ Sydney, Australian Breast Canc Tissue Bank, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Chang-Claude, Jenny; Hein, Rebecca; Nickels, Stephan] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Chanock, Stephen J.; Hoover, Robert N.; Ziegler, Regina G.] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Cox, Angela] Univ Sheffield, Inst Canc Studies, Dept Oncol, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England; [Diasio, Robert B.; Lee, Adam M.] Mayo Clin, Dept Pharmacol, Rochester, MN USA; [Dimopoulos, Athanasios M.] Univ Athens, Sch Med, Dept Clin Therapeut, Alexandra Hosp, GR-11527 Athens, Greece; [Driver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Durcan, Lorraine; Eccles, Diana; Gerty, Susan M.; Graham, Nikki; Tapper, William J.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Feigelson, Heather S.] Kaiser Permanente Colorado, Denver, CO USA; [Flesch-Janys, Dieter; Heinz, Judith] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Fostira, Florentia; Konstantopoulou, Irene; Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, Inst Radioisotopes & Radiodiagnost Prod, Athens, Greece; [Foersti, Asta] DKFZ, Div Mol Genet Epidemiol, Heidelberg, Germany; [Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Fountzilas, George] Aristotle Univ Thessaloniki, Dept Med Oncol, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Godwin, Andrew K.] Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Lawrence, KS 66045 USA; [Goodfellow, Paul; Ivanovich, Jennifer] Washington Univ, Sch Med, Barnes Jewish Hosp, St Louis, MO USA; [Goodfellow, Paul; Ivanovich, Jennifer] Siteman Canc Ctr, St Louis, MO USA; [Greco, Dario; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Hankinson, Susan E.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hankinson, Susan E.] Harvard Univ, Sch Med, Boston, MA USA; [Hankinson, Susan E.; Hunter, David J.; Lindstrom, Sara; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hartmann, Arndt; Schulz-Wendtland, Ruediger] Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, Erlangen, Germany; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Hunter, David J.; Lindstrom, Sara; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Irwanto, Astrid; Liu, Jianjun] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [John, Esther M.] Stanford Univ, Stanford Canc Ctr, Stanford, CA 94305 USA; [Johnson, Nicola] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Jukkola-Vuorinen, Arja] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu, Finland; [Kaaks, Rudolf] DKFZ, Div Canc Epidemiol, Heidelberg, Germany; [Ko, Yon-Dschun] Evangel Kliniken Johanniter & Waldkrankenhaus Bon, Dept Internal Med, Bonn, Germany; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Imaging Ctr, Dept Pathol, SF-70210 Kuopio, Finland; [Kulkarni, Swati] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Lambrechts, Diether; Wauters, Els] Vlaams Inst Biotechnol, Vesalius Res Ctr, Louvain, Belgium; [Lambrechts, Diether; Wauters, Els] Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Mannermaa, Arto] Univ Eastern Finland, Bioctr Kuopio, Dept Pathol, Inst Clin Med, Kuopio, Finland; [Margolin, Sara] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res QIMR Genome Wide Assoc St, Brisbane, Qld, Australia; [Miron, Penelope] Dana Farber Canc Inst, Boston, MA 02115 USA; [Palmer, Julie; Rosenberg, Lynn] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Pathak, Harsh; Weaver, JoEllen] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med, Oncol Sect, Athens, Greece; [Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27599 USA; [Peto, Julian; Silva, Isabel dos Santos] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Press, Michael F.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Canc Genet Lab, Dept Clin Genet, Oulu Univ Hosp, Oulu, Finland; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Bioctr Oulu, Oulu Univ Hosp, Oulu, Finland; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Ross, Eric] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA; [Ruediger, Thomas] Stadt Klinikum Karlsruhe, Inst Pathol, Karlsruhe, Germany; [Sawyer, Elinor] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res Comprehens Biomed Res Ctr, London, England; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Epidemiol, Amsterdam, Netherlands; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Expt Therapy & Mol Pathol, Amsterdam, Netherlands; [Sinn, Hans-Peter] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Hogervorst, Frans B. L.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands; [Wildiers, Hans] Univ Hosp Gasthuisberg, Multidisciplinary Breast Ctr, B-3000 Louvain, Belgium; [Siddiq, Afshan] Univ London Imperial Coll Sci Technol & Med, London, England; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Southern California; Mayo Clinic; Helmholtz Association; German Cancer Research Center (DKFZ); Mayo Clinic; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Cancer Council Victoria; University of Melbourne; University of Melbourne; University of Sydney; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Erlangen Nuremberg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki; Helsinki University Central Hospital; Vanderbilt University; Vanderbilt University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Sydney; Westmead Institute for Medical Research; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sheffield; University of Sheffield; Mayo Clinic; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; American Cancer Society; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kaiser Permanente; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Centre of Scientific Research "Demokritos"; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Aristotle University of Thessaloniki; Papageorgiou Hospital; University of Kansas; University of Kansas Medical Center; Barnes-Jewish Hospital; Washington University (WUSTL); Siteman Cancer Center; University of Helsinki; Helsinki University Central Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Erlangen Nuremberg; University of Miami; University of Miami; Harvard University; Harvard T.H. Chan School of Public Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oulu; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Research Center of Hawaii; University of Hawaii System; Kuopio University Hospital; University of Eastern Finland; Roswell Park Cancer Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Eastern Finland; Karolinska Institutet; Karolinska University Hospital; QIMR Berghofer Medical Research Institute; Harvard University; Dana-Farber Cancer Institute; Boston University; Fox Chase Cancer Center; Hippokration General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; London School of Hygiene & Tropical Medicine; University of Southern California; University of Oulu; University of Oulu; University of Pennsylvania; Fox Chase Cancer Center; Municipal Hospital Karlsruhe; Guy's & St Thomas' NHS Foundation Trust; Netherlands Cancer Institute; Netherlands Cancer Institute; Ruprecht Karls University Heidelberg; University of Melbourne; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Netherlands Cancer Institute; KU Leuven; University Hospital Leuven; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health	Haiman, CA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	haiman@usc.edu; couch.fergus@mayo.edu	Sinn, Hans-Peter/C-5661-2008; Fostira, Florentia/Z-5730-2019; Zheng, Wei/O-3351-2013; Verdrengh, Evelien/H-4571-2012; zhang, weihua/GXV-1334-2022; Bandera, Elisa V/M-4169-2014; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Fountzilas, George/ABF-2139-2020; Severi, Gianluca/H-3774-2018; Ross, Eric A./S-8478-2019; Berg, Christine/K-1047-2014; Schmidt, Marjanka K/G-9058-2011; Margolin, Sara/AAX-9034-2020; Severi, Gianluca/Q-1824-2019; Jorge L. Rodriguez-Gil, D.Phil/AAD-3523-2020; Montgomery, Grant W/B-7148-2008; Lambrechts, Diether/AAJ-3167-2020; Rebbeck, Timothy/GLU-8348-2022; Diver, Ryan/AAG-3469-2019; Van Den Berg, David J/G-8598-2017; Pharoah, Paul/V-6658-2019; wildiers, hans/AAV-8158-2021; Facility, Biospecimen Processing/AAC-7837-2022; Martin, Nicholas/R-9235-2019; Schumacher, Fredrick/R-6043-2019; Baglietto, Laura/AAB-9051-2019; Fasching, Peter A/ABH-9912-2020; Eccles, Diana/K-6327-2019; Greco, Dario/T-7113-2019; Canzian, Federico/I-2804-2014; Ekici, Arif B/C-3971-2013; Perou, Charles M/H-9934-2014; Purrington, Kristen/AAN-6494-2021; Konstantopoulou, Irene/B-5309-2009	Sinn, Hans-Peter/0000-0003-2836-6699; Zheng, Wei/0000-0003-1226-070X; Bandera, Elisa V/0000-0002-8789-2755; Severi, Gianluca/0000-0001-7157-419X; Schmidt, Marjanka K/0000-0002-2228-429X; Severi, Gianluca/0000-0001-7157-419X; Jorge L. Rodriguez-Gil, D.Phil/0000-0002-1125-1281; Montgomery, Grant W/0000-0002-4140-8139; Lambrechts, Diether/0000-0002-3429-302X; Rebbeck, Timothy/0000-0002-4799-1900; Diver, Ryan/0000-0002-5418-9000; Van Den Berg, David J/0000-0002-5404-5218; Pharoah, Paul/0000-0001-8494-732X; Martin, Nicholas/0000-0003-4069-8020; Schumacher, Fredrick/0000-0002-3073-7463; Fasching, Peter A/0000-0003-4885-8471; Eccles, Diana/0000-0002-9935-3169; Greco, Dario/0000-0001-9195-9003; Ekici, Arif B/0000-0001-6099-7066; Perou, Charles M/0000-0001-9827-2247; Purrington, Kristen/0000-0002-5710-1692; Blomqvist, Carl/0000-0003-3041-1938; dos Santos Silva, Isabel/0000-0002-6596-8798; Tapper, William/0000-0002-5896-1889; Dimopoulos, Meletios/0000-0001-8990-3254; Yannoukakos, Drakoulis/0000-0001-7509-3510; Cross, Simon/0000-0003-2044-1754; Margolin, Sara/0000-0002-5526-5570; Baglietto, Laura/0000-0002-8193-7529; Wauters, Els/0000-0002-0115-0030; Cox, Angela/0000-0002-5138-1099; Dunning, Alison Margaret/0000-0001-6651-7166; Brauch, Hiltrud/0000-0001-7531-2736; Pylkas, Katri/0000-0002-2449-0521; Roth, Rebecca/0000-0002-2841-4921; Giles, Graham/0000-0003-4946-9099; Canzian, Federico/0000-0002-4261-4583; Southey, Melissa/0000-0002-6313-9005; Zaghow, Monika/0000-0002-4790-1047; Liu, Jianjun/0000-0002-3255-3019; Konstantopoulou, Irene/0000-0002-0470-0309; Rosenberg, Lynn/0000-0003-2760-2987; Winqvist, Robert/0000-0003-0932-9104; Clarke, Christine/0000-0001-7568-111X; ADEMUYIWA, FOLUSO/0000-0002-6766-2258; Nyante, Sarah/0000-0002-1770-5993; Siddiq, Afshan/0000-0002-9110-1434; Nevanlinna, Heli/0000-0002-0916-2976	US Department of Defense [W81XWH-08-1-0383]; Norris Foundation; Mayo Clinic College of Medicine; Breast Cancer Research Foundation; US National Institutes of Health [CA128978, CA122340, CA148065]; Komen Foundation for the Cure; Cancer Research UK [11022, 10118] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA092447, U19CA148065, ZIACP010201, R01CA128978, R25CA092049, R01CA122340, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); Norris Foundation; Mayo Clinic College of Medicine; Breast Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a US Department of Defense Breast Cancer Research Program Era of Hope Scholar Award to C.A.H. (W81XWH-08-1-0383), the Norris Foundation, the Mayo Clinic College of Medicine, Komen Foundation for the Cure, the Breast Cancer Research Foundation and US National Institutes of Health grants CA128978, CA122340 and CA148065. Study specific acknowledgments are listed in the Supplementary Note.	Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586	15	234	235	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1210	U61		10.1038/ng.985	http://dx.doi.org/10.1038/ng.985			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22037553	Green Published, Green Accepted			2022-12-25	WOS:000297931400013
J	Dubois, NC; Craft, AM; Sharma, P; Elliott, DA; Stanley, EG; Elefanty, AG; Gramolini, A; Keller, G				Dubois, Nicole C.; Craft, April M.; Sharma, Parveen; Elliott, David A.; Stanley, Edouard G.; Elefanty, Andrew G.; Gramolini, Anthony; Keller, Gordon			SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							SIGNAL-REGULATORY PROTEIN; DIFFERENTIATION; CD47; MACROPHAGES; ACTIVATION; SCAFFOLD; SHPS-1; ALPHA	To identify cell-surface markers specific to human cardiomyocytes, we screened cardiovascular cell populations derived from human embryonic stem cells (hESCs) against a panel of 370 known CD antibodies. This screen identified the signal-regulatory protein alpha (SIRPA) as a marker expressed specifically on cardiomyocytes derived from hESCs and human induced pluripotent stem cells (hiPSCs), and PECAM, THY1, PDGFRB and ITGA1 as markers of the nonmyocyte population. Cell sorting with an antibody against SIRPA allowed for the enrichment of cardiac precursors and cardiomyocytes from hESC/hiPSC differentiation cultures, yielding populations of up to 98% cardiac troponin T-positive cells. When plated in culture, SIRPA-positive cells were contracting and could be maintained over extended periods of time. These findings provide a simple method for isolating populations of cardiomyocytes from human pluripotent stem cell cultures, and thereby establish a readily adaptable technology for generating large numbers of enriched cardiomyocytes for therapeutic applications.	[Dubois, Nicole C.; Craft, April M.; Keller, Gordon] Univ Hlth Network, Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Sharma, Parveen; Gramolini, Anthony] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Elliott, David A.; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Monash University	Keller, G (corresponding author), Univ Hlth Network, Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON, Canada.	gkeller@uhnresearch.ca	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008; Elliott, David/H-3334-2012	Stanley, Ed G/0000-0002-6389-3665; Elliott, David/0000-0003-1052-7407; Sharma, Parveen/0000-0002-5534-2417; Elefanty, Andrew/0000-0001-6448-8314; Keller, Gordon/0000-0001-9309-9297	VistaGen Therapeutics (San Francisco); Canadian Institute of Health Research (CIHR) [MOP-84524, MOP-106538]; Ontario's Ministry of Research and Innovation (MRI) [GL2-CBD3P3]; Swiss National Foundation; Heart and Stroke Foundation of Ontario [T6281, NS6636]; Australian Stem Cell Centre, the National Health and Medical Research Council (NHMRC, Australia); National Heart Foundation (Australia)	VistaGen Therapeutics (San Francisco); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario's Ministry of Research and Innovation (MRI); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Australian Stem Cell Centre, the National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation (Australia)(National Heart Foundation of Australia)	We would like to thank members of the Keller laboratory for discussion and critical reading of the manuscript, G. Daley (Harvard Medical School, Boston) for providing the MSC-iPS1 and 38-2 cell line, B. Neel for providing the Sirpa-mutant mice and for discussion and suggestions, L. Ailles, J. Paterson and E. Hyatt from the antibody core facility, R. Hamilton for assistance in obtaining fetal tissue samples and the Sick Kids/UHN Flow Cytometry Facility for their assistance with cell sorting. This work was supported by funding from VistaGen Therapeutics (San Francisco) and by grants from Canadian Institute of Health Research (CIHR, MOP-84524) and Ontario's Ministry of Research and Innovation (MRI, GL2-CBD3P3) to G.K. N.C.D. was supported by a Swiss National Foundation postdoctoral fellowship. A.G. and P.S. were supported by the Heart and Stroke Foundation of Ontario (T6281 and NS6636) and CIHR (MOP-106538). A.G.E., E.G.S. and D.A.E. are supported by grants from the Australian Stem Cell Centre, the National Health and Medical Research Council (NHMRC, Australia) and the National Heart Foundation (Australia). E.G.S. and A.G.E. are Senior Research Fellows of the NHMRC (Australia).	Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Braam SR, 2009, TRENDS PHARMACOL SCI, V30, P536, DOI 10.1016/j.tips.2009.07.001; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Sharma P, 2011, MOL BIOSYST, V7, P1185, DOI 10.1039/c0mb00235f; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Timms JF, 1999, CURR BIOL, V9, P927, DOI 10.1016/S0960-9822(99)80401-1; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	30	370	396	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1011	U82		10.1038/nbt.2005	http://dx.doi.org/10.1038/nbt.2005			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22020386	Green Accepted			2022-12-25	WOS:000296801300022
J	Hothorn, M; Dabi, T; Chory, J				Hothorn, Michael; Dabi, Tsegaye; Chory, Joanne			Structural basis for cytokinin recognition by Arabidopsis thaliana histidine kinase 4	NATURE CHEMICAL BIOLOGY			English	Article							PLANT HORMONE; LIGAND-BINDING; CHASE DOMAIN; TRANSFER-RNA; RECEPTOR; FAMILY; AHK4; MOLECULE; KINETIN; ROOT	Cytokinins are classic hormones that orchestrate plant growth and development and the integrity of stem cell populations. Cytokinin receptors are eukaryotic sensor histidine kinases that are activated by both naturally occurring adenine-type cytokinins and urea-based synthetic compounds. Crystal structures of the Arabidopsis thaliana histidine kinase 4 sensor domain in complex with different cytokinin ligands now rationalize the hormone-binding specificity of the receptor and may spur the design of new cytokinin ligands.	[Hothorn, Michael; Dabi, Tsegaye; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Dabi, Tsegaye; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu	Hothorn, Michael/C-6807-2011	Hothorn, Michael/0000-0002-3597-5698	European Molecular Biology Organization; International Human Frontier Science Program Organization; Marc and Eva Stern foundation; US National Institutes of Health (NIH) [5R01GM52413]; US National Science Foundation [IOS-0649389]; Howard Hughes Medical Institute; NIH [P30 NS057096]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); Marc and Eva Stern foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Mizuno for providing plasmid pCold IV-AHK4 and strain KMI001, M. Jinek and Y. Jaillais for comments on the manuscript and W. Kwiatkowski and staff at beamlines BL 8.2.1 and 8.2.2 of the Advanced Light Source in Berkeley, California, for technical support. This work was supported by long-term fellowships from the European Molecular Biology Organization, the International Human Frontier Science Program Organization and the Marc and Eva Stern foundation (M.H.) and by grants from the US National Institutes of Health (NIH) (5R01GM52413), the US National Science Foundation (IOS-0649389) and the Howard Hughes Medical Institute (J.C.). Maintenance of the Salk X-ray equipment is supported by NIH grant P30 NS057096.	Amasino R, 2005, PLANT PHYSIOL, V138, P1177, DOI 10.1104/pp.104.900160; Bajguz A, 2009, PHYTOCHEMISTRY, V70, P957, DOI 10.1016/j.phytochem.2009.05.006; CAILLET J, 1988, J BACTERIOL, V170, P4147, DOI 10.1128/jb.170.9.4147-4152.1988; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gray J, 1996, PLANT PHYSIOL, V110, P431, DOI 10.1104/pp.110.2.431; Heyl A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-62; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; Mizuno T, 2010, METHOD ENZYMOL, V471, P335, DOI 10.1016/S0076-6879(10)71018-1; Pas J, 2004, FEBS LETT, V576, P287, DOI 10.1016/j.febslet.2004.09.020; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010	24	111	116	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					766	768		10.1038/nchembio.667	http://dx.doi.org/10.1038/nchembio.667			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21964459	Green Accepted			2022-12-25	WOS:000296381600005
J	Leuschner, F; Dutta, P; Gorbatov, R; Novobrantseva, TI; Donahoe, JS; Courties, G; Lee, KM; Kim, JI; Markmann, JF; Marinelli, B; Panizzi, P; Lee, WW; Iwamoto, Y; Milstein, S; Epstein-Barash, H; Cantley, W; Wong, J; Cortez-Retamozo, V; Newton, A; Love, K; Libby, P; Pittet, MJ; Swirski, FK; Koteliansky, V; Langer, R; Weissleder, R; Anderson, DG; Nahrendorf, M				Leuschner, Florian; Dutta, Partha; Gorbatov, Rostic; Novobrantseva, Tatiana I.; Donahoe, Jessica S.; Courties, Gabriel; Lee, Kang Mi; Kim, James I.; Markmann, James F.; Marinelli, Brett; Panizzi, Peter; Lee, Won Woo; Iwamoto, Yoshiko; Milstein, Stuart; Epstein-Barash, Hila; Cantley, William; Wong, Jamie; Cortez-Retamozo, Virna; Newton, Andita; Love, Kevin; Libby, Peter; Pittet, Mikael J.; Swirski, Filip K.; Koteliansky, Victor; Langer, Robert; Weissleder, Ralph; Anderson, Daniel G.; Nahrendorf, Matthias			Therapeutic siRNA silencing in inflammatory monocytes in mice	NATURE BIOTECHNOLOGY			English	Article							LIPID-LIKE MATERIALS; MYOCARDIAL-INFARCTION; SPLENIC RESERVOIR; IN-VIVO; MACROPHAGES; CCR2; DELIVERY; CANCER; ATHEROSCLEROSIS; PROGRESSION	Excessive and prolonged activity of inflammatory monocytes is a hallmark of many diseases with an inflammatory component. In such conditions, precise targeting of these cells could be therapeutically beneficial while sparing many essential functions of the innate immune system, thus limiting unwanted effects. Inflammatory monocytes-but not the noninflammatory subset-depend on the chemokine receptor CCR2 for localization to injured tissue. Here we present an optimized lipid nanoparticle and a CCR2-silencing short interfering RNA that, when administered systemically in mice, show rapid blood clearance, accumulate in spleen and bone marrow, and localize to monocytes. Efficient degradation of CCR2 mRNA in monocytes prevents their accumulation in sites of inflammation. Specifically, the treatment attenuates their number in atherosclerotic plaques, reduces infarct size after coronary artery occlusion, prolongs normoglycemia in diabetic mice after pancreatic islet transplantation, and results in reduced tumor volumes and lower numbers of tumor-associated macrophages.	[Leuschner, Florian; Dutta, Partha; Gorbatov, Rostic; Donahoe, Jessica S.; Courties, Gabriel; Marinelli, Brett; Iwamoto, Yoshiko; Cortez-Retamozo, Virna; Newton, Andita; Pittet, Mikael J.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Leuschner, Florian; Dutta, Partha; Gorbatov, Rostic; Donahoe, Jessica S.; Courties, Gabriel; Marinelli, Brett; Iwamoto, Yoshiko; Cortez-Retamozo, Virna; Newton, Andita; Pittet, Mikael J.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Harvard Univ, Sch Med, Boston, MA USA; [Novobrantseva, Tatiana I.; Milstein, Stuart; Epstein-Barash, Hila; Cantley, William; Wong, Jamie; Koteliansky, Victor] Alnylam Pharmaceut, Cambridge, MA USA; [Lee, Kang Mi; Kim, James I.; Markmann, James F.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Panizzi, Peter] Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Auburn, AL 36849 USA; [Lee, Won Woo] Seoul Natl Univ, Bundang Hosp, Dept Nucl Med, Seoul, South Korea; [Love, Kevin; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Div Hlth Sci Technol, Cambridge, MA 02139 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Auburn University System; Auburn University; Seoul National University (SNU); Seoul National University Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; mnahrendorf@mgh.harvard.edu	Libby, Peter/AAY-6404-2021; Lee, Won Woo/J-5589-2012; Panizzi, Peter/A-6072-2019; Swirski, Filip/AAF-1340-2019; Pittet, Mikael/ABD-6300-2021	Libby, Peter/0000-0002-1502-502X; Panizzi, Peter/0000-0003-0141-8807; Swirski, Filip/0000-0002-3163-9152; /0000-0003-0828-4143; Courties, Gabriel/0000-0002-0003-7407	US National Institutes of Health [R01-HL096576, R01-HL095629, R01-EB006432, T32-CA79443, U24-CA92782, P50-CA86355, HHSN268201000044C, R01-CA132091, R01-CA115527, R37-EB000244]; Deutsche Herzstiftung; SNUBH Research Fund [02-2007-013]; NATIONAL CANCER INSTITUTE [R01CA132091, U24CA092782, P50CA086355, T32CA079443, R01CA115527] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612, R01HL096576, R01HL095629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880, R01AI057851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432, R37EB000244] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Herzstiftung; SNUBH Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank M. Waring, A. Chicoine and the Ragon Institute (MGH) for cell sorting, the CSB Mouse Imaging Program (P. Waterman, B. Sena) and B. Bettencourt for designing initial sets of siRNA. We acknowledge the small, medium and large scale RNA synthesis groups at Alnylam as well as analytical, duplex annealing and QC groups for synthesizing and characterizing RNAs. This work was funded in part by grants from the US National Institutes of Health R01-HL096576, R01-HL095629 (M.N.); R01-EB006432, T32-CA79443, U24-CA92782, P50-CA86355, HHSN268201000044C (R.W.); R01-CA132091, R01-CA115527, R37-EB000244 (R.L.); Deutsche Herzstiftung (F.L.); and the SNUBH Research Fund 02-2007-013 (W.W.L.).	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Buxton DB, 2011, CIRC RES, V109, P250, DOI 10.1161/RES.0b013e31822a97cd; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; De Palma M, 2011, NATURE, V472, P303, DOI 10.1038/472303a; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hart KM, 2009, NEOPLASIA, V11, P564, DOI 10.1593/neo.09228; Heyes J, 2005, J CONTROL RELEASE, V107, P276, DOI 10.1016/j.jconrel.2005.06.014; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Moore DJ, 2004, TRANSPL INT, V17, P261, DOI 10.1111/j.1432-2277.2004.tb00440.x; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nahrendorf M, 2010, P NATL ACAD SCI USA, V107, P7910, DOI 10.1073/pnas.0915163107; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Peer D, 2008, SCIENCE, V319, P627, DOI 10.1126/science.1149859; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; ROBERTS R, 1976, CIRCULATION, V53, P204; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742	43	585	623	10	246	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1005	U73		10.1038/nbt.1989	http://dx.doi.org/10.1038/nbt.1989			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	21983520	Green Accepted, Green Submitted			2022-12-25	WOS:000296801300021
J	Myllykangas, S; Buenrostro, JD; Natsoulis, G; Bell, JM; Ji, HP				Myllykangas, Samuel; Buenrostro, Jason D.; Natsoulis, Georges; Bell, John M.; Ji, Hanlee P.			Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing	NATURE BIOTECHNOLOGY			English	Article							EXON CAPTURE; GENERATION	We describe an approach for targeted genome resequencing, called oligonucleotide-selective sequencing (OS-Seq), in which we modify the immobilized lawn of oligonucleotide primers of a next-generation DNA sequencer to function as both a capture and sequencing substrate. We apply OS-Seq to resequence the exons of either 10 or 344 cancer genes from human DNA samples. In our assessment of capture performance, >87% of the captured sequence originated from the intended target region with sequencing coverage falling within a tenfold range for a majority of all targets. Single nucleotide variants (SNVs) called from OS-Seq data agreed with >95% of variants obtained from whole-genome sequencing of the same individual. We also demonstrate mutation discovery from a colorectal cancer tumor sample matched with normal tissue. Overall, we show the robust performance and utility of OS-Seq for the resequencing analysis of human germline and cancer genomes.	[Myllykangas, Samuel; Natsoulis, Georges; Ji, Hanlee P.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Buenrostro, Jason D.; Bell, John M.; Ji, Hanlee P.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Ji, HP (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA.	genomics_ji@stanford.edu			US National Institutes of Health [K08CA96879, DK56339, P01HG000205, RC2HG005570, R21CA140089]; Sigrid Juselius Foundation; Academy of Finland; Doris Duke Clinical Foundation; Howard Hughes Medical Foundation; Reddere Foundation; Liu Bie Ju Cha and Family Fellowship in Cancer; Wang Family Foundation; NATIONAL CANCER INSTITUTE [K08CA096879, R21CA140089] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005570, P01HG000205, R01HG006137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Doris Duke Clinical Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Foundation(Howard Hughes Medical Institute); Reddere Foundation; Liu Bie Ju Cha and Family Fellowship in Cancer; Wang Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health grants K08CA96879 (H.P.J.), DK56339 (H.P.J.), P01HG000205 (J.D.B., J.M.B. and H.P.J.), RC2HG005570 (G.N., J.M.B. and H.P.J.), R21CA140089 (G.N., J.M.B. and H.P.J.), the Sigrid Juselius Foundation Fellowship (S.M.), the Academy of Finland Grant (S.M.), Doris Duke Clinical Foundation Clinical Scientist Development Award (H.P.J.), the Howard Hughes Medical Foundation Early Career Grant (H.P.J.), the Reddere Foundation Award (H.P.J.), the Liu Bie Ju Cha and Family Fellowship in Cancer (H.P.J.), and the Wang Family Foundation Research Grant (G.N. and H.P.J.).	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GONZALEZ G, 2008, SUMMIT TRANSLAT BIOI, P26; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Natsoulis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021088; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248	17	34	78	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1024	U95		10.1038/nbt.1996	http://dx.doi.org/10.1038/nbt.1996			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22020387	Green Accepted			2022-12-25	WOS:000296801300024
J	Zhang, Z; Cai, YQ; Zou, F; Bie, BH; Pan, ZZZ				Zhang, Zhi; Cai, You-Qing; Zou, Fang; Bie, Bihua; Pan, Zhizhong Z.			Epigenetic suppression of GAD65 expression mediates persistent pain	NATURE MEDICINE			English	Article							HISTONE DEACETYLASE INHIBITORS; ROSTRAL VENTROMEDIAL MEDULLA; PATHOLOGICAL PAIN; NERVOUS-SYSTEM; MODULATION; TRANSMISSION; MECHANISMS; RECEPTORS; NUCLEUS; NEURONS	Chronic pain is a common neurological disease involving lasting, multifaceted maladaptations ranging from gene modulation to synaptic dysfunction and emotional disorders. Sustained pathological stimuli in many diseases alter the output activities of certain genes through epigenetic modifications, but it is unclear how epigenetic mechanisms operate in the development of chronic pain. We show here that in the rat brainstem nucleus raphe magnus, which is important for central mechanisms of chronic pain, persistent inflammatory and neuropathic pain epigenetically suppresses Gad2 (encoding glutamic acid decarboxylase 65 (GAD65)) transcription through histone deacetylase (HDAC)-mediated histone hypoacetylation, resulting in impaired gamma-aminobutyric acid (GABA) synaptic inhibition. Gad2 knockout mice showed sensitized pain behavior and impaired GABA synaptic function in their brainstem neurons. In wild-type but not Gad2 knockout mice, HDAC inhibitors strongly increased GAD65 activity, restored GABA synaptic function and relieved sensitized pain behavior. These findings suggest GAD65 and HDACs as potential therapeutic targets in an epigenetic approach to the treatment of chronic pain.	[Zhang, Zhi; Cai, You-Qing; Zou, Fang; Bie, Bihua; Pan, Zhizhong Z.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Pain Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, ZZZ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Pain Med, Houston, TX 77030 USA.	zzpan@mdanderson.org	Zou, Fang/F-3270-2013; CAI, YOU-QING/A-4315-2013	CAI, YOU-QING/0000-0002-1440-6779	US National Institutes of Health National Institute on Drug Abuse [DA023069, DA027541]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027541, R01DA023069] Funding Source: NIH RePORTER	US National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health National Institute on Drug Abuse grants DA023069 and DA027541. We thank L. Gao of Baylor College of Medicine for his generous gifts of GAD67 primers.	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; Blackburn-Munro G, 2001, J NEUROENDOCRINOL, V13, P1009, DOI 10.1046/j.0007-1331.2001.00727.x; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Doehring A, 2011, EUR J PAIN, V15, P11, DOI 10.1016/j.ejpain.2010.06.004; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gilbert AK, 2001, PAIN, V90, P25, DOI 10.1016/S0304-3959(00)00383-3; Grayson DR, 2010, MOL PHARMACOL, V77, P126, DOI 10.1124/mol.109.061333; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; HEINRICHER MM, 1991, PAIN, V47, P105, DOI 10.1016/0304-3959(91)90017-R; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubo K, 2009, J PHARMACOL EXP THER, V331, P162, DOI 10.1124/jpet.109.156034; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; Ma JY, 2006, PAIN, V122, P163, DOI 10.1016/j.pain.2006.01.031; Ma JY, 2006, MOL PHARMACOL, V69, P1137, DOI 10.1124/mol.105.019109; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Munro G, 2009, TRENDS PHARMACOL SCI, V30, P453, DOI 10.1016/j.tips.2009.06.004; Pan ZZ, 1998, TRENDS PHARMACOL SCI, V19, P94, DOI 10.1016/S0165-6147(98)01169-9; Pan ZZ, 1997, NATURE, V389, P382, DOI 10.1038/38730; PAN ZZ, 1990, J PHYSIOL-LONDON, V427, P519, DOI 10.1113/jphysiol.1990.sp018185; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Ren WJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-93; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Scascighini L, 2008, NAT CLIN PRACT RHEUM, V4, P74, DOI 10.1038/ncprheum0680; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Vit JP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-42; Watkins LR, 2000, ANNU REV PSYCHOL, V51, P29, DOI 10.1146/annurev.psych.51.1.29; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Woolf Clifford J, 2004, Curr Opin Investig Drugs, V5, P61; Zhang L, 2010, PAIN, V149, P107, DOI 10.1016/j.pain.2010.01.017; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	51	198	214	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1448	U152		10.1038/nm.2442	http://dx.doi.org/10.1038/nm.2442			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	21983856	Green Accepted			2022-12-25	WOS:000296779300036
J	Gantt, RW; Peltier-Pain, P; Cournoyer, WJ; Thorson, JS				Gantt, Richard W.; Peltier-Pain, Pauline; Cournoyer, William J.; Thorson, Jon S.			Using simple donors to drive the equilibria of glycosyltransferase-catalyzed reactions	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCT GLYCODIVERSIFICATION; IN-VITRO CHARACTERIZATION; DIRECTED EVOLUTION; MACROLIDE GLYCOSYLTRANSFERASES; CHEMOENZYMATIC SYNTHESIS; SUGAR BIOSYNTHESIS; GLYCORANDOMIZATION; GLYCOSYLATION; REVERSIBILITY; OLIGOSACCHARIDES	We report that simple glycoside donors can drastically shift the equilibria of glycosyltransferase-catalyzed reactions, transforming NDP-sugar formation from an endothermic to an exothermic process. To demonstrate the utility of this thermodynamic adaptability, we highlight the glycosyltransferase-catalyzed synthesis of 22 sugar nucleotides from simple aromatic sugar donors, as well as the corresponding in situ formation of sugar nucleotides as a driving force in the context of glycosyltransferase-catalyzed reactions for small-molecule glycodiversification. These simple aromatic donors also enabled a general colorimetric assay for glycosyltransfer, applicable to drug discovery, protein engineering and other fundamental sugar nucleotide-dependent investigations. This study directly challenges the general notion that NDP-sugars are 'high-energy' sugar donors when taken out of their traditional biological context.	[Gantt, Richard W.; Peltier-Pain, Pauline; Cournoyer, William J.; Thorson, Jon S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Wisconsin Ctr Nat Prod Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Thorson, JS (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Wisconsin Ctr Nat Prod Res, 425 N Charter St, Madison, WI 53706 USA.	jsthorson@pharmacy.wisc.edu	Thorson, Jon S/L-3696-2013	Thorson, Jon S/0000-0002-7148-0721	US National Institutes of Health [AI52218]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052218, R01AI052218] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This manuscript is dedicated to the late C. Richard Hutchinson for his pioneering contributions to engineered natural product glycosylation. We thank the School of Pharmacy Analytical Instrumentation Center (University of Wisconsin-Madison) for analytical support and G.J. Williams (North Carolina State University) for materials and helpful discussion. R. W. G. is an American Foundation for Pharmaceutical Education -Pre-Doctoral Fellow. J.S.T. is a University of Wisconsin H. I. Romnes Fellow and holds the Laura and Edward Kremers Chair in Natural Products. This work was supported by US National Institutes of Health grant AI52218.	Bojarova P, 2009, GLYCOBIOLOGY, V19, P509, DOI 10.1093/glycob/cwp010; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Dickmanns A, 2011, J MOL BIOL, V405, P461, DOI 10.1016/j.jmb.2010.10.057; Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909; Gantt RW, 2008, ANGEW CHEM INT EDIT, V47, P8889, DOI 10.1002/anie.200803508; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hanson S, 2004, TRENDS BIOCHEM SCI, V29, P656, DOI 10.1016/j.tibs.2004.10.004; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kittl R, 2010, CARBOHYD RES, V345, P1272, DOI 10.1016/j.carres.2010.04.002; Ko HJ, 2009, BIOORGAN MED CHEM, V17, P5298, DOI 10.1016/j.bmc.2009.05.024; Lairson LL, 2007, CHEM COMMUN, P365, DOI 10.1039/b614636h; Lau K, 2010, CHEM COMMUN, V46, P6066, DOI 10.1039/c0cc01381a; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Losey HC, 2002, CHEM BIOL, V9, P1305, DOI 10.1016/S1074-5521(02)00270-3; Lougheed B, 1999, J BIOL CHEM, V274, P37717, DOI 10.1074/jbc.274.53.37717; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Minami A, 2005, TETRAHEDRON LETT, V46, P6187, DOI 10.1016/j.tetlet.2005.07.083; Modolo LV, 2009, FEBS LETT, V583, P2131, DOI 10.1016/j.febslet.2009.05.046; Okada T, 2009, GLYCOBIOLOGY, V19, P368, DOI 10.1093/glycob/cwn145; Pesnot T, 2010, CHEMBIOCHEM, V11, P1392, DOI 10.1002/cbic.201000013; Quiros LM, 2000, J BIOL CHEM, V275, P11713, DOI 10.1074/jbc.275.16.11713; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Rupprath C, 2007, ADV SYNTH CATAL, V349, P1489, DOI 10.1002/adsc.200700058; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Schitter G, 2009, EXPERT OPIN DRUG DIS, V4, P315, DOI 10.1517/17460440902778725; Takahashi H, 2006, J AM CHEM SOC, V128, P1432, DOI 10.1021/ja0562144; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Timmons SC, 2007, ORG LETT, V9, P857, DOI 10.1021/ol0630853; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wagner GK, 2010, CHEMBIOCHEM, V11, P1939, DOI 10.1002/cbic.201000201; Wagner GK, 2009, NAT PROD REP, V26, P1172, DOI 10.1039/b909621n; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Williams GJ, 2008, CHEM BIOL, V15, P393, DOI 10.1016/j.chembiol.2008.02.017; Williams GJ, 2008, NAT PROTOC, V3, P357, DOI 10.1038/nprot.2007.538; Williams GJ, 2007, NAT CHEM BIOL, V3, P657, DOI 10.1038/nchembio.2007.28; Williams GJ, 2011, ACS CHEM BIOL, V6, P95, DOI 10.1021/cb100267k; Williams GJ, 2008, CURR OPIN CHEM BIOL, V12, P556, DOI 10.1016/j.cbpa.2008.07.013; Yang J, 2004, BIOORGAN MED CHEM, V12, P1577, DOI 10.1016/j.bmc.2003.12.046; Yang M, 2005, J AM CHEM SOC, V127, P9336, DOI 10.1021/ja051482n; Zhang BC, 2011, P NATL ACAD SCI USA, V108, P5110, DOI 10.1073/pnas.1016144108; Zhang CS, 2008, CHEMBIOCHEM, V9, P2506, DOI 10.1002/cbic.200800349; Zhang CS, 2006, J AM CHEM SOC, V128, P16420, DOI 10.1021/ja065950k; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	46	98	106	11	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					685	691		10.1038/NCHEMBIO.638	http://dx.doi.org/10.1038/NCHEMBIO.638			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21857660	Green Accepted			2022-12-25	WOS:000295027100012
J	Takahashi, N; Kuwaki, T; Kiyonaka, S; Numata, T; Kozai, D; Mizuno, Y; Yamamoto, S; Naito, S; Knevels, E; Carmeliet, P; Oga, T; Kaneko, S; Suga, S; Nokami, T; Yoshida, J; Mori, Y				Takahashi, Nobuaki; Kuwaki, Tomoyuki; Kiyonaka, Shigeki; Numata, Tomohiro; Kozai, Daisuke; Mizuno, Yusuke; Yamamoto, Shinichiro; Naito, Shinji; Knevels, Ellen; Carmeliet, Peter; Oga, Toru; Kaneko, Shuji; Suga, Seiji; Nokami, Toshiki; Yoshida, Jun-ichi; Mori, Yasuo			TRPA1 underlies a sensing mechanism for O-2	NATURE CHEMICAL BIOLOGY			English	Article							ION-CHANNEL TRPA1; COVALENT MODIFICATION; SENSORY NEURONS; ZINC FINGERS; ACTIVATION; HYPOXIA; COLD; PAIN; INHIBITION; CYSTEINES	Oxygen (O-2) is a prerequisite for cellular respiration in aerobic organisms but also elicits toxicity. To understand how animals cope with the ambivalent physiological nature of O-2, it is critical to elucidate the molecular mechanisms responsible for O-2 sensing. Here our systematic evaluation of transient receptor potential (TRP) cation channels using reactive disulfides with different redox potentials reveals the capability of TRPA1 to sense O-2. O-2 sensing is based upon disparate processes: whereas prolyl hydroxylases (PHDs) exert O-2-dependent inhibition on TRPA1 activity in normoxia, direct O-2 action overrides the inhibition via the prominent sensitivity of TRPA1 to cysteine-mediated oxidation in hyperoxia. Unexpectedly, TRPA1 is activated through relief from the same PHD-mediated inhibition in hypoxia. In mice, disruption of the Trpa1 gene abolishes hyperoxia- and hypoxia-induced cationic currents in vagal and sensory neurons and thereby impedes enhancement of in vivo vagal discharges induced by hyperoxia and hypoxia. The results suggest a new O-2-sensing mechanism mediated by TRPA1.	[Takahashi, Nobuaki; Kiyonaka, Shigeki; Numata, Tomohiro; Kozai, Daisuke; Mizuno, Yusuke; Yamamoto, Shinichiro; Suga, Seiji; Nokami, Toshiki; Yoshida, Jun-ichi; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan; [Takahashi, Nobuaki; Kiyonaka, Shigeki; Numata, Tomohiro; Kozai, Daisuke; Mizuno, Yusuke; Yamamoto, Shinichiro; Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Kyoto, Japan; [Takahashi, Nobuaki] Kyoto Univ, Adv Biomed Engn Res Unit, Kyoto, Japan; [Kuwaki, Tomoyuki] Kagoshima Univ, Dept Physiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Japan Sci & Technol Agcy, Tokyo, Japan; [Naito, Shinji] Natl Ureshino Hosp, Div Pathol, Ureshino, Japan; [Knevels, Ellen; Carmeliet, Peter] Catholic Univ Louvain, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Knevels, Ellen; Carmeliet, Peter] Flanders Inst Biotechnol, Vesalius Res Ctr, Louvain, Belgium; [Oga, Toru] Kyoto Univ, Dept Resp Care & Sleep Control Med, Grad Sch Med, Kyoto, Japan; [Kaneko, Shuji] Kyoto Univ, Dept Mol Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kagoshima University; Japan Science & Technology Agency (JST); Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Kyoto University; Kyoto University	Mori, Y (corresponding author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan.	mori@sbchem.kyoto-u.ac.jp	Nokami, Toshiki/ABA-2915-2021; Numata, Tomohiro/AAW-2453-2020; KOZAI, Daisuke/ABG-3019-2021; Carmeliet, Peter/AAQ-5140-2020; Kiyonaka, Shigeki/AAM-7303-2021; Kaneko, Shuji/AAR-1005-2021; Kuwaki, Tomoyuki/B-3247-2019; Numata, Tomohiro/AAC-2330-2021; Yoshida, Jun-ichi/E-8786-2010; Nokami, Toshiki/H-4380-2013; Takahashi, Nobuaki/AAG-9411-2019	Numata, Tomohiro/0000-0002-5719-4884; Carmeliet, Peter/0000-0001-7961-1821; Kuwaki, Tomoyuki/0000-0003-4226-3610; Numata, Tomohiro/0000-0002-5719-4884; Yoshida, Jun-ichi/0000-0001-8439-2272; Takahashi, Nobuaki/0000-0002-0606-3921; Kaneko, Shuji/0000-0001-5152-5809	Grants-in-Aid for Scientific Research [22681033, 21106002, 20249015] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DESANCTIS GT, 1991, J APPL PHYSIOL, V70, P1168, DOI 10.1152/jappl.1991.70.3.1168; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gruss M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-12; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hathout Y, 1996, DRUG METAB DISPOS, V24, P1395; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HOWE A, 1981, J PHYSIOL-LONDON, V320, P309, DOI 10.1113/jphysiol.1981.sp013951; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lane N., 2002, OXYGEN MOL MADE WORL; Longhurst JC, 2001, ANN NY ACAD SCI, V940, P74; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McElroy M.B., 2002, ATMOSPHERIC ENV EFFE; MELLER ST, 1992, NEUROSCIENCE, V48, P501, DOI 10.1016/0306-4522(92)90398-L; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Neubauer JA, 2004, J APPL PHYSIOL, V96, P367, DOI 10.1152/japplphysiol.00831.2003; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Topol IA, 2001, PROTEIN SCI, V10, P1434, DOI 10.1110/ps.52601; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; WALLACE TJ, 1963, J ORG CHEM, V28, P1311, DOI 10.1021/jo01040a038; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	50	195	199	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					701	711		10.1038/NCHEMBIO.640	http://dx.doi.org/10.1038/NCHEMBIO.640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21873995	Green Published			2022-12-25	WOS:000295027100014
J	Mukherji, S; Ebert, MS; Zheng, GXY; Tsang, JS; Sharp, PA; van Oudenaarden, A				Mukherji, Shankar; Ebert, Margaret S.; Zheng, Grace X. Y.; Tsang, John S.; Sharp, Phillip A.; van Oudenaarden, Alexander			MicroRNAs can generate thresholds in target gene expression	NATURE GENETICS			English	Article							MAMMALIAN MICRORNAS; MESSENGER-RNAS; DIFFERENTIATION; IMPACT; ROBUSTNESS; SPONGES; LET-7	MicroRNAs (miRNAs) are short, highly conserved noncoding RNA molecules that repress gene expression in a sequence-dependent manner. We performed single-cell measurements using quantitative fluorescence microscopy and flow cytometry to monitor a target gene's protein expression in the presence and absence of regulation by miRNA. We find that although the average level of repression is modest, in agreement with previous population-based measurements, the repression among individual cells varies dramatically. In particular, we show that regulation by miRNAs establishes a threshold level of target mRNA below which protein production is highly repressed. Near this threshold, protein expression responds sensitively to target mRNA input, consistent with a mathematical model of molecular titration. These results show that miRNAs can act both as a switch and as a fine-tuner of gene expression.	[Mukherji, Shankar] MIT, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Ebert, Margaret S.; Sharp, Phillip A.; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zheng, Grace X. Y.] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Tsang, John S.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Ebert, Margaret S.; Zheng, Grace X. Y.; Sharp, Phillip A.; van Oudenaarden, Alexander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		US National Institutes of Health (NIH) [1DP1OD003936]; NIH-National Cancer Institute (NCI) Physical Sciences Oncology Center at the Massachusetts Institute of Technology [U54CA143874]; NIH [R01-CA133404, R01-GM34277]; NCI [PO1-CA42063, P30-CA14051]; Howard Hughes Medical Institute; Paul and Cleo Schimmel Scholarship; Natural Sciences and Engineering Research Council of Canada; NATIONAL CANCER INSTITUTE [DP1CA174420, R01CA133404, U54CA143874, P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Cancer Institute (NCI) Physical Sciences Oncology Center at the Massachusetts Institute of Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Paul and Cleo Schimmel Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Institutes of Health (NIH) Director's Pioneer Award to A.v.O. (1DP1OD003936) and the NIH-National Cancer Institute (NCI) Physical Sciences Oncology Center at the Massachusetts Institute of Technology (U54CA143874); and by US Public Health Service grants R01-CA133404, R01-GM34277 from the NIH, PO1-CA42063 from the NCI (to P. A. S.) and partially by Cancer Center Support (core) grant P30-CA14051 from the NCI. M. S. E. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship and a Paul and Cleo Schimmel Scholarship. G.X.Y.Z. and J.S.T. were partially supported by Natural Sciences and Engineering Research Council of Canada Post Graduate Scholarships. We thank G. Neuert for help with cloning the reporter genes, Koch Institute flow cytometry staff for training and cell sorting and D. Bartel for helpful discussions.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	28	466	497	0	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					854	U60		10.1038/ng.905	http://dx.doi.org/10.1038/ng.905			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21857679	Green Submitted, Green Accepted			2022-12-25	WOS:000294325800010
J	Linterman, MA; Pierson, W; Lee, SK; Kallies, A; Kawamoto, S; Rayner, TF; Srivastava, M; Divekar, DP; Beaton, L; Hogan, JJ; Fagarasan, S; Liston, A; Smith, KGC; Vinuesa, CG				Linterman, Michelle A.; Pierson, Wim; Lee, Sau K.; Kallies, Axel; Kawamoto, Shimpei; Rayner, Tim F.; Srivastava, Monika; Divekar, Devina P.; Beaton, Laura; Hogan, Jennifer J.; Fagarasan, Sidonia; Liston, Adrian; Smith, Kenneth G. C.; Vinuesa, Carola G.			Foxp3(+) follicular regulatory T cells control the germinal center response	NATURE MEDICINE			English	Article							HELPER-CELLS; PERIPHERAL HOMEOSTASIS; CUTTING EDGE; DIFFERENTIATION; BLIMP-1; BCL6; DYSREGULATION; INFLAMMATION; SUPPRESSION; ENTEROPATHY	Follicular helper (T-FH) cells provide crucial signals to germinal center B cells undergoing somatic hypermutation and selection that results in affinity maturation. Tight control of T-FH numbers maintains self tolerance. We describe a population of Foxp3(+) Blimp-1(+) CD4(+) T cells constituting 10-25% of the CXCR5(high)PD-1(high)CD4(+) T cells found in the germinal center after immunization with protein antigens. These follicular regulatory T (T-FR) cells share phenotypic characteristics with T-FH and conventional Foxp3(+) regulatory T (T-reg) cells yet are distinct from both. Similar to T-FH cells, T-FR cell development depends on Bcl-6, SLAM-associated protein (SAP), CD28 and B cells; however, T-FR cells originate from thymic-derived Foxp3(+) precursors, not naive or T-FH cells. T-FR cells are suppressive in vitro and limit T-FH cell and germinal center B cell numbers in vivo. In the absence of T-FR cells, an outgrowth of non-antigen-specific B cells in germinal centers leads to fewer antigen-specific cells. Thus, the T-FH differentiation pathway is co-opted by T-reg cells to control the germinal center response.	[Linterman, Michelle A.; Lee, Sau K.; Srivastava, Monika; Beaton, Laura; Hogan, Jennifer J.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Linterman, Michelle A.; Rayner, Tim F.; Divekar, Devina P.; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Linterman, Michelle A.; Rayner, Tim F.; Divekar, Devina P.; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; [Pierson, Wim; Liston, Adrian] Catholic Univ Louvain VIB, B-3000 Louvain, Belgium; [Pierson, Wim; Liston, Adrian] Catholic Univ Louvain, Dept Expt Med, B-3000 Louvain, Belgium; [Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Dept Immunol, Parkville, Vic 3050, Australia; [Kawamoto, Shimpei; Fagarasan, Sidonia] RIKEN Res Ctr Allergy & Immunol, Lab Mucosal Immun, Yokohama, Kanagawa, Japan	Australian National University; John Curtin School of Medical Research; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Royal Melbourne Hospital; Walter & Eliza Hall Institute; RIKEN	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	adrian.liston@vib.be; kgcs2@cam.ac.uk; carola.vinuesa@anu.edu.au	Liston, Adrian/G-8606-2013; Vinuesa, Carola G/B-1108-2010; Linterman, Michelle/AAN-4210-2021; Fagarasan, Sidonia/A-5258-2016	Liston, Adrian/0000-0002-6272-4085; Vinuesa, Carola G/0000-0001-9799-0298; Linterman, Michelle/0000-0001-6047-1996; Fagarasan, Sidonia/0000-0003-2086-6402; Pierson, Wim/0000-0003-1369-4606; Rayner, Tim/0000-0002-6992-5592; Beaton, Laura/0000-0002-5885-6915; Kallies, Axel/0000-0002-6312-6968; Smith, Kenneth/0000-0003-3829-4326	National Health and Medical Research Council; Vlaams Instituut voor Biotechnologie; Wellcome Trust [083650/Z/07/Z]; EMBO [ALTF 1041-2009]; Churchill College, Cambridge; Viertel Senior Medical Research Fellowship; Lister Prize Fellowship; National Institute of Health Research, Cambridge Biomedical Research Centre; Juvenile Diabetes Research Foundation; Marie Curie Reintegration Grant Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Vlaams Instituut voor Biotechnologie; Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Churchill College, Cambridge; Viertel Senior Medical Research Fellowship; Lister Prize Fellowship; National Institute of Health Research, Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Marie Curie Reintegration Grant Fellowship(European Commission)	We thank X. Hu and J. Fitch for technical assistance, D. Zotos for help with experiments not included in this manuscript, A. Rudensky for kind provision of Foxp3<SUP>gfp</SUP> mice and M. Espeli for helpful discussions. This work was funded by National Health and Medical Research Council program and project grants to C. G. V., a Vlaams Instituut voor Biotechnologie principal investigator grant to A. L. and a Wellcome Trust Programme grant (083650/Z/07/Z) to K. G. C. S. M. A. L. is supported by an EMBO post-doctoral long-term fellowship (ALTF 1041-2009) and a Raymond and Beverly Sackler Junior Research Fellowship, Churchill College, Cambridge; C. G. V. is supported by a Viertel Senior Medical Research Fellowship; K. G. C. S. is supported by a Lister Prize Fellowship; T. F. R. is supported by the National Institute of Health Research, Cambridge Biomedical Research Centre; and A. L. is supported by a Juvenile Diabetes Research Foundation Career Development Fellowship and a Marie Curie Reintegration Grant Fellowship.	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Fields ML, 2005, J IMMUNOL, V175, P4255, DOI 10.4049/jimmunol.175.7.4255; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Guo WZ, 2010, J EXP MED, V207, P2225, DOI 10.1084/jem.20092712; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wehner JR, 2010, TRANSPLANTATION, V89, P1141, DOI 10.1097/TP.0b013e3181d3f271; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yoshida K, 2006, EUR J IMMUNOL, V36, P3146, DOI 10.1002/eji.200636165; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	50	869	899	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					975	U95		10.1038/nm.2425	http://dx.doi.org/10.1038/nm.2425			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785433	Green Submitted, Green Accepted			2022-12-25	WOS:000293507400031
J	Hansson, GK; Klareskog, L				Hansson, Goran K.; Klareskog, Lars			Pulling the plug on atherosclerosis Cooling down the inflammasome	NATURE MEDICINE			English	Editorial Material							INTERLEUKIN-1-RECEPTOR ANTAGONIST; DEFICIENT MICE; IMMUNE-SYSTEM; CRYSTALS; ACTIVATION; PROTEIN; DANGER; GOUT; BETA	Atherosclerotic lesions can result in fatal cardiovascular disease, but what triggers the formation of the atheroma plaques and their progression still begs further investigation. In 'Bench to Bedside', Goran K Hansson and Lars Klareskog peruse how the NLRP3 inflammasome can be activated by cholesterol crystals and worsen atherosclerosis by triggering inflammation through the release of IL-1 beta from macrophages. But these cells can also die at the lesion site, forming a necrotic core in the atheroma by building up apoptotic cells and debris. In 'Bedside to Bench', Ira Tabas discusses a human study showing that lesional necrosis along with thinning of the fibrotic cap are predictive of culprit lesions involved in fatal disease. Understanding the molecular underpinnings of these two morphological features may lead to new therapies to prevent or decrease the risk for major cardiovascular disease.	[Hansson, Goran K.; Klareskog, Lars] Karolinska Inst, Dept Med, Stockholm, Sweden; [Hansson, Goran K.; Klareskog, Lars] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Hansson, GK (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	goran.hansson@ki.se; lars.klareskog@ki.se	Hansson, Goran K/B-7423-2012	Klareskog, Lars/0000-0001-9601-6186; Hansson, Goran/0000-0003-4148-5190				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	17	20	22	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					790	791		10.1038/nm0711-790	http://dx.doi.org/10.1038/nm0711-790			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738158				2022-12-25	WOS:000292500800030
J	Lee, KJ; Jeong, CS; An, YJ; Lee, HJ; Park, SJ; Seok, YJ; Kim, P; Lee, JH; Lee, KH; Cha, SS				Lee, Kyung-Jo; Jeong, Chang-Sook; An, Young Jun; Lee, Hyun-Jung; Park, Soon-Jung; Seok, Yeong-Jae; Kim, Pil; Lee, Jung-Hyun; Lee, Kyu-Ho; Cha, Sun-Shin			FrsA functions as a cofactor-independent decarboxylase to control metabolic flux	NATURE CHEMICAL BIOLOGY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; ENZYME PYRUVATE DECARBOXYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROFICIENT ENZYME; ZYMOMONAS-MOBILIS; MECHANISM; RESOLUTION; IIA(GLC); BINDING	The interaction between fermentation-respiration switch (FrsA) protein and glucose-specific enzyme IIA(Glc) increases glucose fermentation under oxygen-limited conditions. We show that FrsA converts pyruvate to acetaldehyde and carbon dioxide in a cofactor-independent manner and that its pyruvate decarboxylation activity is enhanced by the dephosphorylated form of IIA(Glc) (d-IIA(Glc)). Crystal structures of FrsA and its complex with d-IIA(Glc) revealed residues required for catalysis as well as the structural basis for the activation by d-IIA(Glc).	[Lee, Kyung-Jo; Lee, Hyun-Jung; Lee, Kyu-Ho] Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea; [Jeong, Chang-Sook; An, Young Jun; Lee, Jung-Hyun; Cha, Sun-Shin] KORDI, Marine Biotechnol Res Ctr, Ansan, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Dept Environm Med Biol, Seoul, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Inst Trop Med, Brain Korea Project 21, Seoul, South Korea; [Seok, Yeong-Jae] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul, South Korea; [Kim, Pil] Catholic Univ Korea, Dept Biotechnol, Puchon, South Korea; [Lee, Jung-Hyun; Cha, Sun-Shin] Univ Sci & Technol, Dept Marine Biotechnol, Taejon, South Korea	Hankuk University Foreign Studies; Korea Institute of Ocean Science & Technology (KIOST); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Catholic University of Korea	Lee, KJ (corresponding author), Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea.	khlee@hufs.ac.kr; chajung@kordi.re.kr		Kim, Pil/0000-0002-6285-2466; Seok, Yeong-Jae/0000-0003-0379-3619; Cha, Sun-Shin/0000-0002-0913-8706; Park, Soon-Jung/0000-0002-0423-1944	Ministry of Land, Transport and Maritime Affairs; Ministry of Education, Science and Technology [2009-0092822]; KORDI in-house program [PE98513]	Ministry of Land, Transport and Maritime Affairs(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); KORDI in-house program	We are grateful to Y.-J. Lee, H.-S. Lee, S.J. Chung and J.K. Lee for comments on the manuscript. This work was supported by the Marine and Extreme Genome Research Center program of Ministry of Land, Transport and Maritime Affairs, the Mid-career Researcher Program through National Research Foundation grant funded by the Ministry of Education, Science and Technology (2009-0092822), a KORDI in-house program (PE98513) and the Development of Biohydrogen Production Technology Using Hyperthermophilic Archaea program of Ministry of Land, Transport and Maritime Affairs.	Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Arjunan P, 1996, J MOL BIOL, V256, P590, DOI 10.1006/jmbi.1996.0111; BRINGERMEYER S, 1986, ARCH MICROBIOL, V146, P105, DOI 10.1007/BF00402334; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Chan KK, 2009, BIOCHEMISTRY-US, V48, P5518, DOI 10.1021/bi900623r; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Dobritzsch D, 1998, J BIOL CHEM, V273, P20196, DOI 10.1074/jbc.273.32.20196; DYDA F, 1993, BIOCHEMISTRY-US, V32, P6165, DOI 10.1021/bi00075a008; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Kim YJ, 2010, FEBS LETT, V584, P4537, DOI 10.1016/j.febslet.2010.10.035; Koo BM, 2004, J BIOL CHEM, V279, P31613, DOI 10.1074/jbc.M405048200; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Nam TW, 2008, P NATL ACAD SCI USA, V105, P3751, DOI 10.1073/pnas.0709295105; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PETERKOFSKY A, 1993, PROG NUCLEIC ACID RE, V44, P31, DOI 10.1016/S0079-6603(08)60216-0; SAIER MH, 1983, J BACTERIOL, V155, P1351, DOI 10.1128/JB.155.3.1351-1357.1983; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Sergienko EA, 2001, BIOCHEMISTRY-US, V40, P7369, DOI 10.1021/bi002856m; STEPHENSON MP, 1971, J GEN MICROBIOL, V69, P331, DOI 10.1099/00221287-69-3-331; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	25	18	20	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					434	436		10.1038/NCHEMBIO.589	http://dx.doi.org/10.1038/NCHEMBIO.589			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21623357				2022-12-25	WOS:000292252100010
J	Adamo, A; Sese, B; Boue, S; Castano, J; Paramonov, I; Barrero, MJ; Belmonte, JCI				Adamo, Antonio; Sese, Borja; Boue, Stephanie; Castano, Julio; Paramonov, Ida; Barrero, Maria J.; Izpisua Belmonte, Juan Carlos			LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells	NATURE CELL BIOLOGY			English	Article							PROTEIN-INTERACTION NETWORK; DEVELOPMENTAL REGULATORS; TRANSCRIPTION; PROMOTES; GENES; RNA; DEMETHYLATION; METHYLATION; EXPRESSION; REPRESSION	We identify LSD1 (lysine-specific demethylase 1; also known as KDM1A and A0F2) as a key histone modifier that participates in the maintenance of pluripotency through the regulation of bivalent domains, a chromatin environment present at the regulatory regions of developmental genes that contains both H3K4 di/trimethylation and H3K27 trimethylation marks. LSD1 occupies the promoters of a subset of developmental genes that contain bivalent domains and are co-occupied by OCT4 and NANOG in human embryonic stem cells, where it controls the levels of H3K4 methylation through its demethylase activity. Thus, LSD1 has a role in maintaining the silencing of several developmental genes in human embryonic stem cells by regulating the critical balance between H3K4 and H3K27 methylation at their regulatory regions.	[Adamo, Antonio; Sese, Borja; Boue, Stephanie; Castano, Julio; Paramonov, Ida; Barrero, Maria J.; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	Belmonte@salk.edu	Cardoso, Julio Castaño/AAB-5820-2019; Barrero, Maria J./Q-1785-2017	Barrero, Maria J./0000-0002-5990-7040; Sese, Borja/0000-0001-8554-897X; Adamo, Antonio/0000-0003-1080-3547; Castano Cardoso, Julio/0000-0002-0712-5856; Boue, Stephanie/0000-0003-0680-4168	Ramon y Cajal programme; Ministerio de Ciencia e Innovacion of Spain [RYC-2007-01510, SAF2009-08588]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; MICINN; GIBER; Fundacion Cellex	Ramon y Cajal programme(Spanish Government); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); GIBER; Fundacion Cellex(Foundation CELLEX)	We thank S. Malik and I. Martinez for critical reading of the manuscript, D. Trono for plasmids pLVTHM and psPAX2, T. Pratt for plasmid pTP6, A. Consiglio for assistance with viral preparations and infection, R. Vassena, I. Rodriguez and A. Sanchez for help with the differentiation experiments, B. Christen for advice on cell treatments and V. Astro for assistance with movie preparation. M.J.B. was partially supported by the Ramon y Cajal programme. B.S. is a predoctoral fellow from the Ministerio de Ciencia e Innovacion of Spain. This work was partially supported by grants RYC-2007-01510 and SAF2009-08588 from the Ministerio de Ciencia e Innovacion of Spain to M.J.B. and grants from the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, MICINN, GIBER and Fundacion Cellex to J.C.I.B.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; de la Cruz CC, 2005, CHROMOSOMA, V114, P183, DOI 10.1007/s00412-005-0008-6; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greco SJ, 2007, J BIOL CHEM, V282, P30039, DOI 10.1074/jbc.M703026200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Macfarlan T. S., 2011, GENES DEV; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	43	225	256	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					652	U265		10.1038/ncb2246	http://dx.doi.org/10.1038/ncb2246			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21602794				2022-12-25	WOS:000291147400005
J	Wright, FA; Strug, LJ; Doshi, VK; Commander, CW; Blackman, SM; Sun, L; Berthiaume, Y; Cutler, D; Cojocaru, A; Collaco, JM; Corey, M; Dorfman, R; Goddard, K; Green, D; Kent, JW; Lange, EM; Lee, S; Li, WL; Luo, JC; Mayhew, GM; Naughton, KM; Pace, RG; Pare, P; Rommens, JM; Sandford, A; Stonebraker, JR; Sun, W; Taylor, C; Vanscoy, LL; Zou, F; Blangero, J; Zielenski, J; O'Neal, WK; Drumm, ML; Durie, PR; Knowles, MR; Cutting, GR				Wright, Fred A.; Strug, Lisa J.; Doshi, Vishal K.; Commander, Clayton W.; Blackman, Scott M.; Sun, Lei; Berthiaume, Yves; Cutler, David; Cojocaru, Andreea; Collaco, J. Michael; Corey, Mary; Dorfman, Ruslan; Goddard, Katrina; Green, Deanna; Kent, Jack W., Jr.; Lange, Ethan M.; Lee, Seunggeun; Li, Weili; Luo, Jingchun; Mayhew, Gregory M.; Naughton, Kathleen M.; Pace, Rhonda G.; Pare, Peter; Rommens, Johanna M.; Sandford, Andrew; Stonebraker, Jaclyn R.; Sun, Wei; Taylor, Chelsea; Vanscoy, Lori L.; Zou, Fei; Blangero, John; Zielenski, Julian; O'Neal, Wanda K.; Drumm, Mitchell L.; Durie, Peter R.; Knowles, Michael R.; Cutting, Garry R.			Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2	NATURE GENETICS			English	Article							PULMONARY-FUNCTION; ESE-3; SPECIFICITY; ACTIVATION; APOPTOSIS; SURVIVAL; PROTEIN; CELLS; APIP	A combined genome-wide association and linkage study was used to identify loci causing variation in cystic fibrosis lung disease severity. We identified a significant association (P = 3.34 x 10(-8)) near EHF and APIP (chr11p13) in p. Phe508del homozygotes (n = 1,978). The association replicated in p. Phe508del homozygotes (P = 0.006) from a separate family based study (n = 557), with P = 1.49 x 10(-9) for the three-study joint meta-analysis. Linkage analysis of 486 sibling pairs from the family based study identified a significant quantitative trait locus on chromosome 20q13.2 (log(10) odds = 5.03). Our findings provide insight into the causes of variation in lung disease severity in cystic fibrosis and suggest new therapeutic targets for this life-limiting disorder.	[Commander, Clayton W.; Pace, Rhonda G.; Stonebraker, Jaclyn R.; O'Neal, Wanda K.; Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA; [Wright, Fred A.; Lange, Ethan M.; Lee, Seunggeun; Mayhew, Gregory M.; Sun, Wei; Zou, Fei] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Strug, Lisa J.; Sun, Lei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Doshi, Vishal K.; Naughton, Kathleen M.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Blackman, Scott M.; Collaco, J. Michael; Green, Deanna; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Berthiaume, Yves] CHU Montreal, Ctr Rech, Dept Med, Montreal, PQ, Canada; [Cutler, David] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Dorfman, Ruslan; Rommens, Johanna M.; Zielenski, Julian] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Goddard, Katrina] Oregon Clin Translat Res Inst, Ctr Hlth Res, Portland, OR USA; [Kent, Jack W., Jr.; Blangero, John] SW Fdn Biomed Res, San Antonio, TX 78284 USA; [Lange, Ethan M.; Sun, Wei] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Luo, Jingchun] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Pare, Peter; Sandford, Andrew] Univ British Columbia, Providence Heart Lung Inst, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Rommens, Johanna M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Vanscoy, Lori L.] Naval Med Ctr, Cyst Fibrosis Ctr, Portsmouth, VA USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Durie, Peter R.] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Durie, Peter R.] Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; Johns Hopkins University; Johns Hopkins University; Universite de Montreal; Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Texas Biomedical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of British Columbia; University of Toronto; Case Western Reserve University; Case Western Reserve University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Knowles, MR (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA.	knowles@med.unc.edu; gcutting@jhmi.edu	Pare, Peter D/C-7425-2011; Berthiaume, Yves/K-7588-2012; Cojocaru, Andreea/AAN-6033-2021; Green, Deanna/HGU-5890-2022; Blangero, John/ABA-7175-2021; Rommens, Johanna/AAT-7465-2021	Cojocaru, Andreea L./0000-0003-0210-4113; Kent, Jack/0000-0002-0758-7639; Pace, Rhonda/0000-0001-8606-0327; Blackman, Scott/0000-0002-4532-6421; Commander, Clayton/0000-0001-8477-932X; Strug, Lisa/0000-0003-0503-9740	US National Heart, Lung and Blood Institute [R01HL068927, R01HL068890, R01HL095396]; US National Institute of Diabetes and Digestive and Kidney Diseases [R01DK066368, K23DK083551, P30DK027651]; US National Institute of Mental Health [SOLAR-MH059490]; US National Human Genome Research Institute [HG-0004314]; US Cystic Fibrosis Foundation [CUTTIN00A0, CUTTIN06P0, COLLAC07A0, RDP-R025-CR07, KNOWLE00A0, RDP-R026-CR07, DRUMM0A00, GENOMEQUEBEC07DDS0]; Flight Attendant Medical Research Institute [FAMRI2006]; Lawson Wilkins Pediatric Endocrine Society; Canadian Cystic Fibrosis Foundation; Genome Canada through the Ontario Genomics Institute [2004-OGI-3-05]; Ontario Research Fund; Lloyd Carr-Harris Foundation; Canadian Institutes of Health Research; Ontario Women's Health Council; US Cystic Fibrosis Foundation (CFF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748, R01HL068890, R01HL095396, R01HL068927] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG004314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066368, K23DK083551, P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	US National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US Cystic Fibrosis Foundation; Flight Attendant Medical Research Institute; Lawson Wilkins Pediatric Endocrine Society; Canadian Cystic Fibrosis Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Research Fund; Lloyd Carr-Harris Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council; US Cystic Fibrosis Foundation (CFF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by grants from the US National Heart, Lung and Blood Institute R01HL068927, R01HL068890, R01HL095396, the US National Institute of Diabetes and Digestive and Kidney Diseases R01DK066368, K23DK083551, P30DK027651, the US National Institute of Mental Health SOLAR-MH059490 and the US National Human Genome Research Institute HG-0004314; US Cystic Fibrosis Foundation grants CUTTIN00A0, CUTTIN06P0, COLLAC07A0, RDP-R025-CR07, KNOWLE00A0, RDP-R026-CR07, DRUMM0A00 and contract GENOMEQUEBEC07DDS0; Flight Attendant Medical Research Institute grant FAMRI2006; Lawson Wilkins Pediatric Endocrine Society grant LWPES Clinical Scholar Award; The Canadian Cystic Fibrosis Foundation; Genome Canada through the Ontario Genomics Institute as per research agreement 2004-OGI-3-05; Ontario Research Fund, Research Excellence Program; Lloyd Carr-Harris Foundation; and the Joint Fellowship of Canadian Institutes of Health Research and Ontario Women's Health Council. Funds for genome-wide genotyping were generously provided by the US Cystic Fibrosis Foundation (CFF).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Cao GD, 2004, J NEUROSCI, V24, P6189, DOI 10.1523/JNEUROSCI.1426-04.2004; Chalmers JD, 2011, GLYCOBIOLOGY, V21, P271, DOI 10.1093/glycob/cwq161; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Dorlochter Ludger, 2002, J Cyst Fibros, V1, P131, DOI 10.1016/S1569-1993(02)00076-0; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Getting SJ, 2008, PULM PHARMACOL THER, V21, P866, DOI 10.1016/j.pupt.2008.09.004; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harris JF, 2005, AM J RESP CRIT CARE, V171, P764, DOI 10.1164/rccm.200408-1108OC; HUBERT HB, 1982, AM REV RESPIR DIS, V125, P409; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee YS, 2002, J CLIN ENDOCR METAB, V87, P1423, DOI 10.1210/jc.87.3.1423; Li W, 2011, CLIN GENET, V79, P136, DOI 10.1111/j.1399-0004.2010.01502.x; LI Y, 2006, AM SOC HUM GEN ANN M, V416; Mc Closkey M, 2004, CLIN NUTR, V23, P1405, DOI 10.1016/j.clnu.2004.06.010; MCCLEARN GE, 1994, J GERONTOL, V49, pM264, DOI 10.1093/geronj/49.6.M264; McKeon DJ, 2008, THORAX, V63, P660, DOI 10.1136/thx.2008.096834; NETER J, 1989, APPL LINEAR REGRESSI, P282; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Savastano DM, 2009, AM J CLIN NUTR, V90, P912, DOI 10.3945/ajcn.2009.27537; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Taylor C, 2011, PEDIATR PULM, V46, P857, DOI 10.1002/ppul.21456; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Yoo YJ, 2010, GENET EPIDEMIOL, V34, P107, DOI 10.1002/gepi.20438	60	185	188	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					539	U67		10.1038/ng.838	http://dx.doi.org/10.1038/ng.838			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21602797	Green Accepted, Green Submitted			2022-12-25	WOS:000291017000010
J	Dissanayake, D; Hall, H; Berg-Brown, N; Elford, AR; Hamilton, SR; Murakami, K; Deluca, LS; Gommerman, JL; Ohashi, PS				Dissanayake, Dilan; Hall, Hakan; Berg-Brown, Nancy; Elford, Alisha R.; Hamilton, Sara R.; Murakami, Kiichi; Deluca, Leslie Summers; Gommerman, Jennifer L.; Ohashi, Pamela S.			Nuclear factor-kappa B1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells	NATURE MEDICINE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ANTIGEN-PRESENTING CELLS; P50 SUBUNIT; TOLERANCE; MICE; ASSOCIATION; INDUCTION; ROLES; RISK	Mature dendritic cells (DCs) are crucial for the induction of adaptive immune responses and perturbed DC homeostasis can result in autoimmune disease. Either uncontrolled expansion(1) or enhanced survival(2,3) of DCs can result in a variety of autoimmune diseases in mouse models. In addition, increased maturation signals, through overexpression of surface Toll-like receptors (TLRs)(4) or stimulation by type I interferon (IFN)(5), has been associated with systemic autoimmunity. Whereas recent studies have focused on identifying factors required for initiating the maturation process, the possibility that resting DCs also express molecules that 'hold' them in an immature state has generally not been considered. Here we show that nuclear factor-kappa B1 (NF-kappa B1) is crucial for maintaining the resting state of DCs. Self-antigen-pulsed unstimulated DCs that do not express NF-kappa B1 were able to activate CD8(+) T lymphocytes and induce autoimmunity. We further show that NF-kappa B1 negatively regulates the spontaneous production of tumor necrosis factor-alpha (TNF-alpha), which is associated with increased granzyme B expression in cytotoxic T lymphocytes (CTLs). These findings provide a new perspective on functional DC maturation and a potential mechanism that may account for pathologic T cell activation.	[Dissanayake, Dilan; Hall, Hakan; Berg-Brown, Nancy; Elford, Alisha R.; Hamilton, Sara R.; Murakami, Kiichi; Ohashi, Pamela S.] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada; [Dissanayake, Dilan; Deluca, Leslie Summers; Gommerman, Jennifer L.; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Ohashi, PS (corresponding author), Ontario Canc Inst, Campbell Family Inst Breast Canc Res, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	pohashi@uhnresearch.ca		Dissanayake, Dilan/0000-0003-4270-7015; Hamilton, Sara/0000-0001-6062-2037; Ohashi, Pamela S./0000-0003-2915-9317; Gommerman, Jennifer/0000-0003-4576-6168	Canadian Institutes for Health Research (CIHR); Ontario Ministry of Health and Long Term Care (OMHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care (OMHLTC)(Ministry of Health and Long-Term Care, Ontario)	We would like to thank S. Mariathasan (Genentech) for kindly providing Pycard-deficient mice. We would also like to thank L.T. Nguyen for critical evaluation of the manuscript. This work was supported by a Canadian Institutes for Health Research (CIHR) grant to P.S.O. and CIHR studentship to D.D. P.S.O. holds a Canada Research Chair in Autoimmunity and Tumor Immunity. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMHLTC). The views expressed do not necessarily reflect those of the OMHLTC.	Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; CAVALLO MG, 1991, CLIN EXP IMMUNOL, V86, P256; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Corvol JC, 2008, P NATL ACAD SCI USA, V105, P11839, DOI 10.1073/pnas.0805065105; Date Y, 1999, ARTHRITIS RHEUM, V42, P2577, DOI 10.1002/1529-0131(199912)42:12<2577::AID-ANR10>3.0.CO;2-O; De Cesaris P, 1998, J BIOL CHEM, V273, P7566, DOI 10.1074/jbc.273.13.7566; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Hilliard B, 1999, J IMMUNOL, V163, P2937; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Li N, 2008, CLIN BIOCHEM, V41, P881, DOI 10.1016/j.clinbiochem.2008.04.014; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Ruan QG, 2010, DIABETES, V59, P2549, DOI 10.2337/db10-0480; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Stayoussef M, 2010, EUR CYTOKINE NETW, V21, P285, DOI 10.1684/ecn.2010.0215; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Weaver DJ, 2001, J IMMUNOL, V167, P1461, DOI 10.4049/jimmunol.167.3.1461; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Wheat W, 2004, EUR J IMMUNOL, V34, P1395, DOI 10.1002/eji.200324490; Zhao JL, 1996, J EXP MED, V183, P777, DOI 10.1084/jem.183.3.777; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	40	62	68	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1663	U182		10.1038/nm.2556	http://dx.doi.org/10.1038/nm.2556			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081022				2022-12-25	WOS:000297978000040
J	Wang, K; Kan, JS; Yuen, ST; Shi, ST; Chu, KM; Law, S; Chan, TL; Kan, ZY; Chan, ASY; Tsui, WY; Lee, SP; Ho, SL; Chan, AKW; Cheng, GHW; Roberts, PC; Rejto, PA; Gibson, NW; Pocalyko, DJ; Mao, M; Xu, JC; Leung, SY				Wang, Kai; Kan, Junsuo; Yuen, Siu Tsan; Shi, Stephanie T.; Chu, Kent Man; Law, Simon; Chan, Tsun Leung; Kan, Zhengyan; Chan, Annie S. Y.; Tsui, Wai Yin; Lee, Siu Po; Ho, Siu Lun; Chan, Anthony K. W.; Cheng, Grace H. W.; Roberts, Peter C.; Rejto, Paul A.; Gibson, Neil W.; Pocalyko, David J.; Mao, Mao; Xu, Jiangchun; Leung, Suet Yi			Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; MYELOID-LEUKEMIA GENOME; MICROSATELLITE INSTABILITY; SOMATIC MUTATIONS; CELL-CARCINOMA; BETA RECEPTOR; TARGET GENES; PATTERNS; EXPRESSION; BREAST	Gastric cancer is a heterogeneous disease with multiple environmental etiologies and alternative pathways of carcinogenesis(1,2). Beyond mutations in TP53, alterations in other genes or pathways account for only small subsets of the disease. We performed exome sequencing of 22 gastric cancer samples and identified previously unreported mutated genes and pathway alterations; in particular, we found genes involved in chromatin modification to be commonly mutated. A downstream validation study confirmed frequent inactivating mutations or protein deficiency of ARID1A, which encodes a member of the SWI-SNF chromatin remodeling family, in 83% of gastric cancers with microsatellite instability (MSI), 73% of those with Epstein-Barr virus (EBV) infection and 11% of those that were not infected with EBV and microsatellite stable (MSS). The mutation spectrum for ARID1A differs between molecular subtypes of gastric cancer, and mutation prevalence is negatively associated with mutations in TP53. Clinically, ARID1A alterations were associated with better prognosis in a stage-independent manner. These results reveal the genomic landscape, and highlight the importance of chromatin remodeling, in the molecular taxonomy of gastric cancer.	[Kan, Junsuo; Yuen, Siu Tsan; Chan, Tsun Leung; Chan, Annie S. Y.; Tsui, Wai Yin; Lee, Siu Po; Ho, Siu Lun; Chan, Anthony K. W.; Cheng, Grace H. W.; Leung, Suet Yi] Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China; [Wang, Kai; Kan, Zhengyan; Rejto, Paul A.; Gibson, Neil W.; Pocalyko, David J.; Mao, Mao; Xu, Jiangchun] Pfizer Worldwide Res & Dev, Oncol Res Unit, La Jolla, CA USA; [Shi, Stephanie T.] Pfizer Worldwide Res & Dev, External Res Solut, La Jolla, CA USA; [Chu, Kent Man; Law, Simon] Univ Hong Kong, Dept Surg, Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China; [Roberts, Peter C.] Pfizer Worldwide Res & Dev, Res Embedded Business Technol, La Jolla, CA USA	University of Hong Kong; Pfizer; Pfizer; University of Hong Kong; Pfizer	Leung, SY (corresponding author), Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China.	jiangchun.xu@pfizer.com; suetyi@hku.hk	Rejto, Paul/M-4782-2019; Leung, Suet Yi/C-4340-2009; Law, Simon/C-4324-2009; Yuen, Siu/K-6311-2014; Leung, Suet Yi/T-9620-2019	Law, Simon/0000-0002-6518-5806; Wang, Kai/0000-0003-0567-3004; Leung, Suet Yi/0000-0001-8614-4619				Ahn CH, 2009, CANCER RES TREAT, V41, P224, DOI 10.4143/crt.2009.41.4.224; BECKER KF, 1994, CANCER RES, V54, P3845; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; DosSantos NR, 1996, GASTROENTEROLOGY, V110, P38, DOI 10.1053/gast.1996.v110.pm8536886; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hempen PM, 2003, CANCER RES, V63, P994; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Inoue H, 2011, BIOCHEM J, V434, P83, DOI 10.1042/BJ20101358; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Lauwers G, 2010, WHO CLASSIFICATION T, P48; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leung SY, 1999, BRIT J CANCER, V79, P582, DOI 10.1038/sj.bjc.6690092; Leung SY, 1999, CANCER RES, V59, P159; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li VSW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-29; LI WH, 1983, MOL BIOL EVOL, V1, P94; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Murphy MA, 2011, INT J CANCER, V129, P1914, DOI 10.1002/ijc.25835; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; NAKATSURU S, 1992, HUM MOL GENET, V1, P559, DOI 10.1093/hmg/1.8.559; Osato T, 1996, SEMIN CANCER BIOL, V7, P175, DOI 10.1006/scbi.1996.0024; Park WS, 1999, CANCER RES, V59, P4257; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; UCHINO S, 1993, INT J CANCER, V54, P759, DOI 10.1002/ijc.2910540509; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang JY, 2003, VIRCHOWS ARCH, V442, P437, DOI 10.1007/s00428-003-0803-5; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner Stefan M., 2006, Cancer Biomarkers, V2, P69; Yuen ST, 2002, CANCER RES, V62, P6451; YUEN ST, 1994, AM J SURG PATHOL, V18, P1158, DOI 10.1097/00000478-199411000-00010	50	559	592	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1219	U73		10.1038/ng.982	http://dx.doi.org/10.1038/ng.982			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22037554				2022-12-25	WOS:000297931400015
J	Zhang, FR; Liu, H; Chen, SM; Low, H; Sun, LD; Cui, Y; Chu, TS; Li, Y; Fu, X; Yu, YX; Yu, GQ; Shi, BQ; Tian, HQ; Liu, DC; Yu, XL; Li, JH; Lu, N; Bao, FF; Yuan, CY; Liu, J; Liu, HX; Zhang, L; Sun, YH; Chen, MF; Yang, Q; Yang, HT; Yang, RD; Zhang, LH; Wang, Q; Liu, H; Zuo, FG; Zhang, HZ; Khor, CC; Hibberd, ML; Yang, S; Liu, JJ; Zhang, XJ				Zhang, Furen; Liu, Hong; Chen, Shumin; Low, Huiqi; Sun, Liangdan; Cui, Yong; Chu, Tongsheng; Li, Yi; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Shi, Benqing; Tian, Hongqing; Liu, Dianchang; Yu, Xiulu; Li, Jinghui; Lu, Nan; Bao, Fangfang; Yuan, Chunying; Liu, Jian; Liu, Huaxu; Zhang, Lin; Sun, Yonghu; Chen, Mingfei; Yang, Qing; Yang, Haitao; Yang, Rongde; Zhang, Lianhua; Wang, Qiang; Liu, Hong; Zuo, Fuguang; Zhang, Haizhen; Khor, Chiea Chuen; Hibberd, Martin L.; Yang, Sen; Liu, Jianjun; Zhang, Xuejun			Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; METAANALYSIS; VARIANTS	We performed a genome-wide association study with 706 individuals with leprosy and 5,581 control individuals and replicated the top 24 SNPs in three independent replication samples, including a total of 3,301 individuals with leprosy and 5,299 control individuals from China. Two loci not previously associated with the disease were identified with genome-wide significance: rs2275606 (combined P = 3.94 x 10(-14), OR = 1.30) on 6q24.3 and rs3762318 (combined P = 3.27 x 10(-11), OR = 0.69) on 1p31.3. These associations implicate IL23R and RAB32 as new susceptibility genes for leprosy. Furthermore, we identified evidence of interaction between the NOD2 and RIPK2 loci, which is consistent with the biological association of the proteins encoded by these genes (NOD2-RIPK2 complex) in activating the NF-kappa B pathway as a part of the host defense response to infection. Our findings have expanded the biological functions of IL23R by uncovering its involvement in infectious disease susceptibility and suggest a potential involvement of autophagocytosis in leprosy pathogenesis. The IL23R association supports previous observations of the marked overlap of susceptibility genes for leprosy and Crohn's disease, implying common pathogenesis mechanisms.	[Zhang, Furen; Liu, Hong; Chen, Shumin; Chu, Tongsheng; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Liu, Dianchang; Yu, Xiulu; Li, Jinghui; Lu, Nan; Bao, Fangfang; Yuan, Chunying; Liu, Jian; Liu, Huaxu; Zhang, Lin; Sun, Yonghu; Chen, Mingfei; Yang, Qing; Liu, Hong; Zuo, Fuguang; Zhang, Haizhen; Liu, Jianjun] Prov Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Zhang, Furen; Shi, Benqing; Tian, Hongqing] Shandong Univ, Shandong Prov Hosp Skin Dis, Jinan 250100, Peoples R China; [Zhang, Furen; Liu, Hong; Chen, Shumin; Chu, Tongsheng; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Liu, Dianchang; Yu, Xiulu; Li, Jinghui; Lu, Nan; Bao, Fangfang; Yuan, Chunying; Liu, Jian; Liu, Huaxu; Zhang, Lin; Sun, Yonghu; Chen, Mingfei; Yang, Qing; Liu, Hong; Zuo, Fuguang; Zhang, Haizhen] Shandong Prov Key Lab Dermatovenereol, Jinan, Peoples R China; [Zhang, Furen; Shi, Benqing; Tian, Hongqing] Shandong Prov Med Ctr Dermatovenereol, Jinan, Peoples R China; [Low, Huiqi; Li, Yi; Khor, Chiea Chuen; Hibberd, Martin L.; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Sun, Liangdan; Cui, Yong; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei, Peoples R China; [Sun, Liangdan; Cui, Yong; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei, Peoples R China; [Sun, Liangdan; Cui, Yong; Yang, Sen; Zhang, Xuejun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Peoples R China; [Yang, Haitao; Zhang, Lianhua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Yang, Rongde] Wenshan Inst Dermatol, Wenshan, Peoples R China; [Wang, Qiang] Anhui Prov Inst Dermatol, Hefei, Peoples R China; [Khor, Chiea Chuen; Liu, Jianjun] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Hibberd, Martin L.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Liu, Jianjun] Anhui Med Univ, Sch Life Sci, Hefei, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Anhui Medical University; Anhui Medical University; Jiangsu Provincial Center for Disease Control & Prevention; National University of Singapore; National University of Singapore; Anhui Medical University	Zhang, FR (corresponding author), Prov Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China.	zhangfuren@hotmail.com	Liu, Jianjun/AAK-4989-2020; Cui, Yong/AAF-9300-2020; Hibberd, Martin L/D-5050-2009; Chen, Gang/G-2722-2010	Liu, Jianjun/0000-0002-3255-3019; Hibberd, Martin/0000-0001-8587-1849; Khor, Chiea Chuen/0000-0002-1128-4729; Sun, Yonghu/0000-0003-4553-2871	National Natural Science Foundation of China [81071288, 81072391]; Research Foundation of the Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support; Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore; Project of Taishan scholar; Project of Medical leading scholar of Shandong Province; Taishan scholar award; Medical Leading Scholar of Shandong Province award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support; Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Project of Taishan scholar; Project of Medical leading scholar of Shandong Province; Taishan scholar award; Medical Leading Scholar of Shandong Province award	We thank the individuals who participated in this project. This work was funded by grants from the National Natural Science Foundation of China (81071288, 81072391), the Project of Research Foundation of the Shandong Provincial Institute of Dermatology and Venereology (2008.07-2011.07), the Shandong Provincial Leprosy Control Special Financial Support (2009-2011), the Anhui Provincial Special Scientific Program (2007.07-2011.07) and the Agency for Science, Technology, and Research of Singapore. Grant support was also provided by the Project of Taishan scholar (2008-) and the Project of Medical leading scholar of Shandong Province (2010-). F. Zhang was supported by funding from the Project of Taishan scholar award (2008-) and the Project of Medical Leading Scholar of Shandong Province award (2010-).	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P337; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; MANTEL N, 1959, J NATL CANCER I, V22, P719; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Sheng YJ, 2011, RHEUMATOLOGY, V50, P682, DOI 10.1093/rheumatology/keq313; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	31	126	132	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1247	U111		10.1038/ng.973	http://dx.doi.org/10.1038/ng.973			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019778				2022-12-25	WOS:000297931400021
J	MacGregor, S; Montgomery, GW; Liu, JZ; Zhao, ZZ; Henders, AK; Stark, M; Schmid, H; Holland, EA; Duffy, DL; Zhang, M; Painter, JN; Nyholt, DR; Maskiell, JA; Jetann, J; Ferguson, M; Cust, AE; Jenkins, MA; Whiteman, DC; Olsson, H; Puig, S; Bianchi-Scarra, G; Hansson, J; Demenais, F; Landi, MT; Debniak, T; Mackie, R; Azizi, E; Bressac-de Paillerets, B; Goldstein, AM; Kanetsky, PA; Gruis, NA; Elder, DE; Newton-Bishop, JA; Bishop, DT; Iles, MM; Helsing, P; Amos, CI; Wei, QY; Wang, LE; Lee, JE; Qureshi, AA; Kefford, RF; Giles, GG; Armstrong, BK; Aitken, JF; Han, JL; Hopper, JL; Trent, JM; Brown, KM; Martin, NG; Mann, GJ; Hayward, NK				MacGregor, Stuart; Montgomery, Grant W.; Liu, Jimmy Z.; Zhao, Zhen Zhen; Henders, Anjali K.; Stark, Mitchell; Schmid, Helen; Holland, Elizabeth A.; Duffy, David L.; Zhang, Mingfeng; Painter, Jodie N.; Nyholt, Dale R.; Maskiell, Judith A.; Jetann, Jodie; Ferguson, Megan; Cust, Anne E.; Jenkins, Mark A.; Whiteman, David C.; Olsson, Hakan; Puig, Susana; Bianchi-Scarra, Giovanna; Hansson, Johan; Demenais, Florence; Landi, Maria Teresa; Debniak, Tadeusz; Mackie, Rona; Azizi, Esther; Bressac-de Paillerets, Brigitte; Goldstein, Alisa M.; Kanetsky, Peter A.; Gruis, Nelleke A.; Elder, David E.; Newton-Bishop, Julia A.; Bishop, D. Timothy; Iles, Mark M.; Helsing, Per; Amos, Christopher I.; Wei, Qingyi; Wang, Li-E; Lee, Jeffrey E.; Qureshi, Abrar A.; Kefford, Richard F.; Giles, Graham G.; Armstrong, Bruce K.; Aitken, Joanne F.; Han, Jiali; Hopper, John L.; Trent, Jeffrey M.; Brown, Kevin M.; Martin, Nicholas G.; Mann, Graham J.; Hayward, Nicholas K.		Lund Melanoma Grp	Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3	NATURE GENETICS			English	Article							VARIANTS; COMPONENTS; DESIGN; GENES; RISK	We performed a genome-wide association study of melanoma in a discovery cohort of 2,168 Australian individuals with melanoma and 4,387 control individuals. In this discovery phase, we confirm several previously characterized melanoma-associated loci at MC1R, ASIP and MTAP-CDKN2A. We selected variants at nine loci for replication in three independent case-control studies (Europe: 2,804 subjects with melanoma, 7,618 control subjects; United States 1: 1,804 subjects with melanoma, 1,026 control subjects; United States 2: 585 subjects with melanoma, 6,500 control subjects). The combined meta-analysis of all case-control studies identified a new susceptibility locus at 1q21.3 (rs7412746, P = 9.0 x 10(-11), OR in combined replication cohorts of 0.89 (95% CI 0.85-0.95)). We also show evidence suggesting that melanoma associates with 1q42.12 (rs3219090, P = 9.3 x 10(-8)). The associated variants at the 1q21.3 locus span a region with ten genes, and plausible candidate genes for melanoma susceptibility include ARNT and SETDB1. Variants at the 1q21.3 locus do not seem to be associated with human pigmentation or measures of nevus density.	[MacGregor, Stuart; Montgomery, Grant W.; Liu, Jimmy Z.; Zhao, Zhen Zhen; Henders, Anjali K.; Stark, Mitchell; Duffy, David L.; Painter, Jodie N.; Nyholt, Dale R.; Whiteman, David C.; Martin, Nicholas G.; Hayward, Nicholas K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Schmid, Helen; Holland, Elizabeth A.; Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Schmid, Helen; Holland, Elizabeth A.; Kefford, Richard F.; Mann, Graham J.] Melanoma Inst Australia, Westmead, NSW, Australia; [Zhang, Mingfeng; Qureshi, Abrar A.; Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Maskiell, Judith A.; Cust, Anne E.; Jenkins, Mark A.; Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Jetann, Jodie; Ferguson, Megan; Aitken, Joanne F.] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Cust, Anne E.; Armstrong, Bruce K.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Olsson, Hakan] Univ Lund Hosp, Dept Oncol, Lund Canc Ctr, S-22185 Lund, Sweden; [Puig, Susana] Univ Barcelona, Inst Invest Biomed August Pi Sune, Hosp Clin, Dept Dermatol,Melanoma Unit, Barcelona, Spain; [Puig, Susana] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Barcelona, Spain; [Bianchi-Scarra, Giovanna] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Hansson, Johan] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hansson, Johan] Karolinska Univ Hosp, Stockholm, Sweden; [Demenais, Florence; Bressac-de Paillerets, Brigitte] Fdn Jean Dausset CEPH, INSERM, U946, Paris, France; [Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol Paris, Paris, France; [Landi, Maria Teresa; Goldstein, Alisa M.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Debniak, Tadeusz] Int Hereditary Canc Ctr, Szczecin, Poland; [Mackie, Rona] Univ Glasgow, Dept Publ Hlth, Glasgow, Lanark, Scotland; [Azizi, Esther] Sheba Med Ctr, Dermatooncol Unit, Dept Dermatol, Tel Hashomer, Israel; [Bressac-de Paillerets, Brigitte] Inst Canc Gustave Roussy, Serv Genet, Villejuif, France; [Kanetsky, Peter A.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kanetsky, Peter A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Elder, David E.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Newton-Bishop, Julia A.; Bishop, D. Timothy; Iles, Mark M.] St James Univ Hosp, Canc Res UK Clin Ctr Leeds, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Helsing, Per] Oslo Univ Hosp, Dept Dermatol, Oslo, Norway; [Amos, Christopher I.; Wei, Qingyi; Wang, Li-E] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Qureshi, Abrar A.; Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trent, Jeffrey M.] Translat Genom Res Inst, Genet Basis Human Dis Div, Phoenix, AZ USA; [Trent, Jeffrey M.] Van Andel Res Inst, Ctr Canc Genom & Computat Biol, Grand Rapids, MI USA; [Brown, Kevin M.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA	QIMR Berghofer Medical Research Institute; University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Melbourne; Cancer Council Queensland; University of Sydney; Lund University; Skane University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Genoa; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Glasgow; Chaim Sheba Medical Center; UNICANCER; Gustave Roussy; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Oslo; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cancer Council Victoria; Harvard University; Harvard T.H. Chan School of Public Health; Translational Genomics Research Institute; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	MacGregor, S (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	stuart.macgregor@qimr.edu.au	Whiteman, David C/P-2728-2014; Mann, Graham J/G-4758-2014; Paillerets, Brigitte Bressac-de/D-8954-2018; Duffy, David L/B-7392-2013; hayward, nick/AAV-8802-2020; Scarrà, Giovanna Bianchi/G-8933-2014; Nyholt, Dale Robert/J-3174-2017; hayward, nicholas k/C-1367-2015; Macgregor, Stuart/C-6442-2009; Montgomery, Grant W/B-7148-2008; Martin, Nicholas/R-9235-2019; Stark, Mitchell S/E-3542-2010; Demenais, Florence/G-3298-2013; Puig, Susana/AAB-2091-2020; Cust, Anne/J-1797-2019; Painter, Jodie N/AAC-6332-2019; Stark, Mitchell/K-6794-2019; Stark, Mitchell/K-3874-2019; Armstrong, Bruce K/K-9464-2015; Jenkins, Mark/P-7803-2015; Henders, Anjali/E-3126-2017	Whiteman, David C/0000-0003-2563-9559; Mann, Graham J/0000-0003-1301-405X; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Duffy, David L/0000-0001-7227-632X; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Nyholt, Dale Robert/0000-0001-7159-3040; hayward, nicholas k/0000-0003-4760-1033; Macgregor, Stuart/0000-0001-6731-8142; Montgomery, Grant W/0000-0002-4140-8139; Martin, Nicholas/0000-0003-4069-8020; Stark, Mitchell S/0000-0002-4510-2161; Demenais, Florence/0000-0001-8361-0936; Puig, Susana/0000-0003-1337-9745; Cust, Anne/0000-0002-5331-6370; Painter, Jodie N/0000-0002-4992-2458; Stark, Mitchell/0000-0002-4510-2161; Armstrong, Bruce K/0000-0001-8940-7525; Jetann, Jodie/0000-0002-9760-3099; Jenkins, Mark/0000-0002-8964-6160; Gruis, Nelleke/0000-0002-5210-9150; Iles, Mark/0000-0002-2603-6509; Bishop, Tim/0000-0002-8752-8785; Aitken, Joanne Frances/0000-0001-6859-2186; Kefford, Richard/0000-0001-9251-9229; Henders, Anjali/0000-0003-3672-1451; Newton-Bishop, Julia/0000-0001-9147-6802; Giles, Graham/0000-0003-4946-9099; Olsson, Hakan/0000-0002-8794-9635	Melanoma Research Alliance; National Cancer Institute (NCI) of the US National Institutes of Health (NIH) [CA88363, CA83115, CA122838, CA87969, CA055075, CA100264, CA133996, CA49449]; National Health and Medical Research Council (NHMRC) of Australia [107359, 200071, 241944, 339462, 380385, 389927, 389875, 389891, 389892, 389938, 402761, 443036, 442915, 442981, 496610, 496675, 496739, 552485, 552498]; Cancer Councils New South Wales, Victoria and Queensland; Cancer Institute New South Wales; Cooperative Research Centre (CRC) for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne); Australian Cancer Research Foundation; Wellcome Trust [WT084766/Z/08/Z]; Australian National Health and Medical Research Council (NHMRC) [2004-2009]; NHMRC [496674, 613705, 520018]; NCI of the NIH [CA109544]; University of Sydney Medical Foundation; Cancer Institute [10/ECF/2-06]; DCEG; European Commission [LSHC-CT-2006-018702]; Cancer Research UK [C588/A4994]; NIH [CA83115, CA100264, 2P50CA093459, P30CA016672, R01CA133996, HG004446]; Fondo de Investigaciones Sanitarias [09/1393];  [HHSN268200782096C]; Cancer Research UK [10589] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA109544, R01CA083115, P01CA055075, U01CA049449, P50CA093459, P01CA087969, R01CA122838, R01CA049449, R01CA088363, R01CA133996, R01CA100264, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036120] Funding Source: NIH RePORTER	Melanoma Research Alliance; National Cancer Institute (NCI) of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Councils New South Wales, Victoria and Queensland(Cancer Council New South Wales); Cancer Institute New South Wales; Cooperative Research Centre (CRC) for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Cancer Research Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NCI of the NIH; University of Sydney Medical Foundation(University of Sydney); Cancer Institute; DCEG; European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); ; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Melanoma Research Alliance, the National Cancer Institute (NCI) of the US National Institutes of Health (NIH) (CA88363, CA83115, CA122838, CA87969, CA055075, CA100264, CA133996 and CA49449), the National Health and Medical Research Council (NHMRC) of Australia (107359, 200071, 241944, 339462, 380385, 389927, 389875, 389891, 389892, 389938, 402761, 443036, 442915, 442981, 496610, 496675, 496739, 552485 and 552498), the Cancer Councils New South Wales, Victoria and Queensland, the Cancer Institute New South Wales, the Cooperative Research Centre (CRC) for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne), the Australian Cancer Research Foundation, The Wellcome Trust and donations from Neville and Shirley Hawkins. Endometriosis sample genotyping was funded by a grant from the Wellcome Trust (WT084766/Z/08/Z). The Australian Twin Registry is supported by an Australian National Health and Medical Research Council (NHMRC) Enabling Grant (2004-2009). D.L.D., N.K.H. and G.W.M. are supported by the NHMRC Fellowships scheme and J.L.H. is an Australia Fellow of the NHMRC. S.M. is the recipient of a Career Development Award from the NHMRC (496674, 613705). D.C.W. is a Future Fellow of the Australian Research Council. K.M.B. is supported by the NCI of the NIH. J.M.T. is supported by the NCI of the NIH (CA109544). B.K.A. is supported by the University of Sydney Medical Foundation. A.E.C. is the recipient of a NHMRC public health postdoctoral fellowship (520018) and a Cancer Institute NSW Early Career Development Fellowship (10/ECF/2-06). A.M.G. and M.T.L. were supported by the Intramural Research Program of the NIH, NCI and DCEG. The GenoMEL replication sample was funded by the European Commission under the 6<SUP>th</SUP> Framework Programme (contract no. LSHC-CT-2006-018702), by Cancer Research UK Programme Award (C588/A4994) and by the NIH (CA83115). Research at M.D. Anderson Cancer Center (MDACC) was partially supported by NIH grants (CA100264, 2P50CA093459, P30CA016672 and R01CA133996). The Center for Inherited Disease Research performed genotyping for MDACC and is supported by contract (HHSN268200782096C). GENEVA performed data cleaning and is supported by an NIH grant (HG004446). Research by the Barcelona team was supported by Fondo de Investigaciones Sanitarias (09/1393).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307; Do KA, 2004, TWIN RES, V7, P98, DOI 10.1375/13690520460741480; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queensland Cancer Registry, 2008, CANC QUEENSL INC MOR; Zhang MF, 2011, DNA REPAIR, V10, P111, DOI 10.1016/j.dnarep.2010.08.005	21	116	118	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1114	U104		10.1038/ng.958	http://dx.doi.org/10.1038/ng.958			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21983785	Green Accepted			2022-12-25	WOS:000296584000016
J	Moran, JH				Moran, Jeffery H.			Smart resource allocation needed to study 'legal highs'	NATURE MEDICINE			English	Editorial Material								Ground-breaking science in the area of cannabinoid signaling holds great promise for new drug development, but an unintended consequence of this research has led to the emergence of an onslaught of deadly 'legal highs'. Providing public health scientists with access to laboratory resources designed to investigate emerging chemicals of concern is crucial for timely, sound evaluation of products that pose major threats to public health.	[Moran, Jeffery H.] Arkansas Dept Hlth, Publ Hlth Lab, Little Rock, AR 72205 USA; [Moran, Jeffery H.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Moran, JH (corresponding author), Arkansas Dept Hlth, Publ Hlth Lab, Little Rock, AR 72205 USA.							Dresen S, 2010, J MASS SPECTROM, V45, P1186, DOI 10.1002/jms.1811; Fattore L, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00060; Hudson S, 2010, J ANAL TOXICOL, V34, P252, DOI 10.1093/jat/34.5.252; Wang LD, 2010, CHEM ENG NEWS, V88, P43, DOI 10.1021/cen-v088n026.p043	4	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1339	1339		10.1038/nm1111-1339	http://dx.doi.org/10.1038/nm1111-1339			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064403	Bronze			2022-12-25	WOS:000296779300014
J	Park, KS; Martelotto, LG; Peifer, M; Sos, ML; Karnezis, AN; Mahjoub, MR; Bernard, K; Conklin, JF; Szczepny, A; Yuan, J; Guo, RB; Ospina, B; Falzon, J; Bennett, S; Brown, TJ; Markovic, A; Devereux, WL; Ocasio, CA; Chen, JK; Stearns, T; Thomas, RK; Dorsch, M; Buonamici, S; Watkins, DN; Peacock, CD; Sage, J				Park, Kwon-Sik; Martelotto, Luciano G.; Peifer, Martin; Sos, Martin L.; Karnezis, Anthony N.; Mahjoub, Moe R.; Bernard, Katie; Conklin, Jamie F.; Szczepny, Anette; Yuan, Jing; Guo, Ribo; Ospina, Beatrice; Falzon, Jeanette; Bennett, Samara; Brown, Tracey J.; Markovic, Ana; Devereux, Wendy L.; Ocasio, Cory A.; Chen, James K.; Stearns, Tim; Thomas, Roman K.; Dorsch, Marion; Buonamici, Silvia; Watkins, D. Neil; Peacock, Craig D.; Sage, Julien			A crucial requirement for Hedgehog signaling in small cell lung cancer	NATURE MEDICINE			English	Article							STEM-CELL; MOUSE MODEL; PATHWAY; INHIBITION; GROWTH; MEDULLOBLASTOMA; ACTIVATION; INACTIVATION; EXPRESSION; REVEALS	Small-cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer for which there is no effective treatment(1,2). Using a mouse model in which deletion of Rb1 and Trp53 in the lung epithelium of adult mice induces SCLC3,4, we found that the Hedgehog signaling pathway is activated in SCLC cells independently of the lung microenvironment. Constitutive activation of the Hedgehog signaling molecule Smoothened (Smo) promoted the clonogenicity of human SCLC in vitro and the initiation and progression of mouse SCLC in vivo. Reciprocally, deletion of Smo in Rb1 and Trp53-mutant lung epithelial cells strongly suppressed SCLC initiation and progression in mice. Furthermore, pharmacological blockade of Hedgehog signaling inhibited the growth of mouse and human SCLC, most notably following chemotherapy. These findings show a crucial cell-intrinsic role for Hedgehog signaling in the development and maintenance of SCLC and identify Hedgehog pathway inhibition as a therapeutic strategy to slow the progression of disease and delay cancer recurrence in individuals with SCLC.	[Markovic, Ana; Devereux, Wendy L.; Peacock, Craig D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA; [Park, Kwon-Sik; Bernard, Katie; Conklin, Jamie F.; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Park, Kwon-Sik; Mahjoub, Moe R.; Bernard, Katie; Conklin, Jamie F.; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Martelotto, Luciano G.; Szczepny, Anette; Watkins, D. Neil] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Peifer, Martin; Sos, Martin L.; Thomas, Roman K.] Univ Cologne, Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, Cologne, Germany; [Peifer, Martin; Sos, Martin L.; Thomas, Roman K.] Univ Cologne, Fac Med, Cologne, Germany; [Sos, Martin L.; Thomas, Roman K.] Univ Cologne, Dept Internal Med, Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Lab Translat Canc Genom, Cologne, Germany; [Karnezis, Anthony N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Mahjoub, Moe R.; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Yuan, Jing; Guo, Ribo; Ospina, Beatrice; Dorsch, Marion; Buonamici, Silvia] Novartis Inst Biomed Res, Cambridge, MA USA; [Falzon, Jeanette; Bennett, Samara; Brown, Tracey J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Ocasio, Cory A.; Chen, James K.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Johns Hopkins University; Stanford University; Stanford University; Monash University; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of California System; University of California San Francisco; Stanford University; Novartis; Monash University; Stanford University	Peacock, CD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA.	cpeacoc3@jhmi.edu; julsage@stanford.edu	Martelotto, Luciano/A-6017-2012; Martelotto, Luciano/D-1946-2015; Watkins, David N/I-6113-2013; Sos, Martin L/I-1852-2014; Chen, James/G-9972-2011	Martelotto, Luciano/0000-0002-9625-1183; Chen, James/0000-0002-9220-8436; Mahjoub, Moe/0000-0001-8129-7464; Ocasio, Cory Antonio/0000-0002-4957-4131; Peifer, Martin/0000-0002-5243-5503; Stearns, Tim/0000-0002-0671-6582; Park, Kwon-Sik/0000-0003-3346-9086	Lucile Packard Foundation for Children's Health; Damon Runyon Cancer Research Foundation; American Lung Association; Francis Family Foundation; American Cancer Society; Tobacco-Related Disease Research Program of California; US National Institutes of Health (NIH) National Cancer Institute [R01 CA136574]; Flight Attendant Medical Research Institute [YCSA 072033]; NIH [5T32 CA009302-33]; National Health and Medical Research Council of Australia [546024, 546098]; Victorian Cancer Agency; Deutsche Krebshilfe [107954]; German Ministry of Science and Education as part of the Nationales Genomforschungsnetz [01GS08100]; Max Planck Society [MIFA NEUR8061]; Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereiche [TP6]; Ministry for Innovation, Science, Research and Technology of the State of Nordrhein-Westfalen (MIWT) [4000-12 09]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA136574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; Damon Runyon Cancer Research Foundation; American Lung Association; Francis Family Foundation; American Cancer Society(American Cancer Society); Tobacco-Related Disease Research Program of California(University of California System); US National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Flight Attendant Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; Deutsche Krebshilfe(Deutsche Krebshilfe); German Ministry of Science and Education as part of the Nationales Genomforschungsnetz; Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereiche(German Research Foundation (DFG)); Ministry for Innovation, Science, Research and Technology of the State of Nordrhein-Westfalen (MIWT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Berns (The Netherlands Cancer Institute) and M. Scott (Stanford University) for the Trp53<SUP>lox</SUP> and Ptch1<SUP>lacZ/+</SUP> mice, respectively, J. Whitsett (Cincinnati Children's Hospital) for the antibodies to surfactant protein C, C. Janke (Orsay Curie Institute) for antibodies to polyglutamylated tubulin and C.-M. Fan (Carnegie Institution of Washington) for the adenovirally expressed SmoM2 virus, as well as T. Oro, James Kim, Jynho Kim and P. Beachy for helpful discussions throughout the course of this study. We thank R. Toftgard (Karolinska Institute) and K. McGovern at Infinity Pharmaceuticals for their generous gift of the GANT-61 and cyclopamine, respectively, R. Rohatgi for help with the immunoblot analysis and B. Schaffer for help with the cell culture. This work was supported by the Lucile Packard Foundation for Children's Health (J. S.), the Damon Runyon Cancer Research Foundation (J. S.), the American Lung Association (J. S. and K.-S.P.), the Francis Family Foundation (K.-S.P.), the American Cancer Society (J. S.), the Tobacco-Related Disease Research Program of California (J.F.C.), US National Institutes of Health (NIH) National Cancer Institute R01 CA136574 (J.K.C.), the Flight Attendant Medical Research Institute (YCSA 072033) (C. D. P.), NIH 5T32 CA009302-33 (C.O.), the National Health and Medical Research Council of Australia project grants 546024 and 546098 and the Victorian Cancer Agency (D.N.W., L. G. M. and A. S.), the Deutsche Krebshilfe (107954) (R. K. T.), the German Ministry of Science and Education as part of the Nationales Genomforschungsnetz (NGFN-plus) program (01GS08100) (R. K. T.), the Max Planck Society (MIFA NEUR8061) (R. K. T.), the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereiche (TP6) (R. K. T.), the Ministry for Innovation, Science, Research and Technology of the State of Nordrhein-Westfalen (MIWT, 4000-12 09) (R. K. T.) and by an anonymous foundation to R.K.T.	Arimura S, 2009, GASTROENTEROLOGY, V137, P629, DOI 10.1053/j.gastro.2009.04.059; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Long FX, 2001, DEVELOPMENT, V128, P5099; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Rudin Charles M, 2008, J Natl Compr Canc Netw, V6, P315; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Singh S, 2011, CANCER RES, V71, P4454, DOI 10.1158/0008-5472.CAN-10-2313; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vestergaard J, 2006, LUNG CANCER, V52, P281, DOI 10.1016/j.lungcan.2005.12.014; Voortman J, 2010, P NATL ACAD SCI USA, V107, P13040, DOI 10.1073/pnas.1008132107; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860	40	183	196	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1504	U1506		10.1038/nm.2473	http://dx.doi.org/10.1038/nm.2473			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	21983857	Green Accepted			2022-12-25	WOS:000296779300043
J	Rantala, JK; Pouwels, J; Pellinen, T; Veltel, S; Laasola, P; Mattila, E; Potter, CS; Duffy, T; Sundberg, JP; Kallioniemi, O; Askari, JA; Humphries, MJ; Parsons, M; Salmi, M; Ivaska, J				Rantala, Juha K.; Pouwels, Jeroen; Pellinen, Teijo; Veltel, Stefan; Laasola, Petra; Mattila, Elina; Potter, Christopher S.; Duffy, Ted; Sundberg, John P.; Kallioniemi, Olli; Askari, Janet A.; Humphries, Martin J.; Parsons, Maddy; Salmi, Marko; Ivaska, Johanna			SHARPIN is an endogenous inhibitor of beta 1-integrin activation	NATURE CELL BIOLOGY			English	Article							KAPPA-B ACTIVITY; INTEGRIN ACTIVATION; PROTEIN-KINASE; CANCER-CELLS; TALIN; BINDING; MIGRATION; INVASION; DENSITY; COMPLEX	Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate beta 1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of beta 1-integrins in an RNAi screen. SHARPIN inhibited beta 1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased beta 1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin alpha-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of beta 1-integrins from inactive to active conformations.	[Rantala, Juha K.; Pouwels, Jeroen; Pellinen, Teijo; Veltel, Stefan; Laasola, Petra; Mattila, Elina; Kallioniemi, Olli; Ivaska, Johanna] VTT Tech Res Ctr Finland, Turku 20521, Finland; [Pouwels, Jeroen; Pellinen, Teijo; Veltel, Stefan; Mattila, Elina; Ivaska, Johanna] Univ Turku, Ctr Biotechnol, FIN-20520 Turku, Finland; [Potter, Christopher S.; Duffy, Ted; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Kallioniemi, Olli] Univ Helsinki, Inst Mol Med Finland FIMM, Biomedicum 2U, FIN-00014 Helsinki, Finland; [Askari, Janet A.; Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Salmi, Marko] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Salmi, Marko] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Salmi, Marko] Natl Inst Hlth & Welfare, FIN-20520 Turku, Finland; [Ivaska, Johanna] Univ Turku, Dept Biochem & Food Chem, FIN-20520 Turku, Finland	VTT Technical Research Center Finland; University of Turku; Jackson Laboratory; University of Helsinki; University of Manchester; University of London; King's College London; University of Turku; University of Turku; Finland National Institute for Health & Welfare; University of Turku	Ivaska, J (corresponding author), VTT Tech Res Ctr Finland, Turku 20521, Finland.	Johanna.ivaska@vtt.fi	Kallioniemi, Olli P/H-5111-2011; Parsons, Maddy/B-2203-2013	Kallioniemi, Olli P/0000-0002-3231-0332; Parsons, Maddy/0000-0002-2021-8379; Ivaska, Johanna/0000-0002-6295-6556; Humphries, Martin/0000-0002-4331-6967; Pouwels, Jeroen/0000-0002-5388-6103; Veltel, Stefan/0000-0002-4925-3776; Rantala, Juha/0000-0002-4999-5585	Academy of Finland; EU; European Research Council; Sigrid Juselius Foundation; European Molecular Biology Organization (EMBO); Finnish Cancer Organizations; Turku Graduate School of Biomedical Sciences; Alexander von Humbold foundation; EMBO; National Institutes of Health [T32 DK07449-28, AR49288]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007449] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); EU(European Commission); European Research Council(European Research Council (ERC)European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Finnish Cancer Organizations; Turku Graduate School of Biomedical Sciences; Alexander von Humbold foundation(Alexander von Humboldt Foundation); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Marttila, J. Siivonen, L. Lahtinen, R. Kaukonen, E. Vaananen, K. Silva and A. Arola for technical assistance. P. R. Elliot is acknowledged for the recombinant talin 1-400 protein. R. Fassler, M. Ginsberg, J. Norman and S. Lee are acknowledged for the plasmids. This study has been supported by the Academy of Finland, EU-FP06 project ENLIGHT, a European Research Council Starting Grant, the Sigrid Juselius Foundation, the European Molecular Biology Organization (EMBO) Young Investigator Programme and Finnish Cancer Organizations. J.P. and E. M., Academy of Finland postdoc grant; T.P., Turku Graduate School of Biomedical Sciences; S. V., Alexander von Humbold foundation and an EMBO long-term fellowship. C.S.P. and J.P. S were supported by the National Institutes of Health (T32 DK07449-28 to C.S.P. and AR49288 to J.P.S.).	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Cantor JM, 2008, IMMUNOL REV, V223, P236, DOI 10.1111/j.1600-065X.2008.00640.x; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CHEN YP, 1994, J BIOL CHEM, V269, P18307; Clark AJ, 2000, TRANSGENIC RES, V9, P439, DOI 10.1023/A:1026552629493; Clark K, 2005, J CELL SCI, V118, P291, DOI 10.1242/jcs.01623; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harper MT, 2010, J THROMB HAEMOST, V8, P454, DOI 10.1111/j.1538-7836.2009.03722.x; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; HOGAN B, 1986, MANIPULATING MOUSE E; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ivaska J, 2003, BIOCHEM SOC T, V31, P90, DOI 10.1042/bst0310090; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nevo J, 2010, ONCOGENE, V29, P6452, DOI 10.1038/onc.2010.376; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Rantala JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-162; Schwartz MA, 2001, J CELL SCI, V114, P2553; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	59	150	157	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1315	U77		10.1038/ncb2340	http://dx.doi.org/10.1038/ncb2340			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	21947080	Green Accepted			2022-12-25	WOS:000296737900008
J	Yaffe, E; Tanay, A				Yaffe, Eitan; Tanay, Amos			Probabilistic modeling of Hi-C contact maps eliminates systematic biases to characterize global chromosomal architecture	NATURE GENETICS			English	Article							CONFORMATION CAPTURE; NUCLEAR-ORGANIZATION; CHROMATIN STATE; GENOME; TRANSCRIPTION; PLURIPOTENT; FACTORIES; DYNAMICS	Hi-C experiments measure the probability of physical proximity between pairs of chromosomal loci on a genomic scale. We report on several systematic biases that substantially affect the Hi-C experimental procedure, including the distance between restriction sites, the GC content of trimmed ligation junctions and sequence uniqueness. To address these biases, we introduce an integrated probabilistic background model and develop algorithms to estimate its parameters and renormalize Hi-C data. Analysis of corrected human lymphoblast contact maps provides genome-wide evidence for interchromosomal aggregation of active chromatin marks, including DNase-hypersensitive sites and transcriptionally active foci. We observe extensive long-range (up to 400 kb) cis interactions at active promoters and derive asymmetric contact profiles next to transcription start sites and CTCF binding sites. Clusters of interacting chromosomal domains suggest physical separation of centromere-proximal and centromere-distal regions. These results provide a computational basis for the inference of chromosomal architectures from Hi-C experiments.	[Yaffe, Eitan; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	tanay@weizmann.ac.il		Yaffe, Eitan/0000-0002-2896-3349	Israeli Science Foundation; European Commission	Israeli Science Foundation(Israel Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank W. de Laat for discussions and members of the Tanay group for critical reading of the manuscript. Research at A.T.s laboratory was supported by the Israeli Science Foundation and by the EPIGENESYS FP7 program of the European Commission.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Miele Adriana, 2008, V464, P105; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]	26	399	414	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1059	U40		10.1038/ng.947	http://dx.doi.org/10.1038/ng.947			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	22001755				2022-12-25	WOS:000296584000008
J	Dassanayake, M; Oh, DH; Haas, JS; Hernandez, A; Hong, H; Ali, S; Yun, DJ; Bressan, RA; Zhu, JK; Bohnert, HJ; Cheeseman, JM				Dassanayake, Maheshi; Oh, Dong-Ha; Haas, Jeffrey S.; Hernandez, Alvaro; Hong, Hyewon; Ali, Shahjahan; Yun, Dae-Jin; Bressan, Ray A.; Zhu, Jian-Kang; Bohnert, Hans J.; Cheeseman, John M.			The genome of the extremophile crucifer Thellungiella parvula	NATURE GENETICS			English	Article							COPY NUMBER VARIATION; ARABIDOPSIS-THALIANA; SALT TOLERANCE; SEQUENCE; STRESS; GENE; HALOPHYTE; EVOLUTION; BRASSICACEAE; MECHANISMS	Thellungiella parvula(1) is related to Arabidopsis thaliana and is endemic to saline, resource-poor habitats(2), making it a model for the evolution of plant adaptation to extreme environments. Here we present the draft genome for this extremophile species. Exclusively by next generation sequencing, we obtained the de novo assembled genome in 1,496 gap-free contigs, closely approximating the estimated genome size of 140 Mb. We anchored these contigs to seven pseudo chromosomes without the use of maps. We show that short reads can be assembled to a near-complete chromosome level for a eukaryotic species lacking prior genetic information. The sequence identifies a number of tandem duplications that, by the nature of the duplicated genes, suggest a possible basis for T. parvula's extremophile lifestyle. Our results provide essential background for developing genomically influenced testable hypotheses for the evolution of environmental stress tolerance.	[Dassanayake, Maheshi; Oh, Dong-Ha; Haas, Jeffrey S.; Hong, Hyewon; Bohnert, Hans J.; Cheeseman, John M.] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [Haas, Jeffrey S.] Univ Illinois, Off Networked Informat Technol, Sch Integrat Biol, Urbana, IL USA; [Hernandez, Alvaro] Univ Illinois, Ctr Comparat & Funct Genom, Urbana, IL USA; [Hong, Hyewon; Yun, Dae-Jin; Bressan, Ray A.; Bohnert, Hans J.] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju, South Korea; [Ali, Shahjahan] King Abdullah Univ Sci & Technol, Biosci Core Lab Genom, Thuwal, Saudi Arabia; [Bressan, Ray A.; Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Bressan, Ray A.; Zhu, Jian-Kang; Bohnert, Hans J.] King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Biotechnol, Thuwal, Saudi Arabia; [Bohnert, Hans J.] Univ Illinois, Dept Crop Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Gyeongsang National University; King Abdullah University of Science & Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus; King Abdullah University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign	Dassanayake, M (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL USA.	maheshi.dassanayake@gmail.com; ohdongha@gmail.com; djyun@gnu.ac.kr	Bohnert, Hans J/A-7104-2009; Oh, Dong-Ha/O-7591-2019; Dassanayake, Maheshi/B-7331-2012; Zhu, Jian-Kang/F-7658-2011	Oh, Dong-Ha/0000-0003-1526-9814; Dassanayake, Maheshi/0000-0003-3123-3731; Zhu, Jian-Kang/0000-0001-5134-731X; Yun, Dae-Jin/0000-0002-3638-6043; Bressan, Ray/0000-0002-8754-606X	King Abdullah University of Science and Technology, Thuwal, Saudi Arabia; World Class; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138] Funding Source: NIH RePORTER	King Abdullah University of Science and Technology, Thuwal, Saudi Arabia(King Abdullah University of Science & Technology); World Class; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. P. D'Urzo (Purdue University, West Lafayette, Indiana, USA) for providing plant materials and J.-H. Mun (National Academy of Agricultural Science, Suwon, Korea) for providing the B. rapa chromosome sequence. We also gratefully acknowledge M. Vaughn (University of Texas, Austin, Texas, USA), S. Jackman, M. Krzywinski (Michael Smith Genome Sciences Center, Vancouver, British Columbia, Canada) and SeqAnswers online forum (see URLs) for advice on genome assembly and visualization. Funding has been provided by King Abdullah University of Science and Technology, Thuwal, Saudi Arabia, by the World Class by recording the numbers of genes included or not included in a subcategory for each species and ranking the statistical significance of the differences.	Al-Shehbaz Ihsan A., 1995, Novon, V5, P309, DOI 10.2307/3391953; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Amtmann A, 2009, MOL PLANT, V2, P3, DOI 10.1093/mp/ssn094; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dassanayake M, 2011, TRENDS PLANT SCI, V16, P1, DOI 10.1016/j.tplants.2010.10.006; DeBolt S, 2010, GENOME BIOL EVOL, V2, P441, DOI 10.1093/gbe/evq033; Gao F, 2006, J EXP BOT, V57, P3259, DOI 10.1093/jxb/erl090; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Inan G, 2004, PLANT PHYSIOL, V135, P1718, DOI 10.1104/pp.104.041723; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lugan R, 2010, PLANT J, V64, P215, DOI 10.1111/j.1365-313X.2010.04323.x; Lysak MA, 2006, P NATL ACAD SCI USA, V103, P5224, DOI 10.1073/pnas.0510791103; Lysak MA, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0_1; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Mun JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r94; Oh DH, 2010, PLANT PHYSIOL, V154, P1040, DOI 10.1104/pp.110.163923; Oh DH, 2010, J EXP BOT, V61, P1205, DOI 10.1093/jxb/erp391; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [10.1005667/978-3-642-86659-3.567, 10.1007/978-3-642-86659-3, DOI 10.1007/978-3-642-86659-3, 10. 1007/978-3-642-86659-3]; Orsini F, 2010, J EXP BOT, V61, P3787, DOI 10.1093/jxb/erq188; Plett DC, 2010, PLANT CELL ENVIRON, V33, P612, DOI 10.1111/j.1365-3040.2009.02086.x; Quan RD, 2007, PLANT CELL, V19, P1415, DOI 10.1105/tpc.106.042291; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	235	246	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					913	U137		10.1038/ng.889	http://dx.doi.org/10.1038/ng.889			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822265	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000294325800022
J	Albers, CA; Cvejic, A; Favier, R; Bouwmans, EE; Alessi, MC; Bertone, P; Jordan, G; Kettleborough, RNW; Kiddle, G; Kostadima, M; Read, RJ; Sipos, B; Sivapalaratnam, S; Smethurst, PA; Stephens, J; Voss, K; Nurden, A; Rendon, A; Nurden, P; Ouwehand, WH				Albers, Cornelis A.; Cvejic, Ana; Favier, Remi; Bouwmans, Evelien E.; Alessi, Marie-Christine; Bertone, Paul; Jordan, Gregory; Kettleborough, Ross N. W.; Kiddle, Graham; Kostadima, Myrto; Read, Randy J.; Sipos, Botond; Sivapalaratnam, Suthesh; Smethurst, Peter A.; Stephens, Jonathan; Voss, Katrin; Nurden, Alan; Rendon, Augusto; Nurden, Paquita; Ouwehand, Willem H.			Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome	NATURE GENETICS			English	Article							CHEDIAK-HIGASHI-SYNDROME	Gray platelet syndrome (GPS) is a predominantly recessive platelet disorder that is characterized by mild thrombocytopenia with large platelets and a paucity of alpha-granules; these abnormalities cause mostly moderate but in rare cases severe bleeding. We sequenced the exomes of four unrelated individuals and identified NBEAL2 as the causative gene; it has no previously known function but is a member of a gene family that is involved in granule development. Silencing of nbeal2 in zebrafish abrogated thrombocyte formation.	[Albers, Cornelis A.; Cvejic, Ana; Kettleborough, Ross N. W.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Albers, Cornelis A.; Cvejic, Ana; Bouwmans, Evelien E.; Kiddle, Graham; Smethurst, Peter A.; Stephens, Jonathan; Voss, Katrin; Rendon, Augusto; Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge, England; [Favier, Remi] Hop Armand Trousseau, AP HP, Dept Hematol, Ctr Reference Pathol Plaquettaires, Paris, France; [Favier, Remi] INSERM, U1009, Villejuif, France; [Alessi, Marie-Christine] INSERM, U626, Fac Med, F-13258 Marseille, France; [Bertone, Paul; Jordan, Gregory; Kostadima, Myrto; Sipos, Botond] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Read, Randy J.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Sivapalaratnam, Suthesh] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Nurden, Alan; Nurden, Paquita] Hop Xavier Arnozan, Ctr Reference Pathol Plaquettaires, Hematol Lab, Pessac, France; [Rendon, Augusto] Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England	Wellcome Trust Sanger Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; European Molecular Biology Laboratory (EMBL); University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; CHU Bordeaux; MRC Biostatistics Unit; University of Cambridge	Albers, CA (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	caa@sanger.ac.uk; who1000@cam.ac.uk	ALESSI, Marie-christine/AAK-3582-2020; Bertone, Paul/Z-3734-2019; Albers, Kees/A-4170-2015; Bertone, Paul/A-6600-2013; Read, Randy/L-1418-2013	ALESSI, Marie-christine/0000-0003-3927-5792; Bertone, Paul/0000-0001-5059-4829; Albers, Kees/0000-0003-4115-3727; Bertone, Paul/0000-0001-5059-4829; Kostadima, Myrto Areti/0000-0002-1818-4050; Jordan, Gregory/0000-0002-7655-6000; Stephens, Jonathan/0000-0003-2020-9330; Read, Randy/0000-0001-8273-0047; Ouwehand, Willem/0000-0002-7744-1790; Cvejic, Ana/0000-0003-3204-9311; Rendon, Augusto/0000-0001-8994-0039	MRC [MC_U105260799] Funding Source: UKRI; British Heart Foundation [RG/09/012/28096] Funding Source: Medline; Medical Research Council [MC_U105260799] Funding Source: Medline; Wellcome Trust [082961, 082597, 084183] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BRETONGORIUS J, 1981, AM J PATHOL, V102, P10; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Fabbro S, 2011, BLOOD, V117, P3430, DOI 10.1182/blood-2010-12-322990; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gunay-Aygun M, 2010, BLOOD, V116, P4990, DOI 10.1182/blood-2010-05-286534; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Maynard DM, 2010, J THROMB HAEMOST, V8, P1786, DOI 10.1111/j.1538-7836.2010.03932.x; Medrihan L, 2009, J PHYSIOL-LONDON, V587, P5095, DOI 10.1113/jphysiol.2009.178236; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; RACCUGLIA G, 1971, AM J MED, V51, P818, DOI 10.1016/0002-9343(71)90311-1; Spritz RA, 1998, J CLIN IMMUNOL, V18, P97, DOI 10.1023/A:1023247215374; Wang XL, 2000, J NEUROSCI, V20, P8551	14	177	184	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					735	737		10.1038/ng.885	http://dx.doi.org/10.1038/ng.885			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21765411	Green Accepted, Green Submitted			2022-12-25	WOS:000293178300007
J	Ptashne, M				Ptashne, Mark			Principles of a switch	NATURE CHEMICAL BIOLOGY			English	Article							SIGNAL-TRANSDUCTION; GENE-REGULATION; ARCHITECTURE; SEQUENCE; LOGIC; CELL		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Ptashne, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	m-ptashne@mskcc.org						Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Davidson EH, 2006, REG GEN GEN REG; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Gomes JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004485; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Ptashne M, 2004, GENETIC SWITCH PHAGE; PTASHNE M, 2002, GENES SIGNALS; Ptashne M, 2007, CURR BIOL, V17, pR740, DOI 10.1016/j.cub.2007.06.053; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang X, 2011, NAT STRUCT MOL BIOL, V18, P507, DOI 10.1038/nsmb.2017; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	26	42	42	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					484	487		10.1038/nchembio.611	http://dx.doi.org/10.1038/nchembio.611			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769089				2022-12-25	WOS:000292825400003
J	Paiardini, M; Cervasi, B; Reyes-Aviles, E; Micci, L; Ortiz, AM; Chahroudi, A; Vinton, C; Gordon, SN; Bosinger, SE; Francella, N; Hallberg, PL; Cramer, E; Schlub, T; Chan, ML; Riddick, NE; Collman, RG; Apetrei, C; Pandrea, I; Else, J; Munch, J; Kirchhoff, F; Davenport, MP; Brenchley, JM; Silvestri, G				Paiardini, Mirko; Cervasi, Barbara; Reyes-Aviles, Elane; Micci, Luca; Ortiz, Alexandra M.; Chahroudi, Ann; Vinton, Carol; Gordon, Shari N.; Bosinger, Steven E.; Francella, Nicholas; Hallberg, Paul L.; Cramer, Elizabeth; Schlub, Timothy; Chan, Ming Liang; Riddick, Nadeene E.; Collman, Ronald G.; Apetrei, Cristian; Pandrea, Ivona; Else, James; Munch, Jan; Kirchhoff, Frank; Davenport, Miles P.; Brenchley, Jason M.; Silvestri, Guido			Low levels of SIV infection in sooty mangabey central memory CD4(+) T cells are associated with limited CCR5 expression	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; AFRICAN-GREEN MONKEYS; IMMUNE ACTIVATION; DOWN-REGULATION; NATURAL HOSTS; DEPLETION; REPLICATION; HOMEOSTASIS; RESPONSES; LESSONS	Naturally simian immunodeficiency virus (SIV)-infected sooty mangabeys do not progress to AIDS despite high-level virus replication. We previously showed that the fraction of CD4(+)CCR5(+) T cells is lower in sooty mangabeys compared to humans and macaques. Here we found that, after in vitro stimulation, sooty mangabey CD4(+) T cells fail to upregulate CCR5 and that this phenomenon is more pronounced in CD4(+) central memory T cells (T-CM cells). CD4(+) T cell activation was similarly uncoupled from CCR5 expression in sooty mangabeys in vivo during acute SIV infection and the homeostatic proliferation that follows antibody-mediated CD4(+) T cell depletion. Sooty mangabey CD4(+) TCM cells that express low amounts of CCR5 showed reduced susceptibility to SIV infection both in vivo and in vitro when compared to CD4(+) TCM cells of rhesus macaques. These data suggest that low CCR5 expression on sooty mangabey CD4(+) T cells favors the preservation of CD4(+) T cell homeostasis and promotes an AIDS-free status by protecting CD4(+) TCM cells from direct virus infection.	[Paiardini, Mirko; Cervasi, Barbara; Micci, Luca; Ortiz, Alexandra M.; Chahroudi, Ann; Gordon, Shari N.; Bosinger, Steven E.; Else, James; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Paiardini, Mirko; Cervasi, Barbara; Micci, Luca; Ortiz, Alexandra M.; Chahroudi, Ann; Gordon, Shari N.; Bosinger, Steven E.; Else, James; Silvestri, Guido] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Paiardini, Mirko; Cervasi, Barbara; Reyes-Aviles, Elane; Ortiz, Alexandra M.; Gordon, Shari N.; Francella, Nicholas; Hallberg, Paul L.; Cramer, Elizabeth; Silvestri, Guido] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Micci, Luca] Univ Urbino, I-61029 Urbino, Italy; [Vinton, Carol; Brenchley, Jason M.] US Natl Inst Hlth, Mol Microbiol Lab, Bethesda, MD USA; [Schlub, Timothy; Chan, Ming Liang; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Kensington, NSW 2033, Australia; [Riddick, Nadeene E.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Apetrei, Cristian; Pandrea, Ivona] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Munch, Jan; Kirchhoff, Frank] Univ Hosp Ulm, Inst Mol Virol, Ulm, Germany	Emory University; Emory University; University of Pennsylvania; University of Urbino; National Institutes of Health (NIH) - USA; University of New South Wales Sydney; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ulm University	Silvestri, G (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	mirko.paiardini@emory.edu; gsilves@emory.edu	Brenchley, Jason/AAC-5085-2019; Kirchhoff, Frank/O-8367-2018; Apetrei, Cristian/AAG-9032-2021	Kirchhoff, Frank/0000-0002-7052-2360; Apetrei, Cristian/0000-0002-0322-7185; Davenport, Miles/0000-0002-4751-1831; Schlub, Timothy/0000-0001-7746-9649; Jan, Munch/0000-0001-7316-7141; Brenchley, Jason/0000-0001-8357-2984; Collman, Ronald/0000-0002-0508-3701	 [R01-AI66998];  [P01-AI76074];  [R56-AI087186];  [P51-RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084836, R01AI066998, P01AI076174, ZIAAI001029, R56AI087186, R37AI066998, T32AI007632] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank L. Picker, D. Sodora and Z. Grossman for helpful discussions; F. Villinger, B. Lawson, F. Shaheen and J. Tilton for their technical support; and S. Ehnert and T. Meeker for their assistance with primate studies. We are grateful to the Emory Center for AIDS Research Virology Core and the Penn Center for AIDS Research Virology Core for their assistance. This work was supported by grant R01-AI66998 and P01-AI76074 (to G.S.), R56-AI087186 (to M.P.) and P51-RR-00165 (to Yerkes National Primate Research Center).	Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Engram JC, 2010, BLOOD, V116, P748, DOI 10.1182/blood-2010-01-263814; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Gautam R, 2007, VIROLOGY, V362, P257, DOI 10.1016/j.virol.2006.12.037; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; Mummidi S, 2007, J IMMUNOL, V178, P5668, DOI 10.4049/jimmunol.178.9.5668; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Onlamoon N, 2006, J MED PRIMATOL, V35, P178, DOI 10.1111/j.1600-0684.2006.00182.x; Paiardini M, 2009, BLOOD, V113, P612, DOI 10.1182/blood-2008-06-159442; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Palacios E, 1998, CURR BIOL, V8, P943, DOI 10.1016/S0960-9822(07)00378-8; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rey-Cuille MA, 1998, J VIROL, V72, P3872; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sumpter B, 2007, J IMMUNOL, V178, P1680, DOI 10.4049/jimmunol.178.3.1680; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	34	150	150	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					830	U197		10.1038/nm.2395	http://dx.doi.org/10.1038/nm.2395			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21706028	Green Accepted			2022-12-25	WOS:000292500800037
J	Burdon, KP; Macgregor, S; Hewitt, AW; Sharma, S; Chidlow, G; Mills, RA; Danoy, P; Casson, R; Viswanathan, AC; Liu, JZ; Landers, J; Henders, AK; Wood, J; Souzeau, E; Crawford, A; Leo, P; Wang, JJ; Rochtchina, E; Nyholt, DR; Martin, NG; Montgomery, GW; Mitchell, P; Brown, MA; Mackey, DA; Craig, JE				Burdon, Kathryn P.; Macgregor, Stuart; Hewitt, Alex W.; Sharma, Shiwani; Chidlow, Glyn; Mills, Richard A.; Danoy, Patrick; Casson, Robert; Viswanathan, Ananth C.; Liu, Jimmy Z.; Landers, John; Henders, Anjali K.; Wood, John; Souzeau, Emmanuelle; Crawford, April; Leo, Paul; Wang, Jie Jin; Rochtchina, Elena; Nyholt, Dale R.; Martin, Nicholas G.; Montgomery, Grant W.; Mitchell, Paul; Brown, Matthew A.; Mackey, David A.; Craig, Jamie E.			Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1	NATURE GENETICS			English	Article							VISUALIZATION; GENOTYPE; FAMILY; ANRIL; GENE	We report a genome-wide association study for open-angle glaucoma (OAG) blindness using a discovery cohort of 590 individuals with severe visual field loss (cases) and 3,956 controls. We identified associated loci at TMCO1 (rs4656461[G] odds ratio (OR) = 1.68, P = 6.1 x 10(-10)) and CDKN2B-AS1 (rs4977756[A] OR = 1.50, P = 4.7 x 10(-9)). We replicated these associations in an independent cohort of cases with advanced OAG (rs4656461 P = 0.010; rs4977756 P = 0.042) and two additional cohorts of less severe OAG (rs4656461 combined discovery and replication P = 6.00 x 10(-14), OR = 1.51, 95% CI 1.35-1.68; rs4977756 combined P = 1.35 x 10(-14), OR = 1.39, 95% CI 1.28-1.51). We show retinal expression of genes at both loci in human ocular tissues. We also show that CDKN2A and CDKN2B are upregulated in the retina of a rat model of glaucoma.	[Burdon, Kathryn P.; Hewitt, Alex W.; Sharma, Shiwani; Mills, Richard A.; Landers, John; Souzeau, Emmanuelle; Crawford, April; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Macgregor, Stuart; Liu, Jimmy Z.; Henders, Anjali K.; Nyholt, Dale R.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Hewitt, Alex W.; Wang, Jie Jin; Mackey, David A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Chidlow, Glyn; Casson, Robert; Wood, John] Univ Adelaide, Adelaide, SA, Australia; [Chidlow, Glyn; Casson, Robert; Wood, John] Hanson Inst, S Australian Inst Ophthalmol, Adelaide, SA, Australia; [Danoy, Patrick; Leo, Paul; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Viswanathan, Ananth C.] Moorfields Eye Hosp, London, England; [Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW 2145, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Mackey, David A.] Univ Tasmania, Discipline Med, Hobart, Tas, Australia	Flinders Medical Centre; Flinders University South Australia; QIMR Berghofer Medical Research Institute; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Adelaide; Hanson Institute; University of Queensland; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Lions Eye Institute; University of Western Australia; University of Tasmania	Craig, JE (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia.	jamie.craig@flinders.edu.au	Montgomery, Grant W/B-7148-2008; Martin, Nicholas/R-9235-2019; Burdon, Kathryn/AAD-2334-2022; Macgregor, Stuart/C-6442-2009; Mitchell, Paul/P-1498-2014; wang, jie/GRS-0942-2022; Casson, Robert/D-1561-2013; Hewitt, Alex W/D-1936-2013; Mackey, David A/H-5340-2014; Wang, Jie Jin/P-1499-2014; Leo, Paul/R-4464-2019; Nyholt, Dale Robert/J-3174-2017; Leo, Paul J/B-3470-2011; Souzeau, Emmanuelle/AAB-5608-2022; Brown, Matthew A/E-5749-2010; Burdon, Kathryn/A-5026-2009; Henders, Anjali/E-3126-2017	Montgomery, Grant W/0000-0002-4140-8139; Martin, Nicholas/0000-0003-4069-8020; Burdon, Kathryn/0000-0001-8217-1249; Macgregor, Stuart/0000-0001-6731-8142; Hewitt, Alex W/0000-0002-5123-5999; Mackey, David A/0000-0001-7914-4709; Wang, Jie Jin/0000-0001-9491-4898; Nyholt, Dale Robert/0000-0001-7159-3040; Leo, Paul J/0000-0001-8325-4134; Souzeau, Emmanuelle/0000-0002-2015-6577; Brown, Matthew A/0000-0003-0538-8211; Burdon, Kathryn/0000-0001-8217-1249; Henders, Anjali/0000-0003-3672-1451; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X; Mills, Richard/0000-0002-7386-2571	National Health and Medical Research Council (NHMRC) of Australia [535074]; Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation; Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia (ORIA); Pfizer Australia; Glaucoma Australia; American Health Assistance Foundation (AHAF); Peggy and Leslie Cranbourne Foundation; Jack Brockhoff Foundation; National Eye Institute (NEI); NHMRC [241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485, 552498, 496674, 613705, 595944, 613674]; Cooperative Research Centre for Discovery of Genes for Common Human Diseases; Cerylid Biosciences (Melbourne); Australian Research Council [FT0991022]; Glaucoma Australia and Endometriosis Associations	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation; Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia (ORIA); Pfizer Australia(PfizerPfizer Australia); Glaucoma Australia; American Health Assistance Foundation (AHAF); Peggy and Leslie Cranbourne Foundation; Jack Brockhoff Foundation; National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Discovery of Genes for Common Human Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cerylid Biosciences (Melbourne); Australian Research Council(Australian Research Council); Glaucoma Australia and Endometriosis Associations	This research was funded by the National Health and Medical Research Council (NHMRC) of Australia, project grant 535074 to J.E.C., A. W. H., S. M., D. A. M. and K. P. B. We also thank the following organizations for their financial support: Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation, Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), Pfizer Australia, Glaucoma Australia, American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Jack Brockhoff Foundation, and National Eye Institute (NEI) Project Grant (2007-2010). The Australian Twin Registry is supported by an NHMRC Enabling Grant (2004-2009). The Queensland Institute of Medical Research (QIMR) Study was also supported by grants from the NHMRC (241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485 and 552498), the Cooperative Research Centre for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne) and donations from N. and S. Hawkins.; S. M. and K. P. B. are supported by NHMRC Career Development Awards (496674, 613705 and 595944). D. R. N. was supported by the NHMRC Fellowship (339462 and 613674) and Australian Research Council Future Fellowship (FT0991022) schemes. G. W. M., M. A. B. and J.E.C. are supported by the NHMRC Fellowships Scheme. D. A. M. is a recipient of the Pfizer Australia Senior Research Fellowship.; We thank all participants of the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG), the Glaucoma Inheritance Study in Tasmania (GIST), the Blue Mountains Eye study (BMES), the Queensland Institute of Medical Research (QIMR) study, Oxford Endometriosis Gene Study (OXEGENE), the Nurses Health Study (NHS) and the Brisbane Adolescent Twin Study (BATS) and the staff who have collated clinical data and DNA samples over many years. We thank Glaucoma Australia and Endometriosis Associations for supporting study recruitment. We thank S. Nicolaides, Queensland Medical Laboratory and SA Pathology for pro bono collection and delivery of blood samples and other pathology services for assistance with blood collection.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beavis W.D., 1994, P 49 ANN CORN SORGH, P250; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Green CM, 2007, CLIN EXP OPHTHALMOL, V35, P793, DOI 10.1111/j.1442-9071.2007.01612.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hewitt AW, 2009, CLIN EXP OPHTHALMOL, V37, P836, DOI 10.1111/j.1442-9071.2009.02181.x; HEWITT AW, 2009, CLIN EXPT OPHTHALMOL, V37, P903; Iwamuro S, 1999, J BIOCHEM-TOKYO, V126, P48, DOI 10.1093/oxfordjournals.jbchem.a022435; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; R Core Team, 2022, R LANG ENV STAT COMP; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rao KN, 2010, INVEST OPHTH VIS SCI, V51, P4937, DOI 10.1167/iovs.10-5553; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Xin BZ, 2010, P NATL ACAD SCI USA, V107, P258, DOI 10.1073/pnas.0908457107; Zhang ZS, 2010, MOL BIOL REP, V37, P1611, DOI 10.1007/s11033-009-9573-8	32	314	329	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					574	U110		10.1038/ng.824	http://dx.doi.org/10.1038/ng.824			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532571	Green Accepted			2022-12-25	WOS:000291017000016
J	Delahaye, NF; Rusakiewicz, S; Martins, I; Menard, C; Roux, S; Lyonnet, L; Paul, P; Sarabi, M; Chaput, N; Semeraro, M; Minard-Colin, V; Poirier-Colame, V; Chaba, K; Flament, C; Baud, V; Authier, H; Kerdine-Romer, S; Pallardy, M; Cremer, I; Peaudecerf, L; Rocha, B; Valteau-Couanet, D; Gutierrez, JC; Nunes, JA; Commo, F; Bonvalot, S; Ibrahim, N; Terrier, P; Opolon, P; Bottino, C; Moretta, A; Tavernier, J; Rihet, P; Coindre, JM; Blay, JY; Isambert, N; Emile, JF; Vivier, E; Lecesne, A; Kroemer, G; Zitvogel, L				Delahaye, Nicolas F.; Rusakiewicz, Sylvie; Martins, Isabelle; Menard, Cedric; Roux, Stephan; Lyonnet, Luc; Paul, Pascale; Sarabi, Matthieu; Chaput, Nathalie; Semeraro, Michaela; Minard-Colin, Veronique; Poirier-Colame, Vichnou; Chaba, Kariman; Flament, Caroline; Baud, Veronique; Authier, Helene; Kerdine-Roemer, Saadia; Pallardy, Marc; Cremer, Isabelle; Peaudecerf, Laetitia; Rocha, Benedita; Valteau-Couanet, Dominique; Gutierrez, Javier Celis; Nunes, Jacques A.; Commo, Frederic; Bonvalot, Sylvie; Ibrahim, Nicolas; Terrier, Philippe; Opolon, Paule; Bottino, Cristina; Moretta, Alessandro; Tavernier, Jan; Rihet, Pascal; Coindre, Jean-Michel; Blay, Jean-Yves; Isambert, Nicolas; Emile, Jean-Francois; Vivier, Eric; Lecesne, Axel; Kroemer, Guido; Zitvogel, Laurence			Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors	NATURE MEDICINE			English	Article							NATURAL-KILLER-CELLS; HUMAN DENDRITIC CELLS; NK CELLS; HUMAN MHC; CYTOTOXICITY RECEPTORS; TRIGGERING RECEPTOR; IL-10 PRODUCTION; CLASS-III; C-KIT; EXPRESSION	The natural killer (NK) cell receptor NKp30 is involved in the recognition of tumor and dendritic cells (DCs). Here we describe the influence of three NKp30 splice variants on the prognosis of gastrointestinal sarcoma (GIST), a malignancy that expresses NKp30 ligands and that is treated with NK-stimulatory KIT tyrosine kinase inhibitors. Healthy individuals and those with GIST show distinct patterns of transcription of functionally different NKp30 isoforms. In a retrospective analysis of 80 individuals with GIST, predominant expression of the immunosuppressive NKp30c isoform (over the immunostimulatory NKp30a and NKp30b isoforms) was associated with reduced survival of subjects, decreased NKp30-dependent tumor necrosis factor-alpha (TNF-alpha) and CD107a release, and defective interferon-gamma (IFN-gamma) and interleukin-12 (IL-12) secretion in the NK-DC cross-talk that could be restored by blocking of IL-10. Preferential NKp30c expression resulted partly from a single-nucleotide polymorphism at position 3790 in the 3' untranslated region of the gene encoding NKp30. The genetically determined NKp30 status predicts the clinical outcomes of individuals with GIST independently from KIT mutation.	[Delahaye, Nicolas F.; Rusakiewicz, Sylvie; Menard, Cedric; Roux, Stephan; Sarabi, Matthieu; Chaput, Nathalie; Semeraro, Michaela; Minard-Colin, Veronique; Chaba, Kariman; Flament, Caroline; Valteau-Couanet, Dominique; Zitvogel, Laurence] IGR, INSERM, U1015, Villejuif, France; [Delahaye, Nicolas F.; Rusakiewicz, Sylvie; Menard, Cedric; Roux, Stephan; Sarabi, Matthieu; Chaput, Nathalie; Poirier-Colame, Vichnou; Flament, Caroline; Lecesne, Axel; Zitvogel, Laurence] IGR, Ctr Clin Invest CBT507, Villejuif, France; [Martins, Isabelle; Baud, Veronique; Authier, Helene; Kroemer, Guido] Univ Paris 05, Paris, France; [Martins, Isabelle; Kroemer, Guido] IGR, INSERM, U848, Villejuif, France; [Lyonnet, Luc; Paul, Pascale] Hop Conception, Hematol Unit, Marseille, France; [Semeraro, Michaela; Minard-Colin, Veronique; Valteau-Couanet, Dominique] IGR, Dept Pediat Oncol, Villejuif, France; [Baud, Veronique; Authier, Helene] Inst Cochin, INSERM, U1016, Paris, France; [Baud, Veronique; Authier, Helene] CNRS, UMR8104, Paris, France; [Kerdine-Roemer, Saadia; Pallardy, Marc] Universud, INSERM, Fac Pharm, UMR 996, Chatenay Malabry, France; [Cremer, Isabelle] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Cremer, Isabelle] Univ Paris 06, UMRS 872, Paris, France; [Peaudecerf, Laetitia; Rocha, Benedita] INSERM, U1020, Paris, France; [Peaudecerf, Laetitia; Rocha, Benedita] Fac Med Rene Descartes, Paris, France; [Gutierrez, Javier Celis; Nunes, Jacques A.] Ctr Rech Cancerol Marseille, INSERM, U891, Marseille, France; [Gutierrez, Javier Celis; Nunes, Jacques A.] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Commo, Frederic] IGR, INSERM, U981, Villejuif, France; [Bonvalot, Sylvie; Terrier, Philippe; Lecesne, Axel] IGR, Dept Med, Sarcoma Comm, Villejuif, France; [Ibrahim, Nicolas; Terrier, Philippe] IGR, Dept Pathol, Villejuif, France; [Opolon, Paule] IGR, Expt Pathol Unit, Villejuif, France; [Opolon, Paule] Univ Paris 11, Fac Med Paris Sud, Le Kremlin Bicetre, France; [Bottino, Cristina; Moretta, Alessandro] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy; [Bottino, Cristina] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Tavernier, Jan] Univ Ghent, Fac Med & Hlth, Dept Med Prot Res, B-9000 Ghent, Belgium; [Tavernier, Jan] Univ Ghent VIB, Ghent, Belgium; [Rihet, Pascal] Aix Marseille Univ, INSERM, TAGC, U928, Marseille, France; [Coindre, Jean-Michel] Inst Bergonie, Dept Pathol, Bordeaux, France; [Blay, Jean-Yves] Ctr Leon Berard, Dept Med, F-69373 Lyon, France; [Isambert, Nicolas] Ctr Georges Francois Leclerc, Dept Oncol, Dijon, France; [Isambert, Nicolas] INSERM, CIC P 803, Dijon, France; [Emile, Jean-Francois] Hop Ambroise Pare, Dept Pathol, EA4340, Boulogne, France; [Vivier, Eric] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, Marseille, France; [Vivier, Eric] INSERM, U631, F-13258 Marseille, France; [Vivier, Eric] CNRS, UniteMixte Rech 6102, Marseille, France; [Vivier, Eric] Hop Conception, AP HM, Marseille, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Bergonie; UNICANCER; Centre Leon Berard; UNICANCER; Centre Georges-Francois Leclerc; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), IGR, INSERM, U1015, Villejuif, France.	kroemer@orange.fr; zitvogel@igr.fr	Ménard, Cédric/AAB-3180-2020; Kerdine-Römer, Saadia/AAT-9855-2020; Cremer, Isabelle/D-4278-2017; PAUL, Pascale/R-1484-2016; GUTIERREZ, Javier CELIS/AAB-2605-2020; Blay, Jean-Yves/N-3966-2016; Rihet, Pascal/L-2173-2016; Rihet, Pascal/AAD-2018-2022; Rihet, Pascal/GQP-1381-2022; Baud, Veronique/F-7699-2013; PAUL, Pascale/AAI-1772-2020; Kerdine-Römer, Saadia/A-9789-2014; KROEMER, Guido/B-4263-2013; Baud, Veronique/AAL-3950-2020; Tavernier, Jan/AAG-3636-2019; NUNES, Jacques A/F-4952-2013; Vivier, Eric/F-8939-2010; Kroemer, Guido/AAY-9859-2020; Bottino, Cristina/J-9977-2016	Ménard, Cédric/0000-0002-2207-361X; Cremer, Isabelle/0000-0002-0963-1031; PAUL, Pascale/0000-0002-6734-4479; Blay, Jean-Yves/0000-0001-7190-120X; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Baud, Veronique/0000-0002-4090-718X; PAUL, Pascale/0000-0002-6734-4479; KROEMER, Guido/0000-0002-9334-4405; Baud, Veronique/0000-0002-4090-718X; NUNES, Jacques A/0000-0003-4865-0400; Vivier, Eric/0000-0001-7022-8287; Sarabi, Matthieu/0000-0003-4588-0585; Kerdine-Romer, Saadia/0000-0003-3313-952X; authier, helene/0000-0002-5556-4570; Bottino, Cristina/0000-0001-6695-1739; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale; European Union; INCa; Agence Nationale de la Recherche; Fondation de France; Institut National du Cancer; Fondation Gustave Roussy; Ligue contre le Cancer; Association pour la Recherche contre le Cancer; Belgian Interuniversity Attraction Pole; Canceropole Ile-de-France; Universite Paris Descartes; Fundayacucho-CNOUS joint program	Ligue contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union(European Commission); INCa(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Gustave Roussy; Ligue contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Belgian Interuniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-de-France(Region Ile-de-France); Universite Paris Descartes; Fundayacucho-CNOUS joint program	We thank P. Anderson for providing the CD3 zeta-specific antibody (2H2 clone), M. Baratin for helpful discussions and the affected subjects as well as the healthy volunteers for their kind participation. U848 and U1015 are supported by Ligue contre le Cancer (equipes labellisees), Fondation pour la Recherche Medicale, European Union (Apo-Sys, ArtForce, ChemoRes, INFLACARE), INCa ('NKp30' in 2006; 'NCR3 isoforms' in 2008), Agence Nationale de la Recherche and Fondation de France (2009-2011). N.F.D. was supported by Institut National du Cancer and Fondation Gustave Roussy. S. Rusakiewicz was supported by a studentship from the Fondation pour la Recherche Medicale. V.B. was supported by the Ligue contre le Cancer, Agence Nationale de la Recherche, Association pour la Recherche contre le Cancer, Belgian Interuniversity Attraction Pole, Canceropole Ile-de-France and Universite Paris Descartes. J.C.G. was supported by the Fundayacucho-CNOUS joint program. Some materials and data used in this study were provided by the conticagist (https://www.conticagist.org/).	Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Delahaye NF, 2007, MICROBES INFECT, V9, P160, DOI 10.1016/j.micinf.2006.11.002; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emile JF, 2002, DIAGN MOL PATHOL, V11, P107, DOI 10.1097/00019606-200206000-00007; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fuller CL, 2007, CELL MICROBIOL, V9, P962, DOI 10.1111/j.1462-5822.2006.00844.x; Grant LR, 2008, GENES IMMUN, V9, P316, DOI 10.1038/gene.2008.20; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hermann E, 2006, PEDIATR RES, V60, P38, DOI 10.1203/01.pdr.0000220335.05588.ea; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hollyoake M, 2005, MOL BIOL EVOL, V22, P1661, DOI 10.1093/molbev/msi162; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Menard C, 2009, CANCER RES, V69, P3563, DOI 10.1158/0008-5472.CAN-08-3807; Miettinen M, 2002, EUR J CANCER, V38, pS39, DOI 10.1016/S0959-8049(02)80602-5; Nalabolu SR, 1996, GENOMICS, V31, P215, DOI 10.1006/geno.1996.0034; Neville MJ, 1999, J IMMUNOL, V162, P4745; Pandey R, 2007, J IMMUNOL, V179, P7385, DOI 10.4049/jimmunol.179.11.7385; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Poggi A, 2007, ANN NY ACAD SCI, V1109, P47, DOI 10.1196/annals.1398.007; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rutjens E, 2007, J IMMUNOL, V178, P1702, DOI 10.4049/jimmunol.178.3.1702; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Sivakamasundari R, 2000, IMMUNOGENETICS, V51, P723, DOI 10.1007/s002510000192; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Van Glabbeke M, 2010, J CLIN ONCOL, V28, P1247, DOI 10.1200/JCO.2009.24.2099; Vankayalapati R, 2005, J IMMUNOL, V175, P4611, DOI 10.4049/jimmunol.175.7.4611; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; VITALE M, 1995, P NATL ACAD SCI USA, V92, P3536, DOI 10.1073/pnas.92.8.3536; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vivier E, 2009, CELL HOST MICROBE, V6, P493, DOI 10.1016/j.chom.2009.12.001; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Xie T, 2003, GENOME RES, V13, P2621, DOI 10.1101/gr.1736803; Yutkin V, 2007, J UROLOGY, V178, P2660, DOI 10.1016/j.juro.2007.07.118	43	241	252	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					700	+		10.1038/nm.2366	http://dx.doi.org/10.1038/nm.2366			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21552268				2022-12-25	WOS:000291308800030
J	Krencik, R; Weick, JP; Liu, Y; Zhang, ZJ; Zhang, SC				Krencik, Robert; Weick, Jason P.; Liu, Yan; Zhang, Zhi-Jian; Zhang, Su-Chun			Specification of transplantable astroglial subtypes from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							FIBRILLARY ACIDIC PROTEIN; NEURAL DIFFERENTIATION; GLIAL-CELLS; ASTROCYTES; BRAIN; EXPRESSION; NEURONS; HETEROGENEITY; GLIOGENESIS; CLEARANCE	Human pluripotent stem cells (hPSCs) have been differentiated efficiently to neuronal cell types. However, directed differentiation of hPSCs to astrocytes and astroglial subtypes remains elusive. In this study, hPSCs were directed to nearly uniform populations of immature astrocytes (>90% S100 beta(+) and GFAP(+)) in large quantities. The immature human astrocytes exhibit similar gene expression patterns as primary astrocytes, display functional properties such as glutamate uptake and promotion of synaptogenesis, and become mature astrocytes by forming connections with blood vessels after transplantation into the mouse brain. Furthermore, hPSC-derived neuroepithelia, patterned to rostral-caudal and dorsal-ventral identities with the same morphogens used for neuronal subtype specification, generate immature astrocytes that express distinct homeodomain transcription factors and display phenotypic differences of different astroglial subtypes. These human astroglial progenitors and immature astrocytes will be useful for studying astrocytes in brain development and function, understanding the roles of astrocytes in disease processes and developing novel treatments for neurological disorders.	[Krencik, Robert; Zhang, Su-Chun] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Krencik, Robert; Weick, Jason P.; Zhang, Zhi-Jian; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Liu, Yan; Zhang, Su-Chun] Fudan Univ Shanghai Med Sch, Dept Human Anat & Histol, Shanghai, Peoples R China; [Zhang, Su-Chun] Univ Wisconsin, Dept Neurosci, Madison, WI USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Fudan University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	zhang@waisman.wisc.edu		Krencik, Robert/0000-0002-2968-3162	ALS Association; National Institute of Neurological Disorders and Stroke [NS045926, NS057778, NS064578]; National MS Society [NMSS TR-3761]; NYSTEM [C024406]; Bleser Family Foundation; Busta Family Foundation; Neuroscience Training Program [T32 GM007507]; National Institute of Child Health and Human Development [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064578, P01NS057778, R01NS045926] Funding Source: NIH RePORTER	ALS Association; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National MS Society(National Multiple Sclerosis Society); NYSTEM; Bleser Family Foundation; Busta Family Foundation; Neuroscience Training Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank A. Messing for critical reading of the manuscript. This study was supported by the ALS Association, National Institute of Neurological Disorders and Stroke (NS045926, NS057778, NS064578), National MS Society (NMSS TR-3761), NYSTEM (C024406), Bleser Family Foundation, Busta Family Foundation, Neuroscience Training Program (T32 GM007507) and partly by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P30 HD03352).	Abe K, 2000, BIOL PHARM BULL, V23, P204; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Blomstrand F, 1999, NEUROSCIENCE, V92, P255, DOI 10.1016/S0306-4522(98)00738-6; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Doengi M, 2009, P NATL ACAD SCI USA, V106, P17570, DOI 10.1073/pnas.0809513106; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Guatteo E, 1996, GLIA, V16, P196; Guillaume DJ, 2006, J NEUROSCI RES, V84, P1165, DOI 10.1002/jnr.21022; Haas B, 2006, CEREB CORTEX, V16, P237, DOI 10.1093/cercor/bhi101; Hewett JA, 2009, J NEUROCHEM, V110, P1717, DOI 10.1111/j.1471-4159.2009.06288.x; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kessaris N, 2008, PHILOS T R SOC B, V363, P71, DOI 10.1098/rstb.2006.2013; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nishiyama A, 2005, J ANAT, V207, P687, DOI 10.1111/j.1469-7580.2005.00489.x; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Pal U, 1999, NEUROCHEM RES, V24, P637, DOI 10.1023/A:1021096224161; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Silver DJ, 2009, TRENDS NEUROSCI, V32, P303, DOI 10.1016/j.tins.2009.01.008; Simard M, 2003, J NEUROSCI, V23, P9254; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; WILKINSON M, 1990, NEUROPATH APPL NEURO, V16, P193, DOI 10.1111/j.1365-2990.1990.tb01156.x; Yeh TH, 2009, GLIA, V57, P1239, DOI 10.1002/glia.20845; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT REV NEUROSCI, V2, P840, DOI 10.1038/35097593; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005	50	281	300	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2011	29	6					528	U92		10.1038/nbt.1877	http://dx.doi.org/10.1038/nbt.1877			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	773WL	21602806	Green Accepted			2022-12-25	WOS:000291342100019
J	Suhre, K; Wallaschofski, H; Raffler, J; Friedrich, N; Haring, R; Michael, K; Wasner, C; Krebs, A; Kronenberg, F; Chang, D; Meisinger, C; Wichmann, HE; Hoffmann, W; Volzke, H; Volker, U; Teumer, A; Biffar, R; Kocher, T; Felix, SB; Illig, T; Kroemer, HK; Gieger, C; Roemisch-Margl, W; Nauck, M				Suhre, Karsten; Wallaschofski, Henri; Raffler, Johannes; Friedrich, Nele; Haring, Robin; Michael, Kathrin; Wasner, Christina; Krebs, Alexander; Kronenberg, Florian; Chang, David; Meisinger, Christa; Wichmann, H-Erich; Hoffmann, Wolfgang; Voelzke, Henry; Voelker, Uwe; Teumer, Alexander; Biffar, Reiner; Kocher, Thomas; Felix, Stephan B.; Illig, Thomas; Kroemer, Heyo K.; Gieger, Christian; Roemisch-Margl, Werner; Nauck, Matthias			A genome-wide association study of metabolic traits in human urine	NATURE GENETICS			English	Article							CHRONIC KIDNEY-DISEASE; ASYMMETRIC DIMETHYLARGININE; LOCI; PROGRESSION; EXCRETION; POMERANIA; FAILURE; PROLINE; HEALTH; LIVER	We present a genome-wide association study of metabolic traits in human urine, designed to investigate the detoxification capacity of the human body. Using NMR spectroscopy, we tested for associations between 59 metabolites in urine from 862 male participants in the population-based SHIP study. We replicated the results using 1,039 additional samples of the same study, including a 5-year follow-up, and 992 samples from the independent KORA study. We report five loci with joint P values of association from 3.2 x 10(-19) to 2.1 x 10(-182). Variants at three of these loci have previously been linked with important clinical outcomes: SLC7A9 is a risk locus for chronic kidney disease, NAT2 for coronary artery disease and genotype-dependent response to drug toxicity, and SLC6A20 for iminoglycinuria. Moreover, we identify rs37369 in AGXT2 as the genetic basis of hyper-beta-aminoisobutyric aciduria.	[Suhre, Karsten; Raffler, Johannes] Univ Munich, Fac Biol, Munich, Germany; [Wallaschofski, Henri; Friedrich, Nele; Haring, Robin; Michael, Kathrin; Wasner, Christina; Krebs, Alexander; Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, D-17487 Greifswald, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Chang, David] Chenomx Inc, Edmonton, AB, Canada; [Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Hoffmann, Wolfgang; Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Voelker, Uwe; Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Biffar, Reiner] Ernst Moritz Arndt Univ Greifswald, Ctr Oral Hlth, Dept Prosthet Dent Gerodontol & Biomat, D-17487 Greifswald, Germany; [Suhre, Karsten; Raffler, Johannes; Roemisch-Margl, Werner] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Kocher, Thomas] Ernst Moritz Arndt Univ Greifswald, Dept Restorat Dent Periodontol & Endodontol, Ctr Oral Hlth, Unit Periodontol, D-17487 Greifswald, Germany; [Felix, Stephan B.] Ernst Moritz Arndt Univ Greifswald, Dept Cardiol, D-17487 Greifswald, Germany; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Unit Mol Epidemiol, Neuherberg, Germany; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Dept Pharmacol, Ctr Pharmacol & Expt Therapeut, D-17487 Greifswald, Germany; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany	University of Munich; Ernst Moritz Arndt Universitat Greifswald; Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Suhre, K (corresponding author), Educ City Qatar Fdn, Dept Physiol & Biophys, Weill Cornell Med Coll Qatar, POB 24144, Doha, Qatar.	karsten@suhre.fr	Wichmann, Heinz Erich/AAA-5695-2022; Hoffmann, Wolfgang/E-6001-2013; Teumer, Alexander/S-7438-2019; Kronenberg, Florian/B-1736-2008; Meisinger, Christine/B-5358-2014; Suhre, Karsten/AAF-1778-2020; Wilkening, Robin/J-5535-2018	Teumer, Alexander/0000-0002-8309-094X; Kronenberg, Florian/0000-0003-2229-1120; Suhre, Karsten/0000-0001-9638-3912; Volker, Uwe/0000-0002-5689-3448; Gieger, Christian/0000-0001-6986-9554; Wilkening, Robin/0000-0002-8332-5016; Raffler, Johannes/0000-0003-2495-4020; Meisinger, Christa/0000-0002-9026-6544	German Federal Ministry of Education and Research (BMBF) [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare; Federal State of Mecklenburg-West Pomerania; Bruker BioSpin; Austrian Genome Research Programme; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [03IS2061A]; Helmholtz Zentrum Munchen-National Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German National Genome Research Network [NGFNPlus 01GS0823]; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; Deutsche Forschungsgemeinschaft Graduiertenkolleg [GRK 1563]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare(Siemens AG); Federal State of Mecklenburg-West Pomerania; Bruker BioSpin; Austrian Genome Research Programme; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; Helmholtz Zentrum Munchen-National Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German National Genome Research Network; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; Deutsche Forschungsgemeinschaft Graduiertenkolleg(German Research Foundation (DFG))	SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the German Federal Ministry of Education and Research (BMBF; grants 01ZZ9603, 01ZZ0103 and 01ZZ0403), the German Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide studies were supported by BMBF (grant 03ZIK012) and a joint grant from Siemens Healthcare and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the Siemens 'Center of Knowledge Interchange' program. NMR studies were supported by Bruker BioSpin. This study was also supported in part by a grant from BMBF to the German Center for Diabetes Research (DZD e.V.), and by the Genomics of Lipid-associated Disorders project of the Austrian Genome Research Programme. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the BMBF and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03IS2061A). The KORA research platform and the 'Monitoring trends and determinants on cardiovascular diseases' (MONICA) Augsburg studies were initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFNPlus 01GS0823). Part of this research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. J.R. is supported by Deutsche Forschungsgemeinschaft Graduiertenkolleg 'GRK 1563, Regulation and Evolution of Cellular Systems' (RECESS). Computing resources have been provided by the Leibniz Supercomputing Centre of the Bavarian Academy of Sciences and Humanities (HLRB project h1231) and the DEISA Extreme Computing Initiative (project PHAGEDA). We thank P. Lichtner, G. Eckstein, G. Fischer, T. Strom and all other members of the Helmholtz Zentrum Munchen genotyping staff for generating the KORA SNP data set, as well as all field staff members involved in the MONICA and KORA Augsburg studies. The KORA group consists of H. E. Wichmann (speaker), A. Peters, C. Meisinger, T. Illig, R. Holle, J. John and their co-workers, who are responsible for the design and conduct of the KORA studies. We thank all participants in the SHIP and KORA studies for donating their blood, urine and time.	Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; CRUMPLER HR, 1951, NATURE, V167, P307, DOI 10.1038/167307a0; Daly AK, 2010, PHARMACOGENOMICS, V11, P607, DOI [10.2217/pgs.10.24, 10.2217/PGS.10.24]; Deeken JF, 2010, PHARMACOGENOMICS J, V10, P191, DOI 10.1038/tpj.2009.57; Evan AP, 2006, KIDNEY INT, V69, P2227, DOI 10.1038/sj.ki.5000268; Fliser D, 2005, J AM SOC NEPHROL, V16, P2456, DOI 10.1681/ASN.2005020179; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; HARRIS H, 1953, ANN EUGENIC, V18, P43; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; KAKIMOTO Y, 1969, J BIOL CHEM, V244, P335; Kayrak M, 2010, CIRC J, V74, P1135, DOI 10.1253/circj.CJ-09-0419; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Rodionov RN, 2010, J BIOL CHEM, V285, P5385, DOI 10.1074/jbc.M109.091280; Sanderson S, 2007, AM J EPIDEMIOL, V166, P741, DOI 10.1093/aje/kwm167; Scott CR, 2006, AM J MED GENET C, V142C, P121, DOI 10.1002/ajmg.c.30092; Scriver CR, 1989, METABOLIC BASIS INHE, V1, P755; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Takanaga H, 2005, J BIOL CHEM, V280, P8974, DOI 10.1074/jbc.M413027200; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Tang WHW, 2008, EUR HEART J, V29, P2506, DOI 10.1093/eurheartj/ehn360; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VALLANCE P, 1992, LANCET, V339, P572; van Kuilenburg ABP, 2004, HUM MOL GENET, V13, P2793, DOI 10.1093/hmg/ddh303; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; YANAI J, 1969, AM J HUM GENET, V21, P115	35	181	187	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					565	U97		10.1038/ng.837	http://dx.doi.org/10.1038/ng.837			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21572414				2022-12-25	WOS:000291017000014
J	Chen, XW; Leto, D; Xiao, JY; Goss, J; Wang, Q; Shavit, JA; Xiong, TT; Yu, GG; Ginsburg, D; Toomre, D; Xu, ZH; Saltiel, AR				Chen, Xiao-Wei; Leto, Dara; Xiao, Junyu; Goss, John; Wang, Qian; Shavit, Jordan A.; Xiong, Tingting; Yu, Genggeng; Ginsburg, David; Toomre, Derek; Xu, Zhaohui; Saltiel, Alan R.			Exocyst function is regulated by effector phosphorylation	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; STIMULATED GLUT4 TRAFFICKING; READILY RELEASABLE POOL; PLASMA-MEMBRANE; CELL-MIGRATION; RAL-GTPASES; EXOCYTOSIS; COMPLEX; SEC5; INSULIN	The exocyst complex tethers vesicles at sites of fusion through interactions with small GTPases. The G protein RalA resides on Glut4 vesicles, and binds to the exocyst after activation by insulin, but must then disengage to ensure continuous exocytosis. Here we report that, after recognition of the exocyst by activated RalA, disengagement occurs through phosphorylation of its effector Sec5, rather than RalA inactivation. Sec5 undergoes phosphorylation in the G-protein binding domain, allosterically reducing RalA interaction. The phosphorylation event is catalysed by protein kinase C and is reversed by an exocyst-associated phosphatase. Introduction of Sec5 bearing mutations of the phosphorylation site to either alanine or aspartate disrupts insulin-stimulated Glut4 exocytosis, as well as other trafficking processes in polarized epithelial cells and during development of zebrafish embryos. The exocyst thus serves as a 'gatekeeper' for exocytic vesicles through a circuit of engagement, disengagement and re-engagement with G proteins.	[Chen, Xiao-Wei; Leto, Dara; Xiao, Junyu; Shavit, Jordan A.; Xiong, Tingting; Yu, Genggeng; Ginsburg, David; Xu, Zhaohui; Saltiel, Alan R.] Univ Michigan Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; [Chen, Xiao-Wei; Xiong, Tingting; Saltiel, Alan R.] Univ Michigan Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Leto, Dara; Saltiel, Alan R.] Univ Michigan Med Ctr, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Xiao, Junyu; Wang, Qian; Xu, Zhaohui] Univ Michigan Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Goss, John; Toomre, Derek] Yale Univ Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Shavit, Jordan A.; Ginsburg, David; Saltiel, Alan R.] Univ Michigan Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Shavit, Jordan A.; Ginsburg, David] Univ Michigan Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@lsi.umich.edu	Saltiel, Alan/L-3632-2019; Chen, Xiaowei/F-7026-2014; Xiao, Junyu/ABE-2192-2020	Xiao, Junyu/0000-0003-1822-1701; Ginsburg, David/0000-0002-6436-8942; Chen, Xiao-Wei/0000-0001-6466-6248; Saltiel, Alan/0000-0002-9726-9828; Goss, John/0000-0001-7999-2900	NIH [RO1 DK061618, DK076906]; Diabetes Research and Training Center at the University of Michigan [P60 DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076906, P60DK020572, R01DK061618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Training Center at the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work is supported by NIH RO1 DK061618 and DK076906 to A.R.S., and P60 DK020572 to the Diabetes Research and Training Center at the University of Michigan. D.G. is an investigator of Howard Hughes Medical Institute.	Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2007, DEV CELL, V12, P4, DOI 10.1016/j.devcel.2006.12.008; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; CHEN XW, MOL BIOL CELL, V22, P141; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Mott HR, 2003, J BIOL CHEM, V278, P17053, DOI 10.1074/jbc.M300155200; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Novick P, 2006, BIOCHEM SOC T, V34, P683, DOI 10.1042/BST0340683; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	44	56	60	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					580	U186		10.1038/ncb2226	http://dx.doi.org/10.1038/ncb2226			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21516108	Green Accepted			2022-12-25	WOS:000290148700017
J	Lupberger, J; Zeisel, MB; Xiao, F; Thumann, C; Fofana, I; Zona, L; Davis, C; Mee, CJ; Turek, M; Gorke, S; Royer, C; Fischer, B; Zahid, MN; Lavillette, D; Fresquet, J; Cosset, FL; Rothenberg, SM; Pietschmann, T; Patel, AH; Pessaux, P; Doffoel, M; Raffelsberger, W; Poch, O; McKeating, JA; Brino, L; Baumert, TF				Lupberger, Joachim; Zeisel, Mirjam B.; Xiao, Fei; Thumann, Christine; Fofana, Isabel; Zona, Laetitia; Davis, Christopher; Mee, Christopher J.; Turek, Marine; Gorke, Sebastian; Royer, Cathy; Fischer, Benoit; Zahid, Muhammad N.; Lavillette, Dimitri; Fresquet, Judith; Cosset, Francois-Loic; Rothenberg, S. Michael; Pietschmann, Thomas; Patel, Arvind H.; Pessaux, Patrick; Doffoel, Michel; Raffelsberger, Wolfgang; Poch, Olivier; McKeating, Jane A.; Brino, Laurent; Baumert, Thomas F.			EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy	NATURE MEDICINE			English	Article							EPIDERMAL-GROWTH-FACTOR; B TYPE-I; FACTOR RECEPTOR; NEUTRALIZING ANTIBODIES; CELL TRANSMISSION; HUMAN LIVER; INFECTION; ACTIVATION; ERLOTINIB; MOUSE	Hepatitis C virus (HCV) is a major cause of liver disease, but therapeutic options are limited and there are no prevention strategies. Viral entry is the first step of infection and requires the cooperative interaction of several host cell factors. Using a functional RNAi kinase screen, we identified epidermal growth factor receptor and ephrin receptor A2 as host cofactors for HCV entry. Blocking receptor kinase activity by approved inhibitors broadly impaired infection by all major HCV genotypes and viral escape variants in cell culture and in a human liver chimeric mouse model in vivo. The identified receptor tyrosine kinases (RTKs) mediate HCV entry by regulating CD81-claudin-1 co-receptor associations and viral glycoprotein-dependent membrane fusion. These results identify RTKs as previously unknown HCV entry cofactors and show that tyrosine kinase inhibitors have substantial antiviral activity. Inhibition of RTK function may constitute a new approach for prevention and treatment of HCV infection.	[Lupberger, Joachim; Zeisel, Mirjam B.; Xiao, Fei; Thumann, Christine; Fofana, Isabel; Zona, Laetitia; Turek, Marine; Royer, Cathy; Zahid, Muhammad N.; Baumert, Thomas F.] INSERM, U748, Strasbourg, France; [Lupberger, Joachim; Zeisel, Mirjam B.; Xiao, Fei; Thumann, Christine; Fofana, Isabel; Zona, Laetitia; Turek, Marine; Royer, Cathy; Zahid, Muhammad N.; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Davis, Christopher; Mee, Christopher J.; McKeating, Jane A.] Univ Birmingham, Div Immun & Infect, Hepatitis C Res Grp, Birmingham, W Midlands, England; [Gorke, Sebastian] Univ Freiburg, Dept Med 2, Freiburg, Germany; [Fischer, Benoit; Raffelsberger, Wolfgang; Poch, Olivier; Brino, Laurent; Baumert, Thomas F.] Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire,U964,UMR1704, Illkirch Graffenstaden, France; [Lavillette, Dimitri; Fresquet, Judith; Cosset, Francois-Loic] Univ Lyon 1, INSERM, Ecole Normale Super, Inst Fed Rech 128,U758, F-69365 Lyon, France; [Rothenberg, S. Michael] Massachusetts Gen Hosp, Ctr Canc, Howard Hughes Med Inst, Charlestown, MA USA; [Rothenberg, S. Michael] Harvard Univ, Sch Med, Charlestown, MA USA; [Pietschmann, Thomas] Ctr Expt & Clin Infect Res, TWINCORE, Div Expt Virol, Hannover, Germany; [Patel, Arvind H.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Pessaux, Patrick; Doffoel, Michel; Baumert, Thomas F.] Hop Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Birmingham; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Glasgow; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Baumert, TF (corresponding author), INSERM, U748, Strasbourg, France.	thomas.baumert@unistra.fr	Pietschmann, Thomas/E-9241-2015; Lupberger, Joachim/AAL-7721-2020; Xiao, Fei/E-7133-2013; Cosset, François-Loïc/M-5862-2019; zahid, Muhammad Nauman/F-8793-2013; Zeisel, Mirjam B/E-9205-2016; Baumert, Thomas/ABF-4718-2020	Pietschmann, Thomas/0000-0001-5138-6239; Lupberger, Joachim/0000-0003-3996-3907; Xiao, Fei/0000-0001-7353-2700; Cosset, François-Loïc/0000-0001-8842-3726; Zeisel, Mirjam B/0000-0003-1606-0131; Baumert, Thomas/0000-0002-8864-2168; Mee, Christopher/0000-0002-6359-2694; Brino, laurent/0000-0002-9036-1461; davis, chris/0000-0002-7317-3266; Fischer, Benoit/0000-0002-9911-1397; McKeating, Jane/0000-0002-7229-5886; Lavillette, Dimitri/0000-0002-4706-1519	European Research Council [ERC-2008-AdG-233130-HEPCENT]; INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net; Agence Nationale de la Recherche [ANR-05-CEXC-008]; Agence Nationale de Recherche sur le Sida [2008/354]; Region Alsace; Institut National du Cancer; Institut de Genetique et de Biologie Moleculaire et Cellulaire; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite de Strasbourg; US National Insititutes of Health [1K08DE020139-01A1]; UK Medical Research Council; Wellcome Trust; Medical Research Council [MC_U130184144, G0400802, G0801976] Funding Source: researchfish; MRC [G0400802, MC_U130184144, G0801976] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE020139] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net; Agence Nationale de la Recherche(French National Research Agency (ANR)); Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); Region Alsace(Region Grand-Est); Institut National du Cancer(Institut National du Cancer (INCA) France); Institut de Genetique et de Biologie Moleculaire et Cellulaire; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; US National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the European Research Council (ERC-2008-AdG-233130-HEPCENT), INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009, Agence Nationale de la Recherche (ANR-05-CEXC-008), Agence Nationale de Recherche sur le Sida 2008/354, Region Alsace, Institut National du Cancer, the Institut de Genetique et de Biologie Moleculaire et Cellulaire, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite de Strasbourg, the US National Insititutes of Health (1K08DE020139-01A1), the UK Medical Research Council and the Wellcome Trust. We acknowledge A.-L. Morand, L. Froidevaux, A. Weiss, L. Poidevin, S. Durand and E. Soulier for excellent technical work. We thank R. Bartenschlager (University of Heidelberg) for providing Jc1 and Luc-Jc1 expression vectors, J. Ball (University of Nottingham) for UKN2A.2.4, UKN3A1.28 and UKN4.21.16 expression vectors, T. Wakita (National Institute of Infectious Diseases, Japan) for JFH1 constructs, C. M. Rice (The Rockefeller University) for Huh7.5 cells, F. V. Chisari (The Scripps Research Institute) for Huh7.5.1 cells, E. Harlow (Harvard University) for CDC2 expression plasmids and M. Tanaka (Hamamatsu University) for EphA2 expression plasmids.	Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Chahbouni A, 2009, THER DRUG MONIT, V31, P683, DOI 10.1097/FTD.0b013e3181c05a14; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Flores-Benitez D, 2009, AM J PHYSIOL-CELL PH, V297, pC611, DOI 10.1152/ajpcell.00622.2008; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hidalgo M, 2003, SEMIN ONCOL, V30, P25, DOI 10.1016/S0093-7754(03)00186-6; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Hiraga N, 2009, J HEPATOL, V51, P1046, DOI 10.1016/j.jhep.2009.09.002; Kamiya N, 2010, J GEN VIROL, V91, P1668, DOI 10.1099/vir.0.019315-0; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reiter JL, 1996, NUCLEIC ACIDS RES, V24, P4050, DOI 10.1093/nar/24.20.4050; Rothenberg SM, 2008, P NATL ACAD SCI USA, V105, P12480, DOI 10.1073/pnas.0803217105; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Tai AW, 2009, J HEPATOL, V50, P412, DOI 10.1016/j.jhep.2008.11.010; Thoresen GH, 1998, J CELL PHYSIOL, V175, P10, DOI 10.1002/(SICI)1097-4652(199804)175:1<10::AID-JCP2>3.3.CO;2-6; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wang YJ, 2002, BIOCHEM BIOPH RES CO, V296, P214, DOI 10.1016/S0006-291X(02)00806-9; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Zeisel MB, 2008, HEPATOLOGY, V48, P299, DOI 10.1002/hep.22307; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994	53	510	541	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					589	U109		10.1038/nm.2341	http://dx.doi.org/10.1038/nm.2341			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21516087	Green Submitted, Green Accepted			2022-12-25	WOS:000290250400035
J	Geiger, R; Andritschke, D; Friebe, S; Herzog, F; Luisoni, S; Heger, T; Helenius, A				Geiger, Roger; Andritschke, Daniel; Friebe, Sarah; Herzog, Fabian; Luisoni, Stefania; Heger, Thomas; Helenius, Ari			BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol	NATURE CELL BIOLOGY			English	Article							CAPSID PROTEIN VP1; MISFOLDED GLYCOPROTEINS; CAVEOLAR ENDOCYTOSIS; RETRO-TRANSLOCATION; POLYOMA-VIRUS; SIMIAN-VIRUS-40; ER; COMPLEX; DEGRADATION; TRANSPORT	How non-enveloped viruses overcome host cell membranes is poorly understood. Here, we show that after endocytosis and transport to the endoplasmic reticulum (ER), but before crossing the ER membrane to the cytosol, incoming simian virus 40 particles are structurally remodelled leading to exposure of the amino-terminal sequence of the minor viral protein VP2. These hydrophobic sequences anchor the virus to membranes. A negatively charged residue, Glu 17, in the alpha-helical, membrane-embedded peptide is essential for infection, most likely by introducing an 'irregularity' recognized by the ER-associated degradation (ERAD) system for membrane proteins. Using a siRNA-mediated screen, the lumenal chaperone BiP and the ER-membrane protein BAP31 (both involved in ERAD) were identified as being essential for infection. they co-localized with the virus in discrete foci and promoted its ER-to-cytosol dislocation. Virus-like particles devoid of VP2 failed to cross the membrane. The results demonstrated that ERAD-factors assist virus transport across the ER membrane.	[Geiger, Roger; Andritschke, Daniel; Friebe, Sarah; Herzog, Fabian; Luisoni, Stefania; Heger, Thomas; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch		Geiger, Roger/0000-0002-8016-1669	National Science Foundation of Switzerland; LipidX programme of SystemsX; European research council (ERC); ETH Zurich	National Science Foundation of Switzerland(Swiss National Science Foundation (SNSF)); LipidX programme of SystemsX; European research council (ERC)(European Research Council (ERC)); ETH Zurich(ETH Zurich)	We thank H. Ploegh, G. Shore, E. Wiertz, H. Meyer, H. Kasamatsu, A. Oppenheim, L. Hendershot and K. Johnsson for sharing reagents. We are grateful to A. Smith, P. Deprez, J. Kartenbeck and R. Mancini for preparing mPy and microsomes and for help with electron microscopy. We thank D. Roderer for help with circular dichroism spectroscopy measurements. We thank members of the Helenius group for discussions, especially M. Schelhaas. This work was supported by the National Science Foundation of Switzerland, the LipidX programme of SystemsX, the European research council (ERC) and ETH Zurich.	Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Daniels R, 2006, MOL CELL, V24, P955, DOI 10.1016/j.molcel.2006.11.001; Easha S, 2006, CELL MOL LIFE SCI, V63, P865, DOI 10.1007/s00018-005-5454-z; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Engelman DM, 2003, MOL CELL, V11, P5, DOI 10.1016/S1097-2765(03)00016-9; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; ISHII N, 1994, J VIROL, V68, P8209, DOI 10.1128/JVI.68.12.8209-8216.1994; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nakanishi A, 1996, P NATL ACAD SCI USA, V93, P96, DOI 10.1073/pnas.93.1.96; Nakanishi A, 2002, J VIROL, V76, P9368, DOI 10.1128/JVI.76.18.9368-9377.2002; Neu U, 2009, VIROLOGY, V384, P389, DOI 10.1016/j.virol.2008.12.021; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Ray-Sinha A, 2009, MOL MEMBR BIOL, V26, P448, DOI 10.3109/09687680903333839; Richards AA, 2002, MOL BIOL CELL, V13, P1750, DOI 10.1091/mbc.01-12-0592; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; STREULI CH, 1987, NATURE, V326, P619, DOI 10.1038/326619a0; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai B, 2010, CURR TOP MICROBIOL, V343, P177, DOI 10.1007/82_2010_38; VARSHAVSKY AJ, 1977, NUCLEIC ACIDS RES, V4, P3303, DOI 10.1093/nar/4.10.3303; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	60	125	128	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1305	U60		10.1038/ncb2339	http://dx.doi.org/10.1038/ncb2339			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	21947079				2022-12-25	WOS:000296737900007
J	Long, JZ; Cisar, JS; Milliken, D; Niessen, S; Wang, C; Trauger, SA; Siuzdak, G; Cravatt, BF				Long, Jonathan Z.; Cisar, Justin S.; Milliken, David; Niessen, Sherry; Wang, Chu; Trauger, Sunia A.; Siuzdak, Gary; Cravatt, Benjamin F.			Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids	NATURE CHEMICAL BIOLOGY			English	Article							MASS-SPECTROMETRY; OXIDIZED PHOSPHOLIPIDS; SERINE HYDROLASES; ENZYME; SUPERFAMILIES	All organisms, including humans, possess a huge number of uncharacterized enzymes. Here we describe a general cell-based screen for enzyme substrate discovery by untargeted metabolomics and its application to identify the protein alpha/beta-hydrolase domain-containing 3 (ABHD3) as a lipase that selectively cleaves medium-chain and oxidatively truncated phospholipids. Abhd3(-/-) mice possess elevated myristoyl (C14)-phospholipids, including the bioactive lipid C14-lysophosphatidylcholine, confirming the physiological relevance of our substrate assignments.	[Long, Jonathan Z.; Cisar, Justin S.; Milliken, David; Niessen, Sherry; Wang, Chu; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Long, Jonathan Z.; Cisar, Justin S.; Milliken, David; Niessen, Sherry; Wang, Chu; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niessen, Sherry] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	wang, chu/GYJ-2191-2022; Wang, Chu/AAE-8759-2021; Wang, Chu/C-4442-2015; cisar, justin/C-4002-2012	Wang, Chu/0000-0002-6925-1268; Wang, Chu/0000-0002-6925-1268; Siuzdak, Gary/0000-0002-4749-0014; Long, Jonathan/0000-0003-2631-7463; Trauger, Sunia/0000-0002-1678-8715	US National Institutes of Health [CA132630]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA132630] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge D. Bachovchin and S. Ji (both at The Scripps Research Institute) for providing the serine hydrolase expression plasmids, A. Saghatelian for the fatty acyl-CoA extraction protocol, and S. Palmer for the Matlab script used to generate Figure 2a. This work was supported by the US National Institutes of Health (CA132630) and the Skaggs Institute for Chemical Biology.	Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Nakanishi H, 2009, J CHROMATOGR B, V877, P1366, DOI 10.1016/j.jchromb.2008.09.041; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rottig M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000636; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yea K, 2009, J BIOL CHEM, V284, P33833, DOI 10.1074/jbc.M109.024869	24	46	48	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					763	765		10.1038/nchembio.659	http://dx.doi.org/10.1038/nchembio.659			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21926997	Green Accepted			2022-12-25	WOS:000296381600004
J	Selkoe, DJ				Selkoe, Dennis J.			Resolving controversies on the path to Alzheimer's therapeutics	NATURE MEDICINE			English	Article							APOLIPOPROTEIN-E GENOTYPE; TAU-HYPERPHOSPHORYLATION; SYNAPTIC PLASTICITY; AMYLOID HYPOTHESIS; DISEASE; IMMUNIZATION; DEPOSITION; MISSENSE; GENE; DEGENERATION	Alzheimer's disease constitutes a personal and societal tragedy of immense proportions. Since 1960, research in laboratories and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents. However, some of these agents have already failed. Gnawing controversies and important gaps in our knowledge seem to cast additional doubt on the ability of the field to move forward effectively. Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future. Rigorous preclinical validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their associated biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.							Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gozes I, 2009, CURR ALZHEIMER RES, V6, P455, DOI 10.2174/156720509789207895; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; HYMAN BT, 1995, P NATL ACAD SCI USA, V92, P3586, DOI 10.1073/pnas.92.8.3586; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; REBECK GW, 1993, NEURON, V11, P575; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	38	398	414	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1060	1065		10.1038/nm.2460	http://dx.doi.org/10.1038/nm.2460			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900936				2022-12-25	WOS:000294605100025
J	Solanas, G; Cortina, C; Sevillano, M; Batlle, E				Solanas, Guiomar; Cortina, Carme; Sevillano, Marta; Batlle, Eduard			Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling	NATURE CELL BIOLOGY			English	Article							INTESTINAL EPITHELIUM; STEM-CELLS; NOTCH; EXPRESSION; RECEPTORS; CANCER; EPHRINS; DIFFERENTIATION; INHIBITION; RENEWAL	The formation and maintenance of complex organs requires segregation of distinct cell populations into defined territories (that is, cell sorting) and the establishment of boundaries between them. Here we have investigated the mechanism by which Eph/ephrin signalling controls the compartmentalization of cells in epithelial tissues. We show that EphB/ephrin-B signalling in epithelial cells regulates the formation of E-cadherin-based adhesions. EphB receptors interact with E-cadherin and with the metalloproteinase ADAM10 at sites of adhesion and their activation induces shedding of E-cadherin by ADAM10 at interfaces with ephrin-B1-expressing cells. This process results in asymmetric localization of E-cadherin and, as a consequence, in differences in cell affinity between EphB-positive and ephrin-B-positive cells. Furthermore, genetic inhibition of ADAM10 activity in the intestine of mice results in a lack of compartmentalization of Paneth cells within the crypt stem cell niche, a defect that phenocopies that of EphB3-null mice. These results provide important insights into the regulation of cell migration in the intestinal epithelium and may help in the understanding of the nature of the cell sorting process in other epithelial tissues where Eph-ephrin interactions play a central role.	[Solanas, Guiomar; Cortina, Carme; Sevillano, Marta; Batlle, Eduard] Inst Res Biomed IRB Barcelona, Oncol Program, Barcelona 08028, Spain; [Batlle, Eduard] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Batlle, E (corresponding author), Inst Res Biomed IRB Barcelona, Oncol Program, Baldiri Reixac 10, Barcelona 08028, Spain.	eduard.batlle@irbbarcelona.org	Cortina Duran, Carme/K-7203-2017; Batlle, Eduard/K-8080-2014	Cortina Duran, Carme/0000-0003-3477-4322; Batlle, Eduard/0000-0003-2422-0326; Solanas, Guiomar/0000-0001-8388-8647; SEVILLANO, MARTA/0000-0001-5761-0879	European Research Council (ERC); Spanish Ministry of Science and Innovation; MICINN; department of education from the Generalitat de Catalunya; ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); department of education from the Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	We thank J. W. Nelson (Stanford University, USA) for the E-cadherin-GFP fusion construct, Z. Werb (University of California, San Francisco, USA) for ADAM10 expression constructs, J. I. Gordon (Washington University, St Louis, USA) for the CR2 expression plasmid, the Advanced Digital Microscopy Facility (ADM-IRB) for support with imaging, the Mouse Mutant Core Facility, X. Hernando and S. Palomo-Ponce for help with generation and maintenance of transgenic mice and all members of the Batlle laboratory for support and useful discussions. This study was supported by grants awarded to E.B. by the European Research Council (ERC) and the Spanish Ministry of Science and Innovation (SAF and Consolider). G.S. was supported by a fellowship from the MICINN and C.C. held a predoctoral fellowship from the department of education from the Generalitat de Catalunya.	Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Chiu ST, 2009, CARCINOGENESIS, V30, P1475, DOI 10.1093/carcin/bgp133; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Di Pietro M, 2005, GASTROENTEROLOGY, V129, P1047, DOI 10.1053/j.gastro.2005.06.028; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; TROUGHTON WD, 1969, J CELL BIOL, V41, P251, DOI 10.1083/jcb.41.1.251; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705	30	119	120	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1100	U128		10.1038/ncb2298	http://dx.doi.org/10.1038/ncb2298			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21804545				2022-12-25	WOS:000294487000015
J	Bonger, KM; Chen, LC; Liu, CW; Wandless, TJ				Bonger, Kimberly M.; Chen, Ling-chun; Liu, Corey W.; Wandless, Thomas J.			Small-molecule displacement of a cryptic degron causes conditional protein degradation	NATURE CHEMICAL BIOLOGY			English	Article							FKBP; UBIQUITINATION; SPECIFICITY; SYSTEM; IDENTIFICATION; DESTRUCTION; FIBROBLASTS; EXPRESSION; RECEPTOR; LIGANDS	The ability to rapidly regulate the functions of specific proteins in living cells is a valuable tool for biological research. Here we describe a new technique by which the degradation of a specific protein is induced by a small molecule. A protein of interest is fused to a ligand-induced degradation (LID) domain, resulting in the expression of a stable and functional fusion protein. The LID domain is comprised of the FK506- and rapamycin-binding protein (FKBP) and a 19-amino-acid degron fused to the C terminus of FKBP. In the absence of the small molecule Shield-1, the degron is bound to the FKBP fusion protein and the protein is stable. When present, Shield-1 binds tightly to FKBP, displacing the degron and inducing rapid and processive degradation of the LID domain and any fused partner protein. Structure-function studies of the 19-residue peptide showed that a 4-amino-acid sequence within the peptide is responsible for degradation.	[Bonger, Kimberly M.; Chen, Ling-chun; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Bonger, KM (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu	Bonger, Kimberly M/A-5900-2015	Bonger, Kimberly M/0000-0001-9498-2620	US National Institutes of Health [GM073046]; Human Frontiers Science Program fellowship; Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program fellowship(Human Frontier Science Program); Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health (GM073046). K.M.B. gratefully acknowledges the support of a Human Frontiers Science Program fellowship. C.W.L. and the Stanford Magnetic Resonance Laboratory are supported in part by the Stanford University School of Medicine. We would like to thank J. Lee and M. Verdoes for technical assistance.	ALBERS MW, 1990, J ORG CHEM, V55, P4984, DOI 10.1021/jo00304a003; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOSINK MM, 1995, P NATL ACAD SCI USA, V92, P9117, DOI 10.1073/pnas.92.20.9117; Grimley JS, 2008, BIOORG MED CHEM LETT, V18, P759, DOI 10.1016/j.bmcl.2007.11.044; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Lawson TG, 1999, J BIOL CHEM, V274, P9871, DOI 10.1074/jbc.274.14.9871; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Raina K, 2010, J BIOL CHEM, V285, P11057, DOI 10.1074/jbc.R109.078105; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	29	123	132	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					531	537		10.1038/NCHEMBIO.598	http://dx.doi.org/10.1038/NCHEMBIO.598			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21725303	Green Accepted			2022-12-25	WOS:000292825400014
J	Hoischen, A; van Bon, BWM; Rodriguez-Santiago, B; Gilissen, C; Vissers, LELM; de Vries, P; Janssen, I; van Lier, B; Hastings, R; Smithson, SF; Newbury-Ecob, R; Kjaergaard, S; Goodship, J; McGowan, R; Bartholdi, D; Rauch, A; Peippo, M; Cobben, JM; Wieczorek, D; Gillessen-Kaesbach, G; Veltman, JA; Brunner, HG; de Vries, BBBA				Hoischen, Alexander; van Bon, Bregje W. M.; Rodriguez-Santiago, Benjamin; Gilissen, Christian; Vissers, Lisenka E. L. M.; de Vries, Petra; Janssen, Irene; van Lier, Bart; Hastings, Rob; Smithson, Sarah F.; Newbury-Ecob, Ruth; Kjaergaard, Susanne; Goodship, Judith; McGowan, Ruth; Bartholdi, Deborah; Rauch, Anita; Peippo, Maarit; Cobben, Jan M.; Wieczorek, Dagmar; Gillessen-Kaesbach, Gabriele; Veltman, Joris A.; Brunner, Han G.; de Vries, Bert B. B. A.			De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome	NATURE GENETICS			English	Article							TRIGONOCEPHALY SYNDROME; VARIANTS; LEUKEMIA	Bohring-Opitz syndrome is characterized by severe intellectual disability, distinctive facial features and multiple congenital malformations. We sequenced the exomes of three individuals with Bohring-Opitz syndrome and in each identified heterozygous de novo nonsense mutations in ASXL1, which is required for maintenance of both activation and silencing of Hox genes. In total, 7 out of 13 subjects with a Bohring-Opitz phenotype had de novo ASXL1 mutations, suggesting that the syndrome is genetically heterogeneous.	[Hoischen, Alexander; van Bon, Bregje W. M.; Rodriguez-Santiago, Benjamin; Gilissen, Christian; Vissers, Lisenka E. L. M.; de Vries, Petra; Janssen, Irene; van Lier, Bart; Veltman, Joris A.; Brunner, Han G.; de Vries, Bert B. B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Rodriguez-Santiago, Benjamin] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Rodriguez-Santiago, Benjamin] CIBERER, Barcelona, Spain; [Hastings, Rob; Smithson, Sarah F.; Newbury-Ecob, Ruth] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [Kjaergaard, Susanne] Rigshosp, Univ Copenhagen Hosp, Dept Clin Genet, Copenhagen, Denmark; [Goodship, Judith] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McGowan, Ruth] Yorkhill Hosp, Dept Med Genet, Glasgow, Lanark, Scotland; [Bartholdi, Deborah; Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Peippo, Maarit] Family Federat Finland, Dept Med Genet, Helsinki, Finland; [Cobben, Jan M.] Emma Kinderziekenhuis Acad Med Ctr AMC, Dept Pediat Genet, Amsterdam, Netherlands; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Gillessen-Kaesbach, Gabriele] Univ Lubeck, Inst Humangenet Lubeck, Lubeck, Germany	Radboud University Nijmegen; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Rigshospitalet; University of Copenhagen; Newcastle University - UK; University of Zurich; Family Federation of Finland; Emma Children's Hospital; University of Duisburg Essen; University of Lubeck	Brunner, HG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	h.brunner@antrg.umcn.nl	Pinheiro, Maísa/E-7424-2012; Janssen, Irene M/V-3667-2018; Gilissen, Christian/E-5246-2012; Vissers, Lisenka ELM/A-2598-2015; Veltman, Joris A/F-5128-2010; Wieczorek, Dagmar/AAU-6008-2021; Hoischen, Alexander/AGF-7293-2022; Rauch, Anita/C-5568-2014; van Bon, Bregje/Q-2445-2015; Brunner, Han/C-9928-2013; van Bon, Bregje/D-3720-2013; Hoischen, Alexander/D-1282-2013	Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Veltman, Joris A/0000-0002-3218-8250; Wieczorek, Dagmar/0000-0003-2812-6492; Hoischen, Alexander/0000-0002-8072-4476; Rauch, Anita/0000-0003-2930-3163; van Bon, Bregje/0000-0003-2234-0105; Hoischen, Alexander/0000-0002-8072-4476; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852	Netherlands Organization for Health Research and Development (ZonMW) [917-66-36, 911-08-025, 916-86-016, 917-86-319]; EU [Health-F5-2009-223143, LSHG-CT-2006-3762]; Finland's Slot Machine Association; Fondo Investigacion Sanitaria, Spain [FIS CD06/00019]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); EU(European Commission); Finland's Slot Machine Association; Fondo Investigacion Sanitaria, Spain(Instituto de Salud Carlos III)	We thank the subjects and their parents for participation in this study. We thank P. Arts, M. Steehouwer and personnel from the Microarray Facility and Sequencing Facility Nijmegen for technical assistance. We thank N. Wieskamp, J. de Ligt and M. Rosario for bioinformatics support in data analysis. The authors are grateful to M. Sipponen and J. Ignatius for collaborative efforts relating to patient 4 and to C. Fisher for information on the Asxl1 knockout mouse. This study was financially supported by the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J.A.V., 916-86-016 to L. E. L. M. V. and 917-86-319 to B.B.B.A.d.V.), the EU-funded TECHGENE project (Health-F5-2009-223143 to J.A.V.) and the AnEUploidy project (LSHG-CT-2006-37627 to A. H., B. W. M. v. B., H. G. B., B.B.B.A.d.V. and J.A.V.). The Family Federation of Finland is funded by Finland's Slot Machine Association (RAY). B.R.-S. was supported by a postdoctoral fellowship of the Fondo Investigacion Sanitaria, Spain (FIS CD06/00019).	Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Bisgaard AM, 2007, EUR J MED GENET, V50, P243, DOI 10.1016/j.ejmg.2007.03.004; Bohring A, 2006, AM J MED GENET A, V140A, P1257, DOI 10.1002/ajmg.a.31265; Boultwood J, 2010, LEUKEMIA, V24, P1062, DOI 10.1038/leu.2010.20; Fisher CL, 2010, DEV BIOL, V337, P9, DOI 10.1016/j.ydbio.2009.10.004; Gelsi-Boyer V, 2010, BRIT J HAEMATOL, V151, P365, DOI 10.1111/j.1365-2141.2010.08381.x; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hastings R, 2011, EUR J HUM GENET, V19, P513, DOI 10.1038/ejhg.2010.234; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Kaname T, 2007, AM J HUM GENET, V81, P835, DOI 10.1086/522014; Kleefstra T., 1993, GENEREVIEWS; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; OBERKLAID F, 1975, AM J DIS CHILD, V129, P1348, DOI 10.1001/archpedi.1975.02120480062016; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002	14	192	197	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					729	731		10.1038/ng.868	http://dx.doi.org/10.1038/ng.868			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21706002				2022-12-25	WOS:000293178300005
J	Makhortova, NR; Hayhurst, M; Cerqueira, A; Sinor-Anderson, AD; Zhao, WN; Heiser, PW; Arvanites, AC; Davidow, LS; Waldon, ZO; Steen, JA; Lam, K; Ngo, HD; Rubin, LL				Makhortova, Nina R.; Hayhurst, Monica; Cerqueira, Antonio; Sinor-Anderson, Amy D.; Zhao, Wen-Ning; Heiser, Patrick W.; Arvanites, Anthony C.; Davidow, Lance S.; Waldon, Zachary O.; Steen, Judith A.; Lam, Kelvin; Ngo, Hien D.; Rubin, Lee L.			A screen for regulators of survival of motor neuron protein levels	NATURE CHEMICAL BIOLOGY			English	Article							SPINAL MUSCULAR-ATROPHY; SMN PROTEIN; MESSENGER-RNA; KINASE INHIBITORS; SMALL-MOLECULE; GROWTH CONES; GENE-PRODUCT; STEM-CELLS; INACTIVATION; EXPRESSION	The motor neuron disease spinal muscular atrophy (SMA) results from mutations that lead to low levels of the ubiquitously expressed protein survival of motor neuron (SMN). An ever-increasing collection of data suggests that therapeutics that elevate SMN may be effective in treating SMA. We executed an image-based screen of annotated chemical libraries and discovered several classes of compounds that were able to increase cellular SMN. Among the most important was the RTK-PI3K-AKT-GSK-3 signaling cascade. Chemical inhibitors of glycogen synthase kinase 3 (GSK-3) and short hairpin RNAs (shRNAs) directed against this target elevated SMN levels primarily by stabilizing the protein. It was particularly notable that GSK-3 chemical inhibitors were also effective in motor neurons, not only in elevating SMN levels, but also in blocking the death that was produced when SMN was acutely reduced by an SMN-specific shRNA. Thus, we have established a screen capable of detecting drug-like compounds that correct the main phenotypic change underlying SMA.	[Makhortova, Nina R.; Hayhurst, Monica; Cerqueira, Antonio; Sinor-Anderson, Amy D.; Zhao, Wen-Ning; Heiser, Patrick W.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Makhortova, Nina R.; Hayhurst, Monica; Cerqueira, Antonio; Arvanites, Anthony C.; Davidow, Lance S.; Lam, Kelvin; Ngo, Hien D.; Rubin, Lee L.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Waldon, Zachary O.; Steen, Judith A.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA	Harvard University; Harvard University; Harvard University; Boston Children's Hospital	Makhortova, NR (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu		Heiser, Patrick/0000-0002-8831-4973; Rubin, Lee/0000-0002-8658-841X	Spinal Muscular Atrophy Foundation; Harvard Stem Cell Institute; US National Institute of Neurological Disorders and Stroke (NINDS) [P01NS066888-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	Spinal Muscular Atrophy Foundation; Harvard Stem Cell Institute; US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank K. Kotkow, Y. M. Yang and K. Chen for helpful comments, K. Krumholz for technical help and J. LaLonde for editorial assistance. Additionally, we would like to thank R. Sivasankaran and C. Song at Novartis for sharing the conditions of the splicing assay design. The work was supported by the Spinal Muscular Atrophy Foundation, by the Harvard Stem Cell Institute and by a P01 grant (P01NS066888-01A1) from the US National Institute of Neurological Disorders and Stroke (NINDS). Mouse Hb9::CFP was a gift from K. Eggan, Harvard University.	Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; BURT JM, 1982, CIRC RES, V51, P543, DOI 10.1161/01.RES.51.5.543; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cheng H, 2011, J MOL CELL CARDIOL, V51, P607, DOI 10.1016/j.yjmcc.2010.11.020; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dodson AW, 2007, VIROLOGY, V366, P340, DOI 10.1016/j.virol.2007.05.001; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kunick C, 2005, CHEMBIOCHEM, V6, P541, DOI 10.1002/cbic.200400099; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Man NT, 2008, NEUROLOGY, V71, P1757, DOI 10.1212/01.wnl.0000313038.34337.b1; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Patrizi AL, 1999, EUR J HUM GENET, V7, P301, DOI 10.1038/sj.ejhg.5200286; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pessa HKJ, 2008, P NATL ACAD SCI USA, V105, P8655, DOI 10.1073/pnas.0803646105; Pullen MA, 2004, J PHARMACOL EXP THER, V310, P319, DOI 10.1124/jpet.104.065250; Rak K, 2009, NEUROBIOL DIS, V36, P477, DOI 10.1016/j.nbd.2009.08.014; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Shafey D, 2008, J NEUROSCI RES, V86, P2839, DOI 10.1002/jnr.21743; Steitz JA, 2008, P NATL ACAD SCI USA, V105, P8485, DOI 10.1073/pnas.0804024105; Takadera T, 2010, CELL MOL NEUROBIOL, V30, P193, DOI 10.1007/s10571-009-9442-y; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; YEH HJ, 1993, P NATL ACAD SCI USA, V90, P1952, DOI 10.1073/pnas.90.5.1952; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	50	66	77	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					544	552		10.1038/NCHEMBIO.595	http://dx.doi.org/10.1038/NCHEMBIO.595			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21685895	Green Accepted, Green Submitted			2022-12-25	WOS:000292825400016
J	Ambrose, PG				Ambrose, Paul G.			Antibiotic bill doesn't GAIN enough ground	NATURE MEDICINE			English	Editorial Material								With an eye to tackling the growing problem of antimicrobial drug resistance, US lawmakers last month proposed new incentives to jump-start the ailing antibiotic industry. but the legislation as written is not likely to have the intended consequences, as it fails to adequately shield companies from competition with generic drugs. To truly entice investment and research from the drug industry, the bill needs to simplify the path to regulatory approval, provide greater protection from generic competition and aid drug companies with intellectual property extensions, tax relief and guaranteed market commitments.	[Ambrose, Paul G.] Inst Clin Pharmacodynam, Latham, NY USA; [Ambrose, Paul G.] Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Ambrose, PG (corresponding author), Inst Clin Pharmacodynam, Latham, NY USA.								0	10	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					772	772		10.1038/nm0711-772	http://dx.doi.org/10.1038/nm0711-772			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738147				2022-12-25	WOS:000292500800018
J	Fedeles, SV; Tian, X; Gallagher, AR; Mitobe, M; Nishio, S; Lee, SH; Cai, YQ; Geng, L; Crews, CM; Somlo, S				Fedeles, Sorin V.; Tian, Xin; Gallagher, Anna-Rachel; Mitobe, Michihiro; Nishio, Saori; Lee, Seung Hun; Cai, Yiqiang; Geng, Lin; Crews, Craig M.; Somlo, Stefan			A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT; MOLECULAR-BASIS; GLUCOSIDASE II; MUTATIONS; MICE; EXPRESSION; PROTEIN; CILIA; PKD1; RECOMBINATION	Autosomal dominant polycystic liver disease results from mutations in PRKCSH or SEC63. The respective gene products, glucosidase II beta and SEC63p, function in protein translocation and quality control pathways in the endoplasmic reticulum. Here we show that glucosidase II beta and Sec63p are required in mice for adequate expression of a functional complex of the polycystic kidney disease gene products, polycystin-1 and polycystin-2. We find that polycystin-1 is the rate-limiting component of this complex and that there is a dose-response relationship between cystic dilation and levels of functional polycystin-1 following mutation of Prkcsh or Sec63. Reduced expression of polycystin-1 also serves to sensitize the kidney to cyst formation resulting from mutations in Pkhd1, the recessive polycystic kidney disease gene. Finally, we show that proteasome inhibition increases steady-state levels of polycystin-1 in cells lacking glucosidase II beta and that treatment with a proteasome inhibitor reduces cystic disease in orthologous gene models of human autosomal dominant polycystic liver disease.	[Fedeles, Sorin V.; Tian, Xin; Gallagher, Anna-Rachel; Mitobe, Michihiro; Nishio, Saori; Lee, Seung Hun; Cai, Yiqiang; Geng, Lin; Somlo, Stefan] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Fedeles, Sorin V.; Somlo, Stefan] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Crews, Craig M.] Yale Univ, Sch Med, Dept Mol Cellular & Dev Biol, New Haven, CT 06510 USA; [Crews, Craig M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Crews, Craig M.] Yale Univ, Sch Med, Dept Chem, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Somlo, S (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	stefan.somlo@yale.edu	Fedeles, Sorin/AAI-7395-2020; Crews, Craig M./ABH-9346-2020; Nishio, Saori/G-2022-2012	Crews, Craig M./0000-0002-8456-2005; 	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)/US National Institutes of Health (NIH) [R01DK51041, R01DK54053, F31DK083904]; Mizutani Foundation for Glycoscience; Nephrology Training Grant [T32DK007276]; Joseph LeRoy and Ann C. Warner Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK083904, R01DK054053, R01DK051041, T32DK007276, P50DK057328, P30DK079310] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)/US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mizutani Foundation for Glycoscience; Nephrology Training Grant; Joseph LeRoy and Ann C. Warner Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Carfilzomib was a kind gift from Proteolix, Inc. This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)/US National Institutes of Health (NIH) (R01DK51041 and R01DK54053 to S.S. and F31DK083904 to S.V.F.) and a grant from the Mizutani Foundation for Glycoscience (S.S.). We are grateful for support from the Nephrology Training Grant (T32DK007276) to S.V.F. and the Joseph LeRoy and Ann C. Warner Fund (S.S.). The authors are members of the Yale PKD Center (P50DK57328). We are grateful for Core services from the Yale O'Brien Kidney Center (P30DK079310).	Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Garcia-Gonzalez MA, 2007, HUM MOL GENET, V16, P1940, DOI 10.1093/hmg/ddm141; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Kaimori JY, 2007, HUM MOL GENET, V16, P942, DOI 10.1093/hmg/ddm039; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Menezes LF, 2009, METHOD CELL BIOL, V94, P273, DOI 10.1016/S0091-679X(08)94014-0; Misselwitz E, 1999, J BIOL CHEM, V274, P20110, DOI 10.1074/jbc.274.29.20110; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishio S, 2010, J AM SOC NEPHROL, V21, P295, DOI 10.1681/ASN.2009060603; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pei Y, 2001, AM J HUM GENET, V68, P355, DOI 10.1086/318188; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian Q, 2003, HEPATOLOGY, V37, P164, DOI 10.1053/jhep.2003.50006; Reynolds DM, 2000, AM J HUM GENET, V67, P1598, DOI 10.1086/316904; Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Spirli C, 2010, GASTROENTEROLOGY, V138, P360, DOI 10.1053/j.gastro.2009.09.005; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; van Keimpema L, 2011, LIVER INT, V31, P92, DOI 10.1111/j.1478-3231.2010.02247.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WANG S, 2004, J AM SOC NEPHROL, V15, pA12; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; WARD CJ, 1994, CELL, V77, P881; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106	53	160	164	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					639	U163		10.1038/ng.860	http://dx.doi.org/10.1038/ng.860			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21685914	Green Accepted			2022-12-25	WOS:000292184600007
J	Baba, A; Ohtake, F; Okuno, Y; Yokota, K; Okada, M; Imai, Y; Ni, M; Meyer, CA; Igarashi, K; Kanno, J; Brown, M; Kato, S				Baba, Atsushi; Ohtake, Fumiaki; Okuno, Yosuke; Yokota, Kenichi; Okada, Maiko; Imai, Yuuki; Ni, Min; Meyer, Clifford A.; Igarashi, Katsuhide; Kanno, Jun; Brown, Myles; Kato, Shigeaki			PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B	NATURE CELL BIOLOGY			English	Article							DOMAIN-CONTAINING PROTEINS; HEPATIC GLUCONEOGENESIS; CHROMATIN MODIFICATIONS; GLUCOSE-METABOLISM; NUCLEAR RECEPTORS; DIOXIN RECEPTOR; TRANSCRIPTION; COACTIVATOR; FAMILY; PGC-1	Reversible histone methylation and demethylation are highly regulated processes that are crucial for chromatin reorganization and regulation of gene transcription in response to extracellular conditions. However, the mechanisms that regulate histone-modifying enzymes are largely unknown. Here, we characterized a protein kinase A (PKA)-dependent histone lysine demethylase complex, PHF2-ARID5B. PHF2, a jmjC demethylase, is enzymatically inactive by itself, but becomes an active H3K9Me2 demethylase through PKA-mediated phosphorylation. We found that phosphorylated PHF2 then associates with ARID5B, a DNA-binding protein, and induce demethylation of methylated ARID5B. This modification leads to targeting of the PHF2 ARID5B complex to its target promoters, where it removes the repressive H3K9Me2 mark. These findings suggest that the PHF2 ARID5B complex is a signal-sensing modulator of histone methylation and gene transcription, in which phosphorylation of PHF2 enables subsequent formation of a competent and specific histone demethylase complex.	[Baba, Atsushi; Ohtake, Fumiaki; Okuno, Yosuke; Yokota, Kenichi; Okada, Maiko; Imai, Yuuki; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Ohtake, Fumiaki; Okuno, Yosuke; Okada, Maiko; Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchishi, Saitama 3320012, Japan; [Imai, Yuuki; Ni, Min; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Imai, Yuuki; Ni, Min; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Meyer, Clifford A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Meyer, Clifford A.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Igarashi, Katsuhide; Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Setagaya Ku, Tokyo 1588501, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; National Institute of Health Sciences - Japan	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp	Brown, Myles/AAX-5332-2021; Imai, Yuuki/ABC-4687-2020; Brown, Myles/B-6906-2008	Brown, Myles/0000-0002-8213-1658; 	Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan; JSPS; Naito Foundation; Grants-in-Aid for Scientific Research [23791051] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank D. D. Moore for critical discussion, R. Sato and J. Inoue for providing materials, N. Moriyama and S. Fujiyama for technical assistance and M. Yamaki for manuscript preparation. This work was supported in part by Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan, JSPS, and The Naito Foundation (to F.O. and S.K.).	Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hasenpusch-Theil K, 1999, MAMM GENOME, V10, P294, DOI 10.1007/s003359900989; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Okada M, 2008, EMBO REP, V9, P563, DOI 10.1038/embor.2008.55; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tsukada YI, 2010, GENE DEV, V24, P432, DOI 10.1101/gad.1864410; Unno A, 2005, BIOCHEM BIOPH RES CO, V327, P933, DOI 10.1016/j.bbrc.2004.12.095; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Whitson RH, 1999, BIOCHEM BIOPH RES CO, V258, P326, DOI 10.1006/bbrc.1999.0643; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	37	132	142	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					668	U101		10.1038/ncb2228	http://dx.doi.org/10.1038/ncb2228			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21532585				2022-12-25	WOS:000291147400007
J	Kashyap, DR; Wang, MH; Liu, LH; Boons, GJ; Gupta, D; Dziarski, R				Kashyap, Des Raj; Wang, Minhui; Liu, Li-Hui; Boons, Geert-Jan; Gupta, Dipika; Dziarski, Roman			Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems	NATURE MEDICINE			English	Article							L-ALANINE AMIDASE; BACILLUS-SUBTILIS; SECRETION STRESS; STAPHYLOCOCCUS-AUREUS; REGULATORY SYSTEM; ESCHERICHIA-COLI; CELL-SEPARATION; PEPTIDES; GROWTH; DEATH	Mammalian peptidoglycan recognition proteins (PGRPs), similar to antimicrobial lectins, bind the bacterial cell wall and kill bacteria through an unknown mechanism. We show that PGRPs enter the Gram-positive cell wall at the site of daughter cell separation during cell division. In Bacillus subtilis, PGRPs activate the CssR-CssS two-component system that detects and disposes of misfolded proteins that are usually exported out of bacterial cells. This activation results in membrane depolarization, cessation of intracellular peptidoglycan, protein, RNA and DNA synthesis, and production of hydroxyl radicals, which are responsible for bacterial death. PGRPs also bind the outer membrane of Escherichia coli and activate the functionally homologous CpxA-CpxR two-component system, which kills the bacteria. We exclude other potential bactericidal mechanisms, including inhibition of extracellular peptidoglycan synthesis, hydrolysis of peptidoglycan and membrane permeabilization. Thus, we reveal a previously unknown mechanism by which innate immunity proteins that bind the cell wall or outer membrane exploit the bacterial stress defense response to kill bacteria.	[Kashyap, Des Raj; Wang, Minhui; Liu, Li-Hui; Gupta, Dipika; Dziarski, Roman] Indiana Univ Sch Med NW, Gary, IN USA; [Boons, Geert-Jan] Univ Georgia, Athens, GA 30602 USA	Indiana University System; Indiana University Northwest; University System of Georgia; University of Georgia	Dziarski, R (corresponding author), Indiana Univ Sch Med NW, Gary, IN USA.	rdziar@iun.edu	Boons, Geert-Jan P H/J-3211-2016	Boons, Geert-Jan P H/0000-0003-3111-5954; Kashyap, Des/0000-0002-7151-2404	US Public Health Service from the US National Institutes of Health [AI073290, AI028797, GM061761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073290, R01AI028797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761] Funding Source: NIH RePORTER	US Public Health Service from the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J.M. van Dijl, O.P. Kuipers and V.P. Kontinen and their associates J. Zweers and S. Holsappel (University of Groningen and National Institute of Health and Welfare Finland), J. Sekiguchi (Shinshu University) and S.J. Foster (University of Sheffield) for providing B. subtilis mutants; to J.J. Collins and M.A. Kohanski (Boston University) for providing E. coli mutants; to J.M. van Dijl and his associates T. Kouwen and M. Sibbald (University of Groningen) for the pGDL48 plasmid and its sequence; to M. Wang for analyzing samples by mass spectrometry; and to Huvepharma for providing moenomycin. This work was supported by the US Public Health Service grants from the US National Institutes of Health AI073290 and AI028797 to R.D. and D.G. and GM061761 to G.-J.B.	Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Darmon E, 2002, J BACTERIOL, V184, P5661, DOI 10.1128/JB.184.20.5661-5671.2002; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Dziarski R, 2006, CELL MICROBIOL, V8, P1059, DOI 10.1111/j.1462-5822.2006.00726.x; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; MEIJER WJJ, 1995, MOL MICROBIOL, V17, P621, DOI 10.1111/j.1365-2958.1995.mmi_17040621.x; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Westers H, 2006, FEBS J, V273, P3816, DOI 10.1111/j.1742-4658.2006.05389.x; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Yamamoto H, 2003, J BACTERIOL, V185, P6666, DOI 10.1128/JB.185.22.6666-6677.2003	36	116	127	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					676	U64		10.1038/nm.2357	http://dx.doi.org/10.1038/nm.2357			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602801	Green Accepted			2022-12-25	WOS:000291308800027
J	Snape, K; Hanks, S; Ruark, E; Barros-Nunez, P; Elliott, A; Murray, A; Lane, AH; Shannon, N; Callier, P; Chitayat, D; Clayton-Smith, J; FitzPatrick, DR; Gisselsson, D; Jacquemont, S; Asakura-Hay, K; Micale, MA; Tolmie, J; Turnpenny, PD; Wright, M; Douglas, J; Rahman, N				Snape, Katie; Hanks, Sandra; Ruark, Elise; Barros-Nunez, Patricio; Elliott, Anna; Murray, Anne; Lane, Andrew H.; Shannon, Nora; Callier, Patrick; Chitayat, David; Clayton-Smith, Jill; FitzPatrick, David R.; Gisselsson, David; Jacquemont, Sebastien; Asakura-Hay, Keiko; Micale, Mark A.; Tolmie, John; Turnpenny, Peter D.; Wright, Michael; Douglas, Jenny; Rahman, Nazneen			Mutations in CEP57 cause mosaic variegated aneuploidy syndrome	NATURE GENETICS			English	Article							HUMAN CANCER; PROTEIN	Using exome sequencing and a variant prioritization strategy that focuses on loss-of-function variants, we identified biallelic, loss-of-function CEP57 mutations as a cause of constitutional mosaic aneuploidies. CEP57 is a centrosomal protein and is involved in nucleating and stabilizing microtubules. Our findings indicate that these and/or additional functions of CEP57 are crucial for maintaining correct chromosomal number during cell division.	[Snape, Katie; Hanks, Sandra; Ruark, Elise; Elliott, Anna; Murray, Anne; Douglas, Jenny; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Barros-Nunez, Patricio] Inst Mexicano Seguro Social, Div Genet, Ctr Invest Biomed Occidente, Guadalajara, Jalisco, Mexico; [Lane, Andrew H.] SUNY Stony Brook, Div Pediat Endocrinol, Stony Brook, NY 11794 USA; [Shannon, Nora] City Hosp, Clin Genet Serv, Nottingham NG5 1PB, England; [Callier, Patrick] CHU Dijon, Cytogenet Serv, Dijon, France; [Chitayat, David] Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Chitayat, David] Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Clayton-Smith, Jill] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Manchester M13 0JH, Lancs, England; [FitzPatrick, David R.] Western Gen Hosp, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Gisselsson, David] Lund Univ, Dept Clin Genet, Univ & Reg Labs, Skane Univ Hosp, Lund, Sweden; [Jacquemont, Sebastien] CHU Vaudois, Div Med Genet, CH-1011 Lausanne, Switzerland; [Asakura-Hay, Keiko] Tayside Univ Hosp Natl Hlth Serv NHS Trust, Ninewells Hosp & Med Sch, Dundee, Scotland; [Micale, Mark A.] Royal Oak & Oakland Univ, William Beaumont Sch Med, William Beaumont Hosp, Dept Anat Pathol, Rochester, MI USA; [Tolmie, John] Royal Hosp Sick Children, Dept Clin Genet, Ferguson Smith Ctr, Glasgow G3 8SJ, Lanark, Scotland; [Turnpenny, Peter D.] Royal Devon & Exeter Healthcare NHS Trust, Peninsula Clin Genet Serv, Exeter, Devon, England; [Turnpenny, Peter D.] Royal Devon & Exeter Healthcare NHS Trust, Peninsula Med Sch, Exeter, Devon, England; [Wright, Michael] Newcastle Upon Tyne Hosp Fdn Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England	University of London; Institute of Cancer Research - UK; Instituto Mexicano del Seguro Social; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Nottingham; CHU Dijon Bourgogne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Manchester; University of Edinburgh; Lund University; Skane University Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Dundee; Beaumont Health; University of Glasgow; University of Exeter; University of Exeter; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	nazneen.rahman@icr.ac.uk	FitzPatrick, David R/C-7301-2013; Rahman, Nazneen/B-8890-2012; Jacquemont, Sebastien/AAS-5060-2021; Snape, Katie/AAA-8101-2022; Rahman, Nazneen/D-2802-2013	Jacquemont, Sebastien/0000-0001-6838-8767; FitzPatrick, David R./0000-0003-4861-969X; Barros-Nunez, Jaime Patricio/0000-0002-6607-5553; Rahman, Nazneen/0000-0003-4376-0440	Michael and Betty Kadoorie Cancer Genetics Research Programme; NHS; Cancer Research UK [C8620_A9024, C8620_A8857]; Institute of Cancer Research (UK); MRC [MC_U127561093] Funding Source: UKRI; Medical Research Council [MC_U127561093] Funding Source: researchfish	Michael and Betty Kadoorie Cancer Genetics Research Programme; NHS; Cancer Research UK(Cancer Research UK); Institute of Cancer Research (UK)(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are very grateful to all the families that participated in this study and to A. Zachariou, M. Warren-Perry, R. Linger, D. Dudakia and J. Bull for assistance in their recruitment. We thank D. Leongamornlert for assistance with exome sequencing, A. Renwick, S. Seal, G. Bowden, D. Hughes and C. Turnbull for assistance in Solexa optimization and validation experiments and B. Ebbs for DNA extraction and for running the ABI sequencer. We thank K. Tatton-Brown for assistance with clinical review of cases, A. I. Vasquez and J. Swansbury for the karyotyping and A. Strydom for secretarial assistance with the manuscript. K. S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme. We acknowledge NHS funding to the National Institute for Health Research Biomedical Research Centre. This work was supported by Cancer Research UK (grants C8620_A9024 and C8620_A8857) and the Institute of Cancer Research (UK).	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Garcia-Castillo H, 2008, AM J MED GENET A, V146A, P1687, DOI 10.1002/ajmg.a.32315; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Lane AH, 2002, AM J MED GENET, V110, P273, DOI 10.1002/ajmg.10462; Meunier S, 2009, TRAFFIC, V10, P1765, DOI 10.1111/j.1600-0854.2009.00985.x; Momotani K, 2008, BIOCHEM J, V412, P265, DOI 10.1042/BJ20071501; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Suijkerbuijk SJE, 2010, CANCER RES, V70, P4891, DOI 10.1158/0008-5472.CAN-09-4319; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878	13	86	89	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					527	529		10.1038/ng.822	http://dx.doi.org/10.1038/ng.822			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21552266	Green Accepted			2022-12-25	WOS:000291017000008
J	[Anonymous]				[Anonymous]			Tracing the roots of squamous cell carcinomas	NATURE MEDICINE			English	Editorial Material							TUMORS; ORIGIN; SKIN											Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Epstein EH, 2011, J CLIN INVEST, V121, P1681, DOI 10.1172/JCI57700; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	9	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					668	668		10.1038/nm0611-668	http://dx.doi.org/10.1038/nm0611-668			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21647146				2022-12-25	WOS:000291308800022
J	Karim, L; Takeda, H; Lin, L; Druet, T; Arias, JAC; Baurain, D; Cambisano, N; Davis, SR; Farnir, F; Grisart, B; Harris, BL; Keehan, MD; Littlejohn, MD; Spelman, RJ; Georges, M; Coppieters, W				Karim, Latifa; Takeda, Haruko; Lin, Li; Druet, Tom; Arias, Juan A. C.; Baurain, Denis; Cambisano, Nadine; Davis, Stephen R.; Farnir, Frederic; Grisart, Bernard; Harris, Bevin L.; Keehan, Mike D.; Littlejohn, Mathew D.; Spelman, Richard J.; Georges, Michel; Coppieters, Wouter			Variants modulating the expression of a chromosome domain encompassing PLAG1 influence bovine stature	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; HUMAN HEIGHT; BIOLOGICAL PATHWAYS; CARCASS TRAITS; ANGUS CATTLE; BEEF-CATTLE; GROWTH; IDENTIFICATION; QTL	We report mapping of a quantitative trait locus (QTL) with a major effect on bovine stature to a similar to 780-kb interval using a Hidden Markov Model-based approach that simultaneously exploits linkage and linkage disequilibrium. We re-sequenced the interval in six sires with known QTL genotype and identified 13 clustered candidate quantitative trait nucleotides (QTNs) out of > 9,572 discovered variants. We eliminated five candidate QTNs by studying the phenotypic effect of a recombinant haplotype identified in a breed diversity panel. We show that the QTL influences fetal expression of seven of the nine genes mapping to the similar to 780-kb interval. We further show that two of the eight candidate QTNs, mapping to the PLAG1-CHCHD7 intergenic region, influence bidirectional promoter strength and affect binding of nuclear factors. By performing expression QTL analyses, we identified a splice site variant in CHCHD7 and exploited this naturally occurring null allele to exclude CHCHD7 as single causative gene.	[Karim, Latifa; Takeda, Haruko; Lin, Li; Druet, Tom; Baurain, Denis; Cambisano, Nadine; Farnir, Frederic; Grisart, Bernard; Georges, Michel; Coppieters, Wouter] Univ Liege B34, Unit Anim Genom, Interdisciplinary Inst Appl Genom GIGA R, Liege, Belgium; [Karim, Latifa; Takeda, Haruko; Lin, Li; Druet, Tom; Baurain, Denis; Cambisano, Nadine; Farnir, Frederic; Grisart, Bernard; Georges, Michel; Coppieters, Wouter] Univ Liege B34, Fac Vet Med, Liege, Belgium; [Arias, Juan A. C.; Harris, Bevin L.; Keehan, Mike D.; Spelman, Richard J.] LIC, Hamilton, New Zealand; [Davis, Stephen R.] ViaLactia BioSci, Auckland, New Zealand; [Littlejohn, Mathew D.] DairyNZ, Hamilton, New Zealand	University of Liege; University of Liege; DairyNZ	Georges, M (corresponding author), Univ Liege B34, Unit Anim Genom, Interdisciplinary Inst Appl Genom GIGA R, Liege, Belgium.	michel.georges@ulg.ac.be	Coppieters, Wouter/AAF-5030-2021; Baurain, Denis/S-4048-2019	Coppieters, Wouter/0000-0001-8109-7825; Baurain, Denis/0000-0003-2388-6185; Georges, Michel/0000-0003-4124-2375; Littlejohn, Mathew/0000-0001-9044-047X; Druet, Tom/0000-0003-1637-1706; Keehan, Michael/0000-0001-5607-7347	Livestock Improvement Corporation (LIC; Hamilton, New Zealand); Unit of Animal Genomics; University of Liege; Communaute Francaise de Belgique (ARC Biomod); Belgian Science Policy Organisation (SSTC Genefunc PAI)	Livestock Improvement Corporation (LIC; Hamilton, New Zealand); Unit of Animal Genomics; University of Liege(University of Liege); Communaute Francaise de Belgique (ARC Biomod); Belgian Science Policy Organisation (SSTC Genefunc PAI)	This work was funded by Livestock Improvement Corporation (LIC; Hamilton, New Zealand) and by grants from the Unit of Animal Genomics, the University of Liege, the Communaute Francaise de Belgique (ARC Biomod) and the Belgian Science Policy Organisation (SSTC Genefunc PAI). T.D. is Research Associate of the Fond National de Recherche Scientifique. We are grateful for the support of the GIGA-R sequencing core facility.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; [Anonymous], 1997, GENETICS ANAL QUANTI; Arias JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-18; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Buchanan FC, 2005, ANIM GENET, V36, P127, DOI 10.1111/j.1365-2052.2005.01255.x; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; CHURCHILL GA, 1994, GENETICS, V138, P963; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; Coppieters W, 1998, GENETICS, V149, P1547; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Galton F, 1885, J R ANTHR I, V5, P329; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; HALEY CS, 1994, GENETICS, V136, P1195; Hensen K, 2004, DEV GROWTH DIFFER, V46, P459, DOI 10.1111/j.1440-169x.2004.00762.x; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kneeland J, 2004, J ANIM SCI, V82, P3405; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Long AD, 1996, GENETICS, V144, P1497; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Misztal I., 2002, P 7 WORLD C GEN APPL, p28.07; Mizoshita K, 2005, MAMM GENOME, V16, P532, DOI 10.1007/s00335-005-0024-0; Mizoshita K, 2004, J ANIM SCI, V82, P3415; NELSEN TC, 1986, J ANIM SCI, V63, P409, DOI 10.2527/jas1986.632409x; Nezer C, 2003, GENETICS, V165, P277; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; NORTHCUTT SL, 1993, J ANIM SCI, V71, P1148, DOI 10.2527/1993.7151148x; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; SERVICE PM, 2004, SCI AGING KNOWLEDGE, V12, pPE13; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Takasuga A, 2007, MAMM GENOME, V18, P125, DOI 10.1007/s00335-006-0096-5; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Van Dyck F, 2007, INT J ONCOL, V30, P765; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Visscher PM, 1996, GENETICS, V143, P1013; Voz ML, 2004, ONCOGENE, V23, P179, DOI 10.1038/sj.onc.1207013; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	57	230	237	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2011	43	5					405	+		10.1038/ng.814	http://dx.doi.org/10.1038/ng.814			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21516082				2022-12-25	WOS:000289972600008
J	Won, H; Mah, W; Kim, E; Kim, JW; Hahm, EK; Kim, MH; Cho, S; Kim, J; Jang, H; Cho, SC; Kim, BN; Shin, MS; Seo, J; Jeong, J; Choi, SY; Kim, D; Kang, C; Kim, E				Won, Hyejung; Mah, Won; Kim, Eunjin; Kim, Jae-Won; Hahm, Eun-Kyoung; Kim, Myoung-Hwan; Cho, Sukhee; Kim, Jeongjin; Jang, Hyeran; Cho, Soo-Churl; Kim, Boong-Nyun; Shin, Min-Sup; Seo, Jinsoo; Jeong, Jaeseung; Choi, Se-Young; Kim, Daesoo; Kang, Changwon; Kim, Eunjoon			GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice	NATURE MEDICINE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SPINE MORPHOGENESIS; MOUSE MODEL; SYNAPSE FORMATION; GENOMEWIDE SCAN; LINKAGE; INHIBITION; CHILDREN; FAMILY	Attention deficit hyperactivity disorder (ADHD) is a psychiatric disorder that affects similar to 5% of school-aged children; however, the mechanisms underlying ADHD remain largely unclear. Here we report a previously unidentified association between G protein-coupled receptor kinase-interacting protein-1 (GIT1) and ADHD in humans. An intronic single-nucleotide polymorphism in GIT1, the minor allele of which causes reduced GIT1 expression, shows a strong association with ADHD susceptibility in humans. Git1-deficient mice show ADHD-like phenotypes, with traits including hyperactivity, enhanced electroencephalogram theta rhythms and impaired learning and memory. Hyperactivity in Git1(-/-) mice is reversed by amphetamine and methylphenidate, psychostimulants commonly used to treat ADHD. In addition, amphetamine normalizes enhanced theta rhythms and impaired memory. GIT1 deficiency in mice leads to decreases in ras-related C3 botulinum toxin substrate-1 (RAC1) signaling and inhibitory presynaptic input; furthermore, it shifts the neuronal excitation-inhibition balance in postsynaptic neurons toward excitation. Our study identifies a previously unknown involvement of GIT1 in human ADHD and shows that GIT1 deficiency in mice causes psychostimulant-responsive ADHD-like phenotypes.	[Won, Hyejung; Mah, Won; Kim, Eunjin; Hahm, Eun-Kyoung; Kim, Myoung-Hwan; Kim, Jeongjin; Kim, Daesoo; Kang, Changwon; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Won, Hyejung; Mah, Won; Hahm, Eun-Kyoung; Kim, Myoung-Hwan; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; [Kim, Jae-Won; Cho, Soo-Churl; Kim, Boong-Nyun; Shin, Min-Sup] Seoul Natl Univ Hosp, Coll Med, Dept Child & Adolescent Psychiat, Seoul 110744, South Korea; [Cho, Sukhee; Seo, Jinsoo; Choi, Se-Young] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul, South Korea; [Jang, Hyeran; Jeong, Jaeseung] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, World Class Univ, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	ckang@kaist.ac.kr; kime@kaist.ac.kr	Kim, Boong Nyun/J-5397-2012; Cho, Soo Churl/J-5667-2012; Seo, Jinsoo/AAD-4950-2019; Kim, Daesoo/C-1625-2011; Kim, Jae Won/J-5430-2012; Jeong, Jaeseung/C-1620-2011; Kim, Myoung-Hwan/J-2444-2012; Kang, Changwon/C-1938-2011; Shin, Min Sup/J-5521-2012; Kim, Eunjoon/C-1566-2011	Seo, Jinsoo/0000-0001-6432-6964; Kim, Daesoo/0000-0001-9915-1463; Kang, Changwon/0000-0002-0867-6385; Kim, Eunjin/0000-0002-2309-4420; Choi, Se-Young/0000-0001-7534-5167	Ministry of Education, Science, and Technology [R31-2008-000-10071-0]; National Research Foundation of Korea [2010-0014162, 313-2007-2-C00630, 2010-0002283, 20100000032]; Seoul National University Hospital [09-2008-001-0]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Hospital	We thank the Vector Integration Site Analysis service at the University of California-Davis Mouse Biology Program for providing the data on the single-copy status of the Git1 gene trap. This work was supported by the Korean National Creative Research Initiative program and WCU (World Class University) program (R31-2008-000-10071-0) funded by the Ministry of Education, Science, and Technology (to Eunjoon K.), the National Research Foundation of Korea 2010-0014162 to C. K. and 313-2007-2-C00630 to S.-Y.C.), the Basic Science Program through the National Research Foundation of Korea (2010-0002283 to J.K.), the Mid-career Researcher Program through the National Research Foundation of Korea (20100000032 to D. K.), the Seoul National University Hospital Research Fund (09-2008-001-0 to J.K.) and by a T.J. Park Doctoral Fellowship (to H. W.).	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Arcos-Burgos M, 2004, AM J HUM GENET, V75, P998, DOI 10.1086/426154; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; BARKLEY RA, 1977, J CHILD PSYCHOL PSYC, V18, P137, DOI 10.1111/j.1469-7610.1977.tb00425.x; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2006, HDB DIAGNOSIS TREATM; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Boda B, 2006, MOL NEUROBIOL, V34, P67, DOI 10.1385/MN:34:1:67; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Clarke AR, 2002, PSYCHOPHARMACOLOGY, V164, P277, DOI 10.1007/s00213-002-1205-0; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Deutsch SI, 2001, CLIN NEUROPHARMACOL, V24, P43, DOI 10.1097/00002826-200101000-00008; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gilden DL, 2007, PSYCHOL SCI, V18, P796, DOI 10.1111/j.1467-9280.2007.01982.x; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Kim YS, 2004, YONSEI MED J, V45, P81, DOI 10.3349/ymj.2004.45.1.81; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Ko J, 2003, J NEUROSCI, V23, P1667; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Moll GH, 2000, NEUROSCI LETT, V284, P121, DOI 10.1016/S0304-3940(00)00980-0; Moll GH, 2003, ACTA PSYCHIAT SCAND, V107, P69, DOI 10.1034/j.1600-0447.2003.02114.x; Ogdie MN, 2004, AM J HUM GENET, V75, P661, DOI 10.1086/424387; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Pouget P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005208; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Richter MM, 2007, NEUROSCI LETT, V419, P137, DOI 10.1016/j.neulet.2007.04.024; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Rosa-Neto P, 2005, NEUROIMAGE, V25, P868, DOI 10.1016/j.neuroimage.2004.11.031; Russell VA, 2007, J NEUROSCI METH, V166, pI, DOI 10.1016/j.jneumeth.2006.12.020; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Schmalzigaug R, 2009, NEUROSCI LETT, V458, P79, DOI 10.1016/j.neulet.2009.04.037; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shilyansky C, 2010, P NATL ACAD SCI USA, V107, P13141, DOI 10.1073/pnas.1004829107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	60	93	96	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					566	+		10.1038/nm.2330	http://dx.doi.org/10.1038/nm.2330			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499268				2022-12-25	WOS:000290250400032
J	Barrett, JH; Iles, MM; Harland, M; Taylor, JC; Aitken, JF; Andresen, PA; Akslen, LA; Armstrong, BK; Avril, MF; Azizi, E; Bakker, B; Bergman, W; Bianchi-Scarra, G; Bressac-de Paillerets, B; Calista, D; Cannon-Albright, LA; Corda, E; Cust, AE; Debniak, T; Duffy, D; Dunning, AM; Easton, DF; Friedman, E; Galan, P; Ghiorzo, P; Giles, GG; Hansson, J; Hocevar, M; Hoiom, V; Hopper, JL; Ingvar, C; Janssen, B; Jenkins, MA; Jonsson, G; Kefford, RF; Landi, G; Landi, MT; Lang, J; Lubinski, J; Mackie, R; Malvehy, J; Martin, NG; Molven, A; Montgomery, GW; van Nieuwpoort, FA; Novakovic, S; Olsson, H; Pastorino, L; Puig, S; Puig-Butille, JA; Randerson-Moor, J; Snowden, H; Tuominen, R; VanBelle, P; van der Stoep, N; Whiteman, DC; Zelenika, D; Han, JL; Fang, SY; Lee, JE; Wei, QY; Lathrop, GM; Gillanders, EM; Brown, KM; Goldstein, AM; Kanetsky, PA; Mann, GJ; MacGregor, S; Elder, DE; Amos, CI; Hayward, NK; Gruis, NA; Demenais, F; Bishop, JAN; Bishop, DT				Barrett, Jennifer H.; Iles, Mark M.; Harland, Mark; Taylor, John C.; Aitken, Joanne F.; Andresen, Per Arne; Akslen, Lars A.; Armstrong, Bruce K.; Avril, Marie-Francoise; Azizi, Esther; Bakker, Bert; Bergman, Wilma; Bianchi-Scarra, Giovanna; Bressac-de Paillerets, Brigitte; Calista, Donato; Cannon-Albright, Lisa A.; Corda, Eve; Cust, Anne E.; Debniak, Tadeusz; Duffy, David; Dunning, Alison M.; Easton, Douglas F.; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Giles, Graham G.; Hansson, Johan; Hocevar, Marko; Hoeiom, Veronica; Hopper, John L.; Ingvar, Christian; Janssen, Bart; Jenkins, Mark A.; Joensson, Goeran; Kefford, Richard F.; Landi, Giorgio; Landi, Maria Teresa; Lang, Julie; Lubinski, Jan; Mackie, Rona; Malvehy, Josep; Martin, Nicholas G.; Molven, Anders; Montgomery, Grant W.; van Nieuwpoort, Frans A.; Novakovic, Srdjan; Olsson, Hakan; Pastorino, Lorenza; Puig, Susana; Puig-Butille, Joan Anton; Randerson-Moor, Juliette; Snowden, Helen; Tuominen, Rainer; VanBelle, Patricia; van der Stoep, Nienke; Whiteman, David C.; Zelenika, Diana; Han, Jiali; Fang, Shenying; Lee, Jeffrey E.; Wei, Qingyi; Lathrop, G. Mark; Gillanders, Elizabeth M.; Brown, Kevin M.; Goldstein, Alisa M.; Kanetsky, Peter A.; Mann, Graham J.; MacGregor, Stuart; Elder, David E.; Amos, Christopher I.; Hayward, Nicholas K.; Gruis, Nelleke A.; Demenais, Florence; Bishop, Julia A. Newton; Bishop, D. Timothy		GenoMEL Consortium	Genome-wide association study identifies three new melanoma susceptibility loci	NATURE GENETICS			English	Article							CUTANEOUS MELANOMA; PHENOTYPIC CHARACTERISTICS; MALIGNANT-MELANOMA; SEQUENCE VARIANTS; RISK; CANCER; WOMEN; GENE; METAANALYSIS; EXPOSURE	We report a genome-wide association study for melanoma that was conducted by the GenoMEL Consortium. Our discovery phase included 2,981 individuals with melanoma and 1,982 study-specific control individuals of European ancestry, as well as an additional 6,426 control subjects from French or British populations, all of whom were genotyped for 317,000 or 610,000 single-nucleotide polymorphisms (SNPs). Our analysis replicated previously known melanoma susceptibility loci. Seven new regions with at least one SNP with P < 10(-5) and further local imputed or genotyped support were selected for replication using two other genome-wide studies (from Australia and Texas, USA). Additional replication came from case-control series from the UK and The Netherlands. Variants at three of the seven loci replicated at P < 10(-3): an SNP in ATM (rs1801516, overall P = 3.4 x 10(-9)), an SNP in MX2 (rs45430, P = 2.9 x 10-9) and an SNP adjacent to CASP8 (rs13016963, P = 8.6 x 10(-10)). A fourth locus near CCND1 remains of potential interest, showing suggestive but inconclusive evidence of replication (rs1485993, overall P = 4.6 x 10(-7) under a fixed-effects model and P = 1.2 x 10(-3) under a random-effects model). These newly associated variants showed no association with nevus or pigmentation phenotypes in a large British case-control series.	[Barrett, Jennifer H.; Iles, Mark M.; Harland, Mark; Taylor, John C.; Randerson-Moor, Juliette; Snowden, Helen; Bishop, Julia A. Newton; Bishop, D. Timothy] St James Univ Hosp, Leeds Canc Res UK Ctr, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Aitken, Joanne F.] Canc Council, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Andresen, Per Arne] Oslo Univ Hosp, Rikshosp, Dept Pathol, Oslo, Norway; [Akslen, Lars A.; Molven, Anders] Univ Bergen, Gade Inst, Bergen, Norway; [Akslen, Lars A.; Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Armstrong, Bruce K.; Kefford, Richard F.; Mann, Graham J.] Westmead Millennium Inst, Westmead, NSW, Australia; [Avril, Marie-Francoise] Univ Descartes, Serv Dermatol, Hop Cochin, Assistance Publ Hop Paris, Paris, France; [Azizi, Esther; Friedman, Eitan] Sheba Med Ctr, Dept Dermatol, Tel Hashomer, Israel; [Azizi, Esther; Friedman, Eitan] Sheba Med Ctr, Oncogenet Unit, Tel Hashomer, Israel; [Azizi, Esther; Friedman, Eitan] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Bakker, Bert; van der Stoep, Nienke] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Clin Genet, Leiden, Netherlands; [Bergman, Wilma; van Nieuwpoort, Frans A.; Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Bianchi-Scarra, Giovanna; Ghiorzo, Paola; Pastorino, Lorenza] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Bressac-de Paillerets, Brigitte; Corda, Eve; Demenais, Florence] Fdn Jean Daussel CEPH, INSERM, U946, Paris, France; [Bressac-de Paillerets, Brigitte] Inst Canc Gustave Roussy, Serv Genet, Dept Biopathol, Villejuif, France; [Calista, Donato; Landi, Giorgio] Maurizio Bufalini Hosp, Dermatol Unit, Cesena, Italy; [Cannon-Albright, Lisa A.] Univ Utah, Sch Med, Dept Internal Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cust, Anne E.; Giles, Graham G.; Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Cust, Anne E.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Debniak, Tadeusz; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Szczecin, Poland; [Duffy, David; Martin, Nicholas G.; Montgomery, Grant W.; Whiteman, David C.; MacGregor, Stuart; Hayward, Nicholas K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Cambridge, England; [Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Galan, Pilar] INSERM, UMR U557, Bobigny, France; [Galan, Pilar] Ctr Rech Nutr Humaine, Inst Natl Rech Agron, U1125, Bobigny, France; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Hansson, Johan; Hoeiom, Veronica; Tuominen, Rainer] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hocevar, Marko; Novakovic, Srdjan] Inst Oncol Ljubljana, Ljubljana, Slovenia; [Ingvar, Christian] Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden; [Janssen, Bart] ServiceXS, Leiden, Netherlands; [Joensson, Goeran; Olsson, Hakan] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; [Landi, Maria Teresa; Goldstein, Alisa M.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Lang, Julie; Mackie, Rona] Univ Glasgow, Dept Med Genet, Glasgow, Lanark, Scotland; [Malvehy, Josep; Puig, Susana; Puig-Butille, Joan Anton] Univ Barcelona, Inst Invest Biomed August Pi Sune, Dept Dermatol, Melanoma Unit,Hosp Clin, Barcelona, Spain; [Puig, Susana; Puig-Butille, Joan Anton] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Barcelona, Spain; [VanBelle, Patricia; Elder, David E.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Zelenika, Diana; Lathrop, G. Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France; [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Unit 1365, Houston, TX 77030 USA; [Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Gillanders, Elizabeth M.] NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA; [Brown, Kevin M.] NCI, Div Canc Epidemiol & Genet, NIH, Gaithersburg, MD USA; [Kanetsky, Peter A.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kanetsky, Peter A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Demenais, Florence] Univ Paris 07, Inst Univ Hematol, Paris, France	Saint James's University Hospital; University of Leeds; University of Oslo; National Hospital Norway; University of Bergen; University of Bergen; Haukeland University Hospital; University of Sydney; Westmead Institute for Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Genoa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Ospedale Maurizio Bufalini; Utah System of Higher Education; University of Utah; University of Melbourne; University of Sydney; Pomeranian Medical University; QIMR Berghofer Medical Research Institute; University of Cambridge; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Cancer Council Victoria; Karolinska Institutet; Institute of Oncology - Slovenia; Lund University; Skane University Hospital; Lund University; Skane University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Glasgow; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Pennsylvania; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Texas System; UTMD Anderson Cancer Center; UDICE-French Research Universities; Universite Paris Cite	Bishop, DT (corresponding author), St James Univ Hosp, Leeds Canc Res UK Ctr, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England.	d.t.bishop@leeds.ac.uk	Mann, Graham J/G-4758-2014; Aitken, Joanne F/C-5289-2009; Martin, Nicholas/R-9235-2019; Ingvar, Christian/AAE-9841-2019; Pastorino, Lorenza/E-6084-2018; Armstrong, Bruce K/K-9464-2015; Paillerets, Brigitte Bressac-de/D-8954-2018; CARRERA, CRISTINA/N-1887-2019; Puig, Susana/AAB-2091-2020; Martin, Ludovic/K-2674-2015; hayward, nick/AAV-8802-2020; Bruno, William/N-7477-2013; Höiom, Veronica/F-4153-2012; Marti, Rosa/A-2256-2010; Whiteman, David C/P-2728-2014; Jönsson, Göran/D-1212-2014; Cust, Anne/J-1797-2019; Akslen, Lars A/C-1202-2017; Macgregor, Stuart/C-6442-2009; Andresen, Per Arne/AAA-6122-2020; Akslen, Lars A./AAG-6097-2021; hayward, nicholas k/C-1367-2015; Andreotti, Virginia/AAB-5169-2022; Bakker, Egbert/D-3525-2009; Vabres, Pierre/V-3850-2019; Duffy, David L/B-7392-2013; Lesueur, Fabienne/R-2178-2017; Demenais, Florence/G-3298-2013; Andreotti, Virginia/K-4506-2016; bertazzi, pietro alberto/D-5039-2017; Montgomery, Grant W/B-7148-2008; Maubec, Eve/V-4296-2017; Calista, Donato/AAM-1567-2020; Badenas, Celia/ABH-5480-2020; Ghiorzo, Paola/CAG-0673-2022; Scarrà, Giovanna Bianchi/G-8933-2014; Pilar, Galan/F-2908-2017; Jenkins, Mark/P-7803-2015	Mann, Graham J/0000-0003-1301-405X; Martin, Nicholas/0000-0003-4069-8020; Pastorino, Lorenza/0000-0002-2575-8331; Armstrong, Bruce K/0000-0001-8940-7525; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; CARRERA, CRISTINA/0000-0003-1608-8820; Puig, Susana/0000-0003-1337-9745; Bruno, William/0000-0002-0337-0168; Marti, Rosa/0000-0001-6866-6114; Whiteman, David C/0000-0003-2563-9559; Cust, Anne/0000-0002-5331-6370; Akslen, Lars A/0000-0003-2710-9543; Macgregor, Stuart/0000-0001-6731-8142; Akslen, Lars A./0000-0003-2710-9543; hayward, nicholas k/0000-0003-4760-1033; Andreotti, Virginia/0000-0002-2569-0832; Bakker, Egbert/0000-0002-2843-7357; Vabres, Pierre/0000-0001-8693-3183; Duffy, David L/0000-0001-7227-632X; Lesueur, Fabienne/0000-0001-7404-4549; Demenais, Florence/0000-0001-8361-0936; Andreotti, Virginia/0000-0002-2569-0832; bertazzi, pietro alberto/0000-0003-3475-2449; Montgomery, Grant W/0000-0002-4140-8139; Maubec, Eve/0000-0003-1658-6686; Badenas, Celia/0000-0002-0621-0477; Ghiorzo, Paola/0000-0002-3651-8173; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Pilar, Galan/0000-0003-1706-3107; Dunning, Alison Margaret/0000-0001-6651-7166; Bishop, Tim/0000-0002-8752-8785; BERARD, frederic/0000-0003-0094-6122; Kefford, Richard/0000-0001-9251-9229; Newton-Bishop, Julia/0000-0001-9147-6802; Aguilera, Paula/0000-0002-1825-7707; albright, lisa/0000-0003-2602-3668; Randerson-Moor, Juliette/0000-0003-0303-0072; Vasen, Hans/0000-0003-2682-2603; Iles, Mark/0000-0002-2603-6509; Fang, Shenying/0000-0002-0604-793X; Barrett, Jenny/0000-0002-1720-7724; Arance, Ana/0000-0003-2896-1957; Jenkins, Mark/0000-0002-8964-6160; malvehy, josep/0000-0002-6998-914X; Giles, Graham/0000-0003-4946-9099; Olsson, Hakan/0000-0002-8794-9635; Aitken, Joanne Frances/0000-0001-6859-2186; Gruis, Nelleke/0000-0002-5210-9150; Novakovic, Srdjan/0000-0002-8888-4810; Tuominen, Rainer/0000-0002-5871-3682; Lubinski, Jan/0000-0003-2931-3003	Wellcome Trust [076113]; European Commission [LSHC-CT-2006-018702]; Cancer Research UK [C588/A4994, C588/A10589, C8216/A6129]; US National Institutes of Health (NIH) [CA83115]; NIH, National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics; Cancer Research UK [10118, 11022, 10589] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA100264, U01CA049449, P01CA087969, R01CA133996, R01CA102422, P01CA055075, R01CA088363, R01CA033996, R01CA049449, R01CA122838, R01CA083115] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from their website (see URLs). Funding for the project was provided by the Wellcome Trust under award 076113.; The GenoMEL study was funded by the European Commission under the 6<SUP>th</SUP> Framework Programme (contract no. LSHC-CT-2006-018702), by Cancer Research UK Programme Awards (C588/A4994 and C588/A10589), by a Cancer Research UK Project grant (C8216/A6129) and by a grant from the US National Institutes of Health (NIH; CA83115). This research was also supported by the Intramural Research Program of the NIH, National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics. Funding specific to particular locations is acknowledged below.	Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Bataille V, 1996, BRIT J CANCER, V73, P1605, DOI 10.1038/bjc.1996.302; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Cannon-Albright L A, 1991, Important Adv Oncol, P39; Chang YM, 2009, INT J CANCER, V124, P420, DOI 10.1002/ijc.23869; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P934, DOI 10.1093/oxfordjournals.aje.a117360; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Kanetsky PA, 2006, CANCER RES, V66, P9330, DOI 10.1158/0008-5472.CAN-06-1634; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Newton-Bishop JA, 2011, EUR J CANCER, V47, P732, DOI 10.1016/j.ejca.2010.10.008; Newton-Bishop JA, 2010, CANCER EPIDEM BIOMAR, V19, P2043, DOI 10.1158/1055-9965.EPI-10-0233; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Yin M, 2010, CARCINOGENESIS, V31, P850, DOI 10.1093/carcin/bgq047	35	190	191	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1108	U98		10.1038/ng.959	http://dx.doi.org/10.1038/ng.959			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21983787	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000296584000015
J	Choi, YJ; Lin, CP; Ho, JJ; He, XY; Okada, N; Bu, PC; Zhong, YC; Kim, SY; Bennett, MJ; Chen, CF; Ozturk, A; Hicks, GG; Hannon, GJ; He, L				Choi, Yong Jin; Lin, Chao-Po; Ho, Jaclyn J.; He, Xingyue; Okada, Nobuhiro; Bu, Pengcheng; Zhong, Yingchao; Kim, Sang Yong; Bennett, Margaux J.; Chen, Caifu; Ozturk, Arzu; Hicks, Geoffrey G.; Hannon, Greg J.; He, Lin			miR-34 miRNAs provide a barrier for somatic cell reprogramming	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; SELF-RENEWAL; MOUSE; PLURIPOTENCY; MICRORNAS; EXPRESSION; DIFFERENTIATION; BIOGENESIS; MECHANISMS	Somatic reprogramming induced by defined transcription factors is a low-efficiency process that is enhanced by p53 deficiency(1-5). So far, p21 is the only p53 target shown to contribute to p53 repression of iPSC (induced pluripotent stem cell) generation(1,3), indicating that additional p53 targets may regulate this process. here, we demonstrate that miR-34 microRNAs (miRNAs), particularly miR-34a, exhibit p53-dependent induction during reprogramming. Mir34a deficiency in mice significantly increased reprogramming efficiency and kinetics, with miR-34a and p21 cooperatively regulating somatic reprogramming downstream of p53. Unlike p53 deficiency, which enhances reprogramming at the expense of iPSC pluripotency, genetic ablation for Mir34a promoted iPSC generation without compromising self-renewal or differentiation. Suppression of reprogramming by miR-34a was due, at least in part, to repression of pluripotency genes, including Nanog, Sox2 and Mycn (also known as N-Myc). This post-transcriptional gene repression by miR-34a also regulated iPSC differentiation kinetics. miR-34b and c similarly repressed reprogramming; and all three miR-34 miRNAs acted cooperatively in this process. taken together, our findings identified miR-34 miRNAs as p53 targets that play an essential role in restraining somatic reprogramming.	[Choi, Yong Jin; Lin, Chao-Po; Ho, Jaclyn J.; Okada, Nobuhiro; Bu, Pengcheng; Zhong, Yingchao; Bennett, Margaux J.; He, Lin] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cellular & Dev Biol, Berkeley, CA 94705 USA; [Kim, Sang Yong] Iransgenet Facil, Woodbury, NY 11797 USA; [Chen, Caifu] Life Technol Corp, Genom Assays R&D, Foster City, CA 94404 USA; [Ozturk, Arzu; Hicks, Geoffrey G.] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; [Hannon, Greg J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Berkeley; Thermo Fisher Scientific; Cold Spring Harbor Laboratory	He, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cellular & Dev Biol, Berkeley, CA 94705 USA.	lhe@berkeley.edu	Bu, Pengcheng/N-4134-2013; Hannon, Gregory/AAB-3568-2019	Hicks, Geoffrey/0000-0003-4688-2312; Ho, Jaclyn/0000-0001-9166-5953; Bu, Pengcheng/0000-0002-3208-0354; Okada, Nobuhiro/0000-0002-0434-6039; Lin, Chao-Po/0000-0002-1457-1635; Kim, Sang Yong/0000-0001-7326-7505	California Institute for Regenerative Medicine [RN2-00923-1]; National Cancer Institute (NCI) [R01 CA139067, R00 CA126186]; Siebel postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA139067, P01CA013106, R00CA126186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, R01GM062534] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Siebel postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Zaghi, A. Basila, A. Perez, G. Lai, M. Foth, A. Kemp, A. Fresnoza, A. Valeros, A. Fritz, D. Schichnes and H. Noller for technical assistance and A. Economides for discussions and input. We also thank J.M. Halbleib, D. Schaffer and R.M. Harland for reading the manuscripts, and I. Lemischka, Q. Li, M. Hemann and B. Vogelstein for sharing reagents. In particular, we are grateful for the pathological expertise R. Van Andel offered us. L.H. is a Searle Scholar, and is supported by a new faculty award by California Institute for Regenerative Medicine (RN2-00923-1) and an R01 (R01 CA139067) and an R00 grant (R00 CA126186) from the National Cancer Institute (NCI). G.J.H. is a Howard Hughes Medical Institute investigator, and is supported by a program project grant from the NCI. C-P.L. is supported by a Siebel postdoctoral fellowship.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Kuijk EW, 2010, STEM CELLS DEV, V19, P979, DOI 10.1089/scd.2009.0276; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	46	300	320	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1353	U154		10.1038/ncb2366	http://dx.doi.org/10.1038/ncb2366			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	22020437	Green Accepted			2022-12-25	WOS:000296737900012
J	Ellingsgaard, H; Hauselmann, I; Schuler, B; Habib, AM; Baggio, LL; Meier, DT; Eppler, E; Bouzakri, K; Wueest, S; Muller, YD; Hansen, AMK; Reinecke, M; Konrad, D; Gassmann, M; Reimann, F; Halban, PA; Gromada, J; Drucker, DJ; Gribble, FM; Ehses, JA; Donath, MY				Ellingsgaard, Helga; Hauselmann, Irina; Schuler, Beat; Habib, Abdella M.; Baggio, Laurie L.; Meier, Daniel T.; Eppler, Elisabeth; Bouzakri, Karim; Wueest, Stephan; Muller, Yannick D.; Hansen, Ann Maria Kruse; Reinecke, Manfred; Konrad, Daniel; Gassmann, Max; Reimann, Frank; Halban, Philippe A.; Gromada, Jesper; Drucker, Daniel J.; Gribble, Fiona M.; Ehses, Jan A.; Donath, Marc Y.			Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells	NATURE MEDICINE			English	Article							BETA-CELL; SKELETAL-MUSCLE; IN-VITRO; GLUCOSE-HOMEOSTASIS; BENEFICIAL ROLE; EXPRESSION; HORMONE; GLP-1; PROGLUCAGON; EXERCISE	Exercise, obesity and type 2 diabetes are associated with elevated plasma concentrations of interleukin-6 (IL-6). Glucagon-like peptide-1 (GLP-1) is a hormone that induces insulin secretion. Here we show that administration of IL-6 or elevated IL-6 concentrations in response to exercise stimulate GLP-1 secretion from intestinal L cells and pancreatic alpha cells, improving insulin secretion and glycemia. IL-6 increased GLP-1 production from alpha cells through increased proglucagon (which is encoded by GCG) and prohormone convertase 1/3 expression. In models of type 2 diabetes, the beneficial effects of IL-6 were maintained, and IL-6 neutralization resulted in further elevation of glycemia and reduced pancreatic GLP-1. Hence, IL-6 mediates crosstalk between insulin-sensitive tissues, intestinal L cells and pancreatic islets to adapt to changes in insulin demand. This previously unidentified endocrine loop implicates IL-6 in the regulation of insulin secretion and suggests that drugs modulating this loop may be useful in type 2 diabetes.	[Ellingsgaard, Helga; Hauselmann, Irina; Meier, Daniel T.; Donath, Marc Y.] Univ Basel Hosp, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland; [Ellingsgaard, Helga; Hauselmann, Irina; Meier, Daniel T.; Donath, Marc Y.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Schuler, Beat; Gassmann, Max] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, Zurich, Switzerland; [Schuler, Beat; Wueest, Stephan; Konrad, Daniel; Gassmann, Max] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Habib, Abdella M.; Reimann, Frank; Gribble, Fiona M.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; [Habib, Abdella M.; Reimann, Frank; Gribble, Fiona M.] Addenbrookes Hosp, Dept Clin Biochem, Cambridge, England; [Baggio, Laurie L.; Drucker, Daniel J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Eppler, Elisabeth; Reinecke, Manfred] Univ Zurich, Inst Anat, Res Grp Neuroendocrine Immune Interact, Zurich, Switzerland; [Bouzakri, Karim; Halban, Philippe A.] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, Geneva, Switzerland; [Wueest, Stephan; Konrad, Daniel] Univ Zurich, Univ Childrens Hosp, Div Pediat Endocrinol & Diabetol, Zurich, Switzerland; [Muller, Yannick D.] Univ Geneva, Univ Med Ctr, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Hansen, Ann Maria Kruse] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Gromada, Jesper] Novartis Inst Biomed Res, Cardiovasc & Metab Dis Area, Cambridge, MA USA; [Ehses, Jan A.] Univ British Columbia, Dept Surg, Fac Med, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	University of Basel; University of Basel; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Zurich; University of Geneva; University Children's Hospital Zurich; University of Zurich; University of Geneva; Novo Nordisk; Novartis; Child & Family Research Institute; University of British Columbia	Ellingsgaard, H (corresponding author), Univ Basel Hosp, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland.	helga.ellingsgaard@unibas.ch	Ehses, Jan/AAK-1635-2020; Wueest, Stephan/H-9864-2012; Drucker, Daniel J/A-4092-2010; Ellingsgaard, Helga/AAD-5705-2022; Wüest, Stephan/AAG-9706-2020	Ellingsgaard, Helga/0000-0002-9105-5247; Wüest, Stephan/0000-0002-0176-8906; Reimann, Frank/0000-0001-9399-6377; Gassmann, Max/0000-0003-2750-8878; Gribble, Fiona/0000-0002-4232-2898; Zeman-Meier, Daniel/0000-0003-3348-4657; Konrad, Daniel/0000-0001-9067-4356; Muller, Yannick/0000-0003-0513-7156; Habib, Abdella Mohammed/0000-0001-7453-3932; Ehses, Jan/0000-0001-9066-7607	Swiss National Science Foundation; Merck; Hartman Muller organization; Child and Family Research Institute; University of British Columbia; Canadian Diabetes Association; Juvenile Diabetes Research Foundation [31-2008-416]; Canada Research Chair in Regulatory Peptides; Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology; Canadian Institutes of Health Research [93749]; Wellcome Trust [WT088357, WT084210]; EU [266408]; Medical Research Council [G0600717B] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Merck(Merck & Company); Hartman Muller organization; Child and Family Research Institute; University of British Columbia; Canadian Diabetes Association; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canada Research Chair in Regulatory Peptides(Canada Research Chairs); Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge O. Madsen and D. Steiner for their suggestion to investigate the role of IL-6 on GLP-1 and PC1/3. We thank R. Prazak and M. Borsigova for technical assistance and M. Niessen for discussions. This work was supported by grants from the Swiss National Science Foundation and by the Merck Investigator Studies Program. J.A.E. was supported by grants from the Hartman Muller organization, the Child and Family Research Institute and the University of British Columbia and has salary support from the Canadian Diabetes Association. We obtained human islets thanks to grant 31-2008-416 from the Juvenile Diabetes Research Foundation. D.J.D. is supported by the Canada Research Chair in Regulatory Peptides, the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology and Canadian Institutes of Health Research operating grant 93749. F. M. G., F. R. and A. M. H. are supported by grants from the Wellcome Trust (WT088357 to F. M. G. and WT084210 to F. R.) and EU FP7 grant 266408.	Adam TCM, 2004, PHYSIOL BEHAV, V83, P459, DOI 10.1016/j.physbeh.2004.08.035; Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252; BELL GI, 1983, NATURE, V302, P716, DOI 10.1038/302716a0; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chanoine JP, 2008, OBESITY, V16, P202, DOI 10.1038/oby.2007.39; CREUTZFELDT W, 1979, DIABETOLOGIA, V16, P75, DOI 10.1007/BF01225454; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Delmeire D, 2004, BIOCHEM PHARMACOL, V68, P33, DOI 10.1016/j.bcp.2004.02.035; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Febbraio MA, 2003, J PHYSIOL-LONDON, V549, P607, DOI 10.1113/jphysiol.2003.042374; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Holmes AG, 2008, J ENDOCRINOL, V198, P367, DOI 10.1677/JOE-08-0113; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Jansson JO, 2007, J APPL PHYSIOL, V102, P821, DOI 10.1152/japplphysiol.01353.2006; Jevdjovic T, 2005, HISTOCHEM CELL BIOL, V123, P179, DOI 10.1007/s00418-005-0760-y; Jevdjovic T, 2004, EUR J ENDOCRINOL, V151, P223, DOI 10.1530/eje.0.1510223; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Li M, 2010, J AUTOIMMUN, V35, P414, DOI 10.1016/j.jaut.2010.09.001; LUND PK, 1982, P NATL ACAD SCI-BIOL, V79, P345, DOI 10.1073/pnas.79.2.345; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mooney RA, 2007, J APPL PHYSIOL, V102, P816, DOI 10.1152/japplphysiol.01208a.2006; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; Ostrowski K, 1998, J PHYSIOL-LONDON, V508, P949, DOI 10.1111/j.1469-7793.1998.949bp.x; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rouille Y, 1997, J BIOL CHEM, V272, P32810, DOI 10.1074/jbc.272.52.32810; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488, DOI 10.1074/jbc.270.44.26488; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sadagurski M, 2010, DIABETOLOGIA, V53, P525, DOI 10.1007/s00125-009-1580-8; Schuler B, 2010, P NATL ACAD SCI USA, V107, P419, DOI 10.1073/pnas.0912924107; Sporeno E, 1996, BLOOD, V87, P4510, DOI 10.1182/blood.V87.11.4510.bloodjournal87114510; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Ueda S, 2009, J ENDOCRINOL, V201, P151, DOI 10.1677/JOE-08-0500; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200; Weigert C, 2007, J APPL PHYSIOL, V102, P820, DOI 10.1152/japplphysiol.01353.2006; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yamaguchi K, 2011, LAB INVEST, V91, P609, DOI 10.1038/labinvest.2011.2; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	57	566	588	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1481	U1500		10.1038/nm.2513	http://dx.doi.org/10.1038/nm.2513			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22037645	Green Accepted			2022-12-25	WOS:000296779300040
J	Kersten, RD; Yang, YL; Xu, YQ; Cimermancic, P; Nam, SJ; Fenical, W; Fischbach, MA; Moore, BS; Dorrestein, PC				Kersten, Roland D.; Yang, Yu-Liang; Xu, Yuquan; Cimermancic, Peter; Nam, Sang-Jip; Fenical, William; Fischbach, Michael A.; Moore, Bradley S.; Dorrestein, Pieter C.			A mass spectrometry-guided genome mining approach for natural product peptidogenomics	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; STREPTOMYCES-COELICOLOR; BIOSYNTHESIS; DIVERSITY; IDENTIFICATION; SEQUENCE; ANTIBIOTICS; ANNOTATION; MORPHOGEN; BACTERIAL	Peptide natural products show broad biological properties and are commonly produced by orthogonal ribosomal and nonribosomal pathways in prokaryotes and eukaryotes. To harvest this large and diverse resource of bioactive molecules, we introduce here natural product peptidogenomics (NPP), a new MS-guided genome-mining method that connects the chemotypes of peptide natural products to their biosynthetic gene clusters by iteratively matching de novo tandem MS (MSn) structures to genomics-based structures following biosynthetic logic. In this study, we show that NPP enabled the rapid characterization of over ten chemically diverse ribosomal and nonribosomal peptide natural products of previously unidentified composition from Streptomycete bacteria as a proof of concept to begin automating the genome-mining process. We show the identification of lantipeptides, lasso peptides, linardins, formylated peptides and lipopeptides, many of which are from well-characterized model Streptomycetes, highlighting the power of NPP in the discovery of new peptide natural products from even intensely studied organisms.	[Kersten, Roland D.; Nam, Sang-Jip; Fenical, William; Moore, Bradley S.; Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Yang, Yu-Liang; Xu, Yuquan; Fenical, William; Moore, Bradley S.; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Cimermancic, Peter; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Cimermancic, Peter; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Dorrestein, PC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu; pdorrestein@ucsd.edu	Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012	Moore, Bradley/0000-0002-4652-1253; Fischbach, Michael/0000-0003-3079-8247; Fenical, William/0000-0002-8955-1735	US National Institutes of Health [GM085770, GM086283]; Beckman Foundation; NATIONAL CANCER INSTITUTE [R37CA044848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085770, R01GM086283] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Castellana and V. Bafna for providing the algorithm to enable the six-frame translations of supercontigs. We also thank M. Meehan for FTMS training. Financial support was provided by the US National Institutes of Health (GM085770 to B.S.M. and GM086283 to P.C.D.) and the Beckman Foundation.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BODANSZKY M, 1969, J AM CHEM SOC, V91, P2351, DOI 10.1021/ja01037a028; Caboche S, 2010, J BACTERIOL, V192, P5143, DOI 10.1128/JB.00315-10; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Claesen J, 2010, P NATL ACAD SCI USA, V107, P16297, DOI 10.1073/pnas.1008608107; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Daffre S, 2008, STUD NAT PROD CHEM, V35, P597; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Duncan MW, 2010, NAT BIOTECHNOL, V28, P659, DOI 10.1038/nbt0710-659; Duquesne S, 2007, J MOL MICROB BIOTECH, V13, P200, DOI 10.1159/000104748; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Gressler M, 2011, CHEM BIOL, V18, P198, DOI 10.1016/j.chembiol.2010.12.011; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Knappe TA, 2010, FEBS LETT, V584, P785, DOI 10.1016/j.febslet.2009.12.046; Koal T, 2010, CURR MOL MED, V10, P216, DOI 10.2174/156652410790963312; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; LIU WT, J AM CHEM S IN PRESS; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Moore BS, 2008, ANGEW CHEM INT EDIT, V47, P9386, DOI 10.1002/anie.200803868; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Ng J, 2009, NAT METHODS, V6, P596, DOI 10.1038/nmeth.1350; Nolan EM, 2009, CHEMBIOCHEM, V10, P34, DOI 10.1002/cbic.200800438; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Romano A, 2011, J NAT PROD, V74, P145, DOI 10.1021/np100408y; Roongsawang N, 2011, INT J MOL SCI, V12, P141, DOI 10.3390/ijms12010141; Strieker M, 2009, CHEMBIOCHEM, V10, P607, DOI 10.1002/cbic.200800546; Tsur D, 2005, NAT BIOTECHNOL, V23, P1562, DOI 10.1038/nbt1168; Ueda K, 2002, J BACTERIOL, V184, P1488, DOI 10.1128/JB.184.5.1488-1492.2002; Vats P, 2007, P NATL ACAD SCI USA, V104, P17795, DOI 10.1073/pnas.0708739104; Velasquez JE, 2011, CURR OPIN CHEM BIOL, V15, P11, DOI 10.1016/j.cbpa.2010.10.027; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Wilkinson B, 2009, METHOD ENZYMOL, V458, P353, DOI 10.1016/S0076-6879(09)04814-9; Willey JM, 2006, MOL MICROBIOL, V59, P731, DOI 10.1111/j.1365-2958.2005.05018.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252	50	278	291	1	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					794	802		10.1038/nchembio.684	http://dx.doi.org/10.1038/nchembio.684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21983601	Green Submitted, Green Accepted			2022-12-25	WOS:000296381600009
J	Rafnar, T; Gudbjartsson, DF; Sulem, P; Jonasdottir, A; Sigurdsson, A; Jonasdottir, A; Besenbacher, S; Lundin, P; Stacey, SN; Gudmundsson, J; Magnusson, OT; le Roux, L; Orlygsdottir, G; Helgadottir, HT; Johannsdottir, H; Gylfason, A; Tryggvadottir, L; Jonasson, JG; de Juan, A; Ortega, E; Ramon-Cajal, JM; Garcia-Prats, MD; Mayordomo, C; Panadero, A; Rivera, F; Aben, KKH; van Altena, AM; Massuger, LFAG; Aavikko, M; Kujala, PM; Staff, S; Aaltonen, LA; Olafsdottir, K; Bjornsson, J; Kong, A; Salvarsdottir, A; Saemundsson, H; Olafsson, K; Benediktsdottir, KR; Gulcher, J; Masson, G; Kiemeney, LA; Mayordomo, JI; Thorsteinsdottir, U; Stefansson, K				Rafnar, Thorunn; Gudbjartsson, Daniel F.; Sulem, Patrick; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Besenbacher, Soren; Lundin, Par; Stacey, Simon N.; Gudmundsson, Julius; Magnusson, Olafur T.; le Roux, Louise; Orlygsdottir, Gudbjorg; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Gylfason, Arnaldur; Tryggvadottir, Laufey; Jonasson, Jon G.; de Juan, Ana; Ortega, Eugenia; Ramon-Cajal, Jose M.; Garcia-Prats, Maria D.; Mayordomo, Carlos; Panadero, Angeles; Rivera, Fernando; Aben, Katja K. H.; van Altena, Anne M.; Massuger, Leon F. A. G.; Aavikko, Mervi; Kujala, Paula M.; Staff, Synnove; Aaltonen, Lauri A.; Olafsdottir, Kristrun; Bjornsson, Johannes; Kong, Augustine; Salvarsdottir, Anna; Saemundsson, Hafsteinn; Olafsson, Karl; Benediktsdottir, Kristrun R.; Gulcher, Jeffrey; Masson, Gisli; Kiemeney, Lambertus A.; Mayordomo, Jose I.; Thorsteinsdottir, Unnur; Stefansson, Kari			Mutations in BRIP1 confer high risk of ovarian cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; FAMILY-HISTORY; HELICASE BRIP1; BRCA2; GENE; SUSCEPTIBILITY; BACH1; RECOMBINATION; POPULATION	Ovarian cancer causes more deaths than any other gynecologic malignancy in developed countries. Sixteen million sequence variants, identified through whole-genome sequencing of 457 Icelanders, were imputed to 41,675 Icelanders genotyped using SNP chips, as well as to their relatives. Sequence variants were tested for association with ovarian cancer (N of affected individuals = 656). We discovered a rare (0.41% allelic frequency) frameshift mutation, c.2040_2041insTT, in the BRIP1 (FANCJ) gene that confers an increase in ovarian cancer risk (odds ratio (OR) = 8.13, P = 2.8 x 10(-14)). The mutation was also associated with increased risk of cancer in general and reduced lifespan by 3.6 years. In a Spanish population, another frameshift mutation in BRIP1, c.1702_1703del, was seen in 2 out of 144 subjects with ovarian cancer and 1 out of 1,780 control subjects (P = 0.016). This allele was also associated with breast cancer (seen in 6/927 cases; P = 0.0079). Ovarian tumors from heterozygous carriers of the Icelandic mutation show loss of the wild-type allele, indicating that BRIP1 behaves like a classical tumor suppressor gene in ovarian cancer.	[Rafnar, Thorunn; Gudbjartsson, Daniel F.; Sulem, Patrick; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Besenbacher, Soren; Lundin, Par; Stacey, Simon N.; Gudmundsson, Julius; Magnusson, Olafur T.; le Roux, Louise; Orlygsdottir, Gudbjorg; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Gylfason, Arnaldur; Kong, Augustine; Gulcher, Jeffrey; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Tryggvadottir, Laufey; Jonasson, Jon G.] Iceland Canc Registry, Reykjavik, Iceland; [Tryggvadottir, Laufey; Jonasson, Jon G.; Benediktsdottir, Kristrun R.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [de Juan, Ana; Rivera, Fernando] Marques de Valdecilla Univ Hosp, Div Med Oncol, Santander, Spain; [Ortega, Eugenia] Arnau de Vilanova Univ Hosp, Div Med Oncol, Lerida, Spain; [Ramon-Cajal, Jose M.] San Jorge Gen Hosp, Div Gynecol, Huesca, Spain; [Garcia-Prats, Maria D.] San Jorge Gen Hosp, Div Pathol, Huesca, Spain; [Mayordomo, Carlos] Univ Zaragoza, Sch Med, Zaragoza, Spain; [Panadero, Angeles] Ciudad Coria Hosp, Div Med Oncol, Coria, Spain; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Comprehens Canc Ctr Netherlands, Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assesment, NL-6525 ED Nijmegen, Netherlands; [van Altena, Anne M.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Aavikko, Mervi; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki, Finland; [Kujala, Paula M.] Univ Tampere, Dept Pathol, Ctr Lab Med, FIN-33101 Tampere, Finland; [Staff, Synnove] Tampere Univ Hosp, Dept Obstet & Gynecol, Tampere, Finland; [Staff, Synnove] Univ Tampere, Inst Biomed Technol, Canc Biol Lab, FIN-33101 Tampere, Finland; [Olafsdottir, Kristrun; Bjornsson, Johannes; Benediktsdottir, Kristrun R.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Salvarsdottir, Anna; Saemundsson, Hafsteinn; Olafsson, Karl] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza, Spain	University of Iceland; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universidad San Jorge; Hospital Universidad San Jorge; University of Zaragoza; Radboud University Nijmegen; Radboud University Nijmegen; University of Helsinki; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Landspitali National University Hospital; Landspitali National University Hospital; Radboud University Nijmegen; Miguel Servet University Hospital	Rafnar, T (corresponding author), DeCODE Genet, Reykjavik, Iceland.	thorunn.rafnar@decode.is; kstefans@decode.is	Mayordomo, Jose/K-3453-2013; Aaltonen, Lauri/A-5375-2010; Massuger, Leon F.A.G./H-8072-2014; Aben, Katja KH/G-9686-2016; van Altena, Anne M/B-9824-2016; Kiemeney, Lambertus A./D-3357-2009; Stefansson, Kari/AAE-7187-2019	Aaltonen, Lauri/0000-0001-6839-4286; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; le Roux, Louise/0000-0002-9491-9653; Staff, Synnove/0000-0001-7280-1673; Jonasson, Jon G./0000-0002-2635-5032; Helgadottir, Hafdis/0000-0003-4352-152X; Gudbjartsson, Daniel/0000-0002-5222-9857; Tryggvadottir, Laufey/0000-0001-8067-9030; Kong, Augustine/0000-0001-8193-5438; Besenbacher, Soren/0000-0003-1455-1738	European Commission [218071]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was partly funded by the European Commission 7<SUP>th</SUP> Framework Programme FP7-MC-IAPP (grant agreement no. 218071 CancerGene).	Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2011, FUTURE ONCOL, V7, P253, DOI [10.2217/fon.10.191, 10.2217/FON.10.191]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GODWIN AK, 1994, AM J HUM GENET, V55, P666; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Malander S, 2006, GYNECOL ONCOL, V101, P238, DOI 10.1016/j.ygyno.2005.10.029; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Rafnar T, 2004, EUR J CANCER, V40, P2788, DOI 10.1016/j.ejca.2004.09.008; Ramus SJ, 2009, MOL ONCOL, V3, P138, DOI 10.1016/j.molonc.2009.02.001; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; Sarantaus L, 2000, EUR J HUM GENET, V8, P757, DOI 10.1038/sj.ejhg.5200529; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Sulem P., NAT GENET IN PRESS; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	29	263	266	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1104	U91		10.1038/ng.955	http://dx.doi.org/10.1038/ng.955			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21964575				2022-12-25	WOS:000296584000014
J	Sir, JH; Barr, AR; Nicholas, AK; Carvalho, OP; Khurshid, M; Sossick, A; Reichelt, S; D'Santos, C; Woods, CG; Gergely, F				Sir, Joo-Hee; Barr, Alexis R.; Nicholas, Adeline K.; Carvalho, Ofelia P.; Khurshid, Maryam; Sossick, Alex; Reichelt, Stefanie; D'Santos, Clive; Woods, C. Geoffrey; Gergely, Fanni			A primary microcephaly protein complex forms a ring around parental centrioles	NATURE GENETICS			English	Article							SMALL-MOLECULE INHIBITOR; BRAIN SIZE; CENTROSOME DUPLICATION; HUMAN-CELLS; CHROMOSOME SEGREGATION; GENOME MAINTENANCE; SPINDLE POLE; CDK5RAP2; CEP152; MUTATIONS	Autosomal recessive primary microcephaly (MCPH) is characterized by a substantial reduction in prenatal human brain growth without alteration of the cerebral architecture and is caused by biallelic mutations in genes coding for a subset of centrosomal proteins(1-10). Although at least three of these proteins have been implicated in centrosome duplication(11), the nature of the centrosome dysfunction that underlies the neurodevelopmental defect in MCPH is unclear. Here we report a homozygous MCPH-causing mutation in human CEP63. CEP63 forms a complex with another MCPH protein, CEP152, a conserved centrosome duplication factor(12-15). Together, these two proteins are essential for maintaining normal centrosome numbers in cells. Using super-resolution microscopy, we found that CEP63 and CEP152 co-localize in a discrete ring around the proximal end of the parental centriole, a pattern specifically disrupted in CEP63-deficient cells derived from patients with MCPH. This work suggests that the CEP152-CEP63 ring-like structure ensures normal neurodevelopment and that its impairment particularly affects human cerebral cortex growth.	[Nicholas, Adeline K.; Carvalho, Ofelia P.; Khurshid, Maryam; Woods, C. Geoffrey] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; [Sir, Joo-Hee; Barr, Alexis R.; Reichelt, Stefanie; D'Santos, Clive; Gergely, Fanni] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Sir, Joo-Hee; Barr, Alexis R.; Gergely, Fanni] Univ Cambridge, Dept Oncol, Cambridge, England; [Sossick, Alex] Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Woods, CG (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England.	cw347@cam.ac.uk; fanni.gergely@cancer.org.uk	Carvalho, Ofelia/L-2780-2014	Carvalho, Ofelia/0000-0002-7450-9980; Barr, Alexis/0000-0002-6684-8114; Nicholas, Adeline/0000-0002-7124-629X; Sossick, Alex/0000-0003-0012-7004; Gergely, Fanni/0000-0002-2441-8095; Reichelt, Stefanie/0000-0003-4151-0712	Wellcome Trust; Cancer Research UK; Royal Society University	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Royal Society University(Royal Society of London)	We thank S. Munro, J. Pines and R. Rios for constructs and reagents; J. Cox, H. Ebrahimi and G. Thornton for their contribution; P. Lakshminarasimhan, K.J. Patel and R. Rios for critical reading of the manuscript; and M. Bornens and the Gergely lab for helpful suggestions. We also thank the families for their participation. We are grateful for the support provided by the microscopy and proteomics core facilities at the Cambridge Research Institute. This work was made possible by funding from the Wellcome Trust (to A.K.N., C.G.W., M.K. and O.P.C.), from Cancer Research UK (to A.R.B., C.D., F.G., J.-H.S. and S. R.) and a Royal Society University Research Fellowship (to F.G.).	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Darlington G.J, 2006, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot4480, DOI 10.1101/PDB.PROT4480]; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Evans PD, 2006, GENE, V375, P75, DOI 10.1016/j.gene.2006.02.019; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Gillingham AK, 2000, EMBO REP, V1, P524; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Keryer G, 2003, MOL BIOL CELL, V14, P2436, DOI 10.1091/mbc.E02-09-0614; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lewis AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003376; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Loffler H, 2011, CANCER RES, V71, P2129, DOI 10.1158/0008-5472.CAN-10-2684; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	53	151	160	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1147	U150		10.1038/ng.971	http://dx.doi.org/10.1038/ng.971			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21983783	Green Accepted			2022-12-25	WOS:000296584000022
J	Kahsai, AW; Xiao, KH; Rajagopal, S; Ahn, S; Shukla, AK; Sun, JP; Oas, TG; Lefkowitz, RJ				Kahsai, Alem W.; Xiao, Kunhong; Rajagopal, Sudarshan; Ahn, Seungkirl; Shukla, Arun K.; Sun, Jinpeng; Oas, Terrence G.; Lefkowitz, Robert J.			Multiple ligand-specific conformations of the beta(2)-adrenergic receptor	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; CRYSTAL-STRUCTURE; FUNCTIONAL-ROLE; DRUG DISCOVERY; ARRESTIN; RHODOPSIN; ACTIVATION; STATE	Seven-transmembrane receptors (7TMRs), also called G protein-coupled receptors (GPCRs), represent the largest class of drug targets, and they can signal through several distinct mechanisms including those mediated by G proteins and the multifunctional adaptor proteins beta-arrestins. Moreover, several receptor ligands with differential efficacies toward these distinct signaling pathways have been identified. However, the structural basis and mechanism underlying this 'biased agonism' remains largely unknown. Here, we develop a quantitative mass spectrometry strategy that measures specific reactivities of individual side chains to investigate dynamic conformational changes in the beta(2)-adrenergic receptor occupied by nine functionally distinct ligands. Unexpectedly, only a minority of residues showed reactivity patterns consistent with classical agonism, whereas the majority showed distinct patterns of reactivity even between functionally similar ligands. These findings demonstrate, contrary to two-state models for receptor activity, that there is significant variability in receptor conformations induced by different ligands, which has significant implications for the design of new therapeutic agents.	[Kahsai, Alem W.; Xiao, Kunhong; Rajagopal, Sudarshan; Ahn, Seungkirl; Shukla, Arun K.; Sun, Jinpeng; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kahsai, Alem W.; Shukla, Arun K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Oas, Terrence G.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	khxiao@receptor-biol.duke.edu; lefko001@receptor-biol.duke.edu	sun, Jinpeng/AAR-9196-2020; SUN, JINPENG/F-9551-2013; Lefkowitz, Robert/AAW-2649-2021; Xiao, Kunhong/AAG-4275-2020; Oas, Terrence/F-8916-2011; Rajagopal, Sudarshan/G-8975-2013	Xiao, Kunhong/0000-0002-1069-1226; Oas, Terrence/0000-0002-3067-2743; Rajagopal, Sudarshan/0000-0002-3443-5040; shukla, arun/0000-0003-2910-8288	US National Institutes of Health [HL16037, HL70631]; US National Institute of General Medical Sciences [5RO1GM081666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081666] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.J.L. is an investigator with the Howard Hughes Medical Institute. This work was supported in part by grants from the US National Institutes of Health (HL16037 and HL70631) to R.J.L. T.G.O. is supported by a grant from the US National Institute of General Medical Sciences (5RO1GM081666). We gratefully acknowledge T. Haystead (Duke University) and D. Loiselle for valuable assistance with the mass spectrometry experiments, and Theravance, Inc. (South San Francisco, California, USA) for the supply of THRX-144877; we are also grateful to R. T. Strachan, J. Kovacs, R. Dror (D. E. Shaw Research, New York, New York, USA), C. H. Borchers (University of Victoria, Victoria, British Columbia, Canada), I. A. Kaltashov (University of Massachusetts), B. Donald (Duke University) and members of his laboratory for stimulating ideas and helpful discussions; we also thank X. Jiang and C. M. Lam for excellent technical assistance and D. Addison and Q. Lennon for secretarial assistance.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bouley R, 2003, AM J PHYSIOL-CELL PH, V285, pC750, DOI 10.1152/ajpcell.00477.2002; CANTOR CR, 1980, BEHAV BIOL MACROMOLE, P915; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Kelly BL, 2003, NAT STRUCT BIOL, V10, P280, DOI 10.1038/nsb908; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2002, J CELL SCI, V115, P455; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Raman D, 2003, J NEUROCHEM, V84, P1040, DOI 10.1046/j.1471-4159.2003.01598.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; STADEL JM, 1979, MOL PHARMACOL, V16, P709; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	50	196	205	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					692	700		10.1038/NCHEMBIO.634	http://dx.doi.org/10.1038/NCHEMBIO.634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21857662	Green Accepted			2022-12-25	WOS:000295027100013
J	Kuo, TC; Chen, CT; Baron, D; Onder, TT; Loewer, S; Almeida, S; Weismann, CM; Xu, P; Houghton, JM; Gao, FB; Daley, GQ; Doxsey, S				Kuo, Tse-Chun; Chen, Chun-Ting; Baron, Desiree; Onder, Tamer T.; Loewer, Sabine; Almeida, Sandra; Weismann, Cara M.; Xu, Ping; Houghton, Jean-Marie; Gao, Fen-Biao; Daley, George Q.; Doxsey, Stephen			Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; NEURAL PROGENITORS; ASYMMETRIC INHERITANCE; MEMBRANE; CYTOKINESIS; CENTROSOME; DISEASE; DEGRADATION; DIVISION; LITHIUM	The midbody is a singular organelle formed between daughter cells during cytokinesis and required for their final separation. Midbodies persist in cells long after division as midbody derivatives (MB(d)s), but their fate is unclear. Here we show that MB(d)s are inherited asymmetrically by the daughter cell with the older centrosome. They selectively accumulate in stem cells, induced pluripotent stem cells and potential cancer 'stem cells' in vivo and in vitro. MBd loss accompanies stem-cell differentiation, and involves autophagic degradation mediated by binding of the autophagic receptor NBR1 to the midbody protein CEP55. Differentiating cells and normal dividing cells do not accumulate MB(d)s and possess high autophagic activity. Stem cells and cancer cells accumulate MB(d)s by evading autophagosome encapsulation and exhibit low autophagic activity. MBd enrichment enhances reprogramming to induced pluripotent stem cells and increases the in vitro tumorigenicity of cancer cells. These results indicate unexpected roles for MB(d)s in stem cells and cancer 'stem cells'.	[Kuo, Tse-Chun; Chen, Chun-Ting; Baron, Desiree; Weismann, Cara M.; Xu, Ping; Doxsey, Stephen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Onder, Tamer T.; Loewer, Sabine; Daley, George Q.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Onder, Tamer T.; Loewer, Sabine; Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol & Oncol, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Onder, Tamer T.; Loewer, Sabine; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Onder, Tamer T.; Loewer, Sabine; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Onder, Tamer T.; Loewer, Sabine; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Almeida, Sandra; Weismann, Cara M.; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Houghton, Jean-Marie] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Doxsey, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	stephen.doxsey@umassmed.edu	Onder, Tamer T/H-3330-2013; Onder, Tamer/O-3669-2019	Onder, Tamer T/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158	National Institute of Child Health and Human Development; National Institutes of Health [GM051994, F32 GM084660-02]; W.M. Keck Foundation; Ellison Foundation [AG-SS-1918-07]; Department of Defense [W81XWH-08-1-0457, W81XWH-06-1-0140]; Diabetes and Endocrine Resource Center [5P30DK3252025]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051994, F32GM084660, R01GM051994] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); Ellison Foundation(Lawrence Ellison Foundation); Department of Defense(United States Department of Defense); Diabetes and Endocrine Resource Center; Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Baehrecke for critical reading of the manuscript, T. Schlaeger and colleagues for assistance with H1-OGN and associated cell lines, the University of Massachusetts Medical School (UMMS) Flow Facility for assistance with MB<SUP>d</SUP> enrichment, P. Furcinitti of UMMS Digital Light Microscopy Core Facility for assistance with imaging, the UMMS DERC Morphology Core for assistance with immunohistochemitry, D. Guertin and C. Sparks for assistance with SMP preparation, S. Lyle and C. Powers for sample preparation and H-L. Liu for assistance with clone construction. We thank N. Mizushima for GFP-LC3-expressing Atg5<SUP>-/-</SUP> and matched wild-type MEFs, M. Komatsu and T. Ishii for p62<SUP>-/-</SUP> and matched wild-type MEFs, S. Jones for ex vivo C57BL/6 MEFs, B. Lewis for mouse hepatocellular cancer lines, S. Pino for in vitro activated T cells, W. Jiang for MKLP1-GFP plasmid, K. Khanna for CEP55-eGFP plasmid, J. Lippincott Schwartz and G. Gaietta for plasmids for FPP assay, B. Levine (UT Southwestern) for Flag-tagged BECN1-expressing plasmid, A. Khodjakov for CETN1-GFP-expressing plasmids, K. Lee for hCenexin1 antibody and the Progeria Society for cell lines. The alpha 6F antibody to Na/K-ATPase developed by D. M. Fambrough and the H4B4 antibody to LAMP2 developed by J.T. August and J. E. K. Hildreth were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biology. This work was supported by funding from the National Institutes of Health (GM051994 to S.D. and F32 GM084660-02 to D.B.), the W.M. Keck Foundation to S.D., the Ellison Foundation (AG-SS-1918-07) to S.D., the Department of Defense (W81XWH-08-1-0457 to S.D. and W81XWH-06-1-0140 to C-T.C.) and the Diabetes and Endocrine Resource Center (5P30DK3252025). Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used.	Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Conboy MJ, 2010, METHODS MOL BIOL, V621, P165, DOI 10.1007/978-1-60761-063-2_11; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Sachdev S., 2009, BMC CANCER, V12, P9; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Waters S, 2009, FEBS LETT, V583, P1846, DOI 10.1016/j.febslet.2009.04.049; Xu P, 2010, MOL CELL BIOL, V30, P1329, DOI 10.1128/MCB.00795-09; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	70	171	177	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1214	U110		10.1038/ncb2332	http://dx.doi.org/10.1038/ncb2332			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21909099	Green Accepted			2022-12-25	WOS:000295617900011
J	Gabriel, R; Lombardo, A; Arens, A; Miller, JC; Genovese, P; Kaeppel, C; Nowrouzi, A; Bartholomae, CC; Wang, JB; Friedman, G; Holmes, MC; Gregory, PD; Glimm, H; Schmidt, M; Naldini, L; von Kalle, C				Gabriel, Richard; Lombardo, Angelo; Arens, Anne; Miller, Jeffrey C.; Genovese, Pietro; Kaeppel, Christine; Nowrouzi, Ali; Bartholomae, Cynthia C.; Wang, Jianbin; Friedman, Geoffrey; Holmes, Michael C.; Gregory, Philip D.; Glimm, Hanno; Schmidt, Manfred; Naldini, Luigi; von Kalle, Christof			An unbiased genome-wide analysis of zinc-finger nuclease specificity	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; RESTRICTION ENZYMES; VECTOR INTEGRATION; LENTIVIRAL VECTORS; GENE MODIFICATION; DNA CLEAVAGE; IN-VIVO; KNOCKOUT; SITES	Zinc-finger nucleases (ZFNs) allow gene editing in live cells by inducing a targeted DNA double-strand break (DSB) at a specific genomic locus. However, strategies for characterizing the genome-wide specificity of ZFNs remain limited. We show that nonhomologous end-joining captures integrase-defective lentiviral vectors at DSBs, tagging these transient events. Genome-wide integration site analysis mapped the actual in vivo cleavage activity of four ZFN pairs targeting CCR5 or IL2RG. Ranking loci with repeatedly detectable nuclease activity by deep-sequencing allowed us to monitor the degree of ZFN specificity in vivo at these positions. Cleavage required binding of ZFNs in specific spatial arrangements on DNA bearing high homology to the intended target site and only tolerated mismatches at individual positions of the ZFN binding sites. Whereas the consensus binding sequence derived in vivo closely matched that obtained in biochemical experiments, the ranking of in vivo cleavage sites could not be predicted in silico. Comprehensive mapping of ZFN activity in vivo will facilitate the broad application of these reagents in translational research.	[Lombardo, Angelo; Genovese, Pietro; Naldini, Luigi] Univ Vita Salute San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy; [Gabriel, Richard; Arens, Anne; Kaeppel, Christine; Nowrouzi, Ali; Bartholomae, Cynthia C.; Glimm, Hanno; Schmidt, Manfred; von Kalle, Christof] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Gabriel, Richard; Arens, Anne; Kaeppel, Christine; Nowrouzi, Ali; Bartholomae, Cynthia C.; Glimm, Hanno; Schmidt, Manfred; von Kalle, Christof] German Canc Res Ctr, Heidelberg, Germany; [Miller, Jeffrey C.; Wang, Jianbin; Friedman, Geoffrey; Holmes, Michael C.; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Sangamo Therapeutics, Inc.	Naldini, L (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy.	naldini.luigi@hsr.it; christof.kalle@NCT-Heidelberg.de	Genovese, Pietro/H-3710-2018; lombardo, angelo/J-6241-2016; Naldini, Luigi/E-9083-2012; Wilson, Matthew H/K-3193-2013	Genovese, Pietro/0000-0001-9507-9003; lombardo, angelo/0000-0001-8262-042X; Gregory, Philip/0000-0001-9249-2468; NALDINI, Luigi/0000-0002-7835-527X	Deutsche Forschungsgemeinschaft [SPP1230]; Bundesministerium fur Bildung und Forschung (iGene; European Commission (EC) [FP7-HEALTH-2009-222878, 249845]; European Network for the Advancement of Clinical Gene Transfer and Therapy (CLINIGENE); Persisting Transgenesis (PERSIST); Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; Telethon	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (iGene(Federal Ministry of Education & Research (BMBF)); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); European Network for the Advancement of Clinical Gene Transfer and Therapy (CLINIGENE)(European Commission); Persisting Transgenesis (PERSIST); Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; Telethon(Fondazione Telethon)	We thank U. Abel for fruitful discussions. Funding was provided by the Deutsche Forschungsgemeinschaft (SPP1230, grant of the Tumor Center Heidelberg/Mannheim), by the Bundesministerium fur Bildung und Forschung (iGene), by the VIth + VIIth Framework Programs of the European Commission (EC, European Network for the Advancement of Clinical Gene Transfer and Therapy (CLINIGENE) and Persisting Transgenesis (PERSIST) and by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer to C.v.K. and M.S. Funding to L.N. was provided by Telethon (TIGET grant), EC (FP7-HEALTH-2009-222878, PERSIST; ERC Advanced Grant FP7, Targeting gene therapy - 249845).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Gaur M, 1998, J VIROL, V72, P4678, DOI 10.1128/JVI.72.6.4678-4685.1998; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lin YF, 2001, NUCLEIC ACIDS RES, V29, P3975, DOI 10.1093/nar/29.19.3975; Lin YF, 2001, GENETICS, V158, P1665; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petek LM, 2010, MOL THER, V18, P983, DOI 10.1038/mt.2010.35; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Vargas J, 2004, HUM GENE THER, V15, P361, DOI 10.1089/104303404322959515	45	396	492	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					816	U72		10.1038/nbt.1948	http://dx.doi.org/10.1038/nbt.1948			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21822255				2022-12-25	WOS:000294718400022
J	Panizzi, P; Nahrendorf, M; Figueiredo, JL; Panizzi, J; Marinelli, B; Iwamoto, Y; Keliher, E; Maddur, AA; Waterman, P; Kroh, HK; Leuschner, F; Aikawa, E; Swirski, FK; Pittet, MJ; Hackeng, TM; Fuentes-Prior, P; Schneewind, O; Bock, PE; Weissleder, R				Panizzi, Peter; Nahrendorf, Matthias; Figueiredo, Jose-Luiz; Panizzi, Jennifer; Marinelli, Brett; Iwamoto, Yoshiko; Keliher, Edmund; Maddur, Ashoka A.; Waterman, Peter; Kroh, Heather K.; Leuschner, Florian; Aikawa, Elena; Swirski, Filip K.; Pittet, Mikael J.; Hackeng, Tilman M.; Fuentes-Prior, Pablo; Schneewind, Olaf; Bock, Paul E.; Weissleder, Ralph			In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation	NATURE MEDICINE			English	Article							COAGULASE-DEFICIENT MUTANTS; INFECTIVE ENDOCARDITIS; STAPHYLOCOAGULASE; DIAGNOSIS; VIRULENCE; PROBES	Coagulase-positive Staphylococcus aureus (S. aureus) is the major causal pathogen of acute endocarditis, a rapidly progressing, destructive infection of the heart valves. Bacterial colonization occurs at sites of endothelial damage, where, together with fibrin and platelets, the bacteria initiate the formation of abnormal growths known as vegetations. Here we report that an engineered analog of prothrombin could be used to detect S. aureus in endocarditic vegetations via noninvasive fluorescence or positron emission tomography (PET) imaging. These prothrombin derivatives bound staphylocoagulase and intercalated into growing bacterial vegetations. We also present evidence for bacterial quorum sensing in the regulation of staphylocoagulase expression by S. aureus. Staphylocoagulase expression was limited to the growing edge of mature vegetations, where it was exposed to the host and co-localized with the imaging probe. When endocarditis was induced with an S. aureus strain with genetic deletion of coagulases, survival of mice improved, highlighting the role of staphylocoagulase as a virulence factor.	[Panizzi, Peter; Nahrendorf, Matthias; Figueiredo, Jose-Luiz; Marinelli, Brett; Iwamoto, Yoshiko; Keliher, Edmund; Waterman, Peter; Leuschner, Florian; Aikawa, Elena; Swirski, Filip K.; Pittet, Mikael J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Panizzi, Peter] Auburn Univ, Dept Pharmacal Sci, Harrison Sch Pharm, Auburn, AL 36849 USA; [Panizzi, Jennifer] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Maddur, Ashoka A.; Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Hackeng, Tilman M.] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Fuentes-Prior, Pablo] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain; [Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Auburn University System; Auburn University; Harvard University; Massachusetts General Hospital; Vanderbilt University; Maastricht University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; University of Chicago	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	mnahrendorf@mgh.harvard.edu; rweissleder@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019; Panizzi, Peter/A-6072-2019; Aikawa, Elena/L-6173-2019; Pittet, Mikael/ABD-6300-2021	Panizzi, Peter/0000-0003-0141-8807; /0000-0003-0828-4143; Hackeng, Tilman/0000-0003-0142-0843; Fuentes-Prior, Pablo/0000-0002-6618-3204; Swirski, Filip/0000-0002-3163-9152; Aikawa, Elena/0000-0001-7835-2135	US National Institutes of Health [F32-HL094010, K99-HL094533, F32DK083868, R01-HL096576, R01-HL095629, R01-EB006432, T32-CA79443, R24-CA92782, P50-CA86355, R37-HL071544, R01-HL038779]; Deutsche Herzstiftung; NATIONAL CANCER INSTITUTE [T32CA079443, P50CA086355, R24CA092782] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095629, R01HL038779, K99HL094533, F32HL094010, R01HL096576, R37HL071544, R00HL094533, R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK083868] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Herzstiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Y. Fisher-Jeffes for review of the manuscript and C. Vinegoni, Z. Mueller and J. Sullivan for help with imaging and data analysis. We would also like to thank T. Foster for materials and helpful suggestions. This work was funded in part by grants from the US National Institutes of Health F32-HL094010, K99-HL094533 (P.P.); F32DK083868 (J.P.); R01-HL096576, R01-HL095629 (M.N.); R01-EB006432, T32-CA79443, R24-CA92782, P50-CA86355 (R.W.) and R37-HL071544, R01-HL038779 (P.E.B.) and a Deutsche Herzstiftung grant (F.L.).	BADDOUR LM, 1994, J MED MICROBIOL, V41, P259, DOI 10.1099/00222615-41-4-259; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; Berny MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010415; Bleeker-Rovers CP, 2007, J NUCL MED, V48, P337; BOCK PE, 1992, J BIOL CHEM, V267, P14963; Cabell CH, 2004, HEART, V90, P975, DOI 10.1136/hrt.2003.031328; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Chevalier C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000809; Dumarey N, 2006, J NUCL MED, V47, P625; DURACK DT, 1990, HEART ARTERIES VEINS, V63, P1230; Friedrich R, 2006, J BIOL CHEM, V281, P1188, DOI 10.1074/jbc.M507957200; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Loeb L, 1904, J MED RES, V10, P407; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Panizzi P, 2006, J BIOL CHEM, V281, P1179, DOI 10.1074/jbc.M507956200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; PHONIMDAENG P, 1990, MOL MICROBIOL, V4, P393, DOI 10.1111/j.1365-2958.1990.tb00606.x; Rennen HJJM, 2007, NUCL MED BIOL, V34, P691, DOI 10.1016/j.nucmedbio.2007.04.012; Rouzet F, 2008, CIRCULATION, V117, P781, DOI 10.1161/CIRCULATIONAHA.107.718114; SALAMAH AA, 1992, MICROBIOLOGICA, V15, P75; Sawai T, 1997, INFECT IMMUN, V65, P466, DOI 10.1128/IAI.65.2.466-471.1997	24	119	126	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1142	U153		10.1038/nm.2423	http://dx.doi.org/10.1038/nm.2423			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857652	Green Accepted			2022-12-25	WOS:000294605100037
J	Sloan, JL; Johnston, JJ; Manoli, I; Chandler, RJ; Krause, C; Carrillo-Carrasco, N; Chandrasekaran, SD; Sysol, JR; O'Brien, K; Hauser, NS; Sapp, JC; Dorward, HM; Huizing, M; Barshop, BA; Berry, SA; James, PM; Champaigne, NL; de Lonlay, P; Valayannopoulos, V; Geschwind, MD; Gavrilov, DK; Nyhan, WL; Biesecker, LG; Venditti, CP				Sloan, Jennifer L.; Johnston, Jennifer J.; Manoli, Irini; Chandler, Randy J.; Krause, Caitlin; Carrillo-Carrasco, Nuria; Chandrasekaran, Suma D.; Sysol, Justin R.; O'Brien, Kevin; Hauser, Natalie S.; Sapp, Julie C.; Dorward, Heidi M.; Huizing, Marjan; Barshop, Bruce A.; Berry, Susan A.; James, Philip M.; Champaigne, Neena L.; de Lonlay, Pascale; Valayannopoulos, Vassilli; Geschwind, Michael D.; Gavrilov, Dimitar K.; Nyhan, William L.; Biesecker, Leslie G.; Venditti, Charles P.		NIH Intramural Sequencing Ctr Grp	Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria	NATURE GENETICS			English	Article							MUTATIONAL ANALYSIS; ACYL-COENZYME; SYNTHETASE; RESIDUES; ENZYMES; GENOME; COA	We used exome sequencing to identify the genetic basis of combined malonic and methylmalonic aciduria (CMAMMA). We sequenced the exome of an individual with CMAMMA and followed up with sequencing of eight additional affected individuals (cases). This included one individual who was identified and diagnosed by searching an exome database. We identify mutations in ACSF3, encoding a putative methylmalonyl-CoA and malonyl-CoA synthetase as a cause of CMAMMA. We also examined a canine model of CMAMMA, which showed pathogenic mutations in a predicted ACSF3 ortholog. ACSF3 mutant alleles occur with a minor allele frequency of 0.0058 in similar to 1,000 control individuals, predicting a CMAMMA population incidence of similar to 1:30,000. ACSF3 deficiency is the first human disorder identified as caused by mutations in a gene encoding a member of the acyl-CoA synthetase family, a diverse group of evolutionarily conserved proteins, and may emerge as one of the more common human metabolic disorders.	[Johnston, Jennifer J.; Krause, Caitlin; Sapp, Julie C.; Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Sloan, Jennifer L.; Manoli, Irini; Chandler, Randy J.; Carrillo-Carrasco, Nuria; Chandrasekaran, Suma D.; Sysol, Justin R.; Hauser, Natalie S.; Venditti, Charles P.] NHGRI, Genet & Mol Biol Branch, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Chandler, Randy J.] George Washington Univ, Dept Pharmacol, Inst Biomed Sci, Washington, DC 20052 USA; [O'Brien, Kevin; Dorward, Heidi M.; Huizing, Marjan] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [NIH Intramural Sequencing Ctr Grp] NIH Intramural Sequencing Ctr, NIH, Rockville, MD USA; [Barshop, Bruce A.; Nyhan, William L.] Univ Calif San Diego, Dept Pediat, Biochem Genet Lab, San Diego, CA 92103 USA; [Berry, Susan A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [James, Philip M.] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp Boston, Boston, MA 02115 USA; [Champaigne, Neena L.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [de Lonlay, Pascale; Valayannopoulos, Vassilli] Necker Enfants Malades Hosp, Reference Ctr Inherited Metab Disorders, Paris, France; [Geschwind, Michael D.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Gavrilov, Dimitar K.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); George Washington University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Harvard Medical School; Greenwood Genetic Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; Mayo Clinic	Biesecker, LG (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Huizing, Marjan/AAR-8860-2020; Carrillo-Carrasco, Nuria/B-9034-2009; Gavrilov, Dimitar/AAB-9453-2021; Biesecker, Leslie/AAG-2526-2021; Chandler, Randy Joseph/Y-1164-2019	Carrillo-Carrasco, Nuria/0000-0003-0374-0808; Chandler, Randy Joseph/0000-0002-6047-5230; Berry, Susan/0000-0001-7970-688X; Manoli, Irini/0000-0003-1543-2941; Sapp, Julie/0000-0002-4003-258X	NHGRI, NIH; NIA [K23 AG021989, R01-AG031189]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322, ZIAHG200318, ZIAHG200328, ZIBHG000196, ZIAHG200359, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031189, K23AG021989] Funding Source: NIH RePORTER	NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the subjects and families for participating, E. Ostrander for the gift of unrelated Labrador DNA samples, K. M. Gibson and R. Wander for performing the malonyl-CoA decarboxylase assay on fibroblasts from subjects 2 and 9, J. Teer for bioinformatics assistance, S. Suchy for subject referral, M. Podell and W. Gahl for helpful discussions, R. Fisher, I. Bernardini, A. Gropman, L. Hecht, F. Facio, C. Gitiaux, C. Ottolenghi, D. Rabier and G. Touati for laboratory assistance and clinical care, and M. Oglesbee and A. Genders for searching for dogs related to the affected Labrador retriever. J. L. S., J. J. J., I. M., R. J. C., N.C.-C., S. D. C., J. R. S., H. M. D., M. H., K.O., N.S.H., J. C. S., C. K., L. G. B. and C. P. V. were supported by the Intramural Research Program of the NHGRI, NIH. M. D. G. was supported by NIA K23 AG021989 and R01-AG031189.	An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; Chandler RJ, 2006, MOL GENET METAB, V89, P64, DOI 10.1016/j.ymgme.2006.06.001; Gregg AR, 1998, J INHERIT METAB DIS, V21, P382, DOI 10.1023/A:1005302607897; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Koo HM, 2000, ARCH BIOCHEM BIOPHYS, V378, P167, DOI 10.1006/abbi.2000.1813; Podell M, 1996, METAB BRAIN DIS, V11, P239, DOI 10.1007/BF02237961; Sniderman LC, 1999, J PEDIATR-US, V134, P675, DOI 10.1016/S0022-3476(99)70280-5; Stuible HP, 2000, FEBS LETT, V467, P117, DOI 10.1016/S0014-5793(00)01133-9; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	13	64	69	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					883	U96		10.1038/ng.908	http://dx.doi.org/10.1038/ng.908			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21841779	Green Accepted			2022-12-25	WOS:000294325800016
J	Bancroft, I; Morgan, C; Fraser, F; Higgins, J; Wells, R; Clissold, L; Baker, D; Long, Y; Meng, JL; Wang, XW; Liu, SY; Trick, M				Bancroft, Ian; Morgan, Colin; Fraser, Fiona; Higgins, Janet; Wells, Rachel; Clissold, Leah; Baker, David; Long, Yan; Meng, Jinling; Wang, Xiaowu; Liu, Shengyi; Trick, Martin			Dissecting the genome of the polyploid crop oilseed rape by transcriptome sequencing	NATURE BIOTECHNOLOGY			English	Article							BRASSICA-NAPUS; SNP DISCOVERY; LINKAGE MAP; SEGMENTS; OLERACEA	Polyploidy complicates genomics-based breeding of many crops, including wheat, potato, cotton, oat and sugarcane. To address this challenge, we sequenced leaf transcriptomes across a mapping population of the polyploid crop oilseed rape (Brassica napus) and representative ancestors of the parents of the population. Analysis of sequence variation(1) and transcript abundance enabled us to construct twin single nucleotide polymorphism linkage maps of B. napus, comprising 23,037 markers. We used these to align the B. napus genome with that of a related species, Arabidopsis thaliana, and to genome sequence assemblies of its progenitor species, Brassica rapa and Brassica oleracea. We also developed methods to detect genome rearrangements and track inheritance of genomic segments, including the outcome of an interspecific cross. By revealing the genetic consequences of breeding, cost-effective, high-resolution dissection of crop genomes by transcriptome sequencing will increase the efficiency of predictive breeding even in the absence of a complete genome sequence.	[Bancroft, Ian; Morgan, Colin; Fraser, Fiona; Higgins, Janet; Wells, Rachel; Clissold, Leah; Trick, Martin] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Baker, David] Genome Anal Ctr, Biotechnol & Biol Sci Res Council, Norwich, Norfolk, England; [Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Key Lab Hort Crop Genet Improvement, Minist Agr, Beijing 100193, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Sino Dutch Joint Lab Hort Genom Technol, Beijing 100193, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Liu, Shengyi] Chinese Acad Agr Sci, Key Lab Oil Crops Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; The Genome Analysis Centre (TGAC); Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Bancroft, I (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	ian.bancroft@jic.ac.uk	Bancroft, Ian/AAH-3831-2020; Wang, Xiaowu/L-2579-2019; Liu, Shengyi/S-6772-2016	Bancroft, Ian/0000-0001-7707-1171; Liu, Shengyi/0000-0002-4955-4763	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBSRC BB/E017363/1, ERAPG08.008]; UK Department for Environment, Food and Rural Affairs (Defra) [Defra IF0144]; China National Basic Research and Development Program [2006CB101600, 2011CB109300]; BBSRC [BB/G024952/1, BB/E017363/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G024952/1, BB/E017363/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); China National Basic Research and Development Program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank The Genome Analysis Centre for generating Illumina sequence data and the Warwick HRI Genetic Resources Unit for seeds of cultivar Regent. This work was supported by UK Biotechnology and Biological Sciences Research Council (BBSRC BB/E017363/1, ERAPG08.008), UK Department for Environment, Food and Rural Affairs (Defra IF0144) and by China National Basic Research and Development Program (2006CB101600 and 2011CB109300).	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Lagercrantz U, 1996, GENETICS, V144, P1903; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Rounsley S, 2009, RICE, V2, P35, DOI 10.1007/s12284-009-9025-z; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Sharpe AG, 2003, GENOME, V46, P461, DOI 10.1139/G03-031; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Suwabe K, 2008, GENOME, V51, P169, DOI 10.1139/G07-113; The Brassica rapa Genome Sequencing Consortium, NAT GENET IN PRESS; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; U. N., 1935, Japanese Journal of Botany, V7, P389; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59	27	143	148	1	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					762	U128		10.1038/nbt.1926	http://dx.doi.org/10.1038/nbt.1926			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804563				2022-12-25	WOS:000293696500030
J	Devenport, D; Oristian, D; Heller, E; Fuchs, E				Devenport, Danelle; Oristian, Daniel; Heller, Evan; Fuchs, Elaine			Mitotic internalization of planar cell polarity proteins preserves tissue polarity	NATURE CELL BIOLOGY			English	Article							SPINDLE ORIENTATION; ASYMMETRIC LOCALIZATION; DROSOPHILA; FLAMINGO; DIVISION; ESTABLISHMENT; POLARIZATION; STRABISMUS; EPITHELIUM; FRIZZLED6	Planar cell polarity (PCP) is the collective polarization of cells along the epithelial plane, a process best understood in the terminally differentiated Drosophila wing. Proliferative tissues such as mammalian skin also show PCP, but the mechanisms that preserve tissue polarity during proliferation are not understood. During mitosis,a symmetrically distributed PCP components risk mislocalization or unequal inheritance, which could have profound consequences for the long-range propagation of polarity. Here, we show that when mouse epidermal basal progenitors divide PCP components are selectively internalized into endosomes, which are inherited equally by daughter cells. Following mitosis, PCP proteins are recycled to the cell surface, where asymmetry is re-established by a process reliant on neighbouring PCP. A cytoplasmic dileucine motif governs mitotic internalization of a typical cadherin Celsr1, which recruits Vang2 and Fzd6 to endosomes. Moreover, embryos transgenic for a Celsr1 that cannot mitotically internalize exhibit perturbed hair-follicle angling, a hallmark of defective PCP. This underscores the physiological relevance and importance of this mechanism for regulating polarity during cell division.	[Devenport, Danelle; Oristian, Daniel; Heller, Evan; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave,Box 300, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Devenport, Danelle/0000-0002-5464-259X	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883, R00AR057501, K99AR057501, R01AR050452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank N. Stokes for her assistance in the mouse facility, M. Montcouquoil for Vangl2 antibodies, and E. Vladar and J. Axelrod for sharing the lenti-Celsr1<SUP>Delta N</SUP>-GFP construct. We thank S. Simon laboratory members L. Macro and C. Atkinson for advice and constructs for TIRF imaging. We are grateful to S. Williams for retroviral vectors and technical assistance and to B. Short and members of the Fuchs laboratory for discussions and reading of the manuscript. We thank A. North and K. Thomas at the RU Bioimaging Resource Center for assistance with image acquisition, and the Comparative Biology Center (CBC) for their help in veterinary care. D.D. is the recipient of a K99 Award from the National Institutes of Health. E.F. is an investigator in the Howard Hughes Medical Institute. Work was supported by the Howard Hughes Medical Institute and the National Institutes of Health.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Axelrod JD, 2001, GENE DEV, V15, P1182; BAKER J, 1993, J CELL SCI, V104, P415; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Strutt D, 2007, DEV BIOL, V302, P181, DOI 10.1016/j.ydbio.2006.09.026; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Taylor J, 1998, GENETICS, V150, P199; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	36	101	105	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					893	U418		10.1038/ncb2284	http://dx.doi.org/10.1038/ncb2284			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21743464	Green Accepted			2022-12-25	WOS:000293373700007
J	Dickinson, BC; Chang, CJ				Dickinson, Bryan C.; Chang, Christopher J.			Chemistry and biology of reactive oxygen species in signaling or stress responses	NATURE CHEMICAL BIOLOGY			English	Article							CELLULAR HYDROGEN-PEROXIDE; TYROSINE-PHOSPHATASE 1B; CYSTEINE-SULFINIC ACID; LIVING CELLS; OXIDATIVE STRESS; NITRIC-OXIDE; IN-VIVO; TRANSCRIPTION FACTOR; FLUORESCENT-PROBES; REDOX REGULATION	Reactive oxygen species (ROS) are a family of molecules that are continuously generated, transformed and consumed in all living organisms as a consequence of aerobic life. The traditional view of these reactive oxygen metabolites is one of oxidative stress and damage that leads to decline of tissue and organ systems in aging and disease. However, emerging data show that ROS produced in certain situations can also contribute to physiology and increased fitness. This Perspective provides a focused discussion on what factors lead ROS molecules to become signal and/or stress agents, highlighting how increasing knowledge of the underlying chemistry of ROS can lead to advances in understanding their disparate contributions to biology. An important facet of this emerging area at the chemistry-biology interface is the development of new tools to study these small molecules and their reactivity in complex biological systems.	[Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dickinson, BC (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	chrischang@berkeley.edu			Packard Foundation; Amgen; Astra Zeneca; Novartis; US National Institutes of Health (NIH) [GM 79465]; NIH [T32 GM066698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM066698] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); Amgen(Amgen); Astra Zeneca(AstraZeneca); Novartis(Novartis); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Packard Foundation, Amgen, Astra Zeneca and Novartis and the US National Institutes of Health (NIH; GM 79465) for providing funding for this work. C.J.C. is an Investigator with the Howard Hughes Medical Institute. B.C.D. was partially supported by a Chemical Biology Training Grant from the NIH (T32 GM066698). Due to space limitations, we apologize if we inadvertently omitted citations of major contributions to this area.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Bao L, 2009, J NEUROSCI, V29, P9002, DOI 10.1523/JNEUROSCI.1706-09.2009; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Bryan NS, 2009, FRONT BIOSCI-LANDMRK, V14, P1, DOI 10.2741/3228; Chang MCY, 2004, J AM CHEM SOC, V126, P15392, DOI 10.1021/ja0441716; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; DELRIO LA, 1992, FREE RADICAL BIO MED, V13, P557, DOI 10.1016/0891-5849(92)90150-F; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Garner AL, 2009, NAT CHEM, V1, P316, DOI [10.1038/NCHEM.240, 10.1038/nchem.240]; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kenmoku S, 2007, J AM CHEM SOC, V129, P7313, DOI 10.1021/ja068740g; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Lippert AR, 2011, J AM CHEM SOC, V133, P3776, DOI 10.1021/ja111589a; Mahon KP, 2007, CHEM BIOL, V14, P923, DOI 10.1016/j.chembiol.2007.07.011; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller EW, 2007, J AM CHEM SOC, V129, P3458, DOI 10.1021/ja0668973; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; Miller EW, 2010, J AM CHEM SOC, V132, P17071, DOI 10.1021/ja107783j; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Srikun D, 2008, J AM CHEM SOC, V130, P4596, DOI 10.1021/ja711480f; Srikun D, 2011, CHEM SCI, V2, P1156, DOI 10.1039/c1sc00064k; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yang D, 2006, J AM CHEM SOC, V128, P6004, DOI 10.1021/ja0603756	100	1144	1174	26	483	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					504	511		10.1038/NCHEMBIO.607	http://dx.doi.org/10.1038/NCHEMBIO.607			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769097	Green Accepted			2022-12-25	WOS:000292825400010
J	Vedadi, M; Barsyte-Lovejoy, D; Liu, F; Rival-Gervier, S; Allali-Hassani, A; Labrie, V; Wigle, TJ; DiMaggio, PA; Wasney, GA; Siarheyeva, A; Dong, AP; Tempel, W; Wang, SC; Chen, X; Chau, I; Mangano, TJ; Huang, XP; Simpson, CD; Pattenden, SG; Norris, JL; Kireev, DB; Tripathy, A; Edwards, A; Roth, BL; Janzen, WP; Garcia, BA; Petronis, A; Ellis, J; Brown, PJ; Frye, SV; Arrowsmith, CH; Jin, J				Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Liu, Feng; Rival-Gervier, Sylvie; Allali-Hassani, Abdellah; Labrie, Viviane; Wigle, Tim J.; DiMaggio, Peter A.; Wasney, Gregory A.; Siarheyeva, Alena; Dong, Aiping; Tempel, Wolfram; Wang, Sun-Chong; Chen, Xin; Chau, Irene; Mangano, Thomas J.; Huang, Xi-ping; Simpson, Catherine D.; Pattenden, Samantha G.; Norris, Jacqueline L.; Kireev, Dmitri B.; Tripathy, Ashutosh; Edwards, Aled; Roth, Bryan L.; Janzen, William P.; Garcia, Benjamin A.; Petronis, Arturas; Ellis, James; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Jin, Jian			A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells	NATURE CHEMICAL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; HISTONE METHYLTRANSFERASES; DNA METHYLATION; LYSINE-9 METHYLATION; CHROMATIN-STRUCTURE; CANCER-CELLS; P53; TRANSCRIPTION; REPRESSION; COMPLEXES	Protein lysine methyltransferases G9a and GLP modulate the transcriptional repression of a variety of genes via dimethylation of Lys9 on histone H3 (H3K9me2) as well as dimethylation of non-histone targets. Here we report the discovery of UNC0638, an inhibitor of G9a and GLP with excellent potency and selectivity over a wide range of epigenetic and non-epigenetic targets. UNC0638 treatment of a variety of cell lines resulted in lower global H3K9me2 levels, equivalent to levels observed for small hairpin RNA knockdown of G9a and GLP with the functional potency of UNC0638 being well separated from its toxicity. UNC0638 markedly reduced the clonogenicity of MCF7 cells, reduced the abundance of H3K9me2 marks at promoters of known G9a-regulated endogenous genes and disproportionately affected several genomic loci encoding microRNAs. In mouse embryonic stem cells, UNC0638 reactivated G9a-silenced genes and a retroviral reporter gene in a concentration-dependent manner without promoting differentiation.	[Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Allali-Hassani, Abdellah; Wasney, Gregory A.; Siarheyeva, Alena; Dong, Aiping; Tempel, Wolfram; Chau, Irene; Edwards, Aled; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Liu, Feng; Wigle, Tim J.; Chen, Xin; Simpson, Catherine D.; Pattenden, Samantha G.; Norris, Jacqueline L.; Kireev, Dmitri B.; Janzen, William P.; Frye, Stephen V.; Jin, Jian] Univ N Carolina, UNC Eshelman Sch Pharm, Div Med Chem & Nat Prod, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA; [Rival-Gervier, Sylvie; Ellis, James] SickKids Hosp, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Ellis, James] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rival-Gervier, Sylvie] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France; [Labrie, Viviane; Wang, Sun-Chong; Petronis, Arturas] Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON, Canada; [DiMaggio, Peter A.; Garcia, Benjamin A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Mangano, Thomas J.; Huang, Xi-ping; Roth, Bryan L.] Univ N Carolina, Drug Screening Program, Natl Inst Mental Hlth Psychoact, Chapel Hill, NC USA; [Tripathy, Ashutosh] Univ N Carolina, Dept Biochem & Biophys, UNC Macromol Interact Facil, Chapel Hill, NC USA; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Princeton University; National Central University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	carrow@uhnres.utoronto.ca; jianjin@unc.edu	Roth, Bryan L/F-3928-2010; Ellis, James/F-4789-2011; Kireev, Dmitri/B-7225-2012; Rival-Gervier, Sylvie/M-7649-2014; Petronis, Art/AAD-4491-2019	Ellis, James/0000-0002-4400-0091; Kireev, Dmitri/0000-0001-8479-8555; Rival-Gervier, Sylvie/0000-0001-8266-8095; Labrie, Viviane/0000-0002-8851-0093; Arrowsmith, Cheryl/0000-0002-4971-3250; Edwards, Aled/0000-0002-4782-6016; Labrie, Viviane/0000-0003-1037-1967; Brown, Peter/0000-0002-8454-0367; Chen, Xin/0000-0002-5208-2154; DiMaggio, Peter/0000-0003-1996-0813	National Institute of General Medical Sciences; US National Institutes of Health (NIH) [RC1GM090732]; University of North Carolina at Chapel Hill; US National Science Foundation (NSF); Ontario Research Fund; Ontario Ministry of Health and Long-term Care; Structural Genomics Consortium; Canadian Institutes for Health Research (CIHR) [199170, 186007, IG1-102956]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co. Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NIH [MH074127, MH088413, DP3DK085698, HG004535]; NSF [CBET-0941143]; American Society for Mass Spectrometry; NIH Office of the Director [DP2OD007447]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK085698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM090732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074127, R01MH088413] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; US National Science Foundation (NSF)(National Science Foundation (NSF)); Ontario Research Fund; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co. Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Society for Mass Spectrometry; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Tumber for JMJD2E assay support; J. Moffat (University of Toronto) for the gift of shRNAs; R. Bristow (University Health Network) for RV221 and PC3 cells; T. Hajian and F. Syeda for protein purification; G. Senisterra for contributing to DSF and DSLS data analysis; M. Herold for graphical design and illustration; I. Korboukh, M. Herold and J. Yost for critical reading of the manuscript; and R. Trump and C. Yates for helpful discussion. The research described here was supported by the National Institute of General Medical Sciences, US National Institutes of Health (NIH; grant RC1GM090732), the Carolina Partnership and University Cancer Research Fund from the University of North Carolina at Chapel Hill, the US National Science Foundation (NSF), the Ontario Research Fund, the Ontario Ministry of Health and Long-term Care and the Structural Genomics Consortium. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research (CIHR), the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co. Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. C.H.A. holds a Canada Research Chair in Structural Genomics. V.L. is supported by a CIHR fellowship. A.P. is supported by grants from the CIHR (199170 and 186007) and from the NIH (MH074127, MH088413, DP3DK085698 and HG004535). A.P. is Tapscott Chair in Schizophrenia Studies and a Senior Fellow of the Ontario Mental Health Foundation. J.E. is supported by CIHR grant IG1-102956. B.A.G. is supported by grants from the NSF (Early Faculty CAREER award and CBET-0941143), the American Society for Mass Spectrometry and the NIH Office of the Director (DP2OD007447). P.A.D. is supported by NIH postdoctoral fellowship F32 NRSA.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chang YQ, 2010, J MOL BIOL, V400, P1, DOI 10.1016/j.jmb.2010.04.048; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Chen LH, 2010, EMBO J, V29, P2538, DOI 10.1038/emboj.2010.140; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gelato KA, 2008, BIOL CHEM, V389, P353, DOI 10.1515/BC.2008.048; Goyama S, 2010, LEUKEMIA, V24, P81, DOI 10.1038/leu.2009.202; Hosey AM, 2010, EPIGENETICS-US, V5, P273, DOI 10.4161/epi.5.4.11522; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Link PA, 2009, MOL CANCER RES, V7, P851, DOI 10.1158/1541-7786.MCR-08-0497; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Liu F, 2009, J MED CHEM, V52, P7950, DOI 10.1021/jm901543m; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Plazas-Mayorca MD, 2010, MOL BIOSYST, V6, P1719, DOI 10.1039/c003307c; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Wigle TJ, 2010, CHEM BIOL, V17, P695, DOI 10.1016/j.chembiol.2010.04.014; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784	50	376	391	4	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					566	574		10.1038/NCHEMBIO.599	http://dx.doi.org/10.1038/NCHEMBIO.599			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21743462	Green Published, Green Accepted			2022-12-25	WOS:000292825400019
J	Guilluy, C; Swaminathan, V; Garcia-Mata, R; O'Brien, ET; Superfine, R; Burridge, K				Guilluy, Christophe; Swaminathan, Vinay; Garcia-Mata, Rafael; O'Brien, E. Timothy; Superfine, Richard; Burridge, Keith			The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins	NATURE CELL BIOLOGY			English	Article							SIGNAL-TRANSDUCTION; FOCAL ADHESIONS; LIVING CELLS; MAP KINASE; RECRUITMENT; BINDING; STRESS; GAPS	How individual cells respond to mechanical forces is of considerable interest to biologists as force affects many aspects of cell behaviour(1). The application of force on integrins triggers cytoskeletal rearrangements and growth of the associated adhesion complex, resulting in increased cellular stiffness(2,3), also known as reinforcement(4). Although RhoA has been shown to play a role during reinforcement(3), the molecular mechanisms that regulate its activity are unknown. By combining biochemical and biophysical approaches, we identified two guanine nucleotide exchange factors (GEFs), LARG and GEF-H1, as key molecules that regulate the cellular adaptation to force. We show that stimulation of integrins with tensional force triggers activation of these two GEFs and their recruitment to adhesion complexes. Surprisingly, activation of LARG and GEF-H1 involves distinct signalling pathways. Our results reveal that LARG is activated by the Src family tyrosine kinase Fyn, whereas GEF-H1 catalytic activity is enhanced by ERK downstream of a signalling cascade that includes FAK and Ras.	[Guilluy, Christophe; Garcia-Mata, Rafael; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Swaminathan, Vinay] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA; [O'Brien, E. Timothy; Superfine, Richard] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Burridge, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	keith_burridge@med.unc.edu	guilluy, christophe/C-6002-2014; Superfine, Richard/A-1968-2012; Guilluy, Christophe/Z-1015-2019	guilluy, christophe/0000-0003-1141-0809; Superfine, Richard/0000-0002-2569-071X; Guilluy, Christophe/0000-0003-1141-0809; Garcia-Mata, Rafael/0000-0002-7116-4411	National Institutes of Health [GM029860, GM029860-28S, P41-EB002025-23A1, R01-HL077546-03A2]; Lineberger Comprehensive Cancer Center; European Union [254747]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lineberger Comprehensive Cancer Center; European Union(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank L. Sharek for her technical support. This study was supported by National Institutes of Health Grant nos GM029860 and GM029860-28S (to K.B.), P41-EB002025-23A1 (R.S.) and R01-HL077546-03A2 (R.S.), and a grant from the University Cancer Research Fund from the Lineberger Comprehensive Cancer Center. C.G. is supported by a Marie Curie Outgoing International Fellowship from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 254747.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fisher JK, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2166509; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Mair L, 2009, J BIOMED NANOTECHNOL, V5, P182, DOI 10.1166/jbn.2009.1024; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; O'Brien ET, 2008, METHOD CELL BIOL, V89, P433, DOI 10.1016/S0091-679X(08)00616-X; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; SCHLAEPFER DD, 1994, NATURE, V372, P786; Thoumine O, 1997, J CELL SCI, V110, P2109; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	40	261	267	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					722	U211		10.1038/ncb2254	http://dx.doi.org/10.1038/ncb2254			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21572419	Green Accepted, Green Submitted			2022-12-25	WOS:000291147400014
J	Small, KS; Hedman, AK; Grundberg, E; Nica, AC; Thorleifsson, G; Kong, A; Thorsteindottir, U; Shin, SY; Richards, HB; Soranzo, N; Ahmadi, KR; Lindgren, CM; Stefansson, K; Dermitzakis, ET; Deloukas, P; Spector, TD; McCarthy, MI				Small, Kerrin S.; Hedman, Asa K.; Grundberg, Elin; Nica, Alexandra C.; Thorleifsson, Gudmar; Kong, Augustine; Thorsteindottir, Unnur; Shin, So-Youn; Richards, Hannah B.; Soranzo, Nicole; Ahmadi, Kourosh R.; Lindgren, Cecilia M.; Stefansson, Kari; Dermitzakis, Emmanouil T.; Deloukas, Panos; Spector, Timothy D.; McCarthy, Mark I.		GIANT Consortium; MAGIC Investigators; DIAGRAM Consortium; MuTHER Consortium	Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes	NATURE GENETICS			English	Article							WIDE ASSOCIATION ANALYSIS; BODY-MASS INDEX; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; TWIN COHORT; VARIANTS; DISEASES; RISK	Genome-wide association studies have identified many genetic variants associated with complex traits. However, at only a minority of loci have the molecular mechanisms mediating these associations been characterized. In parallel, whereas cis regulatory patterns of gene expression have been extensively explored, the identification of trans regulatory effects in humans has attracted less attention. Here we show that the type 2 diabetes and high-density lipoprotein cholesterol-associated cis-acting expression quantitative trait locus (eQTL) of the maternally expressed transcription factor KLF14 acts as a master trans regulator of adipose gene expression. Expression levels of genes regulated by this trans-eQTL are highly correlated with concurrently measured metabolic traits, and a subset of the trans-regulated genes harbor variants directly associated with metabolic phenotypes. This trans-eQTL network provides a mechanistic understanding of the effect of the KLF14 locus on metabolic disease risk and offers a potential model for other complex traits.	[Hedman, Asa K.; Lindgren, Cecilia M.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Small, Kerrin S.; Grundberg, Elin; Soranzo, Nicole; Ahmadi, Kourosh R.; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Small, Kerrin S.; Grundberg, Elin; Shin, So-Youn; Soranzo, Nicole; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Nica, Alexandra C.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Thorleifsson, Gudmar; Kong, Augustine; Thorsteindottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Thorsteindottir, Unnur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Richards, Hannah B.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London; Wellcome Trust Sanger Institute; University of Geneva; University of Iceland; University of Oxford; University of Oxford	McCarthy, MI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mark.mccarthy@drl.ox.ac.uk	Zondervan, Krina T/M-1143-2013; Deloukas, Panos/B-2922-2013; Benediktsson, Rafn/R-2457-2018; Meitinger, Thomas/O-1318-2015; Dermitzakis, Emmanouil/B-7687-2013; Roden, Michael/AAD-3843-2019; Hide, Winston/R-3815-2019; Walters, G. Bragi/L-4215-2013; Stefansson, Kari/AAE-7187-2019; Ahmadi, Kourosh R/B-6379-2012; FROGUEL, Philippe/O-6799-2017; Hide, Winston A/V-2727-2017; Boehm, Bernhard Otto/F-8750-2015; Langenberg, Claudia/ABG-9067-2021; Rudan, Igor/I-1467-2012; Hide, Winston Hide/C-7217-2009; Aulchenko, Yurii/M-8270-2013; McCarthy, Mark/M-3763-2015	Zondervan, Krina T/0000-0002-0275-9905; Deloukas, Panos/0000-0001-9251-070X; Benediktsson, Rafn/0000-0002-2954-9801; Hide, Winston/0000-0002-8621-3271; Walters, G. Bragi/0000-0002-5415-6487; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston A/0000-0002-8621-3271; Langenberg, Claudia/0000-0002-5017-7344; Rudan, Igor/0000-0001-6993-6884; Hide, Winston Hide/0000-0002-8621-3271; Lindgren, Cecilia/0000-0002-4903-9374; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Aulchenko, Yurii/0000-0002-7899-1575; Jorgensen, Torben/0000-0001-9453-2830; Bergman, Richard/0000-0003-1539-4471; Meitinger, Thomas/0000-0002-8838-8403; Hedman, Asa/0000-0001-5413-204X; Hattersley, Andrew/0000-0001-5620-473X; Weedon, Michael/0000-0002-6174-6135; McCarthy, Mark/0000-0002-4393-0510; Couper, David/0000-0002-4313-9235; Van Duijn, Cornelia/0000-0002-2374-9204; Small, Kerrin/0000-0003-4566-0005; Soranzo, Nicole/0000-0003-1095-3852; Kong, Augustine/0000-0001-8193-5438; Zeggini, Eleftheria/0000-0003-4238-659X; Dina, Christian/0000-0002-7722-7348; Gloyn, Anna/0000-0003-1205-1844	Wellcome Trust [081917]; ENGAGE project [HEALTH-F4-2007-201413]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Oxford NIHR Biomedical Research Centre; Louis-Jeantet Foundation; NIH-NIMH [R01 MH090941]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090941] Funding Source: NIH RePORTER; Medical Research Council [G0900339] Funding Source: researchfish; MRC [G0900339] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ENGAGE project(General Electric); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Louis-Jeantet Foundation; NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MuTHER study was funded by the Wellcome Trust Program grant # 081917. Genotyping of TwinsUK samples was provided by the Wellcome Trust Sanger Institute and the National Eye Institute via a US National Institutes of Health (NIH)/Center for Inherited Disease Research (CIDR) genotyping project. TwinsUK also receives support from the ENGAGE project grant agreement HEALTH-F4-2007-201413 and from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London. T. D. S. is an NIHR senior investigator and European Research Council (ERC) senior investigator. M. I. M. is supported by the Oxford NIHR Biomedical Research Centre. Additional support was provided by the Louis-Jeantet Foundation to E. T. D. and A.C.N. and via NIH-NIMH grant R01 MH090941 to E. T. D. and M.I.M.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Falchi M, 2008, DIABETES, V57, P1120, DOI 10.2337/db07-0708; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Richards JB, 2007, J CLIN ENDOCR METAB, V92, P1517, DOI 10.1210/jc.2006-2097; Skidmore PML, 2008, J CLIN ENDOCR METAB, V93, P516, DOI 10.1210/jc.2007-1424; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Visscher PM, 2004, TWIN RES, V7, P670, DOI 10.1375/1369052042663742; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	27	234	238	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					561	U90		10.1038/ng.833	http://dx.doi.org/10.1038/ng.833			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21572415	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000291017000013
J	Mitsunaga, M; Ogawa, M; Kosaka, N; Rosenblum, LT; Choyke, PL; Kobayashi, H				Mitsunaga, Makoto; Ogawa, Mikako; Kosaka, Nobuyuki; Rosenblum, Lauren T.; Choyke, Peter L.; Kobayashi, Hisataka			Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODY; PHOTODYNAMIC THERAPY; SINGLET OXYGEN; OVARIAN-CANCER; TUMOR; PHOTOSENSITIZERS; HEMATOPORPHYRIN	Three major modes of cancer therapy (surgery, radiation and chemotherapy) are the mainstay of modern oncologic therapy. To minimize the side effects of these therapies, molecular-targeted cancer therapies, including armed antibody therapy, have been developed with limited success. In this study, we have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was induced immediately after irradiating mAbIR-700-bound target cells with NIR light. We observed in vivo tumor shrinkage after irradiation with NIR light in target cells expressing the epidermal growth factor receptor. The mAb-IR700 conjugates were most effective when bound to the cell membrane and produced no phototoxicity when not bound, suggesting a different mechanism for PIT as compared to conventional photodynamic therapies. Target-selective PIT enables treatment of cancer based on mAb binding to the cell membrane.	[Mitsunaga, Makoto; Ogawa, Mikako; Kosaka, Nobuyuki; Rosenblum, Lauren T.; Choyke, Peter L.; Kobayashi, Hisataka] NCI, Mol Imaging Program, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kobayashi, H (corresponding author), NCI, Mol Imaging Program, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA.	kobayash@mail.nih.gov			US National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010656] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research. We would like to thank C. Regino, T. Hirano and C. Paik for their technical support.	Carcenac M, 2001, BRIT J CANCER, V85, P1787, DOI 10.1054/bjoc.2001.2170; Detty MR, 2004, J MED CHEM, V47, P3897, DOI 10.1021/jm040074b; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; Hamblin MR, 1996, CANCER RES, V56, P5205; Kosaka N, 2010, PROC SPIE, V7576, DOI 10.1117/12.842090; Kosaka N, 2010, CANCER SCI, V101, P820, DOI 10.1111/j.1349-7006.2009.01423.x; Mandler R, 2004, CANCER RES, V64, P1460, DOI 10.1158/0008-5472.CAN-03-2485; MEW D, 1985, CANCER RES, V45, P4380; MEW D, 1983, J IMMUNOL, V130, P1473; Nanus DM, 2003, J UROLOGY, V170, pS84, DOI 10.1097/01.ju.0000095151.97404.7c; Ogawa M, 2009, BIOCONJUGATE CHEM, V20, P2177, DOI 10.1021/bc900362k; Ogawa M, 2009, MOL CANCER THER, V8, P232, DOI 10.1158/1535-7163.MCT-08-0862; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; PATTERSON MS, 1990, J PHOTOCH PHOTOBIO B, V5, P69, DOI 10.1016/1011-1344(90)85006-I; POOLER JP, 1979, PHOTOCHEM PHOTOBIOL, V30, P581, DOI 10.1111/j.1751-1097.1979.tb07183.x; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sobolev AS, 2000, PROG BIOPHYS MOL BIO, V73, P51, DOI 10.1016/S0079-6107(00)00002-X; THORPE WP, 1995, BIOPHYS J, V68, P2198, DOI 10.1016/S0006-3495(95)80402-9; van Dongen GAMS, 2004, ADV DRUG DELIVER REV, V56, P31, DOI 10.1016/j.addr.2003.09.003; Vrouenraets MB, 1999, CANCER RES, V59, P1505; Vrouenraets MB, 2001, CANCER RES, V61, P1970; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; Wilson BC, 1990, PHOTODYNAMIC THERAPY, V1, P129; Yang XD, 1999, CANCER RES, V59, P1236; Zhong W, 2009, BRIT J CANCER, V101, P2015, DOI 10.1038/sj.bjc.6605436	28	675	705	15	334	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1685	U210		10.1038/nm.2554	http://dx.doi.org/10.1038/nm.2554			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057348	Green Accepted			2022-12-25	WOS:000297978000044
J	Shi, YY; Hu, ZB; Wu, C; Dai, JC; Li, HZ; Dong, J; Wang, ML; Miao, XP; Zhou, YF; Lu, F; Zhang, HZ; Hu, LM; Jiang, Y; Li, ZQ; Chu, MJ; Ma, HX; Chen, JP; Jin, GF; Tan, W; Wu, TC; Zhang, ZD; Lin, DX; Shen, HB				Shi, Yongyong; Hu, Zhibin; Wu, Chen; Dai, Juncheng; Li, Huizhang; Dong, Jing; Wang, Meilin; Miao, Xiaoping; Zhou, Yifeng; Lu, Feng; Zhang, Hanze; Hu, Lingmin; Jiang, Yue; Li, Zhiqiang; Chu, Minjie; Ma, Hongxia; Chen, Jiaping; Jin, Guangfu; Tan, Wen; Wu, Tangchun; Zhang, Zhengdong; Lin, Dongxin; Shen, Hongbing			A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1	NATURE GENETICS			English	Article							GENETIC-VARIATION; CELL CARCINOMA; ESOPHAGEAL; STRATIFICATION; PLCE1; 10Q23; RISK; PSCA	Gastric cancer, including the cardia and non-cardia types, is the second leading cause of cancer-related deaths worldwide. To identify genetic risk variants for non-cardia gastric cancer, we performed a genome-wide association study in 3,279 individuals (1,006 with non-cardia gastric cancer and 2,273 controls) of Chinese descent. We replicated significant associations in an additional 6,897 subjects (3,288 with non-cardia gastric cancer and 3,609 controls). We identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 x 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 x 10(-9)). Imputation analyses also confirmed previously reported associations of rs2294008 and rs2976392 on 8q24, rs4072037 on 1q22 and rs13042395 on 20p13 with non-cardia gastric cancer susceptibility in the Han Chinese population.	[Hu, Zhibin; Dai, Juncheng; Li, Huizhang; Dong, Jing; Lu, Feng; Zhang, Hanze; Hu, Lingmin; Jiang, Yue; Chu, Minjie; Ma, Hongxia; Chen, Jiaping; Jin, Guangfu; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Minist Educ Key Lab Modern Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Shi, Yongyong; Li, Zhiqiang] Shanghai Jiao Tong Univ, Bio X Inst, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Hu, Zhibin; Chen, Jiaping; Jin, Guangfu; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wu, Chen; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wu, Chen; Tan, Wen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Occupat Med & Environm Hlth, Sch Publ Hlth, Nanjing, Peoples R China; [Miao, Xiaoping; Wu, Tangchun] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Minist Educ, Key Lab Environm & Hlth,Sch Publ Hlth,Tongi Med C, Wuhan 430074, Peoples R China; [Zhou, Yifeng] Soochow Univ, Cyrus Tang Hematol Ctr, Jiangsu Inst Hematol, Coll Med, Suzhou, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing Medical University; Huazhong University of Science & Technology; Soochow University - China	Shen, HB (corresponding author), Nanjing Med Univ, Dept Epidemiol & Biostat, Minist Educ Key Lab Modern Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.	shiyongyong@gmail.com; lindx72@cicams.ac.cn; hbshen@njmu.edu.cn	Li, Zhiqiang/AAI-4003-2021; Shi, Yongyong/GSO-1627-2022; zhang, zheng/HCH-9684-2022; miao, xiaoping/C-4336-2011	Li, Zhiqiang/0000-0002-0174-9254; Shi, Yongyong/0000-0003-1710-1505; miao, xiaoping/0000-0002-6818-9722; Lin, Dongxin/0000-0002-8723-8868; Jin, Guangfu/0000-0003-0249-5337; Dong, Jing/0000-0001-9856-5963; Shen, Hongbing/0000-0002-2581-5906; Wu, Chen/0000-0003-4954-1011	China National High-Tech Research and Development Program [2009AA022705, 2009AA022704, 2009AA022701]; National Natural Science Foundation of China [30700684, 81130022, 30671814, 81001276, 81072380, 31000553]; Jiangsu Natural Science Foundation [BK2008221]; Foundation for the Author of National Excellent Doctoral Dissertation [201081, 201026]; Program for New Century Excellent Talents in University [NCET-09-0550, NCET-10-0178]; Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	China National High-Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Foundation for the Author of National Excellent Doctoral Dissertation(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	We thank all the study participants, research staff and students who took part in this work. Funding was provided by grants from the China National High-Tech Research and Development Program (2009AA022705, 2009AA022704 and 2009AA022701), the National Natural Science Foundation of China (30700684, 81130022, 30671814, 81001276, 81072380 and 31000553), the Jiangsu Natural Science Foundation (BK2008221), the Foundation for the Author of National Excellent Doctoral Dissertation (201081 and 201026), the Program for New Century Excellent Talents in University (NCET-09-0550 and NCET-10-0178) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Mayne ST, 2002, J NUTR, V132, p3467S, DOI 10.1093/jn/132.11.3467S; Okuyama T, 2002, J LAB CLIN MED, V140, P92, DOI 10.1067/mlc.2002.125784; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2009, MOL CARCINOGEN, V48, P1131, DOI 10.1002/mc.20565; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051; Zhang WP, 2001, BIOCHEM BIOPH RES CO, V282, P1067, DOI 10.1006/bbrc.2001.4689	22	216	235	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1215	U66		10.1038/ng.978	http://dx.doi.org/10.1038/ng.978			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22037551				2022-12-25	WOS:000297931400014
J	Yang, W				Yang, Walter			Biotech plummets in 3Q11	NATURE BIOTECHNOLOGY			English	News Item									BioCentury, San Carlos, CA 94070 USA		Yang, W (corresponding author), BioCentury, San Carlos, CA 94070 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					962	962		10.1038/nbt.2036	http://dx.doi.org/10.1038/nbt.2036			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068525	Bronze			2022-12-25	WOS:000296801300008
J	Cottee, MA; Raff, JW; Lea, SM; Roque, H				Cottee, Matthew A.; Raff, Jordan W.; Lea, Susan M.; Roque, Helio			SAS-6 oligomerization: the key to the centriole?	NATURE CHEMICAL BIOLOGY			English	Article							9-FOLD SYMMETRY; BASAL BODY; CENTROSOME BIOGENESIS; DROSOPHILA SPD-2; PROTEIN; DUPLICATION; CARTWHEEL; BLD10P; CEP192; DSAS-6		[Cottee, Matthew A.; Raff, Jordan W.; Lea, Susan M.; Roque, Helio] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Cottee, MA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	jordan.raff@path.ox.ac.uk	Lea, Susan M/B-7678-2009	Lea, Susan M/0000-0001-9287-8053; Cottee, Matthew/0000-0002-3619-3057; Roque, Helio/0000-0002-5930-1989	Biotechnology and Biological Sciences Research Council [984451] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	22	17	18	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					650	653		10.1038/nchembio.660	http://dx.doi.org/10.1038/nchembio.660			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21931303				2022-12-25	WOS:000295027100002
J	Tammela, T; Zarkada, G; Nurmi, H; Jakobsson, L; Heinolainen, K; Tvorogov, D; Zheng, W; Franco, CA; Murtomaki, A; Aranda, E; Miura, N; Yla-Herttuala, S; Fruttiger, M; Makinen, T; Eichmann, A; Pollard, JW; Gerhardt, H; Alitalo, K				Tammela, Tuomas; Zarkada, Georgia; Nurmi, Harri; Jakobsson, Lars; Heinolainen, Krista; Tvorogov, Denis; Zheng, Wei; Franco, Claudio A.; Murtomaki, Aino; Aranda, Evelyn; Miura, Naoyuki; Yla-Herttuala, Seppo; Fruttiger, Marcus; Makinen, Taija; Eichmann, Anne; Pollard, Jeffrey W.; Gerhardt, Holger; Alitalo, Kari			VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-C; ENDOTHELIAL-CELLS; TUMOR ANGIOGENESIS; FACTOR RECEPTOR-3; VASCULAR MORPHOGENESIS; LYMPHATIC ENDOTHELIUM; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODY; LIGAND-BINDING; MOUSE EMBRYOS	Angiogenesis, the growth of new blood vessels, involves specification of endothelial cells to tip cells and stalk cells, which is controlled by Notch signalling, whereas vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3 have been implicated in angiogenic sprouting. Surprisingly, we found that endothelial deletion of Vegfr3, but not VEGFR-3-blocking antibodies, postnatally led to excessive angiogenic sprouting and branching, and decreased the level of Notch signalling, indicating that VEGFR-3 possesses passive and active signalling modalities. Furthermore, macrophages expressing the VEGFR-3 and VEGFR-2 ligand VEGF-C localized to vessel branch points, and Vegfc heterozygous mice exhibited inefficient angiogenesis characterized by decreased vascular branching. FoxC2 is a known regulator of Notch ligand and target gene expression, and Foxc2(+/-); Vegfr3(+/-) compound heterozygosity recapitulated homozygous loss of Vegfr3. These results indicate that macrophage-derived VEGF-C activates VEGFR-3 in tip cells to reinforce Notch signalling, which contributes to the phenotypic conversion of endothelial cells at fusion points of vessel sprouts.	[Tammela, Tuomas; Zarkada, Georgia; Nurmi, Harri; Heinolainen, Krista; Tvorogov, Denis; Zheng, Wei; Murtomaki, Aino; Makinen, Taija; Alitalo, Kari] Univ Helsinki, Res Programs Unit, Mol Canc Biol Lab, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Tammela, Tuomas; Zarkada, Georgia; Nurmi, Harri; Heinolainen, Krista; Tvorogov, Denis; Zheng, Wei; Murtomaki, Aino; Makinen, Taija; Alitalo, Kari] Univ Helsinki, Biomedicum Helsinki, Dept Pathol, Haartman Inst, FIN-00014 Helsinki, Finland; [Jakobsson, Lars; Franco, Claudio A.; Gerhardt, Holger] London Res Inst Canc Res UK, Vasc Biol Lab, London WC2A 3PX, England; [Aranda, Evelyn; Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY 10461 USA; [Miura, Naoyuki] Hamamatsu Univ Sch Med, Dept Biochem, Hamamatsu, Shizuoka 4313192, Japan; [Yla-Herttuala, Seppo] Univ Kuopio, Dept Med, Kuopio 70211, Finland; [Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst, Kuopio 70211, Finland; [Fruttiger, Marcus] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Eichmann, Anne] Coll France, INSERM, U833, F-75005 Paris, France; [Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, B-3000 Louvain, Belgium	University of Helsinki; University of Helsinki; University of London; Institute of Cancer Research - UK; Yeshiva University; Hamamatsu University School of Medicine; University of Eastern Finland; University of Eastern Finland; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Flanders Institute for Biotechnology (VIB)	Alitalo, K (corresponding author), Univ Helsinki, Res Programs Unit, Mol Canc Biol Lab, Inst Mol Med Finland, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	Kari.Alitalo@Helsinki.Fi	Zheng, Wei/J-4088-2019; Jakobsson, Lars/B-4200-2011; Gerhardt, Holger/G-4610-2011; Makinen, Taija/C-5765-2014; Makinen, Taija/CAI-2233-2022; Franco, Claudio A/B-1060-2013; Alitalo, Kari K/J-5013-2014; Franco, Claudio A/D-8117-2015; Gerhardt, Holger/G-4610-2011	Zheng, Wei/0000-0003-0021-6672; Jakobsson, Lars/0000-0001-7956-587X; Gerhardt, Holger/0000-0002-3030-0384; Makinen, Taija/0000-0002-9338-1257; Makinen, Taija/0000-0002-9338-1257; Franco, Claudio A/0000-0002-2861-3883; Alitalo, Kari K/0000-0002-7331-0902; Franco, Claudio A/0000-0002-2861-3883; Gerhardt, Holger/0000-0001-9228-7472; Yla-Herttuala, Seppo/0000-0001-7593-2708; Nurmi, Harri/0000-0003-3173-1474; /0000-0003-3675-6961; Tvorogov, Denis/0000-0002-2009-1347; Fruttiger, Marcus/0000-0002-6962-5485	Academy of Finland; Association for International Cancer Research; Finnish Cancer Organizations; Helsinki University; Sigrid Juselius Foundation; Louis-Jeantet Foundation; European Research Council [ERC-2010-AdG-268804-TX-FACTORS]; Emil Aaltonen Foundation; K. Albin Johansson Foundation; Finnish Medical Foundation; Maud Kuistila Foundation; Orion-Farmos Research Foundation; Paulo Foundation; Ida Montin Foundation; Cancer Research UK; Lister Institute of Preventive Medicine; European Molecular Biology Organization (EMBO); Leducq Transatlantic Network ARTEMIS; EMBO; Marie Curie FP7 postdoctoral fellowship; MRC [G0501711, G1002033] Funding Source: UKRI; Medical Research Council [G1002033, G0501711] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA131270] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Association for International Cancer Research; Finnish Cancer Organizations; Helsinki University; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Louis-Jeantet Foundation; European Research Council(European Research Council (ERC)European Commission); Emil Aaltonen Foundation; K. Albin Johansson Foundation; Finnish Medical Foundation; Maud Kuistila Foundation; Orion-Farmos Research Foundation; Paulo Foundation; Ida Montin Foundation; Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Leducq Transatlantic Network ARTEMIS(Leducq Foundation); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie FP7 postdoctoral fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank T. Petrova (CePO, CHUV and University of Lausanne, Switzerland) for the Foxc2<SUP>+/-</SUP> mice, M. Achen and S. Stacker (Peter MacCallum Cancer Centre, Melbourne, Australia) for the Vegfd<SUP>-/-</SUP> mice, B. Pytowski at Eli Lilly for VEGFR-2- and VEGFR-3-blocking antibodies, M. Jeltsch (Molecular/Cancer Biology Laboratory, University of Helsinki, Finland) for generating VEGF-C antibodies, S. Kaijalainen (Molecular/Cancer Biology Laboratory, University of Helsinki, Finland) for generating mDll4-Fc and mDll4-ECTM-eGFP expression vectors, A. Alitalo (Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland) for valuable help with experiments and K. Helenius for critical comments on the manuscript. The Biomedicum Molecular Imaging Unit is acknowledged for microscopy services, and N. Ihalainen, T. Laakkonen, K. Salo and T. Tainola for excellent technical assistance, as well as personnel of the Meilahti Experimental Animal Center (University of Helsinki) for expert animal husbandry. We also thank I. Rosewell (London Research Institute, UK) for generation of chimaeric mice. This work was supported by grants from the Academy of Finland, the Association for International Cancer Research, the Finnish Cancer Organizations, the Helsinki University Research Fund, the Sigrid Juselius Foundation, the Louis-Jeantet Foundation and the European Research Council (ERC-2010-AdG-268804-TX-FACTORS). T.T. was supported by personal grants from the Emil Aaltonen Foundation, the K. Albin Johansson Foundation, the Finnish Medical Foundation, the Maud Kuistila Foundation, the Orion-Farmos Research Foundation and the Paulo Foundation. G.Z. was supported by personal grants from the K. Albin Johansson Foundation, the Finnish Medical Foundation, The Paulo Foundation, the Ida Montin Foundation and the Orion-Farmos Research Foundation. H.G. was supported by Cancer Research UK, the Lister Institute of Preventive Medicine, the European Molecular Biology Organization (EMBO) Young Investigator Programme and the Leducq Transatlantic Network ARTEMIS. L.J. was supported by an EMBO long-term postdoctoral fellowship. C.A.F. was supported by a Marie Curie FP7 postdoctoral fellowship.	Baldwin ME, 2005, MOL CELL BIOL, V25, P2441, DOI 10.1128/MCB.25.6.2441-2449.2005; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghalamkarpour A, 2009, J MED GENET, V46, P399, DOI 10.1136/jmg.2008.064469; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Haiko P, 2008, MOL CELL BIOL, V28, P4843, DOI 10.1128/MCB.02214-07; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Iida K, 1997, DEVELOPMENT, V124, P4627; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jussila L, 1998, CANCER RES, V58, P1599; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2006, AM J PATHOL, V169, P708, DOI 10.2353/ajpath.2006.051200; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lohela M, 2008, AM J PATHOL, V173, P1891, DOI 10.2353/ajpath.2008.080378; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016/S0002-9440(10)65021-3; Persaud K, 2004, J CELL SCI, V117, P2745, DOI 10.1242/jcs.01138; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Prewett M, 1999, CANCER RES, V59, P5209; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Saharinen P, 2010, GENE DEV, V24, P875, DOI 10.1101/gad.565010; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Zhang LQ, 2010, CELL RES, V20, P1319, DOI 10.1038/cr.2010.116; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800	70	212	222	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1202	1213		10.1038/ncb2331	http://dx.doi.org/10.1038/ncb2331			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21909098	Green Accepted			2022-12-25	WOS:000295617900010
J	Walker, BD; Ahmed, R; Plotkin, S				Walker, Bruce D.; Ahmed, Rafi; Plotkin, Stanley			Moving ahead an HIV vaccine Use both arms to beat HIV	NATURE MEDICINE			English	Editorial Material							NEUTRALIZING ANTIBODIES; INFECTION; TRIAL; CHALLENGE; IMMUNITY; BROAD; SIV		[Walker, Bruce D.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Massachusetts Gen Hosp, Boston, MA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Plotkin, Stanley] Univ Penn & Vaxconsult, Doylestown, PA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; Emory University	Walker, BD (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Massachusetts Gen Hosp, Boston, MA USA.	bwalker@partners.org						[Anonymous], GLOB REP; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Johnston MI, 2011, NEW ENGL J MED, V365, P873, DOI 10.1056/NEJMp1107621; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; PLOTKIN SA, 1994, TRANSPLANTATION, V58, P1176, DOI 10.1097/00007890-199412270-00006; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; SCHEID JF, 2011, SCIENCE         0714, DOI DOI 10.1126/SCIENCE.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WALKER LM, 2011, NATURE          0817, DOI DOI 10.1038/NATURE10373	17	37	37	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1194	1195		10.1038/nm.2529	http://dx.doi.org/10.1038/nm.2529			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21988996	Bronze			2022-12-25	WOS:000296022100031
J	Chu, X; Pan, CM; Zhao, SX; Liang, J; Gao, GQ; Zhang, XM; Yuan, GY; Li, CG; Xue, LQ; Shen, M; Liu, W; Xie, F; Yang, SY; Wang, HF; Shi, JY; Sun, WW; Du, WH; Zuo, CL; Shi, JX; Liu, BL; Guo, CC; Zhan, M; Gu, ZH; Zhang, XN; Sun, F; Wang, ZQ; Song, ZY; Zou, CY; Sun, WH; Guo, T; Cao, HM; Ma, JH; Han, B; Li, P; Jiang, H; Huang, QH; Liang, LM; Liu, LB; Chen, G; Su, Q; Peng, YD; Zhao, JJ; Ning, G; Chen, Z; Chen, JL; Chen, SJ; Huang, W; Song, HD				Chu, Xun; Pan, Chun-Ming; Zhao, Shuang-Xia; Liang, Jun; Gao, Guan-Qi; Zhang, Xiao-Mei; Yuan, Guo-Yue; Li, Chang-Gui; Xue, Li-Qiong; Shen, Min; Liu, Wei; Xie, Fang; Yang, Shao-Ying; Wang, Hai-Feng; Shi, Jing-Yi; Sun, Wei-Wei; Du, Wen-Hua; Zuo, Chun-Lin; Shi, Jin-Xiu; Liu, Bing-Li; Guo, Cui-Cui; Zhan, Ming; Gu, Zhao-Hui; Zhang, Xiao-Na; Sun, Fei; Wang, Zhi-Quan; Song, Zhi-Yi; Zou, Cai-Yan; Sun, Wei-Hua; Guo, Ting; Cao, Huang-Ming; Ma, Jun-Hua; Han, Bing; Li, Ping; Jiang, He; Huang, Qiu-Hua; Liang, Liming; Liu, Li-Bin; Chen, Gang; Su, Qing; Peng, Yong-De; Zhao, Jia-Jun; Ning, Guang; Chen, Zhu; Chen, Jia-Lun; Chen, Sai-Juan; Huang, Wei; Song, Huai-Dong		China Consortium Genetics	A genome-wide association study identifies two new risk loci for Graves' disease	NATURE GENETICS			English	Article							THYROTROPIN RECEPTOR ANTIBODIES; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; GENE; SNPS; VARIANTS; POPULATION; VITILIGO; OMEGA-1; CTLA4	Graves' disease is a common autoimmune disorder characterized by thyroid stimulating hormone receptor autoantibodies (TRAb) and hyperthyroidism. To investigate the genetic architecture of Graves' disease, we conducted a genome-wide association study in 1,536 individuals with Graves' disease (cases) and 1,516 controls. We further evaluated a group of associated SNPs in a second set of 3,994 cases and 3,510 controls. We confirmed four previously reported loci (in the major histocompatibility complex, TSHR, CTLA4 and FCRL3) and identified two new susceptibility loci (the RNASET2-FGFR1OP-CCR6 region at 6q27 (P-combined = 6.85 x 10(-10) for rs9355610) and an intergenic region at 4p14 (P-combined = 1.08 x 10(-13) for rs6832151)). These newly associated SNPs were correlated with the expression levels of RNASET2 at 6q27, of CHRNA9 and of a previously uncharacterized gene at 4p14, respectively. Moreover, we identified strong associations of TSHR and major histocompatibility complex class II variants with persistently TRAb-positive Graves' disease.	[Chu, Xun; Pan, Chun-Ming; Zhao, Shuang-Xia; Xue, Li-Qiong; Liu, Wei; Xie, Fang; Yang, Shao-Ying; Shi, Jing-Yi; Zuo, Chun-Lin; Shi, Jin-Xiu; Liu, Bing-Li; Guo, Cui-Cui; Zhan, Ming; Gu, Zhao-Hui; Zhang, Xiao-Na; Sun, Fei; Wang, Zhi-Quan; Song, Zhi-Yi; Guo, Ting; Cao, Huang-Ming; Ma, Jun-Hua; Han, Bing; Li, Ping; Jiang, He; Huang, Qiu-Hua; Chen, Zhu; Chen, Jia-Lun] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Ruijin Hosp, Shanghai 200030, Peoples R China; [Chu, Xun; Shen, Min; Xie, Fang; Wang, Hai-Feng; Sun, Wei-Wei; Shi, Jin-Xiu; Huang, Wei] Shanghai Minist Sci & Technol MOST, Dept Genet, Key Lab Hlth & Dis Genom, Chinese Natl Human Genome Ctr, Shanghai, Peoples R China; [Pan, Chun-Ming; Zhao, Shuang-Xia; Guo, Ting; Li, Ping; Ning, Guang; Chen, Jia-Lun; Song, Huai-Dong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Endocrinol & Metab,Dept Endocrinol, Shanghai 200030, Peoples R China; [Liang, Jun; Zou, Cai-Yan] Xuzhou Med Coll, Dept Endocrinol, Cent Hosp Xuzhou, Xuzhou, Jiangsu Prov, Peoples R China; [Gao, Guan-Qi; Du, Wen-Hua] Peoples Hosp Linyi, Dept Endocrinol, Linyi, Shandong, Peoples R China; [Zhang, Xiao-Mei; Sun, Wei-Hua] Bengbu Med Coll, Dept Endocrinol, Hosp 1, Bengbu, Anhui, Peoples R China; [Yuan, Guo-Yue] Jiangsu Univ, Dept Endocrinol, Zhenjiang, Jiangsu Prov, Peoples R China; [Li, Chang-Gui] Qingdao Univ, Dept Endocrinol, Med Sch Hosp, Qingdao 266071, Shandong, Peoples R China; [Li, Chang-Gui] Qingdao Univ, Gout Lab, Med Sch Hosp, Qingdao 266071, Shandong, Peoples R China; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA; [Liu, Li-Bin] Fujian Med Univ, Xiehe Hosp, Dept Endocrinol, Fuzhou, Fujian Province, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Fujian Province, Peoples R China; [Su, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol, Xin Hua Hosp, Shanghai 200030, Peoples R China; [Peng, Yong-De] Shanghai Jiao Tong Univ, Dept Endocrinol, Peoples Hosp 1, Shanghai 200030, Peoples R China; [Zhao, Jia-Jun] Shandong Univ, Dept Endocrinol, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Xuzhou Medical University; Bengbu Medical College; Jiangsu University; Qingdao University; Qingdao University; Harvard University; Harvard T.H. Chan School of Public Health; Fujian Medical University; Fujian Provincial Hospital; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Song, HD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Ruijin Hosp, Shanghai 200030, Peoples R China.	guangning@medmail.com.cn; zchen@stn.sh.cn; xuyanrr@yahoo.com.cn; sjchen@stn.sh.cn; huangwei@chgc.sh.cn; huaidong_s1966@163.com	Gu, Zhaohui/L-8586-2015; Zhao, Jiajun/W-2963-2018; Song, Huai-Dong/G-8961-2011	Zhao, Jiajun/0000-0003-3267-9292; Yang, Shaoying/0000-0001-9091-4209; Chu, Xun/0000-0002-7440-1371; Song, Huai-Dong/0000-0002-9609-5803; Wang, Haifeng/0000-0001-5022-0720	National Natural Science Foundation of China [30971595, 30971383, 31000556]; Chinese National Natural Science Fund for Distinguished Young Scholars [30625019]; Chinese High-Tech Program [2007AA02Z175, 2009AA022709]; Shanghai Science and Technology Committee [10JC1410400, 09DZ2291900, 09JC1411300, 10ZR1421400]; Shanghai Municipal Education Committee	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese High-Tech Program; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Municipal Education Committee	We thank all subjects for participating in this study. This work was supported in part by the National Natural Science Foundation of China (30971595, 30971383 and 31000556), Chinese National Natural Science Fund for Distinguished Young Scholars (30625019), Chinese High-Tech Program (2007AA02Z175 and 2009AA022709), Shanghai Science and Technology Committee (10JC1410400, 09DZ2291900, 09JC1411300 and 10ZR1421400) and Program for Innovative Research Team of Shanghai Municipal Education Committee.	Acquati F, 2005, INT J ONCOL, V26, P1159; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Breslow NE, 1980, IARC SCI PUBL, P5; Cappelli C, 2007, ENDOCR J, V54, P713, DOI 10.1507/endocrj.K06-069; Carella C, 2006, THYROID, V16, P295, DOI 10.1089/thy.2006.16.295; Chistiakov DA, 2007, HUM IMMUNOL, V68, P375, DOI 10.1016/j.humimm.2007.01.013; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; FELDTRASMUSSEN U, 1994, J CLIN ENDOCR METAB, V78, P98, DOI 10.1210/jc.78.1.98; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Jin Y, 2010, NAT GENET, V42, P576, DOI 10.1038/ng.602; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JL, 2010, J CELL MOL MED, V14, P1146, DOI 10.1111/j.1582-4934.2009.00749.x; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Song HD, 2009, HUM MOL GENET, V18, P1156, DOI 10.1093/hmg/ddn442; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhao SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009821	32	193	217	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					897	U114		10.1038/ng.898	http://dx.doi.org/10.1038/ng.898			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21841780				2022-12-25	WOS:000294325800019
J	Vilela, M; Danuser, G				Vilela, Marco; Danuser, Gaudenz			What's wrong with correlative experiments?	NATURE CELL BIOLOGY			English	Editorial Material									[Vilela, Marco; Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Vilela, M (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	Marco_Vilela@hms.harvard.edu; Gaudenz_Danuser@hms.harvard.edu		Danuser, Gaudenz/0000-0001-8583-2014	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090317] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM090317-03, R01 GM090317] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	18	18	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1011	1011		10.1038/ncb2325	http://dx.doi.org/10.1038/ncb2325			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21892139	Bronze			2022-12-25	WOS:000294487000001
J	Sakmar, TP				Sakmar, Thomas P.			RECEPTORS Clicking class B GPCR ligands	NATURE CHEMICAL BIOLOGY			English	News Item							PROTEIN-COUPLED RECEPTORS; BINDING; DOMAINS; PROBES; SITE		Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	sakmar@rockefeller.edu	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953				Devigny C, 2011, J AM CHEM SOC, V133, P8927, DOI 10.1021/ja200160s; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Huber T, 2011, TRENDS PHARMACOL SCI, V32, P410, DOI 10.1016/j.tips.2011.03.004; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Unson CG, 2002, BIOCHEMISTRY-US, V41, P11795, DOI 10.1021/bi025711j; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167	9	5	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					500	501		10.1038/nchembio.621	http://dx.doi.org/10.1038/nchembio.621			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769095				2022-12-25	WOS:000292825400008
J	Mavrakis, KJ; Van der Meulen, J; Wolfe, AL; Liu, XP; Mets, E; Taghon, T; Khan, AA; Setti, M; Rondou, P; Vandenberghe, P; Delabesse, E; Benoit, Y; Socci, NB; Leslie, CS; Van Vlierberghe, P; Speleman, F; Wendel, HG				Mavrakis, Konstantinos J.; Van der Meulen, Joni; Wolfe, Andrew L.; Liu, Xiaoping; Mets, Evelien; Taghon, Tom; Khan, Aly A.; Setti, Manu; Rondou, Pieter; Vandenberghe, Peter; Delabesse, Eric; Benoit, Yves; Socci, Nicholas B.; Leslie, Christina S.; Van Vlierberghe, Pieter; Speleman, Frank; Wendel, Hans-Guido			A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)	NATURE GENETICS			English	Article							C-MYC; NOTCH1; EXPRESSION; MUTATIONS; IKAROS; INACTIVATION; SENSITIVITY; INHIBITION; ACTIVATION; RESISTANCE	The importance of individual microRNAs (miRNAs) has been established in specific cancers. However, a comprehensive analysis of the contribution of miRNAs to the pathogenesis of any specific cancer is lacking. Here we show that in T-cell acute lymphoblastic leukemia (T-ALL), a small set of miRNAs is responsible for the cooperative suppression of several tumor suppressor genes. Cross-comparison of miRNA expression profiles in human T-ALL with the results of an unbiased miRNA library screen allowed us to identify five miRNAs (miR-19b, miR-20a, miR-26a, miR-92 and miR-223) that are capable of promoting T-ALL development in a mouse model and which account for the majority of miRNA expression in human T-ALL. Moreover, these miRNAs produce overlapping and cooperative effects on tumor suppressor genes implicated in the pathogenesis of T-ALL, including IKAROS (also known as IKZF1), PTEN, BIM, PHF6, NF1 and FBXW7. Thus, a comprehensive and unbiased analysis of miRNA action in T-ALL reveals a striking pattern of miRNA-tumor suppressor gene interactions in this cancer.	[Mavrakis, Konstantinos J.; Wolfe, Andrew L.; Liu, Xiaoping; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Van der Meulen, Joni; Mets, Evelien; Rondou, Pieter; Van Vlierberghe, Pieter; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Wolfe, Andrew L.; Khan, Aly A.; Setti, Manu] Weill Cornell Grad Sch Med Sci, New York, NY USA; [Taghon, Tom] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Vandenberghe, Peter] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Delabesse, Eric] Fac Med Toulouse, INSERM, U563, F-31073 Toulouse, France; [Benoit, Yves] Ghent Univ Hosp, Dept Pediat Hematol Oncol, B-9000 Ghent, Belgium; [Socci, Nicholas B.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Van Vlierberghe, Pieter] Columbia Univ, Inst Canc Genet, New York, NY USA	Memorial Sloan Kettering Cancer Center; Ghent University; Ghent University Hospital; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ghent University; Ghent University Hospital; Memorial Sloan Kettering Cancer Center; Columbia University	Wendel, HG (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	wendelh@mskcc.org	speleman, frank/AAR-5184-2020; Van Vlierberghe, Pieter/G-8894-2013; Taghon, Tom/M-9111-2018; Van der Meulen, Joni/AFS-1616-2022; DELABESSE, Eric/I-5221-2016	speleman, frank/0000-0002-6628-8559; Van Vlierberghe, Pieter/0000-0001-9063-7205; Van der Meulen, Joni/0000-0002-1916-2769; DELABESSE, Eric/0000-0002-0928-0753; Vandenberghe, Peter/0000-0003-4719-1935; Wolfe, Andrew/0000-0003-0418-716X; van der Meulen, Jan/0000-0002-9451-2335; Taghon, Tom/0000-0002-5781-0288; Setty, Manu/0000-0002-0344-2627	National Cancer Institute (NCI) [R01-CA142798-01]; P30 supplemental award; Louis V. Gerstner Foundation; William Lawrence and Blanche Hughes (WLBH) Foundation; Society of MSKCC; Geoffrey Beene Foundation; May & Samuel Rudin Foundation; W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research; The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Fund for Scientific Research (FWO) Flanders [G.0198.08, G.0869.10N]; GOA-UGent [12051203]; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; NATIONAL CANCER INSTITUTE [R01CA183876, R01CA142798] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); P30 supplemental award; Louis V. Gerstner Foundation; William Lawrence and Blanche Hughes (WLBH) Foundation; Society of MSKCC; Geoffrey Beene Foundation; May & Samuel Rudin Foundation; W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research; The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Fund for Scientific Research (FWO) Flanders(FWO); GOA-UGent; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank A.J. Capobianco, L. Beverly, A.A. Ferrando, J. Cools and W. Pear for reagents. The Memorial Sloan Kettering (MSK) animal facility and Research Animal Resource Center (RARC), A. Viale of the MSK Genomics Core, H. Zhao of Computational Biology (cBIO) program, K. Huberman of the Geoffrey Beene Translational Oncology Core Facility and J. Schatz for editorial advice. This work is supported by grants from the National Cancer Institute (NCI) (R01-CA142798-01) (H.-G.W.), and a P30 supplemental award (H.-G.W.), the Louis V. Gerstner Foundation (H.-G.W.), the William Lawrence and Blanche Hughes (WLBH) Foundation (H.-G.W.), the Society of MSKCC (H.-G.W.), the Geoffrey Beene Foundation (H.-G.W.), and May & Samuel Rudin Foundation Award (H.-G.W.); W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research, The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center (H.-G.W.), the Fund for Scientific Research (FWO) Flanders (postdoctoral grants to T.T. and P.V.V., PhD grant to J.V.d.M., P.V.V. is a Senior Clinical Investigator of FWO-Vlaanderen, Odysseus program grant to T.T., and project grants G.0198.08 and G.0869.10N to F.S.); the GOA-UGent (grant no. 12051203); Stichting tegen Kanker, FOD ALL the Children Cancer Fund Ghent (F.S.); and the Belgian Program of Interuniversity Poles of Attraction and the Belgian Foundation Against Cancer.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Asnafi V, 2009, BLOOD, V113, P3918, DOI 10.1182/blood-2008-10-184069; Balgobind BV, 2008, BLOOD, V111, P4322, DOI 10.1182/blood-2007-06-095075; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marcais A, 2010, LEUKEMIA RES, V34, P426, DOI 10.1016/j.leukres.2009.09.012; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Sun L, 1999, CLIN CANCER RES, V5, P2112; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zuurbier L, 2010, LEUKEMIA, V24, P2014, DOI 10.1038/leu.2010.204	44	210	223	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					673	U89		10.1038/ng.858	http://dx.doi.org/10.1038/ng.858			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21642990	Green Accepted			2022-12-25	WOS:000292184600012
J	Carette, JE; Guimaraes, CP; Wuethrich, I; Blomen, VA; Varadarajan, M; Sun, C; Bell, G; Yuan, BB; Muellner, MK; Nijman, SM; Ploegh, HL; Brummelkamp, TR				Carette, Jan E.; Guimaraes, Carla P.; Wuethrich, Irene; Blomen, Vincent A.; Varadarajan, Malini; Sun, Chong; Bell, George; Yuan, Bingbing; Muellner, Markus K.; Nijman, Sebastian M.; Ploegh, Hidde L.; Brummelkamp, Thijn R.			Global gene disruption in human cells to assign genes to phenotypes by deep sequencing	NATURE BIOTECHNOLOGY			English	Article							CYTOLETHAL-DISTENDING TOXIN; BH3 MIMETIC ABT-737; PROTEINS; GENOME; DATABASE; MUTANTS; SCREENS; CYCLE; LUNG; FORM	Insertional mutagenesis in a haploid background can disrupt gene function(1). We extend our earlier work by using a retroviral gene-trap vector to generate insertions in >98% of the genes expressed in a human cancer cell line that is haploid for all but one of its chromosomes. We apply phenotypic interrogation via tag sequencing (PhITSeq) to examine millions of mutant alleles through selection and parallel sequencing. Analysis of pools of cells, rather than individual clones(1) enables rapid assessment of the spectrum of genes involved in the phenotypes under study. This facilitates comparative screens as illustrated here for the family of cytolethal distending toxins (CDTs). CDTs are virulence factors secreted by a variety of pathogenic Gram-negative bacteria responsible for tissue damage at distinct anatomical sites(2). We identify 743 mutations distributed over 12 human genes important for intoxication by four different CDTs. Although related CDTs may share host factors, they also exploit unique host factors to yield a profile characteristic for each CDT.	[Carette, Jan E.; Guimaraes, Carla P.; Wuethrich, Irene; Blomen, Vincent A.; Varadarajan, Malini; Sun, Chong; Bell, George; Yuan, Bingbing; Ploegh, Hidde L.; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Muellner, Markus K.; Nijman, Sebastian M.] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Austrian Academy of Sciences; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu; t.brummelkamp@nki.nl	blomen, vincent/AAE-1477-2020	Nijman, Sebastian/0000-0003-0464-6661; Carette, Jan/0000-0002-5187-8070; Sun, Chong/0000-0001-9008-2158	Boehringer Ingelheim Fonds; US National Institutes of Health [R21-HG004938-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004938] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank D. Sabatini and J. Roix for critical reading of this manuscript, S. Boulant, M. Nibert and R. Rooswinkel for providing reagents, and T. DiCesare for graphics support. I.W. was supported by a PhD fellowship from the Boehringer Ingelheim Fonds. T.R.B. was supported by US National Institutes of Health grant R21-HG004938-01. The construct for the full operon of E. coli CDT was generously provided by J. Kaper, University of Maryland School of Medicine, Baltimore.	Bao F, 2007, LEUKEMIA RES, V31, P1511, DOI 10.1016/j.leukres.2007.03.002; Bergeret E, 2008, J CELL SCI, V121, P3325, DOI 10.1242/jcs.030163; Brady T, 2009, GENE DEV, V23, P633, DOI 10.1101/gad.1762309; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Ge ZM, 2008, CELL MICROBIOL, V10, P1599, DOI 10.1111/j.1462-5822.2008.01173.x; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; Hauck P, 2009, MOL CANCER THER, V8, P883, DOI 10.1158/1535-7163.MCT-08-1118; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; Steegmaier M, 1997, J CELL SCI, V110, P687; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]	25	162	170	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2011	29	6					542	U108		10.1038/nbt.1857	http://dx.doi.org/10.1038/nbt.1857			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	773WL	21623355	Green Submitted, Green Accepted			2022-12-25	WOS:000291342100021
J	D'Arcy, P; Brnjic, S; Olofsson, MH; Fryknas, M; Lindsten, K; De Cesare, M; Perego, P; Sadeghi, B; Hassan, M; Larsson, R; Linder, S				D'Arcy, Padraig; Brnjic, Slavica; Olofsson, Maria Hagg; Fryknas, Marten; Lindsten, Kristina; De Cesare, Michelandrea; Perego, Paola; Sadeghi, Behnam; Hassan, Moustapha; Larsson, Rolf; Linder, Stig			Inhibition of proteasome deubiquitinating activity as a new cancer therapy	NATURE MEDICINE			English	Article							26S PROTEASOME; CELL-DEATH; DEGRADATION; APOPTOSIS; ROLES; P53; PHOSPHORYLATION; UBIQUITINATION; EXPRESSION; BORTEZOMIB	Ubiquitin-tagged substrates are degraded by the 26S proteasome, which is a multisubunit complex comprising a proteolytic 20S core particle capped by 19S regulatory particles(1,2). The approval of bortezomib for the treatment of multiple myeloma validated the 20S core particle as an anticancer drug target(3). Here we describe the small molecule b-AP15 as a previously unidentified class of proteasome inhibitor that abrogates the deubiquitinating activity of the 19S regulatory particle. b-AP15 inhibited the activity of two 19S regulatory-particle-associated deubiquitinases, ubiquitin C-terminal hydrolase 5 (UCHL5) and ubiquitin-specific peptidase 14 (USP14), resulting in accumulation of polyubiquitin. b-AP15 induced tumor cell apoptosis that was insensitive to TP53 status and overexpression of the apoptosis inhibitor BCL2. We show that treatment with b-AP15 inhibited tumor progression in four different in vivo solid tumor models and inhibited organ infiltration in an acute myeloid leukemia model. Our results show that the deubiquitinating activity of the 19S regulatory particle is a new anticancer drug target.	[D'Arcy, Padraig; Brnjic, Slavica; Olofsson, Maria Hagg; Linder, Stig] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Fryknas, Marten; Larsson, Rolf] Uppsala Univ, Div Clin Pharmacol, Dept Med Sci, Uppsala, Sweden; [Lindsten, Kristina] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [De Cesare, Michelandrea; Perego, Paola] Ist Nazl Studio & Cura Tumori, Fdn Ist Ricovero & Cura Carattere Sci, I-20133 Milan, Italy; [Sadeghi, Behnam] Karolinska Inst, Inst Lab Med, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Clin Res Ctr Novum, Stockholm, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Fondazione IRCCS Istituto Nazionale Tumori Milan; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Linder, S (corresponding author), Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden.	stig.linder@ki.se	D'Arcy, Pádraig/AAB-5045-2019; 高, 雨莉/HGU-8187-2022; Sadeghi, Behnam/AAH-1221-2019; Hassan, Moustapha/H-9260-2015; De Cesare, Michelandrea/M-6667-2017; Perego, Paola/J-7647-2016; D'Arcy, Pádraig/F-7633-2018	D'Arcy, Pádraig/0000-0001-6671-7600; Sadeghi, Behnam/0000-0002-8721-0400; Hassan, Moustapha/0000-0003-1927-5859; De Cesare, Michelandrea/0000-0001-9687-0753; Perego, Paola/0000-0003-2806-7269; D'Arcy, Pádraig/0000-0001-6671-7600	Cancerfonden; Radiumhemmets forskningsfonder; Vetenskapsradet; Strategiska forskningsstiftelsen; Vinnova; European Union CHEMORES [LSHC-CT-2007-037665]; Lions Cancerforskningsfond; Swedish Children Cancer Society	Cancerfonden(Swedish Cancer Society); Radiumhemmets forskningsfonder; Vetenskapsradet(Swedish Research Council); Strategiska forskningsstiftelsen; Vinnova(Vinnova); European Union CHEMORES; Lions Cancerforskningsfond; Swedish Children Cancer Society(Swedish Cancer Society)	We thank M. Glickman (Department of Biology, Technion-Israel Institute of Technology) for providing the Ub-GFP constructs, N. Dantuma (Department of Cell and Molecular Biology, Karolinska Institutet) for providing the MelJuSo Ub-YFP reporter cell line, B. Vogelstein (Sidney Kimmel Comprehensive Cancer Center, John Hopkins University) for providing the HCT-116 cell lines with targeted disruptions, L. Perup Segerstrom for technical advice, Uppsala Array Platform and L. Gatti for drug formulation. We thank Cancerfonden, Radiumhemmets forskningsfonder, Vetenskapsradet, Strategiska forskningsstiftelsen, Vinnova, European Union CHEMORES, Frame Program 6 (LSHC-CT-2007-037665), Lions Cancerforskningsfond and Swedish Children Cancer Society for support.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Berndtsson M, 2009, INT J CANCER, V124, P1463, DOI 10.1002/ijc.24004; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Dimmock JR, 2001, J MED CHEM, V44, P586, DOI 10.1021/jm0002580; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Ling X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-8; MA CP, 1994, J BIOL CHEM, V269, P3539; Maki CG, 1996, CANCER RES, V56, P2649; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mullally JE, 2002, MOL PHARMACOL, V62, P351, DOI 10.1124/mol.62.2.351; Olofsson MH, 2009, CANCER BIOMARK, V5, P117, DOI 10.3233/CBM-2009-0597; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	32	369	378	7	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1636	U150		10.1038/nm.2536	http://dx.doi.org/10.1038/nm.2536			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057347	Green Accepted			2022-12-25	WOS:000297978000035
J	Doucette, CD; Schwab, DJ; Wingreen, NS; Rabinowitz, JD				Doucette, Christopher D.; Schwab, David J.; Wingreen, Ned S.; Rabinowitz, Joshua D.			alpha-ketoglutarate coordinates carbon and nitrogen utilization via enzyme I inhibition	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI K-12; DEPENDENT PHOSPHOTRANSFERASE SYSTEM; ADENYLATE ENERGY-CHARGE; GROWTH-RATE; METABOLISM; PROTEIN; PHOSPHORYLATION; CYANOBACTERIUM; METABOLOMICS; FERMENTATION	Microbes survive in a variety of nutrient environments by modulating their intracellular metabolism. Balanced growth requires coordinated uptake of carbon and nitrogen, the primary substrates for biomass production. Yet the mechanisms that balance carbon and nitrogen uptake are poorly understood. We find in Escherichia coli that a sudden increase in nitrogen availability results in an almost immediate increase in glucose uptake. The concentrations of glycolytic intermediates and known regulators, however, remain homeostatic. Instead, we find that alpha-ketoglutarate, which accumulates in nitrogen limitation, directly blocks glucose uptake by inhibiting enzyme I, the first step of the sugar-phosphoenolpyruvate phosphotransferase system (PTS). This inhibition enables rapid modulation of glycolytic flux without marked changes in the concentrations of glycolytic intermediates by simultaneously altering import of glucose and consumption of the terminal glycolytic intermediate phosphoenolpyruvate. Quantitative modeling shows that this previously unidentified regulatory connection is, in principle, sufficient to coordinate carbon and nitrogen utilization.	[Doucette, Christopher D.; Schwab, David J.; Wingreen, Ned S.; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Doucette, Christopher D.; Schwab, David J.; Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@princeton.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	US National Science Foundation [MCB-0643859]; Department of Energy-Air Force Office of Scientific Research [DOE DE-SC0002077-AFOSR FA9550-09-1-0580]; US National Institutes of Health Center for Quantitative Biology [P50 GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Department of Energy-Air Force Office of Scientific Research; US National Institutes of Health Center for Quantitative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Yuan, whose experiments laid the groundwork for the current study; D. Yan for providing the GOGAT strain; and G. Gosset for providing the W3110 and VH33 strains. This research was funded by US National Science Foundation CAREER award MCB-0643859, joint Department of Energy-Air Force Office of Scientific Research Award DOE DE-SC0002077-AFOSR FA9550-09-1-0580, and the US National Institutes of Health Center for Quantitative Biology Award P50 GM071508.	AMIN N, 1992, BIOCHEM BIOPH RES CO, V182, P1218, DOI 10.1016/0006-291X(92)91861-J; Aoyama K, 1997, J FERMENT BIOENG, V83, P17, DOI 10.1016/S0922-338X(97)87320-5; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; CHULAVATNATOL M, 1973, J BIOL CHEM, V248, P2712; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; DANIEL J, 1986, BIOCHIMIE, V68, P303, DOI 10.1016/S0300-9084(86)80027-X; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Anda R, 2006, METAB ENG, V8, P281, DOI 10.1016/j.ymben.2006.01.002; Goyal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000802; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HOVING H, 1981, BIOCHEMISTRY-US, V20, P87, DOI 10.1021/bi00504a015; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kessler B, 2001, ADV BIOCHEM ENG BIOT, V71, P159; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KUMAZAWA S, 1981, INT J HYDROGEN ENERG, V6, P339, DOI 10.1016/0360-3199(81)90060-4; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2007, J AM SOC MASS SPECTR, V18, P898, DOI 10.1016/j.jasms.2007.01.017; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; MONOT F, 1983, BIOTECHNOL LETT, V5, P213, DOI 10.1007/BF00161117; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Nishio Y, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100201; PEREIRA DS, 1994, J BIOL CHEM, V269, P412; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; Rohwer JM, 2000, J BIOL CHEM, V275, P34909, DOI 10.1074/jbc.M002461200; SEOL WG, 1992, J BIOL CHEM, V267, P6409; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Troshina O, 2002, INT J HYDROGEN ENERG, V27, P1283, DOI 10.1016/S0360-3199(02)00103-9; Wacker I, 2003, MICROBIOL-SGM, V149, P3001, DOI 10.1099/mic.0.26479-0; Wu PSC, 2005, J MAGN RESON, V176, P115, DOI 10.1016/j.jmr.2005.05.018; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	42	167	171	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					894	901		10.1038/NCHEMBIO.685	http://dx.doi.org/10.1038/NCHEMBIO.685			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22002719	Green Accepted			2022-12-25	WOS:000297166200012
J	Lieberman, TD; Michel, JB; Aingaran, M; Potter-Bynoe, G; Roux, D; Davis, MR; Skurnik, D; Leiby, N; LiPuma, JJ; Goldberg, JB; McAdam, AJ; Priebe, GP; Kishony, R				Lieberman, Tami D.; Michel, Jean-Baptiste; Aingaran, Mythili; Potter-Bynoe, Gail; Roux, Damien; Davis, Michael R., Jr.; Skurnik, David; Leiby, Nicholas; LiPuma, John J.; Goldberg, Joanna B.; McAdam, Alexander J.; Priebe, Gregory P.; Kishony, Roy			Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS PATIENTS; BURKHOLDERIA-CEPACIA COMPLEX; LONG-TERM EXPERIMENT; FLUOROQUINOLONE RESISTANCE; ESCHERICHIA-COLI; GENOME EVOLUTION; IN-VIVO; MUTATIONS; TRANSMISSION; INFECTIONS	Bacterial pathogens evolve during the infection of their human host(1-8), but separating adaptive and neutral mutations remains challenging(9-11). Here we identify bacterial genes under adaptive evolution by tracking recurrent patterns of mutations in the same pathogenic strain during the infection of multiple individuals. We conducted a retrospective study of a Burkholderia dolosa outbreak among subjects with cystic fibrosis, sequencing the genomes of 112 isolates collected from 14 individuals over 16 years. We find that 17 bacterial genes acquired nonsynonymous mutations in multiple individuals, which indicates parallel adaptive evolution. Mutations in these genes affect important pathogenic phenotypes, including antibiotic resistance and bacterial membrane composition and implicate oxygen-dependent regulation as paramount in lung infections. Several genes have not previously been implicated in pathogenesis and may represent new therapeutic targets. The identification of parallel molecular evolution as a pathogen spreads among multiple individuals points to the key selection forces it experiences within human hosts.	[Lieberman, Tami D.; Michel, Jean-Baptiste; Leiby, Nicholas; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Michel, Jean-Baptiste] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Aingaran, Mythili; Priebe, Gregory P.] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Roux, Damien; Skurnik, David; Priebe, Gregory P.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Davis, Michael R., Jr.; Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [LiPuma, John J.] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI USA; [LiPuma, John J.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [McAdam, Alexander J.] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Priebe, Gregory P.] Childrens Hosp, Dept Anesthesia, Div Crit Care Med, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; University of Virginia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA.	alexander.mcadam@childrens.harvard.edu; gregory_priebe@childrens.harvard.edu; roy_kishony@hms.harvard.edu	Roux, Damien/L-3671-2014; Weinstock, George M/C-6314-2013; Roux, Damien/C-5618-2014; Michel, Jean-Baptiste/AAH-9336-2020; Priebe, Gregory/AAG-4027-2021	Roux, Damien/0000-0002-6103-6416; Weinstock, George M/0000-0002-2997-4592; Roux, Damien/0000-0002-6103-6416; Priebe, Gregory/0000-0001-9831-0354; /0000-0001-5430-3937; Skurnik, David/0000-0002-4205-9639	Foundational Questions in Evolutionary Biology Prize Fellowship; Harvard Medical School; Center for the Critically Ill Child of Children's Hospital Boston; Cystic Fibrosis Foundation; US National Institutes of Health [GM080177, GM081617]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE) [AI057159]; Harvard Catalyst grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617, T32GM080177] Funding Source: NIH RePORTER	Foundational Questions in Evolutionary Biology Prize Fellowship; Harvard Medical School; Center for the Critically Ill Child of Children's Hospital Boston; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Catalyst grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Caimano, M. Cendron, P. Kokorowski, S. Lory, C. Marx, N. Delany, S. Walker, M. Waldor and R. Ward for insightful discussions and comments, to O. Iartchouk, A. Brown, M. Light and their team at Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) for Illumina sequencing, to J. Deane and L. Williams for technical assistance, to S. Vargas for assistance with IRB protocols and to M. Baym, M. Ernebjerg, A. Palmer, E. Toprak, K. Vetsigian, Z. Yao and all of the Kishony lab members for helpful discussions and general support. J. B. M. was supported by the Foundational Questions in Evolutionary Biology Prize Fellowship and the Systems Biology PhD Program (Harvard Medical School). G. P. P. was supported in part by The Mannion Fund for Research of the Center for the Critically Ill Child of Children's Hospital Boston. J. J. L. was supported by the Cystic Fibrosis Foundation. This work was supported in part by US National Institutes of Health grants (GM080177 to the Systems Biology Department, Harvard Medical School and GM081617 to R. K.), by a grant from the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE; AI057159 to R. K.) and by a Harvard Catalyst grant (to R. K., A. J. M. and M. Cendron).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Biddick R, 2003, FEMS MICROBIOL LETT, V228, P57, DOI 10.1016/S0378-1097(03)00724-9; Crosson S, 2005, P NATL ACAD SCI USA, V102, P8018, DOI 10.1073/pnas.0503022102; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Goodarzi H, 2009, NAT METHODS, V6, P581, DOI 10.1038/nmeth.1352; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Musher DM, 2002, NEW ENGL J MED, V346, P630, DOI 10.1056/NEJM200202213460820; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; REYNA F, 1995, ANTIMICROB AGENTS CH, V39, P1621, DOI 10.1128/AAC.39.7.1621; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vermis K, 2004, INT J SYST EVOL MICR, V54, P689, DOI 10.1099/ijs.0.02888-0; Vinion-Dubiel AD, 2003, J ENDOTOXIN RES, V9, P201, DOI 10.1179/096805103225001404; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Wong A, 2011, MICROBIOL-SGM, V157, P937, DOI 10.1099/mic.0.046870-0; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078	38	259	262	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1275	U148		10.1038/ng.997	http://dx.doi.org/10.1038/ng.997			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22081229	Green Accepted			2022-12-25	WOS:000297931400027
J	Trynka, G; Hunt, KA; Bockett, NA; Romanos, J; Mistry, V; Szperl, A; Bakker, SF; Bardella, MT; Bhaw-Rosun, L; Castillejo, G; de la Concha, EG; de Almeida, RC; Dias, KRM; van Diemen, CC; Dubois, PCA; Duerr, RH; Edkins, S; Franke, L; Fransen, K; Gutierrez, J; Heap, GAR; Hrdlickova, B; Hunt, S; Izurieta, LP; Izzo, V; Joosten, LAB; Langford, C; Mazzilli, MC; Mein, CA; Midah, V; Mitrovic, M; Mora, B; Morelli, M; Nutland, S; Nunez, C; Onengut-Gumuscu, S; Pearce, K; Platteel, M; Polanco, I; Potter, S; Ribes-Koninckx, C; Ricano-Ponce, I; Rich, SS; Rybak, A; Santiago, JL; Senapati, S; Sood, A; Szajewska, H; Troncone, R; Varade, J; Wallace, C; Wolters, VM; Zhernakova, A; Thelma, BK; Cukrowska, B; Urcelay, E; Bilbao, JR; Mearin, ML; Barisani, D; Barrett, JC; Plagnol, V; Deloukas, P; Wijmenga, C; van Heel, DA				Trynka, Gosia; Hunt, Karen A.; Bockett, Nicholas A.; Romanos, Jihane; Mistry, Vanisha; Szperl, Agata; Bakker, Sjoerd F.; Bardella, Maria Teresa; Bhaw-Rosun, Leena; Castillejo, Gemma; de la Concha, Emilio G.; de Almeida, Rodrigo Coutinho; Dias, Kerith-Rae M.; van Diemen, Cleo C.; Dubois, Patrick C. A.; Duerr, Richard H.; Edkins, Sarah; Franke, Lude; Fransen, Karin; Gutierrez, Javier; Heap, Graham A. R.; Hrdlickova, Barbara; Hunt, Sarah; Plaza Izurieta, Leticia; Izzo, Valentina; Joosten, Leo A. B.; Langford, Cordelia; Mazzilli, Maria Cristina; Mein, Charles A.; Midah, Vandana; Mitrovic, Mitja; Mora, Barbara; Morelli, Marinita; Nutland, Sarah; Nunez, Concepcion; Onengut-Gumuscu, Suna; Pearce, Kerra; Platteel, Mathieu; Polanco, Isabel; Potter, Simon; Ribes-Koninckx, Carmen; Ricano-Ponce, Isis; Rich, Stephen S.; Rybak, Anna; Luis Santiago, Jose; Senapati, Sabyasachi; Sood, Ajit; Szajewska, Hania; Troncone, Riccardo; Varade, Jezabel; Wallace, Chris; Wolters, Victorien M.; Zhernakova, Alexandra; Thelma, B. K.; Cukrowska, Bozena; Urcelay, Elena; Ramon Bilbao, Jose; Mearin, M. Luisa; Barisani, Donatella; Barrett, Jeffrey C.; Plagnol, Vincent; Deloukas, Panos; Wijmenga, Cisca; van Heel, David A.		Spanish Consortium Genetics Coelia; PreventCD Study Grp; WTCCC	Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK VARIANTS; LARGE-SCALE; POPULATION; PHENOTYPE; GENE; REGION; LOCI	Using variants from the 1000 Genomes Project pilot European CEU dataset and data from additional resequencing studies, we densely genotyped 183 non-HLA risk loci previously associated with immune-mediated diseases in 12,041 individuals with celiac disease (cases) and 12,228 controls. We identified 13 new celiac disease risk loci reaching genome-wide significance, bringing the number of known loci (including the HLA locus) to 40. We found multiple independent association signals at over one-third of these loci, a finding that is attributable to a combination of common, low-frequency and rare genetic variants. Compared to previously available data such as those from HapMap3, our dense genotyping in a large sample collection provided a higher resolution of the pattern of linkage disequilibrium and suggested localization of many signals to finer scale regions. In particular, 29 of the 54 fine-mapped signals seemed to be localized to single genes and, in some instances, to gene regulatory elements. Altogether, we define the complex genetic architecture of the risk regions of and refine the risk signals for celiac disease, providing the next step toward uncovering the causal mechanisms of the disease.	[Hunt, Karen A.; Bockett, Nicholas A.; Mistry, Vanisha; Dubois, Patrick C. A.; Heap, Graham A. R.; van Heel, David A.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Trynka, Gosia; Romanos, Jihane; Szperl, Agata; de Almeida, Rodrigo Coutinho; van Diemen, Cleo C.; Franke, Lude; Gutierrez, Javier; Hrdlickova, Barbara; Mitrovic, Mitja; Platteel, Mathieu; Ricano-Ponce, Isis; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Trynka, Gosia; Romanos, Jihane; Szperl, Agata; de Almeida, Rodrigo Coutinho; van Diemen, Cleo C.; Franke, Lude; Fransen, Karin; Gutierrez, Javier; Hrdlickova, Barbara; Mitrovic, Mitja; Platteel, Mathieu; Ricano-Ponce, Isis; Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Bakker, Sjoerd F.] Vrije Univ VU Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Bardella, Maria Teresa] Osped Maggiore Policlin Mangiagalli & Regina Elen, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Bardella, Maria Teresa] Univ Milan, Dept Med Sci, Milan, Italy; [Bhaw-Rosun, Leena; Dias, Kerith-Rae M.; Mein, Charles A.] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, John Vane Sci Ctr, London, England; [Castillejo, Gemma] Univ Rovira & Virgili, Dept Paediat Gastroenterol, Hosp Univ St Joan de Reus, E-43201 Reus, Spain; [de la Concha, Emilio G.; Nunez, Concepcion; Luis Santiago, Jose; Varade, Jezabel; Urcelay, Elena] Hosp Clin S Carlos, Dept Immunol, IdISSC, Madrid, Spain; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Edkins, Sarah; Hunt, Sarah; Langford, Cordelia; Potter, Simon; Barrett, Jeffrey C.; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Fransen, Karin] Univ Med Ctr Groningen, Dept Gastroenterol, Groningen, Netherlands; [Plaza Izurieta, Leticia; Ramon Bilbao, Jose] Hosp Cruces, Immunogenet Res Lab, Baracaldo, Bizkaia, Spain; [Izzo, Valentina; Morelli, Marinita] Univ Naples Federico II, European Lab Food Induced Dis, Naples, Italy; [Joosten, Leo A. B.] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Joosten, Leo A. B.] Radboud Univ Nijmegen, Nijmegen Inst Infect Inflammat & Immun N4i, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Mazzilli, Maria Cristina; Mora, Barbara] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Midah, Vandana] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India; [Mitrovic, Mitja] Univ Maribor, Fac Med, Ctr Human Mol Genet & Pharmacogen, SLO-2000 Maribor, Slovenia; [Nutland, Sarah; Wallace, Chris] Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge, England; [Onengut-Gumuscu, Suna] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Pearce, Kerra] UCL, Univ Coll London Genom, Inst Child Hlth, London, England; [Polanco, Isabel] Hosp La Paz, Dept Pediat Gastroenterol, Madrid, Spain; [Ribes-Koninckx, Carmen] La Fe Univ Hosp, Dept Pediat Gastroenterol, Valencia, Spain; [Rybak, Anna] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol & Immunol, Warsaw, Poland; [Senapati, Sabyasachi; Thelma, B. K.] Univ Delhi, Dept Genet, New Delhi, India; [Szajewska, Hania] Med Univ Warsaw, Dept Pediat, Warsaw, Poland; [Troncone, Riccardo] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Wolters, Victorien M.] Univ Med Ctr Utrecht, Dept Paediat Gastroenterol, Utrecht, Netherlands; [Zhernakova, Alexandra] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands; [Cukrowska, Bozena] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Mearin, M. Luisa] Leiden Univ, Dept Paediat, Med Ctr, Leiden, Netherlands; [Barisani, Donatella] Univ Milano Bicocca, Dept Expt Med, Fac Med, Monza, Italy; [Plagnol, Vincent] UCL, Univ Coll London Genet Inst, London, England	University of London; Queen Mary University London; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of London; Queen Mary University London; Universitat Rovira i Virgili; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wellcome Trust Sanger Institute; University of Groningen; Hospital Universitario Cruces; University of Naples Federico II; Radboud University Nijmegen; Radboud University Nijmegen; Sapienza University Rome; Dayanand Medical College & Hospital; University of Maribor; University of Cambridge; University of Virginia; University of London; University College London; Hospital Universitario La Paz; Children's Memorial Health Institute; University of Delhi; Medical University of Warsaw; University of Naples Federico II; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Children's Memorial Health Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Milano-Bicocca; University of London; University College London	van Heel, DA (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England.	c.wijmenga@medgen.umcg.nl; d.vanheel@qmul.ac.uk	Almeida, Rodrigo RA/A-8640-2016; Franke, Lude/P-7036-2016; de Almeida, Rodrigo Coutinho/X-8848-2019; Romanos, Jihane/F-7372-2012; Wijmenga, Cisca/D-2173-2009; Zhernakova, Alexandra/ABA-9372-2020; Rybak, Anna/HGB-1849-2022; Scerri, Christian/D-3077-2012; Plagnol, Vincent/A-5667-2011; Ricaño-Ponce, Isis/ABC-5454-2020; Wijmenga, Cisca/AAE-7719-2019; Varadé, Jezabel/Z-5054-2019; Almeida, Rodrigo/GZH-0682-2022; Duerr, Richard H/B-4188-2009; varade, jezabel/B-2771-2017; Ribes-Koninckx, Maria Carmen/ABH-5577-2020; Varadé, Jezabel/C-8298-2012; Núñez, Concepción/H-8517-2017; Joosten, Leo AB/H-3138-2015; Deloukas, Panos/B-2922-2013; Bilbao, Jose Ramon/A-9177-2008; Szajewska, Hania/M-4141-2018; Hrdlickova, Barbara/M-8065-2016	Almeida, Rodrigo RA/0000-0001-7966-056X; Franke, Lude/0000-0002-5159-8802; de Almeida, Rodrigo Coutinho/0000-0001-7966-056X; Scerri, Christian/0000-0002-6499-234X; Ricaño-Ponce, Isis/0000-0002-7530-9526; Wijmenga, Cisca/0000-0002-5635-1614; Varadé, Jezabel/0000-0002-3964-110X; Duerr, Richard H/0000-0001-6586-3905; varade, jezabel/0000-0002-3964-110X; Joosten, Leo AB/0000-0001-6166-9830; Deloukas, Panos/0000-0001-9251-070X; Bilbao, Jose Ramon/0000-0002-3176-501X; Szajewska, Hania/0000-0002-4596-2874; Hunt, Sarah/0000-0002-8350-1235; Bockett, Nicholas/0000-0002-7630-7637; Mein, Charles/0000-0003-0811-9658; Thelma, B.K/0000-0002-2154-5443; Plagnol, Vincent/0000-0002-5597-9215; Heap, Graham/0000-0003-4131-6792; Senapati, Sabyasachi/0000-0002-9448-7432; Nunez, Concepcion/0000-0002-9489-1603; van Heel, David/0000-0002-0637-2265; Rich, Stephen/0000-0003-3872-7793; Trynka, Gosia/0000-0002-6955-9529; Mitrovic, Mitja/0000-0002-7648-7674; Barrett, Jeffrey/0000-0002-1152-370X; Urcelay, Elena/0000-0001-8470-8396; Zhernakova, Alexandra/0000-0002-4574-0841; Cukrowska, Bozena/0000-0001-6887-0094; Wallace, Chris/0000-0001-9755-1703; Hrdlickova, Barbara/0000-0002-2419-4159	Wellcome Trust [084743, 076113/C/04/Z, 068545/Z/02]; Netherlands Genomics Initiative; Dutch Government [BSIK03009]; Netherlands Organisation for Scientific Research (NWO) [918.66.620]; US National Institutes of Health [1R01CA141743, U01-DK062418]; Fondo de Investigacion Sanitaria [FIS08/1676, FIS07/0353]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International; UK Medical Research Council [G0000934]; Council for Scientific and Industrial Research (CSIR), New Dehli, India; NATIONAL CANCER INSTITUTE [R01CA141743] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; MRC [G0700545, G0000934, G1001799, G1001158] Funding Source: UKRI; Medical Research Council [G0700545, G0801418B, G0000934, G1001799, G1001158] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Genomics Initiative; Dutch Government; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Council for Scientific and Industrial Research (CSIR), New Dehli, India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the Wellcome Trust (084743 to D.A.v.H.), by grants from the Celiac Disease Consortium and an Innovative Cluster approved by the Netherlands Genomics Initiative. Partial funding was provided by the Dutch Government (BSIK03009 to C. Wijmenga) and the Netherlands Organisation for Scientific Research (NWO, grant 918.66.620 to C. Wijmenga). Funding was also provided by the US National Institutes of Health grant 1R01CA141743 (to R.H.D.) and Fondo de Investigacion Sanitaria grants FIS08/1676 and FIS07/0353 (to E.U.). This research utilized resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, the National Human Genome Research Institute, the National Institute of Child Health and Human Development and the Juvenile Diabetes Research Foundation International and is supported by the US National Institutes of Health grant U01-DK062418. We acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS-CC collection), which is funded by the Wellcome Trust grant 076113/C/04/Z and by US National Institute for Health Research program grant to the National Health Service Blood and Transplant (RP-PG-0310-1002). The collection was established as part of the WTCCC<SUP>33</SUP>. We acknowledge the use of DNA from the British 1958 Birth Cohort collection, which is funded by the UK Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. S.S. is supported by a Senior Research Fellowship from the Council for Scientific and Industrial Research (CSIR), New Dehli, India.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asano A, 2007, MAMM GENOME, V18, P779, DOI 10.1007/s00335-007-9062-0; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bingley PJ, 2004, BRIT MED J, V328, P322, DOI 10.1136/bmj.328.7435.322; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jostins L, 2011, EUR J HUM GENET, V19, P662, DOI 10.1038/ejhg.2011.10; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Megiorni F, 2009, HUM IMMUNOL, V70, P55, DOI 10.1016/j.humimm.2008.10.018; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Romanos J, 2009, J MED GENET, V46, P60, DOI 10.1136/jmg.2008.061457; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	40	520	526	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1193	U45		10.1038/ng.998	http://dx.doi.org/10.1038/ng.998			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22057235	Green Accepted			2022-12-25	WOS:000297931400011
J	Prickett, TD; Wei, XM; Cardenas-Navia, I; Teer, JK; Lin, JC; Walia, V; Gartner, J; Jiang, JJ; Cherukuri, PF; Molinolo, A; Davies, MA; Gershenwald, JE; Stemke-Hale, K; Rosenberg, SA; Margulies, EH; Samuels, Y				Prickett, Todd D.; Wei, Xiaomu; Cardenas-Navia, Isabel; Teer, Jamie K.; Lin, Jimmy C.; Walia, Vijay; Gartner, Jared; Jiang, Jiji; Cherukuri, Praveen F.; Molinolo, Alfredo; Davies, Michael A.; Gershenwald, Jeffrey E.; Stemke-Hale, Katherine; Rosenberg, Steven A.; Margulies, Elliott H.; Samuels, Yardena			Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma	NATURE GENETICS			English	Article							PHASE-II; CANCER; GLUTAMATE; REVEALS; METALLOPROTEINASE; INHIBITION; CELLS; BRAF	G protein-coupled receptors (GPCRs), the largest human gene family, are important regulators of signaling pathways. However, knowledge of their genetic alterations is limited. In this study, we used exon capture and massively parallel sequencing methods to analyze the mutational status of 734 GPCRs in melanoma. This investigation revealed that one family member, GRM3, was frequently mutated and that one of its mutations clustered within one position. Biochemical analysis of GRM3 alterations revealed that mutant GRM3 selectively regulated the phosphorylation of MEK, leading to increased anchorage-independent growth and migration. Melanoma cells expressing mutant GRM3 had reduced cell growth and cellular migration after short hairpin RNA-mediated knockdown of GRM3 or treatment with a selective MEK inhibitor, AZD-6244, which is currently being used in phase 2 clinical trials. Our study yields the most comprehensive map of genetic alterations in the GPCR gene family.	[Prickett, Todd D.; Wei, Xiaomu; Cardenas-Navia, Isabel; Walia, Vijay; Gartner, Jared; Jiang, Jiji; Samuels, Yardena] NHGRI, Canc Genet Branch, US NIH, Bethesda, MD 20892 USA; [Teer, Jamie K.; Cherukuri, Praveen F.; Margulies, Elliott H.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Teer, Jamie K.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA; [Molinolo, Alfredo] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Davies, Michael A.; Stemke-Hale, Katherine] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Samuels, Y (corresponding author), NHGRI, Canc Genet Branch, US NIH, Bethesda, MD 20892 USA.	samuelsy@mail.nih.gov	Cherukuri, Praveen/AFU-2005-2022; Stemke-Hale, Katherine/K-9113-2013; Gershenwald, Jeff/AAX-4367-2020; Walia, Vijay/F-1647-2013; Davies, Michael/GWV-2527-2022	Cherukuri, Praveen/0000-0002-9509-1245; Stemke-Hale, Katherine/0000-0002-1231-4192; Gershenwald, Jeff/0000-0003-4519-5369; Samuels, Yardena/0000-0002-3349-7266	National Human Genome Research Institute; National Cancer Institute; US National Institutes of Health, USA; University of Texas MD Anderson Cancer Center Melanoma Informatics, Tissue Resource and Pathology Core; Melanoma Specialized Programs of Research Excellence [P50 CA93459]; Melanoma Research Alliance; American Society of Clinical Oncology; MD Anderson Physician-Scientist Program; National Institute of Dental and Craniofacial Research, NIH; NATIONAL CANCER INSTITUTE [ZIABC010984, P50CA093459, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200337, Z01HG200337] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Melanoma Informatics, Tissue Resource and Pathology Core; Melanoma Specialized Programs of Research Excellence; Melanoma Research Alliance; American Society of Clinical Oncology; MD Anderson Physician-Scientist Program; National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Gutkind, J. Cronin, H. Abaan, P. Cruz, J. Mullikin, N. Hansen and members of the US National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program for generating the sequence data analyzed here. We thank S. Hoogstraten-Miller and I. Ginty for assistance with the mouse experiments and S. Anderson for assistance with FACS analysis. This work was supported by the Intramural Research Programs of the National Human Genome Research Institute and National Cancer Institute, US National Institutes of Health, USA. Grant support was also provided by the University of Texas MD Anderson Cancer Center Melanoma Informatics, Tissue Resource and Pathology Core and the Melanoma Specialized Programs of Research Excellence (P50 CA93459). M.A.D. is supported by funding from the Melanoma Research Alliance, the American Society of Clinical Oncology and the MD Anderson Physician-Scientist Program. A.M. is supported by the Intramural Research program of the National Institute of Dental and Craniofacial Research, NIH.	Aronica E, 2003, EUR J NEUROSCI, V17, P2106, DOI 10.1046/j.1460-9568.2003.02657.x; Bian DF, 2004, CANCER RES, V64, P4209, DOI 10.1158/0008-5472.CAN-04-0060; Brabet I, 1998, NEUROPHARMACOLOGY, V37, P1043, DOI 10.1016/S0028-3908(98)00091-4; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee HJ, 2008, PIGM CELL MELANOMA R, V21, P415, DOI 10.1111/j.1755-148X.2008.00478.x; McDermott DF, 2008, J CLIN ONCOL, V26, P2178, DOI 10.1200/JCO.2007.14.8288; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishi N, 2000, BRIT J PHARMACOL, V130, P1664, DOI 10.1038/sj.bjp.0703464; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Viloria CG, 2009, CANCER RES, V69, P4926, DOI 10.1158/0008-5472.CAN-08-4155; Wei XM, 2010, MOL CANCER RES, V8, P1513, DOI 10.1158/1541-7786.MCR-10-0262; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106	22	110	114	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1119	U114		10.1038/ng.950	http://dx.doi.org/10.1038/ng.950			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21946352	Green Accepted			2022-12-25	WOS:000296584000017
J	Jung, P; Sato, T; Merlos-Suarez, A; Barriga, FM; Iglesias, M; Rossell, D; Auer, H; Gallardo, M; Blasco, MA; Sancho, E; Clevers, H; Batlle, E				Jung, Peter; Sato, Toshiro; Merlos-Suarez, Anna; Barriga, Francisco M.; Iglesias, Mar; Rossell, David; Auer, Herbert; Gallardo, Mercedes; Blasco, Maria A.; Sancho, Elena; Clevers, Hans; Batlle, Eduard			Isolation and in vitro expansion of human colonic stem cells	NATURE MEDICINE			English	Article							COLORECTAL-CANCER; INTESTINAL EPITHELIUM; SELF-RENEWAL	Here we describe the isolation of stem cells of the human colonic epithelium. Differential cell surface abundance of ephrin type-B receptor 2 (EPHB2) allows the purification of different cell types from human colon mucosa biopsies. The highest EPHB2 surface levels correspond to epithelial colonic cells with the longest telomeres and elevated expression of intestinal stem cell (ISC) marker genes. Moreover, using culturing conditions that recreate the ISC niche, a substantial proportion of EPHB2-high cells can be expanded in vitro as an undifferentiated and multipotent population.	[Jung, Peter; Merlos-Suarez, Anna; Barriga, Francisco M.; Sancho, Elena; Batlle, Eduard] Inst Biomed Res, Oncol Program, Barcelona, Spain; [Sato, Toshiro; Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Sato, Toshiro; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Shinjuku Ku, Tokyo, Japan; [Iglesias, Mar] Univ Autonoma Barcelona, Dept Pathol, Hosp Univ Mar, E-08193 Barcelona, Spain; [Rossell, David] Inst Biomed Res, Biostat & Bioinformat Unit, Barcelona, Spain; [Auer, Herbert] Inst Biomed Res, Funct Genom Core Facil, Barcelona, Spain; [Gallardo, Mercedes; Blasco, Maria A.] Spanish Natl Canc Res Ctr, Telomeres & Telomerase Grp, Mol Oncol Program, Madrid, Spain; [Batlle, Eduard] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Keio University; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); ICREA	Batlle, E (corresponding author), Inst Biomed Res, Oncol Program, Barcelona, Spain.	eduard.batlle@irbbarcelona.org	Blasco, Maria A./M-1694-2014; Batlle, Eduard/K-8080-2014; Rossell, David/AAM-4292-2021; Sato, Toshiro/J-3522-2014; Auer, Herbert/AAV-2332-2020; Sancho, Elena/ABH-4867-2020	Blasco, Maria A./0000-0002-4211-233X; Batlle, Eduard/0000-0003-2422-0326; Rossell, David/0000-0002-7104-5789; Sato, Toshiro/0000-0001-8353-8137; Sancho, Elena/0000-0002-8182-513X; Barriga, Francisco/0000-0002-0996-7707	Spanish Ministry of Science and Innovation (MICINN); European Research Council (ERC); Instituto de Salud Carlos III [RD09/0076/00036]; Pla Director d'Oncologia de Catalunya (XBTC); EU; Botin Foundation; Lilly Foundation; Korber European Science Award; Marie Curie Fellowship (FP7); ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council (ERC)(European Research Council (ERC)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Pla Director d'Oncologia de Catalunya (XBTC); EU(European Commission); Botin Foundation; Lilly Foundation; Korber European Science Award; Marie Curie Fellowship (FP7)(European Commission); ICREA(ICREA)	We thank Genentech for the EphB2-specific antibody Mab 2H9 and the Institute for Research in Biomedicine transcriptomic facility, electronic microscopy service (Universitat de Barcelona) and Cell separation unit (UB) for expert assistance. We thank L. Lopez Vilaro and E. Calderon Gomez for help with mucosas. This work is supported by grants to E.B. from the CONSOLIDER and Plan Nacional I+D+i Programs from Spanish Ministry of Science and Innovation (MICINN) and the European Research Council (ERC-FP7). Work was furthermore supported by grants from Instituto de Salud Carlos III FEDER (RD09/0076/00036). The 'Xarxa de Bancs de tumors' is sponsored by Pla Director d'Oncologia de Catalunya (XBTC). The M.A.B. laboratory is founded by the MICINN, the EU, the Botin and Lilly Foundations, and the Korber European Science Award to M.A.B. P.J. holds a Marie Curie Fellowship (FP7).	Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Joseph RR, 2005, APOPTOSIS, V10, P1221, DOI 10.1007/s10495-005-2049-y; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211	10	463	494	6	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1225	1227		10.1038/nm.2470	http://dx.doi.org/10.1038/nm.2470			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21892181				2022-12-25	WOS:000296022100038
J	Liu, PX; Cheng, HL; Santiago, S; Raeder, M; Zhang, F; Isabella, A; Yang, J; Semaan, DJ; Chen, CZ; Fox, EA; Gray, NS; Monahan, J; Schlegel, R; Beroukhim, R; Mills, GB; Zhao, JJ				Liu, Pixu; Cheng, Hailing; Santiago, Stephanie; Raeder, Maria; Zhang, Fan; Isabella, Adam; Yang, Janet; Semaan, Derek J.; Chen, Changzhong; Fox, Edward A.; Gray, Nathanael S.; Monahan, John; Schlegel, Robert; Beroukhim, Rameen; Mills, Gordon B.; Zhao, Jean J.			Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms	NATURE MEDICINE			English	Article							BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; MET AMPLIFICATION; EPITHELIAL-CELLS; COPY NUMBER; MUTATIONS; PIK3CA; INHIBITORS; GDC-0941; PTEN	PIK3CA gain-of-function mutations are a common oncogenic event in human malignancy(1-4), making phosphatidylinositol 3-kinase (PI3K) a target for cancer therapy. Despite the promise of targeted therapy, resistance often develops, leading to treatment failure. To elucidate mechanisms of resistance to PI3K-targeted therapy, we constructed a mouse model of breast cancer conditionally expressing human PIK3CA(H1047R). Notably, most PIK3CA(H1047R)-driven mammary tumors recurred after PIK3CA(H1047R) inactivation. Genomic analyses of recurrent tumors revealed multiple lesions, including focal amplification of Met or Myc (also known as c-Met and c-Myc, respectively). Whereas Met amplification led to tumor survival dependent on activation of endogenous PI3K, tumors with Myc amplification became independent of the PI3K pathway. Functional analyses showed that Myc contributed to oncogene independence and resistance to PI3K inhibition. Notably, PIK3CA mutations and c-MYC elevation co-occur in a substantial fraction of human breast tumors. Together, these data suggest that c-MYC elevation represents a potential mechanism by which tumors develop resistance to current PI3K-targeted therapies.	[Liu, Pixu; Cheng, Hailing; Santiago, Stephanie; Raeder, Maria; Isabella, Adam; Yang, Janet; Semaan, Derek J.; Gray, Nathanael S.; Beroukhim, Rameen; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Pixu; Cheng, Hailing; Santiago, Stephanie; Gray, Nathanael S.; Zhao, Jean J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Cheng, Hailing; Zhao, Jean J.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Raeder, Maria] Univ Bergen, Dept Clin Med, Bergen, Norway; [Raeder, Maria] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Zhang, Fan; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Fox, Edward A.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fox, Edward A.; Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Monahan, John; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA USA; [Beroukhim, Rameen] Broad Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Novartis; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Zhao, JJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	jean_zhao@dfci.harvard.edu		Monahan, John/0000-0002-3125-8704	US National Institutes of Health [CA134502, CA148164-01, K08CA122833]; Stand Up To Cancer; Dana Farber Harvard Cancer Center breast cancer SPORE [P50 CA089393-08S1]; US Department of Defense [BC051565]; V Foundation; Claudia Barr Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [RC2CA148164, P50CA098258, R01CA134502, P50CA089393, K08CA122833, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer; Dana Farber Harvard Cancer Center breast cancer SPORE; US Department of Defense(United States Department of Defense); V Foundation; Claudia Barr Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Roberts, L. Cantley and W. Sellers for scientific discussions and suggestions. We thank L. Clayton and D. Silver for critical review of this manuscript. We thank R. Bronson for pathological analyses of tumor samples. We thank C. Li and E. Allgood for technical assistance. We thank L. Chodosh (University of Pennsylvania School of Medicine) for providing MMTV-rtTA mice. This work was supported by US National Institutes of Health grants CA134502 (J.J.Z.), CA148164-01 (J.J.Z. and N.S.G.) and K08CA122833 (R.B.), Stand Up To Cancer (J.J.Z. and G.B.M.), Dana Farber Harvard Cancer Center breast cancer SPORE grant P50 CA089393-08S1 (J.J.Z.), the US Department of Defense (BC051565 to J.J.Z.), the V Foundation (J.J.Z. and R.B.) and the Claudia Barr Program (J.J.Z.). In compliance with Harvard Medical School guidelines, we disclose that J.J.Z. and R.B. are consultants for Novartis Pharmaceuticals.	Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	28	200	203	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1116	U122		10.1038/nm.2402	http://dx.doi.org/10.1038/nm.2402			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21822287	Green Accepted			2022-12-25	WOS:000294605100032
J	Wu, LC; Wu, LH				Wu, Liangchuan; Wu, Lianghong			Pharmaceutical patent evaluation and licensing using a stochastic model and Monte Carlo simulations	NATURE BIOTECHNOLOGY			English	Editorial Material							OPTIONS; INVESTMENT; FIRM; REAL		[Wu, Lianghong] Natl Cent Univ, Chungli 32054, Taiwan; [Wu, Liangchuan] Natl Chung Hsing Univ, Taichung 40227, Taiwan	National Central University; National Chung Hsing University	Wu, LH (corresponding author), Natl Cent Univ, Chungli 32054, Taiwan.	wlh@mgt.ncu.edu.tw	Wu, Lianghong/AAM-8081-2021	Wu, Liang-Hong/0000-0002-6665-1709				[Anonymous], 2010, PHARM LICENSING OVER; Baudry M, 2006, REV IND ORGAN, V28, P41, DOI 10.1007/s11151-006-0001-0; Burgess P, 2010, NAT BIOTECHNOL, V28, P1267, DOI 10.1038/nbt.1725; David E, 2009, NAT REV DRUG DISCOV, V8, P609, DOI 10.1038/nrd2948; Dixit A.K., 1994, INVESTMENT UNCERTAIN, DOI DOI 10.1515/9781400830176; Kellogg D., 2000, FINANCIAL ANAL J, V56, P76, DOI DOI 10.2469/FAJ.V56.N3.2362; Kulatilaka N, 1998, MANAGE SCI, V44, P1021, DOI 10.1287/mnsc.44.8.1021; MYERS SC, 1974, J FINANC, V29, P1, DOI 10.2307/2978211; Myers SC., 1997, LIFE CYCLE FINANCIAL; PINDYCK RS, 1988, AM ECON REV, V78, P969; Schwartz E., 2004, ECON NOTES, V33, P23, DOI [https://doi.org/10.1111/j.0391-5026.2004.00124.x, DOI 10.1111/J.0391-5026.2004.00124.X]; Stewart JJ, 2001, NAT BIOTECHNOL, V19, P813, DOI 10.1038/nbt0901-813; Villiger R, 2005, NAT BIOTECHNOL, V23, P423, DOI 10.1038/nbt0405-423; Wu MC, 2006, APPL ECON LETT, V13, P313, DOI 10.1080/13504850500393477; 2006, PHARM LICENSING STRA	15	2	2	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					798	802		10.1038/nbt.1963	http://dx.doi.org/10.1038/nbt.1963			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	817ZT	21904321				2022-12-25	WOS:000294718400017
J	d'Ydewalle, C; Krishnan, J; Chiheb, DM; Van Damme, P; Irobi, J; Kozikowski, AP; Vanden Berghe, P; Timmerman, V; Robberecht, W; Van Den Bosch, L				d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Irobi, Joy; Kozikowski, Alan P.; Vanden Berghe, Pieter; Timmerman, Vincent; Robberecht, Wim; Van Den Bosch, Ludo			HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease	NATURE MEDICINE			English	Article							HEAT-SHOCK PROTEINS; HEREDITARY MOTOR NEUROPATHY; NERVOUS-SYSTEM; MITOCHONDRIAL TRANSPORT; NEUROFILAMENT NETWORK; TUBULIN ACETYLATION; CELLULAR FUNCTIONS; TRANSGENIC MICE; GAIT ANALYSIS; MITOFUSIN 2	Charcot-Marie-Tooth disease (CMT) is the most common inherited disorder of the peripheral nervous system. Mutations in the 27-kDa small heat-shock protein gene (HSPB1) cause axonal CMT or distal hereditary motor neuropathy (distal HMN). We developed and characterized transgenic mice expressing two different HSPB1 mutations (S135F and P182L) in neurons only. These mice showed all features of CMT or distal HMN dependent on the mutation. Expression of mutant HSPB1 decreased acetylated a-tubulin abundance and induced severe axonal transport deficits. An increase of a-tubulin acetylation induced by pharmacological inhibition of histone deacetylase 6 (HDAC6) corrected the axonal transport defects caused by HSPB1 mutations and rescued the CMT phenotype of symptomatic mutant HSPB1 mice. Our findings demonstrate the pathogenic role of a-tubulin deacetylation in mutant HSPB1-induced neuropathies and offer perspectives for using HDAC6 inhibitors as a therapeutic strategy for hereditary axonopathies.	[d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo] VIB, Vesalius Res Ctr, Louvain, Belgium; [d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo] Katholieke Univ Leuven, Neurobiol Lab, Louvain, Belgium; [Van Damme, Philip; Robberecht, Wim] Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Irobi, Joy; Timmerman, Vincent] VIB, Dept Mol Genet, Peripheral Neuropathy Grp, Antwerp, Belgium; [Irobi, Joy; Timmerman, Vincent] Univ Antwerp, B-2020 Antwerp, Belgium; [Irobi, Joy; Timmerman, Vincent] Inst Born Bunge, Neurogenet Lab, Antwerp, Belgium; [Kozikowski, Alan P.] Univ Illinois, Dept Med Chem & Pharmacognosy, Drug Discovery Program, Chicago, IL USA; [Vanden Berghe, Pieter] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Lab Enter Neurosci, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; KU Leuven	Van Den Bosch, L (corresponding author), VIB, Vesalius Res Ctr, Campus Gasthuisberg, Louvain, Belgium.	ludo.vandenbosch@vib-kuleuven.be	Timmerman, Vincent/O-7283-2019; Van Den Bosch, Ludo/B-7258-2012; Van Damme, Philip/A-6464-2009	Timmerman, Vincent/0000-0002-2162-0933; Van Damme, Philip/0000-0002-4010-2357; Van Den Bosch, Ludo/0000-0003-0104-4067; Vanden Berghe, Pieter/0000-0002-0009-2094	American Chemical Society; International Rett Syndrome Foundation; Fund for Scientific Research Flanders (FWO-Vlaanderen); University of Leuven [GOA/12/014, OT/10/046]; Belgian government (Belgian Federal Science Policy Office) [P6/43]; Association Belge contre les Maladies neuro-Musculaires; Association Francaise contre les Myopathies [13169, 14471]; Frick Foundation for Amyotrophic Lateral Sclerosis Research; Muscular Dystrophy Association; European Community [259867]; Agency for Innovation by Science and Technology in Flanders	American Chemical Society(American Chemical Society); International Rett Syndrome Foundation; Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); University of Leuven(KU Leuven); Belgian government (Belgian Federal Science Policy Office)(Belgian Federal Science Policy Office); Association Belge contre les Maladies neuro-Musculaires; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Frick Foundation for Amyotrophic Lateral Sclerosis Research; Muscular Dystrophy Association(Muscular Dystrophy Association); European Community(European Commission); Agency for Innovation by Science and Technology in Flanders	We thank L. Almeida-Souza and S. Janssens for their constructive comments and the Molecular Small Animal Imaging Centre (MoSAIC, K. U. Leuven) for the use of the Catwalk system. We are grateful to B. Weynants and N. Hersmus for the technical assistance. We thank R. Mazitschek and J. Bradner (Dana-Farber Cancer Institute, Harvard Medical School) for kindly giving us tubacin. The research to create tubastatin A was supported by an American Chemical Society Fellowship and by the International Rett Syndrome Foundation. We thank J. H. Kalin for helping us with the creation of the HDAC6 homology model. This work was supported by grants from the Fund for Scientific Research Flanders (FWO-Vlaanderen), the University of Leuven (K. U. Leuven, GOA/12/014 and OT/10/046), the Belgian government (Interuniversity Attraction Poles, programme P6/43 of the Belgian Federal Science Policy Office), the Association Belge contre les Maladies neuro-Musculaires, the Association Francaise contre les Myopathies (projects 13169 and 14471), the Frick Foundation for Amyotrophic Lateral Sclerosis Research, the Muscular Dystrophy Association and the European Community's Health Seventh Framework Programme (FP7/2007-2013 under grant agreement 259867). C.d.Y. is supported by the Agency for Innovation by Science and Technology in Flanders. P. V. D. is a clinical researcher, and J. I. is a postdoctoral fellow of the FWO-Vlaanderen. W. R. is supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dequen F, 2010, HUM MOL GENET, V19, P2616, DOI 10.1093/hmg/ddq149; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dierick I, 2008, BRAIN, V131, P1217, DOI 10.1093/brain/awn029; Dietz KC, 2010, PHARMACOL RES, V62, P11, DOI 10.1016/j.phrs.2010.01.011; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ikeda Y, 2009, J NEUROL SCI, V277, P9, DOI 10.1016/j.jns.2008.09.031; Ismailov SM, 2001, EUR J HUM GENET, V9, P646, DOI 10.1038/sj.ejhg.5200686; James PA, 2008, J NEUROL NEUROSUR PS, V79, P461, DOI 10.1136/jnnp.2007.125179; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kijima K, 2005, J HUM GENET, V50, P473, DOI 10.1007/s10038-005-0280-6; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Vanden Berghe P, 2004, AM J PHYSIOL-GASTR L, V286, pG671, DOI 10.1152/ajpgi.00283.2003; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Xanthoudakis S, 2000, NAT CELL BIOL, V2, pE163, DOI 10.1038/35023643; Zhai JB, 2007, HUM MOL GENET, V16, P3103, DOI 10.1093/hmg/ddm272; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071	47	319	348	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					968	U86		10.1038/nm.2396	http://dx.doi.org/10.1038/nm.2396			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785432				2022-12-25	WOS:000293507400030
J	Van Eenennaam, AL; Muir, WM				Van Eenennaam, Alison L.; Muir, William M.			Transgenic salmon: a final leap to the grocery shelf?	NATURE BIOTECHNOLOGY			English	Letter							POSSIBLE ECOLOGICAL RISKS; FISH; ALLERGEN; PARVALBUMIN; STORAGE		[Van Eenennaam, Alison L.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Van Eenennaam, AL (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	alvaneenennaam@ucdavis.edu	Van Eenennaam, Alison L/G-3481-2011	Van Eenennaam, Alison L/0000-0003-1562-162X				AquaBounty Technologies Inc, 2010, ENV ASS ADQADVANTAGE; Conko G, 2010, NAT BIOTECHNOL, V28, P1256, DOI 10.1038/nbt.1730; Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343; Kuehn A, 2010, INT ARCH ALLERGY IMM, V153, P359, DOI 10.1159/000316346; Lindstrom CDV, 1996, SCAND J IMMUNOL, V44, P335, DOI 10.1046/j.1365-3083.1996.d01-314.x; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; Marzban G., 2005, PLANT SCI, V169, P387; Moreau D.T.R.Conway, 2011, EVOL APPL        JUL, DOI [10.1111/j.1752-4571.2011.00196.x, DOI 10.1111/J.1752-4571.2011.00196.X]; Muir W.M., 2001, AM NAT, V158, P1; Muir WM, 2004, EMBO REP, V5, P654, DOI 10.1038/sj.embor.7400197; Muir WM, 2002, TRANSGENIC RES, V11, P101, DOI 10.1023/A:1015203812200; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; National Research Council, 2002, COMM DEF SCI BAS CON; Nordlee JA, 1996, NEW ENGL J MED, V334, P688, DOI 10.1056/NEJM199603143341103; Pollack A., 2010, NY TIMES        0903; Sancho AI, 2006, J AGR FOOD CHEM, V54, P5098, DOI 10.1021/jf0530446; Sancho AI, 2006, J AGR FOOD CHEM, V54, P5917, DOI 10.1021/jf060880m; Schiermeier Q, 2003, NATURE, V425, P753, DOI 10.1038/425753a; Sten E, 2004, APMIS, V112, P21, DOI 10.1111/j.1600-0463.2004.apm1120104.x; United Nations Food and Agriculture Organization and World Health Organization, 2008, GUID COND FOOD SAF A; . US Food and Drug Administration, 2009, FDA FIN GUID IND 187; US Food and Drug Administration, 2010, FDA VET MED ADV COMM; Wild LG, 2005, CURR ALLERGY ASTHM R, V5, P74, DOI 10.1007/s11882-005-0059-z; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Young D., 2011, REP YOUNGS FRANKENFI	26	42	45	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					706	710		10.1038/nbt.1938	http://dx.doi.org/10.1038/nbt.1938			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21822244				2022-12-25	WOS:000293696500019
J	Benson, JM; Sachs, CW; Treacy, G; Zhou, HH; Pendley, CE; Brodmerkel, CM; Shankar, G; Mascelli, MA				Benson, Jacqueline M.; Sachs, Clifford W.; Treacy, George; Zhou, Honghui; Pendley, Charles E.; Brodmerkel, Carrie M.; Shankar, Gopi; Mascelli, Mary A.			Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab	NATURE BIOTECHNOLOGY			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELL POPULATION; IFN-GAMMA; DOUBLE-BLIND; PHASE-I; MULTIPLE-SCLEROSIS; SEVERE PSORIASIS; CYTOKINE; IL-23	Preclinical and clinical studies conducted in the mid-1990s reported strong association and causality between the T-cell helper (T-H) 1 inductor cytokine interleukin (IL)-12 and numerous immune-mediated disorders, which spurred the development of therapeutic agents targeting IL-12 function. One of the first to enter the clinic, ustekinumab, is a human monoclonal antibody (mAb) that binds to the p40 subunit of IL-12. Subsequent to the generation of ustekinumab, it was discovered that IL-23 also contains the p40 subunit. Thus, although ustekinumab was designed to target IL-12, it also modulates IL-23, a cytokine important to the development and/or maintenance of T(H)17 cells. Clinical observations established that IL-12/23p40 is integral to the pathologies of psoriasis, psoriatic arthritis and Crohn's disease. The molecular and cellular evaluations conducted in ustekinumab clinical programs have provided numerous insights into the pathologic processes of these disorders, illustrating how a novel molecular entity can contribute to our understanding of disease. The individual contributions of these cytokines to specific pathologies require investigation and clinical evaluation of the role of IL-12-and IL-23-specific inhibitors.	[Benson, Jacqueline M.; Sachs, Clifford W.; Treacy, George; Zhou, Honghui; Pendley, Charles E.; Brodmerkel, Carrie M.; Shankar, Gopi] Centocor Res & Dev Inc, Malvern, PA USA; [Mascelli, Mary A.] Biopharmaceut Consultant LLC, Ambler, PA USA	Johnson & Johnson; Johnson & Johnson USA	Benson, JM (corresponding author), Centocor Res & Dev Inc, Malvern, PA USA.	jbenson4@its.jnj.com						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Berrebi D, 1998, AM J PATHOL, V152, P667; Bowman EP, 2006, CURR OPIN INFECT DIS, V19, P245, DOI 10.1097/01.qco.0000224818.42729.67; Brodmerkel C, 2010, J DRUGS DERMATOL, V9, P677; Buse E, 2003, TOXICOLOGY, V185, P221, DOI 10.1016/S0300-483X(02)00614-5; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cardenes M, 2010, J MED GENET, V47, P635, DOI 10.1136/jmg.2009.071910; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Curtis MM, 2009, J IMMUNOL, V183, P381, DOI 10.4049/jimmunol.0900939; Davidson NJ, 1998, J IMMUNOL, V161, P3143; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; DILLON SB, 2010, DRUG DISC WORLD  FAL, P87; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Gottlieb A, 2010, LANCET, V376, P1542; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Gottlieb AB, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.06.021; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hong K, 1999, J IMMUNOL, V162, P7480; JUDSON M, J AM ACAD D IN PRESS; Kasper LH, 2006, CURR MED RES OPIN, V22, P1671, DOI 10.1185/030079906X120931; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Leonard JP, 1997, BLOOD, V90, P2541; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Leonardi CL, 2008, LANCET, V371, P1838; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Looney RJ, 2007, CLIN IMMUNOL, V123, P235, DOI 10.1016/j.clim.2007.01.001; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Luo JQ, 2010, J MOL BIOL, V402, P797, DOI 10.1016/j.jmb.2010.07.046; Malfait AM, 1998, CLIN EXP IMMUNOL, V111, P377; MARTIN PL, 2010, BIRTH DEFECTS RES, V83, P1; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Naz RK, 1998, J ANDROL, V19, P302; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nicoletti F, 1996, J NEUROIMMUNOL, V70, P87, DOI 10.1016/S0165-5728(96)00101-4; Novelli F, 2004, CYTOKINE GROWTH F R, V15, P367, DOI 10.1016/j.cytogfr.2004.03.009; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Portielje JEA, 1999, CLIN CANCER RES, V5, P3983; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; SACHS C, 2008, TOXICOLOGIST, V102; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; Torti DC, 2007, J AM ACAD DERMATOL, V57, P1059, DOI 10.1016/j.jaad.2007.07.016; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van Boxel-Dezaire AHH, 1999, ANN NEUROL, V45, P695, DOI 10.1002/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R; van de Wetering D, 2009, INT IMMUNOL, V21, P145, DOI 10.1093/intimm/dxn132; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; WINDHAGEN A, 1995, J EXP MED, V182, P1985, DOI 10.1084/jem.182.6.1985; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x; Zhou HH, 2006, J CLIN PHARMACOL, V46, P1268, DOI 10.1177/0091270006294278; Zhou HH, 2010, J CLIN PHARMACOL, V50, P257, DOI 10.1177/0091270009343695; Zhou HH, 2009, DRUG DISCOV TODAY, V14, P891, DOI 10.1016/j.drudis.2009.05.014; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu YW, 2010, INT J CLIN PHARM TH, V48, P830; Zhu YW, 2007, J CLIN PHARMACOL, V47, P1203; Zhu YW, 2009, J CLIN PHARMACOL, V49, P162, DOI 10.1177/0091270008329556	84	104	107	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					615	624		10.1038/nbt.1903	http://dx.doi.org/10.1038/nbt.1903			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21747388				2022-12-25	WOS:000292595200020
J	Hung, T; Wang, YL; Lin, MF; Koegel, AK; Kotake, Y; Grant, GD; Horlings, HM; Shah, N; Umbricht, C; Wang, P; Wang, Y; Kong, B; Langerod, A; Borresen-Dale, AL; Kim, SK; van de Vijver, M; Sukumar, S; Whitfield, ML; Kellis, M; Xiong, Y; Wong, DJ; Chang, HY				Hung, Tiffany; Wang, Yulei; Lin, Michael F.; Koegel, Ashley K.; Kotake, Yojiro; Grant, Gavin D.; Horlings, Hugo M.; Shah, Nilay; Umbricht, Christopher; Wang, Pei; Wang, Yu; Kong, Benjamin; Langerod, Anita; Borresen-Dale, Anne-Lise; Kim, Seung K.; van de Vijver, Marc; Sukumar, Saraswati; Whitfield, Michael L.; Kellis, Manolis; Xiong, Yue; Wong, David J.; Chang, Howard Y.			Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters	NATURE GENETICS			English	Article							GENE-EXPRESSION; HUMAN FIBROBLASTS; CDK INHIBITORS; BREAST-CANCER; MODULE MAP; GENOME; IDENTIFICATION; DEMARCATION; CHECKPOINTS; INITIATION	Transcription of long noncoding RNAs (lncRNAs) within gene regulatory elements can modulate gene activity in response to external stimuli, but the scope and functions of such activity are not known. Here we use an ultrahigh-density array that tiles the promoters of 56 cell-cycle genes to interrogate 108 samples representing diverse perturbations. We identify 216 transcribed regions that encode putative lncRNAs, many with RT-PCR-validated periodic expression during the cell cycle, show altered expression in human cancers and are regulated in expression by specific oncogenic stimuli, stem cell differentiation or DNA damage. DNA damage induces five lncRNAs from the CDKN1A promoter, and one such lncRNA, named PANDA, is induced in a p53-dependent manner. PANDA interacts with the transcription factor NF-YA to limit expression of pro-apoptotic genes; PANDA depletion markedly sensitized human fibroblasts to apoptosis by doxorubicin. These findings suggest potentially widespread roles for promoter lncRNAs in cell-growth control.	[Hung, Tiffany; Koegel, Ashley K.; Wong, David J.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Hung, Tiffany; Koegel, Ashley K.; Kim, Seung K.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wang, Yulei; Wang, Yu; Kong, Benjamin] Life Technol, Foster City, CA USA; [Lin, Michael F.; Kellis, Manolis] Broad Inst, Cambridge, MA USA; [Lin, Michael F.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kotake, Yojiro; Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kotake, Yojiro] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Kotake, Yojiro] Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Grant, Gavin D.; Whitfield, Michael L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Horlings, Hugo M.; van de Vijver, Marc] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Shah, Nilay; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Umbricht, Christopher] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Wang, Pei; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Langerod, Anita; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Dept Genet, Inst Canc Res, Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway	Stanford University; Howard Hughes Medical Institute; Stanford University; Thermo Fisher Scientific; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Hamamatsu University School of Medicine; Dartmouth College; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Stanford University; University of Oslo; University of Oslo	Wong, DJ (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	davewong@stanford.edu; howchang@stanford.edu	Whitfield, Michael/AAC-5010-2020; Kellis, Manolis/ABE-7385-2020; Shah, Nilay/H-9988-2013; Shah, Nilay/E-4925-2015	Kellis, Manolis/0000-0001-7113-9630; Grant, Gavin/0000-0002-8958-2056; van de Vijver, Marc/0000-0002-0385-4787; Kim, Seung/0000-0001-6135-7810; Shah, Nilay/0000-0002-8906-6844; Wang, Yulei/0000-0002-9057-9786; Wang, Pei/0000-0003-2373-7315	US National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K08-AR054615]; NIH/National Cancer Institute (NCI) [R01-CA118750, R01-CA130795]; Juvenile Diabetes Research Foundation; American Cancer Society; Stanford Graduate Fellowship; National Science Foundation (NSF); Department of Defense (DoD); NATIONAL CANCER INSTITUTE [R01CA140311, R01CA118750, R01CA130795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054615] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22115508] Funding Source: KAKEN	US National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Cancer Society(American Cancer Society); Stanford Graduate Fellowship(Stanford University); National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Defense (DoD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Rinn, M. Guttman and A. Regev for discussions, L. Attardi for careful reading of the manuscript and P. Khavari for reagents. Y.W., B.K. and Yu Wang are employees of Life Technologies. This work was supported by grants from the US National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (K08-AR054615 to D.J.W.), NIH/National Cancer Institute (NCI) (R01-CA118750 to H.Y.C. and R01-CA130795 to M.L.W.), the Juvenile Diabetes Research Foundation (S.K.K. and H.Y.C.) and the American Cancer Society (H.Y.C.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. T.H. is supported by the Stanford Graduate Fellowship, the National Science Foundation (NSF) Graduate Research Fellowship and the Department of Defense (DoD) National Defense Science & Engineering Graduate Fellowship (NDSEG).	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bock C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r14; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Geisler S, 2001, CANCER RES, V61, P2505; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; LIN M, 2010, NATURE PRECEDIN 0818, DOI DOI 10.1038/NPRE.2010.4784.1; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lin MF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000067; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Michlewski G, 2010, RNA, V16, P1673, DOI 10.1261/rna.2136010; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	53	880	952	5	255	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2011	43	7					621	U196		10.1038/ng.848	http://dx.doi.org/10.1038/ng.848			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21642992	Green Accepted, Green Submitted			2022-12-25	WOS:000292184600005
J	Wiley, DM; Kim, JD; Hao, JJ; Hong, CC; Bautch, VL; Jin, SW				Wiley, David M.; Kim, Jun-Dae; Hao, Jijun; Hong, Charles C.; Bautch, Victoria L.; Jin, Suk-Won			Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein	NATURE CELL BIOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN-2; LEFT-RIGHT ASYMMETRY; ROLES; GENE; RECEPTORS; GROWTH; CELLS	Angiogenesis, the formation of new blood vessels from pre-existing vessels, is critical to most physiological processes and many pathological conditions. During zebrafish development, angiogenesis expands the axial vessels into a complex vascular network that is necessary for efficient oxygen delivery. Although the dorsal aorta and the axial vein are spatially juxtaposed, the initial angiogenic sprouts from these vessels extend in opposite directions, indicating that distinct cues may regulate angiogenesis of the axial vessels. We found that angiogenic sprouts from the dorsal aorta are dependent on vascular endothelial growth factor A (Vegf-A) signalling, and do not respond to bone morphogenetic protein (Bmp) signals. In contrast, sprouts from the axial vein are regulated by Bmp signalling independently of Vegf-A signals, indicating that Bmp is a vein-specific angiogenic cue during early vascular development. Our results support a paradigm whereby different signals regulate distinct programmes of sprouting angiogenesis from the axial vein and dorsal aorta, and indicate that signalling heterogeneity contributes to the complexity of vascular networks.	[Wiley, David M.; Bautch, Victoria L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Kim, Jun-Dae] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06511 USA; [Hao, Jijun; Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Cardiovasc Med,Dept Med, Nashville, TN 37232 USA; [Hong, Charles C.] Vet Affairs TVHS, Res Med, Nashville, TN 37212 USA; [Bautch, Victoria L.; Jin, Suk-Won] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Jin, Suk-Won] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Yale University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jin, SW (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06511 USA.	bautch@med.unc.edu; suk-won.jin@yale.edu	, Zebrafish Aquaculture Facility/AAE-2716-2022; , Histology Research Core Facility/ABF-6317-2021	Kim, Jun-dae/0000-0002-9747-6288	NIH [HL090960, HL43174, HL86564]; UNC [T32HL69768]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090960, R01HL043174, T32HL069768, R01HL086564, R01HL104040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank E. Flynn for excellent fish care; the members of the Jin and Bautch laboratories for discussions; the UNC Histology Facility, Michael Hooker Microscopy Facility; W. Comb and M. Aleman for technical assistance; and M. Hammerschmidt and N. Chi for providing transgenic lines, and C-B. Chien for the kdrl 5' entry gateway vector. The authors also thank F. Conlon, M. Majesky, C. Patterson and J. Rawls for discussion and critical reading of the manuscript. This study was supported by grants from the NIH to S W.J. (HL090960) and V.L.B. (HL43174 and HL86564), and the UNC Integrative Vascular Biology Training Grant (T32HL69768) and an American Heart Association Pre-doctoral Fellowship to D.M.W.	Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bressan M, 2009, DEV BIOL, V326, P101, DOI 10.1016/j.ydbio.2008.10.045; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jin Y, 2001, ORAL ONCOL, V37, P225, DOI 10.1016/S1368-8375(00)00087-7; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Monteiro R, 2008, DEV BIOL, V315, P55, DOI 10.1016/j.ydbio.2007.11.038; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Reese DE, 2004, DEV CELL, V6, P699, DOI 10.1016/S1534-5807(04)00127-3; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Thisse B, 2001, ZFIN DIRECT DATA SUB; Thisse C, 1998, ZEBRAFISH SCI MONITO, V5; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	36	139	142	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					686	U138		10.1038/ncb2232	http://dx.doi.org/10.1038/ncb2232			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21572418	Green Accepted, Green Submitted			2022-12-25	WOS:000291147400009
J	Clemente-Blanco, A; Sen, N; Mayan-Santos, M; Sacristan, MP; Graham, B; Jarmuz, A; Giess, A; Webb, E; Game, L; Eick, D; Bueno, A; Merkenschlager, M; Aragon, L				Clemente-Blanco, Andres; Sen, Nicholas; Mayan-Santos, Maria; Sacristan, Maria P.; Graham, Bryony; Jarmuz, Adam; Giess, Adam; Webb, Elizabeth; Game, Laurence; Eick, Dirk; Bueno, Avelino; Merkenschlager, Matthias; Aragon, Luis			Cdc14 phosphatase promotes segregation of telomeres through repression of RNA polymerase II transcription	NATURE CELL BIOLOGY			English	Article							CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; NUCLEOLAR SEGREGATION; RIBOSOMAL DNA; BUDDING YEAST; MITOTIC EXIT; RDNA; ANAPHASE; COMPLEX; MITOSIS	Kinases and phosphatases regulate messenger RNA synthesis through post-translational modification of the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II (ref. 1). In yeast, the phosphatase Cdc14 is required for mitotic exit(2,3) and for segregation of repetitive regions(4). Cdc14 is also a subunit of the silencing complex RENT (refs 5,6), but no roles in transcriptional repression have been described. Here we report that inactivation of Cdc14 causes silencing defects at the intergenic spacer sequences of ribosomal genes during interphase and at Y' repeats in subtelomeric regions during mitosis. We show that the role of Cdc14 in silencing is independent of the RENT deacetylase subunit Sir2. Instead, Cdc14 acts directly on RNA polymerase II by targeting CTD phosphorylation at Ser 2 and Ser 5. We also find that the role of Cdc14 as a CTD phosphatase is conserved in humans. Finally, telomere segregation defects in cdc14 mutants(4) correlate with the presence of subtelomeric Y' elements and can be rescued by transcriptional inhibition of RNA polymerase II.	[Clemente-Blanco, Andres; Sen, Nicholas; Mayan-Santos, Maria; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, MRC Clin Sci Ctr, London W12 0NN, England; [Sacristan, Maria P.; Bueno, Avelino] Univ Salamanca, CSIC, Ctr Invest Canc, Salamanca 37007, Spain; [Graham, Bryony; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, Lymphocyte Dev Grp, MRC Clin Sci Ctr, London W12 0NN, England; [Giess, Adam; Webb, Elizabeth; Game, Laurence] Univ London Imperial Coll Sci Technol & Med, Genom Lab, MRC Clin Sci Ctr, London W12 0NN, England; [Eick, Dirk] Helmholtz Ctr Munich, Ctr Integrated Prot Sci CIPSM, Dept Mol Epigenet, D-81377 Munich, Germany	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Imperial College London; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, MRC Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Blanco, Andrés Clemente/D-4255-2014; Sacristán, María P/A-9587-2016; Sacristan, Maria/Y-4923-2019; Bueno, Avelino/A-9505-2016; Mayan, Maria D./C-8813-2012; Mayán, María D./AAR-9227-2021	Blanco, Andrés Clemente/0000-0002-3674-0671; Sacristán, María P/0000-0003-2314-8430; Sacristan, Maria/0000-0003-2314-8430; Bueno, Avelino/0000-0002-0362-4391; Mayan, Maria D./0000-0002-5809-9440; Mayán, María D./0000-0002-5809-9440; Graham, Bryony/0000-0002-4464-5770; Giess, Adam/0000-0003-1683-2146; Merkenschlager, Matthias/0000-0003-2889-3288	Spanish Science Ministry (MICINN); Deutsche Forschungsgemeinschaft [SFB-Transregio5]; Medical Research Council (MRC) of the UK; Medical Research Council [MC_U120074328, MC_U120027516] Funding Source: researchfish; MRC [MC_U120027516, MC_U120074328] Funding Source: UKRI	Spanish Science Ministry (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council (MRC) of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are very grateful to L. Warfield and S. Hahn for advice. We thank D. Morgan (UCSF) and A. Amon (MIT) for reagents. We are grateful to all members of the Aragon laboratory for discussions and comments on the manuscript. The Bueno and Sacristan laboratories are financially supported by grants from the Spanish Science Ministry (MICINN). The Eick laboratory is supported by the Deutsche Forschungsgemeinschaft, SFB-Transregio5. The Aragon and Merkenschlager laboratories are supported by the Medical Research Council (MRC) of the UK.	Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Chan JNY, 2011, DEV CELL, V20, P867, DOI 10.1016/j.devcel.2011.05.014; Clemente-Blanco A, 2009, NATURE, V458, P219, DOI 10.1038/nature07652; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Dulev S, 2009, P NATL ACAD SCI USA, V106, P14466, DOI 10.1073/pnas.0900190106; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Machin F, 2006, J CELL BIOL, V173, P893, DOI 10.1083/jcb.200511129; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mayan M, 2010, CELL CYCLE, V9, P4328, DOI 10.4161/cc.9.21.13591; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Paulsen MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-25; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Tomson BN, 2006, MOL CELL BIOL, V26, P6239, DOI 10.1128/MCB.00693-06; Torres-Rosell J, 2004, CELL CYCLE, V3, P496; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang BD, 2006, CELL CYCLE, V5, P2260, DOI 10.4161/cc.5.19.3292	38	47	47	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1450	U163		10.1038/ncb2365	http://dx.doi.org/10.1038/ncb2365			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	22020438	Green Accepted, Green Submitted			2022-12-25	WOS:000298157500013
J	He, BJ; Joiner, MLA; Singh, MV; Luczak, ED; Swaminathan, PD; Koval, OM; Kutschke, W; Allamargot, C; Yang, JY; Guan, XQ; Zimmerman, K; Grumbach, IM; Weiss, RM; Spitz, DR; Sigmund, CD; Blankesteijn, WM; Heymans, S; Mohler, PJ; Anderson, ME				He, B. Julie; Joiner, Mei-ling A.; Singh, Madhu V.; Luczak, Elizabeth D.; Swaminathan, Paari Dominic; Koval, Olha M.; Kutschke, William; Allamargot, Chantal; Yang, Jinying; Guan, Xiaoqun; Zimmerman, Kathy; Grumbach, Isabella M.; Weiss, Robert M.; Spitz, Douglas R.; Sigmund, Curt D.; Blankesteijn, W. Matthijs; Heymans, Stephane; Mohler, Peter J.; Anderson, Mark E.			Oxidation of CaMKII determines the cardiotoxic effects of aldosterone	NATURE MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; CALMODULIN KINASE-II; PREVENTS CARDIAC RUPTURE; CONGESTIVE-HEART-FAILURE; MATRIX METALLOPROTEINASES; ANGIOTENSIN-II; NADPH OXIDASE; ACTIVATION; INHIBITION	Excessive activation of the beta-adrenergic, angiotensin II (Ang II) and aldosterone signaling pathways promotes mortality after myocardial infarction, and antagonists targeting these pathways are core therapies for treating this condition. Catecholamines and Ang II activate the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII), the inhibition of which prevents isoproterenol-mediated and Ang II-mediated cardiomyopathy. Here we show that aldosterone exerts direct toxic actions on myocardium by oxidative activation of CaMKII, causing cardiac rupture and increased mortality in mice after myocardial infarction. Aldosterone induces CaMKII oxidation by recruiting NADPH oxidase, and this oxidized and activated CaMKII promotes matrix metalloproteinase 9 (MMP9) expression in cardiomyocytes. Myocardial CaMKII inhibition, overexpression of methionine sulfoxide reductase A (an enzyme that reduces oxidized CaMKII) or NADPH oxidase deficiency prevented aldosterone-enhanced cardiac rupture after myocardial infarction. These findings show that oxidized myocardial CaMKII mediates the cardiotoxic effects of aldosterone on the cardiac matrix and establish CaMKII as a nodal signal for the neurohumoral pathways associated with poor outcomes after myocardial infarction.	[He, B. Julie; Anderson, Mark E.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [He, B. Julie; Joiner, Mei-ling A.; Singh, Madhu V.; Luczak, Elizabeth D.; Swaminathan, Paari Dominic; Koval, Olha M.; Kutschke, William; Yang, Jinying; Guan, Xiaoqun; Grumbach, Isabella M.; Weiss, Robert M.; Anderson, Mark E.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Allamargot, Chantal] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA USA; [Zimmerman, Kathy; Weiss, Robert M.] Univ Iowa, Dept Vet Affairs Med Ctr, Carver Coll Med, Iowa City, IA USA; [Spitz, Douglas R.] Univ Iowa, Free Rad & Radiat Biol Program, Dept Radiat Oncol, Carver Coll Med, Iowa City, IA USA; [Sigmund, Curt D.] Univ Iowa, Dept Pharmacol, Caver Coll Med, Iowa City, IA 52242 USA; [Blankesteijn, W. Matthijs] Maastricht Univ, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [Heymans, Stephane] Maastricht Univ, Ctr Heart Failure Res, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Heymans, Stephane] ICIN Netherlands Heart Inst, Utrecht, Netherlands; [Heymans, Stephane] Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium; [Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Med Ctr, Columbus, OH 43210 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; Maastricht University; Maastricht University; KU Leuven; University System of Ohio; Ohio State University	Anderson, ME (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA.	mark-e-anderson@uiowa.edu	Singh, Madhu V./AAJ-8507-2020; Swaminathan, Paari Dominic/AAN-5265-2021; Sigmund, Curt D./W-1611-2019	Singh, Madhu V./0000-0003-3048-4432; Swaminathan, Paari Dominic/0000-0002-7843-375X; Sigmund, Curt D./0000-0002-1453-0921; Heymans, Stephane/0000-0001-9477-7803; Spitz, Douglas/0000-0002-1254-8765; Weiss, Robert/0000-0003-1307-2647; Koval, Olha/0000-0003-1644-0046; Grumbach, Isabella/0000-0002-2285-3157; Joiner, Mei-ling/0000-0002-7775-7349	US National Institutes of Health [1F30HL-095325, RR-017369, P30 CA086862, R01CA133114, R01HL083422, R01HL70250, R01HL079031, R01HL096652]; Fondation Leducq [08CVD01]; Netherlands Organization for Scientific Research [91796338]; Netherlands Heart Foundation (NHS) [2007B036, 2008B011]; Research Foundation-Flanders (FWO) [1183211N, 1167610N, G074009N]; European Union; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA133114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR017369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061446, T32HL007121, R01HL079031, R01HL083422, F30HL095325, R01HL070250, R01HL096652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337, T32GM067795] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation (NHS)(Netherlands Heart Foundation); Research Foundation-Flanders (FWO)(FWO); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for discussions with K. Campbell, W. Nauseef and F. Abboud (University of Iowa). We acknowledge the technical contributions of D. Farley and M. Scheel (University of Iowa). We thank N. Sinclair, P. Yarolem and J. Schwarting (University of Iowa) for their technical expertise in generating transgenic mice. J. Robbins (University of Cincinnati) provided the alpha MHC complementary DNA (cDNA) for creating the transgenic mice. E. Olson (University of Texas Southwestern) provided mice harboring the MEF2-lacZ reporter gene. MsrA<SUP>-/-</SUP> mice were provided by the late E. Stadtman of the US National Institutes of Health. Transgenic mice were engineered at the University of Iowa Transgenic Animal Facility, and viral constructs were generated at the University of Iowa Gene Vector Transfer Core, which are both funded by the US National Institutes of Health. We acknowledge support by the US National Institutes of Health (1F30HL-095325 to B.J.H., RR-017369 to R.M.W., P30 CA086862 and R01CA133114 to D.R.S., R01HL083422 to P.J.M., and R01HL70250, R01HL079031 and R01HL096652 to M.E.A.) and by a grant (08CVD01) from the Fondation Leducq as part of the 'Alliance for CaMKII Signaling in Heart'. S.H. received a Vidi grant from the Netherlands Organization for Scientific Research (91796338) and research grants from the Netherlands Heart Foundation (NHS 2007B036 and 2008B011), Research Foundation-Flanders (FWO 1183211N, 1167610N, G074009N), European Union, FP7-HEALTH-2010, MEDIA, Large scale integrating project.	AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Beygui F, 2006, CIRCULATION, V114, P2604, DOI 10.1161/CIRCULATIONAHA.106.634626; Beygui F, 2010, AM HEART J, V160, P642, DOI 10.1016/j.ahj.2010.06.049; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Christensen MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000583; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Doerries C, 2007, CIRC RES, V100, P894, DOI 10.1161/01.RES.0000261657.76299.ff; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fonarow GC, 2007, AM HEART J, V154, P637, DOI 10.1016/j.ahj.2007.06.002; GUTIERREZMARCOS FM, 1991, EUR HEART J, V12, P503, DOI 10.1093/oxfordjournals.eurheartj.a059930; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Iwashima F, 2008, ENDOCRINOLOGY, V149, P1009, DOI 10.1210/en.2007-0864; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kinugawa S, 2000, CIRC RES, V87, P392; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; KUSCH M, 1978, AM J PHYSIOL, V235, pC82, DOI 10.1152/ajpcell.1978.235.3.C82; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Munaut C, 1999, J BIOL CHEM, V274, P5588, DOI 10.1074/jbc.274.9.5588; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; Nakamura S, 2004, CIRCULATION, V110, P1787, DOI 10.1161/01.CIR.0000143072.36782.51; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Owusu-Ansah E., 2008, RES SQ; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pouleur AC, 2010, CIRCULATION, V122, P597, DOI 10.1161/CIRCULATIONAHA.110.940619; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Rousseau MF, 2002, J AM COLL CARDIOL, V40, P1596, DOI 10.1016/S0735-1097(02)02382-3; Rude MK, 2005, HYPERTENSION, V46, P555, DOI 10.1161/01.HYP.0000176236.55322.18; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; Thiel WH, 2008, CIRCULATION, V118, P2225, DOI 10.1161/CIRCULATIONAHA.108.788067; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Tomaselli GF, 2010, NAT MED, V16, P648, DOI 10.1038/nm0610-648; van den Bome SWM, 2009, CARDIOVASC PATHOL, V18, P37, DOI 10.1016/j.carpath.2007.12.012; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Wehrens XHT, 2004, INT J CARDIOL, V95, P285, DOI 10.1016/j.ijcard.2003.06.006; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zimmerman MC, 2004, CIRC RES, V95, P532, DOI 10.1161/01.RES.0000139957.22530.b9	60	173	183	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1610	U125		10.1038/nm.2506	http://dx.doi.org/10.1038/nm.2506			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081025	Green Accepted, Green Published			2022-12-25	WOS:000297978000032
J	Liu, Y; Wang, L; Kikuiri, T; Akiyama, K; Chen, CD; Xu, XT; Yang, RL; Chen, WJ; Wang, SL; Shi, ST				Liu, Yi; Wang, Lei; Kikuiri, Takashi; Akiyama, Kentaro; Chen, Chider; Xu, Xingtian; Yang, Ruili; Chen, WanJun; Wang, Songlin; Shi, Songtao			Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha	NATURE MEDICINE			English	Article							NF-KAPPA-B; STROMAL CELLS; BONE-FORMATION; OSTEOGENESIS; INDUCTION; APOPTOSIS; INHIBIT; ASPIRIN; MOUSE	Stem cell-based regenerative medicine is a promising approach in tissue reconstruction. Here we show that proinflammatory T cells inhibit the ability of exogenously added bone marrow mesenchymal stem cells (BMMSCs) to mediate bone repair. This inhibition is due to interferon gamma (IFN-gamma)-induced downregulation of the runt-related transcription factor 2 (Runx-2) pathway and enhancement of tumor necrosis factor alpha (TNF-alpha) signaling in the stem cells. We also found that, through inhibition of nuclear factor kappa B (NF-kappa B), TNF-alpha converts the signaling of the IFN-gamma-activated, nonapoptotic form of TNF receptor superfamily member 6 (Fas) in BMMSCs to a caspase 3- and caspase 8-associated proapoptotic cascade, resulting in the apoptosis of these cells. Conversely, reduction of IFN-gamma and TNF-alpha concentrations by systemic infusion of Foxp3(+) regulatory T cells, or by local administration of aspirin, markedly improved BMMSC-based bone regeneration and calvarial defect repair in C57BL/6 mice. These data collectively show a previously unrecognized role of recipient T cells in BMMSC-based tissue engineering.	[Liu, Yi; Wang, Lei; Kikuiri, Takashi; Akiyama, Kentaro; Chen, Chider; Xu, Xingtian; Yang, Ruili; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Liu, Yi; Wang, Songlin] Capital Med Univ, Mol Lab Gene Therapy & Tooth Regenerat, Sch Stomatol, Beijing, Peoples R China; [Wang, Lei] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China; [Xu, Xingtian] Tongji Univ, Key Lab Translat Res, Sch Stomatol, Shanghai 200092, Peoples R China; [Chen, WanJun] Natl Inst Dent & Craniofacial Res, US Natl Inst Hlth, Bethesda, MD USA	University of Southern California; Capital Medical University; Air Force Military Medical University; Tongji University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Shi, ST (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	songtaos@usc.edu	XU, XINGTIAN/E-4518-2014; Chen, Chider/L-9880-2016	Chen, Chider/0000-0003-2899-1208	US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services [R01DE017449, R01DE019932, R01DE019413]; California Institute for Regenerative Medicine [RN1-00572]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449, ZIADE000101, R01DE019932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE019413] Funding Source: NIH RePORTER	US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank X. Duan and T. Zhou of the Fourth Military Medical University for generating microCT images. This work was supported by grants from the US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services (R01DE017449, R01DE019932 and R01DE019413 to S.S.), a grant from California Institute for Regenerative Medicine (RN1-00572 to S.S.) and the Intramural Program of the US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services.	Ahuja SS, 2003, ENDOCRINOLOGY, V144, P1761, DOI 10.1210/en.2002-221136; Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Buckland M, 2006, AM J TRANSPLANT, V6, P2046, DOI 10.1111/j.1600-6143.2006.01450.x; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fredericks DC, 2004, ORTHOPEDICS, V27, pS167; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Kogianni G, 2004, LIFE SCI, V75, P2879, DOI 10.1016/j.lfs.2004.04.048; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Kwon MS, 2005, PHARMACOLOGY, V74, P152, DOI 10.1159/000084548; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Li ZX, 2011, INT IMMUNOPHARMACOL, V11, P496, DOI 10.1016/j.intimp.2011.01.001; Lourenco EV, 2011, AUTOIMMUNITY, V44, P33, DOI 10.3109/08916931003782155; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; OWEN M, 1988, CIBA F SYMP, V136, P42; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qin JZ, 1999, J BIOL CHEM, V274, P37957, DOI 10.1074/jbc.274.53.37957; Schrum LW, 2003, INFECT IMMUN, V71, P1209, DOI 10.1128/IAI.71.3.1209-1216.2003; Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Tasso R, 2010, BIOMATERIALS, V31, P2121, DOI 10.1016/j.biomaterials.2009.11.064; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5; Ura K, 2000, ENDOCR J, V47, P293, DOI 10.1507/endocrj.47.293; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhou XH, 2011, AUTOIMMUNITY, V44, P43, DOI 10.3109/08916931003782163	40	474	499	5	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1594	U106		10.1038/nm.2542	http://dx.doi.org/10.1038/nm.2542			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101767	Green Accepted			2022-12-25	WOS:000297978000030
J	Takahashi, Y; Kou, I; Takahashi, A; Johnson, TA; Kono, K; Kawakami, N; Uno, K; Ito, M; Minami, S; Yanagida, H; Taneichi, H; Tsuji, T; Suzuki, T; Sudo, H; Kotani, T; Watanabe, K; Chiba, K; Hosono, N; Kamatani, N; Tsunoda, T; Toyama, Y; Kubo, M; Matsumoto, M; Ikegawa, S				Takahashi, Yohei; Kou, Ikuyo; Takahashi, Atsushi; Johnson, Todd A.; Kono, Katsuki; Kawakami, Noriaki; Uno, Koki; Ito, Manabu; Minami, Shohei; Yanagida, Haruhisa; Taneichi, Hiroshi; Tsuji, Taichi; Suzuki, Teppei; Sudo, Hideki; Kotani, Toshiaki; Watanabe, Kota; Chiba, Kazuhiro; Hosono, Naoya; Kamatani, Naoyuki; Tsunoda, Tatsuhiko; Toyama, Yoshiaki; Kubo, Michiaki; Matsumoto, Morio; Ikegawa, Shiro			A genome-wide association study identifies common variants near LBX1 associated with adolescent idiopathic scoliosis	NATURE GENETICS			English	Article							DORSAL SPINAL-CORD; TRANSMITTER PHENOTYPES; GENE POLYMORPHISMS; SUSCEPTIBILITY; NEURONS; CHINESE	Adolescent idiopathic scoliosis is a pediatric spinal deformity affecting 2-3% of school-age children worldwide(1). Genetic factors have been implicated in its etiology(2). Through a genome-wide association study (GWAS) and replication study involving a total of 1,376 Japanese females with adolescent idiopathic scoliosis and 11,297 female controls, we identified a locus at chromosome 10q24.31 associated with adolescent idiopathic scoliosis susceptibility. The most significant SNP (rs11190870; combined P = 1.24 x 10(-19); odds ratio (OR) = 1.56) is located near LBX1 (encoding ladybird homeobox 1). The identification of this susceptibility locus provides new insights into the pathogenesis of adolescent idiopathic scoliosis.	[Takahashi, Yohei; Kou, Ikuyo; Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Tokyo, Japan; [Takahashi, Yohei; Watanabe, Kota; Chiba, Kazuhiro; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Johnson, Todd A.; Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Kono, Katsuki] Saiseikai Cent Hosp, Scoliosis Ctr, Tokyo, Japan; [Kawakami, Noriaki; Tsuji, Taichi] Meijo Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Uno, Koki; Suzuki, Teppei] Kobe Med Ctr, Dept Orthopaed Surg, Natl Hosp Org, Kobe, Hyogo, Japan; [Ito, Manabu; Sudo, Hideki] Hokkaido Univ, Dept Adv Med Spine & Spinal Cord Disorders, Grad Sch Med, Sapporo, Hokkaido, Japan; [Minami, Shohei; Kotani, Toshiaki] Seirei Sakura Citizen Hosp, Dept Orthopaed Surg, Sakura, Japan; [Yanagida, Haruhisa] Fukuoka Childrens Hosp, Dept Orthopaed Surg, Fukuoka, Japan; [Taneichi, Hiroshi] Dokkyo Med Univ, Dept Orthopaed Surg, Sch Med, Mibu, Tochigi, Japan; [Hosono, Naoya; Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Genom Med, Yokohama, Kanagawa, Japan	RIKEN; Keio University; RIKEN; RIKEN; Tokyo Saiseikai Central Hospital; Kobe City Medical Center General Hospital; Hokkaido University; Dokkyo Medical University; RIKEN	Ikegawa, S (corresponding author), RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014; Johnson, Todd/Q-9944-2019; Ikegawa, Shiro/N-6895-2015; Matsumoto, Morio M/L-6227-2013; Johnson, Todd Andrew/ABG-4704-2021; Sudo, Hideki/G-2748-2012; Toyama, Yoshiaki/K-5743-2013	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Johnson, Todd/0000-0003-3377-6692; Ikegawa, Shiro/0000-0003-0316-2147; Johnson, Todd Andrew/0000-0003-3377-6692; 	Japanese Orthopaedic Association (JOA) [2009-1]; BioBank Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japanese Orthopaedic Association (JOA); BioBank Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the individuals who participated in this study. We thank N. Suzuki, M. Saito, M. Kamata, N. Hosogane, E. Okada, H. Hase, I. Karasugi, M. Nakajima and A. Miyake for their help in collecting samples and conducting the experimental study and T. Isono for technical assistance. This work was supported by a grant-in-aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2009-1) and by BioBank Japan.	Cha PC, 2011, NAT GENET, V43, P447, DOI 10.1038/ng.805; Chen ZJ, 2009, EUR J HUM GENET, V17, P525, DOI 10.1038/ejhg.2008.203; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Guo X, 2006, SPINE, V31, pE437, DOI 10.1097/01.brs.0000222048.47010.bf; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Inoue Masatoshi, 2002, Stud Health Technol Inform, V91, P90; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Langerak NG, 2011, J REHABIL MED, V43, P330, DOI 10.2340/16501977-0669; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OHTSUKA Y, 1988, SPINE, V13, P1251, DOI 10.1097/00007632-198811000-00008; PINCOTT JR, 1982, J BONE JOINT SURG BR, V64, P503; Qiu XS, 2007, SPINE, V32, P1748, DOI 10.1097/BRS.0b013e3180b9f0ff; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006; Schafer K, 2003, CIRC RES, V92, P73, DOI 10.1161/01.RES.0000050587.76563.A5; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; Takahashi Y, 2011, J ORTHOP RES, V29, P1055, DOI 10.1002/jor.21347; Takahashi Y, 2011, J ORTHOP RES, V29, P834, DOI 10.1002/jor.21322; Ueno M, 2011, J ORTHOP SCI, V16, P1, DOI 10.1007/s00776-010-0009-z; Wang H, 2008, SPINE, V33, P2199, DOI 10.1097/BRS.0b013e31817c03f9; Ward K, 2010, SPINE, V35, pE1455, DOI 10.1097/BRS.0b013e3181ed2de1; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Wise CA, 2008, CURR GENOMICS, V9, P51, DOI 10.2174/138920208783884874; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f; Yeung HY, 2006, STUD HEALTH TECHNOL, V123, P18; Zhang HQ, 2009, SPINE, V34, P760, DOI 10.1097/BRS.0b013e31818ad5ac	31	160	165	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1237	U96		10.1038/ng.974	http://dx.doi.org/10.1038/ng.974			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019779				2022-12-25	WOS:000297931400019
J	Wang, Q; Rozelle, AL; Lepus, CM; Scanzello, CR; Song, JJ; Larsen, DM; Crish, JF; Bebek, G; Ritter, SY; Lindstrom, TM; Hwang, IY; Wong, HDH; Punzi, L; Encarnacion, A; Shamloo, M; Goodman, SB; Wyss-Coray, T; Goldring, SR; Banda, NK; Thurman, JM; Gobezie, R; Crow, MK; Holers, VM; Lee, DM; Robinson, WH				Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Scanzello, Carla R.; Song, Jason J.; Larsen, D. Meegan; Crish, James F.; Bebek, Gurkan; Ritter, Susan Y.; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Punzi, Leonardo; Encarnacion, Angelo; Shamloo, Mehrdad; Goodman, Stuart B.; Wyss-Coray, Tony; Goldring, Steven R.; Banda, Nirmal K.; Thurman, Joshua M.; Gobezie, Reuben; Crow, Mary K.; Holers, V. Michael; Lee, David M.; Robinson, William H.			Identification of a central role for complement in osteoarthritis	NATURE MEDICINE			English	Article							OLIGOMERIC MATRIX PROTEIN; RHEUMATOID-ARTHRITIS; CARTILAGE DEGRADATION; KNEE OSTEOARTHRITIS; SYNOVIAL-FLUID; IN-VIVO; ACTIVATION; EXPRESSION; GENERATION; INDUCTION	Osteoarthritis, characterized by the breakdown of articular cartilage in synovial joints, has long been viewed as the result of 'wear and tear'(1). Although low-grade inflammation is detected in osteoarthritis, its role is unclear(2-4). Here we identify a central role for the inflammatory complement system in the pathogenesis of osteoarthritis. Through proteomic and transcriptomic analyses of synovial fluids and membranes from individuals with osteoarthritis, we find that expression and activation of complement is abnormally high in human osteoarthritic joints. Using mice genetically deficient in complement component 5 (C5), C6 or the complement regulatory protein CD59a, we show that complement, specifically, the membrane attack complex (MAC)-mediated arm of complement, is crucial to the development of arthritis in three different mouse models of osteoarthritis. Pharmacological modulation of complement in wild-type mice confirmed the results obtained with genetically deficient mice. Expression of inflammatory and degradative molecules was lower in chondrocytes from destabilized joints from C5-deficient mice than C5-sufficient mice, and MAC induced production of these molecules in cultured chondrocytes. Further, MAC colocalized with matrix metalloprotease 13 (MMP13) and with activated extracellular signal-regulated kinase (ERK) around chondrocytes in human osteoarthritic cartilage. Our findings indicate that dysregulation of complement in synovial joints has a key role in the pathogenesis of osteoarthritis.	[Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Song, Jason J.; Larsen, D. Meegan; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Wyss-Coray, Tony; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ Ctr, Palo Alto, CA USA; [Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Song, Jason J.; Larsen, D. Meegan; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Wyss-Coray, Tony; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Clin, Palo Alto, CA USA; [Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Song, Jason J.; Larsen, D. Meegan; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Scanzello, Carla R.] Rush Univ, Med Ctr, Rheumatol Sect, Chicago, IL 60612 USA; [Crish, James F.; Bebek, Gurkan] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH USA; [Bebek, Gurkan] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Ritter, Susan Y.; Lee, David M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Ritter, Susan Y.; Lee, David M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Punzi, Leonardo] Univ Padua, Rheumatol Unit, Dept Clin & Expt Med, Padua, Italy; [Encarnacion, Angelo; Shamloo, Mehrdad] Stanford Univ, Behav & Funct Neurosci Lab, Sch Med, Stanford, CA 94305 USA; [Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Goldring, Steven R.; Crow, Mary K.] Hosp Special Surg, Dept Rheumatol, New York, NY 10021 USA; [Banda, Nirmal K.; Thurman, Joshua M.; Holers, V. Michael] Univ Colorado, Dept Immunol, Hlth Sci Ctr, Aurora, CO USA; [Banda, Nirmal K.; Thurman, Joshua M.; Holers, V. Michael] Univ Colorado, Dept Med, Hlth Sci Ctr, Aurora, CO USA; [Gobezie, Reuben] Case Western Reserve Univ, Dept Orthopaed Surg, Sch Med, Cleveland, OH 44106 USA; [Lee, David M.] Novartis Pharma AG, Novartis Inst Biomed Res, Basel, Switzerland	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Rush University; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Padua; Stanford University; Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Case Western Reserve University; Novartis	Robinson, WH (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ Ctr, Palo Alto, CA USA.	wrobins@stanford.edu	Scanzello, Carla R/AAE-4348-2019; Wyss-Coray, Tony/AAF-3380-2019; Crow, Mary/R-8480-2019; Goodman, Stuart/AAZ-7499-2020	Scanzello, Carla R/0000-0002-9290-188X; Wyss-Coray, Tony/0000-0001-5893-0831; PUNZI, LEONARDO/0000-0002-8853-516X; Goodman, Stuart/0000-0002-1919-3717; Robinson, William/0000-0003-4385-704X; Thurman, Joshua Michael/0000-0002-3476-9956	Department of Veterans Affairs; US National Heart, Lung, and Blood Institute Proteomics Center [N01 HV 28183]; Northern California Chapter Arthritis Foundation; New York Chapter Arthritis Foundation/Merck; Atlantic Philanthropies; American College of Rheumatology Research; Association of Specialty Professors; US National Institute of Arthritis, Musculoskeletal and Skin Diseases [K08 AR057859]; US National Institute of Neurological Disorders and Stroke [NS069375]; US National Institutes of Health [T32 AR007530]; National Institutes of Health [R01 AR051749]; Frankenthaler Foundation; Kohlberg Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051749, T32AR007530, K08AR057859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); US National Heart, Lung, and Blood Institute Proteomics Center; Northern California Chapter Arthritis Foundation; New York Chapter Arthritis Foundation/Merck(Merck & Company); Atlantic Philanthropies; American College of Rheumatology Research; Association of Specialty Professors; US National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frankenthaler Foundation; Kohlberg Foundation; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by a Rehabilitation Research and Development Merit Award from the Department of Veterans Affairs and the US National Heart, Lung, and Blood Institute Proteomics Center contract N01 HV 28183 (W.H.R.); a Northern California Chapter Arthritis Foundation Postdoctoral Fellowship Award (A.L.R.); a New York Chapter Arthritis Foundation/Merck Osteoarthritis Research Fellowship Award, the Atlantic Philanthropies, the American College of Rheumatology Research and the Education Fund, the Association of Specialty Professors and the US National Institute of Arthritis, Musculoskeletal and Skin Diseases Mentored Clinical Scientist Research Career Development Award K08 AR057859 (C.R.S.); US National Institute of Neurological Disorders and Stroke P30 Center Core grant NS069375 (M.S.); US National Institutes of Health training grant T32 AR007530 (S.Y.R.); National Institutes of Health R01 AR051749 (V.M.H.); and the Frankenthaler and Kohlberg Foundations (M.K.C.).	Attur M, 2008, J IMMUNOL, V181, P5082, DOI 10.4049/jimmunol.181.7.5082; Badea TD, 2003, J NEUROIMMUNOL, V142, P58, DOI 10.1016/S0165-5728(03)00261-3; Banda NK, 2009, J IMMUNOL, V183, P5928, DOI 10.4049/jimmunol.0901826; Banda NK, 2002, ARTHRITIS RHEUM-US, V46, P3065, DOI 10.1002/art.10591; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Chen YW, 2007, EUR J IMMUNOL, V37, P167, DOI 10.1002/eji.200636285; COOKE TDV, 1987, J RHEUMATOL, V14, P77; COOKE TDV, 1980, INT ORTHOP, V4, P211, DOI 10.1007/BF00268158; CORVETTA A, 1992, CLIN EXP RHEUMATOL, V10, P433; Daiger SP, 2005, SCIENCE, V308, P362, DOI 10.1126/science.1111655; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; FREI Y, 1987, MOL CELL PROBE, V1, P141, DOI 10.1016/0890-8508(87)90022-3; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Glasson SS, 2007, CURR DRUG TARGETS, V8, P367, DOI 10.2174/138945007779940061; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gobezie R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2172; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Hill CL, 2007, ANN RHEUM DIS, V66, P1599, DOI 10.1136/ard.2006.067470; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kraus S, 2001, CLIN EXP IMMUNOL, V123, P366, DOI 10.1046/j.1365-2249.2001.01477.x; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; OOI YM, 1979, NATURE, V282, P207, DOI 10.1038/282207a0; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rus HG, 1996, J IMMUNOL, V156, P4892; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Scanzello CR, 2011, ARTHRITIS RHEUM-US, V63, P391, DOI 10.1002/art.30137; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sofat N, 2009, INT J EXP PATHOL, V90, P463, DOI 10.1111/j.1365-2613.2009.00676.x; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	40	378	399	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1674	U196		10.1038/nm.2543	http://dx.doi.org/10.1038/nm.2543			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057346	Green Accepted			2022-12-25	WOS:000297978000042
J	Botte, CY; Deligny, M; Roccia, A; Bonneau, AL; Saidani, N; Hardre, H; Aci, S; Yamaryo-Botte, Y; Jouhet, J; Dubots, E; Loizeau, K; Bastien, O; Brehelin, L; Joyard, J; Cintrat, JC; Falconet, D; Block, MA; Rousseau, B; Lopez, R; Marechal, E				Botte, Cyrille Y.; Deligny, Michael; Roccia, Aymeric; Bonneau, Anne-Laure; Saidani, Nadia; Hardre, Helene; Aci, Samia; Yamaryo-Botte, Yoshiki; Jouhet, Juliette; Dubots, Emmanuelle; Loizeau, Karen; Bastien, Olivier; Brehelin, Laurent; Joyard, Jacques; Cintrat, Jean-Christophe; Falconet, Denis; Block, Maryse A.; Rousseau, Bernard; Lopez, Roman; Marechal, Eric			Chemical inhibitors of monogalactosyldiacylglycerol synthases in Arabidopsis thaliana	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHATE DEPRIVATION; PLANT-CELLS; PHOSPHOLIPASES D-ZETA-1; SPINACH-CHLOROPLASTS; OUTER ENVELOPE; BIOSYNTHESIS; STARVATION; MEMBRANE; GALACTOLIPIDS; PROTEIN	Monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG) are the main lipids in photosynthetic membranes in plant cells. They are synthesized in the envelope surrounding plastids by MGD and DGD galactosyltransferases. These galacto-lipids are critical for the biogenesis of photosynthetic membranes, and they act as a source of polyunsaturated fatty acids for the whole cell and as phospholipid surrogates in phosphate shortage. Based on a high-throughput chemical screen, we have characterized a new compound, galvestine-1, that inhibits MGDs in vitro by competing with diacylglycerol binding. Consistent effects of galvestine-1 on Arabidopsis thaliana include root uptake, circulation in the xylem and mesophyll, inhibition of MGDs in vivo causing a reduction of MGDG content and impairment of chloroplast development. The effects on pollen germination shed light on the contribution of galactolipids to pollen-tube elongation. The whole-genome transcriptional response of Arabidopsis points to the potential benefits of galvestine-1 as a unique tool to study lipid homeostasis in plants.	[Botte, Cyrille Y.; Roccia, Aymeric; Saidani, Nadia; Hardre, Helene; Yamaryo-Botte, Yoshiki; Jouhet, Juliette; Dubots, Emmanuelle; Loizeau, Karen; Bastien, Olivier; Joyard, Jacques; Falconet, Denis; Block, Maryse A.; Marechal, Eric] Univ Grenoble 1, CNRS, CEA, Inst Rech Technol & Sci Vivant,INRA,UMR 5168, Grenoble, France; [Botte, Cyrille Y.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Botte, Cyrille Y.] Univ Grenoble 1, CNRS, Inst Jean Roget, UMR 5163, Grenoble, France; [Deligny, Michael; Bonneau, Anne-Laure; Cintrat, Jean-Christophe; Rousseau, Bernard; Lopez, Roman] CEA, Inst Biol & Technol Saclay, Chim Bioorgan Lab, Gif Sur Yvette, France; [Saidani, Nadia] Univ Montpellier 2, CNRS, UMR 5235, Montpellier, France; [Aci, Samia] CNRS, Ctr Biophys Mol, Orleans, France; [Brehelin, Laurent] Univ Montpellier 2, CNRS, Lab Informat Robot & Microelect Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Marechal, E (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Rech Technol & Sci Vivant,INRA,UMR 5168, Grenoble, France.	eric.marechal@cea.fr	Botte, Cyrille/G-1972-2014; Bastien, Olivier/B-9723-2008; Bastien, Olivier/J-3827-2014	Botte, Cyrille/0000-0002-2245-536X; Cintrat, Jean-Christophe/0000-0001-5758-8077; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411	Agence Nationale de la Recherche, France [ANR-05-EMPB-017-01, ANR-06-MDCA-014, ANR-10-BLAN-1524-01, ANR-2010-JCJC-1606-01]; European Commission	Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank C. Albrieux, L. Caillot, C. Cataye, G. Merer, J. Revol and A. Zoppe for technical assistance and L. Lafanechere, P. Legrain and C. Vincent for helpful discussions. This work was supported by ANR-05-EMPB-017-01, ANR-06-MDCA-014, ANR-10-BLAN-1524-01 and ANR-2010-JCJC-1606-01 grants from the Agence Nationale de la Recherche, France. C.Y.B. was supported by a Marie Curie International Outgoing Fellowship action from the European Commission.	ANDERSSON L, 1995, J LIPID RES, V36, P1392; Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Aronsson H, 2008, PLANT PHYSIOL, V148, P580, DOI 10.1104/pp.108.123372; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Chen LJ, 1998, PLANT J, V16, P33, DOI 10.1046/j.1365-313x.1998.00270.x; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; DOUCE R, 1974, SCIENCE, V183, P852, DOI 10.1126/science.183.4127.852; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Gaude N, 2008, PLANT J, V56, P28, DOI 10.1111/j.1365-313X.2008.03582.x; GOUNARIS K, 1983, TRENDS BIOCHEM SCI, V8, P378, DOI 10.1016/0968-0004(83)90366-3; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; HEEMSKERK JWM, 1986, BIOCHIM BIOPHYS ACTA, V877, P281, DOI 10.1016/0005-2760(86)90305-X; Hicks GR, 2009, NAT CHEM BIOL, V5, P268, DOI 10.1038/nchembio0509-268; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Joyard J, 1998, PLANT PHYSIOL, V118, P715, DOI 10.1104/pp.118.3.715; Kobayashi K, 2004, PLANT PHYSIOL, V134, P640, DOI 10.1104/pp.103.032656; Kobayashi K, 2009, PLANT J, V57, P322, DOI 10.1111/j.1365-313X.2008.03692.x; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Kobayashi K, 2009, PLANT PHYSIOL BIOCH, V47, P518, DOI 10.1016/j.plaphy.2008.12.012; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; Nakamura Y, 2007, J BIOL CHEM, V282, P29013, DOI 10.1074/jbc.M704385200; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Nakamura Y, 2009, PLANT PHYSIOL BIOCH, V47, P535, DOI 10.1016/j.plaphy.2008.12.018; Nishiyama Y, 2003, PROTEIN EXPRES PURIF, V31, P79, DOI 10.1016/S1046-5928(03)00158-X; Padham AK, 2007, PLANT PHYSIOL, V143, P1372, DOI 10.1104/pp.106.090811; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tjellstrom H, 2008, PLANT CELL ENVIRON, V31, P1388, DOI 10.1111/j.1365-3040.2008.01851.x; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2006, PLANT J, V47, P296, DOI 10.1111/j.1365-313X.2006.02790.x; Youssef A, 2010, PLANT J, V61, P436, DOI 10.1111/j.1365-313X.2009.04067.x	50	57	57	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					834	842		10.1038/nchembio.658	http://dx.doi.org/10.1038/nchembio.658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946275				2022-12-25	WOS:000296381600014
J	Park, JW; Park, SR; Nepal, KK; Han, AR; Ban, YH; Yoo, YJ; Kim, EJ; Kim, EM; Kim, D; Sohng, JK; Yoon, YJ				Park, Je Won; Park, Sung Ryeol; Nepal, Keshav Kumar; Han, Ah Reum; Ban, Yeon Hee; Yoo, Young Ji; Kim, Eun Ji; Kim, Eui Min; Kim, Dooil; Sohng, Jae Kyung; Yoon, Yeo Joon			Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-FRADIAE NCIMB-8233; GENE-CLUSTER; AMINOGLYCOSIDE ANTIBIOTICS; HETEROLOGOUS EXPRESSION; NEOMYCIN; BUTIROSIN; GENTAMICIN; 2-DEOXYSTREPTAMINE; KANAMYCETICUS; DERIVATIVES	Kanamycin is one of the most widely used antibiotics, yet its biosynthetic pathway remains unclear. Current proposals suggest that the kanamycin biosynthetic products are linearly related via single enzymatic transformations. To explore this system, we have reconstructed the entire biosynthetic pathway through the heterologous expression of combinations of putative biosynthetic genes from Streptomyces kanamyceticus in the non-aminoglycoside-producing Streptomyces venezuelae. Unexpectedly, we discovered that the biosynthetic pathway contains an early branch point, governed by the substrate promiscuity of a glycosyltransferase, that leads to the formation of two parallel pathways in which early intermediates are further modified. Glycosyltransferase exchange can alter flux through these two parallel pathways, and the addition of other biosynthetic enzymes can be used to synthesize known and new highly active antibiotics. These results complete our understanding of kanamycin biosynthesis and demonstrate the potential of pathway engineering for direct in vivo production of clinically useful antibiotics and more robust aminoglycosides.	[Park, Je Won; Nepal, Keshav Kumar; Kim, Eui Min; Sohng, Jae Kyung] Sun Moon Univ, Dept Pharmaceut Engn, Inst Biomol Reconstruct, Chungnam, South Korea; [Park, Je Won; Park, Sung Ryeol; Ban, Yeon Hee; Yoo, Young Ji; Kim, Eun Ji; Yoon, Yeo Joon] Ewha Womans Univ, Dept Chem & Nanosci, Seoul, South Korea; [Han, Ah Reum] Seoul Natl Univ, Interdisciplinary Program Biochem Engn & Biotechn, Seoul, South Korea; [Kim, Dooil] Korea Res Inst Biosci & Biotechnol, Syst Microbiol Res Ctr, Taejon, South Korea	Sun Moon University; Ewha Womans University; Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Sohng, JK (corresponding author), Sun Moon Univ, Dept Pharmaceut Engn, Inst Biomol Reconstruct, Chungnam, South Korea.	sohng@sunmoon.ac.kr; joonyoon@ewha.ac.kr		Park, Je Won/0000-0001-9460-2296; Nepal, Keshav/0000-0002-8991-716X	National Research Laboratory (NRL) [R0A-2008-000-20030-0]; National Research Foundation of Korea (NRF) [2010-0001487, 2010-0028193]; Ministry of Education, Science Technology; Ministry of Land, Transportation and Maritime Affairs, Republic of Korea; Ministry for Food, Agriculture and Fisheries, Republic of Korea [20100623]	National Research Laboratory (NRL)(Korea Science and Engineering Foundation); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Land, Transportation and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Ministry for Food, Agriculture and Fisheries, Republic of Korea	We thank E. Cundliffe for discussions and for critically reading this manuscript. This work was supported by the National Research Laboratory (NRL) program (R0A-2008-000-20030-0) and Global Frontier Program for Intelligent Synthetic Biology through the National Research Foundation of Korea (NRF), NRF grants (2010-0001487 and 2010-0028193) funded by the Ministry of Education, Science & Technology and the Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea. J.W.P. gratefully acknowledges a grant (20100623) from the Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture and Fisheries, Republic of Korea.	Adams E., 1996, European Journal of Pharmaceutical Sciences, V4, pS110, DOI 10.1016/S0928-0987(97)86331-2; Chang L. T., 1980, DEV IND MICROBIOL, V21, P233; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Fan QZ, 2008, ORG BIOMOL CHEM, V6, P3306, DOI 10.1039/b808734b; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Guo JT, 2002, J AM CHEM SOC, V124, P10642, DOI 10.1021/ja026628m; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; HOWELLS JD, 1972, ANTIMICROB AGENTS CH, V2, P79, DOI 10.1128/AAC.2.2.79; Huang FL, 2007, CHEMBIOCHEM, V8, P283, DOI 10.1002/cbic.200600371; Huang FL, 2005, ORG BIOMOL CHEM, V3, P1410, DOI 10.1039/b501199j; Jnawali HN, 2009, BIOTECHNOL LETT, V31, P869, DOI 10.1007/s10529-009-9937-0; Jones D, 1944, SCIENCE, V100, P103, DOI 10.1126/science.100.2588.103; Kharel MK, 2004, ARCH BIOCHEM BIOPHYS, V429, P204, DOI 10.1016/j.abb.2004.06.009; Kharel MK, 2004, FEMS MICROBIOL LETT, V230, P185, DOI 10.1016/S0378-1097(03)00881-4; KOCH KF, 1978, J ORG CHEM, V43, P1430, DOI 10.1021/jo00401a030; KOJIMA M, 1969, AGR BIOL CHEM TOKYO, V33, P1181, DOI 10.1080/00021369.1969.10859438; KOJIMA M, 1968, AGR BIOL CHEM TOKYO, V32, P467, DOI 10.1080/00021369.1968.10859074; Kondo S., 1999, J Infect Chemother, V5, P1, DOI 10.1007/s101560050001; KONDO S, 1977, J ANTIBIOT, V30, P1150, DOI 10.7164/antibiotics.30.1150; Kudo F, 1999, J ANTIBIOT, V52, P559, DOI 10.7164/antibiotics.52.559; Kudo F, 2005, J ANTIBIOT, V58, P766, DOI 10.1038/ja.2005.104; Kudo F, 2009, J ANTIBIOT, V62, P707, DOI 10.1038/ja.2009.107; Kudo F, 2009, J ANTIBIOT, V62, P471, DOI 10.1038/ja.2009.76; Kudo F, 2009, METHOD ENZYMOL, V459, P493, DOI 10.1016/S0076-6879(09)04620-5; LEMIEUX RU, 1973, CAN J CHEM, V51, P53, DOI 10.1139/v73-008; Llewellyn NM, 2008, CHEM COMMUN, P3786, DOI 10.1039/b802248h; Llewellyn NM, 2006, NAT PROD REP, V23, P864, DOI 10.1039/b604709m; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; NAGABHUSHAN TL, 1982, AMINOGLYCOSIDES MICR, P3; Nepal KK, 2009, MOL CELLS, V27, P601, DOI 10.1007/s10059-009-0080-5; Park JW, 2008, P NATL ACAD SCI USA, V105, P8399, DOI 10.1073/pnas.0803164105; Park JW, 2010, ANAL CHIM ACTA, V661, P76, DOI 10.1016/j.aca.2009.12.014; Piepersberg W., 2007, AMINOGLYCOSIDE ANTIB, P15, DOI DOI 10.1002/9780470149676; Stark W M, 1967, Antimicrob Agents Chemother (Bethesda), V7, P314; Thapa LP, 2007, APPL MICROBIOL BIOT, V76, P1357, DOI 10.1007/s00253-007-1096-4; Thuy ML, 2005, BIOTECHNOL LETT, V27, P465, DOI 10.1007/s10529-005-2222-y; Truman AW, 2007, ANGEW CHEM INT EDIT, V46, P1462, DOI 10.1002/anie.200604194; UMEZAWA H, 1957, J ANTIBIOT, V10, P181; UMEZAWA S, 1971, J ANTIBIOT, V24, P274, DOI 10.7164/antibiotics.24.274; WAKSMAN SA, 1949, SCIENCE, V109, P305, DOI 10.1126/science.109.2830.305; Wehmeier UF, 2009, METHOD ENZYMOL, V459, P459, DOI 10.1016/S0076-6879(09)04619-9; WEINSTEIN MJ, 1963, J MED CHEM, V6, P463, DOI 10.1021/jm00340a034; YAMADA Y, 1968, JPN J MED SCI BIOL, V21, P223; Yokoyama K, 2008, CHEMBIOCHEM, V9, P865, DOI 10.1002/cbic.200700717	44	61	70	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					843	852		10.1038/nchembio.671	http://dx.doi.org/10.1038/nchembio.671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21983602				2022-12-25	WOS:000296381600015
J	Bass, AJ; Lawrence, MS; Brace, LE; Ramos, AH; Drier, Y; Cibulskis, K; Sougnez, C; Voet, D; Saksena, G; Sivachenko, A; Jing, R; Parkin, M; Pugh, T; Verhaak, RG; Stransky, N; Boutin, AT; Barretina, J; Solit, DB; Vakiani, E; Shao, WL; Mishina, Y; Warmuth, M; Jimenez, J; Chiang, DY; Signoretti, S; Kaelin, WG; Spardy, N; Hahn, WC; Hoshida, Y; Ogino, S; DePinho, RA; Chin, L; Garraway, LA; Fuchs, CS; Baselga, J; Tabernero, J; Gabriel, S; Lander, ES; Getz, G; Meyerson, M				Bass, Adam J.; Lawrence, Michael S.; Brace, Lear E.; Ramos, Alex H.; Drier, Yotam; Cibulskis, Kristian; Sougnez, Carrie; Voet, Douglas; Saksena, Gordon; Sivachenko, Andrey; Jing, Rui; Parkin, Melissa; Pugh, Trevor; Verhaak, Roel G.; Stransky, Nicolas; Boutin, Adam T.; Barretina, Jordi; Solit, David B.; Vakiani, Evi; Shao, Wenlin; Mishina, Yuji; Warmuth, Markus; Jimenez, Jose; Chiang, Derek Y.; Signoretti, Sabina; Kaelin, William G., Jr.; Spardy, Nicole; Hahn, William C.; Hoshida, Yujin; Ogino, Shuji; DePinho, Ronald A.; Chin, Lynda; Garraway, Levi A.; Fuchs, Charles S.; Baselga, Jose; Tabernero, Josep; Gabriel, Stacey; Lander, Eric S.; Getz, Gad; Meyerson, Matthew			Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion	NATURE GENETICS			English	Article							HUMAN BREAST; TUMOR-SUPPRESSOR; PROSTATE-CANCER; LUNG-CANCER; GENES; COMPLEX; RISK; CHROMOSOME-5Q21; TUMORIGENESIS; REARRANGEMENT	Prior studies have identified recurrent oncogenic mutations in colorectal adenocarcinoma(1) and have surveyed exons of protein-coding genes for mutations in 11 affected individuals(2,3). Here we report whole-genome sequencing from nine individuals with colorectal cancer, including primary colorectal tumors and matched adjacent non-tumor tissues, at an average of 30.7x and 31.9x coverage, respectively. We identify an average of 75 somatic rearrangements per tumor, including complex networks of translocations between pairs of chromosomes. Eleven rearrangements encode predicted inframe fusion proteins, including a fusion of VTI1A and TCF7L2 found in 3 out of 97 colorectal cancers. Although TCF7L2 encodes TCF4, which cooperates with beta-catenin(4) in colorectal carcinogenesis(5,6), the fusion lacks the TCF4 beta-catenin-binding domain. We found a colorectal carcinoma cell line harboring the fusion gene to be dependent on VTI1A-TCF7L2 for anchorage-independent growth using RNA interference-mediated knockdown. This study shows previously unidentified levels of genomic rearrangements in colorectal carcinoma that can lead to essential gene fusions and other oncogenic events.	[Bass, Adam J.; Lawrence, Michael S.; Ramos, Alex H.; Cibulskis, Kristian; Sougnez, Carrie; Voet, Douglas; Saksena, Gordon; Sivachenko, Andrey; Jing, Rui; Parkin, Melissa; Pugh, Trevor; Verhaak, Roel G.; Stransky, Nicolas; Barretina, Jordi; Hahn, William C.; Hoshida, Yujin; Chin, Lynda; Garraway, Levi A.; Gabriel, Stacey; Lander, Eric S.; Getz, Gad; Meyerson, Matthew] Broad Inst, Cambridge, MA USA; [Bass, Adam J.; Brace, Lear E.; Ramos, Alex H.; Pugh, Trevor; Verhaak, Roel G.; Boutin, Adam T.; Kaelin, William G., Jr.; Spardy, Nicole; Hahn, William C.; Ogino, Shuji; DePinho, Ronald A.; Chin, Lynda; Garraway, Levi A.; Fuchs, Charles S.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bass, Adam J.; Kaelin, William G., Jr.; Hahn, William C.; DePinho, Ronald A.; Garraway, Levi A.; Fuchs, Charles S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bass, Adam J.; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Vakiani, Evi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Shao, Wenlin; Mishina, Yuji; Warmuth, Markus] Novartis Inst Biomed Res, Cambridge, MA USA; [Jimenez, Jose; Baselga, Jose; Tabernero, Josep] Hosp Valle De Hebron, Dept Med Oncol, Barcelona, Spain; [Chiang, Derek Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Signoretti, Sabina; Ogino, Shuji; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Signoretti, Sabina; Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Baselga, Jose] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Weizmann Institute of Science; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Novartis; Hospital Universitari Vall d'Hebron; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Getz, G (corresponding author), Broad Inst, Cambridge, MA USA.	gadgetz@broadinstitute.org; matthew_meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Chiang, Derek/L-6452-2019; Drier, Yotam/K-5208-2012; Verhaak, Roel/ABE-7058-2020; Tabernero, Josep/AAG-5026-2019; Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Pugh, Trevor/Y-2535-2019; Hoshida, Yujin/R-7513-2019; Solit, David B./AAC-5309-2019; Barretina, Jordi/A-7192-2013	Drier, Yotam/0000-0003-1725-2995; Tabernero, Josep/0000-0002-2495-8139; Pugh, Trevor/0000-0002-8073-5888; Barretina, Jordi/0000-0002-3478-4080; Jimenez, Jose/0000-0002-2576-1776; Meyerson, Matthew/0000-0002-9133-8108; Ogino, Shuji/0000-0002-3909-2323; Brace, Lear/0000-0001-6961-9758; Cibulskis, Kristian/0000-0003-1343-1582; DePinho, Ronald/0000-0002-5625-577X	US National Institutes of Health [K08CA134931]; GI SPORE Developmental Project Award [P50CA127003]; National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [P50CA101942, K08CA134931, R01CA068490, P50CA127003] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GI SPORE Developmental Project Award; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all members of the Biological Samples Platform and DNA Sequencing Platforms of the Broad Institute, without whose work this sequencing project could not have occurred, and R. Shivdasani and M. Freedman for helpful discussion. This work was supported by US National Institutes of Health grant K08CA134931 (A.J.B.), a GI SPORE Developmental Project Award (P50CA127003; M. M.) and the National Human Genome Research Institute (E.S.L.).	Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boland CR, 1998, CANCER RES, V58, P5248; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Hazra A, 2008, CANCER CAUSE CONTROL, V19, P975, DOI 10.1007/s10552-008-9164-3; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Kriegl L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-123; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	39	225	233	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					964	U67		10.1038/ng.936	http://dx.doi.org/10.1038/ng.936			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892161	Green Accepted, Green Published			2022-12-25	WOS:000295316200010
J	Bollee, G; Flamant, M; Schordan, S; Fligny, C; Rumpel, E; Milon, M; Schordan, E; Sabaa, N; Vandermeersch, S; Galaup, A; Rodenas, A; Casal, I; Sunnarborg, SW; Salant, DJ; Kopp, JB; Threadgill, DW; Quaggin, SE; Dussaule, JC; Germain, S; Mesnard, L; Endlich, K; Boucheix, C; Belenfant, X; Callard, P; Endlich, N; Tharaux, PL				Bollee, Guillaume; Flamant, Martin; Schordan, Sandra; Fligny, Cecile; Rumpel, Elisabeth; Milon, Marine; Schordan, Eric; Sabaa, Nathalie; Vandermeersch, Sophie; Galaup, Ariane; Rodenas, Anita; Casal, Ibrahim; Sunnarborg, Susan W.; Salant, David J.; Kopp, Jeffrey B.; Threadgill, David W.; Quaggin, Susan E.; Dussaule, Jean-Claude; Germain, Stephane; Mesnard, Laurent; Endlich, Karlhans; Boucheix, Claude; Belenfant, Xavier; Callard, Patrice; Endlich, Nicole; Tharaux, Pierre-Louis			Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis	NATURE MEDICINE			English	Article							PARIETAL EPITHELIAL-CELLS; GENE-EXPRESSION; CELLULAR CRESCENTS; ENDOTHELIAL-CELLS; NEPHROTOXIC SERUM; MEDIATED-IMMUNITY; BOWMANS CAPSULE; TRANSGENIC MICE; MESANGIAL CELLS; T-LYMPHOCYTES	Rapidly progressive glomerulonephritis (RPGN) is a life-threatening clinical syndrome and a morphological manifestation of severe glomerular injury that is marked by a proliferative histological pattern ('crescents') with accumulation of T cells and macrophages and proliferation of intrinsic glomerular cells. We show de novo induction of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in intrinsic glomerular epithelial cells (podocytes) from both mice and humans with RPGN. HB-EGF induction increases phosphorylation of the epidermal growth factor receptor (EGFR, also known as ErbB1) in mice with RPGN. In HB-EGF-deficient mice, EGFR activation in glomeruli is absent and the course of RPGN is improved. Autocrine HB-EGF induces a phenotypic switch in podocytes in vitro. Conditional deletion of the Egfr gene from podocytes of mice alleviates the severity of RPGN. Likewise, pharmacological blockade of EGFR also improves the course of RPGN, even when started 4 d after the induction of experimental RPGN. This suggests that targeting the HB-EGF-EGFR pathway could also be beneficial in treatment of human RPGN.	[Bollee, Guillaume; Fligny, Cecile; Milon, Marine; Tharaux, Pierre-Louis] INSERM, Unite Mixte Rech UMR 970, Paris Cardiovasc Res Ctr, Paris, France; [Bollee, Guillaume; Fligny, Cecile; Milon, Marine; Tharaux, Pierre-Louis] Univ Paris 05, Paris, France; [Flamant, Martin; Sabaa, Nathalie] Univ Paris Diderot, Paris, France; [Flamant, Martin; Sabaa, Nathalie] Hop Bichat Claude Bernard, AP HP, Serv Physiol Explorat Fonct, F-75877 Paris, France; [Schordan, Sandra; Rumpel, Elisabeth; Schordan, Eric; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Zellbiol, Greifswald, Germany; [Vandermeersch, Sophie; Dussaule, Jean-Claude; Mesnard, Laurent] Hop Tenon, INSERM, UMR702, F-75970 Paris, France; [Vandermeersch, Sophie; Dussaule, Jean-Claude; Mesnard, Laurent; Callard, Patrice] Sorbonne Univ, Univ Paris 06, Paris, France; [Galaup, Ariane; Germain, Stephane] INSERM, Ctr Interdisciplinary Res Biol, Ctr Natl Rech Sci, UMR 7241,U1050, Paris, France; [Galaup, Ariane; Germain, Stephane] Coll France, Chaire Med Expt, F-75231 Paris, France; [Rodenas, Anita; Callard, Patrice] Hop Tenon, AP HP, Serv Anat & Cytol Pathol, F-75970 Paris, France; [Casal, Ibrahim; Boucheix, Claude] Hop Paul Brousse, INSERM, UMR 1004, Inst Andre Lwoff, Villejuif, France; [Casal, Ibrahim; Boucheix, Claude] Univ Paris 11, Villejuif, France; [Sunnarborg, Susan W.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Salant, David J.] Boston Univ, Med Ctr, Renal Sect, Boston, MA USA; [Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, Bethesda, MD USA; [Threadgill, David W.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Quaggin, Susan E.] Univ Toronto, Mt Sinai Hosp, St Michaels Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Dussaule, Jean-Claude] Hop St Antoine, AP HP, Serv Physiol Explorat Fonct, F-75571 Paris, France; [Belenfant, Xavier] Ctr Hosp Intercommunal Andre Gregoire, Serv Nephrol & Dialyse, Montreuil, France; [Tharaux, Pierre-Louis] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Nephrol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Greifswald Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; North Carolina State University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Tharaux, PL (corresponding author), INSERM, Unite Mixte Rech UMR 970, Paris Cardiovasc Res Ctr, Paris, France.	pierre-louis.tharaux@inserm.fr	Germain, Stephane/E-2301-2016; Tharaux, Pierre-Louis/A-9155-2009; Kopp, Jeffrey B/O-2681-2015; Endlich, Karlhans/G-5485-2013; Threadgill, David W/N-4425-2013	Germain, Stephane/0000-0001-5992-1275; Tharaux, Pierre-Louis/0000-0002-6062-5905; Kopp, Jeffrey B/0000-0001-9052-186X; Threadgill, David W/0000-0003-3538-1635; Endlich, Karlhans/0000-0001-6052-6061; VANDERMEERSCH, sophie/0000-0001-6021-1334; Salant, David/0000-0002-3866-3120; Boucheix, Claude/0000-0003-4184-7008	INSERM; l'Agence Nationale de la Recherche of France [ANR-08-EBIO-003]; German Federal Ministry of Education and Research (BMBF) [01GN0805, 03IP612]; US National Institutes of Health [CA43793, DK30932]; la Fondation pour la Recherche Medicale; la Fondation Lefoulon-Delalande; NATIONAL CANCER INSTITUTE [R01CA043793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030932, R56DK030932] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); l'Agence Nationale de la Recherche of France(French National Research Agency (ANR)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); la Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); la Fondation Lefoulon-Delalande; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by INSERM, grant ANR-08-EBIO-003 (P.-L. T.) from l'Agence Nationale de la Recherche of France, grant 01GN0805 (K.E.) from the German Federal Ministry of Education and Research (BMBF) and grants CA43793 (S.W.S.) and DK30932 (D.S.) from the US National Institutes of Health. We are grateful to la Fondation pour la Recherche Medicale and la Fondation Lefoulon-Delalande for supporting G.B. and C.F., respectively. We thank L.B. Holzman (Perelman School of Medicine, University of Pennsylvania) for the use of podocin-Cre mice crossed with Z/EGFP mice. We also thank X. Biolchini, C. Kitou, C. Martin, E. Huc and the ERI970 team for assistance in animal care and handling, H. Wegner, R. Maciejewski and T. Felix for technical assistance and J. Peters for help with fluorescence-activated cell sorting (FACS; supported by InnoProfile grant 03IP612 of the BMBF). We acknowledge administrative support from M.-C. Poeuf, V. Oberweiss, A. De Rueda, M. Autran and P. Coudol.	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Bariety J, 2006, KIDNEY INT, V69, P194, DOI 10.1038/sj.ki.5000069; Besse-Eschmann V, 2004, HISTOCHEM CELL BIOL, V122, P139, DOI 10.1007/s00418-004-0683-z; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; BOUCHER A, 1987, LAB INVEST, V56, P526; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Feng LL, 2000, J CLIN INVEST, V105, P341, DOI 10.1172/JCI2869; GUETTIER C, 1986, VIRCHOWS ARCH A, V409, P739, DOI 10.1007/BF00713438; HANCOCK WW, 1984, AM J NEPHROL, V4, P177, DOI 10.1159/000166800; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jennette JC, 2001, NEPHROL DIAL TRANSPL, V16, P80, DOI 10.1093/ndt/16.suppl_6.80; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; Khong TF, 2000, KIDNEY INT, V58, P1098, DOI 10.1046/j.1523-1755.2000.00267.x; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; KUME N, 1994, J CLIN INVEST, V93, P907, DOI 10.1172/JCI117047; Le Hir M, 2001, J AM SOC NEPHROL, V12, P2060, DOI 10.1681/ASN.V12102060; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lee D, 2004, MOL CELL BIOL, V24, P8907, DOI 10.1128/MCB.24.20.8907-8916.2004; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; LEE YJ, 1995, BIOCHEM BIOPH RES CO, V207, P216, DOI 10.1006/bbrc.1995.1175; Levy J, 2003, OXFORD TXB MED; Levy JB, 2001, ANN INTERN MED, V134, P1033, DOI 10.7326/0003-4819-134-11-200106050-00009; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Mishra R, 2002, AM J PHYSIOL-RENAL, V283, pF1151, DOI 10.1152/ajprenal.00103.2002; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; NEALE TJ, 1988, LANCET, V2, P421; Ng YY, 1999, NEPHROL DIAL TRANSPL, V14, P2860, DOI 10.1093/ndt/14.12.2860; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Paizis K, 1999, KIDNEY INT, V55, P2310, DOI 10.1046/j.1523-1755.1999.00469.x; Paizis K, 1998, KIDNEY INT, V53, P1162, DOI 10.1046/j.1523-1755.1998.00846.x; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P6547, DOI 10.1073/pnas.92.14.6547; Polihronis M, 1996, EXP NEPHROL, V4, P271; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Segerer S, 2000, J AM SOC NEPHROL, V11, P2231, DOI 10.1681/ASN.V11122231; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Takemura T, 1999, J PATHOL, V189, P431; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Tipping PG, 2003, SPRINGER SEMIN IMMUN, V24, P377, DOI 10.1007/s00281-003-0121-7; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Wassef L, 2004, KIDNEY INT, V66, P1805, DOI 10.1111/j.1523-1755.2004.00955.x; YOSHIZUMI M, 1992, J BIOL CHEM, V267, P9467	56	170	177	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1242	U272		10.1038/nm.2491	http://dx.doi.org/10.1038/nm.2491			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946538	Green Accepted			2022-12-25	WOS:000296022100042
J	Goldstein, JL				Goldstein, Joseph L.			The card players of Caravaggio, Cezanne and Mark Twain: tips for getting lucky in high-stakes research	NATURE MEDICINE			English	Article												joe.goldstein@utsouthwestern.edu							0	0	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1201	1205		10.1038/nm.2465	http://dx.doi.org/10.1038/nm.2465			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989010				2022-12-25	WOS:000296022100033
J	Gronau, I; Hubisz, MJ; Gulko, B; Danko, CG; Siepel, A				Gronau, Ilan; Hubisz, Melissa J.; Gulko, Brad; Danko, Charles G.; Siepel, Adam			Bayesian inference of ancient human demography from individual genome sequences	NATURE GENETICS			English	Article							ANCESTRAL POPULATION SIZES; DIVERGENCE TIMES; HISTORY; DNA; MITOCHONDRIAL; MODELS; RATES	Whole-genome sequences provide a rich source of information about human evolution. Here we describe an effort to estimate key evolutionary parameters based on the whole-genome sequences of six individuals from diverse human populations. We used a Bayesian, coalescent-based approach to obtain information about ancestral population sizes, divergence times and migration rates from inferred genealogies at many neutrally evolving loci across the genome. We introduce new methods for accommodating gene flow between populations and integrating over possible phasings of diploid genotypes. We also describe a custom pipeline for genotype inference to mitigate biases from heterogeneous sequencing technologies and coverage levels. Our analysis indicates that the San population of southern Africa diverged from other human populations approximately 108-157 thousand years ago, that Eurasians diverged from an ancestral African population 38-64 thousand years ago, and that the effective population size of the ancestors of all modern humans was similar to 9,000.	[Gronau, Ilan; Hubisz, Melissa J.; Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA	Cornell University	Siepel, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	acs4@cornell.edu		Siepel, Adam/0000-0002-3557-7219; Hubisz, Melissa/0000-0002-9561-6830; Danko, Charles/0000-0002-1999-7125	Packard Fellowship; National Science Foundation [DBI-0644111]; National Institutes of Health [T32HD052471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER	Packard Fellowship(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a Packard Fellowship (to A. S.), National Science Foundation grant DBI-0644111 and National Institutes of Health training grant T32HD052471 (to C. G. D.). We thank S. Schuster, W. Miller, D. Reich, G. Coop, J. Hey, J. Wall, R. S. Wells, A. Keinan, A. G. Clark, S. C. Choi, C. D. Bustamante, B. Henn and others for helpful discussions and feedback.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beaumont MA, 2002, GENETICS, V162, P2025; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burgess R, 2008, MOL BIOL EVOL, V25, P1979, DOI 10.1093/molbev/msn148; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lewontin R., 1972, EVOLUTIONARY BIOL, V6; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nielsen R, 2001, GENETICS, V158, P885; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Paul JS, 2011, GENETICS, V187, P1115, DOI 10.1534/genetics.110.125534; Rannala B, 2003, GENETICS, V164, P1645; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	35	370	375	4	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					1031	U151		10.1038/ng.937	http://dx.doi.org/10.1038/ng.937			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21926973	Green Accepted			2022-12-25	WOS:000295316200022
J	Mansfeld, J; Collin, P; Collins, MO; Choudhary, JS; Pines, J				Mansfeld, Joerg; Collin, Philippe; Collins, Mark O.; Choudhary, Jyoti S.; Pines, Jonathon			APC15 drives the turnover of MCC-CDC20 to make the spindle assembly checkpoint responsive to kinetochore attachment	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT; APC/C; CDC20; MAD2; INHIBITION; PROTEIN; BUBR1; DESTRUCTION; SUBUNIT	Faithful chromosome segregation during mitosis depends on the spindle assembly checkpoint (SAC), which monitors kinetochore attachment to the mitotic spindle. Unattached kinetochores generate mitotic checkpoint proteins complexes (MCCs) that bind and inhibit the anaphase-promoting complex, or cyclosome (APC/C). How the SAC proficiently inhibits the APC/C but still allows its rapid activation when the last kinetochore attaches to the spindle is important for the understanding of how cells maintain genomic stability. We show that the APC/C subunit APC15 is required for the turnover of the APC/C co-activator CDC20 and release of MCCs during SAC signalling but not for APC/C activity per se. In the absence of APC15, MCCs and ubiquitylated CDC20 remain 'locked' onto the APC/C, which prevents the ubiquitylation and degradation of cyclin B1 when the SAC is satisfied. We conclude that APC15 mediates the constant turnover of CDC20 and MCCs on the APC/C to allow the SAC to respond to the attachment state of kinetochores.	[Mansfeld, Joerg; Collin, Philippe; Pines, Jonathon] Gurdon Inst, Cambridge CB2 1QN, England; [Mansfeld, Joerg; Collin, Philippe; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England; [Collins, Mark O.; Choudhary, Jyoti S.] Wellcome Trust Sanger Inst, Proteom Mass Spectrometry Lab, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Pines, J (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jp103@cam.ac.uk	Collins, Mark/A-3752-2012; Choudhary, Jyoti/S-1232-2017	Choudhary, Jyoti/0000-0003-0881-5477; Pines, Jonathon/0000-0002-5227-6004; Mansfeld, Jorg/0000-0002-0562-8206; Collins, Mark/0000-0002-7656-4975	BBSRC; Cancer Research UK; Wellcome Trust [079643/Z/06/Z]; FEBS; EMBO; Biotechnology and Biological Sciences Research Council [BB/G001537/1] Funding Source: researchfish; BBSRC [BB/G001537/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); FEBS; EMBO(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Taylor for the HeLa FAT cell line, A. Musacchio for the anti-MAD2 and anti-p31<SUP>comet</SUP> antibodies and for communicating results before publication, T. Hunt for the anti-APC3 antibody, members of our laboratory for discussions and O. Nashchekina, F. Walton, E. Russe and S. Wieser for help with somatic cell knock-ins, mass spectrometry, statistical and flow cytometry analyses, respectively. J.M. was supported by FEBS and EMBO fellowships. This work was supported by a project grant from the BBSRC and by a Programme grant from Cancer Research UK to J.P. and core grant support to the Sanger Institute (M.O.C. and J.S.C.) from The Wellcome Trust (grant number 079643/Z/06/Z).	Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Ma HT, 2011, J BIOL CHEM, V286, P13052, DOI 10.1074/jbc.M110.201897; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Miniowitz-Shemtov S, 2010, P NATL ACAD SCI USA, V107, P5351, DOI 10.1073/pnas.1001875107; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Visconti R, 2010, CELL CYCLE, V9, P564, DOI 10.4161/cc.9.3.10581; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	43	109	111	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1234	U152		10.1038/ncb2347	http://dx.doi.org/10.1038/ncb2347			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21926987	Green Accepted			2022-12-25	WOS:000295617900013
J	Qiu, P; Simonds, EF; Bendall, SC; Gibbs, KD; Bruggner, RV; Linderman, MD; Sachs, K; Nolan, GP; Plevritis, SK				Qiu, Peng; Simonds, Erin F.; Bendall, Sean C.; Gibbs, Kenneth D., Jr.; Bruggner, Robert V.; Linderman, Michael D.; Sachs, Karen; Nolan, Garry P.; Plevritis, Sylvia K.			Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE	NATURE BIOTECHNOLOGY			English	Article							FLOW-CYTOMETRY; MASS CYTOMETRY; STEM-CELL; IDENTIFICATION; IMMUNE	The ability to analyze multiple single-cell parameters is critical for understanding cellular heterogeneity. Despite recent advances in measurement technology, methods for analyzing high-dimensional single-cell data are often subjective, labor intensive and require prior knowledge of the biological system. To objectively uncover cellular heterogeneity from single-cell measurements, we present a versatile computational approach, spanning-tree progression analysis of density-normalized events (SPADE). We applied SPADE to flow cytometry data of mouse bone marrow and to mass cytometry data of human bone marrow. In both cases, SPADE organized cells in a hierarchy of related phenotypes that partially recapitulated well-described patterns of hematopoiesis. We demonstrate that SPADE is robust to measurement noise and to the choice of cellular markers. SPADE facilitates the analysis of cellular heterogeneity, the identification of cell types and comparison of functional markers in response to perturbations.	[Qiu, Peng; Plevritis, Sylvia K.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Qiu, Peng] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Simonds, Erin F.; Bendall, Sean C.; Gibbs, Kenneth D., Jr.; Bruggner, Robert V.; Sachs, Karen; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Linderman, Michael D.] Stanford Univ, Comp Syst Lab, Stanford, CA 94305 USA	Stanford University; University of Texas System; UTMD Anderson Cancer Center; Stanford University; Stanford University	Qiu, P (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.	pqiu@mdanderson.org	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Gibbs, Kenneth/0000-0002-3532-5396; Bendall, Sean/0000-0003-1341-2453; Nolan, Garry/0000-0002-8862-9043; Simonds, Erin/0000-0002-3497-4861	National Cancer Institute [U56CA112973, U54CA149145]; A Damon Runyon Cancer Research Foundation; National Science Foundation; Stanford DARE; US National Institutes of Health [U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, 5U54 CA143907, RB2-01592, PN2EY018228, N01-HV-00242]; European Commission [HEALTH.2010.1.2-1]; California Institute for Regenerative Medicine [DR1-01477]; NATIONAL CANCER INSTITUTE [R01CA130826, U54CA143907, P01CA034233, U54CA149145, U56CA112973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Stanford DARE; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors gratefully acknowledge funding from National Cancer Institute Integrative Cancer Biology Program (ICBP), grants U56CA112973 and U54CA149145 to S.K.P. A Damon Runyon Cancer Research Foundation Fellowship supports S.C.B. National Science Foundation Graduate Research Fellowship and Stanford DARE Fellowship support K. D. G. This work is also supported by US National Institutes of Health grants U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, 5U54 CA143907, RB2-01592, PN2EY018228, N01-HV-00242, HEALTH.2010.1.2-1 (European Commission), as well as the California Institute for Regenerative Medicine (DR1-01477) to G.P.N.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bagwell CB, 2010, U.S. Patent, Patent No. [7653509, 7,653,509]; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Boedigheimer MJ, 2008, CYTOM PART A, V73A, P421, DOI 10.1002/cyto.a.20553; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Chan C, 2008, CYTOM PART A, V73A, P693, DOI 10.1002/cyto.a.20583; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Chen W, 2004, BLOOD, V103, P2547, DOI 10.1182/blood-2003-09-3058; Ellis B., 2018, FLOWCORE BASIC STRUC; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; KOTECHA N, 2010, CURR PROT CYTOM, V53; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; MURPHY RF, 1985, CYTOMETRY, V6, P302, DOI 10.1002/cyto.990060405; Pettie S., 1999, J ACM, V49, P49; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Walther Guenther, 2009, Advances in Bioinformatics, V2009, P686759, DOI 10.1155/2009/686759; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	23	651	661	3	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					886	U181		10.1038/nbt.1991	http://dx.doi.org/10.1038/nbt.1991			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21964415	Green Accepted			2022-12-25	WOS:000296273000015
J	Ripke, S; Sanders, AR; Kendler, KS; Levinson, DF; Sklar, P; Holmans, PA; Lin, DY; Duan, J; Ophoff, RA; Andreassen, OA; Scolnick, E; Cichon, S; Clair, DS; Corvin, A; Gurling, H; Werge, T; Rujescu, D; Blackwood, DHR; Pato, CN; Malhotra, AK; Purcell, S; Dudbridge, F; Neale, BM; Rossin, L; Visscher, PM; Posthuma, D; Ruderfer, DM; Fanous, A; Stefansson, H; Steinberg, S; Mowry, BJ; Golimbet, V; De Hert, M; Jonsson, EG; Bitter, I; Pietilainen, OPH; Collier, DA; Tosato, S; Agartz, I; Albus, M; Alexander, M; Amdur, RL; Amin, F; Bass, N; Bergen, SE; Black, DW; Borglum, AD; Brown, MA; Bruggeman, R; Buccola, NG; Byerley, WF; Cahn, W; Cantor, RM; Carr, VJ; Catts, SV; Choudhury, K; Cloninger, CR; Cormican, P; Craddock, N; Danoy, PA; Datta, S; De Haan, L; Demontis, D; Dikeos, D; Djurovic, S; Donnelly, P; Donohoe, G; Duong, L; Dwyer, S; Fink-Jensen, A; Freedman, R; Freimer, NB; Friedl, M; Georgieva, L; Giegling, I; Gill, M; Glenthoj, B; Godard, S; Hamshere, M; Hansen, M; Hansen, T; Hartmann, AM; Henskens, FA; Hougaard, DM; Hultman, CM; Ingason, A; Jablensky, AV; Jakobsen, KD; Jay, M; Jurgens, G; Kahn, R; Keller, MC; Kenis, G; Kenny, E; Kim, Y; Kirov, GK; Konnerth, H; Konte, B; Krabbendam, L; Krasucki, R; Lasseter, VK; Laurent, C; Lawrence, J; Lencz, T; Lerer, FB; Liang, KY; Lichtenstein, P; Lieberman, JA; Linszen, DH; Lonnqvist, J; Loughland, CM; Maclean, AW; Maher, BS; Maier, W; Mallet, J; Malloy, P; Mattheisen, M; Mattingsdal, M; McGhee, KA; McGrath, JJ; McIntosh, A; McLean, DE; McQuillin, A; Melle, I; Michie, PT; Milanova, V; Morris, DW; Mors, O; Mortensen, PB; Moskvina, V; Muglia, P; Myin-Germeys, I; Nertney, DA; Nestadt, G; Nielsen, J; Nikolov, I; Nordentoft, M; Norton, N; Nothen, MM; O'Dushlaine, CT; Olincy, A; Olsen, L; O'Neill, FA; Orntoft, TF; Owen, MJ; Pantelis, C; Papadimitriou, G; Pato, MT; Peltonen, L; Petursson, H; Pickard, B; Pimm, J; Pulver, AE; Puri, V; Quested, D; Quinn, EM; Rasmussen, HB; Rethelyi, JM; Ribble, R; Rietschel, M; Riley, BP; Ruggeri, M; Schall, U; Schulze, TG; Schwab, SG; Scott, RJ; Shi, JX; Sigurdsson, E; Silverman, JM; Spencer, CCA; Stefansson, K; Strange, A; Strengman, E; Stroup, TS; Suvisaari, J; Terenius, L; Thirumalai, S; Thygesen, JH; Timm, S; Toncheva, D; van den Oord, E; van Os, J; van Winkel, R; Veldink, J; Walsh, D; Wang, AG; Wiersma, D; Wildenauer, DB; Williams, HJ; Williams, NM; Wormley, B; Zammit, S; Sullivan, PF; O'Donovan, MC; Daly, MJ; Gejman, PV				Ripke, Stephan; Sanders, Alan R.; Kendler, Kenneth S.; Levinson, Douglas F.; Sklar, Pamela; Holmans, Peter A.; Lin, Dan-Yu; Duan, Jubao; Ophoff, Roel A.; Andreassen, Ole A.; Scolnick, Edward; Cichon, Sven; Clair, David St.; Corvin, Aiden; Gurling, Hugh; Werge, Thomas; Rujescu, Dan; Blackwood, Douglas H. R.; Pato, Carlos N.; Malhotra, Anil K.; Purcell, Shaun; Dudbridge, Frank; Neale, Benjamin M.; Rossin, Lizzy; Visscher, Peter M.; Posthuma, Danielle; Ruderfer, Douglas M.; Fanous, Ayman; Stefansson, Hreinn; Steinberg, Stacy; Mowry, Bryan J.; Golimbet, Vera; De Hert, Marc; Jonsson, Erik G.; Bitter, Istvan; Pietilainen, Olli P. H.; Collier, David A.; Tosato, Sarah; Agartz, Ingrid; Albus, Margot; Alexander, Madeline; Amdur, Richard L.; Amin, Farooq; Bass, Nicholas; Bergen, Sarah E.; Black, Donald W.; Borglum, Anders D.; Brown, Matthew A.; Bruggeman, Richard; Buccola, Nancy G.; Byerley, William F.; Cahn, Wiepke; Cantor, Rita M.; Carr, Vaughan J.; Catts, Stanley V.; Choudhury, Khalid; Cloninger, C. Robert; Cormican, Paul; Craddock, Nicholas; Danoy, Patrick A.; Datta, Susmita; De Haan, Lieuwe; Demontis, Ditte; Dikeos, Dimitris; Djurovic, Srdjan; Donnelly, Peter; Donohoe, Gary; Duong, Linh; Dwyer, Sarah; Fink-Jensen, Anders; Freedman, Robert; Freimer, Nelson B.; Friedl, Marion; Georgieva, Lyudmila; Giegling, Ina; Gill, Michael; Glenthoj, Birte; Godard, Stephanie; Hamshere, Marian; Hansen, Mark; Hansen, Thomas; Hartmann, Annette M.; Henskens, Frans A.; Hougaard, David M.; Hultman, Christina M.; Ingason, Andres; Jablensky, Assen V.; Jakobsen, Klaus D.; Jay, Maurice; Juergens, Gesche; Kahn, Renes; Keller, Matthew C.; Kenis, Gunter; Kenny, Elaine; Kim, Yunjung; Kirov, George K.; Konnerth, Heike; Konte, Bettina; Krabbendam, Lydia; Krasucki, Robert; Lasseter, Virginia K.; Laurent, Claudine; Lawrence, Jacob; Lencz, Todd; Lerer, F. Bernard; Liang, Kung-Yee; Lichtenstein, Paul; Lieberman, Jeffrey A.; Linszen, Don H.; Lonnqvist, Jouko; Loughland, Carmel M.; Maclean, Alan W.; Maher, Brion S.; Maier, Wolfgang; Mallet, Jacques; Malloy, Pat; Mattheisen, Manuel; Mattingsdal, Morten; McGhee, Kevin A.; McGrath, John J.; McIntosh, Andrew; McLean, Duncan E.; McQuillin, Andrew; Melle, Ingrid; Michie, Patricia T.; Milanova, Vihra; Morris, Derek W.; Mors, Ole; Mortensen, Preben B.; Moskvina, Valentina; Muglia, Pierandrea; Myin-Germeys, Inez; Nertney, Deborah A.; Nestadt, Gerald; Nielsen, Jimmi; Nikolov, Ivan; Nordentoft, Merete; Norton, Nadine; Noethen, Markus M.; O'Dushlaine, Colm T.; Olincy, Ann; Olsen, Line; O'Neill, F. Anthony; Orntoft, Torben F.; Owen, Michael J.; Pantelis, Christos; Papadimitriou, George; Pato, Michele T.; Peltonen, Leena; Petursson, Hannes; Pickard, Ben; Pimm, Jonathan; Pulver, Ann E.; Puri, Vinay; Quested, Digby; Quinn, Emma M.; Rasmussen, Henrik B.; Rethelyi, Janos M.; Ribble, Robert; Rietschel, Marcella; Riley, Brien P.; Ruggeri, Mirella; Schall, Ulrich; Schulze, Thomas G.; Schwab, Sibylle G.; Scott, Rodney J.; Shi, Jianxin; Sigurdsson, Engilbert; Silverman, Jeremy M.; Spencer, Chris C. A.; Stefansson, Kari; Strange, Amy; Strengman, Eric; Stroup, T. Scott; Suvisaari, Jaana; Terenius, Lars; Thirumalai, Srinivasa; Thygesen, Johan H.; Timm, Sally; Toncheva, Draga; van den Oord, Edwin; van Os, Jim; van Winkel, Ruud; Veldink, Jan; Walsh, Dermot; Wang, August G.; Wiersma, Durk; Wildenauer, Dieter B.; Williams, Hywel J.; Williams, Nigel M.; Wormley, Brandon; Zammit, Stan; Sullivan, Patrick F.; O'Donovan, Michael C.; Daly, Mark J.; Gejman, Pablo V.		Schizophrenia Psychiat Genome-Wide	Genome-wide association study identifies five new schizophrenia loci	NATURE GENETICS			English	Article							COMMON SNPS EXPLAIN; BIPOLAR DISORDER; HUMAN HEIGHT; LARGE PROPORTION; MICRORNA; VARIANTS; SUSCEPTIBILITY; HERITABILITY; INDIVIDUALS; ANCESTRY	We examined the role of common genetic variation in schizophrenia in a genome-wide association study of substantial size: a stage 1 discovery sample of 21,856 individuals of European ancestry and a stage 2 replication sample of 29,839 independent subjects. The combined stage 1 and 2 analysis yielded genome-wide significant associations with schizophrenia for seven loci, five of which are new (1p21.3, 2q32.3, 8p23.2, 8q21.3 and 10q24.32-q24.33) and two of which have been previously implicated (6p21.32-p22.1 and 18q21.2). The strongest new finding (P = 1.6 x 10(-11)) was with rs1625579 within an intron of a putative primary transcript for MIR137 (microRNA 137), a known regulator of neuronal development. Four other schizophrenia loci achieving genome-wide significance contain predicted targets of MIR137, suggesting MIR137-mediated dysregulation as a previously unknown etiologic mechanism in schizophrenia. In a joint analysis with a bipolar disorder sample (16,374 affected individuals and 14,044 controls), three loci reached genome-wide significance: CACNA1C (rs4765905, P = 7.0 x 10(-9)), ANK3 (rs10994359, P = 2.5 x 10(-8)) and the ITIH3-ITIH4 region (rs2239547, P = 7.8 x 10(-9)).	[Sanders, Alan R.; Duan, Jubao; Gejman, Pablo V.] NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, Evanston, IL USA; [Ripke, Stephan; Sklar, Pamela; Rossin, Lizzy; Ruderfer, Douglas M.; Bergen, Sarah E.; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Sanders, Alan R.; Duan, Jubao; Gejman, Pablo V.] Univ Chicago, Dept Psychiat & Behav Sci, Chicago, IL 60637 USA; [Kendler, Kenneth S.; Maher, Brion S.; Ribble, Robert; Riley, Brien P.; Wormley, Brandon] Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Kendler, Kenneth S.; Fanous, Ayman; Maher, Brion S.; Ribble, Robert; Riley, Brien P.; Wormley, Brandon] Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Richmond, VA USA; [Kendler, Kenneth S.; Maher, Brion S.; Ribble, Robert; Riley, Brien P.; Wormley, Brandon] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA USA; [Levinson, Douglas F.; Alexander, Madeline] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Sklar, Pamela; Silverman, Jeremy M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Holmans, Peter A.; Craddock, Nicholas; Dwyer, Sarah; Georgieva, Lyudmila; Hamshere, Marian; Kirov, George K.; Moskvina, Valentina; Nikolov, Ivan; Norton, Nadine; Owen, Michael J.; Williams, Hywel J.; Williams, Nigel M.; Zammit, Stan; O'Donovan, Michael C.] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Gen, Sch Med, Cardiff, S Glam, Wales; [Holmans, Peter A.; Craddock, Nicholas; Dwyer, Sarah; Georgieva, Lyudmila; Hamshere, Marian; Kirov, George K.; Moskvina, Valentina; Nikolov, Ivan; Norton, Nadine; Owen, Michael J.; Williams, Hywel J.; Williams, Nigel M.; Zammit, Stan; O'Donovan, Michael C.] Cardiff Univ, Dept Psychol Med & Neurol, Sch Med, Cardiff, S Glam, Wales; [Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Ophoff, Roel A.; Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.; Strengman, Eric] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Ophoff, Roel A.; Cantor, Rita M.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Ophoff, Roel A.; Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Andreassen, Ole A.; Agartz, Ingrid; Djurovic, Srdjan; Mattingsdal, Morten; Melle, Ingrid] Univ Oslo, Inst Clin Med, Psychiat Sect, Oslo, Norway; [Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Dept Psychiat, Oslo, Norway; [Scolnick, Edward; Purcell, Shaun; Neale, Benjamin M.] Broad Inst, Cambridge, MA USA; [Cichon, Sven; Mattheisen, Manuel; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Cichon, Sven; Mattheisen, Manuel; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Clair, David St.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Corvin, Aiden; Cormican, Paul; Donohoe, Gary; Gill, Michael; Kenny, Elaine; Morris, Derek W.; O'Dushlaine, Colm T.; Quinn, Emma M.] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Gurling, Hugh; Bass, Nicholas; Choudhury, Khalid; Datta, Susmita; Krasucki, Robert; Lawrence, Jacob; McQuillin, Andrew; Pimm, Jonathan; Puri, Vinay] UCL, Sch Med, Windeyer Inst Med Sci, Mol Psychiat Lab,Res Dept Mental Hlth Sci, London W1N 8AA, England; [Werge, Thomas; Duong, Linh; Hansen, Thomas; Ingason, Andres; Jakobsen, Klaus D.; Olsen, Line; Rasmussen, Henrik B.; Thygesen, Johan H.] Copenhagen Univ Hosp, Inst Biol Psychiat, Mental Hlth Ctr MHC Sct Hans, Roskilde, Denmark; [Rujescu, Dan; Friedl, Marion; Giegling, Ina; Hartmann, Annette M.; Konnerth, Heike; Konte, Bettina] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Blackwood, Douglas H. R.; Maclean, Alan W.; Malloy, Pat; McGhee, Kevin A.; McIntosh, Andrew] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Pato, Carlos N.; Pato, Michele T.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Malhotra, Anil K.; Lencz, Todd] Zucker Hillside Hosp, Div N Shore Long Isl Jewish Hlth Syst, Div Res, Dept Psychiat, Glen Oaks, NY USA; [Malhotra, Anil K.; Lencz, Todd] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA; [Malhotra, Anil K.; Lencz, Todd] Yeshiva Univ, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY 10033 USA; [Dudbridge, Frank] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Visscher, Peter M.] Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia; [Posthuma, Danielle] Vrije Univ Amsterdam, CNCR, Dept Funct Gen, Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Med Genom, Amsterdam, Netherlands; [Fanous, Ayman; Amdur, Richard L.] Vet Affairs Med Ctr, Washington, DC 20422 USA; [Fanous, Ayman; Amdur, Richard L.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA; [Stefansson, Hreinn; Steinberg, Stacy; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Mowry, Bryan J.; McGrath, John J.; Nertney, Deborah A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Mowry, Bryan J.; McGrath, John J.; Nertney, Deborah A.] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Golimbet, Vera] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 109801, Russia; [De Hert, Marc; van Winkel, Ruud] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium; [Jonsson, Erik G.; Terenius, Lars] Karolinska Hosp & Inst, Human Brain Informat HUBIN Project, Dept Clin Neurosci, Stockholm, Sweden; [Bitter, Istvan; Rethelyi, Janos M.] Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary; [Pietilainen, Olli P. H.; Peltonen, Leena] Univ Helsinki, FIMM, Helsinki, Finland; [Pietilainen, Olli P. H.; Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Collier, David A.] Kings Coll London, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Tosato, Sarah; Ruggeri, Mirella] Univ Verona, Sect Psychiat & Clin Psychol, I-37100 Verona, Italy; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Res, Oslo, Norway; [Albus, Margot] State Mental Hosp, Haar, Germany; [Amin, Farooq] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Amin, Farooq] Atlanta Vet Affairs Med Ctr, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Black, Donald W.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Borglum, Anders D.; Demontis, Ditte] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Borglum, Anders D.; Mors, Ole] Aarhus Univ Hosp, Ctr Psychiat Res, Risskov, Denmark; [Brown, Matthew A.; Danoy, Patrick A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Bruggeman, Richard; Wiersma, Durk] Univ Groningen, Dept Psychiat, Univ Med Ctr Groningen, NL-9712 TS Groningen, Netherlands; [Buccola, Nancy G.] Louisiana State Univ, Sch Nursing, Hlth Sci Ctr, New Orleans, LA USA; [Byerley, William F.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Byerley, William F.] NCIRE, San Francisco, CA USA; [Cahn, Wiepke; Kahn, Renes] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Carr, Vaughan J.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Carr, Vaughan J.; Michie, Patricia T.; Schall, Ulrich] Schizophrenia Res Inst, Sydney, NSW, Australia; [Catts, Stanley V.] Univ Queensland, Dept Psychiat, Royal Brisbane Hosp, Brisbane, Qld, Australia; [Cloninger, C. Robert] Washington Univ, Dept Psychiat, St Louis, MO USA; [De Haan, Lieuwe; Linszen, Don H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Dikeos, Dimitris; Papadimitriou, George] Univ Athens, Sch Med, Dept Psychiat, GR-11527 Athens, Greece; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Donnelly, Peter; Spencer, Chris C. A.; Strange, Amy] Wellcome Trust Ctr Human Genet, Oxford, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Fink-Jensen, Anders] Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Freedman, Robert; Olincy, Ann] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Glenthoj, Birte] Copenhagen Univ Hosp, Mental Hlth Ctr Glostrup, Ctr Clin Intervent & Neuropsychiat Schizophrenia, Glostrup, Denmark; [Godard, Stephanie] Hop La Pitie Salpetriere, INSERM, Inst Myol, Paris, France; [Hansen, Mark] Illumina Inc, La Jolla, CA USA; [Henskens, Frans A.] Univ Newcastle, School Elect Engn & Comp Sci, Newcastle, NSW 2300, Australia; [Hougaard, David M.] State Serum Inst, Dept Clin Chem & Immunol, Sect Neonatal Screening & Hormones, Copenhagen, Denmark; [Hultman, Christina M.; Lichtenstein, Paul; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Jablensky, Assen V.] Univ Western Australia, Ctr Clin Res Neuropsychiat, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Jay, Maurice; Laurent, Claudine] Pierre & Marie Curie Fac Med, Dept Child & Adolescent Psychiat, Paris, France; [Juergens, Gesche] Bispebjerg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Keller, Matthew C.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Kenis, Gunter; van Winkel, Ruud] Maastricht Univ Med Ctr, S Limburg Mental Hlth Res & Teaching Network SEAR, European Grad Sch Neurosci EURON, Dept Psychiat & Psychol,Sch Mental Hlth & Neurosc, Maastricht, Netherlands; [Kim, Yunjung; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Krabbendam, Lydia; Myin-Germeys, Inez; van Os, Jim] Maastricht Univ Med Ctr, S Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands; [Lasseter, Virginia K.; Nestadt, Gerald; Pulver, Ann E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Lerer, F. Bernard] Hadassah Hebrew Univ Med Ctr, Dept Psychiat, Jerusalem, Israel; [Liang, Kung-Yee] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lieberman, Jeffrey A.; Stroup, T. Scott] Columbia Univ, Dept Psychiat, New York, NY USA; [Lonnqvist, Jouko; Suvisaari, Jaana] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Loughland, Carmel M.] Univ Newcastle, Schizophrenia Res Inst, Sydney & Ctr Brain & Mental Hlth Res, Newcastle, NSW 2300, Australia; [Maier, Wolfgang; Rietschel, Marcella] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Mallet, Jacques] Hop La Pitie Salpetriere, CNRS, Lab Genet Mol Neurotransmiss & Proc Neurodegener, Paris, France; [Mattheisen, Manuel] Univ Bonn, IMBIE, D-5300 Bonn, Germany; [Mattingsdal, Morten] Sorlandet Hosp, Dept Res, Kristiansand, Norway; [McLean, Duncan E.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Queensland, Australia; [Michie, Patricia T.] Univ Newcastle, Sch Psychol, Funct NeuroImaging Lab, Sydney, NSW, Australia; [Milanova, Vihra] Alexander Univ Hosp, Psychiat Clin 1, Dept Psychiat, Sofia, Bulgaria; [Mortensen, Preben B.] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Muglia, Pierandrea] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Muglia, Pierandrea] NeuroSearch AS, Ballerup, Denmark; [Nielsen, Jimmi] Aalborg Psychiat Hosp, Unit Psychiat Res, Aalborg, Denmark; [Nordentoft, Merete] Copenhagen Univ Hosp, Psychiat Ctr Copenhagen, Copenhagen, Denmark; [O'Neill, F. Anthony] Queens Univ, Dept Psychiat, Belfast, Antrim, North Ireland; [Orntoft, Torben F.] ARoS Appl Biotechnol AS, Skejby, Denmark; [Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Pantelis, Christos] Univ Melbourne & Melbourne Hlth, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Australia; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Petursson, Hannes; Sigurdsson, Engilbert] Natl Univ Hosp Reykjavik, Dept Psychiat, Reykjavik, Iceland; [Pickard, Ben] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Quested, Digby] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Rietschel, Marcella; Schulze, Thomas G.] Heidelberg Univ, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; [Schall, Ulrich] Univ Newcastle, Prior Ctr Brain & Mental Hlth Res, Sydney, NSW, Australia; [Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany; [Schwab, Sibylle G.; Wildenauer, Dieter B.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Schwab, Sibylle G.] Univ Erlangen Nurnberg, Dept Psychiat, Erlangen, Germany; [Schwab, Sibylle G.] Univ Western Australia, Western Australian Inst Med Res, Ctr Med Res, Perth, WA 6009, Australia; [Scott, Rodney J.] Univ Newcastle, Ctr Informat Based Med, Hunter Med Res Inst, Newcastle & Schizophrenia Res Inst, Sydney, NSW, Australia; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Sigurdsson, Engilbert] Univ Iceland, Dept Psychiat, Reykjavik, Iceland; [Silverman, Jeremy M.] Vet Affairs Med Ctr, Dept Psychiat, New York, NY USA; [Thirumalai, Srinivasa] W Berkshire Natl Hlth Serv NHS Trust, Reading, Berks, England; [Timm, Sally] Copenhagen Univ Hosp, Mental Hlth Ctr Frederiksberg, Copenhagen, Denmark; [Toncheva, Draga] Univ Hosp Maichin Dom, Dept Med Genet, Sofia, Bulgaria; [van den Oord, Edwin] Virginia Commonwealth Univ, Dept Pharm, Richmond, VA USA; [Veldink, Jan] Univ Medisch Ctr UMC Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Walsh, Dermot] Hlth Res Board, Dublin, Ireland; [Wang, August G.] Copenhagen Univ Hosp, Mental Hlth Ctr Amager, Copenhagen, Denmark; [Wildenauer, Dieter B.] Graylands Hosp, Ctr Clin Res Neuropsychiat, Mt Claremont, WA, Australia; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	NorthShore University Health System; Harvard University; Massachusetts General Hospital; University of Chicago; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Stanford University; Icahn School of Medicine at Mount Sinai; Cardiff University; Cardiff University; University of North Carolina; University of North Carolina Chapel Hill; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oslo; University of Oslo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Bonn; Helmholtz Association; Research Center Julich; University of Bonn; University of Aberdeen; Trinity College Dublin; University of London; University College London; UCL Medical School; University of Copenhagen; University of Munich; Royal Infirmary of Edinburgh; University of Edinburgh; University of Southern California; Northwell Health; Northwell Health; Yeshiva University; University of London; London School of Hygiene & Tropical Medicine; QIMR Berghofer Medical Research Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Russian Academy of Medical Sciences; KU Leuven; Karolinska Institutet; Karolinska University Hospital; Semmelweis University; University of Helsinki; University of Helsinki; University of London; King's College London; University of Verona; Diakonhjemmet Hospital; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Iowa; Aarhus University; Aarhus University; University of Queensland; University of Groningen; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California San Francisco; Northern California Institute for Research & Education; Utrecht University; Utrecht University Medical Center; University of New South Wales Sydney; Royal Brisbane & Women's Hospital; University of Queensland; Washington University (WUSTL); University of Amsterdam; Academic Medical Center Amsterdam; Athens Medical School; National & Kapodistrian University of Athens; University of Oslo; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Copenhagen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Illumina; University of Newcastle; Statens Serum Institut; Karolinska Institutet; University of Western Australia; UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; Bispebjerg Hospital; University of Colorado System; University of Colorado Boulder; Maastricht University; Maastricht University Medical Centre (MUMC); University of North Carolina; University of North Carolina Chapel Hill; Maastricht University; Maastricht University Medical Centre (MUMC); Johns Hopkins University; Hebrew University of Jerusalem; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; Finland National Institute for Health & Welfare; University of Newcastle; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Bonn; Queensland Centre for Mental Health Research; University of Newcastle; Medical University Sofia; Aarhus University; University of Toronto; Aalborg University; Aalborg University Hospital; Aarhus University; University of Copenhagen; Queens University Belfast; Aarhus University; University of Melbourne; Wellcome Trust Sanger Institute; Landspitali National University Hospital; University of Strathclyde; University of Oxford; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Newcastle; University of Gottingen; University of Western Australia; University of Erlangen Nuremberg; University of Western Australia; Hunter Medical Research Institute; University of Newcastle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iceland; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Copenhagen; Medical University Sofia; Virginia Commonwealth University; Utrecht University; Utrecht University Medical Center; Health Research Board - Ireland; University of Copenhagen; University of Western Australia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gejman, PV (corresponding author), NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, Evanston, IL USA.	pgejman@gmail.com	O'Donovan, Michael C/P-7005-2018; Daly, Mark J/B-2453-2017; Jürgens, Gesche/AAG-4897-2021; Gurling, Hugh M/A-5029-2010; Cichon, Sven/B-9618-2014; Williams, Hywel/AAL-2440-2021; O'Neill, Francis A/C-5582-2008; Bergen, Sarah/I-8313-2012; Maher, Brion S/F-9185-2010; De Hert, Marc/AAH-6090-2021; Nielsen, Jimmi/G-2990-2010; Glenthøj, Birte Y/G-3391-2012; Morris, Derek/AAW-8343-2021; Lencz, Todd/J-3418-2014; Hansen, Thomas Folkmann/O-5965-2014; Melle, Ingrid S/B-4858-2011; Pantelis, Christos/H-7722-2014; Mortensen, Preben B/D-2358-2015; Kendler, Kenneth/AAF-2876-2019; Holmans, Peter/F-4518-2015; Hougaard, David/AAD-6368-2019; Scott, Rodney J/B-2827-2013; Tosato, Sarah/E-6045-2010; Amdur, Richard L/AAE-5345-2019; Collier, David A/D-1649-2011; blackwood, douglas/AIB-8874-2022; Werge, Thomas/G-7263-2012; Hartmann, Annette/AAS-6331-2021; Fanous, Ayman H/O-1263-2017; Visscher, Peter/ABB-6151-2020; Bitter, Istvan/J-8196-2017; Giegling, Ina/ABA-3677-2021; Liang, Kung-Yee/F-8299-2011; Ingason, Andres/G-6817-2012; Mattheisen, Manuel/B-4949-2012; Stroup, Thomas S/F-9188-2014; Cahn, W/B-5743-2013; van Os, Jim/I-9496-2012; Lieberman, Jeffrey/AAY-8239-2020; Jürgens, Gesche/AAC-3610-2020; Silverman, Jeremy M./AAO-4268-2020; Ripke, Stephan/AAK-5486-2021; Stefansson, Kari/AAE-7187-2019; Pickard, Benjamin S/K-3923-2014; Schulze, Thomas G/H-2157-2013; SCHALL, ULRICH ANDREAS/G-7452-2013; McQuillin, Andrew/C-1623-2008; Mattheisen, Manuel/S-3725-2019; Konte, Bettina/AAT-1142-2021; Golimbet, V/E-2328-2016; Ruderfer, Douglas M/M-5795-2016; McGrath, John Joseph/G-5493-2010; Demontis, Ditte/M-4515-2013; McIntosh, Andrew M/B-9379-2008; Mattingsdal, Morten/Q-9367-2016; Stroup, Thomas/AAB-7780-2019; Myin-Germeys, Inez/L-5106-2014; Jablensky, Assen/H-5116-2014; Muglia, Pierandrea/ABD-9235-2020; Cichon, Sven/H-8803-2013; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Catts, Stanley V/G-6917-2013; Brown, Matthew A/E-5749-2010; Donohoe, Gary/J-6481-2013; Nordentoft, Merete/AAH-3253-2019; van Os, Jim/V-8884-2019; Rujescu, Dan/GRS-3875-2022; Andreassen, Ole A./AAY-7531-2020; Cloninger, Claude/F-5357-2012; Sigurdsson, Engilbert/D-2486-2014; Mowry, Bryan/G-5046-2010; krabbendam, lydia/F-9163-2010	O'Donovan, Michael C/0000-0001-7073-2379; Daly, Mark J/0000-0002-0949-8752; Cichon, Sven/0000-0002-9475-086X; Williams, Hywel/0000-0001-7758-0312; O'Neill, Francis A/0000-0002-7531-7657; Bergen, Sarah/0000-0002-5888-0034; Morris, Derek/0000-0002-3413-570X; Lencz, Todd/0000-0001-8586-338X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Melle, Ingrid S/0000-0002-9783-548X; Pantelis, Christos/0000-0002-9565-0238; Mortensen, Preben B/0000-0002-5230-9865; Holmans, Peter/0000-0003-0870-9412; Scott, Rodney J/0000-0001-7724-3404; Tosato, Sarah/0000-0002-9665-7538; Collier, David A/0000-0003-4087-1559; Visscher, Peter/0000-0002-2143-8760; Bitter, Istvan/0000-0002-9464-4709; Mattheisen, Manuel/0000-0002-8442-493X; Stroup, Thomas S/0000-0002-3123-0672; van Os, Jim/0000-0002-7245-1586; Jürgens, Gesche/0000-0002-3317-8118; Pickard, Benjamin S/0000-0002-2374-6329; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; McQuillin, Andrew/0000-0003-1567-2240; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Golimbet, V/0000-0002-9960-7114; Ruderfer, Douglas M/0000-0002-2365-386X; McGrath, John Joseph/0000-0002-4792-6068; McIntosh, Andrew M/0000-0002-0198-4588; Mattingsdal, Morten/0000-0003-4440-0324; Stroup, Thomas/0000-0002-3123-0672; Jablensky, Assen/0000-0003-0602-6810; Muglia, Pierandrea/0000-0002-3973-8606; Cichon, Sven/0000-0002-9475-086X; Brown, Matthew A/0000-0003-0538-8211; Donohoe, Gary/0000-0003-3037-7426; van Os, Jim/0000-0002-7245-1586; Cloninger, Claude/0000-0003-3096-4807; Sigurdsson, Engilbert/0000-0001-9404-7982; Djurovic, Srdjan/0000-0002-8140-8061; Rethelyi, Janos/0000-0002-3641-012X; Fink-Jensen, Anders/0000-0001-7143-1236; lichtenstein, paul/0000-0003-3037-5287; Mowry, Bryan/0000-0002-4115-5645; Glenthoj, Birte/0000-0003-3056-7262; Toncheva, Draga/0000-0002-7451-6363; McLean, Duncan/0000-0002-1125-8424; Escott-Price, Valentina/0000-0003-1784-5483; Amdur, Richard/0000-0002-4900-653X; Borglum, Anders/0000-0001-8627-7219; krabbendam, lydia/0000-0003-4074-5149; KELLER, MATTHEW/0000-0002-6075-9882; Mors, Ole/0000-0002-5660-0393; Andreassen, Ole A./0000-0002-4461-3568; Freedman, Robert/0000-0002-2181-2898; Walters, James/0000-0002-6980-4053; Posthuma, Danielle/0000-0001-7582-2365; Buccola, Nancy/0000-0003-1378-4636; Suvisaari, Jaana/0000-0001-7167-0990; Stefansson, Hreinn/0000-0002-9331-6666; Jonsson, Erik/0000-0001-8368-6332; Nothen, Markus/0000-0002-8770-2464; Agartz, Ingrid/0000-0002-9839-5391; Gill, Michael/0000-0003-0206-5337; Black, Donald/0000-0001-8038-1971; Wang, August G./0000-0003-4518-0466; Zammit, Stanley/0000-0002-2647-9211; Myin-Germeys, Inez/0000-0002-3731-4930; Demontis, Ditte/0000-0001-9124-2766; Kirov, George/0000-0002-3427-3950; Bruggeman, Richard/0000-0002-3238-8471; Corvin, Aiden/0000-0001-6717-4089; De Hert, Marc/0000-0003-4255-5920; Henskens, Frans/0000-0003-2358-5630; Thygesen, Johan H/0000-0002-7479-3459; Quested, Digby/0000-0001-6155-3336	US National Institutes of Health; Medical Research Council [G9817803B, G1000718, G0801418B, G0800509, G1000708] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA142538, R01CA082659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047845, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079470, U01MH085520, K01MH085812, R01MH083094, U01MH085518, R01MH060879, R01MH085548, U01MH046289, R01MH077139, R01MH058693, R01MH067257, R01MH080403, U01MH046318, R01MH059587, R01MH061884, U01MH094421, R01MH079800, R01MH061675, R01MH068921, U01MH085515, R01MH062276, R01MH071681, R01MH068881, R01MH052618, K23MH001760, R01MH078075, R01MH074027, R01MH059586, R01MH060870, R01MH059566, R01MH059588, U01MH046276, P30MH074543, R01MH084098, P50MH066392] Funding Source: NIH RePORTER; MRC [G0800509, G1000718, G1000708] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the study participants and the research staff at the many study sites. Over 40 US National Institutes of Health grants and similar numbers of government grants from other countries, along with substantial private and foundation support, enabled this work. We greatly appreciate the sustained efforts of T. Lehner (National Institute of Mental Health) on behalf of the Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (PGC). Detailed acknowledgments, including grant support, are listed in the Supplementary Note.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Potkin SG, 2010, NEUROIMAGE, V53, P839, DOI 10.1016/j.neuroimage.2010.06.036; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ruderfer DM, 2011, MOL PSYCHIATR, V16, P887, DOI 10.1038/mp.2011.34; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	32	1420	1449	6	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					969	976		10.1038/ng.940	http://dx.doi.org/10.1038/ng.940			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21926974	Green Published, Green Accepted			2022-12-25	WOS:000295316200011
J	Roy, H; Zou, SB; Bullwinkle, TJ; Wolfe, BS; Gilreath, MS; Forsyth, CJ; Navarre, WW; Ibba, M				Roy, Herve; Zou, S. Betty; Bullwinkle, Tammy J.; Wolfe, Benjamin S.; Gilreath, Marla S.; Forsyth, Craig J.; Navarre, William W.; Ibba, Michael			The tRNA synthetase paralog PoxA modifies elongation factor-P with (R)-beta-lysine	NATURE CHEMICAL BIOLOGY			English	Article							FACTOR EF-P; TRANSLATION ELONGATION; SALMONELLA-ENTERICA; PEPTIDE-BOND; CLASS-I; LYSINE; RECOGNITION; MECHANISM; VIRULENCE; RIBOSOME	The lysyl-tRNA synthetase paralog PoxA modifies elongation factor P (EF-P) with alpha-lysine at low efficiency. Cell-free extracts containing non-alpha-lysine substrates of PoxA modified EF-P with a change in mass consistent with addition of beta-lysine, a substrate also predicted by genomic analyses. EF-P was efficiently functionally modified with (R)-beta-lysine but not (S)-beta-lysine or genetically encoded alpha-amino acids, indicating that PoxA has evolved an activity orthogonal to that of the canonical aminoacyl-tRNA synthetases.	[Roy, Herve; Bullwinkle, Tammy J.; Ibba, Michael] Ohio State Univ, Dept Microbiol, Ctr RNA Biol, Columbus, OH 43210 USA; [Zou, S. Betty; Navarre, William W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Wolfe, Benjamin S.; Forsyth, Craig J.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Gilreath, Marla S.; Ibba, Michael] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Toronto; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, Ctr RNA Biol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu		Navarre, William/0000-0002-9293-9220	US National Institutes of Health [GM65183]; Canada Institutes for Health Research [MOP-86683, MSH-87729]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; Ohio State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Michael Thomas (University of Wisconsin) for the generous gift of (S)-beta-lysine. This work was supported by the US National Institutes of Health (GM65183, M. I.), the Canada Institutes for Health Research (MOP-86683 and MSH-87729, W.W.N.) and the Natural Sciences and Engineering Research Council of Canada (RGPIN 386286-10, W.W.N.; Vanier Graduate Scholarship, S.B.Z). We also acknowledge The Ohio State University for partial financial support.	Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0; Ambrogelly A, 2010, FEBS LETT, V584, P3055, DOI 10.1016/j.febslet.2010.05.036; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Aravind L, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-48; Ataide SF, 2004, BIOCHEMISTRY-US, V43, P11836, DOI 10.1021/bi0490542; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Commans S, 1998, J MOL BIOL, V278, P801, DOI 10.1006/jmbi.1998.1711; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FRANCKLYN C, 2005, AMINOACYL TRNA SYNTH, P285; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sakurama H, 2009, J BIOCHEM, V145, P555, DOI 10.1093/jb/mvp014; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P2335, DOI 10.1093/nar/20.9.2335; Vetting MW, 2010, NAT CHEM BIOL, V6, P797, DOI 10.1038/NCHEMBIO.440; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889	25	72	75	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					667	669		10.1038/NCHEMBIO.632	http://dx.doi.org/10.1038/NCHEMBIO.632			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21841797	Green Accepted, Green Submitted			2022-12-25	WOS:000295027100009
J	Zhang, HJ; Abraham, N; Khan, LA; Hall, DH; Fleming, JT; Gobel, V				Zhang, Hongjie; Abraham, Nessy; Khan, Liakot A.; Hall, David H.; Fleming, John T.; Goebel, Verena			Apicobasal domain identities of expanding tubular membranes depend on glycosphingolipid biosynthesis	NATURE CELL BIOLOGY			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EPITHELIAL-CELLS; C-ELEGANS; BRANCHED-CHAIN; FATTY-ACID; ENDOPLASMIC-RETICULUM; GOLGI-COMPLEX; POLARITY; SPHINGOLIPIDS; TRAFFICKING	Metazoan internal organs are assembled from polarized tubular epithelia that must set aside an apical membrane domain as a lumenal surface. In a global Caenorhabditis elegans tubulogenesis screen, interference with several distinct fatty-acid-biosynthetic enzymes transformed a contiguous central intestinal lumen into multiple ectopic lumens. We show that multiple-lumen formation is caused by apicobasal polarity conversion, and demonstrate that in situ modulation of lipid biosynthesis is sufficient to reversibly switch apical domain identities on growing membranes of single post-mitotic cells, shifting lumen positions. Follow-on targeted lipid-biosynthesis pathway screens and functional genetic assays were designed to identify a putative single causative lipid species. They demonstrate that fatty-acid biosynthesis affects polarity through sphingolipid synthesis, and reveal ceramide glucosyltransferases (CGTs) as end-point biosynthetic enzymes in this pathway. Our findings identify glycosphingolipids, CGT products and obligate membrane lipids, as critical determinants of in vivo polarity and indicate that they sort new components to the expanding apical membrane.	[Zhang, Hongjie; Abraham, Nessy; Khan, Liakot A.; Fleming, John T.; Goebel, Verena] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Zhang, Hongjie; Abraham, Nessy; Khan, Liakot A.; Fleming, John T.; Goebel, Verena] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hall, David H.] Albert Einstein Coll Med, Dept Neurosci, Ctr Elegans Anat C, Bronx, NY 10461 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Gobel, V (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.	gobel@helix.mgh.harvard.edu		Zhang, Hongjie/0000-0002-1474-5658	IBD [DK43351]; BA DE [DK57521]; NIH [HD044589, GM078653]; Mattina R. Proctor Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD044589] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078653] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	IBD; BA DE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mattina R. Proctor Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Strains and plasmids were provided by D. Bail lie (Fraser University, Burnaby, British Columbia, Canada), A. Croce (IFOM Istituto FIRC di Oncologia Molecolare, Milan, Italy), B. Grant (Rutgers University, Piscataway, New Jersey, USA), K. Kemphues (Cornell University, Ithaca, New York, USA), K. Nehrke (University of Rochester Medical Center, Rochester New York, USA), G. Ruvkun (Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA), K. Strange (Vanderbilt University Medical Center, Salisbury Cove Maine, USA), J. Simske (Case Western Reserve University School of Medicine, Cleveland, Ohio, USA), S. Mitani (National Bioresource Project Japan) and the Caenorhabditis Genetics Center (NIH Center for Research Resources). We thank G. Ruvkun for the lethal RNAi library, and J. Moore (Avanti Polar Lipids); Mary McKee (MGH Microscopy Core/partially funded by the IBD grant DK43351 and BA DE award DK57521) and K. Nygen; Christopher Crocker; and Edward Membreno for contributions to LC/MS; TEM; illustrations and C. elegans maintenance, respectively. We thank F. Solomon and B. Winckler for critical reading of the manuscript and H. Weinstein and A. Walker for ongoing support. This work was supported by NIH grants HD044589 and GM078653 and a Mattina R. Proctor Award to V.G.	Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; CHITWOOD DJ, 1995, LIPIDS, V30, P567, DOI 10.1007/BF02537032; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Entchev EV, 2008, J BIOL CHEM, V283, P17550, DOI 10.1074/jbc.M800965200; Furukawa K, 2004, SEMIN CELL DEV BIOL, V15, P389, DOI 10.1016/j.semcdb.2004.03.006; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gerdt S, 1997, GLYCOBIOLOGY, V7, P265, DOI 10.1093/glycob/7.2.265; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Hall DH, 1995, METHOD CELL BIOL, V48, P395; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hoekstra D, 2003, J LIPID RES, V44, P869, DOI 10.1194/jlr.R300003-JLR200; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Kuervers LM, 2003, MOL GENET GENOMICS, V270, P121, DOI 10.1007/s00438-003-0900-9; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lippincott-Schwartz J, 2010, ANNU REV BIOPHYS, V39, P559, DOI 10.1146/annurev.biophys.093008.131357; Lynch AM, 2009, FRONT BIOSCI-LANDMRK, V14, P1414, DOI 10.2741/3316; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Martin-Belmonte F, 2009, INT REV CEL MOL BIO, V274, P129, DOI 10.1016/S1937-6448(08)02003-0; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Marza E, 2009, J CELL SCI, V122, P822, DOI 10.1242/jcs.042754; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nomura KH, 2011, GLYCOBIOLOGY, V21, P834, DOI 10.1093/glycob/cwr019; Onelli E, 2008, J EXP BOT, V59, P3051, DOI 10.1093/jxb/ern154; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Rao RP, 2008, PROSTAG OTH LIPID M, V85, P1, DOI 10.1016/j.prostaglandins.2007.10.002; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Seamen E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000589; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Sullards MC, 2003, CELL MOL BIOL, V49, P789; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; van Ijzendoorn SCD, 2004, MOL BIOL CELL, V15, P4115, DOI 10.1091/mbc.E04-04-0290; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance DE, 2008, N COMP BIOC, P1; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wandall HH, 2005, J BIOL CHEM, V280, P4858, DOI 10.1074/jbc.C400571200; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	70	88	108	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1189	U68		10.1038/ncb2328	http://dx.doi.org/10.1038/ncb2328			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21926990	Green Accepted			2022-12-25	WOS:000295617900009
J	Scaffidi, P; Misteli, T				Scaffidi, Paola; Misteli, Tom			In vitro generation of human cells with cancer stem cell properties	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; INITIATING CELLS; TRANSFORMATION; IDENTIFICATION; LEUKEMIA; DIFFERENTIATION; MEDULLOBLASTOMA; FIBROBLASTS; BLASTOCYSTS; EXPRESSION	Cancer stem cells (CSCs) have been implicated in the maintenance and progression of several types of cancer. The origin and cellular properties of human CSCs are poorly characterized. Here we show that CSC-like cells can be generated in vitro by oncogenic reprogramming of human somatic cells during neoplastic transformation. We find that in vitro transformation confers stem-cell properties to primary differentiated fibroblasts, including the ability to self-renew and to differentiate along multiple lineages. Tumours induced by transformed fibroblasts are hierarchically organized, and the cells that act as CSCs to initiate and maintain tumour growth are marked by the stage-specific embryonic antigen SSEA-1. Heterogeneous lineages of cancer cells in the bulk of the tumour arise through differentiation of SSEA-1 fibroblasts, and differentiation is associated with loss of tumorigenic potential. These findings establish an experimental system to characterize cellular and molecular properties of human CSCs and demonstrate that somatic cells have the potential to de-differentiate and acquire properties of CSCs.	[Scaffidi, Paola; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scaffidi, P (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	scaffidp@mail.nih.gov	Scaffidi, Paola/GRS-9019-2022	Scaffidi, Paola/0000-0002-3642-4193	National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Lee for instruction in mice injections, K. McKinnon (NCI CCR Vaccine Branch FAGS Core Facility) for support with flow cytometry, P. Adams, R. A. Weinberg and L. Li for providing reagents and X. Wu for help with microarray analysis. This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Corso C, 2005, CYTOGENET GENOME RES, V111, P27, DOI 10.1159/000085666; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FIALKOW PJ, 1978, J CLIN INVEST, V62, P815, DOI 10.1172/JCI109193; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Holliday DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1775; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perez-Caro M, 2009, EMBO J, V28, P8, DOI 10.1038/emboj.2008.253; Rajasekhar Vinagolu K., 2007, V407, P83, DOI 10.1007/978-1-59745-536-7_7; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ross DD, 2010, METHODS MOL BIOL, V596, P251, DOI 10.1007/978-1-60761-416-6_12; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Singh SK, 2003, CANCER RES, V63, P5821; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	42	94	97	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1051	U72		10.1038/ncb2308	http://dx.doi.org/10.1038/ncb2308			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21857669	Green Accepted			2022-12-25	WOS:000294487000009
J	Mills, AE; Tereskerz, P				Mills, Ann E.; Tereskerz, Patti			Human DNA patent renewals on the decline	NATURE BIOTECHNOLOGY			English	Editorial Material							HUMAN GENOME		[Mills, Ann E.; Tereskerz, Patti] Univ Virginia, Ctr Biomed Eth, Charlottesville, VA 22903 USA	University of Virginia	Mills, AE (corresponding author), Univ Virginia, Ctr Biomed Eth, Charlottesville, VA 22903 USA.	amh2r@virginia.edu						*BRIEF DEP JUST AM, 2010, ASS MOL PATH, P185; *BRIF BIOT IND ORG, 2010, ASS MOL PATH, P185; Carbone J, 2010, NAT BIOTECHNOL, V28, P784, DOI 10.1038/nbt0810-784; CRICHTON M, 2007, NY TIMES        0213; DUNCAN DE, 2010, DNA PATENT DEAD FORT; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kean S, 2011, SCIENCE, V331, P530, DOI 10.1126/science.331.6017.530; Lemley MA, 2001, NORTHWEST U LAW REV, V95, P1495; Mills AE, 2008, NAT BIOTECHNOL, V26, P993, DOI 10.1038/nbt0908-993; Secretary's Advisory Committee on Genetics Health and Society, 2010, REP GEN PAT LIC PRAC	10	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					711	714		10.1038/nbt.1930	http://dx.doi.org/10.1038/nbt.1930			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21822245				2022-12-25	WOS:000293696500020
J	Sun, L; Xie, HM; Mori, MA; Alexander, R; Yuan, BB; Hattangadi, SM; Liu, QQ; Kahn, CR; Lodish, HF				Sun, Lei; Xie, Huangming; Mori, Marcelo A.; Alexander, Ryan; Yuan, Bingbing; Hattangadi, Shilpa M.; Liu, Qingqing; Kahn, C. Ronald; Lodish, Harvey F.			Mir193b-365 is essential for brown fat differentiation	NATURE CELL BIOLOGY			English	Article							ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; TRANSGENIC MICE; PPAR-ALPHA; OBESITY; EXPRESSION; RECEPTOR; GENE; ADIPOGENESIS; ABLATION	Mammals have two principal types of fat. White adipose tissue primarily serves to store extra energy as triglycerides, whereas brown adipose tissue is specialized to burn lipids for heat generation and energy expenditure as a defence against cold and obesity(1,2). Recent studies have demonstrated that brown adipocytes arise in vivo from a Myf5-positive, myoblastic progenitor by the action of Prdm16 (PR domain containing 16). Here, we identified a brown-fat-enriched miRNA cluster, MiR-193b-365, as a key regulator of brown fat development. Blocking miR-193b and/or miR-365 in primary brown preadipocytes markedly impaired brown adipocyte adipogenesis by enhancing Runx1t1 (runt-related transcription factor 1; translocated to, 1) expression, whereas myogenic markers were significantly induced. Forced expression of Mir193b and/or Mir365 in C2C12 myoblasts blocked the entire programme of myogenesis, and, in adipogenic conditions, miR-193b induced myoblasts to differentiate into brown adipocytes. Mir193b-365 was upregulated by Prdm16 partially through Ppar alpha. Our results demonstrate that Mir193b-365 serves as an essential regulator for brown fat differentiation, in part by repressing myogenesis.	[Sun, Lei; Xie, Huangming; Alexander, Ryan; Yuan, Bingbing; Hattangadi, Shilpa M.; Liu, Qingqing; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Xie, Huangming] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117576, Singapore; [Mori, Marcelo A.; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res,Sect Integrat Physiol & Metab, Boston, MA 02115 USA; [Alexander, Ryan; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hattangadi, Shilpa M.] Boston Childrens Hosp, Dept Hematol, Boston, MA 02115 USA; [Lodish, Harvey F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	Kahn, Ronald/AAY-2435-2021; Mori, Marcelo A/R-2881-2018; Xie, Huangming/B-2260-2012; liu, qingqing/HHD-0360-2022	Kahn, Ronald/0000-0002-7583-9228; Mori, Marcelo A/0000-0001-7112-5263; 	NIH [DK047618, DK 068348, DK076848, 5P01 HL066105]; Singapore-MIT Alliance (SMA) [C-382-641-001-091]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047618, R01DK082659, R37DK047618, R56DK068348, K08DK076848, R01DK068348] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance (SMA)(Singapore-MIT Alliance for Research & Technology Centre (SMART)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by NIH grants DK047618, DK 068348, DK076848 and 5P01 HL066105, grant C-382-641-001-091 from the Singapore-MIT Alliance (SMA) and a graduate fellowship from SMA. Thanks for intellectual support, materials and advice from members of the laboratories of Drs P. Seale, D. Bartel and C. Emerson, and from all members of the Lodish laboratory. Thanks to Rochford's laboratory for their generous gifts of Runx1t1 plasmid.	Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Cannon B, 2000, METH MOL B, V155, P213; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; CONNOLLY E, 1982, BRIT J NUTR, V47, P653, DOI 10.1079/BJN19820077; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; HOGAN S, 1980, AM J PHYSIOL, V239, pE301; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE776, DOI 10.1152/ajpendo.1996.270.5.E776; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; RODBELL M, 1964, J BIOL CHEM, V239, P375; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tong YH, 2005, BIOCHEM BIOPH RES CO, V336, P76, DOI 10.1016/j.bbrc.2005.08.041; Tseng YH, 2002, J BIOL CHEM, V277, P31601, DOI 10.1074/jbc.M202932200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	40	236	256	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					958	U198		10.1038/ncb2286	http://dx.doi.org/10.1038/ncb2286			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21743466	Green Submitted, Green Accepted			2022-12-25	WOS:000293373700014
J	Filipovska, A; Razif, MFM; Nygard, KKA; Rackham, O				Filipovska, Aleksandra; Razif, Muhammad F. M.; Nygard, Karoline K. A.; Rackham, Oliver			A universal code for RNA recognition by PUF proteins	NATURE CHEMICAL BIOLOGY			English	Article							PUMILIO-HOMOLOGY DOMAIN; BINDING PROTEINS; 3-HYBRID SYSTEM; GENE-EXPRESSION; MESSENGER-RNAS; MECHANISMS; YEAST; CELL	The design of proteins that can bind any RNA sequence of interest has many potential biological and medical applications. Here we have expanded the recognition of Pumilio and FBF homology protein (PUF) repeats beyond adenine, guanine and uracil and evolved them to specifically bind cytosine. These repeat sequences can be used to create PUF domains capable of selectively binding RNA targets of diverse sequence and structure.	[Filipovska, Aleksandra] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Filipovska, A (corresponding author), Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia.	rackham@waimr.uwa.edu.au	Razif, Muhammad Fazril Mohamad/AAR-8101-2021; Rackham, Oliver/E-1264-2013; Razif, Muhammad Fazril Mohamad/K-4968-2016; Rackham, Oliver/AGO-0005-2022	Razif, Muhammad Fazril Mohamad/0000-0002-3951-8136; Rackham, Oliver/0000-0002-5301-9624; Razif, Muhammad Fazril Mohamad/0000-0002-3951-8136; Rackham, Oliver/0000-0002-5301-9624; Filipovska, Aleksandra/0000-0002-6998-8403	Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank M. Wickens (University of Wisconsin-Madison) for the YBZ1 yeast strain, T. Ito (University of Tokyo) for the pGAD-RC plasmid, R. King for advice on oligonucleotide synthesis with trimer phosphoramidites and K. L. Hamilton for technical assistance. This work was supported by fellowships and grants from the Australian Research Council and the National Health and Medical Research Council.	Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Filipovska A, 2008, ACS CHEM BIOL, V3, P51, DOI 10.1021/cb700185e; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gupta YK, 2008, STRUCTURE, V16, P549, DOI 10.1016/j.str.2008.01.006; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Tilsner J, 2009, PLANT J, V57, P758, DOI 10.1111/j.1365-313X.2008.03720.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; Zamore PD, 1997, RNA, V3, P1421; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	25	130	141	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					425	427		10.1038/NCHEMBIO.577	http://dx.doi.org/10.1038/NCHEMBIO.577			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21572425				2022-12-25	WOS:000292252100007
J	Grabherr, MG; Haas, BJ; Yassour, M; Levin, JZ; Thompson, DA; Amit, I; Adiconis, X; Fan, L; Raychowdhury, R; Zeng, QD; Chen, ZH; Mauceli, E; Hacohen, N; Gnirke, A; Rhind, N; di Palma, F; Birren, BW; Nusbaum, C; Lindblad-Toh, K; Friedman, N; Regev, A				Grabherr, Manfred G.; Haas, Brian J.; Yassour, Moran; Levin, Joshua Z.; Thompson, Dawn A.; Amit, Ido; Adiconis, Xian; Fan, Lin; Raychowdhury, Raktima; Zeng, Qiandong; Chen, Zehua; Mauceli, Evan; Hacohen, Nir; Gnirke, Andreas; Rhind, Nicholas; di Palma, Federica; Birren, Bruce W.; Nusbaum, Chad; Lindblad-Toh, Kerstin; Friedman, Nir; Regev, Aviv			Full-length transcriptome assembly from RNA-Seq data without a reference genome	NATURE BIOTECHNOLOGY			English	Article							SCHIZOSACCHAROMYCES-POMBE; EUKARYOTIC TRANSCRIPTOME; MESSENGER-RNA; ALIGNMENT; GENE; RESOURCE; REVEALS; PROTEIN; YEAST; TOOL	Massively parallel sequencing of cDNA has enabled deep and efficient probing of transcriptomes. Current approaches for transcript reconstruction from such data often rely on aligning reads to a reference genome, and are thus unsuitable for samples with a partial or missing reference genome. Here we present the Trinity method for de novo assembly of full-length transcripts and evaluate it on samples from fission yeast, mouse and whitefly, whose reference genome is not yet available. By efficiently constructing and analyzing sets of de Bruijn graphs, Trinity fully reconstructs a large fraction of transcripts, including alternatively spliced isoforms and transcripts from recently duplicated genes. Compared with other de novo transcriptome assemblers, Trinity recovers more full-length transcripts across a broad range of expression levels, with a sensitivity similar to methods that rely on genome alignments. Our approach provides a unified solution for transcriptome reconstruction in any sample, especially in the absence of a reference genome.	[Yassour, Moran; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci, Jerusalem, Israel; [Grabherr, Manfred G.; Haas, Brian J.; Yassour, Moran; Levin, Joshua Z.; Thompson, Dawn A.; Amit, Ido; Adiconis, Xian; Fan, Lin; Raychowdhury, Raktima; Zeng, Qiandong; Chen, Zehua; Mauceli, Evan; Hacohen, Nir; Gnirke, Andreas; di Palma, Federica; Birren, Bruce W.; Nusbaum, Chad; Lindblad-Toh, Kerstin; Regev, Aviv] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Rhind, Nicholas] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Friedman, Nir] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Massachusetts System; University of Massachusetts Worcester; Uppsala University; Hebrew University of Jerusalem; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Friedman, N (corresponding author), Hebrew Univ Jerusalem, Sch Comp Sci, Jerusalem, Israel.	nir@cs.huji.ac.il; aregev@broad.mit.edu	Chen, Zehua/E-6356-2011; Friedman, Nir/H-9692-2012; Zeng, Qiandong/AAF-3305-2019; chen, zehua/H-1260-2011; Yassour, Moran/ABE-7415-2020	Friedman, Nir/0000-0002-9678-3550; Yassour, Moran/0000-0002-7344-5188; Levin, Joshua/0000-0002-0170-3598; Di-Palma, Federica/0000-0002-4394-0102; Grabherr, Manfred/0000-0001-8792-6508; Rhind, Nicholas/0000-0003-1758-7736	National Human Genome Research Institute [NIH 1 U54 HG03067]; Howard Hughes Medical Institute; National Institutes of Health; US-Israel Binational Science Foundation; National Institute of Allergy and Infectious Diseases [HHSN27220090018C]; Clore Fellowship; European Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069957] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clore Fellowship; European Science Foundation(European Science Foundation (ESF)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Gaffney for help with figure preparation, J. Bochicchio for project management, the Broad Sequencing Platform for all sequencing work, A. Papanicolaou and M. Ott for Inchworm software testing and code enhancements, and F. Ribeiro for helpful discussions regarding error pruning. The work was supported in part by a grant from the National Human Genome Research Institute (NIH 1 U54 HG03067, Lander), the Howard Hughes Medical Institute, a National Institutes of Health PIONEER award, a Burroughs Wellcome Fund-Career Award at the Scientific Interface (A.R.), the US-Israel Binational Science Foundation (N.F. and A.R.), and funds from the National Institute of Allergy and Infectious Diseases under contract no. HHSN27220090018C. M.Y. was supported by a Clore Fellowship. K.L.-T. is a recipient of the European Young Investigator Award (EYRYI) funded by the European Science Foundation. A.R. is a researcher of the Merkin Foundation for Stem Cell Research at the Broad Institute.	Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Good I. J., 1946, J LONDON MATH SOC, V21, P167; Grabherr MG, 2010, BIOINFORMATICS, V26, P1145, DOI 10.1093/bioinformatics/btq102; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Molnar M, 2001, GENETICS, V157, P519; Nakamura T, 2000, GENES CELLS, V5, P463, DOI 10.1046/j.1365-2443.2000.00343.x; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; RHIND N, 2011, SCIENCE         0421, DOI DOI 10.1126/SCIENCE.1203357; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	12092	12621	95	2023	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					644	U130		10.1038/nbt.1883	http://dx.doi.org/10.1038/nbt.1883			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21572440	Green Accepted			2022-12-25	WOS:000292595200023
J	Hao, LM; Thein, M; Brust-Mascher, I; Civelekoglu-Scholey, G; Lu, Y; Acar, S; Prevo, B; Shaham, S; Scholey, JM				Hao, Limin; Thein, Melanie; Brust-Mascher, Ingrid; Civelekoglu-Scholey, Gul; Lu, Yun; Acar, Seyda; Prevo, Bram; Shaham, Shai; Scholey, Jonathan M.			Intraflagellar transport delivers tubulin isotypes to sensory cilium middle and distal segments	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; BETA-TUBULIN; MICROTUBULE DYNAMICS; IFT PARTICLES; KINESIN-II; COMPLEX B; PROTEIN; MUTATIONS; MOTORS; ACTIVATION	Sensory cilia are assembled and maintained by kinesin-2-dependent intraflagellar transport (IFT). We investigated whether two Caenorhabditis elegans alpha- and beta-tubulin isotypes, identified through mutants that lack their cilium distal segments, are delivered to their assembly sites by IFT. Mutations in conserved residues in both tubulins destabilize distal singlet microtubules. One isotype, TBB-4, assembles into microtubules at the tips of the axoneme core and distal segments, where the microtubule tip tracker EB1 is found, and localizes all along the cilium, where as the other, TBA-5, concentrates in distal singlets. IFT assays, fluorescence recovery after photobleaching analysis and modelling indicate that the continual transport of sub-stoichiometric numbers of these tubulin subunits by the IFT machinery can maintain sensory cilia at their steady-state length.	[Hao, Limin; Thein, Melanie; Brust-Mascher, Ingrid; Civelekoglu-Scholey, Gul; Acar, Seyda; Prevo, Bram; Scholey, Jonathan M.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10065 USA; [Prevo, Bram] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Prevo, Bram] Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands	University of California System; University of California Davis; Rockefeller University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Scholey, JM (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, 1 Shields Ave,145-B Briggs Hall, Davis, CA 95616 USA.	jmscholey@ucdavis.edu		Prevo, Bram/0000-0002-6526-5590	NIH National Center for Research Resources; NIH [GM50718, R01NS064273]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073121, R01NS064273] Funding Source: NIH RePORTER	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Zhang (Heyer Laboratory), A. Desai and G. Ou for valuable discussion; M. Shohei (Tokyo Women's Medical University, School of Medicine, Tokyo, Japan) for the deletion mutants, tm2355, tm2394 and tm4200; the Caenorhabditis Genetics Center (funded by the NIH National Center for Research Resources) for strains; and Y. Kohara, Center for Genetic Resource Information, National Institute of Genetics, Japan for EST clones. This work was supported by NIH grant nos GM50718 to J.M.S. and R01NS064273 to S.S.	Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; BRENNER S, 1974, GENETICS, V77, P71; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Cheerambathur DK, 2008, J CELL BIOL, V182, P429, DOI 10.1083/jcb.200804100; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hao LM, 2009, METHOD CELL BIOL, V93, P235, DOI 10.1016/S0091-679X(08)93013-2; Hao LM, 2009, J CELL SCI, V122, P889, DOI 10.1242/jcs.023861; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Hurd DD, 2010, GENETICS, V185, P883, DOI 10.1534/genetics.110.116996; Inglis P. N., 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.126.2; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; James P, 1996, GENETICS, V144, P1425; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; Kobayashi T, 2007, GENES CELLS, V12, P593, DOI 10.1111/j.1365-2443.2007.01076.x; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; MORAN DT, 1982, J NEUROCYTOL, V11, P721, DOI 10.1007/BF01153516; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Nielsen MG, 2001, CURR BIOL, V11, P529, DOI 10.1016/S0960-9822(01)00150-6; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Schroder JM, 2007, CURR BIOL, V17, P1134, DOI 10.1016/j.cub.2007.05.055; Shah JV, 2002, CURR OPIN CELL BIOL, V14, P58, DOI 10.1016/S0955-0674(01)00294-0; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Uchimura S, 2010, EMBO J, V29, P1167, DOI 10.1038/emboj.2010.25; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	51	118	121	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					790	U453		10.1038/ncb2268	http://dx.doi.org/10.1038/ncb2268			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21642982	Green Submitted, Green Accepted			2022-12-25	WOS:000292305700009
J	Guo, WX; Allan, AM; Zong, RT; Zhang, L; Johnson, EB; Schaller, EG; Murthy, AC; Goggin, SL; Eisch, AJ; Oostra, BA; Nelson, DL; Jin, P; Zhao, XY				Guo, Weixiang; Allan, Andrea M.; Zong, Ruiting; Zhang, Li; Johnson, Eric B.; Schaller, Eric G.; Murthy, Adeline C.; Goggin, Samantha L.; Eisch, Amelia J.; Oostra, Ben A.; Nelson, David L.; Jin, Peng; Zhao, Xinyu			Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning	NATURE MEDICINE			English	Article							FRAGILE-X-SYNDROME; ENHANCED SYNAPTIC PLASTICITY; DENTATE GYRUS; KNOCKOUT MICE; DORSAL HIPPOCAMPUS; GENE-EXPRESSION; GRANULE CELLS; MOUSE MODEL; NEUROGENESIS; MEMORY	Deficiency in fragile X mental retardation protein (FMRP) results in fragile X syndrome (FXS), an inherited form of intellectual disability. Despite extensive research, it is unclear how FMRP deficiency contributes to the cognitive deficits in FXS. Fmrp-null mice show reduced adult hippocampal neurogenesis. As Fmrp is also enriched in mature neurons, we investigated the function of Fmrp expression in neural stem and progenitor cells (aNSCs) and its role in adult neurogenesis. Here we show that ablation of Fmrp in aNSCs by inducible gene recombination leads to reduced hippocampal neurogenesis in vitro and in vivo, as well as markedly impairing hippocampus-dependent learning in mice. Conversely, restoration of Fmrp expression specifically in aNSCs rescues these learning deficits in Fmrp-deficient mice. These data suggest that defective adult neurogenesis may contribute to the learning impairment seen in FXS, and these learning deficits can be rectified by delayed restoration of Fmrp specifically in aNSCs.	[Guo, Weixiang; Allan, Andrea M.; Zhang, Li; Johnson, Eric B.; Schaller, Eric G.; Murthy, Adeline C.; Goggin, Samantha L.; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Zong, Ruiting; Nelson, David L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Oostra, Ben A.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	University of New Mexico; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Erasmus University Rotterdam; Erasmus MC; Emory University	Zhao, XY (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	xzhao@waisman.wisc.edu		Eisch, Amelia/0000-0001-6476-5385; Allan, Andrea/0000-0002-6745-4352	NIH [MH080434, MH078972, HD38038, HD024064]; NIH National Institute of Mental Health [MH19101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T34MH019101, R01MH080434, R01MH078972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. T. Strauss for editing the manuscript; H. van Praag, D. Schaffer and T. Xie for critical reading of the manuscript; members of the Zhao lab for discussions; S.J. von Hoyningen-Huene for technical assistance; D. C. Lagace and R. D. Smrt for technical help; and H. van Praag (US National Institutes of Health (NIH)/National Institute of Aging) and F. Gage (Salk Institute) for the Cre-GFP construct. This work was supported by grants from the NIH to X.Z. (MH080434 and MH078972) and D.L.N. (HD38038 and HD024064). E. G. S. is supported by an NIH National Institute of Mental Health Career Opportunity for Research training grant (MH19101). Images in this paper were generated in the University of New Mexico Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed here: http://hsc.unm.edu/crtc/microscopy/acknowledgement.shtml/.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bhattacharyya A, 2008, STEM CELLS DEV, V17, P107, DOI 10.1089/scd.2007.0073; Brennan FX, 2006, GENES BRAIN BEHAV, V5, P467, DOI 10.1111/j.1601-183X.2005.00183.x; Castren M, 2005, P NATL ACAD SCI USA, V102, P17834, DOI 10.1073/pnas.0508995102; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Cunningham CL, 2011, HUM MOL GENET, V20, P64, DOI 10.1093/hmg/ddq432; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eadie BD, 2009, NEUROBIOL DIS, V36, P361, DOI 10.1016/j.nbd.2009.08.001; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Harrell AV, 2003, LEARN MEMORY, V10, P410, DOI 10.1101/lm.56103; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lightbody AA, 2009, DEV DISABIL RES REV, V15, P343, DOI 10.1002/ddrr.77; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; Mercaldo V, 2009, MOL CELLS, V28, P501, DOI 10.1007/s10059-009-0193-x; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moore MD, 2010, NEUROBIOL LEARN MEM, V93, P383, DOI 10.1016/j.nlm.2009.12.004; Paz R, 2007, NEUROPSYCHOPHARMACOL, V32, P693, DOI 10.1038/sj.npp.1301066; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pepper ASR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007618; Quinn JJ, 2002, HIPPOCAMPUS, V12, P495, DOI 10.1002/hipo.10029; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	58	170	172	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					559	U75		10.1038/nm.2336	http://dx.doi.org/10.1038/nm.2336			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21516088	Green Accepted			2022-12-25	WOS:000290250400031
J	Wicks, P; Vaughan, TE; Massagli, MP; Heywood, J				Wicks, Paul; Vaughan, Timothy E.; Massagli, Michael P.; Heywood, James			Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm	NATURE BIOTECHNOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALSFRS-R; MINOCYCLINE; TRIAL; PROGRESSION; EFFICACY; MODEL	Patients with serious diseases may experiment with drugs that have not received regulatory approval. Online patient communities structured around quantitative outcome data have the potential to provide an observational environment to monitor such drug usage and its consequences. Here we describe an analysis of data reported on the website PatientsLikeMe by patients with amyotrophic lateral sclerosis (ALS) who experimented with lithium carbonate treatment. To reduce potential bias owing to lack of randomization, we developed an algorithm to match 149 treated patients to multiple controls (447 total) based on the progression of their disease course. At 12 months after treatment, we found no effect of lithium on disease progression. Although observational studies using unblinded data are not a substitute for double-blind randomized control trials, this study reached the same conclusion as subsequent randomized trials, suggesting that data reported by patients over the internet may be useful for accelerating clinical discovery and evaluating the effectiveness of drugs already in use.	[Wicks, Paul; Vaughan, Timothy E.; Massagli, Michael P.; Heywood, James] PatientsLikeMe Inc, Res & Dev, Cambridge, MA USA		Wicks, P (corresponding author), PatientsLikeMe Inc, Res & Dev, Cambridge, MA USA.	pwicks@patientslikeme.com	Vaughan, Timothy E/A-9968-2009; Wicks, Paul/C-6128-2011	Vaughan, Timothy E/0000-0003-0744-1266; Wicks, Paul/0000-0002-2293-9284				Aggarwal SP, 2010, LANCET NEUROL, V9, P481, DOI 10.1016/S1474-4422(10)70068-5; *ALS UNT GROUP, 2011, LATERAL SCLER, V12, P76; Armon C, 2010, NEUROLOGY, V75, P586, DOI 10.1212/WNL.0b013e3181ed9ef7; BEDLACK RS, 2008, P NATL ACAD SCI USA, V105, pF17; Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920; Call Jerry, 2010, J Gastrointest Cancer, V41, P60, DOI 10.1007/s12029-009-9111-x; Castrillo-Viguera C, 2010, AMYOTROPH LATERAL SC, V11, P178, DOI 10.3109/17482960903093710; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2010, NEUROLOGY, V75, P619, DOI 10.1212/WNL.0b013e3181ed9e7c; Cudkowicz ME, 2010, AMYOTROPH LATERAL SC, V11, P259, DOI 10.3109/17482960903358865; Figlewicz DA, 2008, AMYOTROPH LATERAL SC, V9, P125, DOI 10.1080/17482960802066643; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; FROST JH, 2008, AMIA ANN S P, V6, P217; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Gordon PH, 2009, ARCH NEUROL-CHICAGO, V66, P758, DOI 10.1001/archneurol.2009.1; Gordon PH, 2004, NEUROLOGY, V62, P1845, DOI 10.1212/01.WNL.0000125321.92112.7E; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Meininger V, 2008, AMYOTROPH LATERAL SC, V9, P122, DOI 10.1080/17482960802028247; Miller RG, 2009, ANN NEUROL, V65, pS24, DOI 10.1002/ana.21556; Montes J, 2006, NEUROLOGY, V67, P1294, DOI 10.1212/01.wnl.0000238505.22066.fc; Regenberg AC, 2009, STEM CELLS, V27, P2312, DOI 10.1002/stem.132; Ross E, 2009, LANCET NEUROL, V8, P136, DOI 10.1016/S1474-4422(09)70008-0; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Verstraete E, 2010, LANCET NEUROL, V9, P949, DOI 10.1016/S1474-4422(10)70230-1; Wicks P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1549; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3	28	209	213	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					411	U230		10.1038/nbt.1837	http://dx.doi.org/10.1038/nbt.1837			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21516084	Bronze			2022-12-25	WOS:000290301700020
J	Verrier, F; An, SO; Ferrie, AM; Sun, HY; Kyoung, M; Deng, HY; Fang, Y; Benkovic, SJ				Verrier, Florence; An, Songon; Ferrie, Ann M.; Sun, Haiyan; Kyoung, Minjoung; Deng, Huayun; Fang, Ye; Benkovic, Stephen J.			GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; DYNAMIC MASS REDISTRIBUTION; KINASE CK2; 7-TRANSMEMBRANE RECEPTORS; CELL-METABOLISM; LIVING CELLS; INHIBITORS; ADRENOCEPTORS; SELECTIVITY; PATHWAYS	G protein-coupled receptors (GPCRs) transmit exogenous signals to the nucleus, promoting a myriad of biological responses via multiple signaling pathways in both healthy and cancerous cells. However, little is known about the response of cytosolic metabolic pathways to GPCR-mediated signaling. Here we applied fluorescent live-cell imaging and label-free dynamic mass redistribution assays to study whether purine metabolism is associated with GPCR signaling. Through a library screen of GPCR ligands in conjunction with live-cell imaging of a metabolic multienzyme complex for de novo purine biosynthesis, the purinosome, we demonstrated that the activation of endogenous G(alpha 1)-coupled receptors correlates with purinosome assembly and disassembly in native HeLa cells. Given the implications of GPCRs in mitogenic signaling and of the purinosome in controlling metabolic flux via de novo purine biosynthesis, we hypothesize that regulation of purinosome assembly and disassembly may be one of the downstream events of mitogenic GPCR signaling in human cancer cells.	[Verrier, Florence; Ferrie, Ann M.; Sun, Haiyan; Deng, Huayun; Fang, Ye] Corning Inc, Div Sci & Technol, Biochem Technol, Corning, NY 14831 USA; [An, Songon; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Kyoung, Minjoung] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Corning Inc; State University of New York (SUNY) System; SUNY Community College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University	Fang, Y (corresponding author), Corning Inc, Div Sci & Technol, Biochem Technol, Corning, NY 14831 USA.	fangy2@corning.com; sjb1@psu.edu		An, Songon/0000-0003-2189-7374; Fang, Ye/0000-0002-1322-7365	US National Institutes of Health [GM24129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024129, R01GM024129] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by US National Institutes of Health grant GM24129 (S.J.B.).	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; BARBIERI JT, 1988, INFECT IMMUN, V56, P1934, DOI 10.1128/IAI.56.8.1934-1941.1988; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duncan JS, 2008, MOL CELL PROTEOMICS, V7, P1077, DOI 10.1074/mcp.M700559-MCP200; Fang Y, 2005, ANAL CHEM, V77, P5720, DOI 10.1021/ac050887n; Fang Y., 2011, DRUG DISCOV TODAY TE, V7, pe5; Fang Ye, 2007, Journal of Pharmacological and Toxicological Methods, V55, P314, DOI 10.1016/j.vascn.2006.11.001; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Musnier A, 2010, CELL SIGNAL, V22, P707, DOI 10.1016/j.cellsig.2009.10.012; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rebholz H, 2009, P NATL ACAD SCI USA, V106, P14096, DOI 10.1073/pnas.0906857106; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018	28	64	64	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					909	915		10.1038/NCHEMBIO.690	http://dx.doi.org/10.1038/NCHEMBIO.690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22020552	Green Accepted			2022-12-25	WOS:000297166200014
J	Ivanciu, L; Toso, R; Margaritis, P; Pavani, G; Kim, H; Schlachterman, A; Liu, JH; Clerin, V; Pittman, DD; Rose-Miranda, R; Shields, KM; Erbe, DV; Tobin, JF; Arruda, VR; Camire, RM				Ivanciu, Lacramioara; Toso, Raffaella; Margaritis, Paris; Pavani, Giulia; Kim, Haein; Schlachterman, Alexander; Liu, Jian-Hua; Clerin, Valerie; Pittman, Debra D.; Rose-Miranda, Rosalind; Shields, Kathleen M.; Erbe, David V.; Tobin, James F.; Arruda, Valder R.; Camire, Rodney M.			A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia	NATURE BIOTECHNOLOGY			English	Article							FACTOR VIIA; THROMBIN GENERATION; TISSUE FACTOR; FACTOR-V; RECOMBINANT FVIIA; HUMAN-PLASMA; MOUSE MODEL; HEMOSTASIS; PLATELETS; INHIBITOR	Effective therapies are needed to control excessive bleeding in a range of clinical conditions. We improve hemostasis in vivo using a conformationally pliant variant of coagulation factor Xa (FXa(I16L)) rendered partially inactive by a defect in the transition from zymogen to active protease(1,2). Using mouse models of hemophilia, we show that FXa(I16L) has a longer half-life than wild-type FXa and does not cause excessive activation of coagulation. Once clotting mechanisms are activated to produce its cofactor FVa, FXa(I16L) is driven to the protease state and restores hemostasis in hemophilic animals upon vascular injury. Moreover, using human or murine analogs, we show that FXa(I16L) is more efficacious than FVIIa, which is used to treat bleeding in hemophilia inhibitor patients(3). FXa(I16L) may provide an effective strategy to enhance blood clot formation and act as a rapid pan-hemostatic agent for the treatment of bleeding conditions.	[Ivanciu, Lacramioara; Toso, Raffaella; Margaritis, Paris; Pavani, Giulia; Kim, Haein; Schlachterman, Alexander; Liu, Jian-Hua; Arruda, Valder R.; Camire, Rodney M.] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Margaritis, Paris; Arruda, Valder R.; Camire, Rodney M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Clerin, Valerie; Pittman, Debra D.; Rose-Miranda, Rosalind; Shields, Kathleen M.; Erbe, David V.; Tobin, James F.] Pfizer Inc, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pfizer	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Pavani, Giulia/I-3612-2012; Toso, Raffaella/I-5202-2012	Pavani, Giulia/0000-0002-2522-2684; 	US National Institutes of Health [P01 HL-74124]; Pfizer; National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by US National Institutes of Health grant P01 HL-74124, Project 2; research funding from Pfizer (to R.M.C.); and the Judith Graham Pool Postdoctoral Research Fellowship, National Hemophilia Foundation (to L.I.). We would like to thank L. Albert and B. Carito (Pfizer), and A. Hannan (Children's Hospital of Philadelphia) for their technical assistance. We are also grateful to S. Krishnaswamy (Children's Hospital of Philadelphia/University of Pennsylvania) for useful suggestions and critical review of the manuscript.	Aijarnali MN, 2008, J CLIN INVEST, V118, P1825, DOI 10.1172/JCI32878; Berntorp E, 2009, HAEMOPHILIA, V15, P3, DOI 10.1111/j.1365-2516.2008.01931.x; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Bunce MW, 2011, BLOOD, V117, P290, DOI 10.1182/blood-2010-08-300756; Butenas S, 2003, J THROMB HAEMOST, V1, P1158, DOI 10.1046/j.1538-7836.2003.00181.x; Darby SC, 2004, J THROMB HAEMOST, V2, P1047, DOI 10.1046/j.1538-7836.2004.00710.x; DiMichele D, 2007, BRIT J HAEMATOL, V138, P305, DOI 10.1111/j.1365-2141.2007.06657.x; Escobar MA, 2010, HAEMOPHILIA, V16, P29, DOI 10.1111/j.1365-2516.2010.02257.x; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; GILES AR, 1988, BRIT J HAEMATOL, V69, P491, DOI 10.1111/j.1365-2141.1988.tb02405.x; GILES AR, 1984, J CLIN INVEST, V74, P2219, DOI 10.1172/JCI111648; GITEL SN, 1984, J BIOL CHEM, V259, P6890; Hedner U, 2006, J BIOTECHNOL, V124, P747, DOI 10.1016/j.jbiotec.2006.03.042; Khan AR, 1998, PROTEIN SCI, V7, P815; Kung SH, 1998, BLOOD, V91, P784, DOI 10.1182/blood.V91.3.784.784_784_790; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; MANN KG, 1990, BLOOD, V76, P1; Mannucci PM, 2008, HAEMOPHILIA, V14, P10, DOI 10.1111/j.1365-2516.2008.01708.x; Margaritis P, 2004, J CLIN INVEST, V113, P1025, DOI 10.1172/JCI200420106; Margaritis P, 2011, BLOOD, V117, P3974, DOI 10.1182/blood-2010-09-309732; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Moss J, 2009, J THROMB HAEMOST, V7, P299, DOI 10.1111/j.1538-7836.2008.03253.x; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; Petersen LC, 2005, THROMB RES, V116, P75, DOI 10.1016/j.thromres.2004.11.003; Roberts HR, 2006, HEMOSTASIS THROMBOSI, P877; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Schlachterman A, 2005, J THROMB HAEMOST, V3, P2730, DOI 10.1111/j.1538-7836.2005.01639.x; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; TRACY PB, 1982, BLOOD, V60, P59; Tranholm M, 2003, BLOOD, V102, P3615, DOI 10.1182/blood-2003-05-1369; Turecek PL, 2004, HAEMOPHILIA, V10, P3, DOI 10.1111/j.1365-2516.2004.00934.x; Turecek PL, 2003, PATHOPHYSIOL HAEMO T, V33, P16, DOI 10.1159/000071637; Weeterings C, 2008, SEMIN HEMATOL, V45, pS12, DOI 10.1053/j.seminhematol.2008.03.018; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006	36	61	69	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1028	U103		10.1038/nbt.1995	http://dx.doi.org/10.1038/nbt.1995			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22020385	Green Accepted			2022-12-25	WOS:000296801300025
J	Salker, MS; Christian, M; Steel, JH; Nautiyal, J; Lavery, S; Trew, G; Webster, Z; Al-Sabbagh, M; Puchchakayala, G; Foller, M; Landles, C; Sharkey, AM; Quenby, S; Aplin, JD; Regan, L; Lang, F; Brosens, JJ				Salker, Madhuri S.; Christian, Mark; Steel, Jennifer H.; Nautiyal, Jaya; Lavery, Stuart; Trew, Geoffrey; Webster, Zoe; Al-Sabbagh, Marwa; Puchchakayala, Goverdhan; Foeller, Michael; Landles, Christian; Sharkey, Andrew M.; Quenby, Siobhan; Aplin, John D.; Regan, Lesley; Lang, Florian; Brosens, Jan J.			Deregulation of the serum- and glucocorticoid-inducible kinase SGK1 in the endometrium causes reproductive failure	NATURE MEDICINE			English	Article							STROMAL CELLS; PROGESTERONE-RECEPTOR; OXIDATIVE STRESS; EMBRYO IMPLANTATION; DEPENDENT MANNER; MOUSE UTERUS; IN-VITRO; PREGNANCY; EXPRESSION; MICE	Infertility and recurrent pregnancy loss (RPL) are prevalent but distinct causes of reproductive failure that often remain unexplained despite extensive investigations(1,2). Analysis of midsecretory endometrial samples revealed that SGK1, a kinase involved in epithelial ion transport and cell survival(3-6), is upregulated in unexplained infertility, most prominently in the luminal epithelium, but downregulated in the endometrium of women suffering from RPL. To determine the functional importance of these observations, we first expressed a constitutively active SGK1 mutant in the luminal epithelium of the mouse uterus. This prevented expression of certain endometrial receptivity genes, perturbed uterine fluid handling and abolished embryo implantation. By contrast, implantation was unhindered in Sgk1(-/-) mice, but pregnancy was often complicated by bleeding at the decidual-placental interface and fetal growth retardation and subsequent demise. Compared to wild-type mice, Sgk1(-/-) mice had gross impairment of pregnancy-dependent induction of genes involved in oxidative stress defenses. Relative SGK1 deficiency was also a hallmark of decidualizing stromal cells from human subjects with RPL and sensitized these cells to oxidative cell death. Thus, depending on the cellular compartment, deregulated SGK1 activity in cycling endometrium interferes with embryo implantation, leading to infertility, or predisposes to pregnancy complications by rendering the feto-maternal interface vulnerable to oxidative damage.	[Salker, Madhuri S.; Christian, Mark; Steel, Jennifer H.; Nautiyal, Jaya; Lavery, Stuart; Trew, Geoffrey; Al-Sabbagh, Marwa; Landles, Christian; Regan, Lesley; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Webster, Zoe] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Embryon Stem Cell Facil, London, England; [Puchchakayala, Goverdhan; Foeller, Michael; Lang, Florian] Univ Tubingen, Inst Physiol, Tubingen, Germany; [Sharkey, Andrew M.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Quenby, Siobhan; Brosens, Jan J.] Univ Hosp, Clin Sci Res Labs, Div Reprod Hlth, Warwick Med Sch, Coventry, W Midlands, England; [Aplin, John D.] Univ Manchester, St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Manchester M13 0JH, Lancs, England	Imperial College London; Imperial College London; Eberhard Karls University of Tubingen; University of Cambridge; University of Warwick; University of Manchester	Brosens, JJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Hammersmith Campus, London, England.	j.j.brosens@warwick.ac.uk	Sharkey, Andrew M/H-7015-2013; Steel, Jennifer/B-4737-2013; Aplin, John/AET-4363-2022	Sharkey, Andrew M/0000-0002-5072-7748; Steel, Jennifer/0000-0003-4439-0090; Aplin, John/0000-0001-8777-9261; Landles, Christian/0000-0001-9715-6447; Brosens, Jan/0000-0003-0116-9329; Quenby, Siobhan/0000-0003-3221-5471; Christian, Mark/0000-0002-1616-4179; Salker, Madhuri Sonal/0000-0002-7939-289X	Contraceptive Research and Development Program Consortium for Industrial Collaboration in Contraceptive Research [CIG-08-122]; UK National Institute for Health Research Biomedical Research Centre; Genesis Research Trust	Contraceptive Research and Development Program Consortium for Industrial Collaboration in Contraceptive Research; UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Genesis Research Trust	We are grateful to all the women who participated in this study. This work was further supported by funds to J.J.B. and M. C. from the Contraceptive Research and Development Program Consortium for Industrial Collaboration in Contraceptive Research (CIG-08-122), the UK National Institute for Health Research Biomedical Research Centre funding scheme and from the Genesis Research Trust (M. S. S.) We are grateful to M. Parker for his insightful suggestions.	Aghajanova L, 2010, ENDOCRINOLOGY, V151, P1341, DOI 10.1210/en.2009-0923; Al-Sabbagh M, 2011, ENDOCRINOLOGY, V152, P730, DOI 10.1210/en.2010-0899; Alam SMK, 2007, DEVELOPMENT, V134, P407, DOI 10.1242/dev.02743; Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Campbell EA, 2006, HUM REPROD, V21, P2495, DOI 10.1093/humrep/del195; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Crossey PA, 2002, J CLIN INVEST, V110, P411, DOI 10.1172/JCI200210077; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Feroze-Zaidi F, 2007, ENDOCRINOLOGY, V148, P5020, DOI 10.1210/en.2007-0659; Fluhr Herbert, 2008, Reproductive Medicine and Biology, V7, P169, DOI 10.1111/j.1447-0578.2008.00213.x; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; HIGUCHI T, 1995, ENDOCRINOLOGY, V136, P4973, DOI 10.1210/en.136.11.4973; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; Joswig Anike, 2003, Reprod Biol Endocrinol, V1, P44; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tabibzadeh S, 2000, J CLIN ENDOCR METAB, V85, P2526, DOI 10.1210/jc.85.7.2526; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; Tang MY, 2005, HUM REPROD, V20, P1772, DOI 10.1093/humrep/deh849; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Yang JZ, 2011, FERTIL STERIL, V95, P2100, DOI 10.1016/j.fertnstert.2011.02.036; Yue LM, 2005, ENDOCRINOLOGY, V146, P2424, DOI 10.1210/en.2004-1605	40	128	134	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1509	U1505		10.1038/nm.2498	http://dx.doi.org/10.1038/nm.2498			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22001908	Green Submitted			2022-12-25	WOS:000296779300044
J	Kutter, C; Brown, GD; Goncalves, A; Wilson, MD; Watt, S; Brazma, A; White, RJ; Odom, DT				Kutter, Claudia; Brown, Gordon D.; Goncalves, Angela; Wilson, Michael D.; Watt, Stephen; Brazma, Alvis; White, Robert J.; Odom, Duncan T.			Pol III binding in six mammals shows conservation among amino acid isotypes despite divergence among tRNA genes	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR-BINDING; POLYMERASE-III; TRANSPOSABLE ELEMENTS; GENOME SEQUENCE; NONCODING RNAS; CODON USAGE; HUMAN-CELLS; STEM-CELLS; EXPRESSION; EVOLUTION	RNA polymerase III (Pol III) transcription of tRNA genes is essential for generating the tRNA adaptor molecules that link genetic sequence and protein translation. By mapping Pol III occupancy genome-wide in mouse, rat, human, macaque, dog and opossum livers, we found that Pol III binding to individual tRNA genes varies substantially in strength and location. However, when we took into account tRNA redundancies by grouping Pol III occupancy into 46 anticodon isoacceptor families or 21 amino acid-based isotype classes, we discovered strong conservation. Similarly, Pol III occupancy of amino acid isotypes is almost invariant among transcriptionally and evolutionarily diverse tissues in mouse. Thus, synthesis of functional tRNA isotypes has been highly constrained, although the usage of individual tRNA genes has evolved rapidly.	[Kutter, Claudia; Brown, Gordon D.; Wilson, Michael D.; Watt, Stephen; Odom, Duncan T.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Kutter, Claudia; Wilson, Michael D.; Odom, Duncan T.] Univ Cambridge, Dept Oncol, Hutchison Med Res Council Res Ctr, Cambridge, England; [Goncalves, Angela; Brazma, Alvis] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Goncalves, Angela] Univ Cambridge, Grad Sch Life Sci, Cambridge, England; [White, Robert J.] Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Cambridge; Beatson Institute; Wellcome Trust Sanger Institute	Odom, DT (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England.	duncan.odom@cancer.org.uk	Wilson, Michael D/K-6294-2014; Kutter, Claudia/HHD-1391-2022	Wilson, Michael D/0000-0002-4015-3066; Brazma, Alvis/0000-0001-5988-7409; Goncalves, Angela/0000-0002-3890-7658; Kutter, Claudia/0000-0002-8047-0058; Odom, Duncan/0000-0001-6201-5599	European Research Council; European Molecular Biology Organization; Hutchinson Whampoa; Swiss National Science Foundation; University of Cambridge; Cancer Research UK; European Molecular Biology Laboratory; Cancer Research UK [15603] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Hutchinson Whampoa; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); European Molecular Biology Laboratory; Cancer Research UK(Cancer Research UK)	We thank J. Hadfield, N. Matthews, S. Aldridge, S. Sayalero, C. Fielding, B. Davis, K. Howe, R. Stark, T. Davidge, S. Ballantyne and M. Nixon. This work was supported by the European Research Council Starting Grant; the European Molecular Biology Organization Young Investigator Award; Hutchinson Whampoa (D.T.O.); Swiss National Science Foundation (C. K.); University of Cambridge (C. K., M. D. W. and D.T.O.); Cancer Research UK (C. K., G. D. B., S. W., M. D. W., R. J. W. and D.T.O.) and European Molecular Biology Laboratory (A.G.).	Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Coughlin DJ, 2009, RNA BIOL, V6, P195, DOI 10.4161/rna.6.2.8050; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Fairley JA, 2003, EMBO J, V22, P5841, DOI 10.1093/emboj/cdg544; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lemon J., 2006, R NEWS, V6, P8, DOI DOI 10.1016/J.AGRF0RMET.2007.05.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Paten B, 2009, BIOINFORMATICS, V25, P295, DOI 10.1093/bioinformatics/btn630; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rogers HH, 2010, GENOME BIOL EVOL, V2, P467, DOI 10.1093/gbe/evq034; Romer AS., 1986, VERTEBRATE BODY; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Semont A, 2006, ADV EXP MED BIOL, V585, P19; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	56	68	69	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					948	U50		10.1038/ng.906	http://dx.doi.org/10.1038/ng.906			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21873999	Green Accepted, Green Submitted			2022-12-25	WOS:000295316200008
J	Mauro, C; Leow, SC; Anso, E; Rocha, S; Thotakura, AK; Tornatore, L; Moretti, M; De Smaele, E; Beg, AA; Tergaonkar, V; Chandel, NS; Franzoso, G				Mauro, Claudio; Leow, Shi Chi; Anso, Elena; Rocha, Sonia; Thotakura, Anil K.; Tornatore, Laura; Moretti, Marta; De Smaele, Enrico; Beg, Amer A.; Tergaonkar, Vinay; Chandel, Navdeep S.; Franzoso, Guido			NF-kappa B controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration	NATURE CELL BIOLOGY			English	Article							TNF-ALPHA; MOUSE MODEL; P53; INFLAMMATION; CROSSTALK; APOPTOSIS; AUTOPHAGY; MODULATOR; RELA/P65; PATHWAY	Cell proliferation is a metabolically demanding process(1,2). It requires active reprogramming of cellular bioenergetic pathways towards glucose metabolism to support anabolic growth(1,2). NF-kappa B/Rel transcription factors coordinate many of the signals that drive proliferation during immunity, inflammation and oncogenesis(3), but whether NF-kappa B regulates the metabolic reprogramming required for cell division during these processes is unknown. Here, we report that NF-kappa B organizes energy metabolism networks by controlling the balance between the utilization of glycolysis and mitochondria! respiration. NF-kappa B inhibition causes cellular reprogramming to aerobic glycolysis under basal conditions and induces necrosis on glucose starvation. The metabolic reorganization that results from NF-kappa B inhibition overcomes the requirement for tumour suppressor mutation in oncogenic transformation and impairs metabolic adaptation in cancer in vivo. This NF-kappa B-dependent metabolic pathway involves stimulation of oxidative phosphorylation through upregulation of mitochondrial synthesis of cytochrome c oxidase 2 (SCO2; ref. 4). Our findings identify NF-kappa B as a physiological regulator of mitochondrial respiration and establish a role for NF-kappa B in metabolic adaptation in normal cells and cancer.	[Mauro, Claudio; Leow, Shi Chi; Thotakura, Anil K.; Tornatore, Laura; Moretti, Marta; Franzoso, Guido] Univ London Imperial Coll Sci Technol & Med, Sect Inflammat & Signal Transduct, Dept Med, London W12 0NN, England; [Leow, Shi Chi; Tergaonkar, Vinay] Lab NF kB Signaling, Singapore 138673, Singapore; [Anso, Elena; Chandel, Navdeep S.] Northwestern Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Rocha, Sonia] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Moretti, Marta; De Smaele, Enrico] Sapienza Univ, Dept Expt Med, I-00161 Rome, Italy; [Beg, Amer A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA	Imperial College London; Northwestern University; University of Dundee; Sapienza University Rome; H Lee Moffitt Cancer Center & Research Institute	Franzoso, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Inflammat & Signal Transduct, Dept Med, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	g.franzoso@imperial.ac.uk	Mauro, Claudio/AAN-1848-2021; Moretti, Marta/AAQ-7090-2020; Franzoso, Guido/GRR-8628-2022; De Smaele, Enrico/C-1124-2013	Mauro, Claudio/0000-0002-3736-0099; De Smaele, Enrico/0000-0003-4524-4423; Franzoso, Guido/0000-0002-0778-988X; Rocha, Sonia/0000-0002-2413-4981	AIRC (Italy); A*STAR (Singapore); Pasteur Institute, Cenci Bolognetti Foundation (Italy); NIH [R01 CA084040, R01 CA098583, R01 CA123067]; Cancer Research UK [C26587/A8839]; Cancer Research UK [12918] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA098583, R01CA123067, R01CA084040] Funding Source: NIH RePORTER	AIRC (Italy)(Fondazione AIRC per la ricerca sul cancro); A*STAR (Singapore)(Agency for Science Technology & Research (A*STAR)); Pasteur Institute, Cenci Bolognetti Foundation (Italy)(Istituto Pasteur Italia Fondazione Cenci Bolognetti); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Pagano, F. Dazzi, P. Ashton-Rickardt, F. Marelli-Berg and G. Screaton for critical comments on the manuscript. We also thank K. Ryan (Beatson Institute for Cancer Research, Glasgow, UK) for the eGFP-LC3 plasmid; T. Lindsten and C. B. Thompson (University of Pennsylvania, Philadelphia, USA) for the immortalized Bax<SUP>-/-</SUP>/Bak<SUP>-/-</SUP> MEFs; D. Trono (Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland) for the pWPT lentiviral vector; C. Chevtzoff and D. G. Hardie for assistance with the use of the Seahorse machine; and K. R. Chng for assistance with the analyses of the p53 promoter. C.M. was supported in part by a fellowship from AIRC (Italy). S.C.L. is supported by a scholarship from A*STAR (Singapore). M.M. is supported by a fellowship from the Pasteur Institute, Cenci Bolognetti Foundation (Italy). This work was supported by NIH grants R01 CA084040 and R01 CA098583 and Cancer Research UK grant C26587/A8839 to G.F., and NIH grant R01 CA123067 to N.S.C.	Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gapuzan MER, 2005, ONCOGENE, V24, P6574, DOI 10.1038/sj.onc.1208809; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Kondoh H, 2005, CANCER RES, V65, P177; Leary SC, 2010, ANTIOXID REDOX SIGN, V13, P1403, DOI 10.1089/ars.2010.3116; Locasale JW, 2009, NAT BIOTECHNOL, V27, P916, DOI 10.1038/nbt1009-916; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Vousden KH, 2010, P NATL ACAD SCI USA, V107, P7117, DOI 10.1073/pnas.1002656107; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang HN, 2006, P NATL ACAD SCI USA, V103, P10397, DOI 10.1073/pnas.0604008103; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	40	242	250	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1272	U234		10.1038/ncb2324	http://dx.doi.org/10.1038/ncb2324			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21968997	Green Accepted, Green Submitted			2022-12-25	WOS:000295617900018
J	Lee, SS; Hong, SY; Errey, JC; Izumi, A; Davies, GJ; Davis, BG				Lee, Seung Seo; Hong, Sung You; Errey, James C.; Izumi, Atsushi; Davies, Gideon J.; Davis, Benjamin G.			Mechanistic evidence for a front-side, S(N)i-type reaction in a retaining glycosyltransferase	NATURE CHEMICAL BIOLOGY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; ENZYMATIC GLYCOSYL TRANSFER; TRANSITION-STATE; ALPHA-GALACTOSYLTRANSFERASE; TREHALOSE PHOSPHORYLASE; NEISSERIA-MENINGITIDIS; SCHIZOPHYLLUM-COMMUNE; COVALENT INTERMEDIATE; GLUCOSYL TRANSFER; ACTIVE-SITE	A previously determined crystal structure of the ternary complex of trehalose-6-phosphate synthase identified a putative transition state-like arrangement based on validoxylamine A 6'-O-phosphate and uridine diphosphate in the active site. Here linear free energy relationships confirm that these inhibitors are synergistic transition state mimics, supporting front-face nucleophilic attack involving hydrogen bonding between leaving group and nucleophile. Kinetic isotope effects indicate a highly dissociative oxocarbenium ion-like transition state. Leaving group O-18 effects identified isotopically sensitive bond cleavages and support the existence of a hydrogen bond between the nucleophile and departing group. Bronsted analysis of nucleophiles and Taft analysis highlight participation of the nucleophile in the transition state, also consistent with a front-face mechanism. Together, these comprehensive, quantitative data substantiate this unusual enzymatic reaction mechanism. Its discovery should prompt useful reassessment of many biocatalysts and their substrates and inhibitors.	[Lee, Seung Seo; Hong, Sung You; Errey, James C.; Davis, Benjamin G.] Univ Oxford, Dept Chem, Oxford, England; [Izumi, Atsushi; Davies, Gideon J.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Lee, SS (corresponding author), Univ Oxford, Dept Chem, Oxford, England.	ben.davis@chem.ox.ac.uk	Davies, Gideon J/A-9042-2011; Hong, Sung You/G-2323-2011; Davis, Benjamin G/C-5281-2011; Lee, Seung S/K-8669-2018	Davies, Gideon J/0000-0002-7343-776X; Hong, Sung You/0000-0002-5785-4475; Davis, Benjamin G/0000-0002-5056-407X; Lee, Seung S/0000-0002-8598-3303	Bill and Melinda Gates Foundation; Samsung Fellowship; Biotechnology and Biological Sciences Research Council; Royal Society; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/C510824/1, BB/E004350/1, BB/E001696/1, EGA17763, B20376] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G026688/1, EP/D023343/1, EP/D023335/1, GR/T26542/01, EP/E000614/1, EP/I500200/1] Funding Source: researchfish; BBSRC [BB/E004350/1, BB/E001696/1] Funding Source: UKRI; EPSRC [EP/E000614/1, EP/G026688/1, EP/I500200/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Samsung Fellowship(Samsung); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Bill and Melinda Gates Foundation, the Samsung Fellowship and the Biotechnology and Biological Sciences Research Council for financial support. R. Zhang and S.G. Withers (University of British Columbia) are acknowledged for providing 2-deoxy-2,2-difluoroglucose; R. Gibson (currently at the University of Liverpool) is thanked for initial construction of some OtsA mutants. B.G.D. and G.J.D. are both Royal Society Wolfson Research Merit Award recipients, and B.G.D. is supported by an Engineering and Physical Sciences Research Council Life Sciences Interface Platform grant.	Baxter NJ, 2006, P NATL ACAD SCI USA, V103, P14732, DOI 10.1073/pnas.0604448103; BENNET AJ, 1986, J AM CHEM SOC, V108, P7287, DOI 10.1021/ja00283a025; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Bruner M, 1998, BIOCHEMISTRY-US, V37, P289, DOI 10.1021/bi971624t; Chan J, 2010, NAT CHEM BIOL, V6, P405, DOI 10.1038/nchembio.352; Chenault HK, 1997, J ORG CHEM, V62, P331, DOI 10.1021/jo961715g; Cleland WW, 2005, ARCH BIOCHEM BIOPHYS, V433, P2, DOI 10.1016/j.abb.2004.08.027; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cowdrey WA, 1937, J CHEM SOC, P1252, DOI 10.1039/jr9370001252; Du XL, 2004, P NATL ACAD SCI USA, V101, P8858, DOI 10.1073/pnas.0401675101; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Glad SS, 1997, J AM CHEM SOC, V119, P227, DOI 10.1021/ja962733i; Gloster TM, 2010, ORG BIOMOL CHEM, V8, P305, DOI 10.1039/b915870g; Goedl C, 2006, BIOCHEM J, V397, P491, DOI 10.1042/BJ20060029; Goedl C, 2009, CHEMBIOCHEM, V10, P2333, DOI 10.1002/cbic.200900429; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Greig IR, 2010, CHEM SOC REV, V39, P2272, DOI 10.1039/b902741f; GUTHRIE RD, 1989, ACCOUNTS CHEM RES, V22, P343, DOI 10.1021/ar00166a001; Hansch C, 1979, SUBSTITUENT CONSTANT; Huang XC, 1997, J AM CHEM SOC, V119, P11147, DOI 10.1021/ja963733l; Indurugalla D, 2001, J AM CHEM SOC, V123, P10889, DOI 10.1021/ja011232g; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; JONES CS, 1980, J BIOL CHEM, V255, P1861; KIM SC, 1988, ARCH BIOCHEM BIOPHYS, V267, P54, DOI 10.1016/0003-9861(88)90007-0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lee JK, 2004, J AM CHEM SOC, V126, P3769, DOI 10.1021/ja0394028; Luo M, 2008, J AM CHEM SOC, V130, P2649, DOI 10.1021/ja078008x; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Monegal A, 2006, J AM CHEM SOC, V128, P16030, DOI 10.1021/ja0659931; Nidetzky B, 2001, BIOCHEM J, V360, P727, DOI 10.1042/0264-6021:3600727; NORTHROP DB, 1981, BIOCHEMISTRY-US, V20, P4056, DOI 10.1021/bi00517a017; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; ROSENBERG S, 1981, BIOCHEMISTRY-US, V20, P3196, DOI 10.1021/bi00514a032; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SINNOTT ML, 1980, J AM CHEM SOC, V102, P2026, DOI 10.1021/ja00526a043; Soya N, 2011, GLYCOBIOLOGY, V21, P547, DOI 10.1093/glycob/cwq190; SUNKO DE, 1977, J AM CHEM SOC, V99, P5000, DOI 10.1021/ja00457a018; Tvaroska I, 2006, ACS SYM SER, V930, P285; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178; Ye JD, 2007, ANGEW CHEM INT EDIT, V46, P3714, DOI 10.1002/anie.200605124	50	118	120	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					631	638		10.1038/NCHEMBIO.628	http://dx.doi.org/10.1038/NCHEMBIO.628			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21822275	Green Accepted			2022-12-25	WOS:000294381400014
J	Matmati, M; Jacques, P; Maelfait, J; Verheugen, E; Kool, M; Sze, M; Geboes, L; Louagie, E; Mc Guire, C; Vereecke, L; Chu, YY; Boon, L; Staelens, S; Matthys, P; Lambrecht, BN; Schmidt-Supprian, M; Pasparakis, M; Elewaut, D; Beyaert, R; van Loo, G				Matmati, Mourad; Jacques, Peggy; Maelfait, Jonathan; Verheugen, Eveline; Kool, Mirjam; Sze, Mozes; Geboes, Lies; Louagie, Els; Mc Guire, Conor; Vereecke, Lars; Chu, Yuanyuan; Boon, Louis; Staelens, Steven; Matthys, Patrick; Lambrecht, Bart N.; Schmidt-Supprian, Marc; Pasparakis, Manolis; Elewaut, Dirk; Beyaert, Rudi; van Loo, Geert			A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis	NATURE GENETICS			English	Article							NF-KAPPA-B; ESCHERICHIA-COLI; MICE LACKING; ENZYME A20; RECEPTOR; OSTEOCLASTOGENESIS; PATHOGENESIS; INFLAMMATION; ANTIBODIES; INFECTION	A20 (TNFAIP3) is a protein that is involved in the negative feedback regulation of NF-kappa B signaling in response to specific proinflammatory stimuli in different cell types and has been suggested as a susceptibility gene for rheumatoid arthritis. To define the contribution of A20 to rheumatoid arthritis pathology, we generated myeloid-specific A20-deficient mice and show that specific ablation of Tnfaip3 in myeloid cells results in spontaneous development of a severe destructive polyarthritis with many features of rheumatoid arthritis. Myeloid-A20-deficient mice have high levels of inflammatory cytokines in their serum, consistent with a sustained NF-kappa B activation and higher TNF production by macrophages. Destructive polyarthritis in myeloid A20 knockout mice was TLR4-MyD88 and IL-6 dependent but was TNF independent. Myeloid A20 deficiency also promoted osteoclastogenesis in mice. Together, these observations indicate a critical and cell-specific function for A20 in the etiology of rheumatoid arthritis, supporting the idea of developing A20 modulatory drugs as cell-targeted therapies.	[Matmati, Mourad; Maelfait, Jonathan; Kool, Mirjam; Sze, Mozes; Mc Guire, Conor; Vereecke, Lars; Beyaert, Rudi; van Loo, Geert] VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium; [Matmati, Mourad; Maelfait, Jonathan; Sze, Mozes; Mc Guire, Conor; Vereecke, Lars; Beyaert, Rudi; van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Jacques, Peggy; Verheugen, Eveline; Louagie, Els; Elewaut, Dirk] Ghent Univ Hosp, Dept Rheumatol, Lab Mol Immunol & Inflammat, B-9000 Ghent, Belgium; [Kool, Mirjam; Lambrecht, Bart N.] Ghent Univ Hosp, Dept Resp Dis, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium; [Geboes, Lies; Matthys, Patrick] Leuven Univ, Rega Inst, Louvain, Belgium; [Chu, Yuanyuan; Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Boon, Louis] Bioceros, Utrecht, Netherlands; [Staelens, Steven] Inst Broadband Technol, Ghent, Belgium; [Staelens, Steven] Univ Antwerp, Mol Imaging Ctr Antwerp, B-2020 Antwerp, Belgium; [Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-5000 Cologne, Germany; [Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; KU Leuven; Max Planck Society; University of Antwerp; University of Cologne; University of Cologne	van Loo, G (corresponding author), VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium.	dirk.elewaut@ugent.be; rudi.beyaert@dmbr.ugent.be; geert.vanloo@dmbr.ugent.be	, van Loo Geert/AAD-1220-2019; Vereecke, Lars/H-6639-2016; Matthys, Patrick/B-4813-2018; Lambrecht, Bart N/K-2484-2014; Boon, Laurence/HCI-3629-2022; Elewaut, Dirk/K-6831-2014; Schmidt-Supprian, Marc/F-5893-2011; Staelens, Steven/D-8385-2017; Vereecke, Lars/ABH-2926-2020; Beyaert, Rudi/B-2589-2009; Maelfait, Jonathan/AAE-7827-2021; van Loo, Geert/C-1505-2009; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017	, van Loo Geert/0000-0002-8427-4775; Matthys, Patrick/0000-0002-9685-6836; Lambrecht, Bart N/0000-0003-4376-6834; Schmidt-Supprian, Marc/0000-0002-8543-6166; Staelens, Steven/0000-0003-3376-0519; Vereecke, Lars/0000-0002-1593-862X; Maelfait, Jonathan/0000-0002-1476-0583; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Jacques, Peggy/0000-0001-9227-257X; Beyaert, Rudi/0000-0002-5704-582X; Boon, Louis/0000-0002-0937-9171	Emmanuel van der Schueren award; FWO; Charcot Foundation; Marie Curie Actions; EC [EC-223404]; European Research Council; Ghent University; Interuniversity Attraction Poles program [IAP6/18]; Belgian Foundation against Cancer; IWT; Centrum voor Gezwelziekten; Hercules Foundation; Concerted Research Actions (GOA); Group-ID MRP of Ghent University	Emmanuel van der Schueren award; FWO(FWO); Charcot Foundation; Marie Curie Actions(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Ghent University(Ghent University); Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Belgian Foundation against Cancer; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Centrum voor Gezwelziekten; Hercules Foundation; Concerted Research Actions (GOA); Group-ID MRP of Ghent University	We are grateful to I. Forster for donating the LysM-Cre transgenic mice. We thank H. Heremans for providing us with the IL-6 and control antibodies. We thank T. Hochepied for transgenic services, P. Bogaert and E. Parthoens for technical help, A. Bredan for critical reading of the manuscript and D. Huyghebaert and L. Bellen for animal care. L. V. and J.M. are PhD fellows with the Instituut voor Innovatie door Wetenschap en Technologie (IWT), and J. M. is also supported by an Emmanuel van der Schueren award. C. M. G., L. G. and P. J. are PhD fellows with the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO). G. v. L. is supported, as a postdoctoral researcher, by the FWO, by an FWO Odysseus Grant and by the Charcot Foundation. M. K. is supported by an Intra European fellowship from the Marie Curie Actions. M. P. is supported by an FP7 EC program grant Masterswitch (EC-223404). B.N.L. is supported by an FWO Odysseus grant, a European Research Council Starting grant and the Group-ID Multidisciplinary Research Partnership grant of Ghent University. Work in the lab of R. B. and G. v. L. is further supported by research grants from the Interuniversity Attraction Poles program (IAP6/18), the FWO, the Belgian Foundation against Cancer, the Strategic Basis Research program of the IWT, the Centrum voor Gezwelziekten, the Hercules Foundation, and the Concerted Research Actions (GOA) and Group-ID MRP of Ghent University.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aoki S, 1996, ANN RHEUM DIS, V55, P363, DOI 10.1136/ard.55.6.363; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Geboes L, 2007, ARTHRITIS RHEUM-US, V56, P2595, DOI 10.1002/art.22791; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Huang Qi-Quan, 2009, Curr Rheumatol Rep, V11, P357; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nieuwenhuis EES, 2000, ARTHRITIS RHEUM, V43, P2583, DOI 10.1002/1529-0131(200011)43:11<2583::AID-ANR28>3.0.CO;2-U; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; STARNES HF, 1990, J IMMUNOL, V145, P4185; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yoshino S, 1999, J IMMUNOL, V163, P3417	31	215	222	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					908	U129		10.1038/ng.874	http://dx.doi.org/10.1038/ng.874			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21841782				2022-12-25	WOS:000294325800021
J	Ritz, D; Vuk, M; Kirchner, P; Bug, M; Schutz, S; Hayer, A; Bremer, S; Lusk, C; Baloh, RH; Lee, H; Glatter, T; Gstaiger, M; Aebersold, R; Weihl, CC; Meyer, H				Ritz, Danilo; Vuk, Maja; Kirchner, Philipp; Bug, Monika; Schuetz, Sabina; Hayer, Arnold; Bremer, Sebastian; Lusk, Caleb; Baloh, Robert H.; Lee, Houkeun; Glatter, Timo; Gstaiger, Matthias; Aebersold, Ruedi; Weihl, Conrad C.; Meyer, Hemmo			Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; PAGET-DISEASE; AAA-ATPASE; UBIQUITIN; P97; COMPLEX; CELL; PATHOGENESIS; TRAFFICKING; CDC48/P97	The AAA-ATPase VCP (also known as p97) cooperates with distinct cofactors to process ubiquitylated proteins in different cellular pathways(1-3). VCP missense mutations cause a systemic degenerative disease in humans, but the molecular pathogenesis is unclear(4,5). We used an unbiased mass spectrometry approach and identified a VCP complex with the UBXD1 cofactor, which binds to the plasma membrane protein caveolin-1 (CAV1) and whose formation is specifically disrupted by disease-associated mutations. We show that VCP-UBXD1 targets mono-ubiquitylated CAV1 in SDS-resistant high-molecular-weight complexes on endosomes, which are en route to degradation in endolysosomes(6). Expression of VCP mutant proteins, chemical inhibition of VCP, or siRNA-mediated depletion of UBXD1 leads to a block of CAV1 transport at the limiting membrane of enlarged endosomes in cultured cells. In patient muscle, muscle-specific caveolin-3 accumulates in sarcoplasmic pools and specifically delocalizes from the sarcolemma. These results extend the cellular functions of VCP to mediating sorting of ubiquitylated cargo in the endocytic pathway and indicate that impaired trafficking of caveolin may contribute to pathogenesis in individuals with VCP mutations.	[Lusk, Caleb; Baloh, Robert H.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Ritz, Danilo; Vuk, Maja; Kirchner, Philipp; Bug, Monika; Bremer, Sebastian; Meyer, Hemmo] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany; [Ritz, Danilo; Vuk, Maja; Schuetz, Sabina; Hayer, Arnold; Meyer, Hemmo] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Lee, Houkeun; Glatter, Timo; Gstaiger, Matthias; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Glatter, Timo; Gstaiger, Matthias; Aebersold, Ruedi] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland	Washington University (WUSTL); University of Duisburg Essen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Weihl, CC (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	weihlc@neuro.wustl.edu; hemmo.meyer@uni-due.de	Hayer, Arnold/W-8863-2019; Meyer, Hemmo/GNH-5784-2022	Hayer, Arnold/0000-0001-7808-8880; Meyer, Hemmo/0000-0003-1883-1796; Glatter, Timo/0000-0001-8716-8516; Kirchner, Philipp/0000-0002-7972-2318	ETH [26/05-2, 25/08-1]; DFG [SPP1365/2]; Fondation Suisse de recherche sur les maladies musculaires; NIH [R01 AG031867]; Muscular Dystrophy Association; NATIONAL INSTITUTE ON AGING [K08AG026271, R01AG031867] Funding Source: NIH RePORTER	ETH(ETH Zurich); DFG(German Research Foundation (DFG)); Fondation Suisse de recherche sur les maladies musculaires; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Helenius, M. Kaiser, P. Hanson and A. Pestronk for discussions and reagents, G. Dey for image analysis software, C. Brasseur and G. Csucs for technical help, and R. Deshaies for sharing results before publication. This work was supported by grants from the ETH (26/05-2 and 25/08-1), the DFG priority programme SPP1365/2 and the Fondation Suisse de recherche sur les maladies musculaires (to H.M.). C.C.W. is supported by the NIH (R01 AG031867) and the Muscular Dystrophy Association.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Goode A, 2010, J CLIN PATHOL, V63, P199, DOI 10.1136/jcp.2009.064428; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Meyer H, 2008, BIOCHEM SOC T, V36, P126, DOI 10.1042/BST0360126; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ren JH, 2008, J BIOL CHEM, V283, P21599, DOI 10.1074/jbc.M802982200; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	40	151	155	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1116	U148		10.1038/ncb2301	http://dx.doi.org/10.1038/ncb2301			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21822278	Green Accepted			2022-12-25	WOS:000294487000017
J	Zhang, JY; Zahir, N; Jiang, QH; Miliotis, H; Heyraud, S; Meng, XW; Dong, BX; Xie, G; Qiu, F; Hao, ZY; McCulloch, CA; Keystone, EC; Peterson, AC; Siminovitch, KA				Zhang, Jinyi; Zahir, Naima; Jiang, Qiuhong; Miliotis, Helen; Heyraud, Stephanie; Meng, Xianwang; Dong, Baoxia; Xie, Gang; Qiu, Frank; Hao, Zhenyue; McCulloch, Christopher A.; Keystone, Edward C.; Peterson, Alan C.; Siminovitch, Katherine A.			The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness	NATURE GENETICS			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; RHEUMATOID-ARTHRITIS; KINASE P50(CSK); T-CELLS; GENE; PEP; LYP; DOMAIN; ACTIVATION; SEQUENCE	A variant of the PTPN22-encoded Lyp phosphatase (Lyp620W) confers risk for autoimmune disease, but the mechanisms underlying this association remain unclear. We show here that mice expressing the Lyp variant homolog Pep619W manifest thymic and splenic enlargement accompanied by increases in T-cell number, activation and positive selection and in dendritic-and B-cell activation. Although Ptpn22 (Pep) transcript levels were comparable in Pep619W and wild-type Pep619R mice, Pep protein levels were dramatically reduced in the mutant mice, with Pep619W protein being more rapidly degraded and showing greater association with and in vitro cleavage by calpain 1 than Pep619R. Similarly, levels of the Lyp620W variant were decreased in human T and B cells, and its calpain binding and cleavage were increased relative to wild-type Lyp620R. Thus, calpain-mediated degradation with consequently reduced Lyp/Pep expression and lymphocyte and dendritic cell hyperresponsiveness represents a mechanism whereby Lyp620W may increase risk for autoimmune disease.	[Zhang, Jinyi; Zahir, Naima; Jiang, Qiuhong; Miliotis, Helen; Heyraud, Stephanie; Meng, Xianwang; Dong, Baoxia; Xie, Gang; Qiu, Frank; Keystone, Edward C.; Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Zhang, Jinyi; Zahir, Naima; Jiang, Qiuhong; Miliotis, Helen; Heyraud, Stephanie; Meng, Xianwang; Dong, Baoxia; Xie, Gang; Qiu, Frank; Siminovitch, Katherine A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Zhang, Jinyi; Zahir, Naima; Jiang, Qiuhong; Miliotis, Helen; Heyraud, Stephanie; Meng, Xianwang; Dong, Baoxia; Xie, Gang; Qiu, Frank; Siminovitch, Katherine A.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Zhang, Jinyi; Zahir, Naima; Jiang, Qiuhong; Miliotis, Helen; Heyraud, Stephanie; Meng, Xianwang; Dong, Baoxia; Xie, Gang; Qiu, Frank; Siminovitch, Katherine A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Zhang, Jinyi; Zahir, Naima; Jiang, Qiuhong; Miliotis, Helen; Heyraud, Stephanie; Meng, Xianwang; Dong, Baoxia; Xie, Gang; Qiu, Frank; Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada; [Hao, Zhenyue] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [McCulloch, Christopher A.] Univ Toronto, Canadian Inst Hlth Res Grp Matrix Dynam, Toronto, ON, Canada; [Peterson, Alan C.] McGill Univ, Royal Victoria Hosp, Lab Dev Biol, McGill Univ Hlth Ctr, Montreal, PQ H3A 1A1, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; McGill University; Royal Victoria Hospital	Siminovitch, KA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	ksimin@mshri.on.ca	Siminovitch, Katherine/K-1475-2013		Canadian Institute for Health Research [MOP10730, MOP79321]; Canadian Arthritis Network [07-SRID-IJD-03]; Ontario Research Fund [RE01-061]; Canada Research Chair	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network; Ontario Research Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	The authors acknowledge the assistance of K. Carrington (Mount Sinai Hospital) and M. Keogh (The Feinstein Institute for Medical Research) in recruiting subjects for these studies, H. Yao and G. Jiang for their technical assistance, D. Davidson and A. Veillette (Institute de Recherches Cliniques de Montreal) for their generosity in providing Pep-specific antibody, and A. Goldman in manuscript preparation and review. This work was supported by grants from the Canadian Institute for Health Research (MOP10730 and MOP79321), the Canadian Arthritis Network (07-SRID-IJD-03) and the Ontario Research Fund (RE01-061). K. A. S. is supported by a Canada Research Chair and holds the Sherman Family Chair in Genomic Medicine.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Chien WW, 2003, J BIOL CHEM, V278, P27413, DOI 10.1074/jbc.M304575200; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Decker P, 2006, RHEUMATOLOGY, V45, P1087, DOI 10.1093/rheumatology/kel061; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hill RJ, 2002, EXP HEMATOL, V30, P237, DOI 10.1016/S0301-472X(01)00794-9; Lefvert AK, 2008, J NEUROIMMUNOL, V197, P110, DOI 10.1016/j.jneuroim.2008.04.004; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Mykles DL, 1998, INT REV CYTOL, V184, P157, DOI 10.1016/S0074-7696(08)62181-6; Nagy A., 2003, MANIPULATING MOUSE E; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; van Oene M, 2005, ARTHRITIS RHEUM-US, V52, P1993, DOI 10.1002/art.21123; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	30	200	202	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					902	U122		10.1038/ng.904	http://dx.doi.org/10.1038/ng.904			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21841778				2022-12-25	WOS:000294325800020
J	Gottipati, S; Arbiza, L; Siepel, A; Clark, AG; Keinan, A				Gottipati, Srikanth; Arbiza, Leonardo; Siepel, Adam; Clark, Andrew G.; Keinan, Alon			Analyses of X-linked and autosomal genetic variation in population-scale whole genome sequencing	NATURE GENETICS			English	Article							SIGNATURES; RATIO; SIZE	The ratio of genetic diversity on chromosome X to that on the autosomes is sensitive to both natural selection and demography. On the basis of whole-genome sequences of 69 females, we report that whereas this ratio increases with genetic distance from genes across populations, it is lower in Europeans than in West Africans independent of proximity to genes. This relative reduction is most parsimoniously explained by differences in demographic history without the need to invoke natural selection.	[Gottipati, Srikanth; Arbiza, Leonardo; Siepel, Adam; Clark, Andrew G.; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Cornell University; Cornell University	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	ak735@cornell.edu		Keinan, Alon/0000-0002-9760-1122; Siepel, Adam/0000-0002-3557-7219; Clark, Andrew/0000-0001-7159-8511	NIH [U01-HG005715]; Alfred P. Sloan Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229, U01HG005715] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Nielsen and T. Korneliussen for sharing their software (Supplementary Note); D. Reich and E. Zhong for advice; D. Chang and E. Gazave for comments on earlier versions of this manuscript; and the 1000 Genomes Project. This work was supported in part by NIH grant U01-HG005715 and by an Alfred P. Sloan Research Fellowship (A.K.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Betancourt AJ, 2004, GENETICS, V168, P2261, DOI 10.1534/genetics.104.030999; Bustamante CD, 2009, NAT GENET, V41, P8, DOI 10.1038/ng0109-8; Casto AM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r10; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Emery LS, 2010, AM J HUM GENET, V87, P848, DOI 10.1016/j.ajhg.2010.10.021; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Vicoso B, 2009, EVOLUTION, V63, P2413, DOI 10.1111/j.1558-5646.2009.00719.x	15	61	61	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2011	43	8					741	743		10.1038/ng.877	http://dx.doi.org/10.1038/ng.877			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21775991	Green Accepted			2022-12-25	WOS:000293178300009
J	Noordermeer, D; de Wit, E; Klous, P; van de Werken, H; Simonis, M; Lopez-Jones, M; Eussen, B; de Klein, A; Singer, RH; de Laat, W				Noordermeer, Daan; de Wit, Elzo; Klous, Petra; van de Werken, Harmen; Simonis, Marieke; Lopez-Jones, Melissa; Eussen, Bert; de Klein, Annelies; Singer, Robert H.; de Laat, Wouter			Variegated gene expression caused by cell-specific long-range DNA interactions	NATURE CELL BIOLOGY			English	Article							ODORANT RECEPTOR GENES; BETA-GLOBIN LOCUS; INTERCHROMOSOMAL ASSOCIATIONS; CHROMATIN-STRUCTURE; CONTROL REGION; TRANSCRIPTION; COLOCALIZATION; TRANSVECTION; ORGANIZATION; ACTIVATION	Mammalian genomes contain numerous regulatory DNA sites with unknown target genes. We used mice with an extra beta-globin locus control region (LCR) to investigate how a regulator searches the genome for target genes. We find that the LCR samples a restricted nuclear subvolume, wherein it preferentially contacts genes controlled by shared transcription factors. No contacted gene is detectably upregulated except for endogenous beta-globin genes located on another chromosome. This demonstrates genetically that mammalian trans activation is possible, but suggests that it will be rare. Trans activation occurs not pan-cellularly, but in 'jackpot' cells enriched for the interchromosomal interaction. Therefore, cell-specific long-range DNA contacts can cause variegated expression.	[Noordermeer, Daan; de Wit, Elzo; Klous, Petra; van de Werken, Harmen; Simonis, Marieke; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Noordermeer, Daan; de Wit, Elzo; Klous, Petra; van de Werken, Harmen; Simonis, Marieke; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lopez-Jones, Melissa; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Eussen, Bert; de Klein, Annelies] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Erasmus University Rotterdam; Erasmus MC	de Laat, W (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	w.delaat@hubrecht.eu	Werken, Harmen van de/G-8979-2013; Noordermeer, Daan/F-3306-2011	Werken, Harmen van de/0000-0002-9794-1477; de Laat, Wouter/0000-0002-6393-595X; de Wit, Elzo/0000-0003-2883-1415; Noordermeer, Daan/0000-0002-9296-7002	Dutch Scientific Organization (NWO) [91204082, 935170621]; European Research Council [209700, '4C']; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086217, R01GM080247, R01GM084364] Funding Source: NIH RePORTER	Dutch Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Marteijn and W. Vermeulen for providing Rad23a knockout material, Y. Oz for counting FISH slides, V. Buckle for providing BAC probes, J. van Rheenen and the Hubrecht Imaging Center for help with image analysis and E. Splinter and other members of the group for assistance. This work was financially supported by grants from the Dutch Scientific Organization (NWO) (91204082 and 935170621) and a European Research Council Starting Grant (209700, '4C') to W.d.L.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Kleinjan Dirk-Jan, 2009, Briefings in Functional Genomics & Proteomics, V8, P317, DOI 10.1093/bfgp/elp022; KOLOUNTZAKIS MN, 1992, INFORM PROCESS LETT, V43, P181, DOI 10.1016/0020-0190(92)90197-4; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lower KM, 2009, P NATL ACAD SCI USA, V106, P21771, DOI 10.1073/pnas.0909331106; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Noordermeer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000016; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; WASYLYK B, 1983, CELL, V32, P503, DOI 10.1016/0092-8674(83)90470-1; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	54	121	126	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					944	U161		10.1038/ncb2278	http://dx.doi.org/10.1038/ncb2278			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21706023	Green Accepted			2022-12-25	WOS:000293373700012
J	Prensner, JR; Iyer, MK; Balbin, OA; Dhanasekaran, SM; Cao, Q; Brenner, JC; Laxman, B; Asangani, IA; Grasso, CS; Kominsky, HD; Cao, XH; Jing, XJ; Wang, XJ; Siddiqui, J; Wei, JT; Robinson, D; Iyer, HK; Palanisamy, N; Maher, CA; Chinnaiyan, AM				Prensner, John R.; Iyer, Matthew K.; Balbin, O. Alejandro; Dhanasekaran, Saravana M.; Cao, Qi; Brenner, J. Chad; Laxman, Bharathi; Asangani, Irfan A.; Grasso, Catherine S.; Kominsky, Hal D.; Cao, Xuhong; Jing, Xiaojun; Wang, Xiaoju; Siddiqui, Javed; Wei, John T.; Robinson, Daniel; Iyer, Hari K.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.			Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression	NATURE BIOTECHNOLOGY			English	Article							LONG NONCODING RNA; GENE FUSIONS; HUMAN GENOME; POLYCOMB; REVEALS; BREAST; LOCI; BIOMARKER; ELEMENTS; MARKER	Noncoding RNAs (ncRNAs) are emerging as key molecules in human cancer, with the potential to serve as novel markers of disease and to reveal uncharacterized aspects of tumor biology. Here we discover 121 unannotated prostate cancer-associated ncRNA transcripts (PCATs) by ab initio assembly of high-throughput sequencing of polyA(+) RNA (RNA-Seq) from a cohort of 102 prostate tissues and cells lines. We characterized one ncRNA, PCAT-1, as a prostate-specific regulator of cell proliferation and show that it is a target of the Polycomb Repressive Complex 2 (PRC2). We further found that patterns of PCAT-1 and PRC2 expression stratified patient tissues into molecular subtypes distinguished by expression signatures of PCAT-1-repressed target genes. Taken together, our findings suggest that PCAT-1 is a transcriptional repressor implicated in a subset of prostate cancer patients. These findings establish the utility of RNA-Seq to identify disease-associated ncRNAs that may improve the stratification of cancer subtypes.	[Prensner, John R.; Iyer, Matthew K.; Balbin, O. Alejandro; Dhanasekaran, Saravana M.; Cao, Qi; Brenner, J. Chad; Asangani, Irfan A.; Grasso, Catherine S.; Kominsky, Hal D.; Cao, Xuhong; Jing, Xiaojun; Wang, Xiaoju; Siddiqui, Javed; Robinson, Daniel; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Laxman, Bharathi] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Wei, John T.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Iyer, Hari K.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago; University of Michigan System; University of Michigan; Colorado State University; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010; Wei, John T/E-8967-2012; Palanisamy, Nallasivam/ABC-8844-2020	Cao, Qi/0000-0002-5140-3681; Palanisamy, Nallasivam/0000-0002-0633-9772; Prensner, John/0000-0002-7024-636X; asangani, irfan/0000-0001-5381-1702; Dhanasekaran, saravana mohan/0000-0002-0489-2224	US National Institutes of Health (NIH) [P50CA69568]; Early Detection Research Network [UO1 CA111275]; NIH [R01CA132874-01A1, CA009676-18]; Department of Defense [W81XWH-10-0652, W81XWH-11-1-0337, PC094725, W81XWH-10-1-0551, W81XWH-11-1-0136]; Doris Duke Charitable Foundation; Burroughs Wellcome Foundation; Prostate Cancer Foundation; University of Michigan; American Association of Cancer Research; Canary Foundation; American Cancer Society; NATIONAL CANCER INSTITUTE [U01CA111275, R01CA132874, P50CA069568, T32CA009676] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Prostate Cancer Foundation; University of Michigan(University of Michigan System); American Association of Cancer Research; Canary Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ramnarayanan and R. Morey for technical assistance with next generation sequencing. We thank R.J. Lonigro, S. Kaylana-Sundaram, T. Barrette, and M. Quist for help with sequencing data analysis, and R. Mehra, B. Han and K. Suleman for prostate tissue specimens. We thank C. Trapnell and G. Pertea for assistance with computational analyses. We thank S. Tomlins, Y.-M. Wu, S. Roychowdhury and members of the Chinnaiyan laboratory for advice and discussions. We thank R. Beroukhim for guidance. This work was supported in part by the US National Institutes of Health (NIH) Prostate Specialized Program of Research Excellence grant P50CA69568, the Early Detection Research Network grant UO1 CA111275 (to A.M.C.), the NIH R01CA132874-01A1 (to A.M.C.), the Department of Defense grant W81XWH-10-0652 and W81XWH-11-1-0337 (to A.M.C.) and the National Center for Functional Genomics supported by the Department of Defense (to A.M.C.). A.M.C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award, a Burroughs Wellcome Foundation Award in Clinical Translational Research and the Prostate Cancer Foundation. A.M.C. is an American Cancer Society Research Professor. N.P. was supported by a University of Michigan Prostate SPORE Career Development Award. C. A. M. was supported by the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship, and a Prostate Cancer Foundation Young Investigator Award. Q. C. was supported by a Department of Defense Postdoctoral Fellowship grant PC094725. J.R.P. was supported by the NIH Cancer Biology Training grant CA009676-18 and the Department of Defense Predoctoral Fellowship W81XWH-10-1-0551. M. K. I. was supported by the Department of Defense Predoctoral Fellowship W81XWH-11-1-0136. J.R.P. and M. K. I. are Fellows of the University of Michigan Medical Scientist Training Program.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; de Kok JB, 2002, CANCER RES, V62, P2695; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Prensner JR, 2009, CURR OPIN GENET DEV, V19, P82, DOI 10.1016/j.gde.2008.11.008; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robertson HM, 1996, NAT GENET, V12, P360, DOI 10.1038/ng0496-360; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	776	837	0	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					742	U134		10.1038/nbt.1914	http://dx.doi.org/10.1038/nbt.1914			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804560	Green Accepted			2022-12-25	WOS:000293696500027
J	Gehman, LT; Stoilov, P; Maguire, J; Damianov, A; Lin, CH; Shiue, L; Ares, M; Mody, I; Black, DL				Gehman, Lauren T.; Stoilov, Peter; Maguire, Jamie; Damianov, Andrey; Lin, Chia-Ho; Shiue, Lily; Ares, Manuel, Jr.; Mody, Istvan; Black, Douglas L.			The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain	NATURE GENETICS			English	Article							TEMPORAL-LOBE EPILEPSY; CANDIDATE-GENE; STEM-CELLS; PROTEIN; EXPRESSION; FOX-1; MICE; ACTIVATION; MECHANISMS; MUTATIONS	The Rbfox family of RNA binding proteins regulates alternative splicing of many important neuronal transcripts, but its role in neuronal physiology is not clear1. We show here that central nervous system-specific deletion of the gene encoding Rbfox1 results in heightened susceptibility to spontaneous and kainic acid-induced seizures. Electrophysiological recording revealed a corresponding increase in neuronal excitability in the dentate gyrus of the knockout mice. Whole-transcriptome analyses identified multiple splicing changes in the Rbfox1(-/-) brain with few changes in overall transcript abundance. These splicing changes alter proteins that mediate synaptic transmission and membrane excitation. Thus, Rbfox1 directs a genetic program required in the prevention of neuronal hyperexcitation and seizures. The Rbfox1 knockout mice provide a new model to study the post-transcriptional regulation of synaptic function.	[Gehman, Lauren T.; Black, Douglas L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Stoilov, Peter] W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Maguire, Jamie] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Damianov, Andrey; Lin, Chia-Ho; Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Shiue, Lily; Ares, Manuel, Jr.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90024 USA; [Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; West Virginia University; Tufts University; University of California System; University of California Los Angeles; University of California System; University of California Santa Cruz; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	dougb@microbio.ucla.edu	Damianov, Andrey/G-7039-2014	Ares, Manny/0000-0002-2552-9168	US National Institutes of Health [R01 GM049369, R37 NS30549, R01 MH076994, R01 GM084317, R01 GM49662]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317, R01GM049369, R01GM049662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was done in collaboration with X.-D. Fu (University of California, San Diego). We thank N. Copeland (Institute of Molecular and Cell Biology, Singapore) for the recombineering vectors and bacterial strains used for generating the transgenic Rbfox1 mice and J.P. Donahue for his help with the microarray analyses. D. Geschwind, K. Martin and T. Nilsen gave us helpful comments on the manuscript. This work was supported in part by US National Institutes of Health Grants R01 GM049369 to X.D.F., R37 NS30549 and R01 MH076994 to I.M., R01 GM084317 to M.A. and D.L.B., and R01 GM49662 to D.L.B. D.L.B. is an Investigator of the Howard Hughes Medical Institute.	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Barnby G, 2005, AM J HUM GENET, V76, P950, DOI 10.1086/430454; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bertram EH, 2009, EPILEPSY BEHAV, V14, P32, DOI 10.1016/j.yebeh.2008.09.017; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Chapman AG, 1996, EPILEPSY RES, V26, P25, DOI 10.1016/S0920-1211(96)00036-8; Corradini I, 2009, ANN NY ACAD SCI, V1152, P93, DOI 10.1111/j.1749-6632.2008.03995.x; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Grabowski PJ, 2005, METHODS, V37, P323, DOI 10.1016/j.ymeth.2005.07.014; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; HUH GS, 1994, GENE DEV, V8, P1561, DOI 10.1101/gad.8.13.1561; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Johansson JU, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000278; Kiehl TR, 2001, MAMM GENOME, V12, P595, DOI 10.1007/s00335-001-2056-4; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; KIM KK, 2011, NUCL ACIDS RES; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Mulley JC, 2003, CURR OPIN NEUROL, V16, P171, DOI 10.1097/00019052-200304000-00009; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Papale LA, 2009, HUM MOL GENET, V18, P1633, DOI 10.1093/hmg/ddp081; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zapata A, 1997, BRAIN RES, V745, P114, DOI 10.1016/S0006-8993(96)01134-1; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150	48	238	242	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					706	U133		10.1038/ng.841	http://dx.doi.org/10.1038/ng.841			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21623373	Green Accepted, Green Submitted			2022-12-25	WOS:000292184600018
J	Celli, S; Albert, ML; Bousso, P				Celli, Susanna; Albert, Matthew L.; Bousso, Philippe			Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy	NATURE MEDICINE			English	Article							CD8(+) T-CELLS; DERMAL DENDRITIC CELLS; LANGERHANS CELLS; IN-VIVO; GRAFT-REJECTION; LYMPHOID ORGANS; SITE; LEISHMANIASIS; ELIMINATION; ACTIVATION	Transplant rejection involves a coordinated attack of the innate and the adaptive immune systems of the host. To investigate this dynamic process and the contributions of both donor and host cells, we developed an ear skin graft model suitable for intravital imaging. We found that donor dermal dendritic cells (DCs) migrated rapidly from the graft and were replaced by host CD11b(+) mononuclear cells. The infiltrating host cells captured donor antigen, reached the draining lymph node and cross-primed graft-reactive CD8(+) T cells. Furthermore, we defined the mechanisms by which host T cells target graft cells. We found that primed T cells entered the graft from the surrounding tissue and localized selectively at the dermis-epidermis junction. Later, CD8(+) T cells disseminated throughout the graft and many became arrested. These results provide insights into the antigen presentation pathway and the stepwise progression of CD8(+) T cell activity, thereby offering a framework for evaluating how immunotherapy might abrogate the key steps in allograft rejection.	[Celli, Susanna; Bousso, Philippe] Inst Pasteur, Dept Immunol, Unite Dynam Reponses Immunes, F-75724 Paris, France; [Celli, Susanna; Bousso, Philippe] INSERM, U668, Paris, France; [Albert, Matthew L.] Inst Pasteur, Unite Immunobiol Cellules Dendrit, F-75724 Paris, France; [Albert, Matthew L.] INSERM, U818, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bousso, P (corresponding author), Inst Pasteur, Dept Immunol, Unite Dynam Reponses Immunes, F-75724 Paris, France.	philippe.bousso@pasteur.fr	Celli, Susanna/M-7138-2014; Albert, Matthew L/C-9782-2009; BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X	INSERM; Institut Pasteur; Marie Curie Excellence grant	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); Marie Curie Excellence grant(European Commission)	We wish to thank H. Saklani and C. Auriau (Institut Pasteur) for providing B2m<SUP>-/-</SUP> mOVA mice and E. Robey and the members of the Bousso laboratory for comments on the manuscript. This work was supported by INSERM, Institut Pasteur and a Marie Curie Excellence grant.	Auchincloss H, 1996, CURR OPIN IMMUNOL, V8, P681, DOI 10.1016/S0952-7915(96)80086-0; BARKER CF, 1968, J EXP MED, V128, P197, DOI 10.1084/jem.128.1.197; BEIL WJ, 1992, J LEUKOCYTE BIOL, V52, P135, DOI 10.1002/jlb.52.2.135; Benichou G, 1999, J IMMUNOL, V162, P352; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Garrod KR, 2010, J IMMUNOL, V184, P2329, DOI 10.4049/jimmunol.0902748; Gelman AE, 2009, J IMMUNOL, V182, P3969, DOI 10.4049/jimmunol.0803514; Ingulli E, 2010, PEDIATR NEPHROL, V25, P61, DOI 10.1007/s00467-008-1020-x; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Konjufca V, 2009, CELL MICROBIOL, V11, P551, DOI 10.1111/j.1462-5822.2009.01289.x; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; LARSEN CP, 1990, ANN SURG, V212, P308, DOI 10.1097/00000658-199009000-00009; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Matsuo Shinji, 2007, J Med Invest, V54, P267, DOI 10.2152/jmi.54.267; Ng LG, 2008, IMMUNOL REV, V221, P147, DOI 10.1111/j.1600-065X.2008.00596.x; Nishibu A, 2006, J INVEST DERMATOL, V126, P787, DOI 10.1038/sj.jid.5700107; Obhrai JS, 2008, J INVEST DERMATOL, V128, P1950, DOI 10.1038/jid.2008.52; Ochando JC, 2006, AM J TRANSPLANT, V6, P2488, DOI 10.1111/j.1600-6143.2006.01494.x; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Richards DM, 2004, J IMMUNOL, V172, P3469, DOI 10.4049/jimmunol.172.6.3469; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x; ROSENBERG AS, 1988, P NATL ACAD SCI USA, V85, P7739, DOI 10.1073/pnas.85.20.7739; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; Valujskikh A, 2001, TRANSPLANTATION, V71, P418, DOI 10.1097/00007890-200102150-00014; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Wang J, 2006, AM J TRANSPLANT, V6, P2563, DOI 10.1111/j.1600-6143.2006.01516.x; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Zhou P, 2003, AM J TRANSPLANT, V3, P259, DOI 10.1034/j.1600-6143.2003.00067.x	40	108	110	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					744	U140		10.1038/nm.2376	http://dx.doi.org/10.1038/nm.2376			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21572426				2022-12-25	WOS:000291308800037
J	Pan, X; Zhou, T; Tai, YH; Wang, CG; Zhao, J; Cao, Y; Chen, Y; Zhang, PJ; Yu, M; Zhen, C; Mu, R; Bai, ZF; Li, HY; Li, AL; Liang, B; Jian, Z; Zhang, WN; Man, JH; Gao, YF; Gong, WL; Wei, LX; Zhang, XM				Pan, Xin; Zhou, Tao; Tai, Yan-Hong; Wang, Chenguang; Zhao, Jie; Cao, Yuan; Chen, Yuan; Zhang, Pei-Jing; Yu, Ming; Zhen, Cheng; Mu, Rui; Bai, Zhao-Fang; Li, Hui-Yan; Li, Ai-Ling; Liang, Bing; Jian, Zhao; Zhang, Wei-Na; Man, Jiang-Hong; Gao, Yan-Fei; Gong, Wei-Li; Wei, Li-Xin; Zhang, Xue-Min			Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer	NATURE MEDICINE			English	Article							ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; AROMATASE INHIBITORS; TAMOXIFEN; THERAPY; MECHANISMS; DOMAIN; IMMUNOHISTOCHEMISTRY; OVEREXPRESSION; DEGRADATION	Endocrine resistance is a major obstacle to hormonal therapy for breast cancers. Although reduced expression of estrogen receptor-alpha (ER-alpha) is a known contributing factor to endocrine resistance, the mechanism of ER-alpha downregulation in endocrine resistance is still not fully understood. Here we report that CUE domain-containing protein-2 (CUEDC2), a ubiquitin-binding motif-containing protein, is a key factor in endocrine resistance in breast cancer. We show that CUEDC2 modulates ER-alpha protein stability through the ubiquitin-proteasome pathway. Through the study of specimens from a large cohort of subjects with breast cancer, we found a strong inverse correlation between CUEDC2 and ER-alpha protein expression. Notably, subjects with tumors that highly expressed CUEDC2 had poor responsiveness to tamoxifen treatment and high potential for relapse. We further show that ectopic CUEDC2 expression impaired the responsiveness of breast cancer cells to tamoxifen. Therefore, our findings suggest that CUEDC2 is a crucial determinant of resistance to endocrine therapies in breast cancer.	[Pan, Xin; Zhou, Tao; Zhao, Jie; Chen, Yuan; Zhang, Pei-Jing; Yu, Ming; Zhen, Cheng; Mu, Rui; Bai, Zhao-Fang; Li, Hui-Yan; Li, Ai-Ling; Liang, Bing; Jian, Zhao; Zhang, Wei-Na; Man, Jiang-Hong; Gao, Yan-Fei; Gong, Wei-Li; Zhang, Xue-Min] China Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing, Peoples R China; [Tai, Yan-Hong; Wei, Li-Xin] Gen Hosp Chinese Peoples Liberat Army, Dept Pathol, Beijing, Peoples R China; [Tai, Yan-Hong; Cao, Yuan] 90th Hosp Jinan, Jinan, Peoples R China; [Wang, Chenguang] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University	Zhang, XM (corresponding author), China Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing, Peoples R China.	weilx301@263.net; xmzhang@nic.bmi.ac.cn	tai, yh/GRR-4574-2022	Man, Jianghong/0000-0001-6020-3537; /0000-0002-2681-8711; Zhang, Peijing/0000-0003-1586-8710; Pan, Xin/0000-0002-1982-2261	China National Natural Science Foundation [91029733, 30830097, 30900754]; China National High Technology Research and Development Program [2009AA02Z103]; China National Basic Research Program [2010CB911900, 2010CB529404]; Key State Science and Technology Projects [2009ZX09503-001, 2009ZX09501-031, 2009ZX09301-002, 2008ZX10002-016]; Pennsylvania Department of Health	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National High Technology Research and Development Program(National High Technology Research and Development Program of China); China National Basic Research Program(National Basic Research Program of China); Key State Science and Technology Projects; Pennsylvania Department of Health	We thank Z. Liu for critical reading of the manuscript, L. Hu for assistance with statistical analysis and Q. Ye at Beijing Institute of Biotechnology for DBD-ER-alpha plasmids. This work was supported by grants from the China National Natural Science Foundation (No. 91029733, No. 30830097 and No. 30900754), the China National High Technology Research and Development Program (Grant 2009AA02Z103), the China National Basic Research Program (Grant 2010CB911900, 2010CB529404), the Key State Science and Technology Projects (2009ZX09503-001, 2009ZX09501-031, 2009ZX09301-002 and 2008ZX10002-016). Work conducted at Thomas Jefferson University is funded in part by a Pennsylvania Department of Health grant (to C.W.).	Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Baum M, 2002, LANCET, V359, P2131; Bernoux A, 1998, BREAST CANCER RES TR, V49, P219, DOI 10.1023/A:1006011328655; Chu I, 2007, J CLIN INVEST, V117, P2205, DOI 10.1172/JCI21739; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Ingle JN, 2008, CANCER, V112, P695, DOI 10.1002/cncr.23192; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Jensen EV, 2003, CLIN CANCER RES, V9, P1980; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kenny FS, 1999, CLIN CANCER RES, V5, P2069; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; LIPPMAN ME, 1980, CANCER, V46, P2829, DOI 10.1002/1097-0142(19801215)46:12+<2829::AID-CNCR2820461419>3.0.CO;2-M; Ma CX, 2005, CANCER RES, V65, P11071, DOI 10.1158/0008-5472.CAN-05-1218; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Osborne CK, 2001, CLIN CANCER RES, V7, p4338S; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Rochefort H, 2003, ENDOCR-RELAT CANCER, V10, P261, DOI 10.1677/erc.0.0100261; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602	44	108	128	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					708	U99		10.1038/nm.2369	http://dx.doi.org/10.1038/nm.2369			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21572428				2022-12-25	WOS:000291308800031
J	Ford, CB; Lin, PL; Chase, MR; Shah, RR; Iartchouk, O; Galagan, J; Mohaideen, N; Ioerger, TR; Sacchettini, JC; Lipsitch, M; Flynn, JL; Fortune, SM				Ford, Christopher B.; Lin, Philana Ling; Chase, Michael R.; Shah, Rupal R.; Iartchouk, Oleg; Galagan, James; Mohaideen, Nilofar; Ioerger, Thomas R.; Sacchettini, James C.; Lipsitch, Marc; Flynn, JoAnne L.; Fortune, Sarah M.			Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection	NATURE GENETICS			English	Article							ISONIAZID PREVENTIVE THERAPY; DRUG-RESISTANCE; SURVIVAL; SPECTRUM; YEAST	Tuberculosis poses a global health emergency, which has been compounded by the emergence of drug-resistant Mycobacterium tuberculosis (Mtb) strains. We used whole-genome sequencing to compare the accumulation of mutations in Mtb isolated from cynomolgus macaques with active, latent or reactivated disease. We sequenced 33 Mtb isolates from nine macaques with an average genome coverage of 93% and an average read depth of 117x. Based on the distribution of SNPs observed, we calculated the mutation rates for these disease states. We found a similar mutation rate during latency as during active disease or in a logarithmically growing culture over the same period of time. The pattern of polymorphisms suggests that the mutational burden in vivo is because of oxidative DNA damage. We show that Mtb continues to acquire mutations during disease latency, which may explain why isoniazid monotherapy for latent tuberculosis is a risk factor for the emergence of isoniazid resistance(1,2).	[Ford, Christopher B.; Chase, Michael R.; Shah, Rupal R.; Lipsitch, Marc; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15213 USA; [Iartchouk, Oleg] Harvard Univ, Sch Med, Partners Healthcare Ctr Personalized Genet Med, Cambridge, MA 02138 USA; [Galagan, James] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James] Boston Univ, Dept Microbiol, Boston, MA 02215 USA; [Galagan, James] Broad Inst MIT & Harvard, Cambridge, MA USA; [Mohaideen, Nilofar; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA; [Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Partners Healthcare System; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu	Flynn, JoAnne/ABC-7371-2020; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Fortune, Sarah/0000-0001-7565-9975; Galagan, James/0000-0003-0542-3291; Lipsitch, Marc/0000-0003-1504-9213	Director's Office of the National Institute of Health [DP2 0D001378]; National Institute for Allergy and Infectious Diseases (NIAID) [U19 AI076217]; US National Institutes of Health (NIH) [RO1 HL075845]; Bill and Melinda Gates Foundation; National Institute of Allergy and Infectious Disease, US NIH, US Department of Health and Human Services [HHSN266200400001C]; National Institute of General Medical Sciences [U54GM088558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106804, R01HL075845, R33HL092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI063101, U19AI076217, T32AI007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001378] Funding Source: NIH RePORTER	Director's Office of the National Institute of Health; National Institute for Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Disease, US NIH, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a New Innovator's Award, DP2 0D001378 from the Director's Office of the National Institute of Health to S.M.F., by a subcontract from National Institute for Allergy and Infectious Diseases (NIAID) U19 AI076217 to S.M.F., by the US National Institutes of Health (NIH) RO1 HL075845 to J.L.F. and by the Bill and Melinda Gates Foundation (J.L.F.). The genome sequencing has been funded in part with federal funds from the National Institute of Allergy and Infectious Disease, US NIH, US Department of Health and Human Services, under contract no. HHSN266200400001C. The project described was supported in part by Award Number U54GM088558 to M.L. from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. We thank D. Gurgil and J. Xu of the Enterprise Research IS group at Partners Healthcare for their support and for provision of the HPC facilities and E. Klein for necropsy and pathology of the infected monkeys, as well as the veterinary technical staff for care of the animals. We also thank E. Rubin, C. Sassetti, B. Bloom, T. Rosebrock and B. Aldridge for helpful feedback.	Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Boshoff HIM, 2001, SCAND J INFECT DIS, V33, P101, DOI 10.1080/003655401753382567; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; GUTIERREZVAZQUEZ JM, 1956, AM REV TUBERC PULM, V74, P50; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Munoz-Elias F. I., 2005, INFECT IMMUN, V73, P546; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; PERRIENS JH, 1991, AM REV RESPIR DIS, V144, P750, DOI 10.1164/ajrccm/144.4.750; Saint-Ruf C, 2007, CRIT REV BIOCHEM MOL, V42, P259, DOI 10.1080/10409230701495599; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003	31	299	303	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2011	43	5					482	+		10.1038/ng.811	http://dx.doi.org/10.1038/ng.811			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21516081	Green Accepted			2022-12-25	WOS:000289972600021
J	Jiang, JY; Lazarus, MB; Pasquina, L; Sliz, P; Walker, S				Jiang, Jiaoyang; Lazarus, Michael B.; Pasquina, Lincoln; Sliz, Piotr; Walker, Suzanne			A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase	NATURE CHEMICAL BIOLOGY			English	Article							BETA-N-ACETYLGLUCOSAMINE; COVALENT INHIBITORS; ACCURATE DOCKING; GLYCOSYLTRANSFERASE; GLIDE; IDENTIFICATION; GLCNACYLATION; TALK	Glycosyltransferases (Gtfs) catalyze the formation of a diverse array of glycoconjugates. Small-molecule inhibitors to manipulate Gtf activity in cells have long been sought as tools for understanding Gtf function. Success has been limited because of challenges in designing inhibitors that mimic the negatively charged diphosphate substrates. Here we report the mechanism of action of a small molecule that inhibits O-linked N-acetylglucosamine transferase (OGT), an essential human enzyme that modulates cell signaling pathways by catalyzing a unique intracellular post-translational modification, beta-O-GlcNAcylation. The molecule contains a five-heteroatom dicarbamate core that functions as a neutral diphosphate mimic. One dicarbamate carbonyl reacts with an essential active site lysine that anchors the diphosphate of the nucleotide-sugar substrate. A nearby cysteine then reacts with the lysine adduct to form a carbonyl crosslink in the OGT active site. Though this unprecedented double-displacement mechanism reflects the unique architecture of the OGT active site, related dicarbamate scaffolds may inhibit other enzymes that bind nucleotide-containing substrates.	[Jiang, Jiaoyang; Lazarus, Michael B.; Pasquina, Lincoln; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Sliz, Piotr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sliz, Piotr] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Jiang, JY (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA.	suzanne_walker@hms.harvard.edu		Lazarus, Michael/0000-0002-6738-2563; Sliz, Piotr/0000-0002-6522-0835	Taplin Funds for Discovery Program; NIH [GM076710]; Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263, R01GM076710] Funding Source: NIH RePORTER	Taplin Funds for Discovery Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Brugge (Harvard Medical School) for the MCF-10A ErbB2 cells, L. Tabak (US National Institutes of Health, NIH) for ppGalNAcT2 protein, T. Lupoli (Harvard University) for MurG protein, C. Walsh, N. Gray (Harvard Medical School), E. Jacobson and D. Ford (Harvard University) for helpful discussions and A. Saghatelian (Harvard University) for critical reading of the manuscript. LC/MS data was acquired on an Agilent 6520 Q-TOF spectrophotometer supported by the Taplin Funds for Discovery Program (S. Walker). This work was supported in part by the NIH (GM076710) and the Harvard Biomedical Accelerator Fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Bricogne G., 2010, BUSTER VERSION 2 9; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; DELANO WL, 2002, PYMOL GMOLECULAR GRA; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2010, CHEM BIOL, V17, P1250, DOI 10.1016/j.chembiol.2010.09.014; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gloster TM, 2010, ORG BIOMOL CHEM, V8, P305, DOI 10.1039/b915870g; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hajduch J, 2008, CARBOHYD RES, V343, P189, DOI 10.1016/j.carres.2007.10.027; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Helm JS, 2003, J AM CHEM SOC, V125, P11168, DOI 10.1021/ja036494s; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hu Y, 2004, CHEM BIOL, V11, P703, DOI 10.1016/j.chembiol.2004.02.024; Izumi M, 2009, CURR TOP MED CHEM, V9, P87, DOI 10.2174/156802609787354351; Kiessling LL, 2010, ANNU REV BIOCHEM, V79, P619, DOI 10.1146/annurev.biochem.77.070606.100917; Kim EJ, 2006, J AM CHEM SOC, V128, P4234, DOI 10.1021/ja0582915; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Skropeta D, 2004, GLYCOCONJUGATE J, V21, P205, DOI 10.1023/B:GLYC.0000045093.96413.62; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Trunkfield AE, 2010, BIOORGAN MED CHEM, V18, P2651, DOI 10.1016/j.bmc.2010.02.026; Varki A., 2009, ESSENTIALS GLYCOBIOL; VIJAYALAKSHMI J, 1991, BIOCHEMISTRY-US, V30, P2175, DOI 10.1021/bi00222a022; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Wagner GK, 2010, CHEMBIOCHEM, V11, P1939, DOI 10.1002/cbic.201000201; Wang R, 1997, BIOORGAN MED CHEM, V5, P661, DOI 10.1016/S0968-0896(97)00005-9; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	48	77	82	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					72	77		10.1038/nchembio.711	http://dx.doi.org/10.1038/nchembio.711			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22082911	Green Accepted			2022-12-25	WOS:000298414100014
J	Nieto-Posadas, A; Picazo-Juarez, G; Llorente, I; Jara-Oseguera, A; Morales-Lazaro, S; Escalante-Alcalde, D; Islas, LD; Rosenbaum, T				Nieto-Posadas, Andres; Picazo-Juarez, Giovanni; Llorente, Itzel; Jara-Oseguera, Andres; Morales-Lazaro, Sara; Escalante-Alcalde, Diana; Islas, Leon D.; Rosenbaum, Tamara			Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site	NATURE CHEMICAL BIOLOGY			English	Article							BONE CANCER PAIN; NEUROPATHIC PAIN; CAPSAICIN RECEPTOR; FARNESYL PYROPHOSPHATE; PROTEIN-KINASE; LPA RECEPTORS; CHANNELS; AUTOTAXIN; LYSOPHOSPHOLIPIDS; IDENTIFICATION	Since 1992, there has been growing evidence that the bioactive phospholipid lysophosphatidic acid (LPA), whose amounts are increased upon tissue injury, activates primary nociceptors resulting in neuropathic pain. The TRPV1 ion channel is expressed in primary afferent nociceptors and is activated by physical and chemical stimuli. Here we show that in control mice LPA produces acute pain-like behaviors, which are substantially reduced in Trpv1-null animals. Our data also demonstrate that LPA activates TRPV1 through a unique mechanism that is independent of G protein-coupled receptors, contrary to what has been widely shown for other ion channels, by directly interacting with the C terminus of the channel. We conclude that TRPV1 is a direct molecular target of the pain-producing molecule LPA and that this constitutes, to our knowledge, the first example of LPA binding directly to an ion channel to acutely regulate its function.	[Nieto-Posadas, Andres; Picazo-Juarez, Giovanni; Llorente, Itzel; Morales-Lazaro, Sara; Escalante-Alcalde, Diana; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Jara-Oseguera, Andres; Islas, Leon D.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Nieto-Posadas, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico.	descalante@ifc.unam.mx; islas@liceaga.facmed.unam.mx; trosenba@ifc.unam.mx	Islas, Leon D/AAW-9845-2020	Islas, Leon D/0000-0002-7461-5214; Nieto-Posadas, Andres/0000-0002-3339-8604; Rosenbaum, Tamara/0000-0002-4791-3195; Jara Oseguera, Andres/0000-0001-5921-9320; Escalante-Alcalde, Diana/0000-0003-0325-6602	Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (DGAPA-PAPIIT) [IN209209]; Instituto de Ciencia y Tecnolog a del Distrito Federal (ICYT-DF) [PIFUTP09-262]; PAPIIT [IN216009, IN294111-3]; CONACyT [53777, CB-129474]; Fundacion Miguel Aleman	Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (DGAPA-PAPIIT); Instituto de Ciencia y Tecnolog a del Distrito Federal (ICYT-DF); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman	We thank D. Julius at University of California, San Francisco for providing the TRPV1 and TRPV2 cDNA, A. Patapoutian at the Scripps Research Institute for the TRPA1 cDNA, A. Toker at Harvard Medical School for PKC epsilon dominant-negative and wild-type plasmids, J. A. Garcia-Sainz for his kind gift of BIM I and M. Calcagno for helpful discussion. We also thank L. Ongay, A. Escalante and F. Perez at Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico (UNAM) for expert technical support and F. Sierra for expert help with DRG neuron culture. We are grateful to C. C. Duran and V. G. Soto for very valuable help with paw-withdrawal experiments. This work was supported by Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (DGAPA-PAPIIT) grant IN209209 and Instituto de Ciencia y Tecnolog a del Distrito Federal (ICYT-DF) grant PIFUTP09-262 to L. D. I., PAPIIT grants IN216009 and CONACyT 53777 to D.E.-A., and PAPIIT grants IN294111-3 and CONACyT CB-129474 and a grant from Fundacion Miguel Aleman to T. R. This study was performed in partial fulfillment of the requirements for A.N.-P.'s doctoral degree in biomedical sciences at the UNAM.	Alderton F, 2001, BRIT J PHARMACOL, V134, P6, DOI 10.1038/sj.bjp.0704278; Bang S, 2010, J BIOL CHEM, V285, P19362, DOI 10.1074/jbc.M109.087742; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caccin P, 2006, FEBS LETT, V580, P6317, DOI 10.1016/j.febslet.2006.10.039; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; Chaytor AT, 2003, P NATL ACAD SCI USA, V100, P15212, DOI 10.1073/pnas.2435030100; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Escalante-Alcalde D, 2007, GENESIS, V45, P465, DOI 10.1002/dvg.20314; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Hama K, 2002, FEBS LETT, V523, P187, DOI 10.1016/S0014-5793(02)02976-9; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jara-Oseguera Andres, 2008, Curr Mol Pharmacol, V1, P255; Jiang GW, 2007, CHEMMEDCHEM, V2, P679, DOI 10.1002/cmdc.200600280; Karliner JS, 2002, BBA-MOL CELL BIOL L, V1582, P216, DOI 10.1016/S1388-1981(02)00174-9; KELLY JJ, 1983, NEUROLOGY, V33, P202, DOI 10.1212/WNL.33.2.202; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Ma L, 2010, J NEUROCHEM, V115, P643, DOI 10.1111/j.1471-4159.2010.06955.x; Marincsak R, 2009, ORAL DIS, V15, P328, DOI 10.1111/j.1601-0825.2009.01526.x; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Mintzer E, 2006, BBA-BIOMEMBRANES, V1758, P85, DOI 10.1016/j.bbamem.2005.12.009; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Pan HL, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-85; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Renback K, 2000, MOL BRAIN RES, V75, P350, DOI 10.1016/S0169-328X(99)00333-2; Roedding AS, 2006, LIFE SCI, V80, P89, DOI 10.1016/j.lfs.2006.08.021; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Tang L, 2007, J PHARMACOL EXP THER, V321, P791, DOI 10.1124/jpet.106.117572; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ueda H, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-11; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302	50	140	142	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					78	85		10.1038/nchembio.712	http://dx.doi.org/10.1038/nchembio.712			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101604				2022-12-25	WOS:000298414100015
J	Fairn, GD; Hermansson, M; Somerharju, P; Grinstein, S				Fairn, Gregory D.; Hermansson, Martin; Somerharju, Pentti; Grinstein, Sergio			Phosphatidylserine is polarized and required for proper Cdc42 localization and for development of cell polarity	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; YEAST; PROTEIN; GROWTH; MEMBRANES; MUTANTS; CYCLE; GENE; ENDOSOMES	Polarity is key to the function of eukaryotic cells. On the establishment of a polarity axis, cells can vectorially target secretion, generating an asymmetric distribution of plasma membrane proteins. From Saccharomyces cerevisiae to mammals, the small GTPase Cdc42 is a pivotal regulator of polarity. We used a fluorescent probe to visualize the distribution of phosphatidylserine in live S. cerevisiae. Remarkably, phosphatidylserine was polarized in the plasma membrane, accumulating in bud necks, the bud cortex and the tips of mating projections. Polarization required vectorial delivery of phosphatidylserine-containing secretory vesicles, and phosphatidylserine was largely excluded from endocytic vesicles, contributing to its polarized retention. Mutants lacking phosphatidylserine synthase had impaired polarization of the Cdc42 complex, leading to a delay in bud emergence, and defective mating. The addition of lysophosphatidylserine resulted in resynthesis and polarization of phosphatidylserine, as well as repolarization of Cdc42. The results indicate that phosphatidylserine-and presumably its polarization-are required for optimal Cdc42 targeting and activation during cell division and mating.	[Fairn, Gregory D.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Hermansson, Martin; Somerharju, Pentti] Univ Helsinki, Inst Biomed, Dept Biochem & Dev Biol, FIN-00014 Helsinki, Finland	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Helsinki	Grinstein, S (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sergio.grinstein@sickkids.ca	Hermansson, Martin/B-7854-2008	Hermansson, Martin/0000-0003-3387-8365; Fairn, Greg/0000-0001-6508-168X	Canadian Institutes of Health Research (CIHR) [7075, MOP4665]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank C. McMaster (Dalhousie University, Halifax, Canada), S. Emr (Cornell University, Ithaca, USA), H. Pelham (MRC-LMB, Cambridge, UK), T. Levine (UCL, London, UK), D. Johnson (University of Vermont, Burlington, USA), K. Tanaka (Hokkaido University, Hokkaido, Japan), R. Collins (Cornell University, Ithaca, USA), E. Bi (UPENN, Philadelphia, USA), R. Li (Stowers Institute for Medical Research, Kansas City, USA), F. Cross (Rockefeller University, New York, USA), W. Guo (UPENN, Philadelphia, USA), C. Burd (UPENN, Philadelphia, USA), B. Andrews (University of Toronto, Toronto, Canada) and C. Boone (University of Toronto, Toronto, Canada) for providing strains and plasmids. We also thank C. McMaster for his comments on the manuscript. This work was supported by Canadian Institutes of Health Research (CIHR) grants 7075 and MOP4665. G.D.F. is the recipient of a CIHR postdoctoral fellowship. S.G. is the present holder of the Pitblado Chair in Cell Biology.	ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; CHENEVERT J, 1992, NATURE, V356, P77, DOI 10.1038/356077a0; COTTRELL SF, 1981, J BIOL CHEM, V256, P973; CROSS FR, 1990, MOL CELL BIOL, V10, P6482, DOI 10.1128/MCB.10.12.6482; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; He B, 2007, J CELL BIOL, V176, P771, DOI 10.1083/jcb.200606134; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Koivusalo M, 2001, J LIPID RES, V42, P663; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Mitra P, 2004, J CELL BIOL, V166, P205, DOI 10.1083/jcb.200404150; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Pruyne D, 2000, J CELL SCI, V113, P571; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Toenjes KA, 1999, CURR BIOL, V9, P1183, DOI 10.1016/S0960-9822(00)80022-6; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vinnakota KC, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026011; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; Wiget P, 2004, EMBO J, V23, P1063, DOI 10.1038/sj.emboj.7600123; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	41	128	128	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1424	U98		10.1038/ncb2351	http://dx.doi.org/10.1038/ncb2351			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	21964439				2022-12-25	WOS:000298157500009
J	Zaccai, NR; Chi, B; Thomson, AR; Boyle, AL; Bartlett, GJ; Bruning, M; Linden, N; Sessions, RB; Booth, PJ; Brady, RL; Woolfson, DN				Zaccai, Nathan R.; Chi, Bertie; Thomson, Andrew R.; Boyle, Aimee L.; Bartlett, Gail J.; Bruning, Marc; Linden, Noah; Sessions, Richard B.; Booth, Paula J.; Brady, R. Leo; Woolfson, Derek N.			A de novo peptide hexamer with a mutable channel	NATURE CHEMICAL BIOLOGY			English	Article							COILED-COIL; CRYSTAL-STRUCTURE; PROTEIN FOLD; DESIGN; SPECIFICITY; REVEALS; PROGRAM; PACKING; MODEL	The design of new proteins that expand the repertoire of natural protein structures represents a formidable challenge. Success in this area would increase understanding of protein structure and present new scaffolds that could be exploited in biotechnology and synthetic biology. Here we describe the design, characterization and X-ray crystal structure of a new coiled-coil protein. The de novo sequence forms a stand-alone, parallel, six-helix bundle with a channel running through it. Although lined exclusively by hydrophobic leucine and isoleucine side chains, the 6-angstrom channel is permeable to water. One layer of leucine residues within the channel is mutable, accepting polar aspartic acid and histidine side chains, which leads to subdivision and organization of solvent within the lumen. Moreover, these mutants can be combined to form a stable and unique (Asp-His)(3) heterohexamer. These new structures provide a basis for engineering de novo proteins with new functions.	[Zaccai, Nathan R.; Chi, Bertie; Sessions, Richard B.; Booth, Paula J.; Brady, R. Leo; Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Chi, Bertie; Thomson, Andrew R.; Boyle, Aimee L.; Bartlett, Gail J.; Bruning, Marc; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Linden, Noah] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England	University of Bristol; University of Bristol; University of Bristol	Woolfson, DN (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	R.L.Brady@bris.ac.uk; D.N.Woolfson@bristol.ac.uk	Woolfson, Dek Neil/ABC-4338-2021; Bartlett, Gail/F-3064-2015	Thomson, Andrew/0000-0002-1066-1369; Woolfson, Derek/0000-0002-0394-3202; Booth, Paula Jane/0000-0003-3893-360X; Boyle, Aimee/0000-0003-4176-6080; Sessions, Richard/0000-0003-0320-0895; Zaccai, Nathan/0000-0002-1476-2044	Biotechnology and Biological Sciences Research Council of the UK [BB/G008833/1, BB/F007256/1]; Biotechnology and Biological Sciences Research Council [BB/F01872X/1, BB/F007256/1, BB/G008833/1] Funding Source: researchfish; BBSRC [BB/G008833/1, BB/F007256/1, BB/F01872X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank members of the Woolfson group, in particular C. Armstrong and J. Fletcher, for discussions, and H. Bayley, A. Lupas and J. Spencer for comments on the manuscript. We are grateful to the Biotechnology and Biological Sciences Research Council of the UK for grants to D. N. W. and P. J. B. (BB/G008833/1) and to R. L. B. and D. N. W. (BB/F007256/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bromley EHC, 2009, J AM CHEM SOC, V131, P928, DOI 10.1021/ja804231a; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghirlanda G, 2002, J MOL BIOL, V319, P243, DOI 10.1016/S0022-2836(02)00233-4; Grainger B, 2010, J COMPUT BIOL, V17, P1371, DOI 10.1089/cmb.2009.0265; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Jeoung JH, 2007, J MOL BIOL, V368, P1122, DOI 10.1016/j.jmb.2007.02.079; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104; Liu J, 2004, P NATL ACAD SCI USA, V101, P16156, DOI 10.1073/pnas.0405319101; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; MacDonald JT, 2010, PROTEINS, V78, P1311, DOI 10.1002/prot.22651; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001; North B, 2001, J MOL BIOL, V311, P1081, DOI 10.1006/jmbi.2001.4900; Opella SJ, 1999, NAT STRUCT BIOL, V6, P374, DOI 10.1038/7610; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Reinke AW, 2010, J AM CHEM SOC, V132, P6025, DOI 10.1021/ja907617a; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Taylor WR, 2009, STRUCTURE, V17, P1244, DOI 10.1016/j.str.2009.07.012; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	49	146	159	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					935	941		10.1038/NCHEMBIO.692	http://dx.doi.org/10.1038/NCHEMBIO.692			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22037471	Green Accepted			2022-12-25	WOS:000297166200017
J	Chambers, JC; Zhang, WH; Sehmi, J; Li, XZ; Wass, MN; Van der Harst, P; Holm, H; Sanna, S; Kavousi, M; Baumeister, SE; Coin, LJ; Deng, GH; Gieger, C; Heard-Costa, NL; Hottenga, JJ; Kuhnel, B; Kumar, V; Lagou, V; Liang, LM; Luan, JA; Vidal, PM; Leach, IM; O'Reilly, PF; Peden, JF; Rahmioglu, N; Soininen, P; Speliotes, EK; Yuan, X; Thorleifsson, G; Alizadeh, BZ; Atwood, LD; Borecki, IB; Brown, MJ; Charoen, P; Cucca, F; Das, D; de Geus, EJC; Dixon, AL; Doering, A; Ehret, G; Eyjolfsson, GI; Farrall, M; Forouhi, NG; Friedrich, N; Goessling, W; Gudbjartsson, DF; Harris, TB; Hartikainen, AL; Heath, S; Hirschfield, GM; Hofman, A; Homuth, G; Hypponen, E; Janssen, HLA; Johnson, T; Kangas, AJ; Kema, IP; Kuhn, JP; Lai, S; Lathrop, M; Lerch, MM; Li, Y; Liang, TJ; Lin, JP; Loos, RJF; Martin, NG; Moffatt, MF; Montgomery, GW; Munroe, PB; Musunuru, K; Nakamura, Y; O'Donnell, CJ; Olafsson, I; Penninx, BW; Pouta, A; Prins, BP; Prokopenko, I; Puls, R; Ruokonen, A; Savolainen, MJ; Schlessinger, D; Schouten, JNL; Seedorf, U; Sen-Chowdhry, S; Siminovitch, KA; Smit, JH; Spector, TD; Tan, WT; Teslovich, TM; Tukiainen, T; Uitterlinden, AG; Van der Klauw, MM; Vasan, RS; Wallace, C; Wallaschofski, H; Wichmann, HE; Willemsen, G; Wurtz, P; Xu, C; Yerges-Armstrong, LM; Abecasis, GR; Ahmadi, KR; Boomsma, DI; Caulfield, M; Cookson, WO; van Duijn, CM; Froguel, P; Matsuda, K; McCarthy, MI; Meisinger, C; Mooser, V; Pietilainen, KH; Schumann, G; Snieder, H; Sternberg, MJE; Stolk, RP; Thomas, HC; Thorsteinsdottir, U; Uda, M; Waeber, G; Wareham, NJ; Waterworth, DM; Watkins, H; Whitfield, JB; Witteman, JCM; Wolffenbuttel, BHR; Fox, CS; Ala-Korpela, M; Stefansson, K; Vollenweider, P; Volzke, H; Schadt, EE; Scott, J; Jarvelin, MR; Elliott, P; Kooner, JS				Chambers, John C.; Zhang, Weihua; Sehmi, Joban; Li, Xinzhong; Wass, Mark N.; Van der Harst, Pim; Holm, Hilma; Sanna, Serena; Kavousi, Maryam; Baumeister, Sebastian E.; Coin, Lachlan J.; Deng, Guohong; Gieger, Christian; Heard-Costa, Nancy L.; Hottenga, Jouke-Jan; Kuehnel, Brigitte; Kumar, Vinod; Lagou, Vasiliki; Liang, Liming; Luan, Jian'an; Vidal, Pedro Marques; Leach, Irene Mateo; O'Reilly, Paul F.; Peden, John F.; Rahmioglu, Nilufer; Soininen, Pasi; Speliotes, Elizabeth K.; Yuan, Xin; Thorleifsson, Gudmar; Alizadeh, Behrooz Z.; Atwood, Larry D.; Borecki, Ingrid B.; Brown, Morris J.; Charoen, Pimphen; Cucca, Francesco; Das, Debashish; de Geus, Eco J. C.; Dixon, Anna L.; Doering, Angela; Ehret, Georg; Eyjolfsson, Gudmundur I.; Farrall, Martin; Forouhi, Nita G.; Friedrich, Nele; Goessling, Wolfram; Gudbjartsson, Daniel F.; Harris, Tamara B.; Hartikainen, Anna-Liisa; Heath, Simon; Hirschfield, Gideon M.; Hofman, Albert; Homuth, Georg; Hyppoenen, Elina; Janssen, Harry L. A.; Johnson, Toby; Kangas, Antti J.; Kema, Ido P.; Kuehn, Jens P.; Lai, Sandra; Lathrop, Mark; Lerch, Markus M.; Li, Yun; Liang, T. Jake; Lin, Jing-Ping; Loos, Ruth J. F.; Martin, Nicholas G.; Moffatt, Miriam F.; Montgomery, Grant W.; Munroe, Patricia B.; Musunuru, Kiran; Nakamura, Yusuke; O'Donnell, Christopher J.; Olafsson, Isleifur; Penninx, Brenda W.; Pouta, Anneli; Prins, Bram P.; Prokopenko, Inga; Puls, Ralf; Ruokonen, Aimo; Savolainen, Markku J.; Schlessinger, David; Schouten, Jeoffrey N. L.; Seedorf, Udo; Sen-Chowdhry, Srijita; Siminovitch, Katherine A.; Smit, Johannes H.; Spector, Timothy D.; Tan, Wenting; Teslovich, Tanya M.; Tukiainen, Taru; Uitterlinden, Andre G.; Van der Klauw, Melanie M.; Vasan, Ramachandran S.; Wallace, Chris; Wallaschofski, Henri; Wichmann, H-Erich; Willemsen, Gonneke; Wuertz, Peter; Xu, Chun; Yerges-Armstrong, Laura M.; Abecasis, Goncalo R.; Ahmadi, Kourosh R.; Boomsma, Dorret I.; Caulfield, Mark; Cookson, William O.; van Duijn, Cornelia M.; Froguel, Philippe; Matsuda, Koichi; McCarthy, Mark I.; Meisinger, Christa; Mooser, Vincent; Pietilainen, Kirsi H.; Schumann, Gunter; Snieder, Harold; Sternberg, Michael J. E.; Stolk, Ronald P.; Thomas, Howard C.; Thorsteinsdottir, Unnur; Uda, Manuela; Waeber, Gerard; Wareham, Nicholas J.; Waterworth, Dawn M.; Watkins, Hugh; Whitfield, John B.; Witteman, Jacqueline C. M.; Wolffenbuttel, Bruce H. R.; Fox, Caroline S.; Ala-Korpela, Mika; Stefansson, Kari; Vollenweider, Peter; Voelzke, Henry; Schadt, Eric E.; Scott, James; Jarvelin, Marjo-Riitta; Elliott, Paul; Kooner, Jaspal S.		Alcohol Genome-wide Assoc AlcGen; Diabet Genetics Replication; Genetic Invest Anthropometric; Global Lipids Genetics Consortium; Genetics Liver Dis GOLD Consortium; Int Consortium Blood Pressure ICBP; Meta-Anal Glucose Insulin-Related	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma	NATURE GENETICS			English	Article							C-REACTIVE PROTEIN; SALT EXPORT PUMP; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; SUSCEPTIBILITY LOCI; METABOLIC SYNDROME; GENETIC-VARIANTS; TYPE-2; TWIN; DISEASE	Concentrations of liver enzymes in plasma are widely used as indicators of liver disease. We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci associated with concentrations of liver enzymes in plasma, of which 32 are new associations (P = 10(-8) to P = 10(-190)). We used functional genomic approaches including metabonomic profiling and gene expression analyses to identify probable candidate genes at these regions. We identified 69 candidate genes, including genes involved in biliary transport (ATP8B1 and ABCB11), glucose, carbohydrate and lipid metabolism (FADS1, FADS2, GCKR, JMJD1C, HNF1A, MLXIPL, PNPLA3, PPP1R3B, SLC2A2 and TRIB1), glycoprotein biosynthesis and cell surface glycobiology (ABO, ASGR1, FUT2, GPLD1 and ST3GAL4), inflammation and immunity (CD276, CDH6, GCKR, HNF1A, HPR, ITGA1, RORA and STAT4) and glutathione metabolism (GSTT1, GSTT2 and GGT), as well as several genes of uncertain or unknown function (including ABHD12, EFHD1, EFNA1, EPHA2, MICAL3 and ZNF827). Our results provide new insight into genetic mechanisms and pathways influencing markers of liver function.	[Chambers, John C.; Zhang, Weihua; Coin, Lachlan J.; O'Reilly, Paul F.; Charoen, Pimphen; Sen-Chowdhry, Srijita; Tukiainen, Taru; Wuertz, Peter; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, London, England; [Chambers, John C.; Thomas, Howard C.; Kooner, Jaspal S.] Imperial Coll Healthcare Natl Hlth Serv NHS Trust, London, England; [Chambers, John C.; Zhang, Weihua; Sehmi, Joban; Das, Debashish; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Middlesex, England; [Sehmi, Joban; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Li, Xinzhong] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Inst Clin Sci, London, England; [Wass, Mark N.; Sternberg, Michael J. E.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Struct Bioinformat Grp, London, England; [Van der Harst, Pim; Leach, Irene Mateo] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 AB Groningen, Netherlands; [Holm, Hilma; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Sanna, Serena; Cucca, Francesco; Lai, Sandra; Uda, Manuela] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Kavousi, Maryam; Hofman, Albert; Janssen, Harry L. A.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Kavousi, Maryam; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Netherlands Genom Initiat, Rotterdam, Netherlands; [Baumeister, Sebastian E.; Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Deng, Guohong; Tan, Wenting] Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing, Peoples R China; [Gieger, Christian; Kuehnel, Brigitte] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Heard-Costa, Nancy L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hottenga, Jouke-Jan; de Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] VU Univ Amsterdam VUA, Dept Biol Psychol, Amsterdam, Netherlands; [Kumar, Vinod; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan; [Lagou, Vasiliki; Alizadeh, Behrooz Z.; Prins, Bram P.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Lagou, Vasiliki; Rahmioglu, Nilufer; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lagou, Vasiliki; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Luan, Jian'an; Forouhi, Nita G.; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Vidal, Pedro Marques] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Vidal, Pedro Marques; Ehret, Georg] Univ Lausanne, Lausanne, Switzerland; [Peden, John F.; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; [Soininen, Pasi; Kangas, Antti J.; Savolainen, Markku J.; Tukiainen, Taru; Wuertz, Peter; Ala-Korpela, Mika] Univ Oulu, Inst Clin Med, Computat Med Res Grp, Oulu, Finland; [Soininen, Pasi; Kangas, Antti J.; Savolainen, Markku J.; Tukiainen, Taru; Wuertz, Peter; Ala-Korpela, Mika] Univ Oulu, Bioctr, Oulu, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Dept Biosci, Nucl Magnet Resonance NMR Metabon Lab, Kuopio, Finland; [Speliotes, Elizabeth K.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Speliotes, Elizabeth K.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Yuan, Xin; Mooser, Vincent; Waterworth, Dawn M.] GlaxoSmithKline, Genet, King Of Prussia, PA USA; [Atwood, Larry D.; Musunuru, Kiran] Boston Univ, Sch Med, Boston, MA 02118 USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Brown, Morris J.; Wallace, Chris] Univ Cambridge, Cambridge Inst Med Res, Diabet Inflammat Lab, Cambridge, England; [Charoen, Pimphen] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [de Geus, Eco J. C.] VUA, Amsterdam, Netherlands; [de Geus, Eco J. C.] VUA Med Ctr, Amsterdam, Netherlands; [Dixon, Anna L.; Moffatt, Miriam F.; Cookson, William O.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Doering, Angela; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Ehret, Georg] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Ehret, Georg] CHU Vaudois, IUMSP, CH-1011 Lausanne, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Dept Med, Geneva, Switzerland; [Eyjolfsson, Gudmundur I.] Lab Mjodd, Reykjavik, Iceland; [Farrall, Martin; Watkins, Hugh] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Friedrich, Nele; Wallaschofski, Henri] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, D-17487 Greifswald, Germany; [Goessling, Wolfram] Brigham & Womens Hosp, Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Div Genet, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Div Gastroenterol, Gastrointestinal Canc Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Inst Clin Med, Oulu, Finland; [Heath, Simon; Lathrop, Mark] CEA IG Ctr Natl Genotypage, Evry, France; [Hirschfield, Gideon M.; Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hirschfield, Gideon M.] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Hirschfield, Gideon M.] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Hyppoenen, Elina] Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Janssen, Harry L. A.; Schouten, Jeoffrey N. L.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Johnson, Toby; Munroe, Patricia B.; Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Genome Ctr, London, England; [Kema, Ido P.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Kuehn, Jens P.; Puls, Ralf] Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Lathrop, Mark] Fdn Jean Dausset Ceph, Paris, France; [Lerch, Markus M.] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Li, Yun] Univ N Carolina, Dept Biostat, Dept Genet, Chapel Hill, NC USA; [Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD USA; [Lin, Jing-Ping] NHLBI, Off Biostat Res, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John B.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Musunuru, Kiran] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Musunuru, Kiran] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Musunuru, Kiran] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [O'Donnell, Christopher J.; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, Reykjavik, Iceland; [Penninx, Brenda W.; Smit, Johannes H.] VUA Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W.; Smit, Johannes H.] VUA Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, Oulu, Finland; [Savolainen, Markku J.; Ala-Korpela, Mika] Univ Oulu, Clin Res Ctr, Dept Internal Med, Oulu, Finland; [Savolainen, Markku J.; Ala-Korpela, Mika] Univ Oulu, Clin Res Ctr, Bioctr Oulu, Oulu, Finland; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Siminovitch, Katherine A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Siminovitch, Katherine A.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Siminovitch, Katherine A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada; [Spector, Timothy D.; Ahmadi, Kourosh R.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Teslovich, Tanya M.; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Van der Klauw, Melanie M.; Sternberg, Michael J. E.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, Groningen, Netherlands; [Van der Klauw, Melanie M.; Sternberg, Michael J. E.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Biobank, Groningen, Netherlands; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Willemsen, Gonneke; Boomsma, Dorret I.] VUA Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Xu, Chun] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Xu, Chun] Toronto Gen Res Inst, Toronto, ON, Canada; [Yerges-Armstrong, Laura M.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [van Duijn, Cornelia M.] Ctr Med Syst Biol, Rotterdam, Netherlands; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, London, England; [McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res, Oxford OX3 7LJ, England; [Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Pietilainen, Kirsi H.] Helsinki Univ Hosp, Div Internal Med, Dept Med, Obes Res Unit, Helsinki, Finland; [Pietilainen, Kirsi H.] Inst Mol Med FIMM, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Schumann, Gunter] Kings Coll London, Inst Psychiat, MRC Social Genet Dev Psychiat SGDP Ctr, London WC2R 2LS, England; [Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Thomas, Howard C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol Hypertens & Metab, Boston, MA 02115 USA; [Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC, HPA, Ctr Environm Hlth, London, England	Imperial College London; Imperial College London; Imperial College London; Royal Brompton Hospital; Imperial College London; University of Groningen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Erasmus University Rotterdam; Erasmus MC; Ernst Moritz Arndt Universitat Greifswald; Army Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Boston University; University of Tokyo; University of Groningen; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Oxford; Wellcome Centre for Human Genetics; University of Oulu; University of Oulu; University of Eastern Finland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; GlaxoSmithKline; Boston University; Washington University (WUSTL); University of Cambridge; Mahidol University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Oxford; Ernst Moritz Arndt Universitat Greifswald; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oulu; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Birmingham; Ernst Moritz Arndt Universitat Greifswald; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; University of London; Queen Mary University London; University of Groningen; Ernst Moritz Arndt Universitat Greifswald; Foundation Jean Dausset-CEPH; Greifswald Medical School; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Landspitali National University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Munster; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of London; King's College London; University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; University of Groningen; Boston University; Boston University; University of Munich; University of Munich; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University System of Maryland; University of Maryland Baltimore; Imperial College London; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of London; King's College London; University of Groningen; Imperial College London; University of Iceland; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai; University of Oulu; Health Protection Agency; Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Norfolk Pl, London, England.	john.chambers@ic.ac.uk; p.elliott@ic.ac.uk; j.kooner@ic.ac.uk	Raso, Francesco Mattace-/L-2541-2015; Lerch, Markus M./E-2206-2016; Dominiczak, Anna F/P-9390-2017; EHRET, Georg B/A-9532-2009; Ahmadi, Kourosh R/B-6379-2012; Uda, Manuela/AAC-2645-2019; Benediktsson, Rafn/R-2457-2018; Boomsma, Dorret I/AAX-4470-2020; Siminovitch, Katherine/K-1475-2013; Penninx, Brenda WJH/S-7627-2017; Zgaga, Lina/Q-9415-2018; sanna, serena/H-3009-2019; zhang, weihua/GXV-1334-2022; Singleton, Andrew B/C-3010-2009; Prabhakaran, Dorairaj/B-4147-2011; Kavousi, Maryam/F-1174-2018; li, xin/HHS-9461-2022; Martin, Nicholas/R-9235-2019; Walters, G. Bragi/L-4215-2013; Bonnefond, Amélie/O-2784-2017; Onland-Moret, N. Charlotte/G-9185-2011; Ejebe, Kenechi/I-9238-2016; Cookson, William/HHC-1790-2022; Hide, Winston Hide/C-7217-2009; Mukherjee, Sutapa/U-7262-2017; Coin, Lachlan JM/A-9001-2014; Erdmann, Jeanette/A-4417-2009; Wichmann, Heinz Erich/AAA-5695-2022; MASSON, David/AAC-8896-2022; van der Klauw, M. M./A-2138-2014; Knowles, Josh w/C-9241-2013; Palmer, Lyle John/K-3196-2014; Li, Man/AAX-3400-2020; Grobbee, Diederick/C-7651-2014; Stolk, Ronald P/B-2341-2013; Colaus, PsyColaus/K-6607-2013; Rudan, Igor/I-1467-2012; BOUATIA-NAJI, NABILA/D-5863-2013; Loos, Ruth/GON-5877-2022; Feitosa, Mary F/K-8044-2012; Wass, Mark/H-3398-2019; Bochud, Murielle/A-3981-2010; Kaprio, Jaakko/A-1820-2008; Soininen, Pasi/B-9716-2008; Lagou, Vasiliki/N-8451-2013; Clark, Jeanne/AGG-8199-2022; Charchar, Fadi/I-6656-2017; MASSON, David/R-4557-2017; Visvikis-Siest, Sophie/H-2324-2014; Schumann, Gunter/H-1013-2013; Tzoulaki, Ioanna/ABE-6269-2020; Kronenberg, Florian/B-1736-2008; Laan, Maris/A-4100-2011; Liu, Jianjun/AAK-4989-2020; Visscher, Peter/ABB-6151-2020; Marmot, M G/Y-3920-2019; Aben, Katja KH/G-9686-2016; Elliott, Amanda/G-5120-2012; Naitza, Silvia/D-5620-2017; FROGUEL, Philippe/O-6799-2017; Boehm, Bernhard Otto/F-8750-2015; Hide, Winston A/V-2727-2017; Kiemeney, Lambertus A./D-3357-2009; Kumar, Vinod/ABC-4866-2020; Polasek, Ozren/B-6002-2011; Erdmann, Jeanette/P-7513-2014; Brunner, Eric/H-2114-2011; Hirschfield, Gideon M/M-2143-2015; Alizadeh, Behrooz Z Ziad/J-2921-2017; Loos, Ruth J F/Q-2862-2016; Lucas, Gavin/D-4346-2012; Baumeister, Sebastian-Edgar/P-7894-2019; Ridderstråle, Martin/F-7678-2012; Kanoni, Stavroula/AAN-7161-2021; Montgomery, Grant W/B-7148-2008; Langenberg, Claudia/ABG-9067-2021; rahmioglu, nilufer/AAO-5653-2020; Ramachandran, Vasan/Y-2527-2019; Zhu, Xiaofeng/O-6874-2019; de Geus, Eco J.C./M-9318-2015; Lai, Sandra/AAY-4176-2020; Prokopenko, Inga/AAU-9895-2020; van Dijk, Ko Willems/A-1798-2008; Prokopenko, Inga/H-3241-2014; Boehringer, Stefan/Y-2442-2018; Staessen, Jan A/A-1065-2011; Hypponen, Elina/B-2596-2014; Hernaez, Ruben/C-4039-2014; Beckmann, Jacques S/A-9772-2008; Palmer, Lyle John/N-1948-2019; Heath, Simon C/J-4138-2012; Coin, Lachlan/O-4976-2019; Kuznetsova, Tatiana/I-6882-2013; Gaunt, Tom R/O-3918-2014; Hide, Winston/R-3815-2019; Wolffenbuttel, Bruce/A-8419-2011; Arora, Pankaj/F-3437-2011; Ripatti, Samuli/H-9446-2014; Kyvik, Kirsten O/K-5680-2016; Matullo, Giuseppe/K-6383-2016; Marroni, Fabio/R-1819-2017; Meisinger, Christine/B-5358-2014; Lee, Jong-Young/M-6319-2013; Pattou, Francois/O-6151-2017; Meitinger, Thomas/O-1318-2015; Crisponi, Laura/AAC-2642-2019; Gudnason, Vilmundur/K-6885-2015; Stefansson, Kari/AAE-7187-2019; Smith, Albert Vernon/K-5150-2015; Aulchenko, Yurii/M-8270-2013; Soler Artigas, Maria/L-6529-2013; McCarthy, Mark/M-3763-2015; Doney, Alexander/P-7437-2017; Nyholt, Dale/J-3174-2017; Aspelund, Thor/C-5983-2008; Matsuda, Koichi/D-4597-2011; Carr, John/A-1938-2012; Grarup, Niels/K-2807-2015; Marques-Vidal, Pedro/C-9449-2009; FAVA, Cristiano/K-9590-2015; Okamura, Tomonori/L-1693-2013; Luben, Robert/H-5519-2015	Lerch, Markus M./0000-0002-9643-8263; Dominiczak, Anna F/0000-0003-4913-3608; EHRET, Georg B/0000-0002-5730-0675; Uda, Manuela/0000-0002-4890-6456; Benediktsson, Rafn/0000-0002-2954-9801; Penninx, Brenda WJH/0000-0001-7779-9672; Zgaga, Lina/0000-0003-4089-9703; sanna, serena/0000-0002-3768-1749; Prabhakaran, Dorairaj/0000-0002-3172-834X; Kavousi, Maryam/0000-0001-5976-6519; Martin, Nicholas/0000-0003-4069-8020; Walters, G. Bragi/0000-0002-5415-6487; Bonnefond, Amélie/0000-0001-9976-3005; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Ejebe, Kenechi/0000-0002-6090-8657; Hide, Winston Hide/0000-0002-8621-3271; Mukherjee, Sutapa/0000-0001-5021-1648; Coin, Lachlan JM/0000-0002-4300-455X; MASSON, David/0000-0003-1692-0699; van der Klauw, M. M./0000-0001-7178-009X; Palmer, Lyle John/0000-0002-1628-3055; Li, Man/0000-0002-3839-0281; Grobbee, Diederick/0000-0003-4472-4468; Stolk, Ronald P/0000-0002-0518-1205; Rudan, Igor/0000-0001-6993-6884; Feitosa, Mary F/0000-0002-0933-2410; Wass, Mark/0000-0001-5428-6479; Bochud, Murielle/0000-0002-5727-0218; Kaprio, Jaakko/0000-0002-3716-2455; Clark, Jeanne/0000-0003-1194-0092; Charchar, Fadi/0000-0002-6164-9941; MASSON, David/0000-0003-1692-0699; Visvikis-Siest, Sophie/0000-0001-8104-8425; Tzoulaki, Ioanna/0000-0002-4275-9328; Kronenberg, Florian/0000-0003-2229-1120; Laan, Maris/0000-0002-8519-243X; Liu, Jianjun/0000-0002-3255-3019; Visscher, Peter/0000-0002-2143-8760; Marmot, M G/0000-0002-2431-6419; Aben, Katja KH/0000-0002-0214-2147; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston A/0000-0002-8621-3271; Kiemeney, Lambertus A./0000-0002-2368-1326; Kumar, Vinod/0000-0002-2775-6049; Polasek, Ozren/0000-0002-5765-1862; Erdmann, Jeanette/0000-0002-4486-6231; Brunner, Eric/0000-0002-0595-4474; Hirschfield, Gideon M/0000-0002-6736-2255; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Loos, Ruth J F/0000-0002-8532-5087; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Kanoni, Stavroula/0000-0002-1691-9615; Montgomery, Grant W/0000-0002-4140-8139; Langenberg, Claudia/0000-0002-5017-7344; Ramachandran, Vasan/0000-0001-7357-5970; de Geus, Eco J.C./0000-0001-6022-2666; van Dijk, Ko Willems/0000-0002-2172-7394; Prokopenko, Inga/0000-0003-1624-7457; Boehringer, Stefan/0000-0001-9108-9212; Staessen, Jan A/0000-0002-3026-1637; Hypponen, Elina/0000-0003-3670-9399; Hernaez, Ruben/0000-0002-1518-4020; Beckmann, Jacques S/0000-0002-9741-1900; Palmer, Lyle John/0000-0002-1628-3055; Heath, Simon C/0000-0002-9550-0897; Coin, Lachlan/0000-0002-4300-455X; Kuznetsova, Tatiana/0000-0003-3564-7405; Gaunt, Tom R/0000-0003-0924-3247; Hide, Winston/0000-0002-8621-3271; Wolffenbuttel, Bruce/0000-0001-9262-6921; Arora, Pankaj/0000-0003-2420-3550; Ripatti, Samuli/0000-0002-0504-1202; Kyvik, Kirsten O/0000-0003-2981-0245; Matullo, Giuseppe/0000-0003-0674-7757; Marroni, Fabio/0000-0002-1556-5907; Lee, Jong-Young/0000-0002-0092-9958; Pattou, Francois/0000-0001-8388-3766; Crisponi, Laura/0000-0001-9128-8537; Gudnason, Vilmundur/0000-0001-5696-0084; Voight, Benjamin/0000-0002-6205-9994; SCUTERI, ANGELO/0000-0003-4784-5441; Lakatta, Edward/0000-0002-4772-0035; Smith, Albert Vernon/0000-0003-1942-5845; Shriner, Daniel/0000-0003-1928-5520; Humphries, Stephen E/0000-0002-8221-6547; Ikram, Mohammad Arfan/0000-0003-0372-8585; Seshadri, Sudha/0000-0001-6135-2622; Lindgren, Cecilia/0000-0002-4903-9374; Aulchenko, Yurii/0000-0002-7899-1575; Soler Artigas, Maria/0000-0002-3213-1107; McCarthy, Mark/0000-0002-4393-0510; Frayling, Timothy/0000-0001-8362-2603; Whincup, Peter/0000-0002-5589-4107; CUCCA, Francesco/0000-0002-7414-1995; Gieger, Christian/0000-0001-6986-9554; Rivolta, Carlo/0000-0002-0733-9950; Ballantyne, Christie/0000-0002-6432-1730; Kangas, Antti/0000-0001-7492-1732; Wang, Thomas/0000-0003-4063-6508; Meisinger, Christa/0000-0002-9026-6544; Doney, Alexander/0000-0002-6210-5620; Citterio, Lorena/0000-0001-6455-2291; Yaluri, Alena/0000-0002-1375-0252; Lagou, Vasiliki/0000-0003-3165-8940; Org, Elin/0000-0001-8688-9717; Sim, Xueling/0000-0002-1233-7642; Johnson, Toby/0000-0002-5998-3270; Adeyemo, Adebowale/0000-0002-3105-3231; Dorr, Marcus/0000-0001-7471-475X; Chandak, Giriraj Ratan/0000-0002-3095-9453; Sternberg, Michael/0000-0002-1884-5445; Nyholt, Dale/0000-0001-7159-3040; Zeggini, Eleftheria/0000-0003-4238-659X; Magi, Reedik/0000-0002-2964-6011; Heard-Costa, Nancy/0000-0001-9730-0306; maschio, andrea/0000-0002-4238-9144; Beilby, John/0000-0002-4915-2254; Taylor, Andrew/0000-0003-4194-7113; Terzic, Janos/0000-0003-3228-2076; Schmidt, Carsten Oliver/0000-0001-5266-9396; Wallace, Chris/0000-0001-9755-1703; Abecasis, Goncalo/0000-0003-1509-1825; Pietilainen, Kirsi/0000-0002-8522-1288; Ongen, Halit/0000-0002-4197-5790; Lawlor, Debbie A/0000-0002-6793-2262; Jorgensen, Torben/0000-0001-9453-2830; Ohlsson, Claes/0000-0002-9633-2805; Kivimaki, Mika/0000-0002-4699-5627; Zhu, Xiaofeng/0000-0003-0037-411X; Hattersley, Andrew/0000-0001-5620-473X; Bergman, Richard/0000-0003-1539-4471; Wain, Louise/0000-0003-4951-1867; Elliott, Paul/0000-0002-7511-5684; Aspelund, Thor/0000-0002-7998-5433; Whitfield, John/0000-0002-1103-0876; Watkins, Hugh/0000-0002-5287-9016; O'Reilly, Paul/0000-0001-7515-0845; Kumari, Meena/0000-0001-9716-1035; Tukiainen, Taru/0000-0002-5404-8398; Matsuda, Koichi/0000-0001-7292-2686; Hillman, David/0000-0001-9987-539X; Boekholdt, Matthijs/0000-0002-0861-0765; Pirruccello, James/0000-0001-6088-4037; Tobin, Martin/0000-0002-3596-7874; Zagato, Laura/0000-0002-0441-2120; Carr, John/0000-0002-4398-8237; Hui, Jennie/0000-0002-1653-2496; Raychaudhuri, Soumya/0000-0002-1901-8265; Weyant, Robert/0000-0002-5252-9120; Meitinger, Thomas/0000-0002-8838-8403; Aihie Sayer, Avan/0000-0003-1283-6457; Wurtz, Peter/0000-0002-5832-0221; Hopewell, Jemma/0000-0002-3870-8018; Org, Elin/0000-0003-1451-9375; Forouhi, Nita/0000-0002-5041-248X; RAHMIOGLU, NILUFER/0000-0002-5169-8571; Volker, Uwe/0000-0002-5689-3448; Melander, Olle/0000-0002-2581-484X; Tomaszewski, Maciej/0000-0001-8215-6567; Willemsen, Gonneke/0000-0003-3755-0236; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Caulfield, Mark/0000-0001-9295-3594; Grarup, Niels/0000-0001-5526-1070; Stumvoll, Michael/0000-0001-6225-8240; Dina, Christian/0000-0002-7722-7348; Goessling, Wolfram/0000-0001-9972-1569; Thelle, Dag Steinar/0000-0002-4417-5967; Gloyn, Anna/0000-0003-1205-1844; Demirkan, Ayse/0000-0002-7546-0867; Marques-Vidal, Pedro/0000-0002-4548-8500; Van Duijn, Cornelia/0000-0002-2374-9204; Weedon, Michael/0000-0002-6174-6135; FAVA, Cristiano/0000-0002-8910-7378; Emilsson, Valur/0000-0001-9982-0524; Seedorf, Udo/0000-0003-4652-5358; Gudbjartsson, Daniel/0000-0002-5222-9857; Preuss, Michael/0000-0001-5266-8465; ELOSUA, ROBERTO/0000-0001-8235-0095; Waeber, Gerard/0000-0003-4193-788X; Ouwehand, Willem/0000-0002-7744-1790; Mattace-Raso, Francesco/0000-0002-1688-6497; Kovacs, Peter/0000-0002-0290-5423; Soranzo, Nicole/0000-0003-1095-3852; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Glazer, Nicole/0000-0002-6397-609X; Kraft, Peter/0000-0002-4472-8103; Lucas, Gavin/0000-0003-4166-9416; Eyheramendy, Susana/0000-0003-4723-9660; Ricketts, Sally/0000-0002-5644-7958; Tai, E Shyong/0000-0003-2929-8966; Munroe, Patricia/0000-0002-4176-2947; Pramstaller, Peter P/0000-0002-9831-8302; Okamura, Tomonori/0000-0003-0488-0351; Prins, Bram/0000-0001-5774-034X; Ala-Korpela, Mika/0000-0001-5905-1206; Luben, Robert/0000-0002-5088-6343; Viigimaa, Margus/0000-0001-5575-5978; Chen, Ming-Huei/0000-0003-3551-8726	European Commission; European Science Foundation; European Science Council; US NIH; US National Institute of Mental Health; US NIDDK; Genetic Association Information Network; US National Institute on Aging; US National Human Genome Research Institute; US NHLBI; UK NIHR; NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' NHS Trust; UK Biotechnology and Biological Sciences Research Council; UK MRC; British Heart Foundation; Wellcome Trust; Swiss National Science Foundation; Academy of Finland; Finnish Cardiovascular Research Foundation; Swedish Research Council; Swedish Heart-Lung Foundation; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education and Research; German National Genome Research Network; Netherlands Organization for Scientific Research; Dutch Ministries of Economic Affairs, of Education, Culture and Science, for Health, Welfare and Sports; Netherlands Organization for Health Research and Development; Dutch government; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Dutch Brain Foundation; Dutch Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative; Canadian Institutes for Health Research; Ontario Research Fund; Barts and the London Charity; University Medical Center Groningen; University of Groningen; University of Oulu, Biocenter Oulu; University Hospital Oulu; Biocentrum Helsinki; Erasmus Medical Center and Erasmus University, Rotterdam; Karolinska Institutet; Stockholm County Council; Municipality of Rotterdam; Federal State of Mecklenburg-West Pomerania; AstraZeneca; GlaxoSmithKline; Siemens Healthcare; Novo Nordisk Foundation; Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Gyllenberg Foundation; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg Foundation; Boston University School of Medicine; Instrumentarium Science Foundation; Jenny and Antti Wihuri Foundation; Canadian Primary Biliary Cirrhosis Society; MRC [G0701863, G0601653, MC_UP_A620_1015, G0902037, MC_UP_A100_1003, G0700342, G0601966, G0700931, MC_U127561128, G9521010, MC_U106188470, MC_PC_U127561128] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, R01HL087647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, ZIAAG001050, ZIAAG007380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER; British Heart Foundation [PG/09/002/26056, FS/10/011/27881, RG/07/008/23674, PG/09/023/26806] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1015, G0700342, MC_U106188470, G19/35, G0801056B, G0902037, MC_UP_A100_1003, G0700931, G8802774, G0100222, MC_U127561128, G0701863, G1000143, G0601653, G9817803B, MC_PC_U127561128, MC_U106179471, G9521010, G0401527, G0601966, U1475000002] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014660] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); European Science Council; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US NIDDK; Genetic Association Information Network; US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UK NIHR(National Institute for Health Research (NIHR)); NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' NHS Trust; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland(Academy of Finland); Finnish Cardiovascular Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Ministries of Economic Affairs, of Education, Culture and Science, for Health, Welfare and Sports; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch government; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Dutch Brain Foundation; Dutch Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Barts and the London Charity; University Medical Center Groningen; University of Groningen; University of Oulu, Biocenter Oulu; University Hospital Oulu; Biocentrum Helsinki; Erasmus Medical Center and Erasmus University, Rotterdam; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Municipality of Rotterdam; Federal State of Mecklenburg-West Pomerania; AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Siemens Healthcare(Siemens AG); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Gyllenberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderberg Foundation; Boston University School of Medicine; Instrumentarium Science Foundation; Jenny and Antti Wihuri Foundation; Canadian Primary Biliary Cirrhosis Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank the many colleagues who contributed to collection and phenotypic characterization of the clinical samples, as well as genotyping and analysis of data. We also thank the research participants who took part in these studies. Major support for the work came from European Commission (FP5, FP6 and FP7); European Science Foundation; European Science Council; US NIH; US National Institute of Mental Health; US NIDDK; Genetic Association Information Network; US National Institute on Aging; US National Human Genome Research Institute; US NHLBI; UK NIHR; NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' NHS Trust; UK Biotechnology and Biological Sciences Research Council; UK MRC; British Heart Foundation; Wellcome Trust; Swiss National Science Foundation; Academy of Finland; Finnish Cardiovascular Research Foundation; Swedish Research Council; Swedish Heart-Lung Foundation; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education and Research; German National Genome Research Network; Netherlands Organization for Scientific Research; Dutch Ministries of Economic Affairs, of Education, Culture and Science, for Health, Welfare and Sports; Netherlands Organization for Health Research and Development; Economic Structure Enhancing Fund of the Dutch government; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Dutch Brain Foundation; Dutch Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative; Canadian Institutes for Health Research; Ontario Research Fund; The Barts and the London Charity; University Medical Center Groningen; University of Groningen; University of Oulu, Biocenter Oulu; University Hospital Oulu; Biocentrum Helsinki; Erasmus Medical Center and Erasmus University, Rotterdam; Karolinska Institutet; Stockholm County Council; Municipality of Rotterdam; Federal State of Mecklenburg-West Pomerania; AstraZeneca; GlaxoSmithKline; Siemens Healthcare; Novo Nordisk Foundation; Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Gyllenberg Foundation; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg Foundation; Robert Dawson Evans Endowment, Boston University School of Medicine; Instrumentarium Science Foundation; Jenny and Antti Wihuri Foundation and the Canadian Primary Biliary Cirrhosis Society. A full list of acknowledgments is provided in the Supplementary Note.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dunn JS, 2006, ANN HUM GENET, V70, P587, DOI 10.1111/j.1469-1809.2005.00248.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171; Iwamori M, 2004, BIOCHEM J, V380, P75, DOI 10.1042/BJ20031668; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kaprio J, 2006, TWIN RES HUM GENET, V9, P772, DOI 10.1375/twin.9.6.772; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; LeBoeuf RC, 1998, MAMM GENOME, V9, P710, DOI 10.1007/s003359900851; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Nugent C, 2007, NAT CLIN PRACT GASTR, V4, P432, DOI 10.1038/ncpgasthep0879; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Petit JM, 2010, J CLIN ENDOCR METAB, V95, pE430, DOI 10.1210/jc.2010-0814; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rahmioglu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004435; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Van Mil SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/j.gastro.2004.04.065; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Watkins PB, 2005, TOXICOL PATHOL, V33, P1, DOI 10.1080/01926230590888306; Watkinson C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-144; Wolpin BM, 2010, CANCER EPIDEM BIOMAR, V19, P3140, DOI 10.1158/1055-9965.EPI-10-0751; Wurtz P, 2011, MOL BIOSYST, V7, P385, DOI 10.1039/c0mb00066c; XU KC, 1992, AM J GASTROENTEROL, V87, P991; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	72	394	401	0	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1131	1138		10.1038/ng.970	http://dx.doi.org/10.1038/ng.970			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	22001757	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000296584000019
J	Coulon, S; Dussiot, M; Grapton, D; Maciel, TT; Wang, PHM; Callens, C; Tiwari, MK; Agarwal, S; Fricot, A; Vandekerckhove, J; Tamouza, H; Zermati, Y; Ribeil, JA; Djedaini, K; Oruc, Z; Pascal, V; Courtois, G; Arnulf, B; Alyanakian, MA; Mayeux, P; Leanderson, T; Benhamou, M; Cogne, M; Monteiro, RC; Hermine, O; Moura, IC				Coulon, Severine; Dussiot, Michael; Grapton, Damien; Maciel, Thiago Trovati; Wang, Pamella Huey Mei; Callens, Celine; Tiwari, Meetu Kaushik; Agarwal, Saurabh; Fricot, Aurelie; Vandekerckhove, Julie; Tamouza, Houda; Zermati, Yael; Ribeil, Jean-Antoine; Djedaini, Kamel; Oruc, Zeliha; Pascal, Virginie; Courtois, Genevieve; Arnulf, Bertrand; Alyanakian, Marie-Alexandra; Mayeux, Patrick; Leanderson, Tomas; Benhamou, Marc; Cogne, Michel; Monteiro, Renato C.; Hermine, Olivier; Moura, Ivan C.			Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia	NATURE MEDICINE			English	Article							STEM-CELL FACTOR; TRANSFERRIN-RECEPTOR; STRESS ERYTHROPOIESIS; IMMUNOGLOBULIN (IG)A1; PROGENITOR CELLS; IN-VIVO; IRON; EXPANSION; DISEASE; IDENTIFICATION	Anemia because of insufficient production of and/or response to erythropoietin (Epo) is a major complication of chronic kidney disease and cancer. The mechanisms modulating the sensitivity of erythroblasts to Epo remain poorly understood. We show that, when cultured with Epo at suboptimal concentrations, the growth and clonogenic potential of erythroblasts was rescued by transferrin receptor 1 (TfR1)-bound polymeric IgA1 (pIgA1). Under homeostatic conditions, erythroblast numbers were increased in mice expressing human IgA1 compared to control mice. Hypoxic stress of these mice led to increased amounts of pIgA1 and erythroblast expansion. Expression of human IgA1 or treatment of wild-type mice with the TfR1 ligands pIgA1 or iron-loaded transferrin (Fe-Tf) accelerated recovery from acute anemia. TfR1 engagement by either pIgA1 or Fe-Tf increased cell sensitivity to Epo by inducing activation of mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) signaling pathways. These cellular responses were mediated through the TfR1-internalization motif, YXX Phi. Our results show that pIgA1 and TfR1 are positive regulators of erythropoiesis in both physiological and pathological situations. Targeting this pathway may provide alternate approaches to the treatment of ineffective erythropoiesis and anemia.	[Coulon, Severine; Dussiot, Michael; Grapton, Damien; Callens, Celine; Fricot, Aurelie; Vandekerckhove, Julie; Zermati, Yael; Ribeil, Jean-Antoine; Courtois, Genevieve; Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, CNRS,UMR 8147, Paris, France; [Arnulf, Bertrand] Univ Paris 07, Hop St Louis, Assistance Publ Hop Paris, Paris, France; [Djedaini, Kamel] Clin Geoffroy St Hilaire, Paris, France; [Oruc, Zeliha; Pascal, Virginie; Cogne, Michel] Univ Limoges, CNRS, UMR 6101, Limoges, France; [Arnulf, Bertrand] Fac Med, Serv Immunohematol, Paris, France; [Alyanakian, Marie-Alexandra] Univ Paris 05, Fac Med, Hop Necker Enfants Malad, INSERM,U1013, Paris, France; [Arnulf, Bertrand] Fac Med, Lab EA3963, Paris, France; [Alyanakian, Marie-Alexandra] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Lab Immunol Biol, Paris, France; [Mayeux, Patrick] Inst Cochin, Dept Hematol, Paris, France; [Mayeux, Patrick] INSERM, U567, Paris, France; [Mayeux, Patrick] Univ Paris 05, Fac Med, CNRS, UMR 8104, Paris, France; [Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Hermine, Olivier] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Hematol Clin, Paris, France; [Dussiot, Michael; Grapton, Damien; Maciel, Thiago Trovati; Wang, Pamella Huey Mei; Tiwari, Meetu Kaushik; Agarwal, Saurabh; Tamouza, Houda; Benhamou, Marc; Monteiro, Renato C.; Moura, Ivan C.] INSERM, U699, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Lund University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Moura, IC (corresponding author), INSERM, U699, Paris, France.	renato.monteiro@inserm.fr; olivier.hermine@nck.aphp.fr; ivan.moura@inserm.fr	Hermine, Olivier/Q-7072-2018; cogné, michel/D-7370-2015; Moura, Ivan C/A-9510-2013; Maciel, Thiago/A-4475-2013; Maciel, Thiago Trovati/AAF-5462-2021; Ribeil, Jean-Antoine/F-7896-2017; Monteiro, Renato C/U-8633-2017; Ribeil, Jean-Antoine/AAK-7979-2020; agarwal, saurabh/G-2410-2015; Cruz Moura, Ivan/A-9510-2013	cogné, michel/0000-0002-8519-4427; Moura, Ivan C/0000-0002-2977-0354; Maciel, Thiago/0000-0002-9347-981X; Maciel, Thiago Trovati/0000-0002-9347-981X; Ribeil, Jean-Antoine/0000-0002-5733-9123; Monteiro, Renato C/0000-0001-5202-5646; Ribeil, Jean-Antoine/0000-0002-4549-4783; agarwal, saurabh/0000-0001-9758-6746; Hermine, Olivier/0000-0003-2574-3874; Benhamou, Marc/0000-0001-7763-3795; Cruz Moura, Ivan/0000-0002-8418-2803; courtois, genevieve/0000-0001-6370-5575	Agence Nationale pour la Recherche; Institut National contre le Cancer; canceropole d'Ile de France; Fondation pour la Recherche Medicale; Fondation de France; Association Laurette Fugain; Association pour la Recherche contre le Cancer; Societe Francaise d'Hematologie; cent pour sang la vie; la Ligue contre le Cancer; CNRS [UMR-S 8147];  [INSERM/PNRNU]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National contre le Cancer; canceropole d'Ile de France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Association Laurette Fugain; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Societe Francaise d'Hematologie; cent pour sang la vie; la Ligue contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); 	This work was supported by Agence Nationale pour la Recherche, Institut National contre le Cancer, canceropole d'Ile de France, Fondation pour la Recherche Medicale, Fondation de France, Association Laurette Fugain, Association pour la Recherche contre le Cancer, Societe Francaise d'Hematologie, cent pour sang la vie, la Ligue contre le Cancer and INSERM/PNRNU2007 grants. S. C. is a recipient of Fondation pour la Recherche Medicale grant and a Societe Francaise d'Hematologie grant. We would like to thank J. Kersual and S. Dauzet (CNRS UMR-S 8147) for experimental help and the Departments of Hematology, Obstetrics and Otorhinolaryngology at the Necker Hospital (Paris, France) for providing blood samples, cord blood samples and tonsil samples, respectively. We would like to thank J. L. Danan (CNRS FRE 3210), M. Heinis (INSERM U845), B. Ruiz (INSERM U780) (located at Paris Descartes University, Paris, France) and C. Clerici (INSERM U773, Bichat Hospital, Paris, France) for providing the hypoxia chambers and L.-J. Couderc at the Foch Hospital (Suresnes, France) for providing blood samples. We are especially thankful to S. Izui (Department of Pathology and Immunology, University Medical Center, Geneva, Switzerland) for providing the 34-3C IgG2a monoclonal antibody and for fruitful discussions.	Arcasoy MO, 2005, BRIT J HAEMATOL, V130, P121, DOI 10.1111/j.1365-2141.2005.05580.x; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Besarab A, 2010, NAT REV NEPHROL, V6, P699, DOI 10.1038/nrneph.2010.139; BOZZINI CE, 1994, ANN NY ACAD SCI, V718, P83; Broudy VC, 1996, BLOOD, V88, P75; Callens C, 2010, J EXP MED, V207, P731, DOI 10.1084/jem.20091488; CHAN RYY, 1992, EXP CELL RES, V202, P326, DOI 10.1016/0014-4827(92)90082-J; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; COOK JD, 1976, BLOOD, V48, P449; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Erlandsson L, 2001, J EXP MED, V194, P557, DOI 10.1084/jem.194.5.557; FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126; Fossati-Jimack L, 1999, J EXP MED, V190, P1689, DOI 10.1084/jem.190.11.1689; GOLDWASSER E, 1984, BLOOD CELLS, V10, P147; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hirschler-Laszkiewicz I, 2009, J BIOL CHEM, V284, P4567, DOI 10.1074/jbc.M804734200; HUEBERS HA, 1984, P NATL ACAD SCI-BIOL, V81, P4326, DOI 10.1073/pnas.81.14.4326; Jacob CMA, 2008, J CLIN IMMUNOL, V28, pS56, DOI 10.1007/s10875-007-9163-2; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Keel SB, 2009, NEW ENGL J MED, V361, P1904, DOI 10.1056/NEJMcibr0906391; KELLEY LL, 1993, BLOOD, V82, P2340; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Koury MJ, 2005, EXP HEMATOL, V33, P1263, DOI 10.1016/j.exphem.2005.06.031; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; LEV S, 1992, J BIOL CHEM, V267, P15970; LEV S, 1992, J BIOL CHEM, V267, P10866; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Li K, 2003, BLOOD, V102, P3147, DOI 10.1182/blood-2003-01-0078; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; MEANS RT, 1992, BLOOD, V80, P1639; MEEHAN R, 1988, J CLIN IMMUNOL, V8, P397, DOI 10.1007/BF00917156; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; MESTECKY J, 1991, GASTROENTEROL CLIN N, V20, P441; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Moura IC, 2005, J AM SOC NEPHROL, V16, P2667, DOI 10.1681/ASN.2004111006; Moura IC, 2004, BLOOD, V103, P1838, DOI 10.1182/blood-2003-07-2440; Moura IC, 2004, J AM SOC NEPHROL, V15, P622, DOI 10.1097/01.ASN.0000115401.07980.0C; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rifai A, 2000, J EXP MED, V191, P2171, DOI 10.1084/jem.191.12.2171; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Suzuki M, 2006, BLOOD, V108, P726, DOI 10.1182/blood-2005-10-4064; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	60	51	52	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1456	U163		10.1038/nm.2462	http://dx.doi.org/10.1038/nm.2462			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22019886				2022-12-25	WOS:000296779300037
J	de Pontual, L; Yao, E; Callier, P; Faivre, L; Drouin, V; Cariou, S; Van Haeringen, A; Genevieve, D; Goldenberg, A; Oufadem, M; Manouvrier, S; Munnich, A; Vidigal, JA; Vekemans, M; Lyonnet, S; Henrion-Caude, A; Ventura, A; Amiel, J				de Pontual, Loic; Yao, Evelyn; Callier, Patrick; Faivre, Laurence; Drouin, Valerie; Cariou, Sandra; Van Haeringen, Arie; Genevieve, David; Goldenberg, Alice; Oufadem, Myriam; Manouvrier, Sylvie; Munnich, Arnold; Vidigal, Joana Alves; Vekemans, Michel; Lyonnet, Stanislas; Henrion-Caude, Alexandra; Ventura, Andrea; Amiel, Jeanne			Germline deletion of the miR-17 similar to 92 cluster causes skeletal and growth defects in humans	NATURE GENETICS			English	Article							N-MYC; MICRORNA CLUSTER; FEINGOLD-SYNDROME; GENE; AMPLIFICATION; POLYCISTRON; DISSECTION; EXPRESSION; PHENOTYPE; MIR-17-92	MicroRNAs (miRNAs) are key regulators of gene expression in animals and plants. Studies in a variety of model organisms show that miRNAs modulate developmental processes. To our knowledge, the only hereditary condition known to be caused by a miRNA is a form of adult-onset non-syndromic deafness(1), and no miRNA mutation has yet been found to be responsible for any developmental defect in humans. Here we report the identification of germline hemizygous deletions of MIR17HG, encoding the miR-17 similar to 92 polycistronic miRNA cluster, in individuals with microcephaly, short stature and digital abnormalities. We demonstrate that haploinsufficiency of miR-17 similar to 92 is responsible for these developmental abnormalities by showing that mice harboring targeted deletion of the miR-17 similar to 92 cluster phenocopy several key features of the affected humans. These findings identify a regulatory function for miR-17 similar to 92 in growth and skeletal development and represent the first example of an miRNA gene responsible for a syndromic developmental defect in humans.	[de Pontual, Loic; Cariou, Sandra; Oufadem, Myriam; Munnich, Arnold; Vekemans, Michel; Lyonnet, Stanislas; Henrion-Caude, Alexandra; Amiel, Jeanne] Univ Paris 05, Unite INSERM U781, Paris, France; [de Pontual, Loic] Univ Paris 13, Hop Jean Verdier, AP HP, Serv Pediat, Bondy, France; [Yao, Evelyn; Vidigal, Joana Alves; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Callier, Patrick; Faivre, Laurence] Hop Enfants, Serv Genet, Dijon, France; [Drouin, Valerie; Goldenberg, Alice] Hop Charles Nicolle, Serv Genet, Rouen, France; [Van Haeringen, Arie] Leiden Univ Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands; [Genevieve, David] Hop Arnaud de Villeneuve, Serv Genet, Montpellier, France; [Manouvrier, Sylvie] Hop J de Flandre, Serv Genet Clin, Lille, France; [Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfant Malades, AP HP, Serv Genet, Paris, France; [Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfant Malades, AP HP, Cytogenet Serv, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; Memorial Sloan Kettering Cancer Center; CHU Dijon Bourgogne; CHU de Rouen; Leiden University; Leiden University Medical Center (LUMC); Universite de Montpellier; CHU de Montpellier; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP	Amiel, J (corresponding author), Univ Paris 05, Unite INSERM U781, Paris, France.	venturaa@mskcc.org; jeanne.amiel@inserm.fr	Caude, Alexandra A Henrion/I-2778-2016; Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/H-3501-2017; amiel, jeanne/AGX-1124-2022	Caude, Alexandra A Henrion/0000-0002-8170-2260; Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; Ventura, Andrea/0000-0003-4320-9907; Faivre, Laurence/0000-0001-9770-444X; A. Vidigal, Joana/0000-0003-2765-6985; DE PONTUAL, LOIC/0000-0002-3123-0453	Agence Nationale de la Recherche (ANR); Foundation pour la Recherche Medicale (FRM); Institut National du Cancer-Direction de l'Hospitalisation et de l'Organisation des soins (INCa-DHOS); Institut National du Cancer; US National Institutes of Health (NIH)-National Cancer Institute (NCI) [R01CA149707]; Sidney Kimmel Award; Geoffrey Beene Research Grant; NIH [T32]; NATIONAL CANCER INSTITUTE [R01CA149707] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Foundation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer-Direction de l'Hospitalisation et de l'Organisation des soins (INCa-DHOS); Institut National du Cancer(Institut National du Cancer (INCA) France); US National Institutes of Health (NIH)-National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Award; Geoffrey Beene Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are thankful to the subjects and their referent doctors for their active participation in this study. We are also particularly thankful to P. Hurlin for generously providing forelimbs of Mycn conditional knockout mouse embryos. This work was supported by grants from the Agence Nationale de la Recherche (ANR grant EvoDevoMut), the Foundation pour la Recherche Medicale (FRM), the Institut National du Cancer-Direction de l'Hospitalisation et de l'Organisation des soins (INCa-DHOS), and the Institut National du Cancer. Work in the laboratory of A. V. was funded by US National Institutes of Health (NIH)-National Cancer Institute (NCI) grant R01CA149707, a Sidney Kimmel Award and a Geoffrey Beene Research Grant. E.Y. is a recipient of the NIH Molecular and Cellular Biology T32 training grant. We thank L. Selleri for her expertise in the phenotypic analysis of miR-17 similar to 92-mutant mice skeletons, L. Legeai-Mallet, A. Pelet and P. Ogrodowski for helpful discussion and technical advice and J. Hollenstein for editing the manuscript.	Celli J, 2003, AM J MED GENET A, V122A, P294, DOI 10.1002/ajmg.a.20471; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cognet M, 2011, EUR J HUM GENET, V19, P602, DOI 10.1038/ejhg.2010.225; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Feingold M, 1997, AM J MED GENET, V69, P245, DOI 10.1002/(SICI)1096-8628(19970331)69:3<245::AID-AJMG7>3.3.CO;2-U; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Marcelis CLM, 2008, HUM MUTAT, V29, P1125, DOI 10.1002/humu.20750; Masurel-Paulet A, 2010, CLIN GENET, V78, P149, DOI 10.1111/j.1399-0004.2010.01374.x; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; MOENS CB, 1992, GENE DEV, V6, P691, DOI 10.1101/gad.6.5.691; Morales JA, 2006, CLIN DYSMORPHOL, V15, P139, DOI 10.1097/01.mcd.0000204990.46743.7b; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Quelin C, 2009, EUR J MED GENET, V52, P41, DOI 10.1016/j.ejmg.2008.10.002; SAWAI S, 1993, DEVELOPMENT, V117, P1445; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103	35	207	215	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					1026	U146		10.1038/ng.915	http://dx.doi.org/10.1038/ng.915			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892160	Green Accepted			2022-12-25	WOS:000295316200021
J	Ostergaard, P; Simpson, MA; Connell, FC; Steward, CG; Brice, G; Woollard, WJ; Dafou, D; Kilo, T; Smithson, S; Lunt, P; Murday, VA; Hodgson, S; Keenan, R; Pilz, DT; Martinez-Corral, I; Makinen, T; Mortimer, PS; Jeffery, S; Trembath, RC; Mansour, S				Ostergaard, Pia; Simpson, Michael A.; Connell, Fiona C.; Steward, Colin G.; Brice, Glen; Woollard, Wesley J.; Dafou, Dimitra; Kilo, Tatjana; Smithson, Sarah; Lunt, Peter; Murday, Victoria A.; Hodgson, Shirley; Keenan, Russell; Pilz, Daniela T.; Martinez-Corral, Ines; Makinen, Taija; Mortimer, Peter S.; Jeffery, Steve; Trembath, Richard C.; Mansour, Sahar			Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)	NATURE GENETICS			English	Article							MYELODYSPLASIA; CEBPA	We report an allelic series of eight mutations in GATA2 underlying Emberger syndrome, an autosomal dominant primary lymphedema associated with a predisposition to acute myeloid leukemia. GATA2 is a transcription factor that plays an essential role in gene regulation during vascular development and hematopoietic differentiation. Our findings indicate that haploinsufficiency of GATA2 underlies primary lymphedema and predisposes to acute myeloid leukemia in this syndrome.	[Brice, Glen; Hodgson, Shirley; Mansour, Sahar] St Georges Univ London, SW Thames Reg Genet Serv, London, England; [Ostergaard, Pia; Jeffery, Steve] St Georges Univ London, Med Genet Unit, London, England; [Simpson, Michael A.; Woollard, Wesley J.; Dafou, Dimitra; Trembath, Richard C.] Kings Coll London, Sch Med, Div Genet & Mol Med, Guys Hosp, London WC2R 2LS, England; [Connell, Fiona C.] Guys Hosp, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, London SE1 9RT, England; [Steward, Colin G.] Royal Hosp Children, Bone Marrow Transplant Unit, Bristol, Avon, England; [Kilo, Tatjana] Childrens Hosp Westmead, Haematol Unit, Sydney, NSW, Australia; [Smithson, Sarah; Lunt, Peter] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [Murday, Victoria A.] Yorkhill Hosp, Dept Clin Genet, Glasgow, Lanark, Scotland; [Keenan, Russell] Alder Hey Childrens Hosp, Dept Paediat Haematol, Liverpool L12 2AP, Merseyside, England; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Martinez-Corral, Ines; Makinen, Taija] Canc Res UK London Res Inst, Lymphat Dev Lab, London, England; [Mortimer, Peter S.] St Georges Univ London, Dept Cardiac & Vasc Sci, London, England	St Georges University London; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Bristol Royal Hospital For Children; University of Sydney; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Cardiff University; Cancer Research UK; St Georges University London	Mansour, S (corresponding author), St Georges Univ London, SW Thames Reg Genet Serv, London, England.	smansour@sgul.ac.uk	Makinen, Taija/CAI-2233-2022; Ostergaard, Pia/H-8522-2019; Makinen, Taija/C-5765-2014; Martinez-Corral, Ines/F-1799-2016; Lunt, Peter/AAF-8265-2020; Dafou, Dimitra/N-6094-2015; Simpson, Michael/F-4737-2011	Makinen, Taija/0000-0002-9338-1257; Ostergaard, Pia/0000-0002-2190-1356; Makinen, Taija/0000-0002-9338-1257; Martinez-Corral, Ines/0000-0001-9194-2412; Dafou, Dimitra/0000-0003-4170-0612; Simpson, Michael/0000-0002-8539-8753; Trembath, Richard/0000-0003-0550-3400; Steward, Colin/0000-0001-6291-0710	British Heart Foundation (BHF) [RG/08/006/25302, PG/10/58/28477, FS/06/063/21445]; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; British Heart Foundation [PG/10/58/28477, RG/08/006/25302] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This study has been made possible by the commitment and courage of the families concerned, and we are indebted to them. This work was supported by the British Heart Foundation (BHF) grants RG/08/006/25302, PG/10/58/28477 and FS/06/063/21445. The authors also acknowledge support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. This research utilized the resources of the Biomics Unit at St George's University of London. We also thank T. Enver, University College London Cancer Institute, London for kindly providing the GATA2 reporter constructs.	Callier P, 2009, AM J MED GENET A, V149A, P1323, DOI 10.1002/ajmg.a.32857; DICKINSON RE, 2011, BLOOD           0715, DOI DOI 10.1182/BLOOD-2011-06-360313; Haugas M, 2010, DEV DYNAM, V239, P2452, DOI 10.1002/dvdy.22373; HSU AP, 2011, BLOOD           0613, DOI DOI 10.1182/BLOOD-2011-05-356352; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Mansour S, 2010, AM J MED GENET A, V152A, P2287, DOI 10.1002/ajmg.a.33445; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Rodrigues NP, 2008, BLOOD, V112, P4862, DOI 10.1182/blood-2008-01-136564; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	15	339	347	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					929	931		10.1038/ng.923	http://dx.doi.org/10.1038/ng.923			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892158	Green Submitted			2022-12-25	WOS:000295316200005
J	Galli, M; Munoz, J; Portegijs, V; Boxem, M; Grill, SW; Heck, AJR; van den Heuvel, S				Galli, Matilde; Munoz, Javier; Portegijs, Vincent; Boxem, Mike; Grill, Stephan W.; Heck, Albert J. R.; van den Heuvel, Sander			aPKC phosphorylates NuMA-related LIN-5 to position the mitotic spindle during asymmetric division	NATURE CELL BIOLOGY			English	Article							C-ELEGANS EMBRYOS; CAENORHABDITIS-ELEGANS; CELL-DIVISION; DROSOPHILA-MELANOGASTER; CLEAVAGE PLANE; IN-VIVO; PROTEIN; POLARITY; ORIENTATION; PAR-3	The position of the mitotic spindle controls the plane of cell cleavage and determines whether polarized cells divide symmetrically or asymmetrically(1-3). In animals, an evolutionarily conserved pathway of LIN-5 (homologues: Mud and NuMA), GPR-1/2 (homologues: Pins, LGN, AGS-3) and G alpha mediates spindle positioning, and acts downstream of the conserved PAR-3-PAR-6-aPKC polarity complex(1-6). However, molecular interactions between polarity proteins and LIN-5-GPR-G alpha remain to be identified. Here we describe a quantitative mass spectrometry approach for in vivo identification of protein kinase substrates. Applying this strategy to Caenorhabditis elegans embryos, we found that depletion of the polarity kinase PKC-3 results in markedly decreased levels of phosphorylation of a cluster of four LIN-5 serine residues. These residues are directly phosphorylated by PKC-3 in vitro. Phospho-LIN-5 co-localizes with PKC-3 at the anterior cell cortex and temporally coincides with a switch from anterior- to posterior-directed spindle movements in the one-cell embryo. LIN-5 mutations that prevent phosphorylation increase the extent of anterior-directed spindle movements, whereas phosphomimetic mutations decrease spindle migration. Our results indicate that anterior-located PKC-3 inhibits cortical microtubule pulling forces through direct phosphorylation of LIN-5. This molecular interaction between polarity and spindle-positioning proteins may be used broadly in cell cleavage plane determination.	[Munoz, Javier; Heck, Albert J. R.; van den Heuvel, Sander] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, NL-3584 CH Utrecht, Netherlands; [Munoz, Javier; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Munoz, Javier; Heck, Albert J. R.] Netherlands Prote Ctr, Maastricht, Netherlands; [Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Utrecht University; Utrecht University; Max Planck Society; Max Planck Society	van den Heuvel, S (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, NL-3584 CH Utrecht, Netherlands.	S.J.L.vandenHeuvel@uu.nl	Grill, Stephan/D-9427-2012; van den Heuvel, Sander J.L./B-8892-2011; Heck, Albert/D-7098-2011; Boxem, Mike/B-8857-2011; Munoz, Javier/I-4891-2012	van den Heuvel, Sander J.L./0000-0001-9015-7463; Heck, Albert/0000-0002-2405-4404; Munoz, Javier/0000-0003-3288-3496; Galli, Matilde/0000-0002-2861-7032	Boehringer Ingelheim Fonds; foundation 'De Drie Lichten' in the Netherlands; Netherlands Proteomics Centre, which is part of the Netherlands Genomics Initiative	Boehringer Ingelheim Fonds(Boehringer Ingelheim); foundation 'De Drie Lichten' in the Netherlands; Netherlands Proteomics Centre, which is part of the Netherlands Genomics Initiative	We thank J. Krijgsveld for help in the initial phases of the project, and A. Thomas and M. Tanenbaum for critically reading the manuscript, helpful advice and support throughout the project. We thank members of the van den Heuvel and Boxem laboratories for fruitful discussions. We are grateful to C. Frokjaer-Jensen and E. Jorgensen for reagents and advice on MosSCI. M.G. was supported by a predoctoral fellowship from the Boehringer Ingelheim Fonds and foundation 'De Drie Lichten' in the Netherlands. This work was also supported by the Netherlands Proteomics Centre, which is part of the Netherlands Genomics Initiative.	Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Boyd L, 1996, DEVELOPMENT, V122, P3075; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Galli M, 2008, ANNU REV GENET, V42, P389, DOI 10.1146/annurev.genet.40.110405.090523; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Gouw JW, 2009, MOL CELL PROTEOMICS, V8, P1566, DOI 10.1074/mcp.M900114-MCP200; Green RF, 2004, MOL GENET GENOMICS, V271, P532, DOI 10.1007/s00438-004-1012-x; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hung TJ, 1999, DEVELOPMENT, V126, P127; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Krueger LE, 2010, J CELL BIOL, V189, P481, DOI 10.1083/jcb.201001115; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Panbianco C, 2008, DEV CELL, V15, P198, DOI 10.1016/j.devcel.2008.06.002; Park DH, 2008, DEV BIOL, V315, P42, DOI 10.1016/j.ydbio.2007.11.037; Pinkse MWH, 2008, J PROTEOME RES, V7, P687, DOI 10.1021/pr700605z; Rose LS, 1998, DEVELOPMENT, V125, P1337; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049	40	52	60	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1132	U167		10.1038/ncb2315	http://dx.doi.org/10.1038/ncb2315			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21857670				2022-12-25	WOS:000294487000019
J	Samora, CP; Mogessie, B; Conway, L; Ross, JL; Straube, A; McAinsh, AD				Samora, Catarina P.; Mogessie, Binyam; Conway, Leslie; Ross, Jennifer L.; Straube, Anne; McAinsh, Andrew D.			MAP4 and CLASP1 operate as a safety mechanism to maintain a stable spindle position in mitosis	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; MICROTUBULE DYNAMICS; ELEGANS EMBRYOS; MOTOR PROTEINS; C.-ELEGANS; IN-VITRO; DYNACTIN; CORTEX	Correct positioning of the mitotic spindle is critical to establish the correct cell-division plane. Spindle positioning involves capture of astral microtubules and generation of pushing/pulling forces at the cell cortex. Here we show that the tau-related protein MAP4 and the microtubule rescue factor CLASP1 are essential for maintaining spindle position and the correct cell-division axis in human cells. We propose that CLASP1 is required to correctly capture astral microtubules, whereas MAP4 prevents engagement of excess dynein motors, thereby protecting the system from force imbalance. Consistent with this, MAP4 physically interacts with dynein dynactin in vivo and inhibits dynein-mediated microtubule sliding in vitro. Depletion of MAP4, but not CLASP1, causes spindle misorientation in the vertical plane, demonstrating that force generators are under spatial control. These findings have wide biological importance, because spindle positioning is essential during embiyogenesis and stem-cell homeostasis.	[Samora, Catarina P.; Mogessie, Binyam; Straube, Anne; McAinsh, Andrew D.] Univ Warwick, Warwick Med Sch, Ctr Mechanochem Cell Biol, Coventry CV4 7AL, W Midlands, England; [Conway, Leslie; Ross, Jennifer L.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Warwick; University of Massachusetts System; University of Massachusetts Amherst	Straube, A (corresponding author), Univ Warwick, Warwick Med Sch, Ctr Mechanochem Cell Biol, Coventry CV4 7AL, W Midlands, England.	anne@mechanochemistry.org; andrew@mechanochemistry.org	Mogessie, Binyam/E-5331-2011; Mogessie, Binyam/AAM-6147-2020; Straube, Anne/D-1085-2012; Ross, Jennifer L/D-7208-2012; McAinsh, Andrew/C-6438-2012	Mogessie, Binyam/0000-0002-0702-6356; Straube, Anne/0000-0003-2067-9041; Ross, Jennifer L/0000-0002-4838-3798; McAinsh, Andrew/0000-0001-6808-0711	Marie Curie Cancer Care; Fundacao para a Ciencia e Tecnologia; NSF [DGE-0654128]; Research Corporation	Marie Curie Cancer Care; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NSF(National Science Foundation (NSF)); Research Corporation(Research Corporation for Science Advancement)	We thank A. Garrod for selecting the double stable EB3-tdTomato eGFP-CENP-A cell line, K. Kaseda for selecting the mCherry-alpha-tubulin cell line and D. Roth for assistance with cloning. We are grateful to I. Titley at the Institute of Cancer Research in Sutton, UK, for help with cell sorting, N. Galjart for the gift of CLASP1 antiserum and A. Akhmanova for providing CLASP1 and CLASP2 rescue constructs. This work was supported by programme grants to A.D.M. and A.S. from Marie Curie Cancer Care and a Fundacao para a Ciencia e Tecnologia fellowship (C.P.S.). L.C. is funded by the NSF-sponsored Institute for Cellular Engineering IGERT programme grant DGE-0654128 and L.L.R. is supported by a Cottrell Scholars Award from the Research Corporation.	Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Cha BJ, 1999, J CELL SCI, V112, P4337; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; GIBBONS IR, 1978, P NATL ACAD SCI USA, V75, P2220, DOI 10.1073/pnas.75.5.2220; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Grallert A, 2006, GENE DEV, V20, P2421, DOI 10.1101/gad.381306; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Inoue S, 1998, J CELL SCI, V111, P1555; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; KOBAYASHI T, 1978, BIOCHEM BIOPH RES CO, V81, P1313, DOI 10.1016/0006-291X(78)91279-2; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2009, METHODS MOL BIOL, V545, P81, DOI 10.1007/978-1-60327-993-2_5; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Moore JK, 2010, SEMIN CELL DEV BIOL, V21, P283, DOI 10.1016/j.semcdb.2010.01.020; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; Pereira AL, 2006, MOL BIOL CELL, V17, P4526, DOI 10.1091/mbc.E06-07-0579; Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Schlieper D, 1998, ANAL BIOCHEM, V257, P203, DOI 10.1006/abio.1997.2558; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10	48	85	86	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1040	U59		10.1038/ncb2297	http://dx.doi.org/10.1038/ncb2297			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21822276				2022-12-25	WOS:000294487000008
J	Croce, CM				Croce, Carlo M.			miRNAs in the spotlight: Understanding cancer gene dependency	NATURE MEDICINE			English	Editorial Material							MICRORNA; LEUKEMIA; LYMPHOMA		Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Croce, CM (corresponding author), Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NCI NIH HHS [U01 CA152758] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA152758] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CIALFRE SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103	11	28	30	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					935	936		10.1038/nm0811-935	http://dx.doi.org/10.1038/nm0811-935			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21818092				2022-12-25	WOS:000293507400025
J	Filonov, GS; Piatkevich, KD; Ting, LM; Zhang, JH; Kim, K; Verkhusha, VV				Filonov, Grigory S.; Piatkevich, Kiryl D.; Ting, Li-Min; Zhang, Jinghang; Kim, Kami; Verkhusha, Vladislav V.			Bright and stable near-infrared fluorescent protein for in vivo imaging	NATURE BIOTECHNOLOGY			English	Article							ELECTROSTATIC INTERACTIONS; PHYTOCHROME; BACTERIOPHYTOCHROME; STABILITY; EXPRESSION; BACTERIA; CELLS; CHAIN	Imaging biological processes in mammalian tissues will be facilitated by fluorescent probes with excitation and emission bands within the near-infrared optical window of high transparency(1). Here we report a phytochrome-based near-infrared fluorescent protein (iRFP) with excitation and emission maxima at 690 nm and 713 nm, respectively. iRFP does not require an exogenous supply of the chromophore biliverdin and has higher effective brightness, intracellular stability and photostability than earlier phytochrome-derived fluorescent probes. Compared with far-red GFP-like proteins, iRFP has a substantially higher signal-to-background ratio in a mouse model due to its infrared-shifted spectra.	[Filonov, Grigory S.; Piatkevich, Kiryl D.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Filonov, Grigory S.; Piatkevich, Kiryl D.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA; [Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Zhang, Jinghang] Albert Einstein Coll Med, Flow Cytometry Core Facil, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Verkhusha, VV (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	vladislav.verkhusha@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020	Verkhusha, Vladislav/0000-0002-2083-8121; Kim, Kami/0000-0003-3384-152X	US National Institutes of Health [AI046985, AI087625, GM073913, S10RR027308]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087625, R01AI046985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Giraud (Institute for Research and Development, France) for the plasmid encoding bacteriophytochrome from R. palustris, A. Ulijasz and R. Vierstra (both from University of Wisconsin) for the plasmid encoding the heme-oxygenase from Synechocystis sp. PCC6803 and B. Glick (University of Chicago), D. Chudakov and K. Lukyanov (both from Institute of Bioorganic Chemistry, Russia) for the plasmids encoding GFP-like far-red fluorescent proteins. We are grateful to D. Entenberg for the help with two-photon excitation measurements, A. Muesch and D. Cohen for the assistance with virus purification and providing GFP-encoding adenoviruses and R. Zheng for the help with size-exclusion chromatography (all from Albert Einstein College of Medicine). This work was supported by grants from the US National Institutes of Health, AI046985 and AI087625 to K.K., GM073913 to V.V.V. and S10RR027308 for purchase of the IVIS imager.	Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; LI LM, 1995, BIOCHEMISTRY-US, V34, P7923, DOI 10.1021/bi00024a017; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SENS R, 1981, J LUMIN, V24-5, P709, DOI 10.1016/0022-2313(81)90075-2; Sharrock RA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-230; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Stepartenko OV, 2008, PROTEINS, V73, P539, DOI 10.1002/prot.22089; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Subramanian S, 1996, J BIOTECHNOL, V49, P137, DOI 10.1016/0168-1656(96)01536-2; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838	34	511	533	10	264	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					757	U133		10.1038/nbt.1918	http://dx.doi.org/10.1038/nbt.1918			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21765402	Green Accepted			2022-12-25	WOS:000293696500029
J	Kosman, DJ				Kosman, Daniel J.			TRANSPORT Plutonium's Trojan horse	NATURE CHEMICAL BIOLOGY			English	News Item							HUMAN TRANSFERRIN RECEPTOR		SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA.	camkos@buffalo.edu						CHARLES D, 2011, PLUTONIUM FUEL RODS; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Gorden AEV, 2003, CHEM REV, V103, P4207, DOI 10.1021/cr990114x; Jensen MP, 2011, NAT CHEM BIOL, V7, P560, DOI [10.1038/nchembio.594, 10.1038/NCHEMBIO.594]; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; LEIBMAN A, 1979, BLOOD, V53, P1058; SEABORG GT, 1947, NATURE, V159, P863, DOI 10.1038/159863a0	7	2	2	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					498	499		10.1038/nchembio.616	http://dx.doi.org/10.1038/nchembio.616			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769093				2022-12-25	WOS:000292825400006
J	Lyashenko, N; Winter, M; Migliorini, D; Biechele, T; Moon, RT; Hartmann, C				Lyashenko, Natalia; Winter, Markus; Migliorini, Domenico; Biechele, Travis; Moon, Randall T.; Hartmann, Christine			Differential requirement for the dual functions of beta-catenin in embryonic stem cell self-renewal and germ layer formation	NATURE CELL BIOLOGY			English	Article							WNT SIGNALING PATHWAY; MOUSE ES CELLS; ALPHA-CATENIN; E-CADHERIN; AXIS FORMATION; NEURAL DIFFERENTIATION; HUMAN BLASTOCYSTS; GAMMA-CATENIN; TARGET GENE; IN-VITRO	Canonical Wnt signalling has been implicated in mouse and human embryonic stem cell (ESC) maintenance;however,its requirement is controversial. beta-catenin is the key component in this highly conserved Wnt pathway, acting as a transcriptional transactivator. However, beta-catenin has additional roles at the plasma membrane regulating cell-cell adhesion, complicating the analyses of cells/tissues lacking beta-catenin. We report here the generation of a Ctnnb1 (beta-catenin)-deficient mouse ESC (mESC) line and show that self-renewal is maintained in the absence of beta-catenin. Cell adhesion is partially rescued by plakoglobin upregulation, but fails to be maintained during differentiation. When differentiated as aggregates, wild-type mESCs form descendants of all three germ layers, whereas mesendodermal germ layer formation and neuronal differentiation are defective in Ctnnb1-deficient mESCs. A Tcf/Lef-signalling-defective beta-catenin variant, which re-establishes cadherin-mediated cell adhesion, rescues definitive endoderm and neuroepithelial formation, indicating that the beta-catenin cell-adhesion function is more important than its signalling function for these processes.	[Lyashenko, Natalia; Winter, Markus; Migliorini, Domenico; Hartmann, Christine] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Biechele, Travis; Moon, Randall T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Inst Stem Cell & Regenerat Med,Dept Pharmacol, Seattle, WA 98109 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Hartmann, C (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	hartmann@imp.ac.at	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408	NoE Cells into Organs [LSHM-CT-2003-504468]; Austrian Science Fund (FWF) [P19281-B16]; Arthritis Research Campaign (ARC) [18075]; NIH [R01 GM081619-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073887, P01GM081619] Funding Source: NIH RePORTER	NoE Cells into Organs; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Arthritis Research Campaign (ARC)(Versus Arthritis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Birchmeier (MDC, Berlin, Germany), R. Grosschedl (MPI, Freiburg, Germany) and A. Wutz (CSCR, Cambridge, UK) for reagents, R. Latham for Wnt3aCM, R. Peachey, G. Resch, P. Pasierbeck, G. Stengl, V. Komnenovic and M. Zeba for help and technical advice, M. Radolf and H. Scheuch for help with microarray studies, C. Theussl and J. Wojciechowski for blastocyst injections,and A. Smith for helpful comments. Research in the laboratory of C.H. has been supported by Boehringer Ingelheim, the project has been funded in part by the NoE Cells into Organs (LSHM-CT-2003-504468), N.L. was supported by the Austrian Science Fund (FWF Grant No. P19281-B16) and M.W. is supported by a grant from the Arthritis Research Campaign (ARC Grant No. 18075). R.T.M. is an investigator of the HHMI and T.B. was supported by NIH grant R01 GM081619-01.	Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bajpai S, 2009, J BIOL CHEM, V284, P18252, DOI 10.1074/jbc.M109.000661; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P18331, DOI 10.1073/pnas.0806783105; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; BREEN E, 1993, CELL ADHES COMMUN, V1, P239, DOI 10.3109/15419069309097257; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BURKERT U, 1991, NEW BIOL, V3, P698; Buxton R S, 1992, Semin Cell Biol, V3, P157; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Giannini AL, 2000, J BIOL CHEM, V275, P21883, DOI 10.1074/jbc.M001929200; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hierholzer A, 2010, DEV DYNAM, V239, P191, DOI 10.1002/dvdy.22075; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kofron M, 1997, DEVELOPMENT, V124, P1553; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Murashov AK, 2004, FASEB J, V18, P252, DOI 10.1096/fj.04-2251fje; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Neumann S, 2010, J BIOL CHEM, V285, P34932, DOI 10.1074/jbc.M110.119651; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Ohsugi M, 1996, DEV DYNAM, V206, P391, DOI 10.1002/(SICI)1097-0177(199608)206:4<391::AID-AJA5>3.0.CO;2-D; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Sustmann C, 2008, MOL CELL BIOL, V28, P3526, DOI 10.1128/MCB.01986-07; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Teuliere J, 2004, MOL CELL BIOL, V24, P8649, DOI 10.1128/MCB.24.19.8649-8661.2004; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhou JB, 2007, AM J PHYSIOL-HEART C, V292, pH270, DOI 10.1152/ajpheart.00576.2006	69	186	191	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					753	U365		10.1038/ncb2260	http://dx.doi.org/10.1038/ncb2260			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21685890	Green Accepted			2022-12-25	WOS:000292305700005
J	Reaper, PM; Griffiths, MR; Long, JM; Charrier, JD; MacCormick, S; Charlton, PA; Golec, JMC; Pollard, JR				Reaper, Philip M.; Griffiths, Matthew R.; Long, Joanna M.; Charrier, Jean-Damien; MacCormick, Somhairle; Charlton, Peter A.; Golec, Julian M. C.; Pollard, John R.			Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR	NATURE CHEMICAL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; LUNG-CANCER; CISPLATIN; ACTIVATION; CARCINOMA; CHROMATIN; REPAIR; MODEL; CHK2	Here we report a comprehensive biological characterization of a potent and selective small-molecule inhibitor of the DNA damage response (DDR) kinase ATR. We show a profound synthetic lethal interaction between ATR and the ATM-p53 tumor suppressor pathway in cells treated with DNA-damaging agents and establish ATR inhibition as a way to transform the outcome for patients with cancer treated with ionizing radiation or genotoxic drugs.	[Reaper, Philip M.; Griffiths, Matthew R.; Long, Joanna M.; Charrier, Jean-Damien; MacCormick, Somhairle; Charlton, Peter A.; Golec, Julian M. C.; Pollard, John R.] Vertex Pharmaceut Europe, Abingdon, Oxon, England	Vertex Pharmaceuticals	Reaper, PM (corresponding author), Vertex Pharmaceut Europe, Abingdon, Oxon, England.	john_pollard@vrtx.com	MacCormick, Somhairle/C-5665-2015	MacCormick, Somhairle/0000-0002-2537-2471				Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bolt J, 2005, ORAL ONCOL, V41, P1013, DOI 10.1016/j.oraloncology.2005.06.003; Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wilsker D, 2007, MOL CANCER THER, V6, P1406, DOI 10.1158/1535-7163.MCT-06-0679	25	418	457	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					428	430		10.1038/NCHEMBIO.573	http://dx.doi.org/10.1038/NCHEMBIO.573			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21490603				2022-12-25	WOS:000292252100008
J	Fuchs, E; Horsley, V				Fuchs, Elaine; Horsley, Valerie			Ferreting out stem cells from their niches	NATURE CELL BIOLOGY			English	Article							SITE-SPECIFIC RECOMBINATION; LABEL-RETAINING CELLS; HAIR FOLLICLE; SELF-RENEWAL; CHROMOSOME SEGREGATION; NERVOUS-SYSTEM; CYCLE KINETICS; DROSOPHILA; LINEAGE; IDENTIFICATION	Over the past decade, it has become increasingly clear that many tissues have regenerative capabilities. The challenge has been to find the stem cells or progenitors that are responsible for tissue renewal and repair. The revolution in technological advances that permit sophisticated spatial, temporal and kinetic analyses of stem cells has allowed stem cell hunters to ferret out where stem cells live, and to monitor when they come and go from these hiding places.	[Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Horsley, Valerie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Rockefeller University; Yale University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIH [4R00AR054775, R01-AR050452]; Connecticut Dept. Public Health [09SCAYALE30]; New York State; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060295, R01AR050452, R00AR054775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Dept. Public Health; New York State; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank our colleagues in the stem evil field whose ingenuity and creatbity have developed these technologies for stem cell biology. In particular, we thank T. Tumbar (Cornell University, USA), H. Hock (Harvard Medical School, Harvard Stem Cell Institute and Cancer Center and Centre for Regenerative Medicine, Harvard University, USA), H. Clevers (Hubrecht Institute, the Netherlands), H. Snippert (Clevers Lab, Hubrecht Institute, the Netherlands), N. Barker (Hubrecht Institute, the Netherlands), Y-C. Hsu (Fuchs lab, Rockefeller University, USA) and J. Nowak (Rockefeller University, USA) for providing images. V.H. is a Pew Scholar in Biomedical Research and is funded by funded by the NIH (4R00AR054775) and the Connecticut Dept. Public Health (09SCAYALE30). E.F. is an HHMI investigator and receives support for her research on the identification and tracking of stem cells from the NIH (R01-AR050452) and New York State.	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Cairns J, 2006, GENETICS, V174, P1069, DOI 10.1534/genetics.104.66886; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; CONHOY MJ, 2007, PLOS BIOL, V5, pE102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DICK JE, 1979, ANN NY ACAD SCI, V507, P242; DZIERZAK EA, 1988, NATURE, V331, P35, DOI 10.1038/331035a0; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jetmore A, 2002, BLOOD, V99, P1585, DOI 10.1182/blood.V99.5.1585; KARPOWICZ P, 2009, J CELL BIOL, V88, P397; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Potten CS, 2004, J INVEST DERM SYMP P, V9, P183, DOI 10.1111/j.1087-0024.2004.09305.x; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Punzel M, 2001, ANN NY ACAD SCI, V938, P72; PUNZEL M, 2001, ANN NY ACAD SCI, V72, P81; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sotiropoulou PA, 2008, STEM CELLS, V26, P2964, DOI 10.1634/stemcells.2008-0634; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	53	61	62	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					513	518		10.1038/ncb0511-513	http://dx.doi.org/10.1038/ncb0511-513			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21540847	Green Accepted			2022-12-25	WOS:000290148700006
J	Spurdle, AB; Thompson, DJ; Ahmed, S; Ferguson, K; Healey, CS; O'Mara, T; Walker, LC; Montgomery, SB; Dermitzakis, ET; Fahey, P; Montgomery, GW; Webb, PM; Fasching, PA; Beckmann, MW; Ekici, AB; Hein, A; Lambrechts, D; Coenegrachts, L; Vergote, I; Amant, F; Salvesen, HB; Trovik, J; Njolstad, TS; Helland, H; Scott, RJ; Ashton, K; Proietto, T; Otton, G; Tomlinson, I; Gorman, M; Howarth, K; Hodgson, S; Garcia-Closas, M; Wentzensen, N; Yang, HN; Chanock, S; Hall, P; Czene, K; Liu, JJ; Li, JM; Shu, XO; Zheng, W; Long, JR; Xiang, YB; Shah, M; Morrison, J; Michailidou, K; Pharoah, PD; Dunning, AM; Easton, DF				Spurdle, Amanda B.; Thompson, Deborah J.; Ahmed, Shahana; Ferguson, Kaltin; Healey, Catherine S.; O'Mara, Tracy; Walker, Logan C.; Montgomery, Stephen B.; Dermitzakis, Emmanouil T.; Fahey, Paul; Montgomery, Grant W.; Webb, Penelope M.; Fasching, Peter A.; Beckmann, Matthias W.; Ekici, Arif B.; Hein, Alexander; Lambrechts, Diether; Coenegrachts, Lieve; Vergote, Ignace; Amant, Frederic; Salvesen, Helga B.; Trovik, Jone; Njolstad, Tormund S.; Helland, Harald; Scott, Rodney J.; Ashton, Katie; Proietto, Tony; Otton, Geoffrey; Tomlinson, Ian; Gorman, Maggie; Howarth, Kimberley; Hodgson, Shirley; Garcia-Closas, Montserrat; Wentzensen, Nicolas; Yang, Hannah; Chanock, Stephen; Hall, Per; Czene, Kamila; Liu, Jianjun; Li, Jingmei; Shu, Xiao-Ou; Zheng, Wei; Long, Jirong; Xiang, Yong-Bing; Shah, Mitul; Morrison, Jonathan; Michailidou, Kyriaki; Pharoah, Paul D.; Dunning, Alison M.; Easton, Douglas F.		Australian Natl Endometrial Canc; Natl Study Endometrial Canc Geneti	Genome-wide association study identifies a common variant associated with risk of endometrial cancer	NATURE GENETICS			English	Article							CLEAR-CELL CARCINOMA; PROSTATE-CANCER; DIABETES-MELLITUS; EXPRESSION; FACTOR-1-BETA; METAANALYSIS; REPLICATION; YOUNGER; FAMILY; AGE	Endometrial cancer is the most common malignancy of the female genital tract in developed countries. To identify genetic variants associated with endometrial cancer risk, we performed a genome-wide association study involving 1,265 individuals with endometrial cancer (cases) from Australia and the UK and 5,190 controls from the Wellcome Trust Case Control Consortium. We compared genotype frequencies in cases and controls for 519,655 SNPs. Forty seven SNPs that showed evidence of association with endometrial cancer in stage 1 were genotyped in 3,957 additional cases and 6,886 controls. We identified an endometrial cancer susceptibility locus close to HNF1B at 17q12 (rs4430796, P = 7.1 x 10(-10)) that is also associated with risk of prostate cancer and is inversely associated with risk of type 2 diabetes.	[Spurdle, Amanda B.; Ferguson, Kaltin; O'Mara, Tracy; Walker, Logan C.; Fahey, Paul; Montgomery, Grant W.; Webb, Penelope M.; Australian Natl Endometrial Canc] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [Thompson, Deborah J.; Morrison, Jonathan; Michailidou, Kyriaki; Pharoah, Paul D.; Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England; [Ahmed, Shahana; Healey, Catherine S.; Shah, Mitul; Pharoah, Paul D.; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Cambridge, England; [O'Mara, Tracy] Queensland Univ Technol, Hormone Dependent Canc Program, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Montgomery, Stephen B.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Beckmann, Matthias W.; Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, D-8520 Erlangen, Germany; [Hein, Alexander] Ctr Comprehens Canc, Univ Gynecol Oncol Ctr, Erlangen, Germany; [Lambrechts, Diether] Vlaams Inst Biotechnol, Vesalius Res Ctr, Louvain, Belgium; [Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Coenegrachts, Lieve; Vergote, Ignace; Amant, Frederic] Katholieke Univ Leuven Hosp, Div Gynecol Oncol, Dept Obstet & Gynecol, Louvain, Belgium; [Salvesen, Helga B.; Trovik, Jone; Njolstad, Tormund S.; Helland, Harald] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Salvesen, Helga B.; Trovik, Jone; Njolstad, Tormund S.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Scott, Rodney J.; Ashton, Katie] Univ Newcastle, Ctr Informat Based Med, Callaghan, NSW 2308, Australia; [Scott, Rodney J.; Ashton, Katie] Univ Newcastle, Discipline Med Genet, Sch Biomed Sci & Pharm, Fac Hlth, Callaghan, NSW 2308, Australia; [Scott, Rodney J.; Ashton, Katie] John Hunter Hosp, Hunter Med Res Inst, Newcastle, NSW, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Area Pathol Serv, Div Genet, Newcastle, NSW, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Ctr Gynaecol, Newcastle, NSW, Australia; [Proietto, Tony; Otton, Geoffrey] Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth, Callaghan, NSW 2308, Australia; [Tomlinson, Ian; Gorman, Maggie; Howarth, Kimberley; Natl Study Endometrial Canc Geneti] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hodgson, Shirley] St George Hosp, Sch Med, Dept Clin Genet, London, England; [Garcia-Closas, Montserrat; Wentzensen, Nicolas; Yang, Hannah; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Garcia-Closas, Montserrat] Inst Canc Res, London SW3 6JB, England; [Hall, Per; Czene, Kamila; Li, Jingmei] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Jianjun; Li, Jingmei] Genome Inst Singapore, Singapore, Singapore; [Shu, Xiao-Ou; Zheng, Wei; Long, Jirong] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN USA; [Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	QIMR Berghofer Medical Research Institute; University of Cambridge; University of Cambridge; Queensland University of Technology (QUT); University of Geneva; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Bergen; Haukeland University Hospital; University of Bergen; University of Newcastle; University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; John Hunter Hospital; John Hunter Hospital; University of Newcastle; University of Oxford; Wellcome Centre for Human Genetics; St Georges University London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Vanderbilt University; Shanghai Jiao Tong University	Spurdle, AB (corresponding author), Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia.	amanda.spurdle@qimr.edu.au	Garcia-Closas, Montserrat/AAZ-6930-2021; zhang, weihua/GXV-1334-2022; Montgomery, Grant W/B-7148-2008; Liu, Jianjun/AAK-4989-2020; Verdrengh, Evelien/H-4571-2012; Webb, Penelope/D-5736-2013; Spurdle, Amanda B/A-4978-2011; Ekici, Arif B/C-3971-2013; Li, Jingmei/I-2904-2012; Lambrechts, Diether/AAJ-3167-2020; Garcia-Closas, Montserrat/F-3871-2015; Zheng, Wei/O-3351-2013; Fahey, Paul P/B-7985-2013; Michailidou, Kyriaki/ABD-5122-2020; Hein, Alexander/F-6999-2010; Pharoah, Paul/V-6658-2019; O'Mara, Tracy/M-7508-2016; Dermitzakis, Emmanouil/B-7687-2013; salvesen, Helga B/C-1187-2017; Scott, Rodney J/B-2827-2013; Wentzensen, Nicolas/AAG-8522-2019; Fasching, Peter A/ABH-9912-2020; Amant, Frédéric/W-7436-2019	Garcia-Closas, Montserrat/0000-0003-1033-2650; Montgomery, Grant W/0000-0002-4140-8139; Liu, Jianjun/0000-0002-3255-3019; Webb, Penelope/0000-0003-0733-5930; Spurdle, Amanda B/0000-0003-1337-7897; Ekici, Arif B/0000-0001-6099-7066; Li, Jingmei/0000-0001-8587-7511; Lambrechts, Diether/0000-0002-3429-302X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Zheng, Wei/0000-0003-1226-070X; Fahey, Paul P/0000-0002-6351-9876; Michailidou, Kyriaki/0000-0001-7065-1237; Hein, Alexander/0000-0003-2601-3398; Pharoah, Paul/0000-0001-8494-732X; O'Mara, Tracy/0000-0002-5436-3232; salvesen, Helga B/0000-0002-4438-8831; Scott, Rodney J/0000-0001-7724-3404; Fasching, Peter A/0000-0003-4885-8471; Amant, Frédéric/0000-0002-5452-4905; Long, Jirong/0000-0002-7433-9766; Czene, Kamila/0000-0002-3233-5695; Dunning, Alison Margaret/0000-0001-6651-7166; Walker, Logan/0000-0003-0018-3719; Njolstad, Tormund/0000-0003-4024-3819; Montgomery, Stephen/0000-0002-5200-3903	National Health and Medical Research Council (NHMRC) [552402, 339435]; Wellcome Trust [068545/Z/02, 085475]; Cancer Research UK [C1287/A10118, C490/A1021, C8197/A10865, C8197/A10123, C490/A10124]; Australian Postgraduate Award; Institute of Health and Biomedical Innovation; Joseph Mitchell Trust; Dr. Mildred Scheel Stiftung of the Deutsche Krebshilfe (German Cancer Aid); Medical Research Council [G0000934]; Cancer Council Queensland [4196615]; Cancer Council Tasmania [403031, 457636]; University of Erlangen; Verelst Foundation for endometrial cancer; Helse Vest Grant; University of Bergen; Melzer Foundation; Norwegian Cancer Society (Harald Andersens legat); Research Council of Norway; Haukeland University Hospital; Oxford Comprehensive Biomedical Research Centre [075491/Z/04]; US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch; Agency for Science, Technology and Research of Singapore (A*STAR); US National Institutes of Health (NIH); Susan G. Komen Breast Cancer Foundation; National Cancer Institute of the United States Public Health Service [RO1 CA 092585, R01 CA90899, R01 CA64277]; Cancer Research UK [10118, 11022, 11021] Funding Source: researchfish; The Francis Crick Institute [10119, 10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA090899, R01CA064277, ZIACP010126, R01CA092585] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Australian Postgraduate Award(Australian Government); Institute of Health and Biomedical Innovation(National Institute of Biomedical Innovation); Joseph Mitchell Trust; Dr. Mildred Scheel Stiftung of the Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Council Queensland(Cancer Council Queensland); Cancer Council Tasmania(Cancer Council Tasmania); University of Erlangen; Verelst Foundation for endometrial cancer; Helse Vest Grant; University of Bergen; Melzer Foundation; Norwegian Cancer Society (Harald Andersens legat)(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Haukeland University Hospital; Oxford Comprehensive Biomedical Research Centre; US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Cancer Institute of the United States Public Health Service; Cancer Research UK(Cancer Research UK); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council (NHMRC; ID 552402), the Wellcome Trust and by Cancer Research UK grants C1287/A10118, C490/A1021, C8197/A10865 and C8197/A10123. A.B.S. and P.M.W. are NHMRC Senior Research Fellows, and G.M. is an NHMRC Senior Principle Research Fellow. T.O. is supported by an Australian Postgraduate Award, an Institute of Health and Biomedical Innovation PhD Top-Up and a Smart State PhD Award. L.C.W. is a John Gavin Postdoctoral Fellow (Genesis Oncology Trust, New Zealand). D.F.E. is a Principal Research Fellow of Cancer Research UK. A.M.D. is supported by the Joseph Mitchell Trust. I.T. is supported by Cancer Research UK and the Oxford Comprehensive Biomedical Research Centre. P.A.F. was partly funded by the Dr. Mildred Scheel Stiftung of the Deutsche Krebshilfe (German Cancer Aid).; This study makes use of data generated by the Wellcome Trust Case Control Consortium (WTCCC) 2. A full list of the investigators who contributed to the generation of the data is available from the WTCCC website. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Funding for this project was provided by the Wellcome Trust under award 085475.; We thank the study participants and collaborators and the research teams involved in the design and implementation of the individual studies included (see Supplementary Note for full list of collaborators and specific acknowledgments). Australian National Endometrial Cancer Study (ANECS) recruitment was supported by project grants from the National Health and Medical Research Council of Australia (ID#339435), The Cancer Council Queensland (ID#4196615) and Cancer Council Tasmania (ID#403031 and ID#457636). The Bavarian Endometrial Cancer Study (BECS) was partly funded by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung Fond (ELAN fund) of the University of Erlangen. The Leuven Endometrium Study (LES) was supported by the Verelst Foundation for endometrial cancer. Molecular Markers in Treatment of Endometrial Cancer (MoMaTEC) received financial support from a Helse Vest Grant, the University of Bergen, Melzer Foundation, the Norwegian Cancer Society (Harald Andersens legat), the Research Council of Norway and Haukeland University Hospital. The Newcastle Endometrial Cancer Study (NECS) acknowledges contributions from the University of Newcastle, the National Broadcasting Network (NBN) Children's Cancer Research Group, Jennie Thomas and the Hunter Medical Research Institute. The National Study of Endometrial Cancer Genetics (NSECG) Group was supported principally by Cancer Research UK and by funds from the Oxford Comprehensive Biomedical Research Centre, with core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford provided by grant 075491/Z/04. The Polish Endometrial Cancer Study (PECS) was funded by the intramural research program at the US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch. The Singapore and Swedish Breast/Endometrial Cancer Study (SASBAC) was supported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institutes of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. The Shanghai Endometrial Cancer Genetic Study (SECGS) was supported by grants from the National Cancer Institute of the United States Public Health Service (RO1 CA 092585 and R01 CA90899, R01 CA64277). SEARCH is funded by a program grant from Cancer Research UK (C490/A10124).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernardini L, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-25; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Elliott KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010858; Ferlay J., 2010, CANCERBASE INT AGENC, V2010; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gruber SB, 1996, CANCER EPIDEM BIOMAR, V5, P411; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haidopoulos D, 2010, ACTA OBSTET GYN SCAN, V89, P1326, DOI 10.3109/00016349.2010.515666; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; Hemminki K, 1998, INT J CANCER, V78, P172, DOI 10.1002/(SICI)1097-0215(19981005)78:2<172::AID-IJC9>3.0.CO;2-W; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff L. A., 2010, CATALOG PUBLISHED GE; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Kasper JS, 2009, INT J CANCER, V124, P1398, DOI 10.1002/ijc.24044; Kato N, 2006, MODERN PATHOL, V19, P83, DOI 10.1038/modpathol.3800492; Kato N, 2009, HISTOL HISTOPATHOL, V24, P1479, DOI 10.14670/HH-24.1479; Kato N, 2009, ANAL QUANT CYTOL, V31, P34; Kim L, 2008, MODERN PATHOL, V21, P1075, DOI 10.1038/modpathol.2008.95; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu H, 2011, PROSTATE, V71, P209, DOI 10.1002/pros.21235; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Lucenteforte E, 2009, EUR J CANCER PREV, V18, P95, DOI 10.1097/CEJ.0b013e328305a0c9; Mahata Pritha, 2006, Genome Inform, V17, P184; Noto H, 2010, J DIABETES COMPLICAT, V24, P345, DOI 10.1016/j.jdiacomp.2010.06.004; Oram RA, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.022; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rosato V, 2011, ANN ONCOL, V22, P884, DOI 10.1093/annonc/mdq464; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Stevens VL, 2010, PROSTATE, V70, P601, DOI 10.1002/pros.21094; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Varol N, 2001, AUST NZ J OBSTET GYN, V41, P295, DOI 10.1111/j.1479-828X.2001.tb01231.x; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609	44	115	116	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					451	+		10.1038/ng.812	http://dx.doi.org/10.1038/ng.812			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21499250	Green Accepted, Green Published			2022-12-25	WOS:000289972600015
J	Avci, FY; Li, XM; Tsuji, M; Kasper, DL				Avci, Fikri Y.; Li, Xiangming; Tsuji, Moriya; Kasper, Dennis L.			A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design	NATURE MEDICINE			English	Article							INFLUENZAE TYPE-B; T-CELL RECOGNITION; CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CARRIER PROTEIN; MHCII PATHWAY; POLYSACCHARIDE; ANTIGEN; IMMUNOGENICITY; GLYCOPEPTIDE	Glycoconjugate vaccines have provided enormous health benefits globally, but they have been less successful in some populations at high risk for developing disease. To identify new approaches to enhancing glycoconjugate effectiveness, we investigated molecular and cellular mechanisms governing the immune response to a prototypical glycoconjugate vaccine. We found that in antigen-presenting cells a carbohydrate epitope is generated upon endolysosomal processing of group B streptococcal type III polysaccharide coupled to a carrier protein. In conjunction with a carrier protein-derived peptide, this carbohydrate epitope binds major histocompatibility class II (MHCII) and stimulates carbohydrate-specific CD4(+) T cell clones to produce interleukins 2 and 4-cytokines essential for providing T cell help to antibody-producing B cells. An archetypical glycoconjugate vaccine that we constructed to maximize the presentation of carbohydrate-specific T cell epitopes is 50-100 times more potent and substantially more protective in a neonatal mouse model of group B Streptococcus infection than a vaccine constructed by methods currently used by the vaccine industry. Our discovery of how glycoconjugates are processed resulting in presentation of carbohydrate epitopes that stimulate CD4(+) T cells has key implications for glycoconjugate vaccine design that could result in greatly enhanced vaccine efficacy.	[Avci, Fikri Y.; Kasper, Dennis L.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; [Avci, Fikri Y.; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Li, Xiangming; Tsuji, Moriya] Rockefeller Univ, HIV & Malaria Vaccine Program, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Rockefeller University	Kasper, DL (corresponding author), Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu		Avci, Fikri/0000-0002-1902-7532; Tsuji, Moriya/0000-0001-8587-277X	US National Institutes of Health [AI-089915, AI-070258, AI-081510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089915, R56AI070258, R01AI070258, R01AI081510] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Reinap and S. Mascuch for their valuable technical assistance and L. Paoletti for his advice. We also thank J. McCoy for her outstanding editorial assistance and T. DiCesare for his excellent artwork. This work was supported by funding from the following grants: US National Institutes of Health AI-089915, AI-070258 and AI-081510.	AbdelMotal UM, 1996, EUR J IMMUNOL, V26, P544, DOI 10.1002/eji.1830260307; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Barrett D J, 1985, Adv Pediatr, V32, P139; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; BEUVERY EC, 1982, INFECT IMMUN, V37, P15, DOI 10.1128/IAI.37.1.15-22.1982; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Colino J, 2009, J IMMUNOL, V183, P1551, DOI 10.4049/jimmunol.0900238; COUTINHO A, 1973, NATURE-NEW BIOL, V245, P12, DOI 10.1038/newbio245012a0; DECK B, 1995, J IMMUNOL, V155, P1074; DeNardo GL, 2008, CANCER BIOTHER RADIO, V23, P783, DOI 10.1089/cbr.2008.0589; Duan JY, 2008, P NATL ACAD SCI USA, V105, P5183, DOI 10.1073/pnas.0800974105; Dzhambazov B, 2005, EUR J IMMUNOL, V35, P357, DOI 10.1002/eji.200425637; Gad M, 2002, GLYCOCONJUGATE J, V19, P59, DOI 10.1023/A:1022537031617; GalliStampino L, 1997, CANCER RES, V57, P3214; GREENBERG DP, 1995, J PEDIATR-US, V126, P206, DOI 10.1016/S0022-3476(95)70546-5; Guttormsen HK, 1998, INFECT IMMUN, V66, P2026, DOI 10.1128/IAI.66.5.2026-2032.1998; Guttormsen HK, 1999, INFECT IMMUN, V67, P6375; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Haurum JS, 1995, EUR J IMMUNOL, V25, P3270, DOI 10.1002/eji.1830251211; Hitzel C, 1999, J IMMUNOL, V162, P4671; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; JANEWAY CA, 2005, IMMUNOBIOLOGY, pCH9; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; Kamboj KK, 2003, J INFECT DIS, V187, P1629, DOI 10.1086/374785; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Lai ZZ, 2009, VACCINE, V27, P3137, DOI 10.1016/j.vaccine.2009.03.064; Leonard EG, 2003, INFECT IMMUN, V71, P4186, DOI 10.1128/IAI.71.7.4186-4189.2003; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; MOURITSEN S, 1994, EUR J IMMUNOL, V24, P1066, DOI 10.1002/eji.1830240509; Paoletti LC, 1999, J INFECT DIS, V180, P892, DOI 10.1086/314955; PAOLETTI LC, 1994, INFECT IMMUN, V62, P3236, DOI 10.1128/IAI.62.8.3236-3243.1994; SCHNEERSON R, 1980, J EXP MED, V152, P361, DOI 10.1084/jem.152.2.361; SHIMOJO N, 1994, INT ARCH ALLERGY IMM, V105, P155, DOI 10.1159/000236818; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; TSUJI M, 1990, J EXP MED, V172, P1353, DOI 10.1084/jem.172.5.1353; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; Tsuji Moriya, 2002, Methods Mol Med, V72, P361, DOI 10.1385/1-59259-271-6:361; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; WESSELS MR, 1993, INFECT IMMUN, V61, P4760, DOI 10.1128/IAI.61.11.4760-4766.1993; WESSELS MR, 1990, J CLIN INVEST, V86, P1428, DOI 10.1172/JCI114858	46	231	247	1	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1602	U115		10.1038/nm.2535	http://dx.doi.org/10.1038/nm.2535			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101769	Green Accepted, Bronze			2022-12-25	WOS:000297978000031
J	Luciani, GM; Magomedova, L; Puckrin, R; Urbanus, ML; Wallace, IM; Giaever, G; Nislow, C; Cummins, CL; Roy, PJ				Luciani, Genna M.; Magomedova, Lilia; Puckrin, Rachel; Urbanus, Malene L.; Wallace, Iain M.; Giaever, Guri; Nislow, Corey; Cummins, Carolyn L.; Roy, Peter J.			Dafadine inhibits DAF-9 to promote dauer formation and longevity of Caenorhabditis elegans	NATURE CHEMICAL BIOLOGY			English	Article							LIFE-SPAN; LARVAL DEVELOPMENT; DEVELOPMENTAL AGE; NUCLEAR RECEPTOR; ENCODES; GENE; METABOLISM; DIAPAUSE	The DAF-9 cytochrome P450 is a key regulator of dauer formation, developmental timing and longevity in the nematode Caenorhabditis elegans. Here we describe the first identified chemical inhibitor of DAF-9 and the first reported small-molecule tool that robustly induces dauer formation in typical culture conditions. This molecule (called dafadine) also inhibits the mammalian ortholog of DAF-9(CYP27A1), suggesting that dafadine can be used to interrogate developmental control and longevity in other animals.	[Luciani, Genna M.; Giaever, Guri; Nislow, Corey; Roy, Peter J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Luciani, Genna M.; Puckrin, Rachel; Urbanus, Malene L.; Wallace, Iain M.; Giaever, Guri; Nislow, Corey; Roy, Peter J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Magomedova, Lilia; Giaever, Guri; Cummins, Carolyn L.] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Urbanus, Malene L.; Wallace, Iain M.; Nislow, Corey] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto	Roy, PJ (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	carolyn.cummins@utoronto.ca; peter.roy@utoronto.ca	Giaever, Guri/D-3930-2009; Roy, Peter/G-5357-2014; Wallace, Iain/B-9464-2009	Cummins, Carolyn/0000-0001-7603-6577; Nislow, Corey/0000-0002-4016-8874; Luciani, Genna/0000-0001-8107-2708; Roy, Peter/0000-0003-2959-2276; Wallace, Iain/0000-0002-9491-7025	Canadian Institutes of Health Research [MOP-68813, MOP-97904, MOP-81340, MOP-84305]; Natural Sciences and Engineering Research Council [356873-08]; Canadian Cancer Society [020380]; Marie Curie fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Marie Curie fellowship(European Commission)	We thank A. Antebi, N. Strushkevich, Y. Kohara, H.-J. Knolker, R. Martin, K. S. Pang, D. Mangelsdorf, R. Auchus, S. Wu, A. Orellana and J. Lund for reagents and advice. This work was supported by Canadian Institutes of Health Research grants to P. J. R. (MOP-68813), C. L. C. (MOP-97904), G. G. (MOP-81340) and C. N. (MOP-84305), a Natural Sciences and Engineering Research Council grant to C. L. C. (356873-08), a grant from the Canadian Cancer Society to G. G. (020380), and a Marie Curie fellowship to I. M. W. G. G. and P. J. R. are Canadian Research Chairs in Chemical Biology and Molecular Neurobiology, respectively.	Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jia KL, 2002, DEVELOPMENT, V129, P221; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; VOWELS JJ, 1992, GENETICS, V130, P105	25	19	21	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					891	893		10.1038/NCHEMBIO.698	http://dx.doi.org/10.1038/NCHEMBIO.698			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22057127				2022-12-25	WOS:000297166200011
J	Fang, NN; Ng, AHM; Measday, V; Mayor, T				Fang, Nancy N.; Ng, Alex H. M.; Measday, Vivien; Mayor, Thibault			Hul5 HECT ubiquitin ligase plays a major role in the ubiquitylation and turn over of cytosolic misfolded proteins	NATURE CELL BIOLOGY			English	Article							QUALITY CONTROL DEGRADATION; ENDOPLASMIC-RETICULUM; HEAT-SHOCK; PROTEASOME; YEAST; CHAPERONES; MEMBRANE; PEPTIDES; UBR1; STEP	Cellular toxicity introduced by protein misfolding threatens cell fitness and viability. Failure to eliminate these polypeptides is associated with numerous aggregation diseases. Several protein quality control mechanisms degrade non-native proteins by the ubiquitin-proteasome system. Here, we use quantitative mass spectrometry to demonstrate that heat-shock triggers a large increase in the level of ubiquitylation associated with misfolding of cytosolic proteins. We discover that the Hul5 HECT ubiquitin ligase participates in this heat-shock stress response. Hul5 is required to maintain cell fitness after heat-shock and to degrade short-lived misfolded proteins. In addition, localization of Hul5 in the cytoplasm is important for its quality control function. We identify potential Hul5 substrates in heat-shock and physiological conditions to reveal that Hul5 is required for ubiquitylation of low-solubility cytosolic proteins including the Pin3 prion-like protein. These findings indicate that Hul5 is involved in a cytosolic protein quality control pathway that targets misfolded proteins for degradation.	[Fang, Nancy N.; Ng, Alex H. M.; Mayor, Thibault] Univ British Columbia, Dept Biochem & Mol Biol, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Measday, Vivien] Univ British Columbia, Wine Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Mayor, T (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Ctr High Throughput Biol, 2125 East Mall, Vancouver, BC V6T 1Z4, Canada.	mayor@mail.ubc.ca	Ng, Alex/AAE-6695-2020	Ng, Alex/0000-0001-5075-9750	Canada Institutes of Health Research (CIHR)	Canada Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The authors express gratitude to the following people for providing reagents: D. Finley (Harvard University, USA; HUL5 plasmids); J. Thorner (University of California, Berkeley, USA; anti-Pgk1 antibody); L. Howe (University of British Columbia, Canada; anti-H3 antibody); A. Chruscicki (University of British Columbia, Canada; Dynal-IgG); S. Jentsch (Max Planck Institute of Biochemistry, Germany; E2 double deletion strains); E. Craig (University of Wisconsin-Madison, USA; ssa1-45 strains); L. Conibear (University of British Columbia, Canada; TAP strains); R. Deshaies (California Institute of Technology, USA), C. Boone (University of Toronto, Canada) and M. Roberge (University of British Columbia, Canada) (deletion strains). We also thank P. Kaiser for comments on the manuscript, J. Gsponer for discussion, T.M. laboratory members for their encouragement and discussion and the following people for their support: L. Foster and N. Stoynov (mass spectrometry analysis); A Chang (microscopy); P. Hieter and J. Stoepel (plate reader analysis); E. Jan (<SUP>35</SUP>S labelling and Odyssey). T.M. is supported by a grant from the Canada Institutes of Health Research (CIHR) and is a CIHR New Investigator. V.M. is supported by a grant from the CIHR.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; MILLER MJ, 1979, P NATL ACAD SCI USA, V76, P5222, DOI 10.1073/pnas.76.10.5222; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Searfoss A, 2001, MOL CELL BIOL, V21, P4900, DOI 10.1128/MCB.21.15.4900-4908.2001; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	45	103	104	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1344	U137		10.1038/ncb2343	http://dx.doi.org/10.1038/ncb2343			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	21983566	Green Accepted			2022-12-25	WOS:000296737900011
J	Rivas, MA; Beaudoin, M; Gardet, A; Stevens, C; Sharma, Y; Zhang, CK; Boucher, G; Ripke, S; Ellinghaus, D; Burtt, N; Fennell, T; Kirby, A; Latiano, A; Goyette, P; Green, T; Halfvarson, J; Haritunians, T; Korn, JM; Kuruvilla, F; Lagace, C; Neale, B; Lo, KS; Schumm, P; Torkvist, L; Dubinsky, MC; Brant, SR; Silverberg, MS; Duerr, RH; Altshuler, D; Gabriel, S; Lettre, G; Franke, A; D'Amato, M; McGovern, DPB; Cho, JH; Rioux, JD; Xavier, RJ; Daly, MJ				Rivas, Manuel A.; Beaudoin, Melissa; Gardet, Agnes; Stevens, Christine; Sharma, Yashoda; Zhang, Clarence K.; Boucher, Gabrielle; Ripke, Stephan; Ellinghaus, David; Burtt, Noel; Fennell, Tim; Kirby, Andrew; Latiano, Anna; Goyette, Philippe; Green, Todd; Halfvarson, Jonas; Haritunians, Talin; Korn, Joshua M.; Kuruvilla, Finny; Lagace, Caroline; Neale, Benjamin; Lo, Ken Sin; Schumm, Phil; Torkvist, Leif; Dubinsky, Marla C.; Brant, Steven R.; Silverberg, Mark S.; Duerr, Richard H.; Altshuler, David; Gabriel, Stacey; Lettre, Guillaume; Franke, Andre; D'Amato, Mauro; McGovern, Dermot P. B.; Cho, Judy H.; Rioux, John D.; Xavier, Ramnik J.; Daly, Mark J.		Natl Inst Diabet Digestive Kidney; United Kingdom Inflammatory Bowel; Int Inflammatory Bowel Dis	Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CROHN-DISEASE; CARD15 MUTATIONS; NOD2; FREQUENCY; RISK; RECRUITMENT; AUTOPHAGY; SELECTION	More than 1,000 susceptibility loci have been identified through genome-wide association studies (GWAS) of common variants; however, the specific genes and full allelic spectrum of causal variants underlying these findings have not yet been defined. Here we used pooled next-generation sequencing to study 56 genes from regions associated with Crohn's disease in 350 cases and 350 controls. Through follow-up genotyping of 70 rare and low-frequency protein-altering variants in nine independent case-control series (16,054 Crohn's disease cases, 12,153 ulcerative colitis cases and 17,575 healthy controls), we identified four additional independent risk factors in NOD2, two additional protective variants in IL23R, a highly significant association with a protective splice variant in CARD9 (P < 1 x 10(-16), odds ratio approximate to 0.29) and additional associations with coding variants in IL18RAP, CUL2, C1orf106, PTPN22 and MUC19. We extend the results of successful GWAS by identifying new, rare and probably functional variants that could aid functional experiments and predictive models.	[Rivas, Manuel A.; Ripke, Stephan; Kirby, Andrew; Neale, Benjamin; Altshuler, David; Xavier, Ramnik J.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Rivas, Manuel A.; Stevens, Christine; Ripke, Stephan; Burtt, Noel; Fennell, Tim; Kirby, Andrew; Green, Todd; Korn, Joshua M.; Kuruvilla, Finny; Neale, Benjamin; Altshuler, David; Gabriel, Stacey; Xavier, Ramnik J.; Daly, Mark J.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Rivas, Manuel A.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Beaudoin, Melissa; Boucher, Gabrielle; Goyette, Philippe; Lagace, Caroline; Lo, Ken Sin; Lettre, Guillaume; Rioux, John D.] Univ Montreal, Montreal, PQ, Canada; [Beaudoin, Melissa; Boucher, Gabrielle; Goyette, Philippe; Lagace, Caroline; Lo, Ken Sin; Lettre, Guillaume; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Gardet, Agnes; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Ctr Study Inflammatory Bowe, Boston, MA USA; [Gardet, Agnes; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA; [Sharma, Yashoda; Zhang, Clarence K.; Cho, Judy H.] Yale Univ, Sch Med, New Haven, CT USA; [Ellinghaus, David; Franke, Andre] Inst Clin Mol Biol, Kiel, Germany; [Latiano, Anna] Casa Sollievo Sofferenza Hosp, Ist Ricovero & Cura Carattere Sci, Gastroenterol Unit, San Giovanni Rotondo, Italy; [Halfvarson, Jonas] Univ Orebro, Dept Med, Orebro Univ Hosp, Orebro, Sweden; [Halfvarson, Jonas] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Haritunians, Talin; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Kuruvilla, Finny] Clarus Ventures, Cambridge, MA USA; [Schumm, Phil] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Torkvist, Leif] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Dubinsky, Marla C.] Cedars Sinai Med Ctr, Pediat Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA; [Brant, Steven R.] Johns Hopkins Univ, Sch Med, Dept Med, Meyerhoff Inflammatory Bowel Dis Ctr, Baltimore, MD 21205 USA; [Brant, Steven R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, Inflammatory Bowel Dis Grp, Toronto, ON M5G 1X5, Canada; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Universite de Montreal; Universite de Montreal; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University; IRCCS Casa Sollievo Della Sofferenza; Orebro University; Orebro University; Cedars Sinai Medical Center; University of Chicago; Karolinska Institutet; Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; Cedars Sinai Medical Center	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	rivas@broadinstitute.org; mjdaly@atgu.mgh.harvard.edu	Anderson, Carl A/B-8327-2013; D'Amato, Mauro/F-2450-2010; Silverberg, Mark/B-4183-2008; Henderson, Paul/F-5106-2012; Ellinghaus, David/G-4467-2012; Halfvarson, Jonas/AAU-4687-2020; Altshuler, David M/A-4476-2009; Rivas, Manuel/ABE-8173-2020; Ellinghaus, David/ABC-3610-2020; Radford-Smith, Graham L/G-5749-2017; Palmieri, Orazio/J-7697-2012; Gearry, Richard B/H-3959-2019; Daly, Mark J/B-2453-2017; Franke, Andre/B-2151-2010; D'Amato, Mauro/B-5050-2019; Duerr, Richard H/B-4188-2009; Ripke, Stephan/AAK-5486-2021; Prescott, Natalie J/F-6490-2011; Latiano, Anna/R-1965-2016; Rioux, John D/A-9599-2015; Panes, Julian/H-5991-2015	Anderson, Carl A/0000-0003-1719-7009; D'Amato, Mauro/0000-0003-2743-5197; Henderson, Paul/0000-0003-3634-6428; Altshuler, David M/0000-0002-7250-4107; Rivas, Manuel/0000-0003-1457-9925; Ellinghaus, David/0000-0002-4332-6110; Radford-Smith, Graham L/0000-0002-2047-6239; Palmieri, Orazio/0000-0002-0019-7929; Gearry, Richard B/0000-0002-2298-5141; Daly, Mark J/0000-0002-0949-8752; Franke, Andre/0000-0003-1530-5811; D'Amato, Mauro/0000-0003-2743-5197; Duerr, Richard H/0000-0001-6586-3905; Prescott, Natalie J/0000-0002-5901-7371; Latiano, Anna/0000-0003-3719-2061; Rioux, John D/0000-0001-7560-8326; Halfvarson, Jonas/0000-0003-0122-7234; Simms, Lisa/0000-0002-5387-7397; Panes, Julian/0000-0002-4971-6902; ZHANG, HU/0000-0002-3281-4661; ripke, stephan/0000-0003-3622-835X; Lees, Charlie/0000-0002-0732-8215; Laukens, Debby/0000-0002-1984-5850; Newman, William/0000-0002-6382-4678; Stevens, Christine/0000-0002-2621-2234; Barrett, Jeffrey/0000-0002-1152-370X; Hugot, Jean-Pierre/0000-0002-8446-6056; Parkes, Miles/0000-0002-6467-0631; Schumm, Phil/0000-0002-3050-2429	US National Human Genome Research Institute [DK83756, AI062773, DK060049, DK086502, HG005923, DK043351]; Helmsley Trust; La Fondation pour la Recherche Medicale; CCFA; Canada Research Chair; US National Institutes of Allergy and Infectious Diseases [AI065687, AI067152]; NIDDK [DK064869, DK062432]; CCFA [SRA512]; La Fondation de l'Institut de Cardiologie de Montreal; Crohn's and Colitis Foundation of Canada (CCFC); Fonds de Recherche en Sante du Quebec [17199]; Canadian Institutes of Health Research [01038]; Italian Ministry for Health [GR-2008-1144485]; Giuliani; NCRR [M01-RR00425, U01-DK062413, P01-DK046763]; Southern California Diabetes Endocrinology Research Center [DK063491, R21-DK84554-01, U01 DK062413]; German Ministry of Education and Research through the National Genome Research Network; Swedish Research Council; Bengt Ihre Foundation; rebro University Hospital Research Foundation;  [DK062431];  [DK062422];  [DK062420];  [DK062423];  [DK062413];  [DK062429]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U01HG005923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, U19AI067152, P01AI065687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062422, U01DK062431, U01DK062429, R01DK060049, P01DK046763, P30DK043351, P30DK063491, U01DK062423, RC1DK086502, R01DK083756, U01DK062413, R21DK084554, R01DK064869, U01DK062432, U01DK062420] Funding Source: NIH RePORTER; Medical Research Council [G0800675, G0600329] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75] Funding Source: researchfish; MRC [G0800675, G0600329] Funding Source: UKRI	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Helmsley Trust; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CCFA; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); US National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CCFA; La Fondation de l'Institut de Cardiologie de Montreal; Crohn's and Colitis Foundation of Canada (CCFC); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Italian Ministry for Health(Ministry of Health, Italy); Giuliani; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Southern California Diabetes Endocrinology Research Center; German Ministry of Education and Research through the National Genome Research Network; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bengt Ihre Foundation; rebro University Hospital Research Foundation; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Crohn&quot;s and Colitis UK; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Solomon for designing figures, R. Onofrio for designing PCR primers, K. Ardlie and S. Mahan for assistance in DNA sample preparation, J. Wilkinson and L. Ambrogio for Illumina sequence project management, B. Thomson, G. Crenshaw and A. Taylor for genotyping assistance, E.S. Lander for helpful comments, the Broad Institute Sequencing Platform for sequence data production, J. Flannick and J. Maguire for assistance with pooled sequence analysis, and M. dePristo and the Broad Institute Genome Sequence Analysis Group for sequencing analysis help and useful discussions. The work was supported by US National Human Genome Research Institute sequencing grant DK83756; Funds from the Helmsley Trust to M.J.D. and R.J.X.; and US National Institutes of Health grants AI062773, DK060049, DK086502, HG005923 and DK043351 (to R.J.X.). A. G. was supported by fellowships from La Fondation pour la Recherche Medicale and the CCFA. J.D.R. holds a Canada Research Chair and is funded by grants from the US National Institutes of Allergy and Infectious Diseases (AI065687; AI067152) from the NIDDK (DK064869; DK062432), the CCFA (SRA512), La Fondation de l'Institut de Cardiologie de Montreal, the Crohn's and Colitis Foundation of Canada (CCFC), the Fonds de Recherche en Sante du Quebec (17199) and the Canadian Institutes of Health Research (01038). Genotyping of the Italian samples was supported by the Italian Ministry for Health GR-2008-1144485 and unrestricted research grant of Giuliani, with case collections provided by the Italian Group for IBD. The NIDDK IBDGC is funded by the following grants: DK062431 (S.R.B.), DK062422 (J.H.C.), DK062420 (R.H.D.), DK062432 (J.D.R.), DK062423 (M.S.), DK062413 (D.P.B.M.) and DK062429 (J.H.C.). D.P.B.M. is supported by NCRR grant M01-RR00425 to the Cedars-Sinai General Research Center Genotyping Core, U01-DK062413 (IBD Genetics Research Center), P01-DK046763 (IBD Program Project Grant) and Southern California Diabetes Endocrinology Research Center grants DK063491, R21-DK84554-01 and U01 DK062413. Genotyping of the German samples was supported by the German Ministry of Education and Research through the National Genome Research Network with infrastructure support through the Deutsche Forschungsgemeinschaft cluster of excellence Inflammation at Interfaces. Genotyping of the Swedish samples was supported by the Swedish Research Council, the Bengt Ihre Foundation and the rebro University Hospital Research Foundation.	Ahmad T, 2001, ALIMENT PHARM THER, V15, P731, DOI 10.1046/j.1365-2036.2001.00981.x; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bengtson MB, 2009, J CROHNS COLITIS, V3, P92, DOI 10.1016/j.crohns.2008.11.002; Brant SR, 2011, INFLAMM BOWEL DIS, V17, P1, DOI 10.1002/ibd.21385; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; King K, 2006, HUM MUTAT, V27, P44, DOI 10.1002/humu.20264; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Nadeau JH, 2002, NATURE, V420, P517, DOI 10.1038/420517a; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pearson K, 1901, PHILOS T R SOC LOND, V195, P79; Plenge R, 2006, IMMUNOL REV, V210, P40, DOI 10.1111/j.0105-2896.2006.00372.x; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROTH MP, 1989, GASTROENTEROLOGY, V97, P900, DOI 10.1016/0016-5085(89)91495-9; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tukel T, 2004, AM J HUM GENET, V74, P623, DOI 10.1086/382226; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107	46	544	565	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1066	U50		10.1038/ng.952	http://dx.doi.org/10.1038/ng.952			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21983784	Green Accepted, Green Submitted			2022-12-25	WOS:000296584000009
J	Chang, SH; Wang, RH; Akagi, K; Kim, KA; Martin, BK; Cavallone, L; Haines, DC; Basik, M; Mai, P; Poggi, E; Isaacs, C; Looi, LM; Mun, KS; Greene, MH; Byers, SW; Teo, SH; Deng, CX; Sharan, SK				Chang, Suhwan; Wang, Rui-Hong; Akagi, Keiko; Kim, Kyung-Ae; Martin, Betty K.; Cavallone, Luca; Haines, Diana C.; Basik, Mark; Mai, Phuong; Poggi, Elizabeth; Isaacs, Claudine; Looi, Lai M.; Mun, Kein S.; Greene, Mark H.; Byers, Stephen W.; Teo, Soo H.; Deng, Chu-Xia; Sharan, Shyam K.		Kathleen Cuningham Fdn Consortium	Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155	NATURE MEDICINE			English	Article							CELL-CYCLE CHECKPOINT; DNA-DAMAGE RESPONSE; BREAST-CANCER; LIGASE ACTIVITY; HIGH EXPRESSION; STEM-CELLS; IN-VIVO; C-MYC; PROTEIN; GENE	BRCA1, a well-known tumor suppressor with multiple interacting partners, is predicted to have diverse biological functions. However, so far its only well-established role is in the repair of damaged DNA and cell cycle regulation. In this regard, the etiopathological study of low-penetrant variants of BRCA1 provides an opportunity to uncover its other physiologically important functions. Using this rationale, we studied the R1699Q variant of BRCA1, a potentially moderate-risk variant, and found that it does not impair DNA damage repair but abrogates the repression of microRNA-155 (miR-155), a bona fide oncomir. Mechanistically, we found that BRCA1 epigenetically represses miR-155 expression via its association with HDAC2, which deacetylates histones H2A and H3 on the miR-155 promoter. We show that overexpression of miR-155 accelerates but the knockdown of miR-155 attenuates the growth of tumor cell lines in vivo. Our findings demonstrate a new mode of tumor suppression by BRCA1 and suggest that miR-155 is a potential therapeutic target for BRCA1-deficient tumors.	[Sharan, Shyam K.; Kathleen Cuningham Fdn Consortium] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Chang, Suhwan; Kim, Kyung-Ae] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Wang, Rui-Hong; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, Bethesda, MD USA; [Akagi, Keiko] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol, Columbus, OH 43210 USA; [Akagi, Keiko] Ohio State Univ, Human Canc Genet Program, Dept Immunol, Columbus, OH 43210 USA; [Akagi, Keiko] Ohio State Univ, Human Canc Genet Program, Dept Med Genet, Columbus, OH 43210 USA; [Martin, Betty K.] NCI, Sci Applicat Int Corp SAIC Frederick, Frederick, MD 21701 USA; [Cavallone, Luca; Basik, Mark] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Cavallone, Luca] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Cavallone, Luca] McGill Univ, Dept Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Haines, Diana C.] NCI, Pathol Histotechnol Lab, SAIC Frederick, Frederick, MD 21701 USA; [Mai, Phuong; Greene, Mark H.] NCI, Clin Genet Branch, Rockville, MD USA; [Poggi, Elizabeth; Isaacs, Claudine; Byers, Stephen W.] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA; [Looi, Lai M.; Mun, Kein S.] Univ Malaya, Dept Pathol, Med Ctr, Kuala Lumpur, Malaysia; [Teo, Soo H.] Univ Malaya, Med Ctr, Dept Surg, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia; [Teo, Soo H.] Sime Darby Med Ctr, Canc Res Initiat Fdn, Kuala Lumpur, Malaysia	Peter Maccallum Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Lady Davis Institute; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; Universiti Malaya; Universiti Malaya	Sharan, SK (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	sharans@mail.nih.gov	Looi, Lai Meng/A-3382-2009; Teo, Soo-hwang/H-2353-2014; deng, chuxia/N-6713-2016; Looi, Lai Meng/AAB-9403-2019; Mun, Kein Seong/E-4155-2010	Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117; Chang, Suhwan/0000-0002-0282-0120; Thorne, Heather/0000-0003-3610-2511	Center for Cancer Research, US National Cancer Institute; US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010144, ZIABC011181, ZIABC010387] Funding Source: NIH RePORTER	Center for Cancer Research, US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Acharya, K. Biswas, R. Chittela, I. Daar, K. Reilly and A. Spurdle for helpful discussions and critical review of the manuscript. We also thank D. M. Livingston (Dana-Farber Cancer Institute) and D. L. Turner (University of Michigan) for providing DNA constructs; D. Swing for help with BAC transgenic mice and allograft experiment; W. D. Foulkes, A. Spurdle, H. Thorne, Y.C. Har, P.S. Yee, A. Saleh, the Georgetown-Lombardi Comprehensive Cancer Center, Familial Cancer and Histopathology and Tissue Share Resources, who helped with the human tumor samples; S. Burkett for cytogenetic analysis; C. H. Kim for microarray analysis, and A. Kane and R. Frederickson for illustrations. The research was sponsored by the Center for Cancer Research, US National Cancer Institute and US National Institutes of Health.	Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Cable PL, 2003, MOL CARCINOGEN, V38, P85, DOI 10.1002/mc.10148; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chen JJ, 2000, CANCER RES, V60, P5037; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Deffenbaugh AM, 2002, GENET TEST, V6, P119, DOI 10.1089/10906570260199375; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Garcia EBG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2223; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lovelock PK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1826; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016841; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	46	169	178	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1275	U308		10.1038/nm.2459	http://dx.doi.org/10.1038/nm.2459			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946536	Green Accepted			2022-12-25	WOS:000296022100046
J	Hoorn, EJ; Walsh, SB; McCormick, JA; Furstenberg, A; Yang, CL; Roeschel, T; Paliege, A; Howie, AJ; Conley, J; Bachmann, S; Unwin, RJ; Ellison, DH				Hoorn, Ewout J.; Walsh, Stephen B.; McCormick, James A.; Fuerstenberg, Antje; Yang, Chao-Ling; Roeschel, Tom; Paliege, Alexander; Howie, Alexander J.; Conley, James; Bachmann, Sebastian; Unwin, Robert J.; Ellison, David H.			The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension	NATURE MEDICINE			English	Article							KIDNEY-TRANSPLANTATION; ALTERED EXPRESSION; CL-COTRANSPORTER; DOWN-REGULATION; FOLLOW-UP; CYCLOSPORINE; IMMUNOSUPPRESSION; NEPHROPATHY; MECHANISMS; RECIPIENTS	Calcineurin inhibitors (CNIs) are immunosuppressive drugs that are used widely to prevent rejection of transplanted organs and to treat autoimmune disease. Hypertension and renal tubule dysfunction, including hyperkalemia, hypercalciuria and acidosis, often complicate their use(1,2). These side effects resemble familial hyperkalemic hypertension, a genetic disease characterized by overactivity of the renal sodium chloride cotransporter (NCC) and caused by mutations in genes encoding WNK kinases. We hypothesized that CNIs induce hypertension by stimulating NCC. In wild-type mice, the CNI tacrolimus caused salt-sensitive hypertension and increased the abundance of phosphorylated NCC and the NCC-regulatory kinases WNK3, WNK4 and SPAK. We demonstrated the functional importance of NCC in this response by showing that tacrolimus did not affect blood pressure in NCC-knockout mice, whereas the hypertensive response to tacrolimus was exaggerated in mice overexpressing NCC. Moreover, hydrochlorothiazide, an NCC-blocking drug, reversed tacrolimus-induced hypertension. These observations were extended to humans by showing that kidney transplant recipients treated with tacrolimus had a greater fractional chloride excretion in response to bendroflumethiazide, another NCC-blocking drug, than individuals not treated with tacrolimus; renal NCC abundance was also greater. Together, these findings indicate that tacrolimus-induced chronic hypertension is mediated largely by NCC activation, and suggest that inexpensive and well-tolerated thiazide diuretics may be especially effective in preventing the complications of CNI treatment.	[Hoorn, Ewout J.; McCormick, James A.; Yang, Chao-Ling; Conley, James; Ellison, David H.] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA; [Walsh, Stephen B.; Fuerstenberg, Antje; Unwin, Robert J.] UCL, UCL Ctr Nephrol, London, England; [Roeschel, Tom; Paliege, Alexander; Bachmann, Sebastian] Charite, Dept Anat, Berlin, Germany; [Howie, Alexander J.] UCL, Dept Pathol, London, England; [Ellison, David H.] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA	Oregon Health & Science University; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; University College London; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ellison, DH (corresponding author), Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA.	ellisond@ohsu.edu	McCormick, James A/A-9121-2010; , David/X-5730-2019; Walsh, Stephen Benedict/AAB-9930-2020; Hoorn, Ewout/S-4135-2019	Hoorn, Ewout/0000-0002-8738-3571; Paliege, Alexander/0000-0001-5092-5472; Ellison, David/0000-0003-2915-265X; McCormick, James/0000-0003-4000-6653; Walsh, Stephen/0000-0002-8693-1353	Erasmus Medical Center; Dutch Kidney Foundation [KJPB 08.004]; US National Institutes of Health (NIH) [K01 DK076617]; NIH [RO1 DK51496]; Department of Veterans Affairs; American Heart Association [10 GRNT 2630199]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051496, T32DK067864, K01DK076617] Funding Source: NIH RePORTER	Erasmus Medical Center; Dutch Kidney Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	For technical assistance, we thank N. Desmerais (animal studies), S. Rogers, K. Risowsky (immunohistochemistry), D. Gannon and A. Bakke (tacrolimus measurements in mice). We thank G. Jones and M. Harber for help in identifying human subjects. We also thank G. Shull (University of Cincinnati) for the NCC-knockout mice, and E. Delpire (Vanderbilt Kennedy Center) for SPAK antibodies. E.J.H. is supported by an Erasmus Medical Center Fellowship and Kolff Junior Postdoc Grant (Dutch Kidney Foundation, KJPB 08.004); J.A.M. is supported by the US National Institutes of Health (NIH) (K01 DK076617); D. H. E. is supported by the NIH (RO1 DK51496), the Department of Veterans Affairs (Merit Review) and the American Heart Association (10 GRNT 2630199). Portions of this work were presented at the High Blood Pressure Research Council Meeting of the American Heart Association, 13-16 October 2010, and the American Society of Nephrology, 15-18 November 2010.	ADU D, 1983, LANCET, V2, P370; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Arthur JM, 2000, KIDNEY INT, V58, P325, DOI 10.1046/j.1523-1755.2000.00169.x; Calo L, 2002, KIDNEY INT, V61, P353, DOI 10.1046/j.1523-1755.2002.00128.x; Calo L, 2000, CRIT REV CL LAB SCI, V37, P503, DOI 10.1080/10408360091174295; Colussi G, 2007, CLIN J AM SOC NEPHRO, V2, P454, DOI 10.2215/CJN.02950906; CURTIS JJ, 1988, AM J MED, V85, P134; Curtis JJ, 2002, CURR HYPERTENS REP, V4, P377, DOI 10.1007/s11906-002-0067-5; Esteva-Font C, 2007, NEPHROL DIAL TRANSPL, V22, P2810, DOI 10.1093/ndt/gfm390; Feng MJ, 2009, HYPERTENSION, V54, P802, DOI 10.1161/HYPERTENSIONAHA.109.134569; Gooch JL, 2007, TRANSPLANTATION, V83, P439, DOI 10.1097/01.tp.0000251423.78124.51; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Heering PJ, 2004, CLIN TRANSPLANT, V18, P186, DOI 10.1046/j.1399-0012.2003.00154.x; Higgins R, 2004, NEPHROL DIAL TRANSPL, V19, P444, DOI 10.1093/ndt/gfg515; Hu DC, 2006, AM J MED SCI, V331, P105, DOI 10.1097/00000441-200602000-00021; Jain A, 1999, ANN SURG, V230, P441, DOI 10.1097/00000658-199909000-00016; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kim HC, 2004, TRANSPL P, V36, P2082, DOI 10.1016/j.transproceed.2004.08.006; Koomans HA, 2001, TRANSPLANTATION, V72, pS9; Madala VK, 2008, AM J PHYSIOL-RENAL, V294, pF1222, DOI 10.1152/ajprenal.00604.2007; McCormick JA, 2011, HYPERTENSION, V58, P888, DOI 10.1161/HYPERTENSIONAHA.110.167809; Melnikov S, 2011, EUR J CLIN INVEST, V41, P1113, DOI 10.1111/j.1365-2362.2011.02517.x; Mohebbi N, 2009, AM J PHYSIOL-RENAL, V297, pF499, DOI 10.1152/ajprenal.90489.2008; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; PAVER W K, 1964, Med J Aust, V2, P305; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Schindler R, 2000, NEPHROL DIAL TRANSPL, V15, P8, DOI 10.1093/ndt/15.1.8; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Segal AS, 2002, AM J PHYSIOL-RENAL, V283, pF765, DOI 10.1152/ajprenal.00253.2001; Smith KD, 2003, J AM SOC NEPHROL, V14, P1037, DOI 10.1097/01.ASN.0000057542.86377.5A; Takeda Y, 1999, HYPERTENSION, V33, P130, DOI 10.1161/01.HYP.33.1.130; Van Laecke S, 2009, AM J TRANSPLANT, V9, P2140, DOI 10.1111/j.1600-6143.2009.02752.x; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443	33	227	235	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1304	U339		10.1038/nm.2497	http://dx.doi.org/10.1038/nm.2497			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21963515	Green Accepted			2022-12-25	WOS:000296022100050
J	Boulant, S; Kural, C; Zeeh, JC; Ubelmann, F; Kirchhausen, T				Boulant, Steeve; Kural, Comert; Zeeh, Jean-Christophe; Ubelmann, Florent; Kirchhausen, Tomas			Actin dynamics counteract membrane tension during clathrin-mediated endocytosis	NATURE CELL BIOLOGY			English	Article							HUNTINGTIN-INTERACTING PROTEIN-1; POLARIZED EPITHELIAL-CELLS; CANINE KIDNEY-CELLS; COATED PITS; APICAL SURFACE; N-WASP; HIP1-RELATED PROTEIN; PLASMA-MEMBRANE; ARP2/3 COMPLEX; CYTOCHALASIN-D	Clathrin-mediated endocytosis is independent of actin dynamics in many circumstances but requires actin polymerization in others. We show that membrane tension determines the actin dependence of clathrin-coat assembly. As found previously, clathrin assembly supports formation of mature coated pits in the absence of actin polymerization on both dorsal and ventral surfaces of non-polarized mammalian cells, and also on basolateral surfaces of polarized cells. Actin engagement is necessary, however, to complete membrane deformation into a coated pit on apical surfaces of polarized cells and, more generally, on the surface of any cell in which the plasma membrane is under tension from osmotic swelling or mechanical stretching. We use these observations to alter actin dependence experimentally and show that resistance of the membrane to propagation of the clathrin lattice determines the distinction between 'actin dependent and 'actin independent'. We also find that light-chain-bound Hip1R mediates actin engagement. These data thus provide a unifying explanation for the role of actin dynamics in coated-pit budding.	[Boulant, Steeve; Kural, Comert; Zeeh, Jean-Christophe; Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Boulant, Steeve; Kural, Comert; Zeeh, Jean-Christophe; Kirchhausen, Tomas] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Boulant, Steeve; Kural, Comert; Zeeh, Jean-Christophe; Kirchhausen, Tomas] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Ubelmann, Florent] Inst Curie Paris, Lab Morphogenese & Signalisat Cellulaires, Paris 05, France	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	kirchhausen@crystal.harvard.edu	Boulant, Steeve/W-3754-2019	Boulant, Steeve/0000-0001-8614-4993; Ubelmann, Florent/0000-0002-3746-8614; Kural, Comert/0000-0002-9065-6542	NIH [GM 075252]; Harvard Digestive Disease Consortium; NIH, New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Disease Consortium; NIH, New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant National Institutes of Health GM 075252 (T.K.) and a Harvard Digestive Disease Consortium Feasibility Award (S.B.). We express gratitude to E. Marino (supported by NIH grant U54 AI057159, New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases) for maintaining the imaging resource used in this study and to S.C. Harrison for help with describing the force contributed by membrane tension and for editorial assistance. We gratefully acknowledge M. Ericsson and I. Kim for preparation of samples for electron microscopic analysis and members of the Kirchhausen laboratory for thought-provoking discussions. We thank M. Arpin (Centre National de la Recherche Scientifique (CNRS)/Morphogenese et Signalisation cellulaires, Paris, France) and C. Revenu (Centre National de la Recherche Scientifique/Institut Curie, Paris, France) for the antibody specific for villin-1. We also acknowledge S. Robine for important suggestions involving the villin-l/villin-2 depletion experiments.	Aghamohammadzadeh S, 2009, NAT CELL BIOL, V11, P1039, DOI 10.1038/ncb1918; Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Chen CY, 2005, J BIOL CHEM, V280, P6109, DOI 10.1074/jbc.M408454200; Conibear E, 2010, CURR OPIN CELL BIOL, V22, P513, DOI 10.1016/j.ceb.2010.05.009; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; CURETON DK, 2006, PLOS PATHOG, V6; da Costa SR, 2003, MOL BIOL CELL, V14, P4397, DOI 10.1091/mbc.E03-05-0315; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Fotin A, 2006, J STRUCT BIOL, V156, P453, DOI 10.1016/j.jsb.2006.07.001; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Hyman T, 2006, MOL BIOL CELL, V17, P427, DOI 10.1091/mbc.E05-05-0420; JACKMAN MR, 1994, J CELL SCI, V107, P2547; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Noireaux V, 2000, BIOPHYS J, V78, P1643, DOI 10.1016/S0006-3495(00)76716-6; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; Shmuel M, 2006, J BIOL CHEM, V281, P13300, DOI 10.1074/jbc.M513723200; Shurety W, 1996, J CELL SCI, V109, P2927; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Wilbur JD, 2008, J BIOL CHEM, V283, P32870, DOI 10.1074/jbc.M802863200	45	359	362	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1124	U158		10.1038/ncb2307	http://dx.doi.org/10.1038/ncb2307			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21841790	Green Accepted			2022-12-25	WOS:000294487000018
J	Ten Berge, D; Kurek, D; Blauwkamp, T; Koole, W; Maas, A; Eroglu, E; Siu, RK; Nusse, R				Ten Berge, Derk; Kurek, Dorota; Blauwkamp, Tim; Koole, Wouter; Maas, Alex; Eroglu, Elif; Siu, Ronald K.; Nusse, Roel			Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; SELF-RENEWAL; MOUSE DEVELOPMENT; GROUND-STATE; ES CELLS; PLURIPOTENCY; EXPRESSION; PATHWAYS; GSK-3; TCF3	Pluripotent stem cells exist in naive and primed states, epitomized by mouse embryonic stem cells (ESCs) and the developmentally more advanced epiblast stem cells (EpiSCs; ref. 1). In the naive state of ESCs, the genome has an unusual open conformation and possesses a minimum of repressive epigenetic marks(2). In contrast, EpiSCs have activated the epigenetic machinery that supports differentiation towards the embryonic cell types(3-6). The transition from naive to primed pluripotency therefore represents a pivotal event in cellular differentiation. But the signals that control this fundamental differentiation step remain unclear. We show here that paracrine and autocrine Wnt signals are essential self-renewal factors for ESCs, and are required to inhibit their differentiation into EpiSCs. Moreover, we find that Wnt proteins in combination with the cytokine LIF are sufficient to support ESC self-renewal in the absence of any undefined factors, and support the derivation of new ESC lines, including ones from non-permissive mouse strains. Our results not only demonstrate that Wnt signals regulate the naive-to-primed pluripotency transition, but also identify Wnt as an essential and limiting ESC self-renewal factor.	[Ten Berge, Derk; Kurek, Dorota] Erasmus MC, Dept Cell Biol, Erasmus MC Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands; [Ten Berge, Derk; Blauwkamp, Tim; Koole, Wouter; Eroglu, Elif; Siu, Ronald K.; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Ten Berge, Derk; Blauwkamp, Tim; Koole, Wouter; Eroglu, Elif; Siu, Ronald K.; Nusse, Roel] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Erasmus University Rotterdam; Erasmus MC; Howard Hughes Medical Institute; Stanford University; Stanford University	Ten Berge, D (corresponding author), Erasmus MC, Dept Cell Biol, Erasmus MC Stem Cell Inst, POB 2040, NL-3000 CA Rotterdam, Netherlands.	d.tenberge@erasmusmc.nl	Berge, Derk ten/ABF-2591-2020; Koole, Wouter/P-9299-2015; Berge, Derk ten/C-1967-2012	Berge, Derk ten/0000-0002-5863-0860; Koole, Wouter/0000-0002-8065-0630; Eroglu, Elif/0000-0003-3952-3178; Kurek, Dorota/0000-0002-7168-8944	Howard Hughes Medical Institute; Erasmus MC Stem Cell Institute; California Institute of Regenerative Medicine [RC1-00133-1]; National Institutes of Health [DK67834-01]; European Union [FP7-PEOPLE-2009-RG-256560]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067834] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Erasmus MC Stem Cell Institute; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the Howard Hughes Medical Institute, the Erasmus MC Stem Cell Institute and grants from the California Institute of Regenerative Medicine (RC1-00133-1), the National Institutes of Health (DK67834-01) and the European Union (FP7-PEOPLE-2009-RG-256560). We thank H. Zeng for technical advice, J. Kong-A-San for assistance with blastocyst injections and R. van der Linden for assistance with FAGS. We are grateful for the use of the Cellavista imager and the assistance of V. Vincent and Roche Diagnostics.	Acevedo N, 2007, MOL REPROD DEV, V74, P178, DOI 10.1002/mrd.20495; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gardner RL, 1997, INT J DEV BIOL, V41, P235; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Ohsugi M, 1996, DEV DYNAM, V206, P391, DOI 10.1002/(SICI)1097-0177(199608)206:4<391::AID-AJA5>3.0.CO;2-D; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	40	329	340	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1070	U88		10.1038/ncb2314	http://dx.doi.org/10.1038/ncb2314			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21841791	Green Accepted			2022-12-25	WOS:000294487000011
J	Cooley, J; Whitaker, S; Sweeney, S; Fraser, S; Davidson, B				Cooley, James; Whitaker, Stacia; Sweeney, Sarah; Fraser, Scott; Davidson, Brad			Cytoskeletal polarity mediates localized induction of the heart progenitor lineage	NATURE CELL BIOLOGY			English	Article							ASCIDIAN CIONA-INTESTINALIS; RESONANCE ENERGY-TRANSFER; CELL FATE SPECIFICATION; DROSOPHILA EMBRYOS; SIMPLE CHORDATE; ARP2/3 COMPLEX; RHO GTPASES; MEMBRANE; CDC42; WASP	Cells must make appropriate fate decisions within a complex and dynamic environment(1). In vitro studies indicate that the cytoskeleton acts as an integrative platform for this environmental input(2). External signals regulate cytoskeletal dynamics and the cytoskeleton reciprocally modulates signal transduction(3,4). However, in vivo studies linking cytoskeleton/signalling interactions to embryonic cell fate specification remain limited(5-7). Here we show that the cytoskeleton modulates heart progenitor cell fate. Our studies focus on differential induction of heart fate in the basal chordate Ciona intestinalis. We have found that differential induction does not simply reflect differential exposure to the inductive signal. Instead, pre-cardiac cells employ polarized, invasive protrusions to localize their response to an ungraded signal. Through targeted manipulation of the cytoskeletal regulator CDC42, we are able to depolarize protrusive activity and generate uniform heart progenitor fate specification. Furthermore, we are able to restore differential induction by repolarizing protrusive activity. These findings illustrate how bi-directional interactions between intercellular signalling and the cytoskeleton can influence embryonic development. In particular, these studies high light the potential for dynamic cytoskeletal changes to refine cell fate specification in response to crude signal gradients.	[Cooley, James; Whitaker, Stacia; Sweeney, Sarah; Davidson, Brad] Univ Arizona, Dept Mol & Cellular Biol, Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Sweeney, Sarah; Fraser, Scott] CALTECH, Beckman Inst, Dept Biol, Imaging Ctr, Pasadena, CA 91125 USA	University of Arizona; California Institute of Technology	Davidson, B (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Mol Cardiovasc Res Program, Tucson, AZ 85724 USA.	bjd18@email.arizona.edu	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Davidson, Brad/0000-0001-5082-7872	Caltech Beckman Institute; Beckman Foundation; AHA [0730345N]; NIH [R01HL091027]; American Recovery Act [3R01HL091027-01A1S1]; Science Foundation of Arizona; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091027, K02HL103788] Funding Source: NIH RePORTER	Caltech Beckman Institute; Beckman Foundation; AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery Act; Science Foundation of Arizona; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The ensconsin-GFP construct was generously provided by F. Robin (University of Chicago, USA), the CDC42 constructs by L. Christiaen (New York University, USA), the GPI-GFP construct by A. Gregorio (Weill Medical College of Cornell University, USA) and K. Hadjantonakis (Sloan-Kettering Institute, USA) and the FRET biosensor constructs by M. Matsuda (Osaka University, Japan) and D. Kamiyama (University of Miami, USA); the Rho constructs were designed and tested by J. Norton (University of Arizona). We would also like to thank G. Rogers and D. Buster for their advice and assistance on antibody production, M. Salanga for guidance on FRET imaging, T. Warholac for assistance with statistical analysis and M. Barnet for use of his cooling system for live-embryo imaging. We thank D. Sherwood, H. Granzier, A. Wikramanayake and the members of the U. A. Molecular Cardiovascular Research Program for their input and critical evaluation of the manuscript. Live-embryo imaging was carried out in the facilities of the Biological Imaging Center, under support from the Caltech Beckman Institute and the Beckman Foundation. The work was supported by grants to B. D. from the AHA (0730345N) and NIH (R01HL091027) along with supplemental funding from the American Recovery Act to support J. C. (3R01HL091027-01A1S1) and support for S. W. from the Science Foundation of Arizona.	Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; Coisy-Quivy M, 2006, BIOL CELL, V98, P577, DOI 10.1042/BC20060032; Corbo JC, 1997, DEVELOPMENT, V124, P589; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kamiyama D, 2009, SCIENCE, V324, P1338, DOI 10.1126/science.1170615; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Lemaire P, 2009, DEV BIOL, V332, P48, DOI 10.1016/j.ydbio.2009.05.540; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; MANZANARES MV, 2009, J CELL SCI, V122, P199; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; MUNRO E, 2006, CURR OPIN GENET DEV; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Passamaneck YJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000714; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Picco V, 2007, DEVELOPMENT, V134, P1491, DOI 10.1242/dev.003939; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; Richman TJ, 2004, CURR GENET, V45, P339, DOI 10.1007/s00294-004-0505-9; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yu L, 2008, MOL BIOL CELL, V19, P1739, DOI 10.1091/mbc.E07-08-0757; Yuseff MI, 2009, TRAFFIC, V10, P629, DOI 10.1111/j.1600-0854.2009.00913.x; Zhang X, 2008, DEV CELL, V15, P386, DOI 10.1016/j.devcel.2008.07.005	50	33	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					952	U176		10.1038/ncb2291	http://dx.doi.org/10.1038/ncb2291			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21785423	Green Accepted			2022-12-25	WOS:000293373700013
J	Pinheiro, EM; Xie, ZG; Norovich, AL; Vidaki, M; Tsai, LH; Gertler, FB				Pinheiro, Elaine M.; Xie, Zhigang; Norovich, Amy L.; Vidaki, Marina; Tsai, Li-Huei; Gertler, Frank B.			Lpd depletion reveals that SRF specifies radial versus tangential migration of pyramidal neurons	NATURE CELL BIOLOGY			English	Article							SERUM RESPONSE FACTOR; ACTIN DYNAMICS; LAMELLIPODIN; UNC-6/NETRIN; ACTIVATION; OUTGROWTH; NEOCORTEX; PATTERNS; ADHESION; GUIDANCE	During corticogenesis, pyramidal neurons (similar to 80% of cortical neurons) arise from the ventricular zone, pass through a multipolar stage to become bipolar and attach to radial glia(1,2), and then migrate to their proper position within the cortex(1,3). As pyramidal neurons migrate radially, they remain attached to their glial substrate as they pass through the subventricular and intermediate zones, regions rich in tangentially migrating interneurons and axon fibre tracts. We examined the role of lamellipodin (Lpd), a homologue of a key regulator of neuronal migration and polarization in Caenorhabditis elegans, in corticogenesis. Lpd depletion caused bipolar pyramidal neurons to adopt a tangential, rather than radial-glial, migration mode without affecting cell fate. Mechanistically, Lpd depletion reduced the activity of SRF, a transcription factor regulated by changes in the ratio of polymerized to unpolymerized actin. Therefore, Lpd depletion exposes a role for SRF in directing pyramidal neurons to select a radial migration pathway along glia rather than a tangential migration mode.	[Pinheiro, Elaine M.; Norovich, Amy L.; Vidaki, Marina; Gertler, Frank B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Xie, Zhigang] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Boston University; Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Gertler, FB (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fgertler@mit.edu		Xie, Zhigang/0000-0002-7190-992X; Vidaki, Marina/0000-0001-6706-8366; Xie, Zhigang/0000-0002-5794-2977	NRSA [F32-GM074507]; Koch Institute; NIH [GM068678]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074507, R01GM068678] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Treisman for providing DNA constructs and R. Hayman for help with graphics. E.M.P. was supported by an NRSA grant F32-GM074507. This work was supported by financial support from a Koch Institute Development award and NIH grant # GM068678 to F.B.G.; L-H.T. is an investigator of Howard Hughes Medical Institute.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Elias LAB, 2010, J NEUROSCI, V30, P7072, DOI 10.1523/JNEUROSCI.5728-09.2010; Fode C, 2000, GENE DEV, V14, P67; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Quinn CC, 2006, CURR BIOL, V16, P845, DOI 10.1016/j.cub.2006.03.025; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; SHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; VICTOROV IV, 1980, BRAIN RES, V198, P167, DOI 10.1016/0006-8993(80)90352-2; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yokota Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000794	29	28	28	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					989	U260		10.1038/ncb2292	http://dx.doi.org/10.1038/ncb2292			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21785421	Green Accepted, Green Submitted			2022-12-25	WOS:000293373700018
J	Ishiuchi, T; Takeichi, M				Ishiuchi, Takashi; Takeichi, Masatoshi			Willin and Par3 cooperatively regulate epithelial apical constriction through a PKC-mediated ROCK phosphorylation	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; CELL-POLARITY; TIGHT JUNCTION; DOMAIN SIZE; DROSOPHILA; PATHWAY; SHAPE; ADHESION; BAZOOKA; COMPLEX	Apical-domain constriction is important for regulating epithelial morphogenesis. Epithelial cells are connected by apical junctional complexes (AJCs) that are lined with circumferential actomyosin cables. The contractility of the secables is regulated by Rho-associated kinases (ROCKs). Here, we report that Willin (a FERM-domain protein) and Par3 (a polarity-regulating protein) cooperatively regulate ROCK-dependent apical constriction. We found that Willin recruits aPKC and Par6 to the AJCs, independently of Par3. Simultaneous depletion of Willin and Par3 completely removed aPKC and Par6 from the AJCs and induced apical constriction. Induced constriction was through upregulation of the level of AJC-associated ROCKs, which was due to loss of aPKC. Our results indicate that aPKC phosphorylates ROCK and suppresses its junctional localization, there by allowing cells to retain normally shaped apical domains. Thus, we have uncovered a Willin/Par3-aPKC-ROCK pathway that controls epithelial apical morphology.	[Ishiuchi, Takashi; Takeichi, Masatoshi] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ishiuchi, Takashi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	RIKEN; Kyoto University	Takeichi, M (corresponding author), RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Ishiuchi, Takashi/AAE-9742-2021; Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Ishiuchi, Takashi/0000-0001-8346-4596	Ministry of Education, Science, Sports, and Culture of Japan; RIKEN; Grants-in-Aid for Scientific Research [20002009] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to K. Shinmyozu for LC-MS/MS analysis. We thank S. Ohno and S. Yonemura for reagents; M. Nomura, H. Saitou and Y. Inoue for technical support; and T. Otani for comments on the research. This work was supported by the programme Grants-in-Aid for Specially Promoted Research of the Ministry of Education, Science, Sports, and Culture of Japan to M.T. T.I. is a recipient of the RIKEN Junior Research Associate fellowship.	Amano M, 2000, METHOD ENZYMOL, V325, P149; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Genevet A, 2009, J CELL SCI, V122, P2360, DOI 10.1242/jcs.041806; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gunn-Moore FJ, 2005, FEBS LETT, V579, P5089, DOI 10.1016/j.febslet.2005.07.097; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hamaratoglu F, 2009, J CELL SCI, V122, P2351, DOI 10.1242/jcs.046482; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; LIU YC, 1994, J NEUROSCI, V14, P5807; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Nakajima H, 2010, J CELL SCI, V123, P555, DOI 10.1242/jcs.057752; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Warner SJ, 2009, J CELL BIOL, V187, P119, DOI [10.1083/jcb.200906047, 10.1083/jcb.200901029]; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	35	84	85	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					860	U297		10.1038/ncb2274	http://dx.doi.org/10.1038/ncb2274			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21685893				2022-12-25	WOS:000292305700017
J	Kottke, T; Errington, F; Pulido, J; Galivo, F; Thompson, J; Wongthida, P; Diaz, RM; Chong, H; Ilett, E; Chester, J; Pandha, H; Harrington, K; Selby, P; Melcher, A; Vile, R				Kottke, Timothy; Errington, Fiona; Pulido, Jose; Galivo, Feorillo; Thompson, Jill; Wongthida, Phonphimon; Diaz, Rosa Maria; Chong, Heung; Ilett, Elizabeth; Chester, John; Pandha, Hardev; Harrington, Kevin; Selby, Peter; Melcher, Alan; Vile, Richard			Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors	NATURE MEDICINE			English	Article							VESICULAR STOMATITIS-VIRUS; STEM-CELL ANTIGEN; PROSTATE-CANCER; ONCOLYTIC VIRUSES; MESENCHYMAL TRANSITION; GENE-THERAPY; T-CELLS; IN-VIVO; IMMUNITY; IMMUNOTHERAPY	Effective cancer immunotherapy requires the release of a broad spectrum of tumor antigens in the context of potent immune activation. We show here that a cDNA library of normal tissue, expressed from a highly immunogenic viral platform, cures established tumors of the same histological type from which the cDNA library was derived. Immune escape occurred with suboptimal vaccination, but tumor cells that escaped the immune pressure were readily treated by second-line virus-based immunotherapy. This approach has several major advantages. Use of the cDNA library leads to presentation of a broad repertoire of (undefined) tumor-associated antigens, which reduces emergence of treatment-resistant variants and also permits rational, combined-modality approaches in the clinic. Finally, the viral vectors can be delivered systemically, without the need for tumor targeting, and are amenable to clinical-grade production. Therefore, virus-expressed cDNA libraries represent a novel paradigm for cancer treatment addressing many of the key issues that have undermined the efficacy of immuno-and virotherapy to date.	[Kottke, Timothy; Pulido, Jose; Galivo, Feorillo; Thompson, Jill; Wongthida, Phonphimon; Diaz, Rosa Maria; Vile, Richard] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Errington, Fiona; Ilett, Elizabeth; Chester, John; Selby, Peter; Melcher, Alan; Vile, Richard] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Errington, Fiona; Ilett, Elizabeth; Chester, John; Selby, Peter; Melcher, Alan; Vile, Richard] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; [Pulido, Jose] Mayo Clin, Dept Ophthalmol & Ocular Oncol, Rochester, MN USA; [Chong, Heung] St George Hosp, Sch Med, London, England; [Pandha, Hardev] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Harrington, Kevin] Inst Canc Res, London SW3 6JB, England; [Vile, Richard] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Saint James's University Hospital; University of Leeds; Cancer Research UK; Saint James's University Hospital; University of Leeds; Mayo Clinic; St Georges University London; University of Surrey; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Mayo Clinic	Vile, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	vile.richard@mayo.edu	Errington-Mais, Fiona/AAK-7245-2020	Harrington, Kevin/0000-0002-6014-348X; Melcher, Alan/0000-0002-2042-3380; Errington-Mais, Fiona/0000-0003-2155-534X; Galivo, Feorillo/0000-0002-0553-922X; Ilett, Elizabeth/0000-0002-9875-0322	Richard M. Schulze Family Foundation; Mayo Foundation, Cancer Research UK; US National Institutes of Health [R01 CA107082, R01 CA130878, R01 CA132734]; Terry and Judith Paul; NATIONAL CANCER INSTITUTE [R01CA107082, R01CA132734, R01CA130878] Funding Source: NIH RePORTER	Richard M. Schulze Family Foundation; Mayo Foundation, Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry and Judith Paul; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Higgins for secretarial assistance. This work was supported by The Richard M. Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, the US National Institutes of Health grants R01 CA107082, R01 CA130878 and R01 CA132734, and a grant from Terry and Judith Paul.	Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Braxton CL, 2010, J VIROL, V84, P3552, DOI 10.1128/JVI.01572-09; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Bridle BW, 2009, MOL THER, V17, P1814, DOI 10.1038/mt.2009.154; Cobleigh MA, 2010, J VIROL, V84, P7513, DOI 10.1128/JVI.00200-10; Daniels GA, 2004, NAT BIOTECHNOL, V22, P1125, DOI 10.1038/nbt1007; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Dumas F, 1999, INT J CANCER, V80, P799, DOI 10.1002/(SICI)1097-0215(19990315)80:6<799::AID-IJC1>3.3.CO;2-L; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Ferrone S, 2004, NAT BIOTECHNOL, V22, P1096, DOI 10.1038/nbt0904-1096; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Guevara-Patino JA, 2003, ADV CANCER RES, V90, P157, DOI 10.1016/S0065-230X(03)90005-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ilett EJ, 2009, GENE THER, V16, P689, DOI 10.1038/gt.2009.29; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Koos D, 2010, CELL IMMUNOL, V263, P138, DOI 10.1016/j.cellimm.2010.03.019; Kottke T, 2007, CANCER RES, V67, P11970, DOI 10.1158/0008-5472.CAN-07-2259; Kottke T, 2009, CANCER RES, V69, P7767, DOI 10.1158/0008-5472.CAN-09-1597; Le DT, 2010, CANCER J, V16, P304, DOI 10.1097/PPO.0b013e3181eb33d7; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Motrich RD, 2007, SCAND J IMMUNOL, V66, P217, DOI 10.1111/j.1365-3083.2007.01971.x; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Parato KA, 2009, CURR OPIN MOL THER, V11, P13; Prestwich RJ, 2008, EXPERT REV ANTICANC, V8, P1581, DOI 10.1586/14737140.8.10.1581; Prestwich RJ, 2009, CLIN CANCER RES, V15, P4374, DOI 10.1158/1078-0432.CCR-09-0334; Qiao J, 2008, NAT MED, V14, P37, DOI 10.1038/nm1681; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Sanchez-Perez L, 2007, GENE THER, V14, P998, DOI 10.1038/sj.gt.3302935; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; Sanchez-Perez L, 2006, J IMMUNOL, V177, P4168, DOI 10.4049/jimmunol.177.6.4168; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schwartz JA, 2010, J VIROL, V84, P4611, DOI 10.1128/JVI.02637-09; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Tanaka S, 2000, CANCER GENE THER, V7, P1241, DOI 10.1038/sj.cgt.7700219; Thorne SH, 2008, GENE THER, V15, P753, DOI 10.1038/gt.2008.42; Tsavaler L, 2001, CANCER RES, V61, P3760; Turk MJ, 2002, IMMUNOL REV, V188, P122, DOI 10.1034/j.1600-065X.2002.18811.x; Willmon C, 2009, MOL THER, V17, P1667, DOI 10.1038/mt.2009.194; Yang DM, 2001, CANCER RES, V61, P5857	43	79	84	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					854	U223		10.1038/nm.2390	http://dx.doi.org/10.1038/nm.2390			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21685898	Green Accepted			2022-12-25	WOS:000292500800040
J	Ocbina, PJR; Eggenschwiler, JT; Moskowitz, I; Anderson, KV				Ocbina, Polloneal Jymmiel R.; Eggenschwiler, Jonathan T.; Moskowitz, Ivan; Anderson, Kathryn V.			Complex interactions between genes controlling trafficking in primary cilia	NATURE GENETICS			English	Article							RETROGRADE INTRAFLAGELLAR TRANSPORT; ASPHYXIATING THORACIC DYSTROPHY; REPRESSOR FUNCTIONS; CYTOPLASMIC DYNEIN; HEDGEHOG; PROTEIN; MUTATIONS; CHLAMYDOMONAS; LOCALIZATION; INHERITANCE	Cilia-associated human genetic disorders are striking in the diversity of their abnormalities and their complex inheritance. Inactivation of the retrograde ciliary motor by mutations in DYNC2H1 causes skeletal dysplasias that have strongly variable expressivity. Here we define previously unknown genetic relationships between Dync2h1 and other genes required for ciliary trafficking. Mutations in mouse Dync2h1 disrupt cilia structure, block Sonic hedgehog signaling and cause midgestation lethality. Heterozygosity for Ift172, a gene required for anterograde ciliary trafficking, suppresses cilia phenotypes, Sonic hedgehog signaling defects and early lethality of Dync2h1 homozygotes. Ift122, like Dync2h1, is required for retrograde ciliary trafficking, but reduction of Ift122 gene dosage also suppresses the Dync2h1 phenotype. These genetic interactions illustrate the cell biology underlying ciliopathies and argue that mutations in intraflagellar transport genes cause their phenotypes because of their roles in cilia architecture rather than direct roles in signaling.	[Ocbina, Polloneal Jymmiel R.; Anderson, Kathryn V.] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Ocbina, Polloneal Jymmiel R.] Cornell Univ, Weill Grad Sch Med Sci, Neurosci Program, New York, NY 10021 USA; [Eggenschwiler, Jonathan T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Moskowitz, Ivan] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Moskowitz, Ivan] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Princeton University; University of Chicago; University of Chicago	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY USA.	k-anderson@sloankettering.edu		Anderson, Kathryn/0000-0003-1657-2161; Moskowitz, Ivan/0000-0003-0014-4963; eggenschwiler, jonathan/0000-0001-6444-8865	National Institute of Child Health and Human Development; US National Institutes of Health [R01 NS044385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Vallee (Columbia University College of Physicians and Surgeons) for the Dync2h1 antibody, R. Rohatgi and M. Scott (Stanford University) for expression constructs used to generate antibodies against Smo and Ptch1, and S. Weatherbee for help in antibody production. We thank B. Yoder (University of Alabama at Birmingham) for the mouse Ift88 conditional allele and A. Joyner (Memorial Sloan-Kettering Cancer Center (MSKCC)) for Gli2 and Gli3<SUP>XtJ</SUP> mice. We acknowledge N. Lampen (MSKCC Electron Microscopy Facility) for technical support with scanning electron microscopy; Z. Lazar, Y. Romin and S. Fujisawa (MSKCC Molecular Cytology Core) for assistance with confocal microscopy and MetaMorph analysis, and S. Galdeen (Rockefeller University Bio-Imaging Resource Center) for assistance with DeltaVision microscopy. We are grateful to members of the Anderson lab and Timothy Bestor (Columbia University Medical Center) for helpful discussions and critical reading of the manuscript. We obtained monoclonal antibodies from the Developmental Studies Hybridoma Bank, which was developed under the auspices of the National Institute of Child Health and Human Development and is maintained by the Department of Biological Sciences, University of Iowa. This work was supported by the US National Institutes of Health R01 NS044385 to K.V.A.	Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Kamp A, 2010, HUM MOL GENET, V19, P3105, DOI 10.1093/hmg/ddq211; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Mo R, 1997, DEVELOPMENT, V124, P113; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006	48	133	137	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					547	U75		10.1038/ng.832	http://dx.doi.org/10.1038/ng.832			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21552265	Green Accepted			2022-12-25	WOS:000291017000011
J	Temkin, P; Lauffer, B; Jager, S; Cimermancic, P; Krogan, NJ; von Zastrow, M				Temkin, Paul; Lauffer, Ben; Jaeger, Stefanie; Cimermancic, Peter; Krogan, Nevan J.; von Zastrow, Mark			SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors	NATURE CELL BIOLOGY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; TRANS-GOLGI NETWORK; MANNOSE 6-PHOSPHATE RECEPTOR; MAMMALIAN RETROMER; TGN TRANSPORT; RAB GTPASES; PROTEINS; IDENTIFICATION; RETRIEVAL; COMPLEX	Endocytic sorting of signalling receptors between recycling and degradative pathways is a key cellular process controlling the surface complement of receptors and, accordingly, the cell's ability to respond to specific extracellular stimuli. The beta 2 adrenergic receptor (beta 2AR) is a prototypical seven-transmembrane signalling receptor that recycles rapidly and efficiently to the plasma membrane after ligand-induced endocytosis. beta 2AR recycling is dependent on the receptor's carboxy-terminal PDZ ligand and Rab4 (refs 1,2). This active sorting process is required for functional resensitization of beta 2AR-mediated signalling(3,4). Here we show that sequence-directed sorting occurs at the level of entry into retromer tubules and that retromer tubules are associated with Rab4. Furthermore, we show that sorting nexin 27 (SNX27) serves as an essential adaptor protein linking beta 2ARs to the retromer tubule. SNX27 does not seem to directly interact with the retromer core complex, but does interact with the retromer-associated Wiskott Aldrich syndrome protein and SCAR homologue (WASH) complex. The present results identify a role for retromer in endocytic trafficking of signalling receptors, in regulating a receptor-linked signalling pathway, and in mediating direct endosome-to-plasma membrane traffic.	[Temkin, Paul; Lauffer, Ben; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Jaeger, Stefanie; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Cimermancic, Peter] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu	Temkin, Paul A/F-9262-2011		National Institutes of Health; National Science Foundation;  [P41RR001614]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012864, R37DA010711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Padilla, J. Bonifacino, Y. Prabhu, N. Gulbahce, S. Duleh, M. Welch, R. Rojas, J. Hislop, M. Puthenveedu, K. Mostov, J. Weissman, K. Thorn, the Nikon Imaging Center, A. Burlingame and the UCSF Mass Spectrometry facility (supported by P41RR001614) for reagents, advice, technical training and support. Last, we thank H. Bourne and M. Ray for critical readings of the manuscript. This work was supported by research grants from the National Institutes of Health. P.T. was supported by the National Science Foundation. N.J.K. is a Searle and Keck Young Investigator Fellow.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, CURR BIOL, V15, pR819, DOI 10.1016/j.cub.2005.10.012; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Holmes KD, 2006, J NEUROCHEM, V96, P934, DOI 10.1111/j.1471-4159.2005.03603.x; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; VEHN JK, 2008, P NATL ACAD SCI USA, V105, P17812; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747	44	338	349	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					715	U199		10.1038/ncb2252	http://dx.doi.org/10.1038/ncb2252			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21602791	Green Submitted, Green Accepted			2022-12-25	WOS:000291147400013
J	Bochkov, YA; Palmenberg, AC; Lee, WM; Rathe, JA; Amineva, SP; Sun, X; Pasic, TR; Jarjour, NN; Liggett, SB; Gern, JE				Bochkov, Yury A.; Palmenberg, Ann C.; Lee, Wai-Ming; Rathe, Jennifer A.; Amineva, Svetlana P.; Sun, Xin; Pasic, Thomas R.; Jarjour, Nizar N.; Liggett, Stephen B.; Gern, James E.			Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C	NATURE MEDICINE			English	Article							RECEPTOR; SEQUENCE; EXACERBATIONS; SEROTYPES; ILLNESSES; FEATURES; GENOME	A recently recognized human rhinovirus species C (HRV-C) is associated with up to half of HRV infections in young children. Here we propagated two HRV-C isolates ex vivo in organ culture of nasal epithelial cells, sequenced a new C15 isolate and developed the first, to our knowledge, reverse genetics system for HRV-C. Using contact points for the known HRV receptors, intercellular adhesion molecule-1 (ICAM-1) and low-density lipoprotein receptor (LDLR), inter-and intraspecies footprint analyses predicted a unique cell attachment site for HRV-Cs. Antibodies directed to binding sites for HRV-A and -B failed to inhibit HRV-C attachment, consistent with the alternative receptor footprint. HRV-A and HRV-B infected HeLa and WisL cells but HRV-C did not. However, HRV-C RNA synthesized in vitro and transfected into both cell types resulted in cytopathic effect and recovery of functional virus, indicating that the viral attachment mechanism is a primary distinguishing feature of HRV-C.	[Bochkov, Yury A.; Lee, Wai-Ming; Amineva, Svetlana P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Rathe, Jennifer A.; Liggett, Stephen B.] Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Pasic, Thomas R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI USA; [Jarjour, Nizar N.; Gern, James E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland Baltimore; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bochkov, YA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA.	yabochkov@wisc.edu	liggett, stephen b/E-7453-2012	Bochkov, Yury/0000-0003-2618-4496; Liggett, Stephen B./0000-0002-0128-3669	US National Institutes of Health [U19 AI070503, U19 AI070503-04S1, R01 HL080412, R01 HL091490]; University of Maryland School of Medicine Genome Sequencing Center for Infectious Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080412, R01HL091490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland School of Medicine Genome Sequencing Center for Infectious Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Heatley, G. Hartig and J.S. McMurray (University of Wisconsin-Madison) for providing surgical samples and R. Brockman-Schneider, R. Vrtis, T. Pappas, G. Crisafi, M. Hill, J. Bork, R. Massey, A. Lashua and E. Domyan for technical assistance. This work was supported by US National Institutes of Health grants U19 AI070503, U19 AI070503-04S1, R01 HL080412 and R01 HL091490 and the National Institute of Allergy and Infectious Diseases-funded University of Maryland School of Medicine Genome Sequencing Center for Infectious Disease.	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Arden KE, 2010, J CLIN VIROL, V47, P219, DOI 10.1016/j.jcv.2010.01.001; Arden KE, 2010, REV MED VIROL, V20, P156, DOI 10.1002/rmv.644; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Briese T, 2008, EMERG INFECT DIS, V14, P944, DOI 10.3201/eid1406.080271; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Gern JE, 1999, CLIN MICROBIOL REV, V12, P9, DOI 10.1128/CMR.12.1.9; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Laine P, 2006, J GEN VIROL, V87, P129, DOI 10.1099/vir.0.81137-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; LEE WM, 1995, VIRUS GENES, V9, P177, DOI 10.1007/BF01702661; Lee WM, 2003, J VIROL, V77, P6235, DOI 10.1128/JVI.77.11.6235-6244.2003; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Mackay IM, 2008, EMERG INFECT DIS, V14, P1823, DOI 10.3201/eid1411.080725; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; McManus TE, 2008, RESP MED, V102, P1575, DOI 10.1016/j.rmed.2008.06.006; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Reischl A, 2001, J VIROL, V75, P9312, DOI 10.1128/JVI.75.19.9312-9319.2001; ROSSMANN MG, 1988, VIROLOGY, V164, P373, DOI 10.1016/0042-6822(88)90550-8; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Weber C, 2009, FEBS LETT, V583, P2547, DOI 10.1016/j.febslet.2009.07.015; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004; Zhao R, 1996, STRUCTURE, V4, P1205, DOI 10.1016/S0969-2126(96)00128-1	40	139	144	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					627	U152		10.1038/nm.2358	http://dx.doi.org/10.1038/nm.2358			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21483405	Green Accepted, Green Published			2022-12-25	WOS:000290250400041
J	Rabani, M; Levin, JZ; Fan, L; Adiconis, X; Raychowdhury, R; Garber, M; Gnirke, A; Nusbaum, C; Hacohen, N; Friedman, N; Amit, I; Regev, A				Rabani, Michal; Levin, Joshua Z.; Fan, Lin; Adiconis, Xian; Raychowdhury, Raktima; Garber, Manuel; Gnirke, Andreas; Nusbaum, Chad; Hacohen, Nir; Friedman, Nir; Amit, Ido; Regev, Aviv			Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; MICROARRAY ANALYSIS; STABILITY; SEQUENCE; TRANSCRIPTOMES; RECONSTRUCTION; ACTIVATION; DATABASE; REVEALS; INTRON	Cellular RNA levels are determined by the interplay of RNA production, processing and degradation. However, because most studies of RNA regulation do not distinguish the separate contributions of these processes, little is known about how they are temporally integrated. Here we combine metabolic labeling of RNA at high temporal resolution with advanced RNA quantification and computational modeling to estimate RNA transcription and degradation rates during the response of mouse dendritic cells to lipopolysaccharide. We find that changes in transcription rates determine the majority of temporal changes in RNA levels, but that changes in degradation rates are important for shaping sharp 'peaked' responses. We used sequencing of the newly transcribed RNA population to estimate temporally constant RNA processing and degradation rates genome wide. Degradation rates vary significantly between genes and contribute to the observed differences in the dynamic response. Certain transcripts, including those encoding cytokines and transcription factors, mature faster. Our study provides a quantitative approach to study the integrative process of RNA regulation.	[Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci, Jerusalem, Israel; [Rabani, Michal; Levin, Joshua Z.; Fan, Lin; Adiconis, Xian; Raychowdhury, Raktima; Garber, Manuel; Gnirke, Andreas; Nusbaum, Chad; Hacohen, Nir; Amit, Ido; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA USA; [Rabani, Michal] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Friedman, N (corresponding author), Hebrew Univ Jerusalem, Sch Comp Sci, Jerusalem, Israel.	nir@cs.huji.ac.il; iamit@broadinstitute.org; aregev@broad.mit.edu	Friedman, Nir/H-9692-2012	Friedman, Nir/0000-0002-9678-3550; Levin, Joshua/0000-0002-0170-3598	Human Frontiers Science Program; Howard Hughes Medical Institute; National Institutes of Health [DP1-00003958-01]; Burroughs Wellcome Fund; Merkin Foundation for Stem Cell Research at the Broad Institute; US-Israel Bi-national Science Foundation; EU; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230, DP1OD003958] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Merkin Foundation for Stem Cell Research at the Broad Institute; US-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); EU(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Schwartz for assistance in analyzing splicing signals, J. Bochicchio for project management and the Broad Sequencing Platform for all sequencing work. I. A. was supported by the Human Frontiers Science Program. Work was supported by the Howard Hughes Medical Institute, a National Institutes of Health PIONEER DP1-00003958-01 award, a Burroughs Wellcome Fund Career Award at the Scientific Interface and the Merkin Foundation for Stem Cell Research at the Broad Institute (A. R.) by a US-Israel Bi-national Science Foundation award (N.F. and A. R.) and the EU FP7 "MODEL-IN" consortium grant (N.F.)	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Barenco M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.84; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chechik G, 2009, J COMPUT BIOL, V16, P279, DOI 10.1089/cmb.2008.13TT; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Clement JQ, 1999, RNA, V5, P206, DOI 10.1017/S1355838299981190; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Friedel CC, 2009, MOL BIOSYST, V5, P1271, DOI 10.1039/b911233b; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HODGES JL, 1970, BASIC CONCEPTS PROBA; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim HC, 2001, MOL CELLS, V11, P198; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang RS, 2007, MOL CELLS, V24, P307; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164	50	376	384	2	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					436	U237		10.1038/nbt.1861	http://dx.doi.org/10.1038/nbt.1861			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21516085	Green Accepted, Green Submitted			2022-12-25	WOS:000290301700024
J	Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; McCarthy, S; Fantin, VR; Straley, KS; Lobo, S; Aston, W; Green, CL; Gale, RE; Tirabosco, R; Futreal, A; Campbell, P; Presneau, N; Flanagan, AM				Amary, M. Fernanda; Damato, Stephen; Halai, Dina; Eskandarpour, Malihe; Berisha, Fitim; Bonar, Fiona; McCarthy, Stan; Fantin, Valeria R.; Straley, Kimberly S.; Lobo, Samira; Aston, Will; Green, Claire L.; Gale, Rosemary E.; Tirabosco, Roberto; Futreal, Andrew; Campbell, Peter; Presneau, Nadege; Flanagan, Adrienne M.			Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2	NATURE GENETICS			English	Article							ENCHONDROMATOSIS; GLIOMA	Ollier disease and Maffucci syndrome are characterized by multiple central cartilaginous tumors that are accompanied by soft tissue hemangiomas in Maffucci syndrome. We show that in 37 of 40 individuals with these syndromes, at least one tumor has a mutation in isocitrate dehydrogenase 1 (IDH1) or in IDH2, 65% of which result in a R132C substitution in the protein. In 18 of 19 individuals with more than one tumor analyzed, all tumors from a given individual shared the same IDH1 mutation affecting Arg132. In 2 of 12 subjects, a low level of mutated DNA was identified in non-neoplastic tissue. The levels of the metabolite 2HG were measured in a series of central cartilaginous and vascular tumors, including samples from syndromic and nonsyndromic subjects, and these levels correlated strongly with the presence of IDH1 mutations. The findings are compatible with a model in which IDH1 or IDH2 mutations represent early post-zygotic occurrences in individuals with these syndromes.	[Amary, M. Fernanda; Damato, Stephen; Halai, Dina; Berisha, Fitim; Lobo, Samira; Tirabosco, Roberto; Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp Natl Hlth Serv Trust, Histopathol Unit, Stanmore, Middx, England; [Eskandarpour, Malihe; Green, Claire L.; Gale, Rosemary E.; Presneau, Nadege; Flanagan, Adrienne M.] Univ Coll London Canc Inst, London, England; [Bonar, Fiona] Douglass Hanly Moir Pathol, Sydney, NSW, Australia; [McCarthy, Stan] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Fantin, Valeria R.; Straley, Kimberly S.] Agios Pharmaceut, Cambridge, MA USA; [Aston, Will] Royal Natl Orthopaed Hosp Natl Hlth Serv Trust, Bone Tumour Unit, Stanmore, Middx, England; [Futreal, Andrew; Campbell, Peter] Wellcome Trust Sanger Inst, Cambridge, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; University of Sydney; Agios Pharmaceuticals; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Wellcome Trust Sanger Institute	Flanagan, AM (corresponding author), Royal Natl Orthopaed Hosp Natl Hlth Serv Trust, Histopathol Unit, Stanmore, Middx, England.	a.flanagan@ucl.ac.uk	Amary, Fernanda/AAI-7339-2020; Pillay, Nischalan/F-9536-2012; SHAKOORI, ABDUL RAUF/Q-9373-2019	Flanagan, Adrienne/0000-0002-2832-1303	Skeletal Cancer Action Trust (SCAT) UK; Bone Cancer Research Trust UK; Wellcome Trust [WT077012]	Skeletal Cancer Action Trust (SCAT) UK; Bone Cancer Research Trust UK; Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to the individuals who participated in the research and to the clinicians and support staff in the London Sarcoma Service involved in their care. The research was funded by Skeletal Cancer Action Trust (SCAT) UK, The Bone Cancer Research Trust UK and The Wellcome Trust (WT077012). This research was part of the Royal National Othopaedic Hospital Musculoskeletal Research Programme and Biobank and the University College London Hospital and University College London Comprehensive Biomedical Research Programme.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pansuriya TC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-2; Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557; Preusser M, 2011, J NEUROPATH EXP NEUR, V70, P715, DOI 10.1097/NEN.0b013e31822713f0; Unni K K, 2001, J Orthop Sci, V6, P457, DOI 10.1007/s007760170015	11	249	275	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1262	U129		10.1038/ng.994	http://dx.doi.org/10.1038/ng.994			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22057236				2022-12-25	WOS:000297931400024
J	Li, YB; Fan, CC; Xing, YZ; Jiang, YH; Luo, LJ; Sun, L; Shao, D; Xu, CJ; Li, XH; Xiao, JH; He, YQ; Zhang, QF				Li, Yibo; Fan, Chuchuan; Xing, Yongzhong; Jiang, Yunhe; Luo, Lijun; Sun, Liang; Shao, Di; Xu, Chunjue; Li, Xianghua; Xiao, Jinghua; He, Yuqing; Zhang, Qifa			Natural variation in GS5 plays an important role in regulating grain size and yield in rice	NATURE GENETICS			English	Article							PLANT-CELL CYCLE; TOMATO FRUIT SIZE; JAPONICA RICE; GENETIC-BASIS; MAJOR QTL; T-DNA; ENCODES; WEIGHT; HYBRID; WIDTH	Increasing crop yield is one of the most important goals of plant science research. Grain size is a major determinant of grain yield in cereals and is a target trait for both domestication and artificial breeding(1). We showed that the quantitative trait locus (QTL) GS5 in rice controls grain size by regulating grain width, filling and weight. GS5 encodes a putative serine carboxypeptidase and functions as a positive regulator of grain size, such that higher expression of GS5 is correlated with larger grain size. Sequencing of the promoter region in 51 rice accessions from a wide geographic range identified three haplotypes that seem to be associated with grain width. The results suggest that natural variation in GS5 contributes to grain size diversity in rice and may be useful in improving yield in rice and, potentially, other crops(2).	[Li, Yibo; Fan, Chuchuan; Xing, Yongzhong; Jiang, Yunhe; Luo, Lijun; Sun, Liang; Shao, Di; Xu, Chunjue; Li, Xianghua; Xiao, Jinghua; He, Yuqing; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Li, Yibo; Fan, Chuchuan; Xing, Yongzhong; Jiang, Yunhe; Luo, Lijun; Sun, Liang; Shao, Di; Xu, Chunjue; Li, Xianghua; Xiao, Jinghua; He, Yuqing; Zhang, Qifa] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	He, YQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yqhe@mail.hzau.edu.cn; qifazh@mail.hzau.edu.cn	Li, Yibo/F-4304-2011; Li, Yibo/ABG-8178-2020	Sun, Liang/0000-0001-7851-9329; Jiang, Yunhe/0000-0002-7599-1422; Xing, Yongzhong/0000-0003-1376-1514; Li, Yibo/0000-0001-6105-1969; Fan, Chuchuan/0000-0001-8443-7194	National 863 Project; National Program on the Development of Basic Research; National Program on RAMP;D of Transgenic Plants; National Natural Science Foundation of China; Bill AMP; Melinda Gates Foundation; National 863 Project; National Program on the Development of Basic Research; National Program on RAMP;D of Transgenic Plants; National Natural Science Foundation of China; Bill AMP; Melinda Gates Foundation	National 863 Project(National High Technology Research and Development Program of China); National Program on the Development of Basic Research(National Basic Research Program of China); National Program on RAMP;D of Transgenic Plants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bill AMP; Melinda Gates Foundation; National 863 Project(National High Technology Research and Development Program of China); National Program on the Development of Basic Research(National Basic Research Program of China); National Program on RAMP;D of Transgenic Plants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bill AMP; Melinda Gates Foundation	We thank J. Hu, H. Du, W. Dong and G. Gao for their help and suggestions, and G. An (Kyung Hee University, Crop Biotech Institute, Republic of Korea) for the mutant line. This work was supported by grants from the National 863 Project, the National Program on the Development of Basic Research, the National Program on R&D of Transgenic Plants, the National Natural Science Foundation of China and the Bill & Melinda Gates Foundation.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Francis D, 2007, NEW PHYTOL, V174, P261, DOI 10.1111/j.1469-8137.2007.02038.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Li JX, 2000, THEOR APPL GENET, V101, P248, DOI 10.1007/s001220051476; Li SB, 2009, PLANT J, V58, P592, DOI 10.1111/j.1365-313X.2009.03799.x; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu JP, 2003, PLANT PHYSIOL, V132, P292, DOI 10.1104/pp.102.018143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104	36	598	753	19	328	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1266	+		10.1038/ng.977	http://dx.doi.org/10.1038/ng.977			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019783				2022-12-25	WOS:000297931400025
J	Mateescu, B; Batista, L; Cardon, M; Gruosso, T; de Feraudy, Y; Mariani, O; Nicolas, A; Meyniel, JP; Cottu, P; Sastre-Garau, X; Mechta-Grigoriou, F				Mateescu, Bogdan; Batista, Luciana; Cardon, Melissa; Gruosso, Tina; de Feraudy, Yvan; Mariani, Odette; Nicolas, Andre; Meyniel, Jean-Philippe; Cottu, Paul; Sastre-Garau, Xavier; Mechta-Grigoriou, Fatima			miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION PROFILES; CANCER-CELLS; E-CADHERIN; P38 MAPK; GENE-EXPRESSION; REPRESSORS ZEB1; TARGETING ZEB1; MESSENGER-RNA; FAMILY	Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38 alpha and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38 alpha deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38 alpha and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.	[Mateescu, Bogdan; Batista, Luciana; Cardon, Melissa; Gruosso, Tina; de Feraudy, Yvan; Mechta-Grigoriou, Fatima] Inst Curie, Stress & Canc Lab, Paris, France; [Mateescu, Bogdan; Batista, Luciana; Cardon, Melissa; Gruosso, Tina; de Feraudy, Yvan; Mechta-Grigoriou, Fatima] INSERM, U830, Paris, France; [Mariani, Odette; Nicolas, Andre; Sastre-Garau, Xavier] Inst Curie, Dept Pathol, Paris, France; [Cottu, Paul] Inst Curie, Dept Med Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Mechta-Grigoriou, F (corresponding author), Inst Curie, Stress & Canc Lab, Paris, France.	fatima.mechta-grigoriou@curie.fr	Mateescu, bogdan/A-3101-2014; Cottu, Paul/ABC-8595-2020; MECHTA-GRIGORIOU, Fatima/C-5253-2017; mateescu, bogdan/C-5194-2012	Mateescu, bogdan/0000-0002-0937-352X; MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; mateescu, bogdan/0000-0002-0937-352X; MEYNIEL, Jean-Philippe/0000-0003-0222-3198; Sastre-Garau, Xavier/0000-0001-5992-2083; Cardon, Melissa/0000-0001-9906-3236	Institut National de la Sante et de la Recherche Medicale; Institut Curie; Ligue Nationale Contre le Cancer; Institut National du Cancer; Association pour la Recherche Contre le Cancer; INSERM	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank O. Delattre and S. Chanock for fruitful discussions and comments on the manuscript. We acknowledge S. Alran and B. Baranger (Surgery Department of Institut Curie) and the Biological Resource Center of Institut Curie for providing human ovarian tumors and B. Hasselain and D. Hajage for advice regarding our statistical analyses. We thank the members of the animal facility and the flow-cytometry platform of Institut Curie for their expertise. The experimental work was supported by grants from Institut National de la Sante et de la Recherche Medicale, the Institut Curie, the Ligue Nationale Contre le Cancer, the Institut National du Cancer and the Association pour la Recherche Contre le Cancer. B.M. was supported by a post-doctoral fellowship from the INSERM Avenir program and the Association pour la Recherche Contre le Cancer.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Konstantinopoulos PA, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-59; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Laurent G, 2008, CELL METAB, V7, P113, DOI 10.1016/j.cmet.2007.12.010; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Meyniel Jean-Philippe, 2010, BMC Cancer, V10, P222, DOI 10.1186/1471-2407-10-222; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; van Jaarsveld MTM, 2010, INT J BIOCHEM CELL B, V42, P1282, DOI 10.1016/j.biocel.2010.01.014; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang Z, 2010, BRAIN RES, V1346, P14, DOI 10.1016/j.brainres.2010.05.059; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	60	368	383	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1627	U144		10.1038/nm.2512	http://dx.doi.org/10.1038/nm.2512			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101765				2022-12-25	WOS:000297978000034
J	Meunier, S; Vernos, I				Meunier, Sylvain; Vernos, Isabelle			K-fibre minus ends are stabilized by a RanGTP-dependent mechanism essential for functional spindle assembly	NATURE CELL BIOLOGY			English	Article							KINETOCHORE-MICROTUBULE DYNAMICS; XENOPUS EGG EXTRACTS; MITOTIC-SPINDLE; CHROMOSOME CONGRESSION; CENTROMERIC MCAK; IMPORTIN-ALPHA; HELA-CELLS; PLUS-END; AURORA-A; PROTEIN	Chromosome segregation requires the formation of K-fibres, microtubule bundles that attach sister kinetochores to spindle poles. Most K-fibre microtubules originate around the chromosomes through a non-centrosomal RanGTP-dependent pathway and become oriented with the plus ends attached to the kinetochore and the minus ends focused at the spindle poles. The capture and stabilization of microtubule plus ends at the kinetochore has been extensively studied but very little is known on how their minus-end dynamics are controlled. Here we show that MCRS1 is a RanGTP-regulated factor essential for non-centrosomal microtubule assembly. MCRS1 localizes to the minus ends of chromosomal microtubules and K-fibres, where it protects them from depolymerization. Our data reveal the existence of a mechanism that stabilizes the minus ends of chromosomal microtubules and K-fibres, and is essential for the assembly of a functional bipolar spindle.	[Meunier, Sylvain; Vernos, Isabelle] Univ Pompeu Fabra, CRG, Cell & Dev Biol Program, Barcelona 08003, Spain; [Vernos, Isabelle] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Vernos, I (corresponding author), Univ Pompeu Fabra, CRG, Cell & Dev Biol Program, Barcelona 08003, Spain.	isabelle.vernos@crg.eu	Vernos, Isabelle/C-1687-2015; Meunier, Sylvain/H-7078-2015	Vernos, Isabelle/0000-0003-1469-9214; Meunier, Sylvain/0000-0003-1696-9265	Spanish MEC; MICINN [BFU2006-04694, BFU2009-10202, CSD2006-00023]; ICREA Funding Source: Custom	Spanish MEC(Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); ICREA(ICREA)	We thank S. Gross for statistical analysis of data; M. Mendoza, J. Solon, T. Surrey and the Vernos laboratory's members for helpful discussions and critical comments on the manuscript; P. Meraldi for the gift of the H2B-eGFP/alpha-tubulin-mRFP and H2B-RFP/PA-GFP-tubulin HeLa cell lines and anti-Mad l antibodies, A. Khodjakov for the gift of the GFP-centrin-1 HeLa cell line and S. Rybina and E. Karsenti for the gift of purified MCAK and anti-MCAK antibodies. M. Sanz, N. Mallol, V. Beltran-Sastre and L. Avila provided technical assistance. We thank the Advanced Light Microscopy Unit of the CRG for microscopy support. This work was funded by grants from the Spanish MEC and MICINN BFU2006-04694, BFU2009-10202 and CSD2006-00023.	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Goodwin SS, 2010, CELL, V143, P263, DOI 10.1016/j.cell.2010.09.022; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hirohashi Y, 2006, ONCOGENE, V25, P4937, DOI 10.1038/sj.onc.1209500; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kops GJPL, 2010, CELL MOL LIFE SCI, V67, P2145, DOI 10.1007/s00018-010-0321-y; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maresca TJ, 2009, CURR BIOL, V19, P1210, DOI 10.1016/j.cub.2009.05.061; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Ren Y, 1998, EUR J BIOCHEM, V253, P734, DOI 10.1046/j.1432-1327.1998.2530734.x; Rizk RS, 2009, MOL BIOL CELL, V20, P1639, DOI 10.1091/mbc.E08-09-0985; Rogers GC, 2005, J CELL SCI, V118, P1105, DOI 10.1242/jcs.02284; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sardon T, 2008, EMBO J, V27, P2567, DOI 10.1038/emboj.2008.173; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shimono K, 2005, J BIOL CHEM, V280, P39436, DOI 10.1074/jbc.M507356200; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120	52	70	70	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1406	U237		10.1038/ncb2372	http://dx.doi.org/10.1038/ncb2372			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	22081094				2022-12-25	WOS:000298157500007
J	Nakashima, T; Hayashi, M; Fukunaga, T; Kurata, K; Oh-Hora, M; Feng, JQ; Bonewald, LF; Kodama, T; Wutz, A; Wagner, EF; Penninger, JM; Takayanagi, H				Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Kurata, Kosaku; Oh-hora, Masatsugu; Feng, Jian Q.; Bonewald, Lynda F.; Kodama, Tatsuhiko; Wutz, Anton; Wagner, Erwin F.; Penninger, Josef M.; Takayanagi, Hiroshi			Evidence for osteocyte regulation of bone homeostasis through RANKL expression	NATURE MEDICINE			English	Article							OSTEOBLASTS; MECHANISMS; RECEPTOR; MOUSE	Osteocytes embedded in bone have been postulated to orchestrate bone homeostasis by regulating both bone-forming osteoblasts and bone-resorbing osteoclasts. We find here that purified osteocytes express a much higher amount of receptor activator of nuclear factor-kappa B ligand (RANKL) and have a greater capacity to support osteoclastogenesis in vitro than osteoblasts and bone marrow stromal cells. Furthermore, the severe osteopetrotic phenotype that we observe in mice lacking RANKL specifically in osteocytes indicates that osteocytes are the major source of RANKL in bone remodeling in vivo.	[Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Bunkyo Ku, Tokyo, Japan; [Kurata, Kosaku] Kyushu Univ, Fac Engn, Dept Mech Engn, Nishi Ku, Fukuoka 812, Japan; [Feng, Jian Q.] Baylor Coll Dent, Dept Biomed Sci, Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA; [Bonewald, Lynda F.] Univ Missouri, Dept Oral Biol, Kansas City, MO 64110 USA; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Mol Biol & Med, Tokyo, Japan; [Wutz, Anton] Univ Cambridge, Dept Biochem, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QW, England; [Wagner, Erwin F.] Spanish Natl Canc Ctr, Genes Dev & Dis Grp, Banco Bilbao Vizcaya Argentaria Fdn, Canc Cell Biol Program, Madrid, Spain; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Takayanagi, Hiroshi] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Perth, WA 6009, Australia	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Kyushu University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Missouri System; University of Missouri Kansas City; University of Tokyo; University of Cambridge; Centro Nacional de Investigaciones Oncologicas (CNIO); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Western Australia	Nakashima, T (corresponding author), Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan.	taka.csi@tmd.ac.jp	Penninger, Josef M/I-6860-2013; Bonewald, Lynda/Q-3638-2019	Penninger, Josef M/0000-0002-8194-3777; Wagner, Erwin F/0000-0001-7872-0196	Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokyo Biochemical Research Foundation; Life Science Foundation of Japan; Takeda Science Foundation; Uehara Memorial Foundation; Nakatomi Foundation; Nagao Memorial Foundation; Kowa Life Science Foundation; Naito Foundation; Ichiro Kanehara Foundation; Senri Life Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22021014] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Nagao Memorial Foundation; Kowa Life Science Foundation; Naito Foundation(Naito Memorial Foundation); Ichiro Kanehara Foundation; Senri Life Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to J. Miyazaki for providing CAG-CAT-EGFP transgenic mice and U. Mohle-Steinlein for assisting the generation of A9 embryonic stem cells. We thank S. Fukuse, T. Suda-Kayamori, T. Nishioka-Honda, T. Ando, Y. Kunisawa, E. Idrus, K. Nishikawa, H. Inoue, K. Okamoto, T. Negishi-Koga, M. Shinohara, L. Bakiri,. Uluckan, N. Amizuka, K. Kayamori, A. Yamaguchi and S. Iseki for discussion and assistance. We also thank T. Wada, H. Hara, Y. Nakashima, R. Hanada, T. Hanada, A. Leibbrant, S. J. Cronin, G. G. Neely, N. Joza, J. A. Pospisilik and A. Meixner for technical assistance. This work was supported in part by a grant for the Exploratory Research for Advanced Technology Program, the Takayanagi Osteonetwork Project from the Japan Science and Technology Agency; Grant-in-Aids for Young Scientist A from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Challenging Exploratory Research from the JSPS; grants for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and grants from the Tokyo Biochemical Research Foundation, the Life Science Foundation of Japan, Takeda Science Foundation, Uehara Memorial Foundation, Nakatomi Foundation, Nagao Memorial Foundation, Kowa Life Science Foundation, Naito Foundation, Ichiro Kanehara Foundation, Senri Life Science Foundation and Astellas Foundation for Research on Metabolic Disorders.	Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hanada R, 2011, J MOL MED, V89, P647, DOI 10.1007/s00109-011-0749-z; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Martin T. J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P243; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062	20	1101	1150	12	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1231	1234		10.1038/nm.2452	http://dx.doi.org/10.1038/nm.2452			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21909105				2022-12-25	WOS:000296022100040
J	Burgett, AWG; Poulsen, TB; Wangkanont, K; Anderson, DR; Kikuchi, C; Shimada, K; Okubo, S; Fortner, KC; Mimaki, Y; Kuroda, M; Murphy, JP; Schwalb, DJ; Petrella, EC; Cornella-Taracido, I; Schirle, M; Tallarico, JA; Shair, MD				Burgett, Anthony W. G.; Poulsen, Thomas B.; Wangkanont, Kittikhun; Anderson, D. Ryan; Kikuchi, Chikako; Shimada, Kousei; Okubo, Shuichi; Fortner, Kevin C.; Mimaki, Yoshihiro; Kuroda, Minpei; Murphy, Jason P.; Schwalb, David J.; Petrella, Eugene C.; Cornella-Taracido, Ivan; Schirle, Markus; Tallarico, John A.; Shair, Matthew D.			Natural products reveal cancer cell dependence on oxysterol-binding proteins	NATURE CHEMICAL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; CHOLESTANE GLYCOSIDES; STEROL-BINDING; TUMOR-CELLS; GOLGI; TRANSPORT; 25-HYDROXYCHOLESTEROL; EXPRESSION; IDENTIFICATION; TRAFFICKING	Cephalostatin 1, OSW-1, ritterazine B and schweinfurthin A are natural products that potently, and in some cases selectively, inhibit the growth of cultured human cancer cell lines. The cellular targets of these small molecules have yet to be identified. We have discovered that these molecules target oxysterol binding protein (OSBP) and its closest paralog, OSBP-related protein 4L (ORP4L)-proteins not known to be involved in cancer cell survival. OSBP and the ORPs constitute an evolutionarily conserved protein superfamily, members of which have been implicated in signal transduction, lipid transport and lipid metabolism. The functions of OSBP and the ORPs, however, remain largely enigmatic. Based on our findings, we have named the aforementioned natural products ORPphilins. Here we used ORPphilins to reveal new cellular activities of OSBP. The ORPphilins are powerful probes of OSBP and ORP4L that will be useful in uncovering their cellular functions and their roles in human diseases.	[Burgett, Anthony W. G.; Poulsen, Thomas B.; Wangkanont, Kittikhun; Anderson, D. Ryan; Kikuchi, Chikako; Shimada, Kousei; Okubo, Shuichi; Fortner, Kevin C.; Shair, Matthew D.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Mimaki, Yoshihiro; Kuroda, Minpei] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo, Japan; [Murphy, Jason P.; Schwalb, David J.; Petrella, Eugene C.; Cornella-Taracido, Ivan; Schirle, Markus; Tallarico, John A.] Novartis Inst Biomed Res, Cambridge, MA USA	Harvard University; Tokyo University of Pharmacy & Life Sciences; Novartis	Burgett, AWG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	shair@chemistry.harvard.edu	Poulsen, Thomas/C-5953-2017; Wangkanont, Kittikhun/AAF-8664-2019	Poulsen, Thomas/0000-0002-0763-9996; Cornella-Taracido, Ivan/0000-0002-9433-5041; Shimada, Kousei/0000-0002-9765-526X; Wangkanont, Kittikhun/0000-0002-7190-2955	Lundbeck foundation; Danish Council for Independent Research-Natural Sciences; Susan G. Komen for the Cure Foundation; Novartis Institutes of Biomedical Research; US NIH [R01GM090068]; Harvard Clinical and Translational Science Center (NIH) [UL1RR025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090068] Funding Source: NIH RePORTER	Lundbeck foundation(Lundbeckfonden); Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF)); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Novartis Institutes of Biomedical Research; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NCI for the generous gifts of schweinfurthin A. (J.A. Beutler) and ritterazine B. We gratefully acknowledge the aforementioned reagents provided by G. Romeo (Joslin Diabetes Center), M. Brown and J. Goldstein (University of Texas Southwestern Medical Center), H. Arai (University of Tokyo), B. Vogelstein (Johns Hopkins University) and D. Ory (Washington University, St. Louis). The beta-tubulin monoclonal antibody (E7) developed by M. Klymkowsky was obtained from the Developmental Studies Hybridoma Bank (National Institute of Child Health and Human Development, US National Institutes of Health (NIH) and University of Iowa, Department of Biology). R. King is acknowledged for helpful comments and discussions. T.B.P. would like to thank the Lundbeck foundation for a post-doctoral fellowship and the Danish Council for Independent Research-Natural Sciences for additional financial support. A.W.G.B gratefully thanks the Susan G. Komen for the Cure Foundation for providing a postdoctoral research fellowship. Financial support from the Novartis Institutes of Biomedical Research, the US NIH (grant no. R01GM090068), the Harvard Catalyst and The Harvard Clinical and Translational Science Center (NIH award no. UL1RR025758) is acknowledged. This work was conducted with support and financial contributions from Harvard University and its affiliated academic health care centers.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Beh CT, 2001, GENETICS, V157, P1117; Beutler JA, 1998, J NAT PROD, V61, P1509, DOI 10.1021/np980208m; BEUTLER JA, 2006, MED AROMATIC PLANTS, pCH22; Boyd MR, 2004, CANC DRUG DISC DEV, P41; Collingwood TN, 1997, P NATL ACAD SCI USA, V94, P248, DOI 10.1073/pnas.94.1.248; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dirsch VM, 2003, CANCER RES, V63, P8869; El Khissiin A, 1999, FEBS LETT, V448, P160, DOI 10.1016/S0014-5793(99)00343-9; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; Fortner KC, 2010, J AM CHEM SOC, V132, P275, DOI 10.1021/ja906996c; Fournier, 2001, CANCER RES, V61, P792; Fournier MV, 1999, CANCER RES, V59, P3748; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Komiya T, 2003, CANCER CHEMOTH PHARM, V51, P202, DOI 10.1007/s00280-002-0558-8; KUBO S, 1992, PHYTOCHEMISTRY, V31, P3969, DOI 10.1016/S0031-9422(00)97565-4; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Mimaki Y, 1997, BIOORG MED CHEM LETT, V7, P633, DOI 10.1016/S0960-894X(97)00071-1; Moser BR, 2008, J NAT PROD, V71, P487, DOI 10.1021/np070536z; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nishimura T, 2005, GENES CELLS, V10, P793, DOI 10.1111/j.1365-2443.2005.00879.x; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; PETTIT GR, 1988, J AM CHEM SOC, V110, P2006, DOI 10.1021/ja00214a078; Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; RIDGWAY ND, 1995, J LIPID RES, V36, P1345; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Romeo GR, 2008, J BIOL CHEM, V283, P9595, DOI 10.1074/jbc.M710092200; Rudy A, 2008, J NAT PROD, V71, P482, DOI 10.1021/np070534e; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tasdemir D, 2002, J NAT PROD, V65, P210, DOI 10.1021/np0104020; TAYLOR FR, 1985, CHEM PHYS LIPIDS, V38, P187, DOI 10.1016/0009-3084(85)90066-0; Turbyville TJ, 2010, MOL CANCER THER, V9, P1234, DOI 10.1158/1535-7163.MCT-09-0834; Wang PY, 2008, J BIOL CHEM, V283, P8034, DOI 10.1074/jbc.M707631200; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; Yan D, 2007, ARTERIOSCL THROM VAS, V27, P1618, DOI 10.1161/ATVBAHA.107.144121; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Zerbinatti CV, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-5; Zhou Y, 2005, JNCI-J NATL CANCER I, V97, P1781, DOI 10.1093/jnci/dji404	50	173	174	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					639	647		10.1038/nchembio.625	http://dx.doi.org/10.1038/nchembio.625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21822274	Green Accepted, Green Published			2022-12-25	WOS:000294381400015
J	Haidet-Phillips, AM; Hester, ME; Miranda, CJ; Meyer, K; Braun, L; Frakes, A; Song, SW; Likhite, S; Murtha, MJ; Foust, KD; Rao, MH; Eagle, A; Kammesheidt, A; Christensen, A; Mendell, JR; Burghes, AHM; Kaspar, BK				Haidet-Phillips, Amanda M.; Hester, Mark E.; Miranda, Carlos J.; Meyer, Kathrin; Braun, Lyndsey; Frakes, Ashley; Song, SungWon; Likhite, Shibi; Murtha, Matthew J.; Foust, Kevin D.; Rao, Meghan; Eagle, Amy; Kammesheidt, Anja; Christensen, Ashley; Mendell, Jerry R.; Burghes, Arthur H. M.; Kaspar, Brian K.			Astrocytes from familial and sporadic ALS patients are toxic to motor neurons	NATURE BIOTECHNOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; WILD-TYPE; EXTEND SURVIVAL; STEM-CELLS; SOD1; BRAIN; PROGRESSION; DISEASE; SYSTEM; MODEL	Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, with astrocytes implicated as contributing substantially to motor neuron death in familial (F)ALS(1-5). However, the proposed role of astrocytes in the pathology of ALS derives in part from rodent models of FALS based upon dominant mutations within the superoxide dismutase 1 (SOD1) gene, which account for <2% of all ALS cases(2,4,5). Their role in sporadic (S)ALS, which affects >90% of ALS patients, remains to be established. Using astrocytes generated from postmortem tissue from both FALS and SALS patients, we show that astrocytes derived from both patient groups are similarly toxic to motor neurons. We also demonstrate that SOD1 is a viable target for SALS, as its knockdown significantly attenuates astrocyte-mediated toxicity toward motor neurons. Our data highlight astrocytes as a non-cell autonomous component in SALS and provide an in vitro model system to investigate common disease mechanisms and evaluate potential therapies for SALS and FALS.	[Haidet-Phillips, Amanda M.; Hester, Mark E.; Miranda, Carlos J.; Meyer, Kathrin; Braun, Lyndsey; Frakes, Ashley; Song, SungWon; Likhite, Shibi; Murtha, Matthew J.; Foust, Kevin D.; Rao, Meghan; Eagle, Amy; Mendell, Jerry R.; Kaspar, Brian K.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Haidet-Phillips, Amanda M.; Frakes, Ashley; Mendell, Jerry R.; Kaspar, Brian K.] Ohio State Univ, Coll Med, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Song, SungWon; Likhite, Shibi; Murtha, Matthew J.; Kaspar, Brian K.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Kammesheidt, Anja; Christensen, Ashley] Ambry Genet, Aliso Viejo, CA USA; [Kaspar, Brian K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kaspar, BK (corresponding author), Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.	brian.kaspar@nationwidechildrens.org	Hester, Mark/AAY-8611-2020; Miranda, Carlos/B-7885-2008; Kaspar, Brian/E-3349-2011; Ribeiro, Carlos/Y-9828-2019	Miranda, Carlos/0000-0001-8208-7100; Ribeiro, Carlos/0000-0002-9180-8595; Meyer, Kathrin/0000-0002-5052-2101; Likhite, Shibi/0000-0002-7040-3820; Burghes, Arthur/0000-0001-9031-1555	US National Institutes of Health (NIH) [R01 NS644912-1A1, RC2 NS69476-01]; Project A.L.S.; Packard Center for ALS Research [P2ALS]; Helping Link Foundation; NIH [NRSAF31NS058224]; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069476, R01NS064492, F31NS058224, T32NS077984] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project A.L.S.; Packard Center for ALS Research; Helping Link Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by US National Institutes of Health (NIH) R01 NS644912-1A1, RC2 NS69476-01, Project A.L.S. and Packard Center for ALS Research (P2ALS) and Helping Link Foundation to B.K.K., and an NIH grant NRSAF31NS058224 to A.M.H.-P., K.M. is supported by a fellowship from the Swiss National Science Foundation.	Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bendotti C, 2005, NEURODEGENER DIS, V2, P128, DOI 10.1159/000089617; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dodge JC, 2008, MOL THER, V16, P1056, DOI 10.1038/mt.2008.60; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; HESTER ME, MOL THER IN PRESS; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Wang RG, 2011, GLIA, V59, P946, DOI 10.1002/glia.21167; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842	30	546	568	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					824	U79		10.1038/nbt.1957	http://dx.doi.org/10.1038/nbt.1957			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21832997	Green Accepted			2022-12-25	WOS:000294718400023
J	Kashatus, DF; Lim, KH; Brady, DC; Pershing, NLK; Cox, AD; Counter, CM				Kashatus, David F.; Lim, Kian-Huat; Brady, Donita C.; Pershing, Nicole L. K.; Cox, Adrienne D.; Counter, Christopher M.			RALA and RALBP1 regulate mitochondrial fission at mitosis	NATURE CELL BIOLOGY			English	Article							RAS ONCOGENESIS; GTPASES; KINASE; DRP1; DEGRADATION; ACTIVATION; MORPHOLOGY; DIVISION; MEDIATOR; EXOCYST	Mitochondria exist as dynamic interconnected networks that are maintained through a balance of fusion and fission(1). Equal distribution of mitochondria to daughter cells during mitosis requires fission(2). Mitotic mitochondrial fission depends on both the relocalization of the large GTPase DRP1 to the outer mitochondrial membrane and phosphorylation of Ser 616 on DRP1 by the mitotic kinase cyclin B-CDK1 (ref. 2). We now report that these processes are mediated by the small Ras-like GTPase RALA and its effector RALBP1 (also known as RLIP76, RLIP1 or RIP1; refs 3,4). Specifically, the mitotic kinase Aurora A phosphorylates Ser 194 of RALA, relocalizing it to the mitochondria, where it concentrates RALBP1 and DRP1. Furthermore, RALBP1 is associated with cyclin B-CDK1 kinase activity that leads to phosphorylation of DRP1 on Ser 616. Disrupting either RALA or RALBP1 leads to a loss of mitochondrial fission at mitosis, improper segregation of mitochondria during cytokinesis and a decrease in ATP levels and cell number. Thus, the two mitotic kinases Aurora A and cyclin B-CDK1 converge on RALA and RALBP1 to promote mitochondrial fission, the appropriate distribution of mitochondria to daughter cells and ultimately proper mitochondria! function.	[Kashatus, David F.; Lim, Kian-Huat; Brady, Donita C.; Pershing, Nicole L. K.; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Brady, Donita C.; Cox, Adrienne D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol & Radiat Oncol, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Radiat Oncol, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	count004@mc.duke.edu	Kashatus, David F/D-8299-2012; Brady, Donita/E-3801-2012	Kashatus, David F/0000-0001-8007-0612; Cox, Adrienne D./0000-0002-4901-2454; Counter, Christopher M/0000-0003-0748-3079; Lim, Kian-Huat/0000-0002-2766-200X	NIH [CA94184]; NATIONAL CANCER INSTITUTE [R01CA094184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kornbluth (Duke University, USA) for DRP1 plasmids, C. Freel, S. Johnson, Y. Gao and K. Norris for technical support, S. Issaq (Duke University, USA) for the RALBP1-RALA fusion protein and S. Kornbluth, J. Rathmell, T-P. Yao, C. Der, J. Kashatus and S. Horn for discussions and/or review of the manuscript. This work was supported by NIH grant CA94184 (C.M.C.). D.F.K. is a Leukemia and Lymphoma Society Fellow.	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Cleland MM, 2011, CELL DEATH DIFFER, V18, P235, DOI 10.1038/cdd.2010.89; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Freel CD, 2008, J BIOL CHEM, V283, P367, DOI 10.1074/jbc.M708931200; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Roghi C, 1998, J CELL SCI, V111, P557; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tyagi S, 2010, BIOCHEM PHARMACOL, V80, P1326, DOI 10.1016/j.bcp.2010.07.025; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200	34	245	250	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1108	U138		10.1038/ncb2310	http://dx.doi.org/10.1038/ncb2310			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21822277	Green Accepted, Green Submitted			2022-12-25	WOS:000294487000016
J	Lee, J; Culyba, EK; Powers, ET; Kelly, JW				Lee, Jiyong; Culyba, Elizabeth K.; Powers, Evan T.; Kelly, Jeffery W.			Amyloid-beta forms fibrils by nucleated conformational conversion of oligomers	NATURE CHEMICAL BIOLOGY			English	Article							ALZHEIMERS-DISEASE; PLASMALOGEN DEFICIENCY; PROTEIN; MECHANISM; FLASH; FIBRILLOGENESIS; PROTOFIBRILS; AGGREGATION; MODELS; STATE	Amyloid-beta amyloidogenesis is reported to occur via a nucleated polymerization mechanism. If this is true, the energetically unfavorable oligomeric nucleus should be very hard to detect. However, many laboratories have detected early nonfibrillar amyloid-beta oligomers without observing amyloid fibrils, suggesting that a mechanistic revision may be needed. Here we introduce Cys-Cys-amyloid-beta(1-40r) which cannot bind to the latent fluorophore FlAsH as a monomer, but can bind FlAsH as an nonfibrillar oligomer or as a fibril, rendering the conjugates fluorescent. Through FlAsH monitoring of Cys-Cys-amyloid-beta(1-40) aggregation, we found that amyloid-beta(1-40) rapidly and efficiently forms spherical oligomers in vitro (85% yield) that are kinetically competent to slowly convert to amyloid fibrils by a nucleated conformational conversion mechanism. This methodology was used to show that plasmalogen ethanolamine vesicles eliminate the proteotoxicity-associated oligomerization phase of amyloid-beta amyloidogenesis while allowing fibril formation, rationalizing how low concentrations of plasmalogen ethanolamine in the brain are epidemiologically linked to Alzheimer's disease.	[Lee, Jiyong; Culyba, Elizabeth K.; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Lee, Jiyong; Culyba, Elizabeth K.; Powers, Evan T.; Kelly, Jeffery W.] Skaggs Inst Chem Biol, La Jolla, CA USA; [Lee, Jiyong; Culyba, Elizabeth K.; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Lee, J (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	jkelly@scripps.edu	Lee, Jiyong/B-4894-2017	Powers, Evan/0000-0001-8185-8487; Lee, Jiyong/0000-0002-4455-3358	US National Institutes of Health [NS050636]; Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050636] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the US National Institutes of Health (NS050636), The Skaggs Institute for Chemical Biology and the Lita Annenberg Hazen Foundation for financial support and C. Fearns for critical feedback on the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bieschke J, 2005, BIOCHEMISTRY-US, V44, P4977, DOI 10.1021/bi0501030; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cloe AL, 2011, BIOCHEMISTRY-US, V50, P2026, DOI 10.1021/bi1016217; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Goodman JL, 2009, CHEMBIOCHEM, V10, P1644, DOI 10.1002/cbic.200900207; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Holtzman DM, 2011, SCI TRANSL MED, V3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Krishnan B, 2008, CHEM BIOL, V15, P1104, DOI 10.1016/j.chembiol.2008.09.006; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Roberti MJ, 2007, NAT METHODS, V4, P345, DOI 10.1038/NMETH1026; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sabate R, 2005, J PHYS CHEM B, V109, P11027, DOI 10.1021/jp050716m; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Webber TM, 2009, BIOCHEM BIOPH RES CO, V384, P66, DOI 10.1016/j.bbrc.2009.04.073; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; Wells K, 1995, NEUROCHEM RES, V20, P1329, DOI 10.1007/BF00992508; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yushchenko DA, 2010, J AM CHEM SOC, V132, P7860, DOI 10.1021/ja102838n	51	315	319	8	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					602	609		10.1038/NCHEMBIO.624	http://dx.doi.org/10.1038/NCHEMBIO.624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21804535	Green Accepted			2022-12-25	WOS:000294381400010
J	Jensen, MP; Gorman-Lewis, D; Aryal, B; Paunesku, T; Vogt, S; Rickert, PG; Seifert, S; Lai, B; Woloschak, GE; Soderholm, L				Jensen, Mark P.; Gorman-Lewis, Drew; Aryal, Baikuntha; Paunesku, Tatjana; Vogt, Stefan; Rickert, Paul G.; Seifert, Soenke; Lai, Barry; Woloschak, Gayle E.; Soderholm, L.			An iron-dependent and transferrin-mediated cellular uptake pathway for plutonium	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN SERUM TRANSFERRIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; SEQUESTERING AGENTS; BINDING-SITES; CHEMISTRY; RECEPTOR; DESIGN; FORM	Plutonium is a toxic synthetic element with no natural biological function, but it is strongly retained by humans when ingested. Using small-angle X-ray scattering, receptor binding assays and synchrotron X-ray fluorescence microscopy, we find that rat adrenal gland (PC12) cells can acquire plutonium in vitro through the major iron acquisition pathway-receptor-mediated endocytosis of the iron transport protein serum transferrin; however, only one form of the plutonium-transferrin complex is active. Low-resolution solution models of plutonium-loaded transferrins derived from small-angle scattering show that only transferrin with plutonium bound in the protein's C-terminal lobe (C-lobe) and iron bound in the N-terminal lobe (N-lobe) (PuCFeNTf) adopts the proper conformation for recognition by the transferrin receptor protein. Although the metal-binding site in each lobe contains the same donors in the same configuration and both lobes are similar, the differences between transferrin's two lobes act to restrict, but not eliminate, cellular Pu uptake.	[Jensen, Mark P.; Gorman-Lewis, Drew; Aryal, Baikuntha; Rickert, Paul G.; Soderholm, L.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Aryal, Baikuntha] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Paunesku, Tatjana; Woloschak, Gayle E.] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA; [Paunesku, Tatjana; Woloschak, Gayle E.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Vogt, Stefan; Seifert, Soenke; Lai, Barry] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; United States Department of Energy (DOE); Argonne National Laboratory	Jensen, MP (corresponding author), Argonne Natl Lab, Chem Sci & Engn Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	mjensen@anl.gov	Woloschak, Gayle E/A-3799-2017; Vogt, Stefan/J-7937-2013; Jensen, Mark P/G-9131-2012; Vogt, Stefan/B-9547-2009; Paunesku, Tatjana/A-3488-2017; Soderholm, Lynda/H-4432-2011; Paunesku, Tatjana/AAF-8529-2021	Woloschak, Gayle E/0000-0001-9209-8954; Vogt, Stefan/0000-0002-8034-5513; Jensen, Mark P/0000-0003-4494-6693; Vogt, Stefan/0000-0002-8034-5513; Paunesku, Tatjana/0000-0001-8698-2938; Soderholm, Lynda/0000-0003-4435-2721; Paunesku, Tatjana/0000-0001-8698-2938	US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; US National Institutes of Health [EB002100, U54CA119341]; NATIONAL CANCER INSTITUTE [U54CA119341, R01CA107467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002100] Funding Source: NIH RePORTER	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work at Argonne National Laboratory, including the use of the Advanced Photon Source, was supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357, whereas work at Northwestern University was supported by US National Institutes of Health grants EB002100 and U54CA119341.	ALLARD B, 1980, J INORG NUCL CHEM, V42, P1015, DOI 10.1016/0022-1902(80)80394-0; Antonio MR, 2009, J ELECTROANAL CHEM, V626, P103, DOI 10.1016/j.jelechem.2008.11.009; Baker E., 1994, ADV INORG CHEM, P389, DOI [10.1016/S0898-8838(08)60176-2, DOI 10.1016/S0898-8838(08)60176-2]; Baker HM, 2000, J BIOL INORG CHEM, V5, P692, DOI 10.1007/s007750000157; BALI PK, 1990, ARCH BIOCHEM BIOPHYS, V281, P251, DOI 10.1016/0003-9861(90)90440-A; BOOCOCK G, 1965, NATURE, V208, P282, DOI 10.1038/208282a0; BOOCOCK G, 1970, RADIAT RES, V42, P381, DOI 10.2307/3572805; Cai Z, 2003, J PHYS IV, V104, P17, DOI 10.1051/jp4:200300020; CHASTEEN ND, 1981, BIOCHEM J, V193, P717, DOI 10.1042/bj1930717; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; CHOPPIN GR, 1983, RADIOCHIM ACTA, V32, P43, DOI 10.1524/ract.1983.32.13.43; CLARK D.L., 2006, CHEM ACTINIDE TRANSA, DOI DOI 10.1007/1-4020-3598-5_7; DUFFIELD JR, 1986, INT J NUCL MED BIOL, V12, P483, DOI 10.1016/S0047-0740(86)80012-2; DUFFIELD JR, 1994, HANDB PHYSI, V18, P591; DUFFIELD JR, 1986, HDB PHYSICS CHEM ACT, V4, P129; Durbin P.W., 2006, CHEM ACTINIDE TRANSA, V3, P3339; Durbin PW, 1998, RADIAT PROT DOSIM, V79, P433, DOI 10.1093/oxfordjournals.rpd.a032445; Fang XW, 2000, BIOCHEMISTRY-US, V39, P11107, DOI 10.1021/bi000724n; Giannetti AM, 2003, PLOS BIOL, V1, P341, DOI 10.1371/journal.pbio.0000051; Gorden AEV, 2003, CHEM REV, V103, P4207, DOI 10.1021/cr990114x; GROSSMANN JG, 1993, J MOL BIOL, V229, P585, DOI 10.1006/jmbi.1993.1063; GROSSMANN JG, 1992, J MOL BIOL, V225, P811, DOI 10.1016/0022-2836(92)90402-6; HAGLER HK, 1999, INTERACTIVE CASE STU; Hall DR, 2002, ACTA CRYSTALLOGR D, V58, P70, DOI 10.1107/S0907444901017309; HARRIS WR, 1981, J AM CHEM SOC, V103, P2231, DOI 10.1021/ja00399a016; HE QY, 2002, MOL CELLULAR IRON TR, P95; Hemadi M, 2003, BIOCHEMISTRY-US, V42, P3120, DOI 10.1021/bi020627p; Hoyes KP, 1996, INT J RADIAT BIOL, V70, P467; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Jeanson A, 2010, CHEM-EUR J, V16, P1378, DOI 10.1002/chem.200901209; Jeffrey PD, 1998, BIOCHEMISTRY-US, V37, P13978, DOI 10.1021/bi9812064; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; LEIBMAN A, 1979, BLOOD, V53, P1058; Mason AB, 2005, BIOCHEMISTRY-US, V44, P8013, DOI 10.1021/bi050015f; Mcrae R, 2006, J STRUCT BIOL, V155, P22, DOI 10.1016/j.jsb.2005.09.013; PARK I, 1985, P NATL ACAD SCI USA, V82, P3149, DOI 10.1073/pnas.82.10.3149; PLANASBOHNE F, 1990, HUM EXP TOXICOL, V9, P17, DOI 10.1177/096032719000900105; RAYMOND KN, 1981, STRUCT BOND, V43, P159; Seifert S, 2000, J APPL CRYSTALLOGR, V33, P782, DOI 10.1107/S0021889800001333; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHIH YJ, 1990, J BIOL CHEM, V265, P19077; Sun HZ, 1999, CHEM REV, V99, P2817, DOI 10.1021/cr980430w; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Taylor DM, 1998, J ALLOY COMPD, V271, P6, DOI 10.1016/S0925-8388(98)00014-0; TAYLOR DM, 1973, HDB EXPT PHARM, P323; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Wessling-Resnick M, 2000, ANNU REV NUTR, V20, P129, DOI 10.1146/annurev.nutr.20.1.129; ZUCCOLA HJ, 1992, CRYSTAL STRUCTURE MO	49	65	67	0	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					560	565		10.1038/NCHEMBIO.594	http://dx.doi.org/10.1038/NCHEMBIO.594			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21706034	Green Accepted			2022-12-25	WOS:000292825400018
J	Conrad, DF; Keebler, JEM; DePristo, MA; Lindsay, SJ; Zhang, YJ; Casals, F; Idaghdour, Y; Hartl, CL; Torroja, C; Garimella, KV; Zilversmit, M; Cartwright, R; Rouleau, GA; Daly, M; Stone, EA; Hurles, ME; Awadalla, P				Conrad, Donald F.; Keebler, Jonathan E. M.; DePristo, Mark A.; Lindsay, Sarah J.; Zhang, Yujun; Casals, Ferran; Idaghdour, Youssef; Hartl, Chris L.; Torroja, Carlos; Garimella, Kiran V.; Zilversmit, Martine; Cartwright, Reed; Rouleau, Guy A.; Daly, Mark; Stone, Eric A.; Hurles, Matthew E.; Awadalla, Philip		1000 Genomes Project	Variation in genome-wide mutation rates within and between human families	NATURE GENETICS			English	Article							NUCLEOTIDE	J.B.S. Haldane proposed in 1947 that the male germline may be more mutagenic than the female germline(1). Diverse studies have supported Haldane's contention of a higher average mutation rate in the male germline in a variety of mammals, including humans(2,3). Here we present, to our knowledge, the first direct comparative analysis of male and female germline mutation rates from the complete genome sequences of two parent-offspring trios. Through extensive validation, we identified 49 and 35 germline de novo mutations (DNMs) in two trio offspring, as well as 1,586 non-germline DNMs arising either somatically or in the cell lines from which the DNA was derived. Most strikingly, in one family, we observed that 92% of germline DNMs were from the paternal germline, whereas, in contrast, in the other family, 64% of DNMs were from the maternal germline. These observations suggest considerable variation in mutation rates within and between families.	[Keebler, Jonathan E. M.; Casals, Ferran; Idaghdour, Youssef; Zilversmit, Martine; Awadalla, Philip] Univ Montreal, Fac Med, Dept Pediat, Ste Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Conrad, Donald F.; Lindsay, Sarah J.; Zhang, Yujun; Torroja, Carlos; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge, England; [Conrad, Donald F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Keebler, Jonathan E. M.; Stone, Eric A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [DePristo, Mark A.; Hartl, Chris L.; Garimella, Kiran V.; Daly, Mark] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Cartwright, Reed; Stone, Eric A.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Rouleau, Guy A.] Univ Montreal, Fac Med, Dept Med, Ste Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Wellcome Trust Sanger Institute; Washington University (WUSTL); University of North Carolina; North Carolina State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; North Carolina State University; Universite de Montreal	Awadalla, P (corresponding author), Univ Montreal, Fac Med, Dept Pediat, Ste Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada.	meh@sanger.ac.uk; philip.awadalla@umontreal.ca	Cooper, David N/H-4384-2011; Awadalla, Philip/AAC-4896-2021; Dahl, Andreas/E-3783-2017; Torroja, Carlos/N-6022-2014; Mills, Ryan/F-4225-2010; Casals, Ferran/H-4347-2015; Ye, Kai/B-3640-2012; Li, Yingrui/K-1064-2015; Daly, Mark J/B-2453-2017; Stone, Eric/Q-7840-2016; Browning, Brian L/A-1178-2010; Chen, Wei/AAX-5994-2020; Herrero, Javier/H-6971-2019; Cartwright, Reed/A-9707-2009; Khurana, Ekta/C-4933-2013; Sahinalp, Suleyman Cenk/X-7843-2018; Lindsay, Sarah/CAF-4613-2022; Wilson, Richard K./AAF-4139-2019; Myers, Simon R/A-6792-2015; Rosenstiel, Philip/A-5137-2009	Cooper, David N/0000-0002-8943-8484; Dahl, Andreas/0000-0002-2668-8371; Torroja, Carlos/0000-0001-8914-3400; Mills, Ryan/0000-0003-3425-6998; Casals, Ferran/0000-0002-8941-0369; Daly, Mark J/0000-0002-0949-8752; Browning, Brian L/0000-0001-6454-6633; Chen, Wei/0000-0001-7196-8703; Herrero, Javier/0000-0001-7313-717X; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Wilson, Richard K./0000-0002-1992-1358; Myers, Simon R/0000-0002-2585-9626; Rosenstiel, Philip/0000-0002-9692-8828; Walter, Klaudia/0000-0003-4448-0301; Chinwalla, Asif/0000-0001-7831-3996; Clark, Andrew/0000-0001-7159-8511; Stone, Eric/0000-0002-2725-4209; Keenan, Stephen/0000-0002-9141-7690; Radhakrishnan, Rajesh/0000-0001-7170-699X; Keane, Thomas/0000-0001-7532-6898; Leinonen, Rasko/0000-0002-2639-7187; Haraksingh, Rajini/0000-0002-6644-8874; MacArthur, Daniel/0000-0002-5771-2290; Borodina, Tatiana/0000-0002-6978-016X; Sebat, Jonathan/0000-0002-9087-526X; Lindsay, Sarah/0000-0002-0965-3070; Garimella, Kiran/0000-0002-6212-5736; Hartl, Christopher/0000-0003-3352-4356; Clarke, Laura/0000-0002-5989-6898; Kulesha, Eugene/0000-0002-4285-6232; Swerdlow, Harold/0000-0002-9510-160X; Bustamante, Carlos D./0000-0002-4187-7920; McLaren, William/0000-0001-6218-1116; Zalunin, Vadim/0000-0002-7722-1958	Wellcome Trust [077014/Z/05/Z]; Ministry of Development, Exploration and Innovation in Quebec [PSR-SIIRI-195]; Genome Quebec Award for Population and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070806] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Ministry of Development, Exploration and Innovation in Quebec; Genome Quebec Award for Population and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Kernytsky, G. McVean, T. Massingham, J. Thorne, J. Hussin, A. Motsinger, Coriell Cell Repositories and members of the 1000 Genomes analysis group for their help and support. D.F.C., S.J.L., Y.Z., C.T. and M.E.H. were funded by the Wellcome Trust (grant number 077014/Z/05/Z). J.E.M.K., F.C., Y.I., M.Z., G.A.R. and P.A. were funded by the Ministry of Development, Exploration and Innovation (grant number PSR-SIIRI-195) in Quebec and a Genome Quebec Award for Population and Medical Genomics to P.A.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Nachman MW, 2000, GENETICS, V156, P297; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	18	385	393	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					712	U137		10.1038/ng.862	http://dx.doi.org/10.1038/ng.862			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21666693	Green Accepted			2022-12-25	WOS:000292184600019
J	Koksal, M; Hu, HY; Coates, RM; Peters, RJ; Christianson, DW				Koeksal, Mustafa; Hu, Huayou; Coates, Robert M.; Peters, Reuben J.; Christianson, David W.			Structure and mechanism of the diterpene cyclase ent-copalyl diphosphate synthase	NATURE CHEMICAL BIOLOGY			English	Article							SQUALENE-HOPENE CYCLASE; CRYSTAL-STRUCTURE; BIOSYNTHESIS; CHEMISTRY; MOTIF	The structure of ent-copalyl diphosphate synthase reveals lthree alpha-helical domains (alpha, beta and gamma), as also observed in the related diterpene cyclase taxadiene synthase. However, active sites are located at the interface of the beta gamma domains in ent-copalyl diphosphate synthase but exclusively in the alpha domain of taxadiene synthase. Modular domain architecture in plant diterpene cyclases enables the evolution of alternative active sites and chemical strategies for catalyzing isoprenoid cyclization reactions.	[Koeksal, Mustafa; Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Hu, Huayou; Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University	Koksal, M (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	chris@sas.upenn.edu	Peters, Reuben J./D-1196-2010; Hu, Huayou/B-9521-2013	Peters, Reuben J./0000-0003-4691-8477; Hu, Huayou/0000-0003-4795-0866	US National Institutes of Health [GM56838, GM13956, GM76324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0919735] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the US National Institutes of Health for grants GM56838 (D. W. C.), GM13956 (R. M. C.) and GM76324 (R.J.P.) for support of this research. Additionally, we thank the Advanced Photon Source at Argonne National Laboratory for beamline access.	Bohlmann J, 2008, PLANT J, V54, P656, DOI 10.1111/j.1365-313X.2008.03449.x; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Corey EJ, 1997, J AM CHEM SOC, V119, P1277, DOI 10.1021/ja963227w; GANDOUR RD, 1981, BIOORG CHEM, V10, P169, DOI 10.1016/0045-2068(81)90020-1; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; OCHS D, 1990, EUR J BIOCHEM, V194, P75, DOI 10.1111/j.1432-1033.1990.tb19429.x; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Reinert DJ, 2004, CHEM BIOL, V11, P121, DOI 10.1016/j.chembiol.2003.12.013; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sato T, 1999, BIOSCI BIOTECH BIOCH, V63, P2189, DOI 10.1271/bbb.63.2189; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099	25	114	124	3	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					431	433		10.1038/NCHEMBIO.578	http://dx.doi.org/10.1038/NCHEMBIO.578			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21602811	Green Accepted			2022-12-25	WOS:000292252100009
J	Lancaster, MA; Gopal, DJ; Kim, J; Saleem, SN; Silhavy, JL; Louie, CM; Thacker, BE; Williams, Y; Zaki, MS; Gleeson, JG				Lancaster, Madeline A.; Gopal, Dipika J.; Kim, Joon; Saleem, Sahar N.; Silhavy, Jennifer L.; Louie, Carrie M.; Thacker, Bryan E.; Williams, Yuko; Zaki, Maha S.; Gleeson, Joseph G.			Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome	NATURE MEDICINE			English	Article							RETINAL DEGENERATION; CENTROSOMAL PROTEIN; PROGENITOR POOL; MUTATIONS CAUSE; PRIMARY CILIUM; AHI1 GENE; DISORDERS; MORPHOGENESIS; CEP290; MEDULLOBLASTOMA	The ciliopathy Joubert syndrome is marked by cerebellar vermis hypoplasia, a phenotype for which the pathogenic mechanism is unclear(1-3). To investigate Joubert syndrome pathogenesis, we have examined mice with mutated Ahi1, the first identified Joubert syndrome-associated gene(4,5). These mice show cerebellar hypoplasia with a vermis-midline fusion defect early in development. This defect is concomitant with expansion of the roof plate and is also evident in a mouse mutant for another Joubert syndrome-associated gene, Cep290(6,7). Furthermore, fetal magnetic resonance imaging (MRI) of human subjects with Joubert syndrome reveals a similar midline cleft, suggesting parallel pathogenic mechanisms. Previous evidence has suggested a role for Jouberin (Jbn), the protein encoded by Ahi1, in canonical Wnt signaling(8). Consistent with this, we found decreased Wnt reporter activity at the site of hemisphere fusion in the developing cerebellum of Ahi1-mutant mice. This decrease was accompanied by reduced proliferation at the site of fusion. Finally, treatment with lithium, a Wnt pathway agonist(9), partially rescued this phenotype. Our findings implicate a defect in Wnt signaling in the cerebellar midline phenotype seen in Joubert syndrome that can be overcome with Wnt stimulation.	[Lancaster, Madeline A.; Gopal, Dipika J.; Kim, Joon; Silhavy, Jennifer L.; Louie, Carrie M.; Thacker, Bryan E.; Williams, Yuko; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat & Neurosci,Inst Genom Med, San Diego, CA 92103 USA; [Saleem, Sahar N.] Cairo Univ, Kasr Al Ainy Hosp, Dept Radiol, Cairo, Egypt; [Zaki, Maha S.] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo, Egypt	Howard Hughes Medical Institute; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat & Neurosci,Inst Genom Med, San Diego, CA 92103 USA.	jogleeson@ucsd.edu	Zaki, Maha S/B-9361-2013; Kim, Joon/C-1833-2011; Saleem, Sahar N/A-3651-2008	Saleem, Sahar N/0000-0001-6713-9099; Lancaster, Madeline/0000-0003-2324-8853; Zaki, Maha/0000-0001-7840-0002; Thacker, Bryan/0000-0003-0517-0810	Bear Necessities Pediatric Cancer Foundation; US National Institutes of Health-National Institute of General Medical Sciences [T32 GM08666]; US National Institutes of Health [P30NS047101, R01NS052455, R01NS048453]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS048453, R01NS052455] Funding Source: NIH RePORTER	Bear Necessities Pediatric Cancer Foundation; US National Institutes of Health-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to members of the Gleeson lab for technical expertise and feedback and B. Hamilton, M. Hatten and A. Joyner for helpful discussions on cerebellar development. We also thank the study subjects and the UCSD Neuroscience Microscopy Core. We thank J.K. Lee and B. Zheng for help with the biotinylated dextran amine tracing assay. We are grateful to S. Piccolo (University of Padua) for the BATgal mice. We thank R.T. Moon (University of Washington) for the Super Topflash construct and P. Mellon (UCSD) for the beta-galactosidase expression construct, as well as K. Willert (UCSD) for stably transfected L cells and the beta-catenin expression plasmid. M.A.L. received support from the Bear Necessities Pediatric Cancer Foundation and US National Institutes of Health-National Institute of General Medical Sciences-funded UCSD Genetics Training Program (T32 GM08666). This work was supported by the US National Institutes of Health (grants P30NS047101, R01NS052455 and R01NS048453) and the Burroughs Wellcome Fund in Translational Research (J.G.G.). J.G.G. is an investigator with Howard Hughes Medical Institute.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; COOPER PA, 1991, BEHAV GENET, V21, P405, DOI 10.1007/BF01065976; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; FRIEDE RL, 1978, DEV MED CHILD NEUROL, V20, P758; Grimmer MR, 2008, GENE DEV, V22, P693, DOI 10.1101/gad.1657808; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lee JK, 2009, J NEUROSCI, V29, P8649, DOI 10.1523/JNEUROSCI.1864-09.2009; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Louvi A, 2003, DEVELOPMENT, V130, P5319, DOI 10.1242/dev.00736; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Saleem SN, 2010, AM J NEURORADIOL, V31, P424, DOI 10.3174/ajnr.A1867; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Yachnis AT, 1999, J CHILD NEUROL, V14, P655, DOI 10.1177/088307389901401006; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013	40	104	112	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					726	U119		10.1038/nm.2380	http://dx.doi.org/10.1038/nm.2380			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21623382	Green Accepted			2022-12-25	WOS:000291308800034
J	Lee, G; Yoo, J; Leslie, BJ; Ha, T				Lee, Gwangrog; Yoo, Jungmin; Leslie, Benjamin J.; Ha, Taekjip			Single-molecule analysis reveals three phases of DNA degradation by an exonuclease	NATURE CHEMICAL BIOLOGY			English	Article							LAMBDA-EXONUCLEASE; POLYNUCLEOTIDE PHOSPHORYLASE; FLUORESCENCE SPECTROSCOPY; BACTERIOPHAGE LAMBDA; ENERGY-TRANSFER; RNA-POLYMERASE; LOOP FORMATION; STRANDED-DNA; PROTEIN; HELICASE	lambda exonuclease degrades one strand of duplex DNA in the 5'-to-3' direction to generate a 3' overhang required for recombination. Its ability to hydrolyze thousands of nucleotides processively is attributed to its ring structure, and most studies have focused on the processive phase. Here we have used single-molecule fluorescence resonance energy transfer ( FRET) to reveal three phases of l exonuclease reactions: the initiation, distributive and processive phases. The distributive phase comprises early reactions in which the 3' overhang is too short to stably engage with the enzyme. A mismatched base is digested one-fifth as quickly as a Watson-Crick-paired base, and multiple concatenated mismatches have a cooperatively negative effect, highlighting the crucial role of base pairing in aligning the 5' end toward the active site. The rate-limiting step during processive degradation seems to be the post-cleavage melting of the terminal base pair. We also found that an escape from a known pausing sequence requires enzyme backtracking.	[Lee, Gwangrog; Yoo, Jungmin; Leslie, Benjamin J.; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lee, Gwangrog; Yoo, Jungmin; Leslie, Benjamin J.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Lee, Gwangrog; Leslie, Benjamin J.; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Lee, G (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Lee, Gwangrog/0000-0002-1720-8524	Jane Coffin Childs Medical Institute; US National Science Foundation [0646550, 0822613]; US National Institutes of Health [GM065367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	Jane Coffin Childs Medical Institute; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Roy and X. Shi for experimental help, and J. Park for helpful discussions. G. L. was supported by the Jane Coffin Childs Medical Institute. Funds were provided by grants from the US National Science Foundation (0646550, 0822613) and the US National Institutes of Health (GM065367). T. H. is an investigator with the Howard Hughes Medical Institute.	BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; CARTER DM, 1971, J BIOL CHEM, V246, P2502; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Ceska TA, 1998, TRENDS BIOCHEM SCI, V23, P331, DOI 10.1016/S0968-0004(98)01259-6; Dapprich J, 1999, CYTOMETRY, V36, P163, DOI 10.1002/(SICI)1097-0320(19990701)36:3<163::AID-CYTO3>3.0.CO;2-R; Grossman D, 2006, NAT STRUCT MOL BIOL, V13, P760, DOI 10.1038/nsmb0906-760; GUISSANI A, 1977, EUR J BIOCHEM, V79, P233, DOI 10.1111/j.1432-1033.1977.tb11801.x; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; Hingorani MM, 1998, CURR BIOL, V8, pR83, DOI 10.1016/S0960-9822(98)70052-1; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; KLEE CB, 1968, J BIOL CHEM, V243, P923; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; LITTLE JW, 1967, J BIOL CHEM, V242, P672; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Lucius AL, 2004, J MOL BIOL, V339, P731, DOI 10.1016/j.jmb.2004.04.009; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; Mitsis PG, 1999, NUCLEIC ACIDS RES, V27, P3057, DOI 10.1093/nar/27.15.3057; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Muyrers JPP, 2000, GENE DEV, V14, P1971; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Perkins TT, 2003, SCIENCE, V301, P1914, DOI 10.1126/science.1088047; RADDING CM, 1966, J MOL BIOL, V18, P235, DOI 10.1016/S0022-2836(66)80243-7; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Roberts JW, 2006, SCIENCE, V314, P1097, DOI 10.1126/science.1135746; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Selvin P. R., 2008, SINGLE MOL TECHNIQUE, P3; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shi J, 2006, P NATL ACAD SCI USA, V103, P5775, DOI 10.1073/pnas.0510482103; SRIPRAKASH KS, 1975, J BIOL CHEM, V250, P5438; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; THOMAS KR, 1978, J BIOL CHEM, V253, P424; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Wong CJ, 2006, J MOL BIOL, V362, P26, DOI 10.1016/j.jmb.2006.07.016; Wong CJ, 2005, J MOL BIOL, V352, P765, DOI 10.1016/j.jmb.2005.07.056; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Yin J, 2005, CHEM BIOL, V12, P999, DOI 10.1016/j.chembiol.2005.07.006; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	48	43	43	5	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					367	374		10.1038/NCHEMBIO.561	http://dx.doi.org/10.1038/NCHEMBIO.561			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21552271	Green Accepted			2022-12-25	WOS:000290677900012
J	Nieman, KM; Kenny, HA; Penicka, CV; Ladanyi, A; Buell-Gutbrod, R; Zillhardt, MR; Romero, IL; Carey, MS; Mills, GB; Hotamisligil, GS; Yamada, SD; Peter, ME; Gwin, K; Lengyel, E				Nieman, Kristin M.; Kenny, Hilary A.; Penicka, Carla V.; Ladanyi, Andras; Buell-Gutbrod, Rebecca; Zillhardt, Marion R.; Romero, Iris L.; Carey, Mark S.; Mills, Gordon B.; Hotamisligil, Goekhan S.; Yamada, S. Diane; Peter, Marcus E.; Gwin, Katja; Lengyel, Ernst			Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth	NATURE MEDICINE			English	Article							ACID-BINDING PROTEIN; CELL-GROWTH; CARCINOMA CELLS; PROSTATE-CANCER; METABOLISM; PATHWAY; AP2; PHOSPHORYLATION; OXIDATION; GLUCOSE	Intra-abdominal tumors, such as ovarian cancer(1,2), have a clear predilection for metastasis to the omentum, an organ primarily composed of adipocytes. Currently, it is unclear why tumor cells preferentially home to and proliferate in the omentum, yet omental metastases typically represent the largest tumor in the abdominal cavities of women with ovarian cancer. We show here that primary human omental adipocytes promote homing, migration and invasion of ovarian cancer cells, and that adipokines including interleukin-8 (IL-8) mediate these activities. Adipocyte-ovarian cancer cell coculture led to the direct transfer of lipids from adipocytes to ovarian cancer cells and promoted in vitro and in vivo tumor growth. Furthermore, coculture induced lipolysis in adipocytes and beta-oxidation in cancer cells, suggesting adipocytes act as an energy source for the cancer cells. A protein array identified upregulation of fatty acid-binding protein 4 (FABP4, also known as aP2) in omental metastases as compared to primary ovarian tumors, and FABP4 expression was detected in ovarian cancer cells at the adipocyte-tumor cell interface. FABP4 deficiency substantially impaired metastatic tumor growth in mice, indicating that FABP4 has a key role in ovarian cancer metastasis. These data indicate adipocytes provide fatty acids for rapid tumor growth, identifying lipid metabolism and transport as new targets for the treatment of cancers where adipocytes are a major component of the microenvironment.	[Nieman, Kristin M.; Kenny, Hilary A.; Penicka, Carla V.; Ladanyi, Andras; Zillhardt, Marion R.; Romero, Iris L.; Yamada, S. Diane; Lengyel, Ernst] Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA; [Buell-Gutbrod, Rebecca; Gwin, Katja] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Carey, Mark S.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Broad Inst, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, MIT, Boston, MA 02115 USA; [Peter, Marcus E.] Northwestern Univ, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA	University of Chicago; University of Chicago; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Northwestern University; Feinberg School of Medicine	Lengyel, E (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA.	elengyel@uchicago.edu	Lengyel, Ernst/D-9220-2014; Romero, Iris/N-8451-2018	Lengyel, Ernst/0000-0001-8624-1507; Romero, Iris/0000-0001-5849-5024; Nieman, Kristin/0000-0001-7529-0872; Peter, Marcus Ernst/0000-0003-3216-036X; Curtis, Marion/0000-0002-7152-6929	Burroughs Wellcome Fund; Ovarian Cancer Research Fund; US National Cancer Institute [R01 CA111882]; Bears Care; Committee on Cancer Biology at the University of Chicago; National Cancer Institute [T32 CA959421, K99 CA134750]; US National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK064360]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA169604, K99CA134750, P50CA098258, R01CA111882, P30CA016672, U01CA151461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064360] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ovarian Cancer Research Fund; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bears Care; Committee on Cancer Biology at the University of Chicago; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. F. Haney (University of Chicago) for collecting omental biopsies and D. Bernlohr (University of Minnesota) for helpful discussions and kindly providing the FABP4 inhibitor. We thank S. Dogan for her contribution to the initiation of this project, G. Isenberg (University of Chicago) for editing the manuscript and A. Mitra (University of Chicago) for helpful discussions regarding the in vitro homing assay. We also thank K. Roby (University of Kansas Medical Center), N. Auersperg (University of British Columbia) and C. Clevenger (Northwestern University) for providing the ID8, IOSE and T47D cell lines, respectively. Finally, we thank all the patients, resident physicians and attending physicians in the Department of Obstetrics and Gynecology at the University of Chicago; without their commitment to tissue donation, this project would not have been possible. E. L. holds a Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund. He is also supported by grants from the Ovarian Cancer Research Fund (Liz Tilberis Scholars Program), the US National Cancer Institute (R01 CA111882) and Bears Care, the charitable beneficiary of the Chicago Bears Football Club. K. M. N. is funded by a Cancer Biology Training Grant from the Committee on Cancer Biology at the University of Chicago and the National Cancer Institute (T32 CA959421). H. A. K. is supported by an award from the National Cancer Institute K99 CA134750). G. S. H. is supported by a grant from the US National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK064360).	Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; ELLIOTT BE, 1992, INT J CANCER, V51, P416, DOI 10.1002/ijc.2910510314; Folkins AK, 2009, GYNECOL ONCOL, V113, P391, DOI 10.1016/j.ygyno.2009.01.013; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gagnon A, 2010, METABOLISM, V59, P547, DOI 10.1016/j.metabol.2009.08.018; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Hertzel AV, 2009, J MED CHEM, V52, P6024, DOI 10.1021/jm900720m; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; RODBELL M, 1964, J BIOL CHEM, V239, P375; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; Tokuda Y, 2003, BJU INT, V91, P716, DOI 10.1046/j.1464-410X.2003.04218.x; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	36	1328	1379	10	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1498	U207		10.1038/nm.2492	http://dx.doi.org/10.1038/nm.2492			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22037646	Green Accepted			2022-12-25	WOS:000296779300042
J	Dobbins, SE; Broderick, P; Melin, B; Feychting, M; Johansen, C; Andersson, U; Brannstrom, T; Schramm, J; Olver, B; Lloyd, A; Ma, YP; Hosking, FJ; Lonn, S; Ahlbom, A; Henriksson, R; Schoemaker, MJ; Hepworth, SJ; Hoffmann, P; Muhleisen, TW; Nothen, MM; Moebus, S; Eisele, L; Kosteljanetz, M; Muir, K; Swerdlow, A; Simon, M; Houlston, RS				Dobbins, Sara E.; Broderick, Peter; Melin, Beatrice; Feychting, Maria; Johansen, Christoffer; Andersson, Ulrika; Brannstrom, Thomas; Schramm, Johannes; Olver, Bianca; Lloyd, Amy; Ma, Yussanne P.; Hosking, Fay J.; Lonn, Stefan; Ahlbom, Anders; Henriksson, Roger; Schoemaker, Minouk J.; Hepworth, Sarah J.; Hoffmann, Per; Muehleisen, Thomas W.; Noethen, Markus M.; Moebus, Susanne; Eisele, Lewin; Kosteljanetz, Michael; Muir, Kenneth; Swerdlow, Anthony; Simon, Matthias; Houlston, Richard S.			Common variation at 10p12.31 near MLLT10 influences meningioma risk	NATURE GENETICS			English	Article								To identify susceptibility loci for meningioma, we conducted a genome-wide association study of 859 affected individuals (cases) and 704 controls with validation in two independent sample sets totaling 774 cases and 1,764 controls. We identified a new susceptibility locus for meningioma at 10p12.31 (MLLT10, rs11012732, odds ratio = 1.46, P-combined = 1.88 x 10(-14)). This finding advances our understanding of the genetic basis of meningioma development.	[Dobbins, Sara E.; Broderick, Peter; Olver, Bianca; Lloyd, Amy; Ma, Yussanne P.; Hosking, Fay J.; Muir, Kenneth] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Melin, Beatrice; Andersson, Ulrika; Henriksson, Roger] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Feychting, Maria; Ahlbom, Anders] Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden; [Johansen, Christoffer] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Schramm, Johannes; Simon, Matthias] Univ Kliniken Bonn, Neurochirurg Klin, Bonn, Germany; [Lonn, Stefan] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Henriksson, Roger] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Schoemaker, Minouk J.; Swerdlow, Anthony] Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England; [Hepworth, Sarah J.] Univ Leeds, Ctr Epidemiol & Biostat, Leeds, W Yorkshire, England; [Hoffmann, Per; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Moebus, Susanne; Eisele, Lewin] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Univ Hosp Essen, Essen, Germany; [Kosteljanetz, Michael] Rigshosp, Dept Neurosurg, DK-2100 Copenhagen, Denmark; [Muir, Kenneth] Univ Warwick, Hlth Serv Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of London; Institute of Cancer Research - UK; Umea University; Karolinska Institutet; Danish Cancer Society; Umea University; University of Bonn; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of London; Institute of Cancer Research - UK; University of Leeds; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Duisburg Essen; Rigshospitalet; University of Copenhagen; University of Warwick	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	Henriksson, Roger/AAI-8608-2020; Simon, Matthias/F-3046-2014; Johansen, Christoffer/AAG-7916-2020; Hoffmann, Per/A-5149-2010	Johansen, Christoffer/0000-0002-4384-206X; Hoffmann, Per/0000-0002-6573-983X; Moebus, Susanne/0000-0002-0072-5410; Broderick, Peter/0000-0002-8348-5829; Schoemaker, Minouk/0000-0001-8403-2234; Hosking, Fay/0000-0002-1101-039X; Nothen, Markus/0000-0002-8770-2464; Fleming, Sarah/0000-0002-7655-4806; Houlston, Richard/0000-0002-5268-0242; Swerdlow, Anthony/0000-0001-5550-4159	Cancer Research UK [C1298/A8362]; DJ Fielding Medical Research Trust; National Health Service (NHS); European Union [QLK4-CT-1999-01563]; International Union against Cancer (UICC); Mobile Manufacturers' Forum and Global System for Mobile Communications Association; Swedish Research Council; Cancer Foundation of Northern Sweden; Swedish Cancer Society; Nordic Cancer Union; Danish Cancer Society; Mobile Telecommunications and Health Research (MTHR) Programme; Health and Safety Executive; Department of Health; Safety Executive; UK Network Operators; Emil Aaltonen Foundation	Cancer Research UK(Cancer Research UK); DJ Fielding Medical Research Trust; National Health Service (NHS); European Union(European Commission); International Union against Cancer (UICC); Mobile Manufacturers' Forum and Global System for Mobile Communications Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Foundation of Northern Sweden; Swedish Cancer Society(Swedish Cancer Society); Nordic Cancer Union; Danish Cancer Society(Danish Cancer Society); Mobile Telecommunications and Health Research (MTHR) Programme; Health and Safety Executive; Department of Health; Safety Executive; UK Network Operators; Emil Aaltonen Foundation	Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund) provided principal funding for the study. Additional support for the UK study was provided by the DJ Fielding Medical Research Trust. We acknowledge National Health Service (NHS) funding to the National Institute for Health Research (NIHR) Biomedical Research Centre.; The UK, Swedish and Danish INTERPHONE studies were supported by the European Union Fifth Framework Program 'Quality of Life and Management of Living Resources' (contract number QLK4-CT-1999-01563) and the International Union against Cancer (UICC). The UICC received funds for this purpose from the Mobile Manufacturers' Forum and Global System for Mobile Communications Association. Provision of funds from the UICC was governed by agreements that guaranteed INTERPHONE's complete scientific independence. These agreements are publicly available at http://www.iarc.fr/en/research-groups/RAD/RCAd. html. The Swedish INTERPHONE center was also supported by the Swedish Research Council, the Cancer Foundation of Northern Sweden, the Swedish Cancer Society and the Nordic Cancer Union, and the Danish center was supported by the Danish Cancer Society. The UK centers were also supported by the Mobile Telecommunications and Health Research (MTHR) Programme, and the Northern UK center was supported by the Health and Safety Executive, Department of Health and Safety Executive and the UK Network Operators (O<INF>2</INF>, Orange, T-Mobile, Vodafone and '3'). A. A. received support from the Emil Aaltonen Foundation. We acknowledge the participation of the clinicians and other hospital staff, cancer registries and study staff who contributed to the blood sample and data collection for this study (as detailed in ref. 14).	Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P1137; Hepworth SJ, 2006, BMJ-BRIT MED J, V332, P883, DOI 10.1136/bmj.38720.687975.55; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Mihaila D, 2003, CLIN CANCER RES, V9, P4443; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Simon M, 2007, NEUROSURGERY, V60, P787, DOI 10.1227/01.NEU.0000255421.78431.AE; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3	14	37	37	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					825	827		10.1038/ng.879	http://dx.doi.org/10.1038/ng.879			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21804547	Green Accepted			2022-12-25	WOS:000294325800005
J	Girard, SL; Gauthier, J; Noreau, A; Xiong, L; Zhou, SR; Jouan, L; Dionne-Laporte, A; Spiegelman, D; Henrion, E; Diallo, O; Thibodeau, P; Bachand, I; Bao, JYJ; Tong, AHY; Lin, CH; Millet, B; Jaafari, N; Joober, R; Dion, PA; Lok, S; Krebs, MO; Rouleau, GA				Girard, Simon L.; Gauthier, Julie; Noreau, Anne; Xiong, Lan; Zhou, Sirui; Jouan, Loubna; Dionne-Laporte, Alexandre; Spiegelman, Dan; Henrion, Edouard; Diallo, Ousmane; Thibodeau, Pascale; Bachand, Isabelle; Bao, Jessie Y. J.; Tong, Amy Hin Yan; Lin, Chi-Ho; Millet, Bruno; Jaafari, Nematollah; Joober, Ridha; Dion, Patrick A.; Lok, Si; Krebs, Marie-Odile; Rouleau, Guy A.			Increased exonic de novo mutation rate in individuals with schizophrenia	NATURE GENETICS			English	Article							V(D)J RECOMBINATION; MENTAL-RETARDATION; COMMON VARIANTS; ASSOCIATION; SUBSTITUTIONS; DISEASE; GENE	Schizophrenia is a severe psychiatric disorder that profoundly affects cognitive, behavioral and emotional processes. The wide spectrum of symptoms and clinical variability in schizophrenia suggest a complex genetic etiology, which is consistent with the numerous loci thus far identified by linkage, copy number variation and association studies(1-4). Although schizophrenia heritability may be as high as similar to 80%, the genes responsible for much of this heritability remain to be identified(5). Here we sequenced the exomes of 14 schizophrenia probands and their parents. We identified 15 de novo mutations (DNMs) in eight probands, which is significantly more than expected considering the previously reported DNM rate(6-8). In addition, 4 of the 15 identified DNMs are nonsense mutations, which is more than what is expected by chance(9). Our study supports the notion that DNMs may account for some of the heritability reported for schizophrenia while providing a list of genes possibly involved in disease pathogenesis.	[Girard, Simon L.; Gauthier, Julie; Noreau, Anne; Xiong, Lan; Zhou, Sirui; Jouan, Loubna; Dionne-Laporte, Alexandre; Spiegelman, Dan; Henrion, Edouard; Diallo, Ousmane; Thibodeau, Pascale; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Ctr Hosp Univ Montreal Res Ctr, Montreal, PQ, Canada; [Bachand, Isabelle; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ, Canada; [Bao, Jessie Y. J.; Tong, Amy Hin Yan; Lin, Chi-Ho; Lok, Si] Univ Hong Kong, Li Ka Shing Fac Med, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Millet, Bruno; Jaafari, Nematollah; Krebs, Marie-Odile] Univ Paris 05, INSERM, Lab Physiopathol Malad Psychiat, Ctr Psychiat & Neurosci UMR 894, Paris, France; [Millet, Bruno] Univ Rennes 1, CH Guillaume Regnier Serv Hosp Univ Psychiat, Rennes, France; [Jaafari, Nematollah] Univ Poitiers, CHU, Ctr Hosp Henri Laborit, Unite Rech Clin Intersectorielle Psychiat,INSERM, Poitiers, France; [Joober, Ridha] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Dion, Patrick A.] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ, Canada; [Krebs, Marie-Odile] Univ Paris 05, Fac Med Paris Descartes, Serv Hosp Univ, Ctr Hosp St Anne, Paris, France; [Rouleau, Guy A.] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Hong Kong; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Universite de Rennes; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; McGill University; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, Ctr Excellence Neur, Ctr Hosp Univ Montreal Res Ctr, Montreal, PQ, Canada.	guy.rouleau@umontreal.ca	Krebs, Marie-Odile/O-2104-2017	Krebs, Marie-Odile/0000-0002-4715-9890; Girard, Simon/0000-0002-4089-2280; spiegelman, dan/0000-0003-4971-8868	Fondation Pierre Deniker; Genome Canada; Genome Quebec; Universite de Montreal; Canadian Foundation for Innovation, Brain & Behavior Research Foundation; Canadian Institutes of Health Research (CIHR) [RMF92086]	Fondation Pierre Deniker; Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal; Canadian Foundation for Innovation, Brain & Behavior Research Foundation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Subjects were selected from the Psydev study, promoted by INSERM, through the Collaborative Network for Family Study in Psychiatry ('Reseau d'etude familiale en Psychiatry', REFAPSY), supported by the Fondation Pierre Deniker. We wish to thank S. Bannour, M.-J. Dos Santos, M. A. Gorsane, N. Benjemaa, M. Chayet, S. Leroy, F. Mouaffak, K. Ossian and F. Polides for participating in recruitment of subjects and for their technical help. This work was supported by Genome Canada and Genome Quebec and received co-funding from Universite de Montreal for the Synapse to Disease (S2D) project as well as funding from the Canadian Foundation for Innovation, Brain & Behavior Research Foundation. Bioinformatic analysis was supported by a Canadian Institutes of Health Research (CIHR) Team grant (RMF92086). G. A. R. is grateful for the support received through his positions as Canada Research Chair in Genetics of the Nervous System and Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases. N. Jaafari was supported by an award, bourse chercheur invite, of the Region Poitou-Charente.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hollenbach E, 1998, NEUROLOGY, V50, P1905, DOI 10.1212/WNL.50.6.1905; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6	29	292	298	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					860	U65		10.1038/ng.886	http://dx.doi.org/10.1038/ng.886			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21743468				2022-12-25	WOS:000294325800011
J	Haemmerle, G; Moustafa, T; Woelkart, G; Buttner, S; Schmidt, A; van de Weijer, T; Hesselink, M; Jaeger, D; Kienesberger, PC; Zierler, K; Schreiber, R; Eichmann, T; Kolb, D; Kotzbeck, P; Schweiger, M; Kumari, M; Eder, S; Schoiswohl, G; Wongsiriroj, N; Pollak, NM; Radner, FPW; Preiss-Landl, K; Kolbe, T; Rulicke, T; Pieske, B; Trauner, M; Lass, A; Zimmermann, R; Hoefler, G; Cinti, S; Kershaw, EE; Schrauwen, P; Madeo, F; Mayer, B; Zechner, R				Haemmerle, Guenter; Moustafa, Tarek; Woelkart, Gerald; Buettner, Sabrina; Schmidt, Albrecht; van de Weijer, Tineke; Hesselink, Matthijs; Jaeger, Doris; Kienesberger, Petra C.; Zierler, Kathrin; Schreiber, Renate; Eichmann, Thomas; Kolb, Dagmar; Kotzbeck, Petra; Schweiger, Martina; Kumari, Manju; Eder, Sandra; Schoiswohl, Gabriele; Wongsiriroj, Nuttaporn; Pollak, Nina M.; Radner, Franz P. W.; Preiss-Landl, Karina; Kolbe, Thomas; Ruelicke, Thomas; Pieske, Burkert; Trauner, Michael; Lass, Achim; Zimmermann, Robert; Hoefler, Gerald; Cinti, Saverio; Kershaw, Erin E.; Schrauwen, Patrick; Madeo, Frank; Mayer, Bernd; Zechner, Rudolf			ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1	NATURE MEDICINE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; HORMONE-SENSITIVE LIPASE; LIPID STORAGE DISEASE; ACID-METABOLIZING ENZYMES; TRIGLYCERIDE LIPASE; ENERGY-METABOLISM; HYPOLIPIDEMIC DRUGS; INSULIN SENSITIVITY; GENE-EXPRESSION; TRANSGENIC MICE	Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate genes involved in energy metabolism and inflammation. For biological activity, PPARs require cognate lipid ligands, heterodimerization with retinoic X receptors, and coactivation by PPAR-gamma coactivator-1 alpha or PPAR-gamma coactivator-1 beta (PGC-1 alpha or PGC-1 beta, encoded by Ppargc1a and Ppargc1b, respectively). Here we show that lipolysis of cellular triglycerides by adipose triglyceride lipase (patatin-like phospholipase domain containing protein 2, encoded by Pnpla2; hereafter referred to as Atgl) generates essential mediator(s) involved in the generation of lipid ligands for PPAR activation. Atgl deficiency in mice decreases mRNA levels of PPAR-alpha and PPAR-delta target genes. In the heart, this leads to decreased PGC-1 alpha and PGC-1 beta expression and severely disrupted mitochondrial substrate oxidation and respiration; this is followed by excessive lipid accumulation, cardiac insufficiency and lethal cardiomyopathy. Reconstituting normal PPAR target gene expression by pharmacological treatment of Atgl-deficient mice with PPAR-alpha agonists completely reverses the mitochondrial defects, restores normal heart function and prevents premature death. These findings reveal a potential treatment for the excessive cardiac lipid accumulation and often-lethal cardiomyopathy in people with neutral lipid storage disease, a disease marked by reduced or absent ATGL activity.	[Haemmerle, Guenter; Buettner, Sabrina; Jaeger, Doris; Kienesberger, Petra C.; Zierler, Kathrin; Schreiber, Renate; Eichmann, Thomas; Kolb, Dagmar; Kotzbeck, Petra; Schweiger, Martina; Kumari, Manju; Eder, Sandra; Schoiswohl, Gabriele; Wongsiriroj, Nuttaporn; Pollak, Nina M.; Radner, Franz P. W.; Preiss-Landl, Karina; Lass, Achim; Zimmermann, Robert; Madeo, Frank; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, Graz, Austria; [Moustafa, Tarek; Trauner, Michael] Med Univ Graz, Lab Expt & Mol Hepatol, Dept Internal Med, Graz, Austria; [Woelkart, Gerald; Mayer, Bernd] Graz Univ, Dept Pharmacol & Toxicol, Graz, Austria; [Schmidt, Albrecht; Pieske, Burkert] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria; [van de Weijer, Tineke; Schrauwen, Patrick] Maastricht Univ Med Ctr, Dept Human Biol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Hesselink, Matthijs; Kolbe, Thomas] Maastricht Univ Med Ctr, Dept Human Movement Sci, NUTRIM, Maastricht, Netherlands; [Ruelicke, Thomas] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria; [Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Cinti, Saverio] Univ Ancona, Dept Mol Pathol & Innovat Therapies, Fac Med, Politecn Marche, Ancona, Italy; [Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA USA	University of Graz; Medical University of Graz; University of Graz; Medical University of Graz; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Veterinary Medicine Vienna; Medical University of Graz; Marche Polytechnic University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	rudolf.zechner@uni-graz.at	Hoefler, Gerald/B-7006-2008; Moustafa, Tarek/P-9509-2016; Lass, Achim/C-3332-2008; Kershaw, Erin E/G-9587-2013; Pollak, Nina M./L-3308-2018; Hoefler, Gerald/H-1796-2016	Moustafa, Tarek/0000-0002-6755-4687; Lass, Achim/0000-0002-8190-7151; Kershaw, Erin E/0000-0002-3887-4868; Pollak, Nina M./0000-0001-8437-3303; Madeo, Frank/0000-0002-5070-1329; Schmidt, Albrecht/0000-0003-4783-4603; Zimmermann, Robert/0000-0002-7354-870X; Schweiger, Martina/0000-0002-3419-1007; Schoiswohl, Gabriele/0000-0002-7346-2834; Kienesberger, Petra/0000-0001-9643-8338; schrauwen, patrick/0000-0002-0973-847X; Eichmann, Thomas O./0000-0002-8521-2795; Schreiber, Renate/0000-0002-3475-157X; Buttner, Sabrina/0000-0002-2786-8542; Trauner, Michael/0000-0002-1275-6425; Radner, Franz/0000-0003-3466-0181; Kotzbeck, Petra/0000-0003-4039-3745; Hoefler, Gerald/0000-0002-9056-3063; Mayer, Bernd/0000-0002-2921-3494; Haemmerle, Guenter/0000-0001-9900-5896; Zechner, Rudolf/0000-0001-5483-1182; Woelkart, Gerald/0000-0003-2552-1999; CINTI, Saverio/0000-0003-0362-5017	GOLD - Genomics of Lipid-Associated Disorders; Forschungsforderungsgesellschaft (FFG); Bundesministerium fur Wissenschaft und Forschung (BMWF); Spezialforschungsbereich (SFB [LIPOTOX F30]; Doktoratskolleg: Molecular Enzymology [W901]; Austrian Science Fund (FWF) [2007 Z136, P20602]; Targeting Obesity-driven Inflammation (TOBI) [201608]; LipidomicNet [202272]; European Commission; County of Styria; City of Graz; Netherlands Organization for Scientific Research [918.96.618]; Center for Translational Molecular Medicine (CTMM) [01C-104]; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Austrian Science Fund (FWF) [F 3008, F 3002, W 901, Z 136, F 3003] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090166] Funding Source: NIH RePORTER	GOLD - Genomics of Lipid-Associated Disorders; Forschungsforderungsgesellschaft (FFG); Bundesministerium fur Wissenschaft und Forschung (BMWF); Spezialforschungsbereich (SFB; Doktoratskolleg: Molecular Enzymology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Targeting Obesity-driven Inflammation (TOBI); LipidomicNet; European Commission(European CommissionEuropean Commission Joint Research Centre); County of Styria; City of Graz; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Translational Molecular Medicine (CTMM); Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the following grants: GOLD - Genomics of Lipid-Associated Disorders as part of the Austrian Genome Project (GEN-AU) funded by the Forschungsforderungsgesellschaft (FFG) and the Bundesministerium fur Wissenschaft und Forschung (BMWF); Spezialforschungsbereich (SFB) LIPOTOX F30, Doktoratskolleg: Molecular Enzymology W901, the Wittgenstein Award 2007 Z136 and research grant P20602 funded by the Austrian Science Fund (FWF); Targeting Obesity-driven Inflammation (TOBI) contract no. 201608 and LipidomicNet contract no. 202272 funded by the European Commission. Additional funding for the SFB LIPOTOX was granted by the County of Styria and the City of Graz. P.S. is supported by the Research Grant for Innovative Research from the Netherlands Organization for Scientific Research (Grant 918.96.618). T.v.d.W. was supported by the Center for Translational Molecular Medicine (CTMM) project PREDICCt (Grant 01C-104) and the Netherlands Heart Foundation, the Dutch Diabetes Research Foundation and the Dutch Kidney Foundation. We thank E. Zechner and C. Schober-Trummler for proofreading the manuscript and S. Lang for the preparation of the cartoon. The pBS II SK+ vector containing the alpha-MHC promoter region (Genbank: U71441) was provided by J. Robbins (University of Cincinnati). The expression plasmids for (PPRE)<INF>6</INF>-tk-luciferase and human PPAR-alpha were provided by B. Staels (University of Lille).	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Blattner JR, 2001, ANAL BIOCHEM, V295, P220, DOI 10.1006/abio.2001.5219; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cheng LH, 2004, BIOCHEM BIOPH RES CO, V313, P277, DOI 10.1016/j.bbrc.2003.11.127; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GULICK J, 1991, J BIOL CHEM, V266, P9180; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Igal RA, 1997, J PEDIATR GASTR NUTR, V25, P541, DOI 10.1097/00005176-199711000-00011; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Nemoto Y, 2000, J CLIN INVEST, V105, P1819, DOI 10.1172/JCI9575; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rosenson Robert S, 2008, Expert Rev Cardiovasc Ther, V6, P1319, DOI 10.1586/14779072.6.10.1319; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Song QJ, 2003, J CLIN INVEST, V111, P859, DOI 10.1172/JCI200316738; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vikramadithyan RK, 2005, J PHARMACOL EXP THER, V313, P586, DOI 10.1124/jpet.104.080259; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhao G, 2000, AM J PHYSIOL-HEART C, V279, pH520, DOI 10.1152/ajpheart.2000.279.2.H520; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	60	483	492	5	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1076	U82		10.1038/nm.2439	http://dx.doi.org/10.1038/nm.2439			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857651	Green Accepted			2022-12-25	WOS:000294605100027
J	Liu, F; Park, JE; Qian, WJ; Lim, D; Graber, M; Berg, T; Yaffe, MB; Lee, KS; Burke, TR				Liu, Fa; Park, Jung-Eun; Qian, Wen-Jian; Lim, Dan; Graeber, Martin; Berg, Thorsten; Yaffe, Michael B.; Lee, Kyung S.; Burke, Terrence R., Jr.			Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel	NATURE CHEMICAL BIOLOGY			English	Article							POLO-LIKE KINASES; SMALL-MOLECULE INHIBITOR; BOX DOMAIN; CANCER-CELLS; PEPTIDE; POLO-LIKE-KINASE-1; RECOGNITION; CHEMISTRY; DISCOVERY; DELIVERY	We obtained unanticipated synthetic byproducts from alkylation of the delta(1) nitrogen (N3) of the histidine imidazole ring of the polo-like kinase-1 (Plk1) polo-box domain (PBD)-binding peptide PLHSpT. For the highest-affinity byproduct, bearing a C6H5(CH2)(8)- group, a Plk1 PBD cocrystal structure revealed a new binding channel that had previously been occluded. An N-terminal PEGylated version of this peptide containing a hydrolytically stable phosphothreonyl residue (pT) bound the Plk1 PBD with affinity equal to that of the non-PEGylated parent but showed markedly less interaction with the PBDs of the two closely related proteins Plk2 and Plk3. Treatment of cultured cells with this PEGylated peptide resulted in delocalization of Plk1 from centrosomes and kinetochores and in chromosome misalignment that effectively induced mitotic block and apoptotic cell death. This work provides insights that might advance efforts to develop Plk1 PBD-binding inhibitors as potential Plk1-specific anticancer agents.	[Liu, Fa; Qian, Wen-Jian; Burke, Terrence R., Jr.] NCI, Biol Chem Lab, Mol Discovery Program, Ctr Canc Res, Frederick, MD 21701 USA; [Park, Jung-Eun; Lee, Kyung S.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lim, Dan; Yaffe, Michael B.] MIT, Ctr Canc Res, Dept Biol & Biol Engn, Cambridge, MA 02139 USA; [Graeber, Martin; Berg, Thorsten] Univ Leipzig, Inst Organ Chem, Leipzig, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Massachusetts Institute of Technology (MIT); Leipzig University	Liu, F (corresponding author), NCI, Biol Chem Lab, Mol Discovery Program, Ctr Canc Res, Frederick, MD 21701 USA.	kyunglee@mail.nih.gov; tburke@helix.nih.gov	Qian, Wenjian/L-4982-2017; Burke, Terrence R/N-2601-2014; Berg, Thorsten/A-1306-2012	Qian, Wenjian/0000-0002-0063-8405; Burke, Terrence/0000-0001-9925-8586	US National Institutes of Health [ZIA BC 006198, ZIA BC 010681, GM60594, GM68762, CA112967]; Center for Cancer Research; National Cancer Institute-Frederick; US National Cancer Institute; Deutsche Forschungsgemeinschaft [BE 4572/1-1]; NATIONAL CANCER INSTITUTE [Z01BC006198, ZIABC006198, ZIABC010681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM060594] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute-Frederick; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants ZIA BC 006198 (T.R.B.) and ZIA BC 010681 (K.S.L..) of the Intramural Research Program of the US National Institutes of Health, Center for Cancer Research, National Cancer Institute-Frederick and the US National Cancer Institute, US National Institutes of Health (F.L., J.-E.P., W.-J.Q., K.S.L. and T.R.B.), US National Institutes of Health grants GM60594, GM68762 and CA112967 (M. BY.) and the Deutsche Forschungsgemeinschaft (grant BE 4572/1-1) (TB.). We thank M. Dyba of the Biophysics Resource of the Structural Biophysics Laboratory, National Cancer Institute Frederick for assistance in performing tandem MS studies and W. Dai, New York University School of Medicine for the Flag-Plk3 construct. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial product or organizations imply endorsement by the US government.	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bellouard F, 1999, EUR J ORG CHEM, V1999, P3257; Bhadra D, 2002, PHARMAZIE, V57, P5; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Goh KC, 2004, DRUG DEVELOP RES, V62, P349, DOI 10.1002/ddr.10392; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Huggins DJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000880; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kanda Y, 2003, BIOORG MED CHEM LETT, V13, P455, DOI 10.1016/S0960-894X(02)00949-6; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Khedkar A, 2010, DIABETES OBES METAB, V12, P659, DOI 10.1111/j.1463-1326.2010.01213.x; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li L, 2009, ACTA PHARMACOL SIN, V30, P1443, DOI 10.1038/aps.2009.141; Liu F, 2009, TETRAHEDRON, V65, P9673, DOI 10.1016/j.tet.2009.09.093; Liu XQ, 2003, CELL CYCLE, V2, P424, DOI 10.4161/cc.2.5.505; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lu LY, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-4; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; McGovern S. L., 2006, COMPR MED CHEM 2, V2, P737; McInnes C, 2005, CURR TOP MED CHEM, V5, P181, DOI 10.2174/1568026053507660; Miller MA, 2006, BIOCONJUGATE CHEM, V17, P267, DOI 10.1021/bc0501000; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Reindl W, 2009, CHEMBIOCHEM, V10, P1145, DOI 10.1002/cbic.200900059; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sledz P, 2011, ANGEW CHEM INT EDIT, V50, P4003, DOI 10.1002/anie.201008019; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Swamy KCK, 2009, CHEM REV, V109, P2551, DOI 10.1021/cr800278z; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tsuchida E, 2009, BIOCONJUGATE CHEM, V20, P1419, DOI 10.1021/bc800431d; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Watanabe N, 2009, J BIOL CHEM, V284, P2344, DOI 10.1074/jbc.M805308200; Wipf P, 2009, CURR TOP MED CHEM, V9, P1194, DOI 10.2174/156802609789753590; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	49	83	93	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					595	601		10.1038/nchembio.614	http://dx.doi.org/10.1038/nchembio.614			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21765407	Green Accepted, Green Submitted			2022-12-25	WOS:000294381400009
J	Park, S; Szumlanski, AL; Gu, FW; Guo, F; Nielsen, E				Park, Sungjin; Szumlanski, Amy L.; Gu, Fangwei; Guo, Feng; Nielsen, Erik			A role for CSLD3 during cell-wall synthesis in apical plasma membranes of tip-growing root-hair cells	NATURE CELL BIOLOGY			English	Article							CELLULOSE SYNTHESIS INHIBITOR; ARABIDOPSIS-THALIANA; SYNTHASE COMPLEXES; GROWTH; MICROTUBULES; PROTEIN; MUTANTS; ENCODES; 2,6-DICHLOROBENZONITRILE; MORPHOGENESIS	In plants, cell shape is defined by the cell wall, and changes in cell shape and size are dictated by modification of existing cell walls and deposition of newly synthesized cell-wall material(1). In root hairs, expansion occurs by a process called tip growth, which is shared by root hairs, pollen tubes and fungal hyphae(1). We show that cellulose-like polysaccharides are present in root-hair tips, and de novo synthesis of these polysaccharides is required for tip growth. We also find that eYFP-CSLD3 proteins, but not CESA cellulose synthases, localize to a polarized plasma-membrane domain in root hairs. Using biochemical methods and genetic complementation of a csld3 mutant with a chimaeric CSLD3 protein containing a CESA6 catalytic domain, we provide evidence that CSLD3 represents a distinct (1 -> 4)-beta-glucan synthase activity in apical plasma membranes during tip growth in root-hair cells.	[Park, Sungjin; Szumlanski, Amy L.; Gu, Fangwei; Guo, Feng; Nielsen, Erik] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Nielsen, E (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	nielsene@umich.edu	Nielsen, Erik/G-5843-2013	PARK, SUNGJIN/0000-0003-4856-7965	Department of Energy [DE-FG02-07ER15887]; National Science Foundation [0937323]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	The authors would like to thank C. Somerville and H. Hofte for sharing eYFP-CESA6- and eGFP-CESA3-transformed lines, C. Collins for providing access to the spinning-disc confocal microscope and O. Shafer for access to the Olympus Fluoview confocal microscope. We would also like to thank S. Clark, S. DeBolt, A. Liepman and J. Schiefelbein for discussions. This work was supported by grants from the Department of Energy, DE-FG02-07ER15887 (E.N.), and the National Science Foundation, 0937323 (E.N.).	Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; BASKIN TI, 1992, AUST J PLANT PHYSIOL, V19, P427, DOI 10.1071/PP9920427; Bernal AJ, 2008, PLANT PHYSIOL, V148, P1238, DOI 10.1104/pp.108.121939; Bernal AJ, 2007, PLANT J, V52, P791, DOI 10.1111/j.1365-313X.2007.03281.x; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; Desnos T, 1996, DEVELOPMENT, V122, P683; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; EMONS AMC, 1989, CAN J BOT, V67, P2401, DOI 10.1139/b89-307; EMONS AMC, 1986, CAN J BOT, V64, P2201, DOI 10.1139/b86-293; EMONS AMC, 1987, PLANTA, V170, P145, DOI 10.1007/BF00397882; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Favery B, 2001, GENE DEV, V15, P79, DOI 10.1101/gad.188801; Galway ME, 1997, PLANTA, V201, P209, DOI 10.1007/BF01007706; Galway ME, 2011, PLANTA, V233, P985, DOI 10.1007/s00425-011-1355-6; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; NEWCOMB EH, 1965, J CELL BIOL, V27, P575, DOI 10.1083/jcb.27.3.575; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peng LC, 2001, PLANT PHYSIOL, V126, P981, DOI 10.1104/pp.126.3.981; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Rajangam AS, 2008, PLANT PHYSIOL, V148, P1283, DOI 10.1104/pp.108.121913; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; Scheible WR, 2004, CURR OPIN PLANT BIOL, V7, P285, DOI 10.1016/j.pbi.2004.03.006; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Wightman R, 2010, BIOCHEM SOC T, V38, P755, DOI 10.1042/BST0380755; Williamson RE, 2001, PROTOPLASMA, V215, P116, DOI 10.1007/BF01280308; Zeng WQ, 2008, PLANTA, V228, P823, DOI 10.1007/s00425-008-0785-2	40	92	93	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					973	U227		10.1038/ncb2294	http://dx.doi.org/10.1038/ncb2294			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21765420				2022-12-25	WOS:000293373700016
J	Soboloff, J; Madesh, M; Gill, DL				Soboloff, Jonathan; Madesh, Muniswamy; Gill, Donald L.			Sensing cellular stress through STIM proteins	NATURE CHEMICAL BIOLOGY			English	Article							TRPC CHANNELS; S-GLUTATHIONYLATION; CALCIUM; BINDING; SENSOR; ORAI		[Soboloff, Jonathan; Madesh, Muniswamy; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Soboloff, J (corresponding author), Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA.	dgill@temple.edu	Soboloff, Jonathan/I-6995-2012	Soboloff, Jonathan/0000-0001-5192-1297	NIAID NIH HHS [R01 AI058173] Funding Source: Medline; NIGMS NIH HHS [R01 GM097335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Mancarella S, 2009, CURR BIOL, V19, pR950, DOI 10.1016/j.cub.2009.08.051; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roberts-Thomson SJ, 2010, PHARMACOL THERAPEUT, V127, P121, DOI 10.1016/j.pharmthera.2010.04.016; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	28	33	34	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					488	492		10.1038/nchembio.619	http://dx.doi.org/10.1038/nchembio.619			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769090	Green Accepted			2022-12-25	WOS:000292825400004
J	Takahashi, S; Toyoda, A; Sekiyama, Y; Takagi, H; Nogawa, T; Uramoto, M; Suzuki, R; Koshino, H; Kumano, T; Panthee, S; Dairi, T; Ishikawa, J; Ikeda, H; Sakaki, Y; Osada, H				Takahashi, Shunji; Toyoda, Atsushi; Sekiyama, Yasuyo; Takagi, Hiroshi; Nogawa, Toshihiko; Uramoto, Masakazu; Suzuki, Ryuichiro; Koshino, Hiroyuki; Kumano, Takuto; Panthee, Suresh; Dairi, Tohru; Ishikawa, Jun; Ikeda, Haruo; Sakaki, Yoshiyuki; Osada, Hiroyuki			Reveromycin A biosynthesis uses RevG and RevJ for stereospecific spiroacetal formation	NATURE CHEMICAL BIOLOGY			English	Article							MODULAR POLYKETIDE SYNTHASES; MYXOBACTERIUM SORANGIUM-CELLULOSUM; EPIDERMAL-GROWTH-FACTOR; EUKARYOTIC CELL-GROWTH; GENE-CLUSTER; SACCHAROPOLYSPORA-ERYTHRAEA; SACCHAROMYCES-CEREVISIAE; OXIDATIVE CYCLIZATION; ENZYMATIC DOMAINS; OKADAIC ACID	Spiroacetal compounds are ubiquitous in nature, and their stereospecific structures are responsible for diverse pharmaceutical activities. Elucidation of the biosynthetic mechanisms that are involved in spiroacetal formation will open the door to efficient generation of stereospecific structures that are otherwise hard to synthesize chemically. However, the biosynthesis of these compounds is poorly understood, owing to difficulties in identifying the responsible enzymes and analyzing unstable intermediates. Here we comprehensively describe the spiroacetal formation involved in the biosynthesis of reveromycin A, which inhibits bone resorption and bone metastases of tumor cells by inducing apoptosis in osteoclasts. We performed gene disruption, systematic metabolite analysis, feeding of labeled precursors and conversion studies with recombinant enzymes. We identified two key enzymes, dihydroxy ketone synthase and spiroacetal synthase, and showed in vitro reconstruction of the stereospecific spiroacetal structure from a stable acyclic precursor. Our findings provide insights into the creation of a variety of biologically active spiroacetal compounds for drug leads.	[Takahashi, Shunji; Sekiyama, Yasuyo; Takagi, Hiroshi; Nogawa, Toshihiko; Uramoto, Masakazu; Suzuki, Ryuichiro; Koshino, Hiroyuki; Kumano, Takuto; Panthee, Suresh; Osada, Hiroyuki] RIKEN Adv Sci Inst, Dept Biol Chem, Saitama, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Shizuoka, Japan; [Dairi, Tohru] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 060, Japan; [Ishikawa, Jun] Natl Inst Infect Dis, Dept Bioact Mol, Tokyo, Japan; [Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Kanagawa, Japan; [Sakaki, Yoshiyuki] Toyohashi Univ Technol, Aichi, Japan	RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Hokkaido University; National Institute of Infectious Diseases (NIID); Kitasato University; Toyohashi University of Technology	Takahashi, S (corresponding author), RIKEN Adv Sci Inst, Dept Biol Chem, Saitama, Japan.	hisyo@riken.jp	Nogawa, Toshihiko/ABG-2652-2020; Osada, Hiroyuki/AAY-6254-2020; Osada, Hiroyuki/N-4305-2014; Takahashi, Shunji/N-6921-2015; Sekiyama, Yasuyo/F-2561-2017; Takahashi, Shunji/GLT-3245-2022; Dairi, Tohru/A-5448-2012; Koshino, Hiroyuki/N-7948-2015; Koshino, Hiroyuki/ABF-4899-2021; Kumano, Takuto/ABC-3242-2020; Panthee, Suresh/H-2754-2013; Nogawa, Toshihiko/C-4095-2017	Takahashi, Shunji/0000-0003-1684-9298; Sekiyama, Yasuyo/0000-0002-7057-0864; Takahashi, Shunji/0000-0003-1684-9298; Koshino, Hiroyuki/0000-0002-0954-9839; Koshino, Hiroyuki/0000-0002-0954-9839; Kumano, Takuto/0000-0002-9240-4074; Panthee, Suresh/0000-0003-4021-7936; Dairi, Tohru/0000-0002-3406-7970; Nogawa, Toshihiko/0000-0003-1270-5270	Naito Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan	Naito Foundation(Naito Memorial Foundation); RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Shimizu for discussions on spiroacetal formation; K. Wierzba for reading this paper; T. Nakamura for mass analysis; N. Dohmae for MALDI-TOF and N-terminal sequencing; and E. Oowada for technical assistance. We thank all the technical staff of the Sequence Technology Team at RIKEN Genomic Sciences Center for their assistance. This work was supported in part by the Naito Foundation, the Strategic Programs for R&D of RIKEN, a Grant-in-Aid for Creative Scientific Research and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AGTARAP A, 1967, J AM CHEM SOC, V89, P5737, DOI 10.1021/ja00998a062; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Benach J, 2002, BIOCHEMISTRY-US, V41, P14659, DOI 10.1021/bi0203684; BEVITT DJ, 1992, EUR J BIOCHEM, V204, P39, DOI 10.1111/j.1432-1033.1992.tb16603.x; Bhatt A, 2005, ANGEW CHEM INT EDIT, V44, P7075, DOI 10.1002/anie.200501757; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; DONADIO S, 1992, GENE, V111, P51, DOI 10.1016/0378-1119(92)90602-L; Frank B, 2007, CHEM BIOL, V14, P221, DOI 10.1016/j.chembiol.2006.11.013; Gallimore AR, 2006, CHEM BIOL, V13, P453, DOI 10.1016/j.chembiol.2006.01.013; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Holtzel A, 1998, J ANTIBIOT, V51, P699; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; KOSHINO H, 1992, J ANTIBIOT, V45, P1420, DOI 10.7164/antibiotics.45.1420; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Li WL, 2008, J BIOL CHEM, V283, P28607, DOI 10.1074/jbc.M804279200; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; Mayerhofer LE, 1998, ARCH MICROBIOL, V169, P339, DOI 10.1007/s002030050580; Miyamoto Y, 2002, J BIOL CHEM, V277, P28810, DOI 10.1074/jbc.M203827200; Muguruma H, 2005, CLIN CANCER RES, V11, P8822, DOI 10.1158/1078-0432.CCR-05-1335; Niggemann J, 2005, EUR J ORG CHEM, V2005, P5013, DOI 10.1002/ejoc.200500425; Oliynyk M, 2003, MOL MICROBIOL, V49, P1179, DOI 10.1046/j.1365-2958.2003.03571.x; OSADA H, 1991, J ANTIBIOT, V44, P259, DOI 10.7164/antibiotics.44.259; Paterson I, 2009, CHEM-ASIAN J, V4, P594, DOI 10.1002/asia.200800445; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; Sheppeck JE, 1997, J ORG CHEM, V62, P387, DOI 10.1021/jo961633s; Shimizu T, 2000, ORG LETT, V2, P2153, DOI 10.1021/ol0060634; Shimizu T, 2005, ORG LETT, V7, P5573, DOI 10.1021/ol052039k; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; TAKAHASHI H, 1992, J ANTIBIOT, V45, P1414, DOI 10.7164/antibiotics.45.1414; Takahashi H, 1997, ONCOL RES, V9, P7; Tanaka Y, 2002, J ANTIBIOT, V55, P904, DOI 10.7164/antibiotics.55.904; UBUKATA M, 1994, J CHEM SOC CHEM COMM, P1877, DOI 10.1039/c39940001877; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; WITKOWSKI A, 1991, J BIOL CHEM, V266, P18514; Woo JT, 2006, P NATL ACAD SCI USA, V103, P4729, DOI 10.1073/pnas.0505663103; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105	48	65	67	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					461	468		10.1038/NCHEMBIO.583	http://dx.doi.org/10.1038/NCHEMBIO.583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21642985				2022-12-25	WOS:000292252100014
J	Ma, C; Fan, R; Ahmad, H; Shi, QH; Comin-Anduix, B; Chodon, T; Koya, RC; Liu, CC; Kwong, GA; Radu, CG; Ribas, A; Heath, JR				Ma, Chao; Fan, Rong; Ahmad, Habib; Shi, Qihui; Comin-Anduix, Begonya; Chodon, Thinle; Koya, Richard C.; Liu, Chao-Chao; Kwong, Gabriel A.; Radu, Caius G.; Ribas, Antoni; Heath, James R.			A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells	NATURE MEDICINE			English	Article							CANCER; INFLAMMATION; RESPONSES; DIFFERENTIATION; EXPRESSION; PROTECTION; INFECTION; PROTEINS; MELANOMA; SUBSETS	Cellular immunity has an inherent high level of functional heterogeneity. Capturing the full spectrum of these functions requires analysis of large numbers of effector molecules from single cells. We report a microfluidic platform designed for highly multiplexed (more than ten proteins), reliable, sample-efficient (similar to 1 x 10(4) cells) and quantitative measurements of secreted proteins from single cells. We validated the platform by assessment of multiple inflammatory cytokines from lipopolysaccharide (LPS)-stimulated human macrophages and comparison to standard immunotechnologies. We applied the platform toward the ex vivo quantification of T cell polyfunctional diversity via the simultaneous measurement of a dozen effector molecules secreted from tumor antigen-specific cytotoxic T lymphocytes (CTLs) that were actively responding to tumor and compared against a cohort of healthy donor controls. We observed profound, yet focused, functional heterogeneity in active tumor antigen-specific CTLs, with the major functional phenotypes quantitatively identified. The platform represents a new and informative tool for immune monitoring and clinical assessment.	[Ma, Chao; Fan, Rong; Ahmad, Habib; Shi, Qihui; Kwong, Gabriel A.; Radu, Caius G.; Ribas, Antoni; Heath, James R.] CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA; [Ma, Chao; Fan, Rong; Ahmad, Habib; Shi, Qihui; Liu, Chao-Chao; Kwong, Gabriel A.; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Comin-Anduix, Begonya; Chodon, Thinle; Koya, Richard C.; Radu, Caius G.; Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	California Institute of Technology; California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Heath, JR (corresponding author), CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA.	heath@caltech.edu	Fan, Rong/B-1613-2014; Kwong, Gabriel A/M-5376-2013; Radu, Caius/D-3936-2013; Kwong, Gabriel/AAO-8266-2021	Kwong, Gabriel A/0000-0002-6255-6755; Radu, Caius/0000-0002-9338-5397; Kwong, Gabriel/0000-0002-6255-6755; Liu, Chao/0000-0003-0057-3397	Benjamin M. Rosen Fellowship; US National Institutes of Health [1 K99 CA136759-01, CA-16042, AI-28697]; US National Cancer Institute [5U54 CA119347]; Ivy Foundation; Jean Perkins Foundation; California Institute for Regenerative Medicine New Faculty [RN2-00902-1]; Caltech/UCLA Joint Center for Translational Medicine; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [P30CA016042, K99CA136759, U54CA119347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Benjamin M. Rosen Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ivy Foundation; Jean Perkins Foundation; California Institute for Regenerative Medicine New Faculty; Caltech/UCLA Joint Center for Translational Medicine; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Marzolf at the Institute for Systems Biology for printing DNA-spotted arrays and the UCLA nanolab for photomask fabrication. We thank L. Yang, S. Wang, R. Diamond and H. Wu for valuable discussion. C. M. acknowledges the support of the Benjamin M. Rosen Fellowship. R.F. is supported by the US National Institutes of Health K99 Pathway to Independence Award (No. 1 K99 CA136759-01). This work was funded by the US National Cancer Institute Grant No. 5U54 CA119347 (J.R.H.), by the Ivy Foundation and the Jean Perkins Foundation (J.R.H.), by the California Institute for Regenerative Medicine New Faculty Award RN2-00902-1 (A.R.), by the Caltech/UCLA Joint Center for Translational Medicine (A.R. and J.R.H.) and the Melanoma Research Alliance (A.R. and J.R.H.). The UCLA Flow Cytometry Core Facility is supported by the US National Institutes of Health awards CA-16042 and AI-28697.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Bailey RC, 2007, J AM CHEM SOC, V129, P1959, DOI 10.1021/ja065930i; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Comin-Anduix B, 2006, CLIN CANCER RES, V12, P107, DOI 10.1158/1078-0432.CCR-05-0136; Comin-Anduix B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-22; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hagemann T, 2007, CANCER CELL, V12, P300, DOI 10.1016/j.ccr.2007.10.005; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kwong GA, 2009, J AM CHEM SOC, V131, P9695, DOI 10.1021/ja9006707; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; O'Shea John J, 2008, Nat Immunol, V9, P450, DOI 10.1038/ni0508-450; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Re F, 2004, IMMUNOBIOLOGY, V209, P191, DOI 10.1016/j.imbio.2004.03.005; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shin YS, 2010, CHEMPHYSCHEM, V11, P3063, DOI 10.1002/cphc.201000528; SHIN YS, BIOPHYS J IN PRESS; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; Wang J, 2010, LAB CHIP, V10, P3157, DOI [10.1039/c0lc00132e, 10.1039/c01c00132e]; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	37	326	345	6	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					738	U133		10.1038/nm.2375	http://dx.doi.org/10.1038/nm.2375			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602800	Green Accepted			2022-12-25	WOS:000291308800036
J	Murphy, RF				Murphy, Robert F.			An active role for machine learning in drug development	NATURE CHEMICAL BIOLOGY			English	Article							SYSTEMS BIOLOGY; MICROSCOPY; MODELS		[Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Freiburg Inst Adv Studies, Freiburg, Germany	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Murphy, RF (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	murphy@cmu.edu			NIH [GM075205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Much of the work from my group referred to here was supported by NIH grant GM075205.	Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Danziger SA, 2007, BIOINFORMATICS, V23, pI104, DOI 10.1093/bioinformatics/btm166; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Fujiwara Y, 2008, J CHEM INF MODEL, V48, P930, DOI 10.1021/ci700085q; Giuliano KA, 2009, COMB CHEM HIGH T SCR, V12, P838, DOI 10.2174/138620709789383286; Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006; Mohamed TP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S57; Peng T, 2011, CYTOM PART A, V79A, P383, DOI 10.1002/cyto.a.21066; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pournara I, 2004, BIOINFORMATICS, V20, P2934, DOI 10.1093/bioinformatics/bth337; Shariff A, 2010, J BIOMOL SCREEN, V15, P726, DOI 10.1177/1087057110370894; Shariff A, 2010, CYTOM PART A, V77A, P457, DOI 10.1002/cyto.a.20854; Stegle O, 2009, BIOINFORMATICS, V25, pI374, DOI 10.1093/bioinformatics/btp210; Taylor DL, 2007, METH MOL B, V356, P3; Warmuth MK, 2003, J CHEM INF COMP SCI, V43, P667, DOI 10.1021/ci025620t; Zhao T, 2007, CYTOM PART A, V71A, P978, DOI 10.1002/cyto.a.20487	19	78	85	6	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					327	330		10.1038/nchembio.576	http://dx.doi.org/10.1038/nchembio.576			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21587249	Green Submitted, Green Accepted			2022-12-25	WOS:000290677900003
J	Watanabe, R; Okuno, D; Sakakihara, S; Shimabukuro, K; Iino, R; Yoshida, M; Noji, H				Watanabe, Rikiya; Okuno, Daichi; Sakakihara, Shouichi; Shimabukuro, Katsuya; Iino, Ryota; Yoshida, Masasuke; Noji, Hiroyuki			Mechanical modulation of catalytic power on F-1-ATPase	NATURE CHEMICAL BIOLOGY			English	Article							ATP SYNTHASE; ESCHERICHIA-COLI; MOLECULAR MACHINE; ENZYME CATALYSIS; GAMMA-SUBUNIT; F-1 MOTOR; ROTATION; FORCE; ADP; RESOLUTION	The conformational fluctuation of enzymes has a crucial role in reaction acceleration. However, the contribution to catalysis enhancement of individual substates with conformations far from the average conformation remains unclear. We studied the catalytic power of the rotary molecular motor F-1-ATPase from thermophilic Bacillus PS3 as it was stalled in transient conformations far from a stable pausing angle. The rate constants of ATP binding and hydrolysis were determined as functions of the rotary angle. Both rates exponentially increase with rotation, revealing the molecular basis of positive cooperativity among three catalytic sites: elementary reaction steps are accelerated via the mechanical rotation driven by other reactions on neighboring catalytic sites. The rate enhancement induced by ATP binding upon rotation was greater than that brought about by hydrolysis, suggesting that the ATP binding step contributes more to torque generation than does the hydrolysis step. Additionally, 9% of the ATP-driven rotary step was supported by thermal diffusion, suggesting that acceleration of the ATP docking process occurs via thermally agitated conformational fluctuations.	[Watanabe, Rikiya; Okuno, Daichi; Iino, Ryota; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo, Japan; [Sakakihara, Shouichi] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Shimabukuro, Katsuya] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Yoshida, Masasuke] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 603, Japan	University of Tokyo; Osaka University; State University System of Florida; Florida State University; Kyoto Sangyo University	Watanabe, R (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Watanabe, Rikiya/AAO-1390-2021; Iino, Ryota/B-7746-2011	Watanabe, Rikiya/0000-0001-7146-2745; Iino, Ryota/0000-0003-0110-5704	Ministry of Education, Culture, Sports, Science and Technology, Japan [18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all members of the Noji laboratory. This work was partially supported by a Grant-in-Aid for Scientific Research (no. 18074005) to H.N. and by a Special Education and Research Expenses grant to H.N. from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Iko Y, 2009, FEBS LETT, V583, P3187, DOI 10.1016/j.febslet.2009.08.042; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; KOSHLAND DE, 1958, FED PROC, V17, P1145; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Senior AE, 2007, CELL, V130, P220, DOI 10.1016/j.cell.2007.07.004; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	46	76	76	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					86	92		10.1038/nchembio.715	http://dx.doi.org/10.1038/nchembio.715			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101603				2022-12-25	WOS:000298414100016
J	Fafalios, A; Ma, JH; Tan, XP; Stoops, J; Luo, JH; DeFrances, MC; Zarnegar, R				Fafalios, Arlee; Ma, Jihong; Tan, Xinping; Stoops, John; Luo, Jianhua; DeFrances, Marie C.; Zarnegar, Reza			A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism	NATURE MEDICINE			English	Article							INDUCED FATTY LIVER; UP-REGULATION; C-MET; MICE; REGENERATION; PATHWAY; IRS-2; RATS; FAS	Met is the transmembrane tyrosine kinase cell surface receptor for hepatocyte growth factor (HGF) and is structurally related to the insulin receptor (INSR) tyrosine kinase. Here we report that the HGF-Met axis regulates metabolism by stimulating hepatic glucose uptake and suppressing hepatic glucose output. We show that Met is essential for an optimal hepatic insulin response by directly engaging INSR to form a Met-INSR hybrid complex, which culminates in a robust signal output. We also found that the HGF-Met system restores insulin responsiveness in a mouse model of insulin refractoriness. These results provide new insights into the molecular basis of hepatic insulin resistance and suggest that HGF may have therapeutic potential for type 2 diabetes in the clinical setting.	[Fafalios, Arlee; Ma, Jihong; Tan, Xinping; Stoops, John; Luo, Jianhua; DeFrances, Marie C.; Zarnegar, Reza] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [DeFrances, Marie C.; Zarnegar, Reza] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [DeFrances, Marie C.; Zarnegar, Reza] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zarnegar, R (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	rezazar@pitt.edu	Luo, jian/HGE-7331-2022		US National Institutes of Health [R01NIAA001871301]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018713] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank G. K. Michalopoulos and S. Strom (University of Pittsburgh) for providing primary rodent and human hepatocyte cultures. We also thank A. Eaker and C. Johnson for their technical assistance. This study was supported by an R01 grant (R01NIAA001871301) awarded to R.Z. by the US National Institutes of Health.	APPASAMY R, 1993, LAB INVEST, V68, P270; Bertola A, 2007, J BIOL CHEM, V282, P10325, DOI 10.1074/jbc.M611770200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; Deangelis T, 2010, J CELL PHYSIOL, V224, P658, DOI 10.1002/jcp.22164; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jiang JG, 2001, J BIOL CHEM, V276, P25049, DOI 10.1074/jbc.M101611200; Johnston AM, 2003, FEBS LETT, V546, P32, DOI 10.1016/S0014-5793(03)00438-1; Kosone T, 2007, AM J PHYSIOL-GASTR L, V293, pG204, DOI 10.1152/ajpgi.00021.2007; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LIU ML, 1994, AM J PATHOL, V144, P129; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; Perdomo G, 2008, J BIOL CHEM, V283, P13700, DOI 10.1074/jbc.M707551200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; SURWIT RS, 1986, PSYCHOSOM MED, V48, P278, DOI 10.1097/00006842-198603000-00013; Taniguchi CM, 2005, J CLIN INVEST, V115, P1388, DOI 10.1172/JCI200523187C1; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tomita K, 2004, GASTROENTEROLOGY, V126, P873, DOI 10.1053/j.gastro.2003.12.008; Turner SM, 2005, ACTA DIABETOL, V42, P187, DOI 10.1007/s00592-005-0201-3; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	28	72	75	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1577	U87		10.1038/nm.2531	http://dx.doi.org/10.1038/nm.2531			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081023	Green Accepted			2022-12-25	WOS:000297978000028
J	Jelier, R; Semple, JI; Garcia-Verdugo, R; Lehner, B				Jelier, Rob; Semple, Jennifer I.; Garcia-Verdugo, Rosa; Lehner, Ben			Predicting phenotypic variation in yeast from individual genome sequences	NATURE GENETICS			English	Article							GENETIC INTERACTIONS; NETWORK; MUTATIONS	A central challenge in genetics is to predict phenotypic variation from individual genome sequences. Here we construct and evaluate phenotypic predictions for 19 strains of Saccharomyces cerevisiae. We use conservation-based methods to predict the impact of protein-coding variation within genes on protein function. We then rank strains using a prediction score that measures the total sum of function-altering changes in different sets of genes reported to influence over 100 phenotypes in genome-wide loss-of-function screens. We evaluate our predictions by comparing them with the observed growth rate and efficiency of 15 strains tested across 20 conditions in quantitative experiments. The median predictive performance, as measured by ROC AUC, was 0.76, and predictions were more accurate when the genes reported to influence a trait were highly connected in a functional gene network.	[Jelier, Rob; Semple, Jennifer I.; Garcia-Verdugo, Rosa; Lehner, Ben] Ctr Genom Regulat, European Mol Biol Lab, Syst Biol Res Unit, Barcelona, Spain; [Lehner, Ben] Ctr Genom Regulat, ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), Ctr Genom Regulat, European Mol Biol Lab, Syst Biol Res Unit, Barcelona, Spain.	ben.lehner@crg.eu	Semple, Jennifer/K-4782-2014; Lehner, Ben/ABH-6562-2020; Lehner, Ben/L-3413-2014	Semple, Jennifer/0000-0001-7221-9560; Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Jelier, Rob/0000-0002-6395-1407; Garcia-Verdugo, Rosa/0000-0002-6039-8861	European Research Council (ERC); Spanish Ministry of Science and Innovation (MCINN) [BFU2008-00365]; Catalan Agency for Management of University; ERASysBio+; EMBO; EMBL-CRG; Juan de la Cierva; ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Science and Innovation (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Agency for Management of University; ERASysBio+; EMBO(European Molecular Biology Organization (EMBO)); EMBL-CRG; Juan de la Cierva(Instituto de Salud Carlos III); ICREA(ICREA)	This work was funded by grants from the European Research Council (ERC), the Spanish Ministry of Science and Innovation (MCINN grant BFU2008-00365), the Catalan Agency for Management of University and Research Grants (AGAUR), ERASysBio+, the EMBO Young Investigator Program and the EMBL-CRG Systems Biology Program. R.J. was supported by a Juan de la Cierva Fellowship.	Achaz G, 2007, BIOINFORMATICS, V23, P119, DOI 10.1093/bioinformatics/btl519; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Francesconi M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002077; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kawabata T, 1999, NUCLEIC ACIDS RES, V27, P355, DOI 10.1093/nar/27.1.355; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Leitner F, 2010, IEEE ACM T COMPUT BI, V7, P385, DOI 10.1109/TCBB.2010.61; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; MORTIMER RK, 1986, GENETICS, V113, P35; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	34	45	45	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1270	U141		10.1038/ng.1007	http://dx.doi.org/10.1038/ng.1007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22081227	Bronze			2022-12-25	WOS:000297931400026
J	Mielgo, A; Seguin, L; Huang, M; Camargo, MF; Anand, S; Franovic, A; Weis, SM; Advani, SJ; Murphy, EA; Cheresh, DA				Mielgo, Ainhoa; Seguin, Laetitia; Huang, Miller; Camargo, Maria Fernanda; Anand, Sudarshan; Franovic, Aleksandra; Weis, Sara M.; Advani, Sunil J.; Murphy, Eric A.; Cheresh, David A.			A MEK-independent role for CRAF in mitosis and tumor progression	NATURE MEDICINE			English	Article							B-RAF; SELECTIVE INHIBITOR; MITOTIC ENTRY; KINASE; BRAF; CELLS; POLO; GROWTH; CANCER; CHECKPOINT	RAF kinases regulate cell proliferation and survival and can be dysregulated in tumors(1,2). The role of RAF in cell proliferation has been linked to its ability to activate mitogen-activated protein kinase kinase 1 (MEK) and mitogen-activated protein kinase 1 (ERK). Here we identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tumors with allosteric inhibitors, but not ATP-competitive RAF inhibitors, prevents CRAF phosphorylation on Ser338 and localization to the mitotic spindle and causes cell-cycle arrest at prometaphase. Furthermore, we identify phospho-Ser338 CRAF as a potential biomarker for tumor progression and a surrogate marker for allosteric RAF blockade. Mechanistically, CRAF, but not BRAF, associates with Aurora kinase A (Aurora-A) and Polo-like kinase 1 (Plk1) at the centrosomes and spindle poles during G2/M. Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice. These findings show a previously undefined role for RAF in tumor progression beyond the RAF-MEK-ERK paradigm, opening new avenues for targeting RAF in cancer.	[Mielgo, Ainhoa; Seguin, Laetitia; Huang, Miller; Camargo, Maria Fernanda; Anand, Sudarshan; Franovic, Aleksandra; Weis, Sara M.; Murphy, Eric A.; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA; [Advani, Sunil J.] Univ Calif San Diego, Dept Radiat Oncol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	ANAND, SUDARSHAN/I-5316-2019	ANAND, SUDARSHAN/0000-0002-4969-6884; SEGUIN, Laetitia/0000-0003-2950-4766; Huang, Miller/0000-0002-3371-0100; Mielgo, Ainhoa/0000-0002-4159-5931; Seguin, Laetitia/0000-0002-9610-7093	US National Institutes of Health [CA78045, CA119335, CA95262, CA104898]; NATIONAL CANCER INSTITUTE [U54CA119335, P01CA104898, P01CA078045, R01CA095262, R37CA050286, R01CA045726] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Elliott and J. Lesperance for their assistance with the mouse experiments and immunohistochemistry, and M. Schmid, M. Kaulich and J. Desgrosellier for discussions. We thank K. Lee (US National Institutes of Health National Cancer Institute) and R. Erikson (Harvard University) for providing Plk1 constructs. D.A.C. was supported by grants CA78045, CA119335, CA95262 and CA104898 from the US National Institutes of Health.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Alavi AS, 2007, CANCER RES, V67, P2766, DOI 10.1158/0008-5472.CAN-06-3648; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Borysov SI, 2008, MOL BIOL CELL, V19, P2907, DOI 10.1091/mbc.E07-07-0679; Borysov SI, 2006, J BIOL CHEM, V281, P22586, DOI 10.1074/jbc.M601432200; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Cui YP, 2010, CANCER RES, V70, P675, DOI 10.1158/0008-5472.CAN-09-1491; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hindley A, 2002, J CELL SCI, V115, P1575; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kamata T, 2010, CANCER RES, V70, P8475, DOI 10.1158/0008-5472.CAN-10-0603; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McGlynn LM, 2009, CLIN CANCER RES, V15, P1487, DOI 10.1158/1078-0432.CCR-07-4967; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Murphy EA, 2010, P NATL ACAD SCI USA, V107, P4299, DOI 10.1073/pnas.0909299107; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	37	43	51	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1641	U156		10.1038/nm.2464	http://dx.doi.org/10.1038/nm.2464			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081024	Green Accepted			2022-12-25	WOS:000297978000036
J	Prager-Khoutorsky, M; Lichtenstein, A; Krishnan, R; Rajendran, K; Mayo, A; Kam, Z; Geiger, B; Bershadsky, AD				Prager-Khoutorsky, Masha; Lichtenstein, Alexandra; Krishnan, Ramaswamy; Rajendran, Kavitha; Mayo, Avi; Kam, Zvi; Geiger, Benjamin; Bershadsky, Alexander D.			Fibroblast polarization is a matrix-rigidity-dependent process controlled by focal adhesion mechanosensing	NATURE CELL BIOLOGY			English	Article							SINGLE-CELL RESPONSE; MOLECULAR PROCESSES; NASCENT ADHESIONS; TYROSINE KINASE; ACTIN; SUBSTRATE; FORCE; MECHANOTRANSDUCTION; STIFFNESS; MECHANISMS	Cell elongation and polarization are basic morphogenetic responses to extracellular matrix adhesion. We demonstrate here that human cultured fibroblasts readily polarize when plated on rigid, but not on compliant, substrates. On rigid surfaces, large and uniformly oriented focal adhesions are formed, whereas cells plated on compliant substrates form numerous small and radially oriented adhesions. Live-cell monitoring showed that focal adhesion alignment precedes the overall elongation of the cell, indicating that focal adhesion orientation may direct cell polarization. siRNA-mediated knockdown of 85 human protein tyrosine kinases (PTKs) induced distinct alterations in the cell polarization response, as well as diverse changes in cell traction force generation and focal adhesion formation. Remarkably, changes in rigidity-dependent traction force development, or focal adhesion mechanosensing, were consistently accompanied by abnormalities in the cell polarization response. We propose that the different stages of cell polarization are regulated by multiple, PTK-dependent molecular checkpoints that jointly control cell contractility and focal-adhesion-mediated mechanosensing.	[Prager-Khoutorsky, Masha; Lichtenstein, Alexandra; Mayo, Avi; Kam, Zvi; Geiger, Benjamin; Bershadsky, Alexander D.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Krishnan, Ramaswamy; Rajendran, Kavitha] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Bershadsky, Alexander D.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	Weizmann Institute of Science; Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore	Geiger, B (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il; alexander.bershadsky@weizmann.ac.il	mayo, avi/N-3756-2019; MAYO, AVI E/K-1736-2012	mayo, avi/0000-0002-4479-3423; Bershadsky, Alexander/0000-0002-9571-7375	National Institutes of Health (NIH) [PN2 EY016586]; Israel Science Foundation; Minerva Foundation; Maurice Janin Fund; De Benedetti Foundation-Cherasco; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Maurice Janin Fund; De Benedetti Foundation-Cherasco; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to B. Morgenstern for expert help in preparing this article for publication. This work was financially supported, in part, by the National Institutes of Health (NIH) Common Fund Nanomedicine Program (PN2 EY016586), the Israel Science Foundation, the Minerva Foundation, the Maurice Janin Fund and the De Benedetti Foundation-Cherasco. B.G. holds the Erwin Neter Professorial Chair in Cell and Tumor Biology. A.D.B. holds the Joseph Moss Professorial Chair in Biomedical Research.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; BEELER JF, 1994, MOL CELL BIOL, V14, P982, DOI 10.1128/MCB.14.2.982; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cramer LP, 2010, NAT CELL BIOL, V12, P628, DOI 10.1038/ncb0710-628; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fouchard J, 2011, CELL ADHES MIGR, V5, P16, DOI 10.4161/cam.5.1.13281; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Kam Z, 2001, TRENDS CELL BIOL, V11, P329, DOI 10.1016/S0962-8924(01)02067-0; Mitrossilis D, 2010, P NATL ACAD SCI USA, V107, P16518, DOI 10.1073/pnas.1007940107; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Montgomery D.C., 2002, APPL STAT PROBABILIT; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Saez A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194119; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; VASILIEV JM, 1984, BIOCHIM BIOPHYS ACTA, V780, P21, DOI 10.1016/0304-419X(84)90006-4; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Webster KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017807; Winograd-Katz SE, 2009, J CELL BIOL, V186, P423, DOI 10.1083/jcb.200901105; Zamir E, 1999, J CELL SCI, V112, P1655; 2008, SCIENCE, V2, P1	36	374	379	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1457	U178		10.1038/ncb2370	http://dx.doi.org/10.1038/ncb2370			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	22081092				2022-12-25	WOS:000298157500014
J	Gruber, R; Zhou, ZW; Sukchev, M; Joerss, T; Frappart, PO; Wang, ZQ				Gruber, Ralph; Zhou, Zhongwei; Sukchev, Mikhail; Joerss, Tjard; Frappart, Pierre-Olivier; Wang, Zhao-Qi			MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; DNA-DAMAGE RESPONSE; MISREGULATED CHROMOSOME CONDENSATION; CENTRAL-NERVOUS-SYSTEM; HUMAN BRAIN SIZE; NEUROEPITHELIAL CELLS; SPINDLE ORIENTATION; NEURAL STEM; MICROCEPHALIN; MUTATIONS	Primary microcephaly 1 is a neurodevelopmental disorder caused by mutations in the MCPH1 gene, whose product MCPH1 (also known as microcephalin and BRIT1) regulates DNA-damage response. Here we show that Mcph1 disruption in mice results in primary microcephaly, mimicking human MCPH1 symptoms, owing to a premature switching of neuroprogenitors form symmetric to asymmetric division. MCPH1-deficiency abrogates the localization of Chk1 to centrosomes, causing premature Cdk1 activation and early mitotic entry, which uncouples mitosis and the centrosome cycle. This misorients the mitotic spindle alignment and shifts the division plane of neuroprogenitors, to bias neurogenic cell fate. Silencing Cdc25b, a centrosome substrate of Chk1, corrects MCPH1-deficiency-induced spindle misalignment and rescues the premature neurogenic production in Mcph1-knockout neocortex. Thus, MCPH1, through its function in the Chk1-Cdc25-Cdk1 pathway to couple the centrsome cycle with mitosis, is required for precise mitotic spindle orientation and thereby regulates the progenitor division mode to maintain brain size.	[Gruber, Ralph; Zhou, Zhongwei; Sukchev, Mikhail; Joerss, Tjard; Wang, Zhao-Qi] FLI, Leibniz Inst Age Res, D-07745 Jena, Germany; [Frappart, Pierre-Olivier] CMB, Inst Mol & Cell Biol, D-07745 Jena, Germany; [Wang, Zhao-Qi] Univ Jena, Fac Biol & Pharm, D-07745 Jena, Germany	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Wang, ZQ (corresponding author), FLI, Leibniz Inst Age Res, Beurtenbergstr 11, D-07745 Jena, Germany.		; Zhou, Zhongwei/F-9269-2014	FRAPPART, PIERRE-OLIVIER/0000-0002-8142-3878; Zhou, Zhongwei/0000-0001-7971-2921	Leibniz Graduate School on Ageing (LGSA); Deutschen Forschungsgemeinschaft (DFG); DFG, Germany	Leibniz Graduate School on Ageing (LGSA); Deutschen Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG, Germany(German Research Foundation (DFG))	We thank L. Frappart for the advice and the discussion on histological analysis and Z. Xu for the introduction into the in utero electroporation technology. We are grateful to M. Baldauf for his histological assistance, M. Welzel for her technical support and D. Galendo, C. Birch-Hirschfeld and C. Mueller for their assistance in the maintenance of the animal colonies. We are also grateful to M. Trajkovic-Arsic for the advice on the in situ hybridization techniques and A. Gompf for the FACS. We also would like to thank P. Herrlich, H. Heuer, T. Li and Y. Yang for their critical reading of the manuscript. Further thanks go to E. Stoeckl for editing the manuscript. We are also grateful to many other members of our laboratory for the helpful discussions. R.G., M.S. and Z.W.Z. are supported by a fellowship of the Leibniz Graduate School on Ageing (LGSA) Programme. P-O.F. is supported by an Emmy Noether Grant from the Deutschen Forschungsgemeinschaft (DFG). Z-Q.W. is supported in part by the DFG, Germany.	Akhter S, 2004, MOL CELL BIOL, V24, P10448, DOI 10.1128/MCB.24.23.10448-10455.2004; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; ARAI Y, NAT COMMUN, V2, P154; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Loffler H, 2006, CELL CYCLE, V5, P2543, DOI 10.4161/cc.5.21.3435; Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56	64	165	168	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1325	U100		10.1038/ncb2342	http://dx.doi.org/10.1038/ncb2342			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	21947081				2022-12-25	WOS:000296737900009
J	Moulick, K; Ahn, JH; Zong, HL; Rodina, A; Cerchietti, L; DaGama, EMG; Caldas-Lopes, E; Beebe, K; Perna, F; Hatzi, K; Vu, LP; Zhao, XY; Zatorska, D; Taldone, T; Smith-Jones, P; Alpaugh, M; Gross, SS; Pillarsetty, N; Ku, T; Lewis, JS; Larson, SM; Levine, R; Erdjument-Bromage, H; Guzman, ML; Nimer, SD; Melnick, A; Neckers, L; Chiosis, G				Moulick, Kamalika; Ahn, James H.; Zong, Hongliang; Rodina, Anna; Cerchietti, Leandro; DaGama, Erica M. Gomes; Caldas-Lopes, Eloisi; Beebe, Kristin; Perna, Fabiana; Hatzi, Katerina; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Smith-Jones, Peter; Alpaugh, Mary; Gross, Steven S.; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.; Levine, Ross; Erdjument-Bromage, Hediye; Guzman, Monica L.; Nimer, Stephen D.; Melnick, Ari; Neckers, Len; Chiosis, Gabriela			Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90	NATURE CHEMICAL BIOLOGY			English	Article							BCR-ABL; SIGNAL TRANSDUCER; STAT5 ACTIVATION; TYROSINE KINASE; LEUKEMIA; CHAPERONE; TRANSCRIPTION; CELLS; TRANSFORMATION; DISCOVERY	Most cancers are characterized by multiple molecular alterations, but identification of the key proteins involved in these signaling pathways is currently beyond reach. We show that the inhibitor PU-H71 preferentially targets tumor-enriched Hsp90 complexes and affinity captures Hsp90-dependent oncogenic client proteins. We have used PU-H71 affinity capture to design a proteomic approach that, when combined with bioinformatic pathway analysis, identifies dysregulated signaling networks and key oncoproteins in chronic myeloid leukemia. The identified interactome overlaps with the well-characterized altered proteome in this cancer, indicating that this method can provide global insights into the biology of individual tumors, including primary patient specimens. In addition, we show that this approach can be used to identify previously uncharacterized oncoproteins and mechanisms, potentially leading to new targeted therapies. We further show that the abundance of the PU-H71-enriched Hsp90 species, which is not dictated by Hsp90 expression alone, is predictive of the cell's sensitivity to Hsp90 inhibition.	[Moulick, Kamalika; Ahn, James H.; Rodina, Anna; DaGama, Erica M. Gomes; Caldas-Lopes, Eloisi; Perna, Fabiana; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Alpaugh, Mary; Nimer, Stephen D.; Chiosis, Gabriela] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA; [Zong, Hongliang; Cerchietti, Leandro; Hatzi, Katerina; Guzman, Monica L.; Melnick, Ari] Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA; [Beebe, Kristin; Neckers, Len] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Smith-Jones, Peter; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Gross, Steven S.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA; [Levine, Ross] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Levine, Ross] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Erdjument-Bromage, Hediye] Mem Sloan Kettering Canc Ctr, Microchem & Prote Core Mol Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chiosis, G (corresponding author), Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA.	nimers@mskcc.org; amm2014@med.cornell.edu; neckers@nih.gov; chiosisg@mskcc.org	Zong, Hongliang/F-9366-2013; Melnick, Ari/AAA-5763-2020; Moulick, Kamalika/E-1723-2018; levine, ross/AAE-7658-2019	Zong, Hongliang/0000-0002-5855-5733; Moulick, Kamalika/0000-0002-6131-1270; Cerchietti, Leandro/0000-0003-0608-1350; Perna, Fabiana/0000-0002-3744-8672; Vu, Ly/0000-0002-1682-7702; Lewis, Jason/0000-0001-7065-4534; Zhao, Xinyang/0000-0001-6677-7072; Pillarsetty, Naga Vara Kishore/0000-0002-1750-7436; Erdjument-Bromage, Hediye/0000-0003-0224-3594	Geoffrey Beene Cancer Research Center of the Memorial Sloan-Kettering Cancer Center; Leukemia and Lymphoma Society; Breast Cancer Research Fund; SPORE Pilot Award and Research & Therapeutics Program in Prostate Cance; Hirshberg Foundation for Pancreatic Cancer; Byrne Fund [1U01 AG032969-01A1, 1R01 CA155226-01]; US National Cancer Institute (NCI) Cancer Center [P30 CA08748]; NCI [P50-CA86483]; Ludwig Center for Cancer Immunotherapy at MSKCC; US National Institutes of Health (NIH) through the NIH [1 DP2 OD007399-01]; V foundation; American Italian Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA172546, R01CA155226, ZIASC010074, P30CA008748, R21CA158609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG032969] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007399] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center of the Memorial Sloan-Kettering Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Breast Cancer Research Fund; SPORE Pilot Award and Research & Therapeutics Program in Prostate Cance; Hirshberg Foundation for Pancreatic Cancer; Byrne Fund; US National Cancer Institute (NCI) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center for Cancer Immunotherapy at MSKCC; US National Institutes of Health (NIH) through the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V foundation; American Italian Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the Geoffrey Beene Cancer Research Center of the Memorial Sloan-Kettering Cancer Center (G.C.), Leukemia and Lymphoma Society (G.C., M.L.G., S.D.N., X.Z. and R.L.), Breast Cancer Research Fund (G.C.), the SPORE Pilot Award and Research & Therapeutics Program in Prostate Cancer (G.C.), the Hirshberg Foundation for Pancreatic Cancer (G.C.), the Byrne Fund (G.C.), 1U01 AG032969-01A1 (G.C.), 1R01 CA155226-01 (G.C. and A.M.) and US National Cancer Institute (NCI) Cancer Center Support Grant P30 CA08748 (H.E.B.). K.B. and L.N. were supported by funds from the Intramural Program of the NCI. S.M.L. and P.M.S.-J. are supported by the Ludwig Center for Cancer Immunotherapy at MSKCC and by NCI Grant P50-CA86483. M.L.G. is funded by the US National Institutes of Health (NIH) through the NIH Director's New Innovator Award Program, 1 DP2 OD007399-01 and the V foundation. F.P. is funded by the American Italian Cancer Foundation. We thank D. Toft (Mayo Clinic) and M. Cox (University of Texas) for the gifts of H9010 Hsp90-specific antibodies, L.A. Fabrizio, A.M. Morrishow, H. Deng and J. Fernandez for help with MS analysis, A. Perl, C.T. Jordan, M. Becker and J. Nicoll for providing the primary CML samples or suggestions on their use, and B. Clarkson, J. Bromberg and P. Gregor for suggestions with the manuscript.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Ashman K, 2009, CLIN TRANSL ONCOL, V11, P356, DOI 10.1007/s12094-009-0369-z; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Burke BA, 2010, LEUKEMIA, V24, P1105, DOI 10.1038/leu.2010.67; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hanash S, 2010, NAT REV CANCER, V10, P652, DOI 10.1038/nrc2918; Hendriks RW, 2006, SEMIN IMMUNOL, V18, P67, DOI 10.1016/j.smim.2005.10.002; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Janin YL, 2010, DRUG DISCOV TODAY, V15, P342, DOI 10.1016/j.drudis.2010.03.002; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Le Y, 2009, AM J HEMATOL, V84, P273, DOI 10.1002/ajh.21381; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Mahajan S, 2001, J BIOL CHEM, V276, P31216, DOI 10.1074/jbc.M104874200; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nobukuni T, 2007, CURR OPIN CELL BIOL, V19, P135, DOI 10.1016/j.ceb.2007.02.019; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; SALGIA R, 1995, ONCOGENE, V11, P1149; SAWYERS CL, 1993, LEUKEMIA LYMPHOMA, V11, P45, DOI 10.3109/10428199309047862; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	46	201	206	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					818	826		10.1038/nchembio.670	http://dx.doi.org/10.1038/nchembio.670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946277	Green Accepted			2022-12-25	WOS:000296381600012
J	Brakemann, T; Stiel, AC; Weber, G; Andresen, M; Testa, I; Grotjohann, T; Leutenegger, M; Plessmann, U; Urlaub, H; Eggeling, C; Wahl, MC; Hell, SW; Jakobs, S				Brakemann, Tanja; Stiel, Andre C.; Weber, Gert; Andresen, Martin; Testa, Ilaria; Grotjohann, Tim; Leutenegger, Marcel; Plessmann, Uwe; Urlaub, Henning; Eggeling, Christian; Wahl, Markus C.; Hell, Stefan W.; Jakobs, Stefan			A reversibly photoswitchable GFP-like protein with fluorescence excitation decoupled from switching	NATURE BIOTECHNOLOGY			English	Article							CRYSTAL-STRUCTURE; MICROSCOPY; MECHANISM; CYCLIZATION; NANOSCALE; LIGHT; TOOL	Photoswitchable fluorescent proteins have enabled new approaches for imaging cells, but their utility has been limited either because they cannot be switched repeatedly or because the wavelengths for switching and fluorescence imaging are strictly coupled. We report a bright, monomeric, reversibly photoswitchable variant of GFP, Dreiklang, whose fluorescence excitation spectrum is decoupled from that for optical switching. Reversible on-and-off switching in living cells is accomplished at illumination wavelengths of similar to 365 nm and similar to 405 nm, respectively, whereas fluorescence is elicited at similar to 515 nm. Mass spectrometry and high-resolution crystallographic analysis of the same protein crystal in the photoswitched on- and off-states demonstrate that switching is based on a reversible hydration/dehydration reaction that modifies the chromophore. The switching properties of Dreiklang enable far-field fluorescence nanoscopy in living mammalian cells using both a coordinate-targeted and a stochastic single molecule switching approach.	[Brakemann, Tanja; Stiel, Andre C.; Andresen, Martin; Testa, Ilaria; Grotjohann, Tim; Leutenegger, Marcel; Eggeling, Christian; Hell, Stefan W.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Free Univ Berlin, Inst Chem & Biochem, AG Strukturbiochem, D-1000 Berlin, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, Gottingen, Germany; [Jakobs, Stefan] Univ Gottingen, Sch Med, Gottingen, Germany	Max Planck Society; Free University of Berlin; University of Gottingen; University of Gottingen	Hell, SW (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany.	shell@gwdg.de; sjakobs@gwdg.de	Weber, Gert/I-1800-2013; Wahl, Markus C./D-6365-2017; Jakobs, Stefan/F-4898-2012; Stiel, Andre/B-1644-2014	Weber, Gert/0000-0003-3624-1060; Wahl, Markus C./0000-0002-2811-5307; Jakobs, Stefan/0000-0002-8028-3121; Stiel, Andre/0000-0001-8675-6797; Testa, Ilaria/0000-0003-4005-4997	Deutsche Forschungsgemeinschaft; DFG-Research Center for Molecular Physiology of the Brain	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG))	We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin) through the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum and the Leibniz-Institut fur Molekulare Pharmakologie. We thank V. Belov for insightful discussions and F. Lavoie-Cardinal for help with the set-up for targeted switching. We acknowledge A. Schonle for providing the software ImSpector. We also thank T. Gilat, S. Lobermann, R. Pick and E. Rothermel for excellent technical assistance, H.-H. Hsiao for help in ESI-MS and H. Schill and J. Jethwa for carefully reading the manuscript. We acknowledge R.Y. Tsien for sharing the plasmid pRSET-Citrine. This work was supported by the Deutsche Forschungsgemeinschaft through the Gottfried Wilhelm Leibniz Prize (to S.W.H.) and through the DFG-Research Center for Molecular Physiology of the Brain (to S.J.).	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Barondeau DP, 2005, BIOCHEMISTRY-US, V44, P1960, DOI 10.1021/bi0479205; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bossi M, 2008, NANO LETT, V8, P2463, DOI 10.1021/nl801471d; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Chudakov DM, 2006, TRAFFIC, V7, P1304, DOI 10.1111/j.1600-0854.2006.00468.x; Cinelli RAG, 2001, APPL PHYS LETT, V79, P3353, DOI 10.1063/1.1419047; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Irie M, 2002, NATURE, V420, P759, DOI 10.1038/420759a; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Richter FM, 2010, MOL CELL PROTEOMICS, V9, P1729, DOI 10.1074/mcp.M110.001446; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sauer M, 2005, P NATL ACAD SCI USA, V102, P9433, DOI 10.1073/pnas.0504264102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Siegbahn PEM, 2001, INT J QUANTUM CHEM, V81, P169, DOI 10.1002/1097-461X(2001)81:2<169::AID-QUA9>3.0.CO;2-N; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Testa I, 2008, OPT EXPRESS, V16, P21093, DOI 10.1364/OE.16.021093; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509	48	203	213	2	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					942	U132		10.1038/nbt.1952	http://dx.doi.org/10.1038/nbt.1952			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21909082	Green Published, Green Submitted			2022-12-25	WOS:000296273000022
J	Diouf, B; Cheng, Q; Krynetskaia, NF; Yang, WJ; Cheok, M; Pei, DQ; Fan, YP; Cheng, C; Krynetskiy, EY; Geng, H; Chen, SY; Thierfelder, WE; Mullighan, CG; Downing, JR; Hsieh, P; Pui, CH; Relling, MV; Evans, WE				Diouf, Barthelemy; Cheng, Qing; Krynetskaia, Natalia F.; Yang, Wenjian; Cheok, Meyling; Pei, Deqing; Fan, Yiping; Cheng, Cheng; Krynetskiy, Evgeny Y.; Geng, Hui; Chen, Siying; Thierfelder, William E.; Mullighan, Charles G.; Downing, James R.; Hsieh, Peggy; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.			Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HMUTS-ALPHA; EXPRESSION; MECHANISMS; BINDING; ADULT; TSC1	DNA mismatch repair enzymes (for example, MSH2) maintain genomic integrity, and their deficiency predisposes to several human cancers and to drug resistance. We found that leukemia cells from a substantial proportion of children (similar to 11%) with newly diagnosed acute lymphoblastic leukemia have low or undetectable MSH2 protein levels, despite abundant wild-type MSH2 mRNA. Leukemia cells with low levels of MSH2 contained partial or complete somatic deletions of one to four genes that regulate MSH2 degradation (FRAP1 (also known as MTOR), HERC1, PRKCZ and PIK3C2B); we also found these deletions in individuals with adult acute lymphoblastic leukemia (16%) and sporadic colorectal cancer (13.5%). Knockdown of these genes in human leukemia cells recapitulated the MSH2 protein deficiency by enhancing MSH2 degradation, leading to substantial reduction in DNA mismatch repair and increased resistance to thiopurines. These findings reveal a previously unrecognized mechanism whereby somatic deletions of genes regulating MSH2 degradation result in undetectable levels of MSH2 protein in leukemia cells, DNA mismatch repair deficiency and drug resistance.	[Diouf, Barthelemy; Cheng, Qing; Krynetskaia, Natalia F.; Yang, Wenjian; Cheok, Meyling; Pei, Deqing; Cheng, Cheng; Krynetskiy, Evgeny Y.; Thierfelder, William E.; Mullighan, Charles G.; Downing, James R.; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Hematol Malignancies Program, Memphis, TN 38105 USA; [Diouf, Barthelemy; Cheng, Qing; Krynetskaia, Natalia F.; Yang, Wenjian; Cheok, Meyling; Krynetskiy, Evgeny Y.; Thierfelder, William E.; Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Geng, Hui; Chen, Siying; Hsieh, Peggy] NIDDK, Genet & Biochem Branch, US Natl Inst Hlth NIH, Bethesda, MD USA; [Mullighan, Charles G.; Downing, James R.; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); St Jude Children's Research Hospital; St Jude Children's Research Hospital	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Hematol Malignancies Program, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Cheng, Cheng/N-8075-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012; Downing, James R./N-8102-2018; CHEN, SI/GZL-4800-2022; Cheok, Meyling h/C-3822-2014; Cheok, Meyling/AFS-4025-2022; Mullighan, Charles/H-3253-2011	Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; Cheok, Meyling h/0000-0002-7820-8026; Cheok, Meyling/0000-0002-7820-8026; Mullighan, Charles/0000-0002-1871-1850	NIH National Institute of General Medical Sciences [U01 GM92666]; National Cancer Institute [CA 21765]; American Lebanese Syrian Associated Charities (ALSAC); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH;  [R37 CA36401]; NATIONAL CANCER INSTITUTE [R37CA036401, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the subjects and parents who participated in this study and the outstanding technical support of the Hartwell Center for Bioinformatics and Biotechnology at St. Jude Children's Research Hospital. We also thank Y. Wang, T. Brooks, J. Smith, W. Du, S. Mukatira, Y. Chu, M. Needham, P. Hargrove, G. Stocco and S. Paugh for their advice and technical support; J. Groff for preparation of the figures; K. Crews, N. Kornegay and M. Wilkinson for their research database expertise; J. C. Panetta for his modeling expertise; J. Jenkins for his immunohistochemistry expertise; T. Kunkel and A. B. Clark (National Institute of Environmental Health Sciences) for providing the E. coli strains, the wild-type and mutant M13mp2 phage and for their contributions to our MMR experiments; and J. Luis Rosa (Universitat de Barcelona) for providing us with antibodies to HERC1. We thank M. Kastan and D. Green for their critical review and advice. This work was supported in part by grant R37 CA36401 (W. E. E. and M. V. R.), NIH National Institute of General Medical Sciences Pharmacogenomics Research Network grant U01 GM92666 (M. V. R. and W. E. E.), CGM is a Pew Scholar and a St. Baldrick's scholar, and St. Jude is supported by a Cancer Center Support Grant CA 21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC). H. G., S. C. and P. H. were funded by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH.	Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Belloni M, 1999, J NEUROCHEM, V72, P974, DOI 10.1046/j.1471-4159.1999.0720974.x; Bouffler SD, 2000, BRIT J CANCER, V83, P1291, DOI 10.1054/bjoc.2000.1422; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; de Wind N, 1998, CANCER RES, V58, P248; DeWeese TL, 1998, P NATL ACAD SCI USA, V95, P11915, DOI 10.1073/pnas.95.20.11915; Dosch J, 1998, CARCINOGENESIS, V19, P567, DOI 10.1093/carcin/19.4.567; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Felton KEA, 2007, CLIN GENET, V71, P483, DOI 10.1111/j.1399-0004.2007.00803.x; Fink D, 1996, CANCER RES, V56, P4881; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hernandez-Pigeon H, 2005, J MOL BIOL, V348, P63, DOI 10.1016/j.jmb.2005.02.001; Hernandez-Pigeon H, 2004, FEBS LETT, V562, P40, DOI 10.1016/S0014-5793(04)00181-4; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Krynetskaia NF, 2003, MOL PHARMACOL, V64, P456, DOI 10.1124/mol.64.2.456; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Matheson EC, 1999, ADV EXP MED BIOL, V457, P579; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Papaefthymiou MA, 2008, MED SCI MONITOR, V14, pRA8; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Rowley PT, 2005, ANNU REV MED, V56, P539, DOI 10.1146/annurev.med.56.061704.135235; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968; Zhu YM, 1999, BLOOD, V94, P733, DOI 10.1182/blood.V94.2.733.414k03_733_740	36	95	95	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1298	U332		10.1038/nm.2430	http://dx.doi.org/10.1038/nm.2430			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946537	Green Accepted			2022-12-25	WOS:000296022100049
J	Gattinoni, L; Lugli, E; Ji, Y; Pos, Z; Paulos, CM; Quigley, MF; Almeida, JR; Gostick, E; Yu, ZY; Carpenito, C; Wang, E; Douek, DC; Price, DA; June, CH; Marincola, FM; Roederer, M; Restifo, NP				Gattinoni, Luca; Lugli, Enrico; Ji, Yun; Pos, Zoltan; Paulos, Chrystal M.; Quigley, Maire F.; Almeida, Jorge R.; Gostick, Emma; Yu, Zhiya; Carpenito, Carmine; Wang, Ena; Douek, Daniel C.; Price, David A.; June, Carl H.; Marincola, Francesco M.; Roederer, Mario; Restifo, Nicholas P.			A human memory T cell subset with stem cell-like properties	NATURE MEDICINE			English	Article							BETA-CATENIN; NAIVE RATHER; CANCER; DIFFERENTIATION; LYMPHOCYTE; EXPRESSION; PHENOTYPE; PRECURSOR; IMMUNITY; HOMEOSTASIS	Immunological memory is thought to depend on a stem cell-like, self-renewing population of lymphocytes capable of differentiating into effector cells in response to antigen re-exposure. Here we describe a long-lived human memory T cell population that has an enhanced capacity for self-renewal and a multipotent ability to derive central memory, effector memory and effector T cells. These cells, specific to multiple viral and self-tumor antigens, were found within a CD45RO(-), CCR7(+), CD45RA(+), CD62L(+), CD27(+), CD28(+) and IL-7R alpha(+) T cell compartment characteristic of naive T cells. However, they expressed large amounts of CD95, IL-2R beta, CXCR3, and LFA-1, and showed numerous functional attributes distinctive of memory cells. Compared with known memory populations, these lymphocytes had increased proliferative capacity and more efficiently reconstituted immunodeficient hosts, and they mediated superior antitumor responses in a humanized mouse model. The identification of a human stem cell-like memory T cell population is of direct relevance to the design of vaccines and T cell therapies.	[Gattinoni, Luca; Ji, Yun; Yu, Zhiya; Restifo, Nicholas P.] NCI, Ctr Canc Res, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Lugli, Enrico; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Pos, Zoltan; Wang, Ena; Marincola, Francesco M.] US Natl Inst Hlth, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD USA; [Pos, Zoltan; Wang, Ena; Marincola, Francesco M.] US Natl Inst Hlth, Ctr Human Immunol, Bethesda, MD USA; [Paulos, Chrystal M.; Carpenito, Carmine; June, Carl H.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Paulos, Chrystal M.; Carpenito, Carmine; June, Carl H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Quigley, Maire F.; Gostick, Emma; Price, David A.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales; [Quigley, Maire F.; Almeida, Jorge R.; Douek, Daniel C.; Price, David A.] NIAID, Human Immunol Sect, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gattinoni, L (corresponding author), NCI, Ctr Canc Res, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA.	gattinol@mail.nih.gov; restifo@nih.gov	Waldmann, Thomas/AAT-5972-2021; Pós, Zoltán/C-3623-2014; Restifo, Nicholas P/A-5713-2008; Price, David A/C-7876-2013; Restifo, Nicholas Phillip/Z-1614-2019; Lugli, Enrico/AAB-7933-2019; Gattinoni, Luca/A-2281-2008; Ji, Yun/B-7245-2009; Roederer, Mario/G-1887-2011; Restifo, Nicholas Phillip/M-6549-2019	Waldmann, Thomas/0000-0003-4500-6660; Pós, Zoltán/0000-0002-2574-7616; Price, David A/0000-0001-9416-2737; Lugli, Enrico/0000-0002-1964-7678; Gattinoni, Luca/0000-0003-2239-3282; Ji, Yun/0000-0001-6340-7009; Restifo, Nicholas P./0000-0003-4229-4580; Ramos de Almeida, Jorge/0000-0002-5009-8478; June, Carl/0000-0003-0241-3557	US National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Institute of Allergy and Infectious Diseases; MRC [G0501963] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIABC011037, ZIABC010763] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER; Medical Research Council [G0501963] Funding Source: researchfish	US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Programs of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research and National Institute of Allergy and Infectious Diseases. We thank S.A. Rosenberg and J.R. Wunderlich for providing samples from HLA-A*0201 patients with melanoma; P. Scheinberg for providing HLA-A*0201 samples; M. Sabatino for coordinating phereses; B.J. Hill for assistance with the TREC assay; S. P. Perfetto, R. Nguyen, D. A. Ambrozak, A. Mixon and S. Farid for help with cell sorting; P. K. Chattopadhyay and J. Yu for antibody conjugation; and R. A. Seder and C. A. Klebanoff for critical review of the manuscript.	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Beier CP, 2009, CELL STEM CELL, V5, P128, DOI 10.1016/j.stem.2009.07.008; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Gattinoni L, 2010, NAT MED, V16, P514, DOI 10.1038/nm0510-514; Gattinoni L, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000302; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Khan J, 1998, CANCER RES, V58, P5009; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lugli E, 2007, CYTOM PART A, V71A, P334, DOI 10.1002/cyto.a.20387; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Neuenhahn M, 2009, IMMUNITY, V31, P702, DOI 10.1016/j.immuni.2009.10.002; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schenkel JM, 2010, J IMMUNOL, V185, P2013, DOI 10.4049/jimmunol.0902572; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhao CF, 2010, J EXP MED, V207, P2883, DOI 10.1084/jem.20100598; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658	56	1163	1253	5	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1290	U325		10.1038/nm.2446	http://dx.doi.org/10.1038/nm.2446			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21926977	Green Accepted			2022-12-25	WOS:000296022100048
J	Horwich, AL				Horwich, Arthur L.			Protein folding in the cell: an inside story	NATURE MEDICINE			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; BACTERIAL CHAPERONIN GROEL; T-COMPLEX POLYPEPTIDE-1; CRYSTAL-STRUCTURE; MOLECULAR CHAPERONE; YEAST MITOCHONDRIA; CENTRAL CAVITY; HEAT-SHOCK; ATP; BINDING		Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	arthur.horwich@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHENG MY, 1987, P NATL ACAD SCI USA, V84, P4063, DOI 10.1073/pnas.84.12.4063; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GEORGOPOULOS CP, 1972, NATURE-NEW BIOL, V239, P38, DOI 10.1038/newbio239038a0; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; HORWICH AL, MOL MACHINE IN PRESS; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SAIBIL H, 1991, NATURE, V353, P25, DOI 10.1038/353025b0; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; TAKANO T, 1972, NATURE-NEW BIOL, V239, P34, DOI 10.1038/newbio239034a0; TRENT JD, 1991, NATURE, V354, P490, DOI 10.1038/354490a0; URSIC D, 1991, MOL CELL BIOL, V11, P2629, DOI 10.1128/MCB.11.5.2629; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	41	28	29	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1211	1216		10.1038/nm.2468	http://dx.doi.org/10.1038/nm.2468			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989012				2022-12-25	WOS:000296022100035
J	Kooner, JS; Saleheen, D; Sim, X; Sehmi, J; Zhang, WH; Frossard, P; Been, LF; Chia, KS; Dimas, AS; Hassanali, N; Jafar, T; Jowett, JBM; Li, XZ; Radha, V; Rees, SD; Takeuchi, F; Young, R; Aung, T; Basit, A; Chidambaram, M; Das, D; Grundberg, E; Hedman, AK; Hydrie, ZI; Islam, M; Khor, CC; Kowlessur, S; Kristensen, MM; Liju, S; Lim, WY; Matthews, DR; Liu, JJ; Morris, AP; Nica, AC; Pinidiyapathirage, JM; Prokopenko, I; Rasheed, A; Samuel, M; Shah, N; Shera, AS; Small, KS; Suo, C; Wickremasinghe, AR; Wong, TY; Yang, MY; Zhang, F; Abecasis, GR; Barnett, AH; Caulfield, M; Deloukas, P; Frayling, TM; Froguel, P; Kato, N; Katulanda, P; Kelly, MA; Liang, JB; Mohan, V; Sanghera, DK; Scott, J; Seielstad, M; Zimmet, PZ; Elliott, P; Teo, YY; McCarthy, MI; Danesh, J; Tai, ES; Chambers, JC				Kooner, Jaspal S.; Saleheen, Danish; Sim, Xueling; Sehmi, Joban; Zhang, Weihua; Frossard, Philippe; Been, Latonya F.; Chia, Kee-Seng; Dimas, Antigone S.; Hassanali, Neelam; Jafar, Tazeen; Jowett, Jeremy B. M.; Li, Xinzhong; Radha, Venkatesan; Rees, Simon D.; Takeuchi, Fumihiko; Young, Robin; Aung, Tin; Basit, Abdul; Chidambaram, Manickam; Das, Debashish; Grundberg, Elin; Hedman, Asa K.; Hydrie, Zafar I.; Islam, Muhammed; Khor, Chiea-Chuen; Kowlessur, Sudhir; Kristensen, Malene M.; Liju, Samuel; Lim, Wei-Yen; Matthews, David R.; Liu, Jianjun; Morris, Andrew P.; Nica, Alexandra C.; Pinidiyapathirage, Janani M.; Prokopenko, Inga; Rasheed, Asif; Samuel, Maria; Shah, Nabi; Shera, A. Samad; Small, Kerrin S.; Suo, Chen; Wickremasinghe, Ananda R.; Wong, Tien Yin; Yang, Mingyu; Zhang, Fan; Abecasis, Goncalo R.; Barnett, Anthony H.; Caulfield, Mark; Deloukas, Panos; Frayling, Timothy M.; Froguel, Philippe; Kato, Norihiro; Katulanda, Prasad; Kelly, M. Ann; Liang, Junbin; Mohan, Viswanathan; Sanghera, Dharambir K.; Scott, James; Seielstad, Mark; Zimmet, Paul Z.; Elliott, Paul; Teo, Yik Ying; McCarthy, Mark I.; Danesh, John; Tai, E. Shyong; Chambers, John C.		DIAGRAM; MuTHER	Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci	NATURE GENETICS			English	Article							GENETIC-VARIATION; INSULIN-RESISTANCE; EXPRESSION; METHODOLOGY; PROTEINS; PATTERNS; STORAGE; OBESITY; GRB10; RISK	We carried out a genome-wide association study of type-2 diabetes (T2D) in individuals of South Asian ancestry. Our discovery set included 5,561 individuals with T2D (cases) and 14,458 controls drawn from studies in London, Pakistan and Singapore. We identified 20 independent SNPs associated with T2D at P < 10(-4) for testing in a replication sample of 13,170 cases and 25,398 controls, also all of South Asian ancestry. In the combined analysis, we identified common genetic variants at six loci (GRB14, ST6GAL1, VPS26A, HMG20A, AP3S2 and HNF4A) newly associated with T2D (P = 4.1 x 10(-8) to P = 1.9 x 10(-11)). SNPs at GRB14 were also associated with insulin sensitivity (P = 5.0 x 10(-4)), and SNPs at ST6GAL1 and HNF4A were also associated with pancreatic beta-cell function (P = 0.02 and P = 0.001, respectively). Our findings provide additional insight into mechanisms underlying T2D and show the potential for new discovery from genetic association studies in South Asians, a population with increased susceptibility to T2D.	[Kooner, Jaspal S.; Sehmi, Joban; Das, Debashish; Chambers, John C.] Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England; [Kooner, Jaspal S.; Sehmi, Joban; Li, Xinzhong; Scott, James] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London, England; [Saleheen, Danish; Frossard, Philippe; Rasheed, Asif; Samuel, Maria; Shah, Nabi] Ctr Noncommunicable Dis Pakistan, Karachi, Pakistan; [Saleheen, Danish; Young, Robin; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Sim, Xueling; Chia, Kee-Seng; Khor, Chiea-Chuen; Lim, Wei-Yen; Suo, Chen; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Genet,Coll Med, Oklahoma City, OK 73190 USA; [Chia, Kee-Seng; Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Dimas, Antigone S.; Nica, Alexandra C.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dimas, Antigone S.; Hedman, Asa K.; Morris, Andrew P.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hassanali, Neelam; Matthews, David R.; Katulanda, Prasad; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford, England; [Jafar, Tazeen; Islam, Muhammed] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Jafar, Tazeen] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Jowett, Jeremy B. M.; Kristensen, Malene M.; Zimmet, Paul Z.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Radha, Venkatesan; Chidambaram, Manickam; Liju, Samuel; Mohan, Viswanathan] Madras Diabet Res Fdn, ICMR, Dept Mol Genet, Adv Ctr Genom Diabet, Madras, Tamil Nadu, India; [Rees, Simon D.; Barnett, Anthony H.; Kelly, M. Ann] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Rees, Simon D.; Barnett, Anthony H.; Kelly, M. Ann] Heart England NHS Fdn Trust, BioMed Res Ctr, Birmingham, W Midlands, England; [Takeuchi, Fumihiko; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Aung, Tin; Khor, Chiea-Chuen; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Basit, Abdul; Hydrie, Zafar I.] Baqai Inst Diabetol & Endocrinol, Karachi, Pakistan; [Grundberg, Elin; Small, Kerrin S.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Khor, Chiea-Chuen; Liu, Jianjun; Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Kowlessur, Sudhir] Minist Hlth, Port Louis, Mauritius; [Pinidiyapathirage, Janani M.; Wickremasinghe, Ananda R.] Univ Kelaniya, Fac Med, Dept Publ Hlth, Ragama, Sri Lanka; [Shera, A. Samad] Diabet Assoc Pakistan, Karachi, Pakistan; [Small, Kerrin S.; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Yang, Mingyu; Zhang, Fan; Liang, Junbin] Beijing Genom Inst, Shenzhen, Peoples R China; [Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Barts & London Genome Ctr, London, England; [Frayling, Timothy M.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, London, England; [Katulanda, Prasad] Univ Colombo, Diabet Res Unit, Dept Clin Med, Colombo, Sri Lanka; [Mohan, Viswanathan] Dr Mohans Diabet Specialties Ctr, Madras, Tamil Nadu, India; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, HPA, MRC, Ctr Environm & Hlth, London, England; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res NIHR, Biomed Res Ctr, Oxford OX3 7LJ, England; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	Imperial College London; Imperial College London; University of Cambridge; National University of Singapore; University of Oklahoma System; University of Oklahoma Health Sciences Center; National University of Singapore; University of Geneva; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Aga Khan University; Aga Khan University; Baker Heart and Diabetes Institute; Indian Council of Medical Research (ICMR); Madras Diabetes Research Foundation; University of Birmingham; Heart of England NHS Foundation Trust; National Center for Global Health & Medicine - Japan; National University of Singapore; National University of Singapore; Singapore National Eye Center; Baqai Medical University; University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University Kelaniya; Wellcome Trust Sanger Institute; Centre for Eye Research Australia; University of Melbourne; Beijing Genomics Institute (BGI); University of Michigan System; University of Michigan; University of London; Queen Mary University London; University of Exeter; Imperial College London; University of Colombo; University of California System; University of California San Francisco; Health Protection Agency; Imperial College London; National University of Singapore; National University of Singapore; University of Oxford; National University of Singapore; National University of Singapore	Chambers, JC (corresponding author), Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England.	j.kooner@imperial.ac.uk; john.chambers@ic.ac.uk	Zimmet, Paul/H-7635-2013; Shah, Nabi/Q-1008-2016; Tai, E Shyong/J-9831-2013; zhang, weihua/GXV-1334-2022; Hydrie, Muhammad Zafar Iqbal/H-8490-2017; Prokopenko, Inga/AAU-9895-2020; Seielstad, Mark/T-7841-2019; Prokopenko, Inga/H-3241-2014; Abecasis, Goncalo R/B-7840-2010; Sim, Xueling/AAZ-6652-2020; Zimmet, Paul/O-8486-2019; Wong, Tien Yin/AAC-9724-2020; FROGUEL, Philippe/O-6799-2017; Shah, Nabi/AAG-7378-2021; li, xin/HHS-9461-2022; Pinidiyapathirage, Janani/AAR-8074-2021; Liu, Jianjun/AAK-4989-2020; Deloukas, Panos/B-2922-2013; McCarthy, Mark/M-3763-2015	Shah, Nabi/0000-0003-2764-3615; Hydrie, Muhammad Zafar Iqbal/0000-0002-1317-6975; Prokopenko, Inga/0000-0003-1624-7457; Sim, Xueling/0000-0002-1233-7642; Zimmet, Paul/0000-0003-0627-0776; Wong, Tien Yin/0000-0002-8448-1264; FROGUEL, Philippe/0000-0003-2972-0784; Shah, Nabi/0000-0003-2764-3615; Pinidiyapathirage, Janani/0000-0003-2947-3015; Liu, Jianjun/0000-0002-3255-3019; Deloukas, Panos/0000-0001-9251-070X; Khor, Chiea Chuen/0000-0002-1128-4729; Abecasis, Goncalo/0000-0003-1509-1825; Tai, E Shyong/0000-0003-2929-8966; Seielstad, Mark/0000-0001-5783-1401; Small, Kerrin/0000-0003-4566-0005; Elliott, Paul/0000-0002-7511-5684; Katulanda, Prasad/0000-0003-4313-7528; Caulfield, Mark/0000-0001-9295-3594; Manickam, Chidambaram/0000-0001-8750-8576; McCarthy, Mark/0000-0002-4393-0510; Hedman, Asa/0000-0001-5413-204X; Sanghera, Dharambir/0000-0001-7203-8655	Wellcome Trust [070854/Z/03/Z, 080747/Z/06/Z, 083270/Z/07/Z, 084723/Z/08/Z]; Chennai Wellingdon Corporate Foundation; Diabetes UK [07/0003512]; National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; British Heart Foundation [SP/04/002]; Medical Research Council [G0700931]; National Institute for Health Research [RP-PG-0407-10371]; US National Institutes of Health [DK-25446, KO1TW006087]; KAKENHI; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Center for Global Health and Medicine; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082766]; A*STAR Biomedical Research Council [05/1/21/19/425]; Biomedical Research Council Singapore [09/1/35/19/616, 08/1/35/19/550]; National Medical Research Council Singapore [NMRC/STaR/0003/2008, 1174/2008]; National Science Foundation of Sri Lanka; Oxford NIHR Biomedical Research Centre; MRC [G0601966, G0801056, G0700931] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0801056B, G0801056, G0601966] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10272] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [K01TW006087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025446, R01DK082766] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Chennai Wellingdon Corporate Foundation; Diabetes UK(Diabetes UK); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science Foundation of Sri Lanka; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the many colleagues who contributed to collection and phenotypic characterization of the clinical samples as well as genotyping and analysis of the GWAS data. We would also like to acknowledge those individuals who agreed to participate in these studies. Major funding for the work described in this paper comes from Wellcome Trust awards (070854/Z/03/Z, 080747/Z/06/Z, 083270/Z/07/Z, 084723/Z/08/Z); Chennai Wellingdon Corporate Foundation; Diabetes UK (07/0003512); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; British Heart Foundation (SP/04/002); Medical Research Council (G0700931); National Institute for Health Research (RP-PG-0407-10371); US National Institutes of Health (DK-25446); KAKENHI (Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Center for Global Health and Medicine; US National Institutes of Health (KO1TW006087); National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082766); A*STAR Biomedical Research Council (05/1/21/19/425); Biomedical Research Council Singapore (09/1/35/19/616, 08/1/35/19/550); National Medical Research Council Singapore (NMRC/STaR/0003/2008, 1174/2008); National Science Foundation of Sri Lanka; and Oxford NIHR Biomedical Research Centre. A full list of acknowledgments is provided in the Supplementary Note.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Artegiani B, 2010, J BIOL CHEM, V285, P24740, DOI 10.1074/jbc.M109.090654; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bellary S, 2008, LANCET, V371, P1769, DOI 10.1016/S0140-6736(08)60764-3; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Chambers JC, 2000, LANCET, V355, P523, DOI 10.1016/S0140-6736(99)93019-2; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chidambaram M, 2010, METABOLISM, V59, P1760, DOI 10.1016/j.metabol.2010.04.024; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Harries LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007855; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Holt LJ, 2009, MOL ENDOCRINOL, V23, P1406, DOI 10.1210/me.2008-0386; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jowett JB, 2009, TWIN RES HUM GENET, V12, P44, DOI 10.1375/twin.12.1.44; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Kim E, 2008, BIOCHEM BIOPH RES CO, V375, P16, DOI 10.1016/j.bbrc.2008.07.067; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2004, CLIN GENET, V66, P299, DOI 10.1111/j.1399-0004.2004.00309.x; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Rees SD, 2011, DIABETIC MED, V28, P673, DOI 10.1111/j.1464-5491.2011.03257.x; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Saleheen D, 2009, EUR J EPIDEMIOL, V24, P329, DOI 10.1007/s10654-009-9334-y; Sanghera DK, 2006, HUM BIOL, V78, P43, DOI 10.1353/hub.2006.0027; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Siitonen N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-5; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soderberg S, 2004, J INTERN MED, V256, P37, DOI 10.1111/j.1365-2796.2004.01336.x; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	57	381	388	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					984	U94		10.1038/ng.921	http://dx.doi.org/10.1038/ng.921			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21874001	Green Accepted			2022-12-25	WOS:000295316200013
J	Lee, J; Sun, C; Zhou, YJ; Lee, J; Gokalp, D; Herrema, H; Park, SW; Davis, RJ; Ozcan, U				Lee, Jaemin; Sun, Cheng; Zhou, Yingjiang; Lee, Justin; Gokalp, Deniz; Herrema, Hilde; Park, Sang Won; Davis, Roger J.; Ozcan, Umut			p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SIGNAL-TRANSDUCTION; TRANSMEMBRANE PROTEIN; INSULIN-RESISTANCE; ER STRESS; PHOSPHOLIPID BIOSYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; INFLAMMATION	Here we show that p38 mitogen-activated protein kinase (p38 MAPK) phosphorylates the spliced form of X-box binding protein 1 (Xbp1s) on its Thr48 and Ser61 residues and greatly enhances its nuclear migration in mice, whereas mutation of either residue to alanine substantially reduces its nuclear translocation and activity. We also show that p38 MAPK activity is markedly reduced in the livers of obese mice compared with lean mice. Further, we show that activation of p38 MAPK by expression of constitutively active MAP kinase kinase 6 (MKK6Glu) greatly enhances nuclear translocation of Xbp1s, reduces endoplasmic reticulum stress and establishes euglycemia in severely obese and diabetic mice. Hence, our results define a crucial role for phosphorylation on Thr48 and Ser61 of Xbp1s in the maintenance of glucose homeostasis in obesity, and they suggest that p38 MAPK activation in the livers of obese mice could lead to a new therapeutic approach to the treatment of type 2 diabetes.	[Lee, Jaemin; Sun, Cheng; Zhou, Yingjiang; Lee, Justin; Gokalp, Deniz; Herrema, Hilde; Park, Sang Won; Ozcan, Umut] Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02114 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Ozcan, U (corresponding author), Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02114 USA.	umut.ozcan@childrens.harvard.edu	Lee, Jaemin/AAP-4875-2021	Davis, Roger/0000-0002-0130-1652; Herrema, Hilde/0000-0002-0112-6348; Lee, Jaemin/0000-0002-0224-7141	Children's Hospital Boston [R01DK081009]; US National Institutes of Health [R56DK089111]; Timothy Murphy funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081009, R56DK089111] Funding Source: NIH RePORTER	Children's Hospital Boston; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Timothy Murphy funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Ozcan laboratory for their help during the execution of the experiments. We thank L. Glimcher (Harvard School of Public Health) for providing us with the Xbp1<SUP>flox/flox</SUP> mouse strain. We thank P. Blackshear (National Institute of Environment Health Sciences) for kindly providing us with Zfp<SUP>36-/-</SUP> cells and M. Gaestel (Hannover Medical School, Germany) for generously providing Mapkapk<SUP>2-/-</SUP> cells. We thank R. Davis (University of Massachusetts Medical School) for providing Mapk8<SUP>-/-</SUP>; Mapk9<SUP>-/-</SUP>, Map2k3<SUP>-/-</SUP>; Map2k6<SUP>-/-</SUP>, Map2k4<SUP>-/-</SUP>; Map2k7<SUP>-/-</SUP> and Mapk14<SUP>-/-</SUP> MEFs as well as their wild-type control MEFs. We are grateful to H. Feldman (Harvard Medical School) for helping us with the statistical analysis. This study was supported by the junior faculty start-up funds provided to U.O. by Children's Hospital Boston, an RO1 grant (R01DK081009) and R56 grant (R56DK089111) provided to U.O. by the US National Institutes of Health and the Timothy Murphy funds provided to the Division of Endocrinology, Children's Hospital Boston.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; MORI K, 1993, CELL, V74, P743; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Park SK, 2010, BREAST CANCER RES TR, V124, P361, DOI 10.1007/s10549-010-0786-2; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	50	142	149	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1251	U283		10.1038/nm.2449	http://dx.doi.org/10.1038/nm.2449			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21892182	Green Accepted			2022-12-25	WOS:000296022100043
J	van Dam, GM; Themelis, G; Crane, LMA; Harlaar, NJ; Pleijhuis, RG; Kelder, W; Sarantopoulos, A; de Jong, JS; Arts, HJG; van der Zee, AGJ; Bart, J; Low, PS; Ntziachristos, V				van Dam, Gooitzen M.; Themelis, George; Crane, Lucia M. A.; Harlaar, Niels J.; Pleijhuis, Rick G.; Kelder, Wendy; Sarantopoulos, Athanasios; de Jong, Johannes S.; Arts, Henriette J. G.; van der Zee, Ate G. J.; Bart, Joost; Low, Philip S.; Ntziachristos, Vasilis			Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results	NATURE MEDICINE			English	Article							SURGERY; EXPRESSION; MANAGEMENT; SURVIVAL; FUTURE; MODEL	The prognosis in advanced-stage ovarian cancer remains poor. Tumor-specific intraoperative fluorescence imaging may improve staging and debulking efforts in cytoreductive surgery and thereby improve prognosis. The overexpression of folate receptor-alpha (FR-alpha) in 90-95% of epithelial ovarian cancers prompted the investigation of intraoperative tumor-specific fluorescence imaging in ovarian cancer surgery using an FR-alpha-targeted fluorescent agent. In patients with ovarian cancer, intraoperative tumor-specific fluorescence imaging with an FR-alpha-targeted fluorescent agent showcased the potential applications in patients with ovarian cancer for improved intraoperative staging and more radical cytoreductive surgery.	[van Dam, Gooitzen M.; Crane, Lucia M. A.; Harlaar, Niels J.; Pleijhuis, Rick G.; Kelder, Wendy; de Jong, Johannes S.] Univ Groningen, BioOpt Imaging Ctr, Div Surg Oncol, Dept Surg, Groningen, Netherlands; [Themelis, George; Harlaar, Niels J.; Sarantopoulos, Athanasios; Ntziachristos, Vasilis] Tech Univ Munich, Munich, Germany; [Themelis, George; Harlaar, Niels J.; Sarantopoulos, Athanasios; Ntziachristos, Vasilis] Helmholtz Zentrum, Munich, Germany; [Arts, Henriette J. G.; van der Zee, Ate G. J.] Univ Groningen, Div Gynaecol Oncol, Dept Gynaecol, Groningen, Netherlands; [Bart, Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Mol Biol, Groningen, Netherlands; [Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	University of Groningen; Technical University of Munich; Helmholtz Association; University of Groningen; University of Groningen; Purdue University System; Purdue University; Purdue University West Lafayette Campus	van Dam, GM (corresponding author), Univ Groningen, BioOpt Imaging Ctr, Div Surg Oncol, Dept Surg, Groningen, Netherlands.	g.m.van.dam@umcg.nl	de Jong, J.S./AAC-9908-2019; Bart, Joost/A-5642-2013	Bart, Joost/0000-0002-0985-071X; Low, Philip/0000-0001-9042-5528				Aletti GD, 2006, OBSTET GYNECOL, V107, P77, DOI 10.1097/01.AOG.0000192407.04428.bb; Aletti GD, 2007, MAYO CLIN PROC, V82, P751; Armstrong DK, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5500; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Crane LMA, 2012, CELL ONCOL, V35, P9, DOI 10.1007/s13402-011-0052-6; Gondos A, 2009, ANN ONCOL, V20, P564, DOI 10.1093/annonc/mdn639; Ibeanu OA, 2010, INT J GYNECOL CANCER, V20, pS1, DOI 10.1111/IGC.0b013e3181cff38b; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalli KR, 2008, GYNECOL ONCOL, V108, P619, DOI 10.1016/j.ygyno.2007.11.020; Kennedy MD, 2003, J BIOMED OPT, V8, P636, DOI 10.1117/1.1609453; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koppe MJ, 2006, ANN SURG, V243, P212, DOI 10.1097/01.sla.0000197702.46394.16; Leamon CP, 2002, BIOCONJUGATE CHEM, V13, P1200, DOI 10.1021/bc0200430; Low PS, 2004, ADV DRUG DELIVER REV, V56, P1055, DOI 10.1016/j.addr.2004.02.003; Lu YJ, 2009, AAPS J, V11, P628, DOI 10.1208/s12248-009-9139-7; Lu YJ, 2002, CANCER IMMUNOL IMMUN, V51, P153, DOI 10.1007/s00262-002-0266-6; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Markert S, 2008, ANTICANCER RES, V28, P3567; Mathias CJ, 1998, J NUCL MED, V39, P1579; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Sega EI, 2008, CANCER METAST REV, V27, P655, DOI 10.1007/s10555-008-9155-6; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Themelis G, 2008, OPT LETT, V33, P1023, DOI 10.1364/OL.33.001023; Themelis G, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259362; Tromberg BJ, 2008, MED PHYS, V35, P2443, DOI 10.1118/1.2919078; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Vergote I, 2008, INT J GYNECOL CANCER, V18, P11, DOI 10.1111/j.1525-1438.2007.01098.x; von Burstin J, 2008, INT J CANCER, V123, P2138, DOI 10.1002/ijc.23780; Winter WE, 2008, J CLIN ONCOL, V26, P83, DOI 10.1200/JCO.2007.13.1953	32	1159	1192	11	391	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1315	U202		10.1038/nm.2472	http://dx.doi.org/10.1038/nm.2472			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21926976				2022-12-25	WOS:000296022100052
J	Patgiri, A; Yadav, KK; Arora, PS; Bar-Sagi, D				Patgiri, Anupam; Yadav, Kamlesh K.; Arora, Paramjit S.; Bar-Sagi, Dafna			An orthosteric inhibitor of the Ras-Sos interaction	NATURE CHEMICAL BIOLOGY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ALPHA-HELICES; ACTIVATOR SON; PROTEIN; RECOGNITION; SEVENLESS; ERK/MAPK; COMPLEX	Mimics of alpha-helices on protein surfaces have emerged as powerful reagents for antagonizing protein-protein interactions, which are difficult to target with small molecules. Here we describe the design of a cell-permeable synthetic alpha-helix, based on the guanine nucleotide exchange factor Sos, that interferes with Ras-Sos interaction and downregulates Ras signaling in response to receptor tyrosine kinase activation.	[Patgiri, Anupam; Arora, Paramjit S.] NYU, Dept Chem, New York, NY 10012 USA; [Yadav, Kamlesh K.; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University; New York University	Patgiri, A (corresponding author), NYU, Dept Chem, New York, NY 10012 USA.	arora@nyu.edu; dafna.bar-sagi@nyumc.org	Arora, Paramjit/AAR-3086-2020	Patgiri, Anupam/0000-0002-4184-5961; Bar-Sagi, Dafna/0000-0003-2597-8948	US National Institutes of Health [GM073943, GM078266]; ARRA [GM078266S1]; New York University; New York State Office of Science, Technology and Academic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073943, R01GM078266] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University; New York State Office of Science, Technology and Academic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM073943 to P.S.A. and GM078266 and an ARRA stimulus supplement (GM078266S1) to D.B.-S.). A.P. thanks New York University for the Margaret and Herman Sokol Fellowship. NMR data were collected at the New York Structural Biology Center, a Strategically Targeted Academic Research (STAR) center supported by the New York State Office of Science, Technology and Academic Research. We thank C. Lin (New York University) and A. Natarajan and R. Ghosh (City College, City University of New York) for help with the NMR studies.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Cummings CG, 2010, CURR OPIN CHEM BIOL, V14, P341, DOI 10.1016/j.cbpa.2010.04.001; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Henchey LK, 2010, CHEMBIOCHEM, V11, P2104, DOI 10.1002/cbic.201000378; Henchey LK, 2010, J AM CHEM SOC, V132, P941, DOI 10.1021/ja9082864; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; KORTEMME T, 2004, SCI STKE, pPL2; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Patgiri A, 2010, NAT PROTOC, V5, P1857, DOI 10.1038/nprot.2010.146; Sacco E, 2005, FEBS LETT, V579, P6851, DOI 10.1016/j.febslet.2005.11.024; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005	24	220	245	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					585	587		10.1038/NCHEMBIO.612	http://dx.doi.org/10.1038/NCHEMBIO.612			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21765406	Green Accepted			2022-12-25	WOS:000294381400006
J	Dambournet, D; Machicoane, M; Chesneau, L; Sachse, M; Rocancourt, M; El Marjou, A; Formstecher, E; Salomon, R; Goud, B; Echard, A				Dambournet, Daphne; Machicoane, Mickael; Chesneau, Laurent; Sachse, Martin; Rocancourt, Murielle; El Marjou, Ahmed; Formstecher, Etienne; Salomon, Remi; Goud, Bruno; Echard, Arnaud			Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis	NATURE CELL BIOLOGY			English	Article							SYNDROME PROTEIN OCRL1; LOWE-SYNDROME; ESCRT MACHINERY; BINDING; MIDBODY; PHOSPHOINOSITIDES; 5-PHOSPHATASE; TRAFFICKING; ACTIVATION; MECHANISMS	Abscission is the least understood step of cytokinesis. It consists of the final cut of the intercellular bridge connecting the sister cells at the end of mitosis, and is thought to involve membrane trafficking as well as lipid and cytoskeleton remodelling(1-6). We previously identified the Rab35 GTPase as a regulator of a fast recycling endocytic pathway that is essential for post-furrowing cytokinesis stages(7). Here, we report that the phosphatidylinositol-4,5-bisphosphate (PtdIns(4, 5)P(2)) 5-phosphatase OCRL, which is mutated in Lowe syndrome patients(8,9), is an effector of the Rab35 GTPase in cytokinesis abscission. GTP-bound (active) Rab35 directly interacts with OCRL and controls its localization at the intercellular bridge. Depletion of Rab35 or OCRL inhibits cytokinesis abscission and is associated with local abnormal PtdIns (4, 5)P(2) and F-actin accumulation in the intercellular bridge. These division defects are also found in cell lines derived from Lowe patients and can be corrected by the addition of low doses of F-actin depolymerization drugs. Our data demonstrate that PtdIns(4, 5)P(2) hydrolysis is important for normal cytokinesis abscission to locally remodel the F-actin cytoskeleton in the intercellular bridge. They also reveal an unexpected role for the phosphatase OCRL in cell division and shed new light on the pleiotropic phenotypes associated with Lowe disease.	[Dambournet, Daphne; Machicoane, Mickael; Chesneau, Laurent; Rocancourt, Murielle; Echard, Arnaud] Inst Pasteur, Membrane Traff & Cell Div Lab, F-75724 Paris 15, France; [Dambournet, Daphne; Machicoane, Mickael; Chesneau, Laurent; Rocancourt, Murielle; Echard, Arnaud] CNRS, URA2582, F-75700 Paris, France; [El Marjou, Ahmed; Goud, Bruno] Inst Curie, Mol Mech Intracellular Transport Lab, F-75005 Paris, France; [El Marjou, Ahmed; Goud, Bruno] CNRS, UMR144, F-75700 Paris, France; [Formstecher, Etienne] Hybrigenics SA, F-75014 Paris, France; [Salomon, Remi] Hop Necker Enfants Malad, AP HP, INSERM, Serv Nephrol Pediat,U983, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Echard, A (corresponding author), Inst Pasteur, Membrane Traff & Cell Div Lab, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	arnaud.echard@pasteur.fr	Goud, Bruno/GWC-4807-2022; Sachse, Martin/W-7403-2019	Chesneau, Laurent/0000-0001-7042-443X; Echard, Arnaud/0000-0001-7402-1398; Sachse, Martin/0000-0001-5981-9166; FORMSTECHER, Etienne/0000-0002-6410-4365	Institut PASTEUR; Institut CURIE; CNRS; INSERM; Agence Nationale pour la Recherche [ANR 07 JCJC 0089]; Schlumberger Foundation for Education and Research-FSER; Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer	Institut PASTEUR(European Commission); Institut CURIE; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Schlumberger Foundation for Education and Research-FSER(Schlumberger); Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank R. Woscholski (Imperial College, London, UK), O. Dorseuil (Institut Cochin, Paris, France), A. Gautreau (CNRS Lebs, Gif, France), A. Alcover (Institut Pasteur, Paris), S. Miserey-Lenkei, P. Benaroch and F. Nagano (Institut Curie, Paris, France) for providing reagents and plasmids; V. Chauvet, A. Gautreau, A. Houdusse, B. Payrastre, N. Vitale and R. Weil for helpful discussions; S. Miserey-Lenkei and E. Crowell for critical reading of the manuscript; F. Legendre (Hopital Necker, Paris, France) for the establishment of patients cell lines; and J. Lunardi (CHU Grenoble, France) and G. Baujat for the pediatric network. We thank the 'Association du Syndrome de Lowe', patients and parents. We thank the Plate-Forme d'Imagerie Dynamique (PFID) and Imagopole, Institut Pasteur, for microscopes and assistance. The authors thank V. Fraisier, L. Sengmanivong, J-B. Sibarita and J. Salamero for support in microscopy, and acknowledge the Nikon Imaging Centre at Institut Curie-CNRS. This work has been supported by the Institut PASTEUR (G5 program), the Institut CURIE, the CNRS, the INSERM, the Agence Nationale pour la Recherche (grants ANR-Maladies Rares, GIS-Maladies Rares to B. G. and R. S., and ANR 07 JCJC 0089 to A. E.) and the Schlumberger Foundation for Education and Research-FSER (A. E.). D. D. and M. M. have been supported by the Ministere de la Recherche et de l'Enseignement Superieur, and D. D. and L. C. have been supported by the Association pour la Recherche sur le Cancer.	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Begle A, 2009, J BIOL CHEM, V284, P4836, DOI 10.1074/jbc.M806894200; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Echard A, 2008, BIOCHEM SOC T, V36, P395, DOI 10.1042/BST0360395; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Faucherre A, 2005, HUM MOL GENET, V14, P1441, DOI 10.1093/hmg/ddi153; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hichri H, 2011, HUM MUTAT, V32, P379, DOI 10.1002/humu.21391; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; LENKEI SM, 2010, NAT CELL BIOL, V12, P645; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Ma L, 1998, J CELL BIOL, V140, P1125; Monnier N, 2000, HUM MUTAT, V16, P157, DOI 10.1002/1098-1004(200008)16:2<157::AID-HUMU8>3.0.CO;2-9; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Nizak C, 2003, TRAFFIC, V4, P739, DOI 10.1034/j.1600-0854.2003.00132.x; Oorschot V, 2002, J HISTOCHEM CYTOCHEM, V50, P1067, DOI 10.1177/002215540205000809; RACUSEN LC, 1995, KIDNEY INT, V48, P536, DOI 10.1038/ki.1995.324; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Uzan-Gafsou S, 2007, MOL BIOL CELL, V18, P3169, DOI 10.1091/mbc.E06-09-0779; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	47	191	193	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					981	U245		10.1038/ncb2279	http://dx.doi.org/10.1038/ncb2279			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21706022				2022-12-25	WOS:000293373700017
J	Lemke, EA; Schultz, C				Lemke, Edward A.; Schultz, Carsten			Principles for designing fluorescent sensors and reporters	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; PROTEIN; INDICATORS; PROBES; CHEMISTRY; PEPTIDES; BUFFERS; FRET; DYE		[Lemke, Edward A.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Lemke, EA (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	lemke@embl.de; schultz@embl.de	Lemke, Edward A/J-3337-2015	Lemke, Edward A/0000-0002-0634-0503; Schultz, Carsten/0000-0002-5824-2171				Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Bradley J, 2009, J NEUROSCI, V29, P9197, DOI 10.1523/JNEUROSCI.1240-09.2009; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cobos-Correa A, 2009, NAT CHEM BIOL, V5, P628, DOI 10.1038/nchembio.196; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Fonovic M, 2008, EXPERT REV PROTEOMIC, V5, P721, DOI 10.1586/14789450.5.5.721; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Kuhn B, 2008, P NATL ACAD SCI USA, V105, P7588, DOI 10.1073/pnas.0802462105; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; PILJIC A, 2011, ACS CHEM BIOL, V6, DOI DOI 10.2021/CB100402N; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Plass T, 2011, ANGEW CHEM INT EDIT, V50, P3878, DOI 10.1002/anie.201008178; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; WAGGONER A, 1976, J MEMBRANE BIOL, V27, P317, DOI 10.1007/BF01869143; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	26	79	81	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					480	483		10.1038/nchembio.620	http://dx.doi.org/10.1038/nchembio.620			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769088				2022-12-25	WOS:000292825400002
J	Bisson, N; James, DA; Ivosev, G; Tate, SA; Bonner, R; Taylor, L; Pawson, T				Bisson, Nicolas; James, D. Andrew; Ivosev, Gordana; Tate, Stephen A.; Bonner, Ron; Taylor, Lorne; Pawson, Tony			Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-INTERACTION NETWORKS; RECEPTOR TYROSINE KINASES; QUANTITATIVE PROTEOMICS; SH3 DOMAIN; RAS; PHOSPHORYLATION; TRANSFORMATION; AFFINITY; SHP-2; CELLS	Signaling pathways are commonly organized through inducible protein-protein interactions, mediated by adaptor proteins that link activated receptors to cytoplasmic effectors(1). However, we have little quantitative data regarding the kinetics with which such networks assemble and dissolve to generate specific cellular responses. To address this deficiency, we designed a mass spectrometry method, affinity purification-selected reaction monitoring (AP-SRM), which we used to comprehensively and quantitatively investigate changes in protein interactions with GRB2, an adaptor protein that participates in a remarkably diverse set of protein complexes involved in multiple aspects of cellular function. Our data reliably define context-specific and time-dependent networks that form around GRB2 after stimulation, and reveal core and growth factor-selective complexes comprising 90 proteins identified as interacting with GRB2 in HEK293T cells. Capturing a key hub protein and dissecting its interactions by SRM should be equally applicable to quantifying signaling dynamics for a range of hubs in protein interaction networks.	[Bisson, Nicolas; James, D. Andrew; Taylor, Lorne; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Ivosev, Gordana; Tate, Stephen A.; Bonner, Ron] AB Sciex, Concord, ON, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Joseph & Wolf Lebovic Hlth Complex, Toronto, ON, Canada.	pawson@lunenfeld.ca	Pawson, Tony J/E-4578-2013	tate, stephen/0000-0001-5508-0819; Bonner, Ron/0000-0003-0532-8323; Bisson, Nicolas/0000-0001-7752-9517	Ontario Ministry of Research and Innovation; Genome Canada through the Ontario Genomics Institute; Canadian Institutes of Health Research (CIHR) [MOP-6849]; Terry Fox Research Institute/Ontario Institute for Cancer Research; Canadian Cancer Society Research Institute	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Genome Canada through the Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute/Ontario Institute for Cancer Research; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	The authors would like to thank K. Colwill and A.-C. Gingras for insightful comments on the manuscript, R. Bagshaw, G. Findlay, J. Gish, J. Jin, B. Larsen and O. Rocks for discussions and A. Yu Dai, B. Larsen and B. Liu for technical assistance. This project is supported through Ontario Research Fund grants from the Ontario Ministry of Research and Innovation and grants from Genome Canada through the Ontario Genomics Institute, the Canadian Institutes of Health Research (CIHR, grant MOP-6849), the Terry Fox Research Institute/Ontario Institute for Cancer Research and the Canadian Cancer Society Research Institute. N.B. holds a research fellowship from the CIHR. T.P. holds the Apotex Chair in Molecular Oncology and is a Distinguished Investigator of the CIHR.	Ackermann BL, 2008, ANNU REV ANAL CHEM, V1, P357, DOI 10.1146/annurev.anchem.1.031207.112855; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bazenet CE, 1996, MOL CELL BIOL, V16, P6926; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chook YM, 1996, J BIOL CHEM, V271, P30472, DOI 10.1074/jbc.271.48.30472; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Kaake RM, 2010, MOL CELL PROTEOMICS, V9, P1650, DOI 10.1074/mcp.R110.000265; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mayer BJ, 1998, CURR TOP MICROBIOL, V228, P1; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	30	164	169	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					653	U138		10.1038/nbt.1905	http://dx.doi.org/10.1038/nbt.1905			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21706016				2022-12-25	WOS:000292595200024
J	Barak, T; Kwan, KY; Louvi, A; Demirbilek, V; Saygi, S; Tuysuz, B; Choi, M; Boyaci, H; Doerschner, K; Zhu, Y; Kaymakcalan, H; Yilmaz, S; Bakircioglu, M; Caglayan, AO; Ozturk, AK; Yasuno, K; Brunken, WJ; Atalar, E; Yalcinkaya, C; Dincer, A; Bronen, RA; Mane, S; Ozcelik, T; Lifton, RP; Sestan, N; Bilguvar, K; Gunel, M				Barak, Tanyeri; Kwan, Kenneth Y.; Louvi, Angeliki; Demirbilek, Veysi; Saygi, Serap; Tuysuz, Beyhan; Choi, Murim; Boyaci, Huseyin; Doerschner, Katja; Zhu, Ying; Kaymakcalan, Hande; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Brunken, William J.; Atalar, Ergin; Yalcinkaya, Cengiz; Dincer, Alp; Bronen, Richard A.; Mane, Shrikant; Ozcelik, Tayfun; Lifton, Richard P.; Sestan, Nenad; Bilguevar, Kaya; Guenel, Murat			Recessive LAMC3 mutations cause malformations of occipital cortical development	NATURE GENETICS			English	Article							HUMAN PREFRONTAL CORTEX; LAMININ GAMMA-3 CHAIN; EXPRESSION; NEURONS; POLYMICROGYRIA; MORPHOGENESIS; DIFFUSION; MIGRATION; MEMBRANE; ADULT	The biological basis for regional and inter-species differences in cerebral cortical morphology is poorly understood. We focused on consanguineous Turkish families with a single affected member with complex bilateral occipital cortical gyration abnormalities. By using whole-exome sequencing, we initially identified a homozygous 2-bp deletion in LAMC3, the laminin. 3 gene, leading to an immediate premature termination codon. In two other affected individuals with nearly identical phenotypes, we identified a homozygous nonsense mutation and a compound heterozygous mutation. In human but not mouse fetal brain, LAMC3 is enriched in postmitotic cortical plate neurons, localizing primarily to the somatodendritic compartment. LAMC3 expression peaks between late gestation and late infancy, paralleling the expression of molecules that are important in dendritogenesis and synapse formation. The discovery of the molecular basis of this unusual occipital malformation furthers our understanding of the complex biology underlying the formation of cortical gyrations.	[Barak, Tanyeri; Louvi, Angeliki; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Bronen, Richard A.; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Barak, Tanyeri; Kwan, Kenneth Y.; Louvi, Angeliki; Zhu, Ying; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Sestan, Nenad; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Barak, Tanyeri; Choi, Murim; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Mane, Shrikant; Lifton, Richard P.; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Genet, Ctr Human Genet & Genom, New Haven, CT 06510 USA; [Barak, Tanyeri; Choi, Murim; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Mane, Shrikant; Lifton, Richard P.; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT USA; [Kwan, Kenneth Y.; Zhu, Ying; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Demirbilek, Veysi; Yalcinkaya, Cengiz] Istanbul Univ, Cerrahpasa Fac Med, Dept Neurol, Div Child Neurol, Istanbul, Turkey; [Saygi, Serap] Hacettepe Univ, Sch Med, Dept Neurol, Ankara, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Fac Med, Dept Pediat, Div Genet, Istanbul, Turkey; [Boyaci, Huseyin; Doerschner, Katja] Bilkent Univ, Dept Psychol, Ankara, Turkey; [Boyaci, Huseyin; Doerschner, Katja; Atalar, Ergin] Bilkent Univ, Natl Magnet Resonance Res Ctr, Ankara, Turkey; [Kaymakcalan, Hande] Bahcesehir Univ, Fac Arts & Sci, Istanbul, Turkey; [Brunken, William J.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Brunken, William J.] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Dincer, Alp] Acibadem Univ, Sch Med, Dept Radiol, Istanbul, Turkey; [Bronen, Richard A.] Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06510 USA; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Ozcelik, Tayfun] Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Istanbul University; Istanbul University - Cerrahpasa; Hacettepe University; Istanbul University; Istanbul University - Cerrahpasa; Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Ministry of Energy & Natural Resources - Turkey; Bahcesehir University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Acibadem University; Yale University; Yale University; Ihsan Dogramaci Bilkent University; Howard Hughes Medical Institute; Yale University	Gunel, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	murat.gunel@yale.edu	Choi, Murim/AAP-9120-2021; Kaymakcalan, Hande/AFP-2191-2022; Atalar, Ergin/D-3184-2012; Kwan, Kenneth/AAI-2841-2021; Kaymakcalan, Hande/AAO-4208-2021; Tüysüz, Beyhan/AAN-4858-2020; Dincer, Alp/D-3658-2015; Caglayan, Ahmet O/D-1066-2012; Yalcinkaya, Cengiz/B-6288-2012; Kwan, Kenneth Y/F-8489-2011; Yasuno, Katsuhito/E-1960-2012; Boyaci, Huseyin/ABI-5769-2020; Zhu, Ying/T-2268-2019	Atalar, Ergin/0000-0002-6874-6103; Kwan, Kenneth/0000-0003-4711-071X; Kaymakcalan, Hande/0000-0001-7736-7634; Dincer, Alp/0000-0001-9158-8353; Caglayan, Ahmet O/0000-0002-2332-322X; Yalcinkaya, Cengiz/0000-0002-3443-8524; Kwan, Kenneth Y/0000-0003-4711-071X; Yasuno, Katsuhito/0000-0002-3606-532X; Boyaci, Huseyin/0000-0003-3168-0654; saygi, serap/0000-0002-7329-7138; Barak, Tanyeri/0000-0002-8522-1552; Brunken, William J/0000-0001-7330-1814; Tuysuz, Beyhan/0000-0002-9620-5021; Zhu, Ying/0000-0002-6594-3734	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; US National Institutes of Health [RC2NS070477, UL1RR024139NIH, UO1MH081896]; US National Institutes of Health Neuroscience Microarray Consortium [U24 NS051869-02S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051869, RC2NS070477] Funding Source: NIH RePORTER	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the subjects and families who have contributed to this study. We would like to thank M. State and J. Noonan for critical comments regarding the study and C. Camputaro for her help with the imaging studies. We acknowledge the use of Yale University Biomedical High Performance Computing Center for data analysis and storage. This study was supported by the Yale Program on Neurogenetics, the Yale Center for Human Genetics and Genomics, and US National Institutes of Health grants RC2NS070477 (to M. G.), UL1RR024139NIH (Yale Clinical and Translational Science Award) and UO1MH081896 (to N.S.). SNP genotyping was supported in part by a US National Institutes of Health Neuroscience Microarray Consortium award U24 NS051869-02S1 (to S.M.).	Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Ben Cheikh BOA, 2009, NEUROGENETICS, V10, P35, DOI 10.1007/s10048-008-0143-3; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; CAVINESS VS, 1975, SCIENCE, V189, P18; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FERRIE CD, 1995, NEUROLOGY, V45, P150, DOI 10.1212/WNL.45.1.150; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Louvi A, 2004, DEVELOPMENT, V131, P3093, DOI 10.1242/dev.01191; MRZLJAK L, 1992, J COMP NEUROL, V316, P485, DOI 10.1002/cne.903160408; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Pinzon-Duarte G, 2010, INVEST OPHTH VIS SCI, V51, P1773, DOI 10.1167/iovs.09-4645; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200	35	78	82	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					590	U132		10.1038/ng.836	http://dx.doi.org/10.1038/ng.836			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21572413	Green Accepted, Green Published			2022-12-25	WOS:000291017000019
J	Klein, CJ; Botuyan, MV; Wu, YH; Ward, CJ; Nicholson, GA; Hammans, S; Hojo, K; Yamanishi, H; Karpf, AR; Wallace, DC; Simon, M; Lander, C; Boardman, LA; Cunningham, JM; Smith, GE; Litchy, WJ; Boes, B; Atkinson, EJ; Middha, S; Dyck, PJB; Parisi, JE; Mer, G; Smith, DI; Dyck, PJ				Klein, Christopher J.; Botuyan, Maria-Victoria; Wu, Yanhong; Ward, Christopher J.; Nicholson, Garth A.; Hammans, Simon; Hojo, Kaori; Yamanishi, Hiromitch; Karpf, Adam R.; Wallace, Douglas C.; Simon, Mariella; Lander, Cecilie; Boardman, Lisa A.; Cunningham, Julie M.; Smith, Glenn E.; Litchy, William J.; Boes, Benjamin; Atkinson, Elizabeth J.; Middha, Sumit; Dyck, P. James B.; Parisi, Joseph E.; Mer, Georges; Smith, David I.; Dyck, Peter J.			Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; SERINE PALMITOYLTRANSFERASE; METHYLATION; DEAFNESS; HYPOMETHYLATION; REPLICATION; INSTABILITY; ACTIVATION; NEURONS; BINDING	DNA methyltransferase 1 (DNMT1) is crucial for maintenance of methylation, gene regulation and chromatin stability(1-3). DNA mismatch repair, cell cycle regulation in post-mitotic neurons(4,5) and neurogenesis(6) are influenced by DNA methylation. Here we show that mutations in DNMT1 cause both central and peripheral neurodegeneration in one form of hereditary sensory and autonomic neuropathy with dementia and hearing loss(7,8). Exome sequencing led to the identification of DNMT1 mutation c.1484A>G (p.Tyr495Cys) in two American kindreds and one Japanese kindred and a triple nucleotide change, c.1470-1472TCC>ATA (p.Asp490Glu-Pro491Tyr), in one European kindred. All mutations are within the targeting-sequence domain of DNMT1. These mutations cause premature degradation of mutant proteins, reduced methyltransferase activity and impaired heterochromatin binding during the G2 cell cycle phase leading to global hypomethylation and site-specific hypermethylation. Our study shows that DNMT1 mutations cause the aberrant methylation implicated in complex pathogenesis. The discovered DNMT1 mutations provide a new framework for the study of neurodegenerative diseases.	[Klein, Christopher J.; Litchy, William J.; Dyck, P. James B.; Dyck, Peter J.] Mayo Clin, Dept Neurol, Div Peripheral Nerve Dis, Rochester, MN 55905 USA; [Nicholson, Garth A.] Univ Sydney, Mol Med Lab, Sydney, NSW 2006, Australia; [Hammans, Simon] Southampton Univ Hosp Natl Hlth Serv NHS Trust, Dept Neurol, Southampton, Hants, England; [Yamanishi, Hiromitch] Harima Sanat, Div Psychiat, Hyogo, Japan; [Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Wallace, Douglas C.; Simon, Mariella] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA; [Lander, Cecilie] Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia; [Boardman, Lisa A.] Mayo Clin, Div Gastroenterol, Rochester, MN USA; [Smith, Glenn E.] Mayo Clin, Div Psychol, Rochester, MN USA; [Boes, Benjamin] Roche Appl Sci Genom Sequencing, Indianapolis, IN USA; [Parisi, Joseph E.] Mayo Clin, Div Neuropathol, Rochester, MN USA	Mayo Clinic; University of Sydney; Roswell Park Cancer Institute; University of California System; University of California Irvine; Royal Brisbane & Women's Hospital; University of Queensland; Mayo Clinic; Mayo Clinic; Mayo Clinic	Klein, CJ (corresponding author), Mayo Clin, Dept Neurol, Div Peripheral Nerve Dis, Rochester, MN 55905 USA.	klein.christopher@mayo.edu	Cecilie, Lander/F-8223-2014; Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; Smith, Glenn/0000-0003-1506-9484; Simon, Mariella/0000-0002-8200-3277; Middha, Sumit/0000-0003-4135-6268; Lander, Cecilie/0000-0002-3548-9550; Nicholson, Garth/0000-0001-9694-066X; Karpf, Adam/0000-0002-0866-0666; Klein, Christopher/0000-0002-4012-8856	National Institute of Neurologic Disorders and Strokes (NINDS) [K08 (NS065007)]; NINDS [R01 (NS36797)]; Muscular Dystrophy Association; NIH [UL1 RR024150]; Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; US National Institutes of Health [NS21328, NS070298]; NATIONAL CANCER INSTITUTE [R01CA132878] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS065007, R01NS021328, R01NS036797, R01NS070298] Funding Source: NIH RePORTER	National Institute of Neurologic Disorders and Strokes (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurologic Disorders and Strokes (NINDS) K08 (NS065007), NINDS R01 (NS36797) and a previous grant from the Muscular Dystrophy Association. The authors wish to thank the Mayo Center for Translational Science Activities (supported by NIH UL1 RR024150) and the Mayo Clinic Bioinformatics Core and Sequencing Core for their excellent assistance. We would also like to thank the support from the Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567). D. C. W. and M. S. would like to acknowledge the outstanding clinical contributions of J. Platt. Their portion of this work was supported by US National Institutes of Health grants NS21328 and NS070298.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Brooks PJ, 1996, J NEUROSCI, V16, P939; Brown KD, 2007, NAT GENET, V39, P289, DOI 10.1038/ng0307-289; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hojo K, 1999, EUR J NEUROL, V6, P357, DOI 10.1046/j.1468-1331.1999.630357.x; Hojo K, 2004, NEUROSCI LETT, V367, P340, DOI 10.1016/j.neulet.2004.06.030; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Klein CJ, 2005, PERIPHERAL NEUROPATH, V2, P1809; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Spada F, 2006, ADV ENZYME REGUL, V46, P224, DOI 10.1016/j.advenzreg.2006.01.011; TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; WRIGHT A, 1995, NEUROLOGY, V45, P560, DOI 10.1212/WNL.45.3.560; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	35	261	280	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					595	U140		10.1038/ng.830	http://dx.doi.org/10.1038/ng.830			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532572	Green Accepted			2022-12-25	WOS:000291017000020
J	Maddika, S; Kavela, S; Rani, N; Palicharla, VR; Pokorny, JL; Sarkaria, JN; Chen, JJ				Maddika, Subbareddy; Kavela, Sridhar; Rani, Neelam; Palicharla, Vivek Reddy; Pokorny, Jenny L.; Sarkaria, Jann N.; Chen, Junjie			WWP2 is an E3 ubiquitin ligase for PTEN	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR GENE; GERMLINE MUTATIONS; PROSTATE-CANCER; CELL-SURVIVAL; STEM-CELLS; P53; PHOSPHATASE; DELETION; BREAST; TRANSCRIPTION	PTEN, a lipid phosphatase, is one of the most frequently mutated tumour suppressors in human cancer. Several recent studies have highlighted the importance of ubiquitylation in regulating PTEN tumour-suppressor function, but the enzymatic machinery required for PTEN ubiquitylation is not clear. In this study, by using a tandem affinity-purification approach, we have identified WWP2 (also known as atrophin-l-interacting protein 2, AIP-2) as a PTEN-interacting protein. WWP2 is an E3 ubiquitin ligase that belongs to the NEDD4-like protein family, which is involved in regulating transcription, embryonic stem-cell fate, cellular transport and T-cell activation processes. We show that WWP2 physically interacts with PTEN and mediates its degradation through a ubiquitylation-dependent pathway. Functionally, we show that WWP2 controls cellular apoptosis and is required for tumorigenicity of cells. Collectively, our results reveal a functional E3 ubiquitin ligase for PTEN that plays a vital role in tumour-cell survival.	[Maddika, Subbareddy; Kavela, Sridhar; Rani, Neelam; Palicharla, Vivek Reddy] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India; [Pokorny, Jenny L.; Sarkaria, Jann N.] Mayo Clin, Rochester, MN 55905 USA; [Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center	Maddika, S (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India.	msreddy@cdfd.org.in; jchen8@mdanderson.org	Palicharla, Vivek Reddy/AFP-0418-2022	Chaudhary, Neelam/0000-0002-0327-2824; Palicharla, Venkata Vivek Reddy/0000-0002-2478-8045	Ministry of Science and Technology, India [BT/PR13134/GBD/27/202/2009]; Era of Hope Research Scholar Award [W81XWH-09-0409]; NIH [CA108961]; Department of Defense [W81XWH-05-0470]; Council of Scientific and Industrial Research; University Grants Commission, India; Department of Biotechnology; Institute of Life Sciences, Hyderabad; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA108961] Funding Source: NIH RePORTER	Ministry of Science and Technology, India; Era of Hope Research Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India); Department of Biotechnology; Institute of Life Sciences, Hyderabad; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from the Department of Biotechnology, Ministry of Science and Technology, India (to S.M.; BT/PR13134/GBD/27/202/2009), an Era of Hope Research Scholar Award (to J.C.; W81XWH-09-0409) and an NIH SPORE award (to J.N.S.; CA108961). J.C. is the recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-0470) and a member of MD Anderson Cancer Center (CA016672). S.K., N.R. and V.R.P. acknowledge fellowship support from the Department of Biotechnology, Council of Scientific and Industrial Research and University Grants Commission, India, respectively. S.M. is a recipient of the Department of Biotechnology's IYBA award. We also acknowledge the Institute of Life Sciences, Hyderabad, for providing basic support during some parts of this work.	Andres-Pons A, 2007, CANCER RES, V67, P9731, DOI 10.1158/0008-5472.CAN-07-1278; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Georgescu MM, 2000, CANCER RES, V60, P7033; Guldberg P, 1997, CANCER RES, V57, P3660; He X, 2011, HUM MOL GENET, V20, P80, DOI 10.1093/hmg/ddq434; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; Kato H, 2000, CLIN CANCER RES, V6, P3937; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Paez Juan, 2003, Cancer Treat Res, V115, P145; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Rhei E, 1997, CANCER RES, V57, P3657; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SI, 1997, CANCER RES, V57, P4183; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Zhou MX, 2003, CANCER RES, V63, P6357	40	207	219	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					728	U224		10.1038/ncb2240	http://dx.doi.org/10.1038/ncb2240			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21532586	Green Accepted			2022-12-25	WOS:000291147400015
J	Lamb, D				Lamb, Dolores			Getting to the bare bones of fertility	NATURE MEDICINE			English	Editorial Material							ENERGY-METABOLISM; GENDER		Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA	Baylor College of Medicine	Lamb, D (corresponding author), Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.			Khosla, Sundeep/0000-0002-2936-4372				Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1995, DOI 10.1210/jc.2007-0634; Bouxsein ML, 2004, J BONE MINER RES, V19, P587, DOI 10.1359/JBMR.0301255; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Gundberg CM, 2002, BONE, V31, P703, DOI 10.1016/S8756-3282(02)00902-X; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Wilson JD, 2001, HORM BEHAV, V40, P358, DOI 10.1006/hbeh.2001.1684	7	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					550	551						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21546972				2022-12-25	WOS:000290250400027
J	Ryan, KK; Li, B; Grayson, BE; Matter, EK; Woods, SC; Seeley, RJ				Ryan, Karen K.; Li, Bailing; Grayson, Bernadette E.; Matter, Emily K.; Woods, Stephen C.; Seeley, Randy J.			A role for central nervous system PPAR-gamma in the regulation of energy balance	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-GAMMA; NEUROTROPHIC FACTOR; IN-VIVO; LEPTIN; ROSIGLITAZONE; BRAIN; GENE; RATS; HOMEOSTASIS; WEIGHT	The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a nuclear receptor that is activated by lipids to induce the expression of genes involved in lipid and glucose metabolism, thereby converting nutritional signals into metabolic consequences(1). PPAR-gamma is the target of the thiazolidinedione (TZD) class of insulin-sensitizing drugs, which have been widely prescribed to treat type 2 diabetes mellitus. A common side effect of treatment with TZDs is weight gain(2). Here we report a previously unknown role for central nervous system (CNS) PPAR-gamma in the regulation of energy balance. We found that both acute and chronic activation of CNS PPAR-gamma, by either TZDs or hypothalamic overexpression of a fusion protein consisting of PPAR-gamma and the viral transcriptional activator VP16 (VP16-PPAR-gamma), led to positive energy balance in rats. Blocking the endogenous activation of CNS PPAR-gamma with pharmacological antagonists or reducing its expression with shRNA led to negative energy balance, restored leptin sensitivity in high-fat-diet (HFD)-fed rats and blocked the hyperphagic response to oral TZD treatment. These findings have implications for the widespread clinical use of TZD drugs and for understanding the etiology of diet-induced obesity.	[Ryan, Karen K.; Li, Bailing; Grayson, Bernadette E.; Matter, Emily K.; Seeley, Randy J.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Endocrinol, Cincinnati, OH 45221 USA; [Woods, Stephen C.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Seeley, RJ (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Endocrinol, Cincinnati, OH 45221 USA.	randy.seeley@uc.edu	Ryan, Karen/A-4626-2014	Ryan, Karen/0000-0003-4563-3744; Seeley, Randy/0000-0002-3721-5625	US National Institute of Diabetes and Digestive and Kidney Diseases [DK082173, DK17844, DK056863, DK073505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073505, P01DK056863, F32DK082173, R01DK054890, R01DK017844, R37DK017844] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the US National Institute of Diabetes and Digestive and Kidney Diseases (DK082173 to K. K. R., DK17844 to S. C. W. and DK056863 and DK073505 to R.J.S.). The VP16-PPAR-gamma construct was generously provided by M. Lazar (University of Pennsylvania).	CHAVEZ M, 1995, BEHAV NEUROSCI, V109, P528, DOI 10.1037/0735-7044.109.3.528; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Joosen AMCP, 2006, DIABETES-METAB RES, V22, P204, DOI 10.1002/dmrr.592; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kelly JF, 2004, DIABETES, V53, P911, DOI 10.2337/diabetes.53.4.911; Kouidhi S, 2010, MOL CELL ENDOCRINOL, V317, P44, DOI 10.1016/j.mce.2009.11.001; Larsen PJ, 2003, DIABETES, V52, P2249, DOI 10.2337/diabetes.52.9.2249; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Mouihate A, 2004, J NEUROSCI, V24, P1312, DOI 10.1523/JNEUROSCI.3145-03.2004; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nakano R, 2006, BIOCHEM PHARMACOL, V72, P42, DOI 10.1016/j.bcp.2006.03.023; Patel NG, 2003, DIABETES, V52, P43, DOI 10.2337/diabetes.52.1.43; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Scarpace PJ, 2001, NEUROSCIENCE, V104, P1111, DOI 10.1016/S0306-4522(01)00142-7; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wetzler S, 2004, PHYSIOL BEHAV, V83, P65, DOI [10.1016/j.physbeh.2004.06.024, 10.1016/S0031-9384(04)00311-7]; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	30	161	167	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					623	U145		10.1038/nm.2349	http://dx.doi.org/10.1038/nm.2349			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21532595	Green Accepted			2022-12-25	WOS:000290250400040
J	Yilmaz, P; Kottmann, R; Field, D; Knight, R; Cole, JR; Amaral-Zettler, L; Gilbert, JA; Karsch-Mizrachi, I; Johnston, A; Cochrane, G; Vaughan, R; Hunter, C; Park, J; Morrison, N; Rocca-Serra, P; Sterk, P; Arumugam, M; Bailey, M; Baumgartner, L; Birren, BW; Blaser, MJ; Bonazzi, V; Booth, T; Bork, P; Bushman, FD; Buttigieg, PL; Chain, PSG; Charlson, E; Costello, EK; Huot-Creasy, H; Dawyndt, P; DeSantis, T; Fierer, N; Fuhrman, JA; Gallery, RE; Gevers, D; Gibbs, RA; Gil, IS; Gonzalez, A; Gordon, JI; Guralnick, R; Hankeln, W; Highlander, S; Hugenholtz, P; Jansson, J; Kau, AL; Kelley, ST; Kennedy, J; Knights, D; Koren, O; Kuczynski, J; Kyrpides, N; Larsen, R; Lauber, CL; Legg, T; Ley, RE; Lozupone, CA; Ludwig, W; Lyons, D; Maguire, E; Methe, BA; Meyer, F; Muegge, B; Nakielny, S; Nelson, KE; Nemergut, D; Neufeld, JD; Newbold, LK; Oliver, AE; Pace, NR; Palanisamy, G; Peplies, J; Petrosino, J; Proctor, L; Pruesse, E; Quast, C; Raes, J; Ratnasingham, S; Ravel, J; Relman, DA; Assunta-Sansone, S; Schloss, PD; Schriml, L; Sinha, R; Smith, MI; Sodergren, E; Spor, A; Stombaugh, J; Tiedje, JM; Ward, DV; Weinstock, GM; Wendel, D; White, O; Whiteley, A; Wilke, A; Wortman, JR; Yatsunenko, T; Glockner, FO				Yilmaz, Pelin; Kottmann, Renzo; Field, Dawn; Knight, Rob; Cole, James R.; Amaral-Zettler, Linda; Gilbert, Jack A.; Karsch-Mizrachi, Ilene; Johnston, Anjanette; Cochrane, Guy; Vaughan, Robert; Hunter, Christopher; Park, Joonhong; Morrison, Norman; Rocca-Serra, Philippe; Sterk, Peter; Arumugam, Manimozhiyan; Bailey, Mark; Baumgartner, Laura; Birren, Bruce W.; Blaser, Martin J.; Bonazzi, Vivien; Booth, Tim; Bork, Peer; Bushman, Frederic D.; Buttigieg, Pier Luigi; Chain, Patrick S. G.; Charlson, Emily; Costello, Elizabeth K.; Huot-Creasy, Heather; Dawyndt, Peter; DeSantis, Todd; Fierer, Noah; Fuhrman, Jed A.; Gallery, Rachel E.; Gevers, Dirk; Gibbs, Richard A.; Gil, Inigo San; Gonzalez, Antonio; Gordon, Jeffrey I.; Guralnick, Robert; Hankeln, Wolfgang; Highlander, Sarah; Hugenholtz, Philip; Jansson, Janet; Kau, Andrew L.; Kelley, Scott T.; Kennedy, Jerry; Knights, Dan; Koren, Omry; Kuczynski, Justin; Kyrpides, Nikos; Larsen, Robert; Lauber, Christian L.; Legg, Teresa; Ley, Ruth E.; Lozupone, Catherine A.; Ludwig, Wolfgang; Lyons, Donna; Maguire, Eamonn; Methe, Barbara A.; Meyer, Folker; Muegge, Brian; Nakielny, Sara; Nelson, Karen E.; Nemergut, Diana; Neufeld, Josh D.; Newbold, Lindsay K.; Oliver, Anna E.; Pace, Norman R.; Palanisamy, Giriprakash; Peplies, Joerg; Petrosino, Joseph; Proctor, Lita; Pruesse, Elmar; Quast, Christian; Raes, Jeroen; Ratnasingham, Sujeevan; Ravel, Jacques; Relman, David A.; Assunta-Sansone, Susanna; Schloss, Patrick D.; Schriml, Lynn; Sinha, Rohini; Smith, Michelle I.; Sodergren, Erica; Spor, Ayme; Stombaugh, Jesse; Tiedje, James M.; Ward, Doyle V.; Weinstock, George M.; Wendel, Doug; White, Owen; Whiteley, Andrew; Wilke, Andreas; Wortman, Jennifer R.; Yatsunenko, Tanya; Gloeckner, Frank Oliver			Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications	NATURE BIOTECHNOLOGY			English	Article							DIVERSITY; MICROORGANISMS; PICOPLANKTON; REGIONS	Here we present a standard developed by the Genomic Standards Consortium (GSC) for reporting marker gene sequences-the minimum information about a marker gene sequence (MIMARKS). We also introduce a system for describing the environment from which a biological sample originates. The 'environmental packages' apply to any genome sequence of known origin and can be used in combination with MIMARKS and other GSC checklists. Finally, to establish a unified standard for describing sequence data and to provide a single point of entry for the scientific community to access and learn about GSC checklists, we present the minimum information about any (x) sequence (MIxS). Adoption of MIxS will enhance our ability to analyze natural genetic diversity documented by massive DNA sequencing efforts from myriad ecosystems in our ever-changing biosphere.	[Yilmaz, Pelin; Kottmann, Renzo; Buttigieg, Pier Luigi; Hankeln, Wolfgang; Pruesse, Elmar; Quast, Christian; Gloeckner, Frank Oliver] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Grp, Bremen, Germany; [Yilmaz, Pelin; Buttigieg, Pier Luigi; Hankeln, Wolfgang; Pruesse, Elmar; Gloeckner, Frank Oliver] Jacobs Univ Bremen gGmbH, Bremen, Germany; [Field, Dawn; Morrison, Norman; Sterk, Peter; Bailey, Mark; Booth, Tim; Newbold, Lindsay K.; Oliver, Anna E.; Whiteley, Andrew] Wallington CEH, Environm Bioinformat Ctr, Nat Environm Res Council, Oxford, England; [Knight, Rob; Costello, Elizabeth K.; Kennedy, Jerry; Larsen, Robert; Lozupone, Catherine A.; Nakielny, Sara; Stombaugh, Jesse; Wendel, Doug] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Cole, James R.] Michigan State Univ, Ribosomal Database Project, E Lansing, MI 48824 USA; [Cole, James R.; Chain, Patrick S. G.; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Amaral-Zettler, Linda] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Gilbert, Jack A.] Plymouth Marine Lab, Plymouth, Devon, England; [Gilbert, Jack A.; Meyer, Folker; Wilke, Andreas] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Karsch-Mizrachi, Ilene; Johnston, Anjanette] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Cochrane, Guy; Vaughan, Robert; Hunter, Christopher] European Bioinformat Inst, European Mol Biol Lab EMBL Outstn, Cambridge, England; [Park, Joonhong] Yonsei Univ, Sch Civil & Environm Engn, WCU Ctr Green Metagen, Seoul 120749, South Korea; [Morrison, Norman] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Rocca-Serra, Philippe; Maguire, Eamonn; Assunta-Sansone, Susanna] Univ Oxford, Oxford e Res Ctr, Oxford, England; [Arumugam, Manimozhiyan; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Baumgartner, Laura; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Birren, Bruce W.; Gevers, Dirk; Kuczynski, Justin; Ward, Doyle V.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Birren, Bruce W.; Gevers, Dirk; Kuczynski, Justin; Ward, Doyle V.] Harvard Univ, Cambridge, MA 02138 USA; [Blaser, Martin J.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Blaser, Martin J.] NYU, Dept Microbiol, Langone Med Ctr, New York, NY 10016 USA; [Bonazzi, Vivien; Proctor, Lita] NHGRI, NIH, Bethesda, MD 20892 USA; [Bushman, Frederic D.; Charlson, Emily; Sinha, Rohini] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Chain, Patrick S. G.; Jansson, Janet; Kyrpides, Nikos] DOE Joint Genome Inst, Walnut Creek, CA USA; [Chain, Patrick S. G.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Huot-Creasy, Heather; Ravel, Jacques; Schriml, Lynn; White, Owen; Wortman, Jennifer R.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Dawyndt, Peter] Univ Ghent, Dept Appl Math & Comp Sci, B-9000 Ghent, Belgium; [DeSantis, Todd] Lawrence Berkeley Natl Lab, Ctr Environm Biotechnol, Berkeley, CA USA; [Fierer, Noah; Guralnick, Robert; Legg, Teresa] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fuhrman, Jed A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Gallery, Rachel E.] Natl Ecol Observ Network, Boulder, CO USA; [Gibbs, Richard A.; Highlander, Sarah; Petrosino, Joseph] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gil, Inigo San] Univ New Mexico, Dept Biol, LTER Network Off, Albuquerque, NM 87131 USA; [Gonzalez, Antonio; Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Gordon, Jeffrey I.; Kau, Andrew L.; Muegge, Brian; Smith, Michelle I.; Yatsunenko, Tanya] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Guralnick, Robert] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Highlander, Sarah; Petrosino, Joseph] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Hugenholtz, Philip] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld, Australia; [Jansson, Janet] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Koren, Omry; Ley, Ruth E.; Spor, Ayme] Cornell Univ, Dept Microbiol, Ithaca, NY USA; [Lauber, Christian L.; Lyons, Donna] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Ludwig, Wolfgang] Tech Univ Munich, Lehrstuhl Mikrobiol, D-8050 Freising Weihenstephan, Germany; [Methe, Barbara A.; Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Nemergut, Diana] Univ Colorado, Dept Environm Sci, Boulder, CO 80309 USA; [Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Palanisamy, Giriprakash] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Peplies, Joerg] Ribocon GmbH, Bremen, Germany; [Raes, Jeroen] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Ratnasingham, Sujeevan] Univ Guelph, Biodivers Inst Ontario, Canadian Ctr DNA Barcoding, Guelph, ON N1G 2W1, Canada; [Relman, David A.] Stanford Univ, Dept Microbiol, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Immunol, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Schloss, Patrick D.] Dept Microbiol & Immunol, Ann Arbor, MI USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA	Max Planck Society; Jacobs University; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Michigan State University; Michigan State University; Marine Biological Laboratory - Woods Hole; Plymouth Marine Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); European Molecular Biology Laboratory (EMBL); Yonsei University; University of Manchester; University of Oxford; European Molecular Biology Laboratory (EMBL); University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; United States Department of Energy (DOE); United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Maryland; University of Maryland Baltimore; Ghent University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Colorado System; University of Colorado Boulder; University of Southern California; Baylor College of Medicine; Baylor College of Medicine; University of New Mexico; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; Baylor College of Medicine; University of Queensland; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California State University System; San Diego State University; Cornell University; University of Colorado System; University of Colorado Boulder; Technical University of Munich; J. Craig Venter Institute; University of Colorado System; University of Colorado Boulder; University of Waterloo; United States Department of Energy (DOE); Oak Ridge National Laboratory; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Guelph; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Washington University (WUSTL)	Glockner, FO (corresponding author), Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Grp, Bremen, Germany.	fog@mpi-bremen.de	Knight, Rob/D-1299-2010; Lozupone, Catherine/AAD-9317-2020; Petrosino, Joseph F./AAF-1621-2019; Park, Joonhong/A-3520-2016; raes, jeroen/D-7835-2018; Gilbert, Jack/AAF-3270-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Hugenholtz, Philip/AAD-9138-2019; Koren, Omry/A-5222-2016; Oliver, Anna/D-7830-2019; Ravel, Jacques/D-2530-2009; Park, Joonhong/G-8064-2012; Arumugam, Manimozhiyan/E-1211-2011; Schriml, Lynn/AFO-9472-2022; Fuhrman, Jed A/C-6461-2013; Whiteley, Andrew S/A-3395-2012; Bork, Peer/F-1813-2013; Ley, Ruth E/M-8542-2014; Newbold, Lindsay/E-6733-2012; Chain, Patrick/O-4140-2019; Ratnasingham, Sujeevan/G-9103-2014; Dawyndt, Peter/A-1566-2013; Jansson, Janet/H-5478-2018; Gevers, Dirk/C-1451-2009; Weinstock, George M/C-6314-2013; Gonzalez, Antonio/A-6421-2018; Kyrpides, Nikos C./A-6305-2014; bailey, mark j/I-7149-2012; Jansson, Janet/F-9951-2012; Kau, Andrew/AGX-9881-2022; Gallery, Rachel E/I-2169-2014; Spor, Aymé/A-6271-2012; chain, patrick/B-9777-2013; Pruesse, Elmar/ABE-3658-2020; Wilke, Andreas/F-1816-2018	raes, jeroen/0000-0002-1337-041X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Hugenholtz, Philip/0000-0001-5386-7925; Koren, Omry/0000-0002-7738-1337; Oliver, Anna/0000-0003-4923-277X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Fuhrman, Jed A/0000-0002-2361-1985; Bork, Peer/0000-0002-2627-833X; Ley, Ruth E/0000-0002-9087-1672; Newbold, Lindsay/0000-0001-8895-1406; Chain, Patrick/0000-0003-3949-3634; Jansson, Janet/0000-0002-5487-4315; Weinstock, George M/0000-0002-2997-4592; Kyrpides, Nikos C./0000-0002-6131-0462; bailey, mark j/0000-0002-0147-7316; Spor, Aymé/0000-0002-4707-9559; Pruesse, Elmar/0000-0002-1656-6020; Wortman, Jennifer/0000-0002-8713-1227; Wilke, Andreas/0000-0002-7699-2267; Bushman, Frederic/0000-0003-4740-4056; Meyer, Folker/0000-0003-1112-2284; Dawyndt, Peter/0000-0002-1623-9070; Ravel, Jacques/0000-0002-0851-2233; Sansone, Susanna-Assunta/0000-0001-5306-5690; Muegge, Brian/0000-0002-0044-3704; Sterk, Peter/0000-0003-1668-7778; Relman, David A./0000-0001-8331-1354; Kau, Andrew/0000-0002-9386-3766; Prakash, Giri/0000-0002-2590-5848; Bonazzi, Vivien/0000-0002-7359-9072; Stombaugh, Jesse/0000-0001-9631-0748; Schriml, Lynn/0000-0001-8910-9851; Vaughan, Bob/0000-0001-5060-2219; Hunter, Christopher/0000-0002-1335-0881; Gallery, Rachel/0000-0002-9159-8778; Buttigieg, Pier Luigi/0000-0002-4366-3088; Yilmaz, Pelin/0000-0003-4724-323X; Cochrane, Guy/0000-0001-7954-7057; Quast, Christian/0000-0001-6409-2352; Whiteley, Andrew/0000-0001-7762-1575; Knight, Rob/0000-0002-0975-9019; Morrison, Norman/0000-0003-1604-1512; Karsch Mizrachi, Ilene/0000-0002-0289-7101; Schloss, Patrick/0000-0002-6935-4275	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG005975-02, R01 HG005975, U54 HG003273] Funding Source: Medline; NHLBI NIH HHS [U01 HL098957] Funding Source: Medline; NIAID NIH HHS [P30 AI045008] Funding Source: Medline; NIDDK NIH HHS [UH2 DK083981, K01 DK090285] Funding Source: Medline; Division Of Environmental Biology [0832652, 0936498] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098957] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005975, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981, K01DK090285] Funding Source: NIH RePORTER; Natural Environment Research Council [NE/E006353/1, CEH010021] Funding Source: researchfish; NERC [NE/E006353/1] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Hankeln W, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-358; Hanner R., 2009, DATA STANDARDS BARCO; Hewson I, 2004, APPL ENVIRON MICROB, V70, P3425, DOI 10.1128/AEM.70.6.3425-3433.2004; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Kottmann R, 2008, OMICS, V12, P115, DOI 10.1089/omi.2008.0A10; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Ludwig W, 2005, MICROBIAL PHYLOGENY, P70; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Minz D, 1999, APPL ENVIRON MICROB, V65, P4666; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rocca-Serra P, 2010, BIOINFORMATICS, V26, P2354, DOI 10.1093/bioinformatics/btq415; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444	30	435	443	0	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					415	420		10.1038/nbt.1823	http://dx.doi.org/10.1038/nbt.1823			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21552244	Green Accepted			2022-12-25	WOS:000290301700021
J	Varshney, RK; Chen, WB; Li, YP; Bharti, AK; Saxena, RK; Schlueter, JA; Donoghue, MTA; Azam, S; Fan, GY; Whaley, AM; Farmer, AD; Sheridan, J; Iwata, A; Tuteja, R; Penmetsa, RV; Wu, W; Upadhyaya, HD; Yang, SP; Shah, T; Saxena, KB; Michael, T; McCombie, WR; Yang, BC; Zhang, GY; Yang, HM; Wang, J; Spillane, C; Cook, DR; May, GD; Xu, X; Jackson, SA				Varshney, Rajeev K.; Chen, Wenbin; Li, Yupeng; Bharti, Arvind K.; Saxena, Rachit K.; Schlueter, Jessica A.; Donoghue, Mark T. A.; Azam, Sarwar; Fan, Guangyi; Whaley, Adam M.; Farmer, Andrew D.; Sheridan, Jaime; Iwata, Aiko; Tuteja, Reetu; Penmetsa, R. Varma; Wu, Wei; Upadhyaya, Hari D.; Yang, Shiaw-Pyng; Shah, Trushar; Saxena, K. B.; Michael, Todd; McCombie, W. Richard; Yang, Bicheng; Zhang, Gengyun; Yang, Huanming; Wang, Jun; Spillane, Charles; Cook, Douglas R.; May, Gregory D.; Xu, Xun; Jackson, Scott A.			Draft genome sequence of pigeonpea (Cajanus cajan), an orphan legume crop of resource-poor farmers	NATURE BIOTECHNOLOGY			English	Article							GENES; DIVERSIFICATION; SOFTWARE; DATABASE; PROGRAM; TOOL	Pigeonpea is an important legume food crop grown primarily by smallholder farmers in many semi-arid tropical regions of the world. We used the Illumina next-generation sequencing platform to generate 237.2 Gb of sequence, which along with Sanger-based bacterial artificial chromosome end sequences and a genetic map, we assembled into scaffolds representing 72.7% (605.78 Mb) of the 833.07 Mb pigeonpea genome. Genome analysis predicted 48,680 genes for pigeonpea and also showed the potential role that certain gene families, for example, drought tolerance-related genes, have played throughout the domestication of pigeonpea and the evolution of its ancestors. Although we found a few segmental duplication events, we did not observe the recent genome-wide duplication events observed in soybean. This reference genome sequence will facilitate the identification of the genetic basis of agronomically important traits, and accelerate the development of improved pigeonpea varieties that could improve food security in many developing countries.	[Varshney, Rajeev K.; Saxena, Rachit K.; Azam, Sarwar; Tuteja, Reetu; Upadhyaya, Hari D.; Shah, Trushar; Saxena, K. B.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [Varshney, Rajeev K.] CIMMYT, CGIAR Generat Challenge Programme GCP, Mexico City 06600, DF, Mexico; [Chen, Wenbin; Fan, Guangyi; Yang, Bicheng; Zhang, Gengyun; Yang, Huanming; Wang, Jun; Xu, Xun] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Li, Yupeng; Iwata, Aiko; Jackson, Scott A.] Univ Georgia, Athens, GA 30602 USA; [Bharti, Arvind K.; Farmer, Andrew D.; May, Gregory D.] NCGR, Santa Fe, NM USA; [Schlueter, Jessica A.; Whaley, Adam M.; Sheridan, Jaime] Univ N Carolina, Charlotte, NC 28223 USA; [Donoghue, Mark T. A.; Tuteja, Reetu; Spillane, Charles] NUIG, Galway, Ireland; [Penmetsa, R. Varma; Cook, Douglas R.] Univ Calif Davis, Davis, CA 95616 USA; [Wu, Wei; Yang, Shiaw-Pyng; Michael, Todd] Monsanto Co, Creve Coeur, MO USA; [McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-1168 Copenhagen, Denmark; [Xu, Xun] BGI Amer, Cambridge, MA USA	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Beijing Genomics Institute (BGI); University System of Georgia; University of Georgia; National Center for Genome Resources (NCGR); University of North Carolina; University of North Carolina Charlotte; Ollscoil na Gaillimhe-University of Galway; University of California System; University of California Davis; Monsanto; Cold Spring Harbor Laboratory; University of Copenhagen	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014; Wang, Jun/A-7261-2013; Li, Yupeng/A-7718-2012; Xu, Xun/AAI-6763-2020; Updhayaya, Hari/C-4858-2014; Rachit, Rachit/C-6485-2014; Spillane, Charles/H-3786-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Varshney, Rajeev K/0000-0002-4562-9131; Li, Yupeng/0000-0003-0843-7592; Xu, Xun/0000-0002-5338-5173; Updhayaya, Hari/0000-0002-5166-6844; Michael, Todd/0000-0001-6272-2875; Spillane, Charles/0000-0003-3318-323X; Tuteja, Reetu/0000-0001-7628-4108; Wang, Jun/0000-0002-8540-8931; Shah, Trushar/0000-0002-0091-7981; McCombie, W. Richard/0000-0003-1899-0682; Schlueter, Jessica/0000-0002-6490-0580; Iwata-Otsubo, Aiko/0000-0001-9378-3961; jackson, scott/0000-0002-3172-1607; Wang, Jun/0000-0002-2113-5874	US National Science Foundation [DBI 0605251, BIO 0822258]; BGI-Shenzhen, China; International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), India; Indian Council of Agricultural Research (ICAR), India; Division Of Integrative Organismal Systems [0822258] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); BGI-Shenzhen, China; International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), India(CGIAR); Indian Council of Agricultural Research (ICAR), India(Indian Council of Agricultural Research (ICAR)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank CGIAR Generation Challenge Programme, US National Science Foundation (DBI 0605251, BIO 0822258), BGI-Shenzhen, China, and The International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), India, for their financial contribution to this study. Thanks are also due to Indian Council of Agricultural Research (ICAR), India for financial support to some earlier work that was used for analyzing genome sequence data. We would like to thank N.K. Singh, National Research Centre on Plant Biotechnology, Indian Agricultural Research Institute, New Delhi, India, for his immense help and support in various ways while carrying out this study. Our sincere appreciation to W.D. Dar, D.A. Hoisington, C.L.L. Gowda, O. Riera-Lizarazu from ICRISAT; J.-M. Ribaut from CGIAR Generation Challenge Programme; and M. dela Bastide from Cold Spring Harbor Laboratory for their helpful advice and assistance, wherever required, during the course of the study. We also thank D. Johnson from the University of Ottawa for providing 18S rRNA gene cloned from soybean (G. max).	Abhishek Bohra, 2010, Journal of Plant Biology, V37, P85; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brcic-Kostic K, 2005, GENET RES, V86, P53, DOI 10.1017/S0016672305007688; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; De D. N., 1974, Evolutionary Studies in World Crops., P79; Donoghue MTA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-47; Dubey A, 2011, DNA RES, V18, P153, DOI 10.1093/dnares/dsr007; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Guo WJ, 2007, COMP FUNCT GENOM, DOI 10.1155/2007/21676; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Isokpehi RD, 2011, BIOINFORM BIOL INSIG, V5, P41, DOI 10.4137/BBI.S6061; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LATHAM MC, 1997, FAO FOOD NUTR SERIES, V29; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mula M., 2010, LIFTING LEVEL AWAREN; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Royes W. V., 1976, Evolution of crop plants., P154; Rozen S, 2000, Methods Mol Biol, V132, P365; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmid KJ, 2001, GENETICS, V159, P589; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stokstad E, 2007, SCIENCE, V316, P196, DOI 10.1126/science.316.5822.196; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Vavilov, 1951, CHRON BOT, V13, P13; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	53	505	525	5	125	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					83	U128		10.1038/nbt.2022	http://dx.doi.org/10.1038/nbt.2022			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22057054	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000299110600024
J	Shulzhenko, N; Morgun, A; Hsiao, W; Battle, M; Yao, M; Gavrilova, O; Orandle, M; Mayer, L; Macpherson, AJ; McCoy, KD; Fraser-Liggett, C; Matzinger, P				Shulzhenko, Natalia; Morgun, Andrey; Hsiao, William; Battle, Michele; Yao, Michael; Gavrilova, Oksana; Orandle, Marlene; Mayer, Lloyd; Macpherson, Andrew J.; McCoy, Kathy D.; Fraser-Liggett, Claire; Matzinger, Polly			Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut	NATURE MEDICINE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; COMMON VARIABLE IMMUNODEFICIENCY; IGA RESPONSE; SYSTEM; MICE; HOMEOSTASIS; NETWORKS; CELLS; DIFFERENTIATION; MALABSORPTION	Using a systems biology approach, we discovered and dissected a three-way interaction between the immune system, the intestinal epithelium and the microbiota. We found that, in the absence of B cells, or of IgA, and in the presence of the microbiota, the intestinal epithelium launches its own protective mechanisms, upregulating interferon-inducible immune response pathways and simultaneously repressing Gata4-related metabolic functions. This shift in intestinal function leads to lipid malabsorption and decreased deposition of body fat. Network analysis revealed the presence of two interconnected epithelial-cell gene networks, one governing lipid metabolism and another regulating immunity, that were inversely expressed. Gene expression patterns in gut biopsies from individuals with common variable immunodeficiency or with HIV infection and intestinal malabsorption were very similar to those of the B cell-deficient mice, providing a possible explanation for a longstanding enigmatic association between immunodeficiency and defective lipid absorption in humans.	[Shulzhenko, Natalia; Morgun, Andrey; Matzinger, Polly] NIAID, Ghost Lab, T Cell Tolerance & Memory Sect, Lab Cellular & Mol Immunol,US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Hsiao, William; Fraser-Liggett, Claire] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Battle, Michele] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Yao, Michael] NIAID, Mucosal Immunol Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD USA; [Orandle, Marlene] NIAID, Comparat Med Branch, NIH, Bethesda, MD 20892 USA; [Mayer, Lloyd] Mt Sinai Med Ctr, Inst Immunol, New York, NY 10029 USA; [Macpherson, Andrew J.; McCoy, Kathy D.] Univ Bern, Bern, Switzerland; [McCoy, Kathy D.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Icahn School of Medicine at Mount Sinai; University of Bern; McMaster University	Morgun, A (corresponding author), Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA.	natalia.shulzhenko@oregonstate.edu; anemorgun@hotmail.com; pcm@helix.nih.gov	McCoy, Kathy/ABD-5814-2021	Fraser, Claire/0000-0003-1462-2428	NIAID, NIH; NIH [U24 DK059630];  [P40RR018603]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000581, ZIAAI000903, ZIAAI000868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, ZICDK070002, R01DK087873] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Intramural Research Program of the NIAID, NIH. We thank T. Myers, Q. Su and A. Godinez of the NIAID microarray facility for excellent technical support; R. Schwartz for providing funding for germ-free re-derivation; W. Strober for help with human subjects; C. Jones for technical support of bacterial pyrosequencing; T. D. Randall (Trudeau Institute) for AID/mu S mice; S. Epstein (US Food and Drug Administration), J. Misplon (US Food and Drug Administration) and D. P. Huston (Texas A&M Health Science Center) for IgAKO mice; D. Kaiserlian (Institut National de la Sante et de la Recherche Medicale) and R. Blumberg (Harvard University) for providing the MODE-K cell line; R. Varma for help in experiments; Laboratory of Cellular and Molecular Immunology members and M. Sterman Dolnikoff, I. Shmulevich and A. Dzutsev for discussions and suggestions; Y. Kotliarov for help with graphics; S. Varma for help finding human gene homologues; J. Coursen for excellent technical support; B. Epstein for assistance with software programming; and the personnel of NIH mouse facilities in buildings 4 and 6B. The Cincinnati Mouse Metabolic Phenotyping Center is supported by NIH grant U24 DK059630 and National Gnotobiotic Rodent Resource Center at the University of North Carolina is supported by grant P40RR018603.	Agarwal S, 2009, J ALLERGY CLIN IMMUN, V124, P658, DOI 10.1016/j.jaci.2009.06.018; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; Berger K, 2004, PHYSIOL BEHAV, V83, P623, DOI 10.1016/j.physbeh.2004.08.040; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gordon JI, 1997, AM J PHYSIOL-GASTR L, V273, pG565, DOI 10.1152/ajpgi.1997.273.3.G565; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; HUGHES WS, 1971, ANN INTERN MED, V74, P903, DOI 10.7326/0003-4819-74-6-903; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Koch J, 1996, NUTRITION, V12, P507, DOI 10.1016/S0899-9007(96)91728-1; KOTLER DP, 1987, DIGEST DIS SCI, V32, P129, DOI 10.1007/BF01297100; Lehto M, 2001, J LIPID RES, V42, P1203; Lerner P, 2011, J VIROL, V85, P4772, DOI 10.1128/JVI.02409-10; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Malamut G, 2010, AM J GASTROENTEROL, V105, P2262, DOI 10.1038/ajg.2010.214; Mannon PJ, 2006, GASTROENTEROLOGY, V131, P748, DOI 10.1053/j.gastro.2006.06.022; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Nishiyama Y, 2002, J IMMUNOL, V168, P2626, DOI 10.4049/jimmunol.168.6.2626; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Owens SR, 2007, HISTOPATHOLOGY, V50, P64, DOI 10.1111/j.1365-2559.2006.02547.x; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; SANFORD JP, 1954, NEW ENGL J MED, V250, P1027, DOI 10.1056/NEJM195406172502403; Scamurra RW, 2002, J IMMUNOL, V169, P4008, DOI 10.4049/jimmunol.169.7.4008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shulzhenko N, 2009, GENES IMMUN, V10, P722, DOI 10.1038/gene.2009.70; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Skinner J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-286; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; ULLRICH R, 1991, IMMUNOL RES, V10, P456, DOI 10.1007/BF02919742; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; WATSCHINGER K, 2010, GUT, V107, P13672; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005	58	251	264	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1585	U97		10.1038/nm.2505	http://dx.doi.org/10.1038/nm.2505			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101768	Green Accepted			2022-12-25	WOS:000297978000029
J	Uribesalgo, I; Buschbeck, M; Gutierrez, A; Teichmann, S; Demajo, S; Kuebler, B; Nomdedeu, JF; Martin-Caballero, J; Roma, G; Benitah, SA; Di Croce, L				Uribesalgo, Iris; Buschbeck, Marcus; Gutierrez, Arantxa; Teichmann, Sophia; Demajo, Santiago; Kuebler, Bernd; Nomdedeu, Josep F.; Martin-Caballero, Juan; Roma, Guglielmo; Aznar Benitah, Salvador; Di Croce, Luciano			E-box-independent regulation of transcription and differentiation by MYC	NATURE CELL BIOLOGY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; THYROID-HORMONE; RETINOIC ACID; HISTONE DEACETYLASE; RESPONSE ELEMENTS; CO-REPRESSOR; DNA-BINDING; RECEPTORS; COMPLEX; INHIBITION	MYC proto-oncogene is a key player in cell homeostasis that is commonly deregulated in human carcinogenesis(1). MYC can either activate or repress target genes by forming a complex with MAX (ref. 2). MYC also exerts MAX-independent functions that are not yet fully characterized(3). Cells possess an intrinsic pathway that can abrogate MYC MAX dimerization and E-box interaction, by inducing phosphorylation of MYC in a PAK2-dependent manner at three residues located in its helix loop helix domain(4). Here we show that these carboxy-terminal phosphorylation events switch MYC from an oncogenic to a tumour-suppressive function. In undifferentiated cells, MYC MAX is targeted to the promoters of retinoic-acid-responsive genes by its direct interaction with the retinoic acid receptor-alpha (RAR alpha). MYC MAX cooperates with RAR alpha to repress genes required for differentiation, in an E-box-independent manner. Conversely, on C-terminal phosphorylation of MYC during differentiation, the complex switches from a repressive to an activating function, by releasing MAX and recruiting transcriptional co-activators. Phospho-MYC synergizes with retinoic acid to eliminate circulating leukaemic cells and to decrease the level of tumour invasion. Our results identify an E-box-independent mechanism for transcriptional regulation by MYC that unveils previously unknown functions for MYC in differentiation. These may be exploited to develop alternative targeted therapies.	[Uribesalgo, Iris; Buschbeck, Marcus; Gutierrez, Arantxa; Teichmann, Sophia; Demajo, Santiago; Kuebler, Bernd; Roma, Guglielmo; Aznar Benitah, Salvador; Di Croce, Luciano] CRG, Barcelona 08003, Spain; [Uribesalgo, Iris; Buschbeck, Marcus; Gutierrez, Arantxa; Teichmann, Sophia; Demajo, Santiago; Kuebler, Bernd; Roma, Guglielmo; Aznar Benitah, Salvador; Di Croce, Luciano] UPF, Barcelona 08003, Spain; [Buschbeck, Marcus] Inst Predict & Personalized Med Canc IMPPC, Barcelona 08916, Spain; [Nomdedeu, Josep F.] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Inst Biomed Res IIB St Pau, Dept Lab Hematol, Barcelona 08025, Spain; [Martin-Caballero, Juan] PRBB, Unidad Anim Lab, Barcelona 08003, Spain; [Aznar Benitah, Salvador; Di Croce, Luciano] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Pompeu Fabra University; ICREA	Benitah, SA (corresponding author), CRG, Barcelona 08003, Spain.	salvador.aznar-benitah@crg.es; luciano.dicroce@crg.es	Demajo, Santiago/AAB-1999-2021; Kuebler, Bernd/K-2823-2017; Gutierrez, Arantxa/K-8213-2015; Aznar-Benitah, Salvador/F-4761-2016; Di Croce, Luciano/E-7759-2015; Buschbeck, Marcus/J-8204-2017	Kuebler, Bernd/0000-0002-4472-871X; Gutierrez, Arantxa/0000-0001-9033-3834; Aznar-Benitah, Salvador/0000-0002-9059-5049; Di Croce, Luciano/0000-0003-3488-6228; Buschbeck, Marcus/0000-0002-3218-4567; Demajo Meseguer, Santiago/0000-0003-3998-8784; Nomdedeu, Josep/0000-0003-3399-346X; Uribesalgo, Iris/0000-0001-9492-1000	'Fondo de Investigacion Sanitario' (FIS, Spanish Ministerio de Sanidad); Spanish 'Ministerio de Educacion y Ciencia', AGAUR; Fundacio La Marato; Spanish Ministerio de Ciencia y Educacion; DFG; Ramon y Cajal fellowship; 'La Caixa' fellowship; PFIS; ICREA Funding Source: Custom	'Fondo de Investigacion Sanitario' (FIS, Spanish Ministerio de Sanidad)(Instituto de Salud Carlos III); Spanish 'Ministerio de Educacion y Ciencia', AGAUR; Fundacio La Marato; Spanish Ministerio de Ciencia y Educacion(Spanish Government); DFG(German Research Foundation (DFG)); Ramon y Cajal fellowship(Spanish Government); 'La Caixa' fellowship(La Caixa Foundation); PFIS; ICREA(ICREA)	We thank T. Berg and C. Rochette-Egly for reagents, P. Munoz-Canoves, S. de la Luna and G. Gil for discussions, S. Colomer-Lahiguera and J. Douet for graphical assistance, V. Valero for technical support and V. A. Raker for helpful discussions about the manuscript. This work was supported by grants from the 'Fondo de Investigacion Sanitario' (FIS, Spanish Ministerio de Sanidad) to S.A.B.; and from the Spanish 'Ministerio de Educacion y Ciencia', AGAUR and 'Fundacio La Marato' to L.D.C. I.U. has been supported by an FPI fellowship of the Spanish Ministerio de Ciencia y Educacion, M.B. by a DFG and a Ramon y Cajal fellowship, S.T. by a 'La Caixa' fellowship and S.D. by a PFIS fellowship.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Bour G, 2005, P NATL ACAD SCI USA, V102, P16608, DOI 10.1073/pnas.0505556102; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gallant P, 2009, CELL CYCLE, V8, P3848, DOI 10.4161/cc.8.23.10088; Grant S, 1998, ADV CANCER RES, V72, P197; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Jung JH, 2005, J BIOL CHEM, V280, P40025, DOI 10.1074/jbc.M509075200; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kiessling A, 2006, CHEM BIOL, V13, P745, DOI 10.1016/j.chembiol.2006.05.011; Kurland JF, 2008, CANCER RES, V68, P3624, DOI 10.1158/0008-5472.CAN-07-6552; Lehmann S, 2001, CLIN CANCER RES, V7, P367; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Morey L, 2008, MOL CELL BIOL, V28, P5912, DOI 10.1128/MCB.00467-08; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Villa R, 2004, BIOCHEM PHARMACOL, V68, P1247, DOI 10.1016/j.bcp.2004.05.041; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	38	30	31	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1443	U149		10.1038/ncb2355	http://dx.doi.org/10.1038/ncb2355			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	22020439				2022-12-25	WOS:000298157500012
J	[Anonymous]				[Anonymous]			An unSIRTain role in longevity	NATURE MEDICINE			English	Editorial Material							ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; C. ELEGANS; SIR2						de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; Sinclair, David/0000-0002-9936-436X; de Cabo, Rafael/0000-0002-3354-2442	NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG019719, R01AG028730] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG028730, R01 AG019719, R01 AG028730] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2011, NATURE, V477, P411; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Rizki G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002235; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440	11	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1350	1350		10.1038/nm1111-1350	http://dx.doi.org/10.1038/nm1111-1350			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064411				2022-12-25	WOS:000296779300021
J	Cua, DJ; Sherlock, JP				Cua, Daniel J.; Sherlock, Jonathan P.			Gut microbiota strikes 'back'	NATURE MEDICINE			English	Editorial Material							HOST IMMUNE-SYSTEM; CELLS		[Cua, Daniel J.; Sherlock, Jonathan P.] Merck Res Labs, Palo Alto, CA 94304 USA	Merck & Company	Cua, DJ (corresponding author), Merck Res Labs, Palo Alto, CA 94304 USA.	daniel.cua@merck.com; jonathan.sherlock@merck.com						Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGonagle D, 1998, ARTHRITIS RHEUM, V41, P694, DOI 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#; MIELANTS H, 1995, J RHEUMATOL, V22, P2273; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	16	27	29	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1055	1056		10.1038/nm0911-1055	http://dx.doi.org/10.1038/nm0911-1055			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900923				2022-12-25	WOS:000294605100024
J	Neklesa, TK; Tae, HS; Schneekloth, AR; Stulberg, MJ; Corson, TW; Sundberg, TB; Raina, K; Holley, SA; Crews, CM				Neklesa, Taavi K.; Tae, Hyun Seop; Schneekloth, Ashley R.; Stulberg, Michael J.; Corson, Timothy W.; Sundberg, Thomas B.; Raina, Kanak; Holley, Scott A.; Crews, Craig M.			Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins	NATURE CHEMICAL BIOLOGY			English	Article							SCREEN; GENOME; ADAMANTANE; STABILITY; KINASE; CANCER; CELLS; DRUG	The ability to regulate any protein of interest in living systems with small molecules remains a challenge. We hypothesized that appending a hydrophobic moiety to the surface of a protein would mimic the partially denatured state of the protein, thus engaging the cellular quality control machinery to induce its proteasomal degradation. We designed and synthesized bifunctional small molecules to bind a bacterial dehalogenase (the HaloTag protein) and present a hydrophobic group on its surface. Hydrophobic tagging of the HaloTag protein with an adamantyl moiety induced the degradation of cytosolic, isoprenylated and trans-membrane HaloTag fusion proteins in cell culture. We demonstrated the in vivo utility of hydrophobic tagging by degrading proteins expressed in zebrafish embryos and by inhibiting Hras1(G12V)-driven tumor progression in mice. Therefore, hydrophobic tagging of HaloTag fusion proteins affords small-molecule control over any protein of interest, making it an ideal system for validating potential drug targets in disease models.	[Neklesa, Taavi K.; Tae, Hyun Seop; Stulberg, Michael J.; Corson, Timothy W.; Sundberg, Thomas B.; Holley, Scott A.; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Schneekloth, Ashley R.; Raina, Kanak; Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT USA; [Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT USA	Yale University; Yale University; Yale University	Neklesa, TK (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	craig.crews@yale.edu	Corson, Timothy W./B-6851-2009; Crews, Craig M./ABH-9346-2020	Corson, Timothy W./0000-0002-1402-7875; Crews, Craig M./0000-0002-8456-2005; Stulberg, Michael/0000-0001-8640-1291	US National Institutes of Health [R01AI084140]; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084140] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to acknowledge financial support from the US National Institutes of Health (R01AI084140) and to thank the members of the Crews lab for critical reading of the manuscript. S. Stricker at the Max Planck Institute for Molecular Genetics kindly provided Mouse Ror2, and R. Weinberg at the Massachusetts Institute of Technology (MIT) contributed Addgene plasmid 9051 from which Hras1<SUP>G12V</SUP> was obtained. G. Daley at MIT kindly provided the retroviral pEYK3.1 vector. T.W.C. was the Canadian Institutes of Health Research Jean-Fran ois St-Denis Fellow in Cancer Research and a Bisby Fellow. T.B.S. is a recipient of an American Cancer Society fellowship.	AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BOS JL, 1989, CANCER RES, V49, P4682; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Crews CM, 2010, CHEM BIOL, V17, P551, DOI 10.1016/j.chembiol.2010.05.011; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014410; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kirikoshi H, 1999, BIOCHEM BIOPH RES CO, V264, P955, DOI 10.1006/bbrc.1999.1612; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; MATHIAS LJ, 1996, ACS SYM SER, V624, P197; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ostrand-Rosenberg S, 2004, CURR OPIN IMMUNOL, V16, P143, DOI 10.1016/j.coi.2004.01.003; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Porteus Matthew, 2008, V435, P47, DOI 10.1007/978-1-59745-232-8_4; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Schrader EK, 2010, CHEM BIOL, V17, P917, DOI 10.1016/j.chembiol.2010.09.004; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; TSUZUKI N, 1994, J PHARM SCI, V83, P481, DOI 10.1002/jps.2600830407; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742	43	215	256	18	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					538	543		10.1038/NCHEMBIO.597	http://dx.doi.org/10.1038/NCHEMBIO.597			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21725302	Green Accepted, Green Submitted			2022-12-25	WOS:000292825400015
J	Olszak, AM; van Essen, D; Pereira, AJ; Diehl, S; Manke, T; Maiato, H; Saccani, S; Heun, P				Olszak, Agata M.; van Essen, Dominic; Pereira, Antonio J.; Diehl, Sarah; Manke, Thomas; Maiato, Helder; Saccani, Simona; Heun, Patrick			Heterochromatin boundaries are hotspots for de novo kinetochore formation	NATURE CELL BIOLOGY			English	Article							HISTONE H3 VARIANT; CENP-A CHROMATIN; CENTROMERIC CHROMATIN; MICROTUBULE ATTACHMENT; HUMAN NEOCENTROMERES; DROSOPHILA; CHROMOSOME; DNA; MITOSIS; COMPLEX	The centromere-specific histone H3 variant CENH3 (also known as CENP-A) is considered to be an epigenetic mark for establishment and propagation of centromere identity. Pulse induction of CENH3 (Drosophila CID) in Schneider S2 cells leads to its incorporation into non-centromeric regions and generates CID islands that resist clearing from chromosome arms for multiple cell generations. We demonstrate that CID is lands represent functional ectopic kinetochores, which are non-randomly distributed on the chromosome and show a preferential localization near telomeres and pericentric heterochromatin in transcriptionally silent, intergenic chromatin domains. Although overexpression of heterochromatin protein1 (HP1) or increasing histone acetylation interferes with CID island formation on a global scale,induction of a locally defined region of synthetic heterochromatin by targeting HP1-LacI fusions to stably integrated Lac operator arrays produces a proximal hotspot for CID deposition. These data indicate that the characteristics of regions bordering heterochromatin promote de novo kinetochore assembly and there by contribute to centromere identity.	[Olszak, Agata M.; van Essen, Dominic; Diehl, Sarah; Manke, Thomas; Saccani, Simona; Heun, Patrick] Max Planck Inst Immunol & Epigenet, D-79108 Freiburg, Germany; [Pereira, Antonio J.; Maiato, Helder] Univ Porto, Dept Expt Biol, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Maiato, Helder] Univ Porto, Dept Expt Biol, Fac Med, P-4100 Oporto, Portugal; [Heun, Patrick] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Max Planck Society; Universidade do Porto; Universidade do Porto; University of Freiburg	Heun, P (corresponding author), Max Planck Inst Immunol & Epigenet, Stubeweg 51, D-79108 Freiburg, Germany.	heun@ie-freiburg.mpg.de	Maiato, Helder/J-9466-2013; Manke, Thomas/L-9075-2019; Heun, Patrick/AAH-7390-2020	Maiato, Helder/0000-0002-6200-9997; Heun, Patrick/0000-0001-8400-1892; van Essen, Dominic/0000-0002-7225-1138; Manke, Thomas/0000-0003-3702-0868; Saccani, Simona/0000-0001-7572-3308; Pereira, Antonio/0000-0002-1053-8715	Fundacao para a Ciencia e a Tecnologia of Portugal (COMPETE-FEDER) [PTDC/SAU-GMG/099704/2008, PTDC/SAU-ONC/112917/2009]; Human Frontier Research Program; European Research Council; Max Planck Society; Human Frontier Science Program (CDA); Excellence Initiative of the German Federal and State Governments [EXC 294]	Fundacao para a Ciencia e a Tecnologia of Portugal (COMPETE-FEDER)(Portuguese Foundation for Science and Technology); Human Frontier Research Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Human Frontier Science Program (CDA)(Human Frontier Science Program); Excellence Initiative of the German Federal and State Governments	We thank the following people for antibodies: T. Maresca and E. Salmon, R. Karess, C. Sunkel, S. Heidmann, C. Lehner and G. H. Karpen and R. Tsien for the mRFP construct. We would also like to thank B. Mellone, P. Pasero, B. Duncker and the laboratory members, particularly M-J. Mendiburo and J. Padeken for reagents, discussions and critical reading of the manuscript, and H-J. Schwarz for general assistance. Work in the laboratory of H. M. is funded by grants PTDC/SAU-GMG/099704/2008 and PTDC/SAU-ONC/112917/2009 from Fundacao para a Ciencia e a Tecnologia of Portugal (COMPETE-FEDER), the Human Frontier Research Program and the Seventh Framework Programme grant PRECISE from the European Research Council. Funding for this research project of the laboratory of P. H. was provided by the Max Planck Society, the Human Frontier Science Program (CDA) and by the Excellence Initiative of the German Federal and State Governments (EXC 294).	Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Alonso A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-6; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Capozzi O, 2008, CHROMOSOMA, V117, P339, DOI 10.1007/s00412-008-0150-z; Cardinale S, 2009, MOL BIOL CELL, V20, P4194, DOI 10.1091/mbc.E09-06-0489; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; de Wit E, 2005, GENOME RES, V15, P1265, DOI 10.1101/gr.3198905; Durand-Dubief M, 2008, BIOESSAYS, V30, P526, DOI 10.1002/bies.20763; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Frydrychova RC, 2008, GENETICS, V180, P121, DOI 10.1534/genetics.108.090647; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Kharchenko PV, 2010, NATURE; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Logarinho E, 1998, J CELL SCI, V111, P2897; Losada A, 1999, MOL GEN GENET, V262, P618, DOI 10.1007/s004380051124; Maggert KA, 2001, GENETICS, V158, P1615; Maia AF, 2007, CELL CYCLE, V6, P1367, DOI 10.4161/cc.6.11.4271; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Marshall OJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000370; Mendez-Lago M, 2009, NUCLEIC ACIDS RES, V37, P2264, DOI 10.1093/nar/gkp085; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nasuda S, 2005, P NATL ACAD SCI USA, V102, P9842, DOI 10.1073/pnas.0504235102; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Pereira AJ, 2009, METHODS MOL BIOL, V545, P145, DOI 10.1007/978-1-60327-993-2_9; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Saffery R, 2003, MOL CELL, V12, P509, DOI 10.1016/S1097-2765(03)00279-X; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Tomonaga T, 2003, CANCER RES, V63, P3511; Vagnarelli P, 2008, FEBS LETT, V582, P1950, DOI 10.1016/j.febslet.2008.04.014; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Verschure PJ, 2005, MOL CELL BIOL, V25, P4552, DOI 10.1128/MCB.25.11.4552-4564.2005; Villasante A, 2007, P NATL ACAD SCI USA, V104, P10542, DOI 10.1073/pnas.0703808104; Warburton PE, 2004, CHROMOSOME RES, V12, P617, DOI 10.1023/B:CHRO.0000036585.44138.4b; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30; Wong NC, 2006, PLOS GENET, V2, P172, DOI 10.1371/journal.pgen.0020017; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	64	101	102	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					799	U166		10.1038/ncb2272	http://dx.doi.org/10.1038/ncb2272			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21685892				2022-12-25	WOS:000292305700010
J	Szappanos, B; Kovacs, K; Szamecz, B; Honti, F; Costanzo, M; Baryshnikova, A; Gelius-Dietrich, G; Lercher, MJ; Jelasity, M; Myers, CL; Andrews, BJ; Boone, C; Oliver, SG; Pal, C; Papp, B				Szappanos, Balazs; Kovacs, Karoly; Szamecz, Bela; Honti, Frantisek; Costanzo, Michael; Baryshnikova, Anastasia; Gelius-Dietrich, Gabriel; Lercher, Martin J.; Jelasity, Mark; Myers, Chad L.; Andrews, Brenda J.; Boone, Charles; Oliver, Stephen G.; Pal, Csaba; Papp, Balazs			An integrated approach to characterize genetic interaction networks in yeast metabolism	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENOME; BIOLOGY; DELETION; LANDSCAPE; EPISTASIS; DATABASE; FITNESS; CELLS	Although experimental and theoretical efforts have been applied to globally map genetic interactions, we still do not understand how gene-gene interactions arise from the operation of biomolecular networks. To bridge the gap between empirical and computational studies, we i, quantitatively measured genetic interactions between similar to 185,000 metabolic gene pairs in Saccharomyces cerevisiae, ii, superposed the data on a detailed systems biology model of metabolism and iii, introduced a machine-learning method to reconcile empirical interaction data with model predictions. We systematically investigated the relative impacts of functional modularity and metabolic flux coupling on the distribution of negative and positive genetic interactions. We also provide a mechanistic explanation for the link between the degree of genetic interaction, pleiotropy and gene dispensability. Last, we show the feasibility of automated metabolic model refinement by correcting misannotations in NAD biosynthesis and confirming them by in vivo experiments.	[Szappanos, Balazs; Kovacs, Karoly; Szamecz, Bela; Honti, Frantisek; Pal, Csaba; Papp, Balazs] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Honti, Frantisek] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Costanzo, Michael; Baryshnikova, Anastasia; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Costanzo, Michael; Baryshnikova, Anastasia; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Dept Mol Genet, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Gelius-Dietrich, Gabriel; Lercher, Martin J.] Univ Dusseldorf, Dept Comp Sci, Dusseldorf, Germany; [Jelasity, Mark] Univ Szeged, Res Grp Artificial Intelligence, Szeged, Hungary; [Jelasity, Mark] HAS, Szeged, Hungary; [Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Oliver, Stephen G.; Papp, Balazs] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Papp, Balazs] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Bath; University of Toronto; University of Toronto; Heinrich Heine University Dusseldorf; Szeged University; University of Minnesota System; University of Minnesota Twin Cities; University of Cambridge; University of Cambridge; University of Cambridge	Papp, B (corresponding author), Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	pappb@brc.hu	jelasity, mark/F-3798-2011; Oliver, Stephen/AAQ-5992-2021; Szappanos, Balázs/D-1937-2013; Lercher, Martin/K-7939-2013	jelasity, mark/0000-0001-9363-1482; Oliver, Stephen/0000-0003-3410-6439; Lercher, Martin/0000-0003-3940-1621; Baryshnikova, Anastasia/0000-0002-0123-2052; Szappanos, Balazs/0000-0002-5075-1799; Papp, Balazs/0000-0003-3093-8852	The International Human Frontier Science Program Organization; Hungarian Scientific Research Fund [OTKA PD 75261]; Hungarian Academy of Sciences; European Research Council [202591]; Wellcome Trust; FEBS; Biotechnology & Biological Sciences Research Council [BB/C505140/1]; European Commission [201142]; US National Institutes of Health [1R01HG005084-01A1, 1R01HG005853-01]; University of Minnesota; Canadian Institutes of Health Research [MOP-102629]; Biotechnology and Biological Sciences Research Council [BB/C505140/2, BB/C505140/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005084, R01HG005853] Funding Source: NIH RePORTER	The International Human Frontier Science Program Organization(Human Frontier Science Program); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); FEBS; Biotechnology & Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from The International Human Frontier Science Program Organization, the Hungarian Scientific Research Fund (OTKA PD 75261) and the 'Lendulet Program' of the Hungarian Academy of Sciences (B.P.), European Research Council (202591), Wellcome Trust and Hungarian Scientific Research Fund (C.P.), FEBS Long-Term Fellowship (B. Szamecz), Biotechnology & Biological Sciences Research Council (Grant BB/C505140/1) and the UNICELLSYS Collaborative Project (No. 201142) of the European Commission (S.G.O.), the US National Institutes of Health (1R01HG005084-01A1) and a seed grant from the University of Minnesota Biomedical Informatics and Computational Biology program (C.L.M.), the Canadian Institutes of Health Research (MOP-102629) (C.B. and B.J.A.) and the US National Institutes of Health (1R01HG005853-01) (C.B., B.J.A. and C.L.M.).	Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bouwman J, 2011, YEAST, V28, P43, DOI 10.1002/yea.1819; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Bundy JG, 2007, GENOME RES, V17, P510, DOI 10.1101/gr.5662207; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; FLACHMANN R, 1988, EUR J BIOCHEM, V175, P221, DOI 10.1111/j.1432-1033.1988.tb14187.x; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1111/j.1574-6976.2001.tb00574.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Notebaart RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040026; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Shlomi T, 2007, GENOME RES, V17, P1626, DOI 10.1101/gr.6678707; Snitkin ES, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r140; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Ulitsky I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r140; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101	51	147	159	2	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					656	U182		10.1038/ng.846	http://dx.doi.org/10.1038/ng.846			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21623372	Green Accepted			2022-12-25	WOS:000292184600009
J	Tabas, I				Tabas, Ira			Finding the culprit in your heart	NATURE MEDICINE			English	Editorial Material							APOPTOTIC CELL ACCUMULATION; ATHEROSCLEROSIS; MACROPHAGES		[Tabas, Ira] Columbia Univ, Dept Med, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA	Columbia University; Columbia University	Tabas, I (corresponding author), Columbia Univ, Dept Med, Dept Pathol & Cell Biol, New York, NY 10027 USA.	iat1@columbia.edu			NHLBI NIH HHS [R01 HL107497, P01 HL087123-05, R01 HL075662, R01 HL106019, R01 HL107497-02, P01 HL087123, R01 HL106019-03, R01 HL075662-09] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106019, P01HL087123, R01HL107497, R01HL075662] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Libby P, 2008, J INTERN MED, V263, P517, DOI 10.1111/j.1365-2796.2008.01965.x; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Martinet W, 2006, J PHARMACOL EXP THER, V317, P1356, DOI 10.1124/jpet.106.102970; Martinet W, 2011, BRIT J PHARMACOL, V164, P1, DOI 10.1111/j.1476-5381.2011.01342.x; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Rosenfeld Michael E, 2002, Curr Atheroscler Rep, V4, P238, DOI 10.1007/s11883-002-0025-3; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Steinberg D, 2008, CIRCULATION, V118, P672, DOI 10.1161/CIRCULATIONAHA.107.753152; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x	16	23	25	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					791	793		10.1038/nm0711-791	http://dx.doi.org/10.1038/nm0711-791			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738159	Green Accepted			2022-12-25	WOS:000292500800031
J	Zhang, CL; Darnell, RB				Zhang, Chaolin; Darnell, Robert B.			Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data	NATURE BIOTECHNOLOGY			English	Article							DEPENDENT SPLICING REGULATION; PRE-RIBOSOMAL-RNA; BINDING-SITES; CROSS-LINKING; WIDE IDENTIFICATION; REGULATORY NETWORK; MESSENGER-RNAS; NUCLEIC-ACIDS; MOUSE MODEL; STEM-CELLS	Mammalian RNA complexity is regulated through interactions of RNA-binding proteins (RBPs) with their target transcripts. High-throughput sequencing together with UV-crosslinking and immunoprecipitation (HITS-CLIP) is able to globally map RBPbinding footprint regions at a resolution of similar to 30-60 nucleotides. Here we describe a systematic way to analyze HITS-CLIP data to identify exact crosslink sites, and thereby determine protein-RNA interactions at single-nucleotide resolution. We found that reverse transcriptase used in CLIP frequently skips the crosslinked amino-acid-RNA adduct, resulting in a nucleotide deletion. Genome-wide analysis of these crosslinking-induced mutation sites (CIMS) in HITS-CLIP data for Nova and Argonaute (Ago) proteins in mouse brain tissue revealed deletions in similar to 8-20% of mRNA tags, which mapped to Nova and Ago binding sites on mRNA or miRNA. CIMS analysis provides a general and more precise means of mapping protein-RNA interactions than currently available methods and insight into the biochemical properties of such interactions in living tissues.	[Zhang, Chaolin; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Zhang, CL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY 10021 USA.	czhang@rockefeller.edu; darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088	National Institutes of Health [NS34389, K99GM95713]; Rockefeller University Hospital CTSA [UL1 RR024143]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM095713, R00GM095713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034389, R01NS034389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Hospital CTSA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Ule and all Darnell laboratory members for helpful discussion, and M.A. Frias, J. Luna, C.B. Marney and Y. Yuan for critical reading of the manuscript. This work was supported by grants from the National Institutes of Health (NS34389 to R.B.D. and K99GM95713 to C.Z.), and the Rockefeller University Hospital CTSA (UL1 RR024143). R.B.D. is a Howard Hughes Medical Institute Investigator.	Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Coady TH, 2010, J NEUROSCI, V30, P126, DOI 10.1523/JNEUROSCI.4489-09.2010; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Fecko CJ, 2007, PHOTOCHEM PHOTOBIOL, V83, P1394, DOI 10.1111/j.1751-1097.2007.00179.x; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HOCKENSMITH JW, 1986, J BIOL CHEM, V261, P3512; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; LOZZIO CB, 1971, J CELL PHYSIOL, V78, P25, DOI 10.1002/jcp.1040780105; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Perez I, 1997, RNA, V3, P764; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Urlaub H, 2002, METHODS, V26, P170, DOI 10.1016/S1046-2023(02)00020-8; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Yasukawa K, 2008, J BIOCHEM, V143, P261, DOI 10.1093/jb/mvm217; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	54	303	311	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					607	U86		10.1038/nbt.1873	http://dx.doi.org/10.1038/nbt.1873			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21633356	Green Accepted			2022-12-25	WOS:000292595200019
J	Chidley, C; Haruki, H; Pedersen, MG; Muller, E; Johnsson, K				Chidley, Christopher; Haruki, Hirohito; Pedersen, Miriam Gronlund; Muller, Evelyne; Johnsson, Kai			A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; IN-VIVO; DIHYDROFOLATE-REDUCTASE; SEPIAPTERIN REDUCTASE; SELECTIVE-INHIBITION; GTP CYCLOHYDROLASE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; SMALL MOLECULES; SYNOVIAL-FLUID	We introduce an approach for detection of drug-protein interactions that combines a new yeast three-hybrid screening for identification of interactions with affinity chromatography for their unambiguous validation. We applied the methodology to the profiling of clinically approved drugs, resulting in the identification of previously known and unknown drug-protein interactions. In particular, we were able to identify off-targets for erlotinib and atorvastatin, as well as an enzyme target for the antiinflammatory drug sulfasalazine. We demonstrate that sulfasalazine and its metabolites, sulfapyridine and mesalamine, are inhibitors of the enzyme catalyzing the final step in the biosynthesis of the cofactor tetrahydrobiopterin. The interference with tetrahydrobiopterin metabolism provides an explanation for some of the beneficial and deleterious properties of sulfasalazine and furthermore suggests new and improved therapies for the drug. This work thus establishes a powerful approach for drug profiling and provides new insights in the mechanism of action of clinically approved drugs.	[Chidley, Christopher; Haruki, Hirohito; Pedersen, Miriam Gronlund; Muller, Evelyne; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res Chem Biol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Chidley, C (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res Chem Biol, Lausanne, Switzerland.	kai.johnsson@epfl.ch	johnsson, kai/P-4222-2014	johnsson, kai/0000-0002-8002-1981; Chidley, Christopher/0000-0002-8212-3148	Swiss National Science Foundation; Federal Office for Professional Education and Technology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Professional Education and Technology	We thank D. Auerbach (Dualsystems Biotech) for sharing plasmid pU6H3VSV, strain NMY51, BG-purvalanol B and cDNA libraries; N. Johnsson (Ulm University) for sharing plasmid pSH47; and O. Hantschel and G. Superti-Furga (Center for Molecular Medicine of the Austrian Academy of Sciences) for sharing plasmid pETM30-NQO2. We thank S. Moser, L. Reymond and C. Fellay for technical assistance. We acknowledge R. Chidley, M.J. Hinner and G. Lukinavicius for critically reading the manuscript. This work was supported by the Swiss National Science Foundation and the Federal Office for Professional Education and Technology.	BAGGOTT JE, 1992, BIOCHEM J, V282, P197, DOI 10.1042/bj2820197; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Berti-Mattera LN, 2008, DIABETES, V57, P2801, DOI 10.2337/db07-1274; Blau N, 2001, MOL GENET METAB, V74, P172, DOI 10.1006/mgme.2001.3213; BOLIN JT, 1982, J BIOL CHEM, V257, P13650; Bune AJ, 1996, BIOCHEM BIOPH RES CO, V220, P13, DOI 10.1006/bbrc.1996.0348; Caprilli R, 2009, J CROHNS COLITIS, V3, P149, DOI 10.1016/j.crohns.2009.05.001; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Dahan A, 2010, INT J PHARMACEUT, V386, P216, DOI 10.1016/j.ijpharm.2009.11.021; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; FARR M, 1985, RHEUMATOL INT, V5, P247, DOI 10.1007/BF00541351; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; GROSS SS, 1992, J BIOL CHEM, V267, P25722; Hori T, 2006, J BIOCHEM, V140, P457, DOI 10.1093/jb/mvj176; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Kankuri E, 2001, J PHARMACOL EXP THER, V298, P1128; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Klotz U, 2005, DIGEST LIVER DIS, V37, P381, DOI 10.1016/j.dld.2004.12.011; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Kolaczkowski M, 1998, MICROB DRUG RESIST, V4, P143, DOI 10.1089/mdr.1998.4.143; LAURITSEN K, 1984, GASTROENTEROLOGY, V86, P1496; Licitra EJ, 1996, P NATL ACAD SCI USA, V93, P12817, DOI 10.1073/pnas.93.23.12817; LOCKHART DJ, 2008, Patent No. 7323490; Lotsch J, 2010, PAIN, V148, P103, DOI 10.1016/j.pain.2009.10.021; MAYER RJ, 1986, P NATL ACAD SCI USA, V83, P7718, DOI 10.1073/pnas.83.20.7718; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; MURPHY DJ, 1989, BIOCHEMISTRY-US, V28, P3025, DOI 10.1021/bi00433a043; PULLAR T, 1985, BRIT MED J, V290, P1535, DOI 10.1136/bmj.290.6481.1535; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; SMITH GK, 1992, J BIOL CHEM, V267, P5599; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Sutherland L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub2; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Temperini C, 2009, BIOORGAN MED CHEM, V17, P1214, DOI 10.1016/j.bmc.2008.12.023; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wilson SJ, 2006, J BIOL CHEM, V281, P11780, DOI 10.1074/jbc.M513110200; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7	50	95	98	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					375	383		10.1038/NCHEMBIO.557	http://dx.doi.org/10.1038/NCHEMBIO.557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21499265	Green Published			2022-12-25	WOS:000290677900013
J	Haiman, CA; Chen, GK; Blot, WJ; Strom, SS; Berndt, SI; Kittles, RA; Rybicki, BA; Isaacs, WB; Ingles, SA; Stanford, JL; Diver, WR; Witte, JS; Hsing, AW; Nemesure, B; Rebbeck, TR; Cooney, KA; Xu, JF; Kibel, AS; Hu, JJ; John, EM; Gueye, SM; Watya, S; Signorello, LB; Hayes, RB; Wang, ZM; Yeboah, E; Tettey, Y; Cai, QY; Kolb, S; Ostrander, EA; Zeigler-Johnson, C; Yamamura, Y; Neslund-Dudas, C; Haslag-Minoff, J; Wu, W; Thomas, V; Allen, GO; Murphy, A; Chang, BL; Zheng, SL; Leske, MC; Wu, SY; Ray, AM; Hennis, AJM; Thun, MJ; Carpten, J; Casey, G; Carter, EN; Duarte, ER; Xia, LY; Sheng, X; Wan, P; Pooler, LC; Cheng, I; Monroe, KR; Schumacher, F; Le Marchand, L; Kolonel, LN; Chanock, SJ; Van Den Berg, D; Stram, DO; Henderson, BE				Haiman, Christopher A.; Chen, Gary K.; Blot, William J.; Strom, Sara S.; Berndt, Sonja I.; Kittles, Rick A.; Rybicki, Benjamin A.; Isaacs, William B.; Ingles, Sue A.; Stanford, Janet L.; Diver, W. Ryan; Witte, John S.; Hsing, Ann W.; Nemesure, Barbara; Rebbeck, Timothy R.; Cooney, Kathleen A.; Xu, Jianfeng; Kibel, Adam S.; Hu, Jennifer J.; John, Esther M.; Gueye, Serigne M.; Watya, Stephen; Signorello, Lisa B.; Hayes, Richard B.; Wang, Zhaoming; Yeboah, Edward; Tettey, Yao; Cai, Qiuyin; Kolb, Suzanne; Ostrander, Elaine A.; Zeigler-Johnson, Charnita; Yamamura, Yuko; Neslund-Dudas, Christine; Haslag-Minoff, Jennifer; Wu, William; Thomas, Venetta; Allen, Glenn O.; Murphy, Adam; Chang, Bao-Li; Zheng, S. Lilly; Leske, M. Cristina; Wu, Suh-Yuh; Ray, Anna M.; Hennis, Anselm J. M.; Thun, Michael J.; Carpten, John; Casey, Graham; Carter, Erin N.; Duarte, Edder R.; Xia, Lucy Y.; Sheng, Xin; Wan, Peggy; Pooler, Loreall C.; Cheng, Iona; Monroe, Kristine R.; Schumacher, Fredrick; Le Marchand, Loic; Kolonel, Laurence N.; Chanock, Stephen J.; Van Den Berg, David; Stram, Daniel O.; Henderson, Brian E.			Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21	NATURE GENETICS			English	Article							MULTIPLE LOCI; RISK LOCUS; 8Q24; VARIANTS	In search of common risk alleles for prostate cancer that could contribute to high rates of the disease in men of African ancestry, we conducted a genome-wide association study, with 1,047,986 SNP markers examined in 3,425 African-Americans with prostate cancer (cases) and 3,290 African-American male controls. We followed up the most significant 17 new associations from stage 1 in 1,844 cases and 3,269 controls of African ancestry. We identified a new risk variant on chromosome 17q21 (rs7210100, odds ratio per allele = 1.51, P = 3.4 x 10(-13)). The frequency of the risk allele is similar to 5% in men of African descent, whereas it is rare in other populations (<1%). Further studies are needed to investigate the biological contribution of this allele to prostate cancer risk. These findings emphasize the importance of conducting genome-wide association studies in diverse populations.	[Haiman, Christopher A.; Chen, Gary K.; Ingles, Sue A.; Casey, Graham; Carter, Erin N.; Duarte, Edder R.; Xia, Lucy Y.; Sheng, Xin; Wan, Peggy; Pooler, Loreall C.; Monroe, Kristine R.; Schumacher, Fredrick; Van Den Berg, David; Stram, Daniel O.; Henderson, Brian E.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD USA; [Blot, William J.; Signorello, Lisa B.; Cai, Qiuyin] Vanderbilt Univ, Dept Med, Div Epidemiol, Vanderbilt Epidemiol Ctr, Nashville, TN USA; [Blot, William J.; Signorello, Lisa B.; Cai, Qiuyin] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Strom, Sara S.; Yamamura, Yuko] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Berndt, Sonja I.; Hsing, Ann W.; Wang, Zhaoming; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA; [Rybicki, Benjamin A.; Neslund-Dudas, Christine] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Isaacs, William B.] Johns Hopkins Hosp & Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Stanford, Janet L.; Kolb, Suzanne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Diver, W. Ryan; Thun, Michael J.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Nemesure, Barbara; Zheng, S. Lilly; Leske, M. Cristina; Wu, Suh-Yuh; Hennis, Anselm J. M.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Rebbeck, Timothy R.; Zeigler-Johnson, Charnita; Chang, Bao-Li] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.; Zeigler-Johnson, Charnita; Chang, Bao-Li] Abramson Canc Ctr, Philadelphia, PA USA; [Cooney, Kathleen A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Xu, Jianfeng] Wake Forest Univ, Sch Med, Ctr Canc Genom, Winston Salem, NC 27109 USA; [Kibel, Adam S.; Haslag-Minoff, Jennifer; Wu, William] Washington Univ, Dept Surg, Div Urol, St Louis, MO USA; [Hu, Jennifer J.; Thomas, Venetta; Allen, Glenn O.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Hu, Jennifer J.; Thomas, Venetta; Allen, Glenn O.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [Gueye, Serigne M.] Hop Gen Grand Yoff, Dakar, Senegal; [Watya, Stephen] Makerere Univ, Dept Surg, Urol Unit, Mulago Hosp, Kampala, Uganda; [Hayes, Richard B.] NYU, Dept Environm Med, Langone Med Ctr, Div Epidemiol, New York, NY 10016 USA; [Yeboah, Edward; Tettey, Yao] Univ Ghana, Sch Med, Legon, Ghana; [Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Murphy, Adam] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Hennis, Anselm J. M.] Univ W Indies, Fac Med Sci, Bridgetown, Barbados; [Hennis, Anselm J. M.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Hennis, Anselm J. M.] Minist Hlth, Bridgetown, Barbados; [Carpten, John] Translat Genom Res Inst, Phoenix, AZ USA; [Cheng, Iona; Le Marchand, Loic; Kolonel, Laurence N.] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA	University of Southern California; Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Henry Ford Health System; Henry Ford Hospital; Johns Hopkins University; Johns Hopkins Medicine; Fred Hutchinson Cancer Center; American Cancer Society; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; Wake Forest University; Washington University (WUSTL); University of Miami; University of Miami; Cancer Prevention Institute of California; Makerere University; Mulago National Referral Hospital; New York University; NYU Langone Medical Center; University of Ghana; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Northwestern University; University West Indies Mona Jamaica; University of the West Indies Open Campus; University West Indies Mona Jamaica; University of the West Indies Open Campus; Translational Genomics Research Institute; Cancer Research Center of Hawaii; University of Hawaii System	Haiman, CA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	haiman@usc.edu	wu, william/HII-5817-2022; Rebbeck, Timothy/GLU-8348-2022; Schumacher, Fredrick/R-6043-2019; Berndt, Sonja I/J-8423-2016; Diver, Ryan/AAG-3469-2019; Wang, Zhaoming/R-5527-2018; Van Den Berg, David J/G-8598-2017; Rybicki, Benjamin/L-4614-2019	Rebbeck, Timothy/0000-0002-4799-1900; Schumacher, Fredrick/0000-0002-3073-7463; Diver, Ryan/0000-0002-5418-9000; Wang, Zhaoming/0000-0001-7556-3869; Van Den Berg, David J/0000-0002-5404-5218; Rybicki, Benjamin/0000-0003-3190-3467; Ostrander, Elaine/0000-0001-6075-9738; Zeigler-Johnson, Charnita/0000-0003-2641-7755; Cooney, Kathleen/0000-0003-3831-6943; Hayes, Richard/0000-0002-0918-661X	US National Institutes of Health (NIH) [CA63464, CA54281, CA1326792, CA148085, HG004726]; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), NIH; Cancer Research Fund [99-00524V-10258, 97-12013]; University of California [98-00924V]; Department of Health Services; NCI [CA114379]; NIH [CA056678, CA082664, CA092579, ES011126, S06GM08016, CA092447]; Department of Health and Human Services [N01-PC-35139]; California Department of Health Services [103885]; Centers for Disease Control and Prevention (CDC) [1U58DP000807-3]; Department of Defense (DOD) [W81XWH-07-1-0122, DAMD W81XWH-07-1-0203, DAMD W81XWH-06-1-0066]; Vanderbilt-Ingram Cancer Center [CA68485]; St. Louis Men's Group Against Cancer; David H. Nickerson Foundation; California Cancer Research Program [99-00527V-10182]; Commonwealth of Pennsylvania; American Cancer Society; National Health Genome Research Institute [N01-HG-25487]; Office of Minority Health [N01-HG-25487];  [CA68578];  [ES007784];  [DAMD W81XWH-07-1-0645];  [CA140388];  [CA88164];  [CA127298];  [CA112028];  [CA085074];  [CA105641]; NATIONAL CANCER INSTITUTE [ZIACP010152] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Cancer Research Fund; University of California(University of California System); Department of Health Services; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; California Department of Health Services; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Defense (DOD)(United States Department of Defense); Vanderbilt-Ingram Cancer Center; St. Louis Men's Group Against Cancer; David H. Nickerson Foundation; California Cancer Research Program; Commonwealth of Pennsylvania; American Cancer Society(American Cancer Society); National Health Genome Research Institute; Office of Minority Health(United States Department of Health & Human Services); ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Multiethnic Cohort (MEC) and the genotyping in this study were supported by US National Institutes of Health (NIH) grants CA63464, CA54281, CA1326792, CA148085 and HG004726. Genotyping of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and Ghana samples was funded by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), NIH. The Los Angeles Study of Aggressive Prostate Cancer (LAAPC) was funded by grant 99-00524V-10258 from the Cancer Research Fund under Interagency Agreement #97-12013 (University of California contract #98-00924V) with the Department of Health Services Cancer Research Program. Cancer incidence data for the MEC and LAAPC studies have been collected by the Los Angeles Cancer Surveillance Program of the University of Southern California with Federal funds from the NCI, NIH, Department of Health and Human Services under Contract No. N01-PC-35139 and the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885 and grant number 1U58DP000807-3 from the Centers for Disease Control and Prevention (CDC). The King County (Washington) Prostate Cancer Study (KCPCS) was supported by NIH grants CA056678, CA082664 and CA092579 with additional support from the Fred Hutchinson Cancer Research Center and the Intramural Program of the National Human Genome Research Institute. Prostate Cancer Case-Control Studies at MD Anderson (MDA) was support by grants CA68578, ES007784, DAMD W81XWH-07-1-0645 and CA140388. The Gene-Environment Interaction in Prostate Cancer Study (GECAP) was supported by NIH grant ES011126. Prostate Cancer Genetics Study (CaP Genes) was supported by CA88164 and CA127298. Identifying Prostate Cancer Genes (IPCG) was supported by Department of Defense (DOD) grant W81XWH-07-1-0122. Case-Control Study of Prostate Cancer among African Americans in Washington, DC (DCPC) was supported by NIH grant S06GM08016 and DOD grants DAMD W81XWH-07-1-0203 and DAMD W81XWH-06-1-0066. The Southern Community Cohort Study (SCCS) is funded by NIH grant CA092447. SCCS sample preparation was conducted at the Epidemiology Biospecimen Core Lab, which is supported in part by the Vanderbilt-Ingram Cancer Center (CA68485). Data on SCCS cancer cases used in this publication were provided by the Alabama Statewide Cancer Registry; Kentucky Cancer Registry; Tennessee Department of Health, Office of Cancer Surveillance; Florida Cancer Data System; North Carolina Central Cancer Registry, North Carolina Division of Public Health; Georgia Comprehensive Cancer Registry; Louisiana Tumor Registry; Mississippi Cancer Registry; South Carolina Central Cancer Registry; Virginia Department of Health, Virginia Cancer Registry; and Arkansas Department of Health, Cancer Registry. The Arkansas Central Cancer Registry is fully funded by a grant from National Program of Cancer Registries, CDC. Data on SCCS cancer cases from Mississippi were collected by the Mississippi Cancer Registry, which participates in the National Program of Cancer Registries (NPCR) of the CDC. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the Mississippi Cancer Registry. We thank C. Edlund from the University of Southern California (USC) Genomics Core for his technical and informatics assistance. The authors thank C. Berg and P.; Prorok, Division of Cancer Prevention, NCI, the screening center investigators and staffof the PLCO Cancer Screening Trial, T. Riley and staff at Information Management Services, Inc. and B. O'Brien and staff at Westat, Inc. for their contributions to the PLCO Cancer Screening Trial. We also acknowledge the technical support of M. Gielzak and G. Yan. The authors would like to thank E. Tay and V. Okyne for their expert help in coordinating the Ghana study; A. DeMarzo and G. Netto of Johns Hopkins University for pathology review; V. Devairakkam, N. Kim and J. Heinrich of Research Triangle Institute (RTI) for their expert study management; and S. Niwa and A. Truelove of Westat for study support and data management. The Washington University Prostate Cancer Study (WUPCS) was supported by CA112028, the St. Louis Men's Group Against Cancer and the David H. Nickerson Foundation. The San Francisco Bay Area Prostate Cancer Study (SFPCS) was funded by grant 99-00527V-10182 from the California Cancer Research Program. The Study of Clinical Outcomes, Risk and Ethnicity (SCORE) was supported by CA085074 and CA105641, as well as a grant from the Commonwealth of Pennsylvania. The Cancer Prevention Study II Nutrition Cohort (CPS-II) is supported by the American Cancer Society. Prostate Cancer in a Black Population (PCBP) was supported by grant CA114379 (NCI) and contract N01-HG-25487 (National Health Genome Research Institute and the Office of Minority Health).	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; *AM CANC SOC, 2009, CANC FACTS FIG AFR A; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Callen DF, 2010, ONCOL REP, V23, P1045, DOI 10.3892/or_00000731; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444	21	173	176	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					570	U103		10.1038/ng.839	http://dx.doi.org/10.1038/ng.839			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21602798	Green Submitted, Green Accepted			2022-12-25	WOS:000291017000015
J	Ihara, S; Hagedorn, EJ; Morrissey, MA; Chi, QY; Motegi, F; Kramer, JM; Sherwood, DR				Ihara, Shinji; Hagedorn, Elliott J.; Morrissey, Meghan A.; Chi, Qiuyi; Motegi, Fumio; Kramer, James M.; Sherwood, David R.			Basement membrane sliding and targeted adhesion remodels tissue boundaries during uterine-vulval attachment in Caenorhabditis elegans	NATURE CELL BIOLOGY			English	Article							ANCHOR-CELL INVASION; MATRIX METALLOPROTEINASES; COLLAGEN DEGRADATION; BETA-SUBUNIT; LAMININ; HERMAPHRODITE; MORPHOGENESIS; TURNOVER; BARRIERS; EMT	Large gaps in basement membrane occur at sites of cell invasion and tissue remodelling in development and cancer. Though never followed directly in vivo, basement membrane dissolution or reduced synthesis have been postulated to create these gaps. Using landmark photobleaching and optical highlighting of laminin and type IV collagen, we find that a new mechanism, basement membrane sliding, underlies basement membrane gap enlargement during uterine-vulval attachment in Caenorhabditis elegans. Laser ablation and mutant analysis reveal that the invaginating vulval cells promote basement membrane movement. Further, an RNA interference and expression screen identifies the integrin INA-1/PAT-3 and VAB-19, homologue of the tumour suppressor Kank, as regulators of basement membrane opening. Both concentrate within vulval cells at the basement membrane gap boundary and halt expansion of the shifting basement membrane. Basement membrane sliding followed by targeted adhesion represents a new mechanism for creating precise basement membrane breaches that can be used by cells to break down compartment boundaries.	[Ihara, Shinji; Hagedorn, Elliott J.; Morrissey, Meghan A.; Chi, Qiuyi; Sherwood, David R.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Motegi, Fumio] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Kramer, James M.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Duke University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Northwestern University	Sherwood, DR (corresponding author), Duke Univ, Dept Biol, Sci Dr,Box 90388, Durham, NC 27708 USA.	david.sherwood@duke.edu	Sherwood, David/ABG-4265-2020; Ihara, Shinji/AAH-6730-2019	Sherwood, David/0000-0002-4448-6917	Basil O'Connor Scholars Research Award; Pew Scholars Program in the Biomedical Sciences; NIH [GM079320, GM079320-03S1, HD027211]; JSPS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079320] Funding Source: NIH RePORTER	Basil O'Connor Scholars Research Award; Pew Scholars Program in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Chisholm for the vab-19::GFP vector; J. Culotti for the mig-6(ev700)strain; J. Schwarzbauer for the pat-3 HA-beta-tail vector; S. Mitani for the deletion mutant (tm1291), S. Johnson of the Duke University LMCF for imaging advice, the Caenorhabditis Genetic Center for strains, and A. Schindler, D. Matus and L. Lilley for comments on the manuscript. This work was supported by a Basil O'Connor Scholars Research Award, The Pew Scholars Program in the Biomedical Sciences and NIH grants GM079320 and GM079320-03S1 to D.R.S., HD027211 to J.M.K. and a JSPS Postdoctoral Fellow for Research Abroad Award to S.I.	Altun Z.F., 2009, WORMATLAS, DOI [10.3908/wormatlas.1.7, DOI 10.3908/WORMATLAS.1.7]; BARSKY SH, 1983, LAB INVEST, V49, P140; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; BRENNER S, 1974, GENETICS, V77, P71; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Cox EA, 2004, J CELL SCI, V117, P1867, DOI 10.1242/jcs.01177; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Ding M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003346; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fitzgerald MC, 1998, CURR BIOL, V8, P1285, DOI 10.1016/S0960-9822(07)00540-4; FLUG M, 1995, ACTA ANAT, V152, P69; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FREI JV, 1962, J CELL BIOL, V15, P335, DOI 10.1083/jcb.15.2.335; GARBISA S, 1980, CANCER LETT, V9, P359, DOI 10.1016/0304-3835(80)90030-0; Green RA, 2008, METHOD CELL BIOL, V85, P179, DOI 10.1016/S0091-679X(08)85009-1; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hagedorn E., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2011.230, DOI 10.1038/PROTEX.2011.230]; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kao G, 2006, DEV BIOL, V290, P211, DOI 10.1016/j.ydbio.2005.11.026; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kramer James M, 2005, WormBook, P1; LEARDKAMOLKARN V, 1988, CELL TISSUE RES, V251, P171, DOI 10.1007/BF00215462; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Lints R., 2009, REPROD SYSTEM EGGLAY, DOI [10.3908/wormatlas.1.24, DOI 10.3908/WORMATLAS.1.24]; LIOTTA LA, 1984, CIBA F SYMP, V108, P146; Liu J, 1999, GENETICS, V153, P1257; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; MARLIN SD, 1986, J EXP MED, V164, P855, DOI 10.1084/jem.164.3.855; Matus DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000654; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Newman AP, 1996, DEVELOPMENT, V122, P3617; Newman AP, 1996, P NATL ACAD SCI USA, V93, P9329, DOI 10.1073/pnas.93.18.9329; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PRICE RG, 1977, J BIOL CHEM, V252, P8597; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sameni M, 2008, MOL IMAGING, V7, P199, DOI 10.2310/7290.2008.00019; Sherwood DR, 2006, TRENDS CELL BIOL, V16, P250, DOI 10.1016/j.tcb.2006.03.004; Sherwood DR, 2005, CELL, V121, P951, DOI 10.1016/j.cell.2005.03.031; Sherwood DR, 2003, DEV CELL, V5, P21, DOI 10.1016/S1534-5807(03)00168-0; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; TRIER JS, 1990, J CLIN INVEST, V86, P87, DOI 10.1172/JCI114720; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Ziel JW, 2009, NAT CELL BIOL, V11, P183, DOI 10.1038/ncb1825	55	75	78	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					641	U245		10.1038/ncb2233	http://dx.doi.org/10.1038/ncb2233			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21572423	Green Accepted			2022-12-25	WOS:000291147400004
J	Larman, HB; Zhao, ZM; Laserson, U; Li, MZ; Ciccia, A; Gakidis, MAM; Church, GM; Kesari, S; LeProust, EM; Solimini, NL; Elledge, SJ				Larman, H. Benjamin; Zhao, Zhenming; Laserson, Uri; Li, Mamie Z.; Ciccia, Alberto; Gakidis, M. Angelica Martinez; Church, George M.; Kesari, Santosh; LeProust, Emily M.; Solimini, Nicole L.; Elledge, Stephen J.			Autoantigen discovery with a synthetic human peptidome	NATURE BIOTECHNOLOGY			English	Article							GLUTAMIC-ACID DECARBOXYLASE; PRIMARY SJOGRENS-SYNDROME; OPEN READING FRAMES; PARKINSONS-DISEASE; IDENTIFICATION; AUTOANTIBODIES; DIVERSITY; LIBRARIES; MELANOMA; EPITOPES	Immune responses targeting self-proteins (autoantigens) can lead to a variety of autoimmune diseases. Identification of these antigens is important for both diagnostic and therapeutic reasons. However, current approaches to characterize autoantigens have, in most cases, met only with limited success. Here we present a synthetic representation of the complete human proteome, the T7 peptidome phage display library (T7-Pep), and demonstrate its application to autoantigen discovery. T7-Pep is composed of >413,000 36-residue, overlapping peptides that cover all open reading frames in the human genome, and can be analyzed using high-throughput DNA sequencing. We developed a phage immunoprecipitation sequencing (PhIP-Seq) methodology to identify known and previously unreported autoantibodies contained in the spinal fluid of three individuals with paraneoplastic neurological syndromes. We also show how T7-Pep can be used more generally to identify peptide-protein interactions, suggesting the broader utility of our approach for proteomic research.	[Larman, H. Benjamin; Zhao, Zhenming; Laserson, Uri; Li, Mamie Z.; Ciccia, Alberto; Gakidis, M. Angelica Martinez; Church, George M.; Solimini, Nicole L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Larman, H. Benjamin; Zhao, Zhenming; Li, Mamie Z.; Ciccia, Alberto; Gakidis, M. Angelica Martinez; Solimini, Nicole L.; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Larman, H. Benjamin; Laserson, Uri] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA; [Larman, H. Benjamin] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Laserson, Uri] MIT, Dept Math, Cambridge, MA 02139 USA; [Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, Moores Canc Ctr, Div Neurooncol, La Jolla, CA 92093 USA; [LeProust, Emily M.] Agilent Technol, Genom, Santa Clara, CA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Agilent Technologies	Solimini, NL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	nsolimini@rics.bwh.harvard.edu; selledge@genetics.med.harvard.edu	Kesari, Santosh/E-8461-2013	church, george/0000-0001-6232-9969	Department of Defense [W81XWH-10-1-0994, W81XWH-04-1-0197]; US National Institutes of Health [K08CA124804]; American Recovery and Reinvestment Act [3P30CA023100-25S8]; Sontag Foundation; James S. McDonnell Foundation; NATIONAL CANCER INSTITUTE [K08CA124804, P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Sontag Foundation; James S. McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Department of Defense (W81XWH-10-1-0994 and W81XWH-04-1-0197) to S.J.E., and in part by the US National Institutes of Health (K08CA124804), The American Recovery and Reinvestment Act (3P30CA023100-25S8), Sontag Foundation Distinguished Scientist Award and a James S. McDonnell Foundation award to S.K.N. L.S. is a fellow of the Susan G. Komen for the Cure Foundation. S.J.E. is an investigator with the Howard Hughes Medical Institute. We would like to thank S. Gowrisankar, O. Iartchouk and L. Merrill for assistance with Illumina sequencing, and D. Scepanovic for statistical support.	Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blanco-Arias P, 2002, MAMM GENOME, V13, P463, DOI 10.1007/s00335-002-3010-9; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; CONSUL PC, 1984, COMMUN STAT-THEOR M, V13, P1533; Dalakas MC, 2000, NEUROLOGY, V55, P1531, DOI 10.1212/WNL.55.10.1531; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Faix PH, 2004, BIOTECHNIQUES, V36, P1018, DOI 10.2144/04366RR03; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Huang M, 2005, CLIN EXP IMMUNOL, V142, P148, DOI 10.1111/j.1365-2249.2005.02888.x; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; JIN L, 1992, J MOL BIOL, V226, P851, DOI 10.1016/0022-2836(92)90636-X; Kim Y, 2011, CLIN IMMUNOL, V138, P60, DOI 10.1016/j.clim.2010.09.008; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; LI LS, 1994, J IMMUNOL, V152, P930; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Miyazaki K, 2005, AM J PATHOL, V167, P1051, DOI 10.1016/S0002-9440(10)61194-7; Musunuru K, 2008, J NEURO-ONCOL, V90, P213, DOI 10.1007/s11060-008-9650-1; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Rimoldi D, 2000, J IMMUNOL, V165, P7253, DOI 10.4049/jimmunol.165.12.7253; ROBBINS DC, 1987, DIABETES, V36, P838, DOI 10.2337/diabetes.36.7.838; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; Srivastava S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq670; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Zacchi P, 2003, GENOME RES, V13, P980, DOI 10.1101/gr.861503	34	169	196	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2011	29	6					535	U101		10.1038/nbt.1856	http://dx.doi.org/10.1038/nbt.1856			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	773WL	21602805	Green Accepted, Green Submitted			2022-12-25	WOS:000291342100020
J	Marcet, B; Chevalier, B; Luxardi, G; Coraux, C; Zaragosi, LE; Cibois, M; Robbe-Sermesant, K; Jolly, T; Cardinaud, B; Moreilhon, C; Giovannini-Chami, L; Nawrocki-Raby, B; Birembaut, P; Waldmann, R; Kodjabachian, L; Barbry, P				Marcet, Brice; Chevalier, Benoit; Luxardi, Guillaume; Coraux, Christelle; Zaragosi, Laure-Emmanuelle; Cibois, Marie; Robbe-Sermesant, Karine; Jolly, Thomas; Cardinaud, Bruno; Moreilhon, Chimene; Giovannini-Chami, Lisa; Nawrocki-Raby, Beatrice; Birembaut, Philippe; Waldmann, Rainer; Kodjabachian, Laurent; Barbry, Pascal			Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR; CELL-FATES; XENOPUS; IDENTIFICATION; CILIOGENESIS; EXPRESSION; MICRORNAS; MIGRATION; TARGETS; CILIA	Multiciliated cells lining the surface of some vertebrate epithelia are essential for various physiological processes, such as airway cleansing(1-3). However, the mechanisms governing motile cilia biosynthesis remain poorly elucidated. We identify miR-449 microRNAs as evolutionarily conserved key regulators of vertebrate multiciliogenesis. In human airway epithelium and Xenopus laevis embryonic epidermis, miR-449 microRNAs strongly accumulated in multiciliated cells. In both models, we show that miR-449 microRNAs promote centriole multiplication and multiciliogenesis by directly repressing the Delta/Notch pathway. We established Notch1 and its ligand Delta-like 1 (DLL1) as miR-449 bona fide targets. Human DLL1 and NOTCH1 protein levels were lower in multiciliated cells than in surrounding cells, decreased after miR-449 overexpression and increased after miR-449 inhibition. In frog, miR-449 silencing led to increased Dill expression. Consistently, overexpression of Dill mRNA lacking miR-449 target sites repressed multiciliogenesis, whereas both Dill and Notch1 knockdown rescued multiciliogenesis in miR-449-deficient cells. Antisense-mediated protection of miR-449-binding sites of endogenous human Notch1 or frog Dill strongly repressed multiciliogenesis. Our results unravel a conserved mechanism whereby Notch signalling must undergo miR-449-mediated inhibition to permit differentiation of ciliated cell progenitors.	[Marcet, Brice; Chevalier, Benoit; Zaragosi, Laure-Emmanuelle; Robbe-Sermesant, Karine; Cardinaud, Bruno; Moreilhon, Chimene; Giovannini-Chami, Lisa; Waldmann, Rainer; Barbry, Pascal] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Sophia Antipolis, France; [Marcet, Brice; Chevalier, Benoit; Zaragosi, Laure-Emmanuelle; Robbe-Sermesant, Karine; Cardinaud, Bruno; Moreilhon, Chimene; Giovannini-Chami, Lisa; Waldmann, Rainer; Barbry, Pascal] Univ Nice Sophia Antipolis, F-06560 Sophia Antipolis, France; [Luxardi, Guillaume; Cibois, Marie; Kodjabachian, Laurent] CNRS, Inst Biol Dev Marseille Luminy, F-13288 Marseille, France; [Luxardi, Guillaume; Cibois, Marie; Kodjabachian, Laurent] Univ Mediterranee, F-13288 Marseille, France; [Coraux, Christelle; Jolly, Thomas; Nawrocki-Raby, Beatrice; Birembaut, Philippe] INSERM, U903, F-51092 Reims, France; [Coraux, Christelle; Jolly, Thomas; Nawrocki-Raby, Beatrice; Birembaut, Philippe] Univ Reims, F-51092 Reims, France; [Cardinaud, Bruno] INSERM, U876, F-33076 Bordeaux, France; [Cardinaud, Bruno] Univ Bordeaux 2, F-33076 Bordeaux, France; [Moreilhon, Chimene] CHU Nice, Hop Pasteur, Serv Hematol Biol, F-06000 Nice, France; [Giovannini-Chami, Lisa] CHU Nice, Serv Pediat, Hop Archet 2, F-06200 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Nice; CHU Nice	Barbry, P (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Sophia Antipolis, France.	barbry@ipmc.cnrs.fr	CORAUX, Christelle/P-5668-2016; Raby, Beatrice/P-5666-2016; BIREMBAUT, Philippe/P-5210-2016; Barbry, Pascal/O-5021-2016; Robbe-Sermesant, Karine/Q-2253-2016; GIOVANNINI-CHAMI, Lisa/A-1164-2012; Zaragosi, Laure-Emmanuelle/P-9887-2016; Waldmann, Rainer/Q-2108-2016; Marcet, Brice/Q-1218-2016	CORAUX, Christelle/0000-0001-5345-5074; Raby, Beatrice/0000-0002-3163-8619; Barbry, Pascal/0000-0001-9632-6483; Robbe-Sermesant, Karine/0000-0003-0580-3817; Zaragosi, Laure-Emmanuelle/0000-0001-6747-7928; Waldmann, Rainer/0000-0002-4599-2926; Marcet, Brice/0000-0001-5015-2297; Chevalier, Benoit/0000-0003-0863-6022; Kodjabachian, Laurent/0000-0002-4000-612X	CNRS; INSERM; Region Champagne-Ardenne; Region PACA; CGO6; ANR; Vaincre la Mucoviscidose; ARC; INCa	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Champagne-Ardenne(Region Grand-Est); Region PACA(Region Provence-Alpes-Cote d'Azur); CGO6(Region Provence-Alpes-Cote d'Azur); ANR(French National Research Agency (ANR)); Vaincre la Mucoviscidose; ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France)	This work was supported by CNRS, INSERM, Region Champagne-Ardenne, Region PACA, CGO6 and by grants from ANR, Vaincre la Mucoviscidose, ARC and INCa. We thank V. Magnone, G. Rios, S. Fourre, K. LeBrigand and J. Maurizio, from the IBISA Functional Genomics Platform, S Antipolis, for help with transcriptome analyses and bioinformatics, F. Brau and J. Cazareth, for cellular imaging, V. Thome for in situ hybridization experiments, F. Aguila for artwork and B. Mari for discussions. This work is the object of a CNRS patent N<SUP>o</SUP> 09/03723.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Cardinaud B, 2009, LEUKEMIA, V23, P2174, DOI 10.1038/leu.2009.125; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Feng M, 2010, CELL CYCLE, V9, P213, DOI 10.4161/cc.9.2.10502; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Brigand K, 2010, BIOINFORMATICS, V26, P3131, DOI 10.1093/bioinformatics/btq589; LeSimple P, 2007, AM J RESP CELL MOL, V36, P296, DOI 10.1165/rcmb.2006-0270OC; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lopez SL, 2003, DEVELOPMENT, V130, P2225, DOI 10.1242/dev.00443; Marcet B, 2007, J CELL PHYSIOL, V211, P716, DOI 10.1002/jcp.20979; Marchal L, 2009, P NATL ACAD SCI USA, V106, P17437, DOI 10.1073/pnas.0906352106; Marnellos G, 2000, Pac Symp Biocomput, P329; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Morichika K, 2010, DEV GROWTH DIFFER, V52, P235, DOI 10.1111/j.1440-169X.2009.01164.x; Ortholan C, 2009, CURR MED CHEM, V16, P1047, DOI 10.2174/092986709787581833; Pearson CG, 2007, DEV CELL, V13, P319, DOI 10.1016/j.devcel.2007.08.007; Pohl BS, 2004, DEV GENES EVOL, V214, P200, DOI 10.1007/s00427-004-0391-7; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	40	219	226	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					693	U157		10.1038/ncb2241	http://dx.doi.org/10.1038/ncb2241			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21602795				2022-12-25	WOS:000291147400010
J	Yang, J; Manolio, TA; Pasquale, LR; Boerwinkle, E; Caporaso, N; Cunningham, JM; de Andrade, M; Feenstra, B; Feingold, E; Hayes, MG; Hill, WG; Landi, MT; Alonso, A; Lettre, G; Lin, P; Ling, H; Lowe, W; Mathias, RA; Melbye, M; Pugh, E; Cornelis, MC; Weir, BS; Goddard, ME; Visscher, PM				Yang, Jian; Manolio, Teri A.; Pasquale, Louis R.; Boerwinkle, Eric; Caporaso, Neil; Cunningham, Julie M.; de Andrade, Mariza; Feenstra, Bjarke; Feingold, Eleanor; Hayes, M. Geoffrey; Hill, William G.; Landi, Maria Teresa; Alonso, Alvaro; Lettre, Guillaume; Lin, Peng; Ling, Hua; Lowe, William; Mathias, Rasika A.; Melbye, Mads; Pugh, Elizabeth; Cornelis, Marilyn C.; Weir, Bruce S.; Goddard, Michael E.; Visscher, Peter M.			Genome partitioning of genetic variation for complex traits using common SNPs	NATURE GENETICS			English	Article							VON-WILLEBRAND-FACTOR; BODY-MASS INDEX; WIDE ASSOCIATION; LARGE PROPORTION; AGING RESEARCH; FACTOR-VIII; HERITABILITY; LOCI; POPULATION; VARIANTS	We estimate and partition genetic variation for height, body mass index (BMI), von Willebrand factor and QT interval (QTi) using 586,898 SNPs genotyped on 11,586 unrelated individuals. We estimate that similar to 45%, similar to 17%, similar to 25% and similar to 21% of the variance in height, BMI, von Willebrand factor and QTi, respectively, can be explained by all autosomal SNPs and a further similar to 0.5-1% can be explained by X chromosome SNPs. We show that the variance explained by each chromosome is proportional to its length, and that SNPs in or near genes explain more variation than SNPs between genes. We propose a new approach to estimate variation due to cryptic relatedness and population stratification. Our results provide further evidence that a substantial proportion of heritability is captured by common SNPs, that height, BMI and QTi are highly polygenic traits, and that the additive variation explained by a part of the genome is approximately proportional to the total length of DNA contained within genes therein.	[Yang, Jian; Visscher, Peter M.] Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia; [Manolio, Teri A.] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA; [Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Div Epidemiol, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Caporaso, Neil; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Cunningham, Julie M.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Feenstra, Bjarke; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Feingold, Eleanor] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Hayes, M. Geoffrey] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Hill, William G.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Lettre, Guillaume] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Lin, Peng] Washington Univ, Sch Med, Human & Stat Genet Program, St Louis, MO USA; [Ling, Hua; Pugh, Elizabeth] Johns Hopkins Univ, Sch Med, Ctr Inherited Dis Res, Baltimore, MD USA; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Gen Internal Med, Baltimore, MD USA; [Cornelis, Marilyn C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Weir, Bruce S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Melbourne, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia	QIMR Berghofer Medical Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Mayo Clinic; Statens Serum Institut; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; University of Edinburgh; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; University of Melbourne	Visscher, PM (corresponding author), Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia.	peter.visscher@qimr.edu.au	Yang, Jian/A-5852-2010; Alonso, Alvaro/A-4917-2010; Lin, P/G-7702-2014; Visscher, Peter/ABB-6151-2020; Hill, William/B-3198-2012; Weir, Bruce S/A-2894-2013	Yang, Jian/0000-0003-2001-2474; Alonso, Alvaro/0000-0002-2225-8323; Visscher, Peter/0000-0002-2143-8760; de Andrade, Mariza/0000-0003-2329-2686; Hayes, M Geoffrey/0000-0002-4617-3981; Goddard, Michael/0000-0001-9917-7946; melbye, mads/0000-0001-8264-6785; Feingold, Eleanor/0000-0003-2898-6484; Feenstra, Bjarke/0000-0003-1478-649X	US National Institutes of Health Genes, Environment and Health Initiative; Research to Prevent Blindness in New York City; Canadian Institutes of Health Research; Australian National Health and Medical Research Council (NHMRC) [389892, 613672]; Australian Research Council (ARC) [DP0770096, DP1093900];  [U01 HG 004402];  [U01 HG 004399];  [U01 HG 004728];  [U01 HG04424];  [U01 HG 004446]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004728, U01HG004446, U01HG004424, U01HG004402, U01HG004399] Funding Source: NIH RePORTER	US National Institutes of Health Genes, Environment and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness in New York City(Research to Prevent Blindness (RPB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding support for the Gene, Environment Association Studies (GENEVA) project has been provided through the US National Institutes of Health Genes, Environment and Health Initiative. For the ARIC project, support was from U01 HG 004402 (PI: E. A. Boerwinkle). For the NHS and HPFS support is from U01 HG 004399 and U01 HG 004728 (PIs: F. B. Hu and L. R. Pasquale). The genotyping for the ARIC, NHS and HPFS studies was performed at the Broad Institute of MIT and Harvard with funding support from U01 HG04424 (PI: S. Gabriel). The GENEVA Coordinating Center receives support from U01 HG 004446 (PI: B. S. Weir). Assistance with GENEVA data cleaning was provided by the National Center for Biotechnology Information. D. Crosslin and C. Laurie of the GENEVA project assisted in making the data available for analysis. A Physician Scientist Award from Research to Prevent Blindness in New York City also supports L. R. P. M. C. C. is a recipient of a Canadian Institutes of Health Research Fellowship. We acknowledge funding from the Australian National Health and Medical Research Council (NHMRC grants 389892 and 613672) and the Australian Research Council (ARC grants DP0770096 and DP1093900). We thank D. Posthuma for discussions and the referees for constructive comments.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bulmer MG, 1985, MATH THEORY QUANTITA; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; Dalageorgou C, 2008, J CARDIOVASC ELECTR, V19, P386, DOI 10.1111/j.1540-8167.2007.01030.x; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kent JW, 2005, GENET EPIDEMIOL, V29, P377, DOI 10.1002/gepi.20093; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; O'Donnell J, 2002, ARTERIOSCL THROM VAS, V22, P335, DOI 10.1161/hq0202.103997; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; PRESTON AE, 1964, BRIT J HAEMATOL, V10, P238, DOI 10.1111/j.1365-2141.1964.tb00698.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Shah SH, 2009, NAT GENET, V41, P388, DOI 10.1038/ng0409-388; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	43	609	615	2	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					519	U44		10.1038/ng.823	http://dx.doi.org/10.1038/ng.823			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21552263	Green Accepted			2022-12-25	WOS:000291017000007
J	Levayer, R; Pelissier-Monier, A; Lecuit, T				Levayer, Romain; Pelissier-Monier, Anne; Lecuit, Thomas			Spatial regulation of Dia and Myosin-II by RhoGEF2 controls initiation of E-cadherin endocytosis during epithelial morphogenesis	NATURE CELL BIOLOGY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLANAR CELL POLARITY; ADHERENS JUNCTIONS; MESENCHYMAL TRANSITIONS; DROSOPHILA GASTRULATION; TISSUE MORPHOGENESIS; ACTIN ORGANIZATION; SIGNALING PATHWAY; AXIS ELONGATION; ALPHA-CATENIN	E-cadherin plays a pivotal role in epithelial morphogenesis. It controls the intercellular adhesion required for tissue cohesion and anchors the actomyosin-driven tension needed to change cell shape. In the early Drosophila embryo, Myosin-II (Myo-II) controls the planar polarized remodelling of cell junctions and tissue extension. The E-cadherin distribution is also planar polarized and complementary to the Myosin-II distribution. Here we show that E-cadherin polarity is controlled by the polarized regulation of clathrin- and dynamin-mediated endocytosis. Blocking E-cadherin endocytosis resulted in cell intercalation defects. We delineate a pathway that controls the initiation of E-cadherin endocytosis through the regulation of AP2 and clathrin coat recruitment by E-cadherin. This requires the concerted action of the formin Diaphanous (Dia) and Myosin-II. Their activity is controlled by the guanine exchange factor RhoGEF2, which is planar polarized and absent in non-intercalating regions. Finally, we provide evidence that Dia and Myo-II control the initiation of E-cadherin endocytosis by regulating the lateral clustering of E-cadherin.	[Levayer, Romain; Pelissier-Monier, Anne; Lecuit, Thomas] UMR6216 CNRS Univ Mediterranee, IBDML, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS)	Lecuit, T (corresponding author), UMR6216 CNRS Univ Mediterranee, IBDML, Campus Luminy,Case 907, F-13288 Marseille 09, France.	thomas.lecuit@ibdml.univmed.fr	Levayer, Romain/V-3665-2019	Levayer, Romain/0000-0001-6769-1465	CNRS; Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We are grateful to all of those who generously provided us with reagents, especially H. Chang, M. Freeman, M. Gonzalez-Gaitan, J. Grosshans, U. Hacker, R. Karess, D. Kiehart, K. Klaembt, A. C. Martin, E. Wieschaus, H. Oda, M. Peifer, P. Rorth, E. Scheirer, A. Schmidt, R. Vincentelli and the Bloomington stock centre. We thank the members of the Lecuit laboratory for fruitful discussions and for useful comments on the manuscript, especially S. Kerridge and J-M. Philippe. This work was supported by the CNRS, the Association pour la Recherche sur le Cancer (ARC) and the Fondation pour la Recherche Medicale (equipe labellisee). A.P. was supported by a fellowship from ARC.	Afshar K, 2000, DEVELOPMENT, V127, P1887; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Barmchi MP, 2005, J CELL BIOL, V168, P575, DOI 10.1083/jcb.200407124; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bertet C, 2009, DEVELOPMENT, V136, P4199, DOI 10.1242/dev.040402; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kanerva A, 2007, J GENE MED, V9, P3, DOI 10.1002/jgm.984; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEDBETTER JA, 1987, P NATL ACAD SCI USA, V84, P1384, DOI 10.1073/pnas.84.5.1384; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Levenberg S, 1998, J CELL SCI, V111, P347; Magie CR, 1999, DEVELOPMENT, V126, P5353; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Mostowy S, 2009, CELL MOTIL CYTOSKEL, V66, P816, DOI 10.1002/cm.20353; Mulinari S, 2008, MOL BIOL CELL, V19, P1883, DOI 10.1091/mbc.E07-12-1230; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Quintin S, 2008, TRENDS GENET, V24, P221, DOI 10.1016/j.tig.2008.02.005; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sapir A, 1998, DEVELOPMENT, V125, P191; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	68	190	191	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					529	U83		10.1038/ncb2224	http://dx.doi.org/10.1038/ncb2224			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21516109				2022-12-25	WOS:000290148700012
J	Mu, S; Shimosawa, T; Ogura, S; Wang, H; Uetake, Y; Kawakami-Mori, F; Marumo, T; Yatomi, Y; Geller, DS; Tanaka, H; Fujita, T				Mu, ShengYu; Shimosawa, Tatsuo; Ogura, Sayoko; Wang, Hong; Uetake, Yuzaburo; Kawakami-Mori, Fumiko; Marumo, Takeshi; Yatomi, Yutaka; Geller, David S.; Tanaka, Hirotoshi; Fujita, Toshiro			Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension	NATURE MEDICINE			English	Article							NA-CL COTRANSPORTER; PROTEIN-KINASE-A; MINERALOCORTICOID RECEPTOR FUNCTION; SYMPATHETIC NERVOUS-SYSTEM; GLUCOCORTICOID-RECEPTOR; BLOOD-PRESSURE; HISTONE ACETYLATION; MMTV PROMOTER; WNK KINASES; IN-VIVO	How high salt intake increases blood pressure is a key question in the study of hypertension. Salt intake induces increased renal sympathetic activity resulting in sodium retention. However, the mechanisms underlying the sympathetic control of renal sodium excretion remain unclear. In this study, we found that beta(2)-adrenergic receptor (beta(2)AR) stimulation led to decreased transcription of the gene encoding WNK4, a regulator of sodium reabsorption. beta(2)AR stimulation resulted in cyclic AMP-dependent inhibition of histone deacetylase-8 (HDAC8) activity and increased histone acetylation, leading to binding of the glucocorticoid receptor to a negative glucocorticoid-responsive element in the promoter region. In rat models of salt-sensitive hypertension and sympathetic overactivity, salt loading suppressed renal WNK4 expression, activated the Na(+)-Cl(-) cotransporter and induced salt-dependent hypertension. These findings implicate the epigenetic modulation of WNK4 transcription in the development of salt-sensitive hypertension. The renal beta(2)AR-WNK4 pathway may be a therapeutic target for salt-sensitive hypertension.	[Mu, ShengYu; Shimosawa, Tatsuo; Ogura, Sayoko; Wang, Hong; Uetake, Yuzaburo; Kawakami-Mori, Fumiko; Marumo, Takeshi; Fujita, Toshiro] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan; [Shimosawa, Tatsuo; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab, Tokyo, Japan; [Geller, David S.] Yale Univ, Sch Med, W Haven Vet Affairs Med Ctr, New Haven, CT USA; [Tanaka, Hirotoshi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol, Tokyo, Japan	University of Tokyo; University of Tokyo; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; University of Tokyo	Fujita, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan.	fujita-dis@h.u-tokyo.ac.jp	Shimosawa, Tatsuo/A-2920-2015	Shimosawa, Tatsuo/0000-0002-8742-5129; Fujita, Toshiro/0000-0001-9141-7060; Yatomi, Yutaka/0000-0003-1719-4297	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Tamura (Yokohama City Medical University) for providing mDCT cells. Antibodies targeting NCC and p-NCC were provided by D. H. Ellison (Oregon Health and Science University) and S. Uchida (Tokyo Dental and Medical University), respectively. We also thank G. McMahon for his contribution to data discussion. Eplerenone and olmesartan were provided by Pfizer and Daiichi-Sankyo, respectively. This work was supported by research grants from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (T.F.).	Adams JM, 2007, HYPERTENSION, V50, P354, DOI 10.1161/HYPERTENSIONAHA.107.091843; Astrand C, 2009, EXP CELL RES, V315, P2604, DOI 10.1016/j.yexcr.2009.05.012; BARAJAS L, 1984, AM J PHYSIOL, V247, pF50, DOI 10.1152/ajprenal.1984.247.1.F50; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; CAMPESE VM, 1982, KIDNEY INT, V21, P371, DOI 10.1038/ki.1982.32; Cat AND, 2009, ENDOCRINOLOGY, V150, P2202, DOI 10.1210/en.2008-1531; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; DiBona GF, 2005, AM J PHYSIOL-REG I, V289, pR633, DOI 10.1152/ajpregu.00258.2005; FUJITA T, 1992, HYPERTENSION, V20, P466, DOI 10.1161/01.HYP.20.4.466; FUJITA T, 1980, AM J MED, V69, P334, DOI 10.1016/0002-9343(80)90002-9; FUJITA T, 1988, J CLIN INVEST, V82, P993, DOI 10.1172/JCI113709; GILL JR, 1988, HYPERTENSION, V11, P312, DOI 10.1161/01.HYP.11.4.312; Goodwin JE, 2010, BIOCHEM BIOPH RES CO, V394, P266, DOI 10.1016/j.bbrc.2010.02.123; GREVEN J, 1975, N-S ARCH PHARMACOL, V287, P117, DOI 10.1007/BF00510444; Guild SJ, 2002, AM J PHYSIOL-REG I, V283, pR1177, DOI 10.1152/ajpregu.00151.2002; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Huang BS, 2001, AM J PHYSIOL-HEART C, V281, pH1881, DOI 10.1152/ajpheart.2001.281.5.H1881; ISOHASHI F, 1989, CANCER RES, V49, pS2235; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; KATHOLI RE, 1980, HYPERTENSION, V2, P266, DOI 10.1161/01.HYP.2.3.266; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; KOEPKE JP, 1986, CIRC RES, V58, P241, DOI 10.1161/01.RES.58.2.241; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li CY, 2008, J MOL ENDOCRINOL, V40, P3, DOI 10.1677/JME-07-0049; Li JP, 2007, J HYPERTENS, V25, P1065, DOI 10.1097/HJH.0b013e3280a8b87d; LOHMEIER TE, 1984, HYPERTENSION, V6, pI177, DOI 10.1161/01.HYP.6.2_Pt_2.I177; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Marumo T, 2008, J AM SOC NEPHROL, V19, P1311, DOI 10.1681/ASN.2007091040; Massaad C, 1999, MOL ENDOCRINOL, V13, P57, DOI 10.1210/me.13.1.57; MEIER KE, 1983, J CELL BIOL, V97, P405, DOI 10.1083/jcb.97.2.405; Mulholland NM, 2003, EXP CELL RES, V287, P361, DOI 10.1016/S0014-4827(03)00153-8; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Ono A, 1997, HYPERTENSION, V29, P808, DOI 10.1161/01.HYP.29.3.808; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pojoga L, 2006, HYPERTENSION, V48, P892, DOI 10.1161/01.HYP.0000244688.45472.95; RANGARAJAN PN, 1992, MOL ENDOCRINOL, V6, P1451, DOI 10.1210/me.6.9.1451; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4020, DOI 10.1073/pnas.0611727104; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Snyder EM, 2006, J PHYSIOL-LONDON, V574, P947, DOI 10.1113/jphysiol.2006.107672; Vasquez MM, 2008, J CELL PHYSIOL, V217, P632, DOI 10.1002/jcp.21534; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Willyard C, 2010, NAT MED, V16, P18, DOI 10.1038/nm0110-18; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wurtele H, 2010, NAT MED, V16, P774, DOI 10.1038/nm.2175; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033	53	163	165	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					573	U92		10.1038/nm.2337	http://dx.doi.org/10.1038/nm.2337			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499270				2022-12-25	WOS:000290250400033
J	De, S; Michor, F				De, Subhajyoti; Michor, Franziska			DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes	NATURE BIOTECHNOLOGY			English	Article							COPY-NUMBER; GENES; REPAIR; RECOMBINATION; CHECKPOINT; EVOLUTION; DISEASE; POOLS; CELLS	Somatic copy-number alterations (SCNA) are a hallmark of many cancer types, but the mechanistic basis underlying their genome-wide patterns remains incompletely understood. Here we integrate data on DNA replication timing, long-range interactions between genomic material, and 331,724 SCNAs from 2,792 cancer samples classified into 26 cancer types. We report that genomic regions of similar replication timing are clustered spatially in the nucleus, that the two boundaries of SCNAs tend to be found in such regions, and that regions replicated early and late display distinct patterns of frequencies of SCNA boundaries, SCNA size and a preference for deletions over insertions. We show that long-range interaction and replication timing data alone can identify a significant proportion of SCNAs in an independent test data set. We propose a model for the generation of SCNAs in cancer, suggesting that data on spatial proximity of regions replicating at the same time can be used to predict the mutational landscapes of cancer genomes.	[De, Subhajyoti; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [De, Subhajyoti; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	De, S (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	subho@jimmy.harvard.edu; michor@jimmy.harvard.edu			National Cancer Institute's initiative to found Physical Science-Oncology Centers [U54CA143798]; Human Frontier Science Program long-term fellowship; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	National Cancer Institute's initiative to found Physical Science-Oncology Centers; Human Frontier Science Program long-term fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank K. Polyak, A. Melnick, K.J. Patel, A. Chakravarti and R. Beroukhim for comments and discussions. S. D. is a recipient of Human Frontier Science Program long-term fellowship and is a Research Fellow at King's College, Cambridge. This work was funded by the National Cancer Institute's initiative to found Physical Science-Oncology Centers (U54CA143798).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Fisher R. A., 1966, DESIGN EXPT; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Koboldt DC, 2010, BRIEF BIOINFORM, V11, P484, DOI 10.1093/bib/bbq016; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Meister P, 2006, CELL, V125, P1233, DOI 10.1016/j.cell.2006.06.014; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Rheinfurth MH, 1998, PROBABILITY STAT AER; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; SNYDER RD, 1988, MUTAT RES, V200, P193, DOI 10.1016/0027-5107(88)90082-6; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Wijchers PJ, 2011, TRENDS GENET, V27, P63, DOI 10.1016/j.tig.2010.11.001; Woodfine K, 2005, CELL CYCLE, V4, P172, DOI 10.4161/cc.4.1.1350; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	32	119	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1103	U119		10.1038/nbt.2030	http://dx.doi.org/10.1038/nbt.2030			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22101487	Green Accepted			2022-12-25	WOS:000298038700019
J	Fudenberg, G; Getz, G; Meyerson-, M; Mirny, LA				Fudenberg, Geoff; Getz, Gad; Meyerson-, Matthew; Mirny, Leonid A.			High order chromatin architecture shapes the landscape of chromosomal alterations in cancer	NATURE BIOTECHNOLOGY			English	Article							SEQUENCING REVEALS; COPY-NUMBER; GENOME; REARRANGEMENTS; TRANSLOCATIONS; MECHANISMS; PROXIMITY; MUTATION; CELLS; LOCI	The accumulation of data on structural variation in cancer genomes provides an opportunity to better understand the mechanisms of genomic alterations and the forces of selection that act upon these alterations in cancer. Here we test evidence supporting the influence of two major forces, spatial chromosome structure and purifying (or negative) selection, on the landscape of somatic copy-number alterations (SCNAs) in cancer(1). Using a maximum likelihood approach, we compare SCNA maps and three-dimensional genome architecture as determined by genome-wide chromosome conformation capture (HiC) and described by the proposed fractal-globule model(2,3). This analysis suggests that the distribution of chromosomal alterations in cancer is spatially related to three-dimensional genomic architecture and that purifying selection, as well as positive selection, influences SCNAs during somatic evolution of cancer cells.	[Getz, Gad; Meyerson-, Matthew; Mirny, Leonid A.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Fudenberg, Geoff] Harvard Univ, Program Biophys, Boston, MA 02115 USA; [Meyerson-, Matthew] Harvard Univ, Sch Med, Boston, MA USA; [Meyerson-, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson-, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Mirny, Leonid A.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Mirny, LA (corresponding author), Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA.	leonid@mit.edu	Meyerson, Matthew L/E-7123-2012; Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Fudenberg, Geoffrey/0000-0001-5905-6517; Meyerson, Matthew/0000-0002-9133-8108	US National Institutes of Health/National Cancer Institute Physical Sciences Oncology Center at MIT [U54CA143874]; TCGA (NIH) [U24CA143845, U24CA144025, U24CA143867]; NATIONAL CANCER INSTITUTE [U24CA143867, U24CA144025, U24CA143845, U54CA143874] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute Physical Sciences Oncology Center at MIT; TCGA (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Mirny Lab for helpful conversations, in particular with C. McFarland regarding purifying selection and M. Imakaev regarding fractal globules. We thank C. Mermel for an introduction to SCNA data. We thank V. Agarwala, J. Engrietz, R. McCord and J. Dekker for helpful comments and suggestions. This work was supported by the US National Institutes of Health/National Cancer Institute Physical Sciences Oncology Center at MIT (U54CA143874). G. G. and M. M. are TCGA-funded investigators (NIH U24CA143845, U24CA144025 and U24CA143867).	Armitage P, 2001, STAT METHODS MED RES, V4th; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GROSBERG AY, 1988, J PHYS-PARIS, V49, P2095, DOI 10.1051/jphys:0198800490120209500; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Moran P., 1962, STAT PROCESSES EVOLU; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wijchers PJ, 2011, TRENDS GENET, V27, P63, DOI 10.1016/j.tig.2010.11.001; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	27	145	149	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1109	U75		10.1038/nbt.2049	http://dx.doi.org/10.1038/nbt.2049			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22101486	Green Submitted, Green Accepted			2022-12-25	WOS:000298038700020
J	Schuh, M				Schuh, Melina			An actin-dependent mechanism for long-range vesicle transport	NATURE CELL BIOLOGY			English	Article							MYOSIN VB; PROTEINS; SPINDLE; SPIRE; POLYMERIZATION; ORGANIZATION; ENDOCYTOSIS; ENDOSOMES; FILAMENTS; FORMIN-2	Intracellular transport is vital for the function, survival and architecture of every eukaryotic cell. Long-range transport in animal cells is thought to depend exclusively on microtubule tracks. This study reveals an unexpected actin-dependent but microtubule-independent mechanism for long-range transport of vesicles. Vesicles organize their own actin tracks by recruiting the actin nucleation factors Spire 1, Spire2 and Formin-2, which assemble an extensive actin network from the vesicles' surfaces. The network connects the vesicles with one another and with the plasma membrane. Vesicles move directionally along these connections in a myosin-Vb-dependent manner to converge and to reach the cell surface. The overall outward-directed movement of the vesicle-actin network is driven by recruitment of vesicles to the plasma membrane in the periphery of the oocyte. Being organized in a dynamic vesicle-actin network allows vesicles to move in a local random manner and a global directed manner at the same time: they can reach any position in the cytoplasm, but also move directionally to the cell surface as a collective. Thus, collective movement within a network is a powerful and flexible mode of vesicle transport.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Schuh, M (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	mschuh@mrc-lmb.cam.ac.uk			European Community [241548]; Medical Research Council [MC_U105192711] Funding Source: researchfish; MRC [MC_U105192711] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The author thanks P. Leder, B. Leader and M. Dettenhofer for Fmn2<SUP>-/-</SUP> mice; the staff of the LMB's Animal Facility for expert technical assistance; and M. Freeman, S. Munro and B. Nichols for helpful discussions and critical reading of the manuscript. The research leading to these results has received financial support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 241548.	Alberts B, 2008, MOL BIOL CELL; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; BEGG DA, 1979, J CELL BIOL, V83, P241, DOI 10.1083/jcb.83.1.241; Bittins CM, 2010, CELL MOL NEUROBIOL, V30, P369, DOI 10.1007/s10571-009-9459-2; Bloom GS, 1998, J CELL BIOL, V140, P1277, DOI 10.1083/jcb.140.6.1277; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Ito T, 2011, J MOL BIOL, V408, P18, DOI 10.1016/j.jmb.2010.12.045; Jaffe Laurinda A., 2009, V518, P157, DOI 10.1007/978-1-59745-202-1_12; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lodish H., 2007, MOL CELL BIOL; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; POLLARD TD, 2004, CELL BIOL; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strickland L, 2004, METHOD CELL BIOL, V74, P371; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	45	212	216	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1431	U115		10.1038/ncb2353	http://dx.doi.org/10.1038/ncb2353			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	21983562	Green Accepted			2022-12-25	WOS:000298157500010
J	Bethencourt, V; Scott, C				Bethencourt, Victor; Scott, Christopher			Going viral	NATURE BIOTECHNOLOGY			English	Letter																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					975	975		10.1038/nbt.2033	http://dx.doi.org/10.1038/nbt.2033			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068529				2022-12-25	WOS:000296801300013
J	Cvetanovic, M; Patel, JM; Marti, HH; Kini, AR; Opal, P				Cvetanovic, Marija; Patel, Jay M.; Marti, Hugo H.; Kini, Ameet R.; Opal, Puneet			Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1	NATURE MEDICINE			English	Article							MOTOR-NEURON DEGENERATION; HYPOXIA-RESPONSE ELEMENT; TRANSGENIC MICE; TRINUCLEOTIDE REPEAT; SCA1; NEURODEGENERATION; VEGF; PROTEIN; EXPRESSION; DISORDERS	Spinocerebellar ataxia type 1 (SCA1) is an adult-onset, dominantly inherited neurodegenerative disease caused by expansion of a glutamine repeat tract in ataxin-1 (ATXN1). Although the precise function of ATXN1 remains elusive, it seems to be involved in transcriptional repression. We find that mutant ATXN1 represses transcription of the neurotrophic and angiogenic factor vascular endothelial growth factor (VEGF). Genetic overexpression or pharmacologic infusion of recombinant VEGF mitigates SCA1 pathogenesis, suggesting a new therapeutic strategy for this disease.	[Cvetanovic, Marija; Patel, Jay M.; Opal, Puneet] Northwestern Univ, Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Marti, Hugo H.] Univ Heidelberg, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Kini, Ameet R.] Loyola Univ Chicago, Stritch Sch Med, Dept Pathol, Maywood, IL USA; [Kini, Ameet R.] Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL USA; [Opal, Puneet] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ruprecht Karls University Heidelberg; Loyola University Chicago; Loyola University Chicago; Northwestern University; Feinberg School of Medicine	Opal, P (corresponding author), Northwestern Univ, Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-opal@northwestern.edu	Cvetanovic, Marija/B-8907-2016	Patel, Jay/0000-0003-2746-5716; Marti, Hugo/0000-0002-8456-334X	US National Institutes of Health [K02 NS051340, R21 NS060080, R01 NS062051, T32]; US National Organization for Rare Disorders; US Brain Research Foundation; US National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082351, R01NS062051, R21NS060080, K02NS051340] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Organization for Rare Disorders; US Brain Research Foundation; US National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Zoghbi (Baylor College of Medicine) and H. Orr (University of Minnesota) for generously providing ATXN1 constructs and the SCA1 mouse models, and S. Leibovich (University of Medicine and Dentistry of New Jersey) and P. D'Amore (Harvard Medical School) for VEGF luciferase reporter constructs. We also thank K. Gobeske for assistance with the intracerebroventricular delivery methods, A. Ma for help with pathological analyses and V. Brandt for editorial assistance. This work was funded by US National Institutes of Health grants K02 NS051340, R21 NS060080 and R01 NS062051 (P.O.); a US National Organization for Rare Disorders grant (P.O.), a US Brain Research Foundation Grant (P.O.) and a US National Ataxia Foundation grant (P.O.). M. C. received funding from the US National Institutes of Health training grant T32. The authors wish to dedicate this manuscript to fellow scientist T. Spann, who is currently fighting amyotrophic lateral sclerosis.	Acker T, 2001, MECH DEVELOP, V108, P45, DOI 10.1016/S0925-4773(01)00471-3; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; de Almodovar CR, 2010, J NEUROSCI, V30, P15052, DOI 10.1523/JNEUROSCI.0477-10.2010; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2008, P NATL ACAD SCI USA, V105, P1291, DOI 10.1073/pnas.0711257105; Lambrechts D, 2006, BBA-MOL BASIS DIS, V1762, P1109, DOI 10.1016/j.bbadis.2006.04.005; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Oz G, 2010, MOVEMENT DISORD, V25, P1253, DOI 10.1002/mds.23067; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X	18	72	73	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1445	1447		10.1038/nm.2494	http://dx.doi.org/10.1038/nm.2494			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22001907	Green Accepted			2022-12-25	WOS:000296779300035
J	Lienert, F; Wirbelauer, C; Som, I; Dean, A; Mohn, F; Schubeler, D				Lienert, Florian; Wirbelauer, Christiane; Som, Indrani; Dean, Ann; Mohn, Fabio; Schuebeler, Dirk			Identification of genetic elements that autonomously determine DNA methylation states	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; CPG ISLANDS; CHROMATIN-STRUCTURE; HISTONE; METHYLTRANSFERASE; NANOG; TRANSCRIPTION; PLURIPOTENT; METHYLOME; PROMOTER	Cytosine methylation is a repressive, epigenetically propagated DNA modification. Although patterns of DNA methylation seem tightly regulated in mammals, it is unclear how these are specified and to what extent this process entails genetic or epigenetic regulation. To dissect the role of the underlying DNA sequence, we sequentially inserted over 50 different DNA elements into the same genomic locus in mouse stem cells. Promoter sequences of approximately 1,000 bp autonomously recapitulated correct DNA methylation in pluripotent cells. Moreover, they supported proper de novo methylation during differentiation. Truncation analysis revealed that this regulatory potential is contained within small methylation-determining regions (MDRs). MDRs can mediate both hypomethylation and de novo methylation in cis, and their activity depends on developmental state, motifs for DNA-binding factors and a critical CpG density. These results demonstrate that proximal sequence elements are both necessary and sufficient for regulating DNA methylation and reveal basic constraints of this regulation.	[Lienert, Florian; Wirbelauer, Christiane; Mohn, Fabio; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Lienert, Florian; Schuebeler, Dirk] Univ Basel, Fac Sci, Basel, Switzerland; [Som, Indrani; Dean, Ann] NIDDKD, Cellular & Dev Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	dirk@fmi.ch		Mohn, Fabio/0000-0001-9889-5225	Boehringer Ingelheim; National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health; Novartis Research Foundation; European Union [FP7-HEALTH-2010-257082, LSHG-CT-2006-037415]; European Research Council [ERC-204264]; Swiss initiative in Systems Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075033, ZIADK015508] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novartis Research Foundation; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Swiss initiative in Systems Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to M. Pietrzak for sequencing. We thank M. Lorincz of the University of British Columbia-Vancouver for providing plasmids for RMCE and S. Fiering for advice. We would also like to thank members of the Schubeler group and S. Gasser for critical comments on the manuscript. F.L. is supported by a PhD fellowship of the Boehringer Ingelheim Fonds. Research in the laboratory of A.D. is supported by the Intramural Program of National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health. Research in the laboratory of D.S. is supported by the Novartis Research Foundation, by the European Union (NoE "EpiGeneSys" FP7-HEALTH-2010-257082, LSHG-CT-2006-037415), the European Research Council (ERC-204264) and by the RTD "Cellplasticity" of the Swiss initiative in Systems Biology (SystemsX.ch).	Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Fromm G, 2009, BIOCHEM CELL BIOL, V87, P781, DOI 10.1139/O09-048; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Horvath GC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-63; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	51	274	275	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1091	U78		10.1038/ng.946	http://dx.doi.org/10.1038/ng.946			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21964573				2022-12-25	WOS:000296584000012
J	Pei, LM; Leblanc, M; Barish, G; Atkins, A; Nofsinger, R; Whyte, J; Gold, D; He, MX; Kawamura, K; Li, HR; Downes, M; Yu, RT; Powell, HC; Lingrel, JB; Evans, RM				Pei, Liming; Leblanc, Mathias; Barish, Grant; Atkins, Annette; Nofsinger, Russell; Whyte, Jamie; Gold, David; He, Mingxiao; Kawamura, Kazuko; Li, Hai-Ri; Downes, Michael; Yu, Ruth T.; Powell, Henry C.; Lingrel, Jerry B.; Evans, Ronald M.			Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome	NATURE MEDICINE			English	Article							FETAL LUNG DEVELOPMENT; GENE-EXPRESSION; CO-REPRESSOR; TRANSCRIPTIONAL REGULATION; MASS-SPECTROMETRY; NUCLEAR RECEPTORS; CELL; MATURATION; MICE; MORPHOGENESIS	Although the lung is a defining feature of air-breathing animals, the pathway controlling the formation of type I pneumocytes, the cells that mediate gas exchange, is poorly understood. In contrast, the glucocorticoid receptor and its cognate ligand have long been known to promote type II pneumocyte maturation; prenatal administration of glucocorticoids is commonly used to attenuate the severity of infant respiratory distress syndrome (RDS). Here we show that knock-in mutations of the nuclear co-repressor SMRT (silencing mediator of retinoid and thyroid hormone receptors) in C57BL/6 mice (SMRT(mRID)) produces a previously unidentified respiratory distress syndrome caused by prematurity of the type I pneumocyte. Though unresponsive to glucocorticoids, treatment with anti-thyroid hormone drugs (propylthiouracil or methimazole) completely rescues SMRT-induced RDS, suggesting an unrecognized and essential role for the thyroid hormone receptor (TR) in lung development. We show that TR and SMRT control type I pneumocyte differentiation through Klf2, which, in turn, seems to directly activate the type I pneumocyte gene program. Conversely, mice without lung Klf2 lack mature type I pneumocytes and die shortly after birth, closely recapitulating the SMRTmRID phenotype. These results identify TR as a second nuclear receptor involved in lung development, specifically type I pneumocyte differentiation, and suggest a possible new type of therapeutic option in the treatment of RDS that is unresponsive to glucocorticoids.	[Pei, Liming; Atkins, Annette; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Pei, Liming; Leblanc, Mathias; Barish, Grant; Atkins, Annette; Nofsinger, Russell; Whyte, Jamie; Gold, David; He, Mingxiao; Kawamura, Kazuko; Downes, Michael; Yu, Ruth T.; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Li, Hai-Ri; Powell, Henry C.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Atkins, Annette/0000-0003-2558-7058; Yu, Ruth/0000-0002-9527-9627; Pei, Liming/0000-0002-1924-0333	Francis Family Foundation; Howard Hughes Medical Institute; US National Institutes of Health [2RO1DK057978, 2RO1HL105278, 5U19DK062434, RO1HL57281]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057281, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R37DK057978] Funding Source: NIH RePORTER	Francis Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Juguilon, M. Karunasiri, S. Kaufman and Y. Dayn for technical support, J. Stubbs, C. Kintner, L. Nagy, S.-H. Hong, J. Jonker and J. Fitzpatrick for helpful discussions, M. Montminy of Salk Institute for GFP adenovirus, J. Simon, L. Grabowski and J. Belcovson for artistic work, and E. Ong and S. Ganley for administrative assistance. We appreciate the help and expertise from M. Wood for the electron microscopy study. We thank J. Codey and the Leona M. and Harry B. Helmsley Charitable Trust for their generous support. L. P. is a Parker B. Francis Fellow supported by the Francis Family Foundation. R. M. E. is an investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology. This work was supported by the Howard Hughes Medical Institute and US National Institutes of Health grants 2RO1DK057978, 2RO1HL105278, 5U19DK062434 (R. M. E.) and RO1HL57281 (J.B.L.).	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bizzarro MJ, 2004, OBSTET GYN CLIN N AM, V31, P949, DOI 10.1016/j.ogc.2004.08.001; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Dobbs LG, 2010, CELL PHYSIOL BIOCHEM, V25, P55, DOI 10.1159/000272063; Domyan ET, 2011, DEV DYNAM, V240, P477, DOI 10.1002/dvdy.22504; Evans R, 2004, NAT MED, V10, P1022, DOI 10.1038/nm1004-1022; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Fraichard A, 1997, EMBO J, V16, P4412, DOI 10.1093/emboj/16.14.4412; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; GROSS I, 1990, AM J PHYSIOL, V259, pL337, DOI 10.1152/ajplung.1990.259.6.L337; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; HETZEL BS, 1989, J NUTR, V119, P145, DOI 10.1093/jn/119.2.145; Ho N. K., 1993, Singapore Medical Journal, V34, P74; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jepsen K, 2002, J CELL SCI, V115, P689; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Merrill JD, 1998, CLIN PERINATOL, V25, P983, DOI 10.1016/S0095-5108(18)30093-9; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Purdy Isabell B, 2004, Neonatal Netw, V23, P15; Salto C, 2001, MOL ENDOCRINOL, V15, P2115, DOI 10.1210/me.15.12.2115; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P695, DOI 10.1513/pats.200801-011AW; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Yue BF, 2008, CLIN CHEM, V54, P642, DOI 10.1373/clinchem.2007.098293; Zhang YT, 2005, J AM SOC MASS SPECTR, V16, P1781, DOI 10.1016/j.jasms.2005.06.017; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720	50	51	51	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1466	U172		10.1038/nm.2450	http://dx.doi.org/10.1038/nm.2450			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22001906	Green Accepted			2022-12-25	WOS:000296779300038
J	Cao, J; Schneeberger, K; Ossowski, S; Gunther, T; Bender, S; Fitz, J; Koenig, D; Lanz, C; Stegle, O; Lippert, C; Wang, X; Ott, F; Muller, J; Alonso-Blanco, C; Borgwardt, K; Schmid, KJ; Weigel, D				Cao, Jun; Schneeberger, Korbinian; Ossowski, Stephan; Guenther, Torsten; Bender, Sebastian; Fitz, Joffrey; Koenig, Daniel; Lanz, Christa; Stegle, Oliver; Lippert, Christoph; Wang, Xi; Ott, Felix; Mueller, Jonas; Alonso-Blanco, Carlos; Borgwardt, Karsten; Schmid, Karl J.; Weigel, Detlef			Whole-genome sequencing of multiple Arabidopsis thaliana populations	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; GENETIC-VARIATION; WIDE ASSOCIATION; EVOLUTION; ALIGNMENT; REVEALS; LYRATA; POLYMORPHISMS; RECOMBINATION	The plant Arabidopsis thaliana occurs naturally in many different habitats throughout Eurasia. As a foundation for identifying genetic variation contributing to adaptation to diverse environments, a 1001 Genomes Project to sequence geographically diverse A. thaliana strains has been initiated. Here we present the first phase of this project, based on population-scale sequencing of 80 strains drawn from eight regions throughout the species' native range. We describe the majority of common small-scale polymorphisms as well as many larger insertions and deletions in the A. thaliana pan-genome, their effects on gene function, and the patterns of local and global linkage among these variants. The action of processes other than spontaneous mutation is identified by comparing the spectrum of mutations that have accumulated since A. thaliana diverged from its closest relative 10 million years ago with the spectrum observed in the laboratory. Recent species-wide selective sweeps are rare, and potentially deleterious mutations are more common in marginal populations.	[Cao, Jun; Schneeberger, Korbinian; Ossowski, Stephan; Bender, Sebastian; Fitz, Joffrey; Koenig, Daniel; Lanz, Christa; Stegle, Oliver; Lippert, Christoph; Wang, Xi; Ott, Felix; Mueller, Jonas; Borgwardt, Karsten; Weigel, Detlef] Max Planck Inst Dev Biol, Tubingen, Germany; [Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Ossowski, Stephan] Ctr Genom Regulat, Barcelona, Spain; [Ossowski, Stephan] Univ Pompeu Fabra, Barcelona, Spain; [Guenther, Torsten; Schmid, Karl J.] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Gene, D-7000 Stuttgart, Germany; [Stegle, Oliver; Lippert, Christoph; Borgwardt, Karsten] Max Planck Inst Intelligent Syst, Machine Learning & Computat Biol Res Grp, Tubingen, Germany; [Alonso-Blanco, Carlos] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Max Planck Society; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University Hohenheim; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Schneeberger, Korbinian/U-6329-2019; Cao, Jun/E-5422-2012; Ossowski, Stephan/E-2139-2011; Müller, Jonas/GQA-3371-2022; Stegle, Oliver/AAU-9177-2020; Lippert, Christoph/M-2992-2016; Alonso-Blanco, Carlos/F-8864-2016; Weigel, Detlef/AAR-3312-2021; Günther, Torsten/I-3355-2019	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Schneeberger, Korbinian/0000-0002-5512-0443; Ossowski, Stephan/0000-0002-7416-9568; Stegle, Oliver/0000-0002-8818-7193; Lippert, Christoph/0000-0001-6363-2556; Alonso-Blanco, Carlos/0000-0002-4738-5556; Günther, Torsten/0000-0001-9460-390X; Koenig, Daniel/0000-0002-1037-5346; Borgwardt, Karsten/0000-0001-7221-2393	German Federal Ministry of Education and Research (BMBF)-Bioenergy Initiative (BioOl) [0315429C]; Volkswagen Foundation [I/84 225]; BMBF; German Research Foundation (DFG); Max Planck Society	German Federal Ministry of Education and Research (BMBF)-Bioenergy Initiative (BioOl)(Federal Ministry of Education & Research (BMBF)); Volkswagen Foundation(Volkswagen); BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank M. Koch for discussion of Arabidopsis phylogeography; P. Salome for F<INF>2</INF> recombination data; E. Chae, T. Hu, M. Nordborg and P. Salome for improving the manuscript with their comments; and P. Calabrese, T. Hu and M. Nordborg for communicating their observations regarding the potential effects of biased gene conversion. This work has been supported by grants from the German Federal Ministry of Education and Research (BMBF)-Bioenergy 2021 Initiative (BioOl, 0315429C; K.J.S.), the Volkswagen Foundation (I/84 225; T. G.), ERA-PG grant ARABRAS and GABI-FUTURE grant GABI-GNADE from the BMBF (D. W.), a Gottfried Wilhelm Leibniz Award of the German Research Foundation (DFG) (D. W.) and the Max Planck Society (K.B., D.W.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Fay JC, 2000, GENETICS, V155, P1405; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Friedman N, 2002, J COMPUT BIOL, V9, P331, DOI 10.1089/10665270252935494; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; GAN X, 2011, NATURE IN PRESS; Gossmann TI, 2010, MOL BIOL EVOL, V27, P1822, DOI 10.1093/molbev/msq079; Gunther T, 2010, THEOR APPL GENET, V121, P157, DOI 10.1007/s00122-010-1299-4; Gunther Torsten, 2011, BMC Res Notes, V4, P232, DOI 10.1186/1756-0500-4-232; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ionita-Laza I, 2009, P NATL ACAD SCI USA, V106, P5008, DOI 10.1073/pnas.0807815106; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le Corre V, 2002, MOL BIOL EVOL, V19, P1261, DOI 10.1093/oxfordjournals.molbev.a004187; Lee S, 2008, BIOINFORMATICS, V24, pI59, DOI 10.1093/bioinformatics/btn176; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lynch M, 2007, ORIGINS GENOME ARCHI; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Vlad D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000945; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	75	667	685	2	235	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					956	U60		10.1038/ng.911	http://dx.doi.org/10.1038/ng.911			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21874002	Bronze			2022-12-25	WOS:000295316200009
J	Dorard, C; de Thonel, A; Collura, A; Marisa, L; Svrcek, M; Lagrange, A; Jego, G; Wanherdrick, K; Joly, AL; Buhard, O; Gobbo, J; Penard-Lacronique, V; Zouali, H; Tubacher, E; Kirzin, S; Selves, J; Milano, G; Etienne-Grimaldi, MC; Bengrine-Lefevre, L; Louvet, C; Tournigand, C; Lefevre, JH; Parc, Y; Tiret, E; Flejou, JF; Gaub, MP; Garrido, C; Duval, A				Dorard, Coralie; de Thonel, Aurelie; Collura, Ada; Marisa, Laetitia; Svrcek, Magali; Lagrange, Anais; Jego, Gaetan; Wanherdrick, Kristell; Joly, Anne Laure; Buhard, Olivier; Gobbo, Jessica; Penard-Lacronique, Virginie; Zouali, Habib; Tubacher, Emmanuel; Kirzin, Sylvain; Selves, Janick; Milano, Gerard; Etienne-Grimaldi, Marie-Christine; Bengrine-Lefevre, Leila; Louvet, Christophe; Tournigand, Christophe; Lefevre, Jeremie H.; Parc, Yann; Tiret, Emmanuel; Flejou, Jean-Francois; Gaub, Marie-Pierre; Garrido, Carmen; Duval, Alex			Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis	NATURE MEDICINE			English	Article							MICROSATELLITE INSTABILITY; MONONUCLEOTIDE REPEATS; INDUCED APOPTOSIS; MISMATCH REPAIR; TARGET GENES; MUTATIONS; HEAT-SHOCK-PROTEIN-105; MECHANISM; SEQUENCES; PATHWAY	Heat shock proteins (HSPs) are necessary for cancer cell survival. We identified a mutant of HSP110 (HSP110 Delta E9) in colorectal cancer showing microsatellite instability (MSI CRC), generated from an aberrantly spliced mRNA and lacking the HSP110 substrate-binding domain. This mutant was expressed at variable levels in almost all MSI CRC cell lines and primary tumors tested. HSP11 Delta DE9 impaired both the normal cellular localization of HSP110 and its interaction with other HSPs, thus abrogating the chaperone activity and antiapoptotic function of HSP110 in a dominant-negative manner. HSP110 Delta E9 overexpression caused the sensitization of cells to anticancer agents such as oxaliplatin and 5-fluorouracil, which are routinely prescribed in the adjuvant treatment of people with CRC. The survival and response to chemotherapy of subjects with MSI CRCs was associated with the tumor expression level of HSP110 Delta E9. HSP110 may thus constitute a major determinant for both prognosis and treatment response in CRC.	[Dorard, Coralie; Collura, Ada; Svrcek, Magali; Lagrange, Anais; Wanherdrick, Kristell; Buhard, Olivier; Flejou, Jean-Francois; Duval, Alex] INSERM, Ctr Rech St Antoine, Equipe Instabilite Microsatellites & Canc, Paris, France; [Dorard, Coralie; Collura, Ada; Svrcek, Magali; Lagrange, Anais; Wanherdrick, Kristell; Buhard, Olivier; Lefevre, Jeremie H.; Parc, Yann; Tiret, Emmanuel; Flejou, Jean-Francois; Duval, Alex] Univ Paris 06, Paris, France; [de Thonel, Aurelie; Jego, Gaetan; Joly, Anne Laure; Gobbo, Jessica; Garrido, Carmen] INSERM, Dijon, France; [de Thonel, Aurelie; Jego, Gaetan; Joly, Anne Laure; Gobbo, Jessica; Garrido, Carmen] Univ Burgundy, Dijon, France; [Marisa, Laetitia] Programme Cartes Identite Tumeurs, Paris, France; [Svrcek, Magali] Hop St Antoine, AP HP, Serv Anat & Cytol Pathol, F-75571 Paris, France; [Penard-Lacronique, Virginie] Inst Gustave Roussy, INSERM, F-94805 Villejuif, France; [Zouali, Habib; Tubacher, Emmanuel] Inst Genet Mol, Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, Paris, France; [Kirzin, Sylvain; Selves, Janick] Ctr Physiopathol Toulouse Purpan, INSERM, Toulouse, France; [Milano, Gerard; Etienne-Grimaldi, Marie-Christine] Ctr Antoine Lacassagne, Lab Oncopharmacol, F-06054 Nice, France; [Bengrine-Lefevre, Leila; Louvet, Christophe; Tournigand, Christophe] Hop St Antoine, AP HP, Med Oncol Serv, F-75571 Paris, France; [Lefevre, Jeremie H.; Parc, Yann; Tiret, Emmanuel] Hop St Antoine, AP HP, Serv Chirurg Gen & Digest, F-75571 Paris, France; [Flejou, Jean-Francois] Hop St Antoine, AP HP, Tumorotheque Canc Est, F-75571 Paris, France; [Gaub, Marie-Pierre] INSERM, Strasbourg, France; [Garrido, Carmen] Ctr Hosp Univ Dijon, Dijon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Foundation Jean Dausset-CEPH; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Antoine Lacassagne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Dijon Bourgogne	Duval, A (corresponding author), INSERM, Ctr Rech St Antoine, Equipe Instabilite Microsatellites & Canc, Paris, France.	cgarrido@u-bourgogne.fr; alex.duval@inserm.fr	Garrido, carmen/G-1633-2018; Coralie, Dorard/A-8325-2012; Selves, Janick/M-7719-2014; Tournigand, Christophe/Q-2831-2018; Penard-Lacronique, Virginie/R-1938-2019; Penard-Lacronique, Virginie/E-5729-2016; jego, gaetan/N-7226-2018; Lefevre, Jeremie/I-6952-2019; Garrido, Carolina/GWM-5557-2022	Garrido, carmen/0000-0003-1368-1493; Penard-Lacronique, Virginie/0000-0001-9435-7331; Penard-Lacronique, Virginie/0000-0001-9435-7331; jego, gaetan/0000-0003-0376-9299; Lefevre, Jeremie/0000-0001-7601-7464; Collura, Ada/0000-0003-0496-1768; Milano, Gerard/0000-0003-2478-0040; de Thonel, Aurelie/0000-0003-0405-0745	Ligue Nationale Contre le Cancer; Fondation de France [RAF08005DDA]; Institut National du Cancer (INCa); Conseil Regional de Bourgogne; European Commission [SPEDOC 248835]	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Carte d'Identite des Tumeurs (CIT) program (http://cit.ligue-cancer.net/) from the Ligue Nationale Contre le Cancer and by grants from the Fondation de France (Ref. RAF08005DDA to A. D.), the Institut National du Cancer (INCa) (to A.D. and C.G.), the Conseil Regional de Bourgogne (to C.G.) and the European Commission Seventh Framework Programme (SPEDOC 248835 to C.G.). C.G.'s group is known as 'La Ligue Contre le Cancer'. A.C. is a recipient of an INCa fellowship. We thank B. Iacopetta for critical reading of the manuscript. We thank E. Roux, A. Hamman, E. Fourmaux and E. Bergman for their technical assistance.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Ceballos E, 2005, ONCOGENE, V24, P4559, DOI 10.1038/sj.onc.1208652; Duval A, 2004, P NATL ACAD SCI USA, V101, P5002, DOI 10.1073/pnas.0400945101; Duval A, 2002, CANCER RES, V62, P2447; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Gotoh K, 2004, FEBS LETT, V560, P19, DOI 10.1016/S0014-5793(04)00034-1; Grady WM, 1998, CANCER RES, V58, P3101; Hosaka S, 2006, CANCER SCI, V97, P623, DOI 10.1111/j.1349-7006.2006.00217.x; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kai M, 2003, ONCOL REP, V10, P1777; Manjili MH, 2003, J IMMUNOL, V171, P4054, DOI 10.4049/jimmunol.171.8.4054; Manjili MH, 2002, CANCER RES, V62, P1737; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siatskas C, 2005, FASEB J, V19, P1752, DOI 10.1096/fj.05-4006fje; Slaby O, 2009, ONCOL REP, V21, P1235, DOI 10.3892/or_00000346; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Wang XY, 2003, CANCER RES, V63, P2553; Yamagishi N, 2008, FEBS J, V275, P4558, DOI 10.1111/j.1742-4658.2008.06598.x; Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007; Zaanan A, 2010, ANN ONCOL, V21, P772, DOI 10.1093/annonc/mdp383	27	110	113	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1283	U316		10.1038/nm.2457	http://dx.doi.org/10.1038/nm.2457			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946539				2022-12-25	WOS:000296022100047
J	Loveday, C; Turnbull, C; Ramsay, E; Hughes, D; Ruark, E; Frankum, JR; Bowden, G; Kalmyrzaev, B; Warren-Perry, M; Snape, K; Adlard, JW; Barwell, J; Berg, J; Brady, AF; Brewer, C; Brice, G; Chapman, C; Cook, J; Davidson, R; Donaldson, A; Douglas, F; Greenhalgh, L; Henderson, A; Izatt, L; Kumar, A; Lalloo, F; Miedzybrodzka, Z; Morrison, PJ; Paterson, J; Porteous, M; Rogers, MT; Shanley, S; Walker, L; Eccles, D; Evans, DG; Renwick, A; Seal, S; Lord, CJ; Ashworth, A; Reis-Filho, JS; Antoniou, AC; Rahman, N				Loveday, Chey; Turnbull, Clare; Ramsay, Emma; Hughes, Deborah; Ruark, Elise; Frankum, Jessica R.; Bowden, Georgina; Kalmyrzaev, Bolot; Warren-Perry, Margaret; Snape, Katie; Adlard, Julian W.; Barwell, Julian; Berg, Jonathan; Brady, Angela F.; Brewer, Carole; Brice, Glen; Chapman, Cyril; Cook, Jackie; Davidson, Rosemarie; Donaldson, Alan; Douglas, Fiona; Greenhalgh, Lynn; Henderson, Alex; Izatt, Louise; Kumar, Ajith; Lalloo, Fiona; Miedzybrodzka, Zosia; Morrison, Patrick J.; Paterson, Joan; Porteous, Mary; Rogers, Mark T.; Shanley, Susan; Walker, Lisa; Eccles, Diana; Evans, D. Gareth; Renwick, Anthony; Seal, Sheila; Lord, Christopher J.; Ashworth, Alan; Reis-Filho, Jorge S.; Antoniou, Antonis C.; Rahman, Nazneen		Breast Canc Susceptibility	Germline mutations in RAD51D confer susceptibility to ovarian cancer	NATURE GENETICS			English	Article							BREAST-CANCER; FANCONI-ANEMIA; BRCA2 MUTATIONS; HOMOLOGOUS RECOMBINATION; FAMILIAL OVARIAN; SPLICING SIGNALS; GENE; DNA; PREDICTION; SEQUENCE	Recently, RAD51C mutations were identified in families with breast and ovarian cancer(1). This observation prompted us to investigate the role of RAD51D in cancer susceptibility. We identified eight inactivating RAD51D mutations in unrelated individuals from 911 breast-ovarian cancer families compared with one inactivating mutation identified in 1,060 controls (P = 0.01). The association found here was principally with ovarian cancer, with three mutations identified in the 59 pedigrees with three or more individuals with ovarian cancer (P = 0.0005). The relative risk of ovarian cancer for RAD51D mutation carriers was estimated to be 6.30 (95% CI 2.86-13.85, P = 4.8 x 10(-6)). By contrast, we estimated the relative risk of breast cancer to be 1.32 (95% CI 0.59-2.96, P = 0.50). These data indicate that RAD51D mutation testing may have clinical utility in individuals with ovarian cancer and their families. Moreover, we show that cells deficient in RAD51D are sensitive to treatment with a PARP inhibitor, suggesting a possible therapeutic approach for cancers arising in RAD51D mutation carriers.	[Loveday, Chey; Turnbull, Clare; Ramsay, Emma; Hughes, Deborah; Ruark, Elise; Bowden, Georgina; Kalmyrzaev, Bolot; Warren-Perry, Margaret; Snape, Katie; Renwick, Anthony; Seal, Sheila; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Frankum, Jessica R.; Lord, Christopher J.; Ashworth, Alan; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Adlard, Julian W.] Cookridge Hosp, Yorkshire Reg Ctr Canc Treatment, Leeds LS16 6QB, W Yorkshire, England; [Barwell, Julian] Univ Hosp Leicester Natl Hlth Serv NHS Trust, Leicestershire Genet Ctr, Leicester, Leics, England; [Berg, Jonathan] Univ Dundee, Div Med Sci, Dundee, Scotland; [Brady, Angela F.] Kennedy Galton Ctr, NW Thames Reg Genet Serv, London, England; [Brewer, Carole] Royal Devon & Exeter Hosp, Peninsula Reg Genet Serv, Exeter EX2 5DW, Devon, England; [Brice, Glen] St George Hosp, SW Thames Reg Genet Serv, London, England; [Chapman, Cyril] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Cook, Jackie] Sheffield Childrens NHS Fdn Trust, Sheffield Reg Genet Serv, Sheffield, S Yorkshire, England; [Davidson, Rosemarie] FergusonSmith Ctr Clin Genet, W Scotland Reg Genet Serv, Glasgow, Lanark, Scotland; [Donaldson, Alan] Univ Hosp Bristol NHS Fdn Trust, S Western Reg Genet Serv, Bristol, Avon, England; [Douglas, Fiona] Newcastle Upon Tyne Hosp NHS Fdn Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Greenhalgh, Lynn] Alder Hey Childrens NHS Fdn Trust, Cheshire & Merseyside Clin Genet Serv, Liverpool, Merseyside, England; [Henderson, Alex] Newcastle Upon Tyne Hosp NHS Trust, No Genet Serv Cumbria, Newcastle Upon Tyne, Tyne & Wear, England; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, SE Thames Reg Genet Serv, London, England; [Kumar, Ajith] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London, England; [Lalloo, Fiona; Evans, D. Gareth] St Marys Hosp, Univ Dept Med Genet, Manchester M13 0JH, Lancs, England; [Lalloo, Fiona; Evans, D. Gareth] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; [Miedzybrodzka, Zosia] Univ Aberdeen, Aberdeen, Scotland; [Miedzybrodzka, Zosia] Aberdeen Royal Infirm, N Scotland Clin Genet Serv, Aberdeen, Scotland; [Morrison, Patrick J.] Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland; [Morrison, Patrick J.] Belfast Hlth & Social Care HSC Trust, No Ireland Reg Genet Serv, Belfast, Antrim, North Ireland; [Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, E Anglian Reg Genet Serv, Cambridge, England; [Porteous, Mary] Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Rogers, Mark T.] Univ Wales Hosp, All Wales Med Genet Serv, Cardiff CF4 4XW, S Glam, Wales; [Shanley, Susan] Royal Marsden NHS Fdn Trust, London, England; [Walker, Lisa] Oxford Radcliffe Hosp NHS Trust, Oxford Reg Genet Serv, Oxford, England; [Eccles, Diana] Univ Southampton, Fac Med, Southampton Univ Hosp NHS Trust, Southampton SO9 5NH, Hants, England; [Antoniou, Antonis C.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cookridge Hospital; University Hospitals of Leicester NHS Trust; University of Dundee; University of Exeter; St Georges University London; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; University of Bristol; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Manchester; University of Aberdeen; University of Aberdeen; Queens University Belfast; University of Cambridge; University of Edinburgh; Cardiff University; Royal Marsden NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Cambridge	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	nazneen.rahman@icr.ac.uk	Evans, D Gareth/AAB-4308-2022; Rahman, Nazneen/B-8890-2012; Lord, Christopher/AAX-7130-2021; Eccles, Diana/K-6327-2019; Turnbull, Clare/AAA-6596-2019; Snape, Katie/AAA-8101-2022; Lord, Christopher J/B-3295-2012; Lucassen, Anneke/D-7764-2017; Rahman, Nazneen/D-2802-2013	Evans, D Gareth/0000-0002-8482-5784; Eccles, Diana/0000-0002-9935-3169; Lord, Christopher J/0000-0002-3226-0515; Eeles, Rosalind/0000-0002-3698-6241; Jacobs, Chris/0000-0002-9557-9080; Adlard, Julian/0000-0002-1693-0435; Lucassen, Anneke/0000-0003-3324-4338; Turnbull, Clare/0000-0002-1734-5772; Rahman, Nazneen/0000-0003-4376-0440; Campbell, James/0000-0001-6756-8766; Kalmyrzaev, Bolot/0000-0001-5207-9492	Cancer Research UK [C8620/A8372, C8620/A8857, C12292/A11174]; US Military Acquisition (ACQ) Activity; Era of Hope Award [W81XWH-05-1-0204]; Breakthrough Breast Cancer; Institute of Cancer Research (UK); NHS; Medical Research Council (MRC) [G0000934]; Wellcome Trust [068545/Z/02]; Cancer Research UK [11174] Funding Source: researchfish; Medical Research Council [G0000934, G0700491] Funding Source: researchfish; MRC [G0700491, G0000934] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); US Military Acquisition (ACQ) Activity; Era of Hope Award; Breakthrough Breast Cancer; Institute of Cancer Research (UK)(Cancer Research UK); NHS; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the subjects and families that participated in the research. We thank A. Hall, D. Dudakia, J. Bull, R. Linger and A. Zachariou for their assistance in recruitment, B. Ebbs for assistance in DNA extraction and running the ABI sequencers, L. Thompson for the provision of cell lines and A. Strydom for assistance in preparing the manuscript. We are very grateful to all the clinicians and counselors in the Breast Cancer Susceptibility Collaboration UK (BCSC) that have contributed to the recruitment and collection of the Familial Breast Cancer Study (FBCS) samples. The full list of BCSC contributors is provided in the Supplementary Note. This work was funded by Cancer Research UK (C8620/A8372 and C8620/A8857), US Military Acquisition (ACQ) Activity, Era of Hope Award (W81XWH-05-1-0204), Breakthrough Breast Cancer and the Institute of Cancer Research (UK). We acknowledge NHS funding to the Royal Marsden/Institute of Cancer Research National Institute for Health Research NIHR) Specialist Cancer Biomedical Research Centre. C. T. is a Medical Research Council (MRC)-funded Clinical Research Fellow. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow (C12292/A11174). We acknowledge the use of DNA from the British 1958 Birth Cohort collection funded by the MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; EASTON DF, 1993, AM J HUM GENET, V52, P678; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; International Organization for Accreditation Bodies ILAC, 2002, IBS REAL WORLD SURV, P1; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	35	354	368	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					879	U90		10.1038/ng.893	http://dx.doi.org/10.1038/ng.893			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822267	Green Accepted			2022-12-25	WOS:000294325800015
J	Ho, L; Miller, EL; Ronan, JL; Ho, WQ; Jothi, R; Crabtree, GR				Ho, Lena; Miller, Erik L.; Ronan, Jehnna L.; Ho, Wen Qi; Jothi, Raja; Crabtree, Gerald R.			esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function	NATURE CELL BIOLOGY			English	Article							CHROMATIN REMODELING COMPLEX; SELF-RENEWAL; TRANSCRIPTIONAL ACTIVATOR; DEVELOPMENTAL REGULATORS; STAT3 ACTIVATION; STEM-CELLS; GENES; REPRESSION; BINDING; BRG1	Signalling by the cytokine LIF and its downstream transcription factor, STAT3, prevents differentiation of pluripotent embryonic stem cells (ESCs). This contrasts with most cell types where STAT3 signalling induces differentiation. We find that STAT3 binding across the pluripotent genome is dependent on Brg1, the ATPase subunit of a specialized chromatin remodelling complex (esBAF) found in ESCs. Brg1 is required to establish chromatin accessibility at STAT3 binding targets, preparing these sites to respond to LIF signalling. Brg1 deletion leads to rapid polycomb (PcG) binding and H3K27me3-mediated silencing of many Brg1-activated targets genome wide, including the target genes of the LIF signalling pathway. Hence, one crucial role of Brg1 in ESCs involves its ability to potentiate LIF signalling by opposing PcG. Contrary to expectations, Brg1 also facilitates PcG function at classical PcG targets, including all four Hox loci, reinforcing their repression in ESCs. Therefore, esBAF does not simply antagonize PcG. Rather, the two chromatin regulators act both antagonistically and synergistically with the common goal of supporting pluripotency.	[Jothi, Raja] Natl Inst Environm Hlth Sci, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Ho, Lena; Ho, Wen Qi] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Miller, Erik L.] Stanford Univ, Genet Program, Sch Med, Stanford, CA 94305 USA; [Ronan, Jehnna L.] Stanford Univ, Program Canc Biol, Sch Med, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Jothi, R (corresponding author), Natl Inst Environm Hlth Sci, Biostat Branch, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	jothi@mail.nih.gov; crabtree@stanford.edu	Jothi, Raja/G-3780-2015	Ho, Lena/0000-0002-9358-621X; Jothi, Raja/0000-0002-4833-1090	HHMI; NIH [R01NS46789, R01AI60037, R01HD55391]; NIH, National Institute of Environmental Health Sciences [1ZIAES102625-02]; A*STAR (Singapore); National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); A*STAR (Singapore)(Agency for Science Technology & Research (A*STAR)); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Bejerano, A. Wenger, D. Bristor and C. McLean for their computational expertise and assistance, NIEHS (NIH) core facility for their advice and expertise in carrying out ChIP-seq, and P. Wade and G. Hu for providing useful comments. We thank J. Wu and L. Chen for assistance in the derivation of Brg1<SUP>cond</SUP> ESCs. This work was financially supported by grants from the HHMI and NIH grants R01NS46789, R01AI60037 and R01HD55391 to G.R.C., and the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (1ZIAES102625-02) to R.J. L.H. and W.Q.H. are financially supported by A*STAR (Singapore); E.L.M. and J.L.R. are financially supported by the National Science Foundation.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; SHAO Z, 2009, CELL, V98, P37; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	48	183	183	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					903	U334		10.1038/ncb2285	http://dx.doi.org/10.1038/ncb2285			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21785422	Green Accepted			2022-12-25	WOS:000293373700008
J	Geller, GB				Geller, George Barth			Lung stem cells: looking beyond the hype	NATURE MEDICINE			English	Editorial Material							OCT4 EXPRESSION	The human lung is known to contain regional pools of progenitor cells that can give rise to specific lung structures, but a multipotent stem cell that can give rise to both endodermal and mesodermal lineages has not been described before and was thought to not exist. Jan Kajstura et al.(1) now provide evidence that might overturn this long-held belief. The investigators identified a set of potential stem cells in human lungs that were self renewing, clonogenic and multipotent in vitro and that could regenerate many different lung components-including bronchioles, alveoli, smooth muscle and pulmonary vessels-when injected into a mouse model of lung injury. We asked three experts to discuss the relevance of these findings to understanding of lung development and the implications for regenerative medicine to treat lung disease.	[Geller, George Barth] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Geller, George Barth] Duke Univ, Med Ctr, Dept Pediat, Durham, NC USA; [Geller, George Barth] Duke Univ, Med Ctr, Dept Stem Cell, Durham, NC USA; [Geller, George Barth] Duke Univ, Med Ctr, Regenerat Med Program, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Geller, GB (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.							Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Krause Diane S, 2008, Proc Am Thorac Soc, V5, P323, DOI 10.1513/pats.200712-169DR; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sueblinvong V, 2009, CURR OPIN PHARMACOL, V9, P268, DOI 10.1016/j.coph.2009.03.002	8	24	24	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					788	+						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738157				2022-12-25	WOS:000292500800027
J	Yang, HN; Wang, JR; Didion, JP; Buus, RJ; Bell, TA; Welsh, CE; Bonhomme, F; Yu, AHT; Nachman, MW; Pialek, J; Tucker, P; Boursot, P; McMillan, L; Churchill, GA; de Villena, FPM				Yang, Hyuna; Wang, Jeremy R.; Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; Welsh, Catherine E.; Bonhomme, Francois; Yu, Alex Hon-Tsen; Nachman, Michael W.; Pialek, Jaroslav; Tucker, Priscilla; Boursot, Pierre; McMillan, Leonard; Churchill, Gary A.; de Villena, Fernando Pardo-Manuel			Subspecific origin and haplotype diversity in the laboratory mouse	NATURE GENETICS			English	Article							INBRED STRAINS; HOUSE MICE; RESOURCE; GENOME; GENES; SNPS	Here we provide a genome-wide, high-resolution map of the phylogenetic origin of the genome of most extant laboratory mouse inbred strains. Our analysis is based on the genotypes of wild-caught mice from three subspecies of Mus musculus. We show that classical laboratory strains are derived from a few fancy mice with limited haplotype diversity. Their genomes are overwhelmingly Mus musculus domesticus in origin, and the remainder is mostly of Japanese origin. We generated genome-wide haplotype maps based on identity by descent from fancy mice and show that classical inbred strains have limited and non-randomly distributed genetic diversity. In contrast, wild-derived laboratory strains represent a broad sampling of diversity within M. musculus. Intersubspecific introgression is pervasive in these strains, and contamination by laboratory stocks has played a role in this process. The subspecific origin, haplotype diversity and identity by descent maps can be visualized using the Mouse Phylogeny Viewer (see URLs).	[Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Yang, Hyuna; Churchill, Gary A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wang, Jeremy R.; Welsh, Catherine E.; McMillan, Leonard] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Bonhomme, Francois; Boursot, Pierre] Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR5554, Montpellier, France; [Yu, Alex Hon-Tsen] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Yu, Alex Hon-Tsen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Nachman, Michael W.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Pialek, Jaroslav] Acad Sci Czech Republic, Dept Populat Biol, Inst Vertebrate Biol, Brno, Czech Republic; [Pialek, Jaroslav] Acad Sci Czech Republic, Dept Populat Biol, Inst Vertebrate Biol, Studenec, Czech Republic; [Tucker, Priscilla] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; University of Arizona; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Czech Academy of Sciences; University of Michigan System; University of Michigan	de Villena, FPM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	garyc@jax.org; fernando@med.unc.edu	Bonhomme, Francois/C-6290-2012; Boursot, Pierre/D-5860-2011; Bonhomme, Francois/AAG-6558-2021; Pialek, Jaroslav/B-1237-2008; Wang, Jeremy/L-7971-2019; Churchill, Gary/AAY-7496-2020; Piálek, Jaroslav/AAP-8636-2020	Bonhomme, Francois/0000-0002-8792-9239; Boursot, Pierre/0000-0001-6366-2341; Bonhomme, Francois/0000-0002-8792-9239; Wang, Jeremy/0000-0002-0673-9418; Churchill, Gary/0000-0001-9190-9284; Mott, Richard/0000-0002-1022-9330; Didion, John/0000-0002-8111-6261; Pialek, Jaroslav/0000-0002-0829-7481	National Institute of General Medical Sciences (NIGMS) [GM-076468]; US National Institutes of Health (NIH) [R01 GM74245]; Czech Science Foundation [206-08-0640]; NIH [GM067553-04, P50 MH090338]; University of North Carolina (UNC);  [ISEM 2010-141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553, R01GM074245, P50GM076468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090338] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Science Foundation(Grant Agency of the Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of General Medical Sciences (NIGMS) Centers of Excellence in Systems Biology program, grant GM-076468, by a US National Institutes of Health (NIH) grant to M.W.N. (R01 GM74245), by a grant to F.B. (ISEM 2010-141) and by a Czech Science Foundation grant to J.P. (206-08-0640). J.P.D. was partially supported by NIH Training Grant Number GM067553-04, University of North Carolina (UNC) Bioinformatics and Computational Biology Training Grant. J.P.D., R.J.B. and T.A.B. are partially supported by an NIH grant to F.P.-M.d.V. (P50 MH090338). We also thank F. Oyola for help annotating the samples genotyped in this study.	Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Boursot P, 2006, GENOME RES, V16, P1191, DOI 10.1101/gr.5541806; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; NAGAMINE CM, 1992, MAMM GENOME, V3, P84, DOI 10.1007/BF00431251; Sudbery I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r112; Szatkiewicz JP, 2008, MAMM GENOME, V19, P199, DOI 10.1007/s00335-008-9098-9; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; Wang J., 2010, P ACM INT C BIOINF C; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yonekawa Hiromichi, 1994, P25	22	315	315	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2011	43	7					648	U173		10.1038/ng.847	http://dx.doi.org/10.1038/ng.847			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21623374	Green Submitted, Green Accepted			2022-12-25	WOS:000292184600008
J	Engelen, E; Akinci, U; Bryne, JC; Hou, J; Gontan, C; Moen, M; Szumska, D; Kockx, C; van IJcken, W; Dekkers, DHW; Demmers, J; Rijkers, EJ; Bhattacharya, S; Philipsen, S; Pevny, LH; Grosveld, FG; Rottier, RJ; Lenhard, B; Poot, RA				Engelen, Erik; Akinci, Umut; Bryne, Jan Christian; Hou, Jun; Gontan, Cristina; Moen, Maaike; Szumska, Dorota; Kockx, Christel; van IJcken, Wilfred; Dekkers, Dick H. W.; Demmers, Jeroen; Rijkers, Erik-Jan; Bhattacharya, Shoumo; Philipsen, Sjaak; Pevny, Larysa H.; Grosveld, Frank G.; Rottier, Robbert J.; Lenhard, Boris; Poot, Raymond A.			Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes	NATURE GENETICS			English	Article							INNER-EAR; CHARGE-SYNDROME; SELF-RENEWAL; STEM-CELLS; CAUSE ANOPHTHALMIA; MUTATIONS; JAGGED1; DIFFERENTIATION; IDENTIFICATION; PATTERNS	The HMG-box transcription factor Sox2 plays a role throughout neurogenesis(1) and also acts at other stages of development(2), as illustrated by the multiple organs affected in the anophthalmia syndrome caused by SOX2 mutations(3-5). Here we combined proteomic and genomic approaches to characterize gene regulation by Sox2 in neural stem cells. Chd7, a chromatin remodeling ATPase associated with CHARGE syndrome(6,7), was identified as a Sox2 transcriptional cofactor. Sox2 and Chd7 physically interact, have overlapping genome-wide binding sites and regulate a set of common target genes including Jag1, Gli3 and Mycn, genes mutated in Alagille, Pallister-Hall and Feingold syndromes, which show malformations also associated with SOX2 anophthalmia syndrome or CHARGE syndrome(8-10). Regulation of disease-associated genes by a Sox2-Chd7 complex provides a plausible explanation for several malformations associated with SOX2 anophthalmia syndrome or CHARGE syndrome. Indeed, we found that Chd7-haploinsufficient embryos showed severely reduced expression of Jag1 in the developing inner ear.	[Engelen, Erik; Akinci, Umut; Hou, Jun; Moen, Maaike; Philipsen, Sjaak; Grosveld, Frank G.; Poot, Raymond A.] Erasmus Med Ctr MC, Dept Cell Biol, Rotterdam, Netherlands; [Bryne, Jan Christian; Lenhard, Boris] Univ Bergen, Dept Biol, Bergen, Norway; [Gontan, Cristina; Rottier, Robbert J.] Erasmus MC, Dept Pediat Surg, Rotterdam, Netherlands; [Szumska, Dorota; Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kockx, Christel; van IJcken, Wilfred] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Dekkers, Dick H. W.; Demmers, Jeroen] Erasmus MC, Prote Ctr, Rotterdam, Netherlands; [Rijkers, Erik-Jan] Erasmus MC, Dept Biochem, Rotterdam, Netherlands; [Pevny, Larysa H.] Univ N Carolina, Ctr Neurosci, Dept Genet, Chapel Hill, NC USA	Erasmus University Rotterdam; Erasmus MC; University of Bergen; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of North Carolina; University of North Carolina Chapel Hill	Poot, RA (corresponding author), Erasmus Med Ctr MC, Dept Cell Biol, Rotterdam, Netherlands.	r.poot@erasmusmc.nl	Bhattacharya, Shoumo/F-4127-2010; van ijcken, willem/N-9805-2018; Demmers, Jeroen AA/F-4046-2016; Hou, Jun/AGJ-0692-2022	Bhattacharya, Shoumo/0000-0002-5571-0478; van ijcken, willem/0000-0002-0421-8301; Demmers, Jeroen AA/0000-0002-8757-9611; Rottier, Robbert/0000-0002-9291-4971; Gontan, Cristina/0000-0002-3918-0024; Szumska, Dorota/0000-0001-7764-9551; Kockx, Christel/0000-0002-8871-3659; Lenhard, Boris/0000-0002-1114-1509	Netherlands Organisation for Scientific Research (NWO); EuTRACC; Norwegian Research Council (YFF); Bergen Research Foundation; Sophia Foundation for Medical Research; British Heart Foundation [CH/09/003, PG/08/045/25069]; British Heart Foundation [PG/07/045/22690, RG/10/17/28553] Funding Source: researchfish	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EuTRACC; Norwegian Research Council (YFF)(Research Council of Norway); Bergen Research Foundation; Sophia Foundation for Medical Research; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	We thank G. Abelo for advice on the otocyst stainings, A. Smith for 46C ES cells, S. Pollard for advice on deriving neural stem cells, Z. Ozgur for micro-array hybridizations, M. van den Hout-van Vroonhoven for Illumina GAP analyses and P. Wade for Mi2-beta antibody. R. A. P., E. E. and U. A. were supported by a Vidi grant, ALW-open program grant and a Chemical Sciences ECHO grant, respectively, all from the Netherlands Organisation for Scientific Research (NWO). J.C.B. was supported by EuTRACC, B. L. was supported by grants from the Norwegian Research Council (YFF) and the Bergen Research Foundation. C. G. and R.J.R. were supported in part by the Sophia Foundation for Medical Research. S. B. was supported by a British Heart Foundation Chair Award (CH/09/003) and Project Grant award (PG/08/045/25069).	Alavizadeh A, 2001, DEV BIOL, V234, P244, DOI 10.1006/dbio.2001.0241; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Hu QK, 2010, STEM CELLS, V28, P279, DOI 10.1002/stem.246; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2002, MAMM GENOME, V13, P142, DOI 10.1007/s0033501-2088-9; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; OKUNO T, 1990, ARCH OTOLARYNGOL, V116, P217; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shaw-Smith C, 2006, J MED GENET, V43, P545, DOI 10.1136/jmg.2005.038158; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323	41	179	182	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					607	U153		10.1038/ng.825	http://dx.doi.org/10.1038/ng.825			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532573				2022-12-25	WOS:000291017000022
J	Tkachenko, E; Sabouri-Ghomi, M; Pertz, O; Kim, C; Gutierrez, E; Machacek, M; Groisman, A; Danuser, G; Ginsberg, MH				Tkachenko, Eugene; Sabouri-Ghomi, Mohsen; Pertz, Olivier; Kim, Chungho; Gutierrez, Edgar; Machacek, Matthias; Groisman, Alex; Danuser, Gaudenz; Ginsberg, Mark H.			Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cells	NATURE CELL BIOLOGY			English	Article							CYCLIC-AMP; ALPHA-6-BETA-4 INTEGRIN; REGULATORY PROTEIN; LAMELLAE FORMATION; LEADING-EDGE; AKAP-LBC; ACTIVATION; PHOSPHORYLATION; DYNAMICS; GTPASE	The cyclical protrusion and retraction of the leading edge is a hallmark of many migrating cells involved in processes such as development, inflammation and tumorigenesis. The molecular identity of the signalling mechanisms that control these cycles has remained unknown. Here, we used live-cell imaging of biosensors to monitor spontaneous morphodynamic and signalling activities, and employed correlative image analysis to examine the role of cyclic-AMP-activated protein kinase A (PKA) in protrusion regulation. PKA activity at the leading edge is closely synchronized with rapid protrusion and with the activity of RhoA. Ensuing PKA phosphorylation of RhoA and the resulting increased interaction between RhoA and RhoGDI (Rho GDP-dissociation inhibitor) establish a negative feedback mechanism that controls the cycling of RhoA activity at the leading edge. Thus, cooperation between PKA, RhoA and RhoGDI forms a pacemaker that governs the morphodynamic behaviour of migrating cells.	[Tkachenko, Eugene; Kim, Chungho; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Tkachenko, Eugene; Gutierrez, Edgar; Groisman, Alex] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Sabouri-Ghomi, Mohsen; Machacek, Matthias; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Pertz, Olivier] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Basel	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,Mail Code 0726, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu	Groisman, Alexander/AAU-7843-2021; Tkachenko, Eugene/A-9779-2012	pertz, olivier/0000-0001-8579-4919; Danuser, Gaudenz/0000-0001-8583-2014; Tkachenko, Eugene/0000-0002-7964-484X	NIH [AR27214, HL31950, GM071868, F32 HL094012-01]; Cell Migration Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, F32HL094012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027214, R01AR027214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071868, U54GM064346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Migration Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the NIH (AR27214, M.H.G.; HL31950, M.H.G.; GM071868, G.D.; F32 HL094012-01, E.T.) and the Cell Migration Consortium (M.H.G. and G.D.).	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Deming PB, 2008, J BIOL CHEM, V283, P35199, DOI 10.1074/jbc.M804448200; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dransart E, 2005, BIOCHEM SOC T, V33, P623, DOI 10.1042/BST0330623; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Efron B., 1994, INTRO BOOTSTRAP; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gildea JJ, 2002, CANCER RES, V62, P6418; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gonzalez AM, 2008, J BIOL CHEM, V283, P31849, DOI 10.1074/jbc.M801345200; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; LAVANDERO S, 1993, CARDIOVASC RES, V27, P1634, DOI 10.1093/cvr/27.9.1634; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Nakamura T, 2005, METHODS, V37, P146, DOI 10.1016/j.ymeth.2005.05.021; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Song BH, 2003, DEV DYNAM, V227, P91, DOI 10.1002/dvdy.10296; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Thery M., 2009, COLD SPRING HARBOR P; Tkachenko E, 2009, LAB CHIP, V9, P1085, DOI 10.1039/b812184b; UEDA T, 1990, J BIOL CHEM, V265, P9373; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Zhao L, 2008, J PROTEOME RES, V7, P3994, DOI 10.1021/pr800271b	52	115	118	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					660	U78		10.1038/ncb2231	http://dx.doi.org/10.1038/ncb2231			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21572420	Green Accepted			2022-12-25	WOS:000291147400006
J	Yue, WH; Wang, HF; Sun, LD; Tang, FL; Liu, ZH; Zhang, HX; Li, WQ; Zhang, YL; Zhang, Y; Ma, CC; Du, B; Wang, LF; Ren, YQ; Yang, YF; Hu, XF; Wang, Y; Deng, W; Tan, LW; Tan, YL; Chen, Q; Xu, GM; Yang, GG; Zuo, XB; Yan, H; Ruan, YY; Lu, TL; Han, X; Ma, XH; Wang, Y; Cai, LW; Jin, C; Zhang, HY; Yan, J; Mi, WF; Yin, XY; Ma, WB; Liu, Q; Kang, L; Sun, W; Pan, CY; Shuang, M; Yang, FD; Wang, CY; Yang, JL; Li, KQ; Ma, X; Li, LJ; Yu, X; Li, QZ; Huang, X; Lv, LX; Li, T; Zhao, GP; Huang, W; Zhang, XJ; Zhang, D				Yue, Wei-Hua; Wang, Hai-Feng; Sun, Liang-Dan; Tang, Fu-Lei; Liu, Zhong-Hua; Zhang, Hong-Xing; Li, Wen-Qiang; Zhang, Yan-Ling; Zhang, Yang; Ma, Cui-Cui; Du, Bo; Wang, Li-Fang; Ren, Yun-Qing; Yang, Yong-Feng; Hu, Xiao-Feng; Wang, Yi; Deng, Wei; Tan, Li-Wen; Tan, Yun-Long; Chen, Qi; Xu, Guang-Ming; Yang, Gui-Gang; Zuo, Xian-bo; Yan, Hao; Ruan, Yan-Yan; Lu, Tian-Lan; Han, Xue; Ma, Xiao-Hong; Wang, Yan; Cai, Li-Wei; Jin, Chao; Zhang, Hong-Yan; Yan, Jun; Mi, Wei-Feng; Yin, Xian-Yong; Ma, Wen-Bin; Liu, Qi; Kang, Lan; Sun, Wei; Pan, Cheng-Ying; Shuang, Mei; Yang, Fu-De; Wang, Chuan-Yue; Yang, Jian-Li; Li, Ke-Qing; Ma, Xin; Li, Ling-Jiang; Yu, Xin; Li, Qi-Zhai; Huang, Xun; Lv, Lu-Xian; Li, Tao; Zhao, Guo-Ping; Huang, Wei; Zhang, Xue-Jun; Zhang, Dai			Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2	NATURE GENETICS			English	Article							COMMON VARIANTS; DISORDER; PROTEIN	To identify susceptibility loci for schizophrenia, we performed a two-stage genome-wide association study (GWAS) of schizophrenia in the Han Chinese population (GWAS: 746 individuals with schizophrenia and 1,599 healthy controls; validation: 4,027 individuals with schizophrenia and 5,603 healthy controls). We identified two susceptibility loci for schizophrenia at 6p21-p22.1 (rs1233710 in an intron of ZKSCAN4, P-combined = 4.76 x 10(-11), odds ratio (OR) = 0.79; rs1635 in an exon of NKAPL, P-combined = 6.91 x 10(-12), OR = 0.78; rs2142731 in an intron of PGBD1, P-combined = 5.14 x 10(-10), OR = 0.79) and 11p11.2 (rs11038167 near the 5' UTR of TSPAN18, P-combined = 1.09 x 10(-11), OR = 1.29; rs11038172, P-combined = 7.21 x 10(-10), OR = 1.25; rs835784, P-combined = 2.73 x 10(-11), OR = 1.27). These results add to previous evidence of susceptibility loci for schizophrenia at 6p21-p22.1 in the Han Chinese population. We found that NKAPL and ZKSCAN4 were expressed in postnatal day 0 (P0) mouse brain. These findings may lead to new insights into the pathogenesis of schizophrenia.	[Yue, Wei-Hua; Tang, Fu-Lei; Zhang, Yan-Ling; Zhang, Yang; Wang, Li-Fang; Hu, Xiao-Feng; Yan, Hao; Ruan, Yan-Yan; Lu, Tian-Lan; Wang, Yan; Cai, Li-Wei; Zhang, Hong-Yan; Yan, Jun; Mi, Wei-Feng; Liu, Qi; Kang, Lan; Sun, Wei; Pan, Cheng-Ying; Shuang, Mei; Yu, Xin; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Yue, Wei-Hua; Tang, Fu-Lei; Zhang, Yan-Ling; Zhang, Yang; Wang, Li-Fang; Hu, Xiao-Feng; Yan, Hao; Ruan, Yan-Yan; Lu, Tian-Lan; Wang, Yan; Cai, Li-Wei; Zhang, Hong-Yan; Yan, Jun; Mi, Wei-Feng; Liu, Qi; Kang, Lan; Sun, Wei; Pan, Cheng-Ying; Shuang, Mei; Yu, Xin; Zhang, Dai] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Wang, Hai-Feng; Wang, Yi; Zhao, Guo-Ping; Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai Minist Sci & Technol China, Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Wang, Hai-Feng; Wang, Yi; Huang, Wei] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Shanghai 200030, Peoples R China; [Sun, Liang-Dan; Ren, Yun-Qing; Zuo, Xian-bo; Yin, Xian-Yong; Zhang, Xue-Jun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei, Peoples R China; [Sun, Liang-Dan; Ren, Yun-Qing; Zuo, Xian-bo; Yin, Xian-Yong; Zhang, Xue-Jun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei, Peoples R China; [Sun, Liang-Dan; Ren, Yun-Qing; Zuo, Xian-bo; Yin, Xian-Yong; Zhang, Xue-Jun] Minist Sci & Technol, State Key Lab Dermatol, Hefei, Peoples R China; [Liu, Zhong-Hua; Huang, Xun] Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Zhang, Hong-Xing; Li, Wen-Qiang; Yang, Yong-Feng; Lv, Lu-Xian] Xinxiang Med Univ, Dept Psychiat, Affiliated Hosp 2, Xinxiang, Peoples R China; [Zhang, Hong-Xing; Li, Wen-Qiang; Yang, Yong-Feng; Lv, Lu-Xian] Henan Mental Hosp, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China; [Ma, Cui-Cui; Jin, Chao; Ma, Wen-Bin] Jinzhou Kangning Hosp, Jinzhou, Peoples R China; [Du, Bo; Li, Ke-Qing] Hebei Mental Hlth Ctr, Baoding, Peoples R China; [Deng, Wei; Ma, Xiao-Hong; Li, Tao] Sichuan Univ, Dept Psychiat, W China Hosp, Chengdu 610064, Peoples R China; [Tan, Li-Wen; Han, Xue; Li, Ling-Jiang] Cent S Univ, Inst Mental Hlth, Xiangya Hosp 2, Changsha, Peoples R China; [Tan, Yun-Long; Yang, Gui-Gang; Yang, Fu-De] Beijing Huilongguan Hosp, Beijing, Peoples R China; [Chen, Qi; Wang, Chuan-Yue; Ma, Xin] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Xu, Guang-Ming; Yang, Jian-Li] Tianjin Municipal, Tianjin Anding Hosp, Tianjin, Peoples R China; [Li, Qi-Zhai] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Xinxiang Medical University; Sichuan University; Central South University; Capital Medical University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Zhang, D (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	huangwei@chgc.sh.cn; daizang@bjmu.edu.cn	Chen, Gang/G-2722-2010; Deng, Wei/AAU-9945-2020; Yan, Hao/U-1330-2017; Wang, Chuan-Yue/C-9369-2015; Deng, Wei/GWC-9207-2022	Yan, Hao/0000-0003-0376-9037; Wang, Chuan-Yue/0000-0001-6549-3713; Wang, Haifeng/0000-0001-5022-0720; Zhang, Yang/0000-0001-6898-346X; Zhao, Guo-Ping/0000-0002-7621-6620; Zhang, Dai/0000-0002-9162-7401; Li, Tao/0000-0003-3831-901X; Ma, Xiaohong/0000-0003-2627-9946	National High-Tech Research and Development Program of China [2009AA022702]; National Natural Science Foundation of China [30530290, 30870896, 81071087, 81071088]; National Basic Research Program of China [2007CB512301, 2011CB707805]; International Science & Technology Cooperation Program of China [2010DFB30820]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International Science & Technology Cooperation Program of China	We thank J. Liu from the Human Genetics, Genome Institute of Singapore for his suggestions for revision of the manuscript. We acknowledge with appreciation all the individuals with schizophrenia and healthy control subjects whose contributions made this work possible. This work was supported by research grants from the National High-Tech Research and Development Program of China (2009AA022702), the National Natural Science Foundation of China (30530290, 30870896, 81071087 and 81071088), the National Basic Research Program of China (2007CB512301, 2011CB707805) and the International Science & Technology Cooperation Program of China (2010DFB30820).	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Chen DY, 2003, BIOCHEM BIOPH RES CO, V310, P720, DOI 10.1016/j.bbrc.2003.09.074; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Li J, 2007, BIOCHEM BIOPH RES CO, V363, P895, DOI 10.1016/j.bbrc.2007.08.180; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MANTEL N, 1959, J NATL CANCER I, V22, P719; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Richards A.L., MOL PSYCHIA IN PRESS; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Strous RD, 2006, J AUTOIMMUN, V27, P71, DOI 10.1016/j.jaut.2006.07.006; Thaker GK, 2001, NAT MED, V7, P667, DOI 10.1038/89040; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	29	217	236	3	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1228	U84		10.1038/ng.979	http://dx.doi.org/10.1038/ng.979			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22037552				2022-12-25	WOS:000297931400017
J	Carvalho, CMB; Ramocki, MB; Pehlivan, D; Franco, LM; Gonzaga-Jauregui, C; Fang, P; McCall, A; Pivnick, EK; Hines-Dowell, S; Seaver, LH; Friehling, L; Lee, S; Smith, R; del Gaudio, D; Withers, M; Liu, PF; Cheung, SW; Belmont, JW; Zoghbi, HY; Hastings, PJ; Lupski, JR				Carvalho, Claudia M. B.; Ramocki, Melissa B.; Pehlivan, Davut; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Fang, Ping; McCall, Alanna; Pivnick, Eniko Karman; Hines-Dowell, Stacy; Seaver, Laurie H.; Friehling, Linda; Lee, Sansan; Smith, Rosemarie; del Gaudio, Daniela; Withers, Marjorie; Liu, Pengfei; Cheung, Sau Wai; Belmont, John W.; Zoghbi, Huda Y.; Hastings, P. J.; Lupski, James R.			Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome	NATURE GENETICS			English	Article							BREAK-INDUCED REPLICATION; PELIZAEUS-MERZBACHER-DISEASE; MECP2 DUPLICATION SYNDROME; GENE COPY NUMBER; X-CHROMOSOME; INTRACHROMOSOMAL TRIPLICATIONS; MENTAL-RETARDATION; MECHANISM; MUTATIONS; INVERSION	We identified complex genomic rearrangements consisting of intermixed duplications and triplications of genomic segments at the MECP2 and PLP1 loci. These complex rearrangements were characterized by a triplicated segment embedded within a duplication in 11 unrelated subjects. Notably, only two breakpoint junctions were generated during each rearrangement formation. All the complex rearrangement products share a common genomic organization, duplication-inverted triplication-duplication (DUP-TRP/INV-DUP), in which the triplicated segment is inverted and located between directly oriented duplicated genomic segments. We provide evidence that the DUP-TRP/INV-DUP structures are mediated by inverted repeats that can be separated by >300 kb, a genomic architecture that apparently leads to susceptibility to such complex rearrangements. A similar inverted repeat-mediated mechanism may underlie structural variation in many other regions of the human genome. We propose a mechanism that involves both homology-driven events, via inverted repeats, and microhomologous or nonhomologous events.	[Ramocki, Melissa B.; Hastings, P. J.] Baylor Coll Med, Dept Pediat, Div Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA; [Carvalho, Claudia M. B.; Pehlivan, Davut; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Fang, Ping; del Gaudio, Daniela; Withers, Marjorie; Liu, Pengfei; Cheung, Sau Wai; Belmont, John W.; Zoghbi, Huda Y.; Hastings, P. J.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Pivnick, Eniko Karman] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Div Clin Genet, Memphis, TN USA; [Pivnick, Eniko Karman] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; [Hines-Dowell, Stacy] LeBonheur Childrens Hosp, Nursing Adm, Div Med Genet, Memphis, TN USA; [Seaver, Laurie H.; Lee, Sansan] Kapiolani Med Specialists, Honolulu, HI USA; [Friehling, Linda] Childrens Med Associates, Alexandria, VA USA; [Smith, Rosemarie] Maine Med Ctr, Dept Pediat, Div Genet, Portland, ME 04102 USA; [Belmont, John W.] Baylor Coll Med, Dept Pediat, Div Cardiol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Franco, Luis M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Seaver, Laurie H.] Univ Hawaii, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96822 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Maine Medical Center; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Hawaii System	Ramocki, MB (corresponding author), Baylor Coll Med, Dept Pediat, Div Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA.	mramocki@bcm.edu; jlupski@bcm.edu	Belmont, John W/AAI-2494-2019; Liu, Pengfei/U-9743-2019; Pehlivan, Davut/I-3235-2019; Belmont, John/AAH-6084-2021; Gonzaga-Jauregui, Claudia/H-4752-2019	Belmont, John W/0000-0001-7409-3578; Liu, Pengfei/0000-0002-4177-709X; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Pehlivan, Davut/0000-0001-5788-0270; Zoghbi, Huda/0000-0002-0700-3349	US National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS058529]; NINDS [R01 HD053862, 5K08NS062711-03]; US National Institute of General Medical Sciences (NIGMS) [R01 GM064022]; Eunice Kennedy Shriver US National Institute of Child Health and Human Development (NICHD) [P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819, T32NS043124, K08NS062711, R01NS058529] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eunice Kennedy Shriver US National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of the families who participated in this study. We acknowledge P. Stankiewicz for helpful discussions. This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS058529 to J.R.L., NINDS grant R01 HD053862 to H.Y.Z., US National Institute of General Medical Sciences (NIGMS) grant R01 GM064022 to P.J.H. and NINDS grant 5K08NS062711-03 to M.B.R. Lymphoblast cell lines were developed by the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center cell culture core, which is funded by award P30HD024064 from the Eunice Kennedy Shriver US National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS, NIGMS, NICHD or the US National Institutes of Health. H.Y.Z. is an investigator of the Howard Hughes Medical Institute.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartsch O, 2010, AM J MED GENET A, V152A, P305, DOI 10.1002/ajmg.a.33198; Beunders G, 2010, J MED GENET, V47, P271, DOI 10.1136/jmg.2009.070490; Caceres M, 2007, P NATL ACAD SCI USA, V104, P18571, DOI 10.1073/pnas.0706604104; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; HU XY, 1990, AM J HUM GENET, V46, P682; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Lebofsky R, 2005, MOL CELL BIOL, V25, P6789, DOI 10.1128/MCB.25.15.6789-6797.2005; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee JA, 2005, PRENATAL DIAG, V25, P1188, DOI 10.1002/pd.1308; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Mimault C, 1999, AM J HUM GENET, V65, P360, DOI 10.1086/302483; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; Morrow DM, 1997, GENETICS, V147, P371; Paek AL, 2009, GENE DEV, V23, P2861, DOI 10.1101/gad.1862709; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Reddy KS, 2000, CLIN GENET, V58, P134, DOI 10.1034/j.1399-0004.2000.580208.x; Sheen CR, 2007, HUM MUTAT, V28, P1198, DOI 10.1002/humu.20591; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Vialard F, 2003, AM J MED GENET A, V118A, P229, DOI 10.1002/ajmg.a.10164; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Wang J, 1999, AM J MED GENET, V82, P312, DOI 10.1002/(SICI)1096-8628(19990212)82:4<312::AID-AJMG7>3.0.CO;2-9; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Yatsenko SA, 2009, HUM MOL GENET, V18, P1924, DOI 10.1093/hmg/ddp114; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	41	135	138	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1074	U59		10.1038/ng.944	http://dx.doi.org/10.1038/ng.944			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21964572	Green Accepted			2022-12-25	WOS:000296584000010
J	Lu, R; Neff, NF; Quake, SR; Weissman, IL				Lu, Rong; Neff, Norma F.; Quake, Stephen R.; Weissman, Irving L.			Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding	NATURE BIOTECHNOLOGY			English	Article							CLONAL ANALYSIS; SELF-RENEWAL; PROGENITOR CELLS; CANCER; COMPARTMENT; DIFFERENTIATION; SYSTEM; MOUSE; MICE; RECONSTITUTION	Disentangling cellular heterogeneity is a challenge in many fields, particularly in the stem cell and cancer biology fields. Here we demonstrate how to combine viral genetic barcoding with high-throughput sequencing to track single cells in a heterogeneous population. We use this technique to track the in vivo differentiation of unitary hematopoietic stem cells (HSCs). The results are consistent with single-cell transplantation studies but require two orders of magnitude fewer mice. In addition to its high throughput, the high sensitivity of the technique allows for a direct examination of the clonality of sparse cell populations such as HSCs. We show how these capabilities offer a clonal perspective of the HSC differentiation process. In particular, our data suggest that HSCs do not equally contribute to blood cells after irradiation-mediated transplantation, and that two distinct HSC differentiation patterns co-exist in the same recipient mouse after irradiation. This technique can be applied to any virus-accessible cell type for both in vitro and in vivo processes.	[Lu, Rong; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lu, Rong; Weissman, Irving L.] Stanford Univ, Ludwig Ctr, Sch Med, Stanford, CA 94305 USA; [Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Lu, R (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	rlu@stanford.edu; irv@stanford.edu			NIH [R01-CA86065, U01-HL099999]; CIRM [TG2-01159]; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, R01HL058770, U01HL099999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Mantalas, T. Snyder and B. Passarelli for helping with the high-throughput sequencing; K. Schepers, I. Dimov, J. Seita, A. Czechowicz, M. Inlay M. Drukker and D. Sahoo for helpful discussions; P. Lovelace for FACS core management. We also thank L. Jerabek and T. Storm for laboratory management; C. Muscat and T. Naik for antibody conjugation; A. Mosley for animal supervision. This work is supported by NIH-R01-CA86065 and NIH-U01-HL099999. R. L. is supported by CIRM-TG2-01159.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barese CN, 2011, HUM GENE THER, V22, P659, DOI 10.1089/hum.2010.237; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Gonzalez-Murillo A, 2008, BLOOD, V112, P3138, DOI 10.1182/blood-2008-03-142661; Harkey MA, 2007, STEM CELLS DEV, V16, P381, DOI 10.1089/scd.2007.0015; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim S, 2010, J VIROL, V84, P11771, DOI 10.1128/JVI.01355-10; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Laukkanen MO, 2005, BLOOD, V105, P1010, DOI 10.1182/blood-2004-04-1498; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Maetzig T, 2011, BLOOD, V117, P3053, DOI 10.1182/blood-2010-08-303222; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006	50	287	303	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					928	U229		10.1038/nbt.1977	http://dx.doi.org/10.1038/nbt.1977			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21964413	Green Accepted			2022-12-25	WOS:000296273000020
J	Sweeney, KA; Dao, DN; Goldberg, MF; Hsu, T; Venkataswamy, MM; Henao-Tamayo, M; Ordway, D; Sellers, RS; Jain, P; Chen, B; Chen, M; Kim, J; Lukose, R; Chan, J; Orme, IM; Porcelli, SA; Jacobs, WR				Sweeney, Kari A.; Dao, Dee N.; Goldberg, Michael F.; Hsu, Tsungda; Venkataswamy, Manjunatha M.; Henao-Tamayo, Marcela; Ordway, Diane; Sellers, Rani S.; Jain, Paras; Chen, Bing; Chen, Mei; Kim, John; Lukose, Regy; Chan, John; Orme, Ian M.; Porcelli, Steven A.; Jacobs, William R., Jr.			A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis	NATURE MEDICINE			English	Article							BOVIS BCG; SECRETION SYSTEM; CALMETTE-GUERIN; PHAGOSOME MATURATION; VACCINE; INFECTION; MACROPHAGES; EXPRESSION; PROTECTION; ANTIGEN	We report the involvement of an evolutionarily conserved set of mycobacterial genes, the esx-3 region, in evasion of bacterial killing by innate immunity. Whereas high-dose intravenous infections of mice with the rapidly growing mycobacterial species Mycobacterium smegmatis bearing an intact esx-3 locus were rapidly lethal, infection with an M. smegmatis Delta esx-3 mutant (here designated as the IKE strain) was controlled and cleared by a MyD88-dependent bactericidal immune response. Introduction of the orthologous Mycobacterium tuberculosis esx-3 genes into the IKE strain resulted in a strain, designated IKEPLUS, that remained susceptible to innate immune killing and was highly attenuated in mice but had a marked ability to stimulate bactericidal immunity against challenge with virulent M. tuberculosis. Analysis of these adaptive immune responses indicated that the highly protective bactericidal immunity elicited by IKEPLUS was dependent on CD4(+) memory T cells and involved a distinct shift in the pattern of cytokine responses by CD4(+) cells. Our results establish a role for the esx-3 locus in promoting mycobacterial virulence and also identify the IKE strain as a potentially powerful candidate vaccine vector for eliciting protective immunity to M. tuberculosis.	[Sweeney, Kari A.; Dao, Dee N.; Hsu, Tsungda; Jain, Paras; Chen, Bing; Chen, Mei; Kim, John; Lukose, Regy; Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA; [Sweeney, Kari A.; Dao, Dee N.; Goldberg, Michael F.; Hsu, Tsungda; Venkataswamy, Manjunatha M.; Jain, Paras; Chen, Bing; Chen, Mei; Kim, John; Lukose, Regy; Chan, John; Porcelli, Steven A.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Henao-Tamayo, Marcela; Ordway, Diane; Orme, Ian M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Sellers, Rani S.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Kim, John; Porcelli, Steven A.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Colorado State University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Jacobs, WR (corresponding author), Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA.	jacobsw@hhmi.org	Ordway, Diane/H-9732-2017; Rivet, Catherine A/M-7978-2014; Henao-Tamayo, Marcela/D-8189-2017	Ordway, Diane/0000-0003-0003-326X; Henao-Tamayo, Marcela/0000-0002-4249-9650; Jain, Paras/0000-0002-2288-6776; Jacobs, William/0000-0003-3321-3080	US National Institutes of Health (NIH) (Einstein Center for AIDS Research) [AI063537, AI093649, AI092448, AI26170, AI051519]; Bill and Melinda Gates Foundation; Albert Einstein College of Medicine [T32-AI007501]; Einstein Cancer Center (NIH/National Cancer Institute [CA013330]; Einstein Center for AIDS Research [NIH AI051519]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007501, R01AI093649, R01AI026170, P01AI063537, R37AI026170, P30AI051519, R22AI026170, R21AI092448] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (Einstein Center for AIDS Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Albert Einstein College of Medicine; Einstein Cancer Center (NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge the support of US National Institutes of Health (NIH) grants AI063537, AI093649, AI092448, AI26170 and AI051519 (Einstein Center for AIDS Research), and the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery. K.A.S. acknowledges support from the Albert Einstein College of Medicine's Institutional AIDS Training Grant T32-AI007501. We thank C. Harding, L. Ramachandra, G. Lauvau and S. Morris for advice and suggestions, as well as C. Colon-Berezin and S. Tiwari for helpful editing of the manuscript. Flow cytometry studies were carried out using core facilities supported by the Einstein Cancer Center (NIH/National Cancer Institute CA013330) and the Einstein Center for AIDS Research (NIH AI051519).	Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Dubnau E, 2005, INFECT IMMUN, V73, P3754, DOI 10.1128/IAI.73.6.3754-3757.2005; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kita Y, 2005, VACCINE, V23, P2132, DOI 10.1016/j.vaccine.2005.01.057; Kumar K. Jagadish, 1995, Indian Journal of Pediatrics, V62, P619; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; ORME IM, 1983, J EXP MED, V158, P74, DOI 10.1084/jem.158.1.74; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Yang C, 2009, INT J TUBERC LUNG D, V13, P1360; Yeremeev VV, 2000, CLIN EXP IMMUNOL, V120, P274, DOI 10.1046/j.1365-2249.2000.01212.x; Yi ZJ, 2007, VACCINE, V25, P638, DOI 10.1016/j.vaccine.2006.08.037	50	151	161	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1261	U292		10.1038/nm.2420	http://dx.doi.org/10.1038/nm.2420			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21892180	Green Accepted, Bronze			2022-12-25	WOS:000296022100044
J	Testa, JR; Cheung, M; Pei, JM; Below, JE; Tan, YF; Sementino, E; Cox, NJ; Dogan, AU; Pass, HI; Trusa, S; Hesdorffer, M; Nasu, M; Powers, A; Rivera, Z; Comertpay, S; Tanji, M; Gaudino, G; Yang, HN; Carbone, M				Testa, Joseph R.; Cheung, Mitchell; Pei, Jianming; Below, Jennifer E.; Tan, Yinfei; Sementino, Eleonora; Cox, Nancy J.; Dogan, A. Umran; Pass, Harvey I.; Trusa, Sandra; Hesdorffer, Mary; Nasu, Masaki; Powers, Amy; Rivera, Zeyana; Comertpay, Sabahattin; Tanji, Mika; Gaudino, Giovanni; Yang, Haining; Carbone, Michele			Germline BAP1 mutations predispose to malignant mesothelioma	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; PLEURAL MESOTHELIOMA; ASBESTOS; CHROMOSOME-3; ASSOCIATION	Because only a small fraction of asbestos-exposed individuals develop malignant mesothelioma(1), and because mesothelioma clustering is observed in some families, we searched for genetic predisposing factors. We discovered germline mutations in the gene encoding BRCA1 associated protein-1 (BAP1) in two families with a high incidence of mesothelioma, and we observed somatic alterations affecting BAP1 in familial mesotheliomas, indicating biallelic inactivation. In addition to mesothelioma, some BAP1 mutation carriers developed uveal melanoma. We also found germline BAP1 mutations in 2 of 26 sporadic mesotheliomas; both individuals with mutant BAP1 were previously diagnosed with uveal melanoma. We also observed somatic truncating BAP1 mutations and aberrant BAP1 expression in sporadic mesotheliomas without germline mutations. These results identify a BAP1-related cancer syndrome that is characterized by mesothelioma and uveal melanoma. We hypothesize that other cancers may also be involved and that mesothelioma predominates upon asbestos exposure. These findings will help to identify individuals at high risk of mesothelioma who could be targeted for early intervention.	[Testa, Joseph R.; Cheung, Mitchell; Pei, Jianming; Tan, Yinfei; Sementino, Eleonora] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Below, Jennifer E.; Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dogan, A. Umran] King Fahd Univ Petr & Minerals, Dept Earth Sci, Dhahran 31261, Saudi Arabia; [Dogan, A. Umran] Univ Iowa, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA; [Pass, Harvey I.; Trusa, Sandra] NYU, Langone Med Ctr, New York, NY USA; [Pass, Harvey I.; Trusa, Sandra] NYU, Ctr Canc, New York, NY USA; [Hesdorffer, Mary] Mesothelioma Appl Res Fdn, Alexandria, VA USA; [Nasu, Masaki; Powers, Amy; Rivera, Zeyana; Comertpay, Sabahattin; Tanji, Mika; Gaudino, Giovanni; Yang, Haining; Carbone, Michele] Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Honolulu, HI 96822 USA; [Nasu, Masaki; Rivera, Zeyana; Comertpay, Sabahattin; Tanji, Mika] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Yang, Haining] Univ Hawaii Manoa, John A Burns Sch Med, Dept Pathol, Honolulu, HI 96822 USA	Fox Chase Cancer Center; University of Chicago; University of Chicago; King Fahd University of Petroleum & Minerals; University of Iowa; New York University; NYU Langone Medical Center; New York University; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Testa, JR (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	joseph.testa@fccc.edu; mcarbone@cc.hawaii.edu	Comertpay, Sabahattin/AAG-4506-2019; Ferris, Laura/I-7689-2012; Below, Jennifer E/W-2179-2018; Dogan, Ahmet/B-4087-2010	Comertpay, Sabahattin/0000-0003-4850-6927; Below, Jennifer E/0000-0002-1346-1872; Pass, Harvey/0000-0003-3222-3471; Below, Jennifer/0000-0002-6372-6402	US National Institutes of Health (NIH) [P01CA-114047, P30CA-06927, P30CA-71789]; AACR; International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE [P30CA071789, P30CA006927, P01CA114047] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR; International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the affected individuals and their families for their participation in this study. We thank M. Bianchi, C. Menges, I. Pagano, J.D. Rowley and D. C. Ward for advice and review of the manuscript. We also thank J. Talarchek and R. Harrington for technical assistance, K. Aquino-Michaels for assisting in the collection of samples and clinical information, S. C. Jhanwar for providing some of the mesothelioma cell lines, A. Vachani for blood and tissue samples from one member of the L family and B. Luo for providing exome sequence data. This work was supported by US National Institutes of Health (NIH) grants P01CA-114047, P30CA-06927 and P30CA-71789, by the AACR-Landon Award for International Collaboration in Cancer Research to M. Carbone, N.J.C., H. I. P., J. R. T., M. T. and H.Y., and by the Local No. 14 Mesothelioma Fund of the International Association of Heat and Frost Insulators & Allied Workers to J.R.T.	ALBERT DM, 2011, CANC PRINCIPLES PRAC, V1, P2090; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Britton M, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.30237; Burki T, 2010, LANCET, V375, P626, DOI 10.1016/S0140-6736(10)60251-6; Carbone M, 2007, NAT REV CANCER, V7, P147, DOI 10.1038/nrc2068; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Carbone M, 2011, P NATL ACAD SCI USA, V108, P13618, DOI 10.1073/pnas.1105887108; Cheung M, 2010, ONCOGENE, V29, P1633, DOI 10.1038/onc.2009.455; DAS S, 1994, AM J HUM GENET, V55, P883; FLEJTER WL, 1989, GENE CHROMOSOME CANC, V1, P148, DOI 10.1002/gcc.2870010207; Flores RM, 2008, J THORAC CARDIOV SUR, V135, P620, DOI 10.1016/j.jtcvs.2007.10.054; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldberg M, 2006, OCCUP ENVIRON MED, V63, P390, DOI 10.1136/oem.2005.023200; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Houlston RS, 1999, EYE, V13, P43, DOI 10.1038/eye.1999.9; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LU YY, 1994, GENE CHROMOSOME CANC, V9, P76, DOI 10.1002/gcc.2870090114; Makinen VP, 2005, EUR J HUM GENET, V13, P987, DOI 10.1038/sj.ejhg.5201430; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; Murthy SS, 1999, J CELL PHYSIOL, V180, P150, DOI 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H; Pan XL, 2005, AM J RESP CRIT CARE, V172, P1019, DOI 10.1164/rccm.200412-1731OC; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tweedale G, 2002, NAT REV CANCER, V2, P311, DOI 10.1038/nrc774; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Yang HN, 2010, P NATL ACAD SCI USA, V107, P12611, DOI 10.1073/pnas.1006542107	31	682	691	3	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					1022	U140		10.1038/ng.912	http://dx.doi.org/10.1038/ng.912			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21874000	Green Accepted			2022-12-25	WOS:000295316200020
J	Xiong, JH; Onal, M; Jilka, RL; Weinstein, RS; Manolagas, SC; O'Brien, CA				Xiong, Jinhu; Onal, Melda; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; O'Brien, Charles A.			Matrix-embedded cells control osteoclast formation	NATURE MEDICINE			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; BONE-RESORPTION; OSTEOPROTEGERIN LIGAND; OSTEOBLASTIC CELLS; CRE RECOMBINASE; DIFFERENTIATION; EXPRESSION; RANKL; OSTEOCYTES	Osteoclasts resorb the mineralized matrices formed by chondrocytes or osteoblasts. The cytokine receptor activator of nuclear factor-kappa B ligand (RANKL) is essential for osteoclast formation and thought to be supplied by osteoblasts or their precursors, thereby linking bone formation to resorption. However, RANKL is expressed by a variety of cell types, and it is unclear which of them are essential sources for osteoclast formation. Here we have used a mouse strain in which RANKL can be conditionally deleted and a series of Cre-deleter strains to demonstrate that hypertrophic chondrocytes and osteocytes, both of which are embedded in matrix, are essential sources of the RANKL that controls mineralized cartilage resorption and bone remodeling, respectively. Moreover, osteocyte RANKL is responsible for the bone loss associated with unloading. Contrary to the current paradigm, RANKL produced by osteoblasts or their progenitors does not contribute to adult bone remodeling. These results suggest that the rate-limiting step of matrix resorption is controlled by cells embedded within the matrix itself.	[Xiong, Jinhu; Onal, Melda; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Xiong, Jinhu; Onal, Melda; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA.	caobrien@uams.edu	xiong, jinhu/E-1849-2011; O'Brien, Charles A./AAL-5078-2020; Liu, Juan/J-5155-2015	Warren, Aaron D./0000-0002-0042-9021	US National Institutes of Health [AR049794, AG13918]; Central Arkansas Veteran's Healthcare System; UAMS Translational Research Institute [1UL1RR029884]; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Arkansas Veteran's Healthcare System; UAMS Translational Research Institute; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank P. E. Cazer, S. B. Berryhill, W. Webb, R. Shelton, A. Deloose, L. K. Climer, K. Vyas, L. Han, A. D. Warren, E. A. Hogan and J.J. Goellner for technical support and advice; and M. Almeida and H. Zhao for helpful discussions. We thank the following individuals for providing Cre-deleter strains: C.J. Tabin (Harvard Medical School), Prx1-Cre; H. M. Kronenberg (Harvard Medical School), Osx1-Cre; K. von der Mark (University of Erlangen-Nuremberg) and B. de Crombrugghe (M. D. Anderson Cancer Center), ColX-Cre; T. L. Clemens (Johns Hopkins University School of Medicine), Ocn-Cre; and J.Q. Feng (Baylor College of Dentistry) Dmp1-Cre. We thank P. D. Pajevic (Harvard Medical School) for the collagenase digestion protocol; D. Chen (University of Rochester School of Medicine) for the X-gal staining protocol; T. Bellido (Indiana University School of Medicine) and I. Aguirre (University of Florida) for advice on tail suspension; the staff of the UAMS Department of Laboratory Animal Medicine; and L. Suva and R. Skinner of the UAMS Skeletal Imaging Core. This work was supported by the following grants from the US National Institutes of Health: AR049794 (to C.A.O.) and AG13918 (to S.C.M.). Support was also provided by the Central Arkansas Veteran's Healthcare System (Merit Reviews to C.A.O., S.C.M., R.L.J. and R.S.W.), by the UAMS Translational Research Institute (1UL1RR029884) and by UAMS tobacco settlement funds.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gebhard S, 2008, MATRIX BIOL, V27, P693, DOI 10.1016/j.matbio.2008.07.001; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kobayashi Y, 2009, CRIT REV EUKAR GENE, V19, P61, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.30; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Ogata N, 2007, J BIOL CHEM, V282, P35757, DOI 10.1074/jbc.M611902200; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	43	852	895	5	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1235	U262		10.1038/nm.2448	http://dx.doi.org/10.1038/nm.2448			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21909103	Green Accepted			2022-12-25	WOS:000296022100041
J	Costello, I; Pimeisl, IM; Drager, S; Bikoff, EK; Robertson, EJ; Arnold, SJ				Costello, Ita; Pimeisl, Inga-Marie; Draeger, Sarah; Bikoff, Elizabeth K.; Robertson, Elizabeth J.; Arnold, Sebastian J.			The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation	NATURE CELL BIOLOGY			English	Article							NODAL SIGNALS; EMBRYO; GENE; EXPRESSION; CELLS; DIFFERENTIATION; ENDODERM; ENHANCER; FATE; SPECIFICATION	Instructive programmes guiding cell-fate decisions in the developing mouse embryo are controlled by a few so-termed master regulators. Genetic studies demonstrate that the T-box transcription factor Eomesodermin (Eomes) is essential for epithelial-to-mesenchymal transition, mesoderm migration and specification of definitive endoderm during gastrulation'. Here we report that Eomes expression within the primitive streak marks the earliest cardiac mesoderm and promotes formation of cardiovascular progenitors by directly activating the bHLH (basic-helix-loop-helix) transcription factor gene Mesp1 upstream of the core cardiac transcriptional machinery(2-4). In marked contrast to Eomes/Nodal signalling interactions that cooperatively regulate anterior posterior axis patterning and allocation of the definitive endoderm cell lineage(1,5-8), formation of cardiac progenitors requires only low levels of Nodal activity accomplished through a Foxh1/Smad4-independent mechanism. Collectively, our experiments demonstrate that Eomes governs discrete context-dependent transcriptional programmes that sequentially specify cardiac and definitive endoderm progenitors during gastrulation.	[Costello, Ita; Bikoff, Elizabeth K.; Robertson, Elizabeth J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RF, England; [Pimeisl, Inga-Marie; Draeger, Sarah; Arnold, Sebastian J.] Univ Med Ctr, Renal Dept, Clin Res Ctr, D-79106 Freiburg, Germany	University of Oxford; University of Freiburg	Robertson, EJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RF, England.	elizabeth.robertson@path.ox.ac.uk; sebastian.arnold@uniklinik-freiburg.de		Arnold, Sebastian J./0000-0002-2688-9210; /0000-0001-9410-7404	Emmy Noether Programme; German Research Council [SFB850]; Wellcome Trust	Emmy Noether Programme(German Research Foundation (DFG)); German Research Council(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank N. Hortin, A. Salman and M. Pavlovic for technical assistance, C. Bohlke and A. Hotherr for help with imaging techniques, S. Stefanovic for qPCR primer optimization and H. Niwa and Y. Saga for plasmids. This work was supported by the Emmy Noether Programme and SFB850 of the German Research Council to S.J.A. and a Programme Grant from the Wellcome Trust to E.J.R.	Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Arnold SJ, 2009, GENESIS, V47, P775, DOI 10.1002/dvg.20562; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Costello I, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-54; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Haraguchi S, 2001, MECH DEVELOP, V108, P59, DOI 10.1016/S0925-4773(01)00478-6; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Nagy A., 2003, MANIPULATING MOUSE E; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Norris DP, 2002, DEVELOPMENT, V129, P3455; Oginuma M, 2008, MECH DEVELOP, V125, P432, DOI 10.1016/j.mod.2008.01.010; Powers SE, 2010, DEVELOPMENT, V137, P249, DOI 10.1242/dev.040782; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1998, MECH DEVELOP, V75, P53, DOI 10.1016/S0925-4773(98)00077-X; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tam PPL, 2004, DEV BIOL, V274, P171, DOI 10.1016/j.ydbio.2004.07.005; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144	39	160	166	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2011	13	9					1084	U108		10.1038/ncb2304	http://dx.doi.org/10.1038/ncb2304			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	814WD	21822279	Green Accepted			2022-12-25	WOS:000294487000013
J	Diano, S; Liu, ZW; Jeong, JK; Dietrich, MO; Ruan, HB; Kim, E; Suyama, S; Kelly, K; Gyengesi, E; Arbiser, JL; Belsham, DD; Sarruf, DA; Schwartz, MW; Bennett, AM; Shanabrough, M; Mobbs, CV; Yang, XY; Gao, XB; Horvath, TL				Diano, Sabrina; Liu, Zhong-Wu; Jeong, Jin Kwon; Dietrich, Marcelo O.; Ruan, Hai-Bin; Kim, Esther; Suyama, Shigetomo; Kelly, Kaitlin; Gyengesi, Erika; Arbiser, Jack L.; Belsham, Denise D.; Sarruf, David A.; Schwartz, Michael W.; Bennett, Anton M.; Shanabrough, Marya; Mobbs, Charles V.; Yang, Xiaoyong; Gao, Xiao-Bing; Horvath, Tamas L.			Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CENTRAL LEPTIN INFUSION; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; PPAR-GAMMA; ENDOPLASMIC-RETICULUM; NPY/AGRP NEURONS; ENERGY-BALANCE; HYPOTHALAMUS; INFLAMMATION	Previous studies have proposed roles for hypothalamic reactive oxygen species (ROS) in the modulation of circuit activity of the melanocortin system(1,2). Here we show that suppression of ROS diminishes pro-opiomelanocortin (POMC) cell activation and promotes the activity of neuropeptide Y (NPY)- and agouti-related peptide (AgRP)-co-producing (NPY/AgRP) neurons and feeding, whereas ROS-activates POMC neurons and reduces feeding. The levels of ROS in POMC neurons were positively correlated with those of leptin in lean and ob/ob mice, a relationship that was diminished in diet-induced obese (DIO) mice. High-fat feeding resulted in proliferation of peroxisomes and elevated peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels within the hypothalamus. The proliferation of peroxisomes in POMC neurons induced by the PPAR-gamma agonist rosiglitazone decreased ROS levels and increased food intake in lean mice on high-fat diet. Conversely, the suppression of peroxisome proliferation by the PPAR antagonist GW9662 increased ROS concentrations and c-fos expression in POMC neurons. Also, it reversed high-fat feeding-triggered elevated NPY/AgRP and low POMC neuronal firing, and resulted in decreased feeding of DIO mice. Finally, central administration of ROS alone increased c-fos and phosphorylated signal transducer and activator of transcription 3 (pStat3) expression in POMC neurons and reduced feeding of DIO mice. These observations unmask a previously unknown hypothalamic cellular process associated with peroxisomes and ROS in the central regulation of energy metabolism in states of leptin resistance.	[Diano, Sabrina; Liu, Zhong-Wu; Jeong, Jin Kwon; Dietrich, Marcelo O.; Ruan, Hai-Bin; Suyama, Shigetomo; Kelly, Kaitlin; Gyengesi, Erika; Bennett, Anton M.; Shanabrough, Marya; Yang, Xiaoyong; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Diano, Sabrina; Jeong, Jin Kwon; Kelly, Kaitlin; Gyengesi, Erika; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA; [Diano, Sabrina; Liu, Zhong-Wu; Dietrich, Marcelo O.; Ruan, Hai-Bin; Suyama, Shigetomo; Bennett, Anton M.; Shanabrough, Marya; Yang, Xiaoyong; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Diano, Sabrina; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Dietrich, Marcelo O.; Mobbs, Charles V.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Kim, Esther] Mt Sinai Sch Med, Dept Neurosci, Friedman Brain Inst, New York, NY USA; [Kim, Esther] Mt Sinai Sch Med, Dept Geriatr, Friedman Brain Inst, New York, NY USA; [Arbiser, Jack L.] Emory Univ, Sch Med, Dept Dermatol, Winship Canc Inst,Atlanta VA Med Ctr, Atlanta, GA 30322 USA; [Belsham, Denise D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Belsham, Denise D.] Toronto Gen Hosp, Div Cellular & Mol Biol, Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Sarruf, David A.; Schwartz, Michael W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Sarruf, David A.; Schwartz, Michael W.] Univ Washington, Dept Med, Seattle, WA USA; [Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Universidade Federal do Rio Grande do Sul; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yale University	Diano, S (corresponding author), Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.	sabrina.diano@yale.edu; tamas.horvath@yale.edu	Schwartz, Michael W/H-9950-2012; Gyengesi, Erika/S-1251-2019; Liu, Zhong-Wu/C-2794-2011; Dietrich, Marcelo/A-9928-2009; Gao, Xiao-Bing/C-3121-2011; Ruan, Hai-Bin/AAN-7777-2021; Ruan, Hai-Bin/G-9907-2012; Jeong, Jin Kwon/AAU-2951-2020	Gyengesi, Erika/0000-0001-7371-7385; Dietrich, Marcelo/0000-0001-9781-2221; Gao, Xiao-Bing/0000-0002-2035-4936; Ruan, Hai-Bin/0000-0002-3858-1272; Ruan, Hai-Bin/0000-0002-3858-1272; Mobbs, Charles/0000-0002-5815-8711; Bennett, Anton/0000-0001-5187-7599; Jeong, Jin Kwon/0000-0002-5261-4915	US National Institutes of Health (NIH) [DK084065, DK080000, OD006850]; American Diabetes Association [7-08-MN-25]; NIH [DK089098, DK072033, DK090320, DK052989, AR47901, P30 AR42687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901, P30AR042687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK072033, R01DK052989, R01DK080000, R01DK083042, R01DK084065, R01DK097566, R01DK090320, R01DK089098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087004] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J.M. Olefsky, Department of Medicine, University of California-San Diego, for generating and providing brain-specific PPAR-gamma-knockout mice and B.B. Lowell, Beth Israel Deaconess Medical Center, for providing breeding pairs of UCP2-knockout mice. This work was supported by US National Institutes of Health (NIH) grants DK084065 (S.D.) and DK080000 and OD006850 (T.L.H.) and by American Diabetes Association grant 7-08-MN-25 (T.L.H.). This work was also supported by NIH grants DK089098 (X.Y.), DK072033 (C.V.M.) DK090320 and DK052989 (M.W.S.) and AR47901 and P30 AR42687 (J.L.A.).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Green S, 1995, MUTAT RES-FUND MOL M, V333, P101, DOI 10.1016/0027-5107(95)00136-0; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Horvath TL, 2009, TRENDS ENDOCRIN MET, V20, P78, DOI 10.1016/j.tem.2008.10.003; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Kouidhi S, 2010, MOL CELL ENDOCRINOL, V317, P44, DOI 10.1016/j.mce.2009.11.001; Leloup C, 2006, DIABETES, V55, P2084, DOI 10.2337/db06-0086; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Pal R, 2003, ENDOCRINOLOGY, V144, P3789, DOI 10.1210/en.2002-0148; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Poplawski MM, 2010, ENDOCRINOLOGY, V151, P5206, DOI 10.1210/en.2010-0702; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Yu X, 2008, BRAIN RES, V1200, P146, DOI 10.1016/j.brainres.2008.01.047	37	199	201	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1121	U130		10.1038/nm.2421	http://dx.doi.org/10.1038/nm.2421			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21873987	Green Accepted			2022-12-25	WOS:000294605100033
J	Fawcett, JW; Kalluri, R; Duffield, JS; Silver, J				Fawcett, James W.; Kalluri, Raghu; Duffield, Jeremy S.; Silver, Jerry			Starting the scar: a primary role for pericytes?	NATURE MEDICINE			English	Editorial Material							REACTIVE ASTROCYTES; CELLS		[Fawcett, James W.] Univ Cambridge, Ctr Brain Repair, Cambridge, England; [Kalluri, Raghu] Harvard Univ, Sch Med, Boston, MA USA; [Duffield, Jeremy S.] Univ Washington, Div Renal, Seattle, WA USA; [Duffield, Jeremy S.] Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA USA; [Duffield, Jeremy S.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA USA; [Silver, Jerry] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	University of Cambridge; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Case Western Reserve University	Fawcett, JW (corresponding author), Univ Cambridge, Ctr Brain Repair, Robinson Way, Cambridge, England.		Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; Fawcett, James/0000-0002-7990-4568				Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Shibata T, 1997, J NEUROSCI, V17, P9212; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wirz W, 2008, DIFFERENTIATION, V76, P784, DOI 10.1111/j.1432-0436.2007.00260.x; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	14	3	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1052	1053		10.1038/nm0911-1052	http://dx.doi.org/10.1038/nm0911-1052			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900921				2022-12-25	WOS:000294605100022
J	Urizar, E; Yano, H; Kolster, R; Gales, C; Lambert, N; Javitch, JA				Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Gales, Celine; Lambert, Nevin; Javitch, Jonathan A.			CODA-RET reveals functional selectivity as a result of GPCR heteromerization	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; DOPAMINE-RECEPTOR AGONISTS; MEDIATED CALCIUM SIGNAL; D2 RECEPTOR; LIVING CELLS; CROSS-TALK; ACTIVATION; COMPLEMENTATION; DIMERS; OLIGOMERIZATION	Here we present a new method that combines protein complementation with resonance energy transfer to study conformational changes in response to activation of a defined G protein-coupled receptor heteromer, and we apply the approach to the putative dopamine D1-D2 receptor heteromer. Remarkably, the potency of the D2 dopamine receptor (D2R) agonist R-(-)-10,11-dihydroxy-N-n-propylnoraporphine (NPA) to change the G alpha(i) conformation via the D2R protomer in the D1-D2 heteromer was enhanced ten-fold relative to its potency in the D2R homomer. In contrast, the potencies of the D2R agonists dopamine and quinpirole were the same in the homomer and heteromer. Thus, we have uncovered a molecular mechanism for functional selectivity in which a drug acts differently at a G protein-coupled receptor (GPCR) protomer depending on the identity of the second protomer participating in the formation of the signaling unit-opening the door to enhancing pharmacological specificity by targeting differences between homomeric and heteromeric signaling.	[Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY USA; [Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Urizar, Eneko; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Gales, Celine] Fac Med Toulouse, INSERM, F-31073 Toulouse, France; [Gales, Celine] Univ Toulouse 3, F-31062 Toulouse, France; [Lambert, Nevin] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University System of Georgia; Augusta University	Urizar, E (corresponding author), Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium.	jaj2@columbia.edu	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Yano, Hideaki/0000-0001-9242-3884; Javitch, Jonathan/0000-0001-7395-2967; GALES, Celine/0000-0002-4938-1583	US National Institutes of Health (NIH) [DA022413, MH054137, GM078319]; NIH [TL1 RR024158-04]; Lieber Center for Schizophrenia Research and Treatment; E.U.; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319, R01GM096762, T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lieber Center for Schizophrenia Research and Treatment; E.U.(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by US National Institutes of Health (NIH) grants DA022413 and MH054137 (J.A.J.), GM078319 (N.L.) and NIH TL1 RR024158-04 (H.Y.) as well as by the Lieber Center for Schizophrenia Research and Treatment and EMBO Long-Term and Basque Country fellowships (E.U.).	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; BYGRAVE FL, 1995, FASEB J, V9, P1297, DOI 10.1096/fasebj.9.13.7557019; Costagliola S, 1998, FEBS LETT, V436, P427, DOI 10.1016/S0014-5793(98)01177-6; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Guo NN, 2010, NEUROPSYCHOPHARMACOL, V35, P806, DOI 10.1038/npp.2009.189; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kilts JD, 2002, J PHARMACOL EXP THER, V301, P1179, DOI 10.1124/jpet.301.3.1179; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; MANSOUR A, 1992, EUR J PHARM-MOLEC PH, V227, P205, DOI 10.1016/0922-4106(92)90129-J; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MELLER E, 1992, J PHARMACOL EXP THER, V263, P462; Mervine SM, 2006, MOL PHARMACOL, V70, P194, DOI 10.1124/mol.106.022616; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Mottola DM, 2002, J PHARMACOL EXP THER, V301, P1166, DOI 10.1124/jpet.301.3.1166; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; O'Dowd BF, 2005, J BIOL CHEM, V280, P37225, DOI 10.1074/jbc.M504562200; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; So CH, 2005, MOL PHARMACOL, V68, P568, DOI 10.1124/mol.105.012229; So CH, 2007, MOL PHARMACOL, V72, P450, DOI 10.1124/mol.107.034884; Sponger D, 1993, NATURE, V365, P170; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zhang J, 2009, MED RES REV, V29, P272, DOI 10.1002/med.20130	48	88	88	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					624	630		10.1038/NCHEMBIO.623	http://dx.doi.org/10.1038/NCHEMBIO.623			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21785426	Green Accepted			2022-12-25	WOS:000294381400013
J	Salzman, DW; Weidhaas, JB				Salzman, David W.; Weidhaas, Joanne B.			miRNAs in the spotlight Making 'silent' mutations speak up	NATURE MEDICINE			English	Editorial Material							SEQUENCE VARIANTS; GENE-EXPRESSION; CROHNS-DISEASE; HUMAN GENOME; MICRORNAS; CANCER; POLYMORPHISM; SITE	Genetic mutations can cause numerous diseases. These alterations affect not only protein-coding genes but also regions that were until recently thought to be trivial in disease. In 'Bedside to Bench', David Salzman and Joanne Weidhaas examine a human study showing how a silent mutation impairs the binding of miR-196, increasing the risk for Crohn's disease. Therefore, alterations of miRNA target sites as pathogenic mechanism begs further investigation. miRNAs themselves can also be the root of disease. In 'Bench to Bedside', Carlo Croce peruses a study in vivo showing evidence of tumor addiction to miR-21 in a mouse model of cancer, which highlights the role of miRNAs as initiators of disease. Targeting these drivers will help to develop effective drugs.	[Salzman, David W.; Weidhaas, Joanne B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA	Yale University	Salzman, DW (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	joanne.weidhaas@yale.edu		Weidhaas, Joanne/0000-0002-5096-3281	NATIONAL CANCER INSTITUTE [R01CA131301] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131301] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089	13	7	9	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					934	935		10.1038/nm0811-934	http://dx.doi.org/10.1038/nm0811-934			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21818091				2022-12-25	WOS:000293507400024
J	Comino-Mendez, I; Gracia-Aznarez, FJ; Schiavi, F; Landa, I; Leandro-Garcia, LJ; Leton, R; Honrado, E; Ramos-Medina, R; Caronia, D; Pita, G; Gomez-Grana, A; de Cubas, AA; Inglada-Perez, L; Maliszewska, A; Taschin, E; Bobisse, S; Pica, G; Loli, P; Hernandez-Lavado, R; Diaz, JA; Gomez-Morales, M; Gonzalez-Neira, A; Roncador, G; Rodriguez-Antona, C; Benitez, J; Mannelli, M; Opocher, G; Robledo, M; Cascon, A				Comino-Mendez, Inaki; Gracia-Aznarez, Francisco J.; Schiavi, Francesca; Landa, Inigo; Leandro-Garcia, Luis J.; Leton, Roco; Honrado, Emiliano; Ramos-Medina, Rocio; Caronia, Daniela; Pita, Guillermo; Gomez-Grana, Alvaro; de Cubas, Aguirre A.; Inglada-Perez, Lucia; Maliszewska, Agnieszka; Taschin, Elisa; Bobisse, Sara; Pica, Giuseppe; Loli, Paola; Hernandez-Lavado, Rafael; Diaz, Jose A.; Gomez-Morales, Mercedes; Gonzalez-Neira, Anna; Roncador, Giovanna; Rodriguez-Antona, Cristina; Benitez, Javier; Mannelli, Massimo; Opocher, Giuseppe; Robledo, Mercedes; Cascon, Alberto			Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma	NATURE GENETICS			English	Article							UNIPARENTAL DISOMY; C-MYC; DIMERIZATION PARTNER; CELL-LINE; PARAGANGLIOMA; GENE; TUMOR; TRANSCRIPTION; ACTIVATION; COMPLEX	Hereditary pheochromocytoma (PCC) is often caused by germline mutations in one of nine susceptibility genes described to date(1-4), but there are familial cases without mutations in these known genes. We sequenced the exomes of three unrelated individuals with hereditary PCC (cases) and identified mutations in MAX, the MYC associated factor X gene. Absence of MAX protein in the tumors and loss of heterozygosity caused by uniparental disomy supported the involvement of MAX alterations in the disease. A follow-up study of a selected series of 59 cases with PCC identified five additional MAX mutations and suggested an association with malignant outcome and preferential paternal transmission of MAX mutations. The involvement of the MYC-MAX-MXD1 network in the development and progression of neural crest cell tumors is further supported by the lack of functional MAX in rat PCC (PC12) cells(5) and by the amplification of MYCN in neuroblastoma(6) and suggests that loss of MAX function is correlated with metastatic potential.	[Comino-Mendez, Inaki; Landa, Inigo; Leandro-Garcia, Luis J.; Leton, Roco; Gomez-Grana, Alvaro; de Cubas, Aguirre A.; Inglada-Perez, Lucia; Maliszewska, Agnieszka; Rodriguez-Antona, Cristina; Robledo, Mercedes; Cascon, Alberto] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain; [Comino-Mendez, Inaki; Gracia-Aznarez, Francisco J.; Inglada-Perez, Lucia; Rodriguez-Antona, Cristina; Benitez, Javier; Robledo, Mercedes; Cascon, Alberto] CIBERER, Madrid, Spain; [Gracia-Aznarez, Francisco J.; Benitez, Javier] Spanish Natl Canc Res Ctr, Human Genet Grp, Madrid, Spain; [Schiavi, Francesca; Taschin, Elisa; Bobisse, Sara; Opocher, Giuseppe] Veneto Inst Oncol, Familial Canc Clin, Padua, Italy; [Honrado, Emiliano] Hosp Leon, Serv Anat Pathol, Leon, Spain; [Ramos-Medina, Rocio; Roncador, Giovanna] Spanish Natl Canc Res Ctr, Biotechnol Programme, Monoclonal Antibodies Unit, Madrid, Spain; [Caronia, Daniela; Pita, Guillermo; Gonzalez-Neira, Anna] Spanish Natl Canc Ctr, Human Genotyping Unit CeGen, Human Canc Genet Programme, Madrid, Spain; [Pica, Giuseppe] Univ Foggia, Foggia, Italy; [Loli, Paola] Osped Niguarda Ca Granda, Dept Endocrinol, Milan, Italy; [Hernandez-Lavado, Rafael] Hosp Infanta Cristina, Endocrinol Sect, Badajoz, Spain; [Diaz, Jose A.] Hosp Univ Clin San Carlos, Dept Endocrinol, Madrid, Spain; [Gomez-Morales, Mercedes] Univ Granada, Univ Hosp, Dept Pathol, Granada, Spain; [Mannelli, Massimo] Univ Florence, Dept Clin Pathophysiol, Florence, Italy; [Mannelli, Massimo] Ist Toscano Tumori, Florence, Italy; [Opocher, Giuseppe] Univ Padua, Dept Med & Surg Sci, Padua, Italy	Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); IRCCS Istituto Oncologico Veneto (IOV); Universidad de Leon; Hospital de Leon; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Foggia; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Granada; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Padua	Cascon, A (corresponding author), Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain.	mrobledo@cnio.es; acascon@cnio.es	Robledo, Mercedes/O-2230-2013; Schiavi, Francesca/AAB-9908-2022; Cascon, Alberto/G-3160-2014; inglada-perez, lucia/H-5378-2015; Rodriguez-Antona, Cristina/E-1073-2011; Gracia Aznarez, Francisco Javier/AFV-2344-2022; Roncador, Giovanna/L-1764-2014; Leandro-García, Luis Javier/B-4229-2019; Pinheiro, Maísa/E-7424-2012; Gonzalez-Neira, Anna/C-5791-2015; Opocher, Giuseppe/F-3950-2014; Inglada-Perez, Lucia/Z-3020-2019; Landa, Iñigo/AAK-8789-2020; taschin, elisa/K-3847-2016	Robledo, Mercedes/0000-0001-6256-5902; Schiavi, Francesca/0000-0001-8529-4455; Cascon, Alberto/0000-0003-2119-891X; Rodriguez-Antona, Cristina/0000-0001-8750-7338; Roncador, Giovanna/0000-0002-9807-2875; Leandro-García, Luis Javier/0000-0002-7757-2408; Gonzalez-Neira, Anna/0000-0002-5421-2020; Opocher, Giuseppe/0000-0002-9845-9623; Landa, Iñigo/0000-0002-2817-8295; Honrado Franco, Emiliano/0000-0001-5668-4083; Inglada-Perez, Lucia/0000-0001-9814-4368; INGLADA, LUCIA/0000-0001-9523-2717; Mannelli, Massimo/0000-0002-8001-9857; COMINO-MENDEZ, INAKI/0000-0003-1926-9432; Ramos-Medina, Rocio/0000-0001-6059-4152; taschin, elisa/0000-0001-9426-4071	Fondo de Investigaciones Sanitarias [PS09/00942, P1080883]; Mutua Madrilena [AP2775/2008]; FP7 [HEALTH-F2-2010-259735]; Center for Biomedical Research on Rare Diseases [INTRA-706-2 ISCIII CIBER-ER]; CIBER-ER	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Mutua Madrilena; FP7; Center for Biomedical Research on Rare Diseases; CIBER-ER	This work was supported in part by the Fondo de Investigaciones Sanitarias (projects PS09/00942 and P1080883 to A.C. and M.R., respectively), Mutua Madrilena (project AP2775/2008 to M.R.), FP7-Grant (ENS@T-CANCER; HEALTH-F2-2010-259735) and Innovation project INTRA-706-2 ISCIII CIBER-ER (Center for Biomedical Research on Rare Diseases). I.C.-M. holds a shuttle CIBER-ER fellowship.	Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; ATCHLEY WR, 1995, P NATL ACAD SCI USA, V92, P10217, DOI 10.1073/pnas.92.22.10217; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOUSSET K, 1993, ONCOGENE, V8, P3211; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cascon A, 2006, GENE CHROMOSOME CANC, V45, P213, DOI 10.1002/gcc.20283; Cascon A, 2009, J CLIN ENDOCR METAB, V94, P1701, DOI 10.1210/jc.2008-2756; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Jimenez RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009084; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; Kurosawa K, 2002, AM J MED GENET, V110, P268, DOI 10.1002/ajmg.10404; Landa I, 2010, ENDOCR-RELAT CANCER, V17, P317, DOI 10.1677/ERC-09-0016; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Mannelli M, 2009, J CLIN ENDOCR METAB, V94, P1541, DOI 10.1210/jc.2008-2419; Murthy SK, 2002, MODERN PATHOL, V15, P1241, DOI 10.1097/01.MP.0000032535.62750.D1; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; PRENDERGAST GC, 1992, GENE DEV, V6, P2429, DOI 10.1101/gad.6.12a.2429; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; RIBON V, 1994, MOL CELL NEUROSCI, V5, P277, DOI 10.1006/mcne.1994.1032; Sambrook J, 1989, MOL CLONING LAB MANU, VIII, P1647; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilson M, 2008, AM J MED GENET A, V146A, P137, DOI 10.1002/ajmg.a.32172; Yao L, 2010, JAMA-J AM MED ASSOC, V304, P2611, DOI 10.1001/jama.2010.1830; Zhu JD, 2008, P NATL ACAD SCI USA, V105, P6584, DOI 10.1073/pnas.0802785105	37	365	371	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					663	U189		10.1038/ng.861	http://dx.doi.org/10.1038/ng.861			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21685915				2022-12-25	WOS:000292184600010
J	Magtanong, L; Ho, CH; Barker, SL; Jiao, W; Baryshnikova, A; Bahr, S; Smith, AM; Heisler, LE; Choy, JS; Kuzmin, E; Andrusiak, K; Kobylianski, A; Li, ZJ; Costanzo, M; Basrai, MA; Giaever, G; Nislow, C; Andrews, B; Boone, C				Magtanong, Leslie; Ho, Cheuk Hei; Barker, Sarah L.; Jiao, Wei; Baryshnikova, Anastasia; Bahr, Sondra; Smith, Andrew M.; Heisler, Lawrence E.; Choy, John S.; Kuzmin, Elena; Andrusiak, Kerry; Kobylianski, Anna; Li, Zhijian; Costanzo, Michael; Basrai, Munira A.; Giaever, Guri; Nislow, Corey; Andrews, Brenda; Boone, Charles			Dosage suppression genetic interaction networks enhance functional wiring diagrams of the cell	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; RIBOSOMAL-PROTEINS; GENOMIC DATA; YEAST; COMPLEX; OVEREXPRESSION; KINETOCHORE; EXPRESSION; CYCLE	Dosage suppression is a genetic interaction in which overproduction of one gene rescues a mutant phenotype of another gene. Although dosage suppression is known to map functional connections among genes, the extent to which it might illuminate global cellular functions is unclear. Here we analyze a network of interactions linking dosage suppressors to 437 essential genes in yeast. For 424 genes, we curated interactions from the literature. Analyses revealed that many dosage suppression interactions occur between functionally related genes and that the majority do not overlap with other types of genetic or physical interactions. To confirm the generality of these network properties, we experimentally identified dosage suppressors for 29 genes from pooled populations of temperature-sensitive mutant cells transformed with a high-copy molecular-barcoded open reading frame library, MoBY-ORF 2.0. We classified 87% of the 1,640 total interactions into four general types of suppression mechanisms, which provided insight into their relative frequencies. This work suggests that integrating the results of dosage suppression studies with other interaction networks could generate insights into the functional wiring diagram of a cell.	[Magtanong, Leslie; Ho, Cheuk Hei; Barker, Sarah L.; Jiao, Wei; Baryshnikova, Anastasia; Bahr, Sondra; Smith, Andrew M.; Heisler, Lawrence E.; Kuzmin, Elena; Andrusiak, Kerry; Kobylianski, Anna; Li, Zhijian; Costanzo, Michael; Giaever, Guri; Nislow, Corey; Andrews, Brenda; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Genet, Toronto, ON, Canada; [Choy, John S.; Basrai, Munira A.] NCI, Genet Branch Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Magtanong, Leslie; Ho, Cheuk Hei; Barker, Sarah L.; Jiao, Wei; Baryshnikova, Anastasia; Bahr, Sondra; Smith, Andrew M.; Kuzmin, Elena; Andrusiak, Kerry; Li, Zhijian; Costanzo, Michael; Giaever, Guri; Nislow, Corey; Andrews, Brenda; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University of Toronto	Boone, C (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	brenda.andrews@utoronto.ca; charlie.boone@utoronto.ca	Basrai, Munira/AAV-4422-2020; Giaever, Guri/D-3930-2009; Smith, Andrew/C-1253-2009	Nislow, Corey/0000-0002-4016-8874; Heisler, Lawrence/0000-0002-1332-1802; Choy, John/0000-0001-9196-3280; Baryshnikova, Anastasia/0000-0002-0123-2052	Canadian Institutes of Health Research (CIHR) [020380, MOP-81340, MOP-84305, MOP-57830]; University of Toronto; US National Cancer Institute; US National Institutes of Health; Canadian Cancer Society; Genome Canada through the Ontario Genomics Institute [2004-OGI-3-01]; Natural Sciences and Engineering Research Council of Canada [RGPIN 204899-06]; NATIONAL CANCER INSTITUTE [ZIABC010831, ZIABC010822] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Dixon for critical comments on the manuscript, M. Gebbia for microarray technical support, and C. Myers and J. Bellay for advice and data analysis support. L.M. was supported by a Canadian Institutes of Health Research (CIHR) doctoral research award. A.M.S. was supported by a University of Toronto open fellowship. J.S.C. and M.A.B. were supported by the Intramural Research Program of the US National Cancer Institute, US National Institutes of Health. G.G. was supported by the Canadian Cancer Society and the CIHR (research agreements 020380 and MOP-81340, respectively). C.N. was supported by the CIHR (MOP-84305). C.B. and B. A. were supported by Genome Canada through the Ontario Genomics Institute (2004-OGI-3-01). C.B. was supported by the CIHR (MOP-57830) and the Natural Sciences and Engineering Research Council of Canada (RGPIN 204899-06).	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Balciunas D, 1999, MOL GEN GENET, V262, P589; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Butcher RA, 2006, NAT PROTOC, V1, P569, DOI 10.1038/nprot.2006.80; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GORDON CL, 1994, GENETICS, V136, P427; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; HODGKIN J, 2005, WORMBOOK, V27, P1; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kaizu K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000919; Klein HL, 2001, GENETICS, V159, P1501; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Li J, 2005, MOL CELL BIOL, V25, P767, DOI 10.1128/MCB.25.2.767-778.2005; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Pagliuca C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007640; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Prelich G, 1999, TRENDS GENET, V15, P261, DOI 10.1016/S0168-9525(99)01749-7; REED SI, 1989, J CELL SCI, P29; RINE J, 1991, METHOD ENZYMOL, V194, P239; Rodriguez-Quinones JF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-34; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimada Y, 2004, EMBO J, V23, P1051, DOI 10.1038/sj.emboj.7600124; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Tanaka K, 2009, CANCER SCI, V100, P1158, DOI 10.1111/j.1349-7006.2009.01178.x; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; VANDONGEN S, 2002, CLUSTER ALGORITHM GR; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WATTS FZ, 1987, EMBO J, V6, P3499, DOI 10.1002/j.1460-2075.1987.tb02675.x; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	51	73	73	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2011	29	6					505	U66		10.1038/nbt.1855	http://dx.doi.org/10.1038/nbt.1855			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	773WL	21572441	Green Accepted			2022-12-25	WOS:000291342100016
J	Doherty, TA; Soroosh, P; Khorram, N; Fukuyama, S; Rosenthal, P; Cho, JY; Norris, PS; Choi, H; Scheu, S; Pfeffer, K; Zuraw, BL; Ware, CF; Broide, DH; Croft, M				Doherty, Taylor A.; Soroosh, Pejman; Khorram, Naseem; Fukuyama, Satoshi; Rosenthal, Peter; Cho, Jae Youn; Norris, Paula S.; Choi, Heonsik; Scheu, Stefanie; Pfeffer, Klaus; Zuraw, Bruce L.; Ware, Carl F.; Broide, David H.; Croft, Michael			The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; T-CELL-ACTIVATION; TGF-BETA; LYMPHOTOXIN-BETA; BASEMENT-MEMBRANE; EPITHELIAL-CELLS; TNF SUPERFAMILY; INFLAMMATION; EXPRESSION; RECEPTOR	Individuals with chronic asthma show a progressive decline in lung function that is thought to be due to structural remodeling of the airways characterized by subepithelial fibrosis and smooth muscle hyperplasia. Here we show that the tumor necrosis factor (TNF) family member LIGHT is expressed on lung inflammatory cells after allergen exposure. Pharmacological inhibition of LIGHT using a fusion protein between the IgG Fc domain and lymphotoxin beta receptor (LT beta R) reduces lung fibrosis, smooth muscle hyperplasia and airway hyperresponsiveness in mouse models of chronic asthma, despite having little effect on airway eosinophilia. LIGHT-deficient mice also show a similar impairment in fibrosis and smooth muscle accumulation. Blockade of LIGHT suppresses expression of lung transforming growth factor-beta (TGF-beta) and interleukin-13 (IL-13), cytokines implicated in remodeling in humans, whereas exogenous administration of LIGHT to the airways induces fibrosis and smooth muscle hyperplasia, Thus, LIGHT may be targeted to prevent asthma-related airway remodeling.	[Doherty, Taylor A.; Soroosh, Pejman; Fukuyama, Satoshi; Choi, Heonsik; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA; [Doherty, Taylor A.; Khorram, Naseem; Rosenthal, Peter; Cho, Jae Youn; Zuraw, Bruce L.; Broide, David H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Norris, Paula S.; Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Scheu, Stefanie; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany	La Jolla Institute for Immunology; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Heinrich Heine University Dusseldorf	Croft, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA.	mick@liai.org	Soroosh, Pejman/AAD-8386-2021; Scheu, Stefanie/H-3670-2019	Scheu, Stefanie/0000-0002-9707-8191; Doherty, Taylor/0000-0003-3256-0398; Pfeffer, Klaus/0000-0002-5652-6330; Broide, David/0000-0001-8405-9090	US National Institutes of Health (NIH) [AI070535]; American Academy of Asthma, Allergy and Immunology, UCSD Clinical and Translational Research Institute; NIH [1K08AI080938-01A1, R37AI068033, AI067890]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, U19AI070535, K08AI080938, R01AI067890, R01AI068033, R01AI048073, R37AI038425] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Asthma, Allergy and Immunology, UCSD Clinical and Translational Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Meilan, Y. Adams, X. Tang and M. Macauley for technical assistance and the UCSD histology core for lung section processing and staining. Antibody to LT beta BBF6 was kindly provided by J. Browning, Biogen Idec. This work was supported by US National Institutes of Health (NIH) grant AI070535 to M. C., a fellowship from the American Academy of Asthma, Allergy and Immunology, UCSD Clinical and Translational Research Institute and NIH grant 1K08AI080938-01A1 award to T. A. D. and NIH grants R37AI068033 and AI067890 to C. F. W. This is manuscript number 1285 of the La Jolla Institute for Allergy and Immunology.	Berger P, 2003, FASEB J, V17, P2139, DOI 10.1096/fj.03-0041fje; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bogaert P, 2009, AM J PATHOL, V174, P3, DOI 10.2353/ajpath.2009.071151; Booth BW, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-51; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308, DOI 10.1164/ajrccm.162.4.9910051; Boussaud V, 1998, EUR RESPIR J, V12, P926, DOI 10.1183/09031936.98.12040926; Burton OT, 2010, J IMMUNOL, V185, P2754, DOI 10.4049/jimmunol.1001365; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Cho JY, 2004, AM J RESP CELL MOL, V30, P651, DOI 10.1165/rcmb.2003-0066OC; De Trez C, 2008, J IMMUNOL, V180, P238, DOI 10.4049/jimmunol.180.1.238; DiGiovanni FA, 2009, DIS MODEL MECH, V2, P275, DOI 10.1242/dmm.001859; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Doherty TA, 2009, AM J PHYSIOL-LUNG C, V296, pL229, DOI 10.1152/ajplung.90543.2008; Espinosa K, 2003, J ALLERGY CLIN IMMUN, V111, P1032, DOI 10.1067/mai.2003.1451; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Gandhi R, 2007, J IMMUNOL, V178, P4017, DOI 10.4049/jimmunol.178.7.4017; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; HASTIE AT, 2010, J ALLERGY CLIN IMMUN, V125; Heo SK, 2006, J LEUKOCYTE BIOL, V79, P330, DOI 10.1189/jlb.1104694; Hikichi Y, 2001, BIOCHEM BIOPH RES CO, V289, P670, DOI 10.1006/bbrc.2001.6039; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kelly EA, 2003, CURR OPIN PULM MED, V9, P28, DOI 10.1097/00063198-200301000-00005; KHALIL N, 1993, J CLIN INVEST, V92, P1812, DOI 10.1172/JCI116771; Kitani A, 2000, J EXP MED, V192, P41, DOI 10.1084/jem.192.1.41; Le AV, 2007, J IMMUNOL, V178, P7310, DOI 10.4049/jimmunol.178.11.7310; Lee WH, 2001, ARTERIOSCL THROM VAS, V21, P2004, DOI 10.1161/hq1201.098945; Lim DH, 2006, AM J PHYSIOL-LUNG C, V291, pL265, DOI 10.1152/ajplung.00305.2005; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Luzina IG, 2003, ARTHRITIS RHEUM-US, V48, P2262, DOI 10.1002/art.11080; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Saito A, 2003, INT ARCH ALLERGY IMM, V132, P168, DOI 10.1159/000073718; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Southam DS, 2007, J ALLERGY CLIN IMMUN, V119, P848, DOI 10.1016/j.jaci.2006.12.623; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wei CY, 2006, J CELL PHYSIOL, V209, P735, DOI 10.1002/jcp.20742; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Yang M, 2006, J IMMUNOL, V177, P5595, DOI 10.4049/jimmunol.177.8.5595; Zaslona Z, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-2; Zhou XX, 2005, AM J PHYSIOL-CELL PH, V288, pC435, DOI 10.1152/ajpcell.00035.2004	60	123	132	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					596	U118		10.1038/nm.2356	http://dx.doi.org/10.1038/nm.2356			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499267	Green Accepted			2022-12-25	WOS:000290250400036
J	Kumar, V; Kato, N; Urabe, Y; Takahashi, A; Muroyama, R; Hosono, N; Otsuka, M; Tateishi, R; Omata, M; Nakagawa, H; Koike, K; Kamatani, N; Kubo, M; Nakamura, Y; Matsuda, K				Kumar, Vinod; Kato, Naoya; Urabe, Yuji; Takahashi, Atsushi; Muroyama, Ryosuke; Hosono, Naoya; Otsuka, Motoyuki; Tateishi, Ryosuke; Omata, Masao; Nakagawa, Hidewaki; Koike, Kazuhiko; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma	NATURE GENETICS			English	Article							HEPATITIS-C VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; T-CELLS; GENETIC-VARIATION; HAPLOTYPE MAP; CHAIN-A; MICA; MHC; EXPRESSION	To identify the genetic susceptibility factor(s) for hepatitis C virus-induced hepatocellular carcinoma (HCV-induced HCC), we conducted a genome-wide association study using 432,703 autosomal SNPs in 721 individuals with HCV-induced HCC (cases) and 2,890 HCV-negative controls of Japanese origin. Eight SNPs that showed possible association (P < 1 x 10(-5)) in the genome-wide association study were further genotyped in 673 cases and 2,596 controls. We found a previously unidentified locus in the 5' flanking region of MICA on 6p21.33 (rs2596542, P-combined = 4.21 x 10(-13), odds ratio = 1.39) to be strongly associated with HCV-induced HCC. Subsequent analyses using individuals with chronic hepatitis C (CHC) indicated that this SNP is not associated with CHC susceptibility (P = 0.61) but is significantly associated with progression from CHC to HCC (P = 3.13 x 10(-8)). We also found that the risk allele of rs2596542 was associated with lower soluble MICA protein levels in individuals with HCV-induced HCC (P = 1.38 x 10(-13)).	[Kumar, Vinod; Urabe, Yuji; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Lab Mol Med, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Kumar, Vinod; Takahashi, Atsushi; Hosono, Naoya; Nakagawa, Hidewaki; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Kato, Naoya; Muroyama, Ryosuke] Univ Tokyo, Unit Dis Control Genome Med, Inst Med Sci, Tokyo, Japan; [Otsuka, Motoyuki; Tateishi, Ryosuke; Omata, Masao; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan	University of Tokyo; RIKEN; University of Tokyo; University of Tokyo	Matsuda, K (corresponding author), Univ Tokyo, Lab Mol Med, Ctr Human Genome, Inst Med Sci, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Otsuka, Motoyuki/H-9067-2019; Kumar, Vinod/ABC-4866-2020; Tateishi, Ryosuke/G-7758-2014; Matsuda, Koichi/D-4597-2011	Otsuka, Motoyuki/0000-0003-2869-2881; Kumar, Vinod/0000-0002-2775-6049; Tateishi, Ryosuke/0000-0003-3021-2517; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank all the subjects and the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan who donated their DNA for this work. We also thank the technical staff of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, and the Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University of Tokyo. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	[Anonymous], 1999, NATURE, V401, P921; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Breslow N. E, 1987, IARC SCI PUBL, V1-406; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Jinushi M, 2005, J HEPATOL, V43, P1013, DOI 10.1016/j.jhep.2005.05.026; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kohga K, 2008, CANCER SCI, V99, P1643, DOI 10.1111/j.1349-7006.2008.00859.x; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; TSUKIYAMAKOHARA K, 1991, VIRUS GENES, V5, P243, DOI 10.1007/BF00568974; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Vong S, 2004, HEPATOLOGY, V39, P476, DOI 10.1002/hep.20049; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Wang JH, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-46; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	39	283	293	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					455	+		10.1038/ng.809	http://dx.doi.org/10.1038/ng.809			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21499248				2022-12-25	WOS:000289972600016
J	Deng, XX; Hiatt, JB; Nguyen, DK; Ercan, S; Sturgill, D; Hillier, LW; Schlesinger, F; Davis, CA; Reinke, VJ; Gingeras, TR; Shendure, J; Waterston, RH; Oliver, B; Lieb, JD; Disteche, CM				Deng, Xinxian; Hiatt, Joseph B.; Di Kim Nguyen; Ercan, Sevinc; Sturgill, David; Hillier, LaDeana W.; Schlesinger, Felix; Davis, Carrie A.; Reinke, Valerie J.; Gingeras, Thomas R.; Shendure, Jay; Waterston, Robert H.; Oliver, Brian; Lieb, Jason D.; Disteche, Christine M.			Evidence for compensatory upregulation of expressed X-linked genes in mammals, Caenorhabditis elegans and Drosophila melanogaster	NATURE GENETICS			English	Article							SEX-CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; RNA-SEQ; MUS MUSCULUS; MSL COMPLEX; C-ELEGANS; MOUSE; GENOME; REVEALS; LOCALIZATION	Many animal species use a chromosome-based mechanism of sex determination, which has led to the coordinate evolution of dosage-compensation systems. Dosage compensation not only corrects the imbalance in the number of X chromosomes between the sexes but also is hypothesized to correct dosage imbalance within cells that is due to monoallelic X-linked expression and biallelic autosomal expression, by upregulating X-linked genes twofold (termed 'Ohno's hypothesis'). Although this hypothesis is well supported by expression analyses of individual X-linked genes and by microarray-based transcriptome analyses, it was challenged by a recent study using RNA sequencing and proteomics. We obtained new, independent RNA-seq data, measured RNA polymerase distribution and reanalyzed published expression data in mammals, C. elegans and Drosophila. Our analyses, which take into account the skewed gene content of the X chromosome, support the hypothesis of upregulation of expressed X-linked genes to balance expression of the genome.	[Deng, Xinxian; Di Kim Nguyen; Disteche, Christine M.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Hiatt, Joseph B.; Shendure, Jay; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Ercan, Sevinc] NYU, Dept Biol, New York, NY 10003 USA; [Ercan, Sevinc] NYU, Ctr Genom & Syst Biol, New York, NY USA; [Sturgill, David; Oliver, Brian] NIDDK, Sect Dev Gen, Cellular & Dev Biol Lab, US Natl Inst Hlth, Bethesda, MD USA; [Hillier, LaDeana W.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA; [Schlesinger, Felix; Davis, Carrie A.; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lieb, Jason D.] Yale Univ, Dept Genet, New Haven, CT USA; [Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Disteche, Christine M.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Washington University (WUSTL); Cold Spring Harbor Laboratory; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Disteche, CM (corresponding author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.	oliver@helix.nih.gov; jlieb@bio.unc.edu; cdistech@u.washington.edu	Schlesinger, Felix/E-2143-2011; Shendure, Jay/AAU-3684-2021	Gingeras, Thomas/0000-0001-9106-3573; Sturgill, David/0000-0002-7902-3605; Lieb, Jason/0000-0001-7601-8061; Shendure, Jay/0000-0002-1516-1865	US National Institutes of Health [GM079537]; modENCODE [HG004270, HG004263, AG039173]; ENCODE [HG004557]; National Institute of Diabetes and Digestive and Kidney Diseases; William H. Gates III Endowed Chair of Biomedical Sciences; Achievement Rewards for College Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270, U01HG004263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039173] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); modENCODE; ENCODE; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); William H. Gates III Endowed Chair of Biomedical Sciences; Achievement Rewards for College Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Nelson and C. Ware (University of Washington) for expert assistance with ES cell culture and N. Brockdorff (Oxford University) for the female ES cell line PGK12.1. We thank R. Beyer (University of Washington) and X. Deng (University of Wisconsin-Madison) for help with statistical analyses and F. Yang (University of Washington) for helpful discussions. We thank I. Khrebtukova (Illumina) for RNA-seq data on human tissues. This work was supported by grants from the US National Institutes of Health GM079537 (C.M.D.), modENCODE grants HG004270 (J.D.L.), HG004263 (R.H.W.) and AG039173 (J.B.H.), ENCODE Transcriptome Project grant HG004557 (T.R.G.) and by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (B.O.), the William H. Gates III Endowed Chair of Biomedical Sciences (R.H.W.) and a fellowship from the Achievement Rewards for College Scientists (J.B.H.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Davis TL, 1997, DEVELOPMENT, V124, P1019; Deng XX, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000318; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Gan QA, 2010, CELL RES, V20, P763, DOI 10.1038/cr.2010.64; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Hosseini Parsa, 2010, BMC Res Notes, V3, P183, DOI 10.1186/1756-0500-3-183; Kelly WG, 2002, DEVELOPMENT, V129, P479; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; LEWIS JA, 1987, J NEUROSCI, V7, P3059; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mizuno H, 2002, GENES GENET SYST, V77, P269, DOI 10.1266/ggs.77.269; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; Stevenson RE, 2009, DEV DISABIL RES REV, V15, P361, DOI 10.1002/ddrr.81; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	61	199	199	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1179	U28		10.1038/ng.948	http://dx.doi.org/10.1038/ng.948			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019781	Green Accepted, Green Published			2022-12-25	WOS:000297931400008
J	Patton, GC; Stenmark, P; Gollapalli, DR; Sevastik, R; Kursula, P; Flodin, S; Schuler, H; Swales, CT; Eklund, H; Himo, F; Nordlund, P; Hedstrom, L				Patton, Gregory C.; Stenmark, Pal; Gollapalli, Deviprasad R.; Sevastik, Robin; Kursula, Petri; Flodin, Susanne; Schuler, Herwig; Swales, Colin T.; Eklund, Hans; Himo, Fahmi; Nordlund, Par; Hedstrom, Lizbeth			Cofactor mobility determines reaction outcome in the IMPDH and GMPR (beta-alpha)(8) barrel enzymes	NATURE CHEMICAL BIOLOGY			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EVOLUTION; COMPLEX; MECHANISM; BINDING; GENES; SELECTIVITY; INHIBITION	Inosine monophosphate dehydrogenase (IMPDH) and guanosine monophosphate reductase (GMPR) belong to the same structural family, share a common set of catalytic residues and bind the same ligands. The structural and mechanistic features that determine reaction outcome in the IMPDH and GMPR family have not been identified. Here we show that the GMPR reaction uses the same intermediate E-XMP star as IMPDH, but in this reaction the intermediate reacts with ammonia instead of water. A single crystal structure of human GMPR type 2 with IMP and NADPH fortuitously captures three different states, each of which mimics a distinct step in the catalytic cycle of GMPR. The cofactor is found in two conformations: an 'in' conformation poised for hydride transfer and an 'out' conformation in which the cofactor is 6 angstrom from IMP. Mutagenesis along with substrate and cofactor analog experiments demonstrate that the out conformation is required for the deamination of GMP. Remarkably, the cofactor is part of the catalytic machinery that activates ammonia.	[Stenmark, Pal; Kursula, Petri; Flodin, Susanne; Schuler, Herwig; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Patton, Gregory C.; Gollapalli, Deviprasad R.; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Sevastik, Robin; Himo, Fahmi] Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden; [Swales, Colin T.; Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA; [Eklund, Hans] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, Uppsala, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Karolinska Institutet; Brandeis University; Stockholm University; Stockholm University; Brandeis University; Swedish University of Agricultural Sciences; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nordlund, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	par.nordlund@ki.se; hedstrom@brandeis.edu	Schuler, Herwig/E-5751-2011; Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022; Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012	Schuler, Herwig/0000-0003-4059-3501; Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Stenmark, Pal/0000-0003-4777-3417	US National Institutes of Health (NIH) [GM54403, P41 RR001081]; Swedish Research Council; Swedish Cancer Society; Wenner-Gren Foundations; Swedish Foundation for Strategic Research; National Science Foundation, Division of Biological Infrastructure [DBI-0100085]; Canadian Institutes for Health Research; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Wellcome Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054403] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Foundations; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Science Foundation, Division of Biological Infrastructure(National Science Foundation (NSF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Andrews at the University of Sheffield for supplying the pUC plasmid carrying the E. coli K12 GMPR gene. We also are grateful for construction of pET28a GMPR by I. S. MacPherson. We also thank the staff at BESSY (Berlin, Germany) for support at beamline BL14.1. This work was supported by the US National Institutes of Health (NIH) GM54403 (L. H.) and by grants from the Swedish Research Council (P. N. and P. S.), the Swedish Cancer Society (P. N.), the Wenner-Gren Foundations (P. S.) and the Swedish Foundation for Strategic Research (P. S.). The Q-Tof Ultima mass spectrometer at the University of Illinois was purchased in part with a grant from the National Science Foundation, Division of Biological Infrastructure (DBI-0100085). Molecular graphics images were produced using the University of California, San Fransisco (UCSF) Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the UCSF (supported by NIH P41 RR001081). The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.	Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Martinelli LKB, 2011, MOL BIOSYST, V7, P1289, DOI 10.1039/c0mb00245c; BRADY K, 1990, BIOCHEMISTRY-US, V29, P7608, DOI 10.1021/bi00485a010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Deng YF, 2002, INT J BIOCHEM CELL B, V34, P1035, DOI 10.1016/S1357-2725(02)00024-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch M., 2016, GAUSSIAN 16 REVISION; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Ji R, 2006, BIOGEOCHEMISTRY, V78, P267, DOI 10.1007/s10533-005-4279-z; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li JX, 2006, J MOL BIOL, V355, P980, DOI 10.1016/j.jmb.2005.11.047; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Min DH, 2008, PLOS BIOL, V6, P1802, DOI 10.1371/journal.pbio.0060206; Minegishi S, 2003, J AM CHEM SOC, V125, P286, DOI 10.1021/ja021010y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prosise GL, 2003, J MOL BIOL, V326, P517, DOI 10.1016/S0022-2836(02)01383-9; Riera TV, 2008, BIOCHEMISTRY-US, V47, P8689, DOI 10.1021/bi800674a; ROBERTS RE, 1988, J BACTERIOL, V170, P463, DOI 10.1128/jb.170.1.463-467.1988; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Schlippe YVG, 2004, BIOCHEMISTRY-US, V43, P4511, DOI 10.1021/bi035823q; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; SPECTOR T, 1979, J BIOL CHEM, V254, P2308; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; WEBER G, 1992, ADV ENZYME REGUL, V32, P57; Wise EL, 2004, ACCOUNTS CHEM RES, V37, P149, DOI 10.1021/ar030250v; Zahnle K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004895; Zalatan JG, 2009, NAT CHEM BIOL, V5, P516, DOI 10.1038/nchembio0809-516; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang RG, 1999, CURR MED CHEM, V6, P537	50	30	33	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					950	958		10.1038/NCHEMBIO.693	http://dx.doi.org/10.1038/NCHEMBIO.693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22037469	Green Accepted			2022-12-25	WOS:000297166200019
J	Davis, MI; Hunt, JP; Herrgard, S; Ciceri, P; Wodicka, LM; Pallares, G; Hocker, M; Treiber, DK; Zarrinkar, PP				Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.			Comprehensive analysis of kinase inhibitor selectivity	NATURE BIOTECHNOLOGY			English	Article							INTERACTION MAP; KINOME; BINDING	We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome. Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend. The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compounds tested. Analysis of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily. The data set suggests compounds to use as tools to study kinases for which no dedicated inhibitors exist. It also provides a foundation for further exploring kinase inhibitor biology and toxicity, as well as for studying the structural basis of the observed interaction patterns. Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.	[Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.] Ambit Biosci, San Diego, CA USA		Zarrinkar, PP (corresponding author), Blueprint Med Corp, San Diego, CA 92121 USA.	dtreiber@discoverx.com; pzarrinkar@yahoo.com			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Buchanan SG, 2009, MOL CANCER THER, V8, P3181, DOI 10.1158/1535-7163.MCT-09-0477; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Hasinoff BB, 2010, TOXICOL APPL PHARM, V249, P132, DOI 10.1016/j.taap.2010.08.026; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Miduturu CV, 2011, CHEM BIOL, V18, P868, DOI 10.1016/j.chembiol.2011.05.010; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Olaharski AJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000446; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Simard JR, 2010, J AM CHEM SOC, V132, P4152, DOI 10.1021/ja908083e; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang XA, 2010, J BIOMED INFORM, V43, P376, DOI 10.1016/j.jbi.2010.04.006; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	30	1203	1259	9	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1046	U124		10.1038/nbt.1990	http://dx.doi.org/10.1038/nbt.1990			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22037378				2022-12-25	WOS:000296801300028
J	Johnson, DBF; Xu, JF; Shen, ZX; Takimoto, JK; Schultz, MD; Schmitz, RJ; Xiang, Z; Ecker, JR; Briggs, SP; Wang, L				Johnson, David B. F.; Xu, Jianfeng; Shen, Zhouxin; Takimoto, Jeffrey K.; Schultz, Matthew D.; Schmitz, Robert J.; Xiang, Zheng; Ecker, Joseph R.; Briggs, Steven P.; Wang, Lei			RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites	NATURE CHEMICAL BIOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; SUPPRESSOR TRANSFER-RNAS; ESCHERICHIA-COLI; GENETIC-CODE; RELEASE FACTOR-2; SYSTEM; TRANSLATION; NONSENSE; CODONS; MUTANT	Stop codons have been exploited for genetic incorporation of unnatural amino acids (Uaas) in live cells, but their low incorporation efficiency, which is possibly due to competition from release factors, limits the power and scope of this technology. Here we show that the reportedly essential release factor 1 (RF1) can be knocked out from Escherichia coli by 'fixing' release factor 2 (RF2). The resultant strain JX33 is stable and independent, and it allows UAG to be reassigned from a stop signal to an amino acid when a UAG-decoding tRNA-synthetase pair is introduced. Uaas were efficiently incorporated at multiple UAG sites in the same gene without translational termination in JX33. We also found that amino acid incorporation at endogenous UAG codons is dependent on RF1 and mRNA context, which explains why E. coli tolerates apparent global suppression of UAG. JX33 affords a unique autonomous host for synthesizing and evolving new protein functions by enabling Uaa incorporation at multiple sites.	[Johnson, David B. F.; Xu, Jianfeng; Takimoto, Jeffrey K.; Xiang, Zheng; Wang, Lei] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Schultz, Matthew D.; Schmitz, Robert J.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schultz, Matthew D.] Univ Calif San Diego, Grad Bioinformat Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego	Wang, L (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lwang@salk.edu	Wang, Lei/E-7912-2011; Xiang, Zheng/D-9625-2011; Schmitz, Robert/AAY-7659-2020; Ecker, Joseph R/B-9144-2008	Wang, Lei/0000-0002-5859-2526; Schmitz, Robert/0000-0001-7538-6663; Ecker, Joseph R/0000-0001-5799-5895; Xiang, Zheng/0000-0003-2925-842X	Pioneer Fellowship; National Science Foundation [DGE-0504645]; US National Institutes of Health National Research Service [F32-HG004830]; Mary K. Chapman Foundation; Ray Thomas Edwards Foundation [06-I-119]; March of Dimes Foundation [5-FY08-110]; California Institute for Regenerative Medicine [RN1-00577-1]; US National Institutes of Health [1DP2OD004744-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004744] Funding Source: NIH RePORTER	Pioneer Fellowship; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary K. Chapman Foundation; Ray Thomas Edwards Foundation; March of Dimes Foundation(March of Dimes); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are very grateful to R. Sauer (MIT) for providing strain X90 ssrA1::cat, to L. Isaksson (Stockholm University) for providing strain MRA8, to W. Liu (Texas A&M University) for providing plasmid pET-L11C and to J. Kadonaga (University of California San Diego) for suggestions on H3a purification. We thank V.K. Lacey for proofreading the manuscript. J.X. was partially funded by the Pioneer Fellowship. M.D.S. was supported by National Science Foundation IGERT training grant (DGE-0504645). R.J.S. was supported by an US National Institutes of Health National Research Service Award postdoctoral fellowship (F32-HG004830). J.R.E. acknowledges support from the Mary K. Chapman Foundation. L.W. acknowledges support from the Ray Thomas Edwards Foundation, Searle Scholar Program (06-I-119), Beckman Young Investigator Program, March of Dimes Foundation (#5-FY08-110), California Institute for Regenerative Medicine (RN1-00577-1) and US National Institutes of Health (1DP2OD004744-01).	Abe H, 1999, GENES CELLS, V4, P87, DOI 10.1046/j.1365-2443.1999.00246.x; Agafonov DE, 2001, EMBO REP, V2, P399; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; BENZER S, 1962, P NATL ACAD SCI USA, V48, P1114, DOI 10.1073/pnas.48.7.1114; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Dahlgren A, 2000, BIOCHIMIE, V82, P683, DOI 10.1016/S0300-9084(00)01160-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Huang Y, 2010, MOL BIOSYST, V6, P683, DOI 10.1039/b920120c; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Lee JH, 2004, MOL MICROBIOL, V51, P1745, DOI 10.1111/j.1365-2958.2003.03946.x; Luger K, 1999, METHOD ENZYMOL, V304, P3; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ueda K, 2002, GENES CELLS, V7, P509, DOI 10.1046/j.1365-2443.2002.00537.x; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2003, J ORG CHEM, V68, P174, DOI 10.1021/jo026570u; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Yokoyama Shigeyuki, 1995, P207; ZHANG SP, 1994, J MOL BIOL, V242, P614, DOI 10.1006/jmbi.1994.1611	40	245	256	3	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					779	786		10.1038/nchembio.657	http://dx.doi.org/10.1038/nchembio.657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21926996	Green Accepted, Green Submitted			2022-12-25	WOS:000296381600007
J	Motegi, F; Zonies, S; Hao, YS; Cuenca, AA; Griffin, E; Seydoux, G				Motegi, Fumio; Zonies, Seth; Hao, Yingsong; Cuenca, Adrian A.; Griffin, Erik; Seydoux, Geraldine			Microtubules induce self-organization of polarized PAR domains in Caenorhabditis elegans zygotes	NATURE CELL BIOLOGY			English	Article							ANTERIOR-POSTERIOR AXIS; C-ELEGANS; CELL POLARITY; CENTROSOME MATURATION; PROTEIN PAR-2; EMBRYOS; ESTABLISHMENT; KINASE; CYTOKINESIS; RNAI	A hallmark of polarized cells is the segregation of the PAR polarity regulators into asymmetric domains at the cell cortex(1,2). Antagonistic interactions involving two conserved kinases, atypical protein kinase C (aPKC) and PAR-1, have been implicated in polarity maintenance(1,2), but the mechanisms that initiate the formation of asymmetric PAR domains are not understood. Here, we describe one pathway used by the sperm-donated centrosome to polarize the PAR proteins in Caenorhabditis elegans zygotes. Before polarization, cortical aPKC excludes PAR-1 kinase and its binding partner PAR-2 by phosphorylation. During symmetry breaking, microtubules nucleated by the centrosome locally protect PAR-2 from phosphorylation by aPKC, allowing PAR-2 and PAR-1 to access the cortex nearest the centrosome. Cortical PAR-1 phosphorylates PAR-3, causing the PAR-3-aPKC complex to leave the cortex. Our findings illustrate how microtubules, independently of actin dynamics, stimulate the self-organization of PAR proteins by providing local protection against a global barrier imposed by aPKC	[Motegi, Fumio; Zonies, Seth; Hao, Yingsong; Cuenca, Adrian A.; Griffin, Erik; Seydoux, Geraldine] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst,Ctr Cell Dynam, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Seydoux, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst,Ctr Cell Dynam, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu		Seydoux, Geraldine/0000-0001-8257-0493	Japan Society for the Promotion of Science; American Cancer Society [PF-08-158-01]; National Institute of Health [R01HD37047]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Japan Society for the Promotion of Science (F.M.), the American Cancer Society (PF-08-158-01; E.G.) and the National Institute of Health (R01HD37047; G.S.). G.S. is an investigator of the Howard Hughes Medical Institute. We thank J. Ahringer, A. Audhya, L. Boyd, A. Desai, P. Gonczy, M. Gotta, R. Green, C. Hoege, K. Kemphues, Y. Nishimura, K.F. O'Connell, K. Oegema, L.S. Rose, A. Sugimoto, C.M. Waterman, H. Zaher and the Caenorhabditis Genetic Center for reagents and expertise.	Aono S, 2004, DEVELOPMENT, V131, P2865, DOI 10.1242/dev.01146; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Doerflinger H, 2010, DEVELOPMENT, V137, P1765, DOI 10.1242/dev.045807; Dong Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-19; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Griffin EE, 2011, CELL, V146, P954, DOI 10.1016/j.cell.2011.08.012; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Labbe JC, 2006, GENETICS, V174, P285, DOI 10.1534/genetics.106.060517; Li BS, 2010, DEV BIOL, V344, P745, DOI 10.1016/j.ydbio.2010.05.506; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; MERRITT C, 2010, WORMBOOK, V1; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Morita K, 2005, EMBO REP, V6, P1163, DOI 10.1038/sj.embor.7400533; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Praitis V, 2001, GENETICS, V157, P1217; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Sonneville R, 2004, DEVELOPMENT, V131, P3527, DOI 10.1242/dev.01244; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	39	113	121	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1361	U171		10.1038/ncb2354	http://dx.doi.org/10.1038/ncb2354			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	21983565	Green Accepted			2022-12-25	WOS:000296737900013
J	Sulem, P; Gudbjartsson, DF; Walters, GB; Helgadottir, HT; Helgason, A; Gudjonsson, SA; Zanon, C; Besenbacher, S; Bjornsdottir, G; Magnusson, OT; Magnusson, G; Hjartarson, E; Saemundsdottir, J; Gylfason, A; Jonasdottir, A; Holm, H; Karason, A; Rafnar, T; Stefansson, H; Andreassen, OA; Pedersen, JH; Pack, AI; de Visser, MCH; Kiemeney, LA; Geirsson, AJ; Eyjolfsson, GI; Olafsson, I; Kong, A; Masson, G; Jonsson, H; Thorsteinsdottir, U; Jonsdottir, I; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Walters, G. Bragi; Helgadottir, Hafdis T.; Helgason, Agnar; Gudjonsson, Sigurjon A.; Zanon, Carlo; Besenbacher, Soren; Bjornsdottir, Gyda; Magnusson, Olafur T.; Magnusson, Gisli; Hjartarson, Eirikur; Saemundsdottir, Jona; Gylfason, Arnaldur; Jonasdottir, Adalbjorg; Holm, Hilma; Karason, Ari; Rafnar, Thorunn; Stefansson, Hreinn; Andreassen, Ole A.; Pedersen, Jesper H.; Pack, Allan I.; de Visser, Marieke C. H.; Kiemeney, Lambertus A.; Geirsson, Arni J.; Eyjolfsson, Gudmundur I.; Olafsson, Isleifur; Kong, Augustine; Masson, Gisli; Jonsson, Helgi; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari			Identification of low-frequency variants associated with gout and serum uric acid levels	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; RISK; URATE; METABOLISM; IMPUTATION; GENOTYPES; FAMILY; CANCER; SLC2A9	We tested 16 million SNPs, identified through whole-genome sequencing of 457 Icelanders, for association with gout and serum uric acid levels. Genotypes were imputed into 41,675 chip-genotyped Icelanders and their relatives, for effective sample sizes of 968 individuals with gout and 15,506 individuals for whom serum uric acid measurements were available. We identified a low-frequency missense variant ( c.1580C>G) in ALDH16A1 associated with gout (OR = 3.12, P = 1.5 x 10(-16), at-risk allele frequency = 0.019) and serum uric acid levels (effect = 0.36 s.d., P = 4.5 x 10(-21)). We confirmed the association with gout by performing Sanger sequencing on 6,017 Icelanders. The association with gout was stronger in males relative to females. We also found a second variant on chromosome 1 associated with gout (OR = 1.92, P = 0.046, at-risk allele frequency = 0.986) and serum uric acid levels (effect = 0.48 s.d., P = 4.5 x 10(-16)). This variant is close to a common variant previously associated with serum uric acid levels. This work illustrates how whole-genome sequencing data allow the detection of associations between low-frequency variants and complex traits.	[Sulem, Patrick; Gudbjartsson, Daniel F.; Walters, G. Bragi; Helgadottir, Hafdis T.; Helgason, Agnar; Gudjonsson, Sigurjon A.; Zanon, Carlo; Besenbacher, Soren; Bjornsdottir, Gyda; Magnusson, Olafur T.; Magnusson, Gisli; Hjartarson, Eirikur; Saemundsdottir, Jona; Gylfason, Arnaldur; Jonasdottir, Adalbjorg; Holm, Hilma; Karason, Ari; Rafnar, Thorunn; Stefansson, Hreinn; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Andreassen, Ole A.] Univ Oslo, Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Pedersen, Jesper H.] Univ Copenhagen, Rigshosp, Dept Cardiothorac Surg, DK-2100 Copenhagen, Denmark; [Pack, Allan I.] Univ Penn, Sch Med, Div Sleep Med, Ctr Sleep & Circardian Neurobiol, Philadelphia, PA 19104 USA; [de Visser, Marieke C. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Comprehens Canc Ctr E IKO, Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Geirsson, Arni J.; Jonsson, Helgi] Natl Univ Hosp Iceland, Dept Med, Landspitali, Reykjavik, Iceland; [Eyjolfsson, Gudmundur I.] Iceland Med Ctr Laeknasetrid, Lab Mjodd RAM, Reykjavik, Iceland; [Olafsson, Isleifur] Natl Univ Hosp Iceland, Dept Clin Biochem, Landspitali, Reykjavik, Iceland; [Jonsson, Helgi; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonsdottir, Ingileif] Natl Univ Hosp Iceland, Dept Immunol, Landspitali, Reykjavik, Iceland	University of Oslo; University of Oslo; Rigshospitalet; University of Copenhagen; University of Pennsylvania; Pennsylvania Medicine; Radboud University Nijmegen; Radboud University Nijmegen; University of Iceland	Sulem, P (corresponding author), DeCODE Genet, Reykjavik, Iceland.	patrick.sulem@decode.is; kstefans@decode.is	de Visser, Marieke/AAC-5167-2020; Kiemeney, Lambertus A./D-3357-2009; Andreassen, Ole A./AAY-7531-2020; Walters, G. Bragi/L-4215-2013; Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019	Kiemeney, Lambertus A./0000-0002-2368-1326; Walters, G. Bragi/0000-0002-5415-6487; Stefansson, Hreinn/0000-0002-9331-6666; Gudbjartsson, Daniel/0000-0002-5222-9857; Pack, Allan/0000-0002-2879-0484; Jonsson, Helgi/0000-0003-0187-8985; Kong, Augustine/0000-0001-8193-5438; Bjornsdottir, Gyda/0000-0002-8100-0306; Andreassen, Ole A./0000-0002-4461-3568; Zanon, Carlo/0000-0003-2539-7238; Besenbacher, Soren/0000-0003-1455-1738; Helgason, Agnar/0000-0002-8545-3767; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Helgadottir, Hafdis/0000-0003-4352-152X	European Commission [200800]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was supported by a European Commission Framework 7 Programme grant (200800 TREAT-OA, Translational Research in Europa-Applied Technologies for Osteoarthritis).	Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2010, CURR OPIN RHEUMATOL, V22, P144, DOI 10.1097/BOR.0b013e32833645e8; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Harris MD, 1999, AM FAM PHYSICIAN, V59, P925; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Labuda M, 1996, AM J HUM GENET, V59, P633; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; Yamamoto T, 2005, CLIN CHIM ACTA, V356, P35, DOI 10.1016/j.cccn.2005.01.024; YAMANAKA H, 1994, ADV EXP MED BIOL, V370, P53; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455	30	108	116	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1127	U119		10.1038/ng.972	http://dx.doi.org/10.1038/ng.972			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21983786				2022-12-25	WOS:000296584000018
J	Pasqualucci, L; Trifonov, V; Fabbri, G; Ma, J; Rossi, D; Chiarenza, A; Wells, VA; Grunn, A; Messina, M; Elliot, O; Chan, J; Bhagat, G; Chadburn, A; Gaidano, G; Mullighan, CG; Rabadan, R; Dalla-Favera, R				Pasqualucci, Laura; Trifonov, Vladimir; Fabbri, Giulia; Ma, Jing; Rossi, Davide; Chiarenza, Annalisa; Wells, Victoria A.; Grunn, Adina; Messina, Monica; Elliot, Oliver; Chan, Joseph; Bhagat, Govind; Chadburn, Amy; Gaidano, Gianluca; Mullighan, Charles G.; Rabadan, Raul; Dalla-Favera, Riccardo			Analysis of the coding genome of diffuse large B-cell lymphoma	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; GENETIC ALTERATIONS; MULTIPLE-MYELOMA; HODGKIN LYMPHOMA; ANALYSIS REVEALS; PHD FINGER; MUTATIONS; CANCER	Diffuse large B-cell lymphoma (DLBCL) is the most common form of human lymphoma. Although a number of structural alterations have been associated with the pathogenesis of this malignancy, the full spectrum of genetic lesions that are present in the DLBCL genome, and therefore the identity of dysregulated cellular pathways, remains unknown. By combining next-generation sequencing and copy number analysis, we show that the DLBCL coding genome contains, on average, more than 30 clonally represented gene alterations per case. This analysis also revealed mutations in genes not previously implicated in DLBCL pathogenesis, including those regulating chromatin methylation (MLL2; 24% of samples) and immune recognition by T cells. These results provide initial data on the complexity of the DLBCL coding genome and identify novel dysregulated pathways underlying its pathogenesis.	[Pasqualucci, Laura; Fabbri, Giulia; Chiarenza, Annalisa; Wells, Victoria A.; Grunn, Adina; Messina, Monica; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Pasqualucci, Laura; Bhagat, Govind; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Pasqualucci, Laura; Bhagat, Govind; Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Trifonov, Vladimir; Elliot, Oliver; Chan, Joseph; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Trifonov, Vladimir; Elliot, Oliver; Chan, Joseph; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Ma, Jing; Mullighan, Charles G.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Clin & Expt Med, Novara, Italy; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Chadburn, Amy] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; St Jude Children's Research Hospital; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Northwestern University; Feinberg School of Medicine; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	lp171@columbia.edu; rd10@columbia.edu	Mullighan, Charles/H-3253-2011; Bhagat, Govind/AAE-9493-2021; Gaidano, Gianluca/AAW-2773-2021; Chiarenza, Annalisa/AAC-2013-2019; Rabadan, Raul/AAZ-7367-2020	Mullighan, Charles/0000-0002-1871-1850; Bhagat, Govind/0000-0001-6250-048X; Gaidano, Gianluca/0000-0002-4681-0151; Chiarenza, Annalisa/0000-0002-8759-4854; Chan, Joseph/0000-0001-5249-7395; Rabadan, Raul/0000-0001-7946-9255; Messina, Monica/0000-0003-3531-4766	US National Institutes of Health (NIH) [PO1-CA092625, RO1-CA37295]; Leukemia & Lymphoma Society; NIH [CA121852-05]; Northeast Biodefense Center [U54-AI057158]; National Library of Medicine [1R01LM010140-01]; Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy [10007]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA037295, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank T. Palomero, E. Tzilianos, V. Miljkovic and the Genomics Technologies Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University; D. Burgess at Roche NimbleGen (Madison, Wisconsin, USA) and B. Boese at 454 Life Sciences (Branford, Connecticut, USA) for assistance with the whole-exome capture and sequencing procedure; K. Basso and A. Holmes for help with the manual curation and analysis of the copy number data; M. Malladi and Y. K. Lieu for help with the analysis of B2M and CD58; and J. Zhang for filtering the list of candidate mutations against the database of germline variants discovered from the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project. The Affymetrix SNP6.0 array experiments were processed in part at the Affymetrix Research Services Laboratory. Automated DNA sequencing was performed at Genewiz, Inc. This work was supported by US National Institutes of Health (NIH) Grants PO1-CA092625 and RO1-CA37295 (to R. D.-F.), a Specialized Center of Research grant from the Leukemia & Lymphoma Society (to R. D.-F.), NIH Grant CA121852-05, the Northeast Biodefense Center (U54-AI057158) and the National Library of Medicine (1R01LM010140-01) (to R. R.), and the Associazione Italiana per la Ricerca sul Cancro (AIRC) Special Program Molecular Clinical Oncology-5 per mille (Contract No. 10007, Milan, Italy). A. Chiarenza was on leave from the Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy.	Abramson JS, 2005, BLOOD, V106, P1164, DOI 10.1182/blood-2005-02-0687; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Jordanova ES, 2003, INT J CANCER, V103, P393, DOI 10.1002/ijc.10824; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; MENDEZLAGO M, 2010, BLOOD, P116; Middendorp S, 2009, BLOOD, V114, P2280, DOI 10.1182/blood-2009-03-208215; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pounds S, 2009, BIOINFORMATICS, V25, P315, DOI 10.1093/bioinformatics/btn624; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Riemersma SA, 2000, BLOOD, V96, P3569, DOI 10.1182/blood.V96.10.3569.h8003569_3569_3577; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Swerdlow E., 2008, WHO CLASSIFICATION T; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	65	722	745	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					830	U33		10.1038/ng.892	http://dx.doi.org/10.1038/ng.892			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21804550	Green Accepted			2022-12-25	WOS:000294325800007
J	Garcia-Gonzalo, FR; Corbit, KC; Sirerol-Piquer, MS; Ramaswami, G; Otto, EA; Noriega, TR; Seol, AD; Robinson, JF; Bennett, CL; Josifova, DJ; Garcia-Verdugo, JM; Katsanis, N; Hildebrandt, F; Reiter, JF				Garcia-Gonzalo, Francesc R.; Corbit, Kevin C.; Salome Sirerol-Piquer, Maria; Ramaswami, Gokul; Otto, Edgar A.; Noriega, Thomas R.; Seol, Allen D.; Robinson, Jon F.; Bennett, Christopher L.; Josifova, Dragana J.; Manuel Garcia-Verdugo, Jose; Katsanis, Nicholas; Hildebrandt, Friedhelm; Reiter, Jeremy F.			A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; MULTIPOINT LINKAGE ANALYSIS; PRIMARY CILIUM; SYNDROME PROTEINS; DIFFUSION BARRIER; JOUBERT-SYNDROME; KIDNEY-DISEASE; MOUSE MODEL; BASAL BODY; CILIOPATHIES	Mutations affecting ciliary components cause ciliopathies. As described here, we investigated Tectonic1 (Tctn1), a regulator of mouse Hedgehog signaling, and found that it is essential for ciliogenesis in some, but not all, tissues. Cell types that do not require Tctn1 for ciliogenesis require it to localize select membrane-associated proteins to the cilium, including Arl13b, AC3, Smoothened and Pkd2. Tctn1 forms a complex with multiple ciliopathy proteins associated with Meckel and Joubert syndromes, including Mks1, Tmem216, Tmem67, Cep290, B9d1, Tctn2 and Cc2d2a. Components of this complex co-localize at the transition zone, a region between the basal body and ciliary axoneme. Like Tctn1, loss of Tctn2, Tmem67 or Cc2d2a causes tissue-specific defects in ciliogenesis and ciliary membrane composition. Consistent with a shared function for complex components, we identified a mutation in TCTN1 that causes Joubert syndrome. Thus, a transition zone complex of Meckel and Joubert syndrome proteins regulates ciliary assembly and trafficking, suggesting that transition zone dysfunction is the cause of these ciliopathies.	[Garcia-Gonzalo, Francesc R.; Corbit, Kevin C.; Noriega, Thomas R.; Seol, Allen D.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Garcia-Gonzalo, Francesc R.; Corbit, Kevin C.; Seol, Allen D.; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Salome Sirerol-Piquer, Maria; Manuel Garcia-Verdugo, Jose] Univ Valencia, Lab Morfol Celular, Unidad Mixta Ctr Invest Principe Felipe, Ctr Invest Biomed Red CIBERNED, Valencia, Spain; [Ramaswami, Gokul; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ramaswami, Gokul; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Robinson, Jon F.; Bennett, Christopher L.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC USA; [Robinson, Jon F.; Bennett, Christopher L.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Josifova, Dragana J.] Guys Hosp, Dept Clin Genet, London SE1 9RT, England; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Dept Comparat Neurobiol, Valencia, Spain; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; Prince Felipe Research Center; University of Valencia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University; Duke University; Guy's & St Thomas' NHS Foundation Trust; University of Valencia; Howard Hughes Medical Institute	Reiter, JF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	jeremy.reiter@ucsf.edu	Garcia-Gonzalo, Francesc/W-2639-2017; Katsanis, Nicholas/E-1837-2012; Sirerol, Salome/K-6141-2012; García-Verdugo, José Manuel/L-8421-2017	Garcia-Gonzalo, Francesc/0000-0002-9152-2191; Sirerol, Salome/0000-0002-9678-4502; García-Verdugo, José Manuel/0000-0001-9872-6499; Katsanis, Nicholas/0000-0002-2480-0171; Otto, Edgar/0000-0002-2387-9973; Bennett, Christopher/0000-0002-8467-6192	National Science Foundation; National Institute for General Medical Sciences-Initiative for Maximizing Student Diversity [R25-GM56847]; US National Institutes of Health [HD04260, DK072301, DK075972, DK1069274, DK1068306, RC4-K090917, AR054396]; March of Dimes; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, RC4DK090917, R01DK075972, R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute for General Medical Sciences-Initiative for Maximizing Student Diversity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Institute for Regeneration Medicine and Nikon Imaging Centers at University of California San Francisco. The Servei Central de Suport a la Investigacio Experimental and M. Soriano-Navarro assisted with electron microscopy. Members of the Reiter lab provided valuable discussions. K. Anderson, D. Beier, J. Gleeson, C. Johnson, H. Khanna, R. Molday, K. Mykytyn, G. Pazour, S. Scales, J. Sillibourne and S. Somlo provided antibodies or plasmids. T.R.N. is supported by a National Science Foundation predoctoral grant and an National Institute for General Medical Sciences-Initiative for Maximizing Student Diversity grant (R25-GM56847). N.K. is a Distinguished George W. Brumley Professor. F. H. is an investigator of the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist and a Frederick G. L. Huetwell Professor. This work was funded by grants from the US National Institutes of Health to N.K. (HD04260, DK072301, DK075972), F.H. (DK1069274, DK1068306, RC4-K090917) and to J. F. Reiter (AR054396), and from the March of Dimes, the Burroughs Wellcome Fund, the Packard Foundation and the Sandler Family Supporting Foundation to J.F. Reiter.	Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cook SA, 2009, J AM SOC NEPHROL, V20, P753, DOI 10.1681/ASN.2008040412; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; Holopainen JM, 2010, BIOCHEMISTRY-US, V49, P7439, DOI 10.1021/bi1005249; Hopp K, 2011, HUM MOL GENET, V20, P2524, DOI 10.1093/hmg/ddr151; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nagy A., 2002, MANIPULATING MOUSE E; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Reiter JF, 2006, GENE DEV, V20, P22, DOI 10.1101/gad.1363606; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Shaheen R, 2011, HUM MUTAT, V32, P573, DOI 10.1002/humu.21507; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Won J, 2011, HUM MOL GENET, V20, P482, DOI 10.1093/hmg/ddq494	49	429	447	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					776	U88		10.1038/ng.891	http://dx.doi.org/10.1038/ng.891			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21725307	Green Accepted, Green Submitted			2022-12-25	WOS:000293178300014
J	Marichal, T; Ohata, K; Bedoret, D; Mesnil, C; Sabatel, C; Kobiyama, K; Lekeux, P; Coban, C; Akira, S; Ishii, KJ; Bureau, F; Desmet, CJ				Marichal, Thomas; Ohata, Keiichi; Bedoret, Denis; Mesnil, Claire; Sabatel, Catherine; Kobiyama, Kouji; Lekeux, Pierre; Coban, Cevayir; Akira, Shizuo; Ishii, Ken J.; Bureau, Fabrice; Desmet, Christophe J.			DNA released from dying host cells mediates aluminum adjuvant activity	NATURE MEDICINE			English	Article							INFLAMMATORY DENDRITIC CELLS; INNATE IMMUNE-RESPONSE; HELPER T-CELLS; NALP3 INFLAMMASOME; CYTOSOLIC DNA; STEADY-STATE; I INTERFERON; HYDROXIDE; ACTIVATION; NLRP3	Aluminum-based adjuvants (aluminum salts or alum) are widely used in human vaccination, although their mechanisms of action are poorly understood. Here we report that, in mice, alum causes cell death and the subsequent release of host cell DNA, which acts as a potent endogenous immunostimulatory signal mediating alum adjuvant activity. Furthermore, we propose that host DNA signaling differentially regulates IgE and IgG1 production after alum-adjuvanted immunization. We suggest that, on the one hand, host DNA induces primary B cell responses, including IgG1 production, through interferon response factor 3 (Irf3)-independent mechanisms. On the other hand, we suggest that host DNA also stimulates 'canonical' T helper type 2 (T(H)2) responses, associated with IgE isotype switching and peripheral effector responses, through Irf3-dependent mechanisms. The finding that host DNA released from dying cells acts as a damage-associated molecular pattern that mediates alum adjuvant activity may increase our understanding of the mechanisms of action of current vaccines and help in the design of new adjuvants.	[Marichal, Thomas; Bedoret, Denis; Mesnil, Claire; Sabatel, Catherine; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Grp Interdisciplinaire Genoprote Appl, Lab Cellular & Mol Physiol, Liege, Belgium; [Marichal, Thomas; Bedoret, Denis; Mesnil, Claire; Sabatel, Catherine; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Fac Vet Med, Biochem Lab, Liege, Belgium; [Ohata, Keiichi; Kobiyama, Kouji; Coban, Cevayir; Akira, Shizuo; Ishii, Ken J.] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Kobiyama, Kouji; Ishii, Ken J.] Natl Inst Biomed Innovat, Lab Adjuvant Innovat, Osaka, Japan	University of Liege; University of Liege; Osaka University; National Institute of Health Sciences - Japan	Desmet, CJ (corresponding author), Univ Liege, Grp Interdisciplinaire Genoprote Appl, Lab Cellular & Mol Physiol, Liege, Belgium.	kenishii@biken.osaka-u.ac.jp; christophe.desmet@ulg.ac.be	Akira, Shizuo/C-3134-2009; Coban, Cevayir/B-2129-2012; COBAN, Cevayir/P-1928-2019; Ishii, Ken J/B-1685-2012	COBAN, Cevayir/0000-0002-4467-7799; Ishii, Ken J/0000-0002-6728-3872; Ohata, Keiichi/0000-0002-5635-4292	FRS-FNRS; Belgian Fonds de la Recherche Scientifique Medicale; Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE, Belgian Science Policy); Knowledge Cluster Initiative; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency	FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE, Belgian Science Policy)(Belgian Federal Science Policy Office); Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	T. M., D. B., C. M. and C. S. are research fellows, and C. J. D. is a postdoctoral fellow of the Fonds National de la Recherche Scientifique (FRS-FNRS; Belgium). This work was supported by grants of the FRS-FNRS, the Belgian Fonds de la Recherche Scientifique Medicale and the Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE, Belgian Science Policy). This work was also partly supported by the Knowledge Cluster Initiative (K. J. I.); a Grant-in-Aid for Scientific Research (K. J. I. and C. C.) of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); and by the Core Research Evolutionary Science and Technology (CREST) program at the Japan Science and Technology Agency (K.J.I.).	Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Goto N, 1997, VACCINE, V15, P1364, DOI 10.1016/S0264-410X(97)00054-6; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; MANNHALTER JW, 1985, CLIN EXP IMMUNOL, V61, P143; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nigg AP, 2007, J IMMUNOL, V178, P7251, DOI 10.4049/jimmunol.178.11.7251; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Robinson RT, 2008, J IMMUNOL, V181, P5560, DOI 10.4049/jimmunol.181.8.5560; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	53	371	380	3	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					996	U118		10.1038/nm.2403	http://dx.doi.org/10.1038/nm.2403			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21765404				2022-12-25	WOS:000293507400034
J	Handoko, L; Xu, H; Li, GL; Ngan, CY; Chew, E; Schnapp, M; Lee, CWH; Ye, CP; Ping, JLH; Mulawadi, F; Wong, E; Sheng, JP; Zhang, YB; Poh, T; Chan, CS; Kunarso, G; Shahab, A; Bourque, G; Cacheux-Rataboul, V; Sung, WK; Ruan, YJ; Wei, CL				Handoko, Lusy; Xu, Han; Li, Guoliang; Ngan, Chew Yee; Chew, Elaine; Schnapp, Marie; Lee, Charlie Wah Heng; Ye, Chaopeng; Ping, Joanne Lim Hui; Mulawadi, Fabianus; Wong, Eleanor; Sheng, Jianpeng; Zhang, Yubo; Poh, Thompson; Chan, Chee Seng; Kunarso, Galih; Shahab, Atif; Bourque, Guillaume; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Ruan, Yijun; Wei, Chia-Lin			CTCF-mediated functional chromatin interactome in pluripotent cells	NATURE GENETICS			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; PROTEIN CTCF; CHIP-SEQ; GENOME; ORGANIZATION; INSULATOR; SITES; MAPS; MAINTENANCE	Mammalian genomes are viewed as functional organizations that orchestrate spatial and temporal gene regulation. CTCF, the most characterized insulator-binding protein, has been implicated as a key genome organizer. However, little is known about CTCF-associated higher-order chromatin structures at a global scale. Here we applied chromatin interaction analysis by paired-end tag (ChIA-PET) sequencing to elucidate the CTCF-chromatin interactome in pluripotent cells. From this analysis, we identified 1,480 cis- and 336 trans-interacting loci with high reproducibility and precision. Associating these chromatin interaction loci with their underlying epigenetic states, promoter activities, enhancer binding and nuclear lamina occupancy, we uncovered five distinct chromatin domains that suggest potential new models of CTCF function in chromatin organization and transcriptional control. Specifically, CTCF interactions demarcate chromatin-nuclear membrane attachments and influence proper gene expression through extensive cross-talk between promoters and regulatory elements. This highly complex nuclear organization offers insights toward the unifying principles that govern genome plasticity and function.	[Handoko, Lusy; Xu, Han; Li, Guoliang; Ngan, Chew Yee; Chew, Elaine; Schnapp, Marie; Lee, Charlie Wah Heng; Ye, Chaopeng; Ping, Joanne Lim Hui; Mulawadi, Fabianus; Wong, Eleanor; Zhang, Yubo; Poh, Thompson; Chan, Chee Seng; Shahab, Atif; Bourque, Guillaume; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Ruan, Yijun; Wei, Chia-Lin] Genome Inst Singapore, Singapore, Singapore; [Wong, Eleanor; Sung, Wing-Kin; Wei, Chia-Lin] Natl Univ Singapore, Singapore 117548, Singapore; [Sheng, Jianpeng] Nanyang Technol Univ, Singapore, Singapore; [Kunarso, Galih] Duke NUS Grad Med Sch Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Wei, CL (corresponding author), Joint Genome Inst, Walnut Creek, CA 94598 USA.	ruanyj@gis.a-star.edu.sg; cwei@lbl.gov	Bourque, Guillaume/AFR-2927-2022; Xu, Han/H-1963-2012; Li, Guoliang/D-8014-2012; Handoko, Lusy/C-3645-2017	Bourque, Guillaume/0000-0002-3933-9656; Li, Guoliang/0000-0003-1601-6640; Handoko, Lusy/0000-0001-7989-4243; ngan, chew yee/0000-0001-6055-1072; Zhang, Yubo/0000-0002-4121-8853; Chew, Elaine/0000-0001-9763-703X; Wong, Eleanor/0000-0001-7094-7679; Sung, Wing-Kin/0000-0001-7806-7086	Agency for Science, Technology and Research (A*STAR), Singapore; US National Institutes of Health (NIH) [R01 HG004456-01, R01HG003521-01, 1U54HG004557-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003521, R01HG004456, U54HG004557] Funding Source: NIH RePORTER	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the Genome Technology and Biology Group, particularly the sequencing team, for technical support. We also thank C. Xi and H.H. Ng who provided technical guidance for p300 ChIP optimization, M. Fullwood and B. Han for their 4C assay protocol, L.M. Hui and E. Cheung for 3C optimization and discussion, Z. Jingyao for BAC clone preparation and K. Zawack for reading the manuscript. This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore, and US National Institutes of Health (NIH) ENCODE grants (R01 HG004456-01, R01HG003521-01 and 1U54HG004557-01) to Y.R. and C.-L.W.	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Vega VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005241; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Yoon YS, 2007, MOL CELL BIOL, V27, P3499, DOI 10.1128/MCB.02170-06; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	53	476	500	2	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					630	U198		10.1038/ng.857	http://dx.doi.org/10.1038/ng.857			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21685913	Green Accepted			2022-12-25	WOS:000292184600006
J	Nutiu, R; Friedman, RC; Luo, SJ; Khrebtukova, I; Silva, D; Li, R; Zhang, L; Schroth, GP; Burge, CB				Nutiu, Razvan; Friedman, Robin C.; Luo, Shujun; Khrebtukova, Irina; Silva, David; Li, Robin; Zhang, Lu; Schroth, Gary P.; Burge, Christopher B.			Direct measurement of DNA affinity landscapes on a high-throughput sequencing instrument	NATURE BIOTECHNOLOGY			English	Article							GCN4 ACTIVATOR PROTEIN; TRANSCRIPTION FACTORS; BINDING PROTEINS; HALF-SITE; YEAST; GENOME; SPECIFICITIES; RECOGNITION; MICROARRAYS; EXPRESSION	Several methods for characterizing DNA-protein interactions are available(1-6), but none have demonstrated both high throughput and quantitative measurement of affinity. Here we describe 'high-throughput sequencing'-'fluorescent ligand interaction profiling' (HiTS-FLIP), a technique for measuring quantitative protein-DNA binding affinity at unprecedented depth. In this approach, the optics built into a high-throughput sequencer are used to visualize in vitro binding of a protein to sequenced DNA in a flow cell. Application of HiTS-FLIP to the protein Gcn4 (Gcn4p), the master regulator of the yeast amino acid starvation response7, yielded similar to 440 million binding measurements, enabling determination of dissociation constants for all 12-mer sequences having submicromolar affinity. These data revealed a complex interdependency between motif positions, allowed improved discrimination of in vivo Gcn4p binding sites and regulatory targets relative to previous methods and showed that sets of genes with different promoter affinities to Gcn4p have distinct functions and expression kinetics. Broad application of this approach should increase understanding of the interactions that drive transcription.	[Nutiu, Razvan; Friedman, Robin C.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Friedman, Robin C.; Burge, Christopher B.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Luo, Shujun; Khrebtukova, Irina; Silva, David; Li, Robin; Zhang, Lu; Schroth, Gary P.] Illumina Inc, Hayward, CA USA; [Burge, Christopher B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Illumina; Massachusetts Institute of Technology (MIT)	Burge, CB (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020	Friedman, Robin/0000-0003-2097-8332	Office of Science in the Department of Energy [DE-FG02-97ER25308]; National Science Foundation [0821391]; US National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319] Funding Source: NIH RePORTER	Office of Science in the Department of Energy; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. Braus for providing the GCN4 containing plasmids, N. Clarke for sharing amino acid starvation microarray time course data, A. Keating and A. Reinke for advice on EMSA experiments, T. Theara, S. Levine and the Biomicro Center at Massachusetts Institute of Technology for help with Illumina sequencing technology and initial experiments, and L. Boyer, N. Clarke, W. Gilbert, P. Sharp and members of the Burge laboratory for helpful discussion and comments on the manuscript. This work was supported by a Human Frontiers Science Program long-term fellowship (R.N.), a Computational Science Graduate Fellowship from the Office of Science in the Department of Energy under contract DE-FG02-97ER25308 (R.C.F.), by a major equipment grant from the National Science Foundation (no. 0821391) and by grants from the US National Institutes of Health (C.B.B.).	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bulyk ML, 2006, METHOD ENZYMOL, V410, P279, DOI 10.1016/S0076-6879(06)10013-0; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Cranz S, 2004, BIOCHEMISTRY-US, V43, P718, DOI 10.1021/bi0355793; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gottardo R, 2009, METHODS MOL BIOL, V567, P133, DOI 10.1007/978-1-60327-414-2_9; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Herzog B, 2011, J MOL BIOL, V405, P909, DOI 10.1016/j.jmb.2010.11.033; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; Hollenbeck JJ, 2000, BIOCHEMISTRY-US, V39, P6380, DOI 10.1021/bi992705n; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SELLERS JW, 1990, MOL CELL BIOL, V10, P5077, DOI 10.1128/MCB.10.10.5077; Shi YX, 2009, J COMPUT BIOL, V16, P1035, DOI 10.1089/cmb.2009.0024; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Wang HY, 2007, GENOME RES, V17, P1202, DOI 10.1101/gr.6510207; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	31	135	140	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					659	U146		10.1038/nbt.1882	http://dx.doi.org/10.1038/nbt.1882			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21706015	Green Accepted, Green Submitted			2022-12-25	WOS:000292595200025
J	Yi, F; Pereira, L; Hoffman, JA; Shy, BR; Yuen, CM; Liu, DR; Merrill, BJ				Yi, Fei; Pereira, Laura; Hoffman, Jackson A.; Shy, Brian R.; Yuen, Courtney M.; Liu, David R.; Merrill, Bradley J.			Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; ES CELLS; PLURIPOTENCY; NANOG; NETWORK; OCT4; MAINTENANCE; EXPRESSION; REPRESSION; CLONING	The co-occupancy of Tcf3 with Oct4, Sox2 and Nanog on embryonic stem cell (ESC) chromatin indicated that Tcf3 has been suggested to play an integral role in a poorly understood mechanism underlying Wnt-dependent stimulation of mouse ESC self-renewal of mouse ESCs. Although the conventional view of Tcf proteins as the beta-catenin-binding effectors of Wnt signalling suggested Tcf3-beta-catenin activation of target genes would stimulate self-renewal, here we show that an antagonistic relationship between Wnt3a and Tcf3 on gene expression regulates ESC self-renewal. Genetic ablation of Tcf3 replaced the requirement for exogenous Wnt3a or GSK3 inhibition for ESC self-renewal, demonstrating that inhibition of Tcf3 repressor is the necessary downstream effect of Wnt signalling. Interestingly, both Tcf3-beta-catenin and Tcf1-beta-catenin interactions contributed to Wnt stimulation of self-renewal and gene expression, and the combination of Tcf3 and Tcf1 recruited Wnt-stabilized beta-catenin to Oct4 binding sites on ESC chromatin. This work elucidates the molecular link between the effects of Wnt and the regulation of the Oct4/Sox2/Nanog network.	[Yi, Fei; Pereira, Laura; Hoffman, Jackson A.; Shy, Brian R.; Merrill, Bradley J.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Yuen, Courtney M.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Howard Hughes Medical Institute	Merrill, BJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,MBRB 2270,M-C 669, Chicago, IL 60607 USA.	merrillb@uic.edu		Pereira, Laura/0000-0002-8239-3703; Yuen, Courtney/0000-0002-5219-2599; Hoffman, Jackson/0000-0002-6256-144X	American Cancer Society [RSG GGC 112994]; National Institutes of Health [R01-CA128571, R01-GM065400]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA128571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Plath for helpful discussions and thoughtful comments on the manuscript, and M. Ko and A. Nishiyama for the inducible Tcf3 overexpression cell line. The work was financially supported by grants from the American Cancer Society (RSG GGC 112994, B.J.M.), the National Institutes of Health (R01-CA128571, B.J.M. and R01-GM065400, D.R.L.) and the Howard Hughes Medical Institute (D.R.L.).	Abu-Remaileh M, 2010, EMBO J, V29, P3236, DOI 10.1038/emboj.2010.200; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BIECHELE IL, 2009, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PROT5223; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; IAKAO Y, 2007, BIOCHEM BIOPH RES CO, V353, P699; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	229	237	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2011	13	7					762	U383		10.1038/ncb2283	http://dx.doi.org/10.1038/ncb2283			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	786KD	21685894	Green Accepted, Green Submitted			2022-12-25	WOS:000292305700006
J	Cui, YJ; Niziolek, PJ; MacDonald, BT; Zylstra, CR; Alenina, N; Robinson, DR; Zhong, ZD; Matthes, S; Jacobsen, CM; Conlon, RA; Brommage, R; Liu, QY; Mseeh, F; Powell, DR; Yang, QM; Zambrowicz, B; Gerrits, H; Gossen, JA; He, X; Bader, M; Williams, BO; Warman, ML; Robling, AG				Cui, Yajun; Niziolek, Paul J.; MacDonald, Bryan T.; Zylstra, Cassandra R.; Alenina, Natalia; Robinson, Daniel R.; Zhong, Zhendong; Matthes, Susann; Jacobsen, Christina M.; Conlon, Ronald A.; Brommage, Robert; Liu, Qingyun; Mseeh, Faika; Powell, David R.; Yang, Qi M.; Zambrowicz, Brian; Gerrits, Han; Gossen, Jan A.; He, Xi; Bader, Michael; Williams, Bart O.; Warman, Matthew L.; Robling, Alexander G.			Lrp5 functions in bone to regulate bone mass	NATURE MEDICINE			English	Article							RECEPTOR-RELATED PROTEIN-5; RECOMBINASE EXPRESSION; SEROTONIN SYNTHESIS; NEGATIVE REGULATOR; MISSENSE MUTATIONS; CRE RECOMBINASE; MICE DEFICIENT; WNT CORECEPTOR; GENE; MOUSE	The human skeleton is affected by mutations in low-density lipoprotein receptor-related protein 5 (LRP5). To understand how LRP5 influences bone properties, we generated mice with osteocyte-specific expression of inducible Lrp5 mutations that cause high and low bone mass phenotypes in humans. We found that bone properties in these mice were comparable to bone properties in mice with inherited mutations. We also induced an Lrp5 mutation in cells that form the appendicular skeleton but not in cells that form the axial skeleton; we observed that bone properties were altered in the limb but not in the spine. These data indicate that Lrp5 signaling functions locally, and they suggest that increasing LRP5 signaling in mature bone cells may be a strategy for treating human disorders associated with low bone mass, such as osteoporosis.	[Cui, Yajun; Jacobsen, Christina M.; Warman, Matthew L.] Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Boston, MA 02115 USA; [Cui, Yajun; Conlon, Ronald A.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Niziolek, Paul J.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Niziolek, Paul J.; Robling, Alexander G.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Niziolek, Paul J.; Robling, Alexander G.] Indiana Univ Sch Med, Dept Biomed Engn, Indianapolis, IN USA; [MacDonald, Bryan T.; He, Xi] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [MacDonald, Bryan T.; He, Xi] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Zylstra, Cassandra R.; Robinson, Daniel R.; Zhong, Zhendong; Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis Res, Grand Rapids, MI USA; [Alenina, Natalia; Matthes, Susann; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Brommage, Robert; Liu, Qingyun; Mseeh, Faika; Powell, David R.; Yang, Qi M.; Zambrowicz, Brian] Lexicon Pharmaceut, The Woodlands, TX USA; [Gerrits, Han; Gossen, Jan A.] Merck Sharp & Dohme Res Labs, Oss, Netherlands; [Warman, Matthew L.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Boston Children's Hospital; Case Western Reserve University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Van Andel Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Lexicon Pharmaceuticals; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Warman, ML (corresponding author), Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu	Zhong, Zhendong/K-5223-2013; Williams, Bart/A-3539-2013; Brommage, Robert/J-5670-2019; Bader, Michael/K-2124-2013	Williams, Bart/0000-0002-5261-5301; Brommage, Robert/0000-0002-9947-3822; Bader, Michael/0000-0003-4780-4164; Diegel, Cassandra/0000-0002-6526-9372	US National Institutes of Health (NIH) [AR53237]; Public Health Service [UL 1RR025761-02]; NIH [GM74241, AR053293]; Leukemia and Lymphoma Society; Van Andel Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237, R01AR053293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Van Andel Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratories for technical support: B. Newby, K. Kurek and E. Boyden for assistance with the HBM mouse studies; G. Zhou for assistance with histomorphometry; M. Niedecker and E. Kleinschmidt for assistance with radiography; the Case Transgenic and Targeting Facility; K. Sisson and P. Swiatek of the Van Andel Research Institute Mouse Germline Modification Core; B. Eagleson and the staff of the Van Andel Research Institute Vivarium; J. Bardenhagen, J. Greer, S. Jeter-Jones, J. Liu, M.K. Shadoan, D.D. Smith, W. Xiong and A. Yu of Lexicon Pharmaceuticals; and F. Bourgondien, R. Zhang and S. Yeh of Merck Sharp & Dohme Research Laboratories. This work was supported by the following grants: US National Institutes of Health (NIH) grant AR53237 (to A.G.R.); Public Health Service Career Development Award (UL 1RR025761-02) (to P.J.N.); NIH grant (GM74241) and a Leukemia and Lymphoma Society Scholarship (both to X.H.); NIH grant AR053293 and Van Andel Research Institute funds (to B.O.W.). M.L.W. is an investigator with the Howard Hughes Medical Institute.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; ANDERSON GM, 1987, LIFE SCI, V41, P1777, DOI 10.1016/0024-3205(87)90696-5; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; INGEBRETSEN OC, 1985, CLIN CHEM, V31, P695; Iwaniec UT, 2007, J BONE MINER RES, V22, P394, DOI 10.1359/JBMR.061118; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2008, CELL, V135, P795, DOI 10.1016/j.cell.2008.11.007; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rosen CJ, 2009, NEW ENGL J MED, V360, P957, DOI 10.1056/NEJMp0810058; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Tenner K, 2008, NEUROSCI LETT, V431, P21, DOI 10.1016/j.neulet.2007.11.012; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wolff J., 1892, LAW BONE REMODELING; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	57	330	346	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					684	U73		10.1038/nm.2388	http://dx.doi.org/10.1038/nm.2388			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602802	Green Accepted			2022-12-25	WOS:000291308800028
J	Francis, DM; Rozycki, B; Koveal, D; Hummer, G; Page, R; Peti, W				Francis, Dana M.; Rozycki, Bartosz; Koveal, Dorothy; Hummer, Gerhard; Page, Rebecca; Peti, Wolfgang			Structural basis of p38 alpha regulation by hematopoietic tyrosine phosphatase	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; DOCKING INTERACTIONS; CATALYTIC DOMAIN; SUBSTRATE RECOGNITION; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; PTP-SL; ERK2; P38	MAP kinases regulate essential cellular events, including cell growth, differentiation and inflammation. The solution structure of a complete MAPK-MAPK-regulatory protein complex, p38 alpha-HePTP, was determined, enabling a comprehensive investigation of the molecular basis of specificity and fidelity in MAPK regulation. Structure determination was achieved by combining NMR spectroscopy and small-angle X-ray scattering data with a new ensemble calculation-refinement procedure. We identified 25 residues outside of the HePTP kinase interaction motif necessary for p38 alpha recognition. The complex adopts an extended conformation in solution and rarely samples the conformation necessary for kinase deactivation. Complex formation also does not affect the N-terminal lobe, the activation loop of p38 alpha or the catalytic domain of HePTP. Together, these results show how the downstream tyrosine phosphatase HePTP regulates p38 alpha and provide for fundamentally new insights into MAPK regulation and specificity.	[Koveal, Dorothy; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Francis, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Rozycki, Bartosz; Hummer, Gerhard] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	Brown University; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	rebecca_page@brown.edu; wolfgang_peti@brown.edu	Rozycki, Bartosz/B-7005-2009; Peti, Wolfgang/L-3492-2014; Hummer, Gerhard/A-2546-2013	Rozycki, Bartosz/0000-0001-5938-7308; Hummer, Gerhard/0000-0001-7768-746X	American Cancer Society [RSG-08-067-01-LIB]; Seventh European Community; National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health (NIH); US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100910, T32GM007601] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Seventh European Community; National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Yang and M. Allaire (National Synchrotron Light Source, NSLS) for their support at NSLS beamline X9. The authors thank P. Vogel (Southern Methodist University) for providing SL-ATP for the titration studies. This research was supported by grant RSG-08-067-01-LIB from the American Cancer Society to R. P. B. R. was supported by a Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Program. B. R. and G. H. were supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health (NIH). Use of the NSLS at Brookhaven National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-98CH10886. 800 MHz NMR data were recorded at Brandeis University and were purchased with support from NIH S10-RR017269. Molecular simulations were performed on the Biowulf computing cluster at NIH.	Akella R, 2010, STRUCTURE, V18, P1571, DOI 10.1016/j.str.2010.09.015; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Balasu MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005432; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; COBB MH, 1994, CELL MOL BIOL RES, V40, P253; Critton DA, 2008, BIOCHEMISTRY-US, V47, P13336, DOI 10.1021/bi801724n; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Esposito V, 2006, J BIOMOL NMR, V36, P64, DOI 10.1007/s10858-006-9050-9; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gong HP, 2010, BIOPHYS J, V98, P470, DOI 10.1016/j.bpj.2009.10.031; HENDRIKS W, 1995, BIOCHEM J, V305, P499, DOI 10.1042/bj3050499; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hoffman AD, 2010, PROTEIN J, V29, P373, DOI 10.1007/s10930-010-9262-4; Jeeves M, 2008, BIOMOL NMR ASSIGN, V2, P101, DOI 10.1007/s12104-008-9095-7; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Ma WF, 2010, STRUCTURE, V18, P1502, DOI 10.1016/j.str.2010.08.011; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Mustelin T, 2005, J MOL BIOL, V354, P150, DOI 10.1016/j.jmb.2005.09.049; Perry JJP, 2009, J MOL BIOL, V391, P1, DOI 10.1016/j.jmb.2009.06.005; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Piserchio A, 2011, BIOCHEMISTRY-US, V50, P3660, DOI 10.1021/bi2000559; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Vajpai N, 2008, BIOMOL NMR ASSIGM, V2, P41, DOI 10.1007/s12104-008-9079-7; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Vogtherr M, 2005, J BIOMOL NMR, V32, P175, DOI 10.1007/s10858-005-2449-x; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	47	64	64	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					916	924		10.1038/NCHEMBIO.707	http://dx.doi.org/10.1038/NCHEMBIO.707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22057126	Green Accepted			2022-12-25	WOS:000297166200015
J	Raychaudhuri, S; Iartchouk, O; Chin, K; Tan, PL; Tai, AK; Ripke, S; Gowrisankar, S; Vemuri, S; Montgomery, K; Yu, Y; Reynolds, R; Zack, DJ; Campochiaro, B; Campochiaro, P; Katsanis, N; Daly, MJ; Seddon, JM				Raychaudhuri, Soumya; Iartchouk, Oleg; Chin, Kimberly; Tan, Perciliz L.; Tai, Albert K.; Ripke, Stephan; Gowrisankar, Sivakumar; Vemuri, Soumya; Montgomery, Kate; Yu, Yi; Reynolds, Robyn; Zack, Donald J.; Campochiaro, Betsy; Campochiaro, Peter; Katsanis, Nicholas; Daly, Mark J.; Seddon, Johanna M.			A rare penetrant mutation in CFH confers high risk of age-related macular degeneration	NATURE GENETICS			English	Article							HEMOLYTIC-UREMIC SYNDROME; GENOME-WIDE ASSOCIATION; FACTOR-H POLYMORPHISM; GENE; VARIANTS; SUSCEPTIBILITY; INDIVIDUALS; HAPLOTYPE; LINKAGE; DISEASE	Two common variants in the gene encoding complement factor H (CFH), the Y402H substitution (rs1061170, c.1204C>T)(1-4) and the intronic rs1410996 SNP(5,6), explain 17% of age-related macular degeneration (AMD) liability. However, proof for the involvement of CFH, as opposed to a neighboring transcript, and knowledge of the potential mechanism of susceptibility alleles are lacking. Assuming that rare functional variants might provide mechanistic insights, we used genotype data and high-throughput sequencing to discover a rare, high-risk CFH haplotype with a c.3628C>T mutation that resulted in an R1210C substitution. This allele has been implicated previously in atypical hemolytic uremic syndrome, and it abrogates C-terminal ligand binding(7,8). Genotyping R1210C in 2,423 AMD cases and 1,122 controls demonstrated high penetrance (present in 40 cases versus 1 control, P = 7.0 x 10(-6)) and an association with a 6-year-earlier onset of disease (P = 2.3 x 10(-6)). This result suggests that loss-of-function alleles at CFH are likely to drive AMD risk. This finding represents one of the first instances in which a common complex disease variant has led to the discovery of a rare penetrant mutation.	[Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Iartchouk, Oleg; Gowrisankar, Sivakumar; Vemuri, Soumya; Montgomery, Kate] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Raychaudhuri, Soumya; Ripke, Stephan; Daly, Mark J.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Chin, Kimberly; Yu, Yi; Reynolds, Robyn; Seddon, Johanna M.] Tufts Med Ctr, Ophthalm Epidemiol & Genet Serv, New England Eye Ctr, Boston, MA USA; [Tan, Perciliz L.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Cell Biol, Durham, NC USA; [Tan, Perciliz L.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Tai, Albert K.] Tufts Univ, Sch Med, Dept Pathol, Study Ctr Immunogenet Infect Dis, Boston, MA 02111 USA; [Ripke, Stephan; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Zack, Donald J.; Campochiaro, Betsy; Campochiaro, Peter] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, McKusick Nathans Inst Genet Med,Dept Ophthalmol, Baltimore, MD 21205 USA; [Seddon, Johanna M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts Medical Center; Duke University; Duke University; Tufts University; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Tufts University	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	soumya@broadinstitute.org; jseddon@tuftsmedicalcenter.org	Katsanis, Nicholas/E-1837-2012; Mohammed, Imran/J-8271-2012; Daly, Mark J/B-2453-2017; Ripke, Stephan/AAK-5486-2021	Mohammed, Imran/0000-0002-8412-0768; Daly, Mark J/0000-0002-0949-8752; ripke, stephan/0000-0003-3622-835X; Katsanis, Nicholas/0000-0002-2480-0171; Raychaudhuri, Soumya/0000-0002-1901-8265; Zack, Don/0000-0002-7966-1973	US National Institutes of Health (NIH) [RO1-EY11309, K08AR055688-01A1, U01 MH085520-01]; Massachusetts Lions Eye Research Fund, Inc.; American Macular Degeneration Research Fund; Foundation Fighting Blindness; Macular Vision Research Foundation; Research to Prevent Blindness Challenge Grant; Department of Ophthalmology; Tufts University School of Medicine; Ophthalmic Epidemiology and Genetics Service; New England Eye Center; Tufts Medical Center; NIH National Heart, Lung, and Blood Institute (NLBI) [R01HL087676]; NIH National Center for Research Resources (NCRR); NATIONAL EYE INSTITUTE [R01EY011309] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH085520] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund, Inc.; American Macular Degeneration Research Fund; Foundation Fighting Blindness(European Commission); Macular Vision Research Foundation; Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB)); Department of Ophthalmology; Tufts University School of Medicine; Ophthalmic Epidemiology and Genetics Service; New England Eye Center; Tufts Medical Center; NIH National Heart, Lung, and Blood Institute (NLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We appreciate the contribution to the research of J.M.S. of an anonymous donor. This research was supported in part by grants RO1-EY11309 (J.M.S.), K08AR055688-01A1 (S. Raychaudhuri) and U01 MH085520-01 (S. Ripke) from the US National Institutes of Health (NIH), and by the Massachusetts Lions Eye Research Fund, Inc., the American Macular Degeneration Research Fund, the Foundation Fighting Blindness, the Macular Vision Research Foundation, a Research to Prevent Blindness Challenge Grant to the New England Eye Center, Department of Ophthalmology, Tufts University School of Medicine, and the Macular Degeneration Research Fund of the Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Tufts University School of Medicine. N.K. is a Distinguished Brumley Professor. The MIGen study was funded by grants from the NIH National Heart, Lung, and Blood Institute (NLBI) (R01HL087676) and the NIH National Center for Research Resources (NCRR). We acknowledge informal and helpful discussions from our colleagues B. Neale, R. Plenge, P. de Bakker, D. Reich, E. Stahl, B. Stranger and B. Voight.	Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Martinez-Barricarte R, 2008, J AM SOC NEPHROL, V19, P639, DOI 10.1681/ASN.2007080923; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Neumann HPH, 2003, J MED GENET, V40, P676, DOI 10.1136/jmg.40.9.676; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Servais A, 2007, J MED GENET, V44, P193, DOI 10.1136/jmg.2006.045328; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Weiner DE, 2011, NEPHROL DIAL TRANSPL, V26, P3159, DOI 10.1093/ndt/gfr022; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836	45	241	247	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1232	U91		10.1038/ng.976	http://dx.doi.org/10.1038/ng.976			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019782	Green Accepted			2022-12-25	WOS:000297931400018
J	Braun, M; Lansky, Z; Fink, G; Ruhnow, F; Diez, S; Janson, ME				Braun, Marcus; Lansky, Zdenek; Fink, Gero; Ruhnow, Felix; Diez, Stefan; Janson, Marcel E.			Adaptive braking by Ase1 prevents overlapping microtubules from sliding completely apart	NATURE CELL BIOLOGY			English	Article							FISSION YEAST; SPINDLE MIDZONE; CROSS-LINKERS; PROTEIN; KINESIN-14; BINDING; MOTORS; PRC1; ORGANIZATION; CYTOKINESIS	Short regions of overlap between ends of antiparallel microtubules are central elements within bipolar microtubule arrays. Although their formation requires motors(1), recent in vitro studies demonstrated that stable overlaps cannot be generated by molecular motors alone. Motors either slide microtubules along each other until complete separation(2-4) or, in the presence of opposing motors, generate oscillatory movements(5-7). Here, we show that Ase1, a member of the conserved MAP65/PRC1 family of microtubule-bundling proteins, enables the formation of stable antiparallel overlaps through adaptive braking of Kinesin-14-driven microtubule-microtubule sliding. As overlapping microtubules start to slide apart, Ase1 molecules become compacted in the shrinking overlap and the sliding velocity gradually decreases in a dose-dependent manner. Compaction is driven by moving microtubule ends that act as barriers to Ase1 diffusion. Quantitative modelling showed that the molecular off-rate of Ase1 is sufficiently low to enable persistent overlap stabilization over tens of minutes. The finding of adaptive braking demonstrates that sliding can be slowed down locally to stabilize overlaps at the centre of bipolar arrays, whereas sliding proceeds elsewhere to enable network self-organization.	[Braun, Marcus; Fink, Gero; Ruhnow, Felix; Diez, Stefan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Braun, Marcus; Fink, Gero; Ruhnow, Felix; Diez, Stefan] Tech Univ Dresden, B CUBE, D-01307 Dresden, Germany; [Lansky, Zdenek; Janson, Marcel E.] Wageningen Univ, Lab Plant Cell Biol, NL-6708 PB Wageningen, Netherlands	Max Planck Society; Technische Universitat Dresden; Wageningen University & Research	Diez, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	diez@bcube-dresden.de; marcel.janson@wur.nl	Diez, Stefan/E-8172-2010; Lansky, Zdenek/M-4548-2014; Braun, Marcus/L-8931-2018	Diez, Stefan/0000-0002-0750-8515; Lansky, Zdenek/0000-0001-8474-053X; Braun, Marcus/0000-0003-2026-2238; Ruhnow, Felix/0000-0002-0856-5511	European Research Council (ERC); Boehringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft (DFG); Division for Earth and Life Sciences (ALW); Netherlands Organization for Scientific Research (NWO)	European Research Council (ERC)(European Research Council (ERC)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Division for Earth and Life Sciences (ALW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank C. Brauer for technical assistance; J. Teapal and T. Toda for yeast strains; and R. Schneider, M. Zanic, M. Gardner, J. Howard and B. Mulder for discussions. M.B. and S.D. acknowledge support from the European Research Council (ERC starting grant); G.F. from Boehringer Ingelheim Fonds; S.D. from the Deutsche Forschungsgemeinschaft (DFG Heisenberg Programme); and M.E.J. from the Division for Earth and Life Sciences (ALW) with financial aid from the Netherlands Organization for Scientific Research (NWO).	Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Gardner MK, 2008, NAT CELL BIOL, V10, P379, DOI 10.1038/ncb0408-379; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Smertenko AP, 2008, PLANT CELL, V20, P3346, DOI 10.1105/tpc.108.063362; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; VALE RD, 1992, J CELL BIOL, V119, P1589, DOI 10.1083/jcb.119.6.1589; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	31	75	75	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1259	U201		10.1038/ncb2323	http://dx.doi.org/10.1038/ncb2323			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21892183				2022-12-25	WOS:000295617900016
J	Zenatti, PP; Ribeiro, D; Li, WQ; Zuurbier, L; Silva, MC; Paganin, M; Tritapoe, J; Hixon, JA; Silveira, AB; Cardoso, BA; Sarmento, LM; Correia, N; Toribio, ML; Kobarg, J; Horstmann, M; Pieters, R; Brandalise, SR; Ferrando, AA; Meijerink, JP; Durum, SK; Yunes, JA; Barata, JT				Zenatti, Priscila P.; Ribeiro, Daniel; Li, Wenqing; Zuurbier, Linda; Silva, Milene C.; Paganin, Maddalena; Tritapoe, Julia; Hixon, Julie A.; Silveira, Andre B.; Cardoso, Bruno A.; Sarmento, Leonor M.; Correia, Nadia; Toribio, Maria L.; Kobarg, Joerg; Horstmann, Martin; Pieters, Rob; Brandalise, Silvia R.; Ferrando, Adolfo A.; Meijerink, Jules P.; Durum, Scott K.; Yunes, J. Andres; Barata, Joao T.			Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							INTERLEUKIN-7 RECEPTOR; GENE-EXPRESSION; PRECURSOR-B; ACTIVATION; NOTCH1; PTEN; IL-7; PROLIFERATION; ABNORMALITIES; RESISTANCE	Interleukin 7 (IL-7) and its receptor, formed by IL-7R alpha (encoded by IL7R) and gamma c, are essential for normal T-cell development and homeostasis. Here we show that IL7R is an oncogene mutated in T-cell acute lymphoblastic leukemia (T-ALL). We find that 9% of individuals with T-ALL have somatic gain-of-function IL7R exon 6 mutations. In most cases, these IL7R mutations introduce an unpaired cysteine in the extracellular juxtamembrane-transmembrane region and promote de novo formation of intermolecular disulfide bonds between mutant IL-7Ra subunits, thereby driving constitutive signaling via JAK1 and independently of IL-7, gamma c or JAK3. IL7R mutations induce a gene expression profile partially resembling that provoked by IL-7 and are enriched in the T-ALL subgroup comprising TLX3 rearranged and HOXA deregulated cases. Notably, IL7R mutations promote cell transformation and tumor formation. Overall, our findings indicate that IL7R mutational activation is involved in human T-cell leukemogenesis, paving the way for therapeutic targeting of IL-7R-mediated signaling in T-ALL.	[Ribeiro, Daniel; Silva, Milene C.; Cardoso, Bruno A.; Sarmento, Leonor M.; Correia, Nadia; Barata, Joao T.] Univ Lisbon, Fac Med, Inst Med Mol, Canc Biol Unit, P-1699 Lisbon, Portugal; [Zenatti, Priscila P.; Silveira, Andre B.; Brandalise, Silvia R.; Yunes, J. Andres] Ctr Infantil Boldrini, Lab Biol Mol, Campinas, SP, Brazil; [Li, Wenqing; Tritapoe, Julia; Hixon, Julie A.; Durum, Scott K.] NCI, Immunol Cytokine Grp, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Zuurbier, Linda; Meijerink, Jules P.] Erasmus Med Ctr MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Paganin, Maddalena; Ferrando, Adolfo A.] Columbia Univ Med Ctr, Inst Canc Genet, New York, NY USA; [Toribio, Maria L.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [Kobarg, Joerg] CNPEM, LNBio, Campinas, SP, Brazil; [Horstmann, Martin] German Cooperat Study Grp Childhood Acute Lymphob, Hamburg, Germany; [Horstmann, Martin] Univ Med Ctr Hamburg Eppendorf, Clin Pediat Hematol & Oncol, Childrens Canc Ctr Hamburg, Res Inst, Hamburg, Germany; [Brandalise, Silvia R.] Univ Estadual Campinas, Serv Hematol Oncol Pediat, Campinas, SP, Brazil; [Ferrando, Adolfo A.] Columbia Univ Med Ctr, Dept Pathol, New York, NY USA; [Yunes, J. Andres] Univ Estadual Campinas, Fac Ciencias Med, Dept Genet Med, Campinas, SP, Brazil	Universidade de Lisboa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade Estadual de Campinas; Columbia University; Universidade Estadual de Campinas	Barata, JT (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Canc Biol Unit, P-1699 Lisbon, Portugal.	joao_barata@fm.ul.pt	Meijerink, Jules P/D-4393-2017; Barata, João T./D-9181-2015; Brandalise, Silvia Regina/ABG-9609-2021; Kobarg, Jörg/T-4736-2019; da Silva, Milene Costa/V-1976-2018; Bortolini Silveira, Andre/I-8859-2012; Toribio, Maria L/C-2039-2017	Meijerink, Jules P/0000-0002-6860-798X; Barata, João T./0000-0002-4826-8976; Kobarg, Jörg/0000-0002-9419-0145; da Silva, Milene Costa/0000-0001-6951-2504; Yunes, Jose Andres/0000-0002-1316-3525; Cardoso, Bruno/0000-0002-6521-7257; Pini Zenatti, Priscila/0000-0002-8662-7458; Bortolini Silveira, Andre/0000-0003-3375-1081; Zuurbier, Linda/0000-0002-8473-1147; Sarmento, Leonor/0000-0002-3692-0592; Toribio, Maria L/0000-0002-8637-0373; durum, scott/0000-0003-1307-9582; Ribeiro, Daniel/0000-0003-3660-9646	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-OBD/104816/2008]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/10034-1]; National Cancer Institute, US National Institutes of Health (NIH); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Bolsa de Investigacao (BI); FCT; foundation Children Cancer-Free (Stichting Kinderen Kankervrij; KiKa) [2007-012]; NATIONAL CANCER INSTITUTE [ZIABC009287] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Cancer Institute, US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Bolsa de Investigacao (BI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); foundation Children Cancer-Free (Stichting Kinderen Kankervrij; KiKa); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the subjects and their families for providing the specimens for this study. We thank S. Walsh (University of Maryland) for helpful discussions on the IL7R transmembrane domain; K. Czarra and M. Karwan for animal technical assistance; A. Silva, I. Antunes, A. Melao and J. Buijs-Gladdines for experimental support; P. Vandenabeele for kindly providing the WEHI3B cell line; and J. O'Shea for providing Jak3<SUP>-/-</SUP> bone marrow and CP-690550. This work was supported by grants from Fundacao para a Ciencia e a Tecnologia (FCT; PTDC/SAU-OBD/104816/2008, J. T. B.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 08/10034-1, J.A.Y.) and the intramural program of the National Cancer Institute, US National Institutes of Health (NIH) (S. K. D.). P.P.Z. and A. B. S. have Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PhD scholarships. L. M. S. has a postdoctoral fellowship; D. R., B. A. C. and N.C. have PhD scholarships, and M. C. S. had a Bolsa de Investigacao (BI) fellowship, all from the FCT. L.Z. was supported by a grant (2007-012) from the foundation Children Cancer-Free (Stichting Kinderen Kankervrij; KiKa).	Abraham N, 2005, ONCOGENE, V24, P5252, DOI 10.1038/sj.onc.1208726; Al-Rawi MAA, 2003, HISTOL HISTOPATHOL, V18, P911, DOI 10.14670/HH-18.911; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Barata JT, 2004, HAEMATOLOGICA, V89, P1459; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; BENE MC, 1995, LEUKEMIA, V9, P1783; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Izon DJ, 1998, BLOOD, V92, P383, DOI 10.1182/blood.V92.2.383.414k41_383_393; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kim K, 2003, J IMMUNOL METHODS, V274, P177, DOI 10.1016/S0022-1759(02)00513-6; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Laouar Y, 2004, BLOOD, V103, P1985, DOI 10.1182/blood-2003-06-2126; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Roifman CM, 2000, BLOOD, V96, P2803; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Zuurbier L, 2010, LEUKEMIA, V24, P2014, DOI 10.1038/leu.2010.204	51	262	279	3	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					932	U31		10.1038/ng.924	http://dx.doi.org/10.1038/ng.924			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892159	Green Accepted			2022-12-25	WOS:000295316200006
J	Gui, YT; Guo, GW; Huang, Y; Hu, XD; Tang, AF; Gao, SJ; Wu, RH; Chen, C; Li, XX; Zhou, L; He, MH; Li, ZS; Sun, XJ; Jia, WL; Chen, JN; Yang, SM; Zhou, FJ; Zhao, XK; Wan, SQ; Ye, R; Liang, CZ; Liu, ZS; Huang, PD; Liu, CX; Jiang, H; Wang, Y; Zheng, HC; Sun, L; Liu, XW; Jiang, ZM; Feng, DF; Chen, J; Wu, S; Zou, J; Zhang, ZF; Yang, RL; Zhao, J; Xu, CJ; Yin, WH; Guan, ZC; Ye, JX; Zhang, H; Li, JX; Kristiansen, K; Nickerson, ML; Theodorescu, D; Li, YR; Zhang, XQ; Li, SG; Wang, J; Yang, HM; Wang, J; Cai, ZM				Gui, Yaoting; Guo, Guangwu; Huang, Yi; Hu, Xueda; Tang, Aifa; Gao, Shengjie; Wu, Renhua; Chen, Chao; Li, Xianxin; Zhou, Liang; He, Minghui; Li, Zesong; Sun, Xiaojuan; Jia, Wenlong; Chen, Jinnong; Yang, Shangming; Zhou, Fangjian; Zhao, Xiaokun; Wan, Shengqing; Ye, Rui; Liang, Chaozhao; Liu, Zhisheng; Huang, Peide; Liu, Chunxiao; Jiang, Hui; Wang, Yong; Zheng, Hancheng; Sun, Liang; Liu, Xingwang; Jiang, Zhimao; Feng, Dafei; Chen, Jing; Wu, Song; Zou, Jing; Zhang, Zhongfu; Yang, Ruilin; Zhao, Jun; Xu, Congjie; Yin, Weihua; Guan, Zhichen; Ye, Jiongxian; Zhang, Hong; Li, Jingxiang; Kristiansen, Karsten; Nickerson, Michael L.; Theodorescu, Dan; Li, Yingrui; Zhang, Xiuqing; Li, Songgang; Wang, Jian; Yang, Huanming; Wang, Jun; Cai, Zhiming			Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; CANCER; PATHWAYS; FGFR3	Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we sequenced the exomes of nine individuals with TCC and screened all the somatically mutated genes in a prevalence set of 88 additional individuals with TCC with different tumor stages and grades. In our study, we discovered a variety of genes previously unknown to be mutated in TCC. Notably, we identified genetic aberrations of the chromatin remodeling genes (UTX, MLL-MLL3, CREBBP-EP300, NCOR1, ARID1A and CHD6) in 59% of our 97 subjects with TCC. Of these genes, we showed UTX to be altered substantially more frequently in tumors of low stages and grades, highlighting its potential role in the classification and diagnosis of bladder cancer. Our results provide an overview of the genetic basis of TCC and suggest that aberration of chromatin regulation might be a hallmark of bladder cancer.	[Gui, Yaoting; Huang, Yi; Tang, Aifa; Li, Xianxin; Zhou, Liang; Li, Zesong; Wang, Yong; Sun, Liang; Jiang, Zhimao; Chen, Jing; Wu, Song; Zhang, Zhongfu; Yang, Ruilin; Zhao, Jun; Xu, Congjie; Yin, Weihua; Guan, Zhichen; Ye, Jiongxian; Zhang, Hong; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Guo, Guangwu; Hu, Xueda; Gao, Shengjie; Wu, Renhua; Chen, Chao; He, Minghui; Jia, Wenlong; Chen, Jinnong; Yang, Shangming; Wan, Shengqing; Ye, Rui; Liu, Zhisheng; Huang, Peide; Jiang, Hui; Zheng, Hancheng; Liu, Xingwang; Feng, Dafei; Zou, Jing; Li, Jingxiang; Kristiansen, Karsten; Li, Yingrui; Zhang, Xiuqing; Li, Songgang; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Tang, Aifa; Li, Zesong; Sun, Xiaojuan] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen, Peoples R China; [Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Xiaokun] Cent So Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Peoples R China; [Liu, Chunxiao] So Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Nickerson, Michael L.] NCI, Canc & Inflammat Program, US Natl Inst Hlth NIH, Frederick, MD 21701 USA; [Theodorescu, Dan] Univ Colorado, Dept Surg, Ctr Comprehens Canc, Aurora, CO USA; [Theodorescu, Dan] Univ Colorado, Dept Pharmacol, Ctr Comprehens Canc, Aurora, CO USA	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Beijing Genomics Institute (BGI); Shenzhen University; Sun Yat Sen University; Central South University; Anhui Medical University; Southern Medical University - China; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Cai, ZM (corresponding author), Peking Univ, Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China.	yanghm@genomics.org.cn; wangj@genomics.org.cn; caizhiming2000@yahoo.com.cn	Jia, Justin/AAV-4349-2021; Kristiansen, Karsten/J-5148-2014; gui, yaoting/GLT-3684-2022; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Gao, Shengjie/S-4016-2017; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jia, Justin/0000-0002-7136-9919; Kristiansen, Karsten/0000-0002-6024-0917; Peide, Huang/0000-0001-6108-5069; Gao, Shengjie/0000-0002-5221-8381; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Ye, Rui/0000-0002-4866-088X; Liang, Chaozhao/0000-0003-2317-1323	National High Technology Research and Development Program of China (863 Program) [2006AA02A302, 2009AA022707]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A, CXB201005250016A]; Research Fund for the Doctoral Program of Higher Education of China [20100001110100]; NATIONAL CANCER INSTITUTE [ZIABC011300, R01CA075115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022707] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Promotion Program for Shenzhen Key Laboratory, Shenzhen, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, 2006AA02A302 to H.Y. 2009AA022707 to X.Z.), the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A and CXB201005250016A to Z.C.), and Research Fund for the Doctoral Program of Higher Education of China (20100001110100).	Bakkar AA, 2003, CANCER RES, V63, P8108; CAIRNS P, 1991, ONCOGENE, V6, P2305; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; CORDONCARDO C, 1994, INT J CANCER, V56, P347, DOI 10.1002/ijc.2910560309; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Daser A, 2005, SEMIN CANCER BIOL, V15, P175, DOI 10.1016/j.semcancer.2005.01.007; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lutz T, 2006, FEBS LETT, V580, P5851, DOI 10.1016/j.febslet.2006.09.049; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	30	549	580	1	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					875	878		10.1038/ng.907	http://dx.doi.org/10.1038/ng.907			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822268	Green Accepted			2022-12-25	WOS:000294325800014
J	Li, M; Zhao, H; Zhang, XS; Wood, LD; Anders, RA; Choti, MA; Pawlik, TM; Daniel, HD; Kannangai, R; Offerhaus, GJA; Velculescu, VE; Wang, LF; Zhou, SB; Vogelstein, B; Hruban, RH; Papadopoulos, N; Cai, JQ; Torbenson, MS; Kinzler, KW				Li, Meng; Zhao, Hong; Zhang, Xiaosong; Wood, Laura D.; Anders, Robert A.; Choti, Michael A.; Pawlik, Timothy M.; Daniel, Hubert D.; Kannangai, Rajesh; Offerhaus, G. Johan A.; Velculescu, Victor E.; Wang, Linfang; Zhou, Shibin; Vogelstein, Bert; Hruban, Ralph H.; Papadopoulos, Nick; Cai, Jianqiang; Torbenson, Michael S.; Kinzler, Kenneth W.			Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma	NATURE GENETICS			English	Article							HEPATITIS-B-VIRUS; EXPRESSION; HEPATOCARCINOGENESIS; AFLATOXIN	Through exomic sequencing of ten hepatitis C virus (HCV)-associated hepatocellular carcinomas (HCC) and subsequent evaluation of additional affected individuals, we discovered novel inactivating mutations of ARID2 in four major subtypes of HCC (HCV-associated HCC, hepatitis B virus (HBV)-associated HCC, alcohol-associated HCC and HCC with no known etiology). Notably, 18.2% of individuals with HCV-associated HCC in the United States and Europe harbored ARID2 inactivation mutations, suggesting that ARID2 is a tumor suppressor gene that is relatively commonly mutated in this tumor subtype.	[Li, Meng; Velculescu, Victor E.; Zhou, Shibin; Vogelstein, Bert; Papadopoulos, Nick; Kinzler, Kenneth W.] Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21218 USA; [Zhao, Hong; Cai, Jianqiang] Chinese Acad Med Sci, Dept Abdominal Surg Oncol, Canc Hosp, Beijing 100730, Peoples R China; [Zhao, Hong; Wang, Linfang; Cai, Jianqiang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Xiaosong] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wood, Laura D.; Anders, Robert A.; Daniel, Hubert D.; Kannangai, Rajesh; Hruban, Ralph H.; Torbenson, Michael S.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Choti, Michael A.; Pawlik, Timothy M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Offerhaus, G. Johan A.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Wang, Linfang] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100730, Peoples R China	Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Utrecht University; Utrecht University Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Kinzler, KW (corresponding author), Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21218 USA.	caijianqiang188@sina.com; mtorben@jhmi.edu; kinzlke@jhmi.edu	Daniel, Hubert Darius/B-7430-2011; Velculescu, Victor/ABF-4846-2020; Wood, Laura/ABF-1531-2020; Pawlik, Timothy/AAO-9335-2020; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; 	Virginia and D.K. Ludwig Fund for Cancer Research; US National Institutes of Health [CA43460, CA57345, CA62924, CA121113, DK078686, DK080736, DK081417]; AACR; National Science and Technology Major Project [2008ZX10002-025]; NATIONAL CANCER INSTITUTE [R01CA057345, P50CA062924, R37CA043460, R37CA057345, R01CA121113, R01CA043460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078686, R01DK080736, R01DK081417] Funding Source: NIH RePORTER	Virginia and D.K. Ludwig Fund for Cancer Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR; National Science and Technology Major Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Silliman, J. Ptak, L. Dobbyn, J. Schaeffer, M. Whalen, Z. Khan, J. Ma, Z. Wang and R. Mi for expert technical assistance. This work was supported by The Virginia and D.K. Ludwig Fund for Cancer Research and US National Institutes of Health grants CA43460, CA57345, CA62924, CA121113, DK078686, DK080736, DK081417, AACR Stand Up to Cancer Dream Team Translational Cancer Research Grant and National Science and Technology Major Project Grant 2008ZX10002-025.	American Cancer Society, 2009, CANC FACTS FIG 2009; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kew MC, 2003, LIVER INT, V23, P405, DOI 10.1111/j.1478-3231.2003.00869.x; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Melen K, 2004, J MED VIROL, V73, P536, DOI 10.1002/jmv.20123; Ming L, 2002, HEPATOLOGY, V36, P1214, DOI 10.1053/jhep.2002.36366; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Okada T, 2003, FEBS LETT, V555, P583, DOI 10.1016/S0014-5793(03)01345-0; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805	14	307	331	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					828	829		10.1038/ng.903	http://dx.doi.org/10.1038/ng.903			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822264	Green Accepted			2022-12-25	WOS:000294325800006
J	Cherfils, J; Zeghouf, M				Cherfils, Jacqueline; Zeghouf, Mahel			Chronicles of the GTPase switch	NATURE CHEMICAL BIOLOGY			English	Article							CONFORMATIONAL SWITCH; SIGNAL-TRANSDUCTION; EXCHANGE FACTOR; G-PROTEINS; RAS; DOMAIN; DIMERIZATION; INHIBITION		[Cherfils, Jacqueline; Zeghouf, Mahel] Ctr Rech Gif, CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cherfils, J (corresponding author), Ctr Rech Gif, CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	cherfils@lebs.cnrs-gif.fr		Zeghouf, Mahel/0000-0003-3686-2510				Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Biou V, 2010, J MOL BIOL, V402, P696, DOI 10.1016/j.jmb.2010.08.002; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brown ED, 2005, BIOCHEM CELL BIOL, V83, P738, DOI 10.1139/O05-162; Buosi V, 2010, J BIOL CHEM, V285, P37987, DOI 10.1074/jbc.M110.134445; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Stalder D, 2011, J BIOL CHEM, V286, P3873, DOI 10.1074/jbc.M110.145532; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	26	38	38	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					493	495		10.1038/nchembio.608	http://dx.doi.org/10.1038/nchembio.608			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769091				2022-12-25	WOS:000292825400005
J	Pajvani, UB; Shawber, CJ; Samuel, VT; Birkenfeld, AL; Shulman, GI; Kitajewski, J; Accili, D				Pajvani, Utpal B.; Shawber, Carrie J.; Samuel, Varman T.; Birkenfeld, Andreas L.; Shulman, Gerald I.; Kitajewski, Jan; Accili, Domenico			Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; GLUCOSE-6-PHOSPHATASE GENE-EXPRESSION; GLUCOSE-PRODUCTION; ADIPOSE-TISSUE; PROTEIN-KINASE; MICE LACKING; FACTOR FKHR; IN-VIVO; DIFFERENTIATION; LIVER	Transcription factor FoxO1 promotes hepatic glucose production. Genetic inhibition of FoxO1 function prevents diabetes in experimental animal models, providing impetus to identify pharmacological approaches to modulate this function. Altered Notch signaling is evident in tumorigenesis, and Notch antagonists are in clinical testing for application in cancer. Here we report that FoxO1 and Notch coordinately regulate hepatic glucose metabolism. Combined haploinsufficiency of FoxO1 and Notch1 markedly raises insulin sensitivity in diet-induced insulin resistance, as does liver-specific knockout of the Notch transcriptional effector Rbp-J kappa. Conversely, Notch1 gain-of-function promotes insulin resistance in a FoxO1-dependent manner and induces glucose-6-phosphatase expression. Pharmacological blockade of Notch signaling with gamma-secretase inhibitors raises insulin sensitivity after in vivo administration in lean mice and in obese, insulin-resistant mice. The data identify a heretofore unknown metabolic function of Notch and suggest that Notch inhibition is beneficial in diabetes treatment, in part by helping to offset excessive FoxO1-driven hepatic glucose production.	[Pajvani, Utpal B.; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10027 USA; [Shawber, Carrie J.; Kitajewski, Jan] Columbia Univ, Dept Pathol, New York, NY USA; [Shawber, Carrie J.; Kitajewski, Jan] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Samuel, Varman T.; Birkenfeld, Andreas L.; Shulman, Gerald I.] Yale Univ, Dept Internal Med, New Haven, CT USA	Columbia University; Columbia University; Columbia University; Yale University	Accili, D (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	da230@columbia.edu	Birkenfeld, Andreas L./U-3954-2019; Shulman, Gerald I./P-7176-2019	Birkenfeld, Andreas L./0000-0003-1407-9023; Shulman, Gerald I./0000-0003-1529-5668	US National Institutes of Health [DK57539, DK084583, HL062454]; US National Institutes of Health (Columbia Diabetes and Endocrinology Research Center) [DK63608]; US National Institutes of Health (Yale Mouse Metabolic Phenotyping Center) [DK76169]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085638, U24DK059635, R37DK058282, P30DK063608, R01DK057539, R01DK040936, P30DK045735, U24DK076169, F32DK084583] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Columbia Diabetes and Endocrinology Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Yale Mouse Metabolic Phenotyping Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants DK57539 (D. A.), DK084583 (U. B. P.), DK63608 (Columbia Diabetes and Endocrinology Research Center), HL062454 (J.K.) and DK76169 (Yale Mouse Metabolic Phenotyping Center). We thank D. Schmoll (Sanofi-Aventis) for the G6pc-luciferase constructs, members of the Accili, Kitajewski and Shulman laboratories for insightful discussion of the data, and A. Flete, T. Kolar and T. Lu for technical support.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fujikura J, 2006, CELL METAB, V3, P59, DOI 10.1016/j.cmet.2005.12.005; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang A, 2004, FEBS LETT, V558, P69, DOI 10.1016/S0014-5793(03)01499-6; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kim-Muller JY, 2011, SCIENCE, V331, P1529, DOI 10.1126/science.1204504; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Krebs LT, 2000, GENE DEV, V14, P1343; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; OKA C, 1995, DEVELOPMENT, V121, P3291; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Purow B, 2009, CURR PHARM BIOTECHNO, V10, P154, DOI 10.2174/138920109787315060; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang J, 2001, DIABETES OBES METAB, V3, P367, DOI 10.1046/j.1463-1326.2001.00173.x; Weinmaster G, 2006, DEVELOPMENT, V133, P3277, DOI 10.1242/dev.02515; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Woo HN, 2009, BIOCHEM BIOPH RES CO, V390, P1093, DOI 10.1016/j.bbrc.2009.10.093; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	46	135	144	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					961	U78		10.1038/nm.2378	http://dx.doi.org/10.1038/nm.2378			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21804540	Green Accepted			2022-12-25	WOS:000293507400029
J	Xu, X; Nagarajan, H; Lewis, NE; Pan, SK; Cai, ZM; Liu, X; Chen, WB; Xie, M; Wang, WL; Hammond, S; Andersen, MR; Neff, N; Passarelli, B; Koh, W; Fan, HC; Wang, JB; Gui, YT; Lee, KH; Betenbaugh, MJ; Quake, SR; Famili, I; Palsson, BO; Wang, J				Xu, Xun; Nagarajan, Harish; Lewis, Nathan E.; Pan, Shengkai; Cai, Zhiming; Liu, Xin; Chen, Wenbin; Xie, Min; Wang, Wenliang; Hammond, Stephanie; Andersen, Mikael R.; Neff, Norma; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Wang, Jianbin; Gui, Yaoting; Lee, Kelvin H.; Betenbaugh, Michael J.; Quake, Stephen R.; Famili, Iman; Palsson, Bernhard O.; Wang, Jun			The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line	NATURE BIOTECHNOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; HEPARAN-SULFATE 6-SULFOTRANSFERASE; THERAPEUTIC ANTIBODIES; SIALIC-ACID; GLYCOSYLATION; EXPRESSION; CHO; SURFACE; PURIFICATION; RECEPTORS	Chinese hamster ovary (CHO)-derived cell lines are the preferred host cells for the production of therapeutic proteins. Here we present a draft genomic sequence of the CHO-K1 ancestral cell line. The assembly comprises 2.45 Gb of genomic sequence, with 24,383 predicted genes. We associate most of the assembled scaffolds with 21 chromosomes isolated by microfluidics to identify chromosomal locations of genes. Furthermore, we investigate genes involved in glycosylation, which affect therapeutic protein quality, and viral susceptibility genes, which are relevant to cell engineering and regulatory concerns. Homologs of most human glycosylation-associated genes are present in the CHO-K1 genome, although 141 of these homologs are not expressed under exponential growth conditions. Many important viral entry genes are also present in the genome but not expressed, which may explain the unusual viral resistance property of CHO cell lines. We discuss how the availability of this genome sequence may facilitate genome-scale science for the optimization of biopharmaceutical protein production.	[Xu, Xun; Pan, Shengkai; Liu, Xin; Chen, Wenbin; Xie, Min; Wang, Wenliang; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Nagarajan, Harish; Lewis, Nathan E.; Famili, Iman; Palsson, Bernhard O.] GT Life Sci, San Diego, CA USA; [Cai, Zhiming; Gui, Yaoting] Peking Univ, Shenzhen PKU HKUST Med Ctr, Guangdong Key Lab Male Reprod Med & Genet, Shenzhen Hosp, Shenzhen, Peoples R China; [Hammond, Stephanie; Lee, Kelvin H.] Univ Delaware, Dept Chem Engn, Newark, DE USA; [Hammond, Stephanie; Lee, Kelvin H.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA; [Andersen, Mikael R.] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Neff, Norma; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Neff, Norma; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Betenbaugh, Michael J.; Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Horsholm, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; University of Delaware; University of Delaware; Technical University of Denmark; Stanford University; Howard Hughes Medical Institute; Stanford University; Johns Hopkins University; Novo Nordisk Foundation; Technical University of Denmark; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	palsson@ucsd.edu; wangj@genomics.org.cn	Lewis, Nathan/ABE-7290-2020; Wang, Jun/A-7261-2013; Betenbaugh, Michael J./A-3252-2010; Andersen, Mikael R/F-9377-2013; Andersen, Mikael Rørdam/P-6743-2019; Crozier, Laura/C-2170-2011; Xu, Xun/AAI-6763-2020; Chen, Wenbin/ABI-1111-2020; gui, yaoting/GLT-3684-2022; Wang, Jianbin/G-7533-2015; Koh, Lian Chye Winston/GYD-5873-2022; XIE, MIN/P-8062-2019; Lee, Kelvin H/A-4673-2010; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Lewis, Nathan/0000-0001-7700-3654; Betenbaugh, Michael J./0000-0002-6336-4659; Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; Xu, Xun/0000-0002-5338-5173; Chen, Wenbin/0000-0002-8690-4822; Wang, Jianbin/0000-0001-6725-7925; Koh, Lian Chye Winston/0000-0003-4611-6490; XIE, MIN/0000-0002-5652-5039; Lee, Kelvin H/0000-0003-0908-2981; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Liu, Xin/0000-0003-3256-2940; Palsson, Bernhard/0000-0003-2357-6785	National Natural Science Foundation (NSFC) of China [30725008]; Shenzhen government [ZYC200903240077A]; Guangdong Innovation Team; National Basic Research Program of China (973 program) [2007CB815703]; US National Institutes of Health (NIH) [2P20RR016472-10]; National Cancer Institute [NIH R44CA139977]; Danish Agency for Science, Technology and Innovation [07-015498];  [CXB200903110066A]; NATIONAL CANCER INSTITUTE [R44CA139977] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	National Natural Science Foundation (NSFC) of China(National Natural Science Foundation of China (NSFC)); Shenzhen government; Guangdong Innovation Team; National Basic Research Program of China (973 program)(National Basic Research Program of China); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Agency for Science, Technology and Innovation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors wish to acknowledge B. Kingham at the University of Delaware for technical assistance. This work was funded in part by National Natural Science Foundation (NSFC) of China award to a young scientist (30725008), funding from Shenzhen government (ZYC200903240077A), funding for Shenzhen Key labs (CXB200903110066A), Guangdong Innovation Team Funding, National Basic Research Program of China (973 program, 2007CB815703), US National Institutes of Health (NIH) 2P20RR016472-10 and National Cancer Institute Small Business Innovation Research grant (NIH R44CA139977). M.R.A. acknowledges funding from the Danish Agency for Science, Technology and Innovation grant 07-015498.	Beck A, 2008, CURR PHARM BIOTECHNO, V9, P482, DOI 10.2174/138920108786786411; Bosques CJ, 2010, NAT BIOTECHNOL, V28, P1153, DOI 10.1038/nbt1110-1153; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Conner J, 2005, J VIROL, V79, P9970, DOI 10.1128/JVI.79.15.9970-9981.2005; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; Derouazi M, 2007, CELL TECHNOLOGY FOR CELL PRODUCTS, P443, DOI 10.1007/978-1-4020-5476-1_73; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Gao Shan-dian, 2008, Virologica Sinica, V23, P1, DOI 10.1007/s12250-008-2886-2; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Gianni T, 2010, P NATL ACAD SCI USA, V107, P22260, DOI 10.1073/pnas.1014923108; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Ianelli CJ, 1998, J BIOL CHEM, V273, P23367, DOI 10.1074/jbc.273.36.23367; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Mullins LJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-221; Nakano K, 2005, MOL THER, V11, P617, DOI 10.1016/j.ymthe.2004.12.012; Natsume A, 2006, J BIOCHEM, V140, P359, DOI 10.1093/jb/mvj157; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Rostand KS, 1997, INFECT IMMUN, V65, P1; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; SAWITZKY D, 1990, ARCH VIROL, V115, P309, DOI 10.1007/BF01310539; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Seth G, 2007, CURR OPIN BIOTECH, V18, P557, DOI 10.1016/j.copbio.2007.10.012; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Smit A, 1996, REPEATMASKER OPEN 30; Smit A., 2008, REPEATMASKER OPEN 1; SPEHNER D, 1988, J VIROL, V62, P1297, DOI 10.1128/JVI.62.4.1297-1304.1988; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiebe M.E., 1989, MULTIFACETED APPROAC; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xie M, 2005, CHINESE MED J-PEKING, V118, P2072; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yoo EM, 2010, MABS-AUSTIN, V2, P320, DOI 10.4161/mabs.2.3.11802	55	551	615	3	143	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					735	U131		10.1038/nbt.1932	http://dx.doi.org/10.1038/nbt.1932			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804562	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000293696500026
J	Mi, S; Lee, XH; Hu, YH; Ji, BX; Shao, ZH; Yang, WX; Huang, GR; Walus, L; Rhodes, K; Gong, BJ; Miller, RH; Pepinsky, RB				Mi, Sha; Lee, Xinhua; Hu, Yinghui; Ji, Benxiu; Shao, Zhaohui; Yang, Weixing; Huang, Guanrong; Walus, Lee; Rhodes, Kenneth; Gong, Bang Jian; Miller, Robert H.; Pepinsky, R. Blake			Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; TNF RECEPTOR; AXON REGENERATION; NOGO RECEPTOR; FAMILY-MEMBER; REMYELINATION; CNS; DIFFERENTIATION; LINGO-1; MOUSE	Survival and differentiation of oligodendrocytes are important for the myelination of central nervous system (CNS) axons during development and crucial for myelin repair in CNS demyelinating diseases such as multiple sclerosis. Here we show that death receptor 6 (DR6) is a negative regulator of oligodendrocyte maturation. DR6 is expressed strongly in immature oligodendrocytes and weakly in mature myelin basic protein (MBP)-positive oligodendrocytes. Overexpression of DR6 in oligodendrocytes leads to caspase 3 (casp3) activation and cell death. Attenuation of DR6 function leads to enhanced oligodendrocyte maturation, myelination and downregulation of casp3. Treatment with a DR6 antagonist antibody promotes remyelination in both lysolecithin-induced demyelination and experimental autoimmune encephalomyelitis (EAE) models. Consistent with the DR6 antagoinst antibody studies, DR6-null mice show enhanced remyelination in both demyelination models. These studies reveal a pivotal role for DR6 signaling in immature oligodendrocyte maturation and myelination that may provide new therapeutic avenues for the treatment of demyelination disorders such as multiple sclerosis.	[Mi, Sha; Lee, Xinhua; Hu, Yinghui; Ji, Benxiu; Shao, Zhaohui; Yang, Weixing; Huang, Guanrong; Walus, Lee; Rhodes, Kenneth; Gong, Bang Jian; Pepinsky, R. Blake] Biogen Idec Inc, Cambridge, MA USA; [Miller, Robert H.] Case Western Reserve Univ, Dept Neurosci, Sch Med, Ctr Translat Neurosci, Cleveland, OH 44106 USA	Biogen; Case Western Reserve University	Mi, S (corresponding author), Biogen Idec Inc, Cambridge, MA USA.	sha.mi@biogenidec.com						Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Clarke P, 2009, J VIROL, V83, P6161, DOI 10.1128/JVI.02488-08; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Franklin RJM, 1999, J NEUROSCI RES, V58, P207, DOI 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1; Franklin RJM, 2002, BRAIN RES BULL, V57, P827, DOI 10.1016/S0361-9230(01)00765-1; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Guan J, 2001, J CEREBR BLOOD F MET, V21, P493, DOI 10.1097/00004647-200105000-00003; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Mason JL, 2003, J NEUROSCI, V23, P7710; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; MI S, 2007, NAT PROTOC, DOI DOI 10.1038/NPROT.2007.389; Mi S, 2008, INT J BIOCHEM CELL B, V40, P1971, DOI 10.1016/j.biocel.2008.03.018; Mi S, 2008, CYTOKINE GROWTH F R, V19, P245, DOI 10.1016/j.cytogfr.2008.04.007; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pang Y, 2005, J NEUROSCI RES, V80, P226, DOI 10.1002/jnr.20450; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220	40	62	70	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					816	U180		10.1038/nm.2373	http://dx.doi.org/10.1038/nm.2373			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21725297				2022-12-25	WOS:000292500800035
J	Xiao, BL; Coste, B; Mathur, J; Patapoutian, A				Xiao, Bailong; Coste, Bertrand; Mathur, Jayanti; Patapoutian, Ardem			Temperature-dependent STIM1 activation induces Ca2+ influx and modulates gene expression	NATURE CHEMICAL BIOLOGY			English	Article							STROMAL INTERACTION MOLECULE-1; OPERATED CALCIUM-ENTRY; T-CELL; IMMUNE-RESPONSE; PLASMA-MEMBRANE; ORAI CHANNELS; TRPC CHANNELS; CRAC CHANNELS; STORE; SENSOR	Intracellular Ca2+ is essential for diverse cellular functions. Ca2+ entry into many cell types including immune cells is triggered by depleting endoplasmic reticulum ( ER) Ca2+, a process termed store-operated Ca2+ entry (SOCE). STIM1 is an ER Ca2+ sensor. Upon Ca2+ store depletion, STIM1 clusters at ER-plasma membrane junctions where it interacts with and gates Ca2+-permeable Orai1 ion channels. Here we show that STIM1 is also activated by temperature. Heating cells caused clustering of STIM1 at temperatures above 35 degrees C without depleting Ca2+ stores and led to Orai1-mediated Ca2+ influx as a heat off-response ( response after cooling). Notably, the functional coupling of STIM1 and Orai1 is prevented at high temperatures, potentially explaining the heat off-response. Additionally, physiologically relevant temperature shifts modulate STIM1-dependent gene expression in Jurkat T cells. Therefore, temperature is an important regulator of STIM1 function.	[Xiao, Bailong; Coste, Bertrand; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Mathur, Jayanti; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Novartis	Xiao, BL (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	apatapou@gnf.org	Xiao, Bailong/B-6187-2012	Coste, Bertrand/0000-0002-0163-2494	US National Institutes of Health [DE016927, NS046303]; Novartis Research Foundation; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; American Heart Association; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R.Y. Tsien (University of California, San Diego), P. Shultz (The Scripps Research Institute), S.-S. Tian (Genomics Institute of the Novartis Research Foundation, GNF), A. Parker (GNF), D. Tully (GNF) and S. F. Pan (GNF) for providing reagents; E. Rodrigo, E. Peters, J. Liu, K. Spencer, T. Earley, D. Li and J. Mitsios for experimental help; M. Schmidt for providing advice on GFP-STIM1 puncta analysis; C. Schmedt, M. Cooke, D. Geurini, S.-S. Tian and S. Sanford for discussions; and N. Hong and J. Grandl for reading the manuscript. This research was supported by US National Institutes of Health grants DE016927 and NS046303 and by the Novartis Research Foundation. B. X. is a postdoctoral fellowship recipient from Canadian Institutes of Health Research, Alberta Heritage Foundation for Medical Research and American Heart Association. B. C. is a postdoctoral fellowship recipient from American Heart Association.	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; GERN JE, 1991, CYTOKINE, V3, P389, DOI 10.1016/1043-4666(91)90042-C; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hanson DF, 1997, ANN NY ACAD SCI, V813, P453, DOI 10.1111/j.1749-6632.1997.tb51733.x; HANSON DF, 1983, J IMMUNOL, V130, P216; HANSON DF, 1993, J IMMUNOL, V151, P436; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kenny GP, 2003, J APPL PHYSIOL, V94, P2350, DOI 10.1152/japplphysiol.01107.2002; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LEDERMAN HM, 1987, J IMMUNOL, V138, P3808; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Oliver AE, 2000, BIOPHYS J, V78, P2116, DOI 10.1016/S0006-3495(00)76758-0; PaltaufDoburzynska J, 1997, CELL CALCIUM, V21, P43, DOI 10.1016/S0143-4160(97)90095-6; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xie Y., 2006, Compounds for inflammation and immune-related uses, Patent No. [2006081391 A2, 2006081391]; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	47	95	101	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					351	358		10.1038/NCHEMBIO.558	http://dx.doi.org/10.1038/NCHEMBIO.558			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21499266	Green Accepted			2022-12-25	WOS:000290677900010
J	Wong, ASL; Lee, RHK; Cheung, AY; Yeung, PK; Chung, SK; Cheung, ZH; Ip, NY				Wong, Alan S. L.; Lee, Rebecca H. K.; Cheung, Anthony Y.; Yeung, Patrick K.; Chung, Sookja K.; Cheung, Zelda H.; Ip, Nancy Y.			Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; ALPHA-SYNUCLEIN; CELL-DEATH; NEURONAL SURVIVAL; CDK5; PROTEIN; DEGRADATION; INHIBITION; TOXICITY; MUTANT	Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine kinase that is increasingly implicated in various neurodegenerative diseases. Deregulated Cdk5 activity has been associated with neuronal death, but the underlying mechanisms are not well understood. Here we report an unexpected role for Cdk5 in the regulation of induced autophagy in neurons. We have identified endophilin B1 (EndoB1) as a Cdk5 substrate, and show that Cdk5-mediated phosphorylation of EndoB1 is required for autophagy induction in starved neurons. Furthermore, phosphorylation of EndoB1 facilitates EndoB1 dimerization and recruitment of UVRAG (UV radiation resistance-associated gene). More importantly, Cdk5-mediated phosphorylation of EndoB1 is essential for autophagy induction and neuronal loss in models of Parkinson's disease. Our findings not only establish Cdk5 as a critical regulator of autophagy induction, but also reveal a role for Cdk5 and EndoB1 in the pathophysiology of Parkinson's disease through modulating autophagy.	[Wong, Alan S. L.; Lee, Rebecca H. K.; Cheung, Anthony Y.; Cheung, Zelda H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Wong, Alan S. L.; Lee, Rebecca H. K.; Cheung, Anthony Y.; Cheung, Zelda H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; [Wong, Alan S. L.; Lee, Rebecca H. K.; Cheung, Anthony Y.; Cheung, Zelda H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Yeung, Patrick K.; Chung, Sookja K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chung, Sookja K.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Hong Kong; University of Hong Kong	Cheung, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	zelda@ust.hk; boip@ust.hk	Cheung, Zelda Hiu Yee/C-1402-2012	Wong, Alan S.L./0000-0003-1790-3233; Ip, Nancy Yuk-Yu/0000-0002-2763-8907	Research Grants Council of Hong Kong (HKUST) [661007, 661109, 660309, 660210, 1/06C, 6/CRF/08]; University Grants Committee [AoE/B-15/01]; Hong Kong Jockey Club; Croucher Foundation	Research Grants Council of Hong Kong (HKUST)(Hong Kong Research Grants Council); University Grants Committee; Hong Kong Jockey Club; Croucher Foundation	We are grateful to A. B. Kulkarni (National Institutes of Health, USA) and T. Curran (St Jude Children's Research Hospital, USA) for the Cdk5-knockout mice. p35-knockout mice were provided by L. H. Tsai (Massachusetts Institute of Technology, USA). We thank T. Yoshimori (Osaka University, Japan) for the mRFP-LC3 construct, V.M.Y. Lee (University of Pennsylvania School of Medicine, USA) for the SNL-1 antibody and wild-type alpha synuclein and alpha-synuclein<SUP>A53T</SUP> constructs and J. Yuan (Harvard Medical School) for the pcDNA3-Beclin 1 construct. We thank J. Li, G. Ke, W.Y. Fu, K. Cheng, J. Wan, Y.P. Ng, V. Lee and A. Lai for technical assistance, and members of the Ip lab oratory for discussions. This work was supported in part by the Research Grants Council of Hong Kong (HKUST 661007, 661109, 660309, 660210, 1/06C and 6/CRF/08), the Area of Excellence Scheme of the University Grants Committee (AoE/B-15/01) and the Hong Kong Jockey Club. N.Y.I. and Z.H.C. were recipients of the Croucher Foundation Senior Research Fellowship and Croucher Foundation Fellowship, respectively.	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Cheung ZH, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-29; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Huttner WB, 2002, TRENDS CELL BIOL, V12, P155, DOI 10.1016/S0962-8924(02)02252-3; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lai KO, 2004, J BIOL CHEM, V279, P13383, DOI 10.1074/jbc.M313356200; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Paoletti P, 2008, J NEUROSCI, V28, P10090, DOI 10.1523/JNEUROSCI.3237-08.2008; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	53	110	115	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					568	U167		10.1038/ncb2217	http://dx.doi.org/10.1038/ncb2217			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21499257				2022-12-25	WOS:000290148700016
J	Cho, BK; Federowicz, S; Park, YS; Zengler, K; Palsson, BO				Cho, Byung-Kwan; Federowicz, Stephen; Park, Young-Seoub; Zengler, Karsten; Palsson, Bernhard O.			Deciphering the transcriptional regulatory logic of amino acid metabolism	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI K-12; ARGININE REGULON; BINDING; REPRESSOR; SYSTEM; DNA; EXPRESSION; NETWORK; PROTEIN; GENES	Although metabolic networks have been reconstructed on a genome scale, the corresponding reconstruction and integration of governing transcriptional regulatory networks has not been fully achieved. Here we reconstruct such an integrated network for amino acid metabolism in Escherichia coli. Analysis of ChIP-chip and gene expression data for the transcription factors ArgR, Lrp and TrpR showed that 19 out of 20 amino acid biosynthetic pathways are either directly or indirectly controlled by these regulators. Classifying the regulated genes into three functional categories of transport, biosynthesis and metabolism leads to the elucidation of regulatory motifs that constitute the integrated network's basic building blocks. The regulatory logic of these motifs was determined on the basis of relationships between transcription factor binding and changes in the amount of transcript in response to exogenous amino acids. Remarkably, the resulting logic shows how amino acids are differentiated as signaling and nutrient molecules, revealing the overarching regulatory principles of the amino acid stimulon.	[Cho, Byung-Kwan] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Cho, Byung-Kwan; Federowicz, Stephen; Park, Young-Seoub; Zengler, Karsten; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California San Diego	Cho, BK (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea.	bkcho01@gmail.com; palsson@ucsd.edu	Cho, Byung-Kwan/C-1830-2011	Palsson, Bernhard/0000-0003-2357-6785; Zengler, Karsten/0000-0002-8062-3296	US National Institutes of Health [GM062791]; Office of Science-Biological and Environmental Research, US Department of Energy [DE-FOA-0000143]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062791] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science-Biological and Environmental Research, US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Abrams and J. Lerman for critical reading of the manuscript. The US National Institutes of Health (through grant GM062791) and the Office of Science-Biological and Environmental Research, US Department of Energy (through grant DE-FOA-0000143) supported this work.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Caldara M, 2007, J MOL BIOL, V373, P251, DOI 10.1016/j.jmb.2007.08.013; Caldara M, 2006, MICROBIOL-SGM, V152, P3343, DOI 10.1099/mic.0.29088-0; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CHARLIER D, 1992, J MOL BIOL, V226, P367, DOI 10.1016/0022-2836(92)90953-H; Cho BK, 2006, BIOTECHNIQUES, V40, P67, DOI 10.2144/000112039; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Cho Byung-Kwan, 2008, V439, P131, DOI 10.1007/978-1-59745-188-8_9; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Hershberg R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r62; Jeeves M, 1999, EUR J BIOCHEM, V265, P919, DOI 10.1046/j.1432-1327.1999.00792.x; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Kiupakis AK, 2002, J BACTERIOL, V184, P2940, DOI 10.1128/JB.184.11.2940-2950.2002; KLIG LS, 1988, GENETICS, V120, P651; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; MAAS WK, 1964, J MOL BIOL, V8, P365, DOI 10.1016/S0022-2836(64)80200-X; Makarova KS, 2001, GENOME BIOL, V2; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Semsey S, 2007, MOL MICROBIOL, V65, P465, DOI 10.1111/j.1365-2958.2007.05798.x; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; VanDuyne GD, 1996, J MOL BIOL, V256, P377, DOI 10.1006/jmbi.1996.0093; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang J, 1996, J MOL BIOL, V258, P37, DOI 10.1006/jmbi.1996.0232; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0	39	68	70	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					65	71		10.1038/nchembio.710	http://dx.doi.org/10.1038/nchembio.710			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22082910	Green Accepted			2022-12-25	WOS:000298414100013
J	Jia, GF; Fu, Y; Zhao, X; Dai, Q; Zheng, GQ; Yang, Y; Yi, CQ; Lindahl, T; Pan, T; Yang, YG; He, C				Jia, Guifang; Fu, Ye; Zhao, Xu; Dai, Qing; Zheng, Guanqun; Yang, Ying; Yi, Chengqi; Lindahl, Tomas; Pan, Tao; Yang, Yun-Gui; He, Chuan			N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO	NATURE CHEMICAL BIOLOGY			English	Article							GENOME-WIDE ASSOCIATION; MESSENGER-RNA; ADULT OBESITY; DNA; GENE; ALKB; RESIDUES; REPAIR; METHYLATION; SPECIFICITY	We report here that fat mass and obesity-associated protein (FTO) has efficient oxidative demethylation activity targeting the abundant N6-methyladenosine (m(6)A) residues in RNA in vitro. FTO knockdown with siRNA led to increased amounts of m(6)A in mRNA, whereas overexpression of FTO resulted in decreased amounts of m(6)A in human cells. We further show the partial colocalization of FTO with nuclear speckles, which supports the notion that m(6)A in nuclear RNA is a major physiological substrate of FTO.	[Jia, Guifang; Fu, Ye; Dai, Qing; Zheng, Guanqun; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zhao, Xu; Yang, Ying; Yang, Yun-Gui] Chinese Acad Sci, Beijing Inst Genom, Genome Struct & Stabil Grp, Dis Genom & Individualized Med Lab, Beijing, Peoples R China; [Yi, Chengqi; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Lindahl, Tomas] London Res Inst, Clare Hall Labs, Canc Res UK, S Mimms, Herts, England; [Pan, Tao] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Chicago; Cancer Research UK; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Dai, Qing/ABD-8444-2021; Yang, Yungui/ABF-2507-2021	Yi, Chengqi/0000-0003-2540-9729; Zhao, Xu/0000-0002-0233-9660; Fu, Ye/0000-0003-4434-6014; Yang, Yun-Gui/0000-0002-2821-8541; Fu, Ye/0000-0002-3807-9717	US National Institutes of Health (NIH) [GM071440]; NIH EUREKA [GM088599]; Chinese Academy of Sciences (CAS); Chicago Biomedical Consortium (CBC); Beijing Institute of Genomics at CAS; CAS [2009S2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088599, R01GM071440] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH EUREKA; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Chicago Biomedical Consortium (CBC); Beijing Institute of Genomics at CAS; CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the US National Institutes of Health (NIH) (GM071440 to C. H.), an NIH EUREKA award (GM088599 to C. H. and T. P.) and the Chinese Academy of Sciences (CAS) '100 Talents' Professor Program to Y.-G. Y. Q. D. is supported by the Chicago Biomedical Consortium (CBC). X. Z. and Y. Y. are supported by the Graduate Student Program of the Beijing Institute of Genomics at CAS. T. L. is supported by the CAS Senior Foreign Research Fellow Award (2009S2-1). We thank the CBC and University of Illinois at Chicago Research Resources Center Proteomics and Informatics Services Facility for performing the LC-MS/MS analysis, L. A. Godley for the suggestion and P. Jin for providing the pcDNA3-FTO plasmid. We thank S. F. Reichard for editing the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Bokar JA, 1997, RNA, V3, P1233; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lawrence JB, 2008, J CELL BIOL, V182, P1035, DOI 10.1083/jcb.200808121; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726	25	2062	2172	47	541	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					885	887		10.1038/NCHEMBIO.687	http://dx.doi.org/10.1038/NCHEMBIO.687			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22002720	Green Accepted			2022-12-25	WOS:000297166200009
J	Miller, J; Arrasate, M; Brooks, E; Libeu, CP; Legleiter, J; Hatters, D; Curtis, J; Cheung, K; Krishnan, P; Mitra, S; Widjaja, K; Shaby, BA; Lotz, GP; Newhouse, Y; Mitchell, EJ; Osmand, A; Gray, M; Thulasiramin, V; Saudou, F; Segal, M; Yang, XW; Masliah, E; Thompson, LM; Muchowski, PJ; Weisgraber, KH; Finkbeiner, S				Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Shaby, Benjamin A.; Lotz, Gregor P.; Newhouse, Yvonne; Mitchell, Emily J.; Osmand, Alex; Gray, Michelle; Thulasiramin, Vanitha; Saudou, Frederic; Segal, Mark; Yang, X. William; Masliah, Eliezer; Thompson, Leslie M.; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven			Identifying polyglutamine protein species in situ that best predict neurodegeneration	NATURE CHEMICAL BIOLOGY			English	Article							INCLUSION-BODY FORMATION; MUTANT HUNTINGTIN; MONOCLONAL-ANTIBODIES; TRINUCLEOTIDE REPEAT; NUCLEAR-LOCALIZATION; DISEASE; AGGREGATION; LENGTH; PATHOGENESIS; MECHANISM	Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins that contain them and cause at least nine neurological disorders. The basis for this toxicity threshold is unclear. Although polyQ expansions render proteins prone to aggregate into inclusion bodies, this may be a neuronal coping response to more toxic forms of polyQ. The exact structure of these more toxic forms is unknown. Here we show that the monoclonal antibody 3B5H10 recognizes a species of polyQ protein in situ that strongly predicts neuronal death. The epitope selectively appears among some of the many low-molecular-weight conformational states assumed by expanded polyQ and disappears in higher-molecular-weight aggregated forms, such as inclusion bodies. These results suggest that protein monomers and possibly small oligomers containing expanded polyQ stretches can adopt a conformation that is recognized by 3B5H10 and is toxic or closely related to a toxic species.	[Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Lotz, Gregor P.; Newhouse, Yvonne; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Lotz, Gregor P.; Newhouse, Yvonne; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA USA; [Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Lotz, Gregor P.; Newhouse, Yvonne; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA USA; [Miller, Jason] Univ Calif San Francisco, Chem & Chem Biol Program, San Francisco, CA 94143 USA; [Miller, Jason; Mitra, Siddhartha] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Arrasate, Montserrat; Brooks, Elizabeth; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Widjaja, Kartika; Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94143 USA; [Libeu, Clare Peters; Hatters, Danny; Newhouse, Yvonne; Weisgraber, Karl H.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Mitra, Siddhartha; Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Shaby, Benjamin A.] Cornell Univ, Dept Stat Sci, Ithaca, NY USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Osmand, Alex] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN USA; [Gray, Michelle; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Ctr Neurobehav Genet,Semel Inst Neurosci & Human, Los Angeles, CA 90095 USA; [Thulasiramin, Vanitha] Biorad Labs, Fremont, CA USA; [Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Saudou, Frederic] CNRS, Unite Mixte Rech 3306, F-91405 Orsay, France; [Saudou, Frederic] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Segal, Mark] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Thompson, Leslie M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Cornell University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	sfinkbeiner@gladstone.ucsf.edu	Sontag, Emily/L-5232-2019; Arrasate, Montserrat/ABB-4450-2020; SAUDOU, Frédéric/L-3454-2014	Sontag, Emily/0000-0003-3068-6253; Arrasate, Montserrat/0000-0002-8911-8990; SAUDOU, Frédéric/0000-0001-6107-1046; Legleiter, Justin/0000-0002-5262-1867; Miller, Jason/0000-0002-2784-9560; Shaby, Benjamin Adam/0000-0002-8663-536X; Lotz, Gregor/0000-0002-0231-5503; Hatters, Danny/0000-0002-9965-2847	HDF; US National Institute of Neurological Disease and Stroke; Hillblom Foundation; US National Institutes of Health (NIH)-National Institute of General Medical Sciences University of California San Fransisco; Achievement Rewards for College Scientists Foundation; John Douglas French Alzheimer's Foundation; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049501, R01NS039074] Funding Source: NIH RePORTER	HDF; US National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hillblom Foundation; US National Institutes of Health (NIH)-National Institute of General Medical Sciences University of California San Fransisco(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); John Douglas French Alzheimer's Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kazantzev, D. Housman and the Hereditary Disease Foundation (HDF) for pcDNA3.1-Htt<SUP>ex1</SUP>-(Q<INF>46</INF>, Q<INF>97</INF>)-GFP plasmids. We also thank R. Truant for eGFP-full-length Htt-beta-galactosidase (Q<INF>17</INF>, Q<INF>138</INF>) plasmids, M. Diamond for the HA-AR (Q<INF>25</INF>, Q<INF>65</INF>) plasmids, J. Burke and CHDI, Inc. for the GST-atrophin-1 (Q<INF>19</INF>, Q<INF>81</INF>) plasmids, R. Kopito for Htt<SUP>ex1</SUP>-CFP (Q<INF>25</INF>, Q<INF>97</INF>) and Htt<SUP>ex1</SUP> YFP (Q<INF>25</INF>, Q<INF>97</INF>) plasmids, D. Devys for GST Htt-171 (Q<INF>66</INF>, Q<INF>142</INF>) plasmids, R. Pittman for Myc-ataxin-3 (Q<INF>27</INF> Q<INF>78</INF>) plasmids, O. Onodera for Htt<SUP>ex1</SUP>-mCFP (Q<INF>17</INF>, Q<INF>58</INF>) and Htt<SUP>ex1</SUP>-mYFP (Q<INF>17</INF>, Q<INF>58</INF>) plasmids, P. Bjorkman for the thio-Htt<SUP>ex1</SUP>-Q<INF>39</INF>-His<INF>6</INF> plasmid and P. Daugherty for mammalian codon-optimized CyPet and YPet plasmids. We thank P. Patterson for the monoclonal antibodies MW1, MW7 and MW8 and C. Glabe for the oligomer-specific polyclonal antibody. We thank members of the Finkbeiner lab for useful discussions, S. Ordway and G. Howard for editorial assistance, K. Nelson for administrative assistance and M. Sutherland for her interest and support. Primary support for this work was provided by the Lieberman Award of the HDF and the US National Institute of Neurological Disease and Stroke (S. F.). Additional support was provided by the National Institute of Aging, the High Q Foundation, the Huntington's Disease Society of America, the National Center for Research Resources, the Taube-Koret Center for Huntington's Disease Research, the Hellman Family Foundation Program for Alzheimer's Disease Research and the J. David Gladstone Institutes (S. F.). M. A. and J. M. are supported by the Hillblom Foundation. J. M. and S. M. are supported by the US National Institutes of Health (NIH)-National Institute of General Medical Sciences University of California San Fransisco Medical Scientist Training Program. J. M is supported by a fellowship from the Achievement Rewards for College Scientists Foundation. D. H. is supported by a postdoctoral fellowship from the John Douglas French Alzheimer's Foundation. J. L. and A. O. are supported by the HDF. E. J. M. is supported by a grant from the NIH. The animal care facility was partly supported by an NIH Extramural Research Facilities Improvement Project. The electron microscopy core (E. M.) is supported by a grant from the National Institute of Neurological Disease and Stroke.	Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Brooks Elizabeth, 2004, V277, P103; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fleming TR, 2000, BIOMETRICS, V56, P971, DOI 10.1111/j.0006-341X.2000.0971.x; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gelman A., 2004, BAYESIAN DATA ANAL; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Roodnat JI, 2004, TRANSPLANTATION, V77, P483, DOI 10.1097/01.TP.0000110424.27977.A1; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yu ZX, 2002, HUM MOL GENET, V11, P905, DOI 10.1093/hmg/11.8.905	49	142	145	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					925	934		10.1038/NCHEMBIO.694	http://dx.doi.org/10.1038/NCHEMBIO.694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22037470	Green Submitted, Green Accepted			2022-12-25	WOS:000297166200016
J	Small, BG; McColl, BW; Allmendinger, R; Pahle, J; Lopez-Castejon, G; Rothwell, NJ; Knowles, J; Mendes, P; Brough, D; Kell, DB				Small, Ben G.; McColl, Barry W.; Allmendinger, Richard; Pahle, Juergen; Lopez-Castejon, Gloria; Rothwell, Nancy J.; Knowles, Joshua; Mendes, Pedro; Brough, David; Kell, Douglas B.			Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing	NATURE CHEMICAL BIOLOGY			English	Article							DRUG-COMBINATIONS; CLOSED-LOOP; MULTIOBJECTIVE OPTIMIZATION; SYSTEMS BIOLOGY; INTERLEUKIN-1; RESPONSES; SEARCH	The control of biochemical fluxes is distributed, and to perturb complex intracellular networks effectively it is often necessary to modulate several steps simultaneously. However, the number of possible permutations leads to a combinatorial explosion in the number of experiments that would have to be performed in a complete analysis. We used a multiobjective evolutionary algorithm to optimize reagent combinations from a dynamic chemical library of 33 compounds with established or predicted targets in the regulatory network controlling IL-1 beta expression. The evolutionary algorithm converged on excellent solutions within 11 generations, during which we studied just 550 combinations out of the potential search space of similar to 9 billion. The top five reagents with the greatest contribution to combinatorial effects throughout the evolutionary algorithm were then optimized pairwise. A p38 MAPK inhibitor together with either an inhibitor of IkB kinase or a chelator of poorly liganded iron yielded synergistic inhibition of macrophage IL-1 beta expression. Evolutionary searches provide a powerful and general approach to the discovery of new combinations of pharmacological agents with therapeutic indices potentially greater than those of single drugs.	[Small, Ben G.; Kell, Douglas B.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester Ctr Integrat Syst Biol, Doctoral Training Ctr, Manchester, Lancs, England; [Small, Ben G.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England; [McColl, Barry W.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [McColl, Barry W.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Allmendinger, Richard; Pahle, Juergen; Knowles, Joshua; Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Lopez-Castejon, Gloria; Rothwell, Nancy J.; Brough, David] Univ Manchester, Fac Life Sci, NeuroSyst Sect, Manchester, Lancs, England; [Mendes, Pedro] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester, Lancs, England	University of Manchester; University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Manchester; University of Manchester; Virginia Polytechnic Institute & State University; University of Manchester	Kell, DB (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester Ctr Integrat Syst Biol, Doctoral Training Ctr, Manchester, Lancs, England.	dbk@manchester.ac.uk	Allmendinger, Richard/AAX-2294-2021; Lopez-Castejon, Gloria/F-6985-2015; Kell, Douglas/E-8318-2011	Allmendinger, Richard/0000-0003-1236-3143; Lopez-Castejon, Gloria/0000-0002-8585-3381; Pahle, Jurgen/0000-0002-7637-7547; Kell, Douglas/0000-0001-5838-7963; Brough, David/0000-0002-2250-2381; Small, Ben/0000-0002-4387-5689; Knowles, Joshua/0000-0001-8112-6112; Mendes, Pedro/0000-0001-6507-9168; McColl, Barry W/0000-0002-0521-9656	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F018398/1]; Engineering and Physical Sciences Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/C008219/1, BB/F018398/1] Funding Source: researchfish; BBSRC [BB/F018398/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank the Biotechnology and Biological Sciences Research Council (BBSRC) for funding this project (BB/F018398/1) and the BBSRC, Engineering and Physical Sciences Research Council and Wellcome Trust for the funding of studentships and fellowships. We thank the Manchester Centre for Integrative Systems Biology for providing access to the Sciclone instrument. B. G. S. would like to thank S. Wasley and D. Stubbs of Caliper Life Sciences for their help and assistance in commissioning and their image of the Sciclone instrument (Fig. 1), respectively. The images of the computer and 96-well plate (Fig. 1) were used under the Creative Commons CC0 Public Domain Dedication and were obtained from Clker.com.	Akella LB, 2010, CURR OPIN CHEM BIOL, V14, P325, DOI 10.1016/j.cbpa.2010.03.017; Allmendinger R., 2009, MLO12009, P1; Allmendinger R, 2010, LECT NOTES COMPUT SC, V6239, P151, DOI 10.1007/978-3-642-15871-1_16; Bornkamp B, 2007, J BIOPHARM STAT, V17, P965, DOI 10.1080/10543400701643848; Chatterjee MS, 2010, NAT BIOTECHNOL, V28, P727, DOI 10.1038/nbt.1642; Deb K., 2008, MULTIOBJECTIVE PROBL; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; Goldberg, 2002, DESIGN INNOVATION LE; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hammaker D, 2010, ANN RHEUM DIS, V69, P77, DOI 10.1136/ard.2009.119479; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Horackova M, 2000, CARDIOVASC RES, V47, P529, DOI 10.1016/S0008-6363(00)00088-2; Hughes EJ, 2001, LECT NOTES COMPUT SC, V1993, P329; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Jia J., 2009, NAT REV DRUG DISCOV, V8, P516; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Knight CG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn899; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Knowles J, 2009, IEEE COMPUT INTELL M, V4, P77, DOI 10.1109/MCI.2009.933095; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lofdahl CG, 2008, CLIN RESPIR J, V2, P59, DOI 10.1111/j.1752-699X.2008.00085.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; O'Hagan S, 2005, ANAL CHEM, V77, P290, DOI 10.1021/ac049146x; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Scully P, 2010, AM J GASTROENTEROL, V105, P2235, DOI 10.1038/ajg.2010.159; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sun CP, 2009, INTEGR BIOL-UK, V1, P123, DOI 10.1039/b815225j; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zitzler E, 2004, LECT NOTES COMPUT SC, V3242, P832	51	47	48	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					902	908		10.1038/NCHEMBIO.689	http://dx.doi.org/10.1038/NCHEMBIO.689			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22020553	Green Accepted, Green Submitted			2022-12-25	WOS:000297166200013
J	Cheng, LZ				Cheng, Linzhao			Zinc fingers hit off target	NATURE MEDICINE			English	Editorial Material							NUCLEASES; GENOME; CELLS		Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Cheng, LZ (corresponding author), Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21218 USA.				NCI NIH HHS [P01 CA065493] Funding Source: Medline; NHLBI NIH HHS [R01 HL073781] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073781] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161	8	6	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1192	1193		10.1038/nm1011-1192	http://dx.doi.org/10.1038/nm1011-1192			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21988995				2022-12-25	WOS:000296022100030
J	Foley, EA; Maldonado, M; Kapoor, TM				Foley, Emily A.; Maldonado, Maria; Kapoor, Tarun M.			Formation of stable attachments between kinetochores and microtubules depends on the B56-PP2A phosphatase	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; AURORA B KINASE; PROPER CHROMOSOME SEGREGATION; CELL-DIVISION; HUMAN CANCERS; MEIOSIS-I; 2A; PROTEINS; REVEALS; COHESION	Error-free chromosome segregation depends on the precise regulation of phosphorylation to stabilize kinetochore-microtubule attachments (K-fibres) on sister chromatids that have attached to opposite spindle poles (bi-oriented)(1). In many instances, phosphorylation correlates with K-fibre destabilization(2-7). Consistent with this, multiple kinases, including Aurora B and Plk1, are enriched at kinetochores of mal-oriented chromosomes when compared with bi-oriented chromosomes, which have stable attachments(2,8). Paradoxically, however, these kinases also target to prometaphase chromosomes that have not yet established spindle attachments and it is therefore unclear how kinetochore-microtubule interactions can be stabilized when kinase levels are high. Here we show that the generation of stable K-fibres depends on the B56-PP2A phosphatase, which is enriched at centromeres/kinetochores of unattached chromosomes. When B56-PP2A is depleted, K-fibres are destabilized and chromosomes fail to align at the spindle equator. Strikingly, B56-PP2A depletion increases the level of phosphorylation of Aurora B and Plk1 kinetochore substrates as well as Plk1 recruitment to kinetochores. Consistent with increased substrate phosphorylation, we find that chemical inhibition of Aurora or Plk1 restores K-fibres in B56-PP2A-depleted cells. Our findings reveal that PP2A, an essential tumour suppressor(9), tunes the balance of phosphorylation to promote chromosome-spindle interactions during cell division.	[Foley, Emily A.; Maldonado, Maria; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA	Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@mail.rockefeller.edu		Maldonado, Maria/0000-0002-3428-1053	Damon Runyon Cancer Research postdoctoral fellowship [DRG 1936-07]; Charles H. Revson Foundation; NIH [GM65933]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	Damon Runyon Cancer Research postdoctoral fellowship; Charles H. Revson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Cheeseman (MIT, Cambridge, Massachusetts, USA), A. Desai (University of California San Diego, San Diego, California, USA), S. Elowe (Centre de Recherche du CHUQ, Quebec, Canada) and H. Yu (UT Southwestern Medical Center, Dallas, Texas, USA) for antibodies and W. Harper for plasmids. E.A.F. was supported by a Damon Runyon Cancer Research postdoctoral fellowship (DRG 1936-07) and the Charles H. Revson Foundation. This work was supported by NIH GM65933 (T.M.K.).	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Salimian KJ, 2011, CURR BIOL, V21, P1158, DOI 10.1016/j.cub.2011.06.015; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wong OK, 2005, J CELL BIOL, V170, P709, DOI 10.1083/jcb.200502163; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	42	196	198	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2011	13	10					1265	U216		10.1038/ncb2327	http://dx.doi.org/10.1038/ncb2327			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	829WY	21874008	Green Accepted			2022-12-25	WOS:000295617900017
J	Locasale, JW; Grassian, AR; Melman, T; Lyssiotis, CA; Mattaini, KR; Bass, AJ; Heffron, G; Metallo, CM; Muranen, T; Sharfi, H; Sasaki, AT; Anastasiou, D; Mullarky, E; Vokes, NI; Sasaki, M; Beroukhim, R; Stephanopoulos, G; Ligon, AH; Meyerson, M; Richardson, AL; Chin, L; Wagner, G; Asara, JM; Brugge, JS; Cantley, LC; Vander Heiden, MG				Locasale, Jason W.; Grassian, Alexandra R.; Melman, Tamar; Lyssiotis, Costas A.; Mattaini, Katherine R.; Bass, Adam J.; Heffron, Gregory; Metallo, Christian M.; Muranen, Taru; Sharfi, Hadar; Sasaki, Atsuo T.; Anastasiou, Dimitrios; Mullarky, Edouard; Vokes, Natalie I.; Sasaki, Mika; Beroukhim, Rameen; Stephanopoulos, Gregory; Ligon, Azra H.; Meyerson, Matthew; Richardson, Andrea L.; Chin, Lynda; Wagner, Gerhard; Asara, John M.; Brugge, Joan S.; Cantley, Lewis C.; Vander Heiden, Matthew G.			Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis	NATURE GENETICS			English	Article							MASS ISOTOPOMER DISTRIBUTIONS; HUMAN-BREAST-CANCER; 3-PHOSPHOGLYCERATE DEHYDROGENASE; METABOLISM; SERINE; PROLIFERATION; BIOSYNTHESIS; EXPRESSION; ABUNDANCE; GLYCINE	Most tumors exhibit increased glucose metabolism to lactate, however, the extent to which glucose-derived metabolic fluxes are used for alternative processes is poorly understood(1,2). Using a metabolomics approach with isotope labeling, we found that in some cancer cells a relatively large amount of glycolytic carbon is diverted into serine and glycine metabolism through phosphoglycerate dehydrogenase (PHGDH). An analysis of human cancers showed that PHGDH is recurrently amplified in a genomic region of focal copy number gain most commonly found in melanoma. Decreasing PHGDH expression impaired proliferation in amplified cell lines. Increased expression was also associated with breast cancer subtypes, and ectopic expression of PHGDH in mammary epithelial cells disrupted acinar morphogenesis and induced other phenotypic alterations that may predispose cells to transformation. Our findings show that the diversion of glycolytic flux into a specific alternate pathway can be selected during tumor development and may contribute to the pathogenesis of human cancer.	[Locasale, Jason W.; Melman, Tamar; Lyssiotis, Costas A.; Sharfi, Hadar; Sasaki, Atsuo T.; Anastasiou, Dimitrios; Mullarky, Edouard; Sasaki, Mika; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Locasale, Jason W.; Melman, Tamar; Lyssiotis, Costas A.; Sharfi, Hadar; Sasaki, Atsuo T.; Anastasiou, Dimitrios; Mullarky, Edouard; Sasaki, Mika; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Grassian, Alexandra R.; Muranen, Taru; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Mattaini, Katherine R.; Vokes, Natalie I.; Vander Heiden, Matthew G.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA USA; [Bass, Adam J.; Beroukhim, Rameen; Ligon, Azra H.; Meyerson, Matthew; Richardson, Andrea L.; Chin, Lynda; Vander Heiden, Matthew G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bass, Adam J.; Beroukhim, Rameen; Meyerson, Matthew] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Heffron, Gregory; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biochem & Mol Pharmacol, Boston, MA USA; [Metallo, Christian M.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ligon, Azra H.; Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Locasale, JW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jlocasal@bidmc.harvard.edu; lcantley@hms.harvard.edu; mvh@mit.edu	Muranen, Taru/AAM-9349-2021; Meyerson, Matthew L/E-7123-2012; Locasale, Jason W/ABE-6505-2020; ravegnini, gloria/K-1330-2016; Cantley, Lewis C/D-1800-2014; Metallo, Christian/HCH-3476-2022; Lyssiotis, Costas A/AAI-1923-2019	Locasale, Jason W/0000-0002-7766-3502; ravegnini, gloria/0000-0002-7774-402X; Cantley, Lewis C/0000-0002-1298-7653; Metallo, Christian/0000-0003-2404-3040; Lyssiotis, Costas A/0000-0001-9309-6141; Sasaki, Atsuo/0000-0003-2963-4501; Meyerson, Matthew/0000-0002-9133-8108; Anastasiou, Dimitrios/0000-0002-1269-843X; Muranen, Taru/0000-0003-4158-9002	US National Institutes of Health (NIH); American Cancer Society; National Science Foundation (NSF); NIH; National Cancer Institute (NCI); Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P30CA014051, P01CA120964, R01CA160458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy data for this study were acquired and analyzed in the Nikon Imaging Center at Harvard Medical School. J.W.L. was supported by postdoctoral fellowships from the US National Institutes of Health (NIH) and the American Cancer Society. A. R. G. is a recipient of a National Science Foundation (NSF) Graduate Research Fellowship. L. C. C. and J.S.B. were supported by grants from the NIH and the National Cancer Institute (NCI). M. G. V. H. was supported by grants from the NIH, NCI, Smith Family, Damon Runyon Cancer Research Foundation and the Burroughs Wellcome Fund. We thank N. Vena for technical assistance with the FISH analysis and K. Webster and I. Carrecedo for help with immunohistochemistry. We thank J. Rabinowitz, A. Carrecedo and S.-C. Ng for helpful comments on the manuscript.	Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BISMUT H, 1995, BIOCHEM J, V308, P761, DOI 10.1042/bj3080761; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Greshock J, 2007, CANCER RES, V67, P10173, DOI 10.1158/0008-5472.CAN-07-2102; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; KIT S, 1955, CANCER RES, V15, P715; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SNELL K, 1987, BIOCHEM J, V245, P609, DOI 10.1042/bj2450609; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Warburg O, 1924, BIOCHEM Z, V152, P319	31	748	772	4	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					869	U79		10.1038/ng.890	http://dx.doi.org/10.1038/ng.890			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21804546	Green Submitted, Green Accepted			2022-12-25	WOS:000294325800013
J	Evans, DM; Spencer, CCA; Pointon, JJ; Su, Z; Harvey, D; Kochan, G; Opperman, U; Dilthey, A; Pirinen, M; Stone, MA; Appleton, L; Moutsianis, L; Leslie, S; Wordsworth, T; Kenna, TJ; Karaderi, T; Thomas, GP; Ward, MM; Weisman, MH; Farrar, C; Bradbury, LA; Danoy, P; Inman, RD; Maksymowych, W; Gladman, D; Rahman, P; Morgan, A; Marzo-Ortega, H; Bowness, P; Gaffney, K; Gaston, JSH; Smith, M; Bruges-Armas, J; Couto, AR; Sorrentino, R; Paladini, F; Ferreira, MA; Xu, HJ; Liu, Y; Jiang, L; Lopez-Larrea, C; Diaz-Pena, R; Lopez-Vazquez, A; Zayats, T; Band, G; Bellenguez, C; Blackburn, H; Blackwell, JM; Bramon, E; Bumpstead, SJ; Casas, JP; Corvin, A; Craddock, N; Deloukas, P; Dronov, S; Duncanson, A; Edkins, S; Freeman, C; Gillman, M; Gray, E; Gwilliam, R; Hammond, N; Hunt, SE; Jankowski, J; Jayakumar, A; Langford, C; Liddle, J; Markus, HS; Mathew, CG; McCann, OT; McCarthy, MI; Palmer, CNA; Peltonen, L; Plomin, R; Potter, SC; Rautanen, A; Ravindrarajah, R; Ricketts, M; Samani, N; Sawcer, SJ; Strange, A; Trembath, RC; Viswanathan, AC; Waller, M; Weston, P; Whittaker, P; Widaa, S; Wood, NW; McVean, G; Reveille, JD; Wordsworth, BP; Brown, MA; Donnelly, P				Evans, David M.; Spencer, Chris C. A.; Pointon, Jennifer J.; Su, Zhan; Harvey, David; Kochan, Grazyna; Opperman, Udo; Dilthey, Alexander; Pirinen, Matti; Stone, Millicent A.; Appleton, Louise; Moutsianis, Loukas; Leslie, Stephen; Wordsworth, Tom; Kenna, Tony J.; Karaderi, Tugce; Thomas, Gethin P.; Ward, Michael M.; Weisman, Michael H.; Farrar, Claire; Bradbury, Linda A.; Danoy, Patrick; Inman, Robert D.; Maksymowych, Walter; Gladman, Dafna; Rahman, Proton; Morgan, Ann; Marzo-Ortega, Helena; Bowness, Paul; Gaffney, Karl; Gaston, J. S. Hill; Smith, Malcolm; Bruges-Armas, Jacome; Couto, Ana-Rita; Sorrentino, Rosa; Paladini, Fabiana; Ferreira, Manuel A.; Xu, Huji; Liu, Yu; Jiang, Lei; Lopez-Larrea, Carlos; Diaz-Pena, Roberto; Lopez-Vazquez, Antonio; Zayats, Tetyana; Band, Gavin; Bellenguez, Celine; Blackburn, Hannah; Blackwell, Jenefer M.; Bramon, Elvira; Bumpstead, Suzannah J.; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas; Deloukas, Panos; Dronov, Serge; Duncanson, Audrey; Edkins, Sarah; Freeman, Colin; Gillman, Matthew; Gray, Emma; Gwilliam, Rhian; Hammond, Naomi; Hunt, Sarah E.; Jankowski, Janusz; Jayakumar, Alagurevathi; Langford, Cordelia; Liddle, Jennifer; Markus, Hugh S.; Mathew, Christopher G.; McCann, Owen T.; McCarthy, Mark I.; Palmer, Colin N. A.; Peltonen, Leena; Plomin, Robert; Potter, Simon C.; Rautanen, Anna; Ravindrarajah, Radhi; Ricketts, Michelle; Samani, Nilesh; Sawcer, Stephen J.; Strange, Amy; Trembath, Richard C.; Viswanathan, Ananth C.; Waller, Matthew; Weston, Paul; Whittaker, Pamela; Widaa, Sara; Wood, Nicholas W.; McVean, Gilean; Reveille, John D.; Wordsworth, B. Paul; Brown, Matthew A.; Donnelly, Peter		Australo-Anglo-Amer Spondyloarthri; Wellcome Trust Case Control Consor; Spondyloarthrit Res Consortium Can	Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; GENETIC ASSOCIATION; TRIMS PRECURSORS; AMINOPEPTIDASE; RISK; HLA; POPULATION; PROMOTES; CELLS	Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. Here we report the identification of three variants in the RUNX3, LTBR-TNFRSF1A and IL12B regions convincingly associated with ankylosing spondylitis (P < 5 x 10(-8) in the combined discovery and replication datasets) and a further four loci at PTGER4, TBKBP1, ANTXR2 and CARD9 that show strong association across all our datasets (P < 5 x 10(-6) overall, with support in each of the three datasets studied). We also show that polymorphisms of ERAP1, which encodes an endoplasmic reticulum aminopeptidase involved in peptide trimming before HLA class I presentation, only affect ankylosing spondylitis risk in HLA-B27-positive individuals. These findings provide strong evidence that HLA-B27 operates in ankylosing spondylitis through a mechanism involving aberrant processing of antigenic peptides.	[Spencer, Chris C. A.; Su, Zhan; Band, Gavin; Bellenguez, Celine; Freeman, Colin; Strange, Amy; McVean, Gilean; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Evans, David M.; Dilthey, Alexander; Pirinen, Matti; Zayats, Tetyana] Univ Bristol, Sch Social & Community Med, Med Res Council MRC Ctr Causal Anal Translat Epid, Bristol, Avon, England; [Pointon, Jennifer J.; Harvey, David; Appleton, Louise; Wordsworth, Tom; Karaderi, Tugce; Farrar, Claire; Bowness, Paul; Wordsworth, B. Paul] Nuffield Orthopaed Ctr, Natl Inst Hlth Res Musculoskeletal Biomed Res Uni, Oxford OX3 7LD, England; [Kochan, Grazyna; Opperman, Udo] Univ Oxford, Struct Genom Consortium, Oxford, England; [Stone, Millicent A.] Univ Bath, Bath BA2 7AY, Avon, England; [Moutsianis, Loukas] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Leslie, Stephen] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Kenna, Tony J.; Thomas, Gethin P.; Bradbury, Linda A.; Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Ward, Michael M.] NIAMSD, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Weisman, Michael H.] Cedars Sinai Med Ctr, Dept Med Rheumatol, Los Angeles, CA 90048 USA; [Inman, Robert D.; Gladman, Dafna] Univ Toronto, Toronto, ON, Canada; [Maksymowych, Walter] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Rahman, Proton] Mem Univ Newfoundland, St John, NF, Canada; [Morgan, Ann; Marzo-Ortega, Helena] Univ Leeds, NIHR, Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Gaffney, Karl] Norfolk & Norwich Univ Hosp, Dept Rheumatol, Norwich, Norfolk, England; [Gaston, J. S. Hill] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Smith, Malcolm] Repatriat Gen Hosp, Adelaide, SA, Australia; [Bruges-Armas, Jacome; Couto, Ana-Rita] Hosp Santo Espirito, Serv Especializado Epidemiol & Biol Mol, Terceira, The Azores, Portugal; [Bruges-Armas, Jacome] Univ Porto, Inst Mol & Cell Biol IBMC, Genet & Arthrit Res Grp, P-4100 Oporto, Portugal; [Sorrentino, Rosa; Paladini, Fabiana] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Ferreira, Manuel A.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Xu, Huji; Liu, Yu; Jiang, Lei] Second Mil Med Univ Hosp, Shanghai Changzheng Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China; [Lopez-Larrea, Carlos; Diaz-Pena, Roberto; Lopez-Vazquez, Antonio; Blackburn, Hannah] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Bramon, Elvira; Bumpstead, Suzannah J.; Deloukas, Panos; Dronov, Serge; Edkins, Sarah; Gillman, Matthew; Gray, Emma; Gwilliam, Rhian; Hammond, Naomi; Hunt, Sarah E.; Jayakumar, Alagurevathi; Langford, Cordelia; Liddle, Jennifer; McCann, Owen T.; Peltonen, Leena; Potter, Simon C.; Rautanen, Anna; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Whittaker, Pamela; Widaa, Sara] Wellcome Trust Sanger Inst, Cambridge, England; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Blackwell, Jenefer M.] Addenbrookes Hosp, Cambridge Inst Med Res, Genet & Infect Lab, Cambridge, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Craddock, Nicholas] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Markus, Hugh S.] St Georges Univ London, London, England; [Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Samani, Nilesh] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, Glaucoma Res Unit, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, Dept Genet, London, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA	University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; Nuffield Orthopaedic Centre; University of Oxford; University of Bath; University of Oxford; University of Oxford; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Cedars Sinai Medical Center; University of Toronto; University of Alberta; Memorial University Newfoundland; University of Leeds; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Flinders University South Australia; Universidade do Porto; Sapienza University Rome; QIMR Berghofer Medical Research Institute; Naval Medical University; Central University Hospital Asturias; Wellcome Trust Sanger Institute; Telethon Kids Institute; University of Western Australia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Trinity College Dublin; Cardiff University; University of London; Queen Mary University London; St Georges University London; University of London; King's College London; University of Oxford; University of Dundee; University of London; King's College London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Texas System; University of Texas Health Science Center Houston	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	matt.brown@uq.edu.au; peter.donnelly@well.ox.ac.uk	Díaz-Peña, Roberto/AAB-1205-2020; Sorrentino, Rosa/G-5472-2012; Palmer, Colin NA/C-7053-2008; Bramon, Elvira/HHC-3809-2022; Ferreira, Manuel A R/D-3609-2013; Brown, Matthew A/E-5749-2010; Plomin, Robert/B-8911-2008; Gaffney, Karl/S-4518-2019; Kenna, Tony/A-6035-2011; Wood, Nicholas W/C-2505-2009; Bowness, Paul/AAH-2484-2019; Díaz-Peña, Roberto/ABF-4396-2020; Deloukas, Panos/B-2922-2013; Bellenguez, Céline/X-4004-2019; Xu, Huji/AAB-2902-2021; Evans, David M/H-6325-2013; Mathew, Christopher G/G-3434-2015; Belllenguez, Céline/Y-3183-2018; Thomas, Gethin P/A-3624-2011; Blackwell, Jenefer M/H-3015-2015; Jankowski, Janusz/H-2706-2012; Bramon, Elvira/A-9463-2011; Kochan, Grazyna/A-1094-2009; Karaderi, Tugce/W-8729-2019; McCarthy, Mark/M-3763-2015	Sorrentino, Rosa/0000-0002-9632-2383; Palmer, Colin NA/0000-0002-6415-6560; Bramon, Elvira/0000-0003-1369-5983; Ferreira, Manuel A R/0000-0001-9059-1825; Brown, Matthew A/0000-0003-0538-8211; Wood, Nicholas W/0000-0002-9500-3348; Díaz-Peña, Roberto/0000-0002-0114-2292; Deloukas, Panos/0000-0001-9251-070X; Bellenguez, Céline/0000-0002-1240-7874; Xu, Huji/0000-0002-8588-118X; Evans, David M/0000-0003-0663-4621; Mathew, Christopher G/0000-0003-4178-1838; Belllenguez, Céline/0000-0002-1240-7874; Jankowski, Janusz/0000-0003-2130-9181; Karaderi, Tugce/0000-0001-9763-8139; Paladini, Fabiana/0000-0003-1040-452X; Inman, Robert/0000-0002-4750-1422; Walters, James/0000-0002-6980-4053; Hunt, Sarah/0000-0002-8350-1235; bowness, paul/0000-0003-4597-0484; Maksymowych, Walter/0000-0002-1291-1755; Kenna, Tony/0000-0001-6844-3463; Morgan, Ann/0000-0003-1109-624X; Corvin, Aiden/0000-0001-6717-4089; Gaffney, Karl/0000-0002-7863-9176; Thomas, Gethin/0000-0001-9081-3686; Couto, Ana Rita/0000-0002-3600-2812; Kochan, Grazyna/0000-0002-0534-9661; McVean, Gil/0000-0002-5012-4162; Pirinen, Matti/0000-0002-1664-1350; Armas, Jacome/0000-0001-7671-6521; Gillman, Matthew S./0000-0002-2340-6930; Potter, Simon/0000-0003-4208-4102; McCarthy, Mark/0000-0002-4393-0510; Plomin, Robert/0000-0002-0756-3629; Trembath, Richard/0000-0003-0550-3400	Wellcome Trust [083948/Z/07/Z, 076113, 068545/Z/02]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [P01-052915, R01-AR046208]; University of Texas at Houston Clinical and Translational Science [UL1RR024188]; Cedars-Sinai General Clinical Research Centre [MO1-RR00425]; Intramural Research Program; NIAMS/US National Institutes of Health; Rebecca Cooper Foundation (Australia); Arthritis Research UK [19536, 18797]; Oxford Comprehensive Biomedical Research Centre [A91202]; Arthritis Society (Canada); Lions Medical Research Foundation fellowship; National Health and Medical Research Council (Australia); National Health and Medical Research Council (Australia) [566938, 569829]; Australian Cancer Research Foundation; Rebecca Cooper Medical Research Foundation; Wolfson-Royal Society Merit Award; National Institute for Health Research (NIHR); Oxford Musculoskeletal Biomedical Research Unit; NIHR Thames Valley Comprehensive Local Research Network; Medical Research Council [G0000934]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; MRC [G0901310, G0600705, G0000934, G0800582, G19/2] Funding Source: UKRI; Medical Research Council [G0901310, G19/2, G1000800g, G0600705, G9817803B, G0800582] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, PDA/02/06/016] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046208, ZIAAR041153, ZIDAR041180] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Texas at Houston Clinical and Translational Science; Cedars-Sinai General Clinical Research Centre; Intramural Research Program; NIAMS/US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rebecca Cooper Foundation (Australia); Arthritis Research UK(Versus Arthritis); Oxford Comprehensive Biomedical Research Centre; Arthritis Society (Canada); Lions Medical Research Foundation fellowship; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Rebecca Cooper Medical Research Foundation; Wolfson-Royal Society Merit Award(Royal Society of London); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Oxford Musculoskeletal Biomedical Research Unit; NIHR Thames Valley Comprehensive Local Research Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank all participating subjects with ankylosing spondylitis and healthy individuals who provided the DNA and clinical information necessary for this study. The Wellcome Trust Case Control Consortium 2 project is funded by the Wellcome Trust (083948/Z/07/Z). We also thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, A. Wilk, C. R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. The TASC study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants P01-052915 and R01-AR046208. Funding was also received from the University of Texas at Houston Clinical and Translational Science Awards grant UL1RR024188, Cedars-Sinai General Clinical Research Centre grant MO1-RR00425, Intramural Research Program, NIAMS/US National Institutes of Health and Rebecca Cooper Foundation (Australia). This study was funded, in part, by Arthritis Research UK (Grants 19536 and 18797), by the Wellcome Trust (grant number 076113) and by the Oxford Comprehensive Biomedical Research Centre ankylosing spondylitis chronic disease cohort (theme code: A91202). The Spondyloarthritis Research Consortium of Canada (SPARCC) was funded by a National Research Initiative Award from the Arthritis Society (Canada). G. P. T. was funded by a Lions Medical Research Foundation fellowship. M. A. B. is funded by a National Health and Medical Research Council (Australia) Principal Research Fellowship, and support for this study was received from a National Health and Medical Research Council (Australia) program grant (566938) and project grant (569829) and from the Australian Cancer Research Foundation and Rebecca Cooper Medical Research Foundation. P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. We are also very grateful for the invaluable support received from the National Ankylosing Spondylitis Society (UK) and Spondyloarthritis Association of America in case recruitment. Additional financial and technical support for subject recruitment was provided by the National Institute for Health Research (NIHR), Oxford Musculoskeletal Biomedical Research Unit and NIHR Thames Valley Comprehensive Local Research Network. We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and we thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust. We would like to thank A. Mathieu (Cagliari University) and S. Brown (Cedars-Sinai Hospital) for providing samples. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.	Amroun H, 2005, HUM IMMUNOL, V66, P1057, DOI 10.1016/j.humimm.2005.09.004; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; BROWN MA, 2009, ARTHRITIS RHEUM S, V60, pS437; CALIN A, 1983, ARTHRITIS RHEUM, V26, P1460, DOI 10.1002/art.1780261207; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Evnouchidou I, 2009, ANAL BIOCHEM, V395, P33, DOI 10.1016/j.ab.2009.07.032; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Gagliardi MC, 2010, J LEUKOCYTE BIOL, V88, P947, DOI 10.1189/jlb.0310139; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jaakkola E, 2006, ANN RHEUM DIS, V65, P775, DOI 10.1136/ard.2005.041103; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; LOPEZLARREA C, 1995, TISSUE ANTIGENS, V45, P169, DOI 10.1111/j.1399-0039.1995.tb02436.x; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pedersen OB, 2008, SCAND J RHEUMATOL, V37, P120, DOI 10.1080/03009740701824613; Pointon JJ, 2011, GENES IMMUN, V12, P319, DOI 10.1038/gene.2011.22; Pointon JJ, 2010, ANN RHEUM DIS, V69, P1243, DOI 10.1136/ard.2009.115147; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Development Team, 2009, R LANG ENV STAT COMP; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; Rudwaleit M, 2009, J RHEUMATOL, V36, P801, DOI 10.3899/jrheum.081048; Ruutu M, 2010, ARTHRITIS RHEUM S, VS1, P1446; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Simon R, 2007, CANCER INFORM, V3, P11; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Yabuki K, 1999, HUM IMMUNOL, V60, P83, DOI 10.1016/S0198-8859(98)00092-5; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	51	630	649	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					761	U67		10.1038/ng.873	http://dx.doi.org/10.1038/ng.873			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21743469	Green Published, Green Accepted			2022-12-25	WOS:000293178300012
J	Jung, K				Jung, Kirsten			MICROBIOLOGY Tuning communication fidelity	NATURE CHEMICAL BIOLOGY			English	News Item							VIBRIO-HARVEYI		Univ Munich, Dept Biol 1, CIPSM, Martinsried, Germany	University of Munich	Jung, K (corresponding author), Univ Munich, Dept Biol 1, CIPSM, Martinsried, Germany.	jung@lmu.de						Anetzberger C, 2009, MOL MICROBIOL, V73, P267, DOI 10.1111/j.1365-2958.2009.06768.x; Chatterjee J, 1996, MOL MICROBIOL, V20, P415, DOI 10.1111/j.1365-2958.1996.tb02628.x; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Wei YZ, 2011, ACS CHEM BIOL, V6, P356, DOI 10.1021/cb1003652	9	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					502	503		10.1038/nchembio.618	http://dx.doi.org/10.1038/nchembio.618			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769096				2022-12-25	WOS:000292825400009
J	Liu, LB; Gardecki, JA; Nadkarni, SK; Toussaint, JD; Yagi, Y; Bouma, BE; Tearney, GJ				Liu, Linbo; Gardecki, Joseph A.; Nadkarni, Seemantini K.; Toussaint, Jimmy D.; Yagi, Yukako; Bouma, Brett E.; Tearney, Guillermo J.			Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography	NATURE MEDICINE			English	Article							SCANNING ELECTRON-MICROSCOPY; PLAQUE RUPTURE; CLASSIFICATION; THROMBOSIS; DEPTH	Progress in understanding, diagnosis, and treatment of coronary artery disease (CAD) has been hindered by our inability to observe cells and extracellular components associated with human coronary atherosclerosis in situ. The current standards for microstructural investigation, histology and electron microscopy are destructive and prone to artifacts. The highest-resolution intracoronary imaging modality, optical coherence tomography (OCT), has a resolution of similar to 10 mu m, which is too coarse for visualizing most cells. Here we report a new form of OCT, termed micro-optical coherence tomography (mu OCT), whose resolution is improved by an order of magnitude. We show that mu OCT images of cadaver coronary arteries provide clear pictures of cellular and subcellular features associated with atherogenesis, thrombosis and responses to interventional therapy. These results suggest that mu OCT can complement existing diagnostic techniques for investigating atherosclerotic specimens, and that mu OCT may eventually become a useful tool for cellular and subcellular characterization of the human coronary wall in vivo.	[Liu, Linbo; Gardecki, Joseph A.; Nadkarni, Seemantini K.; Toussaint, Jimmy D.; Yagi, Yukako; Bouma, Brett E.; Tearney, Guillermo J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA; [Liu, Linbo; Gardecki, Joseph A.; Nadkarni, Seemantini K.; Toussaint, Jimmy D.; Bouma, Brett E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Nadkarni, Seemantini K.; Bouma, Brett E.; Tearney, Guillermo J.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA; [Yagi, Yukako; Tearney, Guillermo J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital	Tearney, GJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	gtearney@partners.org	Liu, Linbo/O-2572-2018	Liu, Linbo/0000-0001-6691-9253	US National Institutes of Health [R01HL076398, R01HL093717]; Cystic Fibrosis Foundation [TEARNE07XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093717, R01HL076398] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to acknowledge contributions from D. Winsor-Hines of Boston Scientific for providing the stents that were used to create Supplementary Figure 4, G. Veytsman of Capital Biosciences for providing explanted human hearts, and J. Zhao and the Wellman Center Photopathology Laboratory staff for expert histology processing. Swine arterial tissue was obtained from the Massachusetts General Hospital Knight Surgical Laboratory. Human tissue was provided by the National Disease Research Interchange and Capital Biosciences. Endothelial cells were supplied by the Schepens Eye Research Institute. This research was supported in part by the US National Institutes of Health (contracts R01HL076398 and R01HL093717) and the Cystic Fibrosis Foundation (contract TEARNE07XX0).	Abela GS, 2006, SCANNING, V28, P1, DOI 10.1002/sca.4950280101; Boppart SA, 1998, NAT MED, V4, P861, DOI 10.1038/nm0798-861; BOURASSA MG, 1976, CIRCULATION, V53, P992, DOI 10.1161/01.CIR.53.6.992; Davies MJ, 1995, EUR HEART J, V16, P3, DOI 10.1093/eurheartj/16.suppl_L.3; Ding ZH, 2002, OPT LETT, V27, P243, DOI 10.1364/OL.27.000243; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gronholdt MLM, 1998, EUR HEART J, V19, pC24; Hausler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Lee KS, 2008, OPT LETT, V33, P1696, DOI 10.1364/OL.33.001696; Leitgeb RA, 2006, OPT LETT, V31, P2450, DOI 10.1364/OL.31.002450; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Liu LB, 2007, OPT LETT, V32, P2375, DOI 10.1364/OL.32.002375; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; PASTERNAK RC, 1980, AM J CARDIOL, V45, P591, DOI 10.1016/S0002-9149(80)80009-9; Povazay B, 2002, OPT LETT, V27, P1800, DOI 10.1364/OL.27.001800; Ralston TS, 2007, NAT PHYS, V3, P129, DOI 10.1038/nphys514; Rasband W., 2006, IMAGEJ; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Vakhtin AB, 2003, APPL OPTICS, V42, P6953, DOI 10.1364/AO.42.006953; Vengrenyuk Yuliya, 2008, Molecular & Cellular Biomechanics, V5, P37; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	27	332	342	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					1010	U132		10.1038/nm.2409	http://dx.doi.org/10.1038/nm.2409			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21743452	Green Accepted			2022-12-25	WOS:000293507400036
J	Gulyani, A; Vitriol, E; Allen, R; Wu, JR; Gremyachinskiy, D; Lewis, S; Dewar, B; Graves, LM; Kay, BK; Kuhlman, B; Elston, T; Hahn, KM				Gulyani, Akash; Vitriol, Eric; Allen, Richard; Wu, Jianrong; Gremyachinskiy, Dmitriy; Lewis, Steven; Dewar, Brian; Graves, Lee M.; Kay, Brian K.; Kuhlman, Brian; Elston, Tim; Hahn, Klaus M.			A biosensor generated via high-throughput screening quantifies cell edge Src dynamics	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN CONFORMATIONAL-CHANGES; GROWTH-FACTOR RECEPTOR; LIVING CELLS; FAMILY KINASES; TYROSINE PHOSPHORYLATION; ACTIN POLYMERIZATION; MEROCYANINE DYES; BINDING-PROTEINS; DORSAL RUFFLES; DISTINCT POOLS	Fluorescent biosensors for living cells currently require laborious optimization and a unique design for each target. They are limited by the availability of naturally occurring ligands with appropriate target specificity. Here we describe a biosensor based on an engineered fibronectin monobody scaffold that can be tailored to bind different targets via high-throughput screening. We made this Src-family kinase (SFK) biosensor by derivatizing a monobody specific for activated SFKs with a bright dye whose fluorescence increases upon target binding. We identified sites for dye attachment and changes to eliminate vesiculation in living cells, providing a generalizable scaffold for biosensor production. This approach minimizes cell perturbation because it senses endogenous, unmodified target, and because sensitivity is enhanced by direct dye excitation. Automated correlation of cell velocities and SFK activity revealed that SFKs are activated specifically during protrusion. Activity correlates with velocity, and peaks 1-2 mm from the leading edge.	[Gulyani, Akash; Vitriol, Eric; Allen, Richard; Wu, Jianrong; Gremyachinskiy, Dmitriy; Dewar, Brian; Graves, Lee M.; Elston, Tim; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Lewis, Steven; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gulyani, A (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	khahn@med.unc.edu	Graves, Lee/AAG-5470-2021	Hahn, Klaus/0000-0002-1970-7562; Gulyani, Akash/0000-0003-4130-4257; Vitriol, Eric/0000-0003-3398-1450	American Heart Association; US National Institutes of Health [GM GM082288, GM057464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960, R55GM057464, R01GM082288, R01GM057464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. MacNevin for assistance with dye synthesis, F. Shen for help with imaging studies, D. Renfrew for assistance with computational modeling, A. Nguyen for technical assistance and B. Clarke for administrative assistance. We gratefully acknowledge funding from the American Heart Association (A.G.) and the US National Institutes of Health (GM GM082288 and GM057464 to K. M. H.).	Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dewar BJ, 2007, MOL PHARMACOL, V72, P1146, DOI 10.1124/mol.107.037549; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gardner OS, 2003, J BIOL CHEM, V278, P46261, DOI 10.1074/jbc.M307827200; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hodgson L., 2010, CURR PROTOC CELL BIO, V46; Karatan E, 2004, CHEM BIOL, V11, P835, DOI 10.1016/j.chembiol.2004.04.009; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Koide A, 2001, BIOCHEMISTRY-US, V40, P10326, DOI 10.1021/bi010916y; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Reis RCM, 1998, EUR J CELL BIOL, V75, P192, DOI 10.1016/S0171-9335(98)80061-7; Renard M, 2002, J MOL BIOL, V318, P429, DOI 10.1016/S0022-2836(02)00023-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Toutchkine A, 2003, J AM CHEM SOC, V125, P4132, DOI 10.1021/ja0290882; Toutchkine A, 2007, ORG LETT, V9, P2775, DOI 10.1021/ol070780h; Toutchkine A, 2007, BIOCONJUGATE CHEM, V18, P1344, DOI 10.1021/bc060376n; Veracini L, 2005, BIOCHEM SOC T, V33, P1313, DOI 10.1042/BST0331313; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Yang L, 2006, CIRC RES, V98, P394, DOI 10.1161/01.RES.0000201958.59020.1a	50	59	60	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					437	444		10.1038/NCHEMBIO.585	http://dx.doi.org/10.1038/NCHEMBIO.585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21666688	Green Submitted, Green Accepted			2022-12-25	WOS:000292252100011
J	Karplus, M				Karplus, Martin			Behind the folding funnel diagram	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN; DYNAMICS; PATHWAYS; KINETICS	This Commentary clarifies the meaning of the funnel diagram, which has been widely cited in papers on protein folding. To aid in the analysis of the funnel diagram, this Commentary reviews historical approaches to understanding the mechanism of protein folding. The primary role of free energy in protein folding is discussed, and it is pointed out that the increase in the configurational entropy as the native state is approached hinders folding, rather than guiding it. Diagrams are introduced that provide a less ambiguous representation of the factors governing the protein folding reaction than the funnel diagram.	[Karplus, Martin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Karplus, Martin] Univ Strasbourg, Inst Sci & Ingn Supramol, Lab Chim Biophys, Strasbourg, France	Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	marci@tammy.harvard.edu						BALDWIN RL, 1994, NATURE, V369, P183, DOI 10.1038/369183a0; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Cavalli A, 2003, PROTEIN SCI, V12, P1801, DOI 10.1110/ps.0366103; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9; Ferrara P, 2000, J PHYS CHEM B, V104, P5000, DOI 10.1021/jp994157t; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; HARRISON SC, 1985, P NATL ACAD SCI USA, V82, P4028, DOI 10.1073/pnas.82.12.4028; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0; Krivov SV, 2008, J PHYS CHEM B, V112, P8701, DOI 10.1021/jp711864r; Kubelka J, 2008, P NATL ACAD SCI USA, V105, P18655, DOI 10.1073/pnas.0808600105; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; MULLERPLATHE F, 2006, SOFT MATTER, V1; Ngo JT, 1994, PROTEIN FOLDING PROB, P435; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Zagrovic B, 2003, J COMPUT CHEM, V24, P1432, DOI 10.1002/jcc.10297; ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20	25	86	88	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					401	404		10.1038/nchembio.565	http://dx.doi.org/10.1038/nchembio.565			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21685880				2022-12-25	WOS:000292252100001
J	Lu, FL; Cui, X; Zhang, SB; Jenuwein, T; Cao, XF				Lu, Falong; Cui, Xia; Zhang, Shuaibin; Jenuwein, Thomas; Cao, Xiaofeng			Arabidopsis REF6 is a histone H3 lysine 27 demethylase	NATURE GENETICS			English	Article							POLYCOMB-GROUP PROTEINS; FLOWERING-LOCUS-T; CHIP-SEQ DATA; JMJC DOMAIN; GENE-EXPRESSION; RNA-SEQ; METHYLATION; TRIMETHYLATION; THALIANA; TIME	Polycomb group (PcG)-mediated histone H3 lysine 27 trimethylation (H3K27me3) has a key role in gene repression and developmental regulation(1-4). There is evidence that H3K27me3 is actively removed in plants(5-8), but it is not known how this occurs. Here we show that RELATIVE OF EARLY FLOWERING 6 (REF6), also known as Jumonji domain-containing protein 12 (JMJ12), specifically demethylates H3K27me3 and H3K27me2, whereas its metazoan counterparts, the KDM4 proteins, are H3K9 and H3K36 demethylases(9,10). Plants overexpressing REF6 resembled mutants defective in H3K27me3-mediated gene silencing. Genetic interaction tests indicated that REF6 acts downstream of H3K27me3 methyltransferases. Mutations in REF6 caused ectopic and increased H3K27me3 level and decreased mRNA expression of hundreds of genes involved in regulating developmental patterning and responses to various stimuli. Our work shows that plants and metazoans use conserved mechanisms to regulate H3K27me3 dynamics but use distinct subfamilies of enzymes.	[Lu, Falong; Cui, Xia; Zhang, Shuaibin; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Lu, Falong; Cui, Xia; Zhang, Shuaibin; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Lu, Falong; Zhang, Shuaibin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Jenuwein, Thomas] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Max Planck Society	Cao, XF (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China.	xfcao@genetics.ac.cn	Lu, Falong/Q-3013-2016	Lu, Falong/0000-0002-8321-4818	National Basic Research Program of China [2009CB941500, 2011CB915400]; National Natural Science Foundation of China [30930048, 30921061, 30971619]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank our colleagues for comments and advice. We thank L. Gu for technical help in handling genomic datasets, Q. Zhu for technical help, the Arabidopsis Biological Resource Center for T-DNA insertion lines and I. Hanson for editing. This work was supported by the National Basic Research Program of China (grants 2009CB941500 and 2011CB915400 to X. Cao), and by the National Natural Science Foundation of China (grants 30930048 and 30921061 to X. Cao and 30971619 to X. Cui).	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Charron JBF, 2009, PLANT CELL, V21, P3732, DOI 10.1105/tpc.109.066845; Chen DH, 2010, CELL RES, V20, P1332, DOI 10.1038/cr.2010.151; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng XA, 2010, P NATL ACAD SCI USA, V107, P19114, DOI 10.1073/pnas.1009669107; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; English JJ, 1997, PLANT J, V12, P597, DOI 10.1046/j.1365-313X.1997.00597.x; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Inagaki S, 2010, EMBO J, V29, P3496, DOI 10.1038/emboj.2010.227; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Ko JH, 2010, EMBO J, V29, P3208, DOI 10.1038/emboj.2010.198; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Larsson AS, 1998, GENETICS, V149, P597; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu FL, 2010, CELL RES, V20, P387, DOI 10.1038/cr.2010.27; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Schatlowski N, 2008, SEMIN CELL DEV BIOL, V19, P547, DOI 10.1016/j.semcdb.2008.07.019; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle IR, 2010, GENE DEV, V24, P986, DOI 10.1101/gad.579910; Shen WH, 2009, MOL PLANT, V2, P600, DOI 10.1093/mp/ssp022; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	249	264	6	143	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					715	U144		10.1038/ng.854	http://dx.doi.org/10.1038/ng.854			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21642989				2022-12-25	WOS:000292184600020
J	Quan, JY; Saaem, I; Tang, N; Ma, SM; Negre, N; Gong, H; White, KP; Tian, JD				Quan, Jiayuan; Saaem, Ishtiaq; Tang, Nicholas; Ma, Siying; Negre, Nicolas; Gong, Hui; White, Kevin P.; Tian, Jingdong			Parallel on-chip gene synthesis and application to optimization of protein expression	NATURE BIOTECHNOLOGY			English	Article							DNA; AMPLIFICATION; MICROARRAY; CLONING	Low-cost, high-throughput gene synthesis and precise control of protein expression are of critical importance to synthetic biology and biotechnology(1-3). Here we describe the development of an on-chip gene synthesis technology, which integrates on a single microchip the synthesis of DNA oligonucleotides using inkjet printing, isothermal oligonucleotide amplification and parallel gene assembly. Use of a mismatch-specific endonuclease for error correction results in an error rate of similar to 0.19 errors per kb. We applied this approach to synthesize pools of thousands of codon-usage variants of lacZ alpha and 74 challenging Drosophila protein antigens, which were then screened for expression in Escherichia coli. In one round of synthesis and screening, we obtained DNA sequences that were expressed at a wide range of levels, from zero to almost 60% of the total cell protein mass. This technology may facilitate systematic investigation of the molecular mechanisms of protein translation and the design, construction and evolution of macromolecular machines, metabolic networks and synthetic cells.	[Quan, Jiayuan; Saaem, Ishtiaq; Tang, Nicholas; Ma, Siying; Gong, Hui; Tian, Jingdong] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Quan, Jiayuan; Saaem, Ishtiaq; Ma, Siying; Tian, Jingdong] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Negre, Nicolas; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Negre, Nicolas; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Duke University; Duke University; University of Chicago; University of Chicago	Tian, JD (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	jtian@duke.edu	Feng, Miao/B-8220-2012	Tang, Nicholas/0000-0003-0162-9743; Negre, Nicolas/0000-0001-9727-3416	NHGRI NIH HHS [R01 HG005862] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005862] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Borovkov AY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq677; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Huang MC, 2009, LAB CHIP, V9, P276, DOI 10.1039/b807688j; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Ma KS, 2009, J MATER CHEM, V19, P7914, DOI 10.1039/b904663a; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Saaem I, 2010, ACS APPL MATER INTER, V2, P491, DOI 10.1021/am900884b; SALIS HM, 2004, NAT BIOTECHNOL, V22, P841; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; Welch M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0520.focus; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	29	106	159	4	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					449	+		10.1038/nbt.1847	http://dx.doi.org/10.1038/nbt.1847			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21516083				2022-12-25	WOS:000290301700026
J	Mercer, TR; Gerhardt, DJ; Dinger, ME; Crawford, J; Trapnell, C; Jeddeloh, JA; Mattick, JS; Rinn, JL				Mercer, Tim R.; Gerhardt, Daniel J.; Dinger, Marcel E.; Crawford, Joanna; Trapnell, Cole; Jeddeloh, Jeffrey A.; Mattick, John S.; Rinn, John L.			Targeted RNA sequencing reveals the deep complexity of the human transcriptome	NATURE BIOTECHNOLOGY			English	Article							NONCODING RNAS; GENE-EXPRESSION; HUMAN EXOMES; GENOME; SEQ; DEMARCATION; LANDSCAPE; VARIANTS; FEATURES; ELEMENTS	Transcriptomic analyses have revealed an unexpected complexity to the human transcriptome, whose breadth and depth exceeds current RNA sequencing capability(1-4). Using tiling arrays to target and sequence select portions of the transcriptome, we identify and characterize unannotated transcripts whose rare or transient expression is below the detection limits of conventional sequencing approaches. We use the unprecedented depth of coverage afforded by this technique to reach the deepest limits of the human transcriptome, exposing widespread, regulated and remarkably complex noncoding transcription in intergenic regions, as well as unannotated exons and splicing patterns in even intensively studied protein-coding loci such as p53 and HOX. The data also show that intermittent sequenced reads observed in conventional RNA sequencing data sets, previously dismissed as noise, are in fact indicative of unassembled rare transcripts. Collectively, these results reveal the range, depth and complexity of a human transcriptome that is far from fully characterized.	[Gerhardt, Daniel J.; Jeddeloh, Jeffrey A.] Roche NimbleGen Inc, Res & Dev, Madison, WI 53719 USA; [Mercer, Tim R.; Dinger, Marcel E.; Crawford, Joanna; Mattick, John S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Trapnell, Cole; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Roche Holding; University of Queensland; Harvard University	Jeddeloh, JA (corresponding author), Roche NimbleGen Inc, Res & Dev, Madison, WI 53719 USA.	jeffrey.jeddeloh@roche.com; j.mattick@uq.edu.au; john_rinn@harvard.edu	Crawford, Joanna/F-9135-2013; Mercer, Tim/AAK-5060-2020; Mattick, John S/I-7789-2012; Mattick, John/ABH-6130-2020; Dinger, Marcel/N-1398-2019	Crawford, Joanna/0000-0003-0786-6889; Mercer, Tim/0000-0001-8780-894X; Mattick, John S/0000-0002-7680-7527; Mattick, John/0000-0002-7680-7527; Dinger, Marcel/0000-0003-4423-934X; Rinn, John/0000-0002-7231-7539	Human Frontiers Science Program; Queensland Government Department of Employment, Economic Development and Innovation; Australian Research Council/University of Queensland [FF0561986]; Australian National Health and Medical Research Council Australia [631668]; Career Development Award [CDA631542]; Damon Runyon-Rachleff; Searle; Smith Family Foundation; Richard Merkin Foundation; US National Institutes of Health [1DP2OD00667-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006102] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Queensland Government Department of Employment, Economic Development and Innovation; Australian Research Council/University of Queensland(University of QueenslandAustralian Research Council); Australian National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Career Development Award; Damon Runyon-Rachleff; Searle; Smith Family Foundation; Richard Merkin Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank M. Garber for his design of the arrays and constructive contribution to the manuscript; M. Koziol and K. Thomas for preparing cDNA and sequencing libraries; T. Albert, T. Arnold, J. Affourtit, B. Dessany, T. Jarvie, D. Green and T. Millard provided sequencing support. The authors would like to thank the following funding sources: Human Frontiers Science Program (to T.R.M.); Queensland Government Department of Employment, Economic Development and Innovation Smart Futures Fellowship (to M.E.D.); Australian Research Council/University of Queensland co-sponsored Federation Fellowship (FF0561986; to J.S.M.); Australian National Health and Medical Research Council Australia Fellowship (631668; to J.S.M.) and Career Development Award (CDA631542; to M.E.D.); Damon Runyon-Rachleff, Searle, Smith Family Foundation and Richard Merkin Foundation Scholar (to J.L.R.); and US National Institutes of Health (1DP2OD00667-01; to J.L.R. and C.T.).	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Crider-Miller SJ, 1997, GENOMICS, V46, P355, DOI 10.1006/geno.1997.5061; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kloc M, 2011, BIOCHIMIE, V93, P1955, DOI 10.1016/j.biochi.2011.07.008; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Bakel H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001102; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; YEHLE CO, 1987, MOL CELL PROBE, V1, P177, DOI 10.1016/0890-8508(87)90026-0	38	322	334	5	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					99	U147		10.1038/nbt.2024	http://dx.doi.org/10.1038/nbt.2024			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22081020	Green Accepted			2022-12-25	WOS:000299110600026
J	Compeau, PEC; Pevzner, PA; Tesler, G				Compeau, Phillip E. C.; Pevzner, Pavel A.; Tesler, Glenn			How to apply de Bruijn graphs to genome assembly	NATURE BIOTECHNOLOGY			English	Article							SEQUENCE; DNA; ALGORITHMS		[Compeau, Phillip E. C.; Tesler, Glenn] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Pevzner, Pavel A.] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Compeau, PEC (corresponding author), Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA.	ppevzner@ucsd.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR024851, P41RR008605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103484] Funding Source: NIH RePORTER; Howard Hughes Medical Institute [52005726] Funding Source: Medline; NCRR NIH HHS [3P41RR024851-02S1, P41 RR024851, P41 RR008605] Funding Source: Medline; NIGMS NIH HHS [P41 GM103484] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bandeira N, 2008, NAT BIOTECHNOL, V26, P1336, DOI 10.1038/nbt1208-1336; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; DRMANAC R, 1989, GENOMICS, V4, P114; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FULER I, 1741, COMMENTARII ACAD SCI, V8, P128; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; KECECIOGLU JD, 1995, ALGORITHMICA, V13, P7, DOI 10.1007/BF01188580; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; LYSOV YP, 1988, DOKL AKAD NAUK SSSR, V303, P1508; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V7, P63, DOI 10.1080/07391102.1989.10507752; Pevzner PA, 2004, GENOME RES, V14, P1786, DOI 10.1101/gr.2395204; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pham SK, 2010, BIOINFORMATICS, V26, P2509, DOI 10.1093/bioinformatics/btq465; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Skiena S. S., 2008, ALGORITHM DESIGN MAN; SOUTHERN E, 1988, Patent No. GB8810400; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [No title captured]	26	312	346	3	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					987	991		10.1038/nbt.2023	http://dx.doi.org/10.1038/nbt.2023			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068540	Green Accepted			2022-12-25	WOS:000296801300019
J	Ly, M; Leach, FE; Laremore, TN; Toida, T; Amster, IJ; Linhardt, RJ				Ly, Mellisa; Leach, Franklin E., III; Laremore, Tatiana N.; Toida, Toshihiko; Amster, I. Jonathan; Linhardt, Robert J.			The proteoglycan bikunin has a defined sequence	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-TRYPSIN INHIBITOR; CHONDROITIN SULFATE OLIGOSACCHARIDES; ELECTRON DETACHMENT DISSOCIATION; COVALENTLY CROSS-LINKS; HEPARAN-SULFATE; HUMAN PLASMA; GLYCOSAMINOGLYCAN OLIGOSACCHARIDES; STRUCTURAL-ANALYSIS; ANTITHROMBIN-III; MASS-SPECTRA	Proteoglycans are complex glycoconjugates that regulate critical biological pathways in all higher organisms. Bikunin, the simplest proteoglycan, with a single glycosaminoglycan chain, is a serine protease inhibitor used to treat acute pancreatitis. Unlike nucleic acids and proteins, whose synthesis is template driven, Golgi-synthesized glycosaminoglycans are not believed to have predictable or deterministic sequences. Bikunin peptidoglycosaminoglycans were prepared and fractionated to obtain a collection of size-similar and charge-similar chains. Fourier transform mass spectral analysis identified a small number of parent molecular ions corresponding to monocompositional peptidoglycosaminoglycans. Fragmentation using collision-induced dissociation unexpectedly afforded a single sequence for each monocompositional parent ion, unequivocally demonstrating the presence of a defined sequence. The biosynthetic pathway common to all proteoglycans suggests that even more structurally complex proteoglycans, such as heparan sulfate, may have defined sequences, requiring a readjustment in the understanding of information storage in complex glycans.	[Ly, Mellisa; Laremore, Tatiana N.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Leach, Franklin E., III; Amster, I. Jonathan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Toida, Toshihiko] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; University System of Georgia; University of Georgia; Chiba University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA.	linhar@rpi.edu	Amster, Jon/D-6957-2011	Amster, Jon/0000-0001-7523-5144; Laremore, Tatiana/0000-0002-1036-8963	US National Institutes of Health [GM38060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank D. Zagorevski for his expertise in the proteomics core at Rensselaer Polytechnic Institute and the US National Institutes of Health for support (GM38060).	ATHA DH, 1987, BIOCHEMISTRY-US, V26, P6454, DOI 10.1021/bi00394a024; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Capon C, 2003, BIOCHIMIE, V85, P101, DOI 10.1016/S0300-9084(03)00066-X; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; CONRAD HE, 2001, CURR PROTOC MOL BIOL, V17; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; GU KN, 1993, CARBOHYD RES, V244, P369, DOI 10.1016/0008-6215(83)85014-9; Gunay NS, 2003, ANAL CHEM, V75, P3226, DOI 10.1021/ac034053l; Hitchcock AM, 2008, PROTEOMICS, V8, P1384, DOI 10.1002/pmic.200700787; Josic D, 2006, PROTEOMICS, V6, P2874, DOI 10.1002/pmic.200500563; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Laremore TN, 2011, INT J MASS SPECTROM, V305, P109, DOI 10.1016/j.ijms.2010.09.020; Laremore TN, 2010, BIOCHEM J, V431, P199, DOI 10.1042/BJ20100788; Laremore TN, 2010, ANAL BIOCHEM, V401, P236, DOI 10.1016/j.ab.2010.03.004; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Liu J, 1995, GLYCOBIOLOGY, V5, P765, DOI 10.1093/glycob/5.8.765; LY M, 2011, THESIS RENSSELAER PO; Ly M, 2011, ANAL BIOANAL CHEM, V399, P737, DOI 10.1007/s00216-010-3679-7; Ly M, 2010, OMICS, V14, P389, DOI 10.1089/omi.2009.0123; McClellan JE, 2002, ANAL CHEM, V74, P3760, DOI 10.1021/ac025506+; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; MICHALSKI C, 1994, VOX SANG, V67, P329, DOI 10.1111/j.1423-0410.1994.tb01269.x; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Perez S., 1998, POLYSACCHARIDES STRU, P41; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; TOYODA H, 1993, BIOL PHARM BULL, V16, P945; TURNBULL JE, 1991, BIOCHEM J, V277, P297, DOI 10.1042/bj2770297; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Wolff JJ, 2008, J AM SOC MASS SPECTR, V19, P1449, DOI 10.1016/j.jasms.2008.06.024; Wolff JJ, 2008, J AM SOC MASS SPECTR, V19, P790, DOI 10.1016/j.jasms.2008.03.010; Wolff JJ, 2007, J AM SOC MASS SPECTR, V18, P234, DOI 10.1016/j.jasms.2006.09.020; Wolff JJ, 2010, ANAL CHEM, V82, P3460, DOI 10.1021/ac100554a; YAMADA S, 1995, GLYCOBIOLOGY, V5, P335, DOI 10.1093/glycob/5.3.335; Zaia J, 2003, J AM SOC MASS SPECTR, V14, P1270, DOI 10.1016/S1044-0305(03)00541-5; Zaia J, 2005, J BIOMACROMOL MASS S, V1, P3; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2002, GLYCOCONJUGATE J, V19, P241, DOI 10.1023/A:1025331929373	50	140	141	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					827	833		10.1038/nchembio.673	http://dx.doi.org/10.1038/nchembio.673			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21983600	Green Accepted			2022-12-25	WOS:000296381600013
J	Prosser, HM; Koike-Yusa, H; Cooper, JD; Law, FC; Bradley, A				Prosser, Haydn M.; Koike-Yusa, Hiroko; Cooper, James D.; Law, Frances C.; Bradley, Allan			A resource of vectors and ES cells for targeted deletion of microRNAs in mice	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC RECOMBINATION; MAMMALIAN-CELLS; FLP RECOMBINASE; ENZYME DICER; CRE; DIFFERENTIATION; GENES; RECOGNITION; EXPRESSION	The 21-23 nucleotide, single-stranded RNAs classified as microRNAs (miRNA) perform fundamental roles in diverse cellular and developmental processes. In contrast to the situation for protein-coding genes, no public resource of miRNA mouse mutant alleles exists. Here we describe a collection of 428 miRNA targeting vectors covering 476 of the miRNA genes annotated in the miRBase registry. Using these vectors, we generated a library of highly germline-transmissible C57BL/6N mouse embryonic stem (ES) cell clones harboring targeted deletions for 392 miRNA genes. For most of these targeted clones, chimerism and germline transmission can be scored through a coat color marker. The targeted alleles have been designed to be adaptable research tools that can be efficiently altered by recombinase-mediated cassette exchange to create reporter, conditional and other allelic variants. This miRNA knockout (mirKO) resource can be searched electronically and is available from ES cell repositories for distribution to the scientific community.	[Prosser, Haydn M.; Koike-Yusa, Hiroko; Cooper, James D.; Law, Frances C.; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Prosser, HM (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	hmp@sanger.ac.uk		Bradley, Allan/0000-0002-2349-8839; Cooper, James/0000-0002-4932-1740	Wellcome Trust [WT079643]; European Union; US National Institutes of Health	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Y. Mok, D. Thomas, M. Li and G. Duddy for assistance with sections of the project. For database support and high-throughput vector designs, we are indebted to V. Iyer, D. Oakley, W. Yang, D. Klose and S. Briois. We thank A. West for advice on long range PCR genotyping. We are grateful for the advice and reagents for high-throughput vector construction received from P. Liu. We thank E. Miska for helpful comments on the manuscript. We thank R. Rad for advice with Q-PCR. We thank the Sanger Institute mouse mutant generation and animal facilities teams. We thank the public distribution repositories at MMRRC University of California Davis, USA, and as part of the EUCOMMTOOLS initiative EuMMCR at the Helmholtz Zentrum Munchen, Munich, Germany, for agreeing to support the future distribution of the mirKO resource. This work was funded by the Wellcome Trust (WT079643). The IKMC database was developed with funding from the European Union and the US National Institutes of Health.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Saba R, 2010, BRAIN RES, V1338, P3, DOI 10.1016/j.brainres.2010.03.107; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Seibler J, 1998, BIOCHEMISTRY-US, V37, P6229, DOI 10.1021/bi980288t; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wobus A M, 2002, Methods Mol Biol, V185, P127; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	41	66	82	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					843	U102		10.1038/nbt.1929	http://dx.doi.org/10.1038/nbt.1929			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21822254	Green Submitted, Green Accepted			2022-12-25	WOS:000294718400026
J	Waterfield, M; Anderson, MS				Waterfield, Michael; Anderson, Mark S.			Immunodeficiency hints at autoreactivity to cytokines	NATURE MEDICINE			English	Editorial Material							CHRONIC MUCOCUTANEOUS CANDIDIASIS; OMENN-SYNDROME; CELLS; AIRE; AUTOANTIBODIES; TOLERANCE; GENE		[Waterfield, Michael] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94122 USA; [Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Waterfield, M (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94122 USA.	manderson@diabetes.ucsf.edu						Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Goyal R, 2009, CURR OPIN RHEUMATOL, V21, P78, DOI 10.1097/BOR.0b013e32831cb939; Honig M, 2006, CURR OPIN RHEUMATOL, V18, P383; Khiong K, 2007, J CLIN INVEST, V117, P1270, DOI 10.1172/JCI30513; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Matsumoto M, 2011, EUR J IMMUNOL, V41, P12, DOI 10.1002/eji.201041024; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983	14	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1054	1055		10.1038/nm0911-1054	http://dx.doi.org/10.1038/nm0911-1054			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900922				2022-12-25	WOS:000294605100023
J	Xu, B; Roos, JL; Dexheimer, P; Boone, B; Plummer, B; Levy, S; Gogos, JA; Karayiorgou, M				Xu, Bin; Roos, J. Louw; Dexheimer, Phillip; Boone, Braden; Plummer, Brooks; Levy, Shawn; Gogos, Joseph A.; Karayiorgou, Maria			Exome sequencing supports a de novo mutational paradigm for schizophrenia	NATURE GENETICS			English	Article							PROTEIN-COUPLED RECEPTORS; POPULATION; VARIANTS; DISEASE; FAMILIES; SPECTRUM; LINKAGE	Despite its high heritability, a large fraction of individuals with schizophrenia do not have a family history of the disease (sporadic cases). Here we examined the possibility that rare de novo protein-altering mutations contribute to the genetic component of schizophrenia by sequencing the exomes of 53 sporadic cases, 22 unaffected controls and their parents. We identified 40 de novo mutations in 27 cases affecting 40 genes, including a potentially disruptive mutation in DGCR2, a gene located in the schizophrenia-predisposing 22q11.2 microdeletion region. A comparison to rare inherited variants indicated that the identified de novo mutations show a large excess of non-synonymous changes in schizophrenia cases, as well as a greater potential to affect protein structure and function. Our analyses suggest a major role for de novo mutations in schizophrenia as well as a large mutational target, which together provide a plausible explanation for the high global incidence and persistence of the disease.	[Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Xu, Bin; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Roos, J. Louw] Univ Pretoria, Weskoppies Hosp, ZA-0002 Pretoria, South Africa; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Dexheimer, Phillip; Boone, Braden; Plummer, Brooks; Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University; University of Pretoria; University of Pretoria; HudsonAlpha Institute for Biotechnology; Columbia University	Karayiorgou, M (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	jag90@columbia.edu; mk2758@columbia.edu		Roos, Johannes/0000-0002-0572-1072; Dexheimer, Phillip/0000-0003-3965-6894; Levy, Shawn/0000-0002-1369-5740	National Institute of Mental Health (NIMH) [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399, R01MH077235] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all the families who participated in this research. We also thank H. Pretorius and nursing sisters R. van Wyk, C. Botha and H. van den Berg for their assistance with subject recruitment, family history assessments and diagnostic evaluations. We thank Y. Sun for technical assistance with DNA extractions and sample preparations and J. Grun for information technology support. We also thank E. Fledderman and S. Thomas for support of the sequencing studies and M. Robinson for critical project support. This work was supported in part by National Institute of Mental Health (NIMH) grants MH061399 (to M. K.) and MH077235 (to J. A. G.) and the Lieber Center for Schizophrenia Research at Columbia University. B. X. was partially supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arguello PA, 2010, SCHIZOPHRENIA BULL, V36, P289, DOI 10.1093/schbul/sbp153; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cruz MT, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00207; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Gloriam DEI, 2005, BBA-GEN SUBJECTS, V1722, P235, DOI 10.1016/j.bbagen.2004.12.001; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V222, P144, DOI 10.1006/bbrc.1996.0712; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	35	326	341	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					864	U72		10.1038/ng.902	http://dx.doi.org/10.1038/ng.902			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822266	Green Accepted			2022-12-25	WOS:000294325800012
J	Gao, YF; Li, T; Chang, Y; Wang, YB; Zhang, WN; Li, WH; He, K; Mu, R; Zhen, C; Man, JH; Pan, X; Li, T; Chen, L; Yu, M; Liang, B; Chen, Y; Xia, Q; Zhou, T; Gong, WL; Li, AL; Li, HY; Zhang, XM				Gao, Yan-Fei; Li, Teng; Chang, Yan; Wang, Yu-Bo; Zhang, Wei-Na; Li, Wei-Hua; He, Kun; Mu, Rui; Zhen, Cheng; Man, Jiang-Hong; Pan, Xin; Li, Tao; Chen, Liang; Yu, Ming; Liang, Bing; Chen, Yuan; Xia, Qing; Zhou, Tao; Gong, Wei-Li; Li, Ai-Ling; Li, Hui-Yan; Zhang, Xue-Min			Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability	NATURE CELL BIOLOGY			English	Article							CELL-DIVISION; CYCLIN-A; COMPLEX; ANEUPLOIDY; MITOSIS; REVEALS; CANCER; CDC20; MAD2; COMPLEX/CYCLOSOME	Aneuploidy and chromosomal instability are major characteristics of human cancer. These abnormalities can result from defects in the spindle assembly checkpoint (SAC), which is a surveillance mechanism for accurate chromosome segregation through restraint of the activity of the anaphase-promoting complex/cyclosome (APC/C). Here, we show that a CUE-domain-containing protein, CUEDC2, is a cell-cycle regulator that promotes spindle checkpoint in activation and releases APC/C from checkpoint inhibition. CUEDC2 is phosphorylated by Cdk1 during mitosis. Depletion of CUEDC2 causes a checkpoint-dependent delay of the metaphase-anaphase transition. Phosphorylated CUEDC2 binds to Cdc20, an activator of APC/C, and promotes the release of Mad2 from APC/C-Cdc20 and subsequent APC/C activation. CUEDC2 overexpression causes earlier activation of APC/C, leading to chromosome missegregation and aneuploidy. Interestingly, CUEDC2 is highly expressed in many types of tumours. These results suggest that CUEDC2 is a key regulator of mitosis progression, and that CUEDC2 dysregulation might contribute to tumour development by causing chromosomal instability.	[Gao, Yan-Fei; Li, Teng; Chang, Yan; Wang, Yu-Bo; Zhang, Wei-Na; Li, Wei-Hua; He, Kun; Mu, Rui; Zhen, Cheng; Man, Jiang-Hong; Pan, Xin; Li, Tao; Chen, Liang; Yu, Ming; Liang, Bing; Chen, Yuan; Xia, Qing; Zhou, Tao; Gong, Wei-Li; Li, Ai-Ling; Li, Hui-Yan; Zhang, Xue-Min] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China		Li, HY (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, 27 Tai Ping Rd, Beijing 100850, Peoples R China.	lihy@nic.bmi.ac.cn; xmzhang@nic.bmi.ac.cn		Pan, Xin/0000-0002-1982-2261; Man, Jianghong/0000-0001-6020-3537; Li, Tao/0000-0002-0746-8322	National Natural Science Foundation of China [91029733, 30830097, 30871234, 30872348, 81025010, 30900754]; National High Technology Research and Development Program of China [2009AA02Z103, 2009ZX09503-001]; National Basic Research Program of China [2010CB911900, 2010CB529904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	We thank H. T. Yu and Y. X. Zheng for discussions, M. W. Kirschner, T. Wu and G. W. Fang for technical help, Z. G. Liu for reading, S. Doxsey for HeLa cells stably expressing GFP-H2B and hTERT-RPE1 cells, E. D. Salmon for GFP-Cdc20 expression plasmid, Y. Liu for pFlag-Cdk1-AF (constitutively active) and pFlag-Cdk1-DN (kinase dead) plasmids, J. Pines for pVenus-N1 Cyclin B1 plasmid, M. W. Kirschner for the plasmids coding securin and geminin, P. K. Jackson for the plasmid pCS2-Cyclin B1, R. Benezra for the plasmid pFlag-CMV2-Mad2, H. T. Yu for pCS2-securin and pCS2-securin (Delta DB) plasmids and H. M. Wang for capturing tissue array images. This work was supported by the National Natural Science Foundation of China (no 91029733; no 30830097; no 30871234; no 30872348; no 81025010; no 30900754), the National High Technology Research and Development Program of China (2009AA02Z103 and 2009ZX09503-001) and the National Basic Research Program of China (2010CB911900 and 2010CB529904).	Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hershko A, 1999, PHILOS T R SOC B, V354, P1571, DOI 10.1098/rstb.1999.0500; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jin BF, 2003, ONCOGENE, V22, P4819, DOI 10.1038/sj.onc.1206738; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Krasinska L, 2008, CELL CYCLE, V7, P1702, DOI 10.4161/cc.7.12.6101; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Man JH, 2010, J CLIN INVEST, V120, P2829, DOI 10.1172/JCI42542; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Pan J, 2008, MOL CANCER RES, V6, P862, DOI 10.1158/1541-7786.MCR-07-2070; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Pines J, 1999, PHILOS T ROY SOC B, V354, P1575; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602	52	60	67	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2011	13	8					924	U381		10.1038/ncb2287	http://dx.doi.org/10.1038/ncb2287			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	800OW	21743465				2022-12-25	WOS:000293373700010
J	Rodriguez-Diaz, R; Dando, R; Jacques-Silva, MC; Fachado, A; Molina, J; Abdulreda, MH; Ricordi, C; Roper, SD; Berggren, PO; Caicedo, A				Rodriguez-Diaz, Rayner; Dando, Robin; Jacques-Silva, M. Caroline; Fachado, Alberto; Molina, Judith; Abdulreda, Midhat H.; Ricordi, Camillo; Roper, Stephen D.; Berggren, Per-Olof; Caicedo, Alejandro			Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans	NATURE MEDICINE			English	Article							POSITIVE AUTOCRINE SIGNAL; INSULIN-RELEASE; VESICULAR ACETYLCHOLINE; GLUCOSE; PANCREAS; GLUCAGON; RECEPTOR; ISLETS; OSCILLATIONS; POLYPEPTIDE	Acetylcholine is a neurotransmitter that has a major role in the function of the insulin-secreting pancreatic beta cell(1,2). Parasympathetic innervation of the endocrine pancreas, the islets of Langerhans, has been shown to provide cholinergic input to the beta cell in several species(1,3,4), but the role of autonomic innervation in human beta cell function is at present unclear. Here we show that, in contrast to the case in mouse islets, cholinergic innervation of human islets is sparse. Instead, we find that the alpha cells of human islets provide paracrine cholinergic input to surrounding endocrine cells. Human alpha cells express the vesicular acetylcholine transporter and release acetylcholine when stimulated with kainate or a lowering in glucose concentration. Acetylcholine secretion by alpha cells in turn sensitizes the beta cell response to increases in glucose concentration. Our results demonstrate that in human islets acetylcholine is a paracrine signal that primes the beta cell to respond optimally to subsequent increases in glucose concentration. Cholinergic signaling within islets represents a potential therapeutic target in diabetes(5), highlighting the relevance of this advance to future drug development.	[Rodriguez-Diaz, Rayner; Jacques-Silva, M. Caroline; Fachado, Alberto; Abdulreda, Midhat H.; Ricordi, Camillo; Berggren, Per-Olof; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Rodriguez-Diaz, Rayner; Ricordi, Camillo; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Dando, Robin; Roper, Stephen D.; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Molina, Judith; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Roper, Stephen D.; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA; [Berggren, Per-Olof] Univ Sci & Technol, World Class Univ Program, Div Integrat Biosci & Biotechnol, Pohang, South Korea	University of Miami; Karolinska Institutet; University of Miami; University of Miami; University of Miami; Pohang University of Science & Technology (POSTECH)	Berggren, PO (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.	per-olof.berggren@ki.se; acaicedo@med.miami.edu	RICORDI, CAMILLO/AAA-4740-2019; Tuluc, Petronel/C-2527-2011; Caicedo, Alejandro/AAC-8544-2020	Tilahin, Shimelis/0000-0001-8975-8026; Berggren, Per-Olof/0000-0001-8991-413X; Ricordi, Camillo/0000-0001-8092-7153; Roper, Stephen/0000-0001-6049-8320	Diabetes Research Institute Foundation; US National Institutes of Health [R56DK084321, R01DK084321, R01DC000374, R01DC007630, F32DK083226, 5U01DK070460-07]; Juvenile Diabetes Research Foundation; Swedish Research Council; Novo Nordisk Foundation; Swedish Diabetes Association; Family Erling-Persson Foundation; Ministry of Education, Science and Technology [R31-2008-000-10105-0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084321, F32DK083226, U01DK070460, R01DK084321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007630, R01DC000374] Funding Source: NIH RePORTER	Diabetes Research Institute Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Family Erling-Persson Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Formoso for help with data analyses, K. Johnson for histological work and M. Correa-Medina for assistance with RT-PCR. This work was funded by the Diabetes Research Institute Foundation, US National Institutes of Health grants R56DK084321 (A.C.), R01DK084321 (A.C.), R01DC000374 (S.D.R.), R01DC007630 (S.D.R.), F32DK083226 (M.H.A.) and 5U01DK070460-07 (C.R.), the Juvenile Diabetes Research Foundation, the Swedish Research Council, the Novo Nordisk Foundation, the Swedish Diabetes Association, the Family Erling-Persson Foundation and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-2008-000-10105-0). Human islets were made available through the Islet Cell Resource basic science islet distribution program, Islet Cell Resource Centers Consortium, Division of Clinical Research, National Center for Research Resources, US National Institutes of Health.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; AHREN B, 1986, DIABETOLOGIA, V29, P827, DOI 10.1007/BF00870137; AMENTA F, 1983, ACTA HISTOCHEM, V73, P273, DOI 10.1016/S0065-1281(83)80038-5; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Becker H D, 1979, World J Surg, V3, P615; BLACKMAN JD, 1992, DIABETES, V41, P1346, DOI 10.2337/diabetes.41.10.1346; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brunicardi FC, 1995, INT J PANCREATOL, V18, P177; BUCK MA, 1990, BIOCHEM BIOPH RES CO, V173, P666, DOI 10.1016/S0006-291X(05)80087-7; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Cabrera O, 2007, CELL TRANSPLANT, V16, P1039, DOI 10.3727/000000007783472408; Conn P.M., 1998, ENDOCRINE SYSTEM END, P153; COUPLAND RE, 1958, J ANAT, V92, P143; DIEM P, 1990, J CLIN INVEST, V86, P2008, DOI 10.1172/JCI114936; Doliba NM, 2004, AM J PHYSIOL-ENDOC M, V286, pE834, DOI 10.1152/ajpendo.00292.2003; Eiden LE, 1998, J NEUROCHEM, V70, P2227; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GREIDER MH, 1970, LAB INVEST, V22, P344; Guenifi A, 2001, PANCREAS, V22, P164, DOI 10.1097/00006676-200103000-00009; Guo Y, 2006, DIABETES, V55, P3625, DOI 10.2337/db06-0379; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Karlsson S, 1997, AM J PHYSIOL-REG I, V272, pR1371, DOI 10.1152/ajpregu.1997.272.5.R1371; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; POZZA G, 1985, BMJ-BRIT MED J, V291, P510, DOI 10.1136/bmj.291.6494.510; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; STAGNER JI, 1992, DIABETES, V41, P93, DOI 10.2337/diabetes.41.1.93; TAYLOR IL, 1982, J CLIN ENDOCR METAB, V55, P1114, DOI 10.1210/jcem-55-6-1114; TEFF KL, 1993, METABOLISM, V42, P1600, DOI 10.1016/0026-0495(93)90157-J; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; WOODS SC, 1974, PHYSIOL REV, V54, P596, DOI 10.1152/physrev.1974.54.3.596; ZAWALICH WS, 1989, ENDOCRINOLOGY, V125, P2400, DOI 10.1210/endo-125-5-2400	40	204	211	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					888	U258		10.1038/nm.2371	http://dx.doi.org/10.1038/nm.2371			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21685896	Green Accepted			2022-12-25	WOS:000292500800045
J	Nair, KS; Hmani-Aifa, M; Ali, Z; Kearney, AL; Ben Salem, S; Macalinao, DG; Cosma, IM; Bouassida, W; Hakim, B; Benzina, Z; Soto, I; Soderkvist, P; Howell, GR; Smith, RS; Ayadi, H; John, SWM				Nair, K. Saidas; Hmani-Aifa, Mounira; Ali, Zain; Kearney, Alison L.; Ben Salem, Salma; Macalinao, Danilo G.; Cosma, Ioan M.; Bouassida, Walid; Hakim, Bochra; Benzina, Zeineb; Soto, Ileana; Soderkvist, Peter; Howell, Gareth R.; Smith, Richard S.; Ayadi, Hammadi; John, Simon W. M.			Alteration of the serine protease PRSS56 causes angle-closure glaucoma in mice and posterior microphthalmia in humans and mice	NATURE GENETICS			English	Article							UVEAL EFFUSION; TRABECULAR MESHWORK; GROWTH; GENOME; WIDE; EYES	Angle-closure glaucoma (ACG) is a subset of glaucoma affecting 16 million people(1-3). Although 4 million people are bilaterally blind from ACG(4,5), the causative molecular mechanisms of ACG remain to be defined. High intraocular pressure induces glaucoma in ACG. High intraocular pressure traditionally was suggested to result from the iris blocking or closing the angle of the eye, thereby limiting aqueous humor drainage. Eyes from individuals with ACG often have a modestly decreased axial length, shallow anterior chamber and relatively large lens, features that predispose to angle closure(6). Here we show that genetic alteration of a previously unidentified serine protease (PRSS56) alters axial length and causes a mouse phenotype resembling ACG. Mutations affecting this protease also cause a severe decrease of axial length in individuals with posterior microphthalmia. Together, these data suggest that alterations of this serine protease may contribute to a spectrum of human ocular conditions including reduced ocular size and ACG.	[Nair, K. Saidas; Ali, Zain; Kearney, Alison L.; Macalinao, Danilo G.; Cosma, Ioan M.; Soto, Ileana; Howell, Gareth R.; Smith, Richard S.; John, Simon W. M.] Jackson Lab, Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Hmani-Aifa, Mounira; Ben Salem, Salma; Hakim, Bochra; Ayadi, Hammadi] Univ Sfax, Ctr Biotechnol Sfax, Lab Microorganismes & Biomol, Equipe Proc Criblages Mol & Cellulaires, Sfax, Tunisia; [Bouassida, Walid; Benzina, Zeineb] Univ Habib Bourguiba, Ctr Hosp, Serv Ophtalmol, Sfax, Tunisia; [Soderkvist, Peter] Fac Hlth Sci, Dept Clin & Expt Med, Div Cell Biol, SE-58185 Linkoping, Sweden; [John, Simon W. M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Howard Hughes Medical Institute; Jackson Laboratory; Centre de Biotechnologie de Sfax; Universite de Sfax; Universite de Sfax; Hopital Habib Bourguiba; Tufts University	John, SWM (corresponding author), Jackson Lab, Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	hmanimounira@yahoo.fr; simon.john@jax.org	Ben-Salem, Salma/E-1702-2016	Ben-Salem, Salma/0000-0001-5023-6781; Soto, Ileana/0000-0002-9315-816X	National Eye Institute [EY11721]; Barbara and Joseph Cohen Foundation; Ministere de l'Enseignement Superieur de la Recherche Scientifique et de la Technologie, Tunisia; Middle East and North Africa region (MENA); Swedish Research Council (VR)/the Swedish International Development Cooperation Agency (SIDA); Project 2006 [348-2005-6336]; NATIONAL EYE INSTITUTE [R01EY011721, R29EY011721] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Barbara and Joseph Cohen Foundation; Ministere de l'Enseignement Superieur de la Recherche Scientifique et de la Technologie, Tunisia; Middle East and North Africa region (MENA); Swedish Research Council (VR)/the Swedish International Development Cooperation Agency (SIDA)(Swedish Research Council); Project 2006; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank A. Bell, S. Kneeland, H. McLaughlin, A. Gillette, M. Ryan, Annette Molbaek, Asa Schipper and The Jackson Laboratory's Fine Mapping Service and Allele Typing and Sequencing services for technical assistance. We thank P. Nishina for generous use of her OCT and J. Vance of Bioptigen for his expert technical assistance, G. Cox, P. Nishina and M. de Vries for comments on the manuscript and J. Hammer for help with graphics. The National Eye Institute grant EY11721, Barbara and Joseph Cohen Foundation, Ministere de l'Enseignement Superieur de la Recherche Scientifique et de la Technologie, Tunisia, the Middle East and North Africa region (MENA) (Swedish research links programme supported by the Swedish Research Council (VR)/the Swedish International Development Cooperation Agency (SIDA)) and the Project 2006 planning grant #348-2005-6336 supported this work. S. W. M. J. is an investigator of the Howard Hughes Medical Institute. We thank the family members for their valuable participation and cooperation.	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Elagouz M, 2010, SURV OPHTHALMOL, V55, P134, DOI 10.1016/j.survophthal.2009.05.003; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Hausman RE, 2007, PROG RETIN EYE RES, V26, P162, DOI 10.1016/j.preteyeres.2006.11.001; Hmani-Aifa M, 2009, HUM GENET, V126, P575, DOI 10.1007/s00439-009-0688-8; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Jackson TL, 2008, INVEST OPHTH VIS SCI, V49, P5033, DOI 10.1167/iovs.08-1980; John SWM, 1997, INVEST OPHTH VIS SCI, V38, P249; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kumar RS, 2008, ARCH OPHTHALMOL-CHIC, V126, P1647, DOI 10.1001/archophthalmol.2008.514; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Quigley HA, 2009, ARCH OPHTHALMOL-CHIC, V127, P693, DOI 10.1001/archophthalmol.2009.80; Ritch R, 1996, GLAUCOMAS, V2, P821; Ritch R., 1996, GLAUCOMAS, P801; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Sakai H, 2005, OPHTHALMOLOGY, V112, P413, DOI 10.1016/j.ophtha.2004.08.026; Seah SKL, 1997, ARCH OPHTHALMOL-CHIC, V115, P1436, DOI 10.1001/archopht.1997.01100160606014; Shields M. B., 1996, TXB GLAUCOMA, P177; Smith RS, 2002, RES METH MUT M SER, P3; Smith RS, 2002, MOL VIS, V8, P26; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025	30	61	66	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					579	U118		10.1038/ng.813	http://dx.doi.org/10.1038/ng.813			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532570	Green Accepted			2022-12-25	WOS:000291017000017
J	So, LH; Ghosh, A; Zong, CH; Sepulveda, LA; Segev, R; Golding, I				So, Lok-Hang; Ghosh, Anandamohan; Zong, Chenghang; Sepulveda, Leonardo A.; Segev, Ronen; Golding, Ido			General properties of transcriptional time series in Escherichia coli	NATURE GENETICS			English	Article							PROTEIN EXPRESSION; SINGLE-CELL; NOISE; MOLECULE; DYNAMICS; REVEALS; STOCHASTICITY; NETWORK; ELONGATION; INITIATION	Gene activity is described by the time series of discrete, stochastic mRNA production events. This transcriptional time series shows intermittent, bursty behavior. One consequence of this temporal intricacy is that gene expression can be tuned by varying different features of the time series. Here we quantify copy-number statistics of mRNA from 20 Escherichia coli promoters using single-molecule fluorescence in situ hybridization in order to characterize the general properties of these transcriptional time series. We find that the degree of burstiness is correlated with gene expression level but is largely independent of other parameters of gene regulation. The observed behavior can be explained by the underlying variation in the duration of bursting events. Using Shannon's mutual information function, we estimate the mutual information transmitted between an outside stimulus, such as the extracellular concentration of inducer molecules, and intracellular levels of mRNA. This suggests that the outside stimulus transmits information reflected in the properties of transcriptional time series.	[So, Lok-Hang; Sepulveda, Leonardo A.; Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [So, Lok-Hang; Zong, Chenghang; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ghosh, Anandamohan; Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ghosh, Anandamohan; Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Sepulveda, Leonardo A.; Golding, Ido] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; Ben Gurion University; Ben Gurion University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Golding, I (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	igolding@illinois.edu	SEGEV, RONEN/F-1550-2012; Zong, Chenghang/F-3243-2013; Sepúlveda, Leonardo A./AAL-3981-2020	Sepúlveda, Leonardo A./0000-0003-3602-1009; Segev, Ronen/0000-0002-8109-1076; Zong, Chenghang/0000-0002-8337-8038	US National Institutes of Health [R01GM082837]; National Science Foundation [082265]; Human Frontier Science Program [RGY 70/2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Adhya, W. Boos, M. Cashel, V. Chakravartty, L. Chubiz, D. Court, J. Cronan, M. Dreyfus, M. Elowitz, Y. Feng, H. Garcia, T. Hwa, J. Imlay, S. Jang, T. Kuhlman, J. Little, A. van Oudenaarden, A. Raj, C. Rao, R. Milo, V. Shahrezaei, A. Sokac and P. Swain for advice and for providing reagents. We thank members of the Golding laboratory for providing help with experiments. We thank H. Garcia, J. Kondev, R. Phillips, A. Raj, A. Sanchez, S. Sawai and G. Tkacik for commenting on earlier versions of the manuscript. Work in the Golding laboratory was supported by grants from US National Institutes of Health (R01GM082837) and the National Science Foundation (082265, PFC: Center for the Physics of Living Cells). Work in the Segev and Golding laboratories was supported by a joint grant from the Human Frontier Science Program (RGY 70/2008).	Abdel-Hamid AM, 2007, J BACTERIOL, V189, P369, DOI 10.1128/JB.01373-06; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Alon U, 2007, INTRO SYSTEMS BIOL D; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BARKER DF, 1980, J BACTERIOL, V143, P789, DOI 10.1128/JB.143.2.789-800.1980; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cox CD, 2008, P NATL ACAD SCI USA, V105, P10809, DOI 10.1073/pnas.0804829105; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fang FC, 2005, P NATL ACAD SCI USA, V102, P4933, DOI 10.1073/pnas.0501417102; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Garcia HG, 2010, TRENDS CELL BIOL, V20, P723, DOI 10.1016/j.tcb.2010.07.002; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2006, CURR BIOL, V16, pR371, DOI 10.1016/j.cub.2006.04.014; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Michalowski CB, 2005, J BACTERIOL, V187, P6430, DOI 10.1128/JB.187.18.6430-6442.2005; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Neidhardt F., 1987, ESCHERICHIA COLI SAL; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Sauer R T, 1990, Adv Protein Chem, V40, P1, DOI 10.1016/S0065-3233(08)60286-7; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simpson ML, 2004, J THEOR BIOL, V229, P383, DOI 10.1016/j.jtbi.2004.04.017; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Singh D, 2009, P NATL ACAD SCI USA, V106, P864, DOI 10.1073/pnas.0810205106; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Tkacik G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031920; TOKESON JPE, 1991, J BACTERIOL, V173, P2319, DOI 10.1128/JB.173.7.2319-2327.1991; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Whitelaw NC, 2010, DEV CELL, V19, P649, DOI 10.1016/j.devcel.2010.11.001; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	75	271	273	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					554	U84		10.1038/ng.821	http://dx.doi.org/10.1038/ng.821			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532574	Green Accepted			2022-12-25	WOS:000291017000012
J	Wang, XX; Kim, Y; Hong, SH; Ma, Q; Brown, BL; Pu, MM; Tarone, AM; Benedik, MJ; Peti, W; Page, R; Wood, TK				Wang, Xiaoxue; Kim, Younghoon; Hong, Seok Hoon; Ma, Qun; Brown, Breann L.; Pu, Mingming; Tarone, Aaron M.; Benedik, Michael J.; Peti, Wolfgang; Page, Rebecca; Wood, Thomas K.			Antitoxin MqsA helps mediate the bacterial general stress response	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI BIOFILMS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CELL-DEATH; EXPRESSION; SYSTEMS; LOCUS; RPOS; INACTIVATION; TRANSLATION	n Although it is well recognized that bacteria respond to environmental stress through global networks, the mechanism by which stress is relayed to the interior of the cell is poorly understood. Here we show that enigmatic toxin-antitoxin systems are vital in mediating the environmental stress response. Specifically, the antitoxin MqsA represses rpoS, which encodes the master regulator of stress. Repression of rpoS by MqsA reduces the concentration of the internal messenger 3,5-cyclic diguanylic acid, leading to increased motility and decreased biofilm formation. Furthermore, the repression of rpoS by MqsA decreases oxidative stress resistance via catalase activity. Upon oxidative stress, MqsA is rapidly degraded by Lon protease, resulting in induction of rpoS. Hence, we show that external stress alters gene regulation controlled by toxin-antitoxin systems, such that the degradation of antitoxins during stress leads to a switch from the planktonic state (high motility) to the biofilm state (low motility).	[Wang, Xiaoxue; Kim, Younghoon; Hong, Seok Hoon; Ma, Qun; Pu, Mingming; Wood, Thomas K.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Brown, Breann L.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Tarone, Aaron M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Benedik, Michael J.; Wood, Thomas K.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Texas A&M University System; Texas A&M University College Station; Brown University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Brown University	Wang, XX (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	Thomas.Wood@chemail.tamu.edu	Hong, Seok Hoon/E-1289-2014; Peti, Wolfgang/L-3492-2014; Benedik, Michael J/H-2478-2011; Pu, Mingming/F-6760-2012; Hong, Seok Hoon/AAF-7163-2021; Tarone, Aaron/I-6483-2012; Wood, Thomas/GWZ-2481-2022	Hong, Seok Hoon/0000-0003-2401-6368; Benedik, Michael J/0000-0002-7435-0092; Hong, Seok Hoon/0000-0003-2401-6368; Wood, Thomas/0000-0001-8962-8571; Wood, Thomas/0000-0002-6258-529X; Tarone, Aaron/0000-0003-0965-7634; Wang, Xiaoxue/0000-0002-7257-1916	US National Institutes of Health; F31 fellowship; US National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F31 fellowship; US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health to T. K. W. and W. P. and an F31 fellowship to B. L. B. and by a US National Science Foundation CAREER award to R. P. We are grateful for the Keio and ASKA strains provided by the Genome Analysis Project in Japan.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Ito A, 2008, BIOTECHNOL BIOENG, V99, P1462, DOI 10.1002/bit.21695; Ito A, 2009, BIOTECHNOL BIOENG, V103, P975, DOI 10.1002/bit.22305; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Landini P, 2009, RES MICROBIOL, V160, P259, DOI 10.1016/j.resmic.2009.03.001; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Macvanin M, 2010, METHODS MOL BIOL, V642, P95, DOI 10.1007/978-1-60327-279-7_7; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Pecota DC, 1996, J BACTERIOL, V178, P2044, DOI 10.1128/jb.178.7.2044-2050.1996; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAMMARTANO LJ, 1986, J BACTERIOL, V168, P13, DOI 10.1128/jb.168.1.13-21.1986; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	50	168	182	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					359	366		10.1038/NCHEMBIO.560	http://dx.doi.org/10.1038/NCHEMBIO.560			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21516113	Green Accepted			2022-12-25	WOS:000290677900011
J	Bai, M; Gad, H; Turacchio, G; Cocucci, E; Yang, JS; Li, J; Beznoussenko, GV; Nie, ZZ; Luo, RB; Fu, LW; Collawn, JF; Kirchhausen, T; Luini, A; Hsu, VW				Bai, Ming; Gad, Helge; Turacchio, Gabriele; Cocucci, Emanuele; Yang, Jia-Shu; Li, Jian; Beznoussenko, Galina V.; Nie, Zhongzhen; Luo, Ruibai; Fu, Lianwu; Collawn, James F.; Kirchhausen, Tomas; Luini, Alberto; Hsu, Victor W.			ARFGAP1 promotes AP-2-dependent endocytosis	NATURE CELL BIOLOGY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CLATHRIN-MEDIATED ENDOCYTOSIS; COPI VESICLE FORMATION; TRANSFERRIN RECEPTOR; SORTING SIGNALS; GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; ADAPTER COMPLEX; ALPHA-APPENDAGE; COATED VESICLES	COPI (coat protein I) and the clathrin-AP-2 (adaptor protein 2) complex are well-characterized coat proteins, but a component that is common to these two coats has not been identified. The GTPase-activating protein (GAP) for ADP-ribosylation factor 1 (ARF1), ARFGAP1, is a known component of the COPI complex. Here, we show that distinct regions of ARFGAP1 interact with AP-2 and coatomer (components of the COPI complex). Selectively disrupting the interaction of ARFGAP1 with either of these two coat proteins leads to selective inhibition in the corresponding transport pathway. The role of ARFGAP1 in AP-2-regulated endocytosis has mechanistic parallels with its roles in COPI transport, as both its GAP activity and coat function contribute to promoting AP-2 transport.	[Bai, Ming; Yang, Jia-Shu; Li, Jian; Hsu, Victor W.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA; [Bai, Ming; Yang, Jia-Shu; Li, Jian; Hsu, Victor W.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Gad, Helge; Turacchio, Gabriele; Beznoussenko, Galina V.; Luini, Alberto] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; [Gad, Helge] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Turacchio, Gabriele] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Cocucci, Emanuele; Kirchhausen, Tomas] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA; [Cocucci, Emanuele; Kirchhausen, Tomas] Immune Dis Inst, Boston, MA 02115 USA; [Nie, Zhongzhen] Univ Florida Coll Med, Dept Urol, Gainesville, FL 32610 USA; [Luo, Ruibai] NCI, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA; [Fu, Lianwu; Collawn, James F.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Luini, Alberto] Telethon Inst Genet & Med, I-80131 Naples, Italy	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Stockholm University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Birmingham; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Hsu, VW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA.	vhsu@rics.bwh.harvard.edu	Gad, Helge/J-2238-2014; Luini, Alberto/L-1372-2013	Luini, Alberto/0000-0002-8729-2549; Cocucci, Emanuele/0000-0002-0088-9845; Gad, Helge/0000-0001-6530-1443; Collawn, James/0000-0002-2528-2759; Fu, Karl/0000-0001-5386-9429	National Institutes of Health [GM058615, GM073016, GM075252, U54 AI057159, DK060065]; Telethon (Italy); AIRC (Italy); Marie Curie Fellowship; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058615, R01GM058615, R01GM075252, R01GM073016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon (Italy)(Fondazione Telethon); AIRC (Italy)(Fondazione AIRC per la ricerca sul cancro); Marie Curie Fellowship(European Commission); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Wendland for critical comments. This work was financially supported by grants from the National Institutes of Health to V.W.H. (GM058615 and GM073016), T.K. (GM075252 and U54 AI057159-NERCE Imaging Resource) and J.F.C. (DK060065). A.L. was financially supported by the Telethon (Italy) and AIRC (Italy). H.G. was supported by a Marie Curie Fellowship. E.C. was supported by a GlaxoSmithKline fellowship.	ALVAREZ E, 1989, EMBO J, V8, P2231, DOI 10.1002/j.1460-2075.1989.tb08347.x; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; Cole NB, 1998, J CELL BIOL, V140, P1, DOI 10.1083/jcb.140.1.1; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hsu VW, 2009, FEBS LETT, V583, P3758, DOI 10.1016/j.febslet.2009.10.056; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; MATSUI W, 1990, BIOCHEMISTRY-US, V29, P10791, DOI 10.1021/bi00500a011; MCGRAW TE, 1991, J CELL BIOL, V112, P853, DOI 10.1083/jcb.112.5.853; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; PEARSE BMF, 1975, J MOL BIOL, V97, P93, DOI 10.1016/S0022-2836(75)80024-6; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Peter K, 2002, J BIOL CHEM, V277, P49952, DOI 10.1074/jbc.M209275200; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Rawet M, 2010, BIOCHEM BIOPH RES CO, V394, P553, DOI 10.1016/j.bbrc.2010.03.017; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saitoh A, 2009, J BIOL CHEM, V284, P13948, DOI 10.1074/jbc.M900749200; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015	58	30	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					559	U144		10.1038/ncb2221	http://dx.doi.org/10.1038/ncb2221			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21499258	Green Accepted			2022-12-25	WOS:000290148700015
J	Wuest, SC; Edwan, JH; Martin, JF; Han, S; Perry, JSA; Cartagena, CM; Matsuura, E; Maric, D; Waldmann, TA; Bielekova, B				Wuest, Simone C.; Edwan, Jehad H.; Martin, Jayne F.; Han, Sungpil; Perry, Justin S. A.; Cartagena, Casandra M.; Matsuura, Eiji; Maric, Dragan; Waldmann, Thomas A.; Bielekova, Bibiana			A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy	NATURE MEDICINE			English	Article							IL-2 RECEPTOR; ALPHA-CHAIN; MULTIPLE-SCLEROSIS; ANTIBODIES; DISEASE; CD25; LYMPHOCYTES; DEFICIENCY; EXPRESSION; DECREASE	Although previous studies have described CD25 expression and production of interleukin-2 (IL-2) by mature dendritic cells (mDCs), it remains unclear how these molecules participate in the activation of T cells. In search of the mechanisms by which daclizumab, a humanized monoclonal antibody against CD25, inhibits brain inflammation in multiple sclerosis, we observed that although the drug has limited effects on polyclonal T cell activation, it potently inhibits activation of antigen-specific T cells by mDCs. We show that mDCs (and antigen-experienced T cells) secrete IL-2 toward the mDC-T cell interface in an antigen-specific manner, and mDCs 'lend' their CD25 to primed T cells in trans to facilitate early high-affinity IL-2 signaling, which is crucial for subsequent T cell expansion and development of antigen-specific effectors. Our data reveal a previously unknown mechanism for the IL-2 receptor system in DC-mediated activation of T cells.	[Wuest, Simone C.; Edwan, Jehad H.; Martin, Jayne F.; Han, Sungpil; Perry, Justin S. A.; Cartagena, Casandra M.; Matsuura, Eiji; Bielekova, Bibiana] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Han, Sungpil] Pusan Natl Univ, Sch Med, Yangsan, South Korea; [Maric, Dragan] NINDS, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA; [Waldmann, Thomas A.] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Pusan National University; Pusan National University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bielekova, B (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	bibi.bielekova@nih.gov	Han, Sungpil/AAL-3279-2021; Bielekova, Bibiana/AAA-8115-2020; MATSUURA, EIJI/E-1231-2013; Waldmann, Thomas/AAT-5972-2021; Bielekova, Bibiana/V-1452-2017	Han, Sungpil/0000-0002-4674-7682; Bielekova, Bibiana/0000-0002-0959-9430; MATSUURA, EIJI/0000-0001-8215-8853; Waldmann, Thomas/0000-0003-4500-6660; Bielekova, Bibiana/0000-0002-0959-9430	NINDS/NIH; NATIONAL CANCER INSTITUTE [ZIASC004002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003056] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the intramural research program of the NINDS/NIH. We thank A. Kashani for expert technical assistance in processing apheresis samples and M. Lenardo, W. Leonard and H. McFarland for their critical review of the manuscript and helpful comments. Additionally, we are thankful to M. Lenardo and H. Su (NIH) for providing cryopreserved peripheral blood mononuclear cells (PBMCs) from the CD25<SUP>-</SUP> individual. Daclizumab F<INF>ab</INF> was provided by Abbott Biotherapeutics, under Material Transfer Agreement.	Aoki CA, 2006, J AUTOIMMUN, V27, P50, DOI 10.1016/j.jaut.2006.04.005; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Bielekova B, 2009, ARCH NEUROL-CHICAGO, V66, P483, DOI 10.1001/archneurol.2009.50; Cartagena CM, 2010, BRAIN RES, V1319, P1, DOI 10.1016/j.brainres.2009.12.080; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Kronin V, 1998, INT IMMUNOL, V10, P237, DOI 10.1093/intimm/10.2.237; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Leonard WJ, 1999, COLD SPRING HARB SYM, V64, P417, DOI 10.1101/sqb.1999.64.417; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Martin JF, 2010, J IMMUNOL, V185, P1311, DOI 10.4049/jimmunol.0902238; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mnasria K, 2008, J LEUKOCYTE BIOL, V84, P460, DOI 10.1189/jlb.1007712; Mnasria K, 2009, TRANSPL P, V41, P695, DOI 10.1016/j.transproceed.2009.01.028; Mnasria K, 2008, INT IMMUNOPHARMACOL, V8, P414, DOI 10.1016/j.intimp.2007.11.004; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; Oh U, 2009, ARCH NEUROL-CHICAGO, V66, P471, DOI 10.1001/archneurol.2009.16; Roifman CM, 2000, PEDIATR RES, V48, P6, DOI 10.1203/00006450-200007000-00004; Rose JW, 2007, NEUROLOGY, V69, P785, DOI 10.1212/01.wnl.0000267662.41734.1f; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Strowig T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040027; Velten FW, 2007, MOL IMMUNOL, V44, P1544, DOI 10.1016/j.molimm.2006.08.020; Waldmann TA, 1998, CURR OPIN IMMUNOL, V10, P507, DOI 10.1016/S0952-7915(98)80215-X; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8	34	196	199	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					604	U125		10.1038/nm.2365	http://dx.doi.org/10.1038/nm.2365			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21532597	Green Accepted			2022-12-25	WOS:000290250400037
J	Dalerba, P; Kalisky, T; Sahoo, D; Rajendran, PS; Rothenberg, ME; Leyrat, AA; Sim, S; Okamoto, J; Johnston, DM; Qian, DL; Zabala, M; Bueno, J; Neff, NF; Wang, JB; Shelton, AA; Visser, B; Hisamori, S; Shimono, Y; van de Wetering, M; Clevers, H; Clarke, MF; Quake, SR				Dalerba, Piero; Kalisky, Tomer; Sahoo, Debashis; Rajendran, Pradeep S.; Rothenberg, Michael E.; Leyrat, Anne A.; Sim, Sopheak; Okamoto, Jennifer; Johnston, Darius M.; Qian, Dalong; Zabala, Maider; Bueno, Janet; Neff, Norma F.; Wang, Jianbin; Shelton, Andrew A.; Visser, Brendan; Hisamori, Shigeo; Shimono, Yohei; van de Wetering, Marc; Clevers, Hans; Clarke, Michael F.; Quake, Stephen R.			Single-cell dissection of transcriptional heterogeneity in human colon tumors	NATURE BIOTECHNOLOGY			English	Article							CANCER STEM-CELLS; GENE-EXPRESSION; DIFFERENTIATION; MARKER; PROGRESSION; EPITHELIUM; PHENOTYPE; EVOLUTION; ADENOMA; DISEASE	Cancer is often viewed as a caricature of normal developmental processes, but the extent to which its cellular heterogeneity truly recapitulates multilineage differentiation processes of normal tissues remains unknown. Here we implement single-cell PCR gene-expression analysis to dissect the cellular composition of primary human normal colon and colon cancer epithelia. We show that human colon cancer tissues contain distinct cell populations whose transcriptional identities mirror those of the different cellular lineages of normal colon. By creating monoclonal tumor xenografts from injection of a single (n = 1) cell, we demonstrate that the transcriptional diversity of cancer tissues is largely explained by in vivo multilineage differentiation and not only by clonal genetic heterogeneity. Finally, we show that the different gene-expression programs linked to multilineage differentiation are strongly associated with patient survival. We develop two-gene classifier systems (KRT20 versus CA1, MS4A12, CD177, SLC26A3) that predict clinical outcomes with hazard ratios superior to those of pathological grade and comparable to those of microarray-derived multigene expression signatures.	[Kalisky, Tomer; Leyrat, Anne A.; Okamoto, Jennifer; Johnston, Darius M.; Neff, Norma F.; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Dalerba, Piero; Clarke, Michael F.] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Dalerba, Piero; Sahoo, Debashis; Rajendran, Pradeep S.; Rothenberg, Michael E.; Sim, Sopheak; Johnston, Darius M.; Qian, Dalong; Zabala, Maider; Hisamori, Shigeo; Shimono, Yohei; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Rothenberg, Michael E.] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Okamoto, Jennifer; Johnston, Darius M.; Quake, Stephen R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bueno, Janet] Stanford Univ, Tissue Bank, Stanford, CA 94305 USA; [Shelton, Andrew A.; Visser, Brendan] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [van de Wetering, Marc; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mfclarke@stanford.edu; quake@stanford.edu	Wang, Jianbin/G-7533-2015; Dalerba, Piero/E-2543-2018	Wang, Jianbin/0000-0001-6725-7925; Dalerba, Piero/0000-0002-8815-4981; Shimono, Yohei/0000-0002-6256-4704	National Institutes of Health (NIH) [U54-CA126524, P01-CA139490, K99-CA151673]; Ludwig foundation; California Institute for Regenerative Medicine (CIRM); BD Biosciences Stem Cell Research Grant; Machiah Foundation; Department of Defense [W81XWH-10-1-0500]; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE [U54CA126524, P01CA139490, K99CA151673] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); BD Biosciences Stem Cell Research Grant; Machiah Foundation; Department of Defense(United States Department of Defense); Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health (NIH) grants U54-CA126524 and P01-CA139490 (to S. R. Q. and M. F. C.), the NIH Director's Pioneer Awards (to S. R. Q.) and a grant from the Ludwig foundation (to M. F. C.). P. D. was supported by a training grant from the California Institute for Regenerative Medicine (CIRM) and by a BD Biosciences Stem Cell Research Grant (Summer 2011). T. K. was supported by a fellowship from the Machiah Foundation. D. S. was supported by NIH grant K99-CA151673, by Department of Defense grant W81XWH-10-1-0500 and a grant from the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation. We wish to thank R. Tibshirani, D. Witten, L. Warren, R. A. White III, E. Gilbert, P. Lovelace, M. Palmor, C. Donkers and S. P. Miranda for helpful discussion and technical support in many moments during the completion of this study.	Bardia A, 2010, SEMIN ONCOL, V37, P39, DOI 10.1053/j.seminoncol.2009.12.005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Beider K, 2008, FRONT BIOSCI-LANDMRK, V13, P6820, DOI 10.2741/3190; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Dalerba P, 2005, CANCER RES, V65, P2321, DOI 10.1158/0008-5472.CAN-04-3678; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; DALLAFAVERA R, 1982, NATURE, V299, P61; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fischer Helene, 2001, BMC Physiology, V1, P1, DOI 10.1186/1472-6793-1-1; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Guastadisegni C, 2010, EUR J CANCER, V46, P2788, DOI 10.1016/j.ejca.2010.05.009; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jiao YF, 2008, ONCOLOGY-BASEL, V74, P127, DOI 10.1159/000151359; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Losi L, 2005, CARCINOGENESIS, V26, P916, DOI 10.1093/carcin/bgi044; Lugli A, 2008, MODERN PATHOL, V21, P1403, DOI 10.1038/modpathol.2008.117; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Oien KA, 2009, SEMIN ONCOL, V36, P8, DOI 10.1053/j.seminoncol.2008.10.009; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Prall F, 1996, J HISTOCHEM CYTOCHEM, V44, P35, DOI 10.1177/44.1.8543780; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Sahoo D, 2007, NUCLEIC ACIDS RES, V35, P3705, DOI 10.1093/nar/gkm284; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wang GP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn125; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	50	512	562	5	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1120	U11		10.1038/nbt.2038	http://dx.doi.org/10.1038/nbt.2038			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22081019	Green Accepted			2022-12-25	WOS:000298038700023
J	March, HN; Rust, AG; Wright, NA; ten Hoeve, J; de Ridder, J; Eldridge, M; van der Weyden, L; Berns, A; Gadiot, J; Uren, A; Kemp, R; Arends, MJ; Wessels, LFA; Winton, DJ; Adams, DJ				March, H. Nikki; Rust, Alistair G.; Wright, Nicholas A.; ten Hoeve, Jelle; de Ridder, Jeroen; Eldridge, Matthew; van der Weyden, Louise; Berns, Anton; Gadiot, Jules; Uren, Anthony; Kemp, Richard; Arends, Mark J.; Wessels, Lodewyk F. A.; Winton, Douglas J.; Adams, David J.			Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis	NATURE GENETICS			English	Article							COLORECTAL-CANCER; BETA-CATENIN; APC(MIN/+) MICE; GASTROINTESTINAL-TRACT; ADENOMA FORMATION; COLON-CANCER; APC GENE; MOUSE; WNT; PROGRESSION	The evolution of colorectal cancer suggests the involvement of many genes. To identify new drivers of intestinal cancer, we performed insertional mutagenesis using the Sleeping Beauty transposon system in mice carrying germline or somatic Apc mutations. By analyzing common insertion sites (CISs) isolated from 446 tumors, we identified many hundreds of candidate cancer drivers. Comparison to human data sets suggested that 234 CIS-targeted genes are also dysregulated in human colorectal cancers. In addition, we found 183 CIS-containing genes that are candidate Wnt targets and showed that 20 CISs-containing genes are newly discovered modifiers of canonical Wnt signaling. We also identified mutations associated with a subset of tumors containing an expanded number of Paneth cells, a hallmark of deregulated Wnt signaling, and genes associated with more severe dysplasia included those encoding members of the FGF signaling cascade. Some 70 genes had co-occurrence of CIS pairs, clustering into 38 sub-networks that may regulate tumor development.	[March, H. Nikki; Eldridge, Matthew; Kemp, Richard; Winton, Douglas J.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Rust, Alistair G.; van der Weyden, Louise; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge, England; [Wright, Nicholas A.] Canc Res UK, London Res Inst, Histopathol Unit, London, England; [ten Hoeve, Jelle; de Ridder, Jeroen; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Bioinformat & Stat Grp, Amsterdam, Netherlands; [de Ridder, Jeroen; Wessels, Lodewyk F. A.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Berns, Anton; Gadiot, Jules; Uren, Anthony] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England	Cancer Research UK; CRUK Cambridge Institute; Wellcome Trust Sanger Institute; Cancer Research UK; Netherlands Cancer Institute; Delft University of Technology; Netherlands Cancer Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Winton, DJ (corresponding author), Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England.	doug.winton@cancer.org.uk	Wright, Nicholas/HHY-7227-2022; Uren, Anthony G/A-5784-2009; van der Weyden, Louise/AAV-5711-2021	Uren, Anthony G/0000-0002-6019-7111; van der Weyden, Louise/0000-0002-0645-1879; de Ridder, Jeroen/0000-0002-0828-3477; Eldridge, Matthew/0000-0002-5799-8911; Rust, Alistair/0000-0001-7287-192X; Wright, Nicholas/0000-0002-5525-3457; Kemp, Richard/0000-0002-0121-7709; Adams, David/0000-0001-9490-0306	Cancer Research-UK; Wellcome Trust; Kay Kendall Leukemia Foundation; Netherlands Organization for Scientific Research (NWO); Netherlands Genomics Initiative; Netherlands Bioinformatics Centre through the Netherlands Genomics Initiative; Cancer Genomics Centre through the Netherlands Genomics Initiative; Medical Research Council [1116184, MC_UP_A652_1001] Funding Source: researchfish; MRC [MC_UP_A652_1001] Funding Source: UKRI	Cancer Research-UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Kay Kendall Leukemia Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; Netherlands Bioinformatics Centre through the Netherlands Genomics Initiative; Cancer Genomics Centre through the Netherlands Genomics Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Cambridge Research Institute core service Biological Resources and Histopathology, and the Sanger Institute sequencing services for their vital contributions to this study. We are grateful to V. Theodorou for critical reading of the manuscript. H.N.M., A.G.R., N.A.W., M.E., R.K., M.J.A., L.v.d.W., D.J.W. and D.J.A. are supported by Cancer Research-UK. D.J.A. is also supported by the Wellcome Trust and L.v.d.W. by the Kay Kendall Leukemia Foundation. A.G.U., L.W., J.t.H. and J.d.R. are supported by the Netherlands Organization for Scientific Research (NWO) Genomics program and the Netherlands Genomics Initiative. J.d.R. was also supported by the BioRange program of the Netherlands Bioinformatics Centre, which is supported by a BSIK grant through the Netherlands Genomics Initiative. A.U. is also supported by the Cancer Genomics Centre through the Netherlands Genomics Initiative.	Alberici P, 2007, AM J PATHOL, V170, P377, DOI 10.2353/ajpath.2007.060853; Albrethsen J, 2010, MOL CELL PROTEOMICS, V9, P988, DOI 10.1074/mcp.M900546-MCP200; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Ciccarelli FD, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-74; Ciznadija D, 2009, CELL DEATH DIFFER, V16, P1530, DOI 10.1038/cdd.2009.94; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, CANCER RES, V65, P9607, DOI 10.1158/0008-5472.CAN-05-3085; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Dopeso H, 2009, CANCER RES, V69, P7430, DOI 10.1158/0008-5472.CAN-09-0706; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Hung KE, 2009, CANCER PREV RES, V2, P224, DOI 10.1158/1940-6207.CAPR-08-0153; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Joo M, 2009, HUM PATHOL, V40, P872, DOI 10.1016/j.humpath.2008.12.003; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Kucherlapati MH, 2008, P NATL ACAD SCI USA, V105, P15493, DOI 10.1073/pnas.0802933105; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Luchtenborg M, 2004, CARCINOGENESIS, V25, P1219, DOI 10.1093/carcin/bgh117; McAlpine CA, 2006, INT J CANCER, V119, P2339, DOI 10.1002/ijc.22115; MILLER DG, 1980, CANCER, V46, P1307, DOI 10.1002/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Schinzel AC, 2008, FRONT BIOSCI-LANDMRK, V13, P71, DOI 10.2741/2661; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Segditsas S, 2009, ONCOGENE, V28, P146, DOI 10.1038/onc.2008.361; Shao J, 2007, CARCINOGENESIS, V28, P2476, DOI 10.1093/carcin/bgm186; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940	60	144	145	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1202	U55		10.1038/ng.990	http://dx.doi.org/10.1038/ng.990			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22057237	Green Submitted, Green Accepted			2022-12-25	WOS:000297931400012
J	O'Donnell, MA; Perez-Jimenez, E; Oberst, A; Ng, A; Massoumi, R; Xavier, R; Green, DR; Ting, AT				O'Donnell, Marie Anne; Perez-Jimenez, Eva; Oberst, Andrew; Ng, Aylwin; Massoumi, Ramin; Xavier, Ramnik; Green, Douglas R.; Ting, Adrian T.			Caspase 8 inhibits programmed necrosis by processing CYLD	NATURE CELL BIOLOGY			English	Article							RECEPTOR-INTERACTING PROTEIN; CELL-DEATH; APOPTOSIS; RIP1; REGULATOR; ALPHA; PHOSPHATIDYLSERINE; UBIQUITINATION; IDENTIFICATION; PHAGOCYTOSIS	Caspase 8 initiates apoptosis downstream of TNF death receptors by undergoing autocleavage and processing the executioner caspase 3 (ref. 1). However, the dominant function of caspase 8 is to transmit a pro-survival signal that suppresses programmed necrosis (or necroptosis) mediated by RIPK1 and RIPK3 (refs 2-6) during embryogenesis and haematopoiesis(7-9). Suppression of necrotic cell death by caspase 8 requires its catalytic activity but not the autocleavage essential for apoptosis(10); however, the key substrate processed by caspase 8 to block necrosis has been elusive. A key substrate must meet three criteria: it must be essential for programmed necrosis; it must be cleaved by caspase 8 in situations where caspase 8 is blocking necrosis; and mutation of the caspase 8 processing site on the substrate should convert a pro-survival response to necrotic death without the need for caspase 8 inhibition. We now identify CYLD as a substrate for caspase 8 that satisfies these criteria. Following TNF stimulation, caspase 8 cleaves CYLD to generate a survival signal. In contrast, loss of caspase 8 prevented CYLD degradation, resulting in necrotic death. A CYLD substitution mutation at Asp 215 that cannot be cleaved by caspase 8 switches cell survival to necrotic cell death in response to TNF.	[O'Donnell, Marie Anne; Perez-Jimenez, Eva; Ting, Adrian T.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Oberst, Andrew; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Ng, Aylwin; Xavier, Ramnik] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Massoumi, Ramin] Lund Univ, Dept Lab Med, Clin Res Ctr, SE-205 Malmo, Sweden	Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; Harvard University; Massachusetts General Hospital; Lund University	O'Donnell, MA (corresponding author), Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA.	marie.a.odonnell@mssm.edu; adrian.ting@mssm.edu	Green, Douglas R/N-8083-2018; Massoumi, Ramin/AAG-4786-2019; Ng, Aylwin/AAQ-6478-2020; Pérez-Jiménez, Eva/K-4345-2014	Green, Douglas R/0000-0002-7332-1417; Pérez-Jiménez, Eva/0000-0001-7076-9577	National Institutes of Health [AI052417, AI44828]; Crohn's and Colitis Foundation of America; Irma T. Hirschl Career Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044828, R01AI052417, R01AI044828, R56AI052417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Irma T. Hirschl Career Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to a number of colleagues for providing reagents used in these studies. We thank X. Wang (UT Southwestern, Dallas, Texas, USA) for his gift of SMAC mimetics and human RIPK3 antibody, M. Kelliher (UMASS, Worcester, Massachusetts, USA) for Ripk1<SUP>+/+</SUP> and Ripk1<SUP>-/-</SUP> MEFs, J. Chipuk (Mount Sinai School of Medicine, New York, USA) for suggesting the use of MCF7 cells and S. Aaronson (Mount Sinai School of Medicine, New York, USA) for providing these cells. This work was supported by National Institutes of Health grants AI052417 (A.T.T.) and AI44828 (D.R.G.). M.A.O'D. is a recipient of a Research Fellowship Award from the Crohn's and Colitis Foundation of America. A.T.T. is a recipient of the Irma T. Hirschl Career Scientist Award.	Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; He KL, 2003, EUR J IMMUNOL, V33, P1917, DOI 10.1002/eji.200323650; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; O'Donnell MA, 2011, FEBS J, V278, P877, DOI 10.1111/j.1742-4658.2011.08016.x; O'Donnell MA, 2010, CELL CYCLE, V9, P1065, DOI 10.4161/cc.9.6.10982; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Peter ME, 2011, NATURE, V471, P310, DOI 10.1038/471310a; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; van Delft MF, 2010, CELL DEATH DIFFER, V17, P821, DOI 10.1038/cdd.2009.166; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Waring P, 1999, CELL DEATH DIFFER, V6, P624, DOI 10.1038/sj.cdd.4400540; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	33	337	347	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2011	13	12					1437	U132		10.1038/ncb2362	http://dx.doi.org/10.1038/ncb2362			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	863JB	22037414	Green Accepted			2022-12-25	WOS:000298157500011
J	Pansuriya, TC; van Eijk, R; d'Adamo, P; van Ruler, MAJH; Kuijjer, ML; Oosting, J; Cleton-Jansen, AM; van Oosterwijk, JG; Verbeke, SLJ; Meijer, D; van Wezel, T; Nord, KH; Sangiorgi, L; Toker, B; Liegl-Atzwanger, B; San-Julian, M; Sciot, R; Limaye, N; Kindblom, LG; Daugaard, S; Godfraind, C; Boon, LM; Vikkula, M; Kurek, KC; Szuhai, K; French, PJ; Bovee, JVMG				Pansuriya, Twinkal C.; van Eijk, Ronald; d'Adamo, Pio; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Nord, Karolin H.; Sangiorgi, Luca; Toker, Berkin; Liegl-Atzwanger, Bernadette; San-Julian, Mikel; Sciot, Raf; Limaye, Nisha; Kindblom, Lars-Gunnar; Daugaard, Soeren; Godfraind, Catherine; Boon, Laurence M.; Vikkula, Miikka; Kurek, Kyle C.; Szuhai, Karoly; French, Pim J.; Bovee, Judith V. M. G.			Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome	NATURE GENETICS			English	Article							GENOME-WIDE ANALYSIS; ACTIVATING MUTATIONS; OSTERIX EXPRESSION; FIBROUS DYSPLASIA; IN-VITRO; CHONDROSARCOMA; LINE; DLX5; DIFFERENTIATION; ESTABLISHMENT	Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome). We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions). In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors. Fourteen of 16 subjects had identical mutations in separate lesions. Immunohistochemistry to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism. IDH1 mutations in cartilage tumors were associated with hypermethylation and downregulated expression of several genes. Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.	[Pansuriya, Twinkal C.; van Eijk, Ronald; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Bovee, Judith V. M. G.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [d'Adamo, Pio] Univ Trieste, Inst Maternal & Child Hlth, Inst Ricovero & Cura Carattere Sci, Trieste, Italy; [Verbeke, Sofie L. J.] Univ Antwerp Hosp, Dept Pathol, Antwerp, Belgium; [Nord, Karolin H.] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Sangiorgi, Luca] Rizzoli Orthoped Inst, Dept Med Genet, Bologna, Italy; [Toker, Berkin] Istanbul Univ, Sch Med, Istanbul, Turkey; [Liegl-Atzwanger, Bernadette] Med Univ, Inst Pathol, Graz, Austria; [San-Julian, Mikel] Univ Navarra Clin, Dept Orthopaed Surg & Traumatol, Pamplona, Spain; [Sciot, Raf; Boon, Laurence M.; Vikkula, Miikka] Katholieke Univ Leuven, Dept Pathol, Louvain, Belgium; [Limaye, Nisha] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Kindblom, Lars-Gunnar] Royal Orthopaed Hosp, Dept Musculoskeletal Pathol, Birmingham B31 2AP, W Midlands, England; [Daugaard, Soeren] Univ Copenhagen, Dept Pathol, Copenhagen, Denmark; [Godfraind, Catherine] Catholic Univ Louvain, Pathol Lab, Clin Univ St Luc, B-1200 Brussels, Belgium; [Boon, Laurence M.] Catholic Univ Louvain, Div Plast Surg, Clin Univ St Luc, Ctr Vasc Anomalies, B-1200 Brussels, Belgium; [Kurek, Kyle C.] Harvard Univ, Sch Med, Dept Pathol, Childrens Hosp Boston, Boston, MA 02115 USA; [Szuhai, Karoly] Leiden Univ, Dept Mol & Cell Biol, Med Ctr, Leiden, Netherlands; [French, Pim J.] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands; [Vikkula, Miikka] Catholic Univ Louvain, Walloon Excellence Lifesci & Biotechnol WELBIO, B-1200 Brussels, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Trieste; University of Antwerp; Lund University; Skane University Hospital; IRCCS Istituto Ortopedico Rizzoli; Istanbul University; Medical University of Graz; University of Navarra; KU Leuven; Universite Catholique Louvain; Royal Orthopaedic Hospital; University of Copenhagen; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Harvard University; Boston Children's Hospital; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Universite Catholique Louvain; WELBIO	Bovee, JVMG (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	J.V.M.G.Bovee@lumc.nl	van Wezel, Tom/A-9599-2008; Meijer, Danielle/AFL-5078-2022; van Wezel, Tom/AAL-5626-2021; kuijjer, marieke/AAG-5844-2019; van Wezel, Tom/Z-3092-2019; Boon, Laurence/HCI-3629-2022; Vikkula, Miikka/Q-1038-2018; d'Adamo, Adamo Pio/G-4064-2011; Sangiorgi, Luca/AHI-1694-2022; Szuhai, Karoly/A-1100-2008	van Wezel, Tom/0000-0001-5773-7730; kuijjer, marieke/0000-0001-6280-3130; van Wezel, Tom/0000-0001-5773-7730; Vikkula, Miikka/0000-0002-6236-338X; d'Adamo, Adamo Pio/0000-0001-9367-4909; Szuhai, Karoly/0000-0002-1228-4245; Hansen Nord, Karolin/0000-0002-2397-2254; Sangiorgi, Luca/0000-0003-3658-1209; sciot, raf/0000-0003-2244-5839; van Eijk, Ronald/0000-0001-7955-6295; French, Pim/0000-0002-0668-9529; Bovee, Judith/0000-0003-1155-0481; van Oosterwijk, Jolieke/0000-0003-2282-6121	Netherlands Organization for Scientific Research [917-76-315]; Liddy Shriver Sarcoma Initiative; Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network [6/05]; US National Institutes of Health [AR048564]; FNRS-Fonds de la Recherche Scientifique; Manton Center for Orphan Disease Research at Children's Hospital Boston [94824-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Liddy Shriver Sarcoma Initiative; Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network(Belgian Federal Science Policy Office); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FNRS-Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Manton Center for Orphan Disease Research at Children's Hospital Boston; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to all of the participants and their families for taking part in this study. We would like to thank S. Romeo and C.M.A. Reijnders for providing DNA from cartilage tumors. We are grateful to A.B. Mohseny for help with statistics, to D. van der Geest and T. Krenacs for constructing TMAs and to P. Wijers-Koster, D. de Jong, B. van den Akker, R. Duim, M. Winter, I.H. Briaire-de Bruijn and M.E. Bowen for expert technical assistance. C.J.F. Waaijer, P.C.W. Hogendoorn and C.E. de Andrea are acknowledged for fruitful discussion. We would like to acknowledge F. Bertoni, E.L. Staals and P. Bacchini for kindly providing peripheral dedifferentiated chondrosarcomas and vascular tumors, T. Kalinski for the C3842 cell line, M. Namba for the OUMS27 cell line, T. Ariizumi for the NDCS1 cell line and A. Llombart Bosch for the CH2879 cell line. J. Mulliken, J. Upton and S. Fishman kindly provided spindle cell hemangiomas. S.H.M. Verdegaal, A.H.M. Taminiau and M.A.J. van de Sande are acknowledged for contributing patient data. We are thankful to S. Boeuf, R. Forsyth and P.P. Mainil-Varlet for providing single Ollier disease cases and to W. Wutys for providing a single metachondromatosis case. The continuous support of the Netherlands Committee on Bone Tumors is highly acknowledged. The study was funded by The Netherlands Organization for Scientific Research (917-76-315 to J.V.M.G.B. and T.C.P.), the Liddy Shriver Sarcoma Initiative (to J.V.M.G.B. and J.O.), the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network 6/05, the US National Institutes of Health (AR048564) and the FNRS-Fonds de la Recherche Scientifique (all to M.V.) and the Manton Center for Orphan Disease Research at Children's Hospital Boston (94824-01 to K.K.). The study was performed within the EuroBoNeT, a European Commission-granted Network of Excellence for studying the pathology and genetics of bone tumors (018814).	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Bovee JVMG, 2010, P NATL ACAD SCI USA, V107, P1813, DOI 10.1073/pnas.0914431107; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Chin HJ, 2007, DEV GROWTH DIFFER, V49, P515, DOI 10.1111/j.1440-169x.2007.00940.x; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Cohen MM, 2001, AM J MED GENET, V98, P290, DOI 10.1002/1096-8628(20010201)98:4<290::AID-AJMG1112>3.0.CO;2-F; Collinson M, 2010, AM J MED GENET A, V152A, P3124, DOI 10.1002/ajmg.a.33567; Couvineau A, 2008, HUM MOL GENET, V17, P2766, DOI 10.1093/hmg/ddn176; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Andrea C.E., 2011, ONCOGENE        0801, DOI [10.1038/onc.2011.311, DOI 10.1038/ONC.2011.311]; de Andrea CE, 2011, J PATHOL, V224, P160, DOI 10.1002/path.2886; EVANS HL, 1977, CANCER-AM CANCER SOC, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gaal J, 2010, J CLIN ENDOCR METAB, V95, P1274, DOI 10.1210/jc.2009-2170; Gil-Benso R, 2003, LAB INVEST, V83, P877, DOI 10.1097/01.LAB.0000073131.34648.EA; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hemerly JP, 2010, EUR J ENDOCRINOL, V163, P747, DOI 10.1530/EJE-10-0473; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Ikota H, 2011, BRAIN TUMOR PATHOL, V28, P107, DOI 10.1007/s10014-010-0016-y; Jones KB, 2010, P NATL ACAD SCI USA, V107, P2054, DOI 10.1073/pnas.0910875107; Kalfa N, 2006, J CLIN ENDOCR METAB, V91, P1842, DOI 10.1210/jc.2005-2710; Kalinski T, 2005, VIRCHOWS ARCH, V446, P287, DOI 10.1007/s00428-004-1194-y; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kudo N, 2007, VIRCHOWS ARCH, V451, P691, DOI 10.1007/s00428-007-0426-3; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Leyva-Carmona M, 2009, J PEDIAT HEMATOL ONC, V31, P304, DOI 10.1097/MPH.0b013e318196a70e; Lietman SA, 2005, J BONE JOINT SURG AM, V87A, P2489, DOI 10.2106/JBJS.E.00160; LUCAS DR, 2002, WHO CLASSIFICATION T, P237; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Meijer D, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-5; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pansuriya TC, 2011, GENE CHROMOSOME CANC, V50, P673, DOI 10.1002/gcc.20889; Pansuriya TC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-2; Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ranger A, 2009, NEUROSURGERY, V65, P1106, DOI 10.1227/01.NEU.0000356984.92242.D5; Reijnders CMA, 2010, AM J PATHOL, V177, P1946, DOI 10.2353/ajpath.2010.100296; Rietveld L, 2009, INT J GYNECOL PATHOL, V28, P464, DOI 10.1097/PGP.0b013e3181a05af4; Rozeman LB, 2004, HUM MUTAT, V24, P466, DOI 10.1002/humu.20095; Rozeman LB, 2009, MODERN PATHOL, V22, P1489, DOI 10.1038/modpathol.2009.120; SCHWARTZ HS, 1987, J BONE JOINT SURG AM, V69A, P269, DOI 10.2106/00004623-198769020-00016; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; SPRANGER J, 1978, PEDIATR RADIOL, V7, P215, DOI 10.1007/BF02386711; Szuhai K, 2011, HUM MUTAT, V32, pE2036, DOI 10.1002/humu.21423; Thomas DM, 2011, J PATHOL, V224, P306, DOI 10.1002/path.2928; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Verbeke SLJ, 2011, HISTOPATHOLOGY, V58, P254, DOI 10.1111/j.1365-2559.2011.03750.x; Verdegaal S.H.M., 1961, ONCOLOGIST IN PRESS; Wolff JN, 2008, BIOTECHNIQUES, V44, P193, DOI 10.2144/000112719; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Zhu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008097	64	323	348	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1256	U124		10.1038/ng.1004	http://dx.doi.org/10.1038/ng.1004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22057234	Green Accepted, Green Submitted			2022-12-25	WOS:000297931400023
J	Robinson, DR; Kalyana-Sundaram, S; Wu, YM; Shankar, S; Cao, XH; Ateeq, B; Asangani, IA; Iyer, M; Maher, CA; Grasso, CS; Lonigro, RJ; Quist, M; Siddiqui, J; Mehra, R; Jing, XJ; Giordano, TJ; Sabel, MS; Kleer, CG; Palanisamy, N; Natrajan, R; Lambros, MB; Reis-Filho, JS; Kumar-Sinha, C; Chinnaiyan, AM				Robinson, Dan R.; Kalyana-Sundaram, Shanker; Wu, Yi-Mi; Shankar, Sunita; Cao, Xuhong; Ateeq, Bushra; Asangani, Irfan A.; Iyer, Matthew; Maher, Christopher A.; Grasso, Catherine S.; Lonigro, Robert J.; Quist, Michael; Siddiqui, Javed; Mehra, Rohit; Jing, Xiaojun; Giordano, Thomas J.; Sabel, Michael S.; Kleer, Celina G.; Palanisamy, Nallasivam; Natrajan, Rachael; Lambros, Maryou B.; Reis-Filho, Jorge S.; Kumar-Sinha, Chandan; Chinnaiyan, Arul M.			Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer	NATURE MEDICINE			English	Article							FUSIONS; ACTIVATION; EXPRESSION	Breast cancer is a heterogeneous disease that has a wide range of molecular aberrations and clinical outcomes. Here we used paired-end transcriptome sequencing to explore the landscape of gene fusions in a panel of breast cancer cell lines and tissues. We observed that individual breast cancers have a variety of expressed gene fusions. We identified two classes of recurrent gene rearrangements involving genes encoding microtubule-associated serine-threonine kinase (MAST) and members of the Notch family. Both MAST and Notch-family gene fusions have substantial phenotypic effects in breast epithelial cells. Breast cancer cell lines harboring Notch gene rearrangements are uniquely sensitive to inhibition of Notch signaling, and overexpression of MAST1 or MAST2 gene fusions has a proliferative effect both in vitro and in vivo. These findings show that recurrent gene rearrangements have key roles in subsets of carcinomas and suggest that transcriptome sequencing could identify individuals with rare, targetable gene fusions.	[Robinson, Dan R.; Kalyana-Sundaram, Shanker; Wu, Yi-Mi; Shankar, Sunita; Cao, Xuhong; Ateeq, Bushra; Asangani, Irfan A.; Iyer, Matthew; Maher, Christopher A.; Grasso, Catherine S.; Lonigro, Robert J.; Quist, Michael; Siddiqui, Javed; Mehra, Rohit; Jing, Xiaojun; Palanisamy, Nallasivam; Kumar-Sinha, Chandan; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan R.; Kalyana-Sundaram, Shanker; Wu, Yi-Mi; Shankar, Sunita; Cao, Xuhong; Ateeq, Bushra; Asangani, Irfan A.; Maher, Christopher A.; Grasso, Catherine S.; Lonigro, Robert J.; Quist, Michael; Siddiqui, Javed; Mehra, Rohit; Jing, Xiaojun; Giordano, Thomas J.; Kleer, Celina G.; Palanisamy, Nallasivam; Kumar-Sinha, Chandan; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kalyana-Sundaram, Shanker] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Iyer, Matthew; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Giordano, Thomas J.; Sabel, Michael S.; Kleer, Celina G.; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Sabel, Michael S.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Natrajan, Rachael; Lambros, Maryou B.; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Bharathidasan University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	chakumar@med.umich.edu; arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020	Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Kumar, Chandan/0000-0002-8696-3400; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Natrajan, Rachael/0000-0002-9987-2946; Giordano, Thomas/0000-0003-0641-8873; asangani, irfan/0000-0001-5381-1702	Department of Defense [W81XWH-08-0110]; American Association for Cancer Research [R01 CA125577]; National Functional Genomics Center [W81XWH-11-1-0520]; US National Institutes of Health through the University of Michigan's Cancer Center [5 P30 CA46592]; US National Cancer Institute's Early Detection Research Network [U01 CA111275]; Doris Duke Charitable Foundation; Burroughs Welcome Foundation; Breakthrough Breast Cancer; NATIONAL CANCER INSTITUTE [U01CA111275, R01CA125577, R00CA149182, P30CA046592] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); American Association for Cancer Research; National Functional Genomics Center; US National Institutes of Health through the University of Michigan's Cancer Center; US National Cancer Institute's Early Detection Research Network; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Welcome Foundation(Burroughs Wellcome Fund); Breakthrough Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Morey for high-throughput sequencing support; T. Barrette for hardware and database management; R. Wang, N. Consul, C. Malla, L. Ma, J. Milton, L. Cai and M. Mei for technical help; and K. Suleman and W. Yan for help with cytogenetic analysis. D. Appledorn from Essen Bioscience performed the IncuCyte analyses. The aims of this project were defined by the Department of Defense Breast Cancer Research Program (W81XWH-08-0110) to A.M.C. This project was supported in part by an American Association for Cancer Research Stand Up to Cancer (SU2C) award to A.M.C. and J.S.R.-F., grant R01 CA125577 to C.G.K. The National Functional Genomics Center (W81XWH-11-1-0520), which is supported by the Department of Defense (A.M.C.) and, in part, by the US National Institutes of Health through the University of Michigan's Cancer Center Support grant 5 P30 CA46592. A.M.C. is supported by the US National Cancer Institute's Early Detection Research Network (U01 CA111275), the Doris Duke Charitable Foundation Clinical Scientist Award and the Burroughs Welcome Foundation Award in Clinical Translational Research. R. N., M. B. L. and J.S.R.-F. are funded in part by Breakthrough Breast Cancer. A.M.C. is an American Cancer Society Research professor and Taubman Scholar. C.K.S. and A.M.C. share senior authorship.	DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Garland P, 2008, BRAIN RES, V1195, P12, DOI 10.1016/j.brainres.2007.12.027; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Ling H, 2010, ONCOGENE, V29, P4543, DOI 10.1038/onc.2010.186; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Prensner JR, 2009, CURR OPIN GENET DEV, V19, P82, DOI 10.1016/j.gde.2008.11.008; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	18	247	251	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1646	U163		10.1038/nm.2580	http://dx.doi.org/10.1038/nm.2580			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101766	Green Accepted			2022-12-25	WOS:000297978000037
J	Meerang, M; Ritz, D; Paliwal, S; Garajova, Z; Bosshard, M; Mailand, N; Janscak, P; Hubscher, U; Meyer, H; Ramadan, K				Meerang, Mayura; Ritz, Danilo; Paliwal, Shreya; Garajova, Zuzana; Bosshard, Matthias; Mailand, Niels; Janscak, Pavel; Huebscher, Ulrich; Meyer, Hemmo; Ramadan, Kristijan			The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks	NATURE CELL BIOLOGY			English	Article							DAMAGE RESPONSE; ENDOPLASMIC-RETICULUM; REPAIR PROTEINS; REPLICATION; CDC48/P97; COMPLEX; LIGASE; CELLS; DISEASE; RNF8	Unrepaired DNA double-strand breaks (DSBs) cause genetic instability that leads to malignant transformation or cell death(1). Cells respond to DSBs with the ordered recruitment of signalling and repair proteins to the site of lesion(2,3). Protein modification with ubiquitin is crucial for the signalling cascade, but how ubiquitylation coordinates the dynamic assembly of these complexes is poorly understood(4-7). Here, we show that the human ubiquitin-selective protein segregase p97 (also known as VCP; valosin-containing protein) cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signalling complexes and efficient DSB repair after exposure to ionizing radiation. p97 is recruited to DNA lesions by its ubiquitin adaptor UFD1-NPL4 and Lys-48-linked ubiquitin (K48-Ub) chains, whose formation is regulated by RNF8. p97 subsequently removes K48-Ub conjugates from sites of DNA damage to orchestrate proper association of 53BP1, BRCA1 and RAD51, three factors critical for DNA repair and genome surveillance mechanisms(3,7,8). Impairment of p97 activity decreases the level of DSB repair and cell survival after exposure to ionizing radiation. These findings identify the p97-UFD1-NPL4 complex as an essential factor inubiquitin-governed DNA-damage response, highlighting its importance in guarding genome stability.	[Ritz, Danilo; Meyer, Hemmo] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, D-45117 Essen, Germany; [Meerang, Mayura; Garajova, Zuzana; Ramadan, Kristijan] Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Meerang, Mayura; Bosshard, Matthias; Huebscher, Ulrich] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Ritz, Danilo; Meyer, Hemmo] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Paliwal, Shreya; Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Mailand, Niels] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Biol, Ubiquitin Signaling Grp, DK-2200 Copenhagen, Denmark	University of Duisburg Essen; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Copenhagen	Meyer, H (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, D-45117 Essen, Germany.	hemmo.meyer@uni-due.de; kristijan.ramadan@vetpharm.uzh.ch	Janscak, Pavel/G-6189-2014; Janscak, Pavel/Q-3795-2018; Meyer, Hemmo/GNH-5784-2022	Janscak, Pavel/0000-0002-1748-7789; Meyer, Hemmo/0000-0003-1883-1796; Meerang, Mayura/0000-0002-5546-3120	University of Zurich [55100203]; Novartis Stiftung fur Biologisch-Medizinische Forschung [09B48]; Swiss National Research Foundation; Oncosuisse grant	University of Zurich; Novartis Stiftung fur Biologisch-Medizinische Forschung; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Oncosuisse grant	We thank C.C. Weihl (Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri, USA) for providing stable transfected U2OS cell lines, J. Stark (Department of Radiation Biology, Beckman Research Institute of City of Hope, Duarte, California, USA) for EJ5-GFP and DR-GFP HEK293 cell lines, J. Lukas (Centre for Genotoxic Stress Research, Institute of Cancer Biology and Danish Cancer Society, Strandboulevarden, Copenhagen, Denmark) for the RNF8-Flag construct, L. Penengo (Laboratory of Molecular Biology, DiSCAFF Department, Novara, Italy) for the RNF168-Flag construct, H. Ploegh (Whitehead Institute for Biomedical Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA) for the SEL1L antibody and Genentech for the K63-Ub and K48-Ub antibodies. We thank T. Ramadan, H. Nageli, M. Stucki and A. Sartori for critical reading of the manuscript, M. Lopes and K. Neelsen for help with establishing the mPFGE method, B. Mihaljevic for help with establishing the laser micro-irradiation method and M. Vitanescu for technical assistance. This work was supported by the 'Forschungskredit' (55100203) of the University of Zurich to K.R., Novartis Stiftung fur Biologisch-Medizinische Forschung (09B48) to K.R. for M.M., the Swiss National Research Foundation to H. M. and P. J. and an Oncosuisse grant to U.H. This project was initiated at the Institute of Veterinary Biochemistry and Molecular Biology by K.R. We also thank the Center for Microscopy and Image Analysis of the University of Zurich-Irchel, for providing the confocal microscope and their assistance with image analysis.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer H, 2008, BIOCHEM SOC T, V36, P126, DOI 10.1042/BST0360126; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Ramadan K, 2011, FEBS LETT, V585, P2868, DOI 10.1016/j.febslet.2011.04.046; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang HT, 2000, DNA CELL BIOL, V19, P253, DOI 10.1089/10445490050021168	46	189	195	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2011	13	11					1376	U204		10.1038/ncb2367	http://dx.doi.org/10.1038/ncb2367			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	844HI	22020440				2022-12-25	WOS:000296737900015
J	Muellner, MK; Uras, IZ; Gapp, BV; Kerzendorfer, C; Smida, M; Lechtermann, H; Craig-Mueller, N; Colinge, J; Duernberger, G; Nijman, SMB				Muellner, Markus K.; Uras, Iris Z.; Gapp, Bianca V.; Kerzendorfer, Claudia; Smida, Michal; Lechtermann, Hannelore; Craig-Mueller, Nils; Colinge, Jacques; Duernberger, Gerhard; Nijman, Sebastian M. B.			A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer	NATURE CHEMICAL BIOLOGY			English	Article							DUAL PI3K/MTOR INHIBITOR; BREAST-CANCER; C-MYC; DRUG-RESISTANCE; NOTCH1; NVP-BEZ235; THERAPY; GENOME; TARGET; CELLS	Linking the molecular aberrations of cancer to drug responses could guide treatment choice and identify new therapeutic applications. However, there has been no systematic approach for analyzing gene-drug interactions in human cells. Here we establish a multiplexed assay to study the cellular fitness of a panel of engineered isogenic cancer cells in response to a collection of drugs, enabling the systematic analysis of thousands of gene-drug interactions. Applying this approach to breast cancer revealed various synthetic-lethal interactions and drug-resistance mechanisms, some of which were known, thereby validating the method. NOTCH pathway activation, which occurs frequently in breast cancer, unexpectedly conferred resistance to phosphoinositide 3-kinase (PI3K) inhibitors, which are currently undergoing clinical trials in breast cancer patients. NOTCH1 and downstream induction of c-MYC over-rode the dependency of cells on the PI3K-mTOR pathway for proliferation. These data reveal a new mechanism of resistance to PI3K inhibitors with direct clinical implications.	[Muellner, Markus K.; Uras, Iris Z.; Gapp, Bianca V.; Kerzendorfer, Claudia; Smida, Michal; Lechtermann, Hannelore; Craig-Mueller, Nils; Colinge, Jacques; Duernberger, Gerhard; Nijman, Sebastian M. B.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Nijman, SMB (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	snijman@cemm.oeaw.ac.at	Uras, Iris/AAH-2221-2021; Colinge, Jacques/Z-2613-2019; Smida, Michal/J-5046-2014; Colinge, Jacques/D-1578-2017	Colinge, Jacques/0000-0003-2466-4824; Smida, Michal/0000-0002-7335-3435; Colinge, Jacques/0000-0003-2466-4824; Uras, Iris/0000-0002-2434-2756; Nijman, Sebastian/0000-0003-0464-6661	Austrian Science Fund (FWF) [P21768-B13]; Vienna Science and Technology Fund (WWTF) [LS09-009]; Austrian Science Fund (FWF) [P 21768] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the T. Berg, A. Harutyunyan, U. Rix and G. Hofbauer for technical assistance; F. Ganglberger, B. Eizinger and P. Markt for assisting in data analysis; and H. Pickersgill, M. Creyghton and G. Superti-Furga for critical reading and suggestions. We are grateful to T. Golub and C. Yu for support and discussions in the early phases of the project; and to A. D'Andrea, H. Dolznig, C. Tabin, T. Brummelkamp, R. Bernards, P. Eichhorn, D. Peeper, W. Hahn, R. Conaway, J. Conaway, R. Weinberg, I. Screpanti, J. Zhao, R. Hynes, Y. Xiong, R. Basch, B. Vogelstein, D. Bulavin, P. Yaswen, R. Kopan, M. Parker, J. Bradner and D. Root for providing reagents. We thank Luminex for providing reagents and support. This work was made possible by research grants from the Austrian Science Fund (FWF, P21768-B13) and the Vienna Science and Technology Fund (WWTF, LS09-009).	Bernards R, 2010, CELL, V141, P13, DOI 10.1016/j.cell.2010.03.018; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Iavarone A, 1997, NATURE, V387, P417; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nijman SMB, 2011, FEBS LETT, V585, P1, DOI 10.1016/j.febslet.2010.11.024; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reinhardt HC, 2009, CELL CYCLE, V8, P3112, DOI 10.4161/cc.8.19.9626; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107	43	123	128	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					787	793		10.1038/nchembio.695	http://dx.doi.org/10.1038/nchembio.695			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946274	Green Accepted			2022-12-25	WOS:000296381600008
J	White, TR; Renzelman, CM; Rand, AC; Rezai, T; McEwen, CM; Gelev, VM; Turner, RA; Linington, RG; Leung, SSF; Kalgutkar, AS; Bauman, JN; Zhang, YZ; Liras, S; Price, DA; Mathiowetz, AM; Jacobson, MP; Lokey, RS				White, Tina R.; Renzelman, Chad M.; Rand, Arthur C.; Rezai, Taha; McEwen, Cayla M.; Gelev, Vladimir M.; Turner, Rushia A.; Linington, Roger G.; Leung, Siegfried S. F.; Kalgutkar, Amit S.; Bauman, Jonathan N.; Zhang, Yizhong; Liras, Spiros; Price, David A.; Mathiowetz, Alan M.; Jacobson, Matthew P.; Lokey, R. Scott			On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds	NATURE CHEMICAL BIOLOGY			English	Article							PASSIVE MEMBRANE-PERMEABILITY; HYDROGEN-BOND; RGD PEPTIDES; CONFORMATION; PREDICTION; PERMEATION; CRYSTAL; CACO-2; SOMATOSTATIN; LIBRARIES	Backbone N-methylation is common among peptide natural products and has a substantial impact on both the physical properties and the conformational states of cyclic peptides. However, the specific impact of N-methylation on passive membrane diffusion in cyclic peptides has not been investigated systematically. Here we report a method for the selective, on-resin N-methylation of cyclic peptides to generate compounds with drug-like membrane permeability and oral bioavailability. The selectivity and degree of N-methylation of the cyclic peptide was dependent on backbone stereochemistry, suggesting that conformation dictates the regiochemistry of the N-methylation reaction. The permeabilities of the N-methyl variants were corroborated by computational studies on a 1,024-member virtual library of N-methyl cyclic peptides. One of the most permeable compounds, a cyclic hexapeptide (molecular mass = 755 Da) with three N-methyl groups, showed an oral bioavailability of 28% in rat.	[White, Tina R.; Renzelman, Chad M.; Rand, Arthur C.; Rezai, Taha; McEwen, Cayla M.; Turner, Rushia A.; Linington, Roger G.; Lokey, R. Scott] Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA; [Gelev, Vladimir M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Leung, Siegfried S. F.; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Kalgutkar, Amit S.; Bauman, Jonathan N.; Zhang, Yizhong] Pfizer Inc, Pharmacokinet & Drug Metab, Groton, CT 06340 USA; [Liras, Spiros; Price, David A.; Mathiowetz, Alan M.] Pfizer Inc, Worldwide Med Chem, Groton, CT 06340 USA	University of California System; University of California Santa Cruz; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Francisco; Pfizer; Pfizer	Lokey, RS (corresponding author), Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA.	matt.Jacobson@ucsf.edu; slokey@ucsc.edu	Jacobson, Matthew/Y-5161-2018; Linington, Roger/ABD-5582-2021	Jacobson, Matthew/0000-0001-6262-655X; Linington, Roger/0000-0003-1818-4971	US National Institutes of Health [GM084530-06, R01-GM086602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086602, R01GM084530] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The synthesis and analytical results were supported by US National Institutes of Health grant GM084530-06 (R.S.L.). The computational results were supported by US National Institutes of Health grant R01-GM086602 to M.P.J. M.P.J. is a consultant to Schrodinger LLC. Cell-based assays and in vivo pharmacokinetics were provided by Pfizer.	Ashwood VA, 2001, J MED CHEM, V44, P2276, DOI 10.1021/jm010825z; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; Bermejo M, 2004, EUR J PHARM SCI, V21, P429, DOI 10.1016/j.ejps.2003.10.009; Biron E, 2008, ANGEW CHEM INT EDIT, V47, P2595, DOI 10.1002/anie.200705797; Boguslavsky V, 2003, J PEPT RES, V61, P287, DOI 10.1034/j.1399-3011.2003.00047.x; Chatterjee J, 2008, ACCOUNTS CHEM RES, V41, P1331, DOI 10.1021/ar8000603; Davies JS, 2003, J PEPT SCI, V9, P471, DOI 10.1002/psc.491; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Doedens L, 2010, J AM CHEM SOC, V132, P8115, DOI 10.1021/ja101428m; Dorner B, 1997, ADV AMIN AC MIM PEPT, V1, P109; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Fujikawa M, 2005, BIOORGAN MED CHEM, V13, P4721, DOI 10.1016/j.bmc.2005.04.076; Fukushima K, 2008, BIOL PHARM BULL, V31, P1209, DOI 10.1248/bpb.31.1209; Fukushima K, 2009, BIOMED PHARMACOTHER, V63, P635, DOI 10.1016/j.biopha.2009.01.008; Gudmundsson OS, 1999, J PEPT RES, V53, P383, DOI 10.1034/j.1399-3011.1999.00076.x; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; Houghten RA, 1996, MOL DIVERS, V2, P41, DOI 10.1007/BF01718699; Hwang KK, 2003, J PHARM PHARM SCI, V6, P315; In Y, 1999, J PEPT RES, V53, P492, DOI 10.1034/j.1399-3011.1999.00046.x; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jin Mingji, 2005, Drug Metab Pharmacokinet, V20, P324, DOI 10.2133/dmpk.20.324; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; Kim YK, 2004, J AM CHEM SOC, V126, P14740, DOI 10.1021/ja048170p; Knipp GT, 1997, PHARMACEUT RES, V14, P1332, DOI 10.1023/A:1012152117703; LOOSLI HR, 1985, HELV CHIM ACTA, V68, P682, DOI 10.1002/hlca.19850680319; Miller SC, 1997, J AM CHEM SOC, V119, P2301, DOI 10.1021/ja9635443; Ovadia O, 2011, MOL PHARMACEUT, V8, P479, DOI 10.1021/mp1003306; Rezai T, 2006, J AM CHEM SOC, V128, P2510, DOI 10.1021/ja0563455; Rezai T, 2006, J AM CHEM SOC, V128, P14073, DOI 10.1021/ja063076p; Steffel LR, 2007, J AM CHEM SOC, V129, P12956, DOI 10.1021/ja076185s; STEINER JR, 1988, INT J PEPT PROT RES, V31, P212; VEBER DF, 1981, NATURE, V292, P55, DOI 10.1038/292055a0	32	259	272	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					810	817		10.1038/nchembio.664	http://dx.doi.org/10.1038/nchembio.664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946276	Green Accepted, Green Submitted			2022-12-25	WOS:000296381600011
J	Hope, TJ				Hope, Thomas J.			To neutralize or not, a key HIV vaccine question	NATURE MEDICINE			English	Editorial Material							BROAD; PROTECTION; ANTIBODIES; INFECTION		Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL USA	Northwestern University	Hope, TJ (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL USA.	thope@northwestern.edu						Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; WALKER LM, 2011, NATURE          0817, DOI DOI 10.1038/NATURE10373; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	14	28	28	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1195	1197		10.1038/nm.2528	http://dx.doi.org/10.1038/nm.2528			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21988997				2022-12-25	WOS:000296022100032
J	Chen, T; Ozel, D; Qiao, Y; Harbinski, F; Chen, LM; Denoyelle, S; He, XY; Zvereva, N; Supko, JG; Chorev, M; Halperin, JA; Aktas, BH				Chen, Ting; Ozel, Duygu; Qiao, Yuan; Harbinski, Fred; Chen, Limo; Denoyelle, Severine; He, Xiaoying; Zvereva, Nela; Supko, Jeffrey G.; Chorev, Michael; Halperin, Jose A.; Aktas, Bertal H.			Chemical genetics identify eIF2 alpha kinase heme-regulated inhibitor as an anticancer target	NATURE CHEMICAL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INITIATION-FACTORS; PROTEIN-KINASE; TRANSLATIONAL CONTROL; EXPRESSION; CELLS; PERK; ACTIVATION; DEPLETION; PKR	Translation initiation plays a critical role in cellular homeostasis, proliferation, differentiation and malignant transformation. Consistently, increasing the abundance of the eIF2-GTP-tRNA(i)(Met) translation initiation complex transforms normal cells and contributes to cancer initiation and the severity of some anemias. The chemical modifiers of the eIF2-GTP-tRNA(i)(Met) ternary complex are therefore invaluable tools for studying its role in the pathobiology of human disorders and for determining whether this complex can be pharmacologically targeted for therapeutic purposes. Using a cell-based assay, we identified N,N'-diarylureas as unique inhibitors of ternary complex accumulation. Direct functional-genetic and biochemical evidence demonstrated that the N,N'-diarylureas activate heme-regulated inhibitor kinase, thereby phosphorylating eIF2 alpha and reducing the abundance of the ternary complex. Using tumor cell proliferation in vitro and tumor growth in vivo as paradigms, we demonstrate that N,N'-diarylureas are potent and specific tools for studying the role of eIF2-GTP-tRNA(i)(Met) ternary complex in the pathobiology of human disorders.	[Chen, Ting; Ozel, Duygu; Qiao, Yuan; Harbinski, Fred; Chen, Limo; Denoyelle, Severine; Chorev, Michael; Halperin, Jose A.; Aktas, Bertal H.] Harvard Univ, Sch Med, Lab Translat Res, Boston, MA 02115 USA; [He, Xiaoying; Zvereva, Nela; Supko, Jeffrey G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Chorev, Michael; Halperin, Jose A.; Aktas, Bertal H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Chen, T (corresponding author), Harvard Univ, Sch Med, Lab Translat Res, Boston, MA 02115 USA.	huseyin_aktas@hms.harvard.edu	Chen, Ting/A-2124-2012	Chen, Ting/0000-0003-1725-7956	NIH [NCDDG 5 U19 CA87427]; Susan B. Komen Foundation for Cancer Research [BCTR0707713]; US Department of Defense [W81ZWH-05-1-0096]; US National Institutes of Health [R21AG032546]; NATIONAL CANCER INSTITUTE [U19CA087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan B. Komen Foundation for Cancer Research(Susan G. Komen Breast Cancer Foundation); US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.C. Tosteson (Harvard Medical School), mentor and role model to authors, for encouragement; J.J. Chen for providing the HRI expression plasmid; and M. Tosteson for critical comments on the manuscript. This work was supported in part by NIH grant NCDDG 5 U19 CA87427 to J.A.H., Susan B. Komen Foundation for Cancer Research grant BCTR0707713, US Department of Defense grant no. W81ZWH-05-1-0096 and US National Institutes of Health grant no. R21AG032546 to B.H.A.	Abraham N, 1998, EXP CELL RES, V244, P394, DOI 10.1006/excr.1998.4201; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Biason-Lauber A, 2002, DIABETES, V51, P2301, DOI 10.2337/diabetes.51.7.2301; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Han AP, 2005, J CLIN INVEST, V115, P1562, DOI 10.1172/JCI24141; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Heaney JD, 2009, HUM MOL GENET, V18, P1395, DOI 10.1093/hmg/ddp045; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; KOROMILAS AE, 1995, J BIOL CHEM, V270, P25426, DOI 10.1074/jbc.270.43.25426; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marbach I, 2001, J BIOL CHEM, V276, P16944, DOI 10.1074/jbc.M100383200; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Palakurthi SS, 2001, CANCER RES, V61, P6213; PROSTKO CR, 1995, J BIOL CHEM, V270, P6211, DOI 10.1074/jbc.270.11.6211; Ranganathan AC, 2008, CANCER RES, V68, P3260, DOI 10.1158/0008-5472.CAN-07-6215; Rosenwald IB, 2003, CANCER-AM CANCER SOC, V98, P1080, DOI 10.1002/cncr.11619; Rosenwald IB, 2008, HUM PATHOL, V39, P910, DOI 10.1016/j.humpath.2007.10.021; ROSENWALD LB, 2001, CANCER, V92, P2164; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Skalnikova H, 2008, PROTEOMICS, V8, P4547, DOI 10.1002/pmic.200800096; SRIVASTAVA SP, 1995, J BIOL CHEM, V270, P16619, DOI 10.1074/jbc.270.28.16619; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ziegeler G, 2010, J BIOL CHEM, V285, P15408, DOI 10.1074/jbc.M110.113365	42	74	80	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					610	616		10.1038/NCHEMBIO.613	http://dx.doi.org/10.1038/NCHEMBIO.613			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21765405	Green Accepted, Green Submitted			2022-12-25	WOS:000294381400011
J	Tang, C; Lee, AS; Volkmer, JP; Sahoo, D; Nag, D; Mosley, AR; Inlay, MA; Ardehali, R; Chavez, SL; Pera, RR; Behr, B; Wu, JC; Weissman, IL; Drukker, M				Tang, Chad; Lee, Andrew S.; Volkmer, Jens-Peter; Sahoo, Debashis; Nag, Divya; Mosley, Adriane R.; Inlay, Matthew A.; Ardehali, Reza; Chavez, Shawn L.; Pera, Renee Reijo; Behr, Barry; Wu, Joseph C.; Weissman, Irving L.; Drukker, Micha			An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells	NATURE BIOTECHNOLOGY			English	Article							MONOCLONAL-ANTIBODY; CYTOTOXIC ANTIBODY; DIFFERENTIATION; ANTIGENS; STAGE; SURFACE; LINES; GLYCOSPHINGOLIPIDS; EXPRESSION; SERIES	An important risk in the clinical application of human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), is teratoma formation by residual undifferentiated cells. We raised a monoclonal antibody against hESCs, designated anti-stage-specific embryonic antigen (SSEA)-5, which binds a previously unidentified antigen highly and specifically expressed on hPSCs-the H type-1 glycan. Separation based on SSEA-5 expression through fluorescence-activated cell sorting (FACS) greatly reduced teratoma-formation potential of heterogeneously differentiated cultures. To ensure complete removal of teratoma-forming cells, we identified additional pluripotency surface markers (PSMs) exhibiting a large dynamic expression range during differentiation: CD9, CD30, CD50, CD90 and CD200. Immunohistochemistry studies of human fetal tissues and bioinformatics analysis of a microarray database revealed that concurrent expression of these markers is both common and specific to hPSCs. Immunodepletion with antibodies against SSEA-5 and two additional PSMs completely removed teratoma-formation potential from incompletely differentiated hESC cultures.	[Tang, Chad; Volkmer, Jens-Peter; Sahoo, Debashis; Mosley, Adriane R.; Inlay, Matthew A.; Ardehali, Reza; Chavez, Shawn L.; Pera, Renee Reijo; Weissman, Irving L.; Drukker, Micha] Stanford Univ Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Lee, Andrew S.; Nag, Divya; Wu, Joseph C.] Stanford Univ Sch Med, Dept Radiol, Div Cardiol, Stanford, CA USA; [Lee, Andrew S.; Nag, Divya; Wu, Joseph C.] Stanford Univ Sch Med, Dept Med, Div Cardiol, Stanford, CA USA; [Volkmer, Jens-Peter] Univ Duesseldorf, Dept Urol, Dusseldorf, Germany; [Behr, Barry] Stanford Univ Sch Med, Dept Gynecol & Obstet, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Drukker, M (corresponding author), Stanford Univ Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA.	irv@stanford.edu; dmicha@stanford.edu	Chavez, Shawn L./ABF-6125-2021; Lee, Andrew/GVU-2817-2022; Wu, Joseph/H-1067-2013	Chavez, Shawn L./0000-0002-8285-0222; Drukker, Micha/0000-0002-4279-1125; Wu, Joseph/0000-0002-6068-8041	California Institute of Regenerative Medicine (CIRM) [RC1-00354-1]; Stanford Medical Scholars Program; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Stanford Medical Scholars Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge C.Contag for providing luciferase constructs, M. van de Rijn and K. Montgomery for their assistance scanning fetal array slides and providing online access to these slides, P. Chu for assistance with hematoxylin and eosin staining, C. Muscat and T. Naik for assistance with hybridoma culture, W. Zhang for assistance in cell culturing, the Consortium for Functional Glycomics for providing and testing glycan arrays, and T. Serwold and C. Bertozzi for critical advice. This work was supported by funds provided by the California Institute of Regenerative Medicine (CIRM) (Comprehensive grant RC1-00354-1). C.T. and A.S.L. are supported by the Howard Hughes Medical Institute Medical Fellows and the Stanford Medical Scholars Program, J.-P.V. is supported by the Deutsche Forschungsgemeinschaft, C.T., M.A.I., R.A. and M.D. are supported by CIRM (Comprehensive grant RC1-00354-1).	ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Behr B, 2000, J ASSIST REPROD GEN, V17, P349, DOI 10.1023/A:1009461213139; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Cao F, 2007, CLONING STEM CELLS, V9, P107, DOI 10.1089/clo.2006.0E16; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Drukker Micha, 2007, V407, P63, DOI 10.1007/978-1-59745-536-7_6; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Mateizel I, 2009, HUM REPROD, V24, P2477, DOI 10.1093/humrep/dep234; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Raman R, 2006, GLYCOBIOLOGY, V16, p82R, DOI 10.1093/glycob/cwj080; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Sahoo D, 2010, P NATL ACAD SCI USA, V107, P5732, DOI 10.1073/pnas.0913635107; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TORRADO J, 1990, TISSUE ANTIGENS, V36, P8, DOI 10.1111/j.1399-0039.1990.tb01791.x; VODYANIK MA, 2007, CURR PROTOC CELL BIO, V36; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	32	282	301	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					829	U86		10.1038/nbt.1947	http://dx.doi.org/10.1038/nbt.1947			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21841799	Green Accepted			2022-12-25	WOS:000294718400024
J	Best, T; Li, DL; Skol, AD; Kirchhoff, T; Jackson, SA; Yasui, Y; Bhatia, S; Strong, LC; Domchek, SM; Nathanson, KL; Olopade, OI; Huang, RS; Mack, TM; Conti, DV; Offit, K; Cozen, W; Robison, LL; Onel, K				Best, Timothy; Li, Dalin; Skol, Andrew D.; Kirchhoff, Tomas; Jackson, Sarah A.; Yasui, Yutaka; Bhatia, Smita; Strong, Louise C.; Domchek, Susan M.; Nathanson, Katherine L.; Olopade, Olufunmilayo I.; Huang, R. Stephanie; Mack, Thomas M.; Conti, David V.; Offit, Kenneth; Cozen, Wendy; Robison, Leslie L.; Onel, Kenan			Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma	NATURE MEDICINE			English	Article							CHILDHOOD-CANCER SURVIVOR; WIDE ASSOCIATION; 5-YEAR SURVIVORS; CELL LYMPHOMA; NEOPLASMS; DISEASE; CHEMOTHERAPY; RADIATION; BLIMP1; RISK	Survivors of pediatric Hodgkin's lymphoma are at risk for radiation therapy-induced second malignant neoplasms (SMNs). We identified two variants at chromosome 6q21 associated with SMNs in survivors of Hodgkin's lymphoma treated with radiation therapy as children but not as adults. The variants comprise a risk locus associated with decreased basal expression of PRDM1 (encoding PR domain containing 1, with ZNF domain) and impaired induction of the PRDM1 protein after radiation exposure. These data suggest a new gene-exposure interaction that may implicate PRDM1 in the etiology of radiation therapy-induced SMNs.	[Best, Timothy; Onel, Kenan] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Li, Dalin; Mack, Thomas M.; Conti, David V.; Cozen, Wendy] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Li, Dalin; Mack, Thomas M.; Conti, David V.; Cozen, Wendy] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Skol, Andrew D.; Jackson, Sarah A.; Olopade, Olufunmilayo I.; Huang, R. Stephanie] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kirchhoff, Tomas; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Yasui, Yutaka] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Bhatia, Smita] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Domchek, Susan M.; Nathanson, Katherine L.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Mack, Thomas M.; Cozen, Wendy] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Robison, Leslie L.] St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Onel, Kenan] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Southern California; University of Southern California; University of Chicago; Memorial Sloan Kettering Cancer Center; University of Alberta; City of Hope; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Southern California; St Jude Children's Research Hospital; University of Chicago	Onel, K (corresponding author), Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA.	konel@uchicago.edu	Li, Dalin/F-4266-2011; Robison, Leslie/N-8122-2018; Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638; Huang, R. Stephanie/0000-0002-9862-0368; Nathanson, Katherine/0000-0002-6740-0901; Kirchhoff, Tomas/0000-0002-9055-2364	US National Institutes of Health [HD0433871, CA129045, CA40046, CA55727, GM089941, CA139278, CA58839, CA110836]; US National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents [U01GM61393, N01-PC-35139]; US Army Medical Research and Materiel Command (Department of Defense) [PR054600]; Department of Defense DAMD [17-097-1-7147]; American Cancer Society-Illinois Division; American Lebanese Syrian Associated Charities; Leukemia Lymphoma Society [TR 6137-07, TR 6202-09]; Breast Cancer Research Foundation; Lymphoma Foundation; Robert and Kate Niehaus Research Fund; University of Chicago Cancer Center [P30 CA14599]; Breast Cancer Specialized Program; Cancer Research Foundation; California Department of Health Services; NATIONAL CANCER INSTITUTE [P01CA040046, U01CA055727, U24CA055727, R01CA058839, R21CA129045, R03CA110836, P30CA014599, R21CA139278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, K08GM089941] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Materiel Command (Department of Defense)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Department of Defense DAMD(United States Department of Defense); American Cancer Society-Illinois Division(American Cancer Society); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Breast Cancer Research Foundation; Lymphoma Foundation; Robert and Kate Niehaus Research Fund; University of Chicago Cancer Center(University of Chicago); Breast Cancer Specialized Program; Cancer Research Foundation; California Department of Health Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health (HD0433871, CA129045 and CA40046 to K. Onel, CA55727 to L. L. R., GM089941 and CA139278 to R. S. H., CA58839 to T. M. M. and CA110836 to W. C.); US National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents grant U01GM61393 (R. S. H.); contract number N01-PC-35139 (W. C.); the US Army Medical Research and Materiel Command (Department of Defense PR054600 to W. C. and Department of Defense DAMD 17-097-1-7147 to K. Offit); the American Cancer Society-Illinois Division (K. Onel); the American Lebanese Syrian Associated Charities (L. L. R.); the Leukemia Lymphoma Society (TR 6137-07 to W. C. and TR 6202-09 to T. K.); the Breast Cancer Research Foundation (S. M. D., K.L.N. and K. Offit); the Lymphoma Foundation (K. Offit); the Robert and Kate Niehaus Research Fund (K. Offit); the University of Chicago Cancer Center Support Grant (#P30 CA14599) (R. S. H.); the Breast Cancer Specialized Program of Research Excellence Career Development Award (R. S. H.); and the Cancer Research Foundation (K. Onel). We thank the University of Chicago Pharmacogenomics of Anticancer Agents Research Group cell core for providing lymphoblastoid cell lines. The collection of some samples from individuals with Hodgkin's lymphoma used in this publication was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. The ideas and opinions expressed herein are those of the authors, and no endorsement by the State of California Department of Health Services is intended or should be inferred. We thank N.A. Ellis for many productive discussions and thoughtful feedback. We are especially grateful for the contributions of the many participating subjects and their parents, without whom this work would not have been possible.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Behrens C, 2000, CANCER EPIDEM BIOMAR, V9, P1027; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Calame K, 2010, J IMMUNOL, V185, P3, DOI 10.4049/jimmunol.1090044; Constine LS, 2008, INT J RADIAT ONCOL, V72, P24, DOI 10.1016/j.ijrobp.2008.04.067; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Brien MM, 2010, J CLIN ONCOL, V28, P1232, DOI 10.1200/JCO.2009.24.8062; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Robison LL, 2005, CANCER-AM CANCER SOC, V104, P2557, DOI 10.1002/cncr.21249; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465	20	111	114	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					941	943		10.1038/nm.2407	http://dx.doi.org/10.1038/nm.2407			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785431	Green Accepted			2022-12-25	WOS:000293507400026
J	Stelzer, AC; Frank, AT; Kratz, JD; Swanson, MD; Gonzalez-Hernandez, MJ; Lee, J; Andricioaei, I; Markovitz, DM; Al-Hashimi, HM				Stelzer, Andrew C.; Frank, Aaron T.; Kratz, Jeremy D.; Swanson, Michael D.; Gonzalez-Hernandez, Marta J.; Lee, Janghyun; Andricioaei, Ioan; Markovitz, David M.; Al-Hashimi, Hashim M.			Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble	NATURE CHEMICAL BIOLOGY			English	Article							HIV-1 TAR RNA; PROTEIN RECOGNITION; NMR-SPECTROSCOPY; INDUCED FIT; BINDING; CONFORMATION; FLUORESCENCE; DESIGN; LIGANDS; BULGE	Current approaches used to identify protein-binding small molecules are not suited for identifying small molecules that can bind emerging RNA drug targets. By docking small molecules onto an RNA dynamic ensemble constructed by combining NMR spectroscopy and computational molecular dynamics, we virtually screened small molecules that target the entire structure landscape of the transactivation response element (TAR) from HIV type 1 (HIV-1). We quantitatively predict binding energies for small molecules that bind different RNA conformations and report the de novo discovery of six compounds that bind TAR with high affinity and inhibit its interaction with a Tat peptide in vitro (K(i) values of 710 nM-169 mu M). One compound binds HIV-1 TAR with marked selectivity and inhibits Tat-mediated activation of the HIV-1 long terminal repeat by 81% in T-cell lines and HIV replication in an HIV-1 indicator cell line (IC(50) similar to 23.1 mu M).	[Stelzer, Andrew C.; Kratz, Jeremy D.; Lee, Janghyun; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Frank, Aaron T.; Andricioaei, Ioan] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Swanson, Michael D.; Gonzalez-Hernandez, Marta J.; Markovitz, David M.] Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Stelzer, AC (corresponding author), Nymirum, Ann Arbor, MI USA.	hashimi@umich.edu		Frank, Aaron/0000-0002-7782-2200	US National Institutes of Health [R01 AI066975-01, R01 CA144043]; US National Science Foundation [CHE-0918817]; NSF; NATIONAL CANCER INSTITUTE [F31CA150523, R01CA144043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008078] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A.V. Kurochkin for NMR expertise, and we thank the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for support of the purchase of a 600-MHz spectrometer. This work was supported by the US National Institutes of Health (R01 AI066975-01 and R01 CA144043), the US National Science Foundation (NSF Career Award CHE-0918817) and an NSF Graduate Research Fellowship for A.C.S. and A.T.F.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Blount KF, 2005, J AM CHEM SOC, V127, P9818, DOI 10.1021/ja050918w; Blount KF, 2003, NUCLEIC ACIDS RES, V31, P5490, DOI 10.1093/nar/gkg755; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bradrick TD, 2004, RNA, V10, P1459, DOI 10.1261/rna.7620304; Cabrera C, 2002, ANTIVIR RES, V53, P1, DOI 10.1016/S0166-3542(01)00188-7; Chen Y, 2007, BIOPHYS J, V93, P2300, DOI [10.1529/biophysj.107.104174, 10.1529/biophysj.l07.104174]; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Clore GM, 2004, BIOCHEMISTRY-US, V43, P10678, DOI 10.1021/bi049357w; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Davidson A, 2011, NUCLEIC ACIDS RES, V39, P248, DOI 10.1093/nar/gkq713; Davidson A, 2009, P NATL ACAD SCI USA, V106, P11931, DOI 10.1073/pnas.0900629106; DeJong ES, 2003, BIOCHEMISTRY-US, V42, P8035, DOI 10.1021/bi034252z; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faber C, 2000, J BIOL CHEM, V275, P20660, DOI 10.1074/jbc.M000920200; Filikov AV, 2000, J COMPUT AID MOL DES, V14, P593, DOI 10.1023/A:1008121029716; Frank AT, 2009, NUCLEIC ACIDS RES, V37, P3670, DOI 10.1093/nar/gkp156; Fulle S, 2010, J MOL RECOGNIT, V23, P220, DOI 10.1002/jmr.1000; Guilbert C, 2008, J CHEM INF MODEL, V48, P1257, DOI 10.1021/ci8000327; Hermann T, 2002, BIOCHIMIE, V84, P869, DOI 10.1016/S0300-9084(02)01460-8; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Kaul M, 2004, J AM CHEM SOC, V126, P3447, DOI 10.1021/ja030568i; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lapidot A, 2004, FEBS LETT, V577, P415, DOI 10.1016/j.febslet.2004.10.038; Lapidot A, 2008, FEBS J, V275, P5236, DOI 10.1111/j.1742-4658.2008.06657.x; Latham MP, 2009, J AM CHEM SOC, V131, P5052, DOI 10.1021/ja900695m; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Matsumoto C, 2000, BIOORG MED CHEM LETT, V10, P1857, DOI 10.1016/S0960-894X(00)00359-0; Parolin C, 2003, ANTIMICROB AGENTS CH, V47, P889, DOI 10.1128/AAC.47.3.889-896.2003; Parsons J, 2009, NAT CHEM BIOL, V5, P823, DOI 10.1038/nchembio.217; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Stelzer AC, 2010, ANGEW CHEM INT EDIT, V49, P5731, DOI 10.1002/anie.201000814; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Vaiana AC, 2009, J MOL BIOL, V386, P648, DOI 10.1016/j.jmb.2008.12.035; WHITE RJ, 1985, INVEST NEW DRUG, V3, P85; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Yang Ming, 2005, Current Drug Targets - Infectious Disorders, V5, P433, DOI 10.2174/156800505774912901; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488	43	181	186	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					553	559		10.1038/NCHEMBIO.596	http://dx.doi.org/10.1038/NCHEMBIO.596			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21706033	Green Accepted			2022-12-25	WOS:000292825400017
J	Geddes, K; Rubino, SJ; Magalhaes, JG; Streutker, C; Le Bourhis, L; Cho, JH; Robertson, SJ; Kim, CJ; Kaul, R; Philpott, DJ; Girardin, SE				Geddes, Kaoru; Rubino, Stephen J.; Magalhaes, Joao G.; Streutker, Catherine; Le Bourhis, Lionel; Cho, Joon Ho; Robertson, Susan J.; Kim, Connie J.; Kaul, Rupert; Philpott, Dana J.; Girardin, Stephen E.			Identification of an innate T helper type 17 response to intestinal bacterial pathogens	NATURE MEDICINE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; INDUCER-LIKE CELLS; HOST-DEFENSE; DENDRITIC CELLS; IL-17; DIFFERENTIATION; INTERLEUKIN-17; INFECTION; EXPRESSION; T(H)17	Interleukin 17 (IL-17) is a central cytokine implicated in inflammation and antimicrobial defense. After infection, both innate and adaptive IL-17 responses have been reported, but the type of cells involved in innate IL-17 induction, as well as their contribution to in vivo responses, are poorly understood. Here we found that Citrobacter and Salmonella infection triggered early IL-17 production, which was crucial for host defense and was mediated by CD4(+) T helper cells. Enteric innate T helper type 17 (iT(H)17) responses occurred principally in the cecum, were dependent on the Nod-like receptors Nod1 and Nod2, required IL-6 induction and were associated with a decrease in mucosal CD103(+) dendritic cells. Moreover, imprinting by the intestinal microbiota was fully required for the generation of iT(H)17 responses. Together, these results identify the Nod-iT(H)17 axis as a central element in controlling enteric pathogens, which may implicate Nod-driven iT(H)17 responses in the development of inflammatory bowel diseases.	[Geddes, Kaoru; Magalhaes, Joao G.; Le Bourhis, Lionel; Cho, Joon Ho; Robertson, Susan J.; Kaul, Rupert; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rubino, Stephen J.; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Streutker, Catherine] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Kim, Connie J.; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Philpott, DJ (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	dana.philpott@utoronto.ca; stephen.girardin@utoronto.ca	Magalhaes, Joao/AAK-2686-2020	Kaul, Rupert/0000-0002-1586-4093; Le Bourhis, Lionel/0000-0002-7524-3539	Crohn's and Colitis Foundation of Canada; Canadian Institute of Health Research [480142, HET-85518]; Ontario HIV Treatment Network [OGB-G123]; Canadian Association of Gastroenterology/Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec graduate scholarship	Crohn's and Colitis Foundation of Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Canadian Association of Gastroenterology/Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec graduate scholarship	We thank L. Morikawa for help with preparing histological sections and K. Banks for help with animal experimentation. We also are very grateful to those individuals who volunteered for intestinal biopsies. Nod2<SUP>-/-</SUP> mice were provided by J.P. Hugot at Institut National de la Sante et de la Recherche Medicale U843. C. rodentium strain DBS100 was provided by B. Finlay at the University of British Columbia. This work was supported by a grant from the Crohn's and Colitis Foundation of Canada to S.E.G., a Crohn's and Colitis Foundation of Canada and a Canadian Institute of Health Research operating grant (480142) to D.J.P. and by a Canadian Institutes of Health Research grant (HET-85518) and an Ontario HIV Treatment Network grant (OGB-G123) to R.K. K.G. was supported by a Canadian Association of Gastroenterology/Canadian Institutes of Health Research postdoctoral research award, and S.J.R. was supported by a Fonds de la Recherche en Sante du Quebec graduate scholarship.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Symonds EL, 2009, CLIN EXP IMMUNOL, V157, P148, DOI 10.1111/j.1365-2249.2009.03934.x; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	42	193	196	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					837	U202		10.1038/nm.2391	http://dx.doi.org/10.1038/nm.2391			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21666695				2022-12-25	WOS:000292500800038
J	Oskarsson, T; Acharyya, S; Zhang, XHF; Vanharanta, S; Tavazoie, SF; Morris, PG; Downey, RJ; Manova-Todorova, K; Brogi, E; Massague, J				Oskarsson, Thordur; Acharyya, Swarnali; Zhang, Xiang H-F; Vanharanta, Sakari; Tavazoie, Sohail F.; Morris, Patrick G.; Downey, Robert J.; Manova-Todorova, Katia; Brogi, Edi; Massague, Joan			Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs	NATURE MEDICINE			English	Article							IN-VITRO PROPAGATION; STEM-CELLS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; SIGNALING PATHWAYS; PROGRESSION; SURVIVAL; GROWTH; NOTCH; FATE	We report that breast cancer cells that infiltrate the lungs support their own metastasis-initiating ability by expressing tenascin C (TNC). We find that the expression of TNC, an extracellular matrix protein of stem cell niches, is associated with the aggressiveness of pulmonary metastasis. Cancer cell-derived TNC promotes the survival and outgrowth of pulmonary micrometastases. TNC enhances the expression of stem cell signaling components, musashi homolog 1 (MSI1) and leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5). MSI1 is a positive regulator of NOTCH signaling, whereas LGR5 is a target gene of the WNT pathway. TNC modulation of stem cell signaling occurs without affecting the expression of transcriptional enforcers of the stem cell phenotype and pluripotency, namely nanog homeobox (NANOG), POU class 5 homeobox 1 (POU5F1), also known as OCT4, and SRY-box 2 (SOX2). TNC protects MSI1-dependent NOTCH signaling from inhibition by signal transducer and activator of transcription 5 (STAT5), and selectively enhances the expression of LGR5 as a WNT target gene. Cancer cell-derived TNC remains essential for metastasis outgrowth until the tumor stroma takes over as a source of TNC. These findings link TNC to pathways that support the fitness of metastasis-initiating breast cancer cells and highlight the relevance of TNC as an extracellular matrix component of the metastatic niche.	[Oskarsson, Thordur; Acharyya, Swarnali; Zhang, Xiang H-F; Vanharanta, Sakari; Tavazoie, Sohail F.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA; [Morris, Patrick G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Downey, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA.	massaguj@mskcc.org	Oskarsson, Thordur/HBP-9601-2022	Zhang, Xiang/0000-0002-5674-8670; Massague, Joan/0000-0001-9324-8408; Oskarsson, Thordur/0000-0002-0983-6969	US National Institutes of Health [CA94060]; Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense; Breast Cancer Alliance; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA094060, P01CA129243] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense(United States Department of Defense); Breast Cancer Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Kim and E. Montalvo for technical support. This work was funded by grant CA94060 from the US National Institutes of Health (J.M.), the Hearst Foundation and the Alan and Sandra Gerry Metastasis Research Initiative. S.A. is supported by a Department of Defense Era of Hope postdoctoral fellowship. E.B. is a recipient of the Exceptional Project Award from the Breast Cancer Alliance. J.M. is an investigator of the Howard Hughes Medical Institute.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anan K, 2010, BREAST CANCER-TOKYO, V17, P48, DOI 10.1007/s12282-009-0103-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Cameron MD, 2000, CANCER RES, V60, P2541; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; CHAMMAS R, 1994, J CELL SCI, V107, P1031; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Deryugina EI, 1996, J CELL SCI, V109, P643; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eilon T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-231; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Ishihara A, 1995, CLIN CANCER RES, V1, P1035; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mackie EJ, 1999, J CELL SCI, V112, P3847; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Ruiz C, 2004, CANCER RES, V64, P7377, DOI 10.1158/0008-5472.CAN-04-1234; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Sandberg EM, 2004, J BIOL CHEM, V279, P34547, DOI 10.1074/jbc.M405045200; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; von Holst A, 2008, CELLS TISSUES ORGANS, V188, P170, DOI 10.1159/000112848; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	59	607	624	0	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					867	U256		10.1038/nm.2379	http://dx.doi.org/10.1038/nm.2379			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21706029	Green Accepted			2022-12-25	WOS:000292500800042
J	Giamas, G; Filipovic, A; Jacob, J; Messier, W; Zhang, H; Yang, DY; Zhang, W; Shifa, BA; Photiou, A; Tralau-Stewart, C; Castellano, L; Green, AR; Coombes, RC; Ellis, IO; Ali, S; Lenz, HJ; Stebbing, J				Giamas, Georgios; Filipovic, Aleksandra; Jacob, Jimmy; Messier, Walter; Zhang, Hua; Yang, Dongyun; Zhang, Wu; Shifa, Belul Assefa; Photiou, Andrew; Tralau-Stewart, Cathy; Castellano, Leandro; Green, Andrew R.; Coombes, R. Charles; Ellis, Ian O.; Ali, Simak; Lenz, Heinz-Josef; Stebbing, Justin			Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR; NONHUMAN-PRIMATES; PROTEIN-KINASE; ALPHA EXPRESSION; ER-ALPHA; PHOSPHORYLATION; ACTIVATION; RESISTANCE; PATHWAYS; TUMORS	Therapies targeting estrogen receptor. (ER alpha, encoded by ESR1) have transformed the treatment of breast cancer. However, large numbers of women relapse, highlighting the need for the discovery of new regulatory targets modulating ER alpha pathways(1-5). An siRNA screen identified kinases whose silencing alters the estrogen response including those previously implicated in regulating ER alpha activity (such as mitogen-activated protein kinase and AKT). Among the most potent regulators was lemur tyrosine kinase-3 (LMTK3), for which a role has not previously been assigned. In contrast to other modulators of ER alpha activity, LMTK3 seems to have been subject to Darwinian positive selection, a noteworthy result given the unique susceptibility of humans to ER alpha(+) breast cancer. LMTK3 acts by decreasing the activity of protein kinase C (PKC) and the phosphorylation of AKT (Ser473), thereby increasing binding of forkhead box O3 (FOXO3) to the ESR1 promoter. LMTK3 phosphorylated ER alpha, protecting it from proteasomal degradation in vitro. Silencing of LMTK3 reduced tumor volume in an orthotopic mouse model and abrogated proliferation of ER alpha(+) but not ER alpha(-) cells, indicative of its role in ER alpha activity. In human cancers, LMTK3 abundance and intronic polymorphisms were significantly associated with disease-free and overall survival and predicted response to endocrine therapies. These findings yield insights into the natural history of breast cancer in humans and reveal LMTK3 as a new therapeutic target.	[Giamas, Georgios; Filipovic, Aleksandra; Jacob, Jimmy; Zhang, Hua; Shifa, Belul Assefa; Photiou, Andrew; Castellano, Leandro; Coombes, R. Charles; Ali, Simak; Stebbing, Justin] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Messier, Walter] Evolutionary Genom Inc, Lafayette, CO USA; [Yang, Dongyun; Zhang, Wu; Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90033 USA; [Tralau-Stewart, Cathy] Univ London Imperial Coll Sci Technol & Med, Ctr Drug Discovery, London, England; [Green, Andrew R.; Ellis, Ian O.] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Green, Andrew R.; Ellis, Ian O.] Nottingham Univ NHS Hosp Trust, Nottingham, England	Imperial College London; University of Southern California; Imperial College London; University of Nottingham; Nottingham University Hospital NHS Trust	Giamas, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Hammersmith Hosp Campus, London, England.	g.giamas@imperial.ac.uk; j.stebbing@imperial.ac.uk	Zhang, Hua/AAV-2344-2020; Yang, Dongyun/M-2579-2019; Castellano, Leandro/AAE-1366-2021; Green, Andrew/AAF-1991-2020; Giamas, Georgios/AAP-3487-2021; Ali, Simak/N-4740-2019	Zhang, Hua/0000-0001-7704-4712; Yang, Dongyun/0000-0003-0736-4977; Ali, Simak/0000-0002-1320-0816; Ellis, Ian/0000-0001-5292-8474; Green, Andrew/0000-0002-0488-5913; Coombes, Raoul Charles/0000-0002-4811-1100; Giamas, Georgios/0000-0002-4417-2707; Castellano, Leandro/0000-0002-3059-4829; Stebbing, Justin/0000-0002-1117-6947	US National Institutes of Health [5 P30CA14089-27I]; Cancer Research UK; Department of Health; Cancer Research UK [12011] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10267] Funding Source: researchfish; Worldwide Cancer Research [10-0510] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Department of Health; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank P. Hexley and J. Elliott of the Flow Cytometry Core Facility (Imperial College London) for analyzing FACS data, J. Gronau for helping with confocal microscopy, P. Trivedi for performing the immunohistochemistry staining and T. Rapoz D'Silva for helping in the laboratory. We are grateful to G. Dranitsaris (Princess Margaret Hospital, Toronto) for statistical advice. Li93 software was a kind gift from W. Hsiung-Li (University of Chicago). The single-nucleotide polymorphism analyses were funded in part by US National Institutes of Health grant 5 P30CA14089-27I. S.A. and R.C.C. are supported by grants from Cancer Research UK and the Department of Health-funded Imperial College Cancer Medicine Centre (ECMC) grant. We thank R. and E. Girling and friends for their support.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Belguise K, 2007, J CLIN INVEST, V117, P4009, DOI 10.1172/JCI32424; BENIASHVILI DS, 1989, J MED PRIMATOL, V18, P423; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunner N, 1997, CANCER RES, V57, P3486; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Cordera F, 2006, SEMIN ONCOL, V33, P631, DOI 10.1053/j.seminoncol.2006.08.020; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Ghosh MG, 2000, CANCER RES, V60, P6367; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; HAMMOND ME, J CLIN ONCOL, V28, P2784; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; MCCLURE HM, 1973, AM J PHYS ANTHROPOL, V38, P425, DOI 10.1002/ajpa.1330380243; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; MORELLI C, MOL CELL BIOL, V30, P857; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Powe DG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2461; Puente XS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-15; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; SEIBOLD HR, 1973, LAB ANIM SCI, V23, P533; Stack G, 1988, Cancer Treat Res, V40, P185; Tolhurst RS, 2011, BREAST CANCER RES TR, V128, P357, DOI 10.1007/s10549-010-1122-6; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Waters DJ, 1998, PROSTATE, V36, P64; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	40	104	110	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					715	U105		10.1038/nm.2351	http://dx.doi.org/10.1038/nm.2351			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602804				2022-12-25	WOS:000291308800032
J	Nishiyama, M; Togashi, K; von Schimmelmann, MJ; Lim, CS; Maeda, S; Yamashita, N; Goshima, Y; Ishii, S; Hong, K				Nishiyama, Makoto; Togashi, Kazunobu; von Schimmelmann, Melanie J.; Lim, Chae-Seok; Maeda, Shin-ichi; Yamashita, Naoya; Goshima, Yoshio; Ishii, Shin; Hong, Kyonsoo			Semaphorin 3A induces Ca(V)2.3 channel-dependent conversion of axons to dendrites	NATURE CELL BIOLOGY			English	Article							GROWTH-CONE; CHEMOTROPIC RESPONSES; PROTEIN-SYNTHESIS; CALCIUM CHANNELS; CA2+ CHANNELS; NERVE GROWTH; SPINAL-CORD; GUIDANCE; NEURONS; PHOSPHORYLATION	Polarized neurites (axons and dendrites) form the functional circuitry of the nervous system. Secreted guidance cues often control the polarity of neuron migration and neurite outgrowth by regulating ion channels. Here, we show that secreted semaphorin 3A (Sema3A) induces the neurite identity of Xenopus spinal commissural interneurons (xSCINs) by activating Ca(V)2.3 channels (Ca(V)2.3). Sema3A treatment converted the identity of axons of cultured xSCINs to that of dendrites by recruiting functional Ca(V)2.3. Inhibition of Sema3A signalling prevented both the expression of Ca(V)2.3 and acquisition of the dendrite identity, and inhibition of Ca(V)2.3 function resulted in multiple axon-like neurites of xSCINs in the spinal cord. Furthermore, Sema3A-triggered cGMP production and PKG activity induced, respectively, the expression of functional Ca(V)2.3 and the dendrite identity. These results reveal a mechanism by which a guidance cue controls the identity of neurites during nervous system development.	[Nishiyama, Makoto; Togashi, Kazunobu; von Schimmelmann, Melanie J.; Lim, Chae-Seok; Hong, Kyonsoo] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Maeda, Shin-ichi; Ishii, Shin] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Uji, Kyoto 6110011, Japan; [Yamashita, Naoya; Goshima, Yoshio] Yokohama City Univ, Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan	New York University; Kyoto University; Yokohama City University	Nishiyama, M (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	nishim01@nyumc.org; hongk02@nyumc.org		Ishii, Shin/0000-0001-9385-8230	NIH/NINDS [NS042823, NS064671]; MEXT; RIKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042823, R01NS064671] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs W. R. Jelinek, N. J. Cowan, M. E. Rice, M-M. Poo, D. Ginty and A. L. Kolodkin for critical comments on the manuscript, S. M. Strittmatter for the NP-1(0111) and L. I. Binder and G. Tian for technical assistance. This work was supported by grants from NIH/NINDS (NS042823 and CRCNS Program, NS064671, K.H.), MEXT (Grants-in-Aid and Targeted Protein Research Project, Y.G.) and RIKEN (Computational Science Research Program, S.I.).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Esch T, 1999, J NEUROSCI, V19, P6417; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Gomis-Ruth S, 2008, CURR BIOL, V18, P992, DOI 10.1016/j.cub.2008.06.026; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; GU X, 1993, J NEUROSCI, V13, P4936; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hong K, 2010, NEUROSCIENTIST, V16, P65, DOI 10.1177/1073858409340702; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jimenez-Gonzalez C, 2003, EUR J NEUROSCI, V18, P2175, DOI 10.1046/j.1460-9568.2003.02955.x; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Li WC, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-17; Li WY, 2001, J NEUROPHYSIOL, V86, P269, DOI 10.1152/jn.2001.86.1.269; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Moon MS, 2005, DEV BIOL, V288, P474, DOI 10.1016/j.ydbio.2005.09.049; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; ROBERTS A, 1987, J COMP NEUROL, V261, P435, DOI 10.1002/cne.902610308; ROBERTS A, 1988, DEVELOPMENT, V103, P447; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stornetta RL, 2011, NEUROSCIENTIST, V17, P54, DOI 10.1177/1073858410365562; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; VIERECK C, 1988, NEUROSCIENCE, V26, P893, DOI 10.1016/0306-4522(88)90107-8; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	50	37	39	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2011	13	6					676	U121		10.1038/ncb2255	http://dx.doi.org/10.1038/ncb2255			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	771HI	21602796	Green Accepted			2022-12-25	WOS:000291147400008
J	Lu, M; Sarruf, DA; Talukdar, S; Sharma, S; Li, PP; Bandyopadhyay, G; Nalbandian, S; Fan, WQ; Gayen, JR; Mahata, SK; Webster, NJ; Schwartz, MW; Olefsky, JM				Lu, Min; Sarruf, David A.; Talukdar, Saswata; Sharma, Shweta; Li, Pingping; Bandyopadhyay, Gautam; Nalbandian, Sarah; Fan, WuQiang; Gayen, Jiaur R.; Mahata, Sushil K.; Webster, Nicholas J.; Schwartz, Michael W.; Olefsky, Jerrold M.			Brain PPAR-gamma promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones	NATURE MEDICINE			English	Article							RESISTANCE; EXPRESSION; MUSCLE; MICE	In adipose tissue, muscle, liver and macrophages, signaling by the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a determinant of insulin sensitivity and this receptor mediates the insulin-sensitizing effects of thiazolidinediones (TZDs)(1-4). As PPAR-gamma is also expressed in neurons(5), we generated mice with neuron-specific Pparg knockout (Pparg brain knockout (BKO)) to determine whether neuronal PPAR-gamma signaling contributes to either weight gain or insulin sensitivity. During high-fat diet (HFD) feeding, food intake was reduced and energy expenditure increased in Pparg-BKO mice compared to Pparg(f/f) mice, resulting in reduced weight gain. Pparg-BKO mice also responded better to leptin administration than Pparg(f/f) mice. When treated with the TZD rosiglitazone, Pparg-BKO mice were resistant to rosiglitazone-induced hyperphagia and weight gain and, relative to rosiglitazone-treated Pparg(f/f) mice, experienced only a marginal improvement in glucose metabolism. Hyperinsulinemic euglycemic clamp studies showed that the increase in hepatic insulin sensitivity induced by rosiglitazone treatment during HFD feeding was completely abolished in Pparg-BKO mice, an effect associated with the failure of rosiglitazone to improve liver insulin receptor signal transduction. We conclude that excess weight gain induced by HFD feeding depends in part on the effect of neuronal PPAR-g signaling to limit thermogenesis and increase food intake. Neuronal PPAR-gamma signaling is also required for the hepatic insulin sensitizing effects of TZDs.	[Lu, Min; Talukdar, Saswata; Sharma, Shweta; Li, Pingping; Bandyopadhyay, Gautam; Nalbandian, Sarah; Fan, WuQiang; Gayen, Jiaur R.; Mahata, Sushil K.; Webster, Nicholas J.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Sarruf, David A.; Schwartz, Michael W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Sharma, Shweta; Gayen, Jiaur R.; Mahata, Sushil K.; Webster, Nicholas J.] Vet Affairs San Diego Healthcare Syst, Med Res Serv, San Diego, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	mschwart@u.washington.edu; jolefsky@ucsd.edu	Webster, Nick/AAI-8410-2021; Mahata, Sushil/AAF-8781-2021; Li, Pingping/F-1109-2019; Schwartz, Michael W/H-9950-2012	Li, Pingping/0000-0003-0679-270X; 	US National Institutes of Health (NIH) [DK033651, DK063491, DK074868, DK09062]; Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH [U54 HD012303-25]; NIH [DK068384, DK083042, DK052989]; National Research Service [F32DK080604-01]; Nutrition Obesity Research Center [DK035816]; Mouse Metabolic Phenotyping Center at the University of Washington [U24 DK076126]; UCSD Cancer Center [P30 CA23100]; Mouse Metabolic Phenotyping Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, U24DK076126, R01DK083042, P01DK068384, R01DK033651, R01DK090320, P30DK063491, R01DK052989, P01DK074868, F32DK009062, F32DK080604, P30DK035816] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; Nutrition Obesity Research Center; Mouse Metabolic Phenotyping Center at the University of Washington; UCSD Cancer Center; Mouse Metabolic Phenotyping Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the P. Mellon lab at UCSD for providing Syn1-Cre mice. We thank J. Pimentel, A. Amidi, B. Scott, J. Meadows and J. Ficsher for technical support. We thank D. Oh, J. Xu, E. Bae, O. Osborne, A. Chen and D. Sears for helpful discussions. We thank the Histology and Immunohistochemistry Resource (L. Gapuz and N. Varki) at the Rebecca & John Moores UCSD Cancer Center. This work was supported by US National Institutes of Health (NIH) grants DK033651, DK063491, DK074868 and DK09062 (to J. M. O.) and by the Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH through cooperative agreement of U54 HD012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by NIH grants DK068384, DK083042 and DK052989 (to M. W. S.), by Ruth L. Kirschstein National Research Service Award fellowship F32DK080604-01 (to D. A. S.), and by the Nutrition Obesity Research Center grant DK035816 and the Mouse Metabolic Phenotyping Center (U24 DK076126) at the University of Washington. UCSD Cancer Center microscopy core is supported by the UCSD Cancer Center Specialized Support Grant P30 CA23100. Body composition and energy expenditure analyses were performed with support from the NIH-funded Mouse Metabolic Phenotyping Center at the University of Washington. Calorimetry was performed by K. Ogimoto and expert assistance in analyses of these data was provided by K. Kaiyala.	Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Gayen JR, 2009, ENDOCRINOLOGY, V150, P5027, DOI 10.1210/en.2009-0429; HE W, 2003, P NATL ACAD SCI US, V100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lu M, 2010, MOL ENDOCRINOL, V24, P1413, DOI 10.1210/me.2009-0462; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shimizu H, 1998, DIABETES CARE, V21, P1470, DOI 10.2337/diacare.21.9.1470; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	19	170	178	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					618	U140		10.1038/nm.2332	http://dx.doi.org/10.1038/nm.2332			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21532596	Green Accepted			2022-12-25	WOS:000290250400039
J	Winer, DA; Winer, S; Shen, L; Wadia, PP; Yantha, J; Paltser, G; Tsui, H; Wu, P; Davidson, MG; Alonso, MN; Leong, HX; Glassford, A; Caimol, M; Kenkel, JA; Tedder, TF; McLaughlin, T; Miklos, DB; Dosch, HM; Engleman, EG				Winer, Daniel A.; Winer, Shawn; Shen, Lei; Wadia, Persis P.; Yantha, Jason; Paltser, Geoffrey; Tsui, Hubert; Wu, Ping; Davidson, Matthew G.; Alonso, Michael N.; Leong, Hwei X.; Glassford, Alec; Caimol, Maria; Kenkel, Justin A.; Tedder, Thomas F.; McLaughlin, Tracey; Miklos, David B.; Dosch, H-Michael; Engleman, Edgar G.			B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; ADIPOCYTE DEATH; OBESITY; MICE; INFLAMMATION; DEPLETION; DISEASE; FAT	Chronic inflammation characterized by T cell and macrophage infiltration of visceral adipose tissue (VAT) is a hallmark of obesity-associated insulin resistance and glucose intolerance. Here we show a fundamental pathogenic role for B cells in the development of these metabolic abnormalities. B cells accumulate in VAT in diet-induced obese (DIO) mice, and DIO mice lacking B cells are protected from disease despite weight gain. B cell effects on glucose metabolism are mechanistically linked to the activation of proinflammatory macrophages and T cells and to the production of pathogenic IgG antibodies. Treatment with a B cell-depleting CD20 antibody attenuates disease, whereas transfer of IgG from DIO mice rapidly induces insulin resistance and glucose intolerance. Moreover, insulin resistance in obese humans is associated with a unique profile of IgG autoantibodies. These results establish the importance of B cells and adaptive immunity in insulin resistance and suggest new diagnostic and therapeutic modalities for managing the disease.	[Winer, Daniel A.; Shen, Lei; Davidson, Matthew G.; Alonso, Michael N.; Leong, Hwei X.; Caimol, Maria; Kenkel, Justin A.; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Winer, Daniel A.; Winer, Shawn] Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Winer, Shawn; Yantha, Jason; Paltser, Geoffrey; Tsui, Hubert; Wu, Ping; Dosch, H-Michael] Univ Toronto, Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Wadia, Persis P.; Miklos, David B.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Glassford, Alec; McLaughlin, Tracey] Stanford Univ, Sch Med, Div Endocrinol, Palo Alto, CA 94304 USA; [Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University; Stanford University; Duke University	Winer, DA (corresponding author), Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA.	dan.winer@uhn.on.ca; edengleman@stanford.edu			NIH [CA141468, DK082537]; NATIONAL CANCER INSTITUTE [U01CA141468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082537, R01DK080436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Jones for secretarial assistance; C. Benike for critical review of the manuscript; A. Chawla for critical review of the figures; C. Wang, L. Tolentino and K. Heydari for assistance with flow cytometry; and Y. Yang and L. Herzenberg for help in developing macrophage and B cell subset gates. These studies were supported by NIH grants CA141468 and DK082537 (E.G.E).	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Falorni A, 2000, J CLIN ENDOCR METAB, V85, P309, DOI 10.1210/jc.85.1.309; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hussain Badrudeen M, 2006, World J Surg Oncol, V4, P89, DOI 10.1186/1477-7819-4-89; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; TOURINO IG, 2010, DIABETIC MED, V27, P246; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zimering MB, 2009, J CLIN ENDOCR METAB, V94, P2171, DOI 10.1210/jc.2008-2354	42	678	701	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					610	U134		10.1038/nm.2353	http://dx.doi.org/10.1038/nm.2353			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499269	Green Accepted			2022-12-25	WOS:000290250400038
